Citrus Sinensis ID: 001384

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------109
Protein Sequence
MNMSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccccccccccccccccccccccEEEccccccEEEEEcccccccEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccEEEcccccEEEEcccccccccccccEEEccccccEEcccccccccccccEEEccccccccccccccccccEEEcccccccccccHHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccHHHHHccccccEEEcccccccccccHHHHccccccEEcccccccccccccHHccccccccEEEcccccccccccHHccccccccEEEccccEEEEcccccccccccccEEEccccccccccccccccccccccccccccEEEEEccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHcccccccEEcccccccccccccccccccccEEcccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccEEEEcccccccHHHHHHHHcccccccEEEEcccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHccccccccccccccEEEEEEcccEEEEEEcccccccHHHHccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEcccccEEEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccccccccccEEEcccccccccccHHHHHHHHcccEEEEccccccccccHHHccccccEEEEcccccccccccHHHccccEEEcccccccccccHHHHHHHccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccHcHcEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEcccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEcccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccEEEEEEcccccccccccHHHHccccccEEEcccccccccccHHHHcHHcccEEEEcccccccccccccccHccccHHHHcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccHHHHHHHHccccHccEEEccccEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHcccccccccHEHEHEEccccccEEEEEEccccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mnmsddendSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFlennnpvneghymqwnqssspcewpgiicspdkarvnglnltdwnisgdifnnfsaltqlsyldlsrntfsgsipddlsscrslkylnlshnilsgdlnlsglrsleildlsvnrihgeisfsfPAICEKLVVANLSlnnltgridtcfdgclnlryldlssnnfrgNIWNGLAQLVEFSVSEnvlsgvvsssvfkencsleifdlsenefigdfpgevsncRNLVVLNLfgnnfsgpipaeigsisglEALFLGKNNFLSVIPesllnlsklevldlssnnfggeVQKIFGRFTQVKILALHSNsyidgmnssgilklpnisrldlshnnftgplpvEISQMRSLKFLILAHNrfngsipavygnmpnlqtldlsfneltgpippsigNLTSLLWLMLANnslsgeipgeignCTSLLWLNlsnnklsgnippevmtigrnarptfeanqrngertiagsseclsmkrwipadyppfsfvYTILTRKSCRSLWDRLlkgtgifpvclpglasrtfQITGYLQlsgnqlsgelspdigklqnfsmvhlgfnqfdgklpsqfdqlplIVLNLtrnnfsgeipsefgnikclqnldlsynnfsgpfpasfnnltELSKlnisynplvsgtipstgqlatfektsylgdplldlpdfiengphhghkypnsngrtgnntKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYrhdlasssggsspwlsdtVKVIRLDKTAFTYSDILKAtgkfsedriigkggfgtvyrgvlpdgREVAVKKLQREGLEGEREFRAEMEVLsgngfgwphpnlvTLYGWCLDGSEKILVYEYmeggslediiSDRTRLTWRRRLDIAIDVARALVFLhhecyppivhrdvkasnVLLDKEGKALVTDFGLARVvsagdshvsttiagtvgyvapeygqtwqattkgdvysFGVLAMELATGRRALEGGEECLVEWGRRvmgygrhgpgraVIPVVLLGSGLAEGAEEMSELLRIGVrctaeapnarpNVKEVLAMLIKILPHCD
Flexible Loop (DISEMBL)
mnmsddendSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARptfeanqrngertiaGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHkypnsngrtgNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLasssggsspwlsDTVKVIRLDKTAFTYSDIlkatgkfsedriigkGGFGtvyrgvlpdgREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTaeapnarpnvKEVLAMLIKILPHCD
Low Complexity Region (SEG)
MNMSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRnlvvlnlfgnnfSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGnctsllwlnlsnnklsgnIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAsssggssPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISdrtrltwrrrldIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD
Disordered region (IsUnstruct)
*********SWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI******************************ECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIEN****************NNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHD*********PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ********EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP***
Disordered Region (DISOPRED)
************FALFVFAVLVIATHVAG**LETDREVLSNLRSFLEN*****E***MQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFI*************************ILAFLALLMACLICGVLSIIIYMLVKRP******************************TVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL**EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM*****GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH**
Disordered Region (DISEMBL)
********DSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHD*********PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD
Disordered Region (DISPRO)
****DDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIEN*****************NTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQ**************************TVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNMSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1088	2.2.26 [Sep-21-2011]
C0LGJ1	1106	Probable LRR receptor-lik	yes	no	0.988	0.972	0.655	0.0
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.928	0.883	0.323	1e-134
Q9LJF3	1164	Receptor-like protein kin	no	no	0.914	0.854	0.322	1e-133
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.885	0.797	0.329	1e-133
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.887	0.828	0.330	1e-133
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.886	0.798	0.326	1e-132
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.896	0.815	0.322	1e-131
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.902	0.823	0.335	1e-129
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.906	0.894	0.326	1e-123
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.892	0.937	0.314	1e-122

>sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1

 Score = 1456 bits (3770), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 711/1085 (65%), Positives = 859/1085 (79%), Gaps = 9/1085 (0%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ 62
            M+DD++ S  F  F+    + A  VAGDSL++DREVL +L+S+LE+ NP N G Y +W  
Sbjct: 9    MTDDDSQSLCFLCFLLFFFITAIAVAGDSLDSDREVLLSLKSYLESRNPQNRGLYTEWKM 68

Query: 63   SSSP--CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIP 120
             +    C+WPGIIC+P ++RV G+NLTD  ISG +F NFSALT+L+YLDLSRNT  G IP
Sbjct: 69   ENQDVVCQWPGIICTPQRSRVTGINLTDSTISGPLFKNFSALTELTYLDLSRNTIEGEIP 128

Query: 121  DDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVAN 180
            DDLS C +LK+LNLSHNIL G+L+L GL +LE+LDLS+NRI G+I  SFP  C  LVVAN
Sbjct: 129  DDLSRCHNLKHLNLSHNILEGELSLPGLSNLEVLDLSLNRITGDIQSSFPLFCNSLVVAN 188

Query: 181  LSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF 240
            LS NN TGRID  F+GC NL+Y+D SSN F G +W G  +LVEFSV++N LSG +S+S+F
Sbjct: 189  LSTNNFTGRIDDIFNGCRNLKYVDFSSNRFSGEVWTGFGRLVEFSVADNHLSGNISASMF 248

Query: 241  KENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLG 300
            + NC+L++ DLS N F G+FPG+VSNC+NL VLNL+GN F+G IPAEIGSIS L+ L+LG
Sbjct: 249  RGNCTLQMLDLSGNAFGGEFPGQVSNCQNLNVLNLWGNKFTGNIPAEIGSISSLKGLYLG 308

Query: 301  KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSG 360
             N F   IPE+LLNL+ L  LDLS N FGG++Q+IFGRFTQVK L LH+NSY+ G+NSS 
Sbjct: 309  NNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGINSSN 368

Query: 361  ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
            ILKLPN+SRLDL +NNF+G LP EISQ++SLKFLILA+N F+G IP  YGNMP LQ LDL
Sbjct: 369  ILKLPNLSRLDLGYNNFSGQLPTEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDL 428

Query: 421  SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
            SFN+LTG IP S G LTSLLWLMLANNSLSGEIP EIGNCTSLLW N++NN+LSG   PE
Sbjct: 429  SFNKLTGSIPASFGKLTSLLWLMLANNSLSGEIPREIGNCTSLLWFNVANNQLSGRFHPE 488

Query: 481  VMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
            +  +G N  PTFE N++N ++ IAGS ECL+MKRWIPA++PPF+FVY ILT+KSCRSLWD
Sbjct: 489  LTRMGSNPSPTFEVNRQNKDKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWD 548

Query: 541  RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
             +LKG G+FPVC  G   RT +I+ YLQLSGN+ SGE+   I ++   S +HLGFN+F+G
Sbjct: 549  HVLKGYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEG 608

Query: 601  KLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS 660
            KLP +  QLPL  LNLTRNNFSGEIP E GN+KCLQNLDLS+NNFSG FP S N+L ELS
Sbjct: 609  KLPPEIGQLPLAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELS 668

Query: 661  KLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNN 720
            K NISYNP +SG IP+TGQ+ATF+K S+LG+PLL  P F     ++  K   SN   GN 
Sbjct: 669  KFNISYNPFISGAIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTRKI--SNQVLGNR 726

Query: 721  TK-LTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSP 779
             + L +I   LAL +A + C V+S I+ M+VK   E +  LL+G K RHD+ SSSGGSSP
Sbjct: 727  PRTLLLIWISLALALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHDMTSSSGGSSP 786

Query: 780  WLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQR 839
            WLS  +KVIRLDK+ FTY+DILKAT  FSE+R++G+GG+GTVYRGVLPDGREVAVKKLQR
Sbjct: 787  WLSGKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQR 846

Query: 840  EGLEGEREFRAEMEVLSGNGFG-WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD 898
            EG E E+EFRAEMEVLS N FG W HPNLV LYGWCLDGSEKILV+EYM GGSLE++I+D
Sbjct: 847  EGTEAEKEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITD 906

Query: 899  RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
            +T+L W++R+DIA DVAR LVFLHHECYP IVHRDVKASNVLLDK G A VTDFGLAR++
Sbjct: 907  KTKLQWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLL 966

Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
            + GDSHVST IAGT+GYVAPEYGQTWQATT+GDVYS+GVL MELATGRRA++GGEECLVE
Sbjct: 967  NVGDSHVSTVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDGGEECLVE 1026

Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            W RRVM       G    P+ L G+    GAE+M+ELL+IGV+CTA+ P ARPN+KEVLA
Sbjct: 1027 WARRVMTGNMTAKGS---PITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLA 1083

Query: 1079 MLIKI 1083
            ML+KI
Sbjct: 1084 MLVKI 1088

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  480 bits (1235), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 377/1164 (32%), Positives = 570/1164 (48%), Gaps = 154/1164 (13%)

Query: 15   LFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIIC 74
            +F+   L  ++     SL+TD   L + ++ ++++ P N      W+   SPC++ G+ C
Sbjct: 19   IFLLTHLSQSSSSDQSSLKTDSLSLLSFKTMIQDD-PNN--ILSNWSPRKSPCQFSGVTC 75

Query: 75   SPDKARVNGLNLTDWNISGDI-FNNFSALTQLSYLDLSRNTFS----------------- 116
                 RV  +NL+   +SG + FN F++L  LS L LS N F                  
Sbjct: 76   L--GGRVTEINLSGSGLSGIVSFNAFTSLDSLSVLKLSENFFVLNSTSLLLLPLTLTHLE 133

Query: 117  -------GSIPDDL-SSCRSLKYLNLSHNILSG----DLNLSGLRSLEILDLSVNRIHGE 164
                   G++P++  S   +L  + LS+N  +G    DL LS  + L+ LDLS N I G 
Sbjct: 134  LSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSS-KKLQTLDLSYNNITGP 192

Query: 165  IS-FSFP-AICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI---WNGLA 219
            IS  + P + C  +   + S N+++G I      C NL+ L+LS NNF G I   +  L 
Sbjct: 193  ISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQIPKSFGELK 252

Query: 220  QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN 279
             L    +S N L+G +   +     SL+   LS N F G  P  +S+C  L  L+L  NN
Sbjct: 253  LLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNN 312

Query: 280  FSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG-------- 330
             SGP P  I  S   L+ L L  N      P S+     L + D SSN F G        
Sbjct: 313  ISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIPPDLCP 372

Query: 331  -----------------EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
                             E+     + ++++ + L  N Y++G     I  L  + +    
Sbjct: 373  GAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLN-YLNGTIPPEIGNLQKLEQFIAW 431

Query: 374  HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI 433
            +NN  G +P EI ++++LK LIL +N+  G IP  + N  N++ +  + N LTG +P   
Sbjct: 432  YNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDF 491

Query: 434  GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFE 493
            G L+ L  L L NN+ +GEIP E+G CT+L+WL+L+ N L+G IPP    +GR       
Sbjct: 492  GILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPR---LGRQP----- 543

Query: 494  ANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFP--- 550
                 G + ++G     +M           +FV  +    SC+ +   L++ +GI P   
Sbjct: 544  -----GSKALSGLLSGNTM-----------AFVRNV--GNSCKGVGG-LVEFSGIRPERL 584

Query: 551  VCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQF-DQL 609
            + +P L S  F             SG +     + Q    + L +NQ  GK+P +  + +
Sbjct: 585  LQIPSLKSCDFT---------RMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMI 635

Query: 610  PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             L VL L+ N  SGEIP   G +K L   D S N   G  P SF+NL+ L ++++S N L
Sbjct: 636  ALQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNEL 695

Query: 670  VSGTIPSTGQLATFEKTSYLGDPLL---DLPDFIENGPHHGHKYPNSNGRTGNNTKLTII 726
             +G IP  GQL+T   T Y  +P L    LP+  +NG +          R  + T+    
Sbjct: 696  -TGPIPQRGQLSTLPATQYANNPGLCGVPLPE-CKNGNNQLPAGTEEGKRAKHGTRAA-- 751

Query: 727  LAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPW------ 780
             ++   ++  ++    S+ I ++       +    +  K  H L + +  ++ W      
Sbjct: 752  -SWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSATT-WKIEKEK 809

Query: 781  --LSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
              LS  V   +       +S +++AT  FS   +IG GGFG V++  L DG  VA+KKL 
Sbjct: 810  EPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLI 869

Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-- 896
            R   +G+REF AEME L        H NLV L G+C  G E++LVYE+M+ GSLE+++  
Sbjct: 870  RLSCQGDREFMAEMETLG----KIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHG 925

Query: 897  ----SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF 952
                  R  L W  R  IA   A+ L FLHH C P I+HRD+K+SNVLLD++ +A V+DF
Sbjct: 926  PRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDF 985

Query: 953  GLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL-- 1009
            G+AR++SA D+H+S +T+AGT GYV PEY Q+++ T KGDVYS GV+ +E+ +G+R    
Sbjct: 986  GMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDK 1045

Query: 1010 -EGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG------------AEEMSELL 1056
             E G+  LV W +     G+H     VI   LL  G +E              +EM   L
Sbjct: 1046 EEFGDTNLVGWSKMKAREGKH---MEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYL 1102

Query: 1057 RIGVRCTAEAPNARPNVKEVLAML 1080
             I +RC  + P+ RPN+ +V+A L
Sbjct: 1103 EIALRCVDDFPSKRPNMLQVVASL 1126

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  477 bits (1228), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 374/1159 (32%), Positives = 561/1159 (48%), Gaps = 164/1159 (14%)

Query: 35   DREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGD 94
            D  +L+  +     ++P N     ++     PC W G+ CS D  RV GL+L +  ++G 
Sbjct: 33   DTALLTAFKQTSIKSDPTNFLGNWRYGSGRDPCTWRGVSCSSD-GRVIGLDLRNGGLTGT 91

Query: 95   I-FNNFSALTQL-----------------------SYLDLSRNTFSGSIPDD--LSSCRS 128
            +  NN +AL+ L                         LDLS N+ + S   D   S+C +
Sbjct: 92   LNLNNLTALSNLRSLYLQGNNFSSGDSSSSSGCSLEVLDLSSNSLTDSSIVDYVFSTCLN 151

Query: 129  LKYLNLSHNILSGDL--------------NLSGLR---------------SLEILDLSVN 159
            L  +N SHN L+G L              +LS  R               SL+ LDLS N
Sbjct: 152  LVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPNSLKHLDLSGN 211

Query: 160  RIHGEISFSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNLRYLDLSSNNFRGNI---- 214
             + G+ S     +CE L V +LS N+++G R       C  L  L+LS N+  G I    
Sbjct: 212  NVTGDFSRLSFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIGKIPGDD 271

Query: 215  -WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVL 273
             W     L + S++ N+ SG +   +     +LE+ DLS N   G  P   ++C +L  L
Sbjct: 272  YWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSL 331

Query: 274  NLFGNNFSGP-IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV 332
            NL  N  SG  +   +  +S +  L+L  NN    +P SL N S L VLDLSSN F GEV
Sbjct: 332  NLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEV 391

Query: 333  QKIFGRFTQVKILA--LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS 390
               F       +L   L +N+Y+ G     + K  ++  +DLS N  TG +P EI  +  
Sbjct: 392  PSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPK 451

Query: 391  LKFLILAHNRFNGSIP-AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW-------- 441
            L  L++  N   G IP ++  +  NL+TL L+ N LTG +P SI   T++LW        
Sbjct: 452  LSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLL 511

Query: 442  ----------------LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIG 485
                            L L NNSL+G IP E+GNC +L+WL+L++N L+GN+P E+ +  
Sbjct: 512  TGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQA 571

Query: 486  RNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKG 545
                P   + ++       G ++C      +  +                R+  +RL   
Sbjct: 572  GLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFE--------------GIRA--ERLEH- 614

Query: 546  TGIFPVCLPGLASRTFQ-ITGYLQLSGNQLSGELSPDIGKLQNFSMVHL--GFNQFDGKL 602
               FP+      +R +  +T Y+  S                N SM++L   +N   G +
Sbjct: 615  ---FPMVHSCPKTRIYSGMTMYMFSS----------------NGSMIYLDLSYNAVSGSI 655

Query: 603  PSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSK 661
            P  +  +  L VLNL  N  +G IP  FG +K +  LDLS+N+  G  P S   L+ LS 
Sbjct: 656  PLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSD 715

Query: 662  LNISYNPLVSGTIPSTGQLATFEKTSY------LGDPLLDLPDFIENGPHHGHKYPNSNG 715
            L++S N L +G IP  GQL TF  T Y       G PL   P    + P   H +P    
Sbjct: 716  LDVSNNNL-TGPIPFGGQLTTFPLTRYANNSGLCGVPLP--PCSSGSRPTRSHAHPKKQS 772

Query: 716  RTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSG 775
                     I+ +F+     C++  ++++     V++  +Q+   +E +      +    
Sbjct: 773  -IATGMSAGIVFSFM-----CIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLS 826

Query: 776  GSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVK 835
                 LS  V          T++ +L+AT  FS D +IG GGFG VY+  L DG  VA+K
Sbjct: 827  SVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIK 886

Query: 836  KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDI 895
            KL +   +G+REF AEME +        H NLV L G+C  G E++LVYEYM+ GSLE +
Sbjct: 887  KLIQVTGQGDREFMAEMETIGK----IKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETV 942

Query: 896  ISDRTR-----LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT 950
            + ++T+     L W  R  IAI  AR L FLHH C P I+HRD+K+SNVLLD++  A V+
Sbjct: 943  LHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVS 1002

Query: 951  DFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
            DFG+AR+VSA D+H+S +T+AGT GYV PEY Q+++ T KGDVYS+GV+ +EL +G++ +
Sbjct: 1003 DFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPI 1062

Query: 1010 E----GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAE 1065
            +    G +  LV W +++    R   G  ++   L+      G  E+   L+I  +C  +
Sbjct: 1063 DPEEFGEDNNLVGWAKQLY---REKRGAEILDPELVTD--KSGDVELLHYLKIASQCLDD 1117

Query: 1066 APNARPNVKEVLAMLIKIL 1084
             P  RP + +V+ M  +++
Sbjct: 1118 RPFKRPTMIQVMTMFKELV 1136

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  476 bits (1226), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 382/1161 (32%), Positives = 562/1161 (48%), Gaps = 198/1161 (17%)

Query: 60   WNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDI---------FNNFSALT------- 103
            W  S+ PC + G+ C    +RV+ ++L++  +S D           +N  +L        
Sbjct: 64   WLSSTDPCSFTGVSCK--NSRVSSIDLSNTFLSVDFSLVTSYLLPLSNLESLVLKNANLS 121

Query: 104  -------------QLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILS--GDLNLS 146
                          L  +DL+ NT SG I D      C +LK LNLS N L   G   L 
Sbjct: 122  GSLTSAAKSQCGVTLDSIDLAENTISGPISDISSFGVCSNLKSLNLSKNFLDPPGKEMLK 181

Query: 147  GLR-SLEILDLSVNRIHG-------------EISF----------SFPAICEK-LVVANL 181
            G   SL++LDLS N I G             E+ F          S P +  K L   +L
Sbjct: 182  GATFSLQVLDLSYNNISGFNLFPWVSSMGFVELEFFSIKGNKLAGSIPELDFKNLSYLDL 241

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLA---QLVEFSVSENVLSGVVSSS 238
            S NN +  +   F  C NL++LDLSSN F G+I + L+   +L   +++ N   G+V   
Sbjct: 242  SANNFS-TVFPSFKDCSNLQHLDLSSNKFYGDIGSSLSSCGKLSFLNLTNNQFVGLVPKL 300

Query: 239  VFKENCSLEIFDLSENEFIGDFPGEVSN-CRNLVVLNLFGNNFSGPIPAEIGSISGLEAL 297
              +   SL+   L  N+F G +P ++++ C+ +V L+L  NNFSG +P  +G  S LE +
Sbjct: 301  PSE---SLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELV 357

Query: 298  FLGKNNFLSVIP-ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYI--- 353
             +  NNF   +P ++LL LS ++ + LS N F G +   F    +++ L + SN+     
Sbjct: 358  DISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGLPDSFSNLPKLETLDMSSNNLTGII 417

Query: 354  ------DGMNSSGILKLPN----------------ISRLDLSHNNFTGPLPVEISQMRSL 391
                  D MN+  +L L N                +  LDLS N  TG +P  +  +  L
Sbjct: 418  PSGICKDPMNNLKVLYLQNNLFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKL 477

Query: 392  KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG 451
            K LIL  N+ +G IP     +  L+ L L FN+LTGPIP S+ N T L W+ L+NN LSG
Sbjct: 478  KDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSG 537

Query: 452  EIPG------------------------EIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRN 487
            EIP                         E+GNC SL+WL+L+ N L+G+IPP +     N
Sbjct: 538  EIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGN 597

Query: 488  ARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTG 547
                    +R       GS EC      +         +  I TR  C            
Sbjct: 598  IAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCN----------- 646

Query: 548  IFPVCLPGLASRTFQITG---YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPS 604
             F     G+   TF   G   +L LS N+L G +  ++G +   S               
Sbjct: 647  -FTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLS--------------- 690

Query: 605  QFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNI 664
                    +LNL  N+ SG IP + G +K +  LDLSYN F+G  P S  +LT L ++++
Sbjct: 691  --------ILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDL 742

Query: 665  SYNPLVSGTIPSTGQLATFEKTSYLGDPL--LDLPDFIENGPHHGHKYPNSNGRTGNNTK 722
            S N L SG IP +    TF    +  + L    LP    +GP       ++N    ++ +
Sbjct: 743  SNNNL-SGMIPESAPFDTFPDYRFANNSLCGYPLPLPCSSGPKS-----DANQHQKSHRR 796

Query: 723  LTIILAFLAL-LMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPW- 780
               +   +A+ L+  L C    II+ +  K+   ++   LE     H  + S+  +S W 
Sbjct: 797  QASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH--SHSATANSAWK 854

Query: 781  LSDTVKVIRLDKTAF-------TYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVA 833
             +   + + ++  AF       T++D+L+AT  F  D ++G GGFG VY+  L DG  VA
Sbjct: 855  FTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVA 914

Query: 834  VKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLE 893
            +KKL     +G+REF AEME +        H NLV L G+C  G E++LVYEYM+ GSLE
Sbjct: 915  IKKLIHVSGQGDREFTAEMETIGK----IKHRNLVPLLGYCKVGEERLLVYEYMKYGSLE 970

Query: 894  DIISDRTR----LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV 949
            D++ DR +    L W  R  IAI  AR L FLHH C P I+HRD+K+SNVLLD+  +A V
Sbjct: 971  DVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARV 1030

Query: 950  TDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008
            +DFG+AR++SA D+H+S +T+AGT GYV PEY Q+++ +TKGDVYS+GV+ +EL TG++ 
Sbjct: 1031 SDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQP 1090

Query: 1009 LEG---GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAE---EMSELLRIGVRC 1062
             +    G+  LV W +       H  G+  I  V     L E A    E+ + L++   C
Sbjct: 1091 TDSADFGDNNLVGWVK------LHAKGK--ITDVFDRELLKEDASIEIELLQHLKVACAC 1142

Query: 1063 TAEAPNARPNVKEVLAMLIKI 1083
              +    RP + +V+AM  +I
Sbjct: 1143 LDDRHWKRPTMIQVMAMFKEI 1163

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  476 bits (1226), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 375/1133 (33%), Positives = 548/1133 (48%), Gaps = 167/1133 (14%)

Query: 59   QWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDI-FNNFSALTQLSYLDLSRNTF-- 115
            ++      C W G+ CS D  R+ GL+L +  ++G +   N +AL  L  L L  N F  
Sbjct: 58   KYESGRGSCSWRGVSCS-DDGRIVGLDLRNSGLTGTLNLVNLTALPNLQNLYLQGNYFSS 116

Query: 116  -----------------SGSIPDD------LSSCRSLKYLNLSHNILSGDLNL--SGLRS 150
                             S SI D        S C +L  +N+S+N L G L    S L+S
Sbjct: 117  GGDSSGSDCYLQVLDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFAPSSLQS 176

Query: 151  LEILDLSVNRIHGEISFSF----PA----------------------ICEKLVVANLSLN 184
            L  +DLS N +  +I  SF    PA                      IC  L   +LS N
Sbjct: 177  LTTVDLSYNILSDKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGNLTFFSLSQN 236

Query: 185  NLTG-RIDTCFDGCLNLRYLDLSSNNFRGNI-----WNGLAQLVEFSVSENVLSGVVSSS 238
            NL+G +       C  L  L++S NN  G I     W     L + S++ N LSG +   
Sbjct: 237  NLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPE 296

Query: 239  VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGP-IPAEIGSISGLEAL 297
            +     +L I DLS N F G+ P + + C  L  LNL  N  SG  +   +  I+G+  L
Sbjct: 297  LSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYL 356

Query: 298  FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILA--LHSNSYIDG 355
            ++  NN    +P SL N S L VLDLSSN F G V   F       +L   L +N+Y+ G
Sbjct: 357  YVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSG 416

Query: 356  MNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-------- 407
                 + K  ++  +DLS N  TGP+P EI  + +L  L++  N   G+IP         
Sbjct: 417  TVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGN 476

Query: 408  ----------VYGNMP-------NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS 450
                      + G++P       N+  + LS N LTG IP  IGNL+ L  L L NNSLS
Sbjct: 477  LETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLS 536

Query: 451  GEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECL 510
            G +P ++GNC SL+WL+L++N L+G++P E+ +      P   + ++       G ++C 
Sbjct: 537  GNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCR 596

Query: 511  SMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITG---YL 567
                 +  +      +  +    SC          T I+     G+   TF   G   Y 
Sbjct: 597  GAGGLVEFEGIRAERLERLPMVHSC--------PATRIYS----GMTMYTFSANGSMIYF 644

Query: 568  QLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPS 627
             +S N +SG + P  G        ++G+ Q               VLNL  N  +G IP 
Sbjct: 645  DISYNAVSGFIPPGYG--------NMGYLQ---------------VLNLGHNRITGTIPD 681

Query: 628  EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTS 687
             FG +K +  LDLS+NN  G  P S  +L+ LS L++S N L +G IP  GQL TF  + 
Sbjct: 682  SFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNL-TGPIPFGGQLTTFPVSR 740

Query: 688  YLGDP-LLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIII 746
            Y  +  L  +P  +        +   S       T  T ++A +A    C +  +L + +
Sbjct: 741  YANNSGLCGVP--LRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFV--MLVMAL 796

Query: 747  YMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPW--------LSDTVKVIRLDKTAFTYS 798
            Y + K   ++Q    +  KY   L +S  GS  W        LS  V          T++
Sbjct: 797  YRVRKVQKKEQ----KREKYIESLPTS--GSCSWKLSSVPEPLSINVATFEKPLRKLTFA 850

Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGN 858
             +L+AT  FS + ++G GGFG VY+  L DG  VA+KKL R   +G+REF AEME +   
Sbjct: 851  HLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGK- 909

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR------LTWRRRLDIAI 912
                 H NLV L G+C  G E++LVYEYM+ GSLE ++ +++       L W  R  IAI
Sbjct: 910  ---IKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAI 966

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAG 971
              AR L FLHH C P I+HRD+K+SNVLLD++ +A V+DFG+AR+VSA D+H+S +T+AG
Sbjct: 967  GAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAG 1026

Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE----ECLVEWGRRVMGYG 1027
            T GYV PEY Q+++ T KGDVYS+GV+ +EL +G++ ++ GE      LV W +++    
Sbjct: 1027 TPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLY--- 1083

Query: 1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            R   G  ++   L+      G  E+   L+I  +C  + P  RP + +++AM 
Sbjct: 1084 REKRGAEILDPELVTD--KSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMF 1134

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  474 bits (1219), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 379/1160 (32%), Positives = 557/1160 (48%), Gaps = 196/1160 (16%)

Query: 60   WNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDI---------FNNFSALT------- 103
            W  S+ PC + G+ C    +RV+ ++L++  +S D           +N  +L        
Sbjct: 64   WLSSTGPCSFTGVSCK--NSRVSSIDLSNTFLSVDFSLVTSYLLPLSNLESLVLKNANLS 121

Query: 104  -------------QLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILS---GDLNL 145
                          L  +DL+ NT SG I D      C +LK LNLS N L     ++  
Sbjct: 122  GSLTSAAKSQCGVTLDSIDLAENTISGPISDISSFGVCSNLKSLNLSKNFLDPPGKEMLK 181

Query: 146  SGLRSLEILDLSVNRIHG-------------EISF----------SFPAICEK-LVVANL 181
            +   SL++LDLS N I G             E+ F          S P +  K L   +L
Sbjct: 182  AATFSLQVLDLSYNNISGFNLFPWVSSMGFVELEFFSLKGNKLAGSIPELDFKNLSYLDL 241

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLA---QLVEFSVSENVLSGVVSSS 238
            S NN +  +   F  C NL++LDLSSN F G+I + L+   +L   +++ N   G+V   
Sbjct: 242  SANNFS-TVFPSFKDCSNLQHLDLSSNKFYGDIGSSLSSCGKLSFLNLTNNQFVGLVPKL 300

Query: 239  VFKENCSLEIFDLSENEFIGDFPGEVSN-CRNLVVLNLFGNNFSGPIPAEIGSISGLEAL 297
              +   SL+   L  N+F G +P ++++ C+ +V L+L  NNFSG +P  +G  S LE +
Sbjct: 301  PSE---SLQYLYLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELV 357

Query: 298  ------FLGK-------------------NNFLSVIPESLLNLSKLEVLDLSSNNFGGEV 332
                  F GK                   N F+  +P+S  NL KLE LD+SSNN  G +
Sbjct: 358  DISYNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGGLPDSFSNLLKLETLDMSSNNLTGVI 417

Query: 333  QKIFGR--FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS 390
                 +     +K+L L +N +  G     +     +  LDLS N  TG +P  +  +  
Sbjct: 418  PSGICKDPMNNLKVLYLQNNLF-KGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSK 476

Query: 391  LKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS 450
            LK LIL  N+ +G IP     +  L+ L L FN+LTGPIP S+ N T L W+ L+NN LS
Sbjct: 477  LKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLS 536

Query: 451  GEIPG------------------------EIGNCTSLLWLNLSNNKLSGNIPPEVMTIGR 486
            GEIP                         E+GNC SL+WL+L+ N L+G+IPP +     
Sbjct: 537  GEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSG 596

Query: 487  NARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGT 546
            N        +R       GS EC      +         +  I TR  C           
Sbjct: 597  NIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCN---------- 646

Query: 547  GIFPVCLPGLASRTFQITG---YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLP 603
              F     G+   TF   G   +L LS N+L G +  ++G +   S              
Sbjct: 647  --FTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLS-------------- 690

Query: 604  SQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLN 663
                     +LNL  N+ SG IP + G +K +  LDLSYN F+G  P S  +LT L +++
Sbjct: 691  ---------ILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEID 741

Query: 664  ISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKL 723
            +S N L SG IP +    TF    +  + L   P  I   P       ++N    ++ + 
Sbjct: 742  LSNNNL-SGMIPESAPFDTFPDYRFANNSLCGYPLPI---PCSSGPKSDANQHQKSHRRQ 797

Query: 724  TIILAFLAL-LMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPW-L 781
              +   +A+ L+  L C    II+ +  K+   ++   LE     H  + S+  +S W  
Sbjct: 798  ASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH--SHSATANSAWKF 855

Query: 782  SDTVKVIRLDKTAF-------TYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAV 834
            +   + + ++  AF       T++D+L+AT  F  D ++G GGFG VY+  L DG  VA+
Sbjct: 856  TSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAI 915

Query: 835  KKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED 894
            KKL     +G+REF AEME +        H NLV L G+C  G E++LVYEYM+ GSLED
Sbjct: 916  KKLIHVSGQGDREFTAEMETIGK----IKHRNLVPLLGYCKVGEERLLVYEYMKYGSLED 971

Query: 895  IISDRTR----LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT 950
            ++ DR +    L W  R  IAI  AR L FLHH C P I+HRD+K+SNVLLD+  +A V+
Sbjct: 972  VLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVS 1031

Query: 951  DFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
            DFG+AR++SA D+H+S +T+AGT GYV PEY Q+++ +TKGDVYS+GV+ +EL TG++  
Sbjct: 1032 DFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPT 1091

Query: 1010 EG---GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAE---EMSELLRIGVRCT 1063
            +    G+  LV W +       H  G+  I  V     L E A    E+ + L++   C 
Sbjct: 1092 DSADFGDNNLVGWVK------LHAKGK--ITDVFDRELLKEDASIEIELLQHLKVACACL 1143

Query: 1064 AEAPNARPNVKEVLAMLIKI 1083
             +    RP + +V+AM  +I
Sbjct: 1144 DDRHWKRPTMIQVMAMFKEI 1163

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  470 bits (1210), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 373/1155 (32%), Positives = 566/1155 (49%), Gaps = 180/1155 (15%)

Query: 59   QWNQSSSPCEWPGIICSPDKARVNGLN-------------------------LTDWNISG 93
             W+ + +PC + G+ C  DK     L+                         L++ +I+G
Sbjct: 54   DWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING 113

Query: 94   DIFNNFSALTQLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILSGDLNLSG---L 148
             + + F     L+ LDLSRN+ SG +     L SC  LK+LN+S N L     +SG   L
Sbjct: 114  SV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 172

Query: 149  RSLEILDLSVNRIHGE--ISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS 206
             SLE+LDLS N I G   + +     C +L    +S N ++G +D     C+NL +LD+S
Sbjct: 173  NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVS 230

Query: 207  SNNFRGNI--WNGLAQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLSENEFIGDFP-- 261
            SNNF   I      + L    +S N LSG  S ++    C+ L++ ++S N+F+G  P  
Sbjct: 231  SNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAI--STCTELKLLNISSNQFVGPIPPL 288

Query: 262  ----------------GEVSN-----CRNLVVLNLFGNNFSGPIPAEIG----------- 289
                            GE+ +     C  L  L+L GN+F G +P   G           
Sbjct: 289  PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 348

Query: 290  --------------SISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDLSSNNFGGEV-- 332
                           + GL+ L L  N F   +PESL NLS  L  LDLSSNNF G +  
Sbjct: 349  SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 408

Query: 333  ----------QKIF-------GRFTQV-----KILALH-SNSYIDGMNSSGILKLPNISR 369
                      Q+++       G+         ++++LH S +Y+ G   S +  L  +  
Sbjct: 409  NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 468

Query: 370  LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
            L L  N   G +P E+  +++L+ LIL  N   G IP+   N  NL  + LS N LTG I
Sbjct: 469  LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 528

Query: 430  PPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNAR 489
            P  IG L +L  L L+NNS SG IP E+G+C SL+WL+L+ N  +G IP  +        
Sbjct: 529  PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM-------- 580

Query: 490  PTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIF 549
              F+ + +     IAG       KR++        ++     +K C    + LL+  GI 
Sbjct: 581  --FKQSGKIAANFIAG-------KRYV--------YIKNDGMKKECHGAGN-LLEFQGIR 622

Query: 550  PVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL 609
               L  L++R         ++     G  SP      +   + + +N   G +P +   +
Sbjct: 623  SEQLNRLSTRN-----PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 677

Query: 610  P-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
            P L +LNL  N+ SG IP E G+++ L  LDLS N   G  P + + LT L+++++S N 
Sbjct: 678  PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 737

Query: 669  LVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPN---SNGRTGNNTKLTI 725
            L SG IP  GQ  TF    +L +P L         P +   Y +   S+GR   +   ++
Sbjct: 738  L-SGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRPASLAGSV 796

Query: 726  ILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRH-DLASSSGGSSPW-LSD 783
             +     L+   +C    I++   +++   ++   LE     H +    +  ++ W L+ 
Sbjct: 797  AMG----LLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTG 852

Query: 784  TVKVIRLDKTAF-------TYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKK 836
              + + ++  AF       T++D+L+AT  F  D +IG GGFG VY+ +L DG  VA+KK
Sbjct: 853  VKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKK 912

Query: 837  LQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII 896
            L     +G+REF AEME +        H NLV L G+C  G E++LVYE+M+ GSLED++
Sbjct: 913  LIHVSGQGDREFMAEMETIG----KIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVL 968

Query: 897  SDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF 952
             D      +L W  R  IAI  AR L FLHH C P I+HRD+K+SNVLLD+  +A V+DF
Sbjct: 969  HDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDF 1028

Query: 953  GLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            G+AR++SA D+H+S +T+AGT GYV PEY Q+++ +TKGDVYS+GV+ +EL TG+R  + 
Sbjct: 1029 GMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDS 1088

Query: 1012 ---GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPN 1068
               G+  LV W   V  + +        P ++      E   E+ + L++ V C  +   
Sbjct: 1089 PDFGDNNLVGW---VKQHAKLRISDVFDPELMKEDPALE--IELLQHLKVAVACLDDRAW 1143

Query: 1069 ARPNVKEVLAMLIKI 1083
             RP + +V+AM  +I
Sbjct: 1144 RRPTMVQVMAMFKEI 1158

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  462 bits (1190), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 394/1173 (33%), Positives = 554/1173 (47%), Gaps = 191/1173 (16%)

Query: 67   CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSC 126
            C+W G+ C     RVN L+L   ++ G I    S+L  L  L L+ N FSG IP ++ + 
Sbjct: 55   CDWVGVTCL--LGRVNSLSLPSLSLRGQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNL 112

Query: 127  RSLKYLNLSHNILSGDLN--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLN 184
            + L+ L+LS N L+G L   LS L  L  LDLS N   G +  SF      L   ++S N
Sbjct: 113  KHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNN 172

Query: 185  NLTGRIDTCFDGCLNLRYLDLSSNNFRGNI-------------------WNG-------- 217
            +L+G I        NL  L +  N+F G I                   +NG        
Sbjct: 173  SLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISK 232

Query: 218  LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFG 277
            L  L +  +S N L   +  S F E  +L I +L   E IG  P E+ NC++L  L L  
Sbjct: 233  LKHLAKLDLSYNPLKCSIPKS-FGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSF 291

Query: 278  NNFSGPIPAEIGSI------------SG-----------LEALFLGKNNF---------- 304
            N+ SGP+P E+  I            SG           L++L L  N F          
Sbjct: 292  NSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIED 351

Query: 305  ------LSV--------IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
                  LS+        IP  L     LE +DLS N   G ++++F   + +  L L +N
Sbjct: 352  CPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLL-TN 410

Query: 351  SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYG 410
            + I+G     + KLP +  LDL  NNFTG +P  + +  +L     ++NR  G +PA  G
Sbjct: 411  NQINGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIG 469

Query: 411  NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            N  +L+ L LS N+LTG IP  IG LTSL  L L  N   G+IP E+G+CTSL  L+L +
Sbjct: 470  NAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGS 529

Query: 471  NKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSF----- 525
            N L G IP ++  + +        N       ++GS        +   + P  SF     
Sbjct: 530  NNLQGQIPDKITALAQLQCLVLSYNN------LSGSIPSKPSAYFHQIEMPDLSFLQHHG 583

Query: 526  VYTILTRKSCRSLWDRLLKGTGIFPVCL---------PGLASRTFQITGYLQLSGNQLSG 576
            ++ +   +    + + L +   +  + L         P   SR   +T  L LSGN L+G
Sbjct: 584  IFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLT-ILDLSGNALTG 642

Query: 577  ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCL 635
             +  ++G       ++L  NQ +G +P  F  L  L+ LNLT+N   G +P+  GN+K L
Sbjct: 643  SIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKEL 702

Query: 636  QNLDLSYNN------------------------FSGPFPASFNNLTELSKLNISYNPLVS 671
             ++DLS+NN                        F+G  P+   NLT+L  L++S N L+S
Sbjct: 703  THMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSEN-LLS 761

Query: 672  GTIPSTGQLATFEKTSYLGDPLLDLPDFIENG-----PHHG-HKYPNSNGRTGNN----- 720
            G IP          T   G P L+  +  +N      P  G  + P+    +GN      
Sbjct: 762  GEIP----------TKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGR 811

Query: 721  ----------TKLTIILAFLALLMACLI---CGVLSIIIYMLVKR------PAEQQGYLL 761
                      TKL        L++   I     V S+  + + KR      P   +   L
Sbjct: 812  VVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRL 871

Query: 762  EGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTV 821
            +G   ++    S   S   LS  + +           DI++AT  FS+  IIG GGFGTV
Sbjct: 872  KGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTV 931

Query: 822  YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI 881
            Y+  LP  + VAVKKL     +G REF AEME L        HPNLV+L G+C    EK+
Sbjct: 932  YKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGK----VKHPNLVSLLGYCSFSEEKL 987

Query: 882  LVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKAS 937
            LVYEYM  GSL+  + ++T     L W +RL IA+  AR L FLHH   P I+HRD+KAS
Sbjct: 988  LVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKAS 1047

Query: 938  NVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGV 997
            N+LLD + +  V DFGLAR++SA +SHVST IAGT GY+ PEYGQ+ +ATTKGDVYSFGV
Sbjct: 1048 NILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGV 1107

Query: 998  LAMELATGR-------RALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAE 1050
            + +EL TG+       +  EGG   LV W  + +  G+      VI  +L+   L     
Sbjct: 1108 ILLELVTGKEPTGPDFKESEGGN--LVGWAIQKINQGK---AVDVIDPLLVSVAL---KN 1159

Query: 1051 EMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                LL+I + C AE P  RPN+ +VL  L +I
Sbjct: 1160 SQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  444 bits (1142), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 348/1067 (32%), Positives = 529/1067 (49%), Gaps = 81/1067 (7%)

Query: 60   WNQSSS-PCEWPGIICS--PDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFS 116
            WN + S PC W G++CS       V  LNL+   +SG +  +   L  L  LDLS N  S
Sbjct: 51   WNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLS 110

Query: 117  GSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICE 174
            G IP ++ +C SL+ L L++N   G++   +  L SLE L +  NRI G +      +  
Sbjct: 111  GKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLS 170

Query: 175  KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI---WNGLAQLVEFSVSENVL 231
               +   S NN++G++         L       N   G++     G   LV   +++N L
Sbjct: 171  LSQLVTYS-NNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQL 229

Query: 232  SGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSI 291
            SG +   +      L    L ENEF G  P E+SNC +L  L L+ N   GPIP E+G +
Sbjct: 230  SGELPKEIGMLK-KLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDL 288

Query: 292  SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS 351
              LE L+L +N     IP  + NLS    +D S N   GE+    G    +++L L  N 
Sbjct: 289  QSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQ 348

Query: 352  YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
             + G     +  L N+S+LDLS N  TGP+P+    +R L  L L  N  +G+IP   G 
Sbjct: 349  -LTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGW 407

Query: 412  MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
              +L  LD+S N L+G IP  +   ++++ L L  N+LSG IP  I  C +L+ L L+ N
Sbjct: 408  YSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARN 467

Query: 472  KLSGNIPPEVMTIGRNARPTFEANQRNGE--RTIAGSSECLSMKRW----------IPAD 519
             L G  P  +             N+  G   R +     C +++R           +P +
Sbjct: 468  NLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVG---NCSALQRLQLADNGFTGELPRE 524

Query: 520  YPPFSFVYTI------LTRK------SCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYL 567
                S + T+      LT +      +C+ L  RL      F   LP      +Q+   L
Sbjct: 525  IGMLSQLGTLNISSNKLTGEVPSEIFNCKML-QRLDMCCNNFSGTLPSEVGSLYQLE-LL 582

Query: 568  QLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP--LIVLNLTRNNFSGEI 625
            +LS N LSG +   +G L   + + +G N F+G +P +   L    I LNL+ N  +GEI
Sbjct: 583  KLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEI 642

Query: 626  PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEK 685
            P E  N+  L+ L L+ NN SG  P+SF NL+ L   N SYN L +G IP    L     
Sbjct: 643  PPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSL-TGPIP---LLRNISM 698

Query: 686  TSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSII 745
            +S++G+  L  P   +           S G+ G   + + I+A  A ++  +   ++++I
Sbjct: 699  SSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGG-MRSSKIIAITAAVIGGVSLMLIALI 757

Query: 746  IYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATG 805
            +Y L++RP                +ASS+    P    ++ +    K  FT+ D++ AT 
Sbjct: 758  VY-LMRRPV-------------RTVASSAQDGQPS-EMSLDIYFPPKEGFTFQDLVAATD 802

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-----EREFRAEMEVLSGNGF 860
             F E  ++G+G  GTVY+ VLP G  +AVKKL      G     +  FRAE+  L GN  
Sbjct: 803  NFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTL-GN-- 859

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALV 919
               H N+V L+G+C      +L+YEYM  GSL +I+ D +  L W +R  IA+  A+ L 
Sbjct: 860  -IRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LHH+C P I HRD+K++N+LLD + +A V DFGLA+V+    S   + IAG+ GY+APE
Sbjct: 919  YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPE 978

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
            Y  T + T K D+YS+GV+ +EL TG+  ++      ++ G  V+ + R    R  +   
Sbjct: 979  YAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-----IDQGGDVVNWVRSYIRRDALSSG 1033

Query: 1040 LLGSGLAEGAE----EMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082
            +L + L    E     M  +L+I + CT+ +P ARP++++V+ MLI+
Sbjct: 1034 VLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  440 bits (1132), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 353/1122 (31%), Positives = 546/1122 (48%), Gaps = 151/1122 (13%)

Query: 13   FALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGI 72
              + +  V  + + V+      D   L  L   L+N + V E     W   S  CEW G+
Sbjct: 1    MVIILLLVFFVGSSVSQPCHPNDLSALRELAGALKNKS-VTE----SWLNGSRCCEWDGV 55

Query: 73   IC--SPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLK 130
             C  S    RV  L L +  + G I  +   LT+L  LDLSRN   G +P ++S    L+
Sbjct: 56   FCEGSDVSGRVTKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQ 115

Query: 131  YLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFS--FPAICEKLVVANLSLNNL 186
             L+LSHN+LSG +   +SGL+ ++ L++S N + G++S    FP     LV+ N+S N  
Sbjct: 116  VLDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPG----LVMLNVSNNLF 171

Query: 187  TGRI--DTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENC 244
             G I  + C      ++ LDLS N   GN+ +GL                        NC
Sbjct: 172  EGEIHPELCSSSG-GIQVLDLSMNRLVGNL-DGLY-----------------------NC 206

Query: 245  SLEI--FDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
            S  I    +  N   G  P  + + R L  L+L GN  SG +   + ++SGL++L + +N
Sbjct: 207  SKSIQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLISEN 266

Query: 303  NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
             F  VIP+   NL++LE LD+SSN F G       + +++++L L +NS    +N +   
Sbjct: 267  RFSDVIPDVFGNLTQLEHLDVSSNKFSGRFPPSLSQCSKLRVLDLRNNSLSGSINLN-FT 325

Query: 363  KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMP--------- 413
               ++  LDL+ N+F+GPLP  +     +K L LA N F G IP  + N+          
Sbjct: 326  GFTDLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLSN 385

Query: 414  -----------------NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE 456
                             NL TL LS N +   IP ++    +L  L L N  L G+IP  
Sbjct: 386  NSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRGQIPSW 445

Query: 457  IGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWI 516
            + NC  L  L+LS N   G IP  +  +       F  N   G   +A +     +K  I
Sbjct: 446  LLNCKKLEVLDLSWNHFYGTIPHWIGKMESLFYIDFSNNTLTGAIPVAITE----LKNLI 501

Query: 517  PADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG 576
                   +   + +T  S   L+ +  K +   P       ++  +    + L+ N+L+G
Sbjct: 502  R-----LNGTASQMTDSSGIPLYVKRNKSSNGLPY------NQVSRFPPSIYLNNNRLNG 550

Query: 577  ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQ 636
             + P+IG+L+   M                       L+L+RNNF+G IP     +  L+
Sbjct: 551  TILPEIGRLKELHM-----------------------LDLSRNNFTGTIPDSISGLDNLE 587

Query: 637  NLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGD----P 692
             LDLSYN+  G  P SF +LT LS+ +++YN L +G IPS GQ  +F  +S+ G+     
Sbjct: 588  VLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRL-TGAIPSGGQFYSFPHSSFEGNLGLCR 646

Query: 693  LLDLP-DFIENG---PHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYM 748
             +D P D + +    P    +  N+ G+ G ++     +  L + +A  I  +LS+I+  
Sbjct: 647  AIDSPCDVLMSNMLNPKGSSRRNNNGGKFGRSS-----IVVLTISLAIGITLLLSVILLR 701

Query: 749  LVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFS 808
            + ++  + +   ++       ++  S    P  S  V          +  ++LK+T  FS
Sbjct: 702  ISRKDVDDRINDVD----EETISGVSKALGP--SKIVLFHSCGCKDLSVEELLKSTNNFS 755

Query: 809  EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +  IIG GGFG VY+   PDG + AVK+L  +  + EREF+AE+E LS       H NLV
Sbjct: 756  QANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSR----AEHKNLV 811

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHE 924
            +L G+C  G++++L+Y +ME GSL+  + +R      L W  RL IA   AR L +LH  
Sbjct: 812  SLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKV 871

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
            C P ++HRDVK+SN+LLD++ +A + DFGLAR++   D+HV+T + GT+GY+ PEY Q+ 
Sbjct: 872  CEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSL 931

Query: 985  QATTKGDVYSFGVLAMELATGRRALE--GGEEC--LVEWGRRVMGYGRHGPGRAVIPVVL 1040
             AT +GDVYSFGV+ +EL TGRR +E   G+ C  LV    ++    R           L
Sbjct: 932  IATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEKREAE--------L 983

Query: 1041 LGSGLAEGAEEMS--ELLRIGVRCTAEAPNARPNVKEVLAML 1080
            + + + E   E +  E+L I  +C    P  RP ++EV+  L
Sbjct: 984  IDTTIRENVNERTVLEMLEIACKCIDHEPRRRPLIEEVVTWL 1025

Phytosulfokine receptor with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1088
255547303	1099	Brassinosteroid LRR receptor kinase prec	0.988	0.979	0.714	0.0
224124210	1067	predicted protein [Populus trichocarpa]	0.967	0.986	0.717	0.0
359491677	1101	PREDICTED: probable LRR receptor-like se	0.989	0.978	0.692	0.0
224121496	1070	predicted protein [Populus trichocarpa]	0.946	0.962	0.698	0.0
449441073	1558	PREDICTED: probable LRR receptor-like se	0.964	0.673	0.673	0.0
449477563	1588	PREDICTED: probable LRR receptor-like se	0.964	0.660	0.673	0.0
18410596	1106	putative LRR receptor-like serine/threon	0.988	0.972	0.655	0.0
12324800	1079	putative receptor protein kinase; 10992-	0.971	0.979	0.661	0.0
297839311	1103	hypothetical protein ARALYDRAFT_895304 [	0.988	0.974	0.648	0.0
356513513	1090	PREDICTED: probable LRR receptor-like se	0.987	0.985	0.645	0.0

>gi|255547303|ref|XP_002514709.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis] gi|223546313|gb|EEF47815.1| Brassinosteroid LRR receptor kinase precursor, putative [Ricinus communis]

 Score = 1531 bits (3963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 777/1088 (71%), Positives = 898/1088 (82%), Gaps = 12/1088 (1%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ 62
            M ++E D W   LF+F +L+    VAGDSL+TDREVL NL+SFLE  N VN G Y QW Q
Sbjct: 1    MPEEEADLWGVVLFIFLILIAGVVVAGDSLDTDREVLLNLKSFLEEKNQVNRGQYTQWGQ 60

Query: 63   -SSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPD 121
             S +PC W GI+CS D +RV G+ L   NISG ++NNFS+LT LSYLDLS+N   G I +
Sbjct: 61   FSKNPCNWSGIMCSEDGSRVTGVKLIGNNISGLLYNNFSSLTALSYLDLSQNYIGGVINN 120

Query: 122  DLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            DLS+C++L +LNLSHN+L G+LNL+GL +L+ILDLS+NR  G I +SFPAIC KLVVAN+
Sbjct: 121  DLSNCQNLAHLNLSHNMLEGELNLTGLSNLQILDLSLNRFFGGIQYSFPAICNKLVVANI 180

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFK 241
            S NN TGRID CFDGCL+L+YLDLSSN F G IWNG ++L EFSVS+N LSG +    F 
Sbjct: 181  SGNNFTGRIDNCFDGCLSLQYLDLSSNLFSGRIWNGFSRLKEFSVSQNFLSGEILGLSFG 240

Query: 242  ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK 301
            ENCSL+  DLSEN F  + P E+SNC+NL VLN++GN F+G IP+EIG IS LE LFLG 
Sbjct: 241  ENCSLQELDLSENNFTNELPKEISNCKNLTVLNVWGNKFNGQIPSEIGLISSLEGLFLGN 300

Query: 302  NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            N+F  +IPESLLNLSKL  LDLS N+FGG+VQKIFGRFTQVK L LH NSY  G+ SSGI
Sbjct: 301  NSFSQIIPESLLNLSKLAFLDLSRNSFGGDVQKIFGRFTQVKFLVLHGNSYTGGLYSSGI 360

Query: 362  LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
            LKL N+ RLDLS+NNF+G LPVEISQM SLK+LILA+N+FNGSIP  YGN P++Q+LDLS
Sbjct: 361  LKLQNVVRLDLSYNNFSGSLPVEISQMPSLKYLILAYNQFNGSIPKEYGNFPSIQSLDLS 420

Query: 422  FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            FN LTGPIP S GNL SLLWLMLANN L+GEIP E+GNC+SLLWLNL+NN LSG+IPPE+
Sbjct: 421  FNSLTGPIPSSFGNLRSLLWLMLANNMLTGEIPKELGNCSSLLWLNLANNNLSGHIPPEL 480

Query: 482  MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDR 541
              IGRN  PTF +NQ+N E  IAGS ECL+MKRWIPADYPPFSFVY ILTRKSCRS+WDR
Sbjct: 481  TNIGRNPTPTFLSNQQN-EGIIAGSGECLAMKRWIPADYPPFSFVYIILTRKSCRSIWDR 539

Query: 542  LLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK 601
            LL+G G+FPVC  G    T +ITGYLQLSGNQLSGE+  DIGK+QN S++HLG NQ  GK
Sbjct: 540  LLRGIGLFPVCAAGSTISTLEITGYLQLSGNQLSGEVPQDIGKMQNLSLLHLGSNQISGK 599

Query: 602  LPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSK 661
            LP Q  +LPL+VLNL++N FSGEIP+E G+IKC+QNLDLSYNNFSG FPA  N+L+ L++
Sbjct: 600  LPPQIGRLPLVVLNLSKNGFSGEIPNEIGSIKCIQNLDLSYNNFSGSFPAILNDLSGLNQ 659

Query: 662  LNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNT 721
             NISYNPL+SG IPSTGQLATFEK SYLG+P L LP FI N       YP  N R G   
Sbjct: 660  FNISYNPLISGIIPSTGQLATFEKDSYLGNPNLVLPKFISNST----DYPPKNRRIGRKK 715

Query: 722  KLTIILA----FLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGS 777
            +  +  A     L L +A L+CGVLS+I+++L K P++  GYLL+ +KYRHDL SSSG S
Sbjct: 716  REHVTWAGLLVVLTLALAFLVCGVLSVIVWILGKSPSDSPGYLLQEIKYRHDLTSSSGSS 775

Query: 778  SPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL 837
            SPWLSDTVKVIRLDKTAFT++DILKATG FSE RIIGKGGFGTVYRGVLPDGREVAVKKL
Sbjct: 776  SPWLSDTVKVIRLDKTAFTHADILKATGNFSESRIIGKGGFGTVYRGVLPDGREVAVKKL 835

Query: 838  QREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIIS 897
            QREG+EGE+EFRAEMEVL+GNGFGWPHPNLVTLYGWCL+GSEKIL+YEYM+GGSLED+IS
Sbjct: 836  QREGIEGEKEFRAEMEVLTGNGFGWPHPNLVTLYGWCLNGSEKILIYEYMKGGSLEDLIS 895

Query: 898  DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
            DR +LTWRRR DIAIDVARALVFLHHECYP IVHRDVKASNVLLDK+GKA VTDFGLAR 
Sbjct: 896  DRMKLTWRRRTDIAIDVARALVFLHHECYPAIVHRDVKASNVLLDKDGKARVTDFGLARF 955

Query: 958  VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
            V AGDSHV+T +AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA++GGEECLV
Sbjct: 956  VDAGDSHVTTMVAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAVDGGEECLV 1015

Query: 1018 EWGRRVMGYGRHG--PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075
            EW RRV+G GR+G   GR++IPV+ LGSGLAEGA EM ELLRIG+RCTAE+P ARPN+KE
Sbjct: 1016 EWARRVIGNGRNGGLSGRSMIPVIFLGSGLAEGAVEMCELLRIGIRCTAESPQARPNMKE 1075

Query: 1076 VLAMLIKI 1083
            VLAMLIKI
Sbjct: 1076 VLAMLIKI 1083

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124210|ref|XP_002330132.1| predicted protein [Populus trichocarpa] gi|222871266|gb|EEF08397.1| predicted protein [Populus trichocarpa]

 Score = 1520 bits (3935), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 762/1062 (71%), Positives = 874/1062 (82%), Gaps = 9/1062 (0%)

Query: 27   VAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ-SSSPCEWPGIICSPDKARVNGLN 85
            V+GDSL+TDR+VL  L+SFLE  N VN G Y QWNQ SS+PC W GI+C+ D +RV G+N
Sbjct: 8    VSGDSLDTDRQVLLGLKSFLEERNHVNRGQYSQWNQQSSNPCNWSGILCTLDGSRVRGIN 67

Query: 86   LTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNL 145
            L   NISGD++ NFS+LT L+YLDLS+NT  G++P DLS+C++L YLNLSHNIL G+LNL
Sbjct: 68   LAVNNISGDLYGNFSSLTALTYLDLSQNTLGGAVPGDLSNCQNLVYLNLSHNILEGELNL 127

Query: 146  SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDL 205
            +GL  LE LDLS NRI G I FSFP IC  L+VAN+S NN +G ID  FDGCL L+YLDL
Sbjct: 128  TGLTKLETLDLSTNRIFGGIQFSFPGICNNLIVANVSANNFSGGIDNFFDGCLKLQYLDL 187

Query: 206  SSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKEN-CSLEIFDLSENEFIGDFPGEV 264
            SSN F G IW G ++L EFSVSEN LSG VS S F EN CSL++ DLS N FIG  P EV
Sbjct: 188  SSNFFSGAIWKGFSRLKEFSVSENYLSGEVSGSFFAENNCSLQVLDLSGNNFIGKVPSEV 247

Query: 265  SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
            SNCRNL +LNL+GN+F+G IP+EIG IS LE LFLG N F   IPESLLNL  L  LDLS
Sbjct: 248  SNCRNLSILNLWGNSFTGEIPSEIGLISSLEGLFLGNNTFSPTIPESLLNLGNLAFLDLS 307

Query: 325  SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE 384
             N+FGG++Q+IFGRFTQ+KIL LH NSYIDG+NSSGILKLPN+  LDLS+N+FTGPLPVE
Sbjct: 308  RNHFGGDIQQIFGRFTQLKILVLHGNSYIDGINSSGILKLPNLVGLDLSNNSFTGPLPVE 367

Query: 385  ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML 444
            IS+M +LKFLILA+N+FN +IP  YGN   LQ LDLSFN L+G IP S+G L SLLWLML
Sbjct: 368  ISEMHNLKFLILAYNQFNSNIPQEYGNFRGLQALDLSFNNLSGQIPSSLGKLRSLLWLML 427

Query: 445  ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIA 504
            ANN+L+GEIP E+G+CTSLLWLNL+NN+LSG+IP E+M +G +   TFE+NQR+G   IA
Sbjct: 428  ANNTLTGEIPAELGSCTSLLWLNLANNQLSGSIPRELMKVGMDPSQTFESNQRDGG-IIA 486

Query: 505  GSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQIT 564
            GS ECL+MKRWIPADYPPFSF+YTIL RK+CRS+WDRL+KG G+FPVC  G   RT QI+
Sbjct: 487  GSGECLTMKRWIPADYPPFSFIYTILNRKTCRSIWDRLIKGVGLFPVCAAGSTVRTLQIS 546

Query: 565  GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            GYLQLSGNQLSGE+  DIGK+ +FSM+HLGFN   G LP Q  QLPL+VLNLT+N FSGE
Sbjct: 547  GYLQLSGNQLSGEVPGDIGKMHSFSMIHLGFNNLSGTLPPQIGQLPLVVLNLTKNTFSGE 606

Query: 625  IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFE 684
            IP+E GN +C++NLDLS NNFSG FP S NNL+ELSK NISYNPL+SGTIP+TGQLATFE
Sbjct: 607  IPNEIGNAECIKNLDLSCNNFSGTFPVSLNNLSELSKFNISYNPLISGTIPTTGQLATFE 666

Query: 685  KTSYLGDPLLDLPDFIENGPHHGHKYPNS--NGRTGNNTKLTIILAFLALLMACLICGVL 742
            K SYLGDPLL LP FI N        PN           K   +L  L + +A LICG+ 
Sbjct: 667  KDSYLGDPLLKLPSFINNSMG---SPPNQYPKIEKKEPKKWVAVLVLLTMTVALLICGLA 723

Query: 743  SIIIYMLVKRPAEQQGYLLEGMKY-RHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDIL 801
            S+++ MLVK PAE  GYLL+  K+ RHD ASSS  SSPW SDTVKVIRLD+TAFT++DIL
Sbjct: 724  SLVVCMLVKSPAESPGYLLDDTKHLRHDFASSSWSSSPWSSDTVKVIRLDRTAFTHADIL 783

Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            KATG F+E RIIGKGGFGTVYRGVLPDGREVAVKKLQREG+EGE+EFRAEMEVL+GNGFG
Sbjct: 784  KATGNFTESRIIGKGGFGTVYRGVLPDGREVAVKKLQREGIEGEKEFRAEMEVLTGNGFG 843

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
            WPHPNLVTLYGWCLDG+EKILVYEYMEGGSLED+ISDRTRLTWRRR+DIAIDVARALVFL
Sbjct: 844  WPHPNLVTLYGWCLDGTEKILVYEYMEGGSLEDLISDRTRLTWRRRIDIAIDVARALVFL 903

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            HHECYP IVHRDVKASNVLLDK+GKA VTDFGLAR V  GDSHVST +AGTVGYVAPEYG
Sbjct: 904  HHECYPAIVHRDVKASNVLLDKDGKARVTDFGLARFVDVGDSHVSTMVAGTVGYVAPEYG 963

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
            QT+ ATTKGDVYSFGVL+MELATGRRA++GGEECL+EW RRVMG GRHG  RA IPVVLL
Sbjct: 964  QTFHATTKGDVYSFGVLSMELATGRRAVDGGEECLLEWARRVMGSGRHGLSRARIPVVLL 1023

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
            GSGLAEGAEEM +LLRIG+ CTAEAP  RPN+KEVLAMLIK+
Sbjct: 1024 GSGLAEGAEEMCDLLRIGIGCTAEAPQWRPNMKEVLAMLIKL 1065

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491677|ref|XP_002281604.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g74360-like [Vitis vinifera]

 Score = 1511 bits (3911), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 751/1084 (69%), Positives = 880/1084 (81%), Gaps = 7/1084 (0%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ 62
            M D+E D     L +  VL+    VAGDSLETDREVL +L+ FLE+NN VN G Y +WN 
Sbjct: 1    MRDEETDIRVVGLMISLVLITGRIVAGDSLETDREVLLSLKKFLEDNNQVNRGRYQEWNL 60

Query: 63   SS-SPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPD 121
            SS +PC+WPGI+CS D  RV  +NL+D +ISG+IF+NFSALT+LS+LDLS+NT  G IP 
Sbjct: 61   SSWNPCDWPGILCSND-GRVISVNLSDNSISGEIFHNFSALTKLSHLDLSKNTLGGRIPA 119

Query: 122  DLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            DL  C SL YLNLSHNI++ +LNL+GL+SLE+LDLS+NRI GEI  +FPA+C++LV+AN+
Sbjct: 120  DLRRCESLVYLNLSHNIINDELNLTGLKSLEVLDLSINRIGGEIQLTFPAVCDRLVLANI 179

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFK 241
            S NN TG ID CFD C +L+YLDLSSNNF G IW G A+L +FS SEN   GVVS S+F 
Sbjct: 180  SENNFTGSIDNCFDECKSLKYLDLSSNNFSGEIWQGFARLQQFSASENRFGGVVSPSIFG 239

Query: 242  ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK 301
              C+L + +LS+N F G+ PGE++NC +L +LNL+GN+F+GPIP E+GS+S LE LFLG 
Sbjct: 240  GVCALGLLELSKNSFGGEVPGEIANCTSLRILNLWGNHFTGPIPPELGSLSSLEGLFLGN 299

Query: 302  NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            NNF   +PESLLNLS L  LDLS NNFGGE+Q+IFG+F QV+ L LH+NSY  G+ SSGI
Sbjct: 300  NNFSRQVPESLLNLSSLAFLDLSKNNFGGEIQEIFGKFKQVRFLVLHTNSYTGGIYSSGI 359

Query: 362  LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
            LKL NISRLDLS NNF+GPLPVE+S+M SL+FLILAHN+F+GSIP  +GN+  LQ LDLS
Sbjct: 360  LKLSNISRLDLSFNNFSGPLPVELSEMPSLEFLILAHNQFSGSIPPEFGNIRRLQALDLS 419

Query: 422  FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            FN L G IP +IG L SLLWLMLANN  SGEIP EIGNCTSLLWLNL+NN+ SG IPPE+
Sbjct: 420  FNSLNGSIPSTIGKLNSLLWLMLANNRFSGEIPPEIGNCTSLLWLNLANNQFSGKIPPEL 479

Query: 482  MTIGRNARPTFEANQRNGERTI-AGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
             TIGRN  PTFE N++N  R I AGS EC  M RWIPA+YPPFSF YT+LTR+SCRSLWD
Sbjct: 480  TTIGRNPFPTFEMNRKN--RGIPAGSGECQVMMRWIPANYPPFSFAYTLLTRRSCRSLWD 537

Query: 541  RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
             LLKG G+FP+CL G   RT QI+GY+Q+SGNQ SGE+ P+I  +QNFS++ +  N+F G
Sbjct: 538  NLLKGHGLFPMCLTGSKVRTLQISGYVQISGNQFSGEVPPEIRNMQNFSLIQMAANKFYG 597

Query: 601  KLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS 660
            KLP    QLP++VLNL+ NNFSGEIP E GN+ CLQNLDLS NNFSG FP S NNL+EL+
Sbjct: 598  KLPPAIGQLPVVVLNLSENNFSGEIPMEIGNLGCLQNLDLSSNNFSGTFPTSLNNLSELN 657

Query: 661  KLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNN 720
            K NISYNPL+SG IPSTGQLATFEK S+LGDPLL LP FI N  +H      S+G+    
Sbjct: 658  KFNISYNPLISGVIPSTGQLATFEKESFLGDPLLVLPPFIGNPSNHPPPTAKSDGKP--K 715

Query: 721  TKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPW 780
             K T    FL L +A ++CG++S+++ +L+K P +  GYLL+  KYRHD ASSS  SSPW
Sbjct: 716  QKFTSAFVFLTLTVAFIMCGLVSLLVCVLLKNPVDSSGYLLDDSKYRHDFASSSEVSSPW 775

Query: 781  LSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQRE 840
            LS  VKVIRLDKTAFTY+DIL AT  FS+ RIIGKGGFGTVYRGVLPDGREVAVKKLQR+
Sbjct: 776  LSGAVKVIRLDKTAFTYADILMATCNFSDSRIIGKGGFGTVYRGVLPDGREVAVKKLQRD 835

Query: 841  GLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT 900
            G+EGE+EFRAEMEVLSGNG GWPHPNLVTLYGWCL+GSEK+LVYEYMEGGSLED+ISDR 
Sbjct: 836  GIEGEKEFRAEMEVLSGNGLGWPHPNLVTLYGWCLNGSEKLLVYEYMEGGSLEDLISDRM 895

Query: 901  RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
            RLTWRRRLD+AIDVARALVFLHHEC+  IVHRDVKASNVLLD+ GKA VTDFGLARVV  
Sbjct: 896  RLTWRRRLDVAIDVARALVFLHHECFTAIVHRDVKASNVLLDRNGKARVTDFGLARVVDD 955

Query: 961  GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020
            G+SHVST +AGTVGYVAPEYGQT QATTKGDVYSFGVL+MELATGR AL+GGEECLVEW 
Sbjct: 956  GNSHVSTMVAGTVGYVAPEYGQTGQATTKGDVYSFGVLSMELATGRHALDGGEECLVEWA 1015

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            RRVMG GR G  RAVIPVV+LGSGLAEGAEEM ELLRIG++CTAE+P ARPN+KEVLAML
Sbjct: 1016 RRVMGNGRQGLSRAVIPVVMLGSGLAEGAEEMRELLRIGIKCTAESPQARPNMKEVLAML 1075

Query: 1081 IKIL 1084
            I IL
Sbjct: 1076 ITIL 1079

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121496|ref|XP_002318597.1| predicted protein [Populus trichocarpa] gi|222859270|gb|EEE96817.1| predicted protein [Populus trichocarpa]

 Score = 1472 bits (3811), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 741/1061 (69%), Positives = 857/1061 (80%), Gaps = 31/1061 (2%)

Query: 27   VAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWN-QSSSPCEWPGIICSPDKARVNGLN 85
            VAGDSLETDR+VL +L+SFLE  N VN G Y QWN QSS+PC W GI+C+ D +RV+ +N
Sbjct: 14   VAGDSLETDRQVLLDLKSFLEERNQVNRGQYSQWNRQSSNPCNWSGILCTHDGSRVSAIN 73

Query: 86   LTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNL 145
             T  NISGD++NNFS+LT L+YLDLSRNTF+G++P DLS+C++L YLNLSHNIL G+LNL
Sbjct: 74   FTASNISGDLYNNFSSLTALTYLDLSRNTFTGAVPSDLSNCQNLVYLNLSHNILEGELNL 133

Query: 146  SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDL 205
            +GL  LE LDLS+NRI G                        GRID  FDGCL L++LDL
Sbjct: 134  TGLSKLETLDLSMNRIFG------------------------GRIDNVFDGCLKLQFLDL 169

Query: 206  SSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF-KENCSLEIFDLSENEFIGDFPGEV 264
            S+N F G IW G ++L EFSVSEN LSG VS S F K NCSL++ DLS N F G  P  V
Sbjct: 170  STNFFSGEIWKGFSRLKEFSVSENYLSGEVSESFFSKNNCSLQVLDLSGNNFTGKVPSNV 229

Query: 265  SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
            SNCRNL +LNL+GNNF+G IP+EIG IS L+ LFLG N F   IPESLLNL  L  LDLS
Sbjct: 230  SNCRNLDILNLWGNNFNGQIPSEIGLISSLKGLFLGNNTFSPTIPESLLNLRNLVFLDLS 289

Query: 325  SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE 384
             NNFGG++QKI GRFTQ+K L LH NSY  G+ SSGILKL N+ RLDLS+NNFTGPLPVE
Sbjct: 290  RNNFGGDIQKIMGRFTQLKFLVLHGNSYTGGLYSSGILKLANLVRLDLSNNNFTGPLPVE 349

Query: 385  ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML 444
            IS+M SLKFLILA+NRFN +IP  YGN  NLQ LDLSFN LTG IP S+G L SLLWLML
Sbjct: 350  ISEMHSLKFLILAYNRFNITIPQEYGNFQNLQALDLSFNNLTGQIPSSLGKLRSLLWLML 409

Query: 445  ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIA 504
            ANN L+GEIP E+GNC+SLLWLNL+NN+LSG+IP E+M +GR+  PTFE+N+++ E  IA
Sbjct: 410  ANNKLTGEIPPELGNCSSLLWLNLANNQLSGSIPHELMNVGRDPTPTFESNKQD-EGIIA 468

Query: 505  GSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQIT 564
            GS ECL+MKRWIPADYPPFSFVYTIL RK+CRS+WDRLLKG G+FPVC  G   RTFQI+
Sbjct: 469  GSGECLTMKRWIPADYPPFSFVYTILNRKTCRSIWDRLLKGVGLFPVCAAGSTVRTFQIS 528

Query: 565  GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            GYLQLSGNQLSGE+  DIGK+Q+FSM+HLGFN+ +G+LP Q  +LPL+VLNLT+N FSGE
Sbjct: 529  GYLQLSGNQLSGEVPGDIGKMQSFSMLHLGFNELNGRLPPQIGKLPLVVLNLTKNKFSGE 588

Query: 625  IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFE 684
            IP+E GN KCLQNLDLSYNNFSG FP S NNL+E+SK NISYNPL+SGT+P+TGQ+ATFE
Sbjct: 589  IPNEIGNTKCLQNLDLSYNNFSGTFPVSLNNLSEVSKFNISYNPLISGTVPTTGQMATFE 648

Query: 685  KTSYLGDPLLDLPDFIENGPHHG-HKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLS 743
            K SYLGDPLL LP+FI N      ++YP    +   N K   +L  L + MA LICG++S
Sbjct: 649  KESYLGDPLLKLPNFIINSMDPPPNEYPKIKKKE--NKKWVAVLVLLTMTMAFLICGLVS 706

Query: 744  IIIYMLVKRPAEQQGYLLEGMKYR-HDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILK 802
            + + MLVK P E   YL E  KYR HD  SSSG SSP  SDTVKVIRLD+TAFT++DILK
Sbjct: 707  LFVCMLVKSPPESPRYLFEDTKYRQHDFESSSGSSSPCFSDTVKVIRLDRTAFTHADILK 766

Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            AT  FSE RIIGKGGFGTVYRGVLPDGREVA+KKLQREG+EGE+EFRAEMEVL+GNGFGW
Sbjct: 767  ATDSFSESRIIGKGGFGTVYRGVLPDGREVAIKKLQREGIEGEKEFRAEMEVLTGNGFGW 826

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            PHPNLV LYGWCL G+EKILVYEYMEGGSLED+ISDR RL WRRR+DIAIDV +ALV+LH
Sbjct: 827  PHPNLVALYGWCLYGAEKILVYEYMEGGSLEDVISDRMRLPWRRRIDIAIDVGQALVYLH 886

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
            HEC   IVHRDVKASNVLLDK+G+A VTDFGLAR V  GDSHVSTT+AGT+GYVAPEYGQ
Sbjct: 887  HECSLAIVHRDVKASNVLLDKDGRARVTDFGLARFVDVGDSHVSTTVAGTIGYVAPEYGQ 946

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
            +  ATTKGDVYSFGVLAMELATGRRA++GGEECL+EW RRVMG  R+G  RA+IPVVLLG
Sbjct: 947  SLHATTKGDVYSFGVLAMELATGRRAVDGGEECLLEWARRVMGSWRYGFSRAMIPVVLLG 1006

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
            SGL E AEEM ELL+IG+RCTAEAP +RPN+KEVLAMLIK+
Sbjct: 1007 SGLVEEAEEMFELLKIGIRCTAEAPQSRPNMKEVLAMLIKL 1047

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449441073|ref|XP_004138308.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g74360-like, partial [Cucumis sativus]

 Score = 1471 bits (3809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 709/1053 (67%), Positives = 853/1053 (81%), Gaps = 4/1053 (0%)

Query: 32   LETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNI 91
            L  + EVL  L+SFLE +NP+  G Y  WN  SSPC W GI C+ +K++V G++L++ +I
Sbjct: 502  LRDNTEVLLQLKSFLEEHNPIKRGKYSSWNLESSPCSWAGISCNQNKSQVIGIDLSNEDI 561

Query: 92   SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSL 151
            SG IF+NFSAL++L+ LDLSRNT SG IP DL++CR+L+ LNLSHNI+   LNLSGL ++
Sbjct: 562  SGKIFHNFSALSELTDLDLSRNTLSGEIPGDLNNCRNLRKLNLSHNIIDDKLNLSGLINI 621

Query: 152  EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
            E LDLSVNRI GEI  +FP IC  L+  N+S NNLTGR D CFD C NL+++DLSSN F 
Sbjct: 622  ETLDLSVNRIWGEIRLNFPGICRTLMFFNVSGNNLTGRTDDCFDECWNLQHVDLSSNEFS 681

Query: 212  GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV 271
            G +W+GLA+   FS SEN LSG VS ++F   C+LE+ DLSEN   G  P EVSNC NL 
Sbjct: 682  GGLWSGLARTRFFSASENKLSGEVSPAIFTGVCNLEVLDLSENALFGGAPAEVSNCGNLS 741

Query: 272  VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
             LNL+GN FSG IPAE+G ISGL+ L+LGKNNF   IPESLLNLS L  LDLS N+FGG+
Sbjct: 742  SLNLWGNQFSGKIPAEMGRISGLQNLYLGKNNFSREIPESLLNLSNLVFLDLSKNHFGGD 801

Query: 332  VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSL 391
            +Q+IFGRFTQV+ L LH N Y  G++SSGILKLP ++RLDLS NNF+GPLPVEIS+M+SL
Sbjct: 802  IQEIFGRFTQVRFLVLHGNFYTGGIHSSGILKLPRVARLDLSFNNFSGPLPVEISEMKSL 861

Query: 392  KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG 451
            +FLILA+N+FNG+IP+ YGN+ NLQ LDLSFN L G IP S GNLTSLLWLMLANNSL+G
Sbjct: 862  EFLILAYNQFNGNIPSEYGNLKNLQALDLSFNRLNGSIPSSFGNLTSLLWLMLANNSLTG 921

Query: 452  EIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLS 511
            EIP E+G+C+SLLWLNL+NNKL G IP E+  IG+NA  TFE N+R  E+ IAGS ECL+
Sbjct: 922  EIPRELGSCSSLLWLNLANNKLHGRIPSELTNIGKNATATFEINRRT-EKFIAGSGECLA 980

Query: 512  MKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSG 571
            MKRWIP DYPPFSFVYTILTRKSCRS+WDRLLKG G+FP C      RT QI+GY+QL+G
Sbjct: 981  MKRWIPVDYPPFSFVYTILTRKSCRSIWDRLLKGYGLFPFCSK---IRTLQISGYVQLTG 1037

Query: 572  NQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGN 631
            NQ SGE+  +IG ++NFSM+HL FN F GKLP Q   LPL+VLN++ NNFSGEIP E G+
Sbjct: 1038 NQFSGEIPNEIGMMKNFSMLHLSFNNFSGKLPPQLGSLPLVVLNISDNNFSGEIPMEIGD 1097

Query: 632  IKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGD 691
            +KCLQNLDLSYNNFSG FP SF NL EL+K NISYNPL++G +  +GQ +TF+K +YLG+
Sbjct: 1098 LKCLQNLDLSYNNFSGMFPRSFVNLNELNKFNISYNPLITGEVIPSGQFSTFDKDAYLGN 1157

Query: 692  PLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVK 751
            PLL LP F    P      P + G +  N++L  +LA L+L++A L+ G  S+I++++V+
Sbjct: 1158 PLLRLPSFFNTTPPKSAGNPRTAGSSKRNSRLVGMLASLSLILAFLVFGTFSLIVFLMVR 1217

Query: 752  RPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDR 811
               E +G+LLE +KY  D  SSS  SSPW S+TV VIRLDKT FT++DILKATG FSEDR
Sbjct: 1218 SSDESRGFLLEDIKYIKDFGSSSHSSSPWFSNTVTVIRLDKTVFTHADILKATGNFSEDR 1277

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +IGKGG+GTVYRG+LPDGR+VAVKKLQREG+EGEREF+AEM++L+GNGF WPHPNLV LY
Sbjct: 1278 VIGKGGYGTVYRGMLPDGRQVAVKKLQREGVEGEREFQAEMQILTGNGFNWPHPNLVQLY 1337

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
            GWCLDGSEKILVYEYMEGGSL+D+I DR RL WRRR+D+AIDVARALVFLHHEC+P +VH
Sbjct: 1338 GWCLDGSEKILVYEYMEGGSLDDLILDRLRLNWRRRIDLAIDVARALVFLHHECFPSVVH 1397

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RDVKASNVLLDK+G+  VTDFGLAR++  GDSHVST +AGT+GYVAPEYGQTW+ATTKGD
Sbjct: 1398 RDVKASNVLLDKDGRGRVTDFGLARIMDVGDSHVSTMVAGTIGYVAPEYGQTWKATTKGD 1457

Query: 992  VYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEE 1051
            VYSFGVLAMELAT RRAL+GGEECLVEW +RVMG GRHG  RAVIPV +LGSGL EGA+E
Sbjct: 1458 VYSFGVLAMELATARRALDGGEECLVEWAKRVMGNGRHGLSRAVIPVAVLGSGLVEGADE 1517

Query: 1052 MSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            M ELL+IGVRCT EAP+ARPN+KEVLAMLI I+
Sbjct: 1518 MCELLKIGVRCTNEAPSARPNMKEVLAMLIDII 1550

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449477563|ref|XP_004155058.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g74360-like [Cucumis sativus]

 Score = 1466 bits (3794), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 709/1053 (67%), Positives = 853/1053 (81%), Gaps = 4/1053 (0%)

Query: 32   LETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNI 91
            L  + EVL  L+SFLE +NP+  G Y  WN  SSPC W GI C+ +K++V G++L++ +I
Sbjct: 523  LRDNTEVLLQLKSFLEEHNPIKRGKYSSWNLESSPCSWAGISCNQNKSQVIGIDLSNEDI 582

Query: 92   SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSL 151
            SG IF+NFSAL++L+ LDLSRNT SG IP DL++CR+L+ LNLSHNI+   LNLSGL ++
Sbjct: 583  SGKIFHNFSALSELTDLDLSRNTLSGEIPGDLNNCRNLRKLNLSHNIIDDKLNLSGLINI 642

Query: 152  EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
            E LDLSVNRI GEI  +FP IC  L+  N+S NNLTGR D CFD C NL+++DLSSN F 
Sbjct: 643  ETLDLSVNRIWGEIRLNFPGICRTLMFFNVSGNNLTGRTDDCFDECWNLQHVDLSSNEFS 702

Query: 212  GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV 271
            G +W+GLA+   FS SEN LSG VS ++F   C+LE+ DLSEN   G  P EVSNC NL 
Sbjct: 703  GGLWSGLARTRFFSASENKLSGEVSPAIFTGVCNLEVLDLSENALFGGAPAEVSNCGNLS 762

Query: 272  VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
             LNL+GN FSG IPAE+G ISGL+ L+LGKNNF   IPESLLNLS L  LDLS N+FGG+
Sbjct: 763  SLNLWGNQFSGKIPAEMGRISGLQNLYLGKNNFSREIPESLLNLSNLVFLDLSKNHFGGD 822

Query: 332  VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSL 391
            +Q+IFGRFTQV+ L LH N Y  G++SSGILKLP ++RLDLS NNF+GPLPVEIS+M+SL
Sbjct: 823  IQEIFGRFTQVRFLVLHGNFYTGGIHSSGILKLPRVARLDLSFNNFSGPLPVEISEMKSL 882

Query: 392  KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG 451
            +FLILA+N+FNG+IP+ YGN+ NLQ LDLSFN L G IP S GNLTSLLWLMLANNSL+G
Sbjct: 883  EFLILAYNQFNGNIPSEYGNLKNLQALDLSFNRLNGSIPSSFGNLTSLLWLMLANNSLTG 942

Query: 452  EIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLS 511
            EIP E+G+C+SLLWLNL+NNKL G IP E+  IG+NA  TFE N+R  E+ IAGS ECL+
Sbjct: 943  EIPRELGSCSSLLWLNLANNKLRGRIPSELANIGKNATATFEINRRT-EKFIAGSGECLA 1001

Query: 512  MKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSG 571
            MKRWIP DYPPFSFVYTILTRKSCRS+WDRLLKG G+FP C      RT QI+GY+QL+G
Sbjct: 1002 MKRWIPVDYPPFSFVYTILTRKSCRSIWDRLLKGYGLFPFCS---KIRTLQISGYVQLTG 1058

Query: 572  NQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGN 631
            NQ SGE+  +IG ++NFSM+HL FN F GKLP Q   LPL+VLN++ NNFSGEIP E G+
Sbjct: 1059 NQFSGEIPNEIGMMKNFSMLHLSFNNFSGKLPPQLGSLPLVVLNISDNNFSGEIPMEIGD 1118

Query: 632  IKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGD 691
            +KCLQNLDLSYNNFSG FP SF NL EL+K NISYNPL++G +  +GQ +TF+K +YLG+
Sbjct: 1119 LKCLQNLDLSYNNFSGMFPRSFVNLNELNKFNISYNPLITGEVIPSGQFSTFDKDAYLGN 1178

Query: 692  PLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVK 751
            PLL LP F    P      P + G +  N++L  +LA L+L++A L+ G  S+I++++V+
Sbjct: 1179 PLLRLPSFFNTTPPKSPGNPRTAGSSKRNSRLVGMLASLSLILAFLVFGTFSLIVFLMVR 1238

Query: 752  RPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDR 811
               E +G+LLE +KY  D  SSS  SSPW S+TV VIRLDKT FT++DILKATG FSEDR
Sbjct: 1239 SSDESRGFLLEDIKYIKDFGSSSHSSSPWFSNTVTVIRLDKTVFTHADILKATGNFSEDR 1298

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +IGKGG+GTVYRG+LPDGR+VAVKKLQREG+EGEREF+AEM++L+GNGF WPHPNLV LY
Sbjct: 1299 VIGKGGYGTVYRGMLPDGRQVAVKKLQREGVEGEREFQAEMQILTGNGFNWPHPNLVQLY 1358

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
            GWCLDGSEKILVYEYMEGGSL+D+I DR RL WRRR+D+AIDVARALVFLHHEC+P +VH
Sbjct: 1359 GWCLDGSEKILVYEYMEGGSLDDLILDRLRLNWRRRIDLAIDVARALVFLHHECFPSVVH 1418

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RDVKASNVLLDK+G+  VTDFGLAR++  GDSHVST +AGT+GYVAPEYGQTW+ATTKGD
Sbjct: 1419 RDVKASNVLLDKDGRGRVTDFGLARIMDVGDSHVSTMVAGTIGYVAPEYGQTWKATTKGD 1478

Query: 992  VYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEE 1051
            VYSFGVLAMELAT RRAL+GGEECLVEW +RVMG GRHG  RAVIPV +LGSGL EGA+E
Sbjct: 1479 VYSFGVLAMELATARRALDGGEECLVEWAKRVMGNGRHGLSRAVIPVAVLGSGLVEGADE 1538

Query: 1052 MSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            M ELL+IGVRCT EAP+ARPN+KEVLAMLI I+
Sbjct: 1539 MCELLKIGVRCTNEAPSARPNMKEVLAMLIDII 1571

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18410596|ref|NP_565084.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|264664459|sp|C0LGJ1.1|Y1743_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g74360; Flags: Precursor gi|224589485|gb|ACN59276.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332197461|gb|AEE35582.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana]

 Score = 1456 bits (3770), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 711/1085 (65%), Positives = 859/1085 (79%), Gaps = 9/1085 (0%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ 62
            M+DD++ S  F  F+    + A  VAGDSL++DREVL +L+S+LE+ NP N G Y +W  
Sbjct: 9    MTDDDSQSLCFLCFLLFFFITAIAVAGDSLDSDREVLLSLKSYLESRNPQNRGLYTEWKM 68

Query: 63   SSSP--CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIP 120
             +    C+WPGIIC+P ++RV G+NLTD  ISG +F NFSALT+L+YLDLSRNT  G IP
Sbjct: 69   ENQDVVCQWPGIICTPQRSRVTGINLTDSTISGPLFKNFSALTELTYLDLSRNTIEGEIP 128

Query: 121  DDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVAN 180
            DDLS C +LK+LNLSHNIL G+L+L GL +LE+LDLS+NRI G+I  SFP  C  LVVAN
Sbjct: 129  DDLSRCHNLKHLNLSHNILEGELSLPGLSNLEVLDLSLNRITGDIQSSFPLFCNSLVVAN 188

Query: 181  LSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF 240
            LS NN TGRID  F+GC NL+Y+D SSN F G +W G  +LVEFSV++N LSG +S+S+F
Sbjct: 189  LSTNNFTGRIDDIFNGCRNLKYVDFSSNRFSGEVWTGFGRLVEFSVADNHLSGNISASMF 248

Query: 241  KENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLG 300
            + NC+L++ DLS N F G+FPG+VSNC+NL VLNL+GN F+G IPAEIGSIS L+ L+LG
Sbjct: 249  RGNCTLQMLDLSGNAFGGEFPGQVSNCQNLNVLNLWGNKFTGNIPAEIGSISSLKGLYLG 308

Query: 301  KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSG 360
             N F   IPE+LLNL+ L  LDLS N FGG++Q+IFGRFTQVK L LH+NSY+ G+NSS 
Sbjct: 309  NNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGINSSN 368

Query: 361  ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
            ILKLPN+SRLDL +NNF+G LP EISQ++SLKFLILA+N F+G IP  YGNMP LQ LDL
Sbjct: 369  ILKLPNLSRLDLGYNNFSGQLPTEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDL 428

Query: 421  SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
            SFN+LTG IP S G LTSLLWLMLANNSLSGEIP EIGNCTSLLW N++NN+LSG   PE
Sbjct: 429  SFNKLTGSIPASFGKLTSLLWLMLANNSLSGEIPREIGNCTSLLWFNVANNQLSGRFHPE 488

Query: 481  VMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
            +  +G N  PTFE N++N ++ IAGS ECL+MKRWIPA++PPF+FVY ILT+KSCRSLWD
Sbjct: 489  LTRMGSNPSPTFEVNRQNKDKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWD 548

Query: 541  RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
             +LKG G+FPVC  G   RT +I+ YLQLSGN+ SGE+   I ++   S +HLGFN+F+G
Sbjct: 549  HVLKGYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEG 608

Query: 601  KLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS 660
            KLP +  QLPL  LNLTRNNFSGEIP E GN+KCLQNLDLS+NNFSG FP S N+L ELS
Sbjct: 609  KLPPEIGQLPLAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELS 668

Query: 661  KLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNN 720
            K NISYNP +SG IP+TGQ+ATF+K S+LG+PLL  P F     ++  K   SN   GN 
Sbjct: 669  KFNISYNPFISGAIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTRKI--SNQVLGNR 726

Query: 721  TK-LTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSP 779
             + L +I   LAL +A + C V+S I+ M+VK   E +  LL+G K RHD+ SSSGGSSP
Sbjct: 727  PRTLLLIWISLALALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHDMTSSSGGSSP 786

Query: 780  WLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQR 839
            WLS  +KVIRLDK+ FTY+DILKAT  FSE+R++G+GG+GTVYRGVLPDGREVAVKKLQR
Sbjct: 787  WLSGKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQR 846

Query: 840  EGLEGEREFRAEMEVLSGNGFG-WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD 898
            EG E E+EFRAEMEVLS N FG W HPNLV LYGWCLDGSEKILV+EYM GGSLE++I+D
Sbjct: 847  EGTEAEKEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITD 906

Query: 899  RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
            +T+L W++R+DIA DVAR LVFLHHECYP IVHRDVKASNVLLDK G A VTDFGLAR++
Sbjct: 907  KTKLQWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLL 966

Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
            + GDSHVST IAGT+GYVAPEYGQTWQATT+GDVYS+GVL MELATGRRA++GGEECLVE
Sbjct: 967  NVGDSHVSTVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDGGEECLVE 1026

Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            W RRVM       G    P+ L G+    GAE+M+ELL+IGV+CTA+ P ARPN+KEVLA
Sbjct: 1027 WARRVMTGNMTAKGS---PITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLA 1083

Query: 1079 MLIKI 1083
            ML+KI
Sbjct: 1084 MLVKI 1088

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|12324800|gb|AAG52362.1|AC011765_14 putative receptor protein kinase; 10992-14231 [Arabidopsis thaliana]

 Score = 1451 bits (3755), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 705/1066 (66%), Positives = 849/1066 (79%), Gaps = 9/1066 (0%)

Query: 22   VIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSP--CEWPGIICSPDKA 79
            + A  VAGDSL++DREVL +L+S+LE+ NP N G Y +W   +    C+WPGIIC+P ++
Sbjct: 1    MAAIAVAGDSLDSDREVLLSLKSYLESRNPQNRGLYTEWKMENQDVVCQWPGIICTPQRS 60

Query: 80   RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL 139
            RV G+NLTD  ISG +F NFSALT+L+YLDLSRNT  G IPDDLS C +LK+LNLSHNIL
Sbjct: 61   RVTGINLTDSTISGPLFKNFSALTELTYLDLSRNTIEGEIPDDLSRCHNLKHLNLSHNIL 120

Query: 140  SGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
             G+L+L GL +LE+LDLS+NRI G+I  SFP  C  LVVANLS NN TGRID  F+GC N
Sbjct: 121  EGELSLPGLSNLEVLDLSLNRITGDIQSSFPLFCNSLVVANLSTNNFTGRIDDIFNGCRN 180

Query: 200  LRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
            L+Y+D SSN F G +W G  +LVEFSV++N LSG +S+S+F+ NC+L++ DLS N F G+
Sbjct: 181  LKYVDFSSNRFSGEVWTGFGRLVEFSVADNHLSGNISASMFRGNCTLQMLDLSGNAFGGE 240

Query: 260  FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE 319
            FPG+VSNC+NL VLNL+GN F+G IPAEIGSIS L+ L+LG N F   IPE+LLNL+ L 
Sbjct: 241  FPGQVSNCQNLNVLNLWGNKFTGNIPAEIGSISSLKGLYLGNNTFSRDIPETLLNLTNLV 300

Query: 320  VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG 379
             LDLS N FGG++Q+IFGRFTQVK L LH+NSY+ G+NSS ILKLPN+SRLDL +NNF+G
Sbjct: 301  FLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGINSSNILKLPNLSRLDLGYNNFSG 360

Query: 380  PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL 439
             LP EISQ++SLKFLILA+N F+G IP  YGNMP LQ LDLSFN+LTG IP S G LTSL
Sbjct: 361  QLPTEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDLSFNKLTGSIPASFGKLTSL 420

Query: 440  LWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNG 499
            LWLMLANNSLSGEIP EIGNCTSLLW N++NN+LSG   PE+  +G N  PTFE N++N 
Sbjct: 421  LWLMLANNSLSGEIPREIGNCTSLLWFNVANNQLSGRFHPELTRMGSNPSPTFEVNRQNK 480

Query: 500  ERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASR 559
            ++ IAGS ECL+MKRWIPA++PPF+FVY ILT+KSCRSLWD +LKG G+FPVC  G   R
Sbjct: 481  DKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWDHVLKGYGLFPVCSAGSTVR 540

Query: 560  TFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRN 619
            T +I+ YLQLSGN+ SGE+   I ++   S +HLGFN+F+GKLP +  QLPL  LNLTRN
Sbjct: 541  TLKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEGKLPPEIGQLPLAFLNLTRN 600

Query: 620  NFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQ 679
            NFSGEIP E GN+KCLQNLDLS+NNFSG FP S N+L ELSK NISYNP +SG IP+TGQ
Sbjct: 601  NFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELSKFNISYNPFISGAIPTTGQ 660

Query: 680  LATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTK-LTIILAFLALLMACLI 738
            +ATF+K S+LG+PLL  P F     ++  K   SN   GN  + L +I   LAL +A + 
Sbjct: 661  VATFDKDSFLGNPLLRFPSFFNQSGNNTRKI--SNQVLGNRPRTLLLIWISLALALAFIA 718

Query: 739  CGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYS 798
            C V+S I+ M+VK   E +  LL+G K RHD+ SSSGGSSPWLS  +KVIRLDK+ FTY+
Sbjct: 719  CLVVSGIVLMVVKASREAEIDLLDGSKTRHDMTSSSGGSSPWLSGKIKVIRLDKSTFTYA 778

Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGN 858
            DILKAT  FSE+R++G+GG+GTVYRGVLPDGREVAVKKLQREG E E+EFRAEMEVLS N
Sbjct: 779  DILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQREGTEAEKEFRAEMEVLSAN 838

Query: 859  GFG-WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
             FG W HPNLV LYGWCLDGSEKILV+EYM GGSLE++I+D+T+L W++R+DIA DVAR 
Sbjct: 839  AFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITDKTKLQWKKRIDIATDVARG 898

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            LVFLHHECYP IVHRDVKASNVLLDK G A VTDFGLAR+++ GDSHVST IAGT+GYVA
Sbjct: 899  LVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLLNVGDSHVSTVIAGTIGYVA 958

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
            PEYGQTWQATT+GDVYS+GVL MELATGRRA++GGEECLVEW RRVM       G    P
Sbjct: 959  PEYGQTWQATTRGDVYSYGVLTMELATGRRAVDGGEECLVEWARRVMTGNMTAKGS---P 1015

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
            + L G+    GAE+M+ELL+IGV+CTA+ P ARPN+KEVLAML+KI
Sbjct: 1016 ITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLAMLVKI 1061

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297839311|ref|XP_002887537.1| hypothetical protein ARALYDRAFT_895304 [Arabidopsis lyrata subsp. lyrata] gi|297333378|gb|EFH63796.1| hypothetical protein ARALYDRAFT_895304 [Arabidopsis lyrata subsp. lyrata]

 Score = 1427 bits (3695), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 704/1085 (64%), Positives = 860/1085 (79%), Gaps = 10/1085 (0%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWN- 61
            M+D++++S  F  F+  VL+ A  VAGDSL+ DREVL +L+S+LE+ NP N G Y +W  
Sbjct: 7    MADNDSESLCFVCFLLFVLITAIAVAGDSLDNDREVLLSLKSYLESRNPQNRGMYSEWKM 66

Query: 62   QSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPD 121
            ++   C+W GI C+P ++RV G+NL+D  I+G +F NFSALT+L+YLDLSRNT  G IPD
Sbjct: 67   ENQDVCQWSGIKCTPQRSRVTGINLSDSTIAGPLFRNFSALTELTYLDLSRNTIQGEIPD 126

Query: 122  DLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            DLS C +LK+LNLSHNIL G+L+LSGL +LE+LDLS+NRI G+I  SFP  C  LVVANL
Sbjct: 127  DLSRCHNLKHLNLSHNILVGELSLSGLSNLEVLDLSLNRIAGDIQSSFPMFCNSLVVANL 186

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFK 241
            S NN TGRID  F+GC NL+Y+D SSN F G +W G  +LVEFSVS+N LSG +S+S+F+
Sbjct: 187  STNNFTGRIDDIFNGCRNLKYVDFSSNGFSGEVWAGFGRLVEFSVSDNHLSGNISASMFR 246

Query: 242  ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK 301
             NC+L++ DLS N F G+FPG+VSNC++L VLNL+GNNF G IPAEIGSIS L  L+LG 
Sbjct: 247  GNCTLQMLDLSGNNFGGEFPGQVSNCQSLSVLNLWGNNFIGNIPAEIGSISSLRGLYLGN 306

Query: 302  NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            N F   IPE+LLNLS L  LDLS N FGG++Q+I GRFTQVK L LH+NSY+ G+NSS I
Sbjct: 307  NTFSRDIPETLLNLSNLVFLDLSRNKFGGDIQEILGRFTQVKYLVLHANSYVGGINSSNI 366

Query: 362  LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
            LKLPN+ RLDL +NNF+G LP EISQ++SLKFLILA+N F+G IP  YGNMP LQ LDLS
Sbjct: 367  LKLPNLLRLDLGYNNFSGQLPAEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDLS 426

Query: 422  FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            FN LTG IP S G LTSLLWLMLANNSLSGEIP +IGNCTSLLW N++NN+LSG   PE+
Sbjct: 427  FNRLTGSIPASFGKLTSLLWLMLANNSLSGEIPRDIGNCTSLLWFNVANNQLSGRFHPEL 486

Query: 482  MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDR 541
              +G +  PTFE N++N ++ IAGS ECL+MKRWIPA++PPF+FVY ILT+KSCRSLWD 
Sbjct: 487  TRMGSDPSPTFEVNRQNNDKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWDH 546

Query: 542  LLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK 601
            +LKG G+FPVC  G   RT +I+ YLQLSGN+ SGE+  +I ++   S +HLGFN+F+GK
Sbjct: 547  VLKGYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPANISQMDRLSTLHLGFNEFEGK 606

Query: 602  LPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSK 661
            LP +  +LPL  LNLTRNNFSG+IP E GN+KCLQNLDLSYNNFSG FPAS N+L ELSK
Sbjct: 607  LPPEIGRLPLAFLNLTRNNFSGQIPQEIGNLKCLQNLDLSYNNFSGNFPASLNDLNELSK 666

Query: 662  LNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNT 721
             NISYNP +SG IP+TGQ+ATF+K S+LG+PLL  P F     ++  K   SN   GN  
Sbjct: 667  FNISYNPFISGVIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTRKI--SNQVLGNRP 724

Query: 722  KLTIILAFL--ALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSP 779
            + T++L ++  AL +A + C V+S I+ M+VK   E +  LL+G K RHD  SSSGGSSP
Sbjct: 725  R-TLLLIWISSALALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHDTTSSSGGSSP 783

Query: 780  WLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQR 839
            WLS  +KVIRLDK+ FTY+DILKAT  FSE+R++G+GG+GTVYRGVLPDGREVAVKKLQR
Sbjct: 784  WLSGKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQR 843

Query: 840  EGLEGEREFRAEMEVLSGNGFG-WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD 898
            EG E E+EFRAEMEVLS N FG W HPNLV LYGWCLDGSEKILV+EYM GGSLE++I+D
Sbjct: 844  EGTEAEKEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITD 903

Query: 899  RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
            +T+L W++R+DIA DVAR LVFLHHECYP IVHRDVKASNVLLD++G A VTDFGLAR++
Sbjct: 904  KTKLPWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDRQGNARVTDFGLARLL 963

Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
            + GDSHVST IAGT+GYVAPEYGQTWQATT+GDVYS+GVL MELATGRRA++GGEECLVE
Sbjct: 964  NVGDSHVSTVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDGGEECLVE 1023

Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            W RRVM       G    P  L G+    GAE+++ELL+IGV+CTA+ P ARPN+KEVLA
Sbjct: 1024 WVRRVMTDNMTAKGS---PFTLSGTKPGNGAEQLTELLKIGVKCTADHPQARPNMKEVLA 1080

Query: 1079 MLIKI 1083
            ML+KI
Sbjct: 1081 MLVKI 1085

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513513|ref|XP_003525458.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g74360-like [Glycine max]

 Score = 1382 bits (3576), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 699/1083 (64%), Positives = 861/1083 (79%), Gaps = 9/1083 (0%)

Query: 3    MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWN- 61
            MS+ E  S    LF F +L+    V G+SL+ D+EVL  L+ +L++    + G Y+ WN 
Sbjct: 1    MSEQETHSCGLLLFFFWILLSGKAVVGESLDKDKEVLLKLKLYLDSKILADRGGYIYWNT 60

Query: 62   QSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPD 121
             SS+PCEW GI CS  K RV G++L++ +I+G+IF NFS LT+L++LDLS+NT S  IP+
Sbjct: 61   NSSNPCEWKGISCSATK-RVVGIDLSNSDITGEIFKNFSQLTELTHLDLSQNTLSDEIPE 119

Query: 122  DLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            DL  C  L +LNLSHNIL G+LNL+GL SL  LDLS NR +G+I  +FPAIC  LV+AN+
Sbjct: 120  DLRHCHKLVHLNLSHNILEGELNLTGLISLCTLDLSNNRFYGDIGLNFPAICANLVIANV 179

Query: 182  SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFK 241
            S N LTGRI++CFD C+ L+YLDLS+NN  G+IW   A+L EF V+EN L+G +    F 
Sbjct: 180  SGNKLTGRIESCFDQCVKLQYLDLSTNNLSGSIWMKFARLNEFYVAENHLNGTIPLEAFP 239

Query: 242  ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK 301
             NCSL+  DLS+N F+G+ P  V+NC+NL  LNL  NN +G IP EIGSISGL+AL+LG 
Sbjct: 240  LNCSLQELDLSQNGFVGEAPKGVANCKNLTSLNLSSNNLTGTIPIEIGSISGLKALYLGN 299

Query: 302  NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            N+F   IPE+LLNL+ L  LDLS N FGG++ KIFG+F QV  L LHSN+Y  G+ SSGI
Sbjct: 300  NSFSRDIPEALLNLTNLSFLDLSRNQFGGDIPKIFGKFKQVSFLLLHSNNYSGGLISSGI 359

Query: 362  LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
            L LPNI RLDLS+NNF+GPLPVEISQM SLKFL+L++N+F+GSIP  +GN+  LQ LDL+
Sbjct: 360  LTLPNIWRLDLSYNNFSGPLPVEISQMTSLKFLMLSYNQFSGSIPPEFGNITQLQALDLA 419

Query: 422  FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            FN L+GPIP S+GNL+SLLWLMLA+NSL+GEIP E+GNC+SLLWLNL+NNKLSG++P E+
Sbjct: 420  FNNLSGPIPSSLGNLSSLLWLMLADNSLTGEIPLELGNCSSLLWLNLANNKLSGSLPSEL 479

Query: 482  MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDR 541
              IGRNA  TFE+N+RN +   AGS ECL+M+RWIPADYPPFSFVY++LTRK+CR LWD+
Sbjct: 480  SKIGRNATTTFESNRRNYQMA-AGSGECLAMRRWIPADYPPFSFVYSLLTRKTCRELWDK 538

Query: 542  LLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK 601
            LLKG G+F +C PG   R  QI+GY+QLS NQLSGE+  +IG + NFSM+HLGFN F GK
Sbjct: 539  LLKGYGVFQICTPGERIRRTQISGYIQLSSNQLSGEIPSEIGTMVNFSMMHLGFNNFSGK 598

Query: 602  LPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSK 661
             P +   +P++VLN+T N FSGEIP E G++KCL NLDLSYNNFSG FP S NNLTEL+K
Sbjct: 599  FPPEIASIPIVVLNITSNQFSGEIPEEIGSLKCLMNLDLSYNNFSGTFPTSLNNLTELNK 658

Query: 662  LNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNT 721
             NISYNPL+SG +PST Q ATFE+ SYLG+PLL LP+FI+N  +H +    S      +T
Sbjct: 659  FNISYNPLISGVVPSTRQFATFEQNSYLGNPLLILPEFIDNVTNHTNT--TSPKEHKKST 716

Query: 722  KLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWL 781
            +L++ L  + + +   + G+L+I++ + VK P+E+  YLL   K  HD +SS   S   +
Sbjct: 717  RLSVFLVCIVITLVFAVFGLLTILVCVSVKSPSEEPRYLLRDTKQWHDSSSSGSSSW--M 774

Query: 782  SDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG 841
            SDTVKVIRL+KT FT++DILKAT  FSEDR+IGKGGFGTVY+GV  DGR+VAVKKLQREG
Sbjct: 775  SDTVKVIRLNKTVFTHADILKATSSFSEDRVIGKGGFGTVYKGVFSDGRQVAVKKLQREG 834

Query: 842  LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR 901
            LEGE+EF+AEMEVLSG+GFGWPHPNLVTLYGWCL+GSEKIL+YEY+EGGSLED+++DRTR
Sbjct: 835  LEGEKEFKAEMEVLSGHGFGWPHPNLVTLYGWCLNGSEKILIYEYIEGGSLEDLVTDRTR 894

Query: 902  LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG 961
             TWRRRL++AIDVARAL++LHHECYP +VHRDVKASNVLLDK+GKA VTDFGLARVV  G
Sbjct: 895  FTWRRRLEVAIDVARALIYLHHECYPSVVHRDVKASNVLLDKDGKAKVTDFGLARVVDVG 954

Query: 962  DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021
            +SHVST +AGTVGYVAPEYG TWQATTKGDVYSFGVL MELAT RRA++GGEECLVEW R
Sbjct: 955  ESHVSTMVAGTVGYVAPEYGHTWQATTKGDVYSFGVLVMELATARRAVDGGEECLVEWAR 1014

Query: 1022 RVMGYGRH-GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            RVMGYGRH G GR+V P++L+GSGL  GAEEM ELLRIGV CT +AP ARPN+KEVLAML
Sbjct: 1015 RVMGYGRHRGLGRSV-PLLLMGSGLVGGAEEMGELLRIGVMCTTDAPQARPNMKEVLAML 1073

Query: 1081 IKI 1083
            IKI
Sbjct: 1074 IKI 1076

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1088
TAIR|locus:2019255	1106	AT1G74360 [Arabidopsis thalian	0.988	0.972	0.623	0.0
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.442	0.412	0.362	1.4e-118
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.878	0.799	0.330	4.4e-116
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.919	0.859	0.322	1.2e-115
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.872	0.830	0.323	1e-114
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.480	0.438	0.366	2.5e-112
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.901	0.872	0.300	1.4e-110
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.464	0.487	0.340	1.6e-110
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.950	0.922	0.311	6.1e-110
TAIR|locus:2005507	976	ER "ERECTA" [Arabidopsis thali	0.468	0.522	0.298	6e-107

TAIR|locus:2019255 AT1G74360 [Arabidopsis thaliana (taxid:3702)]

 Score = 3518 (1243.5 bits), Expect = 0., P = 0.
 Identities = 676/1085 (62%), Positives = 815/1085 (75%)

Query:     3 MSDDENDSWRFALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQ 62
             M+DD++ S  F  F+    + A  VAGDSL++DREVL +L+S+LE+ NP N G Y +W  
Sbjct:     9 MTDDDSQSLCFLCFLLFFFITAIAVAGDSLDSDREVLLSLKSYLESRNPQNRGLYTEWKM 68

Query:    63 SSSP--CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIP 120
              +    C+WPGIIC+P ++RV G+NLTD  ISG +F NFSALT+L+YLDLSRNT  G IP
Sbjct:    69 ENQDVVCQWPGIICTPQRSRVTGINLTDSTISGPLFKNFSALTELTYLDLSRNTIEGEIP 128

Query:   121 DDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVAN 180
             DDLS C +LK+LNLSHNIL G+L+L GL +LE+LDLS+NRI G+I  SFP  C  LVVAN
Sbjct:   129 DDLSRCHNLKHLNLSHNILEGELSLPGLSNLEVLDLSLNRITGDIQSSFPLFCNSLVVAN 188

Query:   181 LSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF 240
             LS NN TGRID  F+GC NL+Y+D SSN F G +W G  +LVEFSV++N LSG +S+S+F
Sbjct:   189 LSTNNFTGRIDDIFNGCRNLKYVDFSSNRFSGEVWTGFGRLVEFSVADNHLSGNISASMF 248

Query:   241 KENCSLEIFDLSENEFIGDFPGEVSNCRXXXXXXXXXXXXSGPIPAEIGSISGLEALFLG 300
             + NC+L++ DLS N F G+FPG+VSNC+            +G IPAEIGSIS L+ L+LG
Sbjct:   249 RGNCTLQMLDLSGNAFGGEFPGQVSNCQNLNVLNLWGNKFTGNIPAEIGSISSLKGLYLG 308

Query:   301 KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSG 360
              N F   IPE+LLNL+ L  LDLS N FGG++Q+IFGRFTQVK L LH+NSY+ G+NSS 
Sbjct:   309 NNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIFGRFTQVKYLVLHANSYVGGINSSN 368

Query:   361 ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
             ILKLPN+SRLDL +NNF+G LP EISQ++SLKFLILA+N F+G IP  YGNMP LQ LDL
Sbjct:   369 ILKLPNLSRLDLGYNNFSGQLPTEISQIQSLKFLILAYNNFSGDIPQEYGNMPGLQALDL 428

Query:   421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXIPPE 480
             SFN+LTG IP S G LTSLLWLMLANNSLSGEIP EIG                    PE
Sbjct:   429 SFNKLTGSIPASFGKLTSLLWLMLANNSLSGEIPREIGNCTSLLWFNVANNQLSGRFHPE 488

Query:   481 VMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
             +  +G N  PTFE N++N ++ IAGS ECL+MKRWIPA++PPF+FVY ILT+KSCRSLWD
Sbjct:   489 LTRMGSNPSPTFEVNRQNKDKIIAGSGECLAMKRWIPAEFPPFNFVYAILTKKSCRSLWD 548

Query:   541 RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
              +LKG G+FPVC  G   RT +I+ YLQLSGN+ SGE+   I ++   S +HLGFN+F+G
Sbjct:   549 HVLKGYGLFPVCSAGSTVRTLKISAYLQLSGNKFSGEIPASISQMDRLSTLHLGFNEFEG 608

Query:   601 KLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS 660
             KLP +  QLPL  LNLTRNNFSGEIP E GN+KCLQNLDLS+NNFSG FP S N+L ELS
Sbjct:   609 KLPPEIGQLPLAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFNNFSGNFPTSLNDLNELS 668

Query:   661 KLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNN 720
             K NISYNP +SG IP+TGQ+ATF+K S+LG+PLL  P F     ++  K   SN   GN 
Sbjct:   669 KFNISYNPFISGAIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTRKI--SNQVLGNR 726

Query:   721 TK-LTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAXXXXXXXP 779
              + L +I   LAL +A + C V+S I+ M+VK   E +  LL+G K RHD+        P
Sbjct:   727 PRTLLLIWISLALALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHDMTSSSGGSSP 786

Query:   780 WLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQR 839
             WLS  +KVIRLDK+ FTY+DILKAT  FSE+R++G+GG+GTVYRGVLPDGREVAVKKLQR
Sbjct:   787 WLSGKIKVIRLDKSTFTYADILKATSNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQR 846

Query:   840 EGLEGEREFRAEMEVLSGNGFG-WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
             EG E E+EFRAEMEVLS N FG W HPNLV LYGWCLDGSEKILV+EYM GGSLE++I+ 
Sbjct:   847 EGTEAEKEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYMGGGSLEELITD 906

Query:   899 XXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
                        IA DVAR LVFLHHECYP IVHRDVKASNVLLDK G A VTDFGLAR++
Sbjct:   907 KTKLQWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDKHGNARVTDFGLARLL 966

Query:   959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
             + GDSHVST IAGT+GYVAPEYGQTWQATT+GDVYS+GVL MELATGRRA++GGEECLVE
Sbjct:   967 NVGDSHVSTVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMELATGRRAVDGGEECLVE 1026

Query:  1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
             W RRVM       G    P+ L G+    GAE+M+ELL+IGV+CTA+ P ARPN+KEVLA
Sbjct:  1027 WARRVMTGNMTAKGS---PITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLA 1083

Query:  1079 MLIKI 1083
             ML+KI
Sbjct:  1084 MLVKI 1088

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 1.4e-118, Sum P(2) = 1.4e-118
 Identities = 184/508 (36%), Positives = 277/508 (54%)

Query:   587 NFSMVH--LGFNQFDGKLPSQFDQLPLI-VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN 643
             N SM++  + +N   G +P  +  +  + VLNL  N  +G IP  FG +K +  LDLS+N
Sbjct:   638 NGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHN 697

Query:   644 NFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDP-LLDLPDFIEN 702
             N  G  P S  +L+ LS L++S N L +G IP  GQL TF  + Y  +  L  +P  +  
Sbjct:   698 NLQGYLPGSLGSLSFLSDLDVSNNNL-TGPIPFGGQLTTFPVSRYANNSGLCGVP--LRP 754

Query:   703 GPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLE 762
                   +   S       T  T ++A +A    C +  V+++     V++  +++   +E
Sbjct:   755 CGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIE 814

Query:   763 GMKYRHDLAXXXXXXXPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVY 822
              +      +         LS  V          T++ +L+AT  FS + ++G GGFG VY
Sbjct:   815 SLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVY 874

Query:   823 RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL 882
             +  L DG  VA+KKL R   +G+REF AEME + G      H NLV L G+C  G E++L
Sbjct:   875 KAQLRDGSVVAIKKLIRITGQGDREFMAEMETI-GK---IKHRNLVPLLGYCKVGEERLL 930

Query:   883 VYEYMEGGSLEDIISXXXXXXX------XXXXXIAIDVARALVFLHHECYPPIVHRDVKA 936
             VYEYM+ GSLE ++                   IAI  AR L FLHH C P I+HRD+K+
Sbjct:   931 VYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKS 990

Query:   937 SNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSF 995
             SNVLLD++ +A V+DFG+AR+VSA D+H+S +T+AGT GYV PEY Q+++ T KGDVYS+
Sbjct:   991 SNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSY 1050

Query:   996 GVLAMELATGRRALEGGE----ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEE 1051
             GV+ +EL +G++ ++ GE      LV W +++  Y R   G  ++   L+      G  E
Sbjct:  1051 GVILLELLSGKKPIDPGEFGEDNNLVGWAKQL--Y-REKRGAEILDPELVTD--KSGDVE 1105

Query:  1052 MSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             +   L+I  +C  + P  RP + +++AM
Sbjct:  1106 LFHYLKIASQCLDDRPFKRPTMIQLMAM 1133

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
 Identities = 335/1013 (33%), Positives = 498/1013 (49%)

Query:   102 LTQLSYLDLSRNTFSGS--IPDDLSS-CRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV 158
             L  L  LDLS N+ SG+  +   LS  C  LK+L +S N +SGD+++S   +LE LD+S 
Sbjct:   172 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSS 231

Query:   159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN-G 217
             N     I F     C  L   ++S N L+G        C  L+ L++SSN F G I    
Sbjct:   232 NNFSTGIPFL--GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP 289

Query:   218 LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRXXXXXXXXX 277
             L  L   S++EN  +G +   +     +L   DLS N F G  P    +C          
Sbjct:   290 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 349

Query:   278 XXXSGPIPAE-IGSISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDLSSNNFGGEVQKI 335
                SG +P + +  + GL+ L L  N F   +PESL NLS  L  LDLSSNNF G +   
Sbjct:   350 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 409

Query:   336 FGRFTQVKILALH-SNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFL 394
               +  +  +  L+  N+   G     +     +  L LS N  +G +P  +  +  L+ L
Sbjct:   410 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 469

Query:   395 ILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP 454
              L  N   G IP     +  L+TL L FN+LTG IP  + N T+L W+ L+NN L+GEIP
Sbjct:   470 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 529

Query:   455 GEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKR 514
               IG                  IP E+             N  NG  TI  +    S K 
Sbjct:   530 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG--TIPAAMFKQSGK- 586

Query:   515 WIPADY---PPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSG 571
              I A++     + ++     +K C    + LL+  GI    L  L++R         ++ 
Sbjct:   587 -IAANFIAGKRYVYIKNDGMKKECHGAGN-LLEFQGIRSEQLNRLSTRN-----PCNITS 639

Query:   572 NQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFG 630
                 G  SP      +   + + +N   G +P +   +P L +LNL  N+ SG IP E G
Sbjct:   640 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 699

Query:   631 NIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLG 690
             +++ L  LDLS N   G  P + + LT L+++++S N L SG IP  GQ  TF    +L 
Sbjct:   700 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL-SGPIPEMGQFETFPPAKFLN 758

Query:   691 DPLL---DLPDFI-ENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIII 746
             +P L    LP     N   + H +  S+GR   +   ++ +  L     C+  G++ ++ 
Sbjct:   759 NPGLCGYPLPRCDPSNADGYAH-HQRSHGRRPASLAGSVAMGLL-FSFVCIF-GLI-LVG 814

Query:   747 YMLVKRPAEQQGYLLEGMKYRHDLAXXXXXXXPW-LSDTVKVIRLDKTAF-------TYS 798
               + KR  +++  L    +   +          W L+   + + ++  AF       T++
Sbjct:   815 REMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFA 874

Query:   799 DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGN 858
             D+L+AT  F  D +IG GGFG VY+ +L DG  VA+KKL     +G+REF AEME + G 
Sbjct:   875 DLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI-GK 933

Query:   859 GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----SXXXXXXXXXXXXIAIDV 914
                  H NLV L G+C  G E++LVYE+M+ GSLED++                 IAI  
Sbjct:   934 ---IKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGS 990

Query:   915 ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTV 973
             AR L FLHH C P I+HRD+K+SNVLLD+  +A V+DFG+AR++SA D+H+S +T+AGT 
Sbjct:   991 ARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTP 1050

Query:   974 GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG---GEECLVEWGRRVMGYGRHG 1030
             GYV PEY Q+++ +TKGDVYS+GV+ +EL TG+R  +    G+  LV W   V  + +  
Sbjct:  1051 GYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGW---VKQHAKLR 1107

Query:  1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                   P ++      E   E+ + L++ V C  +    RP + +V+AM  +I
Sbjct:  1108 ISDVFDPELMKEDPALE--IELLQHLKVAVACLDDRAWRRPTMVQVMAMFKEI 1158

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1140 (406.4 bits), Expect = 1.2e-115, P = 1.2e-115
 Identities = 349/1083 (32%), Positives = 530/1083 (48%)

Query:    39 LSNLRS-FLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFN 97
             LSNLRS +L+ NN      +   + SSS     G  CS +   ++  +LTD +I   +F+
Sbjct:   100 LSNLRSLYLQGNN------FSSGDSSSSS----G--CSLEVLDLSSNSLTDSSIVDYVFS 147

Query:    98 NFSALTQLSYLDLSRNTFSGSIPDDLS-SCRSLKYLNLSHNILSGDLNLSGL----RSLE 152
                 L  +++   S N  +G +    S S + +  ++LS+N  S ++  + +     SL+
Sbjct:   148 TCLNLVSVNF---SHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPNSLK 204

Query:   153 ILDLSVNRIHGEIS-FSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNLRYLDLSSNNF 210
              LDLS N + G+ S  SF  +CE L V +LS N+++G R       C  L  L+LS N+ 
Sbjct:   205 HLDLSGNNVTGDFSRLSF-GLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSL 263

Query:   211 RGNI-----WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVS 265
              G I     W     L + S++ N+ SG +   +     +LE+ DLS N   G  P   +
Sbjct:   264 IGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFT 323

Query:   266 NCRXXXXXXXXXXXXSGP-IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
             +C             SG  +   +  +S +  L+L  NN    +P SL N S L VLDLS
Sbjct:   324 SCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLS 383

Query:   325 SNNFGGEVQKIFGRFTQVKILA--LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP 382
             SN F GEV   F       +L   L +N+Y+ G     + K  ++  +DLS N  TG +P
Sbjct:   384 SNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIP 443

Query:   383 VEISQMRSLKFLILAHNRFNGSIP-AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW 441
              EI  +  L  L++  N   G IP ++  +  NL+TL L+ N LTG +P SI   T++LW
Sbjct:   444 KEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLW 503

Query:   442 LMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNARPTFEANQRNGER 501
             + L++N L+GEIP  IG                  IP E+    +N     + N  N   
Sbjct:   504 ISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNC-KNLI-WLDLNSNNLTG 561

Query:   502 TIAGSSECLSMKRWI-PADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGL-ASR 559
              + G  E  S    + P       F +        R+      +G G   V   G+ A R
Sbjct:   562 NLPG--ELASQAGLVMPGSVSGKQFAFV-------RNEGGTDCRGAGGL-VEFEGIRAER 611

Query:   560 TFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHL--GFNQFDGKLPSQFDQLPLI-VLNL 616
                          ++   ++  +    N SM++L   +N   G +P  +  +  + VLNL
Sbjct:   612 LEHFPMVHSCPKTRIYSGMTMYMFS-SNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNL 670

Query:   617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
               N  +G IP  FG +K +  LDLS+N+  G  P S   L+ LS L++S N L +G IP 
Sbjct:   671 GHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNL-TGPIPF 729

Query:   677 TGQLATFEKTSYLGDPLL---DLPDFIENG-PHHGHKYPNSNG-RTGNNTKLTIILAFLA 731
              GQL TF  T Y  +  L    LP       P   H +P      TG +    I+ +F+ 
Sbjct:   730 GGQLTTFPLTRYANNSGLCGVPLPPCSSGSRPTRSHAHPKKQSIATGMSAG--IVFSFM- 786

Query:   732 LLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAXXXXXXXPWLSDTVKVIRLD 791
                 C++  ++++     V++  +Q+   +E +      +         LS  V      
Sbjct:   787 ----CIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKP 842

Query:   792 KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAE 851
                 T++ +L+AT  FS D +IG GGFG VY+  L DG  VA+KKL +   +G+REF AE
Sbjct:   843 LRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAE 902

Query:   852 MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX-----XX 906
             ME + G      H NLV L G+C  G E++LVYEYM+ GSLE ++               
Sbjct:   903 METI-GK---IKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSA 958

Query:   907 XXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
                IAI  AR L FLHH C P I+HRD+K+SNVLLD++  A V+DFG+AR+VSA D+H+S
Sbjct:   959 RKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLS 1018

Query:   967 -TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE----GGEECLVEWGR 1021
              +T+AGT GYV PEY Q+++ T KGDVYS+GV+ +EL +G++ ++    G +  LV W +
Sbjct:  1019 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAK 1078

Query:  1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081
             ++  Y R   G  ++   L+      G  E+   L+I  +C  + P  RP + +V+ M  
Sbjct:  1079 QL--Y-REKRGAEILDPELVTD--KSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFK 1133

Query:  1082 KIL 1084
             +++
Sbjct:  1134 ELV 1136

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1131 (403.2 bits), Expect = 1.0e-114, P = 1.0e-114
 Identities = 332/1025 (32%), Positives = 497/1025 (48%)

Query:   105 LSYLDLSRNTFSGSIPDDL-SSCRSLKYLNLSHNILSG----DLNLSGLRSLEILDLSVN 159
             L++L+LS +   G++P++  S   +L  + LS+N  +G    DL LS  + L+ LDLS N
Sbjct:   129 LTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGKLPNDLFLSS-KKLQTLDLSYN 187

Query:   160 RIHGEIS-FSFP-AICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI--- 214
              I G IS  + P + C  +   + S N+++G I      C NL+ L+LS NNF G I   
Sbjct:   188 NITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLNLSYNNFDGQIPKS 247

Query:   215 WNGLAQLVEFSVSENVLSGVVSSSVFKENC-SLEIFDLSENEFIGDFPGEVSNCRXXXXX 273
             +  L  L    +S N L+G +   +  + C SL+   LS N F G  P  +S+C      
Sbjct:   248 FGELKLLQSLDLSHNRLTGWIPPEI-GDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSL 306

Query:   274 XXXXXXXSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV 332
                    SGP P  I  S   L+ L L  N      P S+     L + D SSN F G +
Sbjct:   307 DLSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVI 366

Query:   333 QK-IFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSL 391
                +      ++ L L  N  + G     I +   +  +DLS N   G +P EI  ++ L
Sbjct:   367 PPDLCPGAASLEELRLPDN-LVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKL 425

Query:   392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG 451
             +  I  +N   G IP   G + NL+ L L+ N+LTG IPP   N +++ W+   +N L+G
Sbjct:   426 EQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTG 485

Query:   452 EIPGEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNARPTFEANQRNGE--RTIAGSSEC 509
             E+P + G                  IPPE+             N   GE    +      
Sbjct:   486 EVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGS 545

Query:   510 LSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQL 569
              ++   +  +    +FV  +    SC+ +   L++ +GI P        R  QI      
Sbjct:   546 KALSGLLSGN--TMAFVRNV--GNSCKGVGG-LVEFSGIRP-------ERLLQIPSLKSC 593

Query:   570 SGNQL-SGELSPDIGKLQNFSMVHLGFNQFDGKLPSQF-DQLPLIVLNLTRNNFSGEIPS 627
                ++ SG +     + Q    + L +NQ  GK+P +  + + L VL L+ N  SGEIP 
Sbjct:   594 DFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPF 653

Query:   628 EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTS 687
               G +K L   D S N   G  P SF+NL+ L ++++S N L +G IP  GQL+T   T 
Sbjct:   654 TIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNEL-TGPIPQRGQLSTLPATQ 712

Query:   688 YLGDPLL---DLPDFIENGPHHGHKYPNSNGRTGNNTKL-----TIILAFLALLMACLIC 739
             Y  +P L    LP+  +NG +          R  + T+      +I+L    L+ A  +C
Sbjct:   713 YANNPGLCGVPLPE-CKNGNNQLPAGTEEGKRAKHGTRAASWANSIVLG--VLISAASVC 769

Query:   740 GVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAX--XXXXXXPWLSDTVKVIRLDKTAFTY 797
              ++   I +  +R       +L  ++  +            P LS  V   +       +
Sbjct:   770 ILIVWAIAVRARRRDADDAKMLHSLQAVNSATTWKIEKEKEP-LSINVATFQRQLRKLKF 828

Query:   798 SDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSG 857
             S +++AT  FS   +IG GGFG V++  L DG  VA+KKL R   +G+REF AEME L G
Sbjct:   829 SQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETL-G 887

Query:   858 NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX------IA 911
                   H NLV L G+C  G E++LVYE+M+ GSLE+++                   IA
Sbjct:   888 K---IKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIA 944

Query:   912 IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIA 970
                A+ L FLHH C P I+HRD+K+SNVLLD++ +A V+DFG+AR++SA D+H+S +T+A
Sbjct:   945 KGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLA 1004

Query:   971 GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL---EGGEECLVEWGRRVMGYG 1027
             GT GYV PEY Q+++ T KGDVYS GV+ +E+ +G+R     E G+  LV W +     G
Sbjct:  1005 GTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWSKMKAREG 1064

Query:  1028 RHGPGRAVIPVVLLGSGLAEGAEE---------MSELLR---IGVRCTAEAPNARPNVKE 1075
             +H     VI   LL  G +E   E         + E+LR   I +RC  + P+ RPN+ +
Sbjct:  1065 KH---MEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQ 1121

Query:  1076 VLAML 1080
             V+A L
Sbjct:  1122 VVASL 1126

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 2.5e-112, Sum P(2) = 2.5e-112
 Identities = 204/557 (36%), Positives = 286/557 (51%)

Query:   543 LKGTGIFPVCLPGLASRTFQITGYL---QLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD 599
             L+G  +    L G    +F + G L    L+ N+L G +   +G L+  + + L FN   
Sbjct:   654 LQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLS 713

Query:   600 GKLPSQFDQLPLIV-LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTE 658
             G+L S+   +  +V L + +N F+GEIPSE GN+  L+ LD+S N  SG  P     L  
Sbjct:   714 GELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPN 773

Query:   659 LSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTG 718
             L  LN++ N L  G +PS G      K    G+  L       +    G K  ++ G  G
Sbjct:   774 LEFLNLAKNNL-RGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAG 832

Query:   719 NNTKLTIILAFLALLMACLICGVLSIIIYMLVKR------PAEQQGYLLEGMKYRHDLAX 772
                   ++L F  ++       V S+  + + KR      P   +   L+G   ++    
Sbjct:   833 ------LMLGFTIIVFVF----VFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFL 882

Query:   773 XXXXXXPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREV 832
                     LS  + +           DI++AT  FS+  IIG GGFGTVY+  LP  + V
Sbjct:   883 SGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTV 942

Query:   833 AVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL 892
             AVKKL     +G REF AEME L G      HPNLV+L G+C    EK+LVYEYM  GSL
Sbjct:   943 AVKKLSEAKTQGNREFMAEMETL-GKV---KHPNLVSLLGYCSFSEEKLLVYEYMVNGSL 998

Query:   893 EDIISXXXXXXX----XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL 948
             +  +                 IA+  AR L FLHH   P I+HRD+KASN+LLD + +  
Sbjct:   999 DHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPK 1058

Query:   949 VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008
             V DFGLAR++SA +SHVST IAGT GY+ PEYGQ+ +ATTKGDVYSFGV+ +EL TG+  
Sbjct:  1059 VADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEP 1118

Query:  1009 LEGGEECLVEWGRRVMGYG--RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEA 1066
                G +     G  ++G+   +   G+AV  +  L   +A    ++  LL+I + C AE 
Sbjct:  1119 T--GPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQL-RLLQIAMLCLAET 1175

Query:  1067 PNARPNVKEVLAMLIKI 1083
             P  RPN+ +VL  L +I
Sbjct:  1176 PAKRPNMLDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
 Identities = 320/1064 (30%), Positives = 507/1064 (47%)

Query:    67 CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSC 126
             C   G   S +   V  L+L+  N+SG +  +   L  L YL+L+ N  +G IP ++ +C
Sbjct:    73 CSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNC 132

Query:   127 RSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAI--CEKLVVANLS 182
               L+ + L++N   G +   ++ L  L   ++  N++ G +      +   E+LV     
Sbjct:   133 SKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYT-- 190

Query:   183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSV---SENVLSGVVSSSV 239
              NNLTG +         L       N+F GNI   + + +   +   ++N +SG +   +
Sbjct:   191 -NNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEI 249

Query:   240 FKENCSLEIFDLSENEFIGDFPGEVSNCRXXXXXXXXXXXXSGPIPAEIGSISGLEALFL 299
                    E+  L +N+F G  P ++ N               GPIP+EIG++  L+ L+L
Sbjct:   250 GMLVKLQEVI-LWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYL 308

Query:   300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSS 359
              +N     IP+ L  LSK+  +D S N   GE+     + +++++L L  N  + G+  +
Sbjct:   309 YQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNK-LTGIIPN 367

Query:   360 GILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLD 419
              + KL N+++LDLS N+ TGP+P     + S++ L L HN  +G IP   G    L  +D
Sbjct:   368 ELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVD 427

Query:   420 LSFNELTGPIPPSI-----------------GNLT-------SLLWLMLANNSLSGEIPG 455
              S N+L+G IPP I                 GN+        SLL L +  N L+G+ P 
Sbjct:   428 FSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487

Query:   456 EIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRW 515
             E+                   +PPE+ T  +  R    ANQ +        +E   +   
Sbjct:   488 ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLP----NEISKLSNL 543

Query:   516 IPADYPPFSFVYTILTR-KSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQL 574
             +  +    S    I +   +C+ L  RL      F   LP       Q+   L+LS N+ 
Sbjct:   544 VTFNVSSNSLTGPIPSEIANCKML-QRLDLSRNSFIGSLPPELGSLHQLE-ILRLSENRF 601

Query:   575 SGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPL--IVLNLTRNNFSGEIPSEFGNI 632
             SG +   IG L + + + +G N F G +P Q   L    I +NL+ N+FSGEIP E GN+
Sbjct:   602 SGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNL 661

Query:   633 KCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDP 692
               L  L L+ N+ SG  P +F NL+ L   N SYN L +G +P T        TS+LG+ 
Sbjct:   662 HLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNL-TGQLPHTQIFQNMTLTSFLGNK 720

Query:   693 LLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSIIIYMLVKR 752
              L         P H   +P+ +     + +   I+  ++ ++  +   +++I+++ L + 
Sbjct:   721 GLCGGHLRSCDPSHS-SWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL-RN 778

Query:   753 PAEQQGYLLEGMKYRHDLAXXXXXXXPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRI 812
             P E          Y HD         P+  ++  +  + K  FT  DIL+AT  F +  I
Sbjct:   779 PVEPTA------PYVHD-------KEPFFQES-DIYFVPKERFTVKDILEATKGFHDSYI 824

Query:   813 IGKGGFGTVYRGVLPDGREVAVKKLQ--REGLEG-----EREFRAEMEVLSGNGFGWPHP 865
             +G+G  GTVY+ V+P G+ +AVKKL+  REG        +  FRAE+  L G      H 
Sbjct:   825 VGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTL-GK---IRHR 880

Query:   866 NLVTLYGWCL-DGSEK-ILVYEYMEGGSLEDIISXXXXXXXX--XXXXIAIDVARALVFL 921
             N+V LY +C   GS   +L+YEYM  GSL +++               IA+  A  L +L
Sbjct:   881 NIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYL 940

Query:   922 HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
             HH+C P I+HRD+K++N+L+D+  +A V DFGLA+V+    S   + +AG+ GY+APEY 
Sbjct:   941 HHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYA 1000

Query:   982 QTWQATTKGDVYSFGVLAMELATGR---RALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038
              T + T K D+YSFGV+ +EL TG+   + LE G + L  W R  +    H     ++  
Sbjct:  1001 YTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGD-LATWTRNHIR--DHSLTSEILDP 1057

Query:  1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082
              L           M  + +I V CT  +P+ RP ++EV+ MLI+
Sbjct:  1058 YLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 1.6e-110, Sum P(2) = 1.6e-110
 Identities = 186/546 (34%), Positives = 294/546 (53%)

Query:   553 LPGLASRTFQITGY-LQLSGNQLSGELSPDIGKLQNFS-MVHLGFNQFDGKLPSQFDQLP 610
             L G AS+    +G  L +  N+ S  L P   ++  F   ++L  N+ +G +  +  +L 
Sbjct:   503 LNGTASQMTDSSGIPLYVKRNKSSNGL-P-YNQVSRFPPSIYLNNNRLNGTILPEIGRLK 560

Query:   611 -LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
              L +L+L+RNNF+G IP     +  L+ LDLSYN+  G  P SF +LT LS+ +++YN L
Sbjct:   561 ELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRL 620

Query:   670 VSGTIPSTGQLATFEKTSYLGD----PLLDLP-DFIENGPHH--GHKYPNSNGRTGNNTK 722
              +G IPS GQ  +F  +S+ G+      +D P D + +   +  G    N+NG     + 
Sbjct:   621 -TGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRNNNGGKFGRSS 679

Query:   723 LTIILAFLALLMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAXXXXXXXPWLS 782
             + ++   LA+ +  L    LS+I+  + ++  + +   +  +     ++       P  S
Sbjct:   680 IVVLTISLAIGITLL----LSVILLRISRKDVDDR---INDVD-EETISGVSKALGP--S 729

Query:   783 DTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL 842
               V          +  ++LK+T  FS+  IIG GGFG VY+   PDG + AVK+L  +  
Sbjct:   730 KIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCG 789

Query:   843 EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLE----DIISX 898
             + EREF+AE+E LS       H NLV+L G+C  G++++L+Y +ME GSL+    + +  
Sbjct:   790 QMEREFQAEVEALSRA----EHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDG 845

Query:   899 XXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
                        IA   AR L +LH  C P ++HRDVK+SN+LLD++ +A + DFGLAR++
Sbjct:   846 NMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLL 905

Query:   959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE--GGEECL 1016
                D+HV+T + GT+GY+ PEY Q+  AT +GDVYSFGV+ +EL TGRR +E   G+ C 
Sbjct:   906 RPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCR 965

Query:  1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMS--ELLRIGVRCTAEAPNARPNVK 1074
              +   RV  +      R      L+ + + E   E +  E+L I  +C    P  RP ++
Sbjct:   966 -DLVSRV--FQMKAEKREA---ELIDTTIRENVNERTVLEMLEIACKCIDHEPRRRPLIE 1019

Query:  1075 EVLAML 1080
             EV+  L
Sbjct:  1020 EVVTWL 1025

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
 Identities = 346/1110 (31%), Positives = 528/1110 (47%)

Query:    14 ALFVFAVLVIATHVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGII 73
             ALFV A +V+    A D    D ++L   R  + N   + +G    W+     C +PG  
Sbjct:    10 ALFVAAAVVVRGAAAAD----DAQLLEEFRQAVPNQAAL-KG----WSGGDGACRFPGAG 60

Query:    74 CSPDKARVNGLNLTDWNIS-GDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSS-CRS-LK 130
             C   +     L     N     +      L  +  L L     SG++     + C S L+
Sbjct:    61 CRNGRLTSLSLAGVPLNAEFRAVAATLLQLGSVEVLSLRGANVSGALSAAGGARCGSKLQ 120

Query:   131 YLNLSHNI-LSGDL-NLSGLRS----LEILDLSVNRIHG-EISFSFPAICEKLVVANLSL 183
              L+LS N  L G + +++ L S    L+ L+LS + +   ++          L   +LS 
Sbjct:   121 ALDLSGNAALRGSVADVAALASACGGLKTLNLSGDAVGAAKVGGGGGPGFAGLDSLDLSN 180

Query:   184 NNLTGRIDTCF--D-GCLNLRYLDLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSSV 239
             N +T   D  +  D G   +R+LDL+ N   G   +   + L    +S N++ G V    
Sbjct:   181 NKITDDSDLRWMVDAGVGAVRWLDLALNRISGVPEFTNCSGLQYLDLSGNLIVGEVPGGA 240

Query:   240 FKENCSLEIFDLSENEFIGDFPGEVSNCRXXXXXXXXXXXXSGPIPAE-IGSISGLEALF 298
               +   L++ +LS N   G FP +++               SG +P E    +  L AL 
Sbjct:   241 LSDCRGLKVLNLSFNHLAGVFPPDIAGLTSLNALNLSNNNFSGELPGEAFAKLQQLTALS 300

Query:   299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALH-SNSYIDGMN 357
             L  N+F   IP+++ +L +L+ LDLSSN F G +     +    K+  L+  N+Y+ G  
Sbjct:   301 LSFNHFNGSIPDTVASLPELQQLDLSSNTFSGTIPSSLCQDPNSKLHLLYLQNNYLTGGI 360

Query:   358 SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQT 417
                +    ++  LDLS N   G +P  +  + +L+ LIL  N   G IPA    +  L+ 
Sbjct:   361 PDAVSNCTSLVSLDLSLNYINGSIPASLGDLGNLQDLILWQNELEGEIPASLSRIQGLEH 420

Query:   418 LDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXI 477
             L L +N LTG IPP +   T L W+ LA+N LSG IP  +G                  I
Sbjct:   421 LILDYNGLTGSIPPELAKCTKLNWISLASNRLSGPIPSWLGKLSYLAILKLSNNSFSGPI 480

Query:   478 PPEVMTIGRNARPTFEANQRNGE--RTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC 535
             PPE+            +NQ NG   + +A  S  +++   +     P+ ++        C
Sbjct:   481 PPELGDCQSLVWLDLNSNQLNGSIPKELAKQSGKMNVGLIVGR---PYVYLRNDELSSEC 537

Query:   536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGF 595
             R     LL+ T I P  L  + S+  ++  + ++      G       K  +   + L +
Sbjct:   538 RGKGS-LLEFTSIRPDDLSRMPSK--KLCNFTRM----YVGSTEYTFNKNGSMIFLDLSY 590

Query:   596 NQFDGKLPSQF-DQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN 654
             NQ D  +P +  D   L+++NL  N  SG IPS     K L  LDLSYN   GP P SF+
Sbjct:   591 NQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLAVLDLSYNQLEGPIPNSFS 650

Query:   655 NLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDP-LLDLPDFIENGPHHGHKYPNS 713
              L+ LS++N+S N L +GTIP  G LATF K+ Y  +  L   P      P   H  P S
Sbjct:   651 ALS-LSEINLSNNQL-NGTIPELGSLATFPKSQYENNTGLCGFPL-----PPCDHSSPRS 703

Query:   714 NGRTGNNTKLTIILAFLAL-LMACLICGVLSIIIYMLVKRPAEQQGYLLEGMKYRHDLAX 772
             +    ++ +   + + +A+ L+  L C ++ II     +R  + +        Y    + 
Sbjct:   704 SNDHQSHRRQASMASSIAMGLLFSLFCIIVIIIAIGSKRRRLKNEEASTSRDIYIDSRSH 763

Query:   773 XXXXXXPW---LSDTVKVIRLDKTAF-------TYSDILKATGKFSEDRIIGKGGFGTVY 822
                    W   LS T  ++ ++  AF       T +D+++AT  F     IG GGFG VY
Sbjct:   764 SATMNSDWRQNLSGT-NLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDVY 822

Query:   823 RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL 882
             +  L DG+ VA+KKL     +G+REF AEME + G      H NLV L G+C  G E++L
Sbjct:   823 KAQLKDGKVVAIKKLIHVSGQGDREFTAEMETI-GK---IKHRNLVPLLGYCKAGEERLL 878

Query:   883 VYEYMEGGSLEDIISXXXXXXXX----XXXXIAIDVARALVFLHHECYPPIVHRDVKASN 938
             VY+YM+ GSLED++                 IA+  AR L FLHH C P I+HRD+K+SN
Sbjct:   879 VYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSN 938

Query:   939 VLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGV 997
             VL+D++ +A V+DFG+AR++S  D+H+S +T+AGT GYV PEY Q+++ TTKGDVYS+GV
Sbjct:   939 VLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 998

Query:   998 LAMELATGRRALEG---GEEC-LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMS 1053
             + +EL TG+   +    GE+  LV W   V  + +        P +L      E   E+ 
Sbjct:   999 VLLELLTGKPPTDSADFGEDNNLVGW---VKQHTKLKITDVFDPELLKEDPSVE--LELL 1053

Query:  1054 ELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             E L+I   C  + P+ RP + +V+AM  +I
Sbjct:  1054 EHLKIACACLDDRPSRRPTMLKVMAMFKEI 1083

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)]

 Score = 617 (222.3 bits), Expect = 6.0e-107, Sum P(2) = 6.0e-107
 Identities = 165/552 (29%), Positives = 276/552 (50%)

Query:   544 KGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLP 603
             K +G  P     L S T     YL LS N + G +  ++ ++ N   + L  N+ +G +P
Sbjct:   390 KFSGTIPRAFQKLESMT-----YLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIP 444

Query:   604 SQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKL 662
             S    L  L+ +NL+RN+ +G +P +FGN++ +  +DLS N+ SGP P   N L  +  L
Sbjct:   445 SSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILL 504

Query:   663 NISYNPLVSGTIPSTGQLATFEKTSYLGDPLL-DLP---DFIENGPHHGHKYPNSNGRTG 718
              +  N L +G + S     +    +   + L+ D+P   +F    P      P   G   
Sbjct:   505 RLENNNL-TGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWL 563

Query:   719 NN----TKLTIILAFLALLMACLICGVLSIIIYMLVK--RPAEQQGYLLEGMKYRHDLAX 772
             N+    ++ T+ ++     +  +  G L I++ +L+   RP     +L +G      L  
Sbjct:   564 NSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFL-DG-----SLDK 617

Query:   773 XXXXXXPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREV 832
                   P L     ++ ++     Y DI++ T   SE  IIG G   TVY+ VL + + V
Sbjct:   618 PVTYSTPKLV----ILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPV 673

Query:   833 AVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL 892
             A+K+L     +  ++F  E+E+LS       H NLV+L  + L     +L Y+Y+E GSL
Sbjct:   674 AIKRLYSHNPQSMKQFETELEMLSSI----KHRNLVSLQAYSLSHLGSLLFYDYLENGSL 729

Query:   893 EDII---SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV 949
              D++   +            IA   A+ L +LHH+C P I+HRDVK+SN+LLDK+ +A +
Sbjct:   730 WDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARL 789

Query:   950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
             TDFG+A+ +    SH ST + GT+GY+ PEY +T + T K DVYS+G++ +EL T R+A+
Sbjct:   790 TDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAV 849

Query:  1010 EGGEECLVEWGRRVMGY-GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPN 1068
             +  +E  +     +M   G +       P +   +   +    + ++ ++ + CT   PN
Sbjct:   850 D--DESNLH--HLIMSKTGNNEVMEMADPDI---TSTCKDLGVVKKVFQLALLCTKRQPN 902

Query:  1069 ARPNVKEVLAML 1080
              RP + +V  +L
Sbjct:   903 DRPTMHQVTRVL 914

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048281 "inflorescence morphogenesis" evidence=IMP

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005739 "mitochondrion" evidence=IDA

GO:0050832 "defense response to fungus" evidence=IMP

GO:0010103 "stomatal complex morphogenesis" evidence=RCA;IMP

GO:0001558 "regulation of cell growth" evidence=IGI;IMP

GO:0009965 "leaf morphogenesis" evidence=RCA;IMP

GO:0010148 "transpiration" evidence=IMP

GO:0030155 "regulation of cell adhesion" evidence=IMP

GO:0051302 "regulation of cell division" evidence=IGI;IMP

GO:0009664 "plant-type cell wall organization" evidence=IMP

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0031540 "regulation of anthocyanin biosynthetic process" evidence=RCA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:2000027 "regulation of organ morphogenesis" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGJ1	Y1743_ARATH	2, ., 7, ., 1, 1, ., 1	0.6552	0.9889	0.9728	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.1	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1088
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-81
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-43
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	6e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	8e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
pfam03109	117	pfam03109, ABC1, ABC1 family	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
pfam13306	128	pfam13306, LRR_5, Leucine rich repeats (6 copies)	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  285 bits (732), Expect = 2e-81
 Identities = 212/667 (31%), Positives = 313/667 (46%), Gaps = 95/667 (14%)

Query: 36  REVLSNLRSFLEN-NNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGD 94
            E L  L SF  + N+P+   +   WN S+  C W GI C+ + +RV  ++L+  NISG 
Sbjct: 28  AEELELLLSFKSSINDPL--KYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGK 84

Query: 95  IFNNFSALTQLSYLDLSRNTFSGSIPDDLS-SCRSLKYLNLSHNILSGDLNLSGLRSLEI 153
           I +    L  +  ++LS N  SG IPDD+  +  SL+YLNLS+N  +G +    + +LE 
Sbjct: 85  ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLET 144

Query: 154 LDLSVNRIHGEI-----SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN 208
           LDLS N + GEI     SFS       L V +L  N L G+I        +L +L L+SN
Sbjct: 145 LDLSNNMLSGEIPNDIGSFS------SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198

Query: 209 NFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCR 268
              G I   L Q+                       SL+   L  N   G+ P E+    
Sbjct: 199 QLVGQIPRELGQMK----------------------SLKWIYLGYNNLSGEIPYEIGGLT 236

Query: 269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNF 328
           +L  L+L  NN +GPIP+ +G++  L+ LFL +N     IP S+ +L KL  LDLS N+ 
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 329 GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
            GE+ ++                         +++L N+  L L  NNFTG +PV ++ +
Sbjct: 297 SGEIPEL-------------------------VIQLQNLEILHLFSNNFTGKIPVALTSL 331

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
             L+ L L  N+F+G IP   G   NL  LDLS N LTG IP  + +  +L  L+L +NS
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 449 LSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSE 508
           L GEIP  +G C SL  + L +N  SG +P E   +          N   G         
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR-------- 443

Query: 509 CLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQ 568
            ++ ++W   D P    +   L R                F   LP     + ++   L 
Sbjct: 444 -INSRKW---DMPSLQMLS--LARNK--------------FFGGLPDS-FGSKRLEN-LD 481

Query: 569 LSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPS 627
           LS NQ SG +   +G L     + L  N+  G++P +      L+ L+L+ N  SG+IP+
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541

Query: 628 EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTS 687
            F  +  L  LDLS N  SG  P +  N+  L ++NIS+N  + G++PSTG       ++
Sbjct: 542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN-HLHGSLPSTGAFLAINASA 600

Query: 688 YLGDPLL 694
             G+  L
Sbjct: 601 VAGNIDL 607

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  202 bits (514), Expect = 3e-53
 Identities = 149/448 (33%), Positives = 219/448 (48%), Gaps = 33/448 (7%)

Query: 91  ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGL 148
           + G I N+ + LT L +L L+ N   G IP +L   +SLK++ L +N LSG++   + GL
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 149 RSLEILDLSVNRIHGEISFSF---------------------PAI--CEKLVVANLSLNN 185
            SL  LDL  N + G I  S                      P+I   +KL+  +LS N+
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295

Query: 186 LTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSE---NVLSGVVSSSVFKE 242
           L+G I        NL  L L SNNF G I   L  L    V +   N  SG +  ++ K 
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
           N +L + DLS N   G+ P  + +  NL  L LF N+  G IP  +G+   L  + L  N
Sbjct: 356 N-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM-NSSGI 361
           +F   +P     L  +  LD+S+NN  G +         +++L+L  N +  G+ +S G 
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
            +L N   LDLS N F+G +P ++  +  L  L L+ N+ +G IP    +   L +LDLS
Sbjct: 475 KRLEN---LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            N+L+G IP S   +  L  L L+ N LSGEIP  +GN  SL+ +N+S+N L G++P   
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591

Query: 482 MTIGRNARPTFEANQRNGERTIAGSSEC 509
             +  NA          G  T +G   C
Sbjct: 592 AFLAINASAVAGNIDLCGGDTTSGLPPC 619

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (442), Expect = 7e-49
 Identities = 83/277 (29%), Positives = 125/277 (45%), Gaps = 38/277 (13%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLV 868
              +G+G FG VY       G+ VA+K ++++ ++ +RE    E+++L        HPN+V
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKK----LKHPNIV 60

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
             LY    D  +  LV EY EGG L D++  R RL+          +  AL +LH +    
Sbjct: 61   RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--- 117

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQ 982
            IVHRD+K  N+LLD++G   + DFGLAR +        TT  GT  Y+APE      YG 
Sbjct: 118  IVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGKGYG- 174

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
                    D++S GV+  EL TG+    G ++ L  + +         P    I      
Sbjct: 175  -----KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----- 224

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
                    E  +L+R   +   + P  R   +E L  
Sbjct: 225  -------PEAKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  169 bits (430), Expect = 9e-48
 Identities = 72/195 (36%), Positives = 108/195 (55%), Gaps = 13/195 (6%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTL 870
            +G+GGFGTVY       G++VA+K +++E      E    E+E+L        HPN+V L
Sbjct: 1    LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL----NHPNIVKL 56

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPI 929
            YG   D +   LV EY EGGSL+D++ +   +L+    L I + +   L +LH      I
Sbjct: 57   YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 930  VHRDVKASNVLLDK-EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-YGQTWQAT 987
            +HRD+K  N+LLD   GK  + DFGL+++++  D  +  TI GT  Y+APE        +
Sbjct: 114  IHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 988  TKGDVYSFGVLAMEL 1002
             K D++S GV+  EL
Sbjct: 173  EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 1e-47
 Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 12/204 (5%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +   R +G G FGTVY+      G+ VAVK L++   + +++  A  E+         HP
Sbjct: 1    YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS--HP 58

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            N+V L     D     LV EY EGG L D +S    L+      IA+ + R L +LH   
Sbjct: 59   NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN- 117

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE---YGQ 982
               I+HRD+K  N+LLD+ G   + DFGLA+ +    S + TT  GT  Y+APE    G 
Sbjct: 118  --GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFVGTPWYMAPEVLLGGN 174

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
             +    K DV+S GV+  EL TG+
Sbjct: 175  GY--GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (409), Expect = 2e-44
 Identities = 73/209 (34%), Positives = 108/209 (51%), Gaps = 22/209 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDG----REVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHP 865
            + +G+G FG VY+G L        EVAVK L+ +  E ER +F  E  V+     G  HP
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKK--LG--HP 56

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLED---------IISDRTRLTWRRRLDIAIDVAR 916
            N+V L G C +     LV EYMEGG L D            +++ L+ +  L  AI +A+
Sbjct: 57   NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGY 975
             + +L  +     VHRD+ A N L+ ++    ++DFGL+R V   D +   T     + +
Sbjct: 117  GMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            +APE  +    T+K DV+SFGVL  E+ T
Sbjct: 174  MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (407), Expect = 4e-44
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 810  DRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             + +G+G FG VY+G L         EVAVK L+ +  E +  EF  E  ++        
Sbjct: 4    GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD---- 59

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLH 922
            HPN+V L G C +     +V EYMEGG L   +   R +L+    L  A+ +AR + +L 
Sbjct: 60   HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
             +     +HRD+ A N L+ +     ++DFGL+R +   D +        + ++APE   
Sbjct: 120  SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
             G+    T+K DV+SFGVL  E+ T
Sbjct: 177  EGKF---TSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (398), Expect = 6e-43
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 810  DRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             + +G+G FG VY+G L         EVAVK L+ +  E +  EF  E  ++        
Sbjct: 4    GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD---- 59

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFL 921
            HPN+V L G C +    ++V EYM GG L D +  +    L+    L  A+ +AR + +L
Sbjct: 60   HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
              +     +HRD+ A N L+ +     ++DFGL+R +   D +        + ++APE  
Sbjct: 120  ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 980  -YGQTWQATTKGDVYSFGVLAMELAT 1004
              G+    T+K DV+SFGVL  E+ T
Sbjct: 177  KEGKF---TSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  167 bits (425), Expect = 3e-42
 Identities = 137/447 (30%), Positives = 201/447 (44%), Gaps = 53/447 (11%)

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDL 323
           +N   +V ++L G N SG I + I  +  ++ + L  N     IP+ +   S  L  L+L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
           S+NNF G + +                             +PN+  LDLS+N  +G +P 
Sbjct: 126 SNNNFTGSIPRGS---------------------------IPNLETLDLSNNMLSGEIPN 158

Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
           +I    SLK L L  N   G IP    N+ +L+ L L+ N+L G IP  +G + SL W+ 
Sbjct: 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218

Query: 444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTI 503
           L  N+LSGEIP EIG  TSL  L+L  N L+G IP  +  +          N+ +G   I
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP--I 276

Query: 504 AGSSECLSMKRWIPADYPPFSFVYTI----LTRKSCRSLWDRLLKGTGIFPVCLPGLASR 559
             S    S+++ I  D    S    I    +  ++   L       TG  PV L  L   
Sbjct: 277 PPS--IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR- 333

Query: 560 TFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQF-DQLPLIVLNLTR 618
             Q+   LQL  N+ SGE+  ++GK  N +++ L  N   G++P        L  L L  
Sbjct: 334 -LQV---LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389

Query: 619 NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTG 678
           N+  GEIP   G  + L+ + L  N+FSG  P+ F  L  +  L+IS N L  G I S  
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL-QGRINSRK 448

Query: 679 ------QLATFEKTSYLGDPLLDLPDF 699
                 Q+ +  +  + G     LPD 
Sbjct: 449 WDMPSLQMLSLARNKFFG----GLPDS 471

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  154 bits (392), Expect = 5e-42
 Identities = 83/281 (29%), Positives = 126/281 (44%), Gaps = 36/281 (12%)

Query: 810  DRIIGKGGFGTVYRGVL-----PDGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWP 863
             + +G+G FG VY+G L         +VAVK L+     E   EF  E  ++        
Sbjct: 4    GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK----LS 59

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLH 922
            HPN+V L G C  G    +V EYM GG L D +      LT +  L +A+ +A+ + +L 
Sbjct: 60   HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYG 981
             +     VHRD+ A N L+ +     ++DFGL+R +   D +         + ++APE  
Sbjct: 120  SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW-GRRVMGYGRHGPGRAVIPVVL 1040
            +  + T+K DV+SFGVL  E+ T       GE+         V+     G  R   P   
Sbjct: 177  KDGKFTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVLELLEDG-YRLPRP--- 226

Query: 1041 LGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                  E   +E+ EL+    +C A  P  RP   E++  L
Sbjct: 227  ------ENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (349), Expect = 2e-36
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKK--LQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
             ++G+G FG+VY  +  D G  +AVK   L  +  E       E+ +LS       HPN+
Sbjct: 6    ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS----LQHPNI 61

Query: 868  VTLYGWCLDGSEK-ILVY-EYMEGGSLEDIISDRTRLTWR--RRLDIAIDVARALVFLHH 923
            V  YG   D  +  + ++ EY+ GGSL  ++    +L     R+      +   L +LH 
Sbjct: 62   VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLHS 119

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQ 982
                 IVHRD+K +N+L+D +G   + DFG A+ +   ++   T ++ GT  ++APE  +
Sbjct: 120  NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 983  TWQATTKGDVYSFGVLAMELATGRR 1007
              +     D++S G   +E+ATG+ 
Sbjct: 177  GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (348), Expect = 3e-36
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 21/201 (10%)

Query: 813  IGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKGGFG VY+      G+EVA+K ++ E  E + +   E+++L        HPN+V  Y
Sbjct: 8    IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK----CKHPNIVKYY 63

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------IAIDVARALVFLHHEC 925
            G  L   E  +V E+  GGSL+D++      +  + L       +  ++ + L +LH   
Sbjct: 64   GSYLKKDELWIVMEFCSGGSLKDLLK-----STNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               I+HRD+KA+N+LL  +G+  + DFGL+  +S  D+    T+ GT  ++APE      
Sbjct: 118  --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKP 173

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
               K D++S G+ A+ELA G+
Sbjct: 174  YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  129 bits (325), Expect = 3e-33
 Identities = 73/198 (36%), Positives = 106/198 (53%), Gaps = 18/198 (9%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IGKG FG V  G    G++VAVK L+ +     + F AE  V++       HPNLV L G
Sbjct: 14   IGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTT----LRHPNLVQLLG 67

Query: 873  WCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIV 930
              L G+   +V EYM  GSL D +  R R  +T  ++L  A+DV   + +L  +     V
Sbjct: 68   VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTK 989
            HRD+ A NVL+ ++  A V+DFGLA+     ++          V + APE  +  + +TK
Sbjct: 125  HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTK 179

Query: 990  GDVYSFGVLAMEL-ATGR 1006
             DV+SFG+L  E+ + GR
Sbjct: 180  SDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  126 bits (319), Expect = 3e-32
 Identities = 60/196 (30%), Positives = 105/196 (53%), Gaps = 9/196 (4%)

Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            +G+G  G VY+    P G+  A+KK+  +G  E  ++   E++ L         P +V  
Sbjct: 9    LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC----ESPYVVKC 64

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIV 930
            YG      E  +V EYM+GGSL D++    ++       IA  + + L +LH + +  I+
Sbjct: 65   YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--II 122

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD+K SN+L++ +G+  + DFG+++V+       +T + GTV Y++PE  Q    +   
Sbjct: 123  HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181

Query: 991  DVYSFGVLAMELATGR 1006
            D++S G+  +E A G+
Sbjct: 182  DIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 4e-32
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            +IG+G FG VY+G+ L  G  VA+K++  E ++ E  +    E+++L        HPN+V
Sbjct: 7    LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN----LKHPNIV 62

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA---RALVFLHHEC 925
               G         ++ EY E GSL  II             +A+ V    + L +LH + 
Sbjct: 63   KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQVLQGLAYLHEQ- 118

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               ++HRD+KA+N+L  K+G   + DFG+A  ++   S    ++ GT  ++APE  +   
Sbjct: 119  --GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSG 175

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
            A+T  D++S G   +EL TG 
Sbjct: 176  ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 1e-29
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 27/203 (13%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPHPNLVT 869
            IG+G  G VY+      G+EVA+KK++   L  + +     E+ ++        HPN+V 
Sbjct: 27   IGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCK----HPNIVD 79

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPP 928
             Y   L G E  +V EYM+GGSL DII+    R+   +   +  +V + L +LH +    
Sbjct: 80   YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---N 136

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQ 982
            ++HRD+K+ N+LL K+G   + DFG A  ++   S    ++ GT  ++APE      YG 
Sbjct: 137  VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVIKRKDYG- 194

Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
                  K D++S G++ +E+A G
Sbjct: 195  -----PKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (296), Expect = 3e-29
 Identities = 78/282 (27%), Positives = 133/282 (47%), Gaps = 35/282 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREF-RAEMEVLSG-NGFG 861
            K+   + IGKG FG VY      DG+   +K++    + E ERE    E+++L   N   
Sbjct: 1    KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--- 57

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR----LTWRRRLDIAIDVARA 917
              HPN++  Y    +  +  +V EY +GG L   I  + +        + LD  + +  A
Sbjct: 58   --HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L +LH      I+HRD+K  N+ L   G   + DFG+++V+S     ++ T+ GT  Y++
Sbjct: 116  LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLS 171

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
            PE  Q      K D++S G +  EL T +   EG  E L+E   +++  G++ P    IP
Sbjct: 172  PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG--ENLLELALKIL-KGQYPP----IP 224

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
                    ++ + E+  L+        + P  RP++ ++L  
Sbjct: 225  --------SQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  115 bits (290), Expect = 1e-28
 Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 15/194 (7%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   + R+VA+K + REG   E +F  E +V+        HP LV LYG
Sbjct: 12   IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVM----MKLSHPKLVQLYG 66

Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
             C + S   LV+E+ME G L D + + R + +    L + +DV   + +L       ++H
Sbjct: 67   VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQATT 988
            RD+ A N L+ +     V+DFG+ R V   D + S+T  GT   V + +PE     + ++
Sbjct: 124  RDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSST--GTKFPVKWSSPEVFSFSKYSS 180

Query: 989  KGDVYSFGVLAMEL 1002
            K DV+SFGVL  E+
Sbjct: 181  KSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (284), Expect = 8e-28
 Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 18/201 (8%)

Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPNL 867
            +GKG FG V   R     G+  A+K L+++ +   +E      E  +LS       HP +
Sbjct: 1    LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI----NHPFI 55

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLT-WRRRLDIAIDVARALVFLHHEC 925
            V L+ +     EK+ LV EY  GG L   +S   R +  R R   A ++  AL +LH   
Sbjct: 56   VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSL- 112

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               I++RD+K  N+LLD +G   +TDFGLA+ +S+  S  + T  GT  Y+APE      
Sbjct: 113  --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEVLLGKG 169

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
                 D +S GVL  E+ TG+
Sbjct: 170  YGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (288), Expect = 2e-27
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 29/291 (9%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNL 867
            R +G+G FG VY     D + VA+K L ++     +    F  E+++L+        PN+
Sbjct: 6    RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH---PPNI 60

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHE 924
            V LY +  D     LV EY++GGSLED++        L+    L I   +  AL +LH +
Sbjct: 61   VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 925  CYPPIVHRDVKASNVLLDKEGKALV-TDFGLARVVSAGDSHVS-----TTIAGTVGYVAP 978
                I+HRD+K  N+LLD++G+ +   DFGLA+++    S  S     +T  GT GY+AP
Sbjct: 121  G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 979  EYGQTW---QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035
            E         A++  D++S G+   EL TG    EG +        + +      P  ++
Sbjct: 178  EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT--SQTLKIILELPTPSL 235

Query: 1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086
               +   S     ++  S+LL+   +  A+ P  R +    L+  +     
Sbjct: 236  ASPLSP-SNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSHDLLAHLK 282

Length = 384

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  110 bits (277), Expect = 1e-26
 Identities = 73/207 (35%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLVTL 870
            IG G    VY  + LP+  +VA+K++  E  +    E R E++ +S       HPN+V  
Sbjct: 9    IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----HPNVVKY 64

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALVFLHHECYP 927
            Y   + G E  LV  Y+ GGSL DI+             IA    +V + L +LH     
Sbjct: 65   YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-----GD--SHVSTTIAGTVGYVAPE- 979
              +HRD+KA N+LL ++G   + DFG    VSA     GD    V  T  GT  ++APE 
Sbjct: 124  --IHRDIKAGNILLGEDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
              Q      K D++SFG+ A+ELATG 
Sbjct: 178  MEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 2e-26
 Identities = 70/224 (31%), Positives = 113/224 (50%), Gaps = 24/224 (10%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGR----EVAVKKLQRE-GLEGEREFRAEME 853
            ILK T +  + +++G G FGTVY+GV +P+G      VA+K L+ E   +  +E   E  
Sbjct: 3    ILKET-ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAI 912
            V++       HP++V L G CL  S+  L+ + M  G L D + + +  +  +  L+  +
Sbjct: 62   VMASVD----HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116

Query: 913  DVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
             +A+ + +L         +VHRD+ A NVL+       +TDFGLA+++   +        
Sbjct: 117  QIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE-G 170

Query: 971  GTV--GYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
            G V   ++A E       T K DV+S+GV   EL T G +  EG
Sbjct: 171  GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 2e-26
 Identities = 69/197 (35%), Positives = 101/197 (51%), Gaps = 15/197 (7%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VA+K + REG   E +F  E +V+        HPNLV LYG
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMK----LSHPNLVQLYG 66

Query: 873  WCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
             C       +V EYM  G L + + +R  +L     LD+  DV  A+ +L    +   +H
Sbjct: 67   VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IH 123

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQATT 988
            RD+ A N L+ ++    V+DFGLAR V   D + S+   GT   V +  PE     + ++
Sbjct: 124  RDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQ--GTKFPVKWAPPEVFDYSRFSS 180

Query: 989  KGDVYSFGVLAMELATG 1005
            K DV+SFGVL  E+ + 
Sbjct: 181  KSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (272), Expect = 4e-26
 Identities = 69/212 (32%), Positives = 99/212 (46%), Gaps = 32/212 (15%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVK--KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G FG VY  V L  G  +AVK  ++Q    +  +E   EM+VL        HPNLV 
Sbjct: 8    IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL----LKHPNLVK 63

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------IAIDVARALVFLHH 923
             YG  +   +  +  EY  GG+LE++      L   R LD        + +   L +LH 
Sbjct: 64   YYGVEVHREKVYIFMEYCSGGTLEEL------LEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 IVHRD+K +N+ LD  G   + DFG A  +    + +   +    G   Y+APE 
Sbjct: 118  H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 981  GQTWQATTKG-----DVYSFGVLAMELATGRR 1007
              T     KG     D++S G + +E+ATG+R
Sbjct: 175  -ITGG-KGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 4e-26
 Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 42/279 (15%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLVT 869
            +IG+G +G VYRG  +P GR VA+K +  +  + +  + + E+ +LS      P PN+  
Sbjct: 8    LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP-PNITK 66

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDI-----ISDR-TRLTWRRRLDIAIDVARALVFLHH 923
             YG  L G    ++ EY EGGS+  +     I+++   +  R       +V  AL ++H 
Sbjct: 67   YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-------EVLVALKYIHK 119

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--- 980
                 ++HRD+KA+N+L+   G   + DFG+A +++   S   +T  GT  ++APE    
Sbjct: 120  V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITE 175

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040
            G+ +   TK D++S G+   E+ATG           V+  R +M   +  P R      L
Sbjct: 176  GKYYD--TKADIWSLGITIYEMATGNPPY-----SDVDAFRAMMLIPKSKPPR------L 222

Query: 1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
              +G    ++ + E +     C  E P  R + +E+L  
Sbjct: 223  EDNG---YSKLLREFV---AACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (270), Expect = 8e-26
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 20/201 (9%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-----REFRAEMEVLSGNGFGWPHPN 866
            +G G  G V + +  P G+ +AVK ++ E  E       RE     +  S        P 
Sbjct: 9    LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS--------PY 60

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRL-DIAIDVARALVFLHHEC 925
            +V  YG   +  +  +  EYM+GGSL+ I+ +       R L  IA+ V + L +LH + 
Sbjct: 61   IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               I+HRDVK SN+L++  G+  + DFG++  +   +S ++ T  GT  Y+APE  Q   
Sbjct: 121  K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NS-LAKTFVGTSSYMAPERIQGND 175

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
             + K D++S G+  +ELATGR
Sbjct: 176  YSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLV 868
              IGKG FG VY+GVL    EVAVK   R  L  + +R+F  E E+L      + HPN+V
Sbjct: 1    EKIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILK----QYDHPNIV 55

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
             L G C+      +V E + GGSL   +   + RLT ++ L +++D A  + +L  +   
Sbjct: 56   KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYGQTWQA 986
              +HRD+ A N L+ +     ++DFG++R    G   VS  +    + + APE     + 
Sbjct: 114  -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 987  TTKGDVYSFGVLAMELATG 1005
            T++ DV+S+G+L  E  + 
Sbjct: 173  TSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            R +G G FG V+ G+  +   VAVK L + G    ++F AE +++        HP L+ L
Sbjct: 12   RKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKK----LRHPKLIQL 66

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPP 928
            Y  C       +V E M+ GSL + +       L   + +D+A  VA  + +L  + Y  
Sbjct: 67   YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY-- 124

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
             +HRD+ A NVL+ +     V DFGLARV+              + + APE     + + 
Sbjct: 125  -IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183

Query: 989  KGDVYSFGVLAMELAT-GR 1006
            K DV+SFG+L  E+ T GR
Sbjct: 184  KSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 7e-25
 Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 15/196 (7%)

Query: 813  IGKGGFGTVYRGV--LPDGRE--VAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNL 867
            +G G FG+V +GV  +  G+E  VAVK L++E +  G++EF  E  V++       HP +
Sbjct: 3    LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQ----LDHPCI 58

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            V L G C  G   +LV E    G L   +  R  +      ++A  VA  + +L  + + 
Sbjct: 59   VRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF- 116

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVLL    +A ++DFG++R + AG  +   T AG   + + APE     +
Sbjct: 117  --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 986  ATTKGDVYSFGVLAME 1001
             ++K DV+S+GV   E
Sbjct: 175  FSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  104 bits (262), Expect = 7e-25
 Identities = 77/205 (37%), Positives = 110/205 (53%), Gaps = 19/205 (9%)

Query: 811  RIIGKGGFGTVYRGVL--PDGREV--AVKKLQR-EGLEGEREFRAEMEVLSGNGFGWPHP 865
            R+IGKG FG VY G L   DG+++  AVK L R   LE   +F  E  ++      + HP
Sbjct: 1    RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD----FSHP 56

Query: 866  NLVTLYGWCL--DGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLH 922
            N+++L G CL  +GS  ++V  YM+ G L + I   T   T +  +   + VA+ + +L 
Sbjct: 57   NVLSLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAPE 979
             + +   VHRD+ A N +LD+     V DFGLAR +   +    H  T     V ++A E
Sbjct: 116  SKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
              QT + TTK DV+SFGVL  EL T
Sbjct: 173  SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (260), Expect = 1e-24
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 13/221 (5%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRA---EMEVLSGNGFGW 862
            F   R+IGKG FG V      D +++ A+K + ++    +   R    E  +L       
Sbjct: 2    FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE----L 57

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP LV L+    D     LV + + GG L   +S + + +  +      ++  AL +LH
Sbjct: 58   NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    I+HRD+K  N+LLD++G   +TDF +A  V+     ++T+ +GT GY+APE   
Sbjct: 118  SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLC 172

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
                +   D +S GV A E   G+R   G    + +  R  
Sbjct: 173  RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (276), Expect = 2e-24
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 28/291 (9%)

Query: 794  AFTYSDILKATGKFSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEM 852
            + T +DIL +     E+ +I +G  G  Y+G  + +G +  VK++         E  A+M
Sbjct: 682  SITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI-ADM 737

Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
              L        HPN+V L G C       L++EY+EG +L +++ +   L+W RR  IAI
Sbjct: 738  GKLQ-------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAI 787

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
             +A+AL FLH  C P +V  ++    +++D        D    R+   G     T    +
Sbjct: 788  GIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFIS 841

Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE---GGEECLVEWGRRVMGYGRH 1029
              YVAPE  +T   T K D+Y FG++ +EL TG+   +   G    +VEW R    Y   
Sbjct: 842  SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR--YCYSDC 899

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                 + P +     + +   E+ E++ + + CTA  P ARP   +VL  L
Sbjct: 900  HLDMWIDPSIRGDVSVNQ--NEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-24
 Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 29/211 (13%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRA-EMEVLSGNGFGWP 863
             F+    IGKG FG VY+ +     + VA+K +  E  E E E    E++ LS       
Sbjct: 2    LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ----CR 57

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVARA 917
             P +   YG  L GS+  ++ EY  GGS  D       L    +LD   IA    +V   
Sbjct: 58   SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-------LLKPGKLDETYIAFILREVLLG 110

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST---TIAGTVG 974
            L +LH E     +HRD+KA+N+LL +EG   + DFG    VS   +   +   T  GT  
Sbjct: 111  LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG----VSGQLTSTMSKRNTFVGTPF 163

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
            ++APE  +      K D++S G+ A+ELA G
Sbjct: 164  WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (256), Expect = 7e-24
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLEGER-EFRAEMEVLSGNG 859
            KF +   +G+G FG V            G +VAVK L   G E  R +F  E+E+L    
Sbjct: 7    KFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT-- 62

Query: 860  FGWPHPNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVAR 916
                H N+V   G C     +   L+ EY+  GSL D +   R ++  +R L  +  + +
Sbjct: 63   --LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VG 974
             + +L  + Y   +HRD+ A N+L++ E    ++DFGLA+V+     +      G   + 
Sbjct: 121  GMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            + APE  +T + ++  DV+SFGV   EL T
Sbjct: 178  WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 41/287 (14%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +++IG G FG V RG L  P  +E  VA+K L+    + +R +F  E  ++      + H
Sbjct: 9    EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQ----FDH 64

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHH 923
            PN++ L G        +++ EYME GSL+  +  +  + T  + + +   +A  + +L  
Sbjct: 65   PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG--TVGYVAPEYG 981
              Y   VHRD+ A N+L++      V+DFGL+R +   ++   TT  G   + + APE  
Sbjct: 125  MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTTKGGKIPIRWTAPEAI 180

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PGRAVIP 1037
               + T+  DV+SFG++  E                     VM YG         + VI 
Sbjct: 181  AYRKFTSASDVWSFGIVMWE---------------------VMSYGERPYWDMSNQDVIK 219

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             V  G  L    +  S L ++ + C  +  N RP   ++++ L K++
Sbjct: 220  AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +R +G G FG V+ G      +VAVK L + G      F  E +++        H  LV 
Sbjct: 11   ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKK----LRHDKLVQ 65

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYP 927
            LY  C +     +V EYM  GSL D +      +L   + +D+A  +A  + +L    Y 
Sbjct: 66   LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY- 124

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              +HRD+ A N+L+ +     + DFGLAR++   +          + + APE     + T
Sbjct: 125  --IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 988  TKGDVYSFGVLAMELAT-GR 1006
             K DV+SFG+L  E+ T GR
Sbjct: 183  IKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (251), Expect = 2e-23
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 10/200 (5%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            F+ +R +G G FG V+ G+  +   VA+K L+ + L  +++F+ E++ L        H +
Sbjct: 8    FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKR----LRHKH 63

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHE 924
            L++L+  C  G    ++ E ME GSL   +   +   L     +D+A  VA  + +L  +
Sbjct: 64   LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                 +HRD+ A N+L+ ++    V DFGLAR++   D ++S+       + APE     
Sbjct: 124  ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHG 179

Query: 985  QATTKGDVYSFGVLAMELAT 1004
              +TK DV+SFG+L  E+ T
Sbjct: 180  TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.8 bits (246), Expect = 7e-23
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 806  KFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRA--EMEVLSGNGFG 861
            K+ + R++G+G FG V+  R    D + V +K++  E +  +    A  E +VL      
Sbjct: 1    KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL---- 55

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALV 919
              HPN++  Y   L+    ++V EY  GG+L + I  R    L     L   + +   L+
Sbjct: 56   LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LL 112

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             LHH     I+HRD+K  N+LLDK    + + DFG+++++S+     + T+ GT  Y++P
Sbjct: 113  ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISP 170

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D+++ G +  ELA+ +RA E 
Sbjct: 171  ELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 99.1 bits (247), Expect = 1e-22
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 42/210 (20%)

Query: 813  IGKGGFGTVYRG-VLPDGREVAVKKL------QREGLEGE----REFRAEMEVLSGNGFG 861
            IG+G  G V        GR+VAVKK+      +RE L  E    R++             
Sbjct: 27   IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY------------- 73

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              HPN+V +Y   L G E  +V E++EGG+L DI++  TR+   +   + + V +AL FL
Sbjct: 74   -QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLAVLKALSFL 131

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H +    ++HRD+K+ ++LL  +G+  ++DFG    VS  +     ++ GT  ++APE  
Sbjct: 132  HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEVI 187

Query: 980  ----YGQTWQATTKGDVYSFGVLAMELATG 1005
                YG      T+ D++S G++ +E+  G
Sbjct: 188  SRLPYG------TEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 803  ATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
             TG F    +IG+G +G VY+      G+ VA+K +     + E E + E  +L      
Sbjct: 4    PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSN- 61

Query: 862  WPHPNLVTLYGWCL------DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------ 909
              HPN+ T YG  +      +  +  LV E   GGS+ D++  +      +RL       
Sbjct: 62   --HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAY 117

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            I  +  R L +LH      ++HRD+K  N+LL K  +  + DFG++  + +     +T I
Sbjct: 118  ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 970  AGTVGYVAPEY---GQTWQAT--TKGDVYSFGVLAMELATG 1005
             GT  ++APE     +   A+   + DV+S G+ A+ELA G
Sbjct: 175  -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 32/212 (15%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWP 863
            F     +G+G +G+VY+ +    G+ VA+K +  E    E  +E     +  S       
Sbjct: 5    FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS------- 57

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVARA 917
             P +V  YG     ++  +V EY   GS+ DI+    ++T  + L    IA       + 
Sbjct: 58   -PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM----KIT-NKTLTEEEIAAILYQTLKG 111

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVG 974
            L +LH       +HRD+KA N+LL++EG+A + DFG    VS   +       T+ GT  
Sbjct: 112  LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTVIGTPF 164

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
            ++APE  Q      K D++S G+ A+E+A G+
Sbjct: 165  WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 96.9 bits (241), Expect = 8e-22
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 10/201 (4%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA+K++  +    +     E+ V+  N     H
Sbjct: 20   KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN----KH 75

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D++++ T +   +   +  +  +AL FLH  
Sbjct: 76   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 134

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S   +T+ GT  ++APE     
Sbjct: 135  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190

Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K D++S G++A+E+  G
Sbjct: 191  AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 33/277 (11%)

Query: 811  RIIGKGGFG--TVYRGVLPDGREVAVKK--LQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R++GKG FG  T+YR    D   V  K+  L R   +  R+   E+ +LS       HPN
Sbjct: 6    RVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSL----LQHPN 60

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRR--LDIAIDVARALVFLHHE 924
            ++  Y   +D +  ++  EY  GG+L D I  +    +     L     +  A+ ++H  
Sbjct: 61   IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K  N+ L K G   + DFG+++++ +  S  + T+ GT  Y++PE  Q  
Sbjct: 121  ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGV 176

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
            +   K D+++ G +  EL T +R  +      +     ++  G + P  +V         
Sbjct: 177  KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK--IVQ-GNYTPVVSVY-------- 225

Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081
                + E+  L+        + P  RP   EVL   +
Sbjct: 226  ----SSELISLVH---SLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 47/225 (20%)

Query: 811  RIIGKGGFGTVYRG----VLPDGRE--VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            R +G+G FG V+ G    + P+  +  VAVK L+       R+ F  E E+L+       
Sbjct: 11   RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ---- 66

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--------------SDRTRLTWRRRLD 909
            H N+V  YG C +G   I+V+EYME G L   +              S    LT  + L 
Sbjct: 67   HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT---DFGLARVVSAGDSHVS 966
            IA+ +A  +V+L  + +   VHRD+   N L+   G  LV    DFG++R V   D +  
Sbjct: 127  IAVQIASGMVYLASQHF---VHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYY-- 178

Query: 967  TTIAGT----VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
              + G     + ++ PE   Y +    TT+ DV+SFGV+  E+ T
Sbjct: 179  -RVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + +G G FG V+ G      +VA+K +  EG   E +F  E +V+        HP LV L
Sbjct: 10   KELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVM----MKLSHPKLVQL 64

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPI 929
            YG C       +V E+ME G L + +  R  +L+    L +  DV   + +L    +   
Sbjct: 65   YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF--- 121

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HRD+ A N L+   G   V+DFG+ R V   D + S++ A   V +  PE     + ++
Sbjct: 122  IHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 989  KGDVYSFGVLAMELAT-GRRALE 1010
            K DV+SFGVL  E+ T G+   E
Sbjct: 181  KSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.2 bits (234), Expect = 3e-21
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 15/196 (7%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MKLSHEKLVQLYG 66

Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
             C       +V EYM  G L + +     R    + L++  DV   + +L  + +   +H
Sbjct: 67   VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF---IH 123

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQATT 988
            RD+ A N L+D +G   V+DFGL+R V   D + S+   G+   V +  PE     + ++
Sbjct: 124  RDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSV--GSKFPVRWSPPEVLLYSKFSS 180

Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+ +
Sbjct: 181  KSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKK--LQREGLEGEREFRAEMEVLSGNGFGW 862
             K  E   +G+G  G+V +  L +   +   K        + +++   E+E+        
Sbjct: 1    EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKS----C 56

Query: 863  PHPNLVTLYGWCLDGSE---KILVYEYMEGGSLEDI---ISDRTRLTWRRRL-DIAIDVA 915
              P +V  YG  LD S     I + EY EGGSL+ I   +  R      + L  IA  V 
Sbjct: 57   KSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVG 974
            + L +LH      I+HRD+K SN+LL ++G+  + DFG++  +V++       T  GT  
Sbjct: 116  KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG----TFTGTSF 168

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
            Y+APE  Q    +   DV+S G+  +E+A  R
Sbjct: 169  YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 71/207 (34%), Positives = 110/207 (53%), Gaps = 23/207 (11%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGERE-FRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +  E  E E E  + E+ VLS      
Sbjct: 6    FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ----C 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALV 919
              P +   YG  L G++  ++ EY+ GGS  D++    R        IA    ++ + L 
Sbjct: 60   DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLD 115

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAP 978
            +LH E     +HRD+KA+NVLL ++G   + DFG+A  ++  D+ +   T  GT  ++AP
Sbjct: 116  YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATG 1005
            E  Q     +K D++S G+ A+ELA G
Sbjct: 171  EVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 95.0 bits (236), Expect = 4e-21
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 5/205 (2%)

Query: 811  RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +++GKG FG V    L   G   AVK L+++ +  + +    M         W +P L  
Sbjct: 1    KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            LY           V E++ GG L   I D+ R    R    A ++   L FLH +    I
Sbjct: 61   LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GI 117

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            ++RD+K  NV+LD++G   + DFG+ +    GD+  ++T  GT  Y+APE  Q  + T  
Sbjct: 118  IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLKYTFS 176

Query: 990  GDVYSFGVLAMELATGRRALEGGEE 1014
             D +SFGVL  E+  G+    G +E
Sbjct: 177  VDWWSFGVLLYEMLIGQSPFHGDDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 53/281 (18%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKL------QREGLEGEREFR--AEMEVLSGNGFGWP 863
            IGKG FG V++ V   D R  A+K++      +RE  E   E R  A+++          
Sbjct: 8    IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD---------- 57

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTR-----LTWRRRLDIAIDVARA 917
               ++  Y   LD  +  +V EY E G L  ++   R R       WR      I +   
Sbjct: 58   SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLG 113

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH +    I+HRD+K+ N+ LD      + D G+A+++S  +++ + TI GT  Y++
Sbjct: 114  LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLS 169

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVI 1036
            PE  +      K DV++ GV+  E  TG+   +   +  L+    +++        R V 
Sbjct: 170  PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---LKII--------RGVF 218

Query: 1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            P V         ++++++L+    +C  +    RP+  ++L
Sbjct: 219  PPVSQMY-----SQQLAQLID---QCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.0 bits (233), Expect = 7e-21
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 28/274 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA+K++  +    +     E+ V+  N     +
Sbjct: 20   KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN----KN 75

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D++++ T +   +   +  +  +AL FLH  
Sbjct: 76   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN 134

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  ST + GT  ++APE     
Sbjct: 135  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 191  AYGPKVDIWSLGIMAIEMVEGEPP-----------------YLNENPLRALYLIATNGTP 233

Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E +S + R  + RC     + R + KE+L
Sbjct: 234  ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.4 bits (233), Expect = 8e-21
 Identities = 64/234 (27%), Positives = 95/234 (40%), Gaps = 37/234 (15%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVK-----KLQREGLEGE--REFRAEMEVLSGNGFGW 862
            +IIG+G F TV         +E A+K     +L +E        E +  +  L+G     
Sbjct: 7    KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLNG----- 60

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP ++ LY    D      V EY   G L   I     L  +     A ++  AL +LH
Sbjct: 61   -HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA------------ 970
             +    I+HRD+K  N+LLDK+    +TDFG A+V+    S  S                
Sbjct: 120  SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 971  -------GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                   GT  YV+PE      A    D+++ G +  ++ TG+    G  E L 
Sbjct: 177  RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGERE-FRAEMEVLSGNGFGWPHPNLV 868
             IGKG FGTV +     DG+ +  K++    + E E++   +E+ +L        HPN+V
Sbjct: 7    TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRE----LKHPNIV 62

Query: 869  TLYGWCLDGSEKIL--VYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVARALVFLH 922
              Y   +D S + L  V EY EGG L  +I     +R  +       I   +  AL    
Sbjct: 63   RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL---- 118

Query: 923  HECY------PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            +EC+        ++HRD+K +N+ LD      + DFGLA+++   DS  + T  GT  Y+
Sbjct: 119  YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPYYM 177

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGR 1006
            +PE         K D++S G L  EL    
Sbjct: 178  SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 73/215 (33%), Positives = 106/215 (49%), Gaps = 28/215 (13%)

Query: 811  RIIGKGGFGTVYRG----VLPDGRE---VAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
              +G G FG VY G    +L  G     VAVK L++   + E+ EF  E  ++S     +
Sbjct: 1    NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSN----F 56

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-------LTWRRRLDIAIDVA 915
             HPN+V L G CL    + ++ E MEGG L   + D          LT +  LDI +DVA
Sbjct: 57   NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-----VTDFGLARVVSAGDSH-VSTTI 969
            +  V+L    +   +HRD+ A N L+ ++G        + DFGLAR +   D +      
Sbjct: 117  KGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
               V ++APE     + TT+ DV+SFGVL  E+ T
Sbjct: 174  LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VA+K L ++G      F AE  ++        HP LV LY 
Sbjct: 14   LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQ----LQHPRLVRLYA 68

Query: 873  WCLDGSEKI-LVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
              +   E I ++ EYME GSL D +   +  +LT  + +D+A  +A  + F+  + Y   
Sbjct: 69   --VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY--- 123

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            +HRD++A+N+L+ +     + DFGLAR++   +          + + APE       T K
Sbjct: 124  IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 990  GDVYSFGVLAMELAT-GR 1006
             DV+SFG+L  E+ T GR
Sbjct: 184  SDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 51/281 (18%)

Query: 813  IGKGGFGTVYR-GVLPDGREVAVKKL------QREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +GKG +G+VY+   L D +  A+K++      Q+E  +   E R    V         HP
Sbjct: 8    LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV--------NHP 59

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR--------TRLTWRRRLDIAIDVARA 917
            N+++     LDG++  +V EY   G L   IS R         +  WR    I I + R 
Sbjct: 60   NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRG 115

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH +    I+HRD+K++N+LL       + D G+++V+      ++ T  GT  Y+A
Sbjct: 116  LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMA 169

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
            PE  +    + K D++S G L  E+AT     E     + +   +V   G++ P    IP
Sbjct: 170  PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA--RSMQDLRYKVQR-GKYPP----IP 222

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
             +         ++++   +R         P  RPN  ++LA
Sbjct: 223  PIY--------SQDLQNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 92.9 bits (230), Expect = 2e-20
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 28/274 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTV+  + +  G+EVA+K++  +    +     E+ V+        +
Sbjct: 20   KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE----LKN 75

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D++++ T +   +   +  +  +AL FLH  
Sbjct: 76   PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN 134

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ NVLL  +G   +TDFG    ++   S  ST + GT  ++APE     
Sbjct: 135  ---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 190

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 191  AYGPKVDIWSLGIMAIEMVEGEPP-----------------YLNENPLRALYLIATNGTP 233

Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE+L
Sbjct: 234  ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 17/198 (8%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 14   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 68

Query: 872  GWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +   +R  +     L +A  ++ A+ +L  + +   
Sbjct: 69   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 125

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 126  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 182

Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 183  SIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE-FRAEMEVLSGNGFGWPH 864
            F++   IGKG FG VY+G+    +EV A+K +  E  E E E  + E+ VLS        
Sbjct: 6    FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ----CDS 61

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            P +   YG  L G++  ++ EY+ GGS  D++     L       I  ++ + L +LH E
Sbjct: 62   PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE 120

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQT 983
                 +HRD+KA+NVLL ++G   + DFG+A  ++  D+ +   T  GT  ++APE  + 
Sbjct: 121  ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 984  WQATTKGDVYSFGVLAMELATG 1005
                 K D++S G+ A+ELA G
Sbjct: 176  SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 15/210 (7%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            +++GKG FG V    L    E  A+K L+++ +  + +    M    VL      W HP 
Sbjct: 1    KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVL---ALAWEHPF 57

Query: 867  LVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            L  L+  C   +++ L  V EY+ GG L   I    R    R    A ++   L FLH +
Sbjct: 58   LTHLF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I++RD+K  NVLLDK+G   + DFG+ +    G+   S T  GT  Y+APE  +  
Sbjct: 116  ---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS-TFCGTPDYIAPEILKGQ 171

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            +     D +SFGVL  E+  G+    G +E
Sbjct: 172  KYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 90.0 bits (223), Expect = 7e-20
 Identities = 68/195 (34%), Positives = 99/195 (50%), Gaps = 17/195 (8%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H NLV L
Sbjct: 12   QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQ----LRHSNLVQL 64

Query: 871  YGWCL-DGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYP 927
             G  + +     +V EYM  GSL D +  R R  L     L  ++DV  A+ +L    + 
Sbjct: 65   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF- 123

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              VHRD+ A NVL+ ++  A V+DFGL +  S+       T    V + APE  +  + +
Sbjct: 124  --VHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFS 177

Query: 988  TKGDVYSFGVLAMEL 1002
            TK DV+SFG+L  E+
Sbjct: 178  TKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 88/310 (28%), Positives = 132/310 (42%), Gaps = 61/310 (19%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL-----PDGR-EVAVKKLQREGLEGE-REFRAEMEVLSGN 858
            + +  + +G+G FG V +        P+    VAVK L+ +  E +  +  +EME++   
Sbjct: 13   RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR----------------TRL 902
            G    H N++ L G C       +V EY   G+L D +  R                  L
Sbjct: 73   G---KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 903  TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
            T +  +  A  VAR + FL  +     +HRD+ A NVL+ ++    + DFGLAR +   D
Sbjct: 130  TQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 963  SHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021
             +  TT     V ++APE       T + DV+SFGVL  E+ T                 
Sbjct: 187  YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------------- 229

Query: 1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM-------SELLRIGVRCTAEAPNARPNVK 1074
              +G G   PG   IPV  L   L EG   M        EL  +   C  E P+ RP  K
Sbjct: 230  --LG-GSPYPG---IPVEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK 282

Query: 1075 EVLAMLIKIL 1084
            +++  L ++L
Sbjct: 283  QLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 90.6 bits (224), Expect = 1e-19
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 28/274 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 21   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN----KN 76

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D++++ T +   +   +  +  +AL FLH  
Sbjct: 77   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  ST + GT  ++APE     
Sbjct: 136  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 192  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 234

Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE+L
Sbjct: 235  ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 90.8 bits (225), Expect = 1e-19
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 15/210 (7%)

Query: 811  RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            +++GKG FG V+   L    +  A+K L+++ +  + +    M    VLS     W HP 
Sbjct: 1    KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS---LAWEHPF 57

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            L  LY           V EY+ GG L   I    +    R    A ++   L FLH +  
Sbjct: 58   LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-- 115

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTW 984
              IV+RD+K  N+LLD +G   + DFG+ +    GD+    T  GT  Y+APE   GQ +
Sbjct: 116  -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC-TFCGTPDYIAPEILLGQKY 173

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
              +   D +SFGVL  E+  G+    G +E
Sbjct: 174  NTSV--DWWSFGVLLYEMLIGQSPFHGHDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 51/297 (17%)

Query: 811  RIIGKGGFGTVYRGVL--PDGR--EVAVKKLQREG-----LEGEREFRAEMEVLSGNGFG 861
            +I+G+G FG+V  G L   DG   +VAVK ++ +      +E      A M+        
Sbjct: 5    KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD----- 59

Query: 862  WPHPNLVTLYGWCLDGSEK------ILVYEYMEGGSLED-IISDRT-----RLTWRRRLD 909
              HPN++ L G C + S        +++  +M+ G L   ++  R      +L  +  L 
Sbjct: 60   --HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
              +D+A  + +L +  +   +HRD+ A N +L ++    V DFGL++ + +GD +    I
Sbjct: 118  FMVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 970  AGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYG 1027
            A   V ++A E       T+K DV++FGV   E+AT G+    G E         +  Y 
Sbjct: 175  AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYL 228

Query: 1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            RH            G+ L +  + + EL  +   C    P  RP   ++  +L  IL
Sbjct: 229  RH------------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 70/231 (30%), Positives = 110/231 (47%), Gaps = 28/231 (12%)

Query: 811  RIIGKGGFGTVY----RGVLPDGREVAVKKL-------QREGLEGEREFRAEMEVLSGNG 859
            R++G G +G V+     G    G+  A+K L       + +  E  R  R  +E +    
Sbjct: 6    RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRR-RLDIAIDVARA 917
            F      LVTL+ +      K+ L+ +Y+ GG L   +  R   T    R+ IA ++  A
Sbjct: 66   F------LVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLA 117

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH      I++RD+K  N+LLD EG  ++TDFGL++   A +   + +  GT+ Y+A
Sbjct: 118  LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 978  PEY--GQTWQATTKGDVYSFGVLAMELATGRR--ALEGGEECLVEWGRRVM 1024
            PE   G +       D +S GVL  EL TG     ++G +    E  RR++
Sbjct: 175  PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 78/295 (26%), Positives = 139/295 (47%), Gaps = 40/295 (13%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGRE----VAVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +    VA+K+L RE    +  +E   E 
Sbjct: 3    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 60

Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIA 911
             V++       +P++  L G CL  + + L+ + M  G L D + + +  +  +  L+  
Sbjct: 61   YVMAS----VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A D        G
Sbjct: 116  VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-DEKEYHAEGG 171

Query: 972  TV--GYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGR 1028
             V   ++A E       T + DV+S+GV   EL T G +  +G                 
Sbjct: 172  KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----------------- 214

Query: 1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
              P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 215  -IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 61/204 (29%), Positives = 86/204 (42%), Gaps = 23/204 (11%)

Query: 813  IGKGGFGTVYRG--VLPDGR--EVAVKKLQREGLEG-EREFRAE---MEVLSGNGFGWPH 864
            +G G FG V RG      G+   VAVK L+ + L     +F  E   M  L        H
Sbjct: 3    LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-------H 55

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLH 922
             NL+ LYG  L      +V E    GSL D +              D A+ +A  + +L 
Sbjct: 56   ENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEY 980
             +     +HRD+ A N+LL  + K  + DFGL R +   + H        V   + APE 
Sbjct: 115  SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             +T   +   DV+ FGV   E+ T
Sbjct: 172  LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 3e-19
 Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 25/208 (12%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGERE-FRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +  E  E E E  + E+ VLS      
Sbjct: 6    FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ----C 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVARAL 918
              P +   YG  L  ++  ++ EY+ GGS  D++     D T++       I  ++ + L
Sbjct: 60   DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGL 114

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVA 977
             +LH E     +HRD+KA+NVLL + G+  + DFG+A  ++  D+ +   T  GT  ++A
Sbjct: 115  DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMA 169

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATG 1005
            PE  +     +K D++S G+ A+ELA G
Sbjct: 170  PEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 89.2 bits (221), Expect = 3e-19
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 16/197 (8%)

Query: 812  IIGKGGFGTVYRG-VLPDGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            I+G G  GTVY+   L   R +AVK +  +  +E +++  +E+E+L    +    P ++ 
Sbjct: 8    ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL----YKCDSPYIIG 63

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
             YG     +   +  E+M+GGSL+        +  R    IA+ V + L +L       I
Sbjct: 64   FYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR----IAVAVVKGLTYLWSL---KI 116

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            +HRDVK SN+L++  G+  + DFG++  +    + ++ T  GT  Y+APE     Q    
Sbjct: 117  LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 990  GDVYSFGVLAMELATGR 1006
             DV+S G+  MELA GR
Sbjct: 174  SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 63/198 (31%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 14   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 68

Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWR--RRLDIAIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +        R  + +D+A  +A  + ++    Y   
Sbjct: 69   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 123

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 124  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 184  SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQ---REGLEGEREFRA---EMEVLSGNGFGWPHP 865
            ++GKG +GTVY G+   G+ +AVK+++      L  E+E+     E+++L        H 
Sbjct: 7    VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS----LKHV 62

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            N+V   G CLD +   +  E++ GGS+  I++    L           +   + +LH+ C
Sbjct: 63   NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-----TTIAGTVGYVAPEY 980
               +VHRD+K +NV+L   G   + DFG AR ++    H +      ++ GT  ++APE 
Sbjct: 123  ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
                    K D++S G    E+ATG+
Sbjct: 180  INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 37/229 (16%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE----VAVKKLQREGLEGER-EFRAEM 852
            I  +  +F E+  +G+G FG VY+G    P+ R     VA+K L+       + EFR E 
Sbjct: 2    IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59

Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL----------EDIISDRTRL 902
            E++S       HPN+V L G C       +++EY+  G L           D+ ++    
Sbjct: 60   ELMSD----LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115

Query: 903  TWRRRLD------IAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            T +  LD      IAI +A  + +L  HH      VHRD+ A N L+ +     ++DFGL
Sbjct: 116  TVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGL 170

Query: 955  ARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            +R + + D + V +     V ++ PE     + TT+ D++SFGV+  E+
Sbjct: 171  SRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 813  IGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGE------REFRAEMEVLSGNGFGWPHP 865
            IG+G  G V++      G  VA+KK+    LEG       RE +A             HP
Sbjct: 8    IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC--------QHP 59

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHE 924
             +V L      GS  +LV EYM    L +++ D  R L   +       + + + ++H  
Sbjct: 60   YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                I+HRD+K +N+L+  +G   + DFGLAR+ S  +  + +    T  Y APE  YG 
Sbjct: 119  ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 983  TWQATTKG-DVYSFGVLAMELATGR 1006
              +    G D+++ G +  EL  G 
Sbjct: 176  --RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.4 bits (216), Expect = 1e-18
 Identities = 58/194 (29%), Positives = 104/194 (53%), Gaps = 10/194 (5%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V        G++VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 30   IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD----YHHENVVDMY 85

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++  TR+   +   + + V RAL +LH++    ++H
Sbjct: 86   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +     ++ GT  ++APE        T+ D
Sbjct: 142  RDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 201  IWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 15/210 (7%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            +++GKG FG V    L    E+ AVK L+++ +  + +    M    VL+       HP 
Sbjct: 1    KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLA---LAGKHPF 57

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L+  C    +++  V EY+ GG L   I    R    R    A ++   L FLH   
Sbjct: 58   LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER- 115

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               I++RD+K  NVLLD EG   + DFG+ +  +  G +  ++T  GT  Y+APE     
Sbjct: 116  --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQ 171

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                  D ++ GVL  E+  G+   EG +E
Sbjct: 172  PYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 90.6 bits (225), Expect = 2e-18
 Identities = 39/92 (42%), Positives = 56/92 (60%)

Query: 367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT 426
           I  L L +    G +P +IS++R L+ + L+ N   G+IP   G++ +L+ LDLS+N   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 427 GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
           G IP S+G LTSL  L L  NSLSG +P  +G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 87.3 bits (216), Expect = 2e-18
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 13/209 (6%)

Query: 811  RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            R++GKG FG V    L   GR  AVK L+++ +  + +    M    +LS       HP 
Sbjct: 1    RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS---LARNHPF 57

Query: 867  LVTLYGWCLDGSEKIL-VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  LY  C    +++  V E++ GG L   I    R    R    A ++  AL+FLH + 
Sbjct: 58   LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK- 115

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               I++RD+K  NVLLD EG   + DFG+ +     +   ++T  GT  Y+APE  Q   
Sbjct: 116  --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 986  ATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                 D ++ GVL  E+  G    E   E
Sbjct: 173  YGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE----------FRAEMEVLSGNGF 860
            +IGKG +G VY  + +  G  +AVK+++       R            R+E+E L     
Sbjct: 8    LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD--- 64

Query: 861  GWPHPNLVTLYGWCLDGSEKILVY-EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
               H N+V   G      E + ++ EY+ GGS+   +    R   +        V   L 
Sbjct: 65   -LDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR-VVSAGDSHVSTTIAGTVGYVAP 978
            +LH +    I+HRD+KA N+L+D +G   ++DFG+++      D+  + ++ G+V ++AP
Sbjct: 123  YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 979  E----YGQTWQATTKGDVYSFGVLAMELATGRR 1007
            E    Y Q + A  K D++S G + +E+  GRR
Sbjct: 180  EVIHSYSQGYSA--KVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 40/287 (13%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +++IG G FG V  G L  P  RE  VA+K L+    E +R +F +E  ++      + H
Sbjct: 9    EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ----FDH 64

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHH 923
            PN++ L G        ++V EYME GSL+  +     + T  + + +   +A  + +L  
Sbjct: 65   PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              Y   VHRD+ A N+L++      V+DFGL+RV+        TT  G   + + APE  
Sbjct: 125  MGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PGRAVIP 1037
               + T+  DV+S+G++  E                     VM YG         + VI 
Sbjct: 182  AYRKFTSASDVWSYGIVMWE---------------------VMSYGERPYWEMSNQDVIK 220

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             +  G  L    +  + L ++ + C  +  N RP  ++++++L K++
Sbjct: 221  AIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 74/236 (31%), Positives = 110/236 (46%), Gaps = 53/236 (22%)

Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGE-REFRAEM 852
            FT  D LK  G+      IG+G FGTV + +    G  +AVK+++    E E +    ++
Sbjct: 1    FTAED-LKDLGE------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53

Query: 853  EVL--SGNGFGWPHPNLVTLYG--------W-C-------LDGSEKILVYEYMEGGSLED 894
            +V+  S +      P +V  YG        W C       LD   K  VYE ++    E+
Sbjct: 54   DVVMRSSDC-----PYIVKFYGALFREGDCWICMELMDISLDKFYKY-VYEVLKSVIPEE 107

Query: 895  IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            I+             IA+   +AL +L  E    I+HRDVK SN+LLD+ G   + DFG+
Sbjct: 108  ILGK-----------IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 955  A-RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT---TKGDVYSFGVLAMELATGR 1006
            + ++V   DS   T  AG   Y+APE            + DV+S G+   E+ATG+
Sbjct: 155  SGQLV---DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 86.2 bits (213), Expect = 3e-18
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 38/288 (13%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK---KLQREGL--EGEREFRAEME 853
            ILK T +  + +++G G FGTVY+G+ +PDG  V +    K+ RE    +  +E   E  
Sbjct: 3    ILKET-ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAI 912
            V++G G     P +  L G CL  + + LV + M  G L D + + + R+  +  L+  +
Sbjct: 62   VMAGVG----SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
             +A+ + +L       +VHRD+ A NVL+       +TDFGLAR++   ++       G 
Sbjct: 117  QIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-GGK 172

Query: 973  V--GYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
            V   ++A E     + T + DV+S+GV   EL T G +  +G                  
Sbjct: 173  VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG------------------ 214

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P R +  ++  G  L +      ++  I V+C       RP  +E++
Sbjct: 215  IPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVK--KLQREGLEGE---REFRAEMEVLSGNGFGWPH 864
             ++G G FG+VY G+ L DG   AVK   L  +G  G+   ++   E+ +LS       H
Sbjct: 6    ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK----LQH 61

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-------RTRLTWRRRLDIAIDVARA 917
            PN+V   G   +     +  E + GGSL  ++           RL  R+ L         
Sbjct: 62   PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------G 114

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L +LH       VHRD+K +N+L+D  G   + DFG+A+ V       S    G+  ++A
Sbjct: 115  LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMA 169

Query: 978  PEY-----GQTWQATTKGDVYSFGVLAMELATGR 1006
            PE      G    A    D++S G   +E+ATG+
Sbjct: 170  PEVIAQQGGYGLAA----DIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 85/312 (27%), Positives = 141/312 (45%), Gaps = 54/312 (17%)

Query: 794  AFTYSDILKATGKFSEDRIIGKGGFGTVYRG-VLPDG--REVAVKKLQREGLEGE-REFR 849
               ++DI     KF +  +IG+G FG V +  +  DG   + A+K+++    + + R+F 
Sbjct: 3    VLEWNDI-----KFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 55

Query: 850  AEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDI-------------- 895
             E+EVL   G    HPN++ L G C       L  EY   G+L D               
Sbjct: 56   GELEVLCKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 112

Query: 896  ISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG 953
            I++ T   L+ ++ L  A DVAR + +L  + +   +HRD+ A N+L+ +   A + DFG
Sbjct: 113  IANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFG 169

Query: 954  LARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
            L+R     + +V  T+    V ++A E       TT  DV+S+GVL  E+ +       G
Sbjct: 170  LSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226

Query: 1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072
              C   + +   GY    P                  +E+ +L+R   +C  E P  RP+
Sbjct: 227  MTCAELYEKLPQGYRLEKP--------------LNCDDEVYDLMR---QCWREKPYERPS 269

Query: 1073 VKEVLAMLIKIL 1084
              ++L  L ++L
Sbjct: 270  FAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 68/206 (33%), Positives = 93/206 (45%), Gaps = 29/206 (14%)

Query: 813  IGKGGFGTVYR-GVLPDGREVAVKKL---------QREGLEGEREFRAEMEVLSGNGFGW 862
            +G GGFG V    V    R  A+K +         Q+E +  E+E   E           
Sbjct: 1    LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--------- 51

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRL-TWRRRLDIAIDVARALVF 920
             HP +V LY    D  + I ++ EY  GG L  I+ DR     +  R  IA  V  A  +
Sbjct: 52   -HPFIVKLYRTFKD-KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEY 108

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            LH+     I++RD+K  N+LLD  G   + DFG A+ + +G    + T  GT  YVAPE 
Sbjct: 109  LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEI 163

Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
                      D +S G+L  EL TGR
Sbjct: 164  ILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +G VY+   +  G  VA+K ++ E  +     + E+ +L        HPN+V  +
Sbjct: 11   IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR----HPNIVAYF 66

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALVFLHHECYPP 928
            G  L   +  +V EY  GGSL+DI    TR        IA    +  + L +LH      
Sbjct: 67   GSYLRRDKLWIVMEYCGGGSLQDIY-QVTRGPLSELQ-IAYVCRETLKGLAYLHET---G 121

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ---TWQ 985
             +HRD+K +N+LL ++G   + DFG++  ++A  +   + I GT  ++APE         
Sbjct: 122  KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180

Query: 986  ATTKGDVYSFGVLAMELATG 1005
               K D+++ G+ A+ELA  
Sbjct: 181  YDGKCDIWALGITAIELAEL 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 55/294 (18%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ---------REGLEGEREFRAEME 853
             G F  ++ IGKG F  VY+ + L DGR VA+KK+Q         R+    E +   +++
Sbjct: 1    LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----SDRTRLTWRRRLD 909
                      HPN++      ++ +E  +V E  + G L  +I      +  +  R    
Sbjct: 61   ----------HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
              + +  AL  +H +    I+HRD+K +NV +   G   + D GL R  S      S T 
Sbjct: 111  YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS------SKTT 161

Query: 970  A-----GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            A     GT  Y++PE         K D++S G L  E+A  +    G +  L    +++ 
Sbjct: 162  AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI- 220

Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
                + P    +P           A+  SE LR  V RC    P  RP++  VL
Sbjct: 221  EKCDYPP----LP-----------ADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 8e-18
 Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 60/309 (19%)

Query: 810  DRIIGKGGFGTVYRGV------LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGW 862
             + +G+G FG V +              VAVK L+      E R+  +E  +L       
Sbjct: 5    GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--- 61

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII------------SDRTR--------- 901
             HP+++ LYG C      +L+ EY + GSL   +            SD  R         
Sbjct: 62   -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 902  ---LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
               LT    +  A  ++R + +L       +VHRD+ A NVL+ +  K  ++DFGL+R V
Sbjct: 121  ERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 959  SAGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG-GEEC 1015
               DS+V  +     V ++A E       TT+ DV+SFGVL  E+ T G     G   E 
Sbjct: 178  YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075
            L  +     GY    P                 +EEM  L+     C  + P+ RP   +
Sbjct: 238  L--FNLLKTGYRMERPENC--------------SEEMYNLML---TCWKQEPDKRPTFAD 278

Query: 1076 VLAMLIKIL 1084
            +   L K++
Sbjct: 279  ISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 85.1 bits (210), Expect = 9e-18
 Identities = 52/177 (29%), Positives = 96/177 (54%), Gaps = 9/177 (5%)

Query: 829  GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME 888
            GR+VAVK +     +       E+ ++      + H N+V +Y   L G E  ++ E+++
Sbjct: 46   GRQVAVKMMDLRKQQRRELLFNEVVIMRD----YQHQNVVEMYKSYLVGEELWVLMEFLQ 101

Query: 889  GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL 948
            GG+L DI+S +TRL   +   +   V +AL +LH +    ++HRD+K+ ++LL  +G+  
Sbjct: 102  GGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVK 157

Query: 949  VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
            ++DFG    +S  D     ++ GT  ++APE        T+ D++S G++ +E+  G
Sbjct: 158  LSDFGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 27/278 (9%)

Query: 813  IGKGGFGTV----YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +GKG FG+V    Y   L D  G  VAVKKLQ    E  R+F  E+E+L        H N
Sbjct: 12   LGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS----LQHDN 66

Query: 867  LVTLYGWCLDGSEK--ILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHH 923
            +V   G C     +   LV EY+  GSL D +   R RL  R+ L  A  + + + +L  
Sbjct: 67   IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
            + Y   VHRD+   N+L++ E +  + DFGL +V+     +      G   + + APE  
Sbjct: 127  KRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040
               + +   DV+SFGV+  EL T   ++     E +     R+MG  + G       + L
Sbjct: 184  TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-----RMMGNDKQGQMIVYHLIEL 238

Query: 1041 LGSG--LAEGAEEMSELLRIGVRCTAEAPNARPNVKEV 1076
            L +   L       +E+  I   C    P+ RP+  E+
Sbjct: 239  LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 25/213 (11%)

Query: 810  DRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             R +G+G FG VY G+            VA+K +       ER EF  E  V+    F  
Sbjct: 11   IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM--KEFNC 68

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL----------EDIISDRTRLTWRRRLDIAI 912
             H  +V L G    G   ++V E M  G L           +        T ++ + +A 
Sbjct: 69   HH--VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG- 971
            ++A  + +L  + +   VHRD+ A N ++ ++    + DFG+ R +   D +        
Sbjct: 127  EIADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             V ++APE  +    TTK DV+SFGV+  E+AT
Sbjct: 184  PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 24/215 (11%)

Query: 803  ATGKFSE-DRI--IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG-EREFRAEMEVLSG 857
            A    SE +R+  IG G  GTVY+ +  P GR  A+K +     +   R+   E+E+L  
Sbjct: 69   AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDI-ISDRTRLTWRRRLDIAIDVAR 916
                  HPN+V  +       E  ++ E+M+GGSLE   I+D   L      D+A  +  
Sbjct: 129  VN----HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILS 179

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             + +LH      IVHRD+K SN+L++      + DFG++R+++      ++++ GT+ Y+
Sbjct: 180  GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYM 235

Query: 977  APEYGQTWQATTK-----GDVYSFGVLAMELATGR 1006
            +PE   T           GD++S GV  +E   GR
Sbjct: 236  SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 811  RIIGKGGFGTV--YRGVLPD----GREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWP 863
            R++G+G FG V  Y    P     G  VAVK L+RE G +    ++ E+ +L        
Sbjct: 10   RVLGEGHFGKVSLYC-YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT----LY 64

Query: 864  HPNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
            H N+V   G C +   K   L+ EY+  GSL D +  + +L   + L  A  +   + +L
Sbjct: 65   HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYL 123

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPE 979
            H + Y   +HRD+ A NVLLD +    + DFGLA+ V  G  +  V       V + A E
Sbjct: 124  HSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
              +  + +   DV+SFGV   EL T
Sbjct: 181  CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 10/194 (5%)

Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 28   IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 83

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++  TR+   +   + + V +AL  LH +    ++H
Sbjct: 84   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIH 139

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +     ++ GT  ++APE         + D
Sbjct: 140  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 199  IWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKLQ--REGLEGEREFRA---EMEVLSGNGFGWPH 864
            +++G+G FG VY     D GRE+AVK++    +  E ++E  A   E+++L        H
Sbjct: 8    KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN----LQH 63

Query: 865  PNLVTLYGWCLDGSEKILVY-EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
              +V  YG CL   E + ++ EYM GGS++D +     LT          +   + +LH 
Sbjct: 64   ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAGTVGYVAPE-- 979
                 IVHRD+K +N+L D  G   + DFG ++ +    S  +   ++ GT  +++PE  
Sbjct: 123  N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 980  ----YGQTWQATTKGDVYSFGVLAMELAT 1004
                YG+      K DV+S G   +E+ T
Sbjct: 180  SGEGYGR------KADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 16/212 (7%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNG 859
               ++ ++IG G FG V+RG+L  P  +E  VA+K L+    E +R +F +E  ++    
Sbjct: 5    SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ-- 62

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARAL 918
              + H N++ L G        +++ EYME G+L+  + D     +  + + +   +A  +
Sbjct: 63   --FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG--YV 976
             +L    Y   VHRD+ A N+L++   +  V+DFGL+RV+        TT  G +   + 
Sbjct: 121  KYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELAT-GRR 1007
            APE     + T+  DV+SFG++  E+ + G R
Sbjct: 178  APEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 70/199 (35%), Positives = 108/199 (54%), Gaps = 17/199 (8%)

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IIG+G FG V +G    G++VAVK ++ +     + F  E  V++       H NLV L 
Sbjct: 13   IIGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTK----LHHKNLVRLL 65

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPI 929
            G  L     I V E M  G+L + +  R R  ++  + L  ++DVA  + +L  +    +
Sbjct: 66   GVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD+ A N+L+ ++G A V+DFGLARV S G   V  +    V + APE  +  + ++K
Sbjct: 122  VHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL-PVKWTAPEALKHKKFSSK 177

Query: 990  GDVYSFGVLAMELATGRRA 1008
             DV+S+GVL  E+ +  RA
Sbjct: 178  SDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 813  IGKGGFGTVYRGVLPDG-------REV-----AVKKLQREGLEGEREFRAEMEVLSGNGF 860
            +G G FG VY+    +        +E+     A  K +RE  +   +  +E+ ++     
Sbjct: 8    LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-- 65

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVAR 916
               HPN+V  Y   L+     +V + +EG  L +  +     + R T  R  +I + +  
Sbjct: 66   -LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            AL +LH E    IVHRD+  +N++L ++ K  +TDFGLA+          T++ GT+ Y 
Sbjct: 125  ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYS 180

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELAT 1004
             PE  +      K DV++FG +  ++ T
Sbjct: 181  CPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 57/298 (19%)

Query: 811  RIIGKGGFGTVYRG----VLP--DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V+      + P  D   VAVK L+   L   ++F+ E E+L+       H
Sbjct: 11   RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN----LQH 66

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SDRTRLTWRRRL 908
             ++V  YG C DG   I+V+EYM+ G L   +                  +  L   + L
Sbjct: 67   EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VST 967
             IA  +A  +V+L  + +   VHRD+   N L+       + DFG++R V + D + V  
Sbjct: 127  HIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 968  TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG 1027
                 + ++ PE     + TT+ DV+SFGV+  E+ T                     YG
Sbjct: 184  HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------------YG 222

Query: 1028 RH-----GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            +           VI  +  G  L        E+  I + C    P  R N+KE+  +L
Sbjct: 223  KQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 13/209 (6%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            +++GKG FG V    L    EV A+K L+++ +  + +    M    +L+       HP 
Sbjct: 1    KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA---LAAKHPF 57

Query: 867  LVTLYGWCLDGSEKIL-VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L+  C    +++  V EY+ GG L   I    +    R    A +V  AL+FLH   
Sbjct: 58   LTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH- 115

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               +++RD+K  N+LLD EG   + DFG+ +         +TT  GT  Y+APE  Q  +
Sbjct: 116  --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELE 172

Query: 986  ATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                 D ++ GVL  E+  G+   E   E
Sbjct: 173  YGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.6 bits (206), Expect = 2e-17
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 56/296 (18%)

Query: 811  RIIGKGGFGTVYRG----VLPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V+      + P+  +  VAVK L+       ++F  E E+L+       H
Sbjct: 11   RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN----LQH 66

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-------------TRLTWRRRLDIA 911
             ++V  YG C++G   I+V+EYM+ G L   +                  LT  + L IA
Sbjct: 67   EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              +A  +V+L  + +   VHRD+   N L+ +     + DFG++R V + D + V     
Sbjct: 127  QQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRR---ALEGGE--ECLVEWGRRVM 1024
              + ++ PE     + TT+ DV+S GV+  E+ T G++    L   E  EC+ +   RV+
Sbjct: 184  LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--GRVL 241

Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
               R  P                  +E+ +L+   + C    P+ R N+KE+ ++L
Sbjct: 242  QRPRTCP------------------KEVYDLM---LGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.0 bits (207), Expect = 2e-17
 Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 36/288 (12%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKL-QREGLEGEREFRAEME 853
            ILK T +    +++G G FGTVY+G+ +P+G  V    A+K L +  G +   EF  E  
Sbjct: 3    ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
            +++       HP+LV L G CL  + +++      G  L+ +   +  +  +  L+  + 
Sbjct: 62   IMAS----MDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ 117

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A+ +++L       +VHRD+ A NVL+       +TDFGLAR++  GD        G  
Sbjct: 118  IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKM 173

Query: 973  -VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHG 1030
             + ++A E     + T + DV+S+GV   EL T G +  +G                   
Sbjct: 174  PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG------------------I 215

Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            P R +  ++  G  L +      ++  + V+C     ++RP  KE+ A
Sbjct: 216  PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 82/294 (27%), Positives = 117/294 (39%), Gaps = 60/294 (20%)

Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G+           +VAVK L  E    + E    ME L  + F   H
Sbjct: 12   RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFN--H 68

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTR------LTWRRRLDIAIDVARA 917
             N+V L G   +   + ++ E M GG L+  + + R R      LT +  L  A DVA+ 
Sbjct: 69   QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAGT-- 972
              +L    +   +HRD+ A N LL  +G    A + DFG+AR +     +      G   
Sbjct: 129  CKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY---RKGGRAM 182

Query: 973  --VGYVAPEYGQTWQATTKGDVYSFGVLAMEL-------ATGRRALEGGEECLVEWGRRV 1023
              + ++ PE       T+K DV+SFGVL  E+         GR   E   E +   GR  
Sbjct: 183  LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-VMEFVTGGGR-- 239

Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            +   +  PG                      + RI   C    P  RPN   +L
Sbjct: 240  LDPPKGCPGP---------------------VYRIMTDCWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 77/274 (28%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G      +VA+K L + G      F  E +++        H  LV LY 
Sbjct: 14   LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKK----LRHDKLVPLYA 68

Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIIS--DRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
              +   E I +V E+M  GSL D +   D   L   + +D+A  +A  + ++    Y   
Sbjct: 69   --VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY--- 123

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            +HRD++A+N+L+       + DFGLAR++   +          + + APE     + T K
Sbjct: 124  IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 990  GDVYSFGVLAMELAT-GRRALEG--GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046
             DV+SFG+L  EL T GR    G    E L +  R   GY    P            G  
Sbjct: 184  SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---GYRMPCP-----------QGCP 229

Query: 1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            E   E+ +L      C  + P+ RP  + + + L
Sbjct: 230  ESLHELMKL------CWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 47/294 (15%)

Query: 812  IIGKGGFGTVYRGVLP-DGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNL 867
            +IG+G FG V R ++  DG ++  A+K L+    E + R+F  E+EVL   G    HPN+
Sbjct: 9    VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG---HHPNI 65

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIA 911
            + L G C +     +  EY   G+L D +                   + LT ++ L  A
Sbjct: 66   INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
             DVA  + +L  + +   +HRD+ A NVL+ +   + + DFGL+R     + +V  T+  
Sbjct: 126  SDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 972  -TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030
              V ++A E       TTK DV+SFGVL  E+ +       G  C   + +   GY    
Sbjct: 180  LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239

Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            P                  +E+ EL+R   +C  + P  RP   ++   L ++L
Sbjct: 240  PRNC--------------DDEVYELMR---QCWRDRPYERPPFAQISVQLSRML 276

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 10/196 (5%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + +G G FG V+ G   +  +VAVK L + G    + F  E  ++        H  LV L
Sbjct: 12   KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKT----LQHDKLVRL 66

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDII-SDR-TRLTWRRRLDIAIDVARALVFLHHECYPP 928
            Y          ++ EYM  GSL D + SD   ++   + +D +  +A  + ++  + Y  
Sbjct: 67   YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY-- 124

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
             +HRD++A+NVL+ +     + DFGLARV+   +          + + APE       T 
Sbjct: 125  -IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183

Query: 989  KGDVYSFGVLAMELAT 1004
            K DV+SFG+L  E+ T
Sbjct: 184  KSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 45/143 (31%), Positives = 80/143 (55%), Gaps = 7/143 (4%)

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            P +V+ YG  L+ +   +  E+M+ GSL+ I      +       IA+ V   L +L++ 
Sbjct: 63   PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRD+K SN+L++  G+  + DFG++  ++++    ++ T  GT  Y++PE  Q 
Sbjct: 123  HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQG 176

Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
             + T K DV+S G+  +ELA G+
Sbjct: 177  GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 5e-17
 Identities = 66/219 (30%), Positives = 90/219 (41%), Gaps = 55/219 (25%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKL---------QREGLEGEREFRAEMEVLSGNGF 860
            + +G G FG V         +  A+K L         Q E +  E+     +        
Sbjct: 7    KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR------- 59

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR---- 916
               HP LV LYG   D S   LV EY+ GG L       + L    R      VAR    
Sbjct: 60   ---HPFLVNLYGSFQDDSNLYLVMEYVPGGEL------FSHLRKSGRFPE--PVARFYAA 108

Query: 917  ----ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
                AL +LH      IV+RD+K  N+LLD +G   +TDFG A+ V       + T+ GT
Sbjct: 109  QVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGT 161

Query: 973  VGYVAPE------YGQTWQATTKGDVYSFGVLAMELATG 1005
              Y+APE      YG+        D ++ G+L  E+  G
Sbjct: 162  PEYLAPEIILSKGYGKAV------DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VAVK L + G      F  E +++        H  LV LY 
Sbjct: 14   LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKK----LRHDKLVQLYA 68

Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D + D     L     +D+A  VA  + ++    Y   
Sbjct: 69   --VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 123

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            +HRD++++N+L+       + DFGLAR++   +          + + APE     + T K
Sbjct: 124  IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 184  SDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 6e-17
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRA--EMEVLSGNG 859
            ++ + + +G+G +  VY+      GR VA+KK++    +  ++   F A  E+++L    
Sbjct: 1    RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL---- 56

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARAL 918
                HPN++ L       S   LV+E+ME   LE +I D++  LT        +   R L
Sbjct: 57   QELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVA 977
             +LH   +  I+HRD+K +N+L+  +G   + DFGLAR  S G  +   T    T  Y A
Sbjct: 116  EYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRA 170

Query: 978  PE--YGQTWQATTKGDVYSFGVLAMEL 1002
            PE  +G         D++S G +  EL
Sbjct: 171  PELLFGAR-HYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 13/194 (6%)

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVT 869
            ++GKG FG V++G L D   VAVK   +E L  E +  F +E  +L      + HPN+V 
Sbjct: 2    LLGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLSEARILK----QYDHPNIVK 56

Query: 870  LYGWCLDGSEKILVYEYMEGGS-LEDIISDRTRLTWRRRLDIAIDVARALVFLHHE-CYP 927
            L G C       +V E + GG  L  +   +  L  ++ +  A+D A  + +L  + C  
Sbjct: 57   LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              +HRD+ A N L+ +     ++DFG++R    G    S      + + APE     + +
Sbjct: 115  --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 988  TKGDVYSFGVLAME 1001
            ++ DV+S+G+L  E
Sbjct: 173  SESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 81.7 bits (201), Expect = 7e-17
 Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 47/294 (15%)

Query: 812  IIGKGGFGTVYRGVLP-DGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNL 867
            +IG+G FG V +  +  DG  +  A+K+++    + + R+F  E+EVL   G    HPN+
Sbjct: 2    VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---HPNI 58

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIA 911
            + L G C       L  EY   G+L D +                   + L+ ++ L  A
Sbjct: 59   INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
             DVAR + +L  + +   +HRD+ A N+L+ +   A + DFGL+R     + +V  T+  
Sbjct: 119  ADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 172

Query: 972  -TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030
              V ++A E       TT  DV+S+GVL  E+ +       G  C   + +   GY    
Sbjct: 173  LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            P                  +E+ +L+R   +C  E P  RP+  ++L  L ++L
Sbjct: 233  PLNC--------------DDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 63/204 (30%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKL-QREGLEGE-----REFRAEMEVLSGNGFGWPHP 865
            IG+G +G VY+      G  VA+KK+  R   EG      RE +   E+         HP
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL--------NHP 58

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHE 924
            N++ L        +  LV+E+M+   L  +I DR R L           + + L F H  
Sbjct: 59   NIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                I+HRD+K  N+L++ EG   + DFGLAR          T    T  Y APE   G 
Sbjct: 118  ---GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGD 173

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                +T  D++S G +  EL + R
Sbjct: 174  K-GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG +G VY+     DG   AVK L     + + E  AE  +L        HPN+V  Y
Sbjct: 30   IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ---SLPNHPNVVKFY 85

Query: 872  GWC-----LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAIDVARALVFLHH 923
            G       L G +  LV E   GGS+ +++  +  L   +RLD   I+  +  AL+ L H
Sbjct: 86   GMFYKADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE---- 979
                 I+HRDVK +N+LL  EG   + DFG++  +++     +T++ GT  ++APE    
Sbjct: 144  LHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202

Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATG 1005
               Y  ++ A  + DV+S G+ A+EL  G
Sbjct: 203  EQQYDYSYDA--RCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEG-ER-EFRAEMEVLSGNG 859
            K+ + + IG+G FG   + +L     DG++  +K++    +   ER E R E+ VLS   
Sbjct: 1    KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSN-- 55

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRR--LDIAIDVARA 917
                HPN+V       +     +V +Y EGG L   I+ +  + +     LD  + +  A
Sbjct: 56   --MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  +H      I+HRD+K+ N+ L K+G   + DFG+ARV+++      T I GT  Y++
Sbjct: 114  LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLS 169

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
            PE  +      K D+++ G +  E+ T + A E G
Sbjct: 170  PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    + G   A K +Q E  E   +F  E+++LS       HPN+V LY
Sbjct: 13   LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE----CKHPNIVGLY 68

Query: 872  -GWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPI 929
              +  +    IL+ E+ +GG+L+ I+ +  R LT  +   +   +  AL FLH      +
Sbjct: 69   EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVGYVAPEY--GQTW 984
            +HRD+KA N+LL  +G   + DFG    VSA +        T  GT  ++APE    +T+
Sbjct: 125  IHRDLKAGNILLTLDGDVKLADFG----VSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 985  QAT---TKGDVYSFGVLAMELATGR 1006
            +      K D++S G+  +ELA   
Sbjct: 181  KDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 36/280 (12%)

Query: 811  RIIGKGGFGTVY--RGVLPDGREVAVKKL-QREGLEGERE-----FRAEMEVLSGNGFGW 862
            + +G G F + Y  R V   G  +AVK++        E+E      R E+ +++      
Sbjct: 6    QQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR----L 60

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP+++ + G   + S   L  E+M GGS+  ++S          ++    + R L +LH
Sbjct: 61   NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 923  HECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSA---GDSHVSTTIAGTVGYVAP 978
                  I+HRDVK +N+L+D  G+ L + DFG A  ++A   G       + GT+ ++AP
Sbjct: 121  EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038
            E  +  Q     DV+S G + +E+AT +            W        +H    A+I  
Sbjct: 178  EVLRGEQYGRSCDVWSVGCVIIEMATAK----------PPWNAE-----KHSNHLALIFK 222

Query: 1039 VLLGSGLAEGAEEMSELLR-IGVRCTAEAPNARPNVKEVL 1077
            +   +      E +S  LR + +RC    P  RP  +E+L
Sbjct: 223  IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 32/218 (14%)

Query: 812  IIGKGGFGTVYRGVLPDGRE-VAVKKL----QREGL--EGEREFRAEMEVLSGNGFGWPH 864
             IG+G +G VYR       E VA+KK+    +R+G+     RE    + +         H
Sbjct: 14   RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL--------RH 65

Query: 865  PNLVTLY----GWCLDGSEKILVYEYMEG--GSLEDIISDRTRLTWRRRLDIAIDVARAL 918
            PN+V L     G  LD     LV EY E    SL D +   T  +  +   + + + R L
Sbjct: 66   PNIVELKEVVVGKHLDSI--FLVMEYCEQDLASLLDNMP--TPFSESQVKCLMLQLLRGL 121

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH      I+HRD+K SN+LL  +G   + DFGLAR        ++  +  T+ Y AP
Sbjct: 122  QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177

Query: 979  E--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            E   G T   TT  D+++ G +  EL   +  L G  E
Sbjct: 178  ELLLGCTTY-TTAIDMWAVGCILAELLAHKPLLPGKSE 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 811  RIIGKGGFGTV----YRGVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFGWP 863
            R++GKG +G V    +R    DG++  +KKL        RE +A   E ++LS       
Sbjct: 6    RVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQ----LK 57

Query: 864  HPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALV 919
            HPN+V  Y    +G + +L  V  + EGG L   + ++    L   + ++  + +A AL 
Sbjct: 58   HPNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LH +    I+HRD+K  NV L +     V D G+ARV+       ST I GT  Y++PE
Sbjct: 117  YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
                     K DV++ G    E+AT + A 
Sbjct: 173  LFSNKPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 4e-16
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 55/231 (23%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP------ 863
              IG+G +G VY+      G  VA+KK++   +E E+E             G+P      
Sbjct: 5    AQIGEGTYGQVYKARNKKTGELVALKKIR---MENEKE-------------GFPITAIRE 48

Query: 864  --------HPNLVTLYGWCLD--GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
                    HPN+V L             +V+EYM+         D T L     +     
Sbjct: 49   IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTES 100

Query: 914  --------VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                    +   L +LH      I+HRD+K SN+L++ +G   + DFGLAR  +  +S  
Sbjct: 101  QIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157

Query: 966  STTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
             T    T+ Y  PE   G T +   + D++S G +  EL  G+   +G  E
Sbjct: 158  YTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.8 bits (197), Expect = 6e-16
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 811  RIIGKGGFGTVYRGVLPD-GRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V         +      VAVK L+      ERE   +E++++S  G    
Sbjct: 41   KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG---N 97

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFL 921
            H N+V L G C  G   +++ EY   G L + +  +    LT    L  +  VA+ + FL
Sbjct: 98   HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 922  HHE-CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPE 979
              + C    +HRD+ A NVLL       + DFGLAR +    ++V    A   V ++APE
Sbjct: 158  ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 980  YGQTWQATTKGDVYSFGVLAMEL 1002
                   T + DV+S+G+L  E+
Sbjct: 214  SIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 81.8 bits (202), Expect = 6e-16
 Identities = 85/295 (28%), Positives = 131/295 (44%), Gaps = 47/295 (15%)

Query: 806  KFSEDRIIGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEV---LSGNGFG 861
            K+   R++G G  GTV     + DG   AVK +  EG+    + RA+ EV   L+ + F 
Sbjct: 33   KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92

Query: 862  W------------PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWR--RR 907
                          +P  V +           LV +Y   G L   I  R + T R  R 
Sbjct: 93   IVKCHEDFAKKDPRNPENVLMIA---------LVLDYANAGDLRQEIKSRAK-TNRTFRE 142

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVS 966
             +  +   + L+ +HH     ++HRD+K++N+LL   G   + DFG +++ +A  S  V 
Sbjct: 143  HEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202

Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
             T  GT  YVAPE  +    + K D++S GVL  EL T +R  +G  E + E   + +  
Sbjct: 203  RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG--ENMEEVMHKTLA- 259

Query: 1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081
            GR+ P        L  S   E  E ++ LL       +  P  RP+  ++L M I
Sbjct: 260  GRYDP--------LPPSISPEMQEIVTALL-------SSDPKRRPSSSKLLNMPI 299

Length = 496

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            ++   + IG+G FG +Y      D     +K++    +  + +  ++ EV+        H
Sbjct: 1    RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM--KH 58

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--------SDRTRLTWRRRLDIAIDVAR 916
            PN+VT +    +     +V EY +GG L   I        S+   L+W       + ++ 
Sbjct: 59   PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGK-ALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             L  +H      I+HRD+K+ N+ L K G  A + DFG+AR ++     ++ T  GT  Y
Sbjct: 113  GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYY 168

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            ++PE  Q      K D++S G +  EL T +   EG
Sbjct: 169  LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 8e-16
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ----REGLEGE--REFRA--EMEVLSG 857
            + +   +G+G +G VY+      G  VA+KK++     EG+     RE     E++    
Sbjct: 1    YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVAR 916
                  HPN+V L        +  LV+EY +   L+  +  R   L+      I   + R
Sbjct: 57   ------HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L + H      I+HRD+K  N+L++++G   + DFGLAR         +  +  T+ Y 
Sbjct: 110  GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165

Query: 977  APE--YGQTWQATTKGDVYSFG-VLAMELATGR 1006
            APE   G     +T  D++S G + A E+ TG+
Sbjct: 166  APEILLGSK-HYSTAVDIWSVGCIFA-EMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 15/212 (7%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGRE----VAVKKLQREGLEGEREFRAEMEV 854
            ILK T +  + +++G G FGTV++G+ +P+G      VA+K +Q     G + F+   + 
Sbjct: 3    ILKET-ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDH 59

Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAID 913
            +   G    H  +V L G C  G+   LV +    GSL D +   R  L  +R L+  + 
Sbjct: 60   MLAMG-SLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGT 972
            +A+ + +L       +VHR++ A N+LL  +    + DFG+A ++   D  +  +     
Sbjct: 118  IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            + ++A E     + T + DV+S+GV   E+ +
Sbjct: 175  IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQRE--GLEGEREFRAEMEVLSGNGF---GWPHP 865
            +IG G FG+VY G+    G  +AVK+++        +   R+ ++ L+          H 
Sbjct: 7    LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            N+V   G  LD     +  EY+ GGS+  ++++          +    + + L +LH+  
Sbjct: 67   NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST-----TIAGTVGYVAPEY 980
               I+HRD+K +N+L+D +G   ++DFG+++ + A      T     ++ G+V ++APE 
Sbjct: 126  --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
             +    T K D++S G L +E+ TG+
Sbjct: 184  VKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 21/208 (10%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKLQ--REGLEGEREFRA---EMEVLSGNGFGWPH 864
            +++G+G FG VY     D GRE+AVK++Q   E  E  +E  A   E+++L        H
Sbjct: 8    KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN----LLH 63

Query: 865  PNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
              +V  YG   D  E+ L    E+M GGS++D +     LT          +   + +LH
Sbjct: 64   ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR----VVSAGDSHVSTTIAGTVGYVAP 978
                  IVHRD+K +N+L D  G   + DFG ++    +  +G    S T  GT  +++P
Sbjct: 124  SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--GTPYWMSP 178

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E         K D++S G   +E+ T +
Sbjct: 179  EVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 62/175 (35%), Positives = 95/175 (54%), Gaps = 15/175 (8%)

Query: 811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
           ++IGKG FG V       DG+  AVK LQ++ +  ++E +   AE  VL  N     HP 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN---VKHPF 57

Query: 867 LVTLYGWCLDGSEKI-LVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
           LV L+ +    ++K+  V +Y+ GG L   +  +R+    R R   A ++A AL +LH  
Sbjct: 58  LVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSL 115

Query: 925 CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
               I++RD+K  N+LLD +G  ++TDFGL +      S  ++T  GT  Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 813  IGKGGFGTVY----RGVLPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G+G FG V+      +LP+  +  VAVK L+       ++F+ E E+L+       H +
Sbjct: 13   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV----LQHQH 68

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR---------------TRLTWRRRLDIA 911
            +V  YG C +G   ++V+EYM  G L   +                   +LT  + L IA
Sbjct: 69   IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              +A  +V+L    +   VHRD+   N L+ +     + DFG++R + + D + V     
Sbjct: 129  SQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
              + ++ PE     + TT+ D++SFGV+  E+ T
Sbjct: 186  LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 77.7 bits (191), Expect = 3e-15
 Identities = 87/322 (27%), Positives = 135/322 (41%), Gaps = 68/322 (21%)

Query: 801  LKATGKFSEDRII-----GKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-R 846
            L    +F  DR++     G+G FG V R    G+     +    VAVK L+    + +  
Sbjct: 3    LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA 62

Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR------- 899
            +  +EME++   G    H N++ L G C       ++ EY   G+L + +  R       
Sbjct: 63   DLISEMELMKLIG---KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDY 119

Query: 900  ---------TRLTWRRRLDIAIDVARALVFLH-HECYPPIVHRDVKASNVLLDKEGKALV 949
                      +L+++  +  A  VAR + +L    C    +HRD+ A NVL+ ++    +
Sbjct: 120  TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKI 175

Query: 950  TDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008
             DFGLAR V   D +  T+     V ++APE       T + DV+SFG+L  E+ T    
Sbjct: 176  ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT---- 231

Query: 1009 LEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRC 1062
                           +G G   PG   IPV  L   L EG      +    EL  +   C
Sbjct: 232  ---------------LG-GSPYPG---IPVEELFKLLREGHRMDKPSNCTHELYMLMREC 272

Query: 1063 TAEAPNARPNVKEVLAMLIKIL 1084
                P  RP  K+++  L K+L
Sbjct: 273  WHAVPTQRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 23/208 (11%)

Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPNL 867
            I KG FG+VY  +     G   A+K L++  +  + +    +AE  ++   G     P +
Sbjct: 4    ISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES---PYV 59

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLT--WRRRLDIAIDVARALVFLHHE 924
              LY +     + + LV EY+ GG    +I     L   W ++     +V   +  LH  
Sbjct: 60   AKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K  N+L+D+ G   +TDFGL+R         +    GT  Y+APE     
Sbjct: 117  ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGV 168

Query: 985  QATTKGDVYSFGVLAMELATGRRALEGG 1012
                  D +S G +  E   G       
Sbjct: 169  GDDKMSDWWSLGCVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 9/144 (6%)

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++    R+       I+I V R L +L  +
Sbjct: 59   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG--DSHVSTTIAGTVGYVAPEYGQ 982
                I+HRDVK SN+L++  G+  + DFG    VS    DS ++ +  GT  Y++PE  Q
Sbjct: 119  --HKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDS-MANSFVGTRSYMSPERLQ 171

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                T + D++S G+  +E+A GR
Sbjct: 172  GTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 73/229 (31%), Positives = 106/229 (46%), Gaps = 52/229 (22%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKK----LQREGLEGE--REFRAEMEVLSGNGFGWPH 864
             IG+G +GTVY+   L  GR VA+KK    L  EG+     RE  A ++ L    F   H
Sbjct: 6    EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQL--ESFE--H 60

Query: 865  PNLVTLY----GWCLDGSEKI-LVYEYME------------GGSLEDIISDRTRLTWRRR 907
            PN+V L     G   D   K+ LV+E+++             G   + I D  R      
Sbjct: 61   PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR------ 114

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS- 966
                  + R + FLH      IVHRD+K  N+L+  +G+  + DFGLAR+       ++ 
Sbjct: 115  -----QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMAL 163

Query: 967  TTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            T++  T+ Y APE     ++ AT   D++S G +  EL   RR L  G 
Sbjct: 164  TSVVVTLWYRAPEVLLQSSY-ATPV-DMWSVGCIFAELFR-RRPLFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 16/208 (7%)

Query: 811  RIIGKGGFGTVY--RGVL-PD-GREVAVKKLQREGLEGEREFRAEME--VLSGNGFGWPH 864
            +++G+G FG V+  R +  PD G+  A+K L++  L+     R +ME  +L+       H
Sbjct: 2    KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN----H 57

Query: 865  PNLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
            P +V L Y +  +G +  L+ +++ GG L   +S     T     D+   +A   + L H
Sbjct: 58   PFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALDH 113

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 I++RD+K  N+LLD+EG   +TDFGL++     +   + +  GTV Y+APE    
Sbjct: 114  LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNR 172

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEG 1011
               T   D +SFGVL  E+ TG    +G
Sbjct: 173  RGHTQSADWWSFGVLMFEMLTGSLPFQG 200

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 77.0 bits (189), Expect = 4e-15
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 28/231 (12%)

Query: 811  RIIGKGGFGTVY--RGVL--PDGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGW 862
            +++G G +G V+  R V     G+  A+K L++  +    +     R E +VL       
Sbjct: 6    KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE------ 59

Query: 863  PH----PNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
             H    P LVTL+ +      K+ L+ +Y+ GG L   +S R R   +   ++ I     
Sbjct: 60   -HIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGEI 114

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            ++ L H     I++RD+K  N+LLD  G  ++TDFGL++     +   + +  GT+ Y+A
Sbjct: 115  VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 978  PEY--GQTWQATTKGDVYSFGVLAMELATGRR--ALEGGEECLVEWGRRVM 1024
            P+   G         D +S GVL  EL TG     ++G +    E  RR++
Sbjct: 175  PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 77.4 bits (190), Expect = 4e-15
 Identities = 68/202 (33%), Positives = 105/202 (51%), Gaps = 17/202 (8%)

Query: 811  RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
            ++IGKG FG V       DG+  AVK LQ++ +   +E +   AE  VL  N     HP 
Sbjct: 1    KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN---VKHPF 57

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLE-DIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            LV L+ +    +EK+  V +++ GG L   +  +R+    R R   A ++A AL +LH  
Sbjct: 58   LVGLH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS- 114

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQT 983
                IV+RD+K  N+LLD +G  ++TDFGL +  ++  D+  +TT  GT  Y+APE  + 
Sbjct: 115  --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRK 170

Query: 984  WQATTKGDVYSFGVLAMELATG 1005
                   D +  G +  E+  G
Sbjct: 171  QPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 32/275 (11%)

Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            ++ +G G FG V+        +VAVK + + G      F AE  V+        H  LV 
Sbjct: 11   EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKT----LQHDKLVK 65

Query: 870  LYGWCLDGSEKI-LVYEYMEGGSLEDIIS--DRTRLTWRRRLDIAIDVARALVFLHHECY 926
            L+   +   E I ++ E+M  GSL D +   + ++    + +D +  +A  + F+    Y
Sbjct: 66   LHA--VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
               +HRD++A+N+L+       + DFGLARV+   +          + + APE       
Sbjct: 124  ---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 987  TTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045
            T K DV+SFG+L ME+ T GR    G     V    R +  G   P     P        
Sbjct: 181  TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALERGYRMPRPENCP-------- 229

Query: 1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                    EL  I +RC    P  RP  + + ++L
Sbjct: 230  -------EELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.4 bits (190), Expect = 4e-15
 Identities = 53/175 (30%), Positives = 92/175 (52%), Gaps = 8/175 (4%)

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++ +  R+       ++I V R L +L  +
Sbjct: 63   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRDVK SN+L++  G+  + DFG++  +   DS ++ +  GT  Y++PE  Q  
Sbjct: 123  --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DS-MANSFVGTRSYMSPERLQGT 177

Query: 985  QATTKGDVYSFGVLAMELATGRRAL--EGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
              + + D++S G+  +ELA GR  +     +E    +GR V+  G  G   ++ P
Sbjct: 178  HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD-GEEGEPHSISP 231

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 19/197 (9%)

Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG+G FG V+ G L  D   VAVK   RE L  + + +F  E  +L      + HPN+V 
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQ----YSHPNIVR 57

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
            L G C       +V E ++GG     + ++  RL  +  + +  + A  + +L  +    
Sbjct: 58   LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT----VGYVAPEYGQTW 984
             +HRD+ A N L+ ++    ++DFG++R    G   V  +  G     V + APE     
Sbjct: 115  CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG---VYASTGGMKQIPVKWTAPEALNYG 171

Query: 985  QATTKGDVYSFGVLAME 1001
            + +++ DV+SFG+L  E
Sbjct: 172  RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 5e-15
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKLQ--REGLEGEREFRA---EMEVLSGNGFGWPH 864
            +++G+G FG VY     D GRE+A K++Q   E  E  +E  A   E+++L        H
Sbjct: 8    KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN----LQH 63

Query: 865  PNLVTLYGWCLDGSEKILV--YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
              +V  YG   D +EK L    EYM GGS++D +     LT          +   + +LH
Sbjct: 64   ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFG----LARVVSAGDSHVSTTIAGTVGYVAP 978
                  IVHRD+K +N+L D  G   + DFG    L  +  +G    S T  GT  +++P
Sbjct: 124  SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT--GTPYWMSP 178

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E         K DV+S G   +E+ T +
Sbjct: 179  EVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 18/209 (8%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            + +IG G FG V RG L  P  RE  VA+K L+    E +R +F +E  ++      + H
Sbjct: 9    EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ----FDH 64

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHH 923
            PN++ L G        +++ E+ME G+L+  +  +  + T  + + +   +A  + +L  
Sbjct: 65   PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVSTTIAGT--VGYVAPE 979
              Y   VHRD+ A N+L++      V+DFGL+R +     D   ++++ G   + + APE
Sbjct: 125  MNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 980  YGQTWQATTKGDVYSFGVLAME-LATGRR 1007
                 + T+  DV+S+G++  E ++ G R
Sbjct: 182  AIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.0 bits (187), Expect = 8e-15
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 37/222 (16%)

Query: 811  RIIGKGGFGTVYR----GVLPDGRE--VAVKKLQREG-LEGEREFRAEMEVLSGNGFGWP 863
            R IG+G FG V++    G+LP      VAVK L+ E   + + +F+ E  +++     + 
Sbjct: 11   RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE----FD 66

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT----------------------R 901
            HPN+V L G C  G    L++EYM  G L + +  R+                       
Sbjct: 67   HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 902  LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG 961
            L+   +L IA  VA  + +L    +   VHRD+   N L+ +     + DFGL+R + + 
Sbjct: 127  LSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 962  DSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            D +  S   A  + ++ PE     + TT+ DV+++GV+  E+
Sbjct: 184  DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 89/317 (28%), Positives = 138/317 (43%), Gaps = 68/317 (21%)

Query: 806  KFSEDRI-----IGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAE 851
            +FS D++     +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +E
Sbjct: 11   EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 852  MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR------------ 899
            ME++   G    H N++ L G C       ++ EY   G+L + +  R            
Sbjct: 71   MEMMKMIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127

Query: 900  ----TRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
                 ++T++  +     VAR + +L   +C    +HRD+ A NVL+ +     + DFGL
Sbjct: 128  RVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL 183

Query: 955  ARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            AR V+  D +  TT     V ++APE       T + DV+SFGVL  E+ T         
Sbjct: 184  ARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------- 234

Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAP 1067
                      +G G   PG   IPV  L   L EG      A   +EL  +   C    P
Sbjct: 235  ----------LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280

Query: 1068 NARPNVKEVLAMLIKIL 1084
            + RP  K+++  L +IL
Sbjct: 281  SHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 20/223 (8%)

Query: 813  IGKGGFGTVYRGVL---PDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWPHPNL 867
            +G G FGTV +G+       + VAVK L+ +  +   + E   E  V+        +P +
Sbjct: 3    LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQ----LDNPYI 58

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            V + G C +    +LV E  E G L   +     +T +   ++   V+  + +L    + 
Sbjct: 59   VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF- 116

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE    ++
Sbjct: 117  --VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 986  ATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
             ++K DV+SFGVL  E  + G+   + ++G E   ++E G R+
Sbjct: 175  FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 1e-14
 Identities = 87/305 (28%), Positives = 131/305 (42%), Gaps = 63/305 (20%)

Query: 813  IGKGGFGTVYR----GVLPD----GREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            +G+G FG V      G+  D       VAVK L+ +  + +  +  +EME++   G    
Sbjct: 20   LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG---K 76

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRR 907
            H N++ L G C       ++ EY   G+L + +  R                 +LT++  
Sbjct: 77   HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 908  LDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
            +  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR V   D +  
Sbjct: 137  VSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 967  TTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025
            TT     V ++APE       T + DV+SFGVL  E+ T                   +G
Sbjct: 193  TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-------------------LG 233

Query: 1026 YGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             G   PG   IPV  L   L EG      A    EL  I   C    P+ RP  K+++  
Sbjct: 234  -GSPYPG---IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289

Query: 1080 LIKIL 1084
            L ++L
Sbjct: 290  LDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.3 bits (193), Expect = 2e-14
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 22/197 (11%)

Query: 829  GREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPNLVTLY--GWCLDGSEKILV 883
            G EVA+K L+ +  E E +   FR E  + +       HPN+V L   G    G     V
Sbjct: 3    GHEVAIKLLRTDAPEEEHQRARFRRETALCAR----LYHPNIVALLDSGEAPPGL-LFAV 57

Query: 884  YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-- 941
            +EY+ G +L ++++    L       + + V  AL   H++    IVHRD+K  N+++  
Sbjct: 58   FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114

Query: 942  -DKEGKALVTDFGLARVVS-AGDSHVSTTIA-----GTVGYVAPEYGQTWQATTKGDVYS 994
                  A V DFG+  ++    D+ V+T        GT  Y APE  +    T   D+Y+
Sbjct: 115  TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 995  FGVLAMELATGRRALEG 1011
            +G++ +E  TG+R ++G
Sbjct: 175  WGLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 51/218 (23%)

Query: 813  IGKGGFGTVYRG-VLPDGREVAVKK-LQREGLE-----GEREFRAEMEVLSGNGFGWPHP 865
            +G+G +G V +      G  VA+KK  + E  E       RE +  +  L        H 
Sbjct: 9    VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKV-LRQLR-------HE 60

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT--------RLTWRRRLDIAIDVARA 917
            N+V L           LV+EY+E   LE + +              W+        + +A
Sbjct: 61   NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112

Query: 918  LVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            + + H H     I+HRD+K  N+L+ + G   + DFG AR + A  +   T    T  Y 
Sbjct: 113  IAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168

Query: 977  APE-------YGQTWQATTKG-DVYSFGVLAMELATGR 1006
            APE       YG       K  DV++ G +  EL  G 
Sbjct: 169  APELLVGDTNYG-------KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 35/283 (12%)

Query: 810  DRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
             R IG+G FG VY+GV      +   VAVK  +       RE   +   +      + HP
Sbjct: 11   GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ---FDHP 67

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            ++V L G   +    I++     G     +  ++  L     +  +  ++ AL +L  + 
Sbjct: 68   HIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 128  F---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 986  ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR---HG-PGRAVIPVVLL 1041
             T+  DV+ FGV                 C+ E    ++  G     G     VI  +  
Sbjct: 185  FTSASDVWMFGV-----------------CMWE----ILMLGVKPFQGVKNNDVIGRIEN 223

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            G  L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 224  GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 45/292 (15%)

Query: 808  SEDRIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEG-EREFRAEMEVLSGNGF 860
             E   +G+G FG V+        E      V VK LQ+   E  + EFR E+++      
Sbjct: 8    QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK--- 64

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLE---------DIISDRTRLTWRRRLDIA 911
               H N+V L G C +     ++ EY + G L+         D       L+ ++++ + 
Sbjct: 65   -LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
              +A  +  L +  +   VHRD+ A N L+  + +  V+   L++ V   + +       
Sbjct: 124  TQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECLVEWGRRVMGYGR 1028
             + ++APE  Q    +TK DV+SFGVL  E+ T G     G   EE L           R
Sbjct: 181  PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL----------NR 230

Query: 1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
               G+  +PV        EG      L ++  RC A  P  RP+  E+++ L
Sbjct: 231  LQAGKLELPV-------PEGCPS--RLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 46/218 (21%)

Query: 813  IGKGGFGTVY---RGVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
            I KG +G V+   +     G   A+K +++  +  + +      E ++LS        P 
Sbjct: 1    ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQA----QSPY 54

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIIS-------DRTRLTWRRRLDIAIDVARAL 918
            +V LY +   G + + LV EY+ GG L  ++        D  R+          ++  AL
Sbjct: 55   VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-------YIAEIVLAL 106

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-------STTIAG 971
             +LH      I+HRD+K  N+L+D  G   +TDFGL++V                  I G
Sbjct: 107  EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 972  TVGYVAPE----YGQTWQATTKGDVYSFGVLAMELATG 1005
            T  Y+APE     G +       D +S G +  E   G
Sbjct: 164  TPDYIAPEVILGQGHSKTV----DWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 75.0 bits (184), Expect = 3e-14
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 15/209 (7%)

Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ A+K L+++ +  + +    M    VL+ +G     P  
Sbjct: 7    VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG----KPPF 62

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            +T    C    +++  V EY+ GG L   I    R      +  A ++A  L FLH +  
Sbjct: 63   LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-- 120

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  NV+LD EG   + DFG+ +  +  D   + T  GT  Y+APE    +Q 
Sbjct: 121  -GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEI-IAYQP 177

Query: 987  TTKG-DVYSFGVLAMELATGRRALEGGEE 1014
              K  D ++FGVL  E+  G+   EG +E
Sbjct: 178  YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 75.0 bits (184), Expect = 3e-14
 Identities = 60/174 (34%), Positives = 88/174 (50%), Gaps = 13/174 (7%)

Query: 811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
           ++IGKG FG V       DG   AVK LQ++ +  ++E     AE  VL  N     HP 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN---LKHPF 57

Query: 867 LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
           LV L+ +    +EK+  V +Y+ GG L   +         R    A +VA A+ +LH   
Sbjct: 58  LVGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL- 115

Query: 926 YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
              I++RD+K  N+LLD +G  ++TDFGL +         ++T  GT  Y+APE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 813  IGKGGFGTVYRGVL--PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            IGKG +G V++ VL   +G + AVK L     + + E  AE  +L        HPN+V  
Sbjct: 26   IGKGTYGKVFK-VLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALS---DHPNVVKF 80

Query: 871  YGW-----CLDGSEKILVYEYMEGGSLEDIISDRTRLTWR-RRLDIAIDVARALVFLHHE 924
            YG        +G +  LV E   GGS+ D++    +   R     IA  +  AL+ L H 
Sbjct: 81   YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY---G 981
                 +HRDVK +N+LL  EG   + DFG++  +++       T  GT  ++APE     
Sbjct: 141  HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPFWMAPEVIACE 199

Query: 982  QTWQAT--TKGDVYSFGVLAMELATG 1005
            Q   +T   + DV+S G+ A+EL  G
Sbjct: 200  QQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 27/203 (13%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKL---------QREGLEGEREFRAEMEVLSGNGFGW 862
            +G G FG V+           A+K +         Q + +  E+    E+          
Sbjct: 9    VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--------- 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP ++ L+    D     ++ EY+ GG L   + +  R +    L  A ++  AL +LH
Sbjct: 60   -HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    IV+RD+K  N+LLDKEG   +TDFG A+ +   D   + T+ GT  Y+APE  Q
Sbjct: 119  SK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DR--TWTLCGTPEYLAPEVIQ 171

Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
            +       D ++ G+L  E+  G
Sbjct: 172  SKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 5e-14
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 43/228 (18%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEG----EREFRAEMEVLSGNGFGWPHP 865
            R+IGKGG G VY    P   R VA+KK+ RE L      ++ F  E ++ +       HP
Sbjct: 8    RLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAAD----LIHP 62

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWR-----RRLDIAIDVARALVF 920
             +V +Y  C DG        Y+EG +L+ ++    +  W+     + L     V   L  
Sbjct: 63   GIVPVYSICSDGDPVYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSI 118

Query: 921  LHHECYP-------PIVHRDVKASNVLLDKEGKALVTDFGLARVVSA------------- 960
             H  C          ++HRD+K  N+LL   G+ ++ D+G A                  
Sbjct: 119  FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 961  GDSHVSTT----IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
               + S T    I GT  Y+APE      A+   D+Y+ GV+  ++ T
Sbjct: 179  NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 75.0 bits (184), Expect = 6e-14
 Identities = 77/239 (32%), Positives = 111/239 (46%), Gaps = 11/239 (4%)

Query: 242 ENCSLEIFDLSENEFIGDFPG--EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL 299
               L   DL     I    G   + N   L  L+L  N     I  E+  ++ L +L L
Sbjct: 65  SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDL 123

Query: 300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSS 359
             NN   + P   L  S L+ LDLS N     +         +K L L  N   D     
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSD--LPK 180

Query: 360 GILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLD 419
            +  L N++ LDLS N  +  LP EI  + +L+ L L++N     + +   N+ NL  L+
Sbjct: 181 LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238

Query: 420 LSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           LS N+L   +P SIGNL++L  L L+NN +S  I   +G+ T+L  L+LS N LS  +P
Sbjct: 239 LSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP 294

Length = 394

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.9 bits (181), Expect = 6e-14
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPNLV 868
            IG G FG VY        E VAVKK+   G +   +++    E++ L        HPN +
Sbjct: 29   IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ----LKHPNTI 84

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
               G  L      LV EY  G + + +   +  L       I     + L +LH      
Sbjct: 85   EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY---GQTWQ 985
            ++HRD+KA N+LL + G+  + DFG A   S  +S V     GT  ++APE        Q
Sbjct: 142  MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196

Query: 986  ATTKGDVYSFGVLAMELATGRRAL 1009
               K DV+S G+  +ELA  +  L
Sbjct: 197  YDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 17/201 (8%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLV 868
            +GKGGFG V    +   G+  A KKL ++ L+   GE+    E ++L            +
Sbjct: 1    LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK-----VSSRFI 55

Query: 869  TLYGWCLDGSEKI-LVYEYMEGGSLEDIIS--DRTRLTWRRRLDIAIDVARALVFLHHEC 925
                +  +  + + LV   M GG L+  I           R +  A  +   L  LH   
Sbjct: 56   VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               IV+RD+K  NVLLD  G   ++D GLA  +  G        AGT GY+APE  Q   
Sbjct: 115  --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEV 170

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
                 D ++ G    E+  GR
Sbjct: 171  YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 8e-14
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 45/297 (15%)

Query: 811  RIIGKGGFGTV----YRGVLPDG----REVAVKKLQRE-GLEGEREFRAEMEVLSGNGFG 861
            R +G+G FG V    Y    P+G     +VAVK L+ E G     + + E+E+L  N + 
Sbjct: 10   RDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR-NLY- 64

Query: 862  WPHPNLVTLYGWCLD--GSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARAL 918
              H N+V   G C +  G+   L+ E++  GSL++ +  ++ ++  +++L  A+ + + +
Sbjct: 65   --HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGM 122

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYV 976
             +L    Y   VHRD+ A NVL++ E +  + DFGL + +     +  V   +   V + 
Sbjct: 123  DYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036
            APE     +     DV+SFGV   EL T          C  E     +     GP    +
Sbjct: 180  APECLIQSKFYIASDVWSFGVTLYELLT---------YCDSESSPMTLFLKMIGPTHGQM 230

Query: 1037 PVVLLGSGLAEG---------AEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             V  L   L EG          EE+ +L+R   +C    P+ R   + ++     IL
Sbjct: 231  TVTRLVRVLEEGKRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 44/217 (20%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G+G +G V +   +P G  +AVK++ R  +  + + R  M+ L  +      P  VT Y
Sbjct: 9    LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMD-LDISMRSVDCPYTVTFY 66

Query: 872  G--------W--------CLDGSEKILVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDV 914
            G        W         LD   K     Y +G ++ EDI+             IA+ +
Sbjct: 67   GALFREGDVWICMEVMDTSLD---KFYKKVYDKGLTIPEDILGK-----------IAVSI 112

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTV 973
             +AL +LH +    ++HRDVK SNVL+++ G+  + DFG++  +V   DS   T  AG  
Sbjct: 113  VKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCK 167

Query: 974  GYVAPEY--GQTWQA--TTKGDVYSFGVLAMELATGR 1006
             Y+APE    +  Q     K DV+S G+  +ELATGR
Sbjct: 168  PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 31/215 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGR---EVAVKKLQ-----REGLEGEREFRAEMEVLSGNGFGW 862
            + +G+G FG+V  G L       +VAVK ++     R  +E   +F +E   +      +
Sbjct: 5    KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKE----F 57

Query: 863  PHPNLVTLYGWCLDGSEK------ILVYEYMEGGSLEDII------SDRTRLTWRRRLDI 910
             HPN++ L G CL   E       +++  +M+ G L   +           L  +  +  
Sbjct: 58   DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
              D+A  + +L  + +   +HRD+ A N +L++     V DFGL++ +  GD +    IA
Sbjct: 118  MTDIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174

Query: 971  GT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
               V ++A E       TTK DV+SFGV   E+AT
Sbjct: 175  KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.5 bits (180), Expect = 9e-14
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L    ++ A+K +++E +  + +    + E  V         +P 
Sbjct: 1    RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS---SNPF 57

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            LV L+      S   LV EY+ GG L   +  + +L        A ++  AL FLH    
Sbjct: 58   LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER-- 115

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD +G   +TD+G+ +  +  GD+  ++T  GT  Y+APE  +  +
Sbjct: 116  -GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEE 172

Query: 986  ATTKGDVYSFGVLAMELATGRRALE 1010
                 D ++ GVL  E+  GR   +
Sbjct: 173  YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 1e-13
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 17/215 (7%)

Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F + R++GKGGFG V    V   G+  A K+L+++ ++   GE     E ++L       
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEK----- 56

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALV 919
             +   V    +  +  + + LV   M GG L+  I +         R L  A ++   L 
Sbjct: 57   VNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             LH E     V+RD+K  N+LLD  G   ++D GLA  +  G+S       GTVGY+APE
Sbjct: 117  DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPE 171

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                 + T   D +  G L  E+  G+    G +E
Sbjct: 172  VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 808  SEDRII-GKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            + +R++ GKG +G VY    L     +A+K++        +    E+ + S       H 
Sbjct: 10   NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY----LKHR 65

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALVFLH 922
            N+V   G   +     +  E + GGSL  ++  +          I      +   L +LH
Sbjct: 66   NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 923  HECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
                  IVHRD+K  NVL++   G   ++DFG ++ + AG +  + T  GT+ Y+APE  
Sbjct: 126  DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVI 181

Query: 980  ------YGQTWQATTKGDVYSFGVLAMELATGR 1006
                  YG         D++S G   +E+ATG+
Sbjct: 182  DKGPRGYGAP------ADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 807  FSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            F++ R IG G FG VY  R V      VA+KK+   G +   +++    E+  L      
Sbjct: 17   FTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ---- 71

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARAL 918
              HPN +   G  L      LV EY  G S  DI+    +    + ++IA       + L
Sbjct: 72   LRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPL--QEVEIAAICHGALQGL 128

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH       +HRD+KA N+LL + G   + DFG A +VS  +S V     GT  ++AP
Sbjct: 129  AYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180

Query: 979  EY---GQTWQATTKGDVYSFGVLAMELA 1003
            E        Q   K DV+S G+  +ELA
Sbjct: 181  EVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR------EGLEGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG+VY       G  VA+KK+++      E +   RE ++  ++         HP
Sbjct: 7    LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLN-------EHP 58

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHH 923
            N+V L     +  E   V+EYMEG +L  ++ DR     +      I   + + L  +H 
Sbjct: 59   NIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE---- 979
              +    HRD+K  N+L+       + DFGLAR + +   +  T    T  Y APE    
Sbjct: 118  HGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEILLR 172

Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATGR 1006
               Y      ++  D+++ G +  EL T R
Sbjct: 173  STSY------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 22/215 (10%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            G F    ++G G +G VY+G  +  G+  A+K +   G E E E + E+ +L        
Sbjct: 6    GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSH--- 61

Query: 864  HPNLVTLYGWCLDGS------EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI--DVA 915
            H N+ T YG  +  +      +  LV E+   GS+ D+I +    T +      I  ++ 
Sbjct: 62   HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            R L  LH      ++HRD+K  NVLL +  +  + DFG++  +       +T I GT  +
Sbjct: 122  RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 177

Query: 976  VAPEY---GQTWQATT--KGDVYSFGVLAMELATG 1005
            +APE     +   AT   K D++S G+ A+E+A G
Sbjct: 178  MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 72.0 bits (176), Expect = 3e-13
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPN 866
            ++IGKG FG V       + +  AVK LQ++ +   + E+   +E  VL  N     HP 
Sbjct: 1    KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPF 57

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            LV L+       +   V +Y+ GG L   +  +R  L  R R   A ++A AL +LH   
Sbjct: 58   LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL- 115

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
               IV+RD+K  N+LLD +G  ++TDFGL +     +   ++T  GT  Y+APE  + Q 
Sbjct: 116  --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYLAPEVLHKQP 172

Query: 984  WQATTKGDVYSFGVLAMELATG 1005
            +  T   D +  G +  E+  G
Sbjct: 173  YDRTV--DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKL--QREGLEGEREFRA---EMEVLSGNGFGWPH 864
            +++G+G FG VY     D GRE+AVK++    +  E  +E  A   E+++L        H
Sbjct: 8    KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL----RH 63

Query: 865  PNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
              +V  YG   D  EK L    EYM GGS++D +     LT          + + + +LH
Sbjct: 64   DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR----VVSAGDSHVSTTIAGTVGYVAP 978
                  IVHRD+K +N+L D  G   + DFG ++    +  +G    S T  GT  +++P
Sbjct: 124  SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT--GTPYWMSP 178

Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E         K DV+S     +E+ T
Sbjct: 179  EVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            F  ++ IG+G F  VYR   L DG  VA+KK+Q   L   +   +   E+++L       
Sbjct: 4    FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ----L 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII---SDRTRLTWRRRL-DIAIDVARAL 918
             HPN++  Y   ++ +E  +V E  + G L  +I     + RL   + +    + +  AL
Sbjct: 60   NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H      ++HRD+K +NV +   G   + D GL R  S+  +  + ++ GT  Y++P
Sbjct: 120  EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175

Query: 979  EYGQTWQATTKGDVYSFGVLAMELA 1003
            E         K D++S G L  E+A
Sbjct: 176  ERIHENGYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 25/229 (10%)

Query: 811  RIIGKGGFGTVY---RGVLPD-GREVAVKKLQREGL-------EGEREFRAEMEVLSGNG 859
            +++G G +G V+   +    D G+  A+K LQ+  L       E  R  R  +E +  + 
Sbjct: 6    KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQS- 64

Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARAL 918
                 P LVTL+ +      K+ L+ +Y+ GG +   +  R   +     ++       +
Sbjct: 65   -----PFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEII 115

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
            + L H     IV+RD+K  N+LLD EG  ++TDFGL++   + +   + +  GT+ Y+AP
Sbjct: 116  LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 979  EYGQTWQATTKG-DVYSFGVLAMELATGRR--ALEGGEECLVEWGRRVM 1024
            E  +      K  D +S G+L  EL TG     LEG      E  RR++
Sbjct: 176  EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 36/213 (16%)

Query: 813  IGKGGFGTVYRGVL--PDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFGWPH--- 864
            +GKG +G+VY+ VL  P G  +A+K+++ E L+ E +F     E+++L        H   
Sbjct: 9    LGKGNYGSVYK-VLHRPTGVTMAMKEIRLE-LD-ESKFNQIIMELDIL--------HKAV 57

Query: 865  -PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD----IAIDVARALV 919
             P +V  YG         +  EYM+ GSL D +      T     D    I   V + L 
Sbjct: 58   SPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            FL  E    I+HRDVK +NVL++  G+  + DFG++  + A    ++ T  G   Y+APE
Sbjct: 117  FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPE 171

Query: 980  Y------GQTWQATTKGDVYSFGVLAMELATGR 1006
                    Q    T + DV+S G+  +E+A GR
Sbjct: 172  RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 13/195 (6%)

Query: 813  IGKGGFGTVYRGVLPDGR---EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G G FG V +GV    +   +VA+K L+ E    E+  R EM   +       +P +V 
Sbjct: 3    LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
            + G C +    +LV E   GG L   +S  +  +T    +++   V+  + +L  + +  
Sbjct: 60   MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF-- 116

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQA 986
             VHRD+ A NVLL  +  A ++DFGL++ + A DS+     AG   + + APE     + 
Sbjct: 117  -VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 987  TTKGDVYSFGVLAME 1001
            +++ DV+S+G+   E
Sbjct: 176  SSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.5 bits (178), Expect = 6e-13
 Identities = 36/79 (45%), Positives = 51/79 (64%)

Query: 403 GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS 462
           G IP     + +LQ+++LS N + G IPPS+G++TSL  L L+ NS +G IP  +G  TS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 463 LLWLNLSNNKLSGNIPPEV 481
           L  LNL+ N LSG +P  +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 41/214 (19%)

Query: 813  IGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEME---VLSGNGFGWPHPNLV 868
            IG G  G VY+      G  +AVK+++R G + E + R  M+   VL  +      P +V
Sbjct: 23   IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-RILMDLDVVLKSHDC----PYIV 77

Query: 869  TLYGWCLDGSEKILVYEYME-----------GGSLEDIISDRTRLTWRRRLDIAIDVARA 917
              YG+ +  S+  +  E M            G   EDI+             + + + +A
Sbjct: 78   KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK-----------MTVAIVKA 126

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYV 976
            L +L  +    ++HRDVK SN+LLD  G   + DFG++ R+V   DS   T  AG   Y+
Sbjct: 127  LHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYM 181

Query: 977  APEYGQTWQATTK----GDVYSFGVLAMELATGR 1006
            APE         K     DV+S G+  +ELATG+
Sbjct: 182  APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.9 bits (173), Expect = 6e-13
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 23/206 (11%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGEREFR---AEMEVLSGNGF 860
            F++ R IG G FG VY     D R    VA+KK+   G +   +++    E++ L     
Sbjct: 27   FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR--- 81

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
               HPN +   G  L      LV EY  G + + +   +  L       I     + L +
Sbjct: 82   -IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            LH      ++HRD+KA N+LL + G+  + DFG A + S  +S V     GT  ++APE 
Sbjct: 141  LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192

Query: 981  ---GQTWQATTKGDVYSFGVLAMELA 1003
                   Q   K DV+S G+  +ELA
Sbjct: 193  ILAMDEGQYDGKVDVWSLGITCIELA 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 6e-13
 Identities = 44/142 (30%), Positives = 79/142 (55%), Gaps = 5/142 (3%)

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++    R+  +    ++I V + L +L  +
Sbjct: 63   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRDVK SN+L++  G+  + DFG++  +   DS ++ +  GT  Y++PE  Q  
Sbjct: 123  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DS-MANSFVGTRSYMSPERLQGT 177

Query: 985  QATTKGDVYSFGVLAMELATGR 1006
              + + D++S G+  +E+A GR
Sbjct: 178  HYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.5 bits (172), Expect = 7e-13
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGW 862
            FS+ R IG G FG VY    + +   VA+KK+   G +   +++    E+  L       
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK----L 72

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HPN +   G  L      LV EY  G + + +   +  L       +     + L +LH
Sbjct: 73   RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                  ++HRDVKA N+LL + G   + DFG A +++  +  V     GT  ++APE   
Sbjct: 133  SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184

Query: 981  -GQTWQATTKGDVYSFGVLAMELA 1003
                 Q   K DV+S G+  +ELA
Sbjct: 185  AMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.6 bits (174), Expect = 7e-13
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 41/218 (18%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPN 866
            + IG G +G V   V    GR+VA+KK+     + ++ +R  R E+++L        H N
Sbjct: 6    KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLL--RHLR--HEN 60

Query: 867  LVTLYGWCLD-----GSEK----ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
            ++ L    LD       E      +V E ME   L  +I     LT          + R 
Sbjct: 61   IIGL----LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 918  LVFLH--HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            L +LH  +     ++HRD+K SN+L++      + DFGLAR V   D         T  Y
Sbjct: 116  LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGV---DPDEDEKGFLT-EY 166

Query: 976  V------APEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
            V      APE   +    TK  D++S G +  EL T +
Sbjct: 167  VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 69.7 bits (170), Expect = 9e-13
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F + R++GKGGFG V    V   G+  A KKL+++ ++   GE     E ++L       
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK----- 56

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTW--RRRLDIAIDVARALV 919
             +   V    +  +  + + LV   M GG L+  I       +   R +  A ++   L 
Sbjct: 57   VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI---AGTVGYV 976
             LH E    IV+RD+K  N+LLD  G   ++D GLA  V  G      TI    GTVGY+
Sbjct: 117  DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-----TIKGRVGTVGYM 168

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010
            APE  +  + T   D ++ G L  E+  G+   +
Sbjct: 169  APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 74/261 (28%), Positives = 117/261 (44%), Gaps = 60/261 (22%)

Query: 812  IIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPH 864
             IG+G +G VY+    D G  VA+KK++   L+ E+E       R E+++L        H
Sbjct: 14   QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR-EIKILRQ----LNH 65

Query: 865  PNLVTLYGWCLDGSEKI----------LVYEYMEG---GSLE----DIISDRTRLTWRRR 907
             N+V L     D  + +          LV+EYM+    G LE        D  +   ++ 
Sbjct: 66   RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            L+        L + H + +   +HRD+K SN+LL+ +G+  + DFGLAR+ ++ +S   T
Sbjct: 126  LE-------GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 968  TIAGTVGYVAPE-------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEW 1019
                T+ Y  PE       YG         DV+S G +  EL T +   +  +E   +E 
Sbjct: 176  NKVITLWYRPPELLLGEERYGPAI------DVWSCGCILGELFTKKPIFQANQELAQLEL 229

Query: 1020 GRRVMGYGRHGPGRAVIPVVL 1040
              R+ G     P  AV P V+
Sbjct: 230  ISRLCGS----PCPAVWPDVI 246

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 70.2 bits (172), Expect = 1e-12
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L   R + A+K +++E +  + +    + E  V         HP 
Sbjct: 1    RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS---NHPF 57

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            LV L+      S    V E++ GG L   +  + +L        + +++ AL FLH    
Sbjct: 58   LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER-- 115

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++T  GT  Y+APE      
Sbjct: 116  -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPE------ 166

Query: 986  ATTKGDVYSF-------GVLAMELATGR 1006
               +G+ Y F       GVL  E+  GR
Sbjct: 167  -ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 22/211 (10%)

Query: 810  DRIIGK----GGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
              +IGK         + +   P    VAVKK+  +    E     + E+++       HP
Sbjct: 3    LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ--HP 59

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALVFLH 922
            N++      +  SE  +V   M  GS ED++           L IA    DV  AL ++H
Sbjct: 60   NILPYVTSFIVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIH 118

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR-VVSAGDSHV-----STTIAGTVGYV 976
             + +   +HR VKAS++LL  +GK +++    +  ++  G           +    + ++
Sbjct: 119  SKGF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 977  APE-YGQTWQA-TTKGDVYSFGVLAMELATG 1005
            +PE   Q  Q    K D+YS G+ A ELA G
Sbjct: 176  SPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ A+K L+++ +  + +    M    VL         P L
Sbjct: 7    VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL---ALPGKPPFL 63

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
              L+  C    +++  V EY+ GG L   I    +      +  A ++A  L FLH +  
Sbjct: 64   TQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-- 120

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
              I++RD+K  NV+LD EG   + DFG+ +    G    + T  GT  Y+APE      Y
Sbjct: 121  -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQPY 178

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            G++       D ++FGVL  E+  G+   +G +E
Sbjct: 179  GKSV------DWWAFGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 67/220 (30%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 812  IIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHP 865
            ++G+G FG V   V+ +   G   A+K +++  L  +     F  E ++LS +   W  P
Sbjct: 8    LVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-P 64

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSL-------EDIISDRTRLTWRRRLDIAIDVARAL 918
             L   Y +  D     LV EY  GG L       ED   +     +   L +AI      
Sbjct: 65   QL--QYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS---- 117

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H   Y   VHRD+K  NVL+D+ G   + DFG A  ++A     S    GT  Y+AP
Sbjct: 118  --VHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Query: 979  EYGQTWQATTKG------DVYSFGVLAMELATGRRALEGG 1012
            E   T     KG      D +S GV+A E+  GR     G
Sbjct: 173  EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.1 bits (170), Expect = 2e-12
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 48/219 (21%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQ---REGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +GKG +G V++ +    +E VA+KK+    R   + +R FR  M +         HPN+V
Sbjct: 15   LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD----HPNIV 70

Query: 869  TLYGWCLD------GSEKILVYEYME--------GGSLEDIISDRTRLTWRRRLDIAIDV 914
             L    L+        +  LV+EYME           LED+          +R  I   +
Sbjct: 71   KL----LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV---------HKRY-IMYQL 116

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS----TTIA 970
             +AL ++H      ++HRD+K SN+LL+ + +  + DFGLAR +S  + +      T   
Sbjct: 117  LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 971  GTVGYVAPE--YGQTWQATTKG-DVYSFGVLAMELATGR 1006
             T  Y APE   G T    TKG D++S G +  E+  G+
Sbjct: 174  ATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     +   K+ ++ L  + E     + E  V         HP 
Sbjct: 1    RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS---NHPF 57

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            LV L+      S    V EY+ GG L   +  + +L        + +++ AL +LH    
Sbjct: 58   LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 115

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++T  GT  Y+APE  +   
Sbjct: 116  -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 172

Query: 986  ATTKGDVYSFGVLAMELATGRRALE 1010
                 D ++ GVL  E+  GR   +
Sbjct: 173  YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL        
Sbjct: 1    KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT----R 53

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            HP L  L  +     +++  V EY  GG L   +S     T  R      ++  AL +LH
Sbjct: 54   HPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  +
Sbjct: 113  SR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +  GV+  E+  GR
Sbjct: 169  DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 63/214 (29%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 812  IIGKGGFGTV----YRGVLPDGREVAVKKLQREGLEGEREFRAEM------EVLSGNGFG 861
            ++G+G FG V    Y+     G   A+K L++  +    E  + M      E  +     
Sbjct: 6    VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-- 60

Query: 862  WPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
              HP LV L+  C    + +  V EY  GG L   I      +  R +  A  V   L +
Sbjct: 61   --HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQY 116

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            LH      IV+RD+K  N+LLD EG   + DFGL +    G    ++T  GT  ++APE 
Sbjct: 117  LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEV 172

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                  T   D +  GVL  E+  G     G +E
Sbjct: 173  LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            G F    ++G G +G VY+G      ++A  K+     + E E + E+ +L        H
Sbjct: 16   GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH---H 72

Query: 865  PNLVTLYGWCLDGS------EKILVYEYMEGGSLEDIISDRTRLTWRRR--LDIAIDVAR 916
             N+ T YG  +  S      +  LV E+   GS+ D++ +      +      I  ++ R
Sbjct: 73   RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132

Query: 917  ALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             L  LH H+    ++HRD+K  NVLL +  +  + DFG++  +       +T I GT  +
Sbjct: 133  GLAHLHAHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 187

Query: 976  VAPEY---GQTWQAT--TKGDVYSFGVLAMELATG 1005
            +APE     +   AT   + D++S G+ A+E+A G
Sbjct: 188  MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 66/199 (33%), Positives = 95/199 (47%), Gaps = 12/199 (6%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPNLV 868
            IGKG FG VY+    D  R  A+K L ++ +  ++E      E  +L         P +V
Sbjct: 1    IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD-ESPFIV 59

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRR-RLDIAIDVARALVFLHHECYP 927
             L       S+  LV +YM GG L   +    R +  R +  IA ++  AL  LH     
Sbjct: 60   GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY--- 115

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
             IV+RD+K  N+LLD  G   + DFGL++  +  D+  + T  GT  Y+APE     +  
Sbjct: 116  DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 988  TKG-DVYSFGVLAMELATG 1005
            TK  D +S GVL  E+  G
Sbjct: 175  TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 3e-12
 Identities = 44/112 (39%), Positives = 61/112 (54%), Gaps = 9/112 (8%)

Query: 600 GKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTE 658
           G +P+   +L  L  +NL+ N+  G IP   G+I  L+ LDLSYN+F+G  P S   LT 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 659 LSKLNISYNPLVSGTIPST--GQL---ATFEKTSYLGDPLLDLPDFIENGPH 705
           L  LN++ N L SG +P+   G+L   A+F  T   G  L  +P     GPH
Sbjct: 492 LRILNLNGNSL-SGRVPAALGGRLLHRASFNFTDNAG--LCGIPGLRACGPH 540

Length = 623

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 813  IGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLV 868
            +GKGGFG V    V   G+  A KKL ++ L+   GE+    E E+L         P +V
Sbjct: 1    LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN----SPFIV 56

Query: 869  TLYGWCLDGSEKI-LVYEYMEGGSLE-DIISDRTR-LTWRRRLDIAIDVARALVFLHHEC 925
             L  +  +    + LV   M GG L+  I +   R L   R +  +  +   ++ LH   
Sbjct: 57   NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM- 114

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               IV+RD+K  NVLLD +G   ++D GLA  +  G +   T  AGT GY+APE  +   
Sbjct: 115  --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170

Query: 986  ATTKGDVYSFGVLAMELATGR 1006
             +   D ++ G    E+  GR
Sbjct: 171  YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 51/238 (21%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE------------------REFRAEME 853
            +G+G +G V +      G+ VA+KK++   +  +                  RE +   E
Sbjct: 17   LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
            +         H N++ L    ++G    LV + M    L+ ++  + RLT  +   I + 
Sbjct: 77   I--------KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-- 971
            +   L  LH + Y   +HRD+  +N+ ++ +G   + DFGLAR    G    S T++   
Sbjct: 128  ILNGLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLAR--RYGYPPYSDTLSKDE 182

Query: 972  -------------TVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                         T+ Y APE   G   +     D++S G +  EL TG+    G  E
Sbjct: 183  TMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENE 239

Length = 335

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 85/320 (26%), Positives = 137/320 (42%), Gaps = 74/320 (23%)

Query: 806  KFSEDRII-----GKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REF 848
            +   DR++     G+G FG V   V+ +             +VAVK L+ +  E +  + 
Sbjct: 14   EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL 70

Query: 849  RAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR--------- 899
             +EME++   G    H N++ L G C       ++ EY   G+L + +  R         
Sbjct: 71   ISEMEMMKMIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127

Query: 900  -------TRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTD 951
                    +L+++  +  A  VAR + +L   +C    +HRD+ A NVL+ ++    + D
Sbjct: 128  NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIAD 183

Query: 952  FGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010
            FGLAR +   D +  TT     V ++APE       T + DV+SFGVL  E+ T      
Sbjct: 184  FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------ 237

Query: 1011 GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTA 1064
                         +G G   PG   +PV  L   L EG      +   +EL  +   C  
Sbjct: 238  -------------LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWH 280

Query: 1065 EAPNARPNVKEVLAMLIKIL 1084
              P+ RP  K+++  L +IL
Sbjct: 281  AVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 44/288 (15%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            +RI+G G FG + RG L  P  RE  VA+  L R G      R F AE   L      + 
Sbjct: 10   ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ----FD 64

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLH 922
            H N+V L G    G+  ++V EYM  G+L+  +     +L   + + +   +A  + +L 
Sbjct: 65   HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG--TVGYVAPEY 980
               Y   VH+ + A  VL++ +    ++ F   R+       + TT++G   V + APE 
Sbjct: 125  EMGY---VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PGRAVI 1036
             Q    ++  DV+SFG++  E                     VM YG        G+ VI
Sbjct: 180  IQYHHFSSASDVWSFGIVMWE---------------------VMSYGERPYWDMSGQDVI 218

Query: 1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
              V  G  L       + L ++ + C  +    RP   ++ ++L K++
Sbjct: 219  KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.8 bits (165), Expect = 6e-12
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 34/211 (16%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      G+  A+K L++E +  + E      E  VL        
Sbjct: 1    KLLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT----R 53

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSL------EDIIS-DRTRLTWRRRLDIAIDVA 915
            HP L +L  +     +++  V EY+ GG L      E + S DRTR           ++ 
Sbjct: 54   HPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIV 105

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             AL +LH      IV+RD+K  N++LDK+G   +TDFGL +     D+    T  GT  Y
Sbjct: 106  SALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEY 161

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
            +APE  +        D +  GV+  E+  GR
Sbjct: 162  LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 40/212 (18%)

Query: 812  IIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGE----------REFRAEMEVLSGNGF 860
            ++G+G +G V +    + G+ VA+KK     LE E          RE R   ++      
Sbjct: 8    LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQL------ 57

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
               H NLV L           LV+E+++   L+D+      L   R       + R + F
Sbjct: 58   --RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE- 979
             H      I+HRD+K  N+L+ + G   + DFG AR + A    V T    T  Y APE 
Sbjct: 116  CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPEL 171

Query: 980  ------YGQTWQATTKGDVYSFGVLAMELATG 1005
                  YG+        D+++ G L  E+ TG
Sbjct: 172  LVGDTKYGRAV------DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.4 bits (164), Expect = 8e-12
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL  +     
Sbjct: 1    KLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS----R 53

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            HP L  L  +     +++  V EY  GG L   +S     +  R      ++  AL +LH
Sbjct: 54   HPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             E    +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  +
Sbjct: 113  SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLE 169

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +  GV+  E+  GR
Sbjct: 170  DNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 9e-12
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 28/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE----VAVKKLQREGL----EGEREFRAEMEVLSGNGFGW 862
            +++GKGG+G V++     G +     A+K L++  +    +     +AE  +L       
Sbjct: 2    KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA----V 57

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL------EDIISDRTRLTWRRRLDIAIDVAR 916
             HP +V L      G +  L+ EY+ GG L      E I  + T   +   + +A++   
Sbjct: 58   KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE--- 114

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
                LH +    I++RD+K  N+LLD +G   +TDFGL +  S  +  V+ T  GT+ Y+
Sbjct: 115  ---HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYM 167

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATG 1005
            APE           D +S G L  ++ TG
Sbjct: 168  APEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 66.9 bits (163), Expect = 9e-12
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F   R++GKGGFG V    V   G+  A KKL+++ ++   GE     E  +L       
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----- 56

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALV 919
             +   V    +  +  + + LV   M GG L+  I +        +R +  A ++   L 
Sbjct: 57   VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             L  E    IV+RD+K  N+LLD  G   ++D GLA  +  G++       GTVGY+APE
Sbjct: 117  DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPE 171

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
                 + T   D +  G L  E+  G+
Sbjct: 172  VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 18/198 (9%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +G VY+   +  G   A+K ++ E  E     + E+ ++        H N+V  +
Sbjct: 17   IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD----CKHSNIVAYF 72

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
            G  L   +  +  E+  GGSL+DI      L+  +   ++ +  + L +LH +     +H
Sbjct: 73   GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG- 990
            RD+K +N+LL   G   + DFG++  ++A  +   + I GT  ++APE     +   KG 
Sbjct: 130  RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER---KGG 185

Query: 991  -----DVYSFGVLAMELA 1003
                 D+++ G+ A+ELA
Sbjct: 186  YNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 816  GGFGTVYRGVLPDG-----REVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT 869
            G FG ++ G+L D       EV VK ++    +   E +  + +       G  H N++ 
Sbjct: 17   GTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 870  LYGWCLDGSEKILV-YEYMEGGSLEDIISD--------RTRLTWRRRLDIAIDVARALVF 920
            +   C++  E   V Y YM  G+L+  +             L+ ++ + +AI +A  + +
Sbjct: 73   ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPE 979
            LH      ++H+D+ A N ++D+E +  +TD  L+R +   D H +       V ++A E
Sbjct: 133  LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
                 + ++  DV+SFGVL  EL T
Sbjct: 190  SLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 25/203 (12%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    + G   A K ++ +  E   ++  E+E+L+       HP +V L 
Sbjct: 20   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN----HPYIVKLL 75

Query: 872  G-WCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPI 929
            G +  DG   I++ E+  GG+++ I+ +  R LT  +   I   +  AL +LH      I
Sbjct: 76   GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KI 131

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
            +HRD+KA NVLL  +G   + DFG++    + +   DS +     GT  ++APE    +T
Sbjct: 132  IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186

Query: 984  WQATT---KGDVYSFGVLAMELA 1003
             + T    K D++S G+  +E+A
Sbjct: 187  MKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 33/209 (15%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGE-----REFRAEMEVLSGNGFGWPHPN 866
            +G+G + TVY+G      E VA+K++  +  EG      RE     E+         H N
Sbjct: 8    LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL--------KHEN 59

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI------DVARALVF 920
            +V L+      ++ +LV+EYM+   L+  +        R  LD          + + + F
Sbjct: 60   IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAF 115

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
             H      ++HRD+K  N+L++K G+  + DFGLAR      +  S  +  T+ Y AP+ 
Sbjct: 116  CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 981  ---GQTWQATTKGDVYSFGVLAMELATGR 1006
                +T+  +T  D++S G +  E+ TGR
Sbjct: 172  LLGSRTY--STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ A+K L+++ +  + +    M    VL+        P  
Sbjct: 7    VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ----DKPPF 62

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            +T    C    +++  V EY+ GG L   I    +    + +  A +++  L FLH    
Sbjct: 63   LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-- 120

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
              I++RD+K  NV+LD EG   + DFG+ +     D   + T  GT  Y+APE      Y
Sbjct: 121  -GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            G++       D +++GVL  E+  G+   +G +E
Sbjct: 179  GKSV------DWWAYGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ---REGLEGEREFRAEMEVLSGNGFGW 862
            F  ++ IG+G F  VYR   L D + VA+KK+Q       +  ++   E+++L       
Sbjct: 4    FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ----L 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII---SDRTRLTWRRRL-DIAIDVARAL 918
             HPN++      ++ +E  +V E  + G L  +I     + RL   R +    + +  A+
Sbjct: 60   NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H      ++HRD+K +NV +   G   + D GL R  S+  +  + ++ GT  Y++P
Sbjct: 120  EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSP 175

Query: 979  EYGQTWQATTKGDVYSFGVLAMELA 1003
            E         K D++S G L  E+A
Sbjct: 176  ERIHENGYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 812  IIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNL 867
            IIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G   P +
Sbjct: 1    IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFI 59

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            V +  +     +K+  + + M GG L   +S     + +     A ++   L  +H+   
Sbjct: 60   VCM-TYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  Q   A
Sbjct: 118  --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172

Query: 987  -TTKGDVYSFGVLAMELATG 1005
              +  D +S G +  +L  G
Sbjct: 173  YDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 54/218 (24%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGE----------REFRAEMEVLSGNGFG 861
            IG+G +G V++    + G+ VA+KK     +E E          RE R  ++ L      
Sbjct: 9    IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRM-LKQLK----- 58

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-----------EDIISDRTRLTWRRRLDI 910
              HPNLV L        +  LV+EY +   L           E +I    ++ W+     
Sbjct: 59   --HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK---KIIWQ----- 108

Query: 911  AIDVARALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
                 +A+ F H H C    +HRDVK  N+L+ K+G+  + DFG AR+++      +  +
Sbjct: 109  ---TLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161

Query: 970  AGTVGYVAPEY--GQTWQATTKGDVYSFGVLAMELATG 1005
            A T  Y APE   G T Q     DV++ G +  EL TG
Sbjct: 162  A-TRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F   R++GKGGFG V    V   G+  A KKL+++ ++   GE     E ++L       
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--- 58

Query: 863  PHPNLVTL-YGW------CL------DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD 909
                +V+L Y +      CL       G  K  +Y     G  E            R + 
Sbjct: 59   -SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----------ERAVF 106

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
             A ++   L  LH E    IV+RD+K  N+LLD  G   ++D GLA  +  G+     TI
Sbjct: 107  YAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TI 158

Query: 970  ---AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                GTVGY+APE  +  + T   D +  G L  E+  G+      +E
Sbjct: 159  RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVL 855
            + + T ++ + + +G G FG V        G+ VA+KK+ +     +  +R +R E+++L
Sbjct: 5    VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLL 63

Query: 856  SGNGFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLD----- 909
                    H N+++L    +   E I  V E +         +D  RL   R L+     
Sbjct: 64   KH----LRHENIISLSDIFISPLEDIYFVTELLG--------TDLHRLLTSRPLEKQFIQ 111

Query: 910  -IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT 968
                 + R L ++H      +VHRD+K SN+L+++     + DFGLAR+    D  + T 
Sbjct: 112  YFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM-TG 164

Query: 969  IAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGR 1006
               T  Y APE   TWQ    + D++S G +  E+  G+
Sbjct: 165  YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 20/158 (12%)

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDR--------TRLTWRRRLDIAIDV 914
            HPN+V  +    +    + +V EY +GG L   I  +        T L W  ++ + +  
Sbjct: 57   HPNIVA-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ- 114

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
                    H     ++HRD+K+ N+ L + GK  + DFG AR++++  ++  T + GT  
Sbjct: 115  --------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPY 165

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
            YV PE  +      K D++S G +  EL T +   +  
Sbjct: 166  YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 46/217 (21%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      G+  A+K L++E +  + E      E  VL        
Sbjct: 1    KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---- 53

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL------EDIIS-DRTRLTWRRRLDIAIDVAR 916
            HP L  L            V EY  GG L      E + S DR R           ++  
Sbjct: 54   HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVS 106

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGY 975
            AL +LH  C   +V+RD+K  N++LDK+G   +TDFGL +  +S G +    T  GT  Y
Sbjct: 107  ALGYLH-SC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 161

Query: 976  VAPE------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            +APE      YG+        D +  GV+  E+  GR
Sbjct: 162  LAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKL----QREG--LEGEREFRAEMEVLSGNGFGWPHP 865
            I +G +G VYR      G  VA+KKL    ++EG  +   RE    +++         HP
Sbjct: 13   IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL--------QHP 64

Query: 866  NLVTL----YGWCLDGSEKI-LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALV 919
            N+VT+     G      +KI +V EY+E   L+ ++   +          + + +   + 
Sbjct: 65   NIVTVKEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             LH      I+HRD+K SN+LL+  G   + DFGLAR          T +  T+ Y APE
Sbjct: 121  HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPE 176

Query: 980  --YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
               G   + +T  D++S G +  EL T +    G  E
Sbjct: 177  LLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 29/206 (14%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEV-LSGNGFGWPHPNLVTL 870
            IG G +GTVY+   P  G  VA+K ++ +  E         EV L      + HPN+V L
Sbjct: 8    IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 871  YGWC----LDGSEKI-LVYE--------YMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
               C     D   K+ LV+E        Y++      + ++  +       D+     R 
Sbjct: 68   MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK-------DLMRQFLRG 120

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYV 976
            L FLH  C   IVHRD+K  N+L+   G+  + DFGLAR+ S     ++ T +  T+ Y 
Sbjct: 121  LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYR 174

Query: 977  APEYGQTWQATTKGDVYSFGVLAMEL 1002
            APE        T  D++S G +  E+
Sbjct: 175  APEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 6e-11
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 18/217 (8%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGR--EVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            F+  R +G G FG V      +     VA+K+ ++  +  +++     +E ++L+     
Sbjct: 32   FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY---- 87

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              HP  V LYG   D S   LV E++ GG     +    R       D+    A  +V +
Sbjct: 88   INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCFYAAQIVLI 143

Query: 922  HHECYP-PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
                    IV+RD+K  N+LLDK+G   +TDFG A+VV       + T+ GT  Y+APE 
Sbjct: 144  FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI 199

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                      D ++ G+   E+  G       E  L+
Sbjct: 200  LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236

Length = 340

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 35/217 (16%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ--REGLEGER------EFRAEMEVLSGNGFGWPH 864
            +GKG FGTVY  ++ D + VA ++L+  +E   GE       +   E ++LS       H
Sbjct: 8    LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK----LDH 61

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLED----------IISDRTRLTWRRRLDIAIDV 914
            P +V  +   L+     ++ EY EG  L+            +S+     W  +L + +  
Sbjct: 62   PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH- 120

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
                 ++H      I+HRD+KA N+ L K     + DFG++R++  G   ++TT  GT  
Sbjct: 121  -----YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLL-MGSCDLATTFTGTPY 170

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            Y++PE  +     +K D++S G +  E+     A EG
Sbjct: 171  YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 45/286 (15%)

Query: 807  FSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGLEGE--REFRAEMEVLSGNGF 860
            F+  R++GKG FG+V    L       ++VAVK L+ +        EF  E   +     
Sbjct: 1    FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKE--- 57

Query: 861  GWPHPNLVTLYGWCLDGSEK------ILVYEYMEGGSLEDII------SDRTRLTWRRRL 908
             + HPN++ L G  L    K      +++  +M+ G L   +       +   L  +  +
Sbjct: 58   -FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT 968
               ID+A  + +L  +     +HRD+ A N +L++     V DFGL++ + +GD +    
Sbjct: 117  RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 969  IAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGY 1026
             +   V ++A E       TT  DV++FGV   E+ T G+    G E         +  Y
Sbjct: 174  ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EIYNY 227

Query: 1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072
                        ++ G+ L +  + + ++  +  +C +  P  RP+
Sbjct: 228  ------------LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPS 261

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 812  IIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNL 867
            IIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G   P +
Sbjct: 1    IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFI 59

Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            V +  +     +K+  + + M GG L   +S     +       A ++   L  +H+   
Sbjct: 60   VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  Q   A
Sbjct: 118  --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 172

Query: 987  -TTKGDVYSFGVLAMELATG 1005
              +  D +S G +  +L  G
Sbjct: 173  YDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 9e-11
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 43/231 (18%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKL----QREGL--EGEREFRAEMEVLSGNGFGWPHP 865
            +G+G FG VY+   +  GR VA+KK+    +++G      RE +  ++ L        HP
Sbjct: 16   LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI-LKKLK-------HP 67

Query: 866  NLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISDRTRLTWRRRLDIAIDV 914
            N+V L    ++  +K         +V  YM+    G LE+      +LT  +     + +
Sbjct: 68   NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQL 124

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV----------SAGDSH 964
               + +LH      I+HRD+KA+N+L+D +G   + DFGLAR              G + 
Sbjct: 125  LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 965  VSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
              T +  T  Y  PE      + TT  D++  G +  E+ T R  L+G  +
Sbjct: 182  KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 13/197 (6%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    +   +A  K+     E E E +  E+++L+       HPN+V L 
Sbjct: 13   LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS----CDHPNIVKLL 68

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPIV 930
                  +   ++ E+  GG+++ ++ +  R LT  +   +      AL +LH      I+
Sbjct: 69   DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125

Query: 931  HRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
            HRD+KA N+L   +G   + DFG++    R +   DS + T        V  E  +    
Sbjct: 126  HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 987  TTKGDVYSFGVLAMELA 1003
              K DV+S G+  +E+A
Sbjct: 186  DYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 1e-10
 Identities = 33/75 (44%), Positives = 46/75 (61%)

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK 317
           G  P ++S  R+L  +NL GN+  G IP  +GSI+ LE L L  N+F   IPESL  L+ 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 318 LEVLDLSSNNFGGEV 332
           L +L+L+ N+  G V
Sbjct: 492 LRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 31/205 (15%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPNLV 868
            +G+GG+G V+     D  E VA+K++++  L    E R    E ++L+     W    LV
Sbjct: 9    VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW----LV 64

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------IAIDVARALVFLH 922
             L     D     L  EY+ GG        RT L     L          ++  A+  LH
Sbjct: 65   KLLYAFQDDEYLYLAMEYVPGGDF------RTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--Y 980
               Y   +HRD+K  N L+D  G   +TDFGL    S G    + ++ G+  Y+APE   
Sbjct: 119  ELGY---IHRDLKPENFLIDASGHIKLTDFGL----SKGIVTYANSVVGSPDYMAPEVLR 171

Query: 981  GQTWQATTKGDVYSFGVLAMELATG 1005
            G+ +  T   D +S G +  E   G
Sbjct: 172  GKGYDFTV--DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-10
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 63/234 (26%)

Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNL 867
            +IG+G FG V+     D  +V A+K L++  +         RAE ++L+     W    +
Sbjct: 8    VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW----I 63

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLT--WRR----RLDIAIDVARALVFL 921
            V LY    D     LV EYM GG L +++  +        R     L +A+D    L F 
Sbjct: 64   VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF- 122

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDS----------------- 963
                    +HRD+K  N+L+D +G   + DFGL  ++  A D                  
Sbjct: 123  --------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 964  ----------HVSTTIAGTVGYVAPE------YGQTWQATTKGDVYSFGVLAME 1001
                        + +  GT  Y+APE      YG       + D +S GV+  E
Sbjct: 175  VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL------ECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 2e-10
 Identities = 41/117 (35%), Positives = 61/117 (52%), Gaps = 13/117 (11%)

Query: 60  WNQSSSPC-----EWPGIICSPDKAR----VNGLNLTDWNISGDIFNNFSALTQLSYLDL 110
           WN    PC      W G  C  D  +    ++GL L +  + G I N+ S L  L  ++L
Sbjct: 392 WN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINL 449

Query: 111 SRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEI 165
           S N+  G+IP  L S  SL+ L+LS+N  +G +  +L  L SL IL+L+ N + G +
Sbjct: 450 SGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 2e-10
 Identities = 30/85 (35%), Positives = 52/85 (61%)

Query: 350 NSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY 409
           N  + G   + I KL ++  ++LS N+  G +P  +  + SL+ L L++N FNGSIP   
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 410 GNMPNLQTLDLSFNELTGPIPPSIG 434
           G + +L+ L+L+ N L+G +P ++G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.8 bits (155), Expect = 2e-10
 Identities = 80/278 (28%), Positives = 125/278 (44%), Gaps = 38/278 (13%)

Query: 198 LNLRYLDLSSNNFRGNI--WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
           L L  LDL+ N  R NI     L  L    +  N ++ +    +     +L+  DLS+N+
Sbjct: 93  LPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNK 151

Query: 256 FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL 315
            I   P  + N  NL  L+L  N+ S  +P  + ++S L  L L  N  +S +P  +  L
Sbjct: 152 -IESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNK-ISDLPPEIELL 208

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
           S LE LDLS+N+              +++L             S +  L N+S L+LS+N
Sbjct: 209 SALEELDLSNNS-------------IIELL-------------SSLSNLKNLSGLELSNN 242

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
                LP  I  + +L+ L L++N+   S  +  G++ NL+ LDLS N L+  +P     
Sbjct: 243 KLE-DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALL 299

Query: 436 LTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           L  L    L  N L      E+   + LL  N+ +N  
Sbjct: 300 LLLLE---LLLNLLLTLKALELKLNSILLNNNILSNGE 334

Length = 394

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT 869
            IG+G +G V+  R +   GR VA+K+++ +  E         EV        + HPN+V 
Sbjct: 9    IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 870  LYGWCL----DGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRL-----------DIAID 913
            L+  C     D   K+ LV+E++          D+   T+  ++           D+   
Sbjct: 69   LFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
            + R L FLH      +VHRD+K  N+L+   G+  + DFGLAR+ S       T++  T+
Sbjct: 119  LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTL 173

Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
             Y APE        T  D++S G +  E+   +    G  +
Sbjct: 174  WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 56/295 (18%)

Query: 811  RIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
            R +G+G FG VY G          + R VAVK +       ER EF  E  V+   GF  
Sbjct: 12   RELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVM--KGFTC 68

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------SDRTRLTWRRRLDIAI 912
             H  +V L G    G   ++V E M  G L+  +            R   T +  + +A 
Sbjct: 69   HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
            ++A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D +      G 
Sbjct: 127  EIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGK 180

Query: 973  ----VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028
                V ++APE  +    TT  D++SFGV+  E+ +           L E   + +    
Sbjct: 181  GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQPYQGLS--- 226

Query: 1029 HGPGRAVIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                  V+  V+ G  L +     E +++L+R+   C    P  RP   E++ +L
Sbjct: 227  ---NEQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 31/192 (16%)

Query: 832  VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG 890
            VAVK L+ +  +  R +F  E++++S       +PN++ L G C+      ++ EYME G
Sbjct: 47   VAVKMLRADVTKTARNDFLKEIKIMSR----LKNPNIIRLLGVCVSDDPLCMITEYMENG 102

Query: 891  SLEDIISDRT------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN 938
             L   +S R              ++    L +A+ +A  + +L    +   VHRD+   N
Sbjct: 103  DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRN 159

Query: 939  VLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA------TTKGDV 992
             L+       + DFG++R + +GD +    I G    V P     W++      TT  DV
Sbjct: 160  CLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRA--VLPIRWMAWESILLGKFTTASDV 214

Query: 993  YSFGVLAMELAT 1004
            ++FGV   E+ T
Sbjct: 215  WAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            TG F   RI    G G  Y       RE+ +K  Q + +  E+    E+           
Sbjct: 28   TGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELS---------- 76

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIA----IDVARALV 919
            HP +V +     D +    + E++ GG L        R   R   D+A     ++  A  
Sbjct: 77   HPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLAFE 132

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LH +    I++RD+K  N+LLD +G   VTDFG A+ V       + T+ GT  Y+APE
Sbjct: 133  YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185

Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
              Q+       D ++ GVL  E   G
Sbjct: 186  VIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.7 bits (152), Expect = 4e-10
 Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 32/197 (16%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           +P+ +  +  L+ L     + L    E+LLNL  L  LDL+ N                 
Sbjct: 62  LPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRS------------- 107

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS-LKFLILAHNRFN 402
                        N S +L+L N++ LDL +NN T  +P  I  ++S LK L L+ N+  
Sbjct: 108 -------------NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI- 152

Query: 403 GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS 462
            S+P+   N+PNL+ LDLSFN+L+  +P  + NL++L  L L+ N +S ++P EI   ++
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210

Query: 463 LLWLNLSNNKLSGNIPP 479
           L  L+LSNN +   +  
Sbjct: 211 LEELDLSNNSIIELLSS 227

Length = 394

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 4e-10
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 57/221 (25%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE---------REFRAEMEVLSGNGFGW 862
            IG+G +G VY+      G  VA+KK++   LE E         RE     E+        
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKEL-------- 55

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD----IAID----- 913
             HPN+V L       ++  LV+E+++             L  ++ +D      +D     
Sbjct: 56   NHPNIVRLLDVVHSENKLYLVFEFLD-------------LDLKKYMDSSPLTGLDPPLIK 102

Query: 914  -----VARALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                 + + + + H H     ++HRD+K  N+L+D+EG   + DFGLAR          T
Sbjct: 103  SYLYQLLQGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYT 157

Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
                T+ Y APE   G   Q +T  D++S G +  E+   R
Sbjct: 158  HEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 38/220 (17%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPHP 865
            IG+G +G VY+G     G+ VA+KK++   LE E E       R E+ +L        HP
Sbjct: 8    IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIR-EISLLKE----LQHP 59

Query: 866  NLVTLYGWCLDGSEKILVYEYME---GGSLEDIISDRTRLTWRRRLDIAI------DVAR 916
            N+V L    +  S   L++E++       L+ +   +        +D  +       + +
Sbjct: 60   NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-------MDAELVKSYLYQILQ 112

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             ++F H      ++HRD+K  N+L+D +G   + DFGLAR        V T    T+ Y 
Sbjct: 113  GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYR 168

Query: 977  APE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            APE   G   + +T  D++S G +  E+AT +    G  E
Sbjct: 169  APEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 12/200 (6%)

Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKGGFG V    +   G+  A KKL ++ L+  + +   M  +        H   +   
Sbjct: 1    LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM--VEKRILAKVHSRFIVSL 58

Query: 872  GWCLD-GSEKILVYEYMEGGSLE----DIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
             +     ++  LV   M GG L     ++  +       R       +   L  LH    
Sbjct: 59   AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  NVLLD +G   ++D GLA  +  G S  +   AGT G++APE  Q  + 
Sbjct: 117  -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174

Query: 987  TTKGDVYSFGVLAMELATGR 1006
                D ++ GV   E+   R
Sbjct: 175  DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEVLSG 857
            K +  R +G+G FG VY G+        P+ R VA+K +       ER EF  E  V+  
Sbjct: 7    KITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVM-- 63

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRL---------TWRRR 907
              F   H  +V L G    G   +++ E M  G L+  + S R  +         + ++ 
Sbjct: 64   KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            + +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +   
Sbjct: 122  IQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 177

Query: 968  TIAGT----VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
               G     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 178  --GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 6e-10
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 33/233 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G FG V    L +  +V A+K L +  +    E   FR E +VL      W    
Sbjct: 7    KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW---- 62

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSL-------EDIISDRTRLTWRRRLDIAIDVARALV 919
            + TL+    D +   LV +Y  GG L       ED + +     +   + IAID    L 
Sbjct: 63   ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +         VHRD+K  N+L+D  G   + DFG    +    +  S+   GT  Y++PE
Sbjct: 123  Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 980  YGQTWQATTKG------DVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
              Q  +   KG      D +S GV   E+  G        E LVE   ++M +
Sbjct: 174  ILQAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNH 223

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 20/199 (10%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY+   L  G   AVK ++ E  +     + E+ ++        H N+V  +
Sbjct: 17   VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE----CKHCNIVAYF 72

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
            G  L   +  +  EY  GGSL+DI      L+  +   +  +  + L +LH +     +H
Sbjct: 73   GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG- 990
            RD+K +N+LL   G   + DFG+A  ++A  +   + I GT  ++APE      A  K  
Sbjct: 130  RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVA----AVEKNG 184

Query: 991  ------DVYSFGVLAMELA 1003
                  D+++ G+ A+ELA
Sbjct: 185  GYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G + TV++G        VA+K+++ E  EG      R E+ +L        H N+VT
Sbjct: 13   LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKN----LKHANIVT 67

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI-DVARALVFLHHECYPP 928
            L+          LV+EY++   L+  + +   L     + I +  + R L + H      
Sbjct: 68   LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQA 986
            I+HRD+K  N+L++++G+  + DFGLAR  S      S  +  T+ Y  P+   G T + 
Sbjct: 124  ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST-EY 181

Query: 987  TTKGDVYSFGVLAMELATGRRALEG 1011
            +T  D++  G +  E+ATGR    G
Sbjct: 182  STPIDMWGVGCILYEMATGRPMFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 1e-09
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 45/235 (19%)

Query: 790  LDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQR--EGLE-GE 845
            L+KT +   D      ++     +G G +G V        GR+VA+KKL R  +     +
Sbjct: 6    LNKTVWEVPD------RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK 59

Query: 846  REFRAEMEVLSGNGFGWPHPNLVTLYGWCLD------GSEKI----LVYEYMEGGSLEDI 895
            R +R E+ +L        H N++ L    LD        E      LV   M G  L +I
Sbjct: 60   RTYR-ELRLLKH----MDHENVIGL----LDVFTPASSLEDFQDVYLVTHLM-GADLNNI 109

Query: 896  ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA 955
            +  + +L+      +   + R L ++H      I+HRD+K SN+ ++++ +  + DFGLA
Sbjct: 110  VKCQ-KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA 165

Query: 956  RVVSAGDSHVSTTIAGTVG---YVAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
            R       H    + G V    Y APE    W    +  D++S G +  EL TG+
Sbjct: 166  R-------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 806  KFSEDRIIGKGGFGTVYRG--VLP---DGREVAVKKLQR-EGLEGEREFRAEMEVLSGNG 859
            +F E+  +G+  FG +Y+G   LP     + VA+K L+     +   EF+ E  +++   
Sbjct: 8    RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE-- 63

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII------------SD-----RTRL 902
                HPN+V L G         +++EY+  G L + +            SD     ++ L
Sbjct: 64   --LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 903  TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
                 L IAI +A  + +L    +   VH+D+ A N+L+ ++    ++D GL+R + + D
Sbjct: 122  DHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 963  SH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             + V       + ++ PE     + ++  D++SFGV+  E+
Sbjct: 179  YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 63/213 (29%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEMEVLSGNGFGW--- 862
            F   ++IG+G FG V        ++V A+K L +           EM   S + F W   
Sbjct: 45   FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF----------EMIKRSDSAFFWEER 94

Query: 863  ---PHPN---LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                H N   +V L+    D     +V EYM GG L +++S+        R   A +V  
Sbjct: 95   DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA-EVVL 153

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            AL  +H   +   +HRDVK  N+LLDK G   + DFG    + A       T  GT  Y+
Sbjct: 154  ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210

Query: 977  APEY----GQTWQATTKGDVYSFGVLAMELATG 1005
            +PE     G       + D +S GV   E+  G
Sbjct: 211  SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 38/197 (19%)

Query: 832  VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG 890
            VAVK L+ +  +  R +F  E+++LS        PN++ L G C+D     ++ EYME G
Sbjct: 49   VAVKILRPDANKNARNDFLKEVKILSR----LKDPNIIRLLGVCVDEDPLCMITEYMENG 104

Query: 891  SLEDIISDRTRL-------------------TWRRRLDIAIDVARALVFLHHECYPPIVH 931
             L   +S                        ++   L +A+ +A  + +L    +   VH
Sbjct: 105  DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VH 161

Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA----- 986
            RD+   N L+ +     + DFG++R + AGD +    I G    V P     W+      
Sbjct: 162  RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRA--VLPIRWMAWECILMGK 216

Query: 987  -TTKGDVYSFGVLAMEL 1002
             TT  DV++FGV   E+
Sbjct: 217  FTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 71/242 (29%), Positives = 102/242 (42%), Gaps = 45/242 (18%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G FG V    + +  +V A+K L +  +    E   FR E +VL      W    
Sbjct: 7    KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW---- 62

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIIS---DRTRLTWRRRLDIAIDVAR------- 916
            +  L+    D +   LV +Y  GG L  ++S   DR          +  D+AR       
Sbjct: 63   ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----------LPEDMARFYLAEMV 112

Query: 917  -ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             A+  +H   Y   VHRD+K  NVLLDK G   + DFG    + A  +  S    GT  Y
Sbjct: 113  LAIDSVHQLGY---VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169

Query: 976  VAPEYGQTWQATTKG--------DVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG 1027
            ++PE     QA   G        D +S GV   E+  G        E LVE   ++M + 
Sbjct: 170  ISPE---ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHK 224

Query: 1028 RH 1029
             H
Sbjct: 225  EH 226

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 813  IGKGGFGTVYRG--VLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            +G+G + TVY+G   L D   VA+K+++ E  EG      R E+ +L        H N+V
Sbjct: 14   LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKD----LKHANIV 67

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI-DVARALVFLHHECYP 927
            TL+          LV+EY++   L+  + D         + + +  + R L + H     
Sbjct: 68   TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQ 985
             ++HRD+K  N+L+++ G+  + DFGLAR  S      S  +  T+ Y  P+   G T  
Sbjct: 124  KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST-D 181

Query: 986  ATTKGDVYSFGVLAMELATGRRALEG 1011
             +T+ D++  G +  E++TGR    G
Sbjct: 182  YSTQIDMWGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 813  IGKGGFGTVYRG--VLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            +G+G + TV++G   L +   VA+K+++ E  EG      R E+ +L        H N+V
Sbjct: 14   LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKD----LKHANIV 67

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI-DVARALVFLHHECYP 927
            TL+          LV+EY++   L+  + D   +     + I +  + R L + H     
Sbjct: 68   TLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR--- 123

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQ 985
             ++HRD+K  N+L+++ G+  + DFGLAR  S      S  +  T+ Y  P+   G + +
Sbjct: 124  KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS-E 181

Query: 986  ATTKGDVYSFGVLAMELATGRRALEG 1011
             +T+ D++  G +  E+A+GR    G
Sbjct: 182  YSTQIDMWGVGCIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 30/191 (15%)

Query: 832  VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG 890
            VAVK L+ +  +  R +F  E++++S        PN++ L   C+      ++ EYME G
Sbjct: 49   VAVKMLREDANKNARNDFLKEIKIMSR----LKDPNIIRLLAVCITSDPLCMITEYMENG 104

Query: 891  SLEDIIS-----------DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV 939
             L   +S           D   +++   + +A  +A  + +L    +   VHRD+   N 
Sbjct: 105  DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNC 161

Query: 940  LLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA------TTKGDVY 993
            L+ K     + DFG++R + +GD +    I G    V P    +W++      TT  DV+
Sbjct: 162  LVGKNYTIKIADFGMSRNLYSGDYY---RIQGRA--VLPIRWMSWESILLGKFTTASDVW 216

Query: 994  SFGVLAMELAT 1004
            +FGV   E+ T
Sbjct: 217  AFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 6e-09
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 27/161 (16%)

Query: 807 FSEDRIIGKGGFGTVYRGV--LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFG 861
           F   ++IGKG FG V R V     G+  A+K L +  +  + +    +AE +VL+ +   
Sbjct: 3   FHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 862 WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLE------DIIS-DRTRLTWRRRLDIAIDV 914
           W    +V+LY    D     L+ E++ GG L       D  S D TR  +     +AI+ 
Sbjct: 62  W----VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEA 116

Query: 915 ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA 955
              L F         +HRD+K  N+L+D+ G   ++DFGL+
Sbjct: 117 VHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 30/191 (15%)

Query: 832  VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG 890
            VAVK L+ +  +  R +F  E+++LS        PN+  L G C       ++ EYME G
Sbjct: 49   VAVKVLRPDASDNAREDFLKEVKILSR----LSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 891  SL-----------EDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV 939
             L             +  +   L++   L +A  +A  + +L    +   VHRD+   N 
Sbjct: 105  DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNC 161

Query: 940  LLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA------TTKGDVY 993
            L+ K     + DFG++R + + D +    + G      P     W++      TTK DV+
Sbjct: 162  LVGKNYTIKIADFGMSRNLYSSDYY---RVQGRA--PLPIRWMAWESVLLGKFTTKSDVW 216

Query: 994  SFGVLAMELAT 1004
            +FGV   E+ T
Sbjct: 217  AFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 6e-09
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 15/146 (10%)

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH- 922
            +PN + LY         +L+ +Y++ G L D++    +L+      I   +  AL  LH 
Sbjct: 68   NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 923  HECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H     I+H D+K  NVL D  + +  + D+GL +++        +   GT+ Y +PE  
Sbjct: 128  HN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYFSPEKI 178

Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
             G  +  +   D ++ GVL  EL TG
Sbjct: 179  KGHNYDVSF--DWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 813  IGKGGFGTV----YRGVLPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHP 865
            +G+G +G V          +   VA+KK+     + +  +R  R E+++L    F   H 
Sbjct: 8    LGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALR-ELKLL--RHFR-GHK 62

Query: 866  NLVTLYGWCL---DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            N+  LY   +       ++ +YE +    L  II     LT          +   L ++H
Sbjct: 63   NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG----DSHVSTTIAGTVGYVAP 978
                  ++HRD+K  N+L++ + +  + DFGLAR  S         ++  +A T  Y AP
Sbjct: 123  S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAP 178

Query: 979  EYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            E   ++Q+ TK  DV+S G +  EL   +   +G
Sbjct: 179  EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 7e-09
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 23/154 (14%)

Query: 811 RIIGKGGFGTVYRGVLPD-GREVAVKKLQR-EGLEGER--EFRAEMEVLSGNGFGWPHPN 866
           ++IG+G FG V      D G   A+KKL++ E LE E+    RAE ++L+     W    
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW---- 62

Query: 867 LVTLYGWCLDGSEKILVYEYMEGGSL------EDIISDRTRLTWRRRLDIAIDVARALVF 920
           +V LY    D +   L+ EY+ GG +      +D  ++     +     +AID    L +
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 921 LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
                    +HRD+K  N+LLD +G   ++DFGL
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.6 bits (142), Expect = 7e-09
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 810  DRIIGKGGFGTVYRGVLP-DGREVAVKKLQ---REGLEGEREFRAEMEVLSGNGFGWPHP 865
            DR IG G FG V+    P DG+ VA+KK+    +  +  +R FR E+++L      + H 
Sbjct: 5    DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKML----CFFKHD 59

Query: 866  NLVT----LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
            N+++    L    +D  E+I V   +    L  II     L+          + R L +L
Sbjct: 60   NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H      I+HRD+K  N+L++      + DFGLARV    +S   T    T  Y APE  
Sbjct: 120  HS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
             G     T+  D++S G +  EL  GRR L
Sbjct: 177  MGSR-HYTSAVDIWSVGCIFAEL-LGRRIL 204

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 9e-09
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 19/160 (11%)

Query: 881  ILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAI---DVARALVFLHHECYPPIVHRDVK 935
            +L+ EY  GG L   I  R    L ++   ++ +    +  AL  +H      ++HRD+K
Sbjct: 141  LLIMEYGSGGDLNKQIKQRLKEHLPFQEY-EVGLLFYQIVLALDEVHSRK---MMHRDLK 196

Query: 936  ASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYS 994
            ++N+ L   G   + DFG ++  S   S  V+++  GT  Y+APE  +  + + K D++S
Sbjct: 197  SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 995  FGVLAMELATGRRALEGGEECLVEWGRRVMG---YGRHGP 1031
             GV+  EL T  R  +G  +      R +M    YG++ P
Sbjct: 257  LGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYDP 290

Length = 478

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 65/229 (28%), Positives = 96/229 (41%), Gaps = 25/229 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G FG V    +     + A+K L +  +    E   FR E  VL      W    
Sbjct: 7    KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW---- 62

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHEC 925
            + TL+    D +   LV +Y  GG L  ++S    RL          ++  A+  +H   
Sbjct: 63   ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            Y   VHRD+K  NVLLD  G   + DFG    ++   +  S+   GT  Y++PE     Q
Sbjct: 123  Y---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE---ILQ 176

Query: 986  ATTKG--------DVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
            A   G        D +S GV   E+  G        E LVE   ++M +
Sbjct: 177  AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNH 223

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 25   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 79

Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+  + +LT      +   + R L ++H 
Sbjct: 80   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS 138

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 139  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 188

Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
               W    +  D++S G +  EL TGR    G
Sbjct: 189  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 48/150 (32%), Positives = 67/150 (44%), Gaps = 9/150 (6%)

Query: 863  PH--PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
            PH  PN+V L+ + +      LV ++ EGG L   IS    +        A ++  AL  
Sbjct: 41   PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA 100

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            LH E    IV RD+  +N+LLD  G   +T F   R     DS     +     Y APE 
Sbjct: 101  LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEV 153

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALE 1010
            G   + T   D +S G +  EL TG+  +E
Sbjct: 154  GGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 2e-08
 Identities = 79/330 (23%), Positives = 113/330 (34%), Gaps = 59/330 (17%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHN-ILSGD 142
           L+L    +  +I      LT L+ LDL  N  +   P       +LK L+LS N I S  
Sbjct: 98  LDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP 156

Query: 143 LNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRY 202
             L  L +L+ LDLS N +        P +   L                      NL  
Sbjct: 157 SPLRNLPNLKNLDLSFNDL-----SDLPKLLSNL---------------------SNLNN 190

Query: 203 LDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           LDLS N              +      +LS            +LE  DLS N  I +   
Sbjct: 191 LDLSGNKIS-----------DLPPEIELLS------------ALEELDLSNNSII-ELLS 226

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            +SN +NL  L L  NN    +P  IG++S LE L L  N   S+   SL +L+ L  LD
Sbjct: 227 SLSNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQISSI--SSLGSLTNLRELD 283

Query: 323 LSSNNFGGEV-QKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISR---LDLSHNNFT 378
           LS N+    +            +L L        +  + IL   NI              
Sbjct: 284 LSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSI 343

Query: 379 GPLPVEISQMRSLKFLILAHNRFNGSIPAV 408
                 +  + +       +     +  A+
Sbjct: 344 LESLNNLWTLDNALDESNLNRYIVKNPNAI 373

Length = 394

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 15/204 (7%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPHPNLVT 869
            +G+G + TVY+G+   +G+ VA+K +  +  EG   F A  E  +L G      H N+V 
Sbjct: 13   LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKG----LKHANIVL 67

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            L+           V+EYM     + +I     L           + R L ++H +    I
Sbjct: 68   LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQAT 987
            +HRD+K  N+L+   G+  + DFGLAR  S      S+ +  T+ Y  P+   G T   +
Sbjct: 125  LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGAT-DYS 182

Query: 988  TKGDVYSFGVLAMELATGRRALEG 1011
            +  D++  G + +E+  G+ A  G
Sbjct: 183  SALDIWGAGCIFIEMLQGQPAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 36/214 (16%)

Query: 813  IGKGGFGTVYRGV---LPDGREV--------AVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +G+G F  +++G+   + D  E+         + K  R   E   E  + M  LS     
Sbjct: 3    LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS----- 57

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRL---TWRRRLDIAIDVARAL 918
              H +LV  YG C+ G E I+V EY++ GSL+  +     L   +W  +L++A  +A AL
Sbjct: 58   --HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWAL 113

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT------ 972
             FL  +    + H +V A NVLL +E        G    +   D  +S T+         
Sbjct: 114  HFLEDK---GLTHGNVCAKNVLLIREEDRKT---GNPPFIKLSDPGISITVLPKEILLER 167

Query: 973  VGYVAPE-YGQTWQATTKGDVYSFGVLAMELATG 1005
            + +V PE        +   D +SFG    E+ +G
Sbjct: 168  IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 29/221 (13%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGR---EVAVKKLQR---EGLEGEREFRAEMEVLSGNG 859
            ++ + + +G G +GTV   +  D R   +VA+KKL R     L  +R +R E+ +L    
Sbjct: 16   RYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH-- 70

Query: 860  FGWPHPNLVTLYG-----WCLDG-SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
                H N++ L         LD   +  LV  +M G  L  ++    +L+  R   +   
Sbjct: 71   --MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQ 126

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
            + + L ++H      I+HRD+K  N+ ++++ +  + DFGLAR     DS ++  +  T 
Sbjct: 127  MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TR 179

Query: 974  GYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
             Y APE    W   T+  D++S G +  E+ TG+   +G +
Sbjct: 180  WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 33/213 (15%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGFGWPHPNL 867
              IG+G +G V      P G +VA+KK+         +R  R E+++L      + H N+
Sbjct: 11   SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRR----FKHENI 65

Query: 868  VTLYGWCLDGS-----EKILVYEYMEGGSLEDIISDRTRLTWRRRL-DIAI-----DVAR 916
            + +       S     +  +V E ME        +D  +L   + L +  I      + R
Sbjct: 66   IGILDIIRPPSFESFNDVYIVQELME--------TDLYKLIKTQHLSNDHIQYFLYQILR 117

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAGTVG 974
             L ++H      ++HRD+K SN+LL+      + DFGLAR+      H    T    T  
Sbjct: 118  GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 975  YVAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
            Y APE     +  TK  D++S G +  E+ + R
Sbjct: 175  YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        ++V   KL           + EM   S + F W        
Sbjct: 49   KVIGRGAFGEVQLVRHKSSQKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 99

Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVF 920
               P +V L+    D     +V EYM GG L +++S+      W +      +V  AL  
Sbjct: 100  ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY--TAEVVLALDA 157

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPE 979
            +H      ++HRDVK  N+LLDK G   + DFG   ++   G     T + GT  Y++PE
Sbjct: 158  IHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPE 213

Query: 980  Y----GQTWQATTKGDVYSFGVLAMELATG 1005
                 G       + D +S GV   E+  G
Sbjct: 214  VLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 813  IGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPNLV 868
            IGKG FG V +    D + + A+K +++  +    E     AE  VL+        P +V
Sbjct: 1    IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN----CPFIV 56

Query: 869  TLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRL-TWRRRLDIAIDVARALVFLHHECY 926
             L  +     EK+ LV  ++ GG L   +    R    R R   A      L  L +   
Sbjct: 57   PL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHK 111

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              +++RD+K  N+LLD +G   + DFGL + ++  D   + T  GT  Y+APE       
Sbjct: 112  FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Query: 987  TTKGDVYSFGVLAMELATG 1005
            T   D ++ GVL  E+ TG
Sbjct: 171  TKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 42/220 (19%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-------REFRAEMEVLSGNGFGWPH 864
            IG+G +G VY+      G  VA+KK+ R   E E       RE     E+         H
Sbjct: 8    IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL--------NH 58

Query: 865  PNLVTLYGWCLDGSEKILVYE--------YMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
            PN+V L       ++  LV+E        +M+   L  I     +    + L       +
Sbjct: 59   PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL-------Q 111

Query: 917  ALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             L F H H     ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y
Sbjct: 112  GLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 166

Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
             APE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 167  RAPEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 24/209 (11%)

Query: 813  IGKGGFGTVYRGVLPDGREVA---VKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLV 868
            IG G FG V  G    G   A   VK+L+      E+  F  E++          HPN++
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY----RELNHPNVL 58

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTW----RRRLDIAIDVARALVFLHH 923
               G C++    +LV E+   G L++ + S+R  +           +A +VA  L++LH 
Sbjct: 59   QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQ 982
              +   +H D+   N  L  +    + D+GLA      D +++    A  + ++APE  +
Sbjct: 119  ADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 983  TWQA-------TTKGDVYSFGVLAMELAT 1004
                       T K +++S GV   EL T
Sbjct: 176  IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPHPNLVT 869
            +G+G + TVY+G    +G+ VA+K ++ +  EG   F A  E  +L G      H N+V 
Sbjct: 13   LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKG----LKHANIVL 67

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            L+          LV+EY+     + +      L           + R L ++H      I
Sbjct: 68   LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQAT 987
            +HRD+K  N+L+   G+  + DFGLAR  S   SH  +    T+ Y  P+   G T + +
Sbjct: 125  LHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGST-EYS 182

Query: 988  TKGDVYSFGVLAMELATGRRALEG 1011
            T  D++  G + +E+  G  A  G
Sbjct: 183  TCLDMWGVGCIFVEMIQGVAAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 69/244 (28%)

Query: 811  RIIGKGGFGTVY----RGVLPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGWP 863
            +++GKG  G V+    +G    G+  A+K L ++ +    +      E E+L+       
Sbjct: 7    KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD---- 59

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR------ 916
            HP L TLY         + LV +Y  GG L  ++  +      + L  + +VAR      
Sbjct: 60   HPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPG----KCL--SEEVARFYAAEV 112

Query: 917  --ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA------------------- 955
              AL +LH      IV+RD+K  N+LL + G  +++DF L+                   
Sbjct: 113  LLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 956  ---------RVVSAGDSHVSTTIAGTVGYVAPE----YGQTWQATTKGDVYSFGVLAMEL 1002
                        S   S  S +  GT  Y+APE     G         D ++ G+L  E+
Sbjct: 170  RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEM 225

Query: 1003 ATGR 1006
              G 
Sbjct: 226  LYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 65/205 (31%)

Query: 813 IGKGGFGTVYRGVL---PDGREVAVKKLQREGLEGE-------RE---FRAEMEVLSGNG 859
           IG+G +G VY+       DG+E A+KK + +  +         RE    R E++      
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR-ELK------ 60

Query: 860 FGWPHPNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
               H N+V+L    L+ ++K   L+++Y E    + II       + R+    + +  +
Sbjct: 61  ----HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ-II------KFHRQ-AKRVSIPPS 108

Query: 918 LV------------FLHHECYPPIVHRDVKASNVLL----DKEGKALVTDFGLARVVSA- 960
           +V            +LH      ++HRD+K +N+L+     + G   + D GLAR+ +A 
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 961 ------GDSHVSTTIAGTVGYVAPE 979
                  D  V      T+ Y APE
Sbjct: 166 LKPLADLDPVVV-----TIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.4 bits (136), Expect = 6e-08
 Identities = 30/79 (37%), Positives = 46/79 (58%)

Query: 273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV 332
           L L      G IP +I  +  L+++ L  N+    IP SL +++ LEVLDLS N+F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 333 QKIFGRFTQVKILALHSNS 351
            +  G+ T ++IL L+ NS
Sbjct: 483 PESLGQLTSLRILNLNGNS 501

Length = 623

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 60/209 (28%), Positives = 86/209 (41%), Gaps = 28/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        R+V   KL           + EM   S + F W        
Sbjct: 49   KVIGRGAFGEVQLVRHKSTRKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 99

Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVF 920
               P +V L+    D     +V EYM GG L +++S+      W R      +V  AL  
Sbjct: 100  ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--TAEVVLALDA 157

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            +H   +   +HRDVK  N+LLDK G   + DFG    ++        T  GT  Y++PE 
Sbjct: 158  IHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Query: 981  ----GQTWQATTKGDVYSFGVLAMELATG 1005
                G       + D +S GV   E+  G
Sbjct: 215  LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 7e-08
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +IGKG +G V   +    G +VA+KK+    E +        E+++L        HP++V
Sbjct: 7    VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRL----LRHPDIV 62

Query: 869  TLYGWCLDGSEK-----ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
             +    L  S +      +V+E ME   L  +I     LT          + RAL ++H 
Sbjct: 63   EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVSTTIAGTVGYVAPEYG 981
                 + HRD+K  N+L + + K  + DFGLARV       +   T    T  Y APE  
Sbjct: 122  A---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 982  QTW--QATTKGDVYSFGVLAMELATGR 1006
             ++  + T   D++S G +  E+ TG+
Sbjct: 179  GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 7e-08
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPHP 865
            IG+G +GTV++    +  E VA+K+++   L+ + E       R E+ +L        H 
Sbjct: 8    IGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALR-EICLLKE----LKHK 59

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGG------SLEDIISDRTRLTWRRRLDIAIDVARALV 919
            N+V LY       +  LV+EY +        S    I      ++  +L       + L 
Sbjct: 60   NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLA 113

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            F H      ++HRD+K  N+L++K G+  + DFGLAR         S  +  T+ Y  P+
Sbjct: 114  FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPD 169

Query: 980  --YGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
              +G    +T+  D++S G +  ELA   R L
Sbjct: 170  VLFGAKLYSTSI-DMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 1e-07
 Identities = 28/81 (34%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGT 673
           L L      G IP++   ++ LQ+++LS N+  G  P S  ++T L  L++SYN   +G+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF-NGS 481

Query: 674 IP-STGQLATFEKTSYLGDPL 693
           IP S GQL +    +  G+ L
Sbjct: 482 IPESLGQLTSLRILNLNGNSL 502

Length = 623

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 3/114 (2%)

Query: 896  ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA 955
            ++ +  +     L I   V RA+ +LH      I+HRD+KA N+ ++  G   + DFG A
Sbjct: 173  LAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Query: 956  RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
                  +++     AGT+   APE           D++S G++  E+AT   +L
Sbjct: 230  CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 25/222 (11%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G G +G+V        R+ VAVKKL R  + L   R    E+ +L        H N++ 
Sbjct: 23   VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH----MKHENVIG 78

Query: 870  LYGWCL------DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
            L           + +E  LV   M G  L +I+  + +L+      +   + R L ++H 
Sbjct: 79   LLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS 136

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 I+HRD+K SNV ++++ +  + DFGLAR     D  ++  +A T  Y APE    
Sbjct: 137  ---AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVA-TRWYRAPEIMLN 189

Query: 984  WQATTKG-DVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            W    +  D++S G +  EL  G+    G +   ++  +R+M
Sbjct: 190  WMHYNQTVDIWSVGCIMAELLKGKALFPGND--YIDQLKRIM 229

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 19/221 (8%)

Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPHPNLVT 869
            +G+G + TVY+G     G+ VA+K+++ E  EG   F A  E  +L        H N+VT
Sbjct: 13   LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKD----LKHANIVT 67

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI-DVARALVFLHHECYPP 928
            L+          LV+EY++   L+  + D         + + +  + R L + H      
Sbjct: 68   LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---R 123

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQA 986
            ++HRD+K  N+L+ + G+  + DFGLAR  S      S  +  T+ Y  P+   G T + 
Sbjct: 124  VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGST-EY 181

Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR--RVMG 1025
            +T  D++  G +  E+ATGR    G  +   +  +  RV+G
Sbjct: 182  STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG 222

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.4 bits (129), Expect = 2e-07
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 39/213 (18%)

Query: 811  RIIGKGGFGT---VYRG-VLPDGREVAVKKLQR-----EGLEGEREFRAEMEVLSGNGFG 861
            +I+GK G GT   V +      G+  A+K +++     E +   RE +A +  LS     
Sbjct: 2    KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLS----- 55

Query: 862  WPHPNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARAL 918
             PHPN++ L     D       LV+E M+  +L ++I  R R L  +R       + ++L
Sbjct: 56   -PHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H      I HRD+K  N+L+  +   L  DFG  R +        T    T  Y AP
Sbjct: 114  DHMHRN---GIFHRDIKPENILIKDDILKL-ADFGSCRGIY--SKPPYTEYISTRWYRAP 167

Query: 979  E-------YGQTWQATTKGDVYSFGVLAMELAT 1004
            E       YG       K D+++ G +  E+ +
Sbjct: 168  ECLLTDGYYGP------KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 3e-07
 Identities = 39/125 (31%), Positives = 65/125 (52%), Gaps = 8/125 (6%)

Query: 883  VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE-CYPPIVHRDVKASNVLL 941
            +    E    + +I++   L++   +  +  VA  + FL  + C    VHRD+ A NVL+
Sbjct: 217  LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLI 272

Query: 942  DKEGKAL-VTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLA 999
              EGK + + DFGLAR +    +++S  +    + ++APE       TT  DV+SFG+L 
Sbjct: 273  -CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILL 331

Query: 1000 MELAT 1004
             E+ T
Sbjct: 332  WEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 3e-07
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
            ++     IG G +G V   +    G++VA+KK+          +R  R E+++L      
Sbjct: 6    RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH---- 60

Query: 862  WPHPNLVTLYGWCL----DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
            + H N++ +         D  +  +V + ME   L  II     LT          + R 
Sbjct: 61   FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR-VVSAGDSH--VSTTIAGTVG 974
            L ++H      ++HRD+K SN+L++++ +  + DFG+AR + S+   H    T    T  
Sbjct: 120  LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 975  YVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRAL 1009
            Y APE   +    TT  D++S G +  E+  GRR L
Sbjct: 177  YRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 9/105 (8%)

Query: 900  TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR--V 957
              L   + L I   +   L +LH +    I+HRDVK  N+ ++   +  + D G A+  V
Sbjct: 152  RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208

Query: 958  VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            V+         +AGTV   APE     +  +K D++S G++  E+
Sbjct: 209  VAPAF----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 3e-07
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 23/215 (10%)

Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            IG+G +G V      +   +VA+KK+       ++ +R  R E+++L        H N++
Sbjct: 13   IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRH----LDHENVI 67

Query: 869  TLYGWCLDGSEK------ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             +    +    +       +VYE M+   L  II     L+          + R L ++H
Sbjct: 68   AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  ++HRD+K SN+LL+      + DFGLAR  S     ++  +  T  Y APE   
Sbjct: 126  S---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLL 181

Query: 983  TW-QATTKGDVYSFGVLAMELATGRRALEGGEECL 1016
               + TT  DV+S G +  EL  GR+ L  G++ +
Sbjct: 182  NCSEYTTAIDVWSVGCIFAEL-LGRKPLFPGKDYV 215

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 49/189 (25%), Positives = 68/189 (35%), Gaps = 57/189 (30%)

Query: 794 AFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG------------ 841
           A     I++A G       IG G    VY  + P GR+VAV K  R G            
Sbjct: 85  ALVKRGIVEAIGT-----KIGVGKESDVYVAIDPKGRKVAV-KFHRLGRTSFRKVKRNRD 138

Query: 842 ---------------LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
                          L  EREF A ++ L   G   P P         +  +   +V EY
Sbjct: 139 YLADKEHGSWLYVSRLAAEREFEA-LQRLYPEGVKVPKP---------IAWNRHAVVMEY 188

Query: 887 MEGGSLEDIISDRTRLT---WRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK 943
           +EG  L      R RL        LD  ++  R            IVH D+   N+L+ +
Sbjct: 189 IEGVELY-----RLRLDVENPDEILDKILEEVRKAYRRG------IVHGDLSEFNILVTE 237

Query: 944 EGKALVTDF 952
           +G  +V D+
Sbjct: 238 DGDIVVIDW 246

Length = 304

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 23/158 (14%)

Query: 807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG--LEGER--EFRAEMEVLSGNGFGW 862
           F   ++IG+G FG V      D   +   K+ R+   LE E+    RAE ++L      W
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSL------EDIISDRTRLTWRRRLDIAIDVAR 916
               +V ++    D     L+ E++ GG +      +D +S+     +     +AID   
Sbjct: 63  ----VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 917 ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            L F         +HRD+K  N+LLD +G   ++DFGL
Sbjct: 119 QLGF---------IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 5e-07
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 203 LDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
           L L +   RG   N  + L  L   ++S N + G +  S      SLE+ DLS N F G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGS 481

Query: 260 FPGEVSNCRNLVVLNLFGNNFSGPIPAEIG 289
            P  +    +L +LNL GN+ SG +PA +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.2 bits (113), Expect = 5e-07
 Identities = 25/61 (40%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 414 NLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK 472
           NL++LDLS N LT  IP      L +L  L L+ N+L+   P       SL  L+LS N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 473 L 473
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 19/133 (14%)

Query: 883  VYEYMEGGS---LEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV 939
            ++ Y++      LE  I      T +RRL        AL +LH      I+HRDVK  N+
Sbjct: 172  LFTYVDRSGPLPLEQAI------TIQRRL------LEALAYLHGR---GIIHRDVKTENI 216

Query: 940  LLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVL 998
             LD+   A++ DFG A ++ +  D+      +GT+   +PE         K D++S G++
Sbjct: 217  FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276

Query: 999  AMELATGRRALEG 1011
              E++     L G
Sbjct: 277  LFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 52.4 bits (126), Expect = 6e-07
 Identities = 63/267 (23%), Positives = 85/267 (31%), Gaps = 78/267 (29%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDLSSCR---SLKYLNLSHNILS---GDLNLSGLRS- 150
             +    L  LDLS N         L S     SL+ L L++N L      L   GL+  
Sbjct: 76  GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135

Query: 151 ---LEILDLSVNRIHGEISFS----FPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
              LE L L  NR+ G    +      A    L   NL+ N +                 
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANR-DLKELNLANNGIGDA-------------- 180

Query: 204 DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF----IGD 259
                        G+  L E                 K NC+LE+ DL+ N         
Sbjct: 181 -------------GIRALAE---------------GLKANCNLEVLDLNNNGLTDEGASA 212

Query: 260 FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSI-----SGLEALFLGKNN--------FLS 306
               +++ ++L VLNL  NN +    A + S        L  L L  N+           
Sbjct: 213 LAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAE 272

Query: 307 VIPESLLNLSKLEVLDLSSNNFGGEVQ 333
           V+ E       L  LDL  N FG E  
Sbjct: 273 VLAEK----ESLLELDLRGNKFGEEGA 295

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.4 bits (125), Expect = 7e-07
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 11/152 (7%)

Query: 807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG--LEGER--EFRAEMEVLSGNGFGW 862
           F   ++IG+G FG V      D   V   K+ R+   LE E+    RAE ++L      W
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
               +V ++    D     L+ E++ GG +  ++  +  LT         +   A+  +H
Sbjct: 63  ----VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 923 HECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
              +   +HRD+K  N+LLD +G   ++DFGL
Sbjct: 119 QLGF---IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 7e-07
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 13/150 (8%)

Query: 813 IGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLV 868
           I +G FG VY G    + +  AVK +++  +  +    + +AE + L+ +      P +V
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS----KSPFIV 67

Query: 869 TLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            LY + L  +  + LV EY+ GG ++ ++           +    +VA AL +LH     
Sbjct: 68  HLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH--- 123

Query: 928 PIVHRDVKASNVLLDKEGKALVTDFGLARV 957
            I+HRD+K  N+L+  EG   +TDFGL++V
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 813  IGKGGFGTVYRGVLPDGR---EVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNL 867
            +G+G +G VY+    DG+   E A+K+++  G+     RE     E+         HPN+
Sbjct: 9    VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL--------KHPNV 60

Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF----- 920
            + L    L  S++   L+++Y E      I   R     ++ + +   + ++L++     
Sbjct: 61   IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 921  LHHECYPPIVHRDVKASNVLLDKE----GKALVTDFGLARVVSAGDSHVS--TTIAGTVG 974
            +H+     ++HRD+K +N+L+  E    G+  + D G AR+ ++    ++    +  T  
Sbjct: 121  IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 975  YVAPEYGQTWQATTKG-DVYSFGVLAMELAT 1004
            Y APE     +  TK  D+++ G +  EL T
Sbjct: 181  YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 51.6 bits (124), Expect = 9e-07
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 37/197 (18%)

Query: 805 GKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKL----QREGLE--GEREFRAEMEVLS 856
            K+ +   IG+G FG V+  R      + VA+KK+    ++EG      RE +  +++L 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVLMENEKEGFPITALREIKI-LQLLK 69

Query: 857 GNGFGWPHPNLVTLYGWCLDGSEK--------ILVYEYME---GGSLEDIISDRTRLTWR 905
                  H N+V L   C   +           LV+E+ E    G L +     T    +
Sbjct: 70  -------HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK 122

Query: 906 RRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS---AGD 962
           + + + ++    L ++H      I+HRD+KA+N+L+ K+G   + DFGLAR  S      
Sbjct: 123 KVMKMLLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 963 SHVSTTIAGTVGYVAPE 979
            +  T    T+ Y  PE
Sbjct: 177 PNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 34/240 (14%)

Query: 268 RNLVVLNLFGNNFSGP----IPAEIGSISGLEALFLGKNN------FLSVIPESLLNLSK 317
             L VL L GN         + + +     L+ L L  N        L  + + L     
Sbjct: 23  LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82

Query: 318 LEVLDLSSNNFGGEVQKIFGRFTQ---VKILALHSNSYID--GMNSSGILK--LPNISRL 370
           L+ LDLS N  G +   +     +   ++ L L++N   D      +  LK   P + +L
Sbjct: 83  LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142

Query: 371 DLSHNNFTG----PLPVEISQMRSLKFLILAHNRFNGS-IPAVYGNMP---NLQTLDLSF 422
            L  N   G     L   +   R LK L LA+N    + I A+   +    NL+ LDL+ 
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202

Query: 423 NELT----GPIPPSIGNLTSLLWLMLANNSLSGEI-----PGEIGNCTSLLWLNLSNNKL 473
           N LT      +  ++ +L SL  L L +N+L+           +    SLL L+LS N +
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 55/239 (23%)

Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQ-------REGLEGE 845
            +I  +T +F E+  +G+  FG VY+G L         + VA+K L+       RE  + E
Sbjct: 1    EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 846  REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--------- 896
               R+ ++          HPN+V L G         +++ Y     L + +         
Sbjct: 59   AMMRSRLQ----------HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDV 108

Query: 897  ----SDRTRLTWRRRLD---IAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKA 947
                 D+T  +     D   I   +A  + FL  HH     +VH+D+   NVL+  +   
Sbjct: 109  GSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNV 163

Query: 948  LVTDFGLARVVSAGDSHVSTTIAGT----VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             ++D GL R V A D +    + G     + +++PE     + +   D++S+GV+  E+
Sbjct: 164  KISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 26/61 (42%), Positives = 34/61 (55%)

Query: 418 LDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI 477
           L L    L G IP  I  L  L  + L+ NS+ G IP  +G+ TSL  L+LS N  +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 478 P 478
           P
Sbjct: 483 P 483

Length = 623

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 51.1 bits (122), Expect = 2e-06
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 27/195 (13%)

Query: 827  PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
            P G  V V+++  E    E     + E+     F   HPN+V      +  +E  +V  +
Sbjct: 23   PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTSF 80

Query: 887  MEGGSLEDIISDRTRLT-WRRRLDIA---IDVARALVFLHHECYPPIVHRDVKASNVLLD 942
            M  GS +D+I   T        L IA     V +AL ++HH  Y   VHR VKAS++L+ 
Sbjct: 81   MAYGSAKDLIC--THFMDGMSELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILIS 135

Query: 943  KEGK----ALVTDFGL------ARVVSAGDSHVSTTIAGTVGYVAPE-YGQTWQA-TTKG 990
             +GK     L ++  +       RVV     +    +     +++PE   Q  Q    K 
Sbjct: 136  VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP----WLSPEVLQQNLQGYDAKS 191

Query: 991  DVYSFGVLAMELATG 1005
            D+YS G+ A ELA G
Sbjct: 192  DIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRA----EMEVLSGNGF 860
            KF    ++G+G +G V +    + +E VA+KK +    E   E +     E+++L     
Sbjct: 2    KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRT--- 56

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
                 N+V L        +  LV+EY+E   LE +      +   +       + +A+ +
Sbjct: 57   -LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE- 979
             H      IVHRD+K  N+L+       + DFG AR +S G +   T    T  Y +PE 
Sbjct: 116  CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 980  -----YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                 YG+        D++S G +  EL+ G+    G  E
Sbjct: 173  LLGAPYGKAV------DMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)

Query: 813  IGKGGFGTVYRGVL---PDGR--------EVAVKKLQREGLEGEREFRAE--MEVLSGNG 859
            +G+G F  +Y+GVL    D           V +K L  +  +    F     M  LS   
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS--- 59

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARAL 918
                H +LV LYG C+   E I+V EY++ G L+  +  ++  ++   +LD+A  +A AL
Sbjct: 60   ----HKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASAL 114

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKAL-------VTDFGLARVVSAGDSHVSTTIAG 971
             +L  +    +VH +V   N+L+ + G          ++D G+   V + +  V      
Sbjct: 115  HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE----- 166

Query: 972  TVGYVAPEYGQTWQA--TTKGDVYSFGVLAMEL 1002
             + ++APE  +  QA  T   D +SFG   +E+
Sbjct: 167  RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 33/199 (16%)

Query: 827  PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
            P G  V V+    E    E     + EV+  + F   HPN++T +     GS   ++  +
Sbjct: 23   PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF--RHPNIMTSWTVFTTGSWLWVISPF 80

Query: 887  MEGGSLEDIISDRTRLTWRRRL--DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE 944
            M  GS   ++           L  +I     R L +LH   Y   +HR++KAS++L+  +
Sbjct: 81   MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGD 137

Query: 945  GKALVTDFGLARV---VSAGDSHVSTTIAGTVGYVAPEYG---QTWQA-----------T 987
            G  LV+  GL+ +   V  G           V Y  P++      W +            
Sbjct: 138  G--LVSLSGLSHLYSLVRNGQKA-------KVVYDFPQFSTSVLPWLSPELLRQDLYGYN 188

Query: 988  TKGDVYSFGVLAMELATGR 1006
             K D+YS G+ A ELATGR
Sbjct: 189  VKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.0 bits (122), Expect = 3e-06
 Identities = 30/120 (25%), Positives = 49/120 (40%), Gaps = 25/120 (20%)

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYI 353
           ++ L L        IP  +  L  L+ ++LS N+  G +    G  T +++L        
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL-------- 471

Query: 354 DGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMP 413
                            DLS+N+F G +P  + Q+ SL+ L L  N  +G +PA  G   
Sbjct: 472 -----------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 3e-06
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 48/228 (21%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSG---- 857
            +++  + +G G +G+V   +    G +VA+KKL R     +  +R +R E+ +L      
Sbjct: 16   RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHE 74

Query: 858  NGFGW-----PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
            N  G         +      +        LV  YM           +T L       ++ 
Sbjct: 75   NVIGLLDVFTSAVSGDEFQDF-------YLVMPYM-----------QTDLQKIMGHPLSE 116

Query: 913  DVARALVF-----LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            D  + LV+     L +     I+HRD+K  N+ ++++ +  + DFGLAR       H   
Sbjct: 117  DKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADA 169

Query: 968  TIAGTV---GYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
             + G V    Y APE    W    +  D++S G +  E+ TG+   +G
Sbjct: 170  EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 3e-06
 Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 28/229 (12%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
             ++ + R +G G  G V+  V  D  + VAVKK+     +  +    E++++        
Sbjct: 5    SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR----LD 60

Query: 864  HPNLVTLYGWCLDGSEKI--------------LVYEYMEGGSLEDIISDRTRLTWRRRLD 909
            H N+V +Y         +              +V EYME   L +++          RL 
Sbjct: 61   HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL- 118

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTT 968
                + R L ++H      ++HRD+K +NV ++ E   L + DFGLAR+V    SH    
Sbjct: 119  FMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175

Query: 969  IAGTVG--YVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
              G V   Y +P    +    TK  D+++ G +  E+ TG+    G  E
Sbjct: 176  SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 3e-06
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 8/123 (6%)

Query: 884  YEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHE-CYPPIVHRDVKASNVL 940
            Y+      +++++SD     LT    L     VAR + FL  + C    VHRD+ A NVL
Sbjct: 214  YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269

Query: 941  LDKEGKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLA 999
            L +     + DFGLAR +    ++VS  +    V ++APE       TT  DV+S+G+L 
Sbjct: 270  LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 1000 MEL 1002
             E+
Sbjct: 330  WEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 40/122 (32%), Positives = 59/122 (48%), Gaps = 30/122 (24%)

Query: 891  SLEDIISDRTRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALV 949
            +LED+IS             +  VAR + FL   +C    +HRD+ A N+LL +     +
Sbjct: 171  TLEDLIS------------YSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKI 214

Query: 950  TDFGLAR-------VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             DFGLAR        V  GD+ +       + ++APE       TT+ DV+SFGVL  E+
Sbjct: 215  CDFGLARDIYKDPDYVRKGDARLP------LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Query: 1003 AT 1004
             +
Sbjct: 269  FS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 36/219 (16%)

Query: 813  IGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGEREFRAEMEVLSGN------G 859
            +G+G    +Y G L       P+  E+  +    EG    RE R  ++VL  +       
Sbjct: 3    LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 860  F--------GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDI 910
            F           H +L  ++G C+ GSE I+V E++E G L+  +  ++ R+    ++ +
Sbjct: 63   FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122

Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
            A  +A AL +L  +    +VH +V A N+LL + G A     G +  +   D  VS T  
Sbjct: 123  AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE----GTSPFIKLSDPGVSFTAL 175

Query: 971  G------TVGYVAPEYGQTWQA-TTKGDVYSFGVLAMEL 1002
                    + ++APE      + +T  D +SFG   +E+
Sbjct: 176  SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 28/238 (11%)

Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 18   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 74

Query: 863  PHPNLVTLYGW-----CLDGSEKI-LVYEYMEGGSLEDIIS---DRTRLTWRRRLDIAID 913
             H N+++L         L+  + + LV E M+  +L  +I    D  R+++         
Sbjct: 75   -HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYL-------- 124

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
            + + L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T 
Sbjct: 125  LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 182

Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
             Y APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 183  YYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 5e-06
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 914  VARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG- 971
            VAR + FL   +C    +HRD+ A N+LL +     + DFGLAR +     +V    A  
Sbjct: 183  VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             + ++APE       TT+ DV+SFGVL  E+
Sbjct: 239  PLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 55/232 (23%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGL----EGEREFRAEMEVLSGNGFG 861
            F   ++I  G +G VY     + R+  A+KK+ ++ L    + ++ F  E ++L+   F 
Sbjct: 3    FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILT---FA 58

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR----- 916
              +P +V+++          +V EY+EGG    ++ +   L         +D+AR     
Sbjct: 59   -ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGAL--------PVDMARMYFAE 109

Query: 917  ---ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV--------VSAGDSHV 965
               AL +LH+  Y  IVHRD+K  N+L+   G   +TDFGL+++        +  G    
Sbjct: 110  TVLALEYLHN--YG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 966  ST------TIAGTVGYVAPE------YGQTWQATTKGDVYSFGVLAMELATG 1005
             T       + GT  Y+APE      YG+        D ++ G++  E   G
Sbjct: 167  DTREFLDKQVCGTPEYIAPEVILRQGYGKPV------DWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 49/211 (23%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 813  IGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNL 867
            +G+G +G VY+    DG++    A+K+++  G+     RE     E+         HPN+
Sbjct: 9    VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL--------KHPNV 60

Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF----- 920
            ++L    L  +++   L+++Y E      I   R     ++ + +   + ++L++     
Sbjct: 61   ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 921  LHHECYPPIVHRDVKASNVLLDKE----GKALVTDFGLARVVSAGDSHVS--TTIAGTVG 974
            +H+     ++HRD+K +N+L+  E    G+  + D G AR+ ++    ++    +  T  
Sbjct: 121  IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 975  YVAPEYGQTWQATTKG-DVYSFGVLAMELAT 1004
            Y APE     +  TK  D+++ G +  EL T
Sbjct: 181  YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 6e-06
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 34/226 (15%)

Query: 798  SDILKATGK-FSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRAEMEVL 855
            +DI ++  K +    IIG G FG VY  +  D  E VA+KK+ ++     RE    M+ L
Sbjct: 58   NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI-MKNL 116

Query: 856  SGNGFGWPHPNLVTL----YGWCLDGSEK-ILVYEYMEGGSLEDIISDRTRLTWRRRLDI 910
            +       H N++ L    Y  C   +EK I +   ME   +   +    +   R    +
Sbjct: 117  N-------HINIIFLKDYYYTECFKKNEKNIFLNVVME--FIPQTVHKYMKHYARNNHAL 167

Query: 911  AI--------DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAG 961
             +         + RAL ++H +    I HRD+K  N+L+D     L + DFG A+ + AG
Sbjct: 168  PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 962  DSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
               VS   +    Y APE   G T   TT  D++S G +  E+  G
Sbjct: 225  QRSVSYICSRF--YRAPELMLGAT-NYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 8e-06
 Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 1/65 (1%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEI 625
           + LSGN + G + P +G + +  ++ L +N F+G +P    QL  L +LNL  N+ SG +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 626 PSEFG 630
           P+  G
Sbjct: 507 PAALG 511

Length = 623

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 9e-06
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 911  AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  VA+ + FL   +C    +HRD+ A N+LL +     + DFGLAR +     +V    
Sbjct: 185  SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240

Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   + ++APE       T + DV+SFGVL  E+
Sbjct: 241  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 60/231 (25%)

Query: 813  IGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGERE-----------FRAEMEVLSGNGF 860
            IG+G +G VY+       E +A+KK++   LE E E              EM+       
Sbjct: 10   IGEGTYGVVYKARDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQ------- 59

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA----- 915
               H N+V L           LV+EY++             L  ++ +D + D A     
Sbjct: 60   ---HGNIVRLQDVVHSEKRLYLVFEYLD-------------LDLKKHMDSSPDFAKNPRL 103

Query: 916  ---------RALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHV 965
                     R + + H      ++HRD+K  N+L+D+   AL + DFGLAR         
Sbjct: 104  IKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160

Query: 966  STTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            +  +  T+ Y APE   G     +T  D++S G +  E+   +    G  E
Sbjct: 161  THEVV-TLWYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209

Length = 294

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 36/153 (23%), Positives = 72/153 (47%), Gaps = 24/153 (15%)

Query: 866  NLVTLYGWCLDGSEK----ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
            N++ +YG+ +D  +      L+ EY   G L +++     L+++ +LD+AID  + L  L
Sbjct: 79   NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNL 138

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP--- 978
            +     P  ++++ + + L+ +  K  +   GL +++S+        +     Y +    
Sbjct: 139  YKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKML 192

Query: 979  -----EYGQTWQATTKGDVYSFGVLAMELATGR 1006
                 EY      T K D+YS GV+  E+ TG+
Sbjct: 193  NDIFSEY------TIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 51/235 (21%)

Query: 793  TAFTYSDILKATGKFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQR---EGLEGER 846
            + FT   +LK   ++   + IG G  G V   Y  V   G+ VA+KKL R        +R
Sbjct: 10   STFT---VLK---RYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKR 61

Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCL----------DGSEKILVYEYMEGGSLEDII 896
             +R  + +   N     H N++ L    L          +  +  LV E M+  +L  +I
Sbjct: 62   AYRELVLMKLVN-----HKNIIGL----LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI 111

Query: 897  S---DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG 953
                D  R+++         + + L  + H     I+HRD+K SN+++  +    + DFG
Sbjct: 112  QMDLDHERMSYL--------LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163

Query: 954  LARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            LAR  +AG S + T    T  Y APE   G  ++     D++S G +  E+  G 
Sbjct: 164  LAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 24/60 (40%), Positives = 33/60 (55%)

Query: 390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSL 449
           +LK L L++NR        +  +PNL+ LDLS N LT   P +   L SL  L L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 908  LDIAIDVARALVFLHHE-CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
            L  +  VA+ + FL  + C    +HRDV A NVLL     A + DFGLAR +    ++V 
Sbjct: 215  LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 967  TTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
               A   V ++APE       T + DV+S+G+L  E+
Sbjct: 271  KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 15/147 (10%)

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLH 922
            H ++V LYG C+   E I+V E++E G L+  +  ++  LT   +  +A  +A AL +L 
Sbjct: 63   HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG------TVGYV 976
             +    +VH +V   N+LL +EG  +  + G    +   D  +  T+         + ++
Sbjct: 123  DK---DLVHGNVCTKNILLAREG--IDGECG--PFIKLSDPGIPITVLSRQECVERIPWI 175

Query: 977  APE-YGQTWQATTKGDVYSFGVLAMEL 1002
            APE    +   +   D +SFG    E+
Sbjct: 176  APECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.9 bits (107), Expect = 6e-05
 Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 34/159 (21%)

Query: 812 IIGKGGFGTVYRGVLPDGREVAVK----------KLQREGLEGER---EFRAEMEVLSGN 858
           +I KG    +Y G    G +  +K          +L    +  ER   E R         
Sbjct: 1   LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDER-IRRERTRNEARLLSRARK-A 57

Query: 859 GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARAL 918
           G   P    V           K +V EY+EG  L+D+I +          ++  ++ R +
Sbjct: 58  GVNTPVVYDVDPD-------NKTIVMEYIEGKPLKDVIEE-------GNDELLREIGRLV 103

Query: 919 VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
             LH      IVH D+  SN+++ ++ K  + DFGL + 
Sbjct: 104 GKLHKA---GIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 11/82 (13%)

Query: 876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVK 935
           D    ++V EY+EG  L+D +          R D+  +V R +  LH      IVH D+ 
Sbjct: 70  DPDNGLIVMEYIEGELLKDAL-------EEARPDLLREVGRLVGKLHKA---GIVHGDLT 119

Query: 936 ASNVLLDKEGKALVTDFGLARV 957
            SN++L       + DFGL   
Sbjct: 120 TSNIILSGGRIYFI-DFGLGEF 140

Length = 204

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 7e-05
 Identities = 26/62 (41%), Positives = 32/62 (51%), Gaps = 6/62 (9%)

Query: 104 QLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHN---ILSGDLNLSGLRSLEILDLSVN 159
            L  LDLS N  +  IPD       +LK L+LS N    +S +   SGL SL  LDLS N
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEA-FSGLPSLRSLDLSGN 58

Query: 160 RI 161
            +
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 7e-05
 Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 36/254 (14%)

Query: 787  VIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLE 843
             + +  + FT   +LK   ++   + IG G  G V   Y  +L   R VA+KKL R    
Sbjct: 12   SVEIGDSTFT---VLK---RYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63

Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGW-----CLDGSEKILVYEYMEGGSLEDIIS- 897
                 RA  E++        H N++ L         L+  + + +   +   +L  +I  
Sbjct: 64   QTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121

Query: 898  --DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA 955
              D  R+++         + + L  + H     I+HRD+K SN+++  +    + DFGLA
Sbjct: 122  ELDHERMSYL--------LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173

Query: 956  RVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            R  +AG S + T    T  Y APE   G  ++     D++S G +  E+  G   L  G 
Sbjct: 174  R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKG-GVLFPGT 228

Query: 1014 ECLVEWGRRVMGYG 1027
            + + +W + +   G
Sbjct: 229  DHIDQWNKVIEQLG 242

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.7 bits (108), Expect = 9e-05
 Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 13/144 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKL-QNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L L  N ++ ++ P IG L  N   + L  N+    LPS    LP L  L+L+ N+ S 
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATF 683
           ++P    N+  L NLDLS N  S   P     L+ L +L++S N ++   + S+  L+  
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE--LLSS--LSNL 231

Query: 684 EKTSYLGD---PLLDLPDFIENGP 704
           +  S L      L DLP+ I N  
Sbjct: 232 KNLSGLELSNNKLEDLPESIGNLS 255

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 9e-05
 Identities = 26/63 (41%), Positives = 33/63 (52%), Gaps = 5/63 (7%)

Query: 150 SLEILDLSVNRIH--GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSS 207
           +L+ LDLS NR+    + +F        L V +LS NNLT      F G  +LR LDLS 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKG---LPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 208 NNF 210
           NN 
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 19/57 (33%), Positives = 26/57 (45%), Gaps = 6/57 (10%)

Query: 84  LNLTD---WNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHN 137
           L+L++     I    F     L  L  LDLS N  +   P+  S   SL+ L+LS N
Sbjct: 5   LDLSNNRLTVIPDGAFKG---LPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 34/231 (14%)

Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNG 859
            ++ + + IG G  G V   +  VL  G  VAVKKL R        +R +R  + +   N 
Sbjct: 22   RYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN- 78

Query: 860  FGWPHPNLVTLYGW-----CLDGSEKI-LVYEYMEGGSLEDIIS---DRTRLTWRRRLDI 910
                H N+++L         L+  + + LV E M+  +L  +I    D  R+++      
Sbjct: 79   ----HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYL----- 128

Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
               + + L  + H     I+HRD+K SN+++  +    + DFGLAR  +A  + + T   
Sbjct: 129  ---LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYV 183

Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021
             T  Y APE           D++S G +  EL  G    +G +  + +W +
Sbjct: 184  VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNK 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 45.6 bits (109), Expect = 1e-04
 Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 39/197 (19%)

Query: 810 DRIIGKGGFGTVYRGVLPDGREVAVK----KLQR-----EGLEGEREFRAEMEVLS-GNG 859
           D +IGKG    + +G    GR+  +K    K  R     E L  ER  RAE  +LS    
Sbjct: 338 DHLIGKGAEADIKKGE-YLGRDAVIKERVPKGYRHPELDERLRTERT-RAEARLLSEARR 395

Query: 860 FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
            G P P    +Y   +D  EK +V EY+ G  L+D++     L       +   VA+   
Sbjct: 396 AGVPTP---VIYD--VDPEEKTIVMEYIGGKDLKDVLEGNPELVR----KVGEIVAK--- 443

Query: 920 FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS-----AGDSHV-STTIAGTV 973
            LH      IVH D+  SN ++  +   L+ DFGL +        A D HV   ++  T 
Sbjct: 444 -LHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKYSDLIEDKAVDLHVLKQSLEST- 497

Query: 974 GYVAPEYGQTWQATTKG 990
                ++ + W+A  +G
Sbjct: 498 ---HYDFEELWEAFLEG 511

Length = 535

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 34/212 (16%)

Query: 813  IGKGGFGTVYRGVLPDG---REVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            IG G FG V  G +  G    +V VK+L+    ++ + +F  E +          H NL+
Sbjct: 3    IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS----LQHSNLL 58

Query: 869  TLYGWCLDGSEKILVYEYMEGGSL----------EDIISDRTRLTWRRRLDIAIDVARAL 918
               G C + +  +LV E+   G L          E +  D T L       +A ++A  L
Sbjct: 59   QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-----RMACEIALGL 113

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVA 977
            + LH   +   +H D+   N LL  +    + D+GL+      D +V    +   + ++A
Sbjct: 114  LHLHKNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170

Query: 978  PE-----YGQTWQA--TTKGDVYSFGVLAMEL 1002
            PE     +G       T + +V+S GV   EL
Sbjct: 171  PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 2e-04
 Identities = 73/341 (21%), Positives = 113/341 (33%), Gaps = 93/341 (27%)

Query: 148 LRSLEILDLSVNRIH-GEISFSFPAICEK--LVVANLSLNNLTGRIDTCFDGCL------ 198
           L  L++L L  N +          A+  +  L    LSLN  TGRI       L      
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-TGRIPRGLQSLLQGLTKG 80

Query: 199 -NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
             L+ LDLS N    +                   GV+ S     + SL+   L+ N  +
Sbjct: 81  CGLQELDLSDNALGPD-----------------GCGVLES--LLRSSSLQELKLNNNG-L 120

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL-- 315
           GD    +   + L  L                    LE L LG+N       E+L     
Sbjct: 121 GDRGLRLL-AKGLKDLPP-----------------ALEKLVLGRNRLEGASCEALAKALR 162

Query: 316 --SKLEVLDLSSNNFGGE----VQKIFGRFTQVKILALHSNSYID-GMN--SSGILKLPN 366
               L+ L+L++N  G      + +       +++L L++N   D G +  +  +  L +
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222

Query: 367 ISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNEL 425
           +  L+L  NN T      + S + S                       +L TL LS N++
Sbjct: 223 LEVLNLGDNNLTDAGAAALASALLSPN--------------------ISLLTLSLSCNDI 262

Query: 426 T--------GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
           T          +        SLL L L  N    E    + 
Sbjct: 263 TDDGAKDLAEVLA----EKESLLELDLRGNKFGEEGAQLLA 299

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKK----LQREGLEGE--REFRAEMEVLSGNGFGWPH 864
             IG+G +G VY+      G+ VA+KK    +  EG+     RE  + +++LS + +    
Sbjct: 8    KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQMLSESIY---- 62

Query: 865  PNLVTLYGWCLDGSEK-------ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
              +V L    ++  E+        LV+EY++   L+  + D       R L       ++
Sbjct: 63   --IVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFM-DSNGRGPGRPLPAKT--IKS 114

Query: 918  LVF-----LHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAG 971
             ++     + H     ++HRD+K  N+L+DK+   L + D GL R  S      +  I  
Sbjct: 115  FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173

Query: 972  TVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            T+ Y APE   G T   +T  D++S G +  E++  +    G  E
Sbjct: 174  TLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 22/155 (14%)

Query: 808 SEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPH 864
           S  +++  G    VY   L    E  V K+     +G   ERE    +++L+  G   P 
Sbjct: 1   SSIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAI-LQLLARKGL--PV 55

Query: 865 PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
           P ++             L+ E++EG +L++       ++   + DIA  +A  L  LH  
Sbjct: 56  PKVLASGESDGWS---YLLMEWIEGETLDE-------VSEEEKEDIAEQLAELLAKLHQ- 104

Query: 925 CYPPIV--HRDVKASNVLLDKEGKALVTDFGLARV 957
             P +V  H D+   N+L+D      + D+  A  
Sbjct: 105 -LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 2e-04
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 908  LDIAIDVARALVFLHHE-CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
            L  +  VA+ + FL  + C    +HRD+ A N+LL       + DFGLAR +    ++V 
Sbjct: 217  LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272

Query: 967  TTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
               A   V ++APE       T + DV+S+G+L  E+
Sbjct: 273  KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 23/158 (14%)

Query: 807 FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGW 862
           F + + IG G FG V      D   + A+K L++  +    +    +AE ++L+     W
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSL------EDIISDRTRLTWRRRLDIAIDVAR 916
               +V LY    D      V +Y+ GG +        I  +     +   L  AI+   
Sbjct: 63  ----VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH 118

Query: 917 ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            + F         +HRD+K  N+L+D++G   +TDFGL
Sbjct: 119 KMGF---------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/59 (33%), Positives = 30/59 (50%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           L  L+L+ N  +      F  +  L+ LDLS NN +   P +F+ L  L  L++S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 23/61 (37%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 269 NLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN 327
           NL  L+L  N  +  IP      +  L+ L L  NN  S+ PE+   L  L  LDLS NN
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 328 F 328
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 5e-04
 Identities = 77/318 (24%), Positives = 120/318 (37%), Gaps = 36/318 (11%)

Query: 350 NSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY 409
            S +  + S  +L    IS LD S  N    LP        L  L L  NR   +I  + 
Sbjct: 63  PSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLP--------LPSLDLNLNRLRSNISEL- 112

Query: 410 GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM-LANNSLSGEIPGEIGNCTSLLWLNL 468
             + NL +LDL  N +T  IPP IG L S L  + L++N +   +P  + N  +L  L+L
Sbjct: 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170

Query: 469 SNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSE-CLSMKRWIPADYPPFSFVY 527
           S N LS ++P     +   +         N    +    E   +++    ++      + 
Sbjct: 171 SFNDLS-DLPKL---LSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLS 226

Query: 528 TILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQN 587
           ++   K         L+ +      LP        +   L LS NQ+S  +S  +G L N
Sbjct: 227 SLSNLK-----NLSGLELSNNKLEDLPESIGNLSNLE-TLDLSNNQIS-SISS-LGSLTN 278

Query: 588 FSMVHLGFNQFDGKLPSQFDQ--LPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNF 645
              + L  N     LP       L  ++LNL     + E+              L+ N  
Sbjct: 279 LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSIL--------LNNNIL 330

Query: 646 SGPFPASFNNLTELSKLN 663
           S    +S   L+ L  LN
Sbjct: 331 SNGETSSPEALSILESLN 348

Length = 394

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 27/156 (17%)

Query: 813 IGKGGFGTVYRGVL---PDGREVAVKKLQ-REGLEGEREFRAEME---VLSGNGFGWPHP 865
           IG G FG V    +        V VK+L+     + + EF  + +   +L        HP
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-------HP 55

Query: 866 NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRR-------LDIAIDVARAL 918
           N++   G C++    +LV+EY E G L+  +S      W RR         +A ++A  +
Sbjct: 56  NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGV 112

Query: 919 VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
             +H   +   +H D+   N  L  +    V D+G+
Sbjct: 113 THMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 8e-04
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 23/158 (14%)

Query: 807 FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
           F + + +G G FG V      D     A+K L+++ +    +    +AE ++L+     W
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLE------DIISDRTRLTWRRRLDIAIDVAR 916
               +V LY    D      V +Y+ GG +       ++  +     +   L +AI+   
Sbjct: 63  ----VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 917 ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            + F         +HRD+K  N+L+D +G   +TDFGL
Sbjct: 119 KMGF---------IHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 41.4 bits (98), Expect = 8e-04
 Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 56/188 (29%)

Query: 794 AFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG------------ 841
                 ++++ G       IG G    VY  + PDG  VA+K   R G            
Sbjct: 9   TLVKRGVVESLG-----NQIGVGKESDVYLALDPDGNPVALK-FHRLGRTSFRKVKRKRD 62

Query: 842 ---------------LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
                          L  ++EF A ++ L   GF  P P         +D +   +V EY
Sbjct: 63  YLGDRKHASWLYLSRLAAQKEFAA-LKALYEEGFPVPKP---------IDWNRHAVVMEY 112

Query: 887 MEGGSLEDI--ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE 944
           ++G  L  +  + D   +     LD  ++               I+H D+   N+L+D +
Sbjct: 113 IDGVELYRVRVLEDPEEV-----LDEILEEIVKAYKHG------IIHGDLSEFNILVDDD 161

Query: 945 GKALVTDF 952
            K  + D+
Sbjct: 162 EKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 42.5 bits (100), Expect = 0.001
 Identities = 22/67 (32%), Positives = 37/67 (55%)

Query: 246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFL 305
           L+  +LS N   G+ P  + +  +L VL+L  N+F+G IP  +G ++ L  L L  N+  
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 306 SVIPESL 312
             +P +L
Sbjct: 504 GRVPAAL 510

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 366 NISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
           N+  LDLS+N  T  +P      + +LK L L+ N      P  +  +P+L++LDLS N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 425 L 425
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 0.001
 Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 914  VARALV----FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-DSHVSTT 968
            VAR L+    ++H E    I+HRD+K  NVL++      + DFG A        +     
Sbjct: 265  VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 969  IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELA 1003
            IAGTV   APE       T   D++S G++  E A
Sbjct: 322  IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (97), Expect = 0.001
 Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 8/81 (9%)

Query: 876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVK 935
           D    I+V EY+EG  L+D+I+          L+++ ++ R +  LH      I+H D+ 
Sbjct: 70  DPENFIIVMEYIEGEPLKDLINSNG----MEELELSREIGRLVGKLHSA---GIIHGDLT 122

Query: 936 ASNVLLDKEGKALVTDFGLAR 956
            SN++L   GK  + DFGLA 
Sbjct: 123 TSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 15/35 (42%), Positives = 21/35 (60%), Gaps = 1/35 (2%)

Query: 809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE 843
           ++  I       V+R VL DG EVAV K+QR G++
Sbjct: 15  DEEPIAAASIAQVHRAVLKDGEEVAV-KVQRPGVK 48

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 25/159 (15%)

Query: 807 FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
           F + + +G G FG V      D + + A+K L+++ +    +    +AE ++L+     W
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SDRTRLTWRRRLDIAIDVA 915
               +V LY    D      V +Y+ GG +  ++        D  R  +   L  A++  
Sbjct: 63  ----VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF-YIAELTCAVESV 117

Query: 916 RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
             + F         +HRD+K  N+L+D++G   +TDFGL
Sbjct: 118 HKMGF---------IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.004
 Identities = 23/82 (28%), Positives = 31/82 (37%), Gaps = 22/82 (26%)

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
           NL+ LDLS+N                         V+    FK   +L++ DLS N    
Sbjct: 1   NLKSLDLSNNRLT----------------------VIPDGAFKGLPNLKVLDLSGNNLTS 38

Query: 259 DFPGEVSNCRNLVVLNLFGNNF 280
             P   S   +L  L+L GNN 
Sbjct: 39  ISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|205486 pfam13306, LRR_5, Leucine rich repeats (6 copies)

 Score = 38.3 bits (90), Expect = 0.004
 Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 18/128 (14%)

Query: 148 LRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSS 207
           L S+ I   SV  I GE +FS    C  L    L  ++LT      F  C +L  + + S
Sbjct: 13  LTSITIPS-SVTSI-GEYAFSG---CTSLKSITLP-SSLTSIGSYAFYNCSSLTSITIPS 66

Query: 208 N--NFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN-EFIGD--FPG 262
           +  +     ++  + L   ++  N+ +  + S  F  NCSL+   +  +   IGD  F  
Sbjct: 67  SLTSIGEYAFSNCSSLTSITIPSNLTT--IGSYAF-SNCSLKSITIPSSVTTIGDYAF-- 121

Query: 263 EVSNCRNL 270
             SNC +L
Sbjct: 122 --SNCSSL 127

This family includes a number of leucine rich repeats. This family contains a large number of BSPA-like surface antigens from Trichomonas vaginalis. Length = 128

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1088
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
PRK10345	210	hypothetical protein; Provisional	99.72
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.71
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.7
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.69
smart00090	237	RIO RIO-like kinase.	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.61
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.6
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.5
PLN03150	623	hypothetical protein; Provisional	99.49
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.49
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.47
PLN03150	623	hypothetical protein; Provisional	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.35
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.08
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.96
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.9
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.9
KOG3087	229	consensus Serine/threonine protein kinase [General	98.87
COG4248	637	Uncharacterized protein with protein kinase and he	98.86
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.75
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.69
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.67
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.64
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.59
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.57
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.54
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.51
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.51
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.5
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.4
PRK09902	216	hypothetical protein; Provisional	98.39
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.33

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-111  Score=1092.50  Aligned_cols=919  Identities=31%  Similarity=0.490  Sum_probs=710.4

Q ss_pred             CchhhHHHHHHHHhhcccCCCCCcccccccCCCCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeC
Q 001384           31 SLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDL  110 (1088)
Q Consensus        31 ~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~L  110 (1088)
                      ..+.|++||++||+.+.+    +.+.+.+|+...+||.|.||+|+. .++|+.|+|++++++|.+++.+..+++|++|+|
T Consensus        26 ~~~~~~~~l~~~~~~~~~----~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L  100 (968)
T PLN00113         26 LHAEELELLLSFKSSIND----PLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINL  100 (968)
T ss_pred             CCHHHHHHHHHHHHhCCC----CcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence            356899999999999853    345688999888999999999985 569999999999999999999999999999999


Q ss_pred             CCCCCCCCcCccCC-CCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCC
Q 001384          111 SRNTFSGSIPDDLS-SCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR  189 (1088)
Q Consensus       111 s~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~  189 (1088)
                      ++|+++|.+|..+. .+++|++|+|++|.+++..+...+++|++|+|++|.+++.+|..+. .+++|++|+|++|.+.+.
T Consensus       101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~  179 (968)
T PLN00113        101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGK  179 (968)
T ss_pred             CCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHh-cCCCCCEEECccCccccc
Confidence            99999999998765 9999999999999999888888899999999999999988887764 468999999999999999


Q ss_pred             CCccccCCCCCcEEEccCccccccccc---cCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccC
Q 001384          190 IDTCFDGCLNLRYLDLSSNNFRGNIWN---GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSN  266 (1088)
Q Consensus       190 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~  266 (1088)
                      +|..+.++++|++|+|++|++.+.++.   .+.+|+.|++++|.+++.++. .+..+++|++|+|++|++++.+|..+++
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~  258 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY-EIGGLTSLNHLDLVYNNLTGPIPSSLGN  258 (968)
T ss_pred             CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCCh-hHhcCCCCCEEECcCceeccccChhHhC
Confidence            999999999999999999999876653   456777777777777765443 4567777777777777777777777777


Q ss_pred             CCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceee
Q 001384          267 CRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILA  346 (1088)
Q Consensus       267 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  346 (1088)
                      +++|++|+|++|++.+.+|..+..+++|+.|+|++|.+.+.+|..+.++++|+.|++++|.+.+..|..++.+++|+.|+
T Consensus       259 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  338 (968)
T PLN00113        259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQ  338 (968)
T ss_pred             CCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEE
Confidence            77777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             cCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCC
Q 001384          347 LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT  426 (1088)
Q Consensus       347 L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  426 (1088)
                      +++|.+.. ..+..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..++.+++|+.|++++|+++
T Consensus       339 L~~n~l~~-~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~  417 (968)
T PLN00113        339 LWSNKFSG-EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS  417 (968)
T ss_pred             CcCCCCcC-cCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence            77776533 33445666777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCC
Q 001384          427 GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGS  506 (1088)
Q Consensus       427 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~  506 (1088)
                      +.+|..+.++++|+.|++++|++++.+|..+..+++|++|+|++|++.|.+|..+.                        
T Consensus       418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~------------------------  473 (968)
T PLN00113        418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG------------------------  473 (968)
T ss_pred             eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc------------------------
Confidence            77777777777777777777777777777777777777777777777766654220                        


Q ss_pred             ccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCC
Q 001384          507 SECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQ  586 (1088)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~  586 (1088)
                                                                            ...++.|++++|+++|.+|..+++++
T Consensus       474 ------------------------------------------------------~~~L~~L~ls~n~l~~~~~~~~~~l~  499 (968)
T PLN00113        474 ------------------------------------------------------SKRLENLDLSRNQFSGAVPRKLGSLS  499 (968)
T ss_pred             ------------------------------------------------------cccceEEECcCCccCCccChhhhhhh
Confidence                                                                  01346799999999999999999999


Q ss_pred             CccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeecc
Q 001384          587 NFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNIS  665 (1088)
Q Consensus       587 ~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  665 (1088)
                      +|+.|+|++|+++|.+|+.++.+ .|++|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+.++++|+.|+++
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  579 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS  579 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence            99999999999999999999988 69999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCCCcccccccCccCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCcchhHHHHHHHHHHHHHHHHHHHHH
Q 001384          666 YNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTIILAFLALLMACLICGVLSII  745 (1088)
Q Consensus       666 ~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~~P~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (1088)
                      +|++ .|.+|+.+++.++...+|.||+.+|.++.  ....++|...     ........++++++   ++++++++++++
T Consensus       580 ~N~l-~~~~p~~~~~~~~~~~~~~~n~~lc~~~~--~~~~~~c~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~  648 (968)
T PLN00113        580 HNHL-HGSLPSTGAFLAINASAVAGNIDLCGGDT--TSGLPPCKRV-----RKTPSWWFYITCTL---GAFLVLALVAFG  648 (968)
T ss_pred             CCcc-eeeCCCcchhcccChhhhcCCccccCCcc--ccCCCCCccc-----cccceeeeehhHHH---HHHHHHHHHHHH
Confidence            9999 89999999999999999999999994332  1123344321     01111111111111   111112222222


Q ss_pred             HHHHhcCcccccccccccccccccccCCCCCCCCCCCCceeEEeccCCccCHHHHHHHcCCCCccceecccCceEEEEEE
Q 001384          746 IYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV  825 (1088)
Q Consensus       746 ~~~~~kr~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~  825 (1088)
                      ++.+++|+..+.+.. +         ...+   .|....  ........+++.++.   ..|...++||+|+||.||+|+
T Consensus       649 ~~~~~~~~~~~~~~~-~---------~~~~---~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~  710 (968)
T PLN00113        649 FVFIRGRNNLELKRV-E---------NEDG---TWELQF--FDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGK  710 (968)
T ss_pred             HHHHHhhhccccccc-c---------cccc---cccccc--cccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEE
Confidence            222222221111100 0         0000   011000  000111234444443   457778899999999999999


Q ss_pred             eC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCH
Q 001384          826 LP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTW  904 (1088)
Q Consensus       826 ~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~  904 (1088)
                      +. +++.||||++.......    ..|++.+++    ++|||||++++++.+++..++||||+++|+|.++++.   ++|
T Consensus       711 ~~~~~~~vavK~~~~~~~~~----~~~~~~l~~----l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~  779 (968)
T PLN00113        711 SIKNGMQFVVKEINDVNSIP----SSEIADMGK----LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSW  779 (968)
T ss_pred             ECCCCcEEEEEEccCCcccc----HHHHHHHhh----CCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCH
Confidence            74 78999999987543221    345677765    6899999999999999999999999999999999964   899


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCC
Q 001384          905 RRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW  984 (1088)
Q Consensus       905 ~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  984 (1088)
                      .++.+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.+.....     .....++..|+|||++.+.
T Consensus       780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~  853 (968)
T PLN00113        780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETK  853 (968)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCC
Confidence            9999999999999999997666699999999999999999988875 665543321     1223678999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCcCCCCC---chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhh
Q 001384          985 QATTKGDVYSFGVLAMELATGRRALEGG---EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVR 1061 (1088)
Q Consensus       985 ~~~~~~DvwslG~~l~elltg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1061 (1088)
                      .++.++|||||||++|||+||+.||...   .....+|.+......   .....+++..... .....+...++.+++.+
T Consensus       854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~  929 (968)
T PLN00113        854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC---HLDMWIDPSIRGD-VSVNQNEIVEVMNLALH  929 (968)
T ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---chhheeCccccCC-CCccHHHHHHHHHHHHh
Confidence            9999999999999999999999999643   235667766543211   1222233332221 12345667789999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1062 CTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1062 cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      |++.||++||+|+||+++|+++.+
T Consensus       930 Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        930 CTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hCcCCchhCcCHHHHHHHHHHhhc
Confidence            999999999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-57  Score=591.73  Aligned_cols=508  Identities=34%  Similarity=0.513  Sum_probs=436.2

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCccc---CCCCCCCceeecccccccccccCchhhhcccceEE
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA  179 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~---l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L  179 (1088)
                      .+++.|||++|.++|.+|..+..+++|++|+|++|.+++..+   +.++++|++|+|++|.+++.+|..   .+++|++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L  145 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL  145 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence            478999999999999999999999999999999999986443   458999999999999999888863   35789999


Q ss_pred             eccCccCCCCCCccccCCCCCcEEEccCccccccccc---cCcccceecccCcccccccccccccCCCccCEEEcCCCcc
Q 001384          180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN---GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF  256 (1088)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  256 (1088)
                      +|++|.+++.+|..++++++|++|+|++|.+.+.++.   .+++|+.|++++|.+++.++ ..+..+++|++|+|++|++
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l  224 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP-RELGQMKSLKWIYLGYNNL  224 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCC-hHHcCcCCccEEECcCCcc
Confidence            9999999999999999999999999999999876554   56788888888888877654 4567788888888888888


Q ss_pred             cccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhh
Q 001384          257 IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIF  336 (1088)
Q Consensus       257 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  336 (1088)
                      ++.+|..++++++|++|++++|++.+.+|..++++++|+.|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..+
T Consensus       225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~  304 (968)
T PLN00113        225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV  304 (968)
T ss_pred             CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             hcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCc
Q 001384          337 GRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ  416 (1088)
Q Consensus       337 ~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  416 (1088)
                      ..+++|+.|++++|.+.. ..+..+..+++|+.|+|++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+
T Consensus       305 ~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~  383 (968)
T PLN00113        305 IQLQNLEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF  383 (968)
T ss_pred             cCCCCCcEEECCCCccCC-cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence            888888888888887544 3345667788888888888888888888888888888888888888888888888888888


Q ss_pred             EEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccc
Q 001384          417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQ  496 (1088)
Q Consensus       417 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~  496 (1088)
                      .|++++|++.+.+|..++++++|+.|++++|++++.+|..+.++++|+.|++++|+++|.+|..+..+            
T Consensus       384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------------  451 (968)
T PLN00113        384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM------------  451 (968)
T ss_pred             EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccC------------
Confidence            88888888888888888888888888888888888888888888888888888888887666543211            


Q ss_pred             cCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCcccc
Q 001384          497 RNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG  576 (1088)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g  576 (1088)
                                                                                       ..+++|+|++|++.|
T Consensus       452 -----------------------------------------------------------------~~L~~L~L~~n~~~~  466 (968)
T PLN00113        452 -----------------------------------------------------------------PSLQMLSLARNKFFG  466 (968)
T ss_pred             -----------------------------------------------------------------CCCcEEECcCceeee
Confidence                                                                             234679999999999


Q ss_pred             ccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCccccc
Q 001384          577 ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNN  655 (1088)
Q Consensus       577 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  655 (1088)
                      .+|..++ ..+|+.|++++|+++|.+|..+..+ .|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..++.
T Consensus       467 ~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  545 (968)
T PLN00113        467 GLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE  545 (968)
T ss_pred             ecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence            9998764 5899999999999999999999988 6999999999999999999999999999999999999999999999


Q ss_pred             ccccceeeccCCCCccccCCCC-CcccccccCccCCCCCC
Q 001384          656 LTELSKLNISYNPLVSGTIPST-GQLATFEKTSYLGDPLL  694 (1088)
Q Consensus       656 l~~L~~l~l~~N~l~~g~ip~~-~~~~~~~~~~~~~n~~~  694 (1088)
                      +++|+.|+|++|++ +|.+|.. ..+..+....+.+|+..
T Consensus       546 l~~L~~L~Ls~N~l-~~~~p~~l~~l~~L~~l~ls~N~l~  584 (968)
T PLN00113        546 MPVLSQLDLSQNQL-SGEIPKNLGNVESLVQVNISHNHLH  584 (968)
T ss_pred             cccCCEEECCCCcc-cccCChhHhcCcccCEEeccCCcce
Confidence            99999999999999 8899865 45566666777788765

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=421.76  Aligned_cols=286  Identities=48%  Similarity=0.836  Sum_probs=244.7

Q ss_pred             cCCccCHHHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEE
Q 001384          791 DKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL  870 (1088)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l  870 (1088)
                      ....|++.++.++|++|...++||+|+||.||+|...+|+.||||++........++|..|++++.+    ++|||+|++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~----l~H~Nlv~L  136 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSR----LRHPNLVKL  136 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhc----CCCcCcccE
Confidence            4566999999999999999999999999999999999899999998876533215669999999997    679999999


Q ss_pred             eeEEecCC-eEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          871 YGWCLDGS-EKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       871 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      +|||.+.+ +.++|||||++|+|.++++...  .++|.++.+||.++|+||+|||+.+.++||||||||+|||+|+++.+
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            99999998 5999999999999999998765  89999999999999999999999998899999999999999999999


Q ss_pred             EEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC----chhHHHHHHhh
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG----EECLVEWGRRV 1023 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~----~~~~~~~~~~~ 1023 (1088)
                      ||+|||+|+..............||.+|+|||+...+..+.|+|||||||++.|++||+.+.+..    .....+|+...
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            99999999654331111111117999999999999999999999999999999999999988753    23588998766


Q ss_pred             hccCCCCCCccccchhhcCCCcccc-HHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEG-AEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....   ...+++|+.+....  .+ .+...++.+++.+|++.+|.+||+|.||+++|+.+.+
T Consensus       297 ~~~~---~~~eiiD~~l~~~~--~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  297 LEEG---KLREIVDPRLKEGE--YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHCc---chhheeCCCccCCC--CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            5333   66777777765311  12 2678889999999999999999999999999987654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=385.25  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=217.6

Q ss_pred             CccCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEcccc-CccchHHHHHHHHHHhCCCCCCCCCceeEE
Q 001384          793 TAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPHPNLVTL  870 (1088)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~~l~h~niv~l  870 (1088)
                      ..++.+|+.       ..+.||+|..|+|||++++ +++.+|+|++... ..+.++++.+|++++..    .+||+||.+
T Consensus        74 ~~i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~----~~spyIV~~  142 (364)
T KOG0581|consen   74 NGISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRS----CQSPYIVGF  142 (364)
T ss_pred             cccCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhh----CCCCCeeeE
Confidence            345666654       4578999999999999987 6888999999543 34456789999999997    579999999


Q ss_pred             eeEEecCC-eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          871 YGWCLDGS-EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       871 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      ||+|..+. ...++||||++|+|+++++..+++++....+|+.+|++||.|||+..  +||||||||+||||++.|.|||
T Consensus       143 ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKi  220 (364)
T KOG0581|consen  143 YGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKI  220 (364)
T ss_pred             eEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEe
Confidence            99999998 59999999999999999999899999999999999999999999742  9999999999999999999999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      +|||.+..+...   ...+++||..|||||.+.+..|+.++||||||+.++||.+|+.||....+....|          
T Consensus       221 cDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~----------  287 (364)
T KOG0581|consen  221 CDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI----------  287 (364)
T ss_pred             ccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH----------
Confidence            999999877533   6678899999999999999999999999999999999999999998752222222          


Q ss_pred             CCCccccchhhcCCCccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .+.+..++.+.....|.. +..++..++..|+++||.+||+++++++
T Consensus       288 ---~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  288 ---FELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               233333444333334444 6788999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=393.35  Aligned_cols=253  Identities=36%  Similarity=0.567  Sum_probs=211.7

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEccccCccc--hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-eEEEEEE
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-EKILVYE  885 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-~~~lv~e  885 (1088)
                      ..+.||+|+||+||+|.++....||||++.......  .++|.+|+.++.+    ++|||||+++|+|.+.. ..++|||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~----l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSR----LRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHh----CCCCCeeeEEEEEcCCCCceEEEEE
Confidence            345699999999999999744449999998754333  4589999999997    78999999999999887 7999999


Q ss_pred             ecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCEEEcCCC-CEEEeecccceeecCC
Q 001384          886 YMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPP-IVHRDVKASNVLLDKEG-KALVTDFGLARVVSAG  961 (1088)
Q Consensus       886 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~~~~  961 (1088)
                      |+++|+|.++++.  ...+++..+..+|.|||+||+|||++   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999988  57899999999999999999999999   7 99999999999999997 9999999999876532


Q ss_pred             CCcccccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ--TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      . ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+............                
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~----------------  260 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV----------------  260 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----------------
Confidence            2 2333478999999999999  56999999999999999999999999998765222221111                


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       .+.+...+..+...+..++.+||+.||.+||++.||+..|+.+..+
T Consensus       261 -~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  261 -GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             -cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence             1111222334667889999999999999999999999999988653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=375.11  Aligned_cols=202  Identities=33%  Similarity=0.528  Sum_probs=183.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|.+.+.||+|+||+||+|+++ ++.+||||.+.+...  +..+-...|+.+++.    ++|||||++++++..++..
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLke----l~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKE----LKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHh----cCCcceeeEEEEEecCCeE
Confidence            467888899999999999999976 689999999988743  334567899999997    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC------CCEEEeeccc
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE------GKALVTDFGL  954 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~------~~~kl~Dfg~  954 (1088)
                      |+|||||.||+|.+|+++++++++..++.++.|+|.||++||++   +||||||||+|||++..      -.+||+|||+
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999999999999999999999999999999999999   99999999999999865      4689999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      |+...  ......+.+|++.|||||+++..+|+.|+|+||+|+++|+|++|+.||.....
T Consensus       162 AR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  162 ARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            99886  34456678999999999999999999999999999999999999999986543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-43  Score=390.37  Aligned_cols=247  Identities=26%  Similarity=0.399  Sum_probs=215.3

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .+|...+.||+|||+.||.+++ .+|+.||+|++.+..   ....+.+.+|+++.+.    ++|||||+++++|++.+.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~----L~HpnIV~f~~~FEDs~nV   93 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRS----LKHPNIVQFYHFFEDSNNV   93 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHh----cCCCcEEeeeeEeecCCce
Confidence            5799999999999999999998 689999999998743   3345678999999997    7899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+|.|+|+.++|..++++++++++.+++.+.+||+.||.|||+.   +|+|||||..|++++++.++||+|||+|..+..
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999998864


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      . .....+.+||+.|.|||++....++..+||||+|||+|-|+.|++||+...  +.+.+.++..-..      .     
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--vkety~~Ik~~~Y------~-----  236 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--VKETYNKIKLNEY------S-----  236 (592)
T ss_pred             c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--HHHHHHHHHhcCc------c-----
Confidence            3 234567899999999999999999999999999999999999999998742  3333333321111      1     


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .|.....+..++|.++|+++|.+||++++|+.
T Consensus       237 ------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 ------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  13344567788999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=389.24  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=223.2

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +...+.||+|.||+||.|.++....||+|.++... ...++|.+|+++|++    ++|++||+++++|..++..||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~----L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKK----LRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHh----CcccCeEEEEEEEecCCceEEEEEe
Confidence            34568899999999999999877799999998763 345688899999997    7899999999999999999999999


Q ss_pred             cCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          887 MEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       887 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      |+.|+|.++++.  ...+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+........
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            999999999987  45699999999999999999999999   9999999999999999999999999999966555554


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      ......-+..|+|||.+....++.|+|||||||+||||+| |+.||.+...                  .+++...-.|.
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~ev~~~le~Gy  421 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------EEVLELLERGY  421 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------HHHHHHHhccC
Confidence            5555667889999999999999999999999999999999 7778776432                  33444455566


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      +.+.|..++..+++++..||+.+|++|||++.+...++++...
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            7777889999999999999999999999999999999988754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=372.89  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=207.5

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-------chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ..+.|.+.+.+|+|+||.|-+|..+ +|+.||||++.+....       ....+.+|+++|++    ++|||||++++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkk----L~HP~IV~~~d~f  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKK----LSHPNIVRIKDFF  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHh----cCCCCEEEEeeee
Confidence            3456888999999999999999965 7999999999864322       23457899999997    7899999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CCEEEee
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE---GKALVTD  951 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~---~~~kl~D  951 (1088)
                      ..++..||||||++||.|.+.+-.++.+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999999999999999999999999999999999999   99999999999999866   7899999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCcCCCCCchhH---HHHHHhhhc
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEGGEECL---VEWGRRVMG 1025 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~---~~~~~~~~~ 1025 (1088)
                      ||+|+...  +.....+.+||+.|.|||++.+..   +..++|+||+||++|-+++|.+||.+.....   .+..+..+ 
T Consensus       323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y-  399 (475)
T KOG0615|consen  323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY-  399 (475)
T ss_pred             cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc-
Confidence            99999875  334567789999999999877653   3348899999999999999999998653311   11111111 


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ..               ......+...+..++|.+|+..||++||+++|+++
T Consensus       400 -~f---------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  400 -AF---------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cc---------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             00               01123455678889999999999999999999975

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-43  Score=366.10  Aligned_cols=242  Identities=27%  Similarity=0.352  Sum_probs=207.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++.....   .+..++|..++.+    ++||.||+++..|++.+.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~----v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSK----IKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHh----CCCCcEeeeEEecccCCe
Confidence            356899999999999999999976 68899999999875443   3568899999987    689999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+|+||+.||.|...+++.+.+++..++.++.+|+.||.|||++   +||||||||+|||+|.+|+++|+|||+++..-
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      . +...+.+++||+.|||||++....|+..+|+||+|+++|||++|.+||.+.+.  ..+...+....            
T Consensus       177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--~~~~~~I~~~k------------  241 (357)
T KOG0598|consen  177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--KKMYDKILKGK------------  241 (357)
T ss_pred             c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--HHHHHHHhcCc------------
Confidence            3 23345568999999999999999999999999999999999999999997543  33444443111            


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP 1071 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1071 (1088)
                          ....+.-...+..+++.+.++.||++|.
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                1111222446778888899999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-42  Score=398.96  Aligned_cols=256  Identities=29%  Similarity=0.468  Sum_probs=219.9

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +.+..+.||+|+||+||+|+..      +...||||.+++.+.. .+.+|++|++++..    ++|||||+++|+|.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~----l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAE----LQHPNIVRLLGVCREGD  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHh----ccCCCeEEEEEEEccCC
Confidence            3455688999999999999943      3457999999988666 67899999999997    78999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          879 EKILVYEYMEGGSLEDIISDRT--------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ..++|+|||..|+|.+++..+.              +++..+.+.||.|||.||+||.++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            9999999999999999996432              278899999999999999999999   89999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccc-cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHh
Q 001384          945 GKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRR 1022 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1088)
                      ..|||+|||+++.....+.+... ...-+.+|||||.+..++|+.++|||||||+|||+++ |+-||.+...        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            99999999999987766665543 4456789999999999999999999999999999998 8889887533        


Q ss_pred             hhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                                .++++-+..+...+.|+.++.++++|+.+||+..|.+||+++||-..|++..+.
T Consensus       712 ----------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  712 ----------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ----------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                      222222333344556888999999999999999999999999999999987654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-43  Score=349.42  Aligned_cols=253  Identities=25%  Similarity=0.432  Sum_probs=207.5

Q ss_pred             CCCccceecccCceEEEEEEe-CCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeE-EecCC-eE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGW-CLDGS-EK  880 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~-~~~~~-~~  880 (1088)
                      +|++.++||+|+||+||++.. .+|..||.|.++-...  ...++...|+.++++    ++|||||+++++ +.++. ..
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQ----L~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQ----LNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHh----cCCchHHHHHHHhhhccchhh
Confidence            477889999999999999995 4899999999985433  334578899999997    789999999994 33444 48


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      ++|||||++|+|...++.    ++.++++.+|+++.|++.||.++|.+. +.  |+||||||.||+++.+|.+|++|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchh
Confidence            999999999999998864    456999999999999999999999953 24  99999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ++.+... .......+|||.||+||.+...+|++|+||||+||++|||+.-+.||.+.  +..+.-..+..         
T Consensus       175 ~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~q---------  242 (375)
T KOG0591|consen  175 GRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQ---------  242 (375)
T ss_pred             HhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHc---------
Confidence            9988643 33456789999999999999999999999999999999999999999986  33333333321         


Q ss_pred             ccchhhcCCCcccc-HHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1035 VIPVVLLGSGLAEG-AEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                             +...+.| .....++..+|..|+..||+.||+...++..+..
T Consensus       243 -------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 -------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                   1111223 5567789999999999999999986555554443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=369.49  Aligned_cols=252  Identities=27%  Similarity=0.407  Sum_probs=214.1

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +...+|..++.||+|+|++||+|+.+ +++++|||++.+.....+   +.+..|-.+|.++.   .||.|+++|..|.++
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~---~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS---GHPGIVKLYFTFQDE  146 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh---CCCCeEEEEEEeecc
Confidence            33467888999999999999999965 689999999987654333   45677888887743   799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ...|+|+||+++|+|.++|++.+.+++..++.++.||+.|++|||++   |||||||||+|||+|+|++++|+|||.|+.
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999999999999999999999999999999999   999999999999999999999999999998


Q ss_pred             ecCCCCc----------c--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhc
Q 001384          958 VSAGDSH----------V--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       958 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      +.+....          .  ...++||..|.+||++.....++.+|+|+|||++|+|+.|++||.+.++...-.......
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            7642211          1  145899999999999999999999999999999999999999999988754432222221


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      |..                   ++..+..+.+||.+.+..||.+|++.++|.+
T Consensus       304 y~f-------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  304 YEF-------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ccC-------------------CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            211                   2333467788889999999999999988764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=334.31  Aligned_cols=236  Identities=28%  Similarity=0.363  Sum_probs=205.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|+..+.||.|+||.|.+++.+ +|..+|+|++.+.....   .+...+|..+++.    +.||+++++++.+.+.+..|
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~----v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKA----VSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhh----ccCceeEEEEEeeccCCeEE
Confidence            5788899999999999999976 68899999998865433   3467789999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||++||.|..++++.+++++..++.+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+.+.. 
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            9999999999999999999999999999999999999999999   999999999999999999999999999998753 


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                         .+-+.+||+.|+|||++....|..++|+|||||++|||+.|.+||.+..+  .+.+..+..                
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~----------------  255 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILE----------------  255 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHh----------------
Confidence               25567999999999999999999999999999999999999999998665  333333321                


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARP 1071 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1071 (1088)
                       .....|.....++.+++...++.|-.+|.
T Consensus       256 -~~v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  256 -GKVKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             -CcccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence             11122444556788889999999999993

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.8e-41  Score=338.87  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=204.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|+...++|+|+||+|||++.+ +|+.||||++.....  .-++-..+|++++++    ++|+|+|.++++|......+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKq----LkH~NLVnLiEVFrrkrklh   77 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQ----LKHENLVNLIEVFRRKRKLH   77 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHh----cccchHHHHHHHHHhcceeE
Confidence            46888899999999999999987 699999999986532  234557899999997    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +|+|||+. ++.+-+++ ...++.+.+.++.+|++.|+.|+|++   ++|||||||+||+|+.+|.+|+||||+|+.+..
T Consensus        78 LVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            99999988 55444444 45689999999999999999999999   999999999999999999999999999998874


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH-hhh---------ccCCC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR-RVM---------GYGRH 1029 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~~~---------~~~~~ 1029 (1088)
                       .....+.++.|.+|+|||.+-+ .+|+..+||||+||++.||++|.+.|.+..+-..-+.- ...         -+...
T Consensus       154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             2334566788999999997655 89999999999999999999999999987552221111 111         00111


Q ss_pred             CCCcccc-c-hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRAVI-P-VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~~~-~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....+. + +.-........+.....++++++.|++.||++|++-++++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111000 0 00000111112334457889999999999999999998863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=357.06  Aligned_cols=266  Identities=25%  Similarity=0.311  Sum_probs=210.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch-HHHHHHHHHHhCCCCCCC-CCceeEEeeEEecCC-e
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP-HPNLVTLYGWCLDGS-E  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~~~~~l~-h~niv~l~~~~~~~~-~  879 (1088)
                      .++|.+.+.||.|.||.||+|+.+ +|..||||++++....-+ -.-.+|++.+++    +. ||||+++.+++.+.+ .
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~k----ln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRK----LNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHh----cCCCCcchhhHHHhhccCce
Confidence            457899999999999999999965 689999999987643322 234579999987    55 999999999999888 9


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .|+|||||+. +|++++++++ .+++.+++.|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+.+
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999999976 9999998764 599999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccCccc-cCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh-hccCCCCCCcc--
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV-MGYGRHGPGRA-- 1034 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~-- 1034 (1088)
                      ..  ..+.+.++.|.+|+|||+ ++.+.|+.+.||||+|||++|+.+-++.|.+..+...-|.-.. ++-.......+  
T Consensus       161 ~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  161 RS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            53  334567889999999995 6678999999999999999999999999998866333332221 11111000000  


Q ss_pred             --------ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1035 --------VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1035 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                              .++...........+.+..+.++++.+|+..||.+||||+++++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                    000000000011123366789999999999999999999999863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=349.96  Aligned_cols=252  Identities=29%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--eEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--EKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--~~~  881 (1088)
                      .+|...+.||+|+||.||++... +|+.+|||.+........+.+.+|+.++.+    ++|||||+++|......  .++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~----l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSR----LNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHh----CCCCCEEeeCCccccccCeeeE
Confidence            45777899999999999999976 489999999987643335668999999997    67999999999754444  689


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~~  959 (1088)
                      +.|||+++|+|.+++.+.+ ++++..+++++.||++||+|||++   +||||||||+|||++. ++.+||+|||.++...
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999999877 799999999999999999999999   9999999999999999 7999999999998766


Q ss_pred             C--CCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          960 A--GDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       960 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .  ..........||+.|||||++..+ ....++||||+||++.||+||+.||... ....++...+....       ..
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-------~~  241 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-------SL  241 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-------CC
Confidence            3  112234457899999999999853 3345999999999999999999999863 11122222221000       01


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      +        ..+...+.+..+++.+|+..||++||||+++++.
T Consensus       242 P--------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  242 P--------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             C--------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            1        1233455678889999999999999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=361.36  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=209.5

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC----c-cchHHHHHHHHHHhCCCCCCC-CCceeEEeeEE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG----L-EGEREFRAEMEVLSGNGFGWP-HPNLVTLYGWC  874 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~-~~~~~~~~E~~~l~~~~~~l~-h~niv~l~~~~  874 (1088)
                      ...++|.+.+.||+|+||+|+.|.+. +++.||+|++.+..    . ...+.+.+|+.++++    ++ ||||+++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~----~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRR----LRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHH----hccCCCEeEEEEEE
Confidence            34578999999999999999999865 68999999776642    2 234567789999987    55 99999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeecc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFG  953 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Dfg  953 (1088)
                      ......|+||||+.||+|.+++.+.+++.+.++++++.|++.|++|+|++   +|+||||||+||+++.+ +.+||+|||
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999999999989999999999999999999999999   99999999999999999 999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCC-CC-cchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ-AT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+........  .+.      .
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--ki~------~  237 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--KIR------K  237 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH--HHh------c
Confidence            998764 3344567789999999999999877 75 78999999999999999999999854322211  111      0


Q ss_pred             CccccchhhcCCCccccHHH-HHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEE-MSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      ..-.+           +... ..++..++.+|+..||.+|+++.||+
T Consensus       238 ~~~~~-----------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  238 GEFKI-----------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCccC-----------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111           1112 46788899999999999999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=369.39  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=222.0

Q ss_pred             CCccceecccCceEEEEEEeC-C---CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-D---GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ..+.++||.|.||.||+|+++ .   ...||||.++....+ .+.+|..|+.+|.+    +.||||+++.|+.......+
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ----FdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ----FDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc----CCCCcEEEEEEEEecCceeE
Confidence            456789999999999999976 2   346999999976544 45689999999997    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||+|||++|+|+.+++.+ +++++-++..+.++||.||.||.++   ++|||||.++||||+++-.+|++|||+++...+
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999999765 4799999999999999999999999   999999999999999999999999999998755


Q ss_pred             CCCcccc--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          961 GDSHVST--TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       961 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      +.....+  ...-+.+|.|||.+..+.++.++||||||++|||.++ |.+||=+..                  ..+++.
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS------------------NQdVIk  845 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------------------NQDVIK  845 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc------------------hHHHHH
Confidence            4322222  2334579999999999999999999999999999776 888875432                  234444


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCCC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD 1088 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 1088 (1088)
                      .+-.+.+++.|.+++..+.+|+..||++|-.+||.+.+|+.+|.+++.+.+
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            555566777889999999999999999999999999999999999998753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-39  Score=354.03  Aligned_cols=246  Identities=28%  Similarity=0.441  Sum_probs=213.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc--hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.....  -+.+.+|+++++.    ++|||||.++++|+...+.+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~----lkHpniv~m~esfEt~~~~~   77 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRS----LKHPNIVEMLESFETSAHLW   77 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHh----cCCcchhhHHHhhcccceEE
Confidence            57888899999999999999976 67899999998764333  2568999999997    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +|+||+.| +|..++...+.++++.++.++.|++.||.|||+.   +|.|||+||+||+++..+.+|++|||+|+.+.. 
T Consensus        78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            99999987 9999999999999999999999999999999999   999999999999999999999999999998765 


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      .....+...||+.|||||.+.+.+|+..+|.||+||++|||++|++||...  .+.+..+.+...+.             
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--si~~Lv~~I~~d~v-------------  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--SITQLVKSILKDPV-------------  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--HHHHHHHHHhcCCC-------------
Confidence            344566788999999999999999999999999999999999999999863  23333333331111             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ..+......+.+++...+.+||.+|.+..+++.
T Consensus       218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                124456678899999999999999999988763

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-39  Score=350.86  Aligned_cols=266  Identities=24%  Similarity=0.310  Sum_probs=208.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--Ce
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~  879 (1088)
                      +.|+..++||+|.||.||+|++. +|+.||+|+++.+..  ..-....+|+.+|++    +.||||+++.+...+.  ..
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~----l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRR----LDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHh----cCCCcccceeeEEEecCCce
Confidence            45777899999999999999964 799999999987642  333567799999997    7899999999998876  68


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .|+|+|||+. +|.-++... -++++.++..+++|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+.+
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999999988 999988764 3799999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCc-cc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGR-AV 1035 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~-~~ 1035 (1088)
                      ........+..+-|.+|.|||.+. ...|+.++|+||.|||+.||++|++.|.+..+ .-.+-......-.....+. ..
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            877766677788999999999654 56899999999999999999999999998765 1112222222111111111 00


Q ss_pred             cchhhcCCCccc--------cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVVLLGSGLAE--------GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ++..-.......        ........++|+..+|..||.+|.||.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            010000000000        1112345778888999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=356.90  Aligned_cols=249  Identities=30%  Similarity=0.451  Sum_probs=213.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ..|.....||+|+.|.||.|... +++.||||++.......++-+.+|+.+|+.    .+|+|||++++.|..++..|+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~----~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRD----LHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHh----ccchHHHHHHHHhcccceeEEE
Confidence            45777789999999999999954 688999999998877777788999999996    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||||+||+|.|.+... .+++.+++.|.+++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999999998654 499999999999999999999999   999999999999999999999999999988765433


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                       .....+||+.|||||++....|++|+||||||+++.||+-|++||-...+.-..|.-..-     +.           .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-----g~-----------P  487 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-----GT-----------P  487 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-----CC-----------C
Confidence             456678999999999999999999999999999999999999999875442222222111     11           1


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....+......+.+|+.+||+.||++||++.|+++
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            12234556678889999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-39  Score=356.58  Aligned_cols=246  Identities=25%  Similarity=0.332  Sum_probs=208.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      +-|++++.||.|+.|.|-.|++. +|+.+|||++.+...   .....+.+|+-+|+.    +.|||++++|+++++..++
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkL----i~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKL----IEHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHH----hcCCCeeeeeeeeccCceE
Confidence            45788899999999999999975 799999999987632   223467889999886    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+|.||++||.|.+++-++++++++++++++.||+.|++|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-. 
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-  163 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-  163 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence            99999999999999999999999999999999999999999999   99999999999999999999999999998643 


Q ss_pred             CCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                       ......+.+|.+.|.|||++.+.+| +.++||||+|||+|.++||+.||++++-  .....+......           
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--r~LLlKV~~G~f-----------  229 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--RVLLLKVQRGVF-----------  229 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--HHHHHHHHcCcc-----------
Confidence             2334567899999999999999988 5789999999999999999999996543  222111110001           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .-|.....++.+|+.+|++.||++|.+++||.+
T Consensus       230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                  113344567888999999999999999999976

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.5e-39  Score=349.22  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=201.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|+...+||+|+||.||+|+-+ +|..+|+|++++.....   .+.++.|-.+|..    ..+|.||++|..|.+...
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~----~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE----VDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh----cCCCcEEEEEEEecCCCe
Confidence            467999999999999999999965 69999999999875433   3567889888876    479999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||++||++..+|.+.+.+++..++.++.+++.|++-+|+.   |+|||||||+|+|||..|++||+|||++..+.
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999985321


Q ss_pred             C----------------------CCCc----c--------------------cccccccccccCccccCCCCCCcchhHH
Q 001384          960 A----------------------GDSH----V--------------------STTIAGTVGYVAPEYGQTWQATTKGDVY  993 (1088)
Q Consensus       960 ~----------------------~~~~----~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  993 (1088)
                      .                      .+..    .                    ....+|||.|+|||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      0000    0                    0124699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC
Q 001384          994 SFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072 (1088)
Q Consensus       994 slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1072 (1088)
                      |+|||+|||+.|-+||.+.++  .+..+.++.+......    +         .......+..++|.+|+. ||++|..
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp--~~T~rkI~nwr~~l~f----P---------~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETP--QETYRKIVNWRETLKF----P---------EEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhhhccC----C---------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999998654  1222222222211110    0         112223678889999999 9999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-38  Score=315.95  Aligned_cols=266  Identities=24%  Similarity=0.308  Sum_probs=207.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .+|...+++|+|.||.||+|++. +|+.||||+++.....  -.....+|++.++.    ++|+||+.++++|...+...
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqe----l~h~nIi~LiD~F~~~~~l~   77 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQE----LKHPNIIELIDVFPHKSNLS   77 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHH----ccCcchhhhhhhccCCCceE
Confidence            46788899999999999999965 7999999999865322  23567899999997    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +|+|||+. +|+..+++.. .++..++..++.++++|++|+|++   .|+||||||.|+||+++|.+||+|||+|+.+..
T Consensus        78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99999977 9999998755 589999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCcccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhh--ccCCCCCCcccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVM--GYGRHGPGRAVI 1036 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~ 1036 (1088)
                      .+..... .+-|..|.|||.+ ....|+..+||||.||++.||+-|.+-|.+..+ +-.....+..  +-...++....+
T Consensus       154 p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  154 PNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            5543333 3678999999965 456899999999999999999998877777644 1112222222  111112222111


Q ss_pred             chhhcCC------CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1037 PVVLLGS------GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1037 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      +....-.      ....-+.+..+..+++.+|+..+|.+|++++|+++.
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111100      000123345667999999999999999999999763

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=334.25  Aligned_cols=259  Identities=29%  Similarity=0.394  Sum_probs=207.5

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccch-HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .+.|++...||.|..++||+|+. ..++.||||++.-+..... +.+++|+..++.    ++||||++++..|..+...|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl----~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSL----IDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhh----cCCCCcceEEEEEEecceeE
Confidence            35799999999999999999995 4689999999987766655 778999999986    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +||.||.+|++.++++...  .+.+..+..|.+++++||.|||++   |.||||||+.||||+++|.|||+|||.+..+.
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999998743  489999999999999999999999   99999999999999999999999999876554


Q ss_pred             CCC-Ccc-c-ccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          960 AGD-SHV-S-TTIAGTVGYVAPEYGQ--TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       960 ~~~-~~~-~-~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ... ... . ..+.||+.|||||++.  -..|+.|+||||||+...|+.+|..||....+.-+-...-    ....+.-.
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL----qn~pp~~~  253 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL----QNDPPTLL  253 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh----cCCCCCcc
Confidence            322 211 1 4578999999999843  3479999999999999999999999998775532211111    00010000


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .   ..............+.+++..|+++||++|||++++++
T Consensus       254 --t---~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 --T---SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --c---ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              0   00011112233457888999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=354.17  Aligned_cols=264  Identities=27%  Similarity=0.391  Sum_probs=211.8

Q ss_pred             HHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccch--HHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          798 SDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       798 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      .++....+++.+.+.||+|.||+||+|++.  -.||||++.......+  +.|++|+.++++    -+|.||+=|.|||.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkk----TRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKK----TRHENILLFMGACM  458 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhh----cchhhheeeehhhc
Confidence            344444556778899999999999999985  3599999987765443  679999999997    46999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      .+.. .||+.+|+|-+|+.+++.. .+++..+.+.||.|||+||.|||.+   +|||||||..||++.++++|||+|||+
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            8887 9999999999999999864 4799999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCC-CCcccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC
Q 001384          955 ARVVSAG-DSHVSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       955 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1088)
                      +.....- .........|...|||||++..   .+|++.+||||||+|+|||+||..||.....+.+-|...        
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG--------  606 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG--------  606 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec--------
Confidence            9764321 1222334457788999998663   489999999999999999999999998543322222111        


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .+.-..+      .......++.++.+|+..||..++++||.+.+|+..|+++++
T Consensus       607 rG~l~pd------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGYLMPD------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccccCcc------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            1110111      111234566788889999999999999999999999998875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=385.90  Aligned_cols=258  Identities=33%  Similarity=0.509  Sum_probs=218.5

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCc----EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--DGR----EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      .+.+..+.||+|+||.||.|...  .|.    .||||.+.+.. .....+|..|..+|+.    +.|||||+++|++.+.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~----f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSK----FDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhc----CCCcceeeEEEeecCC
Confidence            34566789999999999999964  343    49999998764 3445689999999997    7899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEe
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT  950 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~  950 (1088)
                      ...++++|||++|+|..+|++.       ..++..+...++.|||+|+.||+++   ++|||||.++|+|+++...|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999876       2489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceeecCCCCcccccc-cccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCC
Q 001384          951 DFGLARVVSAGDSHVSTTI-AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      |||+|+.....+.+..... .-+.+|||||.+..+.++.|+|||||||++||++| |..||.+...              
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------------  910 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------------  910 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------------
Confidence            9999996655554443332 44579999999999999999999999999999999 7778776432              


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                          .+++.....+.+.+.|..++..+++++..||+.+|++||++.+|+++++.++..+
T Consensus       911 ----~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  911 ----FEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----HHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                2222333344466678889999999999999999999999999999999887543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=356.97  Aligned_cols=243  Identities=26%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|...++||+|+||+|++|..+ +++.+|||++++..+-.+   +..+.|-+++..+.   +||.+++++.+|+..++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~---~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN---RHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc---cCCeEeecccccccCCe
Confidence            356889999999999999999987 678999999999865443   45677888887654   79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|.||||+.||++..+ +..+.+++..++.||..|+.||.|||++   +|||||||.+|||+|.+|++||+|||+++.--
T Consensus       444 l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999994443 3446799999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      . ....+.+++||+.|+|||++.+..|+..+|+|||||++|||+.|+.||.+.+++..                  ++.+
T Consensus       520 ~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------FdsI  580 (694)
T KOG0694|consen  520 G-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------FDSI  580 (694)
T ss_pred             C-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------HHHH
Confidence            2 22356789999999999999999999999999999999999999999998765222                  1111


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      +... ...|.-...+.++++++++.++|++|..+
T Consensus       581 ~~d~-~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VNDE-VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcCC-CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1111 11234456788899999999999999966

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-39  Score=333.01  Aligned_cols=246  Identities=26%  Similarity=0.459  Sum_probs=211.8

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchH---HHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGER---EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..+|++.+.||+|.||+|-+|.. ..|+.||||.++++.+..++   .+++|+++|+.    ++||||+.+|++|+..+.
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSs----LNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSS----LNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhh----cCCCceeehhhhhcCCce
Confidence            45788999999999999999996 58999999999998877665   47899999997    789999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ..+||||..+|.|+||+.+++.+++.+++.+++||..|+.|+|.+   ++||||||.+|||+|.++.+||+|||++-.+.
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .  .....+++|++-|.+||++.+.+| ++.+|-||+||++|-++.|..||++.+....  .+++.              
T Consensus       205 ~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--vrQIs--------------  266 (668)
T KOG0611|consen  205 D--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--VRQIS--------------  266 (668)
T ss_pred             c--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--HHHhh--------------
Confidence            3  345678999999999999999988 5789999999999999999999998654211  11111              


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .+..  ..+..+....-+|++|+..+|++|.|..||..
T Consensus       267 --~GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  267 --RGAY--REPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             --cccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence              1110  01223345566888999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-38  Score=357.81  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=204.6

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++..... .....+.+|++++..+.   +||||+++++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~~~~~~~~   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG---NHLNVVNLLGACTK   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc---cCcceeeEEeEecC
Confidence            35799999999999999999974      2356899999976432 23356889999998732   79999999998876


Q ss_pred             C-CeEEEEEEecCCCCHHHHHhhc--------------------------------------------------------
Q 001384          877 G-SEKILVYEYMEGGSLEDIISDR--------------------------------------------------------  899 (1088)
Q Consensus       877 ~-~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------  899 (1088)
                      . ...++||||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4688999999999999998652                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-cccccccc
Q 001384          900 ------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGT  972 (1088)
Q Consensus       900 ------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt  972 (1088)
                            .++++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++........ ......++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                  2377889999999999999999999   9999999999999999999999999999865432221 12234456


Q ss_pred             ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHH
Q 001384          973 VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEE 1051 (1088)
Q Consensus       973 ~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1088)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+...... ..               ....+...
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~-~~---------------~~~~~~~~  302 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD-GT---------------RMRAPENA  302 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc-CC---------------CCCCCCCC
Confidence            78999999988899999999999999999997 999998643211 11111110 00               00012223


Q ss_pred             HHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1052 MSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1052 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ...+.+++.+|++.||++||++.|+++.|++++..
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            45688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=343.34  Aligned_cols=248  Identities=30%  Similarity=0.455  Sum_probs=209.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..|+..+.||+|+||.||+|.+. .++.||+|++.-+..+. .+++++|+.++..    ++++||.++|+.+..+...++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~----~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQ----CDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHh----cCcchHHhhhhheeecccHHH
Confidence            35777789999999999999975 68899999998765444 3678999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      +||||.||++.+.++....+++.+...+.+++..|+.|+|.+   +.+|||||+.||++..+|.+|++|||.+..+....
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999999999888889999999999999999999999   99999999999999999999999999998776543


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.     +...      -+.+..++.+  
T Consensus       166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----rvlf------lIpk~~PP~L--  231 (467)
T KOG0201|consen  166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----RVLF------LIPKSAPPRL--  231 (467)
T ss_pred             hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----eEEE------eccCCCCCcc--
Confidence            33 36789999999999999989999999999999999999999999875431     0000      0111111221  


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           .......+.+++..|+++||+.||+|.++++
T Consensus       232 -----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 -----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                 2244556888888999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=344.67  Aligned_cols=239  Identities=26%  Similarity=0.436  Sum_probs=207.0

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      .+-||+|+.|.||.|+.+ ++.||||+++.-.       ..+++-|++    ++||||+.|.|+|.....+|||||||..
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRk----LkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRK----LKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHh----ccCcceeeEeeeecCCceeEEeeecccc
Confidence            466999999999999985 7899999997542       235666765    7899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccc
Q 001384          890 GSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI  969 (1088)
Q Consensus       890 gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  969 (1088)
                      |.|+..++....++....+.|.++||.||.|||.+   .|||||||.=||||+.+..|||+|||.++.....  -....+
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF  271 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF  271 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence            99999999999999999999999999999999999   9999999999999999999999999999877543  234568


Q ss_pred             cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccH
Q 001384          970 AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA 1049 (1088)
Q Consensus       970 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1088)
                      +||..|||||++...+.++|+||||||||||||+||..||.+-+...+-|....-                 ...++.|.
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN-----------------sL~LpvPs  334 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN-----------------SLHLPVPS  334 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC-----------------cccccCcc
Confidence            9999999999999999999999999999999999999999876554444422211                 01233467


Q ss_pred             HHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1050 EEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1050 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      .++..+.=|+++||+..|..||++++|+.-|+-
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            788888889999999999999999999988763

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=331.71  Aligned_cols=253  Identities=26%  Similarity=0.357  Sum_probs=201.8

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------------chHHHHHHHHHHhCCCCCCCCCc
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------------GEREFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      +..++|++.+.||+|.||.|-+|+.. +++.||||++.+....              .-+.+++|+.++++    ++|||
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk----l~H~n  169 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK----LHHPN  169 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh----cCCcC
Confidence            44578999999999999999999975 7899999999754311              12578999999997    78999


Q ss_pred             eeEEeeEEecC--CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          867 LVTLYGWCLDG--SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       867 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ||+++++..+.  +..|||+|||..|.+...-.....+++.++++|+.+++.||+|||.+   +||||||||+|+|++++
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            99999998764  67899999999988765433333399999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCc----ccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhH
Q 001384          945 GKALVTDFGLARVVSAGDSH----VSTTIAGTVGYVAPEYGQTW----QATTKGDVYSFGVLAMELATGRRALEGGEECL 1016 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~ 1016 (1088)
                      |++||+|||.+..+..+...    .....+||+.|+|||...++    ..+.+.||||+||+||.|+.|+.||.+...  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            99999999999877443221    12346899999999987663    236788999999999999999999987432  


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+..+.+......               .+..++...++.++|++++++||++|.+..||..
T Consensus       325 ~~l~~KIvn~pL~---------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  325 LELFDKIVNDPLE---------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             HHHHHHHhcCccc---------------CCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            2233333311111               1112244567889999999999999999999864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=352.86  Aligned_cols=254  Identities=30%  Similarity=0.446  Sum_probs=207.6

Q ss_pred             CCCccceecccCceEEEEEEeCC--C--cE-EEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD--G--RE-VAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +-.+.++||+|+||.||+|.++.  +  .. ||||..+...   .....++.+|+++++.    ++|||||++||++...
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~----l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQ----LNHPNVVRFYGVAVLE  233 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHh----CCCCCEEEEEEEEcCC
Confidence            34455899999999999999653  2  23 8999998532   3445789999999997    7899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++|||+|+||+|.+++++.. .++..+...++.+.|+||+|||++   ++|||||.++|+|++.++.+||+|||+++
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999999877 499999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccc-cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .-.  ...... ...-+.+|+|||.+....|++++|||||||++||+++ |..||.+.... ...+...           
T Consensus       311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~-----------  377 (474)
T KOG0194|consen  311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK-----------  377 (474)
T ss_pred             CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh-----------
Confidence            532  111111 2245689999999999999999999999999999999 88999886542 2222111           


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                             .+.+...+...+..+..++.+|+..+|++||+|.++.+.++.+.+.
T Consensus       378 -------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  378 -------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             -------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence                   0111112334456777788899999999999999999999998654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=328.11  Aligned_cols=268  Identities=29%  Similarity=0.416  Sum_probs=205.6

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----eEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----EKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----~~~l  882 (1088)
                      .+..++||+|.||.||||.+. ++.||||++...   .++.|.+|-++.+...  ++|+||++|+++-....    .+++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~--m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPG--MKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccC--ccchhHHHhhchhccCCccccceeE
Confidence            445688999999999999985 699999999754   5678999999988765  89999999999876555    8899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC------YPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      |+||.+.|+|.+|++.+. ++|.+..+|+..+++||+|||+..      .|+|+|||||.+||||.+|++..|+|||+|.
T Consensus       286 Vt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             EeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999999998765 899999999999999999999863      4789999999999999999999999999999


Q ss_pred             eecCCCCc-ccccccccccccCccccCCCC------CCcchhHHHHHHHHHHHHhCCcCCCC-C-chhHHHHHHhhhccC
Q 001384          957 VVSAGDSH-VSTTIAGTVGYVAPEYGQTWQ------ATTKGDVYSFGVLAMELATGRRALEG-G-EECLVEWGRRVMGYG 1027 (1088)
Q Consensus       957 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~elltg~~p~~~-~-~~~~~~~~~~~~~~~ 1027 (1088)
                      ++.++... .....+||.+|||||++.+.-      .-.+.||||+|.++|||++.-..+.. . .+....+...+   +
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev---G  441 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV---G  441 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh---c
Confidence            98754332 233478999999999877642      12368999999999999985544421 1 11111111111   1


Q ss_pred             CCCCCccccchhhcCCCccccH------HHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1028 RHGPGRAVIPVVLLGSGLAEGA------EEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .+...+++....+.....+..+      ..+..+.+.+..||+.||+.|.|+.=|-+.+.++.
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            2222233333333333332222      23456888999999999999999998888887764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=336.10  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=216.5

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .....+.++||+|.||.|..+....+..||||+++..+... .++|.+|+++|.+    ++||||++++|+|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsq----LkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSR----LKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhc----cCCCCeeEEEeeeecCCchHH
Confidence            45677889999999999999999778999999999875544 4789999999997    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+|||++|+|..++.++..  .......+|+.|||.||+||.+.   ++|||||.++|+|++.++++||+|||+++.+..
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999999987742  34566678999999999999998   999999999999999999999999999997766


Q ss_pred             CCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCcCCCCCch-hHHHHHHhhhccCCCCCCcccc
Q 001384          961 GDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT--GRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       961 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ++.+. ....+-+.+|||||.+.-++++.++|||+||+.+||+++  .+.||....+ ..++-.-...   .... .   
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~---~~~~-~---  762 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF---RDQG-R---  762 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc---CCCC-c---
Confidence            66554 345667889999999888899999999999999999664  7888876644 2222222221   1111 1   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                           ...+..|.-++..+++++.+||..|-++||+++++...|.+.
T Consensus       763 -----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 -----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 112233667788999999999999999999999999988764

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-38  Score=306.57  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=208.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|.||.||.|+.+ ++-.||+|++.+....   -+.++++|+++-+.    ++||||+++|++|.++...
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~----L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSH----LRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecc----cCCccHHhhhhheecccee
Confidence            46899999999999999999965 6778999999876432   34678888888775    7899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIIS--DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      |+++||.++|+++..++  ...++++..++.++.|+|.|+.|+|..   +|+||||||+|+|++.++.+|++|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999998  566799999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .   .....+.+||..|.|||...+..++..+|+|++|++.||++.|.+||+....  .+-++++...      +     
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--~etYkrI~k~------~-----  238 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--SETYKRIRKV------D-----  238 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--HHHHHHHHHc------c-----
Confidence            3   3345678999999999999999999999999999999999999999987542  2222222210      1     


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                            ...+......+.++|.+|+..+|.+|....|+++-
T Consensus       239 ------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 ------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  11123344678889999999999999999998763

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.2e-37  Score=336.37  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=205.0

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.+.||+|+||.||+|.++    .+..||+|+++.... .....+.+|+..+.+    ++||||+++++++..++.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ----FDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhc----CCCCCcCeEEEEEecCCC
Confidence            46888999999999999999853    356899999986532 233568889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++|+|.+++... ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.++++|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999999764 4789999999999999999999999   9999999999999999999999999987653


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ............++..|+|||.+.+..++.++|||||||++||+++ |+.||......  +.......            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~------------  223 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED------------  223 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC------------
Confidence            2221111122345678999999988899999999999999999775 99999765431  11111110            


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                          +...+.+...+..+.+++.+|++.+|++||++++|.+.|++++
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         224 ----GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence                0001112334567888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-37  Score=324.72  Aligned_cols=265  Identities=27%  Similarity=0.374  Sum_probs=208.3

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----CeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----SEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----~~~  880 (1088)
                      .+..+.+.||+|.||.||+|.++ |+.||||++...   .++.+.+|.++++.+.  ++|+||+.|++....+    ...
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvm--LRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVM--LRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHH--hccchhhhhhhccccCCCceEEE
Confidence            56778899999999999999995 899999999864   5678999999998776  8999999999987654    367


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE-----CYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      ++|++|.+.|+|+||+.+ ..++.+...+++..+|.||+|||..     ..|.|.|||||+.||||.+++.+.|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999988 5699999999999999999999975     4589999999999999999999999999999


Q ss_pred             eeecCCCCc---ccccccccccccCccccCCCC------CCcchhHHHHHHHHHHHHh----------CCcCCCCCchhH
Q 001384          956 RVVSAGDSH---VSTTIAGTVGYVAPEYGQTWQ------ATTKGDVYSFGVLAMELAT----------GRRALEGGEECL 1016 (1088)
Q Consensus       956 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ellt----------g~~p~~~~~~~~ 1016 (1088)
                      .........   .....+||.+|||||++...-      .-..+||||||.++||+..          -+.||.+..+..
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            887654322   245678999999999876531      1246899999999999985          344555432211


Q ss_pred             HHHHHhhhccCCCCCCccccchhh-cCC--CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVL-LGS--GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ..++..          ++++.... ...  ..-...+....+.++++.||..+|..|.++-.|.+.|.++.+.
T Consensus       444 Ps~eeM----------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  444 PSFEEM----------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCHHHH----------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            111111          11111000 000  0112456778899999999999999999999999999998753

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-36  Score=337.06  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=201.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CCeEEEE
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GSEKILV  883 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~~~~lv  883 (1088)
                      ..||+|++|.||+|.+ +|+.||||++.......   .+.+.+|+.++.+    ++||||+++++++.+    ....++|
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~nIv~~~g~~~~~~~~~~~~~lv  100 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR----IDSNNILKIYGFIIDIVDDLPRLSLI  100 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHh----cCCCCEEEEeeeEEecccCCCceEEE
Confidence            6799999999999998 68999999998754333   3567799999997    679999999999876    3467899


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++|+|.++++....+++....+++.|++.|++|||+..  +++||||||+||++++++.+||+|||+++...... 
T Consensus       101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999999998888999999999999999999999842  78899999999999999999999999987654321 


Q ss_pred             cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          964 HVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.+...  .+..........             
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~~-------------  239 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIINKNN-------------  239 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCC-------------
Confidence               23457889999999875  6899999999999999999999999987543  122222210000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                        ....+...+..+.+++.+||+.||++||+++|+++.|+.+.
T Consensus       240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              00112234567889999999999999999999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=338.83  Aligned_cols=256  Identities=27%  Similarity=0.456  Sum_probs=223.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC---CCc--EEEEEEcccc-CccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP---DGR--EVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++.....++||+|.||.||+|...   .|+  -||||..+.+ .....+.|.+|..+|+.    ++||||++++|+|.+ 
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrn----fdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRN----FDHPHIIKLIGVCVE-  462 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHh----CCCcchhheeeeeec-
Confidence            344556688999999999999953   233  4899999874 34556789999999987    789999999999975 


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++|||.++-|.|..|++.+. .++......++.||+.||+|||+.   .+|||||..+|||+.+..-+|++|||+++
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            56799999999999999998754 689999999999999999999999   99999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .+.....+..+...-+..|||||.+.-.+++.++|||.|||++||++. |..||.+-.                  ..++
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk------------------NsDV  601 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK------------------NSDV  601 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc------------------ccce
Confidence            998777776666677889999999999999999999999999999765 999998742                  2444


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      +...-.|.+.+.|+.++..++.++.+||..||.+||.+.|+...|++++.
T Consensus       602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            55555677888899999999999999999999999999999999998864

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=342.18  Aligned_cols=249  Identities=28%  Similarity=0.422  Sum_probs=214.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe-E
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE-K  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~-~  880 (1088)
                      ++|..++++|+|+||.++.++++ +++.+|+|.+.-....  .++...+|+.++++    ++|||||.+.+.|.+++. .
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~----~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSK----LLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHh----ccCCCeeeeccchhcCCceE
Confidence            57889999999999999999976 6789999999765433  33467889999997    689999999999999888 8


Q ss_pred             EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      +|||+|++||++.+.+.+.+  -++++.+..|+.|++.|+.|||+.   .|+|||||+.||+++.++.|||+|||+|+..
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence            99999999999999997654  589999999999999999999988   9999999999999999999999999999988


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... .....+.||+.|++||++.+.+|..|+||||+||++|||++-+++|.+.+-.  .                .+..
T Consensus       157 ~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~----------------Li~k  217 (426)
T KOG0589|consen  157 NPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--E----------------LILK  217 (426)
T ss_pred             CCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--H----------------HHHH
Confidence            7543 2456688999999999999999999999999999999999999999875431  1                1112


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      +..+...+.+.....++..+|..|+..+|+.||++.+++..
T Consensus       218 i~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  218 INRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            22222334466777899999999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3e-41  Score=352.31  Aligned_cols=489  Identities=26%  Similarity=0.384  Sum_probs=341.2

Q ss_pred             EEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc-cCCCCCCCceeeccccc
Q 001384           82 NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL-NLSGLRSLEILDLSVNR  160 (1088)
Q Consensus        82 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~N~  160 (1088)
                      ..+.+++|.+.. +.+.+.+|..|.+|++++|+++ ..|.+++.+..++.|+.++|+++... .+.++.+|..|+.++|.
T Consensus        48 ~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~  125 (565)
T KOG0472|consen   48 QKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNE  125 (565)
T ss_pred             hhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccc
Confidence            346667766654 3355777777888888888887 67777888888888888887777533 46666666667766666


Q ss_pred             ccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccc
Q 001384          161 IHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF  240 (1088)
Q Consensus       161 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  240 (1088)
                      +.                          ..++.++.+..|..|+..+|+++.                      . +..+
T Consensus       126 ~~--------------------------el~~~i~~~~~l~dl~~~~N~i~s----------------------l-p~~~  156 (565)
T KOG0472|consen  126 LK--------------------------ELPDSIGRLLDLEDLDATNNQISS----------------------L-PEDM  156 (565)
T ss_pred             ee--------------------------ecCchHHHHhhhhhhhcccccccc----------------------C-chHH
Confidence            65                          233446667778888888887752                      1 2234


Q ss_pred             cCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcE
Q 001384          241 KENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV  320 (1088)
Q Consensus       241 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  320 (1088)
                      ..+.+|..+++.+|+++...|..+ +++.|++||...|-+. .+|+.++.+.+|+.|+|.+|++.. +| +|..++.|.+
T Consensus       157 ~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~E  232 (565)
T KOG0472|consen  157 VNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKE  232 (565)
T ss_pred             HHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHH
Confidence            455678888888888885545444 4999999999999887 889999999999999999999876 45 8999999999


Q ss_pred             EEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccc
Q 001384          321 LDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR  400 (1088)
Q Consensus       321 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  400 (1088)
                      |+++.|+|+..+.+....++++..||+.+|++.+  .+..++.+.+|++||+|+|.++ .+|.+++++ .|++|-+.+|.
T Consensus       233 lh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke--~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  233 LHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKE--VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HHhcccHHHhhHHHHhcccccceeeecccccccc--CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCc
Confidence            9999999987777777777777777777777533  2445566777777777777777 567777777 77777777777


Q ss_pred             cCCcCCcccCCCC---CCcEEE-------ccCCc----CCCCCCc----cccCCCCCcEEEccccccccCCCccccCCCC
Q 001384          401 FNGSIPAVYGNMP---NLQTLD-------LSFNE----LTGPIPP----SIGNLTSLLWLMLANNSLSGEIPGEIGNCTS  462 (1088)
Q Consensus       401 l~~~~p~~~~~l~---~L~~L~-------L~~N~----l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  462 (1088)
                      +. .+-..+-+..   -|++|.       ++.-+    =++..|.    ....+.+.+.|++++-+++ .+|.+...-..
T Consensus       309 lr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~  386 (565)
T KOG0472|consen  309 LR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAK  386 (565)
T ss_pred             hH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhh
Confidence            75 2222221111   011111       11000    0011111    1234567889999999998 78887665555


Q ss_pred             ---CCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhh
Q 001384          463 ---LLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLW  539 (1088)
Q Consensus       463 ---L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  539 (1088)
                         .+..+++.|++. ++|..+..+..+.......|+.                                          
T Consensus       387 ~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~------------------------------------------  423 (565)
T KOG0472|consen  387 SEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK------------------------------------------  423 (565)
T ss_pred             hcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc------------------------------------------
Confidence               788999999998 8998776554332221111111                                          


Q ss_pred             hhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccC-
Q 001384          540 DRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTR-  618 (1088)
Q Consensus       540 ~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~-  618 (1088)
                            .+..|..     -..++.+..|+|++|-+. .+|.+++.+..|++||+++|+|. .+|..+-.+...++.+++ 
T Consensus       424 ------isfv~~~-----l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~  490 (565)
T KOG0472|consen  424 ------ISFVPLE-----LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASN  490 (565)
T ss_pred             ------cccchHH-----HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcc
Confidence                  1111111     122345668999999998 89999999999999999999999 889887777555555555 


Q ss_pred             CcccccCCcc-ccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCcc--cccccCccCCCC
Q 001384          619 NNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL--ATFEKTSYLGDP  692 (1088)
Q Consensus       619 N~l~~~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~--~~~~~~~~~~n~  692 (1088)
                      |++. .+|++ +.++.+|.+|||.+|.|. .||..+++|++|++|++++||++   .|...-+  +|..-.+|.+++
T Consensus       491 nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr---~Pr~~iLmkgT~aiL~ylrdr  562 (565)
T KOG0472|consen  491 NQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR---QPRHQILMKGTAAILSYLRDR  562 (565)
T ss_pred             cccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC---CCHHHHhccChHHHHHHhccc
Confidence            6666 77666 999999999999999998 89999999999999999999993   4433211  344445566554

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-36  Score=339.99  Aligned_cols=267  Identities=23%  Similarity=0.327  Sum_probs=206.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|++. ++..||+|++.... ......+.+|++++.+    ++||||+++++++..++..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE----CNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHH----CCCCCCCeEEEEEEECCEEE
Confidence            367999999999999999999976 68889999987642 2234578899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.++++....+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+|||++......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999999998888999999999999999999999862  6999999999999999999999999998765322


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc--------
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR-------- 1033 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1033 (1088)
                         ......|+..|+|||++.+..++.++||||+||++|||++|+.||........................        
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               223456899999999999889999999999999999999999999765432111100000000000000        


Q ss_pred             --------------------cccchhhcCCCccc-cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1034 --------------------AVIPVVLLGSGLAE-GAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1034 --------------------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                                          +..+.......... ......++.+++.+|++.||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                00000000000000 11234678999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-36  Score=337.17  Aligned_cols=267  Identities=22%  Similarity=0.238  Sum_probs=203.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||.||+|+++ +++.||||++.....  ...+.+.+|+++++.    ++||||+++++++..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   76 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRT----LKQENIVELKEAFRRRGKLY   76 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHh----CCCccccchhhhEecCCEEE
Confidence            46899999999999999999986 678999999876432  234567889999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||++++.+..+.+....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999999987776665566799999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH-HHhhh-c--------cCCCCC
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW-GRRVM-G--------YGRHGP 1031 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~-~--------~~~~~~ 1031 (1088)
                      .........|+..|+|||++.+..++.++||||+||++|||++|+.||.+........ ..... .        +.....
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            3333344578999999999988889999999999999999999999998754311100 00000 0        000000


Q ss_pred             CccccchhhcCCC---ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSG---LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+......   ..........+.+++.+|++.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000   0001113456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=339.34  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.....   ...+.+.+|+++++.    ++||||+++++++.++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~   76 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE----VSHPFIIRLFWTEHDQRFL   76 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHh----CCCCcHhhhHhhhccCCeE
Confidence            36888999999999999999976 689999999875421   234567889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.++++..+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999876542


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+....  +.........             
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~-------------  214 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAGK-------------  214 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-------------
Confidence            2    22346899999999999889999999999999999999999999875431  1112211000             


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                          ...+......+.+++.+|++.||.+||+     ++|+++
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                0011122356788999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-36  Score=337.06  Aligned_cols=246  Identities=28%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |+..+.||+|+||.||+|.+. +|+.||||++......   ....+.+|++++..    +.|++++++++++.+++..++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~----l~~~~iv~~~~~~~~~~~~~l   77 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----VNSRFVVSLAYAYETKDALCL   77 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHh----cCCCcEEEEEEEEccCCeEEE
Confidence            677899999999999999975 7899999998754322   23457789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++.....
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999999999887543  3689999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH--HHHHHhhhccCCCCCCccccch
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL--VEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ..  ......|+..|+|||++.+..++.++||||+||++|||++|+.||.......  ........              
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--------------  218 (285)
T cd05631         155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--------------  218 (285)
T ss_pred             CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh--------------
Confidence            22  2234568999999999999999999999999999999999999998654311  11111111              


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                         ......+......+.+++.+|++.||++||+     ++|+++
T Consensus       219 ---~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 ---EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               0000112223457788999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-36  Score=349.90  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=203.6

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|++++..+.   +||||+++++++.+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~---~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG---NHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc---CCcceeeeeeeecc
Confidence            34688899999999999999974      235689999997543 233456888999998732   79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT--------------------------------------------------------  900 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  900 (1088)
                      ....++||||+++|+|.++++...                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986421                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          901 -------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       901 -------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                                         .+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                               368889999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+...... ..           
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~-~~-----------  334 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKE-GY-----------  334 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHh-Cc-----------
Confidence            221 1222345678999999998899999999999999999998 888887643211 11111110 00           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                          ....+...+.++.+++.+|++.||++||+++||++.|++.+
T Consensus       335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                00001122357889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-36  Score=309.95  Aligned_cols=265  Identities=25%  Similarity=0.293  Sum_probs=207.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--Ce
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~  879 (1088)
                      ++|+..+.|++|+||.||+|+++ +++.||+|+++.+...  -.-...+|+.++.+    .+|||||.+-.+....  +.
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~----~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLK----ARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHh----cCCCCeeeeEEEEeccccce
Confidence            45788899999999999999986 6788999999876321  12356789999987    5799999999988754  57


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .|+|||||+. +|...++... ++...++..++.|+++|++|||..   .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999999987 9999998765 799999999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCC--CCCCcc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGR--HGPGRA 1034 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~--~~~~~~ 1034 (1088)
                      ... ....+..+-|.+|+|||.+ ....|+.+.|+||+|||+.||+++++.|.+..+ +...-....+.++.  .+++..
T Consensus       228 gsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  228 GSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             cCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            754 3345566789999999964 456899999999999999999999999998765 22333333333332  222232


Q ss_pred             ccchhhcCCCccccHH----------HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAE----------EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~----------~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+..........+..          ....-++++..++..||.+|.||.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            2222211111111111          2245678888999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-36  Score=329.53  Aligned_cols=250  Identities=29%  Similarity=0.436  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+.... ....++.+|++++++    ++||||+++++++.++...++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMK----LSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHH----CCCCCceeEEEEEccCCCEEEEE
Confidence            3577889999999999999998888899999987543 335678899999987    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++|+|.++++.. ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999999999753 4689999999999999999999999   999999999999999999999999999876543222


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .......++..|+|||.+....++.++||||||+++|||++ |+.||......  +..........              
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~--------------  219 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR--------------  219 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC--------------
Confidence            22223345668999999988889999999999999999999 89999765431  11111110000              


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                        ...+.....++.+++.+|++++|++||+++|+++.|
T Consensus       220 --~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 --LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              001112235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.3e-36  Score=336.44  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             CCCCccceecccCceEEEEEEeCC-----------------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCc
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-----------------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      ++|++.+.||+|+||.||+|.+++                 +..||+|++..... ....++.+|++++.+    ++|||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSR----LKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhh----cCCCC
Confidence            578889999999999999998532                 33699999876532 234578899999986    67999


Q ss_pred             eeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 001384          867 LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-------------------RLTWRRRLDIAIDVARALVFLHHECYP  927 (1088)
Q Consensus       867 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~  927 (1088)
                      |+++++++.+.+..++||||+++|+|.+++....                   .+++.++++++.||+.||+|||+.   
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            9999999999999999999999999999986431                   367889999999999999999999   


Q ss_pred             CeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--
Q 001384          928 PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-- 1004 (1088)
Q Consensus       928 ~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-- 1004 (1088)
                      +|+||||||+||+++.++.+||+|||+++.+...+.. ......++..|+|||++....++.++||||||+++|||++  
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999999999999999999876443321 1223445788999999888899999999999999999986  


Q ss_pred             CCcCCCCCch-hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1005 GRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1005 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      +..||..... ...........  ...  ....        ...+..++..+.+++.+|++.||++||++.||.+.|++
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~--~~~--~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFR--DQG--RQVY--------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhh--hcc--cccc--------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            5677765433 22222221110  000  0000        00122344678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-36  Score=342.17  Aligned_cols=241  Identities=26%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|+.+ +|+.||+|++.+...   .....+..|++++++    ++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~hp~i~~~~~~~~~~~~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN----TRHPFLTALKYSFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh----CCCCCCCCEEEEEEcCCEEEEEEeC
Confidence            46999999999999975 689999999986432   222457788999886    6799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            99999999999888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....... ..                ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~-~~----------------~~  213 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILM-EE----------------IR  213 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHHc-CC----------------CC
Confidence            34579999999999999899999999999999999999999997654311  1111110 00                00


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      .+.....++.+++.+|++.||++||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1222345678899999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-36  Score=343.29  Aligned_cols=243  Identities=24%  Similarity=0.309  Sum_probs=201.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.....   ...+.+.+|+.++.+    ++||||+++++++.+++..
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME----LSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh----CCCCCCCcEEEEEEcCCEE
Confidence            46888999999999999999976 688999999975422   233567889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....  +........      ..      
T Consensus       171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~------~~------  232 (329)
T PTZ00263        171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKILAG------RL------  232 (329)
T ss_pred             C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHHhcC------Cc------
Confidence            2    22357899999999999989999999999999999999999999865431  111111100      00      


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVL 1077 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil 1077 (1088)
                           ..+.....++.+++.+|++.||.+||+     ++|++
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                 001112346778999999999999997     56665

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-36  Score=347.91  Aligned_cols=257  Identities=27%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|++.      ++..||||++...... ....+.+|+++++.+.   +||||+++++++...
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---~h~nIv~~~~~~~~~  114 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG---QHKNIVNLLGACTHG  114 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc---cCCceeeEeeEecCC
Confidence            46889999999999999999842      2357999999765322 3356888999998632   799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc----------------------------------------------------------
Q 001384          878 SEKILVYEYMEGGSLEDIISDR----------------------------------------------------------  899 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------  899 (1088)
                      ...++||||+++|+|.++++..                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999998542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-cc
Q 001384          900 ------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VS  966 (1088)
Q Consensus       900 ------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~  966 (1088)
                                  .++++.++++++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        2478889999999999999999998   9999999999999999999999999999765432211 12


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      ....++..|+|||++....++.++|||||||++|||++ |+.||........ +..... ...               ..
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~-~~~---------------~~  334 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVK-RGY---------------QM  334 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHH-ccc---------------Cc
Confidence            22345678999999988899999999999999999997 9999976432111 111111 000               00


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+...+.++.+++.+|++.||.+||++.||++.|++++
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            001112357888999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-36  Score=319.46  Aligned_cols=249  Identities=27%  Similarity=0.359  Sum_probs=201.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|++.+.||.|.-|+||+++++ .+..+|+|++.+.....+   .+.+.|-+||+.    ++||.+..+|+.++.++..|
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~----lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSL----LDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHh----cCCCccchhhheeeccceeE
Confidence            4677899999999999999987 458999999998765433   356678888886    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +|||||+||+|....+++  +.+++..++.++.+|+.||+|||.+   |||+|||||+||||.++|++-++||+++....
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999999998764  4699999999999999999999999   99999999999999999999999999863221


Q ss_pred             C---------------------------------CCC----------------------cccccccccccccCccccCCC
Q 001384          960 A---------------------------------GDS----------------------HVSTTIAGTVGYVAPEYGQTW  984 (1088)
Q Consensus       960 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~  984 (1088)
                      .                                 ...                      .....++||-+|.|||++.+.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            0                                 000                      112246799999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcc
Q 001384          985 QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTA 1064 (1088)
Q Consensus       985 ~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1064 (1088)
                      ..+.++|+|+|||++|||+.|..||.+.+... .. ..+.            ...   ...+..+.....+.+||++.+.
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl-~NIv------------~~~---l~Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TL-RNIV------------GQP---LKFPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hH-HHHh------------cCC---CcCCCCCcchhHHHHHHHHHhc
Confidence            99999999999999999999999999864311 11 1111            000   0111122445678899999999


Q ss_pred             cCCCCCCC----HHHHHH
Q 001384         1065 EAPNARPN----VKEVLA 1078 (1088)
Q Consensus      1065 ~dP~~RPs----~~eil~ 1078 (1088)
                      +||.+|..    |.||.+
T Consensus       374 KdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             cChhhhhccccchHHhhc
Confidence            99999998    777753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=342.25  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=205.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||||++.+...   .....+..|++++..    ++||||+++++++.++...
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~iv~~~~~~~~~~~~   76 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT----TKSEWLVKLLYAFQDDEYL   76 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHh----CCCCCCccEEEEEEcCCEE
Confidence            46899999999999999999976 588999999976422   233567889999886    5799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.++++....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                          ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ + .....+.....     .+..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~-~~i~~~~~~~~-----~~~~  222 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-W-ENLKYWKETLQ-----RPVY  222 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-H-HHHHhcccccc-----CCCC
Confidence                23345789999999999988999999999999999999999999986543111 1 11110000000     0000


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                          .........++.+++.+|++.+|.+||+++|+++.
T Consensus       223 ----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 ----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                00001234578889999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-36  Score=327.78  Aligned_cols=254  Identities=29%  Similarity=0.415  Sum_probs=207.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+++.+|++++++    ++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKK----LRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHH----CCCCCccceeEEEecCCCeeee
Confidence            35688899999999999999998778899999987653 335678899999987    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.+++....  .+++.++..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999997654  689999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ..........+..|+|||+..+..++.++||||||+++|||++ |+.||.+..... .+ .......             
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~-~~~~~~~-------------  221 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VL-QQVDQGY-------------  221 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HH-HHHHcCC-------------
Confidence            2211122223468999999988899999999999999999999 999997654311 11 1111000             


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                         ..+.+...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               0011222346788899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=305.11  Aligned_cols=250  Identities=26%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .+++|++.+.||+|.|+.||++... +|+.+|+|++....  ....+++.+|+.+.+.    ++|||||++.+.+.+...
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~----LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK----LQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHh----cCCCcEeehhhhhcccce
Confidence            3567888899999999999999865 78999999886543  2345678899999886    789999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeecccce
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDFGLAR  956 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Dfg~a~  956 (1088)
                      .|+|+|+|+|++|..-+-.+.-.++..+-.++.||++++.|.|.+   +|||||+||+|+++.+   ...+|++|||+|.
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999999999976555556688999999999999999999999   9999999999999963   3469999999999


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh--ccCCCCCCcc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM--GYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 1034 (1088)
                      .+.  +......++||++|||||++...+|+..+|||+.||++|-++.|..||.+.+...  ...+++  .|....+.  
T Consensus       162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd~~~~~--  235 (355)
T KOG0033|consen  162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYDYPSPE--  235 (355)
T ss_pred             EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccCCCCcc--
Confidence            887  3444566789999999999999999999999999999999999999998744311  112222  11111111  


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                   .+....+..+++++|+..||.+|.|+.|.++
T Consensus       236 -------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  236 -------------WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -------------cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                         1222345677888999999999999999874

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.8e-36  Score=328.96  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=206.6

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++    ++|+||+++++++.+....++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKT----LQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHh----CCCCCeeeEEEEEcCCCCcEEEE
Confidence            4688899999999999999998888899999987543 235678899999986    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++|+|.++++..  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999653  4689999999999999999999998   99999999999999999999999999998764332


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCccccchhh
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ........++..|+|||+.....++.++||||||+++|+|++ |+.||...... ...+.....  .             
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--~-------------  222 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY--R-------------  222 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--C-------------
Confidence            222223345678999999988889999999999999999998 99999765432 111111100  0             


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                          .+.....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                001112335688899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-37  Score=322.33  Aligned_cols=258  Identities=28%  Similarity=0.380  Sum_probs=196.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-----e
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-----E  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-----~  879 (1088)
                      .|+..+++|+|+||.||+|+.. +++.||||++..+....    -.|+++|+.    ++|||||++..+|....     .
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~----l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRK----LDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHh----cCCcCeeeEEEEEEecCCCchhH
Confidence            4666799999999999999976 57899999998763322    357788875    68999999999887532     2


Q ss_pred             EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeeccc
Q 001384          880 KILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFGL  954 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Dfg~  954 (1088)
                      ..+|||||+. +|++.++.    +.+++.-.++-++.||.+||+|||+.   +|+||||||+|+|+|.+ |.+||+|||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            3589999987 99999874    56789999999999999999999998   99999999999999966 9999999999


Q ss_pred             ceeecCCCCcccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~ 1031 (1088)
                      |+....++..  ..+..|..|+|||.+ ....|+.+.||||.|||+.||+-|++.|.+...  .+.+..+. ++.+....
T Consensus       173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~-lG~Pt~e~  249 (364)
T KOG0658|consen  173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV-LGTPTRED  249 (364)
T ss_pred             ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH-hCCCCHHH
Confidence            9998765543  456678899999954 556899999999999999999999999998643  23333222 11111111


Q ss_pred             Ccc--------ccchhhcCCC-ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRA--------VIPVVLLGSG-LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~--------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...        ..+....... .........+.++++.++++.+|.+|.++.|++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            110        1111111110 0123345568899999999999999999999874

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=314.72  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEcccc--CccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec---
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQRE--GLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD---  876 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~---  876 (1088)
                      ...+|...+.||+|+||.|+.|.++ +|+.||||++...  .....++..+|+++++.    ++|+||+.+++.+..   
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~----~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRH----LRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHH----hcCCCcceEEeecccccc
Confidence            3456776799999999999999976 7899999999843  33344677899999997    789999999998875   


Q ss_pred             --CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          877 --GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       877 --~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                        -...|+|+|+|+. +|...++.+..++...+..+++|+++|+.|+|+.   +|+|||+||+|++++.+..+||+|||+
T Consensus        96 ~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   96 DKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             cccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence              3568999999954 9999999988899999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCC-CcccccccccccccCccc-cCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          955 ARVVSAGD-SHVSTTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       955 a~~~~~~~-~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |+...... ....+.++-|..|.|||+ +....|+.+.||||.|||+.||++|++.|.+.+. ..+. ..++..-. .+.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql-~lI~~~lG-tP~  248 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQL-QLILELLG-TPS  248 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHH-HHHHHhcC-CCC
Confidence            99875431 222466788999999996 4556899999999999999999999999988643 1000 00000000 000


Q ss_pred             ccccchh--------hc--CC--Ccc---ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVV--------LL--GS--GLA---EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~--------~~--~~--~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+.+..+        +.  +.  ..+   ..+......++++.+|+.-||.+|+|++|+++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000000        00  00  000   01123346788999999999999999999875

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.7e-36  Score=341.96  Aligned_cols=250  Identities=27%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             CCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +|++.+.||+|+||.||+|+..    +++.||+|++.+...    ...+.+..|+.++..+.   +||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR---QSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc---CCCCcccEEEEEecC
Confidence            4788999999999999999853    578999999975421    22345778888888643   699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      +..++||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999999998888899999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      +............||..|+|||++.+. .++.++|||||||++|||++|+.||.....  .............       
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------  227 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-------  227 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC-------
Confidence            644333333456799999999988764 478899999999999999999999975322  1122222222100       


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                                ...+......+.+++.+|++.||++||     +++++++
T Consensus       228 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 ----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                      011122345678889999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.5e-36  Score=327.37  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=205.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      +|++.+.||+|+||.||+|.++ .++.||+|++.... ....++.+|++++++    ++||||+++++++..+...++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKE----IKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHh----CCCCChhheEEEEcCCCCcEEEE
Confidence            4777899999999999999975 58899999987542 334578899999986    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999754  3589999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........++..|+|||...+..++.++||||||+++|||++ |..||.+...  .+..........             
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~-------------  223 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYR-------------  223 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC-------------
Confidence            222222334668999999988899999999999999999998 8999876432  222222211000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                         ...+...+..+.+++.+|++.||++||++.|+++.|+.++
T Consensus       224 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         224 ---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence               0112223467888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-35  Score=342.83  Aligned_cols=259  Identities=29%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|++.      .+..||||++...... ..+.+.+|++++.++.   .||||+++++++.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~---~HpnIv~l~~~~~~  112 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG---PHLNIVNLLGACTK  112 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC---CCCCeeeEEEEEcc
Confidence            568889999999999999999853      1347999999754322 3457889999998732   49999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc---------------------------------------------------------
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR---------------------------------------------------------  899 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------  899 (1088)
                      ....|+||||+++|+|.++++..                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999988642                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001384          900 ---------------------------------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVL  940 (1088)
Q Consensus       900 ---------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIl  940 (1088)
                                                             ..+++.++..++.|++.|++|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                   1377888899999999999999998   9999999999999


Q ss_pred             EcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHH
Q 001384          941 LDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVE 1018 (1088)
Q Consensus       941 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~ 1018 (1088)
                      ++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            999999999999999876432221 1223456788999999988899999999999999999997 99998764321111


Q ss_pred             HHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      +.. ...                +.....+...+..+.+++.+|++.||++||++.+|.++|+++++
T Consensus       350 ~~~-~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 YNK-IKS----------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHH-Hhc----------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            111 110                00011122345678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-36  Score=340.42  Aligned_cols=244  Identities=25%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             CCCCccceecccCceEEEEEEeCC--CcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD--GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.+.||+|+||.||+|.++.  +..||+|++.....   .....+.+|++++..    ++||||+++++++.++..
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY----INHPFCVNLYGSFKDESY  105 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh----CCCCCCcceEEEEEeCCE
Confidence            468889999999999999998643  36899999875422   223467789999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++|+|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ..    .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+......  .......      ....   
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~~i~~~------~~~~---  247 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--YQKILEG------IIYF---  247 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--HHHHhcC------CCCC---
Confidence            22    2345789999999999888899999999999999999999999987544211  1111100      0000   


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                              +......+.+++.+|++.||++|+     +++|+++
T Consensus       248 --------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        248 --------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                    112234577889999999999995     7887764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.9e-36  Score=336.89  Aligned_cols=241  Identities=27%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|+.+ +|+.||+|++.....   .....+..|+++++.    ++||||+++++++...+..|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~i~~~~~~~~~~~~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----TRHPFLTALKYAFQTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh----CCCCCCcceeeEEecCCEEEEEEeC
Confidence            46999999999999975 689999999976432   223456778888886    6799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~  152 (323)
T cd05595          77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1222


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||........  .........                 .
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~~~~~~~-----------------~  213 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELILMEEI-----------------R  213 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHhcCCC-----------------C
Confidence            345789999999999988999999999999999999999999976543211  111110000                 0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      .+.....++.+++.+|++.||++||     ++.++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            1122345678899999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=348.84  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=208.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCC-cEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE-Eec------
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDG-REVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW-CLD------  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~-~~~------  876 (1088)
                      .++++.++|.+|||+.||.|.+..+ .+||+|++.......-+.+++|+++|+.+.   .|+|||.+++. ...      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~---gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS---GHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc---CCCceeeEeccccccccCCCc
Confidence            4567789999999999999998765 999999998876666778999999999864   69999999993 221      


Q ss_pred             CCeEEEEEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          877 GSEKILVYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      ..++++.||||.||.|-|++..  ..++++.++++|++|+++|+++||.. .|+|||||||-+||||+.++..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            2467899999999999999974  34699999999999999999999997 56899999999999999999999999999


Q ss_pred             ceeecCCC-Ccc-------cccccccccccCccc---cCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh
Q 001384          955 ARVVSAGD-SHV-------STTIAGTVGYVAPEY---GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       955 a~~~~~~~-~~~-------~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      |.-..... ...       .-....|+.|+|||+   ..+...++|+|||||||+||-++....||++.....+      
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------  266 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------  266 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE------
Confidence            86432211 111       112357899999996   5577899999999999999999999999997533111      


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                  +...   ...+..+.....+.+||..||+++|++||++.+|+..+.++..
T Consensus       267 ------------lng~---Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 ------------LNGN---YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ------------Eecc---ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                        1100   0112235778899999999999999999999999999988753

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-35  Score=335.17  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|++++..    ++||||+++++++.+++..+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE----CNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHH----CCCCcccceeEEEEECCEEE
Confidence            368999999999999999999976 68889999887542 2234568899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.++++....+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+|||++......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999999999988888999999999999999999999852  7999999999999999999999999998755321


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc--------
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR-------- 1033 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1033 (1088)
                         ......++..|+|||++.+..++.++||||+||++|||++|+.||........................        
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               223356889999999998888999999999999999999999999865432222111100000000000        


Q ss_pred             ------------------cccchhhcCCCccc-cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 ------------------AVIPVVLLGSGLAE-GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ------------------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                        ...+.......... ......++.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                              00000000000000 0112356889999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=352.84  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             CCCccceecccCceEEEEEEeC-C-CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-D-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.    ++||||+++++++..++..|+|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~----l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA----CDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHh----CCCCCEeEEEEEEEECCEEEEE
Confidence            4888999999999999999865 3 67888888765544444567889999986    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          884 YEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      |||+++|+|.++++.    ..++++.++..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999999988754    34689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +.......             
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~~~~-------------  285 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQVLY-------------  285 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-------------
Confidence            4322 1234467999999999999889999999999999999999999999865431  11111110             


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         +...+.+.....++.+++.+|++.||++||++++++.
T Consensus       286 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 ---GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0000112223457888999999999999999999864

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.6e-36  Score=331.52  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=207.7

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|.+.+.||+|+||+||++...      ++..+|+|.+..........+.+|++++.+    ++||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN----LQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEecCC
Confidence            46888899999999999999842      345689999987644455678999999986    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          879 EKILVYEYMEGGSLEDIISDRT-------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      ..++||||+++++|.+++....             .+++.+++.++.|++.||+|||+.   +++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999999997543             389999999999999999999998   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          946 KALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      .+|++|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.......  .....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i  235 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI  235 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence            9999999999765432211 1223345778999999988899999999999999999998 899987654311  11111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                      ....                ....+...+.++.+++.+|++.||.+||++.|+.+.|+++.+..
T Consensus       236 ~~~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         236 TQGR----------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HcCC----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            1000                00011123356889999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-36  Score=300.97  Aligned_cols=254  Identities=26%  Similarity=0.332  Sum_probs=208.5

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      ....+|.-.+.+|+|..++|-++..+ +|.++|+|++......        -.+...+|+.+++++.   .||+|+.+.+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~---GHP~II~l~D   90 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM---GHPYIIDLQD   90 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc---CCCcEEEeee
Confidence            44567888899999999999999876 6889999988643211        1245678999999864   8999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          873 WCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                      +|+.+...++|+|.|+.|.|.|++...-.+++++.++|++|+..|++|||..   +||||||||+|||++++..+||+||
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999999999988999999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCC------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQT------WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      |+|+...+++  .....+||++|.|||.+..      ..|+..+|+||+||++|-++.|.+||-......+--......|
T Consensus       168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            9999887543  4567899999999997653      3678899999999999999999999976444322211111111


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...               .+...+......++|.+|++.||.+|.|++|+++
T Consensus       246 qF~---------------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 QFR---------------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccC---------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111               1122344456788999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-35  Score=329.87  Aligned_cols=253  Identities=28%  Similarity=0.451  Sum_probs=205.4

Q ss_pred             CCCccceecccCceEEEEEEeCC------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +|++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++.+    ++||||+++++++....
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~----l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSD----LQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHh----cCCcccceEEEEEcCCC
Confidence            57888999999999999998642      25799999875432 234568899999986    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          879 EKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ..+++|||+++|+|.+++...                ..+++.+++.++.|++.||+|||+.   +++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            999999999999999999764                4578899999999999999999999   999999999999999


Q ss_pred             CCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHH
Q 001384          943 KEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWG 1020 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 1020 (1088)
                      +++.++|+|||+++.....+. .......++..|+|||.+....++.++|||||||++|||++ |..||.+....  +..
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~  236 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI  236 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence            999999999999986543332 12233456788999999888899999999999999999998 99999865431  111


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      .....                +.....+...+.++.+++.+|++.||.+||+++||++.|+++
T Consensus       237 ~~i~~----------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         237 EMIRS----------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHc----------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11110                001111334557899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.3e-36  Score=328.07  Aligned_cols=254  Identities=30%  Similarity=0.472  Sum_probs=209.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ..+|++.+.||+|+||.||+|.+.+++.+|+|.+.........++..|+.+++.    ++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKR----LRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhc----CCCcchhheeeeEecCCCeEEE
Confidence            346888999999999999999988899999999987755456778899999886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.++++..  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999999753  3589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .. ......++..|+|||......++.++||||||+++|+|++ |+.||......  +.......               
T Consensus       158 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~---------------  219 (261)
T cd05148         158 VY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITA---------------  219 (261)
T ss_pred             cc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHh---------------
Confidence            21 1223345678999999888899999999999999999998 89999765421  11111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                       +...+.+...+..+.+++.+|++.||++||+++++++.|+.+
T Consensus       220 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             000111233446788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-36  Score=336.18  Aligned_cols=238  Identities=26%  Similarity=0.304  Sum_probs=194.8

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||.||+|++. +++.||+|++.+..   ......+..|++++.+    ++||||+++++++.+++..++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQ----VNCPFIVPLKFSFQSPEKLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCcEeceeeEEecCCeEEEEEcCCC
Confidence            699999999999976 57899999987542   1223467789999886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +|+|.+++....++++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            999999998888899999999999999999999999   99999999999999999999999999987543222 22344


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG 1048 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1088)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+...  .+.........                 ...+
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~~~~~~~~~~-----------------~~~~  213 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQEP-----------------LRFP  213 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--HHHHHHHHcCC-----------------CCCC
Confidence            6789999999999998999999999999999999999999986533  22222222100                 0112


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCC---HHHHH
Q 001384         1049 AEEMSELLRIGVRCTAEAPNARPN---VKEVL 1077 (1088)
Q Consensus      1049 ~~~~~~l~~li~~cl~~dP~~RPs---~~eil 1077 (1088)
                      ......+.+++.+|++.||++||+   +.|++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            223456788999999999999985   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-36  Score=329.88  Aligned_cols=247  Identities=35%  Similarity=0.575  Sum_probs=194.1

Q ss_pred             ccceecccCceEEEEEEeC-----CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          809 EDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.+.||+|+||.||+|.++     .+..|+||+++..... ..+++.+|++.+.+    ++||||++++|++...+..++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~----l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRK----LRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHT----HSBTTBE-EEEEEESSSSEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccc----ccccccccccccccccccccc
Confidence            4578999999999999976     2568999999654322 35789999999986    689999999999998888999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.++++..  ..+++.++..|+.||+.||+|||+.   +++|+||+++||++++++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999999999886  6799999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          961 GDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       961 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... ..........|+|||.+....++.++||||||+++|||++ |+.||.....  .++.......            
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~------------  221 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQG------------  221 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTT------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccc------------
Confidence            2221 2233456789999999988889999999999999999999 7789876533  1221211100            


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                          .....+...+..+.+++.+||+.||++||++.||++.|
T Consensus       222 ----~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 ----QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                00111223456788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=324.94  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=206.0

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.+.||+|+||+||+|.++.    ...||||++...... ...++.+|+.++.+    ++||||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQ----FDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHh----CCCCCcceEeEEEecCCc
Confidence            468889999999999999999742    457999998765322 34578889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++++|.+++... ..+++.+++.++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++..
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999999764 4689999999999999999999998   9999999999999999999999999999877


Q ss_pred             cCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          959 SAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       959 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ...... ......++..|+|||...+..++.++||||||+++|+|++ |..||......  +.........         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~---------  225 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY---------  225 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC---------
Confidence            522221 1222345678999999988899999999999999999998 99998654321  1111111000         


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                             ..+.+...+..+.+++.+|++.+|++||++.||++.|++++
T Consensus       226 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         226 -------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                   00112233457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-35  Score=327.74  Aligned_cols=265  Identities=21%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++    ++||||+++++++..+...++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKN----LKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHh----CCCCCEeeEEEEEcCCCeEEE
Confidence            56899999999999999999976 688999999875432 234567789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ +|.+++.... .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9999975 9999887644 478999999999999999999999   9999999999999999999999999999765322


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCC------CCc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHG------PGR 1033 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~ 1033 (1088)
                      .. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... ...............      ...
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            21 2233467899999998754 57899999999999999999999999865431 111111111000000      000


Q ss_pred             cccchhhcCC----CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGS----GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +.........    ..........+..+++.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000000    00001122356789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.7e-35  Score=323.07  Aligned_cols=253  Identities=28%  Similarity=0.420  Sum_probs=205.2

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++    ++||||+++++++. +...++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~----l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKK----LRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHh----CCCCCcceEEEEEC-CCCcEEEE
Confidence            56899999999999999999987777899999986432 34678899999987    67999999999875 45578999


Q ss_pred             EecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++|+|.+++++.  ..+++..+..++.|++.||+|+|+.   +++||||||+||++++++.++|+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999753  3589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........++..|+|||+..+..++.++||||||+++|||++ |..||.+......  ......                
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~~~~~----------------  218 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVER----------------  218 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HHHHhc----------------
Confidence            322223446678999999988899999999999999999999 8888876533111  111110                


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..........+..+.+++.+|+++||++||++.++++.|++.+
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            0001112334567889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-35  Score=323.79  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +|++.+.||+|+||+||+|..+++..+|+|.+.... ....++.+|+.++.+    ++||||+++++++.+....++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMK----LSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhc----CCCCCeeeEEEEEccCCCcEEEEE
Confidence            577889999999999999998777789999987543 335678999999986    679999999999999889999999


Q ss_pred             ecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          886 YMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      |+++|+|.+++... ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999764 4689999999999999999999999   9999999999999999999999999998866433222


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      ......++..|+|||...+..++.++||||||+++|+|++ |..||.......  ..........               
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~---------------  219 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR---------------  219 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC---------------
Confidence            2222345678999999988889999999999999999998 999997654311  1111110000               


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                       ...+......+.+++.+|++.+|.+||++.++++.++
T Consensus       220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             0001122467888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-35  Score=336.25  Aligned_cols=241  Identities=26%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|+.+ +++.||+|++.+...   .....+.+|+++++.    ++||||+++++++..++..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN----TRHPFLTSLKYSFQTKDRLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCCCcceEEEEEcCCEEEEEEeC
Confidence            46999999999999975 689999999976432   223467788888886    6899999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......  +........      .           ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~~~------~-----------~~  213 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME------D-----------IK  213 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhccC------C-----------cc
Confidence            3457899999999999889999999999999999999999999765331  111111100      0           00


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      .+.....++.+++.+|++.||++||     ++.|+++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            1122345678899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=322.66  Aligned_cols=249  Identities=31%  Similarity=0.455  Sum_probs=201.6

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +|++.+.||+|+||.||+|.++++..+|+|++.... ....++.+|+++++.    ++||||+++++++......++|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMK----LSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHh----CCCCCEEEEEEEEcCCCceEEEEe
Confidence            477889999999999999998777789999987542 234578889999986    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          886 YMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      |+++++|.+++... ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999753 4689999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      ......++..|+|||...+..++.++||||||+++|||++ |+.||....... .+ ..... .               .
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~-~~~~~-~---------------~  218 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VV-ESVSA-G---------------Y  218 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HH-HHHHc-C---------------C
Confidence            1122234467999999988899999999999999999999 888987643311 11 11110 0               0


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                      ....+...+.++.+++.+|++.+|++||++.|+++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0011222456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-35  Score=334.73  Aligned_cols=241  Identities=29%  Similarity=0.405  Sum_probs=193.1

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      ++||+|+||+||+|+.. +++.||+|+++....   ...+.+..|..++...   .+||||+++++++..+...++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~hp~i~~~~~~~~~~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA---WEHPFLTHLFCTFQTKEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc---cCCCCccceeeEEEcCCEEEEEEcC
Confidence            46999999999999975 578999999976422   1223445566666532   4799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.++++...++++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999997653322 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||.+......  .......      .           ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~~------~-----------~~  214 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSILND------R-----------PH  214 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcC------C-----------CC
Confidence            445789999999999988999999999999999999999999987544211  1111100      0           00


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVK-EVL 1077 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1077 (1088)
                      .+.....++.+++.+|++.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1122335677888999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-35  Score=338.73  Aligned_cols=261  Identities=23%  Similarity=0.250  Sum_probs=199.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.+. +++.||+|+...      ..+.+|++++++    ++||||+++++++..+...++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRA----INHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHh----CCCCCCCCEeEEEEECCeeEE
Confidence            367999999999999999999975 688999997543      346789999987    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||++. ++|.+++.....+++.+++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||+++......
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            999995 69999998888899999999999999999999999   99999999999999999999999999997543322


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch------hHHHHHHhhhccCC---CCC--
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE------CLVEWGRRVMGYGR---HGP-- 1031 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~------~~~~~~~~~~~~~~---~~~-- 1031 (1088)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ..............   ...  
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            2233446799999999999888999999999999999999999988754321      00111000000000   000  


Q ss_pred             Cccccchhh---------c-CCCc--cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVL---------L-GSGL--AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~---------~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .........         . ....  ......+.++.+++.+|++.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000         0 0000  001123457889999999999999999999984

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=337.84  Aligned_cols=362  Identities=25%  Similarity=0.255  Sum_probs=198.4

Q ss_pred             cCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCC-CCceeecccccccccccCchhhhcccceEEecc
Q 001384          104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLR-SLEILDLSVNRIHGEISFSFPAICEKLVVANLS  182 (1088)
Q Consensus       104 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~  182 (1088)
                      .-+.||+|+|.+...-+..|.++++|++++|.+|.++..+.+++.+ +|+.|+|.+|.|+..-...+. .++.|+.|||+
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~-~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELS-ALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHH-hHhhhhhhhhh
Confidence            3456777777777666777777777777777777777666655543 477777777777654444443 33667777777


Q ss_pred             CccCCCCCCccccCCCCCcEEEccCccccc---cccccCcccceecccCcccccccccccccCCCccCEEEcCCCccccc
Q 001384          183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD  259 (1088)
Q Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  259 (1088)
                      .|.|+.+....|..-.++++|+|++|+++.   .-+.++.+|..|.|++|+++ .++...|++++.|+.|+|..|+|.-.
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeee
Confidence            777777766667666677777777777664   23444455555555555554 34555555555555555555555422


Q ss_pred             CcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcc
Q 001384          260 FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRF  339 (1088)
Q Consensus       260 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  339 (1088)
                      --..|.++++|+.|.|..|.|+......|..+.++++|+|+.|++..+--.++.++++|+.|+||+|.|..+-++.+.-.
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft  316 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT  316 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence            23445555555555555555554444455555555555555555555555555555555555555555555544444444


Q ss_pred             cccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCC---cccCCCCCCc
Q 001384          340 TQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP---AVYGNMPNLQ  416 (1088)
Q Consensus       340 ~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~  416 (1088)
                      ++|+.|+|++|+ +....+..|..+..|++|.|++|+++..-...|..+++|+.|||++|.++..+.   ..|..|++|+
T Consensus       317 qkL~~LdLs~N~-i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr  395 (873)
T KOG4194|consen  317 QKLKELDLSSNR-ITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR  395 (873)
T ss_pred             ccceeEeccccc-cccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence            444444444444 233344444444444444555554443333344444555555555555444332   1234445555


Q ss_pred             EEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEcc
Q 001384          417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLS  469 (1088)
Q Consensus       417 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  469 (1088)
                      .|+|.+|+|....-..|.++..|++|||.+|.|...-|..|..+ .|++|.+.
T Consensus       396 kL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  396 KLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             heeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence            55555555542222344455555555555555544444444444 44444443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-35  Score=340.90  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|+..+.||+|+||+||+|++. +++.||+|++.+...   .....+..|++++..    ++||||+++++++.+.+..+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~----l~h~~iv~l~~~~~~~~~~~   77 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE----ADNEWVVKLYYSFQDKDNLY   77 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh----cCCCCeeeeEEEEecCCEEE
Confidence            5888999999999999999975 688999999976432   223467889999886    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++.+...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++++||+|||+++.+...
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999997543110


Q ss_pred             CC----------------------------------------------cccccccccccccCccccCCCCCCcchhHHHH
Q 001384          962 DS----------------------------------------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSF  995 (1088)
Q Consensus       962 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  995 (1088)
                      ..                                              .......||..|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123569999999999988889999999999


Q ss_pred             HHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhh--hcccCCCCCCCH
Q 001384          996 GVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVR--CTAEAPNARPNV 1073 (1088)
Q Consensus       996 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~ 1073 (1088)
                      ||++|||++|+.||..........  .........    ..+         .......++.+++.+  |+..+|..||++
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~--~i~~~~~~~----~~~---------~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQL--KVINWENTL----HIP---------PQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHH--HHHcccccc----CCC---------CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            999999999999998754422211  111000000    000         011123456677777  556677779999


Q ss_pred             HHHHH
Q 001384         1074 KEVLA 1078 (1088)
Q Consensus      1074 ~eil~ 1078 (1088)
                      +|+++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-35  Score=329.26  Aligned_cols=256  Identities=30%  Similarity=0.468  Sum_probs=207.6

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++    ++||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN----LQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhc----CCCCCcceEEEEEccCC
Confidence            35778899999999999999842      345699999887655555778999999986    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          879 EKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ..++||||+++++|.+++....                .+++..++.++.|++.|++|||++   +|+||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence            9999999999999999996532                388999999999999999999999   999999999999999


Q ss_pred             CCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHH
Q 001384          943 KEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEW 1019 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~ 1019 (1088)
                      .++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999976543221 11233456788999999988899999999999999999999 99998765431 1111


Q ss_pred             HHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                         ... ..               ....+...+..+.+++.+|+++||++||++.+|+++|+++.+.
T Consensus       238 ---~~~-~~---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ---ITQ-GR---------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HhC-CC---------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               110 00               0001122345788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-35  Score=328.19  Aligned_cols=253  Identities=31%  Similarity=0.482  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.+.+|++++..    +.||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN----FQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHh----cCCCCchheeeEEecC
Confidence            458888999999999999998643      478999999865433 45688999999986    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT--------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK  943 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~  943 (1088)
                      ...++||||+++++|.++++..+              .+++.++..++.|++.|++|||+.   +++||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence            99999999999999999997542              478999999999999999999999   9999999999999999


Q ss_pred             CCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHH
Q 001384          944 EGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGR 1021 (1088)
Q Consensus       944 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 1021 (1088)
                      ++.+|++|||+++....... .......++..|+|||++.+..++.++||||+|+++|||++ |..||.......  ...
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~  235 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE  235 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH
Confidence            99999999999976533221 11223345788999999999999999999999999999998 999987654311  111


Q ss_pred             hhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ....                +.....+...+..+.+++.+|++.||++||++.||++.|++
T Consensus       236 ~~~~----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 CITQ----------------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHc----------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1110                00001112334678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=9e-40  Score=341.34  Aligned_cols=424  Identities=27%  Similarity=0.381  Sum_probs=308.8

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      .++.++.++|+++ .+|.+++.+.+|+.|+.++|++. .+|+.++.+-.|+.|+..+|+++. .|..+.++.+|..|++.
T Consensus        92 ~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~  168 (565)
T KOG0472|consen   92 ALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLE  168 (565)
T ss_pred             HHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhcc
Confidence            4455555555555 77888888888999999999988 778888888889999998888876 57778888889999999


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|++...+|.... ++.|+.|+..+|-+  ...+..++.+.+|+.|+|.+|++. .+| +|..+..|++|+++.|+|. .
T Consensus       169 ~n~l~~l~~~~i~-m~~L~~ld~~~N~L--~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~  242 (565)
T KOG0472|consen  169 GNKLKALPENHIA-MKRLKHLDCNSNLL--ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-M  242 (565)
T ss_pred             ccchhhCCHHHHH-HHHHHhcccchhhh--hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-h
Confidence            9999888888777 88888888888864  344666788999999999999999 788 8999999999999999999 7


Q ss_pred             CCcccC-CCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhc
Q 001384          405 IPAVYG-NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT  483 (1088)
Q Consensus       405 ~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~  483 (1088)
                      +|.+.. ++++|.+|||.+|+++ ..|+.++.+.+|++||+++|.++ .+|.++|++ .|+.|-+.||++. +|-.++.+
T Consensus       243 lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~  318 (565)
T KOG0472|consen  243 LPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIIS  318 (565)
T ss_pred             hHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHc
Confidence            887776 8999999999999999 89999999999999999999999 689999999 9999999999998 67666654


Q ss_pred             cCCCCCccccccccCCcccccCCccccccccccCCCCCCCcce--eeehhccccchhhhhcccCCcccccccCCCccc--
Q 001384          484 IGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFV--YTILTRKSCRSLWDRLLKGTGIFPVCLPGLASR--  559 (1088)
Q Consensus       484 ~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~--  559 (1088)
                      .+....+.+-......    .|-++...- ..-....++..++  |...+.    ...+...+....+|.........  
T Consensus       319 ~gT~~vLKyLrs~~~~----dglS~se~~-~e~~~t~~~~~~~~~~~~i~t----kiL~~s~~qlt~VPdEVfea~~~~~  389 (565)
T KOG0472|consen  319 KGTQEVLKYLRSKIKD----DGLSQSEGG-TETAMTLPSESFPDIYAIITT----KILDVSDKQLTLVPDEVFEAAKSEI  389 (565)
T ss_pred             ccHHHHHHHHHHhhcc----CCCCCCccc-ccccCCCCCCcccchhhhhhh----hhhcccccccccCCHHHHHHhhhcc
Confidence            4433222221110000    000000000 0000011111111  111000    00111111111222222111110  


Q ss_pred             --------------------ceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccC
Q 001384          560 --------------------TFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTR  618 (1088)
Q Consensus       560 --------------------~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~  618 (1088)
                                          .-+.+..+.+++|.++ -+|..+..+++|..|+|++|-+. .+|.+++.+ .|+.||++.
T Consensus       390 Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~  467 (565)
T KOG0472|consen  390 VTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF  467 (565)
T ss_pred             eEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence                                0011122445555554 67777888999999999999888 899999888 799999999


Q ss_pred             CcccccCCccccCCccCcEEEccccccCCcCCcc-cccccccceeeccCCCCccccCCCCCcccccccCccCCCCCCC
Q 001384          619 NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS-FNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLD  695 (1088)
Q Consensus       619 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~  695 (1088)
                      |+|. .+|..+..+..|+.+-.++|++. .+|.+ +.++.+|..|||.+|.+ .-..|..|.+.++...-..|||.-.
T Consensus       468 NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdl-q~IPp~LgnmtnL~hLeL~gNpfr~  542 (565)
T KOG0472|consen  468 NRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDL-QQIPPILGNMTNLRHLELDGNPFRQ  542 (565)
T ss_pred             cccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCch-hhCChhhccccceeEEEecCCccCC
Confidence            9998 89999999999999888899997 55554 99999999999999999 3333445888888888889998764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.6e-35  Score=333.49  Aligned_cols=242  Identities=27%  Similarity=0.361  Sum_probs=195.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|++.+.||+|+||.||+|+++ +++.||||++.+...   ...+.+..|.+++....   +|++|+++++++.+.+..|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~i~~~~~~~~~~~~~~   77 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG---KPPFLTQLHSCFQTMDRLY   77 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC---CCCceeeeEEEEEcCCEEE
Confidence            4788899999999999999976 578999999976422   22345677888877632   4567889999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++.....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999998753221


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      . .......||..|+|||++.+..++.++||||+||++|||++|+.||.+......  ........              
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~~~--------------  217 (324)
T cd05587         155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIMEHN--------------  217 (324)
T ss_pred             C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHcCC--------------
Confidence            1 123345789999999999998999999999999999999999999987543211  11111000              


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                         ...+......+.+++.+|++.||.+|++.
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               00011233567889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-35  Score=333.60  Aligned_cols=237  Identities=29%  Similarity=0.393  Sum_probs=193.3

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|+++ +++.||||++.+...   .....+..|..++...   .+||||+++++++.+.+..|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~h~~iv~~~~~~~~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA---RNHPFLTQLYCCFQTPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc---cCCCchhceeeEEEcCCEEEEEEcC
Confidence            46999999999999976 588999999976421   2234566777777653   3799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~  153 (320)
T cd05590          78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT  153 (320)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999987643221 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +....+.....                 .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~~-----------------~  214 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILNDEV-----------------V  214 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCCC-----------------C
Confidence            3457899999999999889999999999999999999999999875431  11122211000                 0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      .+.....++.+++.+|++.||++||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            111234567889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=340.84  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=205.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||++.....   .....+..|++++..    ++||||+++++++.+++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~   76 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD----ADSPWIVKLYYSFQDEEHL   76 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHh----cCCCCccchhhheecCCeE
Confidence            46899999999999999999976 689999999976432   234567889999886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.+...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999999999998888899999999999999999999998   999999999999999999999999999986643


Q ss_pred             CC----------------------------CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC
Q 001384          961 GD----------------------------SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012 (1088)
Q Consensus       961 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 1012 (1088)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11223456899999999999989999999999999999999999999876


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-VKEVLA 1078 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 1078 (1088)
                      ...  +.......+.....    .+         .......++.+++.+|+. ||.+||+ ++|+++
T Consensus       234 ~~~--~~~~~i~~~~~~~~----~p---------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 TLQ--ETYNKIINWKESLR----FP---------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CHH--HHHHHHhccCCccc----CC---------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            531  11222221111000    00         011134578888899997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-35  Score=327.68  Aligned_cols=252  Identities=29%  Similarity=0.378  Sum_probs=211.0

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|++.+......   ..+.+|+++|+++.   .|||||.++++|++..
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~---~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS---GHPNIVQLKDAFEDPD  109 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc---CCCCEEEEEEEEEcCC
Confidence            3467889999999999999999987 499999999988765443   58999999999843   3999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CCEEEeeccc
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE----GKALVTDFGL  954 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~----~~~kl~Dfg~  954 (1088)
                      ..++|||+++||.|.+.+... .+++.++..++.|++.++.|+|+.   ||+|||+||+|+++...    +.+|++|||+
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999999776 499999999999999999999998   99999999999999743    4799999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      +.....  .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+..+...........+   .... 
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---~f~~-  259 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---DFTS-  259 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---CCCC-
Confidence            998765  3445678999999999999999999999999999999999999999998764222221111111   0000 


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 +........+.+++++|+..||.+|+++.++++
T Consensus       260 -----------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  260 -----------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -----------CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                       112233466778888999999999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-35  Score=333.75  Aligned_cols=247  Identities=27%  Similarity=0.342  Sum_probs=196.5

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |++.+.||+|+||.||+|.++ +++.||||++++...   ...+.+..|.+++.... .++||||+++++++......|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~-~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN-SERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-ccCCCChhceeeEEEcCCEEEE
Confidence            667899999999999999975 689999999975421   22345667776654332 3689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|..+++. ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999998865 4699999999999999999999999   99999999999999999999999999987533211


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....  +..........              
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~--------------  218 (324)
T cd05589         156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEV--------------  218 (324)
T ss_pred             -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC--------------
Confidence             2233467899999999999889999999999999999999999999875432  11121110000              


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                         ..+......+.+++.+|++.||.+||+     +.++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               011223456788999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=337.03  Aligned_cols=363  Identities=26%  Similarity=0.305  Sum_probs=330.9

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLS  157 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls  157 (1088)
                      .+..|++++|.|...-+..|-++++|+.+++.+|.++ .||...+...+|+.|+|.+|.|+...  .++.++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            3567999999999888888999999999999999999 89998888899999999999999754  68899999999999


Q ss_pred             cccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc---cccccCcccceecccCcccccc
Q 001384          158 VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGV  234 (1088)
Q Consensus       158 ~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~~~~l~~L~~L~L~~n~l~~~  234 (1088)
                      .|.|+..--.+|++. .++++|+|++|.|+......|.++.+|..|.|+.|+++.   ..+..|++|+.|+|..|.|. .
T Consensus       158 rN~is~i~~~sfp~~-~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-i  235 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAK-VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-I  235 (873)
T ss_pred             hchhhcccCCCCCCC-CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-e
Confidence            999996666667665 689999999999999999999999999999999999875   56778999999999999998 5


Q ss_pred             cccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccC
Q 001384          235 VSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN  314 (1088)
Q Consensus       235 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  314 (1088)
                      +....|.++.+|+.|.|..|.+...-...|..+.++++|+|+.|+++..-..++.+++.|+.|+|++|.|..+.+++..-
T Consensus       236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsf  315 (873)
T KOG4194|consen  236 VEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSF  315 (873)
T ss_pred             ehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhh
Confidence            56778999999999999999999888899999999999999999999888889999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCc---cccCCcCc
Q 001384          315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV---EISQMRSL  391 (1088)
Q Consensus       315 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~l~~l~~L  391 (1088)
                      .++|++|+|++|+|+...+..|..|.+|+.|.|++|+ ++.+....|..+++|+.|||++|.++..+.+   .|..+++|
T Consensus       316 tqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns-i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~L  394 (873)
T KOG4194|consen  316 TQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS-IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSL  394 (873)
T ss_pred             cccceeEeccccccccCChhHHHHHHHhhhhcccccc-hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhh
Confidence            9999999999999999999999999999999999999 4566677888999999999999999876654   47789999


Q ss_pred             ceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcccc
Q 001384          392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN  447 (1088)
Q Consensus       392 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  447 (1088)
                      +.|.|.+|++..+.-.+|..++.|++|||.+|.|...-|..|..+ .|++|.+..-
T Consensus       395 rkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  395 RKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             hheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence            999999999995555789999999999999999998889999998 8998887553

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=340.33  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||++.....   .....+.+|++++..    ++||||+++++++.++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~----l~h~~iv~~~~~~~~~~~~   76 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE----ADNPWVVKLYYSFQDENYL   76 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCCCcceEEEEEcCCeE
Confidence            46889999999999999999976 689999999976421   223457789999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCc-------------------------------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 001384          961 GDSH-------------------------------------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELA 1003 (1088)
Q Consensus       961 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 1003 (1088)
                      ....                                     ......||+.|+|||++....++.++||||+||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011246899999999998889999999999999999999


Q ss_pred             hCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC---HHHHHH
Q 001384         1004 TGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN---VKEVLA 1078 (1088)
Q Consensus      1004 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 1078 (1088)
                      +|..||......  +.......+....    ..+.         .......+.+++.+|+. +|.+|++   ++|+++
T Consensus       234 ~G~~Pf~~~~~~--~~~~~i~~~~~~~----~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQ--ETYRKIINWKETL----QFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHH--HHHHHHHcCCCcc----CCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999999875432  1112222111100    0000         01123466778889996 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-35  Score=333.10  Aligned_cols=241  Identities=26%  Similarity=0.367  Sum_probs=196.8

Q ss_pred             ceecccCceEEEEEEe----CCCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.||+|+||.||+|+.    ..++.||||++.+...    .....+..|+++++.    ++||||+++++++..++..|+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~----l~hp~iv~~~~~~~~~~~~~l   77 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA----VKHPFIVDLIYAFQTGGKLYL   77 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHh----CCCCchhceeeEEecCCeEEE
Confidence            6799999999999985    2578999999976422    223457789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|.++++....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999999999888899999999999999999999999   99999999999999999999999999987543222


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||......  ..........               
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~~~~~~~---------------  216 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKILKGK---------------  216 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC---------------
Confidence             2233457899999999998888999999999999999999999999875431  1111111000               


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                        ...+......+.+++.+|++.||++||     ++.++++
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              001122335678899999999999999     7777755

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.9e-35  Score=333.06  Aligned_cols=242  Identities=27%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|++.+.||+|+||.||+|+++ +++.||+|++.+....   ....+..|..++...   .+|++|+++++++.+.+..+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS---GKPPFLTQLHSCFQTMDRLY   77 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc---cCCCeEeeEEEEEecCCEEE
Confidence            4788899999999999999976 5789999999865322   223456677776653   36899999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++.....+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus        78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+......  ...+.....             
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~~~~~-------------  218 (323)
T cd05616         155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEHNV-------------  218 (323)
T ss_pred             -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHHhCCC-------------
Confidence             1223345789999999999999999999999999999999999999987644211  111110000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                          ..+.....++.+++.+|++.||++|++.
T Consensus       219 ----~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ----AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                0112234567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.7e-35  Score=336.70  Aligned_cols=203  Identities=25%  Similarity=0.376  Sum_probs=176.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+...   .....+..|+.++.+    ++||||+++++++.++...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~----~~~~~iv~~~~~~~~~~~~   76 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE----ADSLWVVKMFYSFQDKLNL   76 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHh----CCCCCcceEEEEEecCCeE
Confidence            46889999999999999999975 688999999976422   223467788888886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++.+...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999999999888999999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 001384          961 GDS----------------------------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006 (1088)
Q Consensus       961 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 1006 (1088)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012357999999999998889999999999999999999999


Q ss_pred             cCCCCCch
Q 001384         1007 RALEGGEE 1014 (1088)
Q Consensus      1007 ~p~~~~~~ 1014 (1088)
                      .||.+...
T Consensus       234 ~Pf~~~~~  241 (363)
T cd05628         234 PPFCSETP  241 (363)
T ss_pred             CCCCCCCH
Confidence            99987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=317.65  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=210.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +=|.+.+.||+|.|++|-+|++- +|..||||++.+....  ...++.+|++.|+.    ++|||||++|++.......|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKL----VQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKL----VQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHH----hcCcCeeeeeehhcccceEE
Confidence            45778899999999999999965 8999999999876543  34678999999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Dfg~a~~~~  959 (1088)
                      +|+|.-++|+|+|||.++ ..+.+.-+.+++.||+.|+.|+|+.   .+|||||||+||++- .-|-||++|||++-.+.
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999999998654 4599999999999999999999999   899999999998875 56899999999998876


Q ss_pred             CCCCcccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ++.  ...+.+|...|-|||++.+-.|+ +++||||+|||+|.+++|+.||+..++.  +...                 
T Consensus       171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ETLT-----------------  229 (864)
T KOG4717|consen  171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ETLT-----------------  229 (864)
T ss_pred             Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--hhhh-----------------
Confidence            543  45667899999999998888886 5689999999999999999999976541  1111                 


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .++.+.-..|.....++.++|..|+..||.+|.+.+||+.
T Consensus       230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            1223444557788889999999999999999999999974

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.7e-35  Score=320.92  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=203.5

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++    ++|+|++++++++. ....++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~----l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKK----LRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHh----cCCCceEEEEeEEC-CCCcEEEE
Confidence            46888999999999999999988888899999976533 34678999999987    67999999999875 45678999


Q ss_pred             EecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++++|.++++..  ..+++.+++.++.|++.|++|||+.   +++||||||+||++++++.++++|||.+..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999753  3589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........++..|+|||...+..++.++||||||+++|||++ |..||.+...  .+....... .              
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~-~--------------  219 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVER-G--------------  219 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc-C--------------
Confidence            222222345668999999888889999999999999999999 8889876432  111111110 0              


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                       ...+.+...+..+.+++.+|++++|++||+++++.+.|++
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0001122334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-35  Score=327.96  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++..... .....+.+|+.+++.    ++||||+++++++.++...+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG----LKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhh----CCCCCcCeEEEEEecCCeEE
Confidence            367999999999999999999976 688999999875432 223467789999986    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||++ ++|.+++... ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9999996 5888877654 5689999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC----CC---
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PG--- 1032 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~--- 1032 (1088)
                      .. .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+................    ..   
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            22 22234567899999998754 46889999999999999999999999875432222111111000000    00   


Q ss_pred             -ccccchhhcCCCccccH------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 -RAVIPVVLLGSGLAEGA------EEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 -~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ....+............      .....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000000000000000      11245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.6e-35  Score=333.05  Aligned_cols=242  Identities=27%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      ++||+|+||.||+|+++ +++.||+|++.+...   .....+..|.+++...   .+||||+++++++.+++..|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~---~~hp~i~~~~~~~~~~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA---AKHPFLTALHCCFQTKDRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhc---cCCCCccceeeEEEcCCeEEEEEeC
Confidence            46999999999999976 578999999976422   2234566788877653   3799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999987643222 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||....+..  .........      ..           
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~i~~~~------~~-----------  214 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFESILHDD------VL-----------  214 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC------CC-----------
Confidence            34578999999999998899999999999999999999999998764421  111121100      00           


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCC-------CHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARP-------NVKEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~ 1078 (1088)
                      .+.....++.+++.+|++.||++||       ++.++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            0111235678899999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=295.39  Aligned_cols=262  Identities=25%  Similarity=0.345  Sum_probs=206.6

Q ss_pred             HcCCCCccceecccCceEEEEEE-eCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      ..++|++.+.+|+|||+.||.++ ..+++.+|+|++.....+..+..++|++..++    ++|||+++++++...+    
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rk----f~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRK----FNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHh----hCCcchHHHHHHHHHhhccC
Confidence            35789999999999999999999 45788999999988766777889999999987    7899999999987543    


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          878 -SEKILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                       .+.|++++|...|+|.+.++..    ..+++.+.++|+.+|++||++||+. .++++||||||.||++++++.+++.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence             3489999999999999988653    3599999999999999999999998 345999999999999999999999999


Q ss_pred             ccceeecCC--CCcc------cccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH
Q 001384          953 GLARVVSAG--DSHV------STTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021 (1088)
Q Consensus       953 g~a~~~~~~--~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 1021 (1088)
                      |.++...-.  .+..      ...-..|..|+|||.+.-   ...++++|||||||++|+|+.|..||+...+       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            998754311  1110      122346889999997654   3568999999999999999999999975211       


Q ss_pred             hhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                            +.....-.+-...  ...+........+.++++.|++.||.+||++.|++..++.++
T Consensus       247 ------~GgSlaLAv~n~q--~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ------QGGSLALAVQNAQ--ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------cCCeEEEeeeccc--cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  0000000000000  011122336678999999999999999999999999998765

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-35  Score=334.74  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=203.1

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-  876 (1088)
                      ++|++.+.||+|+||.||+|...      +++.||+|++...... ..+.+..|+.++.++.   +|+||+++++++.. 
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~---~h~niv~~~~~~~~~   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG---HHLNVVNLLGACTKP   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc---cCcchhheeeeEecC
Confidence            57999999999999999999742      3478999999754322 2346778999888732   79999999998765 


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc---------------------------------------------------------
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR---------------------------------------------------------  899 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------  899 (1088)
                      +...+++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45688999999999999998542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc-ccccccccc
Q 001384          900 ----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVG  974 (1088)
Q Consensus       900 ----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~  974 (1088)
                          .++++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+....... .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                2578999999999999999999999   99999999999999999999999999998764332222 223455678


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHH
Q 001384          975 YVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMS 1053 (1088)
Q Consensus       975 y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1088)
                      |+|||++.+..++.++||||+||++|||++ |..||.+..... .+...... ..               ....+.....
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~-~~---------------~~~~~~~~~~  303 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKE-GT---------------RMRAPEYATP  303 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhc-cC---------------CCCCCccCCH
Confidence            999999999999999999999999999998 999997643211 11111110 00               0001122345


Q ss_pred             HHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1054 ELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1054 ~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ++.+++.+|++.+|++||++.|+++.|++++.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.9e-35  Score=326.37  Aligned_cols=267  Identities=25%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----  876 (1088)
                      .+|++.+.||+|+||+||+|++.  +++.||+|++......  ....+.+|+++++.+. .+.||||+++++++..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE-TFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhc-ccCCCCcceEEEEEecccCC
Confidence            36899999999999999999863  4688999998754322  2345667777776543 3579999999998852    


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          877 -GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                       ....++||||++ ++|.+++...  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence             456899999996 5999998753  3589999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      +++.....  .......|+..|+|||.+....++.++||||+||++|||++|+.||.+..+ ..................
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            99876432  223445689999999999888999999999999999999999999987644 111111111100000000


Q ss_pred             --ccccchhhcCCCccc-----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 --RAVIPVVLLGSGLAE-----GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 --~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ....+..........     .......+.+++.+|++.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              000000000000000     0123356778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-35  Score=307.64  Aligned_cols=266  Identities=26%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCc-eeEEeeEEecCC--
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPN-LVTLYGWCLDGS--  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~n-iv~l~~~~~~~~--  878 (1088)
                      ..|...++||+|+||+||+|+.+ +|+.||+|+++-....  ......+|+.++..    ++|+| ||++++++...+  
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~----L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKR----LSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHH----hCCCcceEEEEeeeeecccc
Confidence            34666788999999999999965 7899999999866432  23456889999997    67999 999999998877  


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEe
Q 001384          879 ----EKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT  950 (1088)
Q Consensus       879 ----~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~  950 (1088)
                          ..++||||++- +|.+++....    .++...+..++.|++.||+|+|++   +|+||||||+||+|+++|.+||+
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence                78999999966 9999997755    477889999999999999999999   99999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccC-
Q 001384          951 DFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYG- 1027 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~- 1027 (1088)
                      |||+|+.+.-.. ...+...+|..|+|||++.+. .|+...||||+||+++||++++..|.+..+. ...-....+.-+ 
T Consensus       163 DFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  163 DFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             ccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            999999665222 223455788999999976654 8999999999999999999999999987551 111112222111 


Q ss_pred             -CCCCCccccchhhcC-C----CccccHHH---HHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1028 -RHGPGRAVIPVVLLG-S----GLAEGAEE---MSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1028 -~~~~~~~~~~~~~~~-~----~~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       ..++.-...+..... .    ........   ..+..+++.+|++.+|.+|.++++++..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111111111111000 0    00001111   1367889999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-35  Score=336.25  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=197.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-----
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-----  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-----  877 (1088)
                      +|++.+.||+|+||.||+|++. +++.||||++....  ......+.+|+++++.    ++||||+++++++...     
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~~   76 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRL----LRHPDIVEIKHIMLPPSRREF   76 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHh----CCCCCEeeecceEeccCCCCC
Confidence            5888999999999999999975 68999999987532  2233467889999986    6799999999988643     


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ...|+||||++ ++|.+++.....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        77 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          77 KDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            24799999995 69999998888899999999999999999999999   999999999999999999999999999976


Q ss_pred             ecCCCC--cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCC---
Q 001384          958 VSAGDS--HVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRH--- 1029 (1088)
Q Consensus       958 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~--- 1029 (1088)
                      ......  .......||..|+|||++.+  ..++.++||||+||++|||++|+.||.+.... ..............   
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  12234578999999998765  67899999999999999999999999765321 11111111000000   


Q ss_pred             -----CCCccccchhhcCCCc---cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 -----GPGRAVIPVVLLGSGL---AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 -----~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ................   .........+.+++.+|++.||++||+++|+++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 0000000000000000   000112346788999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-34  Score=317.97  Aligned_cols=257  Identities=24%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+++++.    ++||||+++++++.+.+..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   77 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ----LNHPNVIKYLDSFIEDNEL   77 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHh----CCCcceeeeeeeEEECCeE
Confidence            57899999999999999999975 78999999876432   2233568889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++++|||.+.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999999999998853    34589999999999999999999999   99999999999999999999999999988


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ....... ......++..|+|||...+..++.++||||+|+++|||++|+.||........++.........        
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  225 (267)
T cd08228         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--------  225 (267)
T ss_pred             eccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--------
Confidence            7643221 1223467889999999988889999999999999999999999997654333333332211000        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      +       ..........+.+++.+|++.+|++||++.||++.++++.
T Consensus       226 ~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 P-------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             C-------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0       0012234467889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-35  Score=324.99  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=201.8

Q ss_pred             HcCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ..++|++.+.||+|+||.||+|.++      .++.||||++..... ....++.+|+.+++.    ++||||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~----l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE----FNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCeeeEEEEEc
Confidence            3567999999999999999999853      246799999865422 234568889998886    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT----------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      ++...++||||+++|+|.++++...          .+++..+..++.|++.|++|||+.   +++||||||+||++++++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence            9999999999999999999997532          357889999999999999999998   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          946 KALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      .++++|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....  +.....
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~  234 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFV  234 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            9999999998765432221 1122345778999999988899999999999999999999 78888765331  111111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ....                ....+...+..+.+++.+|++.||++||++.|+++.|++
T Consensus       235 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 MEGG----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcCC----------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1000                000112234578889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=327.39  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=217.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeCC-CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ...+.....+||-|.||.||.|.|+. .-.||||.++.+.. .-++|..|..+|+.    ++|||+|+++|+|..+..+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKe----ikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKE----IKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHh----hcCccHHHHhhhhccCCCeE
Confidence            33455667899999999999999974 56799999987743 35689999999997    78999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||+|||..|+|.||+++..+  ++.--.+++|.||+.||+||..+   ++|||||.++|+|+.++..+||+|||+++.+.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999987654  77778889999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ......+....-++.|.|||.+....++.|+|||+|||+|||+.| |-.||.+-+-  .+.+....              
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LLE--------------  480 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLLE--------------  480 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHh--------------
Confidence            655555555667889999999999999999999999999999998 6677776432  11111111              


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                        .+.+...+..|+..++++++.||+..|.+||+++||-+.||.++..
T Consensus       481 --kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  481 --KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             --ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence              1122233667888999999999999999999999999999988754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-35  Score=328.95  Aligned_cols=241  Identities=30%  Similarity=0.432  Sum_probs=193.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|++. +++.||||+++....   .....+..|..++...   .+||||+++++++.+++..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~hp~iv~~~~~~~~~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---WEHPFLTHLYCTFQTKENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc---cCCCcCcceEEEEEeCCEEEEEEeC
Confidence            46999999999999976 578999999976421   2234456677777642   4899999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            99999999998888899999999999999999999999   999999999999999999999999999875432221 22


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||.+.....  ...... ...     ..           
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~-~~~-----~~-----------  214 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIR-MDN-----PC-----------  214 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-hCC-----CC-----------
Confidence            34578999999999998899999999999999999999999998754311  111111 000     00           


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVK-EVL 1077 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1077 (1088)
                      .+.....++.+++.+|++.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            0112234677889999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.7e-35  Score=320.22  Aligned_cols=252  Identities=28%  Similarity=0.442  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++    ++|||++++++++. .+..++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~----l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQ----LQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHh----cCCcCeeeEEEEEc-cCCcEEE
Confidence            457889999999999999999988899999999886533 34678899999986    67999999999864 4568999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.+++...  ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++++|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999998653  3689999999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........++..|+|||+.....++.++||||||+++|||++ |+.||.+.....  ....... ..            
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~-~~------------  220 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLER-GY------------  220 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHc-CC------------
Confidence            3222233445678999999988889999999999999999999 999997654311  1111110 00            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                         ..+.+...+.++.+++.+|++.+|++||++++++..|+.
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 ---RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               001112234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4e-35  Score=331.01  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=203.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|++.+.||+|+||.||+|++. +++    .||+|++.... ....+++..|+.+++.    ++||||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEcCC-
Confidence            46899999999999999999864 333    48999987543 2334678889998886    6899999999998765 


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++|+||+++|+|.++++.. ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            567999999999999999764 4689999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      +....... .....++..|+|||.+....++.++||||||+++|||++ |+.||.+....  ++..... ...       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~-~~~-------  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE-KGE-------  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHh-CCC-------
Confidence            65432221 122334678999999998899999999999999999998 99999765331  1111111 000       


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                              ..+.+..+..++.+++.+|++.+|++||++.+++..+.++.+
T Consensus       229 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                    001112233568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.9e-35  Score=321.53  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++    ++||||+++++++..+...++|
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~----~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE----CKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHh----cCCCCeeeeeEEEEeCCEEEEE
Confidence            57999999999999999999974 688999999976543444567889999886    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.++++...++++.++..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            99999999999998888899999999999999999999998   99999999999999999999999999998764321 


Q ss_pred             cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          964 HVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .......++..|+|||.+.   ...++.++||||+||++|||++|+.||.........  ...   ..    ......  
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~---~~----~~~~~~--  229 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM---SK----SNFQPP--  229 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee---ec----CCCCCC--
Confidence            1123346788999999874   345788999999999999999999998654221000  000   00    000000  


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                         ...........+.+++.+|++.+|++||+++++++.
T Consensus       230 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         230 ---KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ---CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence               000112234678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-35  Score=334.72  Aligned_cols=241  Identities=26%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|..+ +|+.||+|++.+....   ....+..|++++..    ++||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~----~~hp~i~~~~~~~~~~~~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN----SRHPFLTALKYSFQTHDRLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCCCCceEEEEEcCCEEEEEEeC
Confidence            46999999999999965 6899999999764322   23456778888875    6799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      +++|+|.+++.....+++.++..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~  152 (325)
T cd05594          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GAT  152 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccc
Confidence            9999999999888889999999999999999999997 6   9999999999999999999999999998754322 122


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....||..|+|||++.+..++.++||||+||++|||++|+.||.+....  +..........                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~~~-----------------  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILMEEI-----------------  213 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcCCC-----------------
Confidence            23456899999999998889999999999999999999999999765431  11111110000                 


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      ..+.....++.+++.+|++.||++|+     +++++++
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            00112335678899999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.3e-35  Score=335.15  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|+++....   ...+.+.+|+.++..    .+||||+++++++.++...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~----~~~~~i~~~~~~~~~~~~~   76 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI----SNSPWIPQLQYAFQDKDNL   76 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCCCcceeeEEecCCeE
Confidence            36889999999999999999976 689999999986532   233457788888876    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++|+|.+++++. ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            9999999999999999876 6799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQ------TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ...........||+.|+|||++.      ...++.++|||||||++|||++|+.||......  ..............  
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~--  229 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYNNIMNFQRFLK--  229 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HHHHHHHcCCCccC--
Confidence            43333334457899999999876      456789999999999999999999999865431  11222221111000  


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .         +........+.+++.+|++ +|.+||+++++++
T Consensus       230 --~---------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 --F---------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --C---------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              0         0111234567788889998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-35  Score=333.62  Aligned_cols=240  Identities=25%  Similarity=0.324  Sum_probs=192.4

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      ++||+|+||.||+|+++ +++.||+|++++....   ....+..|..++...   .+||||+++++++.++...|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~---~~hp~Iv~~~~~~~~~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA---SNHPFLVGLHSCFQTESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc---cCCCCCCceEEEEEcCCEEEEEEeC
Confidence            46999999999999976 6889999999864322   224577888888763   2799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++....++++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~  153 (329)
T cd05588          78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT  153 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch------hHHHHHHhhhccCCCCCCccccchhh
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE------CLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||.....      ...++.....                
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------  217 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI----------------  217 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH----------------
Confidence            346789999999999998999999999999999999999999963211      1111211111                


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      .......+......+.+++.+|++.||.+||++
T Consensus       218 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         218 LEKQIRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            001111122234567889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-35  Score=333.25  Aligned_cols=240  Identities=25%  Similarity=0.323  Sum_probs=191.9

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|+.+ +++.||+|++.+...   .....+..|..++.+.   .+||||+++++++..++..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~---~~hp~iv~~~~~~~~~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPFLVGLHSCFQTESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc---CCCCcCCceeeEEEeCCEEEEEEeC
Confidence            46999999999999976 678999999986432   2234567788877653   3799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++....++++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~  153 (329)
T cd05618          78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT  153 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch------hHHHHHHhhhccCCCCCCccccchhh
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE------CLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||.....      ....+......               
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~---------------  218 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------------  218 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh---------------
Confidence            346789999999999999999999999999999999999999963211      11112111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                       ......+......+.+++.+|++.||++||++
T Consensus       219 -~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 -EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             00011122334567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.2e-35  Score=329.55  Aligned_cols=241  Identities=30%  Similarity=0.429  Sum_probs=193.8

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|+++ +|+.||+|++++...   ........|..++...   .+||||+++++++.+++..|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~~i~~~~~~~~~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA---WENPFLTHLYCTFQTKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc---cCCCCccCeeEEEEeCCEEEEEECC
Confidence            46999999999999976 688999999976421   2234456677776542   4799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++....++++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            99999999998888899999999999999999999999   99999999999999999999999999987532221 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||.+....  +....... ..     .           .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~-~~-----~-----------~  214 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRV-DT-----P-----------H  214 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-CC-----C-----------C
Confidence            4467899999999999989999999999999999999999999865432  11111110 00     0           0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVK-EVL 1077 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1077 (1088)
                      .+.....++.+++.+|++.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0111234677889999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-35  Score=339.51  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=196.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|+..+.||+|+||+||+|+.. +++.||+|++.+...   .....+.+|+++++.    ++||||+++++++.++...|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~----~~h~~iv~~~~~~~~~~~~~   77 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE----ADNEWVVRLYYSFQDKDNLY   77 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh----CCCCcCCeEEEEEEeCCEEE
Confidence            5888999999999999999975 688999999976432   223467889999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999997533110


Q ss_pred             C----------------------------------------------CcccccccccccccCccccCCCCCCcchhHHHH
Q 001384          962 D----------------------------------------------SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSF  995 (1088)
Q Consensus       962 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  995 (1088)
                      .                                              ........||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123468999999999998899999999999


Q ss_pred             HHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC---
Q 001384          996 GVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN--- 1072 (1088)
Q Consensus       996 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 1072 (1088)
                      ||++|||++|+.||.+.......  .....+.....    .+         .......++.+++.+|+ .+|++|++   
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~--~~i~~~~~~~~----~p---------~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQ--MKVINWQTSLH----IP---------PQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHH--HHHHccCCCcC----CC---------CcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            99999999999999876442211  11111110000    00         01112345666676765 49999997   


Q ss_pred             HHHHHH
Q 001384         1073 VKEVLA 1078 (1088)
Q Consensus      1073 ~~eil~ 1078 (1088)
                      ++|+++
T Consensus       299 ~~ei~~  304 (382)
T cd05625         299 ADEIKA  304 (382)
T ss_pred             HHHHhc
Confidence            777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=347.24  Aligned_cols=252  Identities=28%  Similarity=0.356  Sum_probs=202.2

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-  878 (1088)
                      ..++|++.+.||+|+||+||+|++. +|+.||||++......  ....+.+|+.++..    ++|+|++++++.+.... 
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~----~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN----CDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhc----CCCCcEEEeecceecccc
Confidence            3468999999999999999999965 6899999998765322  23467788888875    67999999988765432 


Q ss_pred             -------eEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          879 -------EKILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       879 -------~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                             ..++||||+++|+|.++++..    ..+++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence                   367999999999999998653    4689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          948 LVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...  .+........
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~~~~~~~~  260 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAG  260 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhcC
Confidence            9999999987643221 223446799999999999998999999999999999999999999986532  2222222110


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                                      ...+.+.....++.+++.+|++.||.+||++.++++.
T Consensus       261 ----------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 ----------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                            0011122344678889999999999999999999763

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.6e-35  Score=329.17  Aligned_cols=242  Identities=29%  Similarity=0.382  Sum_probs=196.2

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|.++ +++.||||++++...   .....+..|.+++....   +||||+++++++.+.+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~---~h~~i~~~~~~~~~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG---KHPFLTQLHSCFQTKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc---CCCCccceeeEEEcCCEEEEEEcC
Confidence            46999999999999976 578999999986432   22345667888877532   799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.+..++++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++...... ...
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (318)
T cd05570          78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT  153 (318)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence            99999999998888899999999999999999999999   99999999999999999999999999987532221 222


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....|+..|+|||++.+..++.++||||+||++|+|++|+.||.+....  +.........                 ..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~~~~-----------------~~  214 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSILEDE-----------------VR  214 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCC-----------------CC
Confidence            3456899999999999999999999999999999999999999865431  1111111000                 00


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNV-----KEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 1078 (1088)
                      .+......+.+++.+|++.||.+||++     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            112234567889999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.5e-35  Score=323.14  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|++.+.||+|+||+||+|..     ..++.||+|.+..... .....+.+|++++++    ++||||+++++++..+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE----LHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhh----CCCCCeeeEEEEEecCC
Confidence            3578889999999999999984     2457899999975432 233578889999987    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001384          879 EKILVYEYMEGGSLEDIISDR-----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL  941 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll  941 (1088)
                      ..++||||+++++|.+++...                 ..+++.++..++.|++.||+|||++   +++||||||+||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili  157 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILI  157 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEE
Confidence            999999999999999998532                 2378899999999999999999999   99999999999999


Q ss_pred             cCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCch-hHHH
Q 001384          942 DKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEE-CLVE 1018 (1088)
Q Consensus       942 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~-~~~~ 1018 (1088)
                      ++++.+|++|||+++....... .......++..|+|||+..+..++.++||||||+++|||++ |..||.+... ...+
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987543221 12233445678999999988889999999999999999998 8889876543 1222


Q ss_pred             HHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ......                   ..+.+...+.++.+++.+|+++||++||++.+|.+.|.+
T Consensus       238 ~~~~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRKRQ-------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHcCC-------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            211100                   001122234578889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.6e-35  Score=339.72  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.+...   .....+.+|++++.+    +.||||+++++++.+++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~----l~h~~iv~~~~~~~~~~~~   76 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE----ADNEWVVKLYYSFQDKDNL   76 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHh----CCCCCcceEEEEEEcCCEE
Confidence            36899999999999999999975 689999999875422   233567889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|..+..
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999753310


Q ss_pred             CC------------------------------------------CcccccccccccccCccccCCCCCCcchhHHHHHHH
Q 001384          961 GD------------------------------------------SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVL  998 (1088)
Q Consensus       961 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~  998 (1088)
                      ..                                          ........||+.|+|||++.+..++.++||||+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000123468999999999999899999999999999


Q ss_pred             HHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC---CHHH
Q 001384          999 AMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP---NVKE 1075 (1088)
Q Consensus       999 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 1075 (1088)
                      +|||++|+.||.+.....  +......+....    ..+         ........+.+++.+|+ .+|.+|+   ++.|
T Consensus       234 lyell~G~~Pf~~~~~~~--~~~~i~~~~~~~----~~~---------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE--TQLKVINWETTL----HIP---------SQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             eeehhhCCCCCCCCCHHH--HHHHHhccCccc----cCC---------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            999999999998765421  111111111100    000         01112345666777776 5999999   8888


Q ss_pred             HHH
Q 001384         1076 VLA 1078 (1088)
Q Consensus      1076 il~ 1078 (1088)
                      +++
T Consensus       298 ll~  300 (376)
T cd05598         298 IKA  300 (376)
T ss_pred             HhC
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-34  Score=322.59  Aligned_cols=268  Identities=27%  Similarity=0.380  Sum_probs=204.2

Q ss_pred             CC-CccceecccCceEEEEEEe-----CCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-
Q 001384          806 KF-SEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       806 ~~-~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-  877 (1088)
                      +| +..+.||+|+||+||++..     .+++.||+|.+..... .....+.+|+++++.    ++||||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT----LYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHh----CCCCCEeeEEEEEecCC
Confidence            44 8889999999999988653     3577899999976532 234678899999986    6799999999987653 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||+++++|.+++... .+++.+++.++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence             4678999999999999999764 599999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........  ......++..|+|||......++.++||||||+++|||++|..||........+.......   ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~  232 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG---QMTVVR  232 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc---ccchhh
Confidence            76432221  1122345667999999988889999999999999999999999987543321111110000   000000


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+....+...+.+...+..+.+++.+|++.+|++||++++|++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00001111111223344568899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.8e-35  Score=322.87  Aligned_cols=269  Identities=28%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--C
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--G  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~  877 (1088)
                      .+|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|++++++    ++||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS----LQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHh----CCCCCeeEEEEEEccCCC
Confidence            4688899999999999999974     2578999999987654555678899999987    679999999998754  3


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            4688999999999999999764 4689999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC-c
Q 001384          957 VVSAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG-R 1033 (1088)
Q Consensus       957 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1033 (1088)
                      .........  .....++..|+|||+..+..++.++||||||+++|||++|..++......   +............. .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  233 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchH
Confidence            764332211  11223345699999998889999999999999999999998876543221   11111000000000 0


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      ...+........+.+...+..+.+++.+|++.+|++||++.||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000001111112233456788999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-34  Score=317.09  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|++|.||+|.+..+..+|+|++.... ...+.+.+|++++++    +.|||++++++++. ....++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKK----LRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHh----CCCCCeeeEEEEEc-CCCcEEEE
Confidence            4688889999999999999998777789999887543 334678899999986    67999999999875 45678999


Q ss_pred             EecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++|+|.++++...  .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999997643  489999999999999999999998   99999999999999999999999999998764332


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........++..|+|||...+..++.++||||+|+++|||++ |+.||.+.....  ..........             
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------------  221 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR-------------  221 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-------------
Confidence            222223345678999999988899999999999999999999 899997654311  1111110000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                         ...+...+..+.+++.+|++.||++||++++|++.|++
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01122334678889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.3e-35  Score=316.97  Aligned_cols=247  Identities=26%  Similarity=0.396  Sum_probs=196.9

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      +.||+|+||.||+|.++ +++.||+|.+.... ......+.+|++++++    +.||||+++++++......++||||++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQ----YSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            46999999999999975 68899999887543 2334578899999886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc-c
Q 001384          889 GGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-S  966 (1088)
Q Consensus       889 ~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~  966 (1088)
                      +++|.+++.... .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++.......... .
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            999999997644 589999999999999999999999   99999999999999999999999999987543221111 1


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....+..|+|||.+.+..++.++||||+|+++|||++ |..||........  ...... .               ...
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~~~-~---------------~~~  215 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIEQ-G---------------VRL  215 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHHHc-C---------------CCC
Confidence            11123457999999988899999999999999999998 8888865433111  111110 0               000


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ..+...+..+.+++.+|++.+|++||++.|+.++|++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1122334578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.3e-35  Score=335.88  Aligned_cols=247  Identities=27%  Similarity=0.403  Sum_probs=193.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +|+..+.||+|+||.||+|++. +++.||||++..... .....+.+|+++++.    ++|+||+++++++...+..++|
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD----VNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHh----CCCCCcceeeeEeccCCeEEEE
Confidence            4566789999999999999975 689999999875432 234578899999986    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++|+|.+.    ...++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++...... 
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            999999998653    2456788899999999999999999   99999999999999999999999999998764321 


Q ss_pred             cccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          964 HVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .......||..|+|||++..     ...+.++|||||||++|||++|+.||.....  .+|.........          
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~----------  290 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICM----------  290 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhc----------
Confidence            12234578999999998743     2345689999999999999999999974322  112111110000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                         ......+.....++.+++.+||+.||++||++.|+++.
T Consensus       291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00011122344678899999999999999999999863

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-35  Score=318.64  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=206.5

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.+++++.||||.+.... ...+++.+|+.++++    ++|||++++++++......++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKK----LRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhh----CCCCCEeeeeeeeecCCceEEE
Confidence            46789999999999999999998878899999988653 345678999999987    6799999999999988999999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.+++....  .+++.++..++.|++.|++|||+.   +++|+||||+||++++++.+|++|||.++.....
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999997643  689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ..........+..|+|||...+..++.++||||+|+++|+|++ |+.||.+....  .........              
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~--------------  220 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERG--------------  220 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC--------------
Confidence            2222222334568999999988889999999999999999998 99999765331  111111100              


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                        ...+.+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus       221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0001112224578889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-35  Score=337.86  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|... +++.||||++.+...   ...+.+.+|++++..    ++||||+++++++.++...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~----l~hp~iv~~~~~~~~~~~~   76 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE----SDSPWVVSLYYSFQDAQYL   76 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHh----CCCCCcceEEEEEEcCCee
Confidence            46889999999999999999975 689999999875421   223467889999886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999864321


Q ss_pred             CCCc----------------------------------------------ccccccccccccCccccCCCCCCcchhHHH
Q 001384          961 GDSH----------------------------------------------VSTTIAGTVGYVAPEYGQTWQATTKGDVYS  994 (1088)
Q Consensus       961 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  994 (1088)
                      ....                                              ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                              001246899999999998889999999999


Q ss_pred             HHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCC---C
Q 001384          995 FGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNAR---P 1071 (1088)
Q Consensus       995 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---P 1071 (1088)
                      +||++|||++|..||.+.....  ....+..+.....    ++         .......++.+++.+|++ +|.+|   +
T Consensus       234 lGvil~elltG~~Pf~~~~~~~--~~~~i~~~~~~~~----~p---------~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE--TYRKIINWRETLY----FP---------DDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH--HHHHHHccCCccC----CC---------CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            9999999999999998654311  1111211111000    00         011123467788889997 66665   5


Q ss_pred             CHHHHHH
Q 001384         1072 NVKEVLA 1078 (1088)
Q Consensus      1072 s~~eil~ 1078 (1088)
                      ++.|+++
T Consensus       298 ~~~~~l~  304 (377)
T cd05629         298 GAHEIKS  304 (377)
T ss_pred             CHHHHhc
Confidence            8988875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.7e-35  Score=323.12  Aligned_cols=241  Identities=27%  Similarity=0.337  Sum_probs=193.4

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||+||+|.++ +++.||+|++.......   .+.+..|+++++.    ++||||+++.+++..+...++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~----l~~~~i~~~~~~~~~~~~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK----VHSRFIVSLAYAFQTKTDLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHh----CCCCcEeeeeEEEcCCCeEEEEEeCCC
Confidence            699999999999976 68899999987643222   2456778888886    689999999999999999999999999


Q ss_pred             CCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          889 GGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       889 ~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+........ 
T Consensus        77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9999988743    34689999999999999999999999   999999999999999999999999999987643322 


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCCCCCCccccchhhcC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ......|++.|+|||++.+..++.++||||+|+++|||++|+.||......  ..+.......                 
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------  215 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-----------------  215 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-----------------
Confidence            223457899999999999999999999999999999999999999764321  1111111110                 


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      .....+......+.+++.+|++.||++||     +++++++
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         216 DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            00011223446788899999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=315.14  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-----chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-----GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|++|.||+|... +++.||+|.+......     ..+.+.+|++++++    ++||||+++++++.++.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN----LQHERIVQYYGCLRDDE   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHh----CCCCCeeeeEEEEccCC
Confidence            46889999999999999999965 6899999998754221     12467889998886    68999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..++||||+++++|.+++.....+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.++..
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999999999998888899999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCccc--ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          959 SAGDSHVS--TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       959 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ........  ....++..|+|||...+..++.++||||+|+++|||++|+.||.........+  .......    .   
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~----~---  225 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF--KIATQPT----N---  225 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH--HHhccCC----C---
Confidence            43222111  23457789999999998889999999999999999999999997653321111  1110000    0   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                              ...+......+.+++.+|++.+|.+||++.|+++.
T Consensus       226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    01122334568889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-34  Score=317.44  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=208.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|... +++.+|||.+.....   ....++.+|+++++.    ++||||+++++++.+++..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~   77 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ----LNHPNVIKYYASFIEDNEL   77 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHH----ccCCchhhhhheeEeCCeE
Confidence            46888899999999999999964 789999998865322   223578889999886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++++|.++++.    ...+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.++++|||++.
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999999998864    34589999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ....... ......++..|+|||...+..++.++||||||+++|+|++|..||.+......++.........        
T Consensus       155 ~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  225 (267)
T cd08229         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--------  225 (267)
T ss_pred             ccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC--------
Confidence            6543221 2233468889999999988889999999999999999999999997654332222222210000        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      +       ..........+.+++.+|++.||++||++.+|+++++++.
T Consensus       226 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 P-------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C-------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0       0011234567889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.3e-35  Score=334.62  Aligned_cols=254  Identities=24%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   .....+.+|+.+++.    ++||||+++++++.++.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~----~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----ANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh----CCCCCEeeEEEEEEcCC
Confidence            3467999999999999999999976 578999999875321   223457788888886    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||++...
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999999999654 589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTW----QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ............||+.|+|||++...    .++.++||||+||++|||++|+.||.+....  .....+........   
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~---  267 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GTYSKIMDHKNSLN---  267 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCcccC---
Confidence            54333333456799999999987653    3788999999999999999999999865431  11122211000000   


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLAM 1079 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1079 (1088)
                       .+         ........+.+++.+|++.+|.+  ||++.|+++.
T Consensus       268 -~p---------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 -FP---------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -CC---------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             00         01122355677888999855544  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=324.32  Aligned_cols=247  Identities=30%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|++.++||+|+||+||++... +++.||||++......   ....+.+|+.+++.    ++||||+++++++..++..+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   76 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK----VNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHh----cCCCCEeeeeeeecCCCeEE
Confidence            4788899999999999999975 6899999998754322   23456789999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +||||+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999999988653  3589999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH--HHHHhhhccCCCCCCccccc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV--EWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ...  ......|+..|+|||++.+..++.++||||+|+++|||++|+.||.+......  +......             
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-------------  218 (285)
T cd05605         154 EGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-------------  218 (285)
T ss_pred             CCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-------------
Confidence            322  12234688999999999888999999999999999999999999986543111  1111111             


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                          ......+......+.+++.+|++.||++||     +++++++
T Consensus       219 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         219 ----EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                000111223456788899999999999999     7888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.1e-35  Score=325.98  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=201.1

Q ss_pred             CCCCccceecccCceEEEEEEeCC-Cc--EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-GR--EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|.+++ +.  .+++|.++... ....+.+.+|++++.++.   +||||+++++++.+....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG---HHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc---CCCchhheEEEEccCCcc
Confidence            578899999999999999999753 33  47888887432 223456888999988632   699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          881 ILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++||||+++|+|.++++...                .+++..++.++.|++.|++|||+.   +|+||||||+||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence            99999999999999996532                478899999999999999999998   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      +.+||+|||++......  ........+..|+|||+..+..++.++|||||||++|||++ |+.||......  +.....
T Consensus       156 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~  231 (297)
T cd05089         156 LASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKL  231 (297)
T ss_pred             CeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence            99999999998643211  11112233567999999988889999999999999999997 99999765431  111111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..                +.....+......+.+++.+|++.+|.+||+++++++.|+++..
T Consensus       232 ~~----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         232 PQ----------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             hc----------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            10                00001122234578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.4e-35  Score=334.24  Aligned_cols=252  Identities=24%  Similarity=0.291  Sum_probs=200.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   .....+..|+.+++.    ++||||+++++++.++..
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~----~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH----ANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh----CCCCCcceEEEEEecCCE
Confidence            357899999999999999999976 688999999975321   223457788998886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999999998664 589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTW----QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ...........||+.|+|||++...    .++.++||||+||++|||++|+.||.+....  .....+.......    .
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~----~  267 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMDHKNSL----T  267 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHHHHHcCCCcC----C
Confidence            3332233456799999999987643    4789999999999999999999999875431  1111121100000    0


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~ 1078 (1088)
                      .+         ........+.+++.+|++.+|.+  ||+++|+++
T Consensus       268 ~~---------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         268 FP---------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CC---------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            00         01123457788899999999988  999999965

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-34  Score=317.20  Aligned_cols=247  Identities=27%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          812 IIGKGGFGTVYRGVLP---DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      .||+|+||.||+|.++   +++.+|+|+++....  ...+++..|+.+++.    +.||||+++++++. ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQ----LDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHh----CCCCCcceEEEEEc-CCCcEEEEec
Confidence            5899999999999753   578899999875432  234578889999886    67999999999875 4567899999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc-
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-  965 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  965 (1088)
                      +++|+|.+++.....+++..+..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||+++......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999999998878899999999999999999999999   99999999999999999999999999998764333211 


Q ss_pred             -cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          966 -STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       966 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                       .....++..|+|||......++.++||||||+++|||++ |+.||......  ++........                
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~----------------  215 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE----------------  215 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC----------------
Confidence             122234578999999888889999999999999999998 99999865432  2222221100                


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+.+...+.++.+++.+|++.||++||++++|++.|++.+
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence            00112234467889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.9e-35  Score=328.70  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|+..+.||+|+||+||+|+.+ +|+.||+|++.+...   ...+.+..|..++...   .+|++|+++++++.+.+..|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ---DKPPFLTQLHSCFQTVDRLY   77 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc---cCCCchhheeeEEecCCEEE
Confidence            3677899999999999999975 688999999976422   2224566777777653   25788899999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus        78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                       ........||..|+|||++.+..++.++||||+||++|||++|+.||.+.....  ....+.....             
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~~~-------------  218 (323)
T cd05615         155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNV-------------  218 (323)
T ss_pred             -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC-------------
Confidence             122334568999999999988899999999999999999999999998764421  1111211000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                          ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 ----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                0011233567889999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.8e-35  Score=321.99  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=203.1

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|...+.||+|+||.||+|...      ++..+|+|.+..........+.+|+++++.    ++|+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV----LQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhc----CCCCCCceEEEEEecCC
Confidence            45777899999999999999742      356799999886655556689999999986    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 001384          879 EKILVYEYMEGGSLEDIISDRT---------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK  943 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~  943 (1088)
                      ..++||||+++|+|.+++....               .+++..++.++.|++.|++|||+.   +++||||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence            9999999999999999997643               478999999999999999999998   9999999999999999


Q ss_pred             CCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHH
Q 001384          944 EGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGR 1021 (1088)
Q Consensus       944 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 1021 (1088)
                      ++.+||+|||++......... ......++..|+|||...+..++.++|||||||++|||++ |..||....+...  ..
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~  235 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE  235 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HH
Confidence            999999999999765432211 1222345678999999988899999999999999999998 8999876433111  11


Q ss_pred             hhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      .... ..               ....+...+..+.+++.+|++.||.+||++.||++.|++
T Consensus       236 ~~~~-~~---------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQ-GR---------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHc-Cc---------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1110 00               001112234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-34  Score=322.62  Aligned_cols=255  Identities=28%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +|++.+.||+|+||.||+|...      ....+|+|.+...... ...++.+|+.+++.    +.||||+++++++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ----VNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhh----CCCCCEeeEEEEEecCC
Confidence            4788899999999999999853      2357889988765322 23568889999986    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          879 EKILVYEYMEGGSLEDIISDR------------------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      ..++||||+++|+|.+++...                        ..+++.+++.++.|++.|++|||+.   +++||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence            999999999999999998642                        2478899999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGG 1012 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 1012 (1088)
                      ||+||++++++.+||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |..||.+.
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999997654332221 222345678999999888889999999999999999998 99999765


Q ss_pred             chh-HHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1013 EEC-LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1013 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ... ..++.....                   ....+.....++.+++.+|++.+|++||+++|+++.|++++..
T Consensus       234 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         234 APERLFNLLKTGY-------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CHHHHHHHHhCCC-------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            431 111111100                   0001222345788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=331.29  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=216.7

Q ss_pred             CCccceecccCceEEEEEEeC-CC----cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DG----REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .+..++||+|+||+||+|.+- +|    -+||+|++.... .+...++.+|+-+|.+    ++|||+++++++|.... .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~mas----ldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMAS----LDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhc----CCCchHHHHhhhcccch-H
Confidence            445689999999999999963 44    369999988754 3445789999999986    78999999999998766 7


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .||++||+.|+|.|+++.+ +++..+..+.|..|||+||.|||++   .+|||||.++||||.+-.++||+|||+|+...
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            8999999999999999764 4789999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          960 AGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       960 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ..+... .....-.+.|||-|.+....|+.++|||||||.+||++| |..|+++.                  ..+++.+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi------------------~~~eI~d  911 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI------------------PAEEIPD  911 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC------------------CHHHhhH
Confidence            654333 233445678999999999999999999999999999888 99998874                  2344455


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..-.+.+++.|+.+..+++.++.+||..|+..||+++++...+.+..+
T Consensus       912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            555667788899999999999999999999999999999999987643

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.1e-34  Score=348.28  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.++||+|+||.||+|.+. +|+.||+|++.....   ...+++.+|++++++    ++||||+++++++.+++..
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~----L~HPNIVkl~~v~~d~~~l   77 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD----LIHPGIVPVYSICSDGDPV   77 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHh----CCCcCcCeEEEEEeeCCEE
Confidence            57999999999999999999976 589999999976422   224568899999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          881 ILVYEYMEGGSLEDIISDR-----------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      ++||||++||+|.++++..           ...++..+++++.||+.||+|||++   +|+||||||+||+++.++.++|
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEE
Confidence            9999999999999998641           2356778899999999999999999   9999999999999999999999


Q ss_pred             eecccceeecCCCC-----------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC
Q 001384          950 TDFGLARVVSAGDS-----------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 1012 (1088)
                      +|||+++.......                 .......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            99999987621110                 0112346899999999999999999999999999999999999999764


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHHhhCC
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKILP 1085 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~i~~ 1085 (1088)
                      ......+.....      .....          ......+..+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus       235 ~~~ki~~~~~i~------~P~~~----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        235 KGRKISYRDVIL------SPIEV----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             chhhhhhhhhcc------Chhhc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            332111111100      00000          00112345678899999999999996 67778888887654

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=315.77  Aligned_cols=248  Identities=34%  Similarity=0.475  Sum_probs=204.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.    ++|+|++++++++.+....++||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTT----LRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHh----cCCcceeeeEEEEcCCCCeEEEE
Confidence            46888999999999999999975 88999999987643 45678899999986    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++++|.++++...  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999997765  689999999999999999999999   99999999999999999999999999998663221


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                          .....+..|+|||......++.++||||+|+++|||++ |..||........  ...... ..             
T Consensus       157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~-~~-------------  216 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPHVEK-GY-------------  216 (256)
T ss_pred             ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhc-CC-------------
Confidence                12334668999999988889999999999999999997 9999876533111  111110 00             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                        ....+...+..+.+++.+|++.+|++||++.|++++|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0001122346788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-35  Score=330.01  Aligned_cols=241  Identities=25%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|+.. +++.||+|++.+....   ..+.+..|..++.+.   .+||+|+++++++.+....++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~---~~~~~i~~~~~~~~~~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQA---SSNPFLVGLHSCFQTTSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhh---cCCCCEeeEEEEEEeCCEEEEEEeC
Confidence            46999999999999975 5789999999865322   224577888887763   2799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++.....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (327)
T cd05617          78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT  153 (327)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch----hHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE----CLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....    ...++......                .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~  217 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL----------------E  217 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH----------------h
Confidence            346789999999999998999999999999999999999999964211    11111111110                0


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVK 1074 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1074 (1088)
                      .....+......+.+++.+|++.||++|+++.
T Consensus       218 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         218 KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            01111222335678899999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-34  Score=334.46  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=203.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|.+.+.||+|+||.||+|+++      .++.||+|++....... .+.+..|++++.++.   .||||+++++++..
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---~H~niv~~~~~~~~  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG---PHLNIVNLLGACTK  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC---CCCCeEEEEEEEcc
Confidence            346778899999999999999853      34689999998653222 346888999998732   39999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC--------------------------------------------------------
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT--------------------------------------------------------  900 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  900 (1088)
                      .+..++||||+++|+|.+++++..                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996531                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          901 ------------------------------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       901 ------------------------------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                                                                .+++.+++.++.|++.||+|||+.   +++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                      257778899999999999999998   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |++++++.+|++|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999986533221 11223456788999999988889999999999999999998 889987543211


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+ ..... ..               ....+.....++.+++.+|++.+|.+||+++||++.|++++
T Consensus       350 ~~~-~~~~~-~~---------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 QFY-NAIKR-GY---------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH-HHHHc-CC---------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111 11110 00               00112223467889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=319.07  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=200.7

Q ss_pred             CCccceecccCceEEEEEEeCC----CcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe-
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE-  879 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~-  879 (1088)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++.....  ....+..|++.++.    ++||||+++++++..... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD----FDHPNVMKLIGVCFEASSL   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHh----CCCCCeeeEEeeeccCCcc
Confidence            5678899999999999998642    367999998764322  23568889998886    679999999998876554 


Q ss_pred             -----EEEEEEecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          880 -----KILVYEYMEGGSLEDIISDR------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       880 -----~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                           .++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEE
Confidence                 78999999999999988442      3589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhcc
Q 001384          949 VTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      |+|||.++.+....... .....++..|+|||......++.++||||||+++|||++ |..||.+....  +....... 
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~-  230 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRH-  230 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc-
Confidence            99999998765433221 122335678999999988899999999999999999999 88888764331  12111110 


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                                     +.....+......+.+++.+|++.||.+||++.|+++.|++++
T Consensus       231 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         231 ---------------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             ---------------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                           0001112234467889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-35  Score=331.50  Aligned_cols=238  Identities=27%  Similarity=0.335  Sum_probs=190.8

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|+++ +|+.||+|++.+....   ...++..|...+.+   .++||||+++++++.+++..++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~---~l~hp~iv~~~~~~~~~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK---NVKHPFLVGLHYSFQTADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHh---hCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence            46999999999999976 6899999999754221   22344555544322   26899999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.++++....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~  153 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT  153 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753222 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  .+..........                 .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~-----------------~  214 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEMYDNILNKPL-----------------R  214 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHHHHHHHcCCC-----------------C
Confidence            345789999999999998999999999999999999999999986543  122222221000                 0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVK 1074 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1074 (1088)
                      .+......+.+++.+|++.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0112245678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-34  Score=317.49  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=204.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CC---cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DG---REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .+|+..+.||+|+||.||+|+++ ++   ..+|+|++.... ....+++..|++++.+    ++|||++++.+++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ----FSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhc----CCCCCeeEEEEEEccCCC
Confidence            36778899999999999999975 33   379999987552 2334578889998886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++++|.++++.. ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999999764 5789999999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCcccc--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHVST--TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .........  ....+..|+|||++....++.++||||||+++|||++ |+.||.....  .++........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~--------  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF--------  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCC--------
Confidence            432221111  1223457999999988889999999999999999997 9999976433  12222221000        


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                              ..+.+...+.++.+++.+|++.+|++||++.+|++.|++++
T Consensus       228 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 --------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                    00112223467889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.5e-35  Score=327.09  Aligned_cols=255  Identities=30%  Similarity=0.451  Sum_probs=200.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc--EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR--EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|++.... ......+.+|++++.++.   +||||+++++++..++..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~---~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---HHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc---CCCCcceEEEEECCCCCc
Confidence            46888899999999999999975 454  46777776432 223457888999988732   799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          881 ILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++||||+++|+|.++++...                .+++.+++.++.|++.|++|||+.   +++||||||+||+++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            99999999999999997542                478999999999999999999998   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      +.+||+|||++......  .......++..|+|||++.+..++.++|||||||++|||+| |..||......  +.....
T Consensus       161 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~  236 (303)
T cd05088         161 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL  236 (303)
T ss_pred             CcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH
Confidence            99999999998643211  11112234668999999888889999999999999999998 99999754321  111111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .. ..               ....+......+.+++.+|++.+|++||+++++++.++++++
T Consensus       237 ~~-~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         237 PQ-GY---------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             hc-CC---------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            10 00               000111233567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-34  Score=319.31  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=199.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+...... ...++..|+..+.+    +.||||+++++++.. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~----l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS----LDHAYIVRLLGICPG-A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhc----CCCCCcceEEEEECC-C
Confidence            46788899999999999999974 344    4777887543221 22456667777765    689999999998764 4


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++++||+++|+|.+++... ..+++..+..++.||+.||+|||+.   +++||||||+||++++++.+|++|||.++.
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            577899999999999999764 5689999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ....... ......++..|+|||...+..++.++||||||+++|||++ |+.||.+.... ..++....   ..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~------  229 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG---ER------  229 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---Cc------
Confidence            6433322 2233456778999999988899999999999999999998 99999775432 11211100   00      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                ...+..+...+.+++.+|+..||++||++.|+++.|+.+.+
T Consensus       230 ----------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 ----------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                      00011123467888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.5e-35  Score=327.04  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=204.1

Q ss_pred             CCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ++|.+.+.||+|+||.||+|++.        ++..+|+|.+..... ....++..|++++..+.   +||||+++++++.
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~~   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---KHKNIINLLGACT   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc---CCCCEeeEEEEEe
Confidence            56899999999999999999853        235699999986432 23356788999888632   6999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      ..+..++||||+++|+|.+++....                .+++.++++++.|++.||+|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            9999999999999999999997542                488999999999999999999998   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 1017 (1088)
                      +++.++.+||+|||.++......... .....++..|+|||...+..++.++||||+||++|||++ |..||.+...  .
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--H
Confidence            99999999999999987654322111 112234568999999988889999999999999999998 8888865432  1


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      +....... .               .....+.....++.+++.+|++.+|++||++.||++.|++++..
T Consensus       250 ~~~~~~~~-~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 ELFKLLKE-G---------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHHHHc-C---------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            22111110 0               00111223346788899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6e-35  Score=326.16  Aligned_cols=257  Identities=30%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|....      ...+|+|++..... ....++.+|++++.++.   +||||+++++++..
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~i~~~~~~~~~   87 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---KHKNIINLLGVCTQ   87 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc---CCCCeeeEEEEEcC
Confidence            4578889999999999999998642      36799999876432 22346788999888632   79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVL  940 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIl  940 (1088)
                      +...++||||+++|+|.++++..                ..+++..++.++.|++.|++|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999999642                3589999999999999999999998   9999999999999


Q ss_pred             EcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHH
Q 001384          941 LDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVE 1018 (1088)
Q Consensus       941 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~ 1018 (1088)
                      ++.++.+|++|||.++.+...... ......++..|+|||...+..++.++|||||||++|||++ |..||.+.....  
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  242 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--  242 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence            999999999999999876533221 1222335678999999888899999999999999999997 999987643211  


Q ss_pred             HHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .......                +.....+......+.+++.+|++.||++||++.|+++.|++++
T Consensus       243 ~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLKE----------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHHc----------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1111110                0000112233467889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-34  Score=314.83  Aligned_cols=248  Identities=30%  Similarity=0.435  Sum_probs=199.5

Q ss_pred             ceecccCceEEEEEEeC-C---CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP-D---GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +.||+|+||.||+|++. .   +..+|+|.+...... ..+++.+|+++++.    +.|||++++++++. ....++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQ----LDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHh----cCCCCeeeEEEEEc-CCceEEEEE
Confidence            46999999999999853 2   268999999866432 45678899999986    67999999999876 456799999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++|+|.+++.....+++..+..++.|++.|++|||..   +++||||||+||+++.++.+||+|||.++.........
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999999998887899999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             cc--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          966 ST--TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       966 ~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ..  ...++..|+|||......++.++||||||+++|||++ |+.||......  +..........              
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~--------------  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGER--------------  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCc--------------
Confidence            11  1223467999999988899999999999999999998 99999765431  11111110000              


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                        ...+...+..+.+++.+|++.+|++||++.++++.|+++.
T Consensus       217 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 --LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              0112223457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.1e-34  Score=312.42  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=209.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++    ++|+|++++++++.+++..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~----~~~~~i~~~~~~~~~~~~~   77 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ----LDHPNVIKYLASFIENNEL   77 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHh----CCCCCeeeeeeeeecCCeE
Confidence            57899999999999999999986 78999999886432   2234578899999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++|+|.+++..    ...+++.+++.++.|++.|++|||+.   +++||||+|+||+++.++.++++|||++.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999999998864    34589999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ....... ......++..|+|||...+..++.++||||+|+++|+|++|+.||........+.......           
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  222 (267)
T cd08224         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-----------  222 (267)
T ss_pred             eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-----------
Confidence            6543221 1233467889999999888889999999999999999999999997654322222222110           


Q ss_pred             chhhcCCCccccH-HHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1037 PVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                           +...+.+. .....+.+++.+|++.+|++||++.+|+++|+++.
T Consensus       223 -----~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 -----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 00011111 34467889999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-34  Score=317.93  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=204.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-C---CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-D---GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.+.||+|+||.||+|.+. +   +..+|+|.++.... ...+.+..|+.++.+    ++||||+++++++..++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ----FDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEecCCc
Confidence            46888899999999999999864 2   34799999876432 234578889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++++|.+++... ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.++++|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999999764 4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccc--cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHVST--TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .........  ...++..|+|||.+.+..++.++||||||+++||+++ |..||......  +........   .     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~---~-----  226 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEG---Y-----  226 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCC---C-----
Confidence            543222111  1223568999999998899999999999999999886 99999765331  111111100   0     


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                              ..+.+...+..+.+++.+|++++|.+||++.++++.|++++
T Consensus       227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         227 --------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence                    00111223457789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-34  Score=318.15  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             CCccceecccCceEEEEEEeCC-Cc--EEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPD-GR--EVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+..|+++++.    ++||||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKE----FDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEccCCccc
Confidence            3467899999999999999754 32  68999887542  2233568889999886    6799999999987532    


Q ss_pred             --CeEEEEEEecCCCCHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          878 --SEKILVYEYMEGGSLEDIISD------RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                        ...++||||+++|+|.+++..      ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence              246899999999999998742      23488999999999999999999998   9999999999999999999999


Q ss_pred             eecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccC
Q 001384          950 TDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYG 1027 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1027 (1088)
                      +|||+++.+....... .....++..|+|||......++.++||||||+++|||++ |+.||.+....  +.........
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~  231 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGN  231 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC
Confidence            9999998764332211 123345678999999998899999999999999999999 78898764331  1111111000


Q ss_pred             CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .                ...+......+.+++.+|++.||++||++.|+++.|++++
T Consensus       232 ~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         232 R----------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             C----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0                0111223456889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-35  Score=332.76  Aligned_cols=238  Identities=27%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             ceecccCceEEEEEEe----CCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          811 RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      +.||+|+||.||+++.    .+|+.||+|++......  ....+..|++++.+    ++||||+++++++.++...|+||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE----VNHPFIVKLHYAFQTEGKLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh----CCCCCcccEEEEEEcCCEEEEEE
Confidence            6799999999999985    25789999999864322  23456778888886    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          885 EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      ||+++|+|.+++.+...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            9999999999998888899999999999999999999999   99999999999999999999999999987654321 2


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1088)
                      ......|+..|+|||.+....++.++|||||||++|||++|+.||......  +..........                
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~~~~----------------  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILKAKL----------------  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHcCCC----------------
Confidence            233457899999999998888999999999999999999999999865431  11111110000                


Q ss_pred             ccccHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 001384         1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075 (1088)
Q Consensus      1045 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1075 (1088)
                       ..+......+.+++.+|++.||++||++.+
T Consensus       216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             011123356788999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=313.56  Aligned_cols=246  Identities=26%  Similarity=0.438  Sum_probs=198.5

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      ++||+|+||.||+|...+++.+|+|++...... ....+.+|++++..    ++||||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQ----YDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHh----CCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            368999999999999888899999998765322 23468889999886    6799999999999999999999999999


Q ss_pred             CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          890 GSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       890 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      ++|.+++... ..+++..++.++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++.............
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            9999998754 4589999999999999999999998   99999999999999999999999999987643322212222


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1088)
                      ..++..|+|||+..+..++.++||||||+++|++++ |..||.+......  ...... ..               ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~~~~-~~---------------~~~~  215 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQVEK-GY---------------RMSC  215 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHHc-CC---------------CCCC
Confidence            344678999999998899999999999999999998 9999976543211  111110 00               0001


Q ss_pred             cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1048 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      +...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1223467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2e-34  Score=320.85  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=202.8

Q ss_pred             HcCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.    ++||||+++++++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG----FTCHHVVRLLGVVS   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHh----CCCCCeeeEEEEEc
Confidence            3568999999999999999999753      245799999875432 233467788888886    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR----------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      +....++||||+++|+|.++++..          ...++..+..++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            999999999999999999999752          2356788899999999999999999   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          946 KALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      .++++|||+++........ ......++..|+|||...+..++.++|||||||++|||++ |+.||.+...  .++....
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~~~  234 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV  234 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence            9999999998765432221 1222345678999999988899999999999999999998 7888876432  1122211


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ....                ....+......+.+++.+|++.||++||++.|+++.+++.+
T Consensus       235 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MDGG----------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HcCC----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1000                00011223457889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.5e-35  Score=331.75  Aligned_cols=241  Identities=26%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHH-HhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEV-LSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +.||+|+||+||+|++. +++.||+|++.+...   .....+..|... ++.    ++||||+++++++.+++..++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~----~~h~~Iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN----VKHPFLVGLHFSFQTADKLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHh----CCCCCCCceeEEEEcCCeEEEEEe
Confidence            46999999999999976 578899999975422   122344444443 333    689999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~  152 (325)
T cd05602          77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT  152 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence            999999999998888899999999999999999999999   9999999999999999999999999998754322 122


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +..........                 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~-----------------  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNKPL-----------------  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHhCCc-----------------
Confidence            34467899999999999989999999999999999999999999865432  11112110000                 


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .........+.+++.+|++.||.+||++.+.+.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            001123356788888999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-34  Score=324.57  Aligned_cols=258  Identities=29%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+++.+|+.+++.+.   .||||+++++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~i~~~~~~~   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---KHKNIINLLGAC   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc---cCCCchheeEEE
Confidence            356888899999999999999741        24579999987542 233457889999988632   699999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                      ......++||||+++|+|.+++...                ..+++.++..++.|++.||+|||+.   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            9999999999999999999999753                2478889999999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |+++.++.+||+|||.++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||.+...  
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--  245 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  245 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence            999999999999999998765332221 222345678999999988889999999999999999998 7888865432  


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .++.........                ...+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus       246 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 EELFKLLKEGHR----------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHHHHHcCCc----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            222222210000                01122334678889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-35  Score=330.96  Aligned_cols=241  Identities=28%  Similarity=0.330  Sum_probs=191.7

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||+||+|+.. +|+.||+|++.+...   .....+..|..++.+   .++||||+++++++..++..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~---~~~hp~iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK---NVKHPFLVGLHYSFQTTEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHH---hCCCCCCccEEEEEecCCEEEEEEcC
Confidence            46999999999999975 689999999975422   222345555554322   26899999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|+|.+++....++++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  153 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT  153 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence            99999999998888899999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....||..|+|||++.+..++.++||||+||++|||++|+.||......  +..........                 .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~~~~~~~-----------------~  214 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYDNILHKPL-----------------V  214 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHHHHHcCCc-----------------c
Confidence            3457899999999999989999999999999999999999999875432  11111110000                 0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      ........+.+++.+|++.+|.+||++++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            0112335677889999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-34  Score=319.70  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      +++|.+.+.||+|+||.||+|.+.+      +..||+|.+..... ..+..+..|+.+++.    ++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK----FNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEcc
Confidence            4568899999999999999999753      56789998875432 234568889999986    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---C
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT-------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---K  946 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~  946 (1088)
                      ....++||||+++++|.++++...       .+++.++.+++.||+.|++|||+.   +++||||||+||+++.++   .
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence            999999999999999999997653       489999999999999999999999   999999999999998765   5


Q ss_pred             EEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhh
Q 001384          947 ALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      +|++|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......  +......
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~  235 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVT  235 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence            9999999998763222111 112233568999999988899999999999999999997 99999765331  1111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ....                ...+...+..+.+++.+|++.+|++||++.||++.|++
T Consensus       236 ~~~~----------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         236 GGGR----------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             cCCc----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            0000                00122234578889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-34  Score=331.22  Aligned_cols=257  Identities=23%  Similarity=0.283  Sum_probs=200.1

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      +....++|++.+.||+|+||.||+|+++ +++.||+|++.+...   .....+.+|+.++..    ++||||+++++++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~----~~hp~iv~~~~~~~  113 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----ANSPWVVQLFYAFQ  113 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHh----CCCCCCCeEEEEEE
Confidence            3344578999999999999999999976 678999999865321   223456788888876    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      ++...++||||+++|+|.++++.. .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999998764 589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTW----QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      +..............||+.|+|||++...    .++.++||||+||++|||++|+.||.+....  .....+........
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~  267 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNSLT  267 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCccc
Confidence            87654333333456799999999987653    3789999999999999999999999875431  11122211000000


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLAM 1079 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1079 (1088)
                                   .+........+.+++.+|++.++.+  ||+++|+++.
T Consensus       268 -------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 -------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                         0011223456778888999844433  7788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-34  Score=313.36  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+....  ......+..|+++++.    ++|||++++++++.+++..++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAK----LDSSYIIRYYESFLDKGKLNI   76 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHh----cCCCCeehheeeeccCCEEEE
Confidence            4777899999999999999976 68999999987542  2334578889999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++++|.++++..  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++....
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            99999999999999764  5689999999999999999999998   999999999999999999999999999887654


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ... ......++..|+|||+..+..++.++||||||+++|+|++|+.||....+..  .......               
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---------------  215 (256)
T cd08529         154 NTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILKIIR---------------  215 (256)
T ss_pred             ccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc---------------
Confidence            322 2234467889999999998899999999999999999999999997654311  1111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       +.....+......+.+++.+|++.+|++||++.++++.
T Consensus       216 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 -GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             00011122344678899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=322.50  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=204.2

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|...      .+..||||+++.... ...+.+.+|+++++++.   +||||+++++++...
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~~  111 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG---NHENIVNLLGACTIG  111 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc---CCCCcceEEEEEecC
Confidence            46888999999999999999742      345799999876532 23356889999998732   699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      +..++||||+++|+|.++++...  .+++.++..++.|++.|++|||++   +|+|+||||+||+++.++.++++|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999997643  389999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      +....... .......++..|+|||.+....++.++||||+||++|||++ |..||....... ........ ..     
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~-~~-----  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKE-GY-----  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHc-CC-----
Confidence            76543221 11223345678999999988899999999999999999998 999987653311 11111110 00     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                                ....+.....++.+++.+|++.+|++||++.|+++.|++++
T Consensus       262 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         262 ----------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence                      00011122357888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-34  Score=330.50  Aligned_cols=263  Identities=26%  Similarity=0.321  Sum_probs=199.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----  878 (1088)
                      +|+..+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+++++.    ++||||+++++++....    
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~~   76 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCF----FKHDNVLSALDILQPPHIDPF   76 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHh----CCCCCcCCHhheecCCCcccc
Confidence            4788899999999999999975 78999999987532  2234568889999986    67999999999998776    


Q ss_pred             -eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 -EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                       ..|+||||+. ++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          77 EEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             ceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence             7899999996 58999988888899999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc-
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV- 1035 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1035 (1088)
                      .............++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .. ..+............ 
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~-~~i~~~~g~~~~~~~~  230 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QL-DLITDLLGTPSLEAMR  230 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HH-HHHHHHcCCCCHHHHH
Confidence            65433333344567899999998766 457899999999999999999999998754311 00 000000000000000 


Q ss_pred             ------cchhhcC-CC-------ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 ------IPVVLLG-SG-------LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ------~~~~~~~-~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ....... ..       .........++.+++.+|++.||++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                  0000000 00       0001122456788999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=304.51  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |.+.++||+|+||.||+|.++ .|+.+|+|++..+  ..-+++..|+.++++    ++.|++|++||.|......++|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQ----C~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQ----CKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHH----cCCchhhhhhhhhccCCceEeehh
Confidence            667789999999999999987 6999999999765  445678899999997    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          886 YMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      ||..|++.|.++. +.++++.++..+.+..+.||+|||..   .-||||||+-|||+..+|.+|++|||.|-.+.+. -.
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA  184 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA  184 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence            9999999999975 45799999999999999999999998   7899999999999999999999999999765421 12


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCC
Q 001384          965 VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1088)
                      ...++.||+.|||||++..-.|+.++||||+|+...||..|++||.+-.+.               +....+ +.....-
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMI-PT~PPPT  248 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMI-PTKPPPT  248 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEec-cCCCCCC
Confidence            345678999999999999999999999999999999999999999864321               000111 1111222


Q ss_pred             ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1045 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...++....++.++++.|+-+.|++|.++..+++
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            3347778899999999999999999999988765

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-34  Score=313.59  Aligned_cols=250  Identities=30%  Similarity=0.485  Sum_probs=202.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|++.... ....++.+|++++++    +.|||++++++++......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMK----LSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHh----CCCCCeeeEEEEEccCCceEEEE
Confidence            3577889999999999999998778899999987543 335678899999987    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++++|.++++.. ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999999999764 4689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .......++.+|+|||...+..++.++||||+|+++|||++ |+.||......  +.......      ...        
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~------~~~--------  219 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINA------GFR--------  219 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhC------CCC--------
Confidence            11222334678999999988899999999999999999998 99999764431  11111110      000        


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                        ...+.....++.+++.+|++.+|++||++.|+++.|
T Consensus       220 --~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 --LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              000111236788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-34  Score=318.91  Aligned_cols=241  Identities=30%  Similarity=0.388  Sum_probs=192.4

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||.||+++.+ +|+.||+|++......   .+.....|++++++    ++||||+++++++.++...++||||++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~----l~hp~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK----VNSPFIVNLAYAFESKTHLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHh----cCCCcEEEEEEEEecCCeEEEEEecCC
Confidence            699999999999975 6899999998754222   23445668888886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          889 GGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       889 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|.+++....  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......  ..
T Consensus        77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~  151 (277)
T cd05607          77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TI  151 (277)
T ss_pred             CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--ee
Confidence            999999886543  588999999999999999999999   99999999999999999999999999987764322  22


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCCCCCCccccchhhcCCC
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1088)
                      ....++..|+|||++.+..++.++||||+||++|||++|+.||....+.  ..+.........        ...      
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~------  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--------VKF------  217 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc--------ccc------
Confidence            3356889999999998888999999999999999999999999764331  112222111000        000      


Q ss_pred             ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1045 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .......++.+++.+|++.||++||+++|+++
T Consensus       218 --~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         218 --EHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             --ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence              01123456788999999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.4e-34  Score=318.54  Aligned_cols=250  Identities=27%  Similarity=0.418  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.    +.|||++++++++..+...++|
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~----~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE----NKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHh----CCCCCEeeEEEEEEeCCEEEEe
Confidence            57888999999999999999964 688999999987655556778899999886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.++++.. .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+........
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999999998654 589999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                       ......+++.|+|||...+..++.++|||||||++|+|++|+.||...... ..+..... ...        +      
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~~~~-~~~--------~------  234 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIAT-NGT--------P------  234 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHHHhc-CCC--------C------
Confidence             123346888999999998888999999999999999999999999765431 11111110 000        0      


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ....+......+.+++.+|++.||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            001122344668889999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-34  Score=316.60  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .+|.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.++++    +.||||+++++++.+ ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ----FDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHh----CCCCchhceeEEEcC-CC
Confidence            457888999999999999998643    2468999887654 3344678899999886    679999999998875 55


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++|+|.+++.... .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            789999999999999997643 589999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ............++..|+|||.+....++.++||||||+++||+++ |..||.+.......  .....            
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~~~------------  223 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRIEN------------  223 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHc------------
Confidence            5433222223344568999999888889999999999999999986 99999765431111  11110            


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                          +.....+...+..+.+++.+|+..+|++||++.|+++.|+++..
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         224 ----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                00011122344678889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.3e-34  Score=328.51  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-  878 (1088)
                      ..++|++.+.||+|+||.||+|++. +|+.||||++....  ......+.+|+.+++.    ++||||+++++++.... 
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC----VNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHh----CCCCCEeeeeeeeccCCC
Confidence            3478999999999999999999975 68999999997542  2234567789999886    68999999999986543 


Q ss_pred             -----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          879 -----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       879 -----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                           ..|+||||+++ ++.+.++.  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence                 47999999976 67776643  478999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC----
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH---- 1029 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1029 (1088)
                      +++.....  .......+|..|+|||.+.+..++.++||||+||++|+|++|+.||.+.+. ...|..........    
T Consensus       169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCcHHH
Confidence            99754321  223345789999999999998999999999999999999999999986543 22222111100000    


Q ss_pred             --------------C------CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 --------------G------PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 --------------~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                    .      ...+..+.................+.+++.+|++.||++||++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                          0      000000000000000011122356789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-34  Score=313.11  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=196.0

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          812 IIGKGGFGTVYRGVLP---DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      .||+|+||.||+|.++   .+..||+|++..... ...+.+.+|+.++++    ++||||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~----l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ----LDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHh----cCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999864   355799999976532 223568899999987    68999999999875 45688999999


Q ss_pred             CCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          888 EGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       888 ~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      ++|+|.+++.. ...+++.++++++.|++.||+|||++   +++||||||+||+++.++.+|++|||++...........
T Consensus        77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999999975 45689999999999999999999998   999999999999999999999999999976543322211


Q ss_pred             --ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          967 --TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       967 --~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                        ....++..|+|||......++.++||||||+++||+++ |+.||......  ++.......                .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~----------------~  215 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQG----------------K  215 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC----------------C
Confidence              11233578999999888889999999999999999996 99999865431  111111100                0


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ....+..+..++.+++.+|+..+|++||++.+|.+.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            01112234567888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-34  Score=318.93  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-----CcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD-----GREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-  876 (1088)
                      .++|++.+.||+|+||.||+|.+.+     +..||+|++.... ......+.+|+.++++    ++|||++++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~----l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG----LSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEecC
Confidence            4678899999999999999999765     6789999987543 2234567889998886    689999999998776 


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR--------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                      +...++++||+++|+|.+++...        ..+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence            46789999999999999998653        3589999999999999999999998   999999999999999999999


Q ss_pred             EeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhcc
Q 001384          949 VTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ++|||+++.+...+... .....++..|+|||+.....++.++||||||+++||+++ |+.||.....  .++.......
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~  235 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDG  235 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcC
Confidence            99999998664433221 122345678999999988889999999999999999999 9999976543  2222222100


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .   .             ...+...+.++.+++.+|++.||++||++.|+++.|+++.+.
T Consensus       236 ~---~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         236 Y---R-------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             C---C-------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            0   0             001122345788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-34  Score=315.92  Aligned_cols=249  Identities=30%  Similarity=0.443  Sum_probs=195.7

Q ss_pred             ceecccCceEEEEEEeCC-Cc--EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLPD-GR--EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      ++||+|+||.||+|.+++ +.  .+|+|.+.... ......+..|++++.++.   +||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---HHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc---cCCCeeeEEEEEecCCCceEEEEe
Confidence            368999999999999753 43  47888887542 233457888999988742   799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEe
Q 001384          887 MEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT  950 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~  950 (1088)
                      +++|+|.++++...                .+++.+++.++.|++.|++|||+.   +++||||||+||++++++.+|++
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence            99999999997532                478999999999999999999998   99999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCC
Q 001384          951 DFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      |||++......  ........+..|+|||+.....++.++||||||+++|||++ |+.||.+....  +........   
T Consensus       155 dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~---  227 (270)
T cd05047         155 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQG---  227 (270)
T ss_pred             CCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCC---
Confidence            99998532211  11112234567999999988899999999999999999997 99999764321  111111100   


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                   .....+.....++.+++.+|++.+|.+||++.|+++.|+++++
T Consensus       228 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         228 -------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                         0000112233568899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-34  Score=313.41  Aligned_cols=247  Identities=31%  Similarity=0.397  Sum_probs=199.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe-cCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL-DGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~-~~~~~~lv  883 (1088)
                      .+|++.+.||+|+||.||+|..+ |+.||+|.++..  ...+.+.+|+.++++    ++|+|++++++++. .+...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQ----LRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHh----CCCCCeeeEEEEEEcCCCceEEE
Confidence            36888899999999999999874 788999998754  234578899999987    67999999999764 45678999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.++++...  .+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|++|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999997644  488999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    ....++..|+|||+.....++.++||||||+++|||++ |+.||.....  .+..........            
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~------------  217 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYK------------  217 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCC------------
Confidence            1    22344568999999988899999999999999999997 9999875432  112111110000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                          ...+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                001123346788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=326.03  Aligned_cols=200  Identities=27%  Similarity=0.354  Sum_probs=172.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.++||+|+||.|.+|.+. +++.||||+++... ..-.+-..|+.+|..+..  .-.--|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999999999976 68999999998763 333456778888877551  1223489999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE--GKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~--~~~kl~Dfg~a~~~  958 (1088)
                      |+|.++. +|+++++.+.  .++...++.|+.||+.||.+||+.   +|||+||||+|||+.+.  ..+||+|||.++..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999965 9999998765  588999999999999999999999   99999999999999754  47999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      ...   .. .+..+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+..+
T Consensus       342 ~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  342 SQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             CCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            432   22 66788899999999999999999999999999999999888887644

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-34  Score=313.63  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++    ++|+|++++++++.+ ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKT----LQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHh----cCCCCcceEEEEEcC-CCeEEE
Confidence            46789999999999999999998778889999887642 234578889999986    679999999999887 778999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.+++...  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999763  3578999999999999999999998   9999999999999999999999999999766433


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCccccchh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .........++..|+|||++....++.++||||||+++|++++ |+.||.+.... ...+.....               
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------  220 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------------  220 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------------
Confidence            2222223345678999999988889999999999999999999 89999765432 222111100               


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                          ..+.+...+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                000112234578889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=325.03  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             ceecccCceEEEEEEeCC-CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          811 RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      -++|+|.||+||.|++.+ ....|||.+........+-+..|+...+.    ++|+|||+++|.+.+++..-|.||-++|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~----LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHST----LRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHH----HhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            479999999999999874 56789999987655556678889998886    7899999999999999999999999999


Q ss_pred             CCHHHHHhh-cCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeecccceeecCCCCcc
Q 001384          890 GSLEDIISD-RTRL--TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       890 gsL~~~l~~-~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+|.++++. .+++  .+.+.-.+.+||++||.|||++   .|||||||.+||||. -.|.+||+|||.++++..- ...
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC  732 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence            999999975 4666  7888899999999999999999   999999999999996 5689999999999887543 234


Q ss_pred             cccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          966 STTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      +.++.||..|||||++..+  .|+.++|||||||.+.||.||++||..... ...-+...                 .-.
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-----------------myK  795 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-----------------MYK  795 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-----------------cee
Confidence            5678899999999987654  689999999999999999999999976432 11111111                 111


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..++-|.+...+...+|.+|+.+||.+||++.++++
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            223346778889999999999999999999999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=325.87  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=209.4

Q ss_pred             CCccceecccCceEEEEEEeC--CCc--EEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP--DGR--EVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ....+.||+|.||+|++|.|.  .|+  .||||.++..... .-.+|.+|+.+|-+    ++|||++++||+..+ ....
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~----L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLK----LQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHh----ccCcceeEEeeeecc-chhh
Confidence            445688999999999999986  354  5899999987655 45689999999986    789999999999887 7788


Q ss_pred             EEEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +|||.++.|+|.+.+++  ...+-......++.|||.||.||.++   ++|||||.++|+++-....|||+|||+.+.+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999999987  33578888999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          960 AGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       960 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ..+.+.  .....-.+.|+|||.+....++.++|||+|||.+|||+| |+.||.+-..                  ..+.
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qIL  325 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQIL  325 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHHH
Confidence            655433  223455678999999999999999999999999999999 7789987543                  1222


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ..+-.+.+++.+..+.+++++++++||...|++||++.+|.+.
T Consensus       326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            2222455667788999999999999999999999999999743

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=318.83  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEeCC------CcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|.++.      +..||+|.+.... ......+.+|+.++..    +.||||+++++++...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~   81 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE----FNCHHVVRLLGVVSTG   81 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHh----CCCCceeEEEEEEcCC
Confidence            478889999999999999998642      3689999987553 2334568889998886    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT----------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      ...++||||+++|+|.+++....          .+++..++.++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            99999999999999999986432          368889999999999999999998   99999999999999999999


Q ss_pred             EEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhh
Q 001384          948 LVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVM 1024 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~ 1024 (1088)
                      ||+|||+++.....+. .......++..|+|||......++.++||||||+++||+++ |..||.+.... ...+..  .
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--~  236 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI--D  236 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh--c
Confidence            9999999876543322 12233456788999999888889999999999999999998 89999765431 111111  0


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                        .               .....+...+.++.+++.+|++.+|++||++.|+++.|++
T Consensus       237 --~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 --G---------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             --C---------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence              0               0001122235678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=324.61  Aligned_cols=254  Identities=26%  Similarity=0.303  Sum_probs=196.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+..   ....+.+.+|..++..    ++|+||+++++++.++...
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~   76 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN----GDRRWITNLHYAFQDENNL   76 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh----CCCCCCCceEEEEecCCeE
Confidence            47899999999999999999975 68999999997532   1223457788888875    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      |+||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            999999999999999976 45799999999999999999999999   99999999999999999999999999997765


Q ss_pred             CCCCcccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ...........||+.|+|||++..     ..++.++||||+||++|||++|+.||.+...  .+.............   
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~---  228 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKEHFQ---  228 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCccc---
Confidence            433333334568999999998763     4678899999999999999999999976432  222222221110000   


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCC--CCCCCHHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAP--NARPNVKEVLAM 1079 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~eil~~ 1079 (1088)
                       ++        .........+.+++.+|+..++  ..||++.++++.
T Consensus       229 -~~--------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -FP--------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -CC--------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             00        0011133466777778775433  347888888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-34  Score=316.12  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CC---cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DG---REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .|++.+.||+|+||.||+|.++ ++   ..||||++.... ....+++..|+.+++.    ++||||+++++++.++...
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ----FDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHh----CCCcCcceEEEEECCCCce
Confidence            4778899999999999999975 33   369999987652 2234678999999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++|+|.++++.. ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||.+....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999999763 4689999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCccc--cccc--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCch-hHHHHHHhhhccCCCCCCc
Q 001384          960 AGDSHVS--TTIA--GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEE-CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       960 ~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .......  ....  .+..|+|||+.....++.++||||+|+++|||++ |..||..... ....+.....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---------  228 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---------  228 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            3222111  1111  2457999999998899999999999999999886 9999976543 1222211000         


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                                ..+.+...+..+.+++.+|++++|.+||++.+|++.|++++
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         229 ----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             ----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                      00111233456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-35  Score=328.69  Aligned_cols=237  Identities=27%  Similarity=0.340  Sum_probs=190.1

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHH-HHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEME-VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      ++||+|+||.||+|++. +++.||+|++.+...   .....+..|.. +++.    ++||||+++++++.+.+..|+|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~----~~h~~iv~~~~~~~~~~~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN----LKHPFLVGLHYSFQTAEKLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHh----CCCCCccceeeEEEcCCEEEEEEc
Confidence            46999999999999976 688999999875422   12234555554 3443    689999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++|+|.+++.....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999999999998888899999999999999999999998   99999999999999999999999999987532221 22


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.  .+........                 ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~-----------------~~  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILHK-----------------PL  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhcC-----------------CC
Confidence            3345789999999999988999999999999999999999999987543  1222222100                 00


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVK 1074 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1074 (1088)
                      ..+......+.+++.+|++.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11122345688899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.1e-34  Score=320.00  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +|++.+.||+|+||.||+|...      .++.||+|++...... ....+..|+.++..    ++||||+++++++....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~----l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR----LQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhc----CCCCCcCeEEEEEcCCC
Confidence            4677789999999999999863      2478999999865322 23567888888876    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          879 EKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ..++++||+++++|.+++...                ..+++..+.+++.|++.||+|+|+.   +|+||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence            999999999999999998532                2478889999999999999999999   999999999999999


Q ss_pred             CCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHH
Q 001384          943 KEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWG 1020 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 1020 (1088)
                      +++.+||+|||+++........ ......+++.|+|||.+....++.++||||+|+++|||++ |..||.+...  .++.
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~  236 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVI  236 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            9999999999998865433221 1223345778999999888889999999999999999998 8888876433  2232


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ........                ...+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus       237 ~~i~~~~~----------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQV----------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCc----------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            32221110                01122345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.9e-34  Score=316.31  Aligned_cols=254  Identities=27%  Similarity=0.452  Sum_probs=201.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|++.+.||+|+||+||+|.+. +++    .||+|++..... ...+.+.+|+.++..    ++||||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG----VGSPYVCRLLGICLTS-   81 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHh----cCCCCCceEEEEEcCC-
Confidence            46888899999999999999854 444    489999875432 234567888888876    6799999999998754 


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..+++|||+++|+|.++++.. ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            467999999999999999764 5689999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCch-hHHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEE-CLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      +....... .....++..|+|||...+..++.++|||||||++|||++ |..||..... ....+.....   .      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~------  229 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE---R------  229 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---c------
Confidence            65332211 112234678999999988899999999999999999998 8999876433 1212111100   0      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                .+.+.....++.+++.+|++.||++||++.|+++.|+++..
T Consensus       230 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 ----------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      00112234578889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.2e-34  Score=319.45  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|++..... ....++.+|+.++++    +.||||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~----l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE----FDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHh----cCCCchheEEEEEcC
Confidence            457889999999999999999863      467899999876532 234568889999986    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT----------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      +...++||||+++|+|.+++....                      .+++.+++.++.|++.||+|||+.   +++||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence            999999999999999999996432                      378889999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGG 1012 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 1012 (1088)
                      ||+||++++++.++++|||.+......... .......+..|+|||...+..++.++|||||||++|||++ |..||.+.
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998765432211 1222334667999999888899999999999999999997 88898764


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ...  ++......    ..            ....+...+.++.+++.+|++.||++||++.|+++.|++
T Consensus       237 ~~~--~~~~~~~~----~~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHE--EVIYYVRD----GN------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHH--HHHHHHhc----CC------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            331  22121110    00            001112234678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-34  Score=330.43  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++.....   .....+..|+.++..    ++||+|+++++++.+++..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~iv~~~~~~~~~~~~   76 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE----ADGAWVVKMFYSFQDKRNL   76 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHh----CCCCCEeeEEEEEEcCCEE
Confidence            36888999999999999999976 688999999975421   223567788888876    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.+...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999999998888899999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 001384          961 GDS----------------------------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006 (1088)
Q Consensus       961 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 1006 (1088)
                      ...                                  .......||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0012346899999999999999999999999999999999999


Q ss_pred             cCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC---HHHHH
Q 001384         1007 RALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN---VKEVL 1077 (1088)
Q Consensus      1007 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil 1077 (1088)
                      .||.+....  +..........    ...++.         ......++.+++.+|+. ||.+|++   +.|++
T Consensus       234 ~Pf~~~~~~--~~~~~i~~~~~----~~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~  291 (360)
T cd05627         234 PPFCSETPQ--ETYRKVMNWKE----TLVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK  291 (360)
T ss_pred             CCCCCCCHH--HHHHHHHcCCC----ceecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence            999875442  11122221100    000110         01123456677777764 9999996   45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-34  Score=317.22  Aligned_cols=269  Identities=24%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             CCCccceecccCceEEEEEEe-----CCCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          806 KFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      -|++.+.||+|+||.||.|+.     .+++.||+|.+.... ......+.+|+++++.    +.|||++++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----LYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHh----CCCCCeeeeeeEEecCCC
Confidence            467889999999999999984     257889999987543 2234578899999987    6799999999998875  


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++||||+++++|.+++.+.. .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            56889999999999999997643 589999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........  ......++..|+|||...+..++.++||||||+++|||++++.|+..........   ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM---IGPTHGQMTVTR  234 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh---cccccccccHHH
Confidence            76433221  1223456778999999888889999999999999999999887654321100000   000000000000


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .......+...+.+......+.+++.+|++.+|++||+++|+++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            00000011111112234567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-34  Score=323.03  Aligned_cols=257  Identities=28%  Similarity=0.424  Sum_probs=202.5

Q ss_pred             CCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ++|.+.+.||+|+||.||+|...        ....+|+|+++.... ....++..|+++++++.   +||||+++++++.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~   88 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG---KHKNIINLLGVCT   88 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc---CCCCeeeEEEEEc
Confidence            56888999999999999999742        245799999875432 23356788999888632   6999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      .....++||||+++|+|.+++...                ..+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            999999999999999999999653                2488999999999999999999998   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 1017 (1088)
                      +++.++.+|++|||.++.....+... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999998654322211 112234467999999888899999999999999999999 88888764321  


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      +....... ..               ....+...+.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       244 ~~~~~~~~-~~---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 ELFKLLRE-GH---------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHHHHc-CC---------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11111110 00               000122234578889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.7e-34  Score=313.11  Aligned_cols=248  Identities=25%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---------hHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---------EREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      +|.+.+.||+|++|.||+|.+. +++.+|+|.+.......         .+.+..|+.++++    ++||||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE----LQHENIVQYLGSSL   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHh----cCCCCeeeEEEEEE
Confidence            4778899999999999999975 57899999887543221         1457788998886    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      +....++||||+++++|.+++.....+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          77 DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             eCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999999998888899999999999999999999998   9999999999999999999999999998


Q ss_pred             eeecCCCCc-----ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC
Q 001384          956 RVVSAGDSH-----VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       956 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1088)
                      +........     ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||........  ......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----  226 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IFKIGE-----  226 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HHHHhc-----
Confidence            876421111     11234578899999999888899999999999999999999999986533111  111110     


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 ......+......+.+++.+|++.||.+||++.||++
T Consensus       227 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 -----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                       0001112234467888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-34  Score=312.98  Aligned_cols=246  Identities=34%  Similarity=0.506  Sum_probs=203.0

Q ss_pred             ceecccCceEEEEEEeCC----CcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +.||+|+||.||+|....    +..||+|++....... .+.+.+|++.+..    ++|+|++++++++..+...++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKK----LGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhh----cCCCChheeeeeecCCCceEEEEE
Confidence            469999999999999763    7889999998764333 5678899999986    579999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          886 YMEGGSLEDIISDR---------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      |+++++|.++++..         ..+++.+++.++.|++.|++|||++   +++||||+|+||++++++.+|++|||.+.
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccc
Confidence            99999999999875         6799999999999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ....... .......++..|+|||......++.++||||+|+++|||++ |..||.....  .+.......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~---------  222 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK---------  222 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc---------
Confidence            7654321 12334457889999999888899999999999999999999 6999987533  111111110         


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                             +.....+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus       223 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   0111112333567889999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-34  Score=326.45  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=201.5

Q ss_pred             CCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++..... ....+.+|+.++.++.   +||||+++++++...
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~~~~~~~~~   83 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---HHLNVVNLLGACTKP   83 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc---CCccHhhhcceeecC
Confidence            5799999999999999999974      24678999999764322 2346788999998743   689999999987654


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhc---------------------------------------------------------
Q 001384          878 -SEKILVYEYMEGGSLEDIISDR---------------------------------------------------------  899 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------  899 (1088)
                       ...++||||+++|+|.++++..                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             5678999999999999998642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-cccc
Q 001384          900 ----------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTT  968 (1088)
Q Consensus       900 ----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  968 (1088)
                                ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.+|++|||++......... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      1367888899999999999999999   9999999999999999999999999998765332221 1222


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1088)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........ ..               ....
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~-~~---------------~~~~  303 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKE-GT---------------RMRA  303 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhc-cC---------------CCCC
Confidence            345678999999888899999999999999999997 899987643211 11111110 00               0000


Q ss_pred             cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1048 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      +.....++.+++.+|++.||++||++.||++.|+.++..
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            111234688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=335.96  Aligned_cols=260  Identities=23%  Similarity=0.295  Sum_probs=191.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-----  877 (1088)
                      .++|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.    ++||||+++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~----l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKN----LNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHh----cCCCCCcceeeeEeecccccC
Confidence            467999999999999999999975 68899999886542    234568888886    6799999999876432     


Q ss_pred             ---CeEEEEEEecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEE
Q 001384          878 ---SEKILVYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALV  949 (1088)
Q Consensus       878 ---~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl  949 (1088)
                         ...++||||+++ ++.+++.    ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence               246789999975 7877764    345699999999999999999999999   999999999999999665 6999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhcc
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGY 1026 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~ 1026 (1088)
                      +|||+|+.+....  ......||+.|+|||++.+ ..++.++||||+||++|||++|..||.+....  ....... ...
T Consensus       213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~  289 (440)
T PTZ00036        213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV-LGT  289 (440)
T ss_pred             eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCC
Confidence            9999998764322  2234568999999998755 47899999999999999999999999875431  1111111 000


Q ss_pred             CCC-------CC-CccccchhhcC-CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRH-------GP-GRAVIPVVLLG-SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~-------~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...       .. ....++..... .....+...+.++.+++.+||+.||.+||++.|+++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000       00 00000000000 000011223457889999999999999999999973

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.3e-34  Score=316.57  Aligned_cols=266  Identities=25%  Similarity=0.292  Sum_probs=195.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----C
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----G  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----~  877 (1088)
                      +|++.+.||+|+||+||+|+++ +++.||+|.+......  ....+.+|++++..+. .+.||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE-AFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhh-hcCCCCeeeeeeeeccccCCCC
Confidence            5888999999999999999976 6889999998754221  2245667777776532 2579999999998764     3


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 SEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      ...++||||+++ +|.++++..  ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            457899999975 899988764  3489999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCCCCC--
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRHGPG-- 1032 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~-- 1032 (1088)
                      +......  ......++..|+|||++.+..++.++||||+||++|||++|++||.+..... ................  
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            8764321  2234567899999999988899999999999999999999999997654311 1111111100000000  


Q ss_pred             c-----cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 R-----AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .     .....................+.+++.+|++.||++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0     000000000000001123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-34  Score=318.00  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=200.3

Q ss_pred             CCCCccceecccCceEEEEEEeCC---------------CcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCcee
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD---------------GREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      ++|++.+.||+|+||.||+|....               ...||+|+++... ......+.+|++++.+    ++|||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~----l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSR----LKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHh----CCCCCcC
Confidence            578999999999999999988642               2358999997642 2234578899999987    6799999


Q ss_pred             EEeeEEecCCeEEEEEEecCCCCHHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001384          869 TLYGWCLDGSEKILVYEYMEGGSLEDIISDRT------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKA  936 (1088)
Q Consensus       869 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp  936 (1088)
                      ++++++......++||||+++++|.+++....            .+++..+++++.|++.|++|||+.   +++||||||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            99999999999999999999999999986532            368899999999999999999999   999999999


Q ss_pred             CCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCcCCCCCc
Q 001384          937 SNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT--GRRALEGGE 1013 (1088)
Q Consensus       937 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~ 1013 (1088)
                      +||+++.++.+|++|||++......... ......++..|+|||+.....++.++||||||+++|+|++  |..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            9999999999999999999765432221 1222345678999999888889999999999999999998  667776543


Q ss_pred             h-hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1014 E-CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1014 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      . ..........  .. . .....        ...+...+..+.+++.+|++.||++||++++|++.|++
T Consensus       238 ~~~~~~~~~~~~--~~-~-~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         238 DEQVIENTGEFF--RN-Q-GRQIY--------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             hHHHHHHHHHhh--hh-c-ccccc--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            2 1111111110  00 0 00000        00111234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-33  Score=316.29  Aligned_cols=264  Identities=25%  Similarity=0.359  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....++.+|++++.+    ++||||+++++++.+++..++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE----CNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEeeCCEEEE
Confidence            36889999999999999999975 678899998875422 233568889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++++|.++++...++++..+..++.|++.||+|||+.+  +++||||||+||+++.++.+|++|||++...... 
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999999999988888999999999999999999999742  8999999999999999999999999998754321 


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc---------
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR--------- 1033 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 1033 (1088)
                        ......++..|+|||...+..++.++||||||+++|+|++|+.||......  .+..............         
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCC
Confidence              223456889999999988888999999999999999999999999754321  1111111000000000         


Q ss_pred             -----------cccchhhcCCCcccc-HHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1034 -----------AVIPVVLLGSGLAEG-AEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1034 -----------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                                 +..+..........+ .....++.+++.+|++.+|++||++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       000000000000000 1134568899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.6e-34  Score=316.99  Aligned_cols=260  Identities=24%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-----------------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD-----------------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHP  865 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~  865 (1088)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|++..... ...+.+.+|++++.+    ++||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~----l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSR----LSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHh----cCCC
Confidence            4578999999999999999998642                 24589999876532 234578899999987    6799


Q ss_pred             ceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          866 NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-----------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       866 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      ||+++++++..+...++||||+++++|.+++.+..           .+++..++.++.|++.||+|||+.   +++||||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl  156 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL  156 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence            99999999999999999999999999999997755           689999999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCcCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT--GRRALEG 1011 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~ 1011 (1088)
                      ||+||+++.++.++++|||+++.....+. .......++..|+|||+.....++.++||||||+++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999876543322 12233456778999999888889999999999999999998  6778865


Q ss_pred             Cch-hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1012 GEE-CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1012 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ... ..........  ... ......         ..+...+.++.+++.+|++.||++||++.||++.|++
T Consensus       237 ~~~~~~~~~~~~~~--~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LTDQQVIENAGHFF--RDD-GRQIYL---------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cChHHHHHHHHhcc--ccc-cccccC---------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            433 1111111111  000 000000         0122234678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-34  Score=313.37  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||+|.++.........+.+|+.+++.    ++||||+++++++..++..++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~----l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD----CKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHh----CCCCCeeeEEEEEEeCCEEEEE
Confidence            46788899999999999999965 688999999876543344567788888886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.++++..+.+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+...... .
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~  160 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I  160 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence            99999999999998888899999999999999999999999   9999999999999999999999999998765422 1


Q ss_pred             cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          964 HVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .......|+..|+|||++.   ...++.++||||+||++|+|++|+.||....+....+.....   .      ..+...
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~------~~~~~~  231 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS---N------FQPPKL  231 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc---C------CCCCcc
Confidence            1223456889999999864   456889999999999999999999998754432111111000   0      000000


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .     ........+.+++.+|++.+|++||+++++++
T Consensus       232 ~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 K-----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c-----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0     01112346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-34  Score=311.53  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=201.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +|++.+.||+|+||.||++.+. +++.+|+|.++... ....+.+..|+.+++.    ++|||++++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAK----MKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHh----CCCCCcceEEEEEEECCEEEEE
Confidence            4788899999999999999976 68899999986432 2334567889888886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.+++...  ..+++..++.++.|++.||.|||+.   +|+|+||||+||++++++.++++|||.+......
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999988653  3589999999999999999999999   9999999999999999999999999999766432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      .. ......++..|+|||+..+..++.++||||+|+++|+|++|+.||.........+  .... ..             
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~-~~-------------  216 (255)
T cd08219         154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL--KVCQ-GS-------------  216 (255)
T ss_pred             cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH--HHhc-CC-------------
Confidence            21 2234568889999999988889999999999999999999999998654311111  1110 00             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                        ....+......+.+++.+|++.||++||++.|++..
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 --YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              001122234568889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=308.55  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++    ++||||+++++++.+....+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE----CRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHh----CCCCChhceEEEEEeCCEEEEE
Confidence            57889999999999999999975 578899999987655556788999999986    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++++|.++++.. .++++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+.......
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999999999776 6899999999999999999999998   99999999999999999999999999987654321


Q ss_pred             CcccccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTW---QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                       .......++..|+|||.....   .++.++||||+|+++|||++|+.||................+.         +  
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~---------~--  223 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP---------P--  223 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------C--
Confidence             112334678899999998776   8899999999999999999999999765432111111100000         0  


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ...........++.+++.+|++.+|.+||++.||+.
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 ---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000112344567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-34  Score=314.73  Aligned_cols=251  Identities=32%  Similarity=0.520  Sum_probs=201.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchH--HHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      |++.+.||+|+||+||+|+.. +++.||+|++.........  ....|+.++.+    ++||||+++++++.+....++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~----l~~~~i~~~~~~~~~~~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRR----LRHPNIVQILDVFQDDNYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHH----HTBTTBCHEEEEEEESSEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccc----cccccccccccccccccccccc
Confidence            567899999999999999976 5678999999887544332  23458888886    5799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.+++.....+++.++..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||.+.... ...
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            99999999999999778899999999999999999999999   99999999999999999999999999998652 222


Q ss_pred             cccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccchhhc
Q 001384          964 HVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      .......++..|+|||+.. ...++.++||||+|+++|+|++|..||..... ............        ...... 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR--------PLPSSS-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT--------HHHHHT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--------cccccc-
Confidence            3344567899999999988 88999999999999999999999999987622 111111111100        000000 


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .  ........+.+++.+|++.||++||++.++++
T Consensus       224 --~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 --Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0  00011268899999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=322.01  Aligned_cols=244  Identities=25%  Similarity=0.421  Sum_probs=198.5

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEcccc----CccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe--EE
Q 001384          809 EDRIIGKGGFGTVYRGVLP-DGREVAVKKLQRE----GLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE--KI  881 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~--~~  881 (1088)
                      ...+||+|+|-+||+|.+. +|.+||--.++..    .....+.|..|+++++.    ++||||+++|.+|.+...  ..
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKs----L~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKS----LKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHcc----CCCCceeeeeeheecCCCceee
Confidence            3468999999999999986 5777774333221    12333789999999996    789999999999987654  77


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~~~  960 (1088)
                      +|+|.+..|+|..|+++.++++.+.+..|++||++||.|||++ .|+|||||||.+||+|+. .|.|||+|+|+|+....
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            8999999999999999999999999999999999999999998 689999999999999985 48999999999988753


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ..   ...+.|||.|||||++. ..|...+||||||+++.||+|+..||..= ....+.+++..+.........+.    
T Consensus       199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-~n~AQIYKKV~SGiKP~sl~kV~----  269 (632)
T KOG0584|consen  199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-TNPAQIYKKVTSGIKPAALSKVK----  269 (632)
T ss_pred             cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-CCHHHHHHHHHcCCCHHHhhccC----
Confidence            32   23378999999999988 59999999999999999999999999642 23445555555333321111111    


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 ..++.+||.+|+.. .++||++.|+++
T Consensus       270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 -----------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       24678888899999 999999999975

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.2e-34  Score=325.82  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      ..++|++.+.||+|+||.||+|.+. .++.||||++.....  .....+.+|+.+++.    ++||||+++++++...  
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC----VNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHH----hCCCchhceeeeeecccc
Confidence            4578999999999999999999975 688999999976432  223567788888886    6799999999988643  


Q ss_pred             ----CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          878 ----SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       878 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                          ...++||||+++ ++.+.+..  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence                357999999976 77777654  488999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC----
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH---- 1029 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1029 (1088)
                      +++....  ........+|..|+|||++.+..++.++||||+||++|+|++|+.||.+... ...|..........    
T Consensus       165 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence            9976532  2223345789999999999988999999999999999999999999986542 12221111100000    


Q ss_pred             --------------CC--Cccccch----hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1030 --------------GP--GRAVIPV----VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1030 --------------~~--~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                                    ..  .....+.    ................+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                          00  0000000    00000001112234567899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-33  Score=313.11  Aligned_cols=266  Identities=24%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|+..+.||+|+||.||+|+++ +++.||+|++.....  ...+.+.+|++++++    ++|||++++++++..+...+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~~   76 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQ----LKHPNLVNLIEVFRRKRKLH   76 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHh----CCCCCEeeeeeEEeeCCEEE
Confidence            46888999999999999999986 689999999875422  233567889999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|..++.....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999999999988887777899999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH--HHhhhccCCC----CCCcc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW--GRRVMGYGRH----GPGRA 1034 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~----~~~~~ 1034 (1088)
                      .. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.......+  ..........    .....
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            21 2233457889999998765 567899999999999999999999998654421111  1110000000    00000


Q ss_pred             ccchhhcCC---Cc---cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGS---GL---AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .........   ..   .........+.+++.+|++.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000000   00   000122457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-33  Score=315.60  Aligned_cols=260  Identities=23%  Similarity=0.356  Sum_probs=200.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-----------------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCc
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-----------------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      ++|++.+.||+|+||.||+|...                 ++..||+|++..... ....++.+|+++++.    ++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~----l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSR----LKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCC
Confidence            56899999999999999998632                 234689999976532 234678899999986    67999


Q ss_pred             eeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 001384          867 LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-----------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVK  935 (1088)
Q Consensus       867 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLk  935 (1088)
                      |+++++++..++..++||||+++|+|.+++....           .+++.+++.++.|++.|++|||+.   +++|||||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            9999999999999999999999999999987542           367889999999999999999999   99999999


Q ss_pred             CCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCcCCCCC
Q 001384          936 ASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT--GRRALEGG 1012 (1088)
Q Consensus       936 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~ 1012 (1088)
                      |+||+++.++.++++|||+++.+...... ......++..|+|||......++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999999765432221 1222344678999998888889999999999999999998  77888754


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ...  ++......+........         ..+.+..++..+.+++.+|++.||++||++.||++.|++
T Consensus       238 ~~~--~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDE--QVIENTGEFFRDQGRQV---------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChH--HHHHHHHHHHhhccccc---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            331  11111100000000000         001122344678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.9e-34  Score=318.68  Aligned_cols=265  Identities=21%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++..... .....+.+|++++++    ++||||+++++++..++..++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD----LKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHh----CCCCCcceEEEEEeeCCeEEE
Confidence            56889999999999999999976 678899999875432 233467789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ +|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.....
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            9999976 888887654 3589999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCC------CCc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHG------PGR 1033 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~ 1033 (1088)
                      .. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+.... ...............      ...
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            21 2233457889999997754 56899999999999999999999999865431 111111111000000      000


Q ss_pred             cccchhhcCCC----ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSG----LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...........    .........++.+++.+|++.||.+||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000    0001123456788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-33  Score=307.10  Aligned_cols=247  Identities=31%  Similarity=0.474  Sum_probs=199.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      ++||+|+||.||+|.+.+++.||+|++...... ....+.+|++++++    +.||||+++++++.+....++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQ----YDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999877999999998875443 44678899999886    6799999999999999999999999999


Q ss_pred             CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc-c
Q 001384          890 GSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-T  967 (1088)
Q Consensus       890 gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~  967 (1088)
                      ++|.+++.. ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+........... .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999999965 34689999999999999999999999   999999999999999999999999999876542211111 1


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          968 TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       968 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||......  ..........                ...
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~----------------~~~  215 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY----------------RMP  215 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC----------------CCC
Confidence            2234567999999888899999999999999999999 88888765431  1111111000                001


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      .+...+..+.+++.+|++.+|.+||++.|+++.|++
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            122334578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8e-34  Score=322.41  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=196.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+++.+ +++.+|+|++.+...   .....+..|+.++..    .+|++|+++++++.++...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~   76 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----GDNQWITTLHYAFQDENNL   76 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhh----CCCCCEeeEEEEEecCCEE
Confidence            46889999999999999999976 578899999865321   122347778888775    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++|+|.+++++ ...+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            999999999999999977 45789999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ...........||+.|+|||++.     ...++.++|||||||++|||++|+.||.....  .+....+.....    ..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~~----~~  227 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKE----RF  227 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCc----cc
Confidence            33333334457999999999875     34688999999999999999999999986532  222222221100    00


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLAM 1079 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 1079 (1088)
                      .++.        .......++.+++.+|+..++.+  |++++|+++.
T Consensus       228 ~~p~--------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPA--------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCC--------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0110        01123456777888888654443  6888888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-33  Score=311.96  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=203.5

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ....+.+|++++++    ++||||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK----LSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHh----cCCcceeeeEEEECCC
Confidence            46888999999999999999964      2467999988765333 34678999999987    6799999999999998


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT---------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                      ...++||||+++|+|.++++...         .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence            99999999999999999997655         689999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccC
Q 001384          949 VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYG 1027 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1027 (1088)
                      ++|||++...............++..|+|||.+.+..++.++||||+|+++|+|++ |..||....+..  .......  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~--  233 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQA--  233 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHc--
Confidence            99999987543322222333456778999999888888999999999999999998 788886543311  1111110  


Q ss_pred             CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                        .....           ..+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       234 --~~~~~-----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 --GKLEL-----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --CCcCC-----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence              00000           0011234578889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7e-34  Score=322.59  Aligned_cols=253  Identities=25%  Similarity=0.294  Sum_probs=196.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   .....+.+|..++..    .+|++|+++++++.+++..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~l~~~~~~~~~~   76 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN----GDCQWITTLHYAFQDENYL   76 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEcCCEE
Confidence            47899999999999999999976 678899999875321   223447778888775    5799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      |+||||+++|+|.+++++ ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999999987 46789999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ...........|++.|+|||++.+     ..++.++||||+||++|||++|+.||.....  .+..........    ..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--~~~~~~i~~~~~----~~  227 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHEE----RF  227 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--HHHHHHHHcCCC----cc
Confidence            433333334579999999998765     4678899999999999999999999986543  111122211000    00


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~ 1078 (1088)
                      ..+.        .......++.+++.+|+..++++  |++++++++
T Consensus       228 ~~p~--------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 QFPS--------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCC--------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0010        01122356778888998865544  457777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-33  Score=313.57  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=204.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .+|++.+.||.|++|.||+|.+. +++.||+|.+........+.+.+|+++++.    ++|||++++++++..+...++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE----LKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHh----cCCCceeeeeeeEecCceEEEE
Confidence            46889999999999999999964 789999999976655556678899999886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      +||+++++|.+++... .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999999998654 589999999999999999999999   999999999999999999999999999876543322


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........  ......... ..            
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~~-~~------------  234 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNGT-PE------------  234 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCC-cc------------
Confidence             22334678899999999888899999999999999999999999987544211  111110000 00            


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...+......+.+++.+|+..||++||++.++++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             0012223456888999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-33  Score=307.79  Aligned_cols=246  Identities=28%  Similarity=0.444  Sum_probs=199.5

Q ss_pred             ceecccCceEEEEEEeCC--C--cEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD--G--REVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|+.++++    ++||||+++++++.+ ...++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHS----LDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhh----cCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999999643  3  3699999988765 455688999999987    679999999999988 88999999


Q ss_pred             ecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          886 YMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |+++|+|.+++....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999997754  689999999999999999999999   999999999999999999999999999987654322


Q ss_pred             c--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          964 H--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       964 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .  ......++..|+|||+..+..++.++||||||+++|||++ |+.||.......  ..........            
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~------------  218 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEGE------------  218 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCC------------
Confidence            1  1123456788999999998899999999999999999999 999997653321  1111110000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                         ....+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       219 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ---RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               00111223467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-33  Score=328.41  Aligned_cols=263  Identities=19%  Similarity=0.208  Sum_probs=199.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC---CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP---DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++    ++||||+++++++......
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~----l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKT----ISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHh----cCCCCccceeeeEeeCCEE
Confidence            457999999999999999999853   3578999988654     245678999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++|||++. ++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.++|+|||+++....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99999996 58999997778899999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-----hHHHHHHhhhccCCCCCCcc
Q 001384          961 GDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-----CLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       961 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .... ......||..|+|||++....++.++||||+||++|||++|+.||.+...     .+..................
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            3222 22346799999999999988999999999999999999999999976432     11111110000000000000


Q ss_pred             ---c---cchhhcCCCc--cc-----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1035 ---V---IPVVLLGSGL--AE-----GAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1035 ---~---~~~~~~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                         .   +.........  ..     ......++.+++.+|++.||++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0   0000000000  00     01123467889999999999999999999863

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.3e-34  Score=315.13  Aligned_cols=248  Identities=28%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|+..+.||+|+||.||+|.+. +++.||||.+......   ....+..|+.++++    ++|++++++++.+.+++..+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~----l~~~~i~~~~~~~~~~~~~~   76 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEK----VNSRFVVSLAYAYETKDALC   76 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHh----CCCCCeeeeeEEEecCCEEE
Confidence            3677899999999999999976 6889999998754322   22456789999886    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +||||+++++|.+++...  ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++....
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            999999999999988643  3589999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ....  .....|+..|+|||++.+..++.++||||+|+++|+|++|+.||........ +-.....   .  ....    
T Consensus       154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~---~--~~~~----  222 (285)
T cd05630         154 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---K--EVQE----  222 (285)
T ss_pred             CCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh---h--hhhh----
Confidence            3221  2234689999999999988999999999999999999999999986532111 0000000   0  0000    


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                             ..+......+.+++.+|++.||++||+     ++|+++
T Consensus       223 -------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 -------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                   001123346788999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-33  Score=309.77  Aligned_cols=250  Identities=32%  Similarity=0.464  Sum_probs=192.9

Q ss_pred             ceecccCceEEEEEEeC----CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe-cCCeEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP----DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL-DGSEKILVY  884 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~-~~~~~~lv~  884 (1088)
                      +.||+|+||.||+|.+.    .+..||+|++.... ....+.+.+|+.+++.    ++|||++++++++. .+...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD----FSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHcc----CCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999853    23579999986432 2334577888888876    68999999999775 455688999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+.+|+|.++++.. ...++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++.......
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999999764 3467888899999999999999998   999999999999999999999999999876533211


Q ss_pred             c---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-cCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          964 H---VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR-RALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       964 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .   ......++..|+|||......++.++||||||+++|||++|+ .||.....  .+.........            
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~~------------  219 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQGR------------  219 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCC------------
Confidence            1   112334567899999988889999999999999999999965 45554322  11222221100            


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                          ....+...+..+.+++.+|++.+|++||++.||++.|+++..
T Consensus       220 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 ----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                001111223568899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.9e-34  Score=337.73  Aligned_cols=271  Identities=19%  Similarity=0.211  Sum_probs=195.7

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEec
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~  876 (1088)
                      +...+++|++.+.||+|+||+||+|.+. .++.||||+++... ....+...|++++..+..  ...|.+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345688999999999999999999975 57889999996531 223345556665554321  2356779999998876


Q ss_pred             C-CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----------
Q 001384          877 G-SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----------  945 (1088)
Q Consensus       877 ~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----------  945 (1088)
                      + .+.++|||++ +++|.+++.+.+.+++.++..|+.||+.||+|||+++  +||||||||+|||++.++          
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccc
Confidence            5 5788999998 6799999988888999999999999999999999732  999999999999998765          


Q ss_pred             ------CEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHH
Q 001384          946 ------KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVE 1018 (1088)
Q Consensus       946 ------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~ 1018 (1088)
                            .+||+|||.+....    .......||..|+|||++.+..|+.++|||||||++|||++|+.||.+.... ...
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             cCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  49999999875432    2234567899999999999999999999999999999999999999875431 111


Q ss_pred             HHHhhh-ccCC-----------------CCCCccccchh----hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHH
Q 001384         1019 WGRRVM-GYGR-----------------HGPGRAVIPVV----LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEV 1076 (1088)
Q Consensus      1019 ~~~~~~-~~~~-----------------~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 1076 (1088)
                      ...... ....                 ........+..    ...............+.+|+.+||+.||++||+++|+
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            110100 0000                 00000000000    0000000001123467899999999999999999999


Q ss_pred             HH
Q 001384         1077 LA 1078 (1088)
Q Consensus      1077 l~ 1078 (1088)
                      ++
T Consensus       436 L~  437 (467)
T PTZ00284        436 TT  437 (467)
T ss_pred             hc
Confidence            86

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.2e-34  Score=314.91  Aligned_cols=246  Identities=30%  Similarity=0.391  Sum_probs=197.7

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |+..+.||+|+||+||+|.+. +++.||+|.+......   ....+.+|+++++.    ++|+|++++++++..++..++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~----l~~~~i~~~~~~~~~~~~~~l   77 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEK----VNSQFVVNLAYAYETKDALCL   77 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHH----cCCcCceeEEEEEecCCEEEE
Confidence            677789999999999999975 6889999998764322   22356789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            99999999999988653  3699999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH--HHHHHhhhccCCCCCCccccch
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL--VEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ..  ......|+..|+|||++.+..++.++||||+|+++|||++|..||.+..+..  ..+.......      ...   
T Consensus       155 ~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~------~~~---  223 (285)
T cd05632         155 GE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET------EEV---  223 (285)
T ss_pred             CC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc------ccc---
Confidence            22  2234568999999999988899999999999999999999999998754321  1111111100      000   


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                              .+......+.+++.+|++.||++||+     ++|+++
T Consensus       224 --------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 --------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                    01123346778889999999999999     666655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-33  Score=308.08  Aligned_cols=250  Identities=26%  Similarity=0.430  Sum_probs=201.9

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCc------cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +|.+.+.||+|+||+||+|...+++.+|+|.+.....      .....+.+|++++++    ++|+||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS----LKHVNIVQYLGTCLDDNT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHh----cCCCCEeeEeeEeecCCe
Confidence            4788899999999999999988899999998874321      112457889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++.+..++++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||.+....
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999999999998878899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCC-----CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          960 AGD-----SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       960 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ...     ........++..|+|||+..+..++.++||||+|+++|+|++|+.||...+... .......   .    ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~---~----~~  225 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGA---H----RG  225 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhh---c----cC
Confidence            211     111233568889999999998889999999999999999999999997643311 1111000   0    00


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+        ..+.....++.+++.+|++.+|.+||++.|+++
T Consensus       226 ~~~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMP--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000        012233467888999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-35  Score=329.96  Aligned_cols=243  Identities=28%  Similarity=0.330  Sum_probs=187.9

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||+||+|++. +++.||||++.+......   ..+..|..++.... .-.||||+++++++.++...|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL-LDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc-cCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            699999999999976 689999999975432222   23445555554321 1169999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +|+|.+++.+...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~  155 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT  155 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence            999999998888899999999999999999999999   99999999999999999999999999987543222 22334


Q ss_pred             ccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccc
Q 001384          969 IAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1088)
                      ..||..|+|||++.+. .++.++||||+||++|||++|+.||.+....  +...... ....     ..+          
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~~~i~-~~~~-----~~~----------  217 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRNIA-FGKV-----RFP----------  217 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHHHHHH-cCCC-----CCC----------
Confidence            6789999999987654 5899999999999999999999999865431  1111111 0000     000          


Q ss_pred             cHHHHHHHHHHHhhhcccCCCCCCC----HHHHHH
Q 001384         1048 GAEEMSELLRIGVRCTAEAPNARPN----VKEVLA 1078 (1088)
Q Consensus      1048 ~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 1078 (1088)
                      .......+.+++.+|++.||.+||+    +.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0112346778899999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-33  Score=312.72  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=196.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.++||+|+||.||+|++. +++.||+|++.... ......+.+|++++.+    +.||||+++++++..++..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK----CDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHh----CCCCCeeeEEEEEEECCEEEE
Confidence            36788899999999999999964 68899999987542 2334578899999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++++|..+    ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++...... 
T Consensus        77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999999999765    3478899999999999999999999   9999999999999999999999999999765422 


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-----HHHHHHhhhccCCCCCCccccc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-----LVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                        ......++..|+|||++.+..++.++||||+|+++|+|++|+.||......     ...+........         +
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~  217 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------P  217 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------C
Confidence              223456889999999999889999999999999999999999999653210     111111111000         0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ...      .......++.+++.+|++.+|++||+++|+++.
T Consensus       218 ~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         218 PVL------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCC------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000      011233467889999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-33  Score=321.53  Aligned_cols=257  Identities=29%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      .+|++.+.||+|+||.||+|...        .+..||+|.+..... ...+++.+|++++.++.   +||||+++++++.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG---KHKNIINLLGACT   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc---CCCCeeeeeEEEc
Confidence            46889999999999999999742        123689998875432 23357888999988632   7999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      .+...++||||+++|+|.+++...                ..+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            999999999999999999999753                2478899999999999999999998   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 1017 (1088)
                      +++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+...  .
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~  243 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--E  243 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--H
Confidence            99999999999999998664322211 122334567999999988899999999999999999998 8888876432  2


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ++........                ....+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus       244 ~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ELFKLLKEGH----------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHHHcCC----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            2222221100                001112234578899999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.4e-34  Score=315.39  Aligned_cols=269  Identities=25%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-----CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--  876 (1088)
                      +.|+..+.||+|+||.||+|++.     +++.||||++...... ..+.+.+|+++++.    +.||||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~----l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRT----LDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHh----CCCCChheEEeeeecCC
Confidence            35777899999999999999853     3678999999866443 45679999999886    679999999999887  


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      ....++||||+++++|.+++.... .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            567899999999999999997654 699999999999999999999998   9999999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ..........  .....++..|+|||......++.++||||||+++|||++|+.|+.........+.....   ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~  233 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ---GQMIVT  233 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc---ccccHH
Confidence            8765322211  11234456799999988889999999999999999999999998654321111000000   000000


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      ............+.+..++.++.+++.+|++.+|++||++.||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000000111111233446788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-33  Score=308.49  Aligned_cols=249  Identities=32%  Similarity=0.501  Sum_probs=201.6

Q ss_pred             CCccceecccCceEEEEEEeCC-----CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPD-----GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      +++.+.||+|+||.||+|++.+     +..||+|++...... ..+.+..|++++..    ++|+||+++++++.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRK----LDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHh----cCCCchheEEEEEcCCCee
Confidence            3567899999999999999753     378999999766433 45688899999986    5799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      +++|||+++++|.++++....  +++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+...
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            999999999999999976554  89999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ............++..|+|||...+..++.++||||+|+++|+|++ |..||.....  .+.........          
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~----------  221 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY----------  221 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC----------
Confidence            5443222222346789999999888889999999999999999998 7888875432  11111111000          


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                            ....+...+.++.+++.+|++.||++||++.|+++.|
T Consensus       222 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  0011122456788899999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-33  Score=306.41  Aligned_cols=248  Identities=26%  Similarity=0.415  Sum_probs=203.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|+..+.||+|+||.||.++.. +++.+++|++....  ....+++.+|++++++    ++|+||+++++++.+.+..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSL----LQHPNIIAYYNHFMDDNTLLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHh----CCCCCeeEEEeEEecCCeEEE
Confidence            5888999999999999999965 68899999987543  2334578899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++++|.+++...  ..+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+.....
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            99999999999999765  4689999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ... ......++..|+|||...+..++.++||||+|+++|||++|+.||.....  .+.......               
T Consensus       154 ~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~~~~~~---------------  215 (256)
T cd08221         154 EYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQ---------------  215 (256)
T ss_pred             ccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc---------------
Confidence            332 23345688999999998888889999999999999999999999976543  122212110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       +...+.+.....++.+++.+|++.+|++||++.|+++.
T Consensus       216 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 -GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             00011112334568889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-33  Score=306.92  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=204.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|+..+.||+|+||.||+|..++ ++.+|+|.+.....  .+++.+|++++++    ++||||+++++++.++...++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~----l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQ----CDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHh----CCCCcEeeeeeeeecCCcEEE
Confidence            3578999999999999999999864 78999999876522  5688999999987    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ++||+++++|.+++.. ...+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999999975 45689999999999999999999999   9999999999999999999999999998876433


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      .. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.....  ...   . ..          
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~~~---~-~~----------  215 (256)
T cd06612         153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIP---N-KP----------  215 (256)
T ss_pred             cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--hhc---c-CC----------
Confidence            21 2233457889999999988899999999999999999999999997643311100  000   0 00          


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+......+.+++.+|++.||++||++.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0001112234467889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.2e-33  Score=309.20  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .+++.+.....||+|+||.||+|++. +++.||+|.+........+.+.+|++++++    ++|+||+++++++..++..
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY----LKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHh----cCCCCeeeeeeeeccCCEE
Confidence            34555666689999999999999965 578899999887655556688999999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRL--TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~  956 (1088)
                      ++|+||+++++|.+++... ..+  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999999764 445  8889999999999999999998   9999999999999986 6799999999987


Q ss_pred             eecCCCCcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ....... ......++..|+|||+....  .++.++||||+|+++|+|++|+.||..... ....|.....  .      
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--~------  228 (268)
T cd06624         158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--K------  228 (268)
T ss_pred             ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--c------
Confidence            6543221 22234578899999987654  478899999999999999999999975432 1111211111  0      


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               .....+.....++.+++.+|++.+|++||++.|++.
T Consensus       229 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ---------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                     000112233456888999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-33  Score=314.53  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.    ++|||++++++++..++..++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE----NKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHh----CCCCCEeeEEEEEecCCEEEE
Confidence            367999999999999999999964 789999999986655555678889998886    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++++|.+++.+ ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999999865 4589999999999999999999999   99999999999999999999999999987654322


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      . ......+++.|+|||...+..++.++||||+|+++|+|++|+.||........  .....   ....           
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~~---~~~~-----------  232 (297)
T cd06656         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIA---TNGT-----------  232 (297)
T ss_pred             c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeeec---cCCC-----------
Confidence            1 22334678899999999888899999999999999999999999976432110  00000   0000           


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....+......+.+++.+|++.+|++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000112234456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=310.82  Aligned_cols=247  Identities=30%  Similarity=0.423  Sum_probs=202.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||.|++|.||+|++. +++.||+|++.... ......+.+|+++++.    ++|+|++++++++.++...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ----CRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHH----cCCCCeeeeeEEEEECCeEEE
Confidence            36888899999999999999976 68899999987653 2334567889999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |+||+++++|.++++.. ++++..++.++.|++.|++|||++   +++||||+|+||++++++.++++|||.++......
T Consensus        77 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999999999765 789999999999999999999999   99999999999999999999999999998775432


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                       .......++..|+|||+..+..++.++||||||+++|+|++|+.||.......  .......    .     .....  
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~----~-----~~~~~--  218 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPK----N-----NPPSL--  218 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhh----c-----CCCCC--
Confidence             12233467889999999988889999999999999999999999997654311  1111110    0     00000  


Q ss_pred             CCccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ... ....+.+++.+|+..||++||+++++++
T Consensus       219 -----~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 -----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 111 3456888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-33  Score=323.56  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=197.8

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      ..++|++.+.||+|+||.||+|.+. .++.||||++....  ......+.+|+.+++.    ++||||+++++++...  
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC----VNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHh----cCCCCccccceeeccccc
Confidence            3468999999999999999999975 68899999997642  2233567789998886    6799999999987643  


Q ss_pred             ----CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          878 ----SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       878 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                          ...|+||||+++ +|.+++..  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence                357999999975 78887754  478999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC----
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH---- 1029 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1029 (1088)
                      +++.....  .......+|..|+|||++.+..++.++||||+||++|||++|+.||.+.+. ...|..........    
T Consensus       172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHH
Confidence            99765322  222345689999999999998999999999999999999999999987543 11221111100000    


Q ss_pred             --------------CCC------ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 --------------GPG------RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 --------------~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                    .+.      ......................+.+++.+|++.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                          000      0000000000000011112356789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-33  Score=306.22  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-CCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-GSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-~~~~~  881 (1088)
                      +|++.+.||+|++|.||+|..+ +++.||+|++.....  ...+.+.+|++++++    ++|+|++++++.+.. +...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQ----LKHPNIVAYRESWEGEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHh----CCCCCeeeeeeeecCCCCEEE
Confidence            4888999999999999999976 578899999875432  233567888888886    679999999998764 44678


Q ss_pred             EEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +||||+++++|.+++...  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999999999999763  3589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||...+...  +........            
T Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~------------  218 (257)
T cd08223         154 NQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--LVYRIIEGK------------  218 (257)
T ss_pred             ccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHhcC------------
Confidence            322 22334567889999999998899999999999999999999999997654321  111111000            


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ....+......+.+++.+|++.+|++||++.|+++
T Consensus       219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 ----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                00112234467889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-33  Score=309.54  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      +++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.+..   +|||++++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~---~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS---HHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhc---CCCCeeeEeeEEeecCCCC
Confidence            5678899999999999999999975 57889999987542 34567888998887632   699999999998753    


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          878 --SEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                        ...++||||+++++|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence              4689999999999999999763  3689999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      ++....... .......|+..|+|||++.     ...++.++||||+||++|||++|+.||...............    
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----  231 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----  231 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC----
Confidence            998654322 1233456889999999875     346888999999999999999999999764432111111000    


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .    ...       ......+..+.+++.+|++.+|.+||+++|+++
T Consensus       232 --~----~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 --P----APR-------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --C----CCC-------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              0    000       001123356788999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.6e-33  Score=310.71  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.    +.|||++++++++..+...++|
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILAT----CNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHh----CCCCcEeeeEEEEEeCCeEEEE
Confidence            57899999999999999999976 588999999987655555678889998886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++++|..++.+ ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+...... 
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-  163 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-  163 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence            999999999988754 45689999999999999999999998   9999999999999999999999999998764322 


Q ss_pred             CcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ........++..|+|||++.     ...++.++|||||||++|||++|+.||......  +........   ...     
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~---~~~-----  233 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAKS---EPP-----  233 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHHHhcC---CCc-----
Confidence            11223456788999999874     445788999999999999999999999764321  111111100   000     


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ....+.....++.+++.+|++.+|++||++.|+++
T Consensus       234 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00112233456888999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-33  Score=310.41  Aligned_cols=238  Identities=25%  Similarity=0.360  Sum_probs=186.7

Q ss_pred             eecccCceEEEEEEeCC-------------------------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCc
Q 001384          812 IIGKGGFGTVYRGVLPD-------------------------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      .||+|+||.||+|....                         ...||+|++..........+.+|+.+++.    ++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~----l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQ----VSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhc----CCCCC
Confidence            69999999999997421                         13588999876544444567888888875    68999


Q ss_pred             eeEEeeEEecCCeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          867 LVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       867 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      |+++++++.++...++||||+++|+|.+++.. ...+++..+..++.|+++||+|||++   +|+||||||+||+++..+
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            99999999999999999999999999999865 45789999999999999999999999   999999999999998654


Q ss_pred             -------CEEEeecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHH-hCCcCCCCCchhH
Q 001384          946 -------KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELA-TGRRALEGGEECL 1016 (1088)
Q Consensus       946 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~~ 1016 (1088)
                             .+|++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3899999987644221     12346788999998765 56899999999999999984 7999997654322


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      ........     ..    .           +......+.+++.+|++.+|++||++.+|++.|+
T Consensus       230 ~~~~~~~~-----~~----~-----------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFYEKK-----HR----L-----------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHHhc-----cC----C-----------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11110000     00    0           1111246888999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-33  Score=307.09  Aligned_cols=238  Identities=24%  Similarity=0.369  Sum_probs=187.6

Q ss_pred             ceecccCceEEEEEEeCC-------------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          811 RIIGKGGFGTVYRGVLPD-------------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +.||+|+||.||+|....             ...||+|.+..........+.+|+.++..    ++||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~----l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ----VSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHh----CCCCCEeeEEEEEecC
Confidence            368999999999998532             23588998876544444577888888876    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-------EEE
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-------ALV  949 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-------~kl  949 (1088)
                      ...++||||+++|+|..+++.. ..+++..+++++.||+.||+|||++   +|+||||||+||+++.++.       +++
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999999999998754 5689999999999999999999999   9999999999999987664       899


Q ss_pred             eecccceeecCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHH-hCCcCCCCCchhHHHHHHhhhccC
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELA-TGRRALEGGEECLVEWGRRVMGYG 1027 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1088)
                      +|||.+......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..........  ...   
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~~~---  223 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--FYE---  223 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--HHh---
Confidence            999998654321     2345778899999876 567899999999999999998 5888876543211111  000   


Q ss_pred             CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                      .  . ..            ........+.+++.+|++.||++||++.+|++.+
T Consensus       224 ~--~-~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 G--Q-CM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             c--C-cc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0  0 00            0111235678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-34  Score=344.88  Aligned_cols=254  Identities=20%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             HHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-
Q 001384          801 LKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-  876 (1088)
Q Consensus       801 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-  876 (1088)
                      ....++|++.+.||+|+||+||+|++. .++.||+|++.....  .....+..|+.++..    +.|||||+++++|.. 
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~----L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE----LKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHH----cCCCCcCeEEEEEEec
Confidence            345578999999999999999999976 577899998875432  234568899999997    679999999998864 


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCEEEcCC---
Q 001384          877 -GSEKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECY----PPIVHRDVKASNVLLDKE---  944 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~ivH~DLkp~NIll~~~---  944 (1088)
                       ....|+||||+++|+|.+++..    ...+++..++.|+.||+.||+|||+...    .+||||||||+||||+.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             3568999999999999999865    2469999999999999999999998521    259999999999999642   


Q ss_pred             --------------CCEEEeecccceeecCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcC
Q 001384          945 --------------GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRA 1008 (1088)
Q Consensus       945 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p 1008 (1088)
                                    +.+||+|||++..+...  .......||+.|+|||++..  ..++.++|||||||++|||++|+.|
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                          34899999999865422  22334578999999998743  4688999999999999999999999


Q ss_pred             CCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1009 LEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      |..... ..+..........       .+          ......++.+||.+||+.+|.+||++.+++.
T Consensus       243 F~~~~~-~~qli~~lk~~p~-------lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        243 FHKANN-FSQLISELKRGPD-------LP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcCCc-HHHHHHHHhcCCC-------CC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            976433 1122111110000       00          0112356888999999999999999999983

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-33  Score=309.68  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=198.0

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |++.+.||+|+||.||+|.+. ++..+|+|.+........+.+.+|+++++.    ++|||++++++++..+...++|||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS----CDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHH----CCCCCeeeEEEEEeeCCEEEEEEE
Confidence            677789999999999999976 577889999876544445678889999886    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          886 YMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      |+++++|.+++.+ ..++++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++...... ..
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~  158 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ  158 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-cc
Confidence            9999999998765 45699999999999999999999999   9999999999999999999999999998764322 11


Q ss_pred             ccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          965 VSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ......++..|+|||++.     ...++.++||||+||++|||++|+.||........  .......   ....      
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~---~~~~------  227 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS---EPPT------  227 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhc---CCCC------
Confidence            223456889999999873     44678899999999999999999999976443111  1111100   0000      


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ...+......+.+++.+|++.||.+||++.++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         228 -----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0012223457888999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-33  Score=310.91  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=204.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||.||+|.++ +|+    .+|+|........ ....+.+|+.++.+    +.|||++++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS----VDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEec-C
Confidence            46888899999999999999964 333    5899988765432 34578889999986    679999999999887 7


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++.
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            889999999999999999764 4689999999999999999999998   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ........ .....++..|+|||......++.++||||||+++||+++ |+.||.+...  .++.........       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-------  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGER-------  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCCC-------
Confidence            65332211 112234568999999888899999999999999999998 9999987543  222222221000       


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                               .+.+..+...+.+++.+|+..||.+||++.++++.|+++.+
T Consensus       230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     01112233467888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.5e-33  Score=308.19  Aligned_cols=248  Identities=29%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++    +.||||+++++++.++...++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ----CDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEECCEEEE
Confidence            35777889999999999999975 588999999875432 334568889999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|.+++.. .++++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999999999865 4689999999999999999999998   99999999999999999999999999997764332


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      . ......++..|+|||+..+..++.++||||||+++|||++|+.||..........  ...                ..
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~----------------~~  216 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIP----------------KN  216 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--hhh----------------cC
Confidence            1 2233467889999999988889999999999999999999999997654311110  000                00


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      .........+..+.+++.+|++.+|++||++.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0111234456778899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-33  Score=315.59  Aligned_cols=193  Identities=25%  Similarity=0.393  Sum_probs=160.2

Q ss_pred             cceecccCceEEEEEEeC---CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCeEEEEE
Q 001384          810 DRIIGKGGFGTVYRGVLP---DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSEKILVY  884 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~~~lv~  884 (1088)
                      .++||+|+||+||+|+.+   +++.||+|++....  ....+.+|++++++    ++||||+++++++..  +...++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRE----LKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHh----cCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999964   46789999987652  33457889999987    679999999998864  45688999


Q ss_pred             EecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCCEEEee
Q 001384          885 EYMEGGSLEDIISDR---------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----DKEGKALVTD  951 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----~~~~~~kl~D  951 (1088)
                      ||+++ +|.+++...         ..+++..++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            99965 898887532         2489999999999999999999999   99999999999999    4667899999


Q ss_pred             cccceeecCCCCc--ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCC
Q 001384          952 FGLARVVSAGDSH--VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGG 1012 (1088)
Q Consensus       952 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~ 1012 (1088)
                      ||+++.+......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9999876432211  2234578999999998765 46899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.3e-33  Score=316.00  Aligned_cols=263  Identities=23%  Similarity=0.270  Sum_probs=192.8

Q ss_pred             ccceeccc--CceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          809 EDRIIGKG--GFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       809 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.++||+|  +|++||++..+ +|+.||+|++.....  ...+.+.+|+++++.    ++||||+++++++..++..++|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~----l~hpniv~~~~~~~~~~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKL----FNHPNIVPYRATFIADNELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHh----cCCCCeeeEEEEEEECCEEEEE
Confidence            45789999  78899999975 789999999976532  223457788888886    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            9999999999999653  4589999999999999999999998   9999999999999999999999999865433211


Q ss_pred             CCc------ccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          962 DSH------VSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       962 ~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ...      ......++..|+|||++.+  ..++.++||||+||++|||++|+.||.........+..............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence            110      0122346678999998865  46899999999999999999999999764331111111100000000000


Q ss_pred             -----------------ccc----------chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 -----------------AVI----------PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 -----------------~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                       ...          +........+........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                             000          000000000011223457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-33  Score=306.22  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=202.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||++... +++.||+|++....  ....+++.+|+.++++    ++||||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSN----MKHPNIVQYQESFEENGNLYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHh----CCCCCeeeeEeeecCCCeEEE
Confidence            5888999999999999999965 68899999987542  2234578889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++++|.+++....  .+++.+++.++.|++.|++|||++   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            999999999999987643  578999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ... ......++..|+|||+..+..++.++||||||+++|+|++|+.||......  +......                
T Consensus       154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~----------------  214 (256)
T cd08218         154 TVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NLVLKII----------------  214 (256)
T ss_pred             chh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HHHHHHh----------------
Confidence            221 223345788999999998888999999999999999999999999765331  1111111                


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+.....+......+.+++.+|++.+|++||++.||++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            00111112234567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-33  Score=313.30  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++.+    ++||||+++++++..++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK----AVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHh----cCCCcHHhhhhheecCCeEEE
Confidence            36888999999999999999976 78999999887542 2223578889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++++|.++++..   ..+++..+..++.|++.|+.|||+++  +|+||||||+||+++.++.++++|||.+..+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999999999998763   36899999999999999999999743  89999999999999999999999999987653


Q ss_pred             CCCCcccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTW------QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ..   ......++..|+|||.+.+.      .++.++||||+||++|+|++|+.||........  .....         
T Consensus       155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~---------  220 (286)
T cd06622         155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLS---------  220 (286)
T ss_pred             CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHH---------
Confidence            22   22334578899999987543      358899999999999999999999976432111  11100         


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ....+.....+.....++.+++.+|++.+|++||++++++.
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         221 ----AIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----HHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                00000111123335567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.9e-33  Score=303.60  Aligned_cols=251  Identities=30%  Similarity=0.484  Sum_probs=203.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|++++++    ++|+||+++++++...+..++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~----l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL----LKHPNLVKYYGVEVHREKVYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHh----CCCCChhheeeeEecCCEEEE
Confidence            5888899999999999999965 6889999998866443  45678899999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |+||+++++|.+++.....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999999998887799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             Ccccc---cccccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          963 SHVST---TIAGTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       963 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .....   ...++..|+|||++....   ++.++||||||+++|+|++|+.||....... ........ ..    ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~----~~~~  227 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGA-GH----KPPI  227 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhc-CC----CCCC
Confidence            22211   346788999999987766   8899999999999999999999997653211 11111110 00    0000


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +         ........+.+++.+|++.+|++||++.|++.
T Consensus       228 ~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 P---------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C---------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0         11122456778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-33  Score=311.68  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=201.4

Q ss_pred             CHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          796 TYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       796 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++.+..+.++|++.+.||+|+||.||+|.+. +++.+|+|++.... ....++.+|+.+++.+.   +||||+++++++
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~   84 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALS---DHPNVVKFYGMY   84 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHh---cCCCeeeeeeee
Confidence            34455567889999999999999999999975 67899999876532 23456788888887632   699999999987


Q ss_pred             e-----cCCeEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          875 L-----DGSEKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       875 ~-----~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      .     .+...++||||+++++|.++++.    ...+++..+..++.|++.|+.|||+.   +++||||||+||++++++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            4     34568999999999999998753    34688999999999999999999999   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCcccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          946 KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                      .++++|||.++...... .......|+..|+|||++..     ..++.++||||+||++|||++|+.||....... ...
T Consensus       162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~  239 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALF  239 (286)
T ss_pred             CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHh
Confidence            99999999988764322 22234468899999998653     457889999999999999999999997653311 110


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      . .   .......           ...+......+.+++.+|++.||++||++.|+++.
T Consensus       240 ~-~---~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 K-I---PRNPPPT-----------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-c---cccCCCc-----------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0 0   0000000           00111223568889999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=310.82  Aligned_cols=267  Identities=23%  Similarity=0.264  Sum_probs=205.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||.||+|.++ +++.||+|+++...  ....+.+.+|++++++    +.|+||+++++++..++..+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~   76 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ----LRHENIVNLKEAFRRKGRLY   76 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHh----cCCCCeeehhheEEECCEEE
Confidence            46889999999999999999976 57899999987542  2234678899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||++++.+..+......+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+......
T Consensus        77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999999977777776667799999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccC----------CCC
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG----------RHG 1030 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~ 1030 (1088)
                      .........++..|+|||++.+. .++.++||||+|+++|+|++|+.||.+.......|........          ...
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            33233445678899999998877 8899999999999999999999999865442222211110000          000


Q ss_pred             CCcc-ccchhhcCC--CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRA-VIPVVLLGS--GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~-~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .... .........  ....+.....++.+++.+|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000 000000000  00001123577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-33  Score=310.45  Aligned_cols=264  Identities=25%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|++|.||+|+.+ +++.||+|++.....  .....+.+|+.+++.    ++|||++++++++.++...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKE----LQHPNIVCLQDVLMQESRLYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHh----cCCCCEeeeEEEEeeCCeEEE
Confidence            4788899999999999999975 689999999875422  223567889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||++ ++|.++++..   ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            999997 5899888643   4589999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh--ccC-CCCC----
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM--GYG-RHGP---- 1031 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~--~~~-~~~~---- 1031 (1088)
                      ... .......++..|+|||.+.+ ..++.++||||+|+++|+|+||+.||.+..+....+.....  ... ....    
T Consensus       153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         153 IPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             CCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence            321 12223356889999997754 45789999999999999999999999876442211111000  000 0000    


Q ss_pred             ---CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 ---GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .....+................++.+++.+|++.||++||++.+|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence               00000000000000001123456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=307.67  Aligned_cols=243  Identities=29%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      +.|+.-++||+|+||.||-++.+ +|+.+|.|++.+....   .+....+|-.++.+    +..+.||.+-..|+..+..
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~k----V~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEK----VSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHH----hccCcEEEEeeeecCCCce
Confidence            45777899999999999999965 7999999998765433   33456788888887    5688999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ++|+..|.||+|.-.|...+  .+++..++.+|.+|+.||++||++   +||+||+||+|||+|+.|+++|+|+|+|..+
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999998886655  699999999999999999999999   9999999999999999999999999999988


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH--HHHHHhhhccCCCCCCcccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL--VEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ..+..  ....+||.+|||||+++.+.|+...|+||+||++|||+.|+.||....+-.  .+..++..            
T Consensus       338 ~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~------------  403 (591)
T KOG0986|consen  338 PEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL------------  403 (591)
T ss_pred             CCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh------------
Confidence            75443  344589999999999999999999999999999999999999998754311  11111211            


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                           ......+.....+..++-...+++||++|..-
T Consensus       404 -----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 -----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             -----cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence                 11111133444566666668999999999743

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-33  Score=314.94  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=200.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|+..+.||+|+||.||+|.+. +++    .||+|.+...... ...++.+|+.+++.    ++||||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~----l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS----MDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCcccEEEEEcCC-
Confidence            46788899999999999999864 443    5788888765322 23467889888886    6899999999998754 


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++++||+++|+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            4678999999999999987644 589999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCch-hHHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEE-CLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+... ...++....   ..      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~------  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---ER------  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---CC------
Confidence            65332221 222345678999999988899999999999999999997 9999976432 222221110   00      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                .+.+......+.+++.+|+..+|++||+++|+++.|+++.+
T Consensus       230 ----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         230 ----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      00111233567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-33  Score=303.87  Aligned_cols=247  Identities=25%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +|+..+.||+|+||+||+|... +++.||+|.+.....     ...+.+..|+++++.    ++|+|++++++++.++..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK----LQHPNIVQYLGTEREEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHh----cCCCCchheeeeEecCCe
Confidence            4778899999999999999976 789999999865431     133568889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++.+...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ...  ......++..|+|||...... ++.++|+||+|+++|+|++|+.||....+....+.....  ..    .     
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~----~-----  220 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KE----L-----  220 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--cc----C-----
Confidence            322  223456788999999877666 899999999999999999999999765431111111100  00    0     


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ...+......+.+++.+|++.+|.+||++.++++
T Consensus       221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                  0011223456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.2e-33  Score=312.33  Aligned_cols=265  Identities=24%  Similarity=0.349  Sum_probs=202.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++......  ..+.+.+|+++++.    ++||||+++++++..+...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   76 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQ----LRHENLVNLIEVFRRKKRLY   76 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHh----cCCcchhhHHHhcccCCeEE
Confidence            46888999999999999999986 5899999998754322  24567889999886    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|.++......+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++......
T Consensus        77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999999999999887776799999999999999999999999   9999999999999999999999999998875433


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC-CCccccc--
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG-PGRAVIP-- 1037 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-- 1037 (1088)
                      . .......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... ...+.+......... .......  
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccc
Confidence            2 22334567889999998764 4578899999999999999999999976432 222211110000000 0000000  


Q ss_pred             hhh----cCC------CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVL----LGS------GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~----~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...    ...      ...........+.+++.+|++.+|++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000    000      00001233567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5e-33  Score=311.78  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=198.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.+..... .....+.+|+.+++.    ++||||+++++++..+...++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----LKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHh----cCCCCcceEEEEEecCCeEEE
Confidence            56889999999999999999976 678999999875432 233467789999986    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||++ ++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            999997 4999888654 4689999999999999999999999   9999999999999999999999999998764322


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCCcccc---
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVI--- 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--- 1036 (1088)
                      .. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .....................   
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            21 1223456889999998654 45788999999999999999999999865431 111111111111100000000   


Q ss_pred             -------chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 -------PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 -------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             +.................+.+++.+|++.||.+||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                   000000000001123456788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-33  Score=305.91  Aligned_cols=245  Identities=31%  Similarity=0.455  Sum_probs=197.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|.. +++.||+|++...  .....+.+|+.++++    ++|||++++++++..+ ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTK----LHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHh----CCCCCcCeEEEEEcCC-CcEEEE
Confidence            3588899999999999999985 5788999998754  234578899999886    6799999999998765 478999


Q ss_pred             EecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++++|.+++....  .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+...... 
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999997643  589999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                         ......+..|+|||.+.+..++.++||||+|+++|||++ |+.||......  +..........             
T Consensus       154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------  215 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGYR-------------  215 (254)
T ss_pred             ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCCC-------------
Confidence               112234568999999988899999999999999999997 99999765431  12122110000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                         ...+...+..+.+++.+|++.+|++||+++|+++.|++
T Consensus       216 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 ---MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               00112234577889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.5e-33  Score=305.60  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=196.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--  876 (1088)
                      .+|+..+.||+|+||.||+|... +++.||+|++.....     .....+.+|+.++++    ++||||+++++++.+  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN----LQHERIVQYYGCLRDRA   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHH----cCCCCeeeEEEEEEcCC
Confidence            36888999999999999999975 688999998864321     122457889999886    679999999998875  


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +...+++|||+++++|.+++.....+++...+.++.|++.||+|||+.   +|+||||+|+||+++.++.++|+|||+++
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            357789999999999999998877899999999999999999999998   99999999999999999999999999987


Q ss_pred             eecCCCC--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDS--HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .......  .......++..|+|||.+.+..++.++||||+||++|||++|+.||...... ... ........      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~-~~~~~~~~------  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAI-FKIATQPT------  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHH-HHHhcCCC------
Confidence            6532111  1112345788999999998888999999999999999999999999865321 111 11110000      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               ....+......+.+++ +|+..+|++||+++||++
T Consensus       227 ---------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                     0011222334556666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-33  Score=309.18  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=204.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.    ++||||+++++++......++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE----CRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHH----cCCCCcceEeeeEecCCEEEE
Confidence            46888899999999999999975 68899999887543 2335678899999986    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++++|.+++...+.+++..+..++.+++.|+.|||+..  +++||||+|+||+++.++.++|+|||++...... 
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            9999999999999988888999999999999999999999742  8999999999999999999999999998654321 


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh---------HHHHHHhhhccCCCCCCc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC---------LVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~ 1033 (1088)
                        ......++..|+|||++.+..++.++|||||||++|+|++|+.||......         ..++.......       
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------  228 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence              122356889999999988889999999999999999999999999854321         11121221100       


Q ss_pred             cccchhhcCCCccc-cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1034 AVIPVVLLGSGLAE-GAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                               ..... ....+..+.+++.+|++.||++||++.|+++..
T Consensus       229 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 ---------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                     00000 112445788999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=315.81  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=206.0

Q ss_pred             CCCCccceecccCceEEEEEEeCCCc-EEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|+++.-||-|+||.||+|..++.. ..|.|++.....+.-+++.-|++++..    +.||+||++++.|+.++..+|.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~----CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAE----CDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhc----CCChHHHHHHHHHhccCceEEE
Confidence            44677788999999999999987544 456787776655566789999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      .|||.||-+..++-. ...+++.++..+++|++.||.|||++   .|||||||+-|||++-+|.++++|||.+..... .
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t  183 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-T  183 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-H
Confidence            999999999987755 45699999999999999999999999   999999999999999999999999998765432 2


Q ss_pred             CcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ......+.||++|||||+..     ..+|++++||||||+.+.||..+.+|.....+.-+     .+......      +
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----llKiaKSe------P  252 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSE------P  252 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HHHHhhcC------C
Confidence            33456789999999999744     56899999999999999999999999876554221     11111111      1


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           .-...|......+.+++++|+..+|..||+++++++
T Consensus       253 -----PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 -----PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 112346778889999999999999999999999875

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.2e-33  Score=304.35  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=188.9

Q ss_pred             ceecccCceEEEEEEeCC---CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLPD---GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|...+   +..+|+|+++.... .....+.+|+.++++    ++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRS----LQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHh----CCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            358999999999998643   45799999876532 233578889999886    6799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          887 MEGGSLEDIISDRT-----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +++|+|.++++...     ..++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.....
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            99999999997532     356778889999999999999999   9999999999999999999999999998754332


Q ss_pred             CCcc-cccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          962 DSHV-STTIAGTVGYVAPEYGQTW-------QATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       962 ~~~~-~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .... .....++..|+|||++...       .++.++||||||+++|||++ |+.||........ .......     ..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~-----~~  227 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE-----QQ  227 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc-----cc
Confidence            2211 1234567889999987542       35789999999999999996 9999976543211 1111110     00


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      .....+..       .......+.+++.+|+ .+|++||+++||++.|+
T Consensus       228 ~~~~~~~~-------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRL-------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCcc-------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000000       1112345777888998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=309.32  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++..........+..|++++++    ++|||++++++++..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE----CKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHh----CCCCceeEEEEEEecCCeEEE
Confidence            356889999999999999999975 688999999976644455678899999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++++|.+++... ..+++.+++.++.|++.|+.|||++   +|+|+||+|+||+++.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999998764 4699999999999999999999999   9999999999999999999999999988654322


Q ss_pred             CCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      . .......++..|+|||.+.     ...++.++||||+|+++|||++|+.||.......  ......   ....     
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~---~~~~-----  225 (280)
T cd06611         157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKIL---KSEP-----  225 (280)
T ss_pred             c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHh---cCCC-----
Confidence            1 1223456888999999864     3457889999999999999999999997653311  111111   0000     


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                            .....+......+.+++.+|++.+|.+||++.++++.
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 ------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  0001122334578889999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-33  Score=308.80  Aligned_cols=239  Identities=26%  Similarity=0.400  Sum_probs=188.2

Q ss_pred             ceecccCceEEEEEEeCC--------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.||+|+||.||+|..+.        ..+||+|.+........+.+.+|+.+++.    ++|||++++++++..+...++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQ----LSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHh----CCCCChhheeeEEEeCCCcEE
Confidence            369999999999998642        23488888866544445678888888886    679999999999999899999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC--------EEEeecc
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK--------ALVTDFG  953 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~--------~kl~Dfg  953 (1088)
                      ||||+++|+|.++++... .+++..++.++.||+.|++|||+.   +|+||||||+||+++.++.        ++++|||
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            999999999999997654 589999999999999999999999   9999999999999987765        6899999


Q ss_pred             cceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCC-cCCCCCchhHHHHHHhhhccCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGR-RALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      .+.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|. .||........  .....   .   
T Consensus       154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~~---~---  220 (258)
T cd05078         154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFYE---D---  220 (258)
T ss_pred             cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHHH---c---
Confidence            8865432     223457889999998876 45799999999999999999995 55544322111  11000   0   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                       .           ...+.....++.+++.+|++.||++||+++|+++.|+
T Consensus       221 -~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -R-----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -c-----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             0           0011122356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-33  Score=310.28  Aligned_cols=246  Identities=30%  Similarity=0.450  Sum_probs=199.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+..... ...+.+..|++++++    ++||||+++++++..+...++|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ----CDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHc----CCCCccHhhhcccccCCceEEE
Confidence            3666788999999999999865 578899999875432 233568899999986    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.+++.. ..+++..++.++.|++.|++|||++   +++|+||+|+||++++++.++++|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            999999999999865 4689999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      .......++..|+|||++.+..++.++||||||+++|||++|+.||.........+  ...   ..             .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~---~~-------------~  217 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LIP---KN-------------S  217 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--hhh---cC-------------C
Confidence            12233467889999999998899999999999999999999999997543311111  000   00             0


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...........+.+++.+|++.+|++||++.|+++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00112234467889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=312.89  Aligned_cols=242  Identities=29%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |...+-||+|+||.||-|++. +.+.||||++.-..   .+...++..|+..+.+    +.|||++.+-|||..+...|+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~----l~HPntieYkgCyLre~TaWL  103 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQ----LRHPNTIEYKGCYLREHTAWL  103 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHh----ccCCCcccccceeeccchHHH
Confidence            555688999999999999975 67889999997543   3445678899999997    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||||-| +-.|++.- ..++.+.++..|..+.+.||+|||+.   +.||||||+-|||+++.|.||++|||.|..+.+ 
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            9999955 88888864 34689999999999999999999999   999999999999999999999999999987654 


Q ss_pred             CCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                          ...++||+.|||||++.   .+.|+-++||||+|++..|+...++|+...+....-| +...    ..      .+
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQ----Ne------sP  243 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ----NE------SP  243 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHh----cC------CC
Confidence                34578999999999753   5789999999999999999999999987765421111 1110    00      00


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+      ...+....+.+++..|+++-|.+|||.+++++
T Consensus       244 tL------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 TL------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11      13456778889999999999999999999875

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.8e-33  Score=310.36  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=202.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|... .++.||+|.+.....   .....+.+|+++++.    ++||||+++++.+..++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~   76 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTF----AENPFVVSMFCSFETKRHL   76 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHh----CCCCCeeeeEEEEecCCEE
Confidence            36888999999999999999976 578999999876532   223467788888886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++++|.++++..+.+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999999998888899999999999999999999998   999999999999999999999999998864211


Q ss_pred             CCC--------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          961 GDS--------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       961 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ...              .......++..|+|||.+....++.++||||||+++|||++|..||.+....  ++.......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~~~~~  231 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISD  231 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc
Confidence            000              0111245678899999988888999999999999999999999999765331  111111100


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ....      +        ......+..+.+++.+|++.||++||++.++.+.++.
T Consensus       232 ~~~~------~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 DIEW------P--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccCC------C--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            0000      0        0011234567899999999999999998777776665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=292.80  Aligned_cols=240  Identities=28%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHH---HHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|...++||+|.||+|-.++-+ +++.+|+|+++++....+.+   ...|-++++.    .+||.+..+-..|+..+..
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~----~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQN----CRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHh----ccCcHHHHhhhhhccCceE
Confidence            56888899999999999999965 79999999999987665544   3457778876    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+.||.|.-.+.+.+.+++..++.+...|+.||.|||++   +||+||+|.+|.|+|.+|++||+|||+++.-- 
T Consensus       244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999999999999888899999999999999999999999   99999999999999999999999999997532 


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ........++||+.|.|||++....|+.++|+|.+||++|||++|+.||...+.... +                 +- +
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-F-----------------eL-I  380 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-F-----------------EL-I  380 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-H-----------------HH-H
Confidence            223345678999999999999999999999999999999999999999987543111 0                 00 0


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP 1071 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1071 (1088)
                      ..+....|.....+...++...+.+||.+|.
T Consensus       381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            1111122344445677788899999999997

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.6e-36  Score=329.49  Aligned_cols=365  Identities=27%  Similarity=0.378  Sum_probs=285.1

Q ss_pred             CCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEcc
Q 001384          197 CLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLF  276 (1088)
Q Consensus       197 l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~  276 (1088)
                      ++-.+-.|+++|.++|.-+                     +.....++++++|.|...++. .+|+.++.+.+|++|.++
T Consensus         6 LpFVrGvDfsgNDFsg~~F---------------------P~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~   63 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRF---------------------PHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMA   63 (1255)
T ss_pred             cceeecccccCCcCCCCcC---------------------chhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhh
Confidence            3445667788887775322                     222334456666666666655 667777777777777777


Q ss_pred             CccccCCCccccCCCCCCCEEeCCCCcCC-ccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCC
Q 001384          277 GNNFSGPIPAEIGSISGLEALFLGKNNFL-SVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDG  355 (1088)
Q Consensus       277 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~  355 (1088)
                      +|++. .+-..+..++.|+.+.+.+|++. .-+|..+..+..|+.||||+|++. ..|..+..-+++-.|+|++|+ ++.
T Consensus        64 HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~-Iet  140 (1255)
T KOG0444|consen   64 HNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN-IET  140 (1255)
T ss_pred             hhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc-ccc
Confidence            77776 55566677777777777777664 236677777777777777777776 445556666666677777776 444


Q ss_pred             CCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCC-CCCCcccc
Q 001384          356 MNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT-GPIPPSIG  434 (1088)
Q Consensus       356 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~  434 (1088)
                      ++...|.++..|-+||||+|++. .+|+.+..+..|++|.|++|.+...--..+..|++|++|.+++.+=+ .-+|.++.
T Consensus       141 IPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld  219 (1255)
T KOG0444|consen  141 IPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD  219 (1255)
T ss_pred             CCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchh
Confidence            55556667888889999999998 78889999999999999999886544444556888899999987632 26899999


Q ss_pred             CCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCcccccccc
Q 001384          435 NLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKR  514 (1088)
Q Consensus       435 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~  514 (1088)
                      .|.+|..+||+.|.+. .+|..+.++++|+.|+||+|+++ .+...+                                 
T Consensus       220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~---------------------------------  264 (1255)
T KOG0444|consen  220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTE---------------------------------  264 (1255)
T ss_pred             hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccH---------------------------------
Confidence            9999999999999998 89999999999999999999998 221111                                 


Q ss_pred             ccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEecc
Q 001384          515 WIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLG  594 (1088)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  594 (1088)
                                            .                      ..+.+++|+||.|+|+ .+|..+.+|++|+.|.+.
T Consensus       265 ----------------------~----------------------~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n  299 (1255)
T KOG0444|consen  265 ----------------------G----------------------EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN  299 (1255)
T ss_pred             ----------------------H----------------------HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence                                  1                      1234578999999999 899999999999999999


Q ss_pred             ccccc-cCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCC
Q 001384          595 FNQFD-GKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL  669 (1088)
Q Consensus       595 ~N~l~-g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  669 (1088)
                      +|+|+ .-||+.+|.+ .|+++..++|.+. .+|+.++.+..|+.|.|+.|+|- ++|+.+--++.|+.|||..|+=
T Consensus       300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             cCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            99986 3499999999 7999999999998 99999999999999999999998 8999999999999999999974

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.2e-33  Score=305.26  Aligned_cols=253  Identities=25%  Similarity=0.426  Sum_probs=199.8

Q ss_pred             CCCccceecccCceEEEEEEeCC--CcEEEEEEccccCc----------cchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD--GREVAVKKLQREGL----------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      .|++.+.||+|+||.||+|.++.  ++.+|+|.+.....          ....++..|+.++.+   .++||||++++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---~~~h~~i~~~~~~   77 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE---QLRHPNIVRYYKT   77 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhh---cCCCCCeeeEEee
Confidence            37788999999999999999764  68899998864321          112346677777764   2589999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          874 CLDGSEKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      +.+++..++||||+++++|.+++..    ...+++..++.++.|++.|+.|||+..  +++|+||+|+||+++.++.+|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEE
Confidence            9999999999999999999998743    346899999999999999999999631  8999999999999999999999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      +|||.+.......  ......++..|+|||...+..++.++||||||+++|+|++|+.||.....  ............ 
T Consensus       156 ~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~-  230 (269)
T cd08528         156 TDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVEAVY-  230 (269)
T ss_pred             ecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHhhccC-
Confidence            9999998754332  23445688899999999888899999999999999999999999976433  111111110000 


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      ..       .       ........+.+++.+|++.||++||++.|+..++++
T Consensus       231 ~~-------~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 EP-------L-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             Cc-------C-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            00       0       011223568889999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.4e-33  Score=306.94  Aligned_cols=247  Identities=33%  Similarity=0.521  Sum_probs=195.8

Q ss_pred             ceecccCceEEEEEEeCC-------CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD-------GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.||+|+||.||+|+..+       ++.+|+|.+..... .....+.+|+.+++.    ++||||+++++++......++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSN----FNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHh----cCCCCeeeEeeeecCCCCeEE
Confidence            368999999999998642       25799998875432 334578899999986    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-----CEEEe
Q 001384          883 VYEYMEGGSLEDIISDR-------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-----KALVT  950 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-----~~kl~  950 (1088)
                      ||||+++++|.++++..       ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .++++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEEC
Confidence            99999999999999642       2478899999999999999999998   999999999999999887     89999


Q ss_pred             ecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCC
Q 001384          951 DFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      |||++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......  ......   .
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---~  228 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVT---A  228 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHh---c
Confidence            99998765432211 1223345678999999998899999999999999999998 999997543311  111110   0


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                                   +.....+...+..+.+++.+|+..+|.+||++++|++.|++
T Consensus       229 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 -------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                         00001122344678899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.2e-33  Score=308.15  Aligned_cols=260  Identities=28%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             cCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          795 FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      +++.++..+.++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++.   +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~---~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLP---NHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhc---CCCCeEEEEEE
Confidence            455666677889999999999999999999975 68899999987542 23456778888887632   79999999999


Q ss_pred             EecC-----CeEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          874 CLDG-----SEKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       874 ~~~~-----~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      +...     ...++||||+++++|.++++.    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            8753     358999999999999998863    35689999999999999999999998   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-----QATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~ 1019 (1088)
                      +.+||+|||.+........ ......++..|+|||.+...     .++.++||||+||++|||++|+.||......... 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-  242 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-  242 (291)
T ss_pred             CCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence            9999999999876543221 12234678899999987543     3688999999999999999999999765431110 


Q ss_pred             HHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ....   .... ..          ...+......+.+++.+|++.+|++||++.|+++
T Consensus       243 -~~~~---~~~~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 -FKIP---RNPP-PT----------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHh---cCCC-CC----------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             0110   0000 00          0012233456889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-32  Score=302.22  Aligned_cols=237  Identities=27%  Similarity=0.431  Sum_probs=189.3

Q ss_pred             ceecccCceEEEEEEeCCCc-----------EEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          811 RIIGKGGFGTVYRGVLPDGR-----------EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +.||+|+||.||+|.+++..           .+++|.+...... ...+.+|+.++++    ++||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~----l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQ----LSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHc----CCCcchhheeeEEec-CC
Confidence            46899999999999976432           5788877655332 5678889999886    689999999999888 77


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-------CEEEee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-------KALVTD  951 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-------~~kl~D  951 (1088)
                      .++||||+++|+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+|++|
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            899999999999999998765 789999999999999999999998   999999999999999888       799999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCC
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      ||++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..||.....  .++.....   .
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~---~  221 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ---D  221 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh---c
Confidence            999886543     2233466789999998776  78999999999999999999 5777765432  11111111   0


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      ..    ..           +......+.+++.+|++.+|++||++.||++.|+
T Consensus       222 ~~----~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH----RL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC----CC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00    00           0001167889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.3e-33  Score=303.40  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|++|.||+|..+ +++.||||++..... .....+..|++.+.+    ++|+|++++++++..+...++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS----CESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHh----cCCCCeeeEEEEEccCCeEEE
Confidence            36888999999999999999987 589999999887643 345678899999886    579999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++++|.+++.....+++..++.++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+......
T Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999999999888889999999999999999999999 8   9999999999999999999999999999876433


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .. ......++..|+|||...+..++.++||||||+++|+|++|+.||..... ...+.......    .          
T Consensus       154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~----------  218 (264)
T cd06623         154 LD-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----G----------  218 (264)
T ss_pred             CC-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----C----------
Confidence            22 22345678899999999988999999999999999999999999977642 11111111110    0          


Q ss_pred             cCCCccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1041 LGSGLAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1041 ~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                        .....+.. .+..+.+++.+|++.+|++||++.|+++.
T Consensus       219 --~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 --PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              00011112 44678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.9e-33  Score=303.42  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--c---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--L---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-  877 (1088)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++....  .   ...+.+.+|++++++    ++||||+++++++.+. 
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN----LLHERIVQYYGCLRDPM   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHh----cCCCCeeeEEeEeccCC
Confidence            46888999999999999999975 58999999886431  1   112467889999886    6799999999988764 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||+++++|.+++.....+++..+.+++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence             46789999999999999998877889999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........  ......++..|+|||...+..++.++||||||+++|||++|+.||....... .......  .   .   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~--~---~---  225 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIAT--Q---P---  225 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHHhc--C---C---
Confidence            65422111  1223457889999999888889999999999999999999999997643211 1111110  0   0   


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              .....+......+.+++.+|+. +|++||+++||++
T Consensus       226 --------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 --------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                    0011133445677888889985 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.8e-33  Score=308.03  Aligned_cols=243  Identities=27%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|++++++    +.||||+++++++.++...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   76 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS----IRHPFLVNLYGSFQDDSNL   76 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh----CCCCCccceeeEEEcCCeE
Confidence            36888999999999999999976 689999999875432   234567889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++++|.++++....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.....
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999999998888899999999999999999999998   999999999999999999999999999887643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+ .....    .          
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~-~~~~~----~----------  213 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIY-EKILE----G----------  213 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHH-HHHhc----C----------
Confidence            3    2344688999999998888889999999999999999999999976542 1111 11110    0          


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVL 1077 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil 1077 (1088)
                         ....+......+.+++.+|++.||.+||     +++|++
T Consensus       214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence               0001122245778899999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-32  Score=303.67  Aligned_cols=253  Identities=26%  Similarity=0.427  Sum_probs=198.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc----------chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE----------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      +|.+.+.||+|+||.||+|... +++.||+|.+......          ..+.+..|+.+++.    ++|||++++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD----LDHLNIVQYLGFE   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHh----cCCCCcceEEEEe
Confidence            4778899999999999999865 6889999988642111          11356788888886    6799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      ......++||||+++++|.+++++...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          78 TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999999999998888899999999999999999999998   999999999999999999999999999


Q ss_pred             ceeecCCCCc-ccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          955 ARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQ--ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       955 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ++........ ......++..|+|||......  ++.++||||+|+++|++++|..||.........+  .......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~---  229 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--KLGNKRS---  229 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--Hhhcccc---
Confidence            8765432111 123356788999999877654  7899999999999999999999997543321111  1100000   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...++..       ........+.+++.+|+++||++||+++||++
T Consensus       230 -~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 -APPIPPD-------VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -CCcCCcc-------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             0000100       01123467888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.3e-33  Score=305.05  Aligned_cols=251  Identities=24%  Similarity=0.411  Sum_probs=202.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +|+..+.||+|++|.||+|... +++.||+|++......      ..+.+..|++++++    ++|+|++++++++.+.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR----LNHPHIIRMLGATCEDS   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHH----cCCCceehhhceeccCC
Confidence            4778899999999999999964 6899999998754311      23568889999986    68999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++++|.+++.+..++++..+..++.|++.|++|||++   +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999999998888899999999999999999999999   999999999999998776 599999999877


Q ss_pred             ecCCCC---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCc
Q 001384          958 VSAGDS---HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ......   .......++..|+|||...+..++.++||||+|+++|+|++|..||..... ...........        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  225 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS--------  225 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--------
Confidence            653211   112234678899999998888899999999999999999999999975432 11111111100        


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             .......+.....++.+++.+|++.+|++||++.|+++
T Consensus       226 -------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 -------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   00011123344567889999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.7e-33  Score=306.23  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=197.4

Q ss_pred             CCccceecccCceEEEEEEeC----CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      |.+.++||+|+||.||+|.++    +++.||||++.....  ...+++.+|++++++    ++||||+++++++....  
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKE----FDHPNVIKLIGVSLRSRAK   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhc----CCCCCcceEEEEEccCCCC
Confidence            567789999999999999853    368899999976432  234568889999886    67999999999886532  


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          879 ----EKILVYEYMEGGSLEDIISDR------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       879 ----~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                          ..++++||+++|+|.+++...      ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence                247889999999999887432      2478999999999999999999998   999999999999999999999


Q ss_pred             EeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhcc
Q 001384          949 VTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ++|||.++........ ......++..|++||......++.++||||||+++|||++ |+.||.+....  +........
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~  231 (273)
T cd05074         154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKG  231 (273)
T ss_pred             ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcC
Confidence            9999999866433221 1223345678999999988889999999999999999999 88888765431  111111100


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      ..                ...+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       232 ~~----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NR----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Cc----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00                001122345788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=286.73  Aligned_cols=251  Identities=25%  Similarity=0.285  Sum_probs=196.9

Q ss_pred             HcCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----
Q 001384          803 ATGKFSED-RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----  876 (1088)
Q Consensus       803 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----  876 (1088)
                      .+++|++. ++||-|-.|+|..+..+ +|+.+|+|++...     ...++|++..-..   -.|||||+++++|..    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~---s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMA---SGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhh---cCCCceEEeehhhhhhccC
Confidence            45677765 67999999999999976 7899999999765     2335555544332   279999999999864    


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEee
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTD  951 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~D  951 (1088)
                      .....+|||.|+||.|...+++++.  ++++++..|++||+.|+.|||+.   +|.||||||+|+|.+.   |..+|++|
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            3567899999999999999988764  99999999999999999999999   9999999999999974   45799999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCC
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~ 1030 (1088)
                      ||+|+....  .....+.+.|+.|.|||++....|+...|+||+||++|-|++|.+||..... .+..-.+....-+.  
T Consensus       208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq--  283 (400)
T KOG0604|consen  208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ--  283 (400)
T ss_pred             cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC--
Confidence            999987543  2334556789999999999999999999999999999999999999986532 11111111110000  


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         -       .-..+......++..++|+.++..+|++|.+..|+++
T Consensus       284 ---y-------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 ---Y-------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ---c-------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence               0       0011223455677889999999999999999999874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.8e-33  Score=302.12  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=200.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|+..+.||+|+||.||+|... +++.+|+|++.....  .....+..|++++++    ++|||++++++.+..++..++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL----LSHPNIIEYYENFLEDKALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhh----CCCCchhheeeeEecCCEEEE
Confidence            5888899999999999999975 688999999876432  234578889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++++|.+++...  ..+++..+.+++.|++.|++|||++   +++||||+|+||+++.++ .+|++|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            99999999999999764  3589999999999999999999999   999999999999998654 57999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...  ......++..|+|||......++.++||||+|+++|+|++|+.||...+..  ..........            
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~------------  217 (256)
T cd08220         154 SKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGT------------  217 (256)
T ss_pred             CCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcC------------
Confidence            322  223356788999999998888999999999999999999999999765331  1111111000            


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ....+......+.+++.+|++.+|++||++.|+++
T Consensus       218 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 ----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                00011223457889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-32  Score=301.75  Aligned_cols=254  Identities=29%  Similarity=0.461  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.    ++|+|++++++.+..+...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQ----CNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHh----cCCCCEEEEEEEEeeCCEEEE
Confidence            46889999999999999999965 678999999875432 244678899998886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++++|.++++..   ..+++..++.++.|++.|++|||+.   +++||||+|+||++++++.++++|||++..+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            99999999999999764   4589999999999999999999999   99999999999999999999999999987665


Q ss_pred             CCCCc---ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          960 AGDSH---VSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       960 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .....   ......++..|+|||++... .++.++||||||+++|+|++|+.||........ .......    ..  ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~----~~--~~  226 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQN----DP--PS  226 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcC----CC--CC
Confidence            43322   22344688899999987766 789999999999999999999999976533111 1111110    00  00


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....      .........+.+++.+|++.||++||++.|+++
T Consensus       227 ~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETG------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCc------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000      001233467889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-33  Score=318.65  Aligned_cols=261  Identities=25%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-  877 (1088)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|++++++    ++||||+++++++... 
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH----MKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHh----cCCCchhhhhhhhcccc
Confidence            34578999999999999999999965 678999999876422  233457789999987    6799999999987543 


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          878 -----SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       878 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                           ...|+++|++ +++|.++++. ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+||
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence                 3568999998 6799988754 4699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      |+++.....    .....+|..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... ............  .
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~--~  235 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGT--P  235 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCC--C
Confidence            999865321    234568999999998766 57899999999999999999999999765321 111110000000  0


Q ss_pred             Cccccchh-------hcCCCcccc--------HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVV-------LLGSGLAEG--------AEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~-------~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+.....       ........+        ......+.+++.+|++.||.+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000       000000000        011234678999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-32  Score=321.55  Aligned_cols=262  Identities=23%  Similarity=0.216  Sum_probs=195.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ...|.+.+.||+|+||.||+|.+. .++.||||....      ..+.+|++++++    ++|+|||++++++..++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~----L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRR----LSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHH----CCCCCCCcEEEEEEECCEEEE
Confidence            447999999999999999999976 578899996432      235679999987    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||++. ++|.+++... ..+++.+++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||+++.....
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            999995 6999888654 4699999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch------hHHHHHHhhhccCCCCCC-c
Q 001384          962 DSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE------CLVEWGRRVMGYGRHGPG-R 1033 (1088)
Q Consensus       962 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~-~ 1033 (1088)
                      ... ......||..|+|||++.+..++.++|||||||++|||++|..|+.....      ...+..+.+......... .
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            221 22345689999999999998999999999999999999998876543211      111111111100000000 0


Q ss_pred             c-----ccchhh----cCCCc-------cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1034 A-----VIPVVL----LGSGL-------AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1034 ~-----~~~~~~----~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      .     ......    .....       .........+.+++.+|++.||.+||++.|+++.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0     000000    00000       0001122367889999999999999999999863

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.6e-33  Score=303.93  Aligned_cols=248  Identities=28%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|+..+.||+|++|.||+|.++ +++.||+|++..... ....++.+|++++++    +.||||+++++++..+...++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK----CNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHH----CCCCchhhhheeeecCCEEEE
Confidence            35778899999999999999986 688999999876532 344578899999886    579999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||+++++|.+++... ..+++..+.+++.|++.|++|+|+ .   +++||||||+||+++.++.++|+|||.+.....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999999999876 779999999999999999999999 7   999999999999999999999999999865532


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCc---hhHHHHHHhhhccCCCCCCccccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE---ECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ...   ....++..|+|||...+..++.++||||+|+++|+|++|+.||....   +...+.........          
T Consensus       154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  220 (265)
T cd06605         154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------  220 (265)
T ss_pred             HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------
Confidence            211   12567889999999988899999999999999999999999997642   12222222222100          


Q ss_pred             hhhcCCCccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ....+.. ....+.++|.+|+..||++||++.++++
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 ------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                  0001111 4467889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-33  Score=307.37  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=201.5

Q ss_pred             cCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          795 FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      .++.++..+.+.|++.+.||+|+||.||+|++. +++.+|+|++.... ....++..|+.++.+..   +|||+++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~---~h~~i~~~~~~   81 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYS---HHRNIATYYGA   81 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhc---CCCcEEEEeee
Confidence            345565567789999999999999999999975 68899999886542 23356778888887632   69999999999


Q ss_pred             Eec------CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          874 CLD------GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       874 ~~~------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      +..      ....++||||+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            853      45789999999999999998653  3588899999999999999999999   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          946 KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                      .++|+|||++........ ......++..|+|||.+.     ...++.++||||+||++|||++|+.||....+......
T Consensus       159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            999999999875432211 223456888999999865     34678899999999999999999999976433111110


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ..   . ..     .      ...........+.+++.+|++.||.+||++.|+++
T Consensus       238 --~~---~-~~-----~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 --IP---R-NP-----P------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --Hh---h-CC-----C------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              00   0 00     0      00011223457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-32  Score=305.79  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++.....  .....+.+|+.++++    ++|||++++++++..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA----CQHPYVVKLLDVFPHGSGFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHh----CCCCCCcceeeEEecCCeeEE
Confidence            5888899999999999999975 689999999876542  234678899999986    579999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+ +++|.+++.. ...+++.+++.++.|+++||+|||+.   +++|+||||+||+++.++.++++|||.+......
T Consensus        77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            99999 9999999865 35689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC-----Cccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP-----GRAV 1035 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 1035 (1088)
                      .........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+..+ ...+............     ..+.
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCc
Confidence            3222334568889999998754 3568999999999999999999888866543 2222211110000000     0000


Q ss_pred             c--chhhcCCCc-----cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 I--PVVLLGSGL-----AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~--~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .  .........     .........+.+++.+|++.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0  000000000     001123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-33  Score=304.50  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=197.5

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ...|++.+.||+||.+.||++...+.+.+|+|++......  .-..|.+|+..|.++.   .|.+||++|+|-..++..|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk---g~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK---GHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc---CCceEEEEeeeeccCceEE
Confidence            3568999999999999999999887888898888654322  2356999999999876   7899999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |||||-+. +|..+++.... .....++.+..|++.|+.++|+.   ||||.||||.|+|+ -.|.+||+|||.|..+..
T Consensus       437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence            99999855 99999987664 33348889999999999999999   99999999999999 568999999999988765


Q ss_pred             CCCc-ccccccccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          961 GDSH-VSTTIAGTVGYVAPEYGQTW-----------QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       961 ~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      .... .....+||+.||+||.+...           ..+.++||||+|||+|+|+.|+.||..-.   ..|++...   -
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~a---I  585 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHA---I  585 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHh---h
Confidence            4332 34567899999999975533           25678999999999999999999997522   23333211   0


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+..++--+..       +.  ..+++++++.|+..||.+||+..|+++
T Consensus       586 ~~P~~~Iefp~~-------~~--~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  586 TDPNHEIEFPDI-------PE--NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cCCCccccccCC-------CC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            011111111111       11  123899999999999999999999975

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-32  Score=302.07  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=200.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCeE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSEK  880 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~~  880 (1088)
                      +|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+..|++++++    ++|||++++++++..  +...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRE----LKHPNIVRYYDRIIDRSNQTL   76 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHh----cCCCccceeeeeeecCCCCEE
Confidence            4788899999999999999965 678999999875432  233567889999886    679999999998764  4567


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLH-----HECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                      +++|||+++++|.++++.    ..++++.+++.++.|++.|++|||     +.   +++|+||+|+||+++.++.+|++|
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d  153 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGD  153 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEec
Confidence            899999999999999875    357899999999999999999999     66   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ||++........ ......++..|+|||.+....++.++||||||+++|+|++|+.||.....  .+........     
T Consensus       154 ~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-----  225 (265)
T cd08217         154 FGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEG-----  225 (265)
T ss_pred             ccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcC-----
Confidence            999987654322 12345688999999999888899999999999999999999999987542  1222221100     


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 .....+......+.+++.+|++.+|++||++.+|++
T Consensus       226 -----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 -----------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             -----------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                       001112334567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-32  Score=307.69  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=198.8

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |+....||+|+||.||+|... +++.||+|++........+.+.+|+.++..    +.|||++++++++..++..++|||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~----l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD----YQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHh----CCCCchhhhhhheeeCCeEEEEEe
Confidence            334467999999999999975 689999999876544555678889998886    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++++|.+++.. ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~  173 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK  173 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence            9999999998755 4689999999999999999999999   99999999999999999999999999987543321 22


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....++..|+|||++.+..++.++||||+|+++|||++|+.||........  .........  ...            
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~--~~~------------  237 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLRDSPP--PKL------------  237 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhccCC--CCc------------
Confidence            2345688999999999888999999999999999999999999976543111  111110000  000            


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .........+.+++.+|++.+|++||++.|+++
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            001122346788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.2e-33  Score=309.19  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=198.8

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |.....||+|+||.||++... +++.||||++........+.+.+|+.+++.    ++|||++++++.+...+..++|||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~----l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD----YHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHh----CCCCcHHHHHHheecCCeEEEEEe
Confidence            334467999999999999975 688999999876544455678899998886    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++++|.+++.. .++++.++..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++........ .
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            9999999998854 4689999999999999999999999   999999999999999999999999999875532221 2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....++..|+|||...+..++.++||||+|+++|||++|+.||.........  ....         ...+....    
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~---------~~~~~~~~----  239 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM--RRIR---------DNLPPRVK----  239 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH---------hcCCCccc----
Confidence            23356889999999998888999999999999999999999999865431111  1110         00000000    


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       ........+.+++.+|++.||.+||+++|+++.
T Consensus       240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             011233467788889999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-32  Score=311.16  Aligned_cols=193  Identities=25%  Similarity=0.389  Sum_probs=159.4

Q ss_pred             cceecccCceEEEEEEeC---CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCeEEEEE
Q 001384          810 DRIIGKGGFGTVYRGVLP---DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSEKILVY  884 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~~~lv~  884 (1088)
                      ..+||+|+||.||+|+.+   +++.||+|.+....  ....+.+|+++++.    ++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRE----LKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHh----CCCCCeeeEEEEEeccCCCeEEEEE
Confidence            368999999999999965   35789999987652  33467889999987    679999999998854  56789999


Q ss_pred             EecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCCEEEee
Q 001384          885 EYMEGGSLEDIISDR---------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----DKEGKALVTD  951 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----~~~~~~kl~D  951 (1088)
                      ||+++ +|.+++...         ..+++..++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            99975 888877421         2488999999999999999999999   99999999999999    5677999999


Q ss_pred             cccceeecCCCCc--ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCC
Q 001384          952 FGLARVVSAGDSH--VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGG 1012 (1088)
Q Consensus       952 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~ 1012 (1088)
                      ||+++........  ......+|..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9999876433221  1234568899999998765 46899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.6e-33  Score=316.78  Aligned_cols=192  Identities=22%  Similarity=0.314  Sum_probs=164.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++    ++||||+++++++......+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQN----VNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHh----CCCCCCcChhheEEeCCeeE
Confidence            3467999999999999999999976 5678999985543      23457888876    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+. ++|.+++.. ...+++.+++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||.++....
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            9999995 588888865 45699999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      .  .......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            1  12234568999999999998899999999999999999998766653

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-32  Score=304.38  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=193.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++..... ..+.++..|+..+.+   ..+|||++++++++..+...++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~---~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR---SVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHH---HcCCCCeeeeeEEEecCCcEEE
Confidence            36888999999999999999976 689999999876532 233456666665443   2589999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ||||++ |+|.++++.    ...+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||.+...
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999997 588887754    346899999999999999999999863  8999999999999999999999999998765


Q ss_pred             cCCCCcccccccccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQT----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ...  .......++..|+|||.+.+    ..++.++||||+|+++|+|++|+.||............... ...     .
T Consensus       155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-----~  226 (283)
T cd06617         155 VDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPS-----P  226 (283)
T ss_pred             ccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCC-----C
Confidence            321  12233467889999998754    45688999999999999999999999754322111111110 000     0


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+          ....+.++.+++.+|+..+|++||++.++++
T Consensus       227 ~~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QLP----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCC----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000          1123457888999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=304.21  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=199.9

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC---
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS---  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~---  878 (1088)
                      .+++|++.+.||+|++|.||+|..+ +++.+++|++.... ....++.+|++++++..   .|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~---~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYS---NHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhc---CCCChheEEEEEEecCCCC
Confidence            5688999999999999999999975 57899999987653 23467889999988732   6999999999997644   


Q ss_pred             ---eEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          879 ---EKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       879 ---~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                         ..++||||+++++|.++++.    ...+++..++.++.|++.||+|||+.   +++||||+|+||++++++.++++|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               48999999999999999865    34789999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ||.+....... .......++..|+|||++..     ..++.++||||+|+++|+|++|+.||....... .. ....  
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-~~~~--  231 (275)
T cd06608         157 FGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-AL-FKIP--  231 (275)
T ss_pred             Cccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HH-HHhh--
Confidence            99987654322 22234568889999997653     356789999999999999999999997543211 11 1111  


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       . ..    .+      ....+.....++.+++.+|+..||++||++.|+++
T Consensus       232 -~-~~----~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -R-NP----PP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -c-cC----CC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             0 00    00      00112234567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=341.58  Aligned_cols=251  Identities=29%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      +-+|+....||.|.||.||-|... +|.-.|||-++-....  .-..+.+|+.++..    +.|||+|++||+-..++..
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~----lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEG----LNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHh----ccCccccccCceeecHHHH
Confidence            456778889999999999999954 6888999988754322  23568899999986    7899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +|.||||++|+|.+.++..+..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|..+..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999999998888888888899999999999999999   999999999999999999999999999998865


Q ss_pred             CCCcc---cccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          961 GDSHV---STTIAGTVGYVAPEYGQTW---QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       961 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .....   .....||+.|||||++.+.   ....++||||+|||+.||+||++||...+.   +|+-.+           
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy----------- 1452 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMY----------- 1452 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHh-----------
Confidence            43121   2356899999999987653   456789999999999999999999986543   443332           


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ..-++..+..|.....+-.+++.+|+..||++|.++.++++
T Consensus      1453 ---~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 ---HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ---HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence               22233333445566677788999999999999988877654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.5e-33  Score=307.32  Aligned_cols=264  Identities=23%  Similarity=0.283  Sum_probs=195.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|+..+.||+|+||.||+|+++ +|+.||+|++.....  .....+.+|++++++    ++|||++++++++.+....++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~----l~h~~i~~~~~~~~~~~~~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----LKHKNIVRLYDVLHSDKKLTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHh----cCCCCeeeHHHHhccCCceEE
Confidence            5788899999999999999976 689999999875422  223467789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |+||+++ +|.+++.. ...+++..++.++.||++||+|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        77 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          77 VFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            9999975 88888764 55799999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh--hhccCCC--------C
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR--VMGYGRH--------G 1030 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~--------~ 1030 (1088)
                      .. ......++..|+|||.+.+. .++.++||||+||++|||++|+.|+....+........  .......        .
T Consensus       153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            21 12234568899999987654 57899999999999999999999975443311111110  0000000        0


Q ss_pred             CCccccchhhcC-CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLG-SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+..... ...........++.+++.+|++.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000000000 000001123457788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.8e-32  Score=300.58  Aligned_cols=249  Identities=24%  Similarity=0.309  Sum_probs=185.6

Q ss_pred             eecccCceEEEEEEeCC---CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          812 IIGKGGFGTVYRGVLPD---GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      .||+|+||+||+|...+   ...+|+|.+...... ....+.+|++.++.    ++||||+++++++......++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~----l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE----LNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHh----CCCCCcceEEEEECCCCceEEEEEeC
Confidence            58999999999997543   356888887654322 23567889988876    67999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          888 EGGSLEDIISDRT-----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       888 ~~gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ++|+|.+++....     ..++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9999999997643     246788899999999999999999   99999999999999999999999999986543222


Q ss_pred             Cc-ccccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          963 SH-VSTTIAGTVGYVAPEYGQ-------TWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       963 ~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .. ......++..|+|||+..       ...++.++||||+||++|||++ |..||....+... ....... ..    .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~-~~----~  228 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVRE-QD----I  228 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhc-cC----c
Confidence            11 122334567899999754       3466889999999999999999 7788876543211 1111110 00    0


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      ....+.       ........+.+++..|+ .||++||+++||++.|.
T Consensus       229 ~~~~~~-------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KLPKPQ-------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCCCc-------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            000000       11223355667777888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-32  Score=305.65  Aligned_cols=264  Identities=25%  Similarity=0.319  Sum_probs=199.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-----chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-----GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +|++.+.||+|+||.||+|.+. +++.||||++......     ....+..|++++++    ++|+||+++++++.+...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPNIIGLLDVFGHKSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhh----cCCCCChhhhheeecCCE
Confidence            4778899999999999999975 6899999999865432     23456778888886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+ +|+|.++++... .+++.+++.++.||++||+|||++   +++||||+|+||+++.++.++|+|||+++..
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            99999999 889999998776 799999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC-----C
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP-----G 1032 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 1032 (1088)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+..+ ................     .
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhc
Confidence            54322 2223346788999998754 5678999999999999999999877765433 1111111110000000     0


Q ss_pred             ccccchhhcCCCcc-----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1033 RAVIPVVLLGSGLA-----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ..............     ........+.+++.+|++.||++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000000     012234678899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-32  Score=304.22  Aligned_cols=244  Identities=25%  Similarity=0.294  Sum_probs=189.6

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          812 IIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      .||+|+||.||+|... +++.+|+|.+.+....   ....+.+|..++.... ...|||++.+++++..++..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHh-hCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            4899999999999975 6889999998764322   1223344443333221 247999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccc
Q 001384          888 EGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST  967 (1088)
Q Consensus       888 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  967 (1088)
                      ++|+|.+++.....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......   ..
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~  153 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence            9999999998888899999999999999999999999   99999999999999999999999999987653221   22


Q ss_pred             cccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          968 TIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       968 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ...|+..|+|||... +..++.++||||+||++|||++|..||............... ..               ....
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~---------------~~~~  217 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LT---------------VNVE  217 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hc---------------CCcC
Confidence            346899999999876 456899999999999999999999999754321111111110 00               0001


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      .+.....++.+++.+|++.||++||     +++|+++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            1223446788899999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.7e-32  Score=297.31  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=195.5

Q ss_pred             HHHHHHHcCCCCcccee--cccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          797 YSDILKATGKFSEDRII--GKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      ..+.....++|++.+.+  |+|+||.||++..+ +++.+|+|.+........   ..+...+.     .+|||+++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---e~~~~~~~-----~~h~~iv~~~~~   77 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---EPMVHQLM-----KDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh---hHHHHHHh-----hcCCCEEEEEEE
Confidence            34445555677777776  99999999999975 678899999875422211   11111111     269999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeec
Q 001384          874 CLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDF  952 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Df  952 (1088)
                      +..++..++||||+++++|.++++....+++.++..++.|++.|++|||+.   +++||||||+||+++.++ .++++||
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            999999999999999999999998887899999999999999999999999   999999999999999998 9999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |.++.....     ....++..|+|||++.+..++.++||||+|+++|||++|+.||....+....+.........    
T Consensus       155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  225 (267)
T PHA03390        155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----  225 (267)
T ss_pred             ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc----
Confidence            998765422     22457889999999998899999999999999999999999998553322111111110000    


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-VKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 1078 (1088)
                                 ...........+.+++.+|++.+|.+||+ ++|+++
T Consensus       226 -----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 -----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                       00112234467889999999999999996 588764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-32  Score=304.47  Aligned_cols=267  Identities=22%  Similarity=0.287  Sum_probs=196.9

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.    ++|+||+++++++.++...
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~----l~h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKG----LKHANIVLLHDIIHTKETL   78 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHh----cCCCCEeEEEEEEecCCeE
Confidence            3467999999999999999999965 6889999998754322 23467789998886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||++ +++.+++.. ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            99999996 577777654 35688999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC--------
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG-------- 1030 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 1030 (1088)
                      .... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+..+................        
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            2221 1233456889999998765 35788999999999999999999999865442221111100000000        


Q ss_pred             CCccccchhhcCCCccc------cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAE------GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+..........      .......+.+++.+|++.||++|||++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000000      0011356778899999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=302.71  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=199.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+..... ....++.+|+++++++.. ..|||++++++++..+...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-SQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc-CCCCCeeeEeeeeeeCCEEEEE
Confidence            4777899999999999999974 789999999875432 334568889888886431 3599999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.++++.. .+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+..+.....
T Consensus        81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            9999999999998664 789999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                       ......|+..|+|||...+ ..++.++||||||+++|+|++|+.||.+...  ..+.....   . .     ...... 
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~---~-~-----~~~~~~-  223 (277)
T cd06917         157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMMLIP---K-S-----KPPRLE-  223 (277)
T ss_pred             -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhccc---c-C-----CCCCCC-
Confidence             2234468889999998764 4568999999999999999999999976432  11111100   0 0     000000 


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ......++.+++.+|++.||++||++.|+++
T Consensus       224 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 -----DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                 0113457888999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=289.47  Aligned_cols=268  Identities=24%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             CHHHHHHHcCCCCccceecccCceEEEEEE-eCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          796 TYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       796 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ++.|+-+.++     ++||+|+|+.|--++ ..+|.++|||++.+.....+.++.+|++++....   .|+||+++++||
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq---gh~nilqLiefF  145 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ---GHKNILQLIEFF  145 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc---CCccHHHHHHHh
Confidence            3566655553     789999999999988 5689999999999886666778999999998865   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---CEEEee
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---KALVTD  951 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~~kl~D  951 (1088)
                      +++...|+|||.|.||+|...|+++.-+++.++.++.++|+.||+|||.+   ||.|||+||+|||-.+..   -+||+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence            99999999999999999999999999999999999999999999999999   999999999999997654   589999


Q ss_pred             cccceeecCCC------CcccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          952 FGLARVVSAGD------SHVSTTIAGTVGYVAPEYG-----QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       952 fg~a~~~~~~~------~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                      |+++.-.....      .....+.+|+..|||||+.     ....|+.+.|.||+|||+|-|++|..||.+.-....-|.
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            98875432111      1112346788999999963     345789999999999999999999999987643333332


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccH----HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGA----EEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +...-..   -....++.+..+. ...|.    ....+..+++...+..|+..|.++..++.
T Consensus       303 rGe~Cr~---CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRV---CQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHH---HHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            2100000   0001111111111 11222    23345667777888999999999988875

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-32  Score=304.96  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=202.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.    ++|||++++++++..+...++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~----l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE----NKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhh----cCCCCeeehhheeeeCCcEEEE
Confidence            57889999999999999999865 678999999876544455678889998876    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      +||+++++|.+++.+. .+++.++..++.|++.|++|||++   +++||||+|+||+++.++.++|+|||++........
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999998754 588999999999999999999999   999999999999999999999999998876543322


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                       ......+++.|+|||......++.++||||||+++|++++|+.||.........  ....   ....           .
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~~---~~~~-----------~  233 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIA---TNGT-----------P  233 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eehh---cCCC-----------C
Confidence             223346788999999988888999999999999999999999999764331110  0000   0000           0


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ....+......+.+++.+|++.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001122234568889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.2e-33  Score=302.76  Aligned_cols=247  Identities=28%  Similarity=0.372  Sum_probs=203.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +|++.+.||.|+||.||+|.+. +++.||+|++.+...   ...+.+.+|++++++    ++||||+++++++.++...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   76 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE----LNHPFLVNLWYSFQDEENMY   76 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHh----CCCCChHHHHHhhcCCCeEE
Confidence            4788999999999999999976 689999999976532   234678889999886    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +|+||+++++|.+++....++++.++..++.|+++||+|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999999998877899999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      .  ......++..|+|||...+..++.++||||+|+++|+|++|+.||.........+.......               
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  216 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---------------  216 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---------------
Confidence            2  22345678899999999888899999999999999999999999987543222222211100               


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCH--HHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNV--KEVL 1077 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil 1077 (1088)
                       .....+...+..+.+++.+|++.||.+||++  +|++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             0011122334678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.5e-32  Score=302.65  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=205.0

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++.|+..+.||+|++|.||+|.++ +++.||+|++..... ....+..|+++++.    ++|+|++++++++......+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKD----CKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHH----CCCCCeeEEEEEEEECCEEE
Confidence            4567888899999999999999986 688999999976533 45678889998886    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +|+||+++++|.+++.... .+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999999998876 899999999999999999999998   999999999999999999999999998865543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ... ......++..|+|||++.+..++.++||||||+++|+|++|+.||.........  ........    ..      
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~~~~----~~------  235 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITTKGI----PP------  235 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCC----CC------
Confidence            221 223345788999999988888999999999999999999999999765432111  11110000    00      


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .......+..+.+++.+|++.+|.+||++.++++
T Consensus       236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 ----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                0011223467889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=307.31  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......   ..+.+..|++++..    +.||||+++++++.++...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~   76 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT----LDHPFLPTLYASFQTETYL   76 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHh----CCCCCchhheeeeecCCEE
Confidence            36888999999999999999976 5899999999865433   33567889999886    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ++||||+.+++|.++++..  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999999999754  4689999999999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCc----------------------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCC
Q 001384          959 SAGDSH----------------------------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       959 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      ......                            ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            322110                            1112467889999999988889999999999999999999999997


Q ss_pred             CCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC----HHHHHH
Q 001384         1011 GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN----VKEVLA 1078 (1088)
Q Consensus      1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 1078 (1088)
                      +.... ..+.....   .  ..           ..+........+.+++.+|++.||++||+    ++|+++
T Consensus       234 ~~~~~-~~~~~~~~---~--~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         234 GSNRD-ETFSNILK---K--EV-----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCchH-HHHHHHhc---C--Cc-----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            65432 11111110   0  00           00001114567889999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.2e-32  Score=295.03  Aligned_cols=248  Identities=31%  Similarity=0.503  Sum_probs=204.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      .|+..+.||+|++|.||+|.+. +++.+++|++..........+.+|+++++.    ++|++++++++++..+...++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK----CKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHh----CCCCCEeEEEEEEecCCeEEEEE
Confidence            3777899999999999999986 688999999987654456788999999986    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++++|.+++... ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            999999999999776 5799999999999999999999998   999999999999999999999999999887654332


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                        .....++..|+|||......++.++||||||+++|+|++|+.||...............   .  . .. .       
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~--~-~~-~-------  217 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN---G--P-PG-L-------  217 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---C--C-CC-c-------
Confidence              34456888999999988888999999999999999999999999865321111111000   0  0 00 0       


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .........+.+++.+|++.||++||++.|+++
T Consensus       218 --~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 --RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              001112467889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.6e-32  Score=302.10  Aligned_cols=247  Identities=28%  Similarity=0.436  Sum_probs=200.0

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.+++.    +.|||++++++++...+..++|+|
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~----~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRD----YQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHH----cCCCChheEEEEEEcCCeEEEEEe
Confidence            444579999999999999964 688999999875544445668889998886    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++++|.+++.. .++++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+...... ...
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-~~~  171 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPR  171 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC-Ccc
Confidence            9999999999977 5789999999999999999999999   9999999999999999999999999987654322 112


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....++..|+|||...+..++.++||||+|+++|||++|+.||.....  .+..........         ...     
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~~~---------~~~-----  235 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDNLP---------PKL-----  235 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhcCC---------CCC-----
Confidence            2335688999999999888899999999999999999999999976443  122222211000         000     


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+......+.+++.+|++.+|++||++.|+++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            001123457889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-33  Score=308.12  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=211.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch--HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..+.|.+.+.||+|.|++|..|++. ++..||+|.+.+......  +.+.+|+++|..    +.|||||+++.+......
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~----l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKS----LNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHh----cCCcceeeeeeeeeecce
Confidence            3567899999999999999999975 799999999988754433  458899999986    789999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||+.+|.+++++..++++.+..++.++.|+..|++|+|++   .|||||||++||+++.+..+||+|||++..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999999999999999999999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                        .......++|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-                  .+.-+.
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------k~Lr~r  266 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------KELRPR  266 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------------------ccccch
Confidence              3345677899999999999888766 5789999999999999999999997532                  111122


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      .+.+.. -.+.....++-+++++++-.+|.+|++.++|.+-
T Consensus       267 vl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            222211 1122233467788889999999999999998753

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-32  Score=300.35  Aligned_cols=246  Identities=28%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      -|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++.+    ++||||+++++++.++...++|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ----CDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHh----cCCCCEeEEEEEEEeCCeEEEE
Confidence            3677889999999999999865 688999998865432 233568889998886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++++|.+++.. ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            999999999999865 4689999999999999999999998   99999999999999999999999999987664322 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      .......++..|+|||...+..++.++||||+||++|+|++|..||.......  +......  . .             
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~--~-~-------------  217 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPK--N-N-------------  217 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhc--C-C-------------
Confidence            12233467889999999988889999999999999999999999997644311  1111110  0 0             


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........+..+.+++.+|++.+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00011223456888999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=297.49  Aligned_cols=243  Identities=24%  Similarity=0.312  Sum_probs=190.9

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      +.||+|+||.||+|... +++.||+|++.+.....   ...+..|..++..   ...|+|++++++++..++..++||||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~---~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI---QGESPYVAKLYYSFQSKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh---cCCCCCeeeeeeeEEcCCeEEEEEec
Confidence            56999999999999975 68899999987643222   2234445444433   24799999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++++|.++++....+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++|||++.....     .
T Consensus        79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            99999999998888899999999999999999999998   999999999999999999999999999876432     2


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcc
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1088)
                      ....++..|+|||...+..++.++||||+|+++|+|++|..||....... .+. ........      .+.       .
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-~~~~~~~~------~~~-------~  215 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFD-NILSRRIN------WPE-------E  215 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHH-HHHhcccC------CCC-------c
Confidence            23457889999999888888999999999999999999999997654321 111 11100000      000       0


Q ss_pred             ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1047 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ........+.+++.+|++.+|++||++.++.+.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            111234678899999999999999987655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=330.43  Aligned_cols=253  Identities=26%  Similarity=0.300  Sum_probs=210.2

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ...++|++.++||+|+||.|..++.+ +++.+|+|++.+..   .....-|..|-++|..    -..+=|+++...|.++
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~----~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVF----GNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHc----CCcHHHHHHHHHhcCc
Confidence            34578999999999999999999986 68889999998843   2334568888888875    2467799999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ...|+|||||+||+|-.++.+.+++++..++.|+..|+.||+-+|+.   |+|||||||+|||+|..|++|++|||.+..
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence            99999999999999999999988999999999999999999999999   999999999999999999999999999988


Q ss_pred             ecCCCCcccccccccccccCccccC----C-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQ----T-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      +.......+...+|||.|++||+++    + +.|+..+|+||+||++|||+.|..||..  +.+++.+..++.+..... 
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--dslveTY~KIm~hk~~l~-  301 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--DSLVETYGKIMNHKESLS-  301 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--HHHHHHHHHHhchhhhcC-
Confidence            8766666677889999999999754    3 6899999999999999999999999986  456777777764422111 


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC---HHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN---VKEVL 1077 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil 1077 (1088)
                         +|         .....+.+..+||.+.+. +|+.|..   +.|+.
T Consensus       302 ---FP---------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  302 ---FP---------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             ---CC---------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence               11         012244566777777776 6888887   76664

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-33  Score=331.02  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=188.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      ..+|+..++||+||||.||+++.+ ||+.+|||++.-.. ...-..+.+|++.+++    ++|||||++|..|.+.    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LAr----LnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLAR----LNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhh----cCCcceeeeehhhhccCCcc
Confidence            356788899999999999999987 89999999998664 1222468889999997    7899999998654310    


Q ss_pred             --------------------------------------------------------------------------------
Q 001384          878 --------------------------------------------------------------------------------  877 (1088)
Q Consensus       878 --------------------------------------------------------------------------------  877 (1088)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEEecCCCCHHHHHhhcCCC-CHHHHHHHHHHHHHHHHHH
Q 001384          878 -----------------------------------SEKILVYEYMEGGSLEDIISDRTRL-TWRRRLDIAIDVARALVFL  921 (1088)
Q Consensus       878 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~qi~~~L~yL  921 (1088)
                                                         ...||-||||+..+++++++++... ....+++++++|++||+|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               0127889999998888888776544 5788899999999999999


Q ss_pred             HhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec----C-------------CCCcccccccccccccCccccCCC
Q 001384          922 HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS----A-------------GDSHVSTTIAGTVGYVAPEYGQTW  984 (1088)
Q Consensus       922 H~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~  984 (1088)
                      |++   |||||||||.||++|++..|||+|||+|+...    .             .+....+..+||.-|+|||++.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999998621    0             011123456899999999987765


Q ss_pred             C---CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhh
Q 001384          985 Q---ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVR 1061 (1088)
Q Consensus       985 ~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1061 (1088)
                      .   |+.|+|+||+|||++||+.   ||...    ++-+..........-...   ..       ...+....=.++|.+
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~---~~-------f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEP---AD-------FFDPEHPEEASLIRW  853 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCC---cc-------cccccchHHHHHHHH
Confidence            4   9999999999999999983   56543    222222221111110000   00       012223344567889


Q ss_pred             hcccCCCCCCCHHHHHH
Q 001384         1062 CTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1062 cl~~dP~~RPs~~eil~ 1078 (1088)
                      |+++||.+||||.|+++
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999975

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-32  Score=302.03  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=196.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++    ++||||+++++++.+++..++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKD----LKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhh----CCCcceeeEEEEEecCCeEEE
Confidence            57889999999999999999976 6889999998754322 23456789999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ +|.+++.+. ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9999985 999988764 4689999999999999999999999   9999999999999999999999999998754321


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh--hhccCCCCCC------
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR--VMGYGRHGPG------ 1032 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~------ 1032 (1088)
                      .. ......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.+.......+...  ..........      
T Consensus       157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            11 1122346788999998764 468899999999999999999999997654221111111  0000000000      


Q ss_pred             --------ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 --------RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              ....+....... . .......+.+++.+|++.+|++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHA-P-RLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhC-c-CCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    000000000000 0 0011256788999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-31  Score=298.92  Aligned_cols=254  Identities=28%  Similarity=0.395  Sum_probs=199.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--CeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~~  880 (1088)
                      ++|+..+.||.|++|.||+|.+. +++.+|+|.+..... ....++.+|++++++    ++||||+++++++.+.  ...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKS----CKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHh----CCCCCeeeeeeEEEccCCCeE
Confidence            36788899999999999999985 678999999875432 344678899999986    6899999999988653  468


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            999999999999988753    34589999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch---hHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE---CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ......   .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....   ...+..........    .
T Consensus       154 ~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~  226 (287)
T cd06621         154 ELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN----P  226 (287)
T ss_pred             cccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc----h
Confidence            543221   1234578899999999888999999999999999999999999986521   11222222111000    0


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ..+     ............+.+++.+|++.+|++||++.|+++
T Consensus       227 -~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         227 -ELK-----DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -hhc-----cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             000     000001123467889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.1e-32  Score=296.06  Aligned_cols=242  Identities=28%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|++|.||+|++. +++.||+|++.+...   ...+.+.+|+++++.    ++||||+++++++.++...++||||++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE----CNHPFIVKLYRTFKDKKYIYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHh----CCCCCEeeeeeeEEcCCccEEEEecCC
Confidence            699999999999976 588999999976432   234578899998886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +++|.+++.+...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......  ....
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            999999998888899999999999999999999998   99999999999999999999999999998765332  2233


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG 1048 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1088)
                      ..++..|+|||.+....++.++|+||+|+++|+|++|..||....+...+..........               ....+
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~  216 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG---------------KLEFP  216 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC---------------CCCCC
Confidence            467889999999888889999999999999999999999998765322222222221000               00112


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1049 AEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1049 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                      ......+.+++.+|++.+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222567899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-33  Score=275.52  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=194.6

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          808 SEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +....||+|+.|.|++++.+ +|...|||.+.+..... .+++...++++..   ...+|+||+-+|||..+..+++.||
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~---s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLK---SHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhh---ccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44567999999999999976 58899999998764332 3456666776664   2358999999999999999999999


Q ss_pred             ecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          886 YMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      .|.. .++.++++ ..++++.-+-++...++.||.||.+++  +|+|||+||+|||+|+.|.+|++|||.+-++-  ++.
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSk  246 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSK  246 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee--ccc
Confidence            9954 66666654 446899999999999999999999985  99999999999999999999999999998765  344


Q ss_pred             ccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          965 VSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       965 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ..+..+|.+.|||||.+..   ..|+.++||||||+.++|+.||+.||.+-..++.... .+..         ..++.+.
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-kvln---------~ePP~L~  316 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-KVLN---------EEPPLLP  316 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-HHHh---------cCCCCCC
Confidence            4556679999999998764   3789999999999999999999999998544222111 1110         0011111


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ........+.+++..|+++|+.+||...++++
T Consensus       317 -----~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  317 -----GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -----cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                 12224567889999999999999999988765

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.2e-32  Score=298.10  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=184.5

Q ss_pred             eecccCceEEEEEEeCCC---cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          812 IIGKGGFGTVYRGVLPDG---REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.    ++||||+++++++.+....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~----l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI----LQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhc----cCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999985433   356677766543 2344678889888876    67999999999999999999999999


Q ss_pred             CCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          888 EGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       888 ~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ++|+|.+++++.    ...++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            999999999753    2366778889999999999999998   999999999999999999999999999864322111


Q ss_pred             -cccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          964 -HVSTTIAGTVGYVAPEYGQT-------WQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       964 -~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                       .......++..|+|||+...       ..++.++||||||+++|||++ |..||....+  .+..........    ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~~----~~  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVIKDQQ----VK  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHhhcc----cc
Confidence             11234567889999998643       245789999999999999997 4667765433  111111110000    01


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                      ..++..       ......++.+++..|+ .+|++||+++||++.|.
T Consensus       229 ~~~~~~-------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQL-------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCcc-------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111111       1113356777888999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=338.70  Aligned_cols=325  Identities=28%  Similarity=0.318  Sum_probs=180.0

Q ss_pred             eccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccC-cccCCCCCCCceeeccccccc
Q 001384           84 LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-DLNLSGLRSLEILDLSVNRIH  162 (1088)
Q Consensus        84 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~~l~~l~~L~~L~Ls~N~l~  162 (1088)
                      +|.++..++- ||..+-.-..++.|+++.|-+-...-+.+.+.-+|+.|+|++|+++. +..+..+++|+.|+++.|.|.
T Consensus         3 vd~s~~~l~~-ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~   81 (1081)
T KOG0618|consen    3 VDASDEQLEL-IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR   81 (1081)
T ss_pred             cccccccCcc-cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh
Confidence            3444444433 33334444447777777776653222344455557777777777765 345667777777777777765


Q ss_pred             ccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccC
Q 001384          163 GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKE  242 (1088)
Q Consensus       163 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~  242 (1088)
                      . .|.+. ..+.+|++++|..|.+. ..|..+..+.+|++|++++|++..                       .+..+..
T Consensus        82 ~-vp~s~-~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~-----------------------~Pl~i~~  135 (1081)
T KOG0618|consen   82 S-VPSSC-SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP-----------------------IPLVIEV  135 (1081)
T ss_pred             h-Cchhh-hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC-----------------------CchhHHh
Confidence            2 23222 12245566666555555 334556666777777777766541                       1122333


Q ss_pred             CCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEE
Q 001384          243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD  322 (1088)
Q Consensus       243 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  322 (1088)
                      ++.++.+..++|..+..++.    .. ++.+++..|.+.+.++.++..+..  .|+|.+|.+..   ..+.++.+|+.|.
T Consensus       136 lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~  205 (1081)
T KOG0618|consen  136 LTAEEELAASNNEKIQRLGQ----TS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLH  205 (1081)
T ss_pred             hhHHHHHhhhcchhhhhhcc----cc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhh
Confidence            44566666676632222222    11 666777777777666666666555  57777776651   3455666677777


Q ss_pred             cCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccC
Q 001384          323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN  402 (1088)
Q Consensus       323 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  402 (1088)
                      ...|++....-                             .-++|+.|+.++|.++...+..  .-.+|+++++++|+++
T Consensus       206 c~rn~ls~l~~-----------------------------~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~  254 (1081)
T KOG0618|consen  206 CERNQLSELEI-----------------------------SGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS  254 (1081)
T ss_pred             hhhcccceEEe-----------------------------cCcchheeeeccCcceeecccc--ccccceeeecchhhhh
Confidence            77766653211                             2245555555555555222111  1235556666666665


Q ss_pred             CcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCch
Q 001384          403 GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE  480 (1088)
Q Consensus       403 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~  480 (1088)
                       .+|++++.+.+|+.|+..+|+|+ .+|..+...++|+.|.+.+|.+. -+|+.+..+++|+.|+|..|+|. .+|+.
T Consensus       255 -~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~  328 (1081)
T KOG0618|consen  255 -NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDN  328 (1081)
T ss_pred             -cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchH
Confidence             45555566666666666666665 45555555566666666666665 45555555666666666666654 44543

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=301.17  Aligned_cols=263  Identities=24%  Similarity=0.287  Sum_probs=196.9

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      |++.+.||+|++|.||+|.+. +|+.||+|++.....  .....+.+|+++++.    ++|||++++++++.++...++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~----l~~~~iv~~~~~~~~~~~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKE----LNHPNIVRLLDVVHSENKLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHh----cCCCCccCHhheeccCCeEEEE
Confidence            667889999999999999975 789999999875432  223567889999986    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||++ ++|.+++....  .+++..++.++.|++.||+|||++   +++||||+|+||+++.++.++++|||.+......
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            99995 59999997765  689999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh-ccCCC---------C
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM-GYGRH---------G 1030 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~---------~ 1030 (1088)
                      .. ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.........+..... .....         .
T Consensus       153 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         153 VR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             cc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            11 1122346789999997755 35789999999999999999999999865442111110000 00000         0


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........................+.+++.+|++.||++||+++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000000011122357889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-32  Score=293.37  Aligned_cols=247  Identities=28%  Similarity=0.441  Sum_probs=205.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  .....+.+|++++++    ++|||++++++++.++...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKN----LKHPNIVKYIGSIETSDSLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHh----CCCCCccEEEEEEEeCCEEEE
Confidence            4788899999999999999876 678999999987644  334578899999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++++|.+++.....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999999998888899999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.........|.....   .    .         
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~----~---------  216 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---D----H---------  216 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---C----C---------
Confidence            22 23356788999999988878899999999999999999999999765432222221100   0    0         


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ...+......+.+++.+|++.+|++||++.|++.
T Consensus       217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              0011223457888999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.3e-32  Score=299.05  Aligned_cols=262  Identities=23%  Similarity=0.242  Sum_probs=193.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--CeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~~~l  882 (1088)
                      |++.+.||+|+||.||+|... +++.||+|+++.... ........|+.++.+.   ..|+|++++++++.++  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l---~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhc---CCCCCccceEEEEecCCCCcEEE
Confidence            567889999999999999965 688999999876422 2223445677777763   2599999999999987  88999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ ++.+++.. ...+++.+++.++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.++.....
T Consensus        78 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9999975 88888765 35689999999999999999999999   9999999999999999 99999999999866432


Q ss_pred             CCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCC---------CC
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGR---------HG 1030 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~---------~~ 1030 (1088)
                      .  ......++..|+|||... +..++.++||||+||++|||++|..||.+.+. ....+.........         ..
T Consensus       153 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         153 P--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            2  223345788999999654 45678899999999999999999999987543 11122111110000         00


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+.................+.+++.+|++++|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000000000011234578999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=331.20  Aligned_cols=255  Identities=31%  Similarity=0.464  Sum_probs=212.0

Q ss_pred             CCCCccceecccCceEEEEEEeC----C----CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP----D----GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ++..+.+.+|+|+||.|++|...    .    ...||||.++..... ..+.+..|+++++.+.   +|+||+.++|+|.
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g---~H~niv~llG~~t  372 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG---KHPNIVNLLGACT  372 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc---CCcchhhheeeec
Confidence            34455669999999999999842    1    457999999876444 4467999999999865   8999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      .++..++|+||+..|+|.++++..+                .++..+...++.|||.||+||++.   ++|||||.++||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence            9999999999999999999997765                388999999999999999999999   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCccccccc--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCc--h
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGE--E 1014 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~--~ 1014 (1088)
                      +++++..+||+|||+|+.....+.+......  -+..|||||.+....|+.++|||||||++||++| |..||.+-.  +
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9999999999999999976655444322222  3567999999999999999999999999999999 777876522  1


Q ss_pred             hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .+.+                   ....|.+...|..+..+++++++.||+.+|++||++.++++.++..+
T Consensus       530 ~l~~-------------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  530 ELLE-------------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             HHHH-------------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1211                   12233344557777889999999999999999999999999999854

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.9e-32  Score=300.76  Aligned_cols=240  Identities=29%  Similarity=0.346  Sum_probs=191.9

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||+||+|..+ +|+.||+|.+.....   .....+..|++++++    ++|||++++++++...+..|+||||++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK----VSSRFIVSLAYAFETKDDLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHh----CCCCCEeeeeeEEecCCeEEEEEecCC
Confidence            689999999999865 689999999875432   223456789999986    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccc
Q 001384          889 GGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS  966 (1088)
Q Consensus       889 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  966 (1088)
                      +++|.+++....  .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+.....  ....
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~  151 (277)
T cd05577          77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKI  151 (277)
T ss_pred             CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcc
Confidence            999999997755  689999999999999999999999   999999999999999999999999999876543  1222


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCCCCCCccccchhhcCCC
Q 001384          967 TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044 (1088)
Q Consensus       967 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1088)
                      ....++..|+|||+..+..++.++||||+|+++|+|++|+.||......  ..+......                 ...
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~  214 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----------------EMA  214 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----------------ccc
Confidence            3345778999999988888999999999999999999999999765331  111111110                 000


Q ss_pred             ccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1045 LAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1045 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      ...+......+.+++.+|++.||++||     ++.+++.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            011222345788999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.3e-32  Score=309.28  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      ..++|+..+.||+|+||.||+|.+. +++.||+|++.+..  ......+.+|+.++.+    ++||||+++++++...  
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKL----VNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHh----cCCCCCcceeeeeccCCC
Confidence            4578999999999999999999975 78999999987532  2233467789999886    6799999999988643  


Q ss_pred             ----CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          878 ----SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       878 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                          ...|+||||+++ +|.+.+...  +++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          90 LEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             ccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence                357999999965 898888654  89999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC----
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH---- 1029 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1029 (1088)
                      .++......  ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+. ...|..........    
T Consensus       164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHH
Confidence            998754321  22334678899999999988999999999999999999999999976532 22222111100000    


Q ss_pred             --------------C------CCccccchhhcCCC-ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 --------------G------PGRAVIPVVLLGSG-LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 --------------~------~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                    .      ...+..+....... ..........+.+++.+|++.||++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                          0      00000000000000 0001234567889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=291.38  Aligned_cols=242  Identities=27%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHH---HHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .+|....+||+|+||+|.+|..+ +.+.+|||+++++...+..+   .+.|-+++...   -+-|.++++..+|+.-+..
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~---~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP---GKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC---CCCchHHHHHHHhhhhhhe
Confidence            36888999999999999999977 45679999999876554433   23455666543   2678999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |.||||+.||+|--.++.-+++.+..+..+|.+||-||-+||++   |||+||||.+|||+|.+|++||+|||+++.---
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999975322


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                       +...+.+++||+.|+|||++...+|+..+|+||+||++|||+.|++||++.++...-  ..++            +   
T Consensus       503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--~aI~------------e---  564 (683)
T KOG0696|consen  503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--QAIM------------E---  564 (683)
T ss_pred             -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH------------H---
Confidence             334466789999999999999999999999999999999999999999987653221  1111            0   


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1072 (1088)
                        ..-..|.....+.+.+.+..+.+.|.+|..
T Consensus       565 --hnvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 --HNVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence              001113344567777888999999999963

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.5e-32  Score=298.70  Aligned_cols=247  Identities=25%  Similarity=0.423  Sum_probs=199.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||+|..+ +|..||+|.+.....  ...+.+.+|+++++.    ++|+|++++++++..+...++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~----~~h~~i~~~~~~~~~~~~~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAK----MKHPNIVTFFASFQENGRLFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHh----CCCCChhhhhheeccCCeEEE
Confidence            4788899999999999999976 588999999875422  234567889999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-EEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-ALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-~kl~Dfg~a~~~~  959 (1088)
                      |+||+++++|.+++.+..  .+++..+..++.|++.|++|||+.   +++|+||||+||++++++. +|++|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            999999999999997643  479999999999999999999998   9999999999999998864 6999999987664


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... .......|++.|+|||+.....++.++||||+|+++|||++|+.||.....  .++........        ..  
T Consensus       154 ~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~--------~~--  220 (257)
T cd08225         154 DSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--HQLVLKICQGY--------FA--  220 (257)
T ss_pred             CCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHhccc--------CC--
Confidence            322 122334688899999998888899999999999999999999999976432  12222111000        00  


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .........+.+++.+|++.+|++||++.|+++
T Consensus       221 ------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 ------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  001123356888899999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-31  Score=301.34  Aligned_cols=246  Identities=29%  Similarity=0.397  Sum_probs=196.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..+|+..+.||+|+||.||+|... +++.||+|++.....   ...+++.+|+++++.    ++|||++++++++.+++.
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~----l~h~niv~~~~~~~~~~~   89 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ----LRHPNTIEYKGCYLREHT   89 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHh----CCCCCEEEEEEEEEeCCe
Confidence            356888899999999999999975 689999999864322   223468889999886    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||++ |++.+++.. ...+++.++..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            999999997 477777654 45689999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ...     ....++..|+|||++.   ...++.++||||||+++|||++|+.||..........  ...   . ...   
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~--~~~---~-~~~---  231 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA---Q-NDS---  231 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH--HHh---c-CCC---
Confidence            322     2346788999999863   4578899999999999999999999997654321111  110   0 000   


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                              ...........+.+++.+|++.+|++||++.+|+..
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 --------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                    000122345678899999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.1e-32  Score=302.03  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=198.4

Q ss_pred             CCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +|++.+.||+|+||.||+|+..    +|+.||+|++.....    ...+.+..|++++.++.   +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---QSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc---cCCChhceeeEeecC
Confidence            4778899999999999999863    688999999875422    22356788999988742   699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ...++||||+++++|.+++.....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999999998888899999999999999999999998   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .............++..|+|||....  ..++.++||||+|+++|+|++|+.||.....  ...++........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------  228 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------  228 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC------
Confidence            64433222334568889999998765  3467899999999999999999999964322  1222222221100      


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                                 .+.+......+.+++.+|++.||++||     ++.+++.
T Consensus       229 -----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 -----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                       001122345678899999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.5e-32  Score=301.51  Aligned_cols=263  Identities=24%  Similarity=0.285  Sum_probs=195.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|+..+.||+|++|.||+|+.. +++.||||++.....  .....+.+|++++++    ++||||+++++++.+++..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~~   76 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE----LNHPNIVKLLDVIHTENKLYL   76 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHh----cCCCCCcchhhhcccCCcEEE
Confidence            4788899999999999999975 688999999875432  223568889999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||++ ++|.+++..  ...+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+.....
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999996 589998865  34689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH--HHHHhhhccCCCC-------
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLV--EWGRRVMGYGRHG------- 1030 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~------- 1030 (1088)
                      ... ......++..|+|||...+. .++.++||||||+++|||+||+.||....+...  ....... .....       
T Consensus       153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  230 (284)
T cd07860         153 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGVTS  230 (284)
T ss_pred             Ccc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhhhhH
Confidence            221 12233467889999977654 468899999999999999999999986543111  1111000 00000       


Q ss_pred             --CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 --PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .....++.................+.+++.+|++.||++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              000000000000000001112346778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3e-35  Score=321.24  Aligned_cols=268  Identities=28%  Similarity=0.388  Sum_probs=186.6

Q ss_pred             cCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCcc-ccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA-EIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       246 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      |+.||||+|++. ..|..+...+++-.|+|++|+|. .||. -|.+++.|-.|||++|++.. +|+.+..+..|++|+|+
T Consensus       105 Lt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls  181 (1255)
T KOG0444|consen  105 LTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLS  181 (1255)
T ss_pred             ceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcC
Confidence            333444444433 44545555555555555555555 3332 23445555555555555433 34445555555555555


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC-CCCCccccCCcCcceeeccccccCC
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT-GPLPVEISQMRSLKFLILAHNRFNG  403 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~  403 (1088)
                      +|.+...-                         ...+..+++|+.|++++.+=+ ..+|.++..+.+|..+|+|.|.+. 
T Consensus       182 ~NPL~hfQ-------------------------LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-  235 (1255)
T KOG0444|consen  182 NNPLNHFQ-------------------------LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-  235 (1255)
T ss_pred             CChhhHHH-------------------------HhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-
Confidence            55543221                         112233445556666655422 367888888888888888888888 


Q ss_pred             cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhc
Q 001384          404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT  483 (1088)
Q Consensus       404 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~  483 (1088)
                      .+|+.+.++++|+.|+||+|+|+ .+....+...+|++|+|+.|+++ .+|+.++.|+.|+.|.+.+|+|+         
T Consensus       236 ~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~---------  304 (1255)
T KOG0444|consen  236 IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT---------  304 (1255)
T ss_pred             cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc---------
Confidence            88888888889999999999988 56667777788999999999998 78999999999999988888886         


Q ss_pred             cCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceee
Q 001384          484 IGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQI  563 (1088)
Q Consensus       484 ~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  563 (1088)
                                                                                                      
T Consensus       305 --------------------------------------------------------------------------------  304 (1255)
T KOG0444|consen  305 --------------------------------------------------------------------------------  304 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             eceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccc
Q 001384          564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSY  642 (1088)
Q Consensus       564 l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~  642 (1088)
                                +. -||..||+|.+|++++.++|.|. ..|+.+..+ +|+.|.|+.|++. .+|+.|.-|+.|+.|||..
T Consensus       305 ----------Fe-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre  371 (1255)
T KOG0444|consen  305 ----------FE-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE  371 (1255)
T ss_pred             ----------cc-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence                      00 36777888888888888888888 788888777 7888889999888 8999999999999999999


Q ss_pred             cccC
Q 001384          643 NNFS  646 (1088)
Q Consensus       643 N~l~  646 (1088)
                      |.=-
T Consensus       372 NpnL  375 (1255)
T KOG0444|consen  372 NPNL  375 (1255)
T ss_pred             CcCc
Confidence            8643

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.4e-32  Score=295.41  Aligned_cols=247  Identities=28%  Similarity=0.459  Sum_probs=204.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+..|+++++.    ++|||++++++.+..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~~~~~~~~~~~~~~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKK----LNHPNIIKYYESFEEKGKLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHh----cCCCChhheEEEEecCCEEEE
Confidence            5788899999999999999976 688999999986543  345678889999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      |+||+++++|.++++..    ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeec
Confidence            99999999999999764    6799999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... .......+++.|+|||......++.++||||+|+++|+|++|+.||...+.  .+.........           
T Consensus       154 ~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~-----------  219 (258)
T cd08215         154 SSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILKGQ-----------  219 (258)
T ss_pred             ccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHhcCC-----------
Confidence            5432 223345688899999998888899999999999999999999999976542  11111111000           


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ....+......+.+++.+|++.+|++||++.|+++
T Consensus       220 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 -----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00011233467888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-31  Score=291.94  Aligned_cols=250  Identities=26%  Similarity=0.439  Sum_probs=205.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--CeE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SEK  880 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~~  880 (1088)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++    ++||||+++++++...  ...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSS----LQHPNIVRYYGSERDEEKNTL   76 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHH----cCCCCEeeEEEEEecCCCCeE
Confidence            4778899999999999999976 689999999876543  335678899999987    6799999999999988  889


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++|+||+++++|.+++.....+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          77 NIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999999998877899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .... ......++..|+|||......++.++||||+|+++|+|++|+.||.......... ....   ...         
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~---~~~---------  220 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-YKIG---SSG---------  220 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-Hhcc---ccC---------
Confidence            3321 1234567889999999988889999999999999999999999998754211111 1110   000         


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .....+......+.+++.+|++.+|++||++.|+++
T Consensus       221 ---~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 ---EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               000112233568899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-32  Score=303.59  Aligned_cols=255  Identities=27%  Similarity=0.341  Sum_probs=203.0

Q ss_pred             CCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      +|++.+.||+|++|.||+|+..    +++.||||++++...    ...+.+..|++++.++.   +||||+++++++..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~---~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR---RCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc---CCcchhhhheeeecC
Confidence            4778899999999999999853    568899999875422    22356788999988742   699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ...++||||+++|+|.+++.....+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++++|||+++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999999998877899999999999999999999998   999999999999999999999999999877


Q ss_pred             ecCCCCcccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQ--ATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .............++..|+|||...+..  .+.++||||+|+++|||++|+.||.....  ...++.......       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------  227 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------  227 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence            5443332233456788999999877654  78899999999999999999999964322  112222222110       


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                                ..+.+......+.+++.+|++.||++||++.++.+.|+..
T Consensus       228 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 ----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                      0011222345678899999999999999999888777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.2e-32  Score=299.08  Aligned_cols=243  Identities=26%  Similarity=0.311  Sum_probs=189.5

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          812 IIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      +||+|+||.||+|... +++.||+|.+.+....   .+..+..|..++.... ...||+|+++++++.+++..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHH-hCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999975 5889999998764322   1222344443333211 247999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccc
Q 001384          888 EGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST  967 (1088)
Q Consensus       888 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  967 (1088)
                      ++|+|.+++.....+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.......   ..
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            9999999998888899999999999999999999998   99999999999999999999999999987653221   22


Q ss_pred             cccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          968 TIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       968 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      ...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...... ..........                 ...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~  216 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------MAV  216 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-----------------cCC
Confidence            34688999999988644 6899999999999999999999999865321 1111111110                 000


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                      ..+......+.+++.+|+..+|.+||     ++.|+++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11122346788899999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1e-31  Score=300.04  Aligned_cols=262  Identities=25%  Similarity=0.266  Sum_probs=196.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--Ce
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~  879 (1088)
                      ++|++.+.||+|+||.||+|.++ +++.+|+|.++.....  ....+.+|+.++.+    ++||||+++++++..+  ..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLK----LQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHh----cCCCCEEEEEEEEEecCCCc
Confidence            46888999999999999999986 5889999999754322  22356789998886    6799999999998877  88


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .|+||||+++ +|.+++.... .+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            9999999975 9999987644 589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhc-----------
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMG----------- 1025 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~----------- 1025 (1088)
                      .... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ .-......           
T Consensus       157 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         157 GSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             cCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            5432 122334568899999987653 468999999999999999999999986543111 00000000           


Q ss_pred             -cCCC--CCCccccchhhcCCCccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 -YGRH--GPGRAVIPVVLLGSGLAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 -~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ....  ..............   .+.. ....+.+++.+|++.||++||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKK---FPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhcc---ccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0000  00000000000000   0111 2456788999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=1.5e-31  Score=299.19  Aligned_cols=263  Identities=23%  Similarity=0.259  Sum_probs=194.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe--
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE--  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~--  879 (1088)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++......  ....+.+|+.+++.+.   +||||+++++++.....  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS---ESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc---CCCCccceeeeEeecCCCC
Confidence            46889999999999999999975 6899999998754322  2356788999998743   57999999999887665  


Q ss_pred             ---EEEEEEecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEe
Q 001384          880 ---KILVYEYMEGGSLEDIISDR-----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVT  950 (1088)
Q Consensus       880 ---~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~  950 (1088)
                         .|+||||+++ +|.+++...     ..+++..++.++.||+.||+|||++   +|+||||+|+||+++. ++.+||+
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEe
Confidence               7999999986 898887642     3579999999999999999999999   9999999999999998 8999999


Q ss_pred             ecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          951 DFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      |||.++.+..... ......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||.+..+.. +...... ... 
T Consensus       154 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~-~~~-  229 (295)
T cd07837         154 DLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFK-LLG-  229 (295)
T ss_pred             ecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-HhC-
Confidence            9999886543211 1222346788999997654 567999999999999999999999998754321 1111110 000 


Q ss_pred             CCCccccchh--------hcCCC----ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRAVIPVV--------LLGSG----LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~~~~~~--------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......+..        .....    .........++.++|.+|+++||.+||+++|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000        00000    0001123466889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=8.2e-32  Score=300.47  Aligned_cols=254  Identities=18%  Similarity=0.254  Sum_probs=185.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCccc--hHHH------HHHHHHHhCCCCCCCCCceeEEe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEG--EREF------RAEMEVLSGNGFGWPHPNLVTLY  871 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~~~~------~~E~~~l~~~~~~l~h~niv~l~  871 (1088)
                      .++|++.++||+|+||+||+|.+.+    +..+|+|+........  +...      ..++..+.... .+.|+++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~~~h~~i~~~~   89 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH-NIDHLGIPKYY   89 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhc-cCCCCCCCcEE
Confidence            3679999999999999999999754    3456666543221111  1000      11122121111 36899999999


Q ss_pred             eEEecCC----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          872 GWCLDGS----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       872 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      +++....    ..++++|++.. ++.+.++.....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence            9766543    34788888754 7778777666678999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHH--
Q 001384          948 LVTDFGLARVVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLV-- 1017 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~-- 1017 (1088)
                      +|+|||+|+.+......      ......||+.|+|||+..+..++.++||||+||++|||++|+.||.+...  ...  
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876432211      11234689999999999999999999999999999999999999987532  111  


Q ss_pred             ---HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1018 ---EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1018 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                         ++.....                .+.  ......+..+.+++..|++.+|++||+++++++.+
T Consensus       246 ~~~~~~~~~~----------------~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLH----------------EGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhh----------------hhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence               1111110                000  00112346788899999999999999999999876

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=1.6e-31  Score=300.83  Aligned_cols=266  Identities=27%  Similarity=0.312  Sum_probs=196.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--C
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--S  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~  878 (1088)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++......  ....+.+|++++++    ++|+|++++++++.+.  +
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN----LRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHh----CCCCCCcceEEEEecCCCC
Confidence            357999999999999999999975 6899999998754322  22356679999986    6799999999998765  5


Q ss_pred             eEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++ +|.+++.. ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            68999999975 89888875 35689999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCCC--c
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGPG--R 1033 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~ 1033 (1088)
                      ...... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+.+.... .-.............  .
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            654321 2223345778999998754 5678999999999999999999999986544111 111111000000000  0


Q ss_pred             cccc----hhhcCCCcc----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIP----VVLLGSGLA----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~----~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...+    .........    ........+.+++.+|++.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000    000000000    00112456778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=296.57  Aligned_cols=264  Identities=25%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--CeEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SEKI  881 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~~~  881 (1088)
                      |++.+.||+|++|.||+|+.. +++.+|+|++....  ......+.+|+++++.    ++|||++++++++.+.  +..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~~   76 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQK----LRHPNIVRLKEIVTSKGKGSIY   76 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHh----ccCCCeeeheeeEecCCCCcEE
Confidence            567889999999999999976 58899999998763  2334568889999986    6799999999999988  8899


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++ +|.+++... ..+++.+++.++.|++.|++|||+.   +++|+||+|+||++++++.+|++|||.+.....
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          77 MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             EEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            99999975 899988765 5799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCCccccc-
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIP- 1037 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~- 1037 (1088)
                      ..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...................... 
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            43222334456788999997654 46789999999999999999999999875431 1111111110000000000000 


Q ss_pred             ---hhhcCCC------ccccHH-HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 ---VVLLGSG------LAEGAE-EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ---~~~~~~~------~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .......      ...... ....+.+++.+|++.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0000000      000011 2567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-31  Score=294.32  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=198.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-----ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-----LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-  877 (1088)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++....     ......+.+|++++++    ++||||+++++++.+. 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~----l~h~~i~~~~~~~~~~~   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN----LRHDRIVQYYGCLRDPE   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHH----cCCCCcceEEEEEEcCC
Confidence            47889999999999999999975 68999999875321     1223568889999987    6799999999998764 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||+++++|.+++.....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence             46789999999999999998877899999999999999999999999   99999999999999999999999999997


Q ss_pred             eecCCC--CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGD--SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ......  ........++..|+|||...+..++.++||||||+++|+|++|+.||........ . .....    ..   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~~~~~----~~---  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-I-FKIAT----QP---  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-H-HHHHc----CC---
Confidence            653211  1112235688899999999888899999999999999999999999976533111 1 11110    00   


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              .....+......+.+++.+|++ +|.+||++.+++.
T Consensus       226 --------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 --------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    0011123344678889999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=8.1e-32  Score=294.45  Aligned_cols=245  Identities=28%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|++.+.||+|+||.||+++.. +++.+|+|++.....  ....++..|+++++.    ++|+||+++++++.+....++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS----VNHPNIISYKEAFLDGNKLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHh----CCCCCchhhhhhhccCCEEEE
Confidence            4788899999999999999865 678999999876432  233467788888886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ||||+++++|.+++.+    ...+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++...
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            9999999999999866    35689999999999999999999999   9999999999999999999999999999776


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ...   ......++..|+|||...+..++.++|+||+|+++|+|++|+.||...+....  ......             
T Consensus       154 ~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~-------------  215 (256)
T cd08530         154 KKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQR-------------  215 (256)
T ss_pred             ccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhc-------------
Confidence            543   22234578899999999988999999999999999999999999986543211  111110             


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ......+.....++.+++.+|++.+|++||++.|+++
T Consensus       216 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ---GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0001112345567899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=8.6e-32  Score=295.78  Aligned_cols=245  Identities=26%  Similarity=0.372  Sum_probs=196.9

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||.||+|++. +|+.+|+|++.....   ...+.+.+|++++++    +.|||++++++.+..+...|+||||++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~----~~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQ----AQSPYVVKLYYSFQGKKNLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHh----CCCcchhHHHHheecCcEEEEEEecCC
Confidence            689999999999987 489999999976543   234568888888886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC-----
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-----  963 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----  963 (1088)
                      +++|.+++++...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++++|||++........     
T Consensus        77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999999998877899999999999999999999999   999999999999999999999999999876433211     


Q ss_pred             --cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          964 --HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       964 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                        .......++..|+|||......++.++||||||+++|++++|+.||......  +...........      .+    
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~------~~----  221 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILNGKIE------WP----  221 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCcC------CC----
Confidence              1223346788999999988888999999999999999999999999765431  111121110000      00    


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                           ........+.+++.+|++.+|++||++.++.+.|+
T Consensus       222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                 00012467889999999999999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=6.8e-32  Score=307.42  Aligned_cols=272  Identities=23%  Similarity=0.308  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+..|+.++++    ++||||+++++++...    
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRR----FKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHh----CCCCCcCchhheeecccccc
Confidence            468999999999999999999965 68999999986432 2233567789999987    6799999999987654    


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++|+||+++ ++.+++.. .++++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence             357999999975 88888754 4689999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcc--cccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCC
Q 001384          957 VVSAGDSHV--STTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .........  .....++..|+|||.+. ...++.++||||+||++|+|++|+.||.+.... ...+.............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            754322211  22356788999999754 456899999999999999999999999764321 11111111100000000


Q ss_pred             ccccchh----h----cCCCcc---ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HHhhC
Q 001384         1033 RAVIPVV----L----LGSGLA---EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM--LIKIL 1084 (1088)
Q Consensus      1033 ~~~~~~~----~----~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~i~ 1084 (1088)
                      .......    .    ......   .......++.+++.+|++.||++||++.|+++.  ++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0000000    0    000000   001224568899999999999999999999875  54443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=6e-32  Score=307.58  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----  876 (1088)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  .....+..|+.++.+    ++||||+++++++..    
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~   79 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH----FKHDNIIAIRDILRPPGAD   79 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHh----cCCCCccCHHHhccccCCC
Confidence            468999999999999999999975 689999999876432  334567789999986    679999999998763    


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ....++||||+. |+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          80 FKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             CceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            346899999996 59999998878899999999999999999999998   99999999999999999999999999997


Q ss_pred             eecCCCCc---ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCC
Q 001384          957 VVSAGDSH---VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGP 1031 (1088)
Q Consensus       957 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 1031 (1088)
                      ........   ......++..|+|||.+.. ..++.++||||+|+++|||++|+.||.+...... ..............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            76432211   1233468889999998655 4689999999999999999999999976543111 11011000000000


Q ss_pred             Cccccchh------hcCCCccc-----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVV------LLGSGLAE-----GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........      ........     ......++.+++.+|++.+|++||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00000000      00000000     1123567899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=1.6e-31  Score=297.69  Aligned_cols=243  Identities=27%  Similarity=0.421  Sum_probs=196.7

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ..+||+|+||.||+|..+ +++.||||++..........+.+|+.+++.    ++|+|++++++++..++..++||||++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHh----cCCcchhheeeEEEeCCEEEEEEecCC
Confidence            367999999999999875 789999999865544455678889998886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +++|.+++.. .++++..++.++.|++.|++|||+.   +++||||+|+||++++++.++++|||++....... .....
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~  175 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  175 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence            9999998754 4689999999999999999999999   99999999999999999999999999987654322 12234


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCCccccchhhcCCCccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1088)
                      ..++..|+|||...+..++.++||||+|+++|+|++|+.||.+.... .........            +..     ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------~~~-----~~~  238 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPK-----LKN  238 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC------------Ccc-----cCC
Confidence            56788999999988888999999999999999999999999865331 111111111            000     000


Q ss_pred             cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1048 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......+.+++.+|++.+|.+||++.|+++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1122346778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=7.2e-32  Score=321.22  Aligned_cols=269  Identities=16%  Similarity=0.197  Sum_probs=188.4

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCC--CcEEEEEE--------------ccc---cCccchHHHHHHHHHHhCCCCCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPD--GREVAVKK--------------LQR---EGLEGEREFRAEMEVLSGNGFGW  862 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~~~~~l  862 (1088)
                      ...++|++.+.||+|+||+||+|..+.  +..+++|.              +.+   ........+.+|++++.+    +
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~----l  220 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR----L  220 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh----C
Confidence            345789999999999999999987542  22222221              111   111223467889999987    6


Q ss_pred             CCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001384          863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKAS  937 (1088)
Q Consensus       863 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~  937 (1088)
                      +||||+++++++...+..|+|+|++. ++|.+++...     ......+++.++.|++.||+|||++   +||||||||+
T Consensus       221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~  296 (501)
T PHA03210        221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE  296 (501)
T ss_pred             CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            89999999999999999999999995 4888777542     2244667889999999999999999   9999999999


Q ss_pred             CEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCC-CCch-h
Q 001384          938 NVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE-GGEE-C 1015 (1088)
Q Consensus       938 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~-~~~~-~ 1015 (1088)
                      |||++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++. .... .
T Consensus       297 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9999999999999999998775443333345679999999999999899999999999999999999886543 2221 1


Q ss_pred             HHHHHHhhhccCCCC-CCc----cccchh---hcCCCccc------cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1016 LVEWGRRVMGYGRHG-PGR----AVIPVV---LLGSGLAE------GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1016 ~~~~~~~~~~~~~~~-~~~----~~~~~~---~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..+............ ...    ...+..   ........      ......++.+++.+|++.||.+||++.|+++
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111111000000 000    000000   00000000      0011235677888999999999999999986

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=7.9e-32  Score=298.80  Aligned_cols=248  Identities=28%  Similarity=0.420  Sum_probs=202.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCC-CCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWP-HPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~-h~niv~l~~~~~~~~~  879 (1088)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|++.....   ...+.+..|.+++++    +. ||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~----l~~~~~i~~~~~~~~~~~~   76 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR----LNGHPGIIKLYYTFQDEEN   76 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHh----cccCCCchhHHHHhcCCce
Confidence            46888999999999999999976 689999999876432   223567888888886    45 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++.+...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999999999888899999999999999999999998   99999999999999999999999999988664


Q ss_pred             CCCC-------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          960 AGDS-------------------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       960 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                      ....                   .......++..|+|||......++.++||||+|++++++++|+.||........ . 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-  231 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F-  231 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H-
Confidence            3221                   112234578899999998888899999999999999999999999987643111 1 


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH----HHHHH
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV----KEVLA 1078 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~ 1078 (1088)
                      .....      ..           ...+......+.+++.+|++.+|.+||++    +++++
T Consensus       232 ~~~~~------~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 QKILK------LE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHh------cC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11110      00           01112234678899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=2.7e-31  Score=296.81  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=194.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|++|.||+|.++ +++.||+|++.....  .....+.+|++++++    ++||||+++++++.++...+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   77 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE----MQHGNIVRLQDVVHSEKRLY   77 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHh----ccCCCEeeEEEEEecCCeEE
Confidence            46889999999999999999976 688999999875432  223567889999986    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceee
Q 001384          882 LVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVV  958 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~  958 (1088)
                      +||||++ ++|.+++....  .+++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+|++|||++...
T Consensus        78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            9999996 48888876543  357888899999999999999999   9999999999999985 567999999999765


Q ss_pred             cCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh--hccCCCC--CCc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV--MGYGRHG--PGR 1033 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~ 1033 (1088)
                      .... .......++..|+|||.+.+ ..++.++||||+|+++|+|+||+.||....+.. +.....  .......  ...
T Consensus       154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        154 GIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             CCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhcccc
Confidence            3221 11223456889999998765 467899999999999999999999998654321 111110  0000000  000


Q ss_pred             -------cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 -------AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ...+................++.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000000000000001123456788999999999999999999975

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=9.4e-32  Score=306.24  Aligned_cols=271  Identities=24%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      ..+|.+.+.||+|+||+||+|++. +++.||||++....  ......+..|+.+++.    ++||||+++++++...   
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH----LDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHh----cCCCCccchHHheeccccc
Confidence            457999999999999999999975 68999999987532  2233466789998886    6799999999987654   


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 --SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                        ...++||||+. ++|.+++....++++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence              35799999996 69999998888899999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCC-----
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGR----- 1028 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~----- 1028 (1088)
                      +...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.+.+.. .............     
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            8764332 22234567889999997654 46889999999999999999999999765321 0000000000000     


Q ss_pred             ---CCCCccccch---hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HHhh
Q 001384         1029 ---HGPGRAVIPV---VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM--LIKI 1083 (1088)
Q Consensus      1029 ---~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~i 1083 (1088)
                         ..........   ...............++.+++.+|++.+|++||+++|+++.  ++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               0000000000   00000000112344678899999999999999999999865  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.6e-31  Score=297.81  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=192.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +|+..+.||+|+||.||++.+. +++.||+|++..... .....+..|+.++.+..   .||||+++++++..+...+++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS---DCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc---CCCCEeeeeeEEecCCcEEEE
Confidence            3455688999999999999975 689999999875432 33456888988887632   599999999999999999999


Q ss_pred             EEecCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          884 YEYMEGGSLEDIIS-----DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      |||++. ++.++..     ....+++..+..++.|++.||+|||+.+  +++||||||+||+++.++.++|+|||+++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            999864 6655432     2356999999999999999999999743  8999999999999999999999999998765


Q ss_pred             cCCCCcccccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTW---QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ....  ......++..|+|||.+.+.   .++.++||||+|+++|||++|+.||....... +.......  . ..    
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~--~-~~----  228 (288)
T cd06616         159 VDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLTQVVK--G-DP----  228 (288)
T ss_pred             ccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHhhhcC--C-CC----
Confidence            4221  22334578899999988765   68999999999999999999999997643211 11111110  0 00    


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       + ...   .........++.+++.+|++.||++||+++||++.
T Consensus       229 -~-~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 -P-ILS---NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -C-cCC---CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0 000   00112345678899999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=2.3e-31  Score=295.77  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +|++.+.||+|++|.||+|++. +|+.||||++...... ....+.+|++++++    ++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE----LKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHh----hcCCCEeeeeeeEeeCCcEEEE
Confidence            4788899999999999999986 6889999999765322 34567789999986    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          884 YEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |||+++ +|.+++...   ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++++|||++.....
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            999985 899988654   3589999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh--hhccCCC--------
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR--VMGYGRH-------- 1029 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~-------- 1029 (1088)
                      ... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.... ......  .......        
T Consensus       153 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         153 PVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             Ccc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhc
Confidence            211 1223456789999997755 45788999999999999999999999865321 111000  0000000        


Q ss_pred             -CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 -GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       .......+...........+.....+.+++.+|++.||++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             0000000000000000001223467889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=2.6e-31  Score=298.24  Aligned_cols=269  Identities=25%  Similarity=0.283  Sum_probs=197.9

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++....  .....+.+|++++++    ++|||++++++++.+..
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~----l~h~~i~~~~~~~~~~~   79 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ----LNHRNIVNLKEIVTDKQ   79 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHh----CCCCCeeeeeheecCcc
Confidence            34568999999999999999999986 588999999975432  223567789998886    67999999999987654


Q ss_pred             ----------eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          879 ----------EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       879 ----------~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                                ..++|+||+++ ++.+.+... ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                      78999999986 777777653 4689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhc
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMG 1025 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~ 1025 (1088)
                      ||+|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.. ..........
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999998765433222233456778999997654 45789999999999999999999999865431 1111111110


Q ss_pred             cCCCCCCccc--------cchhhc--CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAV--------IPVVLL--GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..........        .+....  ..........+..+.+++.+|++.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000000        000000  0000001112457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=301.38  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=167.3

Q ss_pred             CCCccceecccCceEEEEEEeCC---CcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      +|++.+.||+|+||.||+|..+.   ++.||+|.+....   ......+.+|+.++..    ++||||+++++++.+.  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE----LKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHh----cCCCCccceEEEEeCCCC
Confidence            47888999999999999999754   7899999998743   2233567789998886    6799999999999988  


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC----CCCEE
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK----EGKAL  948 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~----~~~~k  948 (1088)
                      ...++||||+++ ++.+++...     ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.    ++.+|
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            889999999975 777766432     2588999999999999999999999   9999999999999999    99999


Q ss_pred             EeecccceeecCCCC--cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCc
Q 001384          949 VTDFGLARVVSAGDS--HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGE 1013 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~ 1013 (1088)
                      ++|||++........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            999999886543222  11233567889999997655 467899999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=7.6e-31  Score=296.17  Aligned_cols=245  Identities=28%  Similarity=0.391  Sum_probs=194.9

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |+..+.||+|+||.||+|++. ++..||+|++......   ...++..|+++++.    ++|||++++++++.++...++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR----IKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHh----CCCCCEEEEEEEEeeCCeEEE
Confidence            677789999999999999965 6889999998754222   23467889999886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ ++.+.+.. ..++++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++..... 
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            9999975 88877754 55689999999999999999999999   999999999999999999999999998865432 


Q ss_pred             CCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                          .....++..|+|||++.   ...++.++|||||||++|||++|+.||........ ...... ...          
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~-~~~----------  241 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ-NES----------  241 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHh-ccC----------
Confidence                22345788999999863   45789999999999999999999999976533111 111110 000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                           ...........+.+++.+|++.+|.+||++.|+++...
T Consensus       242 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 -----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                 00011223456888999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=6.3e-31  Score=292.76  Aligned_cols=264  Identities=29%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe----
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE----  879 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~----  879 (1088)
                      |++.+.||+|+||.||+|+++ +++.||+|++......  ....+.+|+.++.++. .+.|||++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE-SFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhh-ccCCCCcceEEEEEeeccCCCCc
Confidence            567889999999999999987 4899999999754222  1235667777776543 3579999999999988776    


Q ss_pred             -EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          880 -KILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       880 -~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       .+++|||+++ +|.++++...  .+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||.+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence             8999999975 8999887643  589999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC----CC
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PG 1032 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 1032 (1088)
                      ......  ......++..|+|||...+..++.++||||||+++|||++|+.||.+..+. ....+.........    ..
T Consensus       156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence            764322  122335788999999998888999999999999999999999999865431 11111110000000    00


Q ss_pred             c-----cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 R-----AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .     ...+.................+.+++.+|++.||.+||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0     000000000001111233467789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=4.6e-31  Score=295.10  Aligned_cols=252  Identities=25%  Similarity=0.434  Sum_probs=193.8

Q ss_pred             CCCCccceecccCceEEEEEEeCC-CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|.+++ ++.||||++..... .....+..|+.++.+.   ..||||+++++++.++...++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~---~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc---cCCCchHhhheeeecCCeEEE
Confidence            568889999999999999999874 89999999976432 2334556677666542   369999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ ++.+++.. ...+++..+..++.|++.|++|||+.+  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9999954 78877755 457899999999999999999999742  8999999999999999999999999998765432


Q ss_pred             CCcccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQ----ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ..  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||....... +..........  .   ..+
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~--~---~~~  240 (296)
T cd06618         169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEEP--P---SLP  240 (296)
T ss_pred             Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcCCC--C---CCC
Confidence            21  22335778999999887543    7889999999999999999999997643221 11111110000  0   000


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                               .......++.+++.+|++.||.+||++.++++.
T Consensus       241 ---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 ---------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     011234578899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.1e-31  Score=301.04  Aligned_cols=266  Identities=22%  Similarity=0.277  Sum_probs=196.8

Q ss_pred             CCCCc-cceecccCceEEEEEEeC-CCcEEEEEEccccCccc--------------hHHHHHHHHHHhCCCCCCCCCcee
Q 001384          805 GKFSE-DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG--------------EREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       805 ~~~~~-~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      ++|.. .+.||+|+||+||+|.++ +++.||||++.......              ...+.+|+++++.    ++||||+
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv   83 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE----IKHENIM   83 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHh----CCCccee
Confidence            45653 577999999999999976 68999999987543221              1247789999886    6799999


Q ss_pred             EEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          869 TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       869 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                      ++++++..+...++||||++ |+|.+++.....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            99999999999999999997 59999998888899999999999999999999998   999999999999999999999


Q ss_pred             EeecccceeecCCC-------------CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          949 VTDFGLARVVSAGD-------------SHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      ++|||.+.......             ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||.+.++
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654111             0111223467789999987653 478999999999999999999999987644


Q ss_pred             h-HHHHHHhhhccCCCC--CCcc------ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1015 C-LVEWGRRVMGYGRHG--PGRA------VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1015 ~-~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      . ...............  ....      ...................++.+++.+|++.+|++||+++|++.
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1 111111111000000  0000      00000000000001122456889999999999999999999985

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=4.7e-31  Score=297.36  Aligned_cols=267  Identities=23%  Similarity=0.296  Sum_probs=193.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      .++|++.+.||+|+||.||+|... +++.||||++......  ....+.+|++++++    ++||||+++++++....  
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL----LKHENVVNLIEICRTKATP   86 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHh----CCCCCccceEEEEeccccc
Confidence            357999999999999999999976 6899999998654222  23456778998886    67999999999987654  


Q ss_pred             ------eEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          879 ------EKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       879 ------~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                            ..++||||+.+ +|.+++.... .+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence                  45999999965 8888876543 689999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCc---ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhc-
Q 001384          952 FGLARVVSAGDSH---VSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMG- 1025 (1088)
Q Consensus       952 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~- 1025 (1088)
                      ||.+..+......   ......++..|+|||...+. .++.++||||+|+++|||++|+.||.+..... ......... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999866433221   12234567889999976553 47889999999999999999999998754311 111111100 


Q ss_pred             cCCC--CCC--ccccchh-hcCCCcc------ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRH--GPG--RAVIPVV-LLGSGLA------EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~--~~~--~~~~~~~-~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....  ...  ....... .......      ........+.+++.+|++.||++||+++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000  000  0000000 0000000      00011245678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-34  Score=332.86  Aligned_cols=459  Identities=28%  Similarity=0.352  Sum_probs=328.9

Q ss_pred             eEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCc-ccCCCCCCCceeecccc
Q 001384           81 VNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD-LNLSGLRSLEILDLSVN  159 (1088)
Q Consensus        81 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~N  159 (1088)
                      ++.|+++.|-+-...-+...+.-.|+.|||++|.+. ..|..+..+.+|+.|+++.|.|... .+..++++|++|.|.+|
T Consensus        23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n  101 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNN  101 (1081)
T ss_pred             HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccc
Confidence            677888777654422233334445999999999997 8888999999999999999998864 46788899999999999


Q ss_pred             cccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCccccccccccc
Q 001384          160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV  239 (1088)
Q Consensus       160 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  239 (1088)
                      ++. ..|.++. .+.+|++|++++|++. .+|..+..++.+..+..++|.... .                         
T Consensus       102 ~l~-~lP~~~~-~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~-~-------------------------  152 (1081)
T KOG0618|consen  102 RLQ-SLPASIS-ELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ-R-------------------------  152 (1081)
T ss_pred             hhh-cCchhHH-hhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh-h-------------------------
Confidence            887 4555553 3478999999999988 456678899999999999982110 0                         


Q ss_pred             ccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCc
Q 001384          240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE  319 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  319 (1088)
                      ++.. .++.++|..|.+.+.++..+.+++.  .|+|++|++.   -..+..+.+|+.|....|++....    -..++|+
T Consensus       153 lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~  222 (1081)
T KOG0618|consen  153 LGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLT  222 (1081)
T ss_pred             hccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchh
Confidence            1111 2677788888888888888887776  7999999887   235677888999999999876541    2346899


Q ss_pred             EEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecccc
Q 001384          320 VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHN  399 (1088)
Q Consensus       320 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  399 (1088)
                      .|+.++|.++...+.                           ..-.+|+++++++|+++ .+|.+++.+.+|+.|...+|
T Consensus       223 ~L~a~~n~l~~~~~~---------------------------p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N  274 (1081)
T KOG0618|consen  223 ALYADHNPLTTLDVH---------------------------PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHN  274 (1081)
T ss_pred             eeeeccCcceeeccc---------------------------cccccceeeecchhhhh-cchHHHHhcccceEecccch
Confidence            999999988732211                           12247889999999998 57788899999999999999


Q ss_pred             ccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccc-cCCCC-CCeEEccCCcCccCC
Q 001384          400 RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI-GNCTS-LLWLNLSNNKLSGNI  477 (1088)
Q Consensus       400 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~-L~~L~L~~N~l~g~i  477 (1088)
                      +|+ .+|..+..+++|+.|++.+|.+. .+|+...++++|++|+|..|+|. .+|+.+ .-+.. |+.|+.+-|++. ..
T Consensus       275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~l  350 (1081)
T KOG0618|consen  275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TL  350 (1081)
T ss_pred             hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-cc
Confidence            997 88888888999999999999998 78888888999999999999997 566543 33322 677777888776 44


Q ss_pred             Cchh-hccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCC
Q 001384          478 PPEV-MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGL  556 (1088)
Q Consensus       478 p~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~  556 (1088)
                      |..- .....++.+.+.+|++                                                   .-.|+|.+
T Consensus       351 p~~~e~~~~~Lq~LylanN~L---------------------------------------------------td~c~p~l  379 (1081)
T KOG0618|consen  351 PSYEENNHAALQELYLANNHL---------------------------------------------------TDSCFPVL  379 (1081)
T ss_pred             ccccchhhHHHHHHHHhcCcc---------------------------------------------------cccchhhh
Confidence            4110 0111111222222221                                                   12222222


Q ss_pred             cccceeeeceEEccCCccccccCc-ccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCcc
Q 001384          557 ASRTFQITGYLQLSGNQLSGELSP-DIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKC  634 (1088)
Q Consensus       557 ~~~~~~~l~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~  634 (1088)
                      .  .+..|+.|+|++|+|. ++|. .+.+|..|++|+||+|+|+ .+|+.+..+ .|++|...+|++. .+| ++..+++
T Consensus       380 ~--~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q  453 (1081)
T KOG0618|consen  380 V--NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ  453 (1081)
T ss_pred             c--cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence            2  2345667788888887 4554 5677778888888888887 677777766 5777777888887 777 7778888


Q ss_pred             CcEEEccccccCC-cCCcccccccccceeeccCCCC
Q 001384          635 LQNLDLSYNNFSG-PFPASFNNLTELSKLNISYNPL  669 (1088)
Q Consensus       635 L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l  669 (1088)
                      |+.+|||.|+|+- .+|...-. ++|++|||++|..
T Consensus       454 L~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  454 LKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             ceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            8888888888753 34443322 7788888888864

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.8e-31  Score=293.04  Aligned_cols=262  Identities=25%  Similarity=0.293  Sum_probs=199.7

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      |++.+.||+|++|.||+|... +++.+|+|++......  ....+..|++++++    ++|+||+++++++.++...++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE----LNHPNIIKLLDVFRHKGDLYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHH----hcCCCcchHHHhhccCCCEEEE
Confidence            567789999999999999975 6889999998765322  34577889999886    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++ ++.+++... ..+++.++..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            999976 888887663 5789999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC--CCCCccc----
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR--HGPGRAV---- 1035 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~---- 1035 (1088)
                       .......++..|+|||...+. .++.++||||+|+++|+|++|+.||...+. ..+..........  .......    
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhh
Confidence             122334577889999987766 789999999999999999999999976543 1111111100000  0000000    


Q ss_pred             ------cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 ------IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .+................++.+++.+|+++||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  0000000000012234568899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.5e-31  Score=302.99  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=197.9

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCC-CCCceeEEeeEEecC-
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGW-PHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l-~h~niv~l~~~~~~~-  877 (1088)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++....  ......+..|+.++.+    + +||||+++++++... 
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~----l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE----LGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHH----hcCCCCccceeeeeccCC
Confidence            3567899999999999999999976 68899999886532  2233457789998887    5 799999999988653 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||+++ +|.++++.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.
T Consensus        81 ~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          81 DKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             CceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence             468999999974 999998776 789999999999999999999998   99999999999999999999999999998


Q ss_pred             eecCCCCc----ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC-
Q 001384          957 VVSAGDSH----VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG- 1030 (1088)
Q Consensus       957 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 1030 (1088)
                      ........    ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..+.. ...+......... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~  234 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence            76443221    2234568889999997644 567899999999999999999999997653311 1110000000000 


Q ss_pred             ---------CCccccchhhcCCC---ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1031 ---------PGRAVIPVVLLGSG---LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1031 ---------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                               ......+.......   .........++.+++.+|++.||++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                     00000000000000   00011134678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-31  Score=302.74  Aligned_cols=269  Identities=25%  Similarity=0.287  Sum_probs=205.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----  878 (1088)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.    ++||||+++++++....    
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~i~~~~~~~~~~~~~~~   76 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRH----LRHENIIGLLDILRPPSPEDF   76 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHh----cCCcchhhhhhhhcccCcccc
Confidence            5888999999999999999976 58999999987653  3344678889999987    67999999999988775    


Q ss_pred             -eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 -EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                       ..|+||||+++ +|.+++++..++++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        77 ~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          77 NDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             cceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence             78999999975 8999998888899999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCC--cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC--
Q 001384          958 VSAGDS--HVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG-- 1032 (1088)
Q Consensus       958 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1032 (1088)
                      ......  .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.+....  +..............  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEED  230 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhH
Confidence            654321  122345678899999998877 8899999999999999999999999876431  111111100000000  


Q ss_pred             -----ccccchhhc--CCCc-----cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH--HHhhC
Q 001384         1033 -----RAVIPVVLL--GSGL-----AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM--LIKIL 1084 (1088)
Q Consensus      1033 -----~~~~~~~~~--~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~i~ 1084 (1088)
                           .........  ....     .........+.+++.+|++.+|++||++.++++.  ++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                 000000000  0000     0011234678899999999999999999999873  55543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=8.2e-31  Score=295.90  Aligned_cols=261  Identities=21%  Similarity=0.221  Sum_probs=190.2

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      .+.+|.|+++.||++.. +++.||||++....  ....+.+..|++++++    ++||||+++++++.+....+++|||+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~----l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ----LQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHh----cCCcchhhhhheeecCCeEEEEEecc
Confidence            34445555555555554 68999999987652  2334578899999987    67999999999999999999999999


Q ss_pred             CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-
Q 001384          888 EGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-  964 (1088)
Q Consensus       888 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  964 (1088)
                      ++|+|.++++..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+......... 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999763  4589999999999999999999999   9999999999999999999999999988765432211 


Q ss_pred             -----ccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC--CCC----
Q 001384          965 -----VSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR--HGP---- 1031 (1088)
Q Consensus       965 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~---- 1031 (1088)
                           ......++..|+|||++..  ..++.++||||+||++|||++|+.||...................  ...    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence                 1123456778999998765  358899999999999999999999998654322111111000000  000    


Q ss_pred             ----Cc-----cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 ----GR-----AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ----~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ..     ....................++.+++.+||+.||++||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                00     000000000011112233457889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-31  Score=293.16  Aligned_cols=262  Identities=25%  Similarity=0.315  Sum_probs=195.2

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCC-CCceeEEeeEEecCCeEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWP-HPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~-h~niv~l~~~~~~~~~~~lv  883 (1088)
                      |++.+.||+|++|+||+|+.. +++.||+|++...... ......+|+..+.+    ++ |||++++++++.+++..++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~----~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRK----LNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHh----ccCCCCchhHHHHhhcCCcEEEE
Confidence            567889999999999999976 5788999998765322 22344567887775    56 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+ +|+|.+++....  .+++.++..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            9999 779999987765  789999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh-hhccCC----------C
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR-VMGYGR----------H 1029 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~----------~ 1029 (1088)
                      .  ......++..|+|||++. ...++.++||||||++++||++|+.||.........+... ......          .
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         153 P--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             C--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            2  223345788999999764 4567899999999999999999999997654311111100 000000          0


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......+................++.+++.+|++.||++||+++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000000000001112467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=305.38  Aligned_cols=270  Identities=30%  Similarity=0.395  Sum_probs=205.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-----
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-----  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-----  878 (1088)
                      .|...+.||+|+||.||+|+.+ +|+.||||.+.... ....+.+..|++++++    ++|+|||++++.-.+..     
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkK----Lnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKK----LNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHH----cCchhhhhhcccCCccccCccc
Confidence            3455688999999999999955 79999999998754 3445678899999997    67999999999765443     


Q ss_pred             -eEEEEEEecCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCC--CEEEe
Q 001384          879 -EKILVYEYMEGGSLEDIISDR---TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD--KEG--KALVT  950 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~--~~~--~~kl~  950 (1088)
                       ...+|||||.||+|+..+++.   ..+++.+.+.+..+++.||.|||++   +||||||||.||++-  ++|  ..||+
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence             568999999999999999763   4699999999999999999999998   999999999999984  334  47999


Q ss_pred             ecccceeecCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh----HHHHHHhhhc
Q 001384          951 DFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEEC----LVEWGRRVMG 1025 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~----~~~~~~~~~~ 1025 (1088)
                      |||.|+.+..+  ......+||..|.+||.+. ...|+..+|.|||||++|+++||..||......    -..|.....+
T Consensus       167 DfG~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk  244 (732)
T KOG4250|consen  167 DFGAARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK  244 (732)
T ss_pred             cccccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence            99999987643  3677889999999999888 489999999999999999999999999765331    1222221110


Q ss_pred             cC-------CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC--CHHHHHHHHHhhCC
Q 001384         1026 YG-------RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP--NVKEVLAMLIKILP 1085 (1088)
Q Consensus      1026 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~i~~ 1085 (1088)
                      -.       ....+.-.....+ ...-.........+..++..++..+|++|-  .+.+....+..|+.
T Consensus       245 p~~v~i~~~~~eNgpv~~s~~l-P~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  245 PSGVAIGAQEEENGPVEWSSTL-PQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             CCceeEeeecccCCceeeeccC-CCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            00       0000000000000 001112344556777888889999999999  77777777777653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=299.63  Aligned_cols=240  Identities=27%  Similarity=0.334  Sum_probs=195.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++.|.....+|.|+|+.|-.+.+. +++..+||++.+..    .+..+|+.++...+   .|||++++.+++.+..+.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~---~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVR---DHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhc---CCCcceeecceecCCceeee
Confidence            677888889999999999999965 68899999998762    22344555555433   79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-cCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll-~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||.+.|+-+.+.+....... .++..|+.+|+.|+.|||++   |||||||||+|||+ ++.++++|+|||.++.....
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999998888876665555 88889999999999999999   99999999999999 59999999999999876543


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                          ....+-|..|.|||+.....|++++||||+|++||+|++|+.||...... .+...++. .+.             
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~-~~~-------------  530 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ-MPK-------------  530 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc-CCc-------------
Confidence                33446788999999999999999999999999999999999999876543 12111111 111             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .   .........+++.+|++.||.+||++.++..
T Consensus       531 --~---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 --F---SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --c---ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              0   1233456778888999999999999999864

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.3e-30  Score=295.85  Aligned_cols=261  Identities=20%  Similarity=0.279  Sum_probs=189.4

Q ss_pred             ceeccc--CceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKG--GFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      ..||+|  +||+||+|++. +|+.||+|++......  ..+.+.+|+.++..    ++||||+++++++..++..++|||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~----l~h~niv~~~~~~~~~~~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHF----FRHPNIMTSWTVFTTGSWLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCcceEeeeEecCCceEEEEe
Confidence            456666  99999999975 7899999998754322  23567788888775    689999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          886 YMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |+.++++.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            99999999998764  3489999999999999999999998   999999999999999999999999986543321111


Q ss_pred             cc------cccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC------
Q 001384          964 HV------STTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH------ 1029 (1088)
Q Consensus       964 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1029 (1088)
                      ..      .....++..|+|||++.+  ..++.++||||+||++|||++|+.||....................      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            00      111234567999998865  3578999999999999999999999986533111110000000000      


Q ss_pred             ------------CCCccccchh--------h--cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 ------------GPGRAVIPVV--------L--LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ------------~~~~~~~~~~--------~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                  .......+..        .  .....+........+.+++.+|++.||++||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                        0000000000        0  00011112345678899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=7.8e-32  Score=273.29  Aligned_cols=201  Identities=27%  Similarity=0.390  Sum_probs=169.3

Q ss_pred             CCCCccceecccCceEEEEEEeCC-----CcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-----GREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-  876 (1088)
                      ..|+....||+|.||.||+|..++     .+.+|+|+++....  .-....-+|+..++.    ++|||++.+..++.+ 
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~RE----l~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRE----LKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHH----hcCCcchhHHHHHhcc
Confidence            468899999999999999997432     33799999986522  223456789999887    689999999999987 


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CCE
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR-----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE----GKA  947 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~----~~~  947 (1088)
                      +...++++||.+. +|...|+-+     ..++...+..|..||+.|+.|||+.   =|+||||||.||||..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            8889999999988 999988643     3589999999999999999999999   59999999999999977    899


Q ss_pred             EEeecccceeecCCCCc--ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCc
Q 001384          948 LVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGE 1013 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~ 1013 (1088)
                      ||+|||+++.+...-..  ....++-|..|.|||.+. ...|+.+.||||.|||+.||+|-++.|.+.+
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999988654322  234577899999999655 5689999999999999999999999887753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-33  Score=275.43  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=194.9

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEec
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYM  887 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~  887 (1088)
                      ...||.|+||+|+|-.++ .|+..|||+++.... ..++++..|.+...+.   -+.||||++||.+..++..|+-||.|
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks---~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS---SNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh---cCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            467999999999999976 799999999997755 3456788888876653   48999999999999999999999999


Q ss_pred             CCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          888 EGGSLEDIIS-----DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       888 ~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      +- ++..+-+     ....+++.-+-.|+...+.||+||-+..  .|||||+||+|||++..|.+|++|||.+-.+.  +
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--~  220 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--D  220 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH--H
Confidence            54 7665432     3456999999999999999999999875  89999999999999999999999999986553  2


Q ss_pred             CcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      +...+.-+|...|||||.+...  .|+.++||||+|+++||+.||..|+.+......+......  +.   .     +.+
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gd---p-----p~l  290 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GD---P-----PIL  290 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CC---C-----Cee
Confidence            3333445688899999987643  5899999999999999999999999887553333222221  11   0     011


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...  .........+.++|.-|+.+|-..||.+.++.+
T Consensus       291 ~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  291 LFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            000  011234567888999999999999999999865

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.9e-31  Score=299.16  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      ..+|...+.||+|+||.||+|++. +|+.||||++.+...  .....+.+|+++++.    +.||||+++++++...   
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH----MQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHh----cCCCCccchhheecccccC
Confidence            478999999999999999999975 689999999875421  223467889999986    6799999999998754   


Q ss_pred             ---CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          878 ---SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       878 ---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                         ...++|+||+.. +|.++..  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence               346899999965 7877653  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC---
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG--- 1030 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 1030 (1088)
                      ++....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+.......+...   
T Consensus       164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         164 ARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence            875432    1223467889999998765 46889999999999999999999999875431 11111110000000   


Q ss_pred             -------CCccc---cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHHhhC
Q 001384         1031 -------PGRAV---IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA--MLIKIL 1084 (1088)
Q Consensus      1031 -------~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~i~ 1084 (1088)
                             .....   .+...........+.....+.+++.+|++.||++||+++|++.  .++.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                   00000   0000000000000122356789999999999999999999984  466553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=3.2e-30  Score=290.46  Aligned_cols=242  Identities=29%  Similarity=0.406  Sum_probs=191.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      |...+.||+|+||+||+|++. +++.||+|++......   ....+..|+++++.    ++|||++++++++.+....|+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ----LKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHh----CCCCCCccEEEEEEeCCEEEE
Confidence            566678999999999999975 6889999998754322   22467789998886    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+. |++.+++.. ..++++.+++.++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++..... 
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            999996 488887754 45689999999999999999999999   999999999999999999999999998864321 


Q ss_pred             CCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                          .....++..|+|||++.   ...++.++||||||+++|+|++|..||.........  ........        +.
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~--------~~  239 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNDS--------PT  239 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCC--------CC
Confidence                22356788999999874   456889999999999999999999999765431111  11110000        00


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .       ........+.+++.+|++.+|.+||++.|+++
T Consensus       240 ~-------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         240 L-------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             C-------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0       01122345788999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.9e-31  Score=287.91  Aligned_cols=246  Identities=25%  Similarity=0.367  Sum_probs=193.7

Q ss_pred             CCCccceecccCceEEEEEEeCC-CcEEEEEEccccC-----ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREG-----LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +|.+.+.||+|+||.||+|++.. +..+++|.++...     .....++..|+.+++.    ++||||+++++++.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK----LDHPAIVKFHASFLERDA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHh----CCCCcHHHHHHHHhcCCc
Confidence            58888999999999999999753 4456666655321     1223356678888876    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          880 KILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      .++||||+++++|.+++..    ...+++.+++.++.|++.|++|||+.   +++|+||+|+||+++. +.++++|||.+
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCce
Confidence            9999999999999998864    34689999999999999999999998   9999999999999975 66999999998


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ....... .......++..|+|||......++.++||||+|+++|+|++|..||.....  .........          
T Consensus       153 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~----------  219 (260)
T cd08222         153 RLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIVE----------  219 (260)
T ss_pred             eecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHc----------
Confidence            7764322 223345678899999998888889999999999999999999999975432  111111110          


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            +.....+.....++.+++.+|++.+|++||++.|+++
T Consensus       220 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 ------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                  0111113344567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.5e-30  Score=292.52  Aligned_cols=245  Identities=28%  Similarity=0.390  Sum_probs=193.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|...+.||+|+||.||+|++. +++.||+|.+.....   ....++.+|+++++.    ++|+|++++++++......+
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK----LRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHh----CCCCCcccEEEEEEcCCeeE
Confidence            4666788999999999999975 678899999864322   223467789998886    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+. |++.+++.. ..++++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9999996 588887754 45689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      .     ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||..........  .......        +
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~--------~  232 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNES--------P  232 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhhcCC--------C
Confidence            2     2345788999999864   4567889999999999999999999987643311111  1110000        0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                             ..........+.+++.+|++.+|++||++.++++.-
T Consensus       233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                   001123445688899999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=8.4e-31  Score=295.43  Aligned_cols=267  Identities=25%  Similarity=0.330  Sum_probs=193.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      .++|++.+.||+|+||.||+|+++ +++.+|+|++......  ....+.+|+++++.    ++||||+++++++.+..  
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKK----LKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHh----cCCCCccchhhheeccccc
Confidence            468999999999999999999976 6889999998654322  23456789999886    67999999999875433  


Q ss_pred             ------eEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          879 ------EKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       879 ------~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                            ..++||||+++ ++...+.. ...+++.++..++.|+++||+|||++   +|+||||||+||++++++.++++|
T Consensus        83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence                  46999999975 77777654 44799999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCc----------ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHH
Q 001384          952 FGLARVVSAGDSH----------VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEW 1019 (1088)
Q Consensus       952 fg~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~ 1019 (1088)
                      ||+++........          ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+..... .+-
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999765432211          1123456788999997654 468899999999999999999999998654411 000


Q ss_pred             HHhhhcc--CCCCCCccccch----hhcCCCccc----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1020 GRRVMGY--GRHGPGRAVIPV----VLLGSGLAE----GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1020 ~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......  ..........+.    .........    .......+.+++.+|++.||++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0000000  000000000000    000000000    0112256889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=280.74  Aligned_cols=274  Identities=22%  Similarity=0.244  Sum_probs=204.9

Q ss_pred             cCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCC-CC-CceeEEe
Q 001384          795 FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW-PH-PNLVTLY  871 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l-~h-~niv~l~  871 (1088)
                      +-+......+++|.+...+|+|.||.|-++.++ .+..||||+++.- ....+..+-|++++.++.... .. --+|.+.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            334434445889999999999999999999976 4689999999864 233455677888888764221 11 1378899


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC------
Q 001384          872 GWCLDGSEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK------  943 (1088)
Q Consensus       872 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~------  943 (1088)
                      +||...++.|+|+|.+ |-+++|++..+.  +++...++.|+.|++++++|||+.   +++|.||||+||++.+      
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            9999999999999999 559999998765  688999999999999999999999   9999999999999942      


Q ss_pred             --------------CCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCC
Q 001384          944 --------------EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009 (1088)
Q Consensus       944 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~ 1009 (1088)
                                    +..+|++|||.|+.-..    .....+.|..|.|||++.+-.++.++||||+||||+|+.||...|
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                          33689999999986432    235677899999999999999999999999999999999999999


Q ss_pred             CCCch--hHHHHHHhhh-ccCCCCCCcc-----------c---------cchhhcCCC-----ccccHHHHHHHHHHHhh
Q 001384         1010 EGGEE--CLVEWGRRVM-GYGRHGPGRA-----------V---------IPVVLLGSG-----LAEGAEEMSELLRIGVR 1061 (1088)
Q Consensus      1010 ~~~~~--~~~~~~~~~~-~~~~~~~~~~-----------~---------~~~~~~~~~-----~~~~~~~~~~l~~li~~ 1061 (1088)
                      +..+.  .+ .-..++. +.+.....+.           .         .......+.     ......+..++++++.+
T Consensus       310 qtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  310 QTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             ccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            87652  11 1111111 0000000000           0         000000000     01234556689999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 001384         1062 CTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1062 cl~~dP~~RPs~~eil~ 1078 (1088)
                      |+..||.+|+|+.|++.
T Consensus       389 mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  389 MLEFDPARRITLREALS  405 (415)
T ss_pred             HHccCccccccHHHHhc
Confidence            99999999999999975

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=276.48  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=214.6

Q ss_pred             CHHHHHHHcCCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCccch-HHHHHHHHHHhCCCCCCCCCcee
Q 001384          796 TYSDILKATGKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       796 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      ...++.....+++...++-+|.||.||.|.+++      .+.|-||.++....+-+ ..+..|.-.+..    ..|||+.
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~----~sH~nll  350 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYG----ASHPNLL  350 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhc----CcCCCcc
Confidence            345566666788888999999999999998753      34577888876543333 346677666665    5799999


Q ss_pred             EEeeEEecC-CeEEEEEEecCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          869 TLYGWCLDG-SEKILVYEYMEGGSLEDIISDR--------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       869 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      ++.+++.++ ...+.++.++.-|+|..++...        ..++..+...++.|++.|++|||+.   +|||.||.++|+
T Consensus       351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC  427 (563)
T KOG1024|consen  351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC  427 (563)
T ss_pred             ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence            999998765 4567889999999999999721        2378889999999999999999999   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCcccc-cccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 1017 (1088)
                      +||+.-++|++|=.+++.+.+.+.+-.. .-..+..||+||.+....|+.++|||||||++|||+| |+.|+..-++..+
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence            9999999999999999988877766432 3345779999999999999999999999999999998 8889876554222


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      +                  .-...|.+...|-.++.+++.++.-||..+|++||++++++.-|.+.
T Consensus       508 ~------------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  508 E------------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             H------------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            1                  12234556667888999999999999999999999999999888765

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=7.4e-31  Score=299.42  Aligned_cols=266  Identities=24%  Similarity=0.280  Sum_probs=194.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-----  877 (1088)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++    ++||||+++++++...     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~----l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR----LDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHh----cCCCcchhhHhhhcccccccc
Confidence            368999999999999999999975 688999999877655556778899999986    6799999999876543     


Q ss_pred             ---------CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCE
Q 001384          878 ---------SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKA  947 (1088)
Q Consensus       878 ---------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~  947 (1088)
                               ...++||||++ ++|.+++.. .++++..++.++.|++.||+|||+.   +|+||||||+||+++ +++.+
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                     35789999997 499988864 4689999999999999999999999   999999999999998 45678


Q ss_pred             EEeecccceeecCCCCcc--cccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH-hh
Q 001384          948 LVTDFGLARVVSAGDSHV--STTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR-RV 1023 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~~ 1023 (1088)
                      |++|||.++.........  .....++..|+|||.+. +..++.++|||||||++|+|++|+.||.+..+....-.. ..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999998654321111  12235788999999754 456888999999999999999999999865431110000 00


Q ss_pred             hccCCCCC---Cccccchhhc--CCCccc-----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1024 MGYGRHGP---GRAVIPVVLL--GSGLAE-----GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1024 ~~~~~~~~---~~~~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........   .....+....  ......     ......++.+++.+|++.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000000   0000000000  000000     1123356888999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=289.19  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=198.4

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|++++++    ++|+|++++++++.+....++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~----~~~~~i~~~~~~~~~~~~~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE----LKHPNIVKLLDVIHTERKLYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHh----cCCCCHHHHHhhhhcCCceEEE
Confidence            566788999999999999976 58999999998753  2234567889999886    5799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||++ ++|.+++... ..+++.++..++.|++.|++|||++   +|+||||+|+||++++++.++|+|||.++......
T Consensus        77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            99998 4999999876 5799999999999999999999999   99999999999999999999999999987654322


Q ss_pred             CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCC---------CCC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGR---------HGP 1031 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~---------~~~ 1031 (1088)
                      . ......++..|+|||.+... .++.++||||+|+++|||++|+.||...... .............         ...
T Consensus       153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence            1 22233457789999987666 8899999999999999999999999765321 1011000000000         000


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....+.................+.+++.+|++.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00001100000000001122467899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.5e-30  Score=295.74  Aligned_cols=266  Identities=24%  Similarity=0.246  Sum_probs=193.2

Q ss_pred             CCCccceecccCceEEEEEEeC-C--CcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-D--GREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++.....  ...+.+.+|++++.++.   .||||+++++++...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR---GHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc---CCCChheeeeeeeecccc
Confidence            4778899999999999999975 4  77899999875321  22456778999888632   699999999875432   


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++++||++ ++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence             45788999986 59999998888899999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc---ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCC
Q 001384          957 VVSAGDSH---VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       957 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ........   ......|+..|+|||...+ ..++.++||||+|+++|+|++|+.||..... .................
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            76432211   1223568899999997655 5689999999999999999999999976542 11111111000000000


Q ss_pred             Cccc-------cchhhcCCC----ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAV-------IPVVLLGSG----LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~-------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....       .........    ..........+.+++.+|++.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000       000000000    0000112356889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.4e-30  Score=294.88  Aligned_cols=267  Identities=21%  Similarity=0.280  Sum_probs=197.7

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      +...+++|++.+.||+|+||.||+|... +++.||+|++.+..  ....+.+..|+++++.    ++|||++++++++..
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~   80 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH----LRHENIISLSDIFIS   80 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHh----cCCCCeeeEeeeEec
Confidence            3456788999999999999999999965 78999999886532  2234567889999986    679999999998875


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          877 -GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                       ....++||||+ +++|.++++. .++++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++++|||.+
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence             56788999999 5599988864 4578899999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccC-----
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYG----- 1027 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~----- 1027 (1088)
                      ......    .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......  ...+........     
T Consensus       156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            754321    123456788999998765 57899999999999999999999999765431  111111000000     


Q ss_pred             --CCCCCccccchhhcCCCcc---ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1028 --RHGPGRAVIPVVLLGSGLA---EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1028 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                        ..................+   ........+.+++.+|++.+|++||++.|++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000000000000000000   001124678899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=287.73  Aligned_cols=242  Identities=28%  Similarity=0.393  Sum_probs=198.6

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEe
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY  886 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~  886 (1088)
                      .++||+|.||+||-|+++ +|+.||||++.+..  ...+.++++|+.+++.    ++||.||.+-..|+..+..++|||.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~----l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQN----LHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHh----cCCCCeeEEEEeecCCceEEEEehh
Confidence            478999999999999975 79999999998754  3345679999999997    7899999999999999999999999


Q ss_pred             cCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CCEEEeecccceeecCCC
Q 001384          887 MEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE---GKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       887 ~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~---~~~kl~Dfg~a~~~~~~~  962 (1088)
                      +.|.-|.-++. +.++++++....++.||+.||.|||.+   +|||+||||+|||+.+.   ..+||+|||+|+....  
T Consensus       645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--  719 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--  719 (888)
T ss_pred             hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence            97644554443 467899999999999999999999999   99999999999999754   3799999999998863  


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ......++||+.|.|||++..+.|...-|+||.|||+|--++|..||..+++.-.+......                +.
T Consensus       720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF----------------My  783 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF----------------MY  783 (888)
T ss_pred             hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc----------------cc
Confidence            34456789999999999999999999999999999999999999999887653222211111                00


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      .. ....+.....+++|...++..-++|.+.+..+
T Consensus       784 Pp-~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  784 PP-NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CC-CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            00 11233445778888899999999999887654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-30  Score=297.24  Aligned_cols=269  Identities=23%  Similarity=0.287  Sum_probs=197.3

Q ss_pred             HHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          797 YSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      ..++...+++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++.+    ++||||++++++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~----l~h~~iv~~~~~   84 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH----MKHENVIGLLDV   84 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHH----cCCCcccceeee
Confidence            3456677899999999999999999999864 68899999997542  2234567789998886    679999999998


Q ss_pred             EecC------CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          874 CLDG------SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       874 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      +...      ...+++++++ +++|.++++.. .+++..++.++.|+++|++|||+.   +|+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence            7643      3467888887 77999888654 589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhc
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMG 1025 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~ 1025 (1088)
                      ||+|||+++....    ......++..|+|||...+ ..++.++||||+||++|||++|+.||....... ..-......
T Consensus       160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999876432    1233467889999998755 568899999999999999999999997643311 000000000


Q ss_pred             cCCCCCC--------ccc---cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPG--------RAV---IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......        ...   .+................++.+++.+|++.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0000000        000   0000000000000012346789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-30  Score=281.22  Aligned_cols=236  Identities=29%  Similarity=0.341  Sum_probs=194.8

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          813 IGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      ||+|+||.||++... +++.+|+|++......   ....+..|++++++    +.|||++++++.+..+...++||||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR----INHPFIVKLHYAFQTEEKLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHH----cCCCcHHHHHHHeecCCeeEEEEecCC
Confidence            699999999999976 5899999998765432   33468889998886    679999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +++|.+++.....+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus        77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            999999998887899999999999999999999998   99999999999999999999999999998764332 12334


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCcccc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEG 1048 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1088)
                      ..++..|+|||...+...+.++|+||||+++|++++|+.||...+.  .+....... .                ....+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~----------------~~~~~  213 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-D----------------PLRFP  213 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-C----------------CCCCC
Confidence            5678899999999888889999999999999999999999976543  111122211 0                00112


Q ss_pred             HHHHHHHHHHHhhhcccCCCCCCCHHH
Q 001384         1049 AEEMSELLRIGVRCTAEAPNARPNVKE 1075 (1088)
Q Consensus      1049 ~~~~~~l~~li~~cl~~dP~~RPs~~e 1075 (1088)
                      ......+.+++.+|+..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            222467888999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=5.3e-30  Score=314.53  Aligned_cols=145  Identities=30%  Similarity=0.472  Sum_probs=131.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|.+. +++.||||+++......   ...+..|+.++..    ++||||+++++++......
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~----l~hp~Iv~~~~~~~~~~~~   79 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL----SKSPFIVHLYYSLQSANNV   79 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHh----cCCCCcCeEEEEEEECCEE
Confidence            57899999999999999999976 68999999997643222   2567788888875    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      |+||||+.+++|.++++....+++..++.|+.||+.||+|||..   +||||||||+|||++.++.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999998888899999999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=281.09  Aligned_cols=256  Identities=26%  Similarity=0.382  Sum_probs=196.3

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cc----hHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EG----EREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~----~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      ...++|-+..+||+|+|+.||+|.+- ..+.||||+-.....   +.    .+...+|.++.+.    +.||.||++|++
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKe----LDHpRIVKlYDy  535 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKE----LDHPRIVKLYDY  535 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhc----cCcceeeeeeee
Confidence            34567888899999999999999964 678899998653321   11    1345567777765    789999999999


Q ss_pred             Eec-CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCCEEE
Q 001384          874 CLD-GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD---KEGKALV  949 (1088)
Q Consensus       874 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~---~~~~~kl  949 (1088)
                      +.- .+.+|-|+|||+|.+|+-|++.+.-+++.+++.|++||+.||.||.+. .++|||-||||.|||+.   .-|.+||
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence            874 567889999999999999999999999999999999999999999997 57999999999999995   4578999


Q ss_pred             eecccceeecCCCCc------ccccccccccccCccccC----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHH
Q 001384          950 TDFGLARVVSAGDSH------VSTTIAGTVGYVAPEYGQ----TWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLV 1017 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~ 1017 (1088)
                      +|||+++.+......      .+....||++|++||.+-    ....+.|+||||.|||+|.++.|+.||...-.  .+.
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            999999988653322      234578999999999533    23568899999999999999999999986532  222


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      +. ..++         ..-+..+..     -+....+...+|++|++..-++|....++.
T Consensus       695 qe-NTIl---------kAtEVqFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 QE-NTIL---------KATEVQFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hh-hchh---------cceeccCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            22 1111         111111101     122334567788899999999998877664

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=270.68  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=198.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchH---HHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGER---EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .+|.+.++||+|+|++|..++++ +.+.+|+|+++++-...++   =++.|-.+..+..   +||.+|.+..+|..+...
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as---n~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS---NNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc---CCCeEEehhhhhcccceE
Confidence            46889999999999999999976 5778999999876433322   2455666665543   899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++|.||++||+|--.+++.++++++.++.+...|+.||.|||++   |||+||+|..||++|..|++|++|+|+++.-- 
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            99999999999999999999999999999999999999999999   99999999999999999999999999997532 


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC-----chhHHHHHHhhhccCCCCCCccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG-----EECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .+...+.+++||+.|.|||++.+..|.+.+|+|++||+++||+.|+.||+--     +.+..++..+..-..+       
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-------  475 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-------  475 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-------
Confidence            2334567799999999999999999999999999999999999999999732     2234444444331111       


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP 1071 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1071 (1088)
                               ...|.....+...+++.-+++||.+|.
T Consensus       476 ---------iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 ---------IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence                     011222234455677789999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.6e-30  Score=280.50  Aligned_cols=222  Identities=24%  Similarity=0.240  Sum_probs=177.3

Q ss_pred             cCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHH
Q 001384          816 GGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED  894 (1088)
Q Consensus       816 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  894 (1088)
                      |.+|.||+|+++ +++.||+|++....     .+..|...+..    ..|||++++++++.+....++||||+++|+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIP----HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHh----cCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999976 68899999997652     12233333322    369999999999999999999999999999999


Q ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccccccccc
Q 001384          895 IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG  974 (1088)
Q Consensus       895 ~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~  974 (1088)
                      ++.+...+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.++++|||.+......    .....++..
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            998877899999999999999999999998   9999999999999999999999999987655322    122345678


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHH
Q 001384          975 YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSE 1054 (1088)
Q Consensus       975 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1088)
                      |+|||......++.++||||+|+++|||++|+.|+........          .    ....         ..+......
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~----~~~~---------~~~~~~~~~  204 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------T----HTTL---------NIPEWVSEE  204 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------c----cccc---------CCcccCCHH
Confidence            9999999888899999999999999999999988754211000          0    0000         011223456


Q ss_pred             HHHHHhhhcccCCCCCCCHHHH
Q 001384         1055 LLRIGVRCTAEAPNARPNVKEV 1076 (1088)
Q Consensus      1055 l~~li~~cl~~dP~~RPs~~ei 1076 (1088)
                      +.+++.+|++.||++||++.+.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCCcc
Confidence            7889999999999999997443

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.8e-30  Score=294.68  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-  878 (1088)
                      ..++|++.+.||+|+||.||+|... +++.||||++.....  .....+.+|++++++    ++||||+++++++..+. 
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----MKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHh----cCCCCccceeeeecCCcc
Confidence            4578999999999999999999965 789999999865321  223467889999987    67999999999887553 


Q ss_pred             -----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          879 -----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       879 -----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                           ..++||||+ +++|.+++.. ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence                 458999999 6799988864 4689999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      ++......    .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||.+....  ............. .
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~-~  236 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTP-S  236 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCC-C
Confidence            98765321    223456889999998765 46889999999999999999999999865431  1111111000000 0


Q ss_pred             ccccc--------h---hhcCCC----ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1033 RAVIP--------V---VLLGSG----LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1033 ~~~~~--------~---~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      .+..+        .   .+....    ..........+.+++.+|++.||++||++.+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            00000        0   000000    000112334688999999999999999999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-30  Score=295.44  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=209.7

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--  876 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--  876 (1088)
                      +...++.|++.++||.|.+|.||+++.+ +++.+|||+.... ...+++++.|.++++..   ..|||++.+||++..  
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~---~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKY---SHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhc---cCCCCcceEEEEEEEec
Confidence            3345677899999999999999999954 6888999988765 34566788888888874   489999999999874  


Q ss_pred             ---CCeEEEEEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          877 ---GSEKILVYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       877 ---~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                         ++..|+|||||.+|+..|+++.  ..++.|..+..|.+.++.|+.+||..   .++|||||-.||+++.++.||+.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence               5689999999999999999875  45799999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-----QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ||.+..+... .....+..||+.|||||++...     .|+..+|+||+|++..||.-|.+|+.+..+.     +.....
T Consensus       167 FGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----raLF~I  240 (953)
T KOG0587|consen  167 FGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLI  240 (953)
T ss_pred             eeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----hhhccC
Confidence            9999877543 2345567899999999987643     5778899999999999999999999876441     111111


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....+           ..+..+.....++.++|..|+.+|.++||++.++++
T Consensus       241 pRNPP-----------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 PRNPP-----------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCC-----------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11111           122346788899999999999999999999998764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.8e-31  Score=298.53  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=196.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..++|++.+.||+|++|.||+|++. +++.||||++....  ......+.+|+.++++    +.|||++++++++.....
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH----MDHENVIGLLDVFTPASS   88 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHh----ccCCCHHHHHHHhhcccc
Confidence            3568999999999999999999976 57899999987532  2233557789999886    679999999998776554


Q ss_pred             ------EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          880 ------KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       880 ------~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                            .++|+||+ +++|.+++.. .++++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence                  89999999 5699999875 4699999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .+......    .....++..|+|||...+ ..++.++||||+|+++|||++|+.||.+....  +.......... ...
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~-~~~  236 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVG-TPD  236 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcC-CCC
Confidence            99765322    233467889999998754 46789999999999999999999999765431  11111110000 000


Q ss_pred             ccccch--------h---hcCCCc----cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPV--------V---LLGSGL----AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~--------~---~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......        .   ......    ........++.+++.+|++.||++||++.||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000000        0   000000    000112467889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.8e-32  Score=264.73  Aligned_cols=266  Identities=26%  Similarity=0.349  Sum_probs=197.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      +.|+...+||+|.||.||+|+.+ +|+.||+|++..+.  ...-....+|++++..    ++|+|++.+++.|..     
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~----lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQL----LKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHH----hcchhHHHHHHHHhhccCCc
Confidence            45777789999999999999976 67889998775431  2223466789999986    689999999988753     


Q ss_pred             ---CCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          877 ---GSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       877 ---~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                         ....|+||++|+. +|.-++... .+++..++.+++.++..||.|+|..   .|+|||+||.|++|+.+|.+||+||
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence               2457999999987 999998765 5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCCcc---cccccccccccCccc-cCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccC
Q 001384          953 GLARVVSAGDSHV---STTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYG 1027 (1088)
Q Consensus       953 g~a~~~~~~~~~~---~~~~~gt~~y~aPE~-~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~ 1027 (1088)
                      |+|+.+...+...   .+..+-|..|.+||. +....|+++.|||..||++.||+|+.+-+.+..+ ...........-.
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9998776543322   334566899999995 5567899999999999999999999999988755 2222222221100


Q ss_pred             C--CCCCc------ccc--chhhcCCCcc-----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1028 R--HGPGR------AVI--PVVLLGSGLA-----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1028 ~--~~~~~------~~~--~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .  .++.-      +.+  ++...+....     .+.....+..+++..++..||.+|+.+++++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            0  00000      011  0000000000     00111225778888999999999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=285.53  Aligned_cols=241  Identities=24%  Similarity=0.296  Sum_probs=202.2

Q ss_pred             CCCccceecccCceEEEEEEeCCCc-EEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      +++.+..||-|+||.|-+++....+ .+|+|.+++....   .++.+..|-.+|..    .+.|.||++|-.|.+....|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~----~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMME----CRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHh----cCchHHHHHHHHhccchhhh
Confidence            4555678999999999999976433 4899999876543   34568888888876    56999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +.||-|=||.+...+++++.++...++.++..+++|++|||++   +||+|||||+|.+++.+|-+|+.|||+|+.+..+
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999999999999999999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                        ..+-+++||+.|.|||++.....+.++|.||+|+++||+++|.+||.+.++.  ..+..++..-      +.      
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--ktYn~ILkGi------d~------  637 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--KTYNLILKGI------DK------  637 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHhhh------hh------
Confidence              3455689999999999999999999999999999999999999999987652  2222222110      11      


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1072 (1088)
                         ...|........++|++.+...|.+|..
T Consensus       638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 ---IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence               1123445567788888999999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.9e-30  Score=281.45  Aligned_cols=203  Identities=26%  Similarity=0.371  Sum_probs=173.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .-|..++.||-|+||+|.+++.. +...+|.|.+++.+.-.   ...+++|-+||...    ..+-||++|..|.+++..
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA----Dn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA----DNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc----CCcceEEEEEEeccCCce
Confidence            34667789999999999999854 45678999998765333   34678899999863    578899999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee--
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~--  958 (1088)
                      |+||||++||++-.++-+.+-+.+.-++.++.++.+|+++.|.+   |+|||||||+|||||.+|++||+|||+++-+  
T Consensus       705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            99999999999999999999999999999999999999999999   9999999999999999999999999998522  


Q ss_pred             -------cCCCCcc--------------------------------cccccccccccCccccCCCCCCcchhHHHHHHHH
Q 001384          959 -------SAGDSHV--------------------------------STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLA  999 (1088)
Q Consensus       959 -------~~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l  999 (1088)
                             ..++...                                ....+||+.|+|||++....|+..+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                   1111000                                1124699999999999999999999999999999


Q ss_pred             HHHHhCCcCCCCCch
Q 001384         1000 MELATGRRALEGGEE 1014 (1088)
Q Consensus      1000 ~elltg~~p~~~~~~ 1014 (1088)
                      |||+.|+.||.+..+
T Consensus       862 ~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTP  876 (1034)
T ss_pred             HHHhhCCCCccCCCC
Confidence            999999999987644

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=293.27  Aligned_cols=243  Identities=29%  Similarity=0.378  Sum_probs=187.7

Q ss_pred             CCccceecccCceE-EEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          807 FSEDRIIGKGGFGT-VYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      |.-.+++|.|+.|+ ||+|.. +|++||||++-..   ...-..+|+..++.-   -.|||||++|+.-.++...|++.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eS---D~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQES---DEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhc---cCCCceEEEEeeccCCceEEEEeh
Confidence            33446789999975 799998 5889999999765   233557899988863   489999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---C--CCEEEeecccce
Q 001384          886 YMEGGSLEDIISDRTR----LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---E--GKALVTDFGLAR  956 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~--~~~kl~Dfg~a~  956 (1088)
                      .|.. +|.|+++....    ......+.+..|++.|+++||+.   +||||||||+||||+.   +  .+++|+|||+++
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9976 99999987421    11245578899999999999998   9999999999999986   3  478999999999


Q ss_pred             eecCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG-RRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .+..+....  .....||.+|+|||++....-+.++||||+||++|+.++| .+||.+.-+.........       .  
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-------~--  730 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-------Y--  730 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-------c--
Confidence            987654332  3457899999999999988888899999999999998886 999986432111000000       0  


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...  .   . ....++  +..++|.+|+++||..||+|.+|+.
T Consensus       731 -~L~--~---L-~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  731 -TLV--H---L-EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -cee--e---e-ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             000  0   0 001111  7778899999999999999999973

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.2e-29  Score=300.96  Aligned_cols=262  Identities=20%  Similarity=0.217  Sum_probs=170.8

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-C----CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE----
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-D----GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW----  873 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~----  873 (1088)
                      ..++|++.+.||+|+||.||+|++. +    +..||||++.....  .+.+..|.  +..    ..+.++..++..    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e~--l~~----~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNER--VRR----ACPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHHH--HHh----hchhhHHHHHHhhhcc
Confidence            3568999999999999999999975 4    68999999865321  11112111  111    112222222211    


Q ss_pred             --EecCCeEEEEEEecCCCCHHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001384          874 --CLDGSEKILVYEYMEGGSLEDIISDRTR--------------------LTWRRRLDIAIDVARALVFLHHECYPPIVH  931 (1088)
Q Consensus       874 --~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  931 (1088)
                        ...+...++||||+++++|.++++....                    .....+..++.|++.||+|||++   +|+|
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH  278 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH  278 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence              2456678999999999999999875421                    12334668999999999999999   9999


Q ss_pred             cCCCCCCEEEcC-CCCEEEeecccceeecCCCCcccccccccccccCccccCCC----------------------CCCc
Q 001384          932 RDVKASNVLLDK-EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW----------------------QATT  988 (1088)
Q Consensus       932 ~DLkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  988 (1088)
                      |||||+|||++. ++.+||+|||+|+.+............+++.|+|||.+...                      .++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 58999999999987654444445567889999999954321                      2445


Q ss_pred             chhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC-CCccccchhhcCC---CccccHHHHHHHHHHHhhhcc
Q 001384          989 KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG-PGRAVIPVVLLGS---GLAEGAEEMSELLRIGVRCTA 1064 (1088)
Q Consensus       989 ~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~ 1064 (1088)
                      ++||||+||++|||+++..++...   ...+........... ......+......   .............+|+.+|++
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            679999999999999977765432   122211111000000 0000000000000   000000112245589999999


Q ss_pred             cCCCCCCCHHHHHH
Q 001384         1065 EAPNARPNVKEVLA 1078 (1088)
Q Consensus      1065 ~dP~~RPs~~eil~ 1078 (1088)
                      .||++||+++|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999986

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-29  Score=237.54  Aligned_cols=200  Identities=27%  Similarity=0.399  Sum_probs=167.4

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ..-...||+|+||.|-+.++. +|+..|||++...-. +.+++...|+.+..+   ...+|.+|++||....+...++.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r---~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMR---TVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhcc---CCCCCeEEEeehhhhccccEEEeH
Confidence            344567999999999999865 799999999986532 334567778887766   358999999999999999999999


Q ss_pred             EecCCCCHHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          885 EYMEGGSLEDI----ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       885 e~~~~gsL~~~----l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |.|+- +|..+    ++....+++.-+-+||..++.||.|||++.  .+||||+||+||||+.+|++|+||||.+-.+..
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99965 87754    345667999999999999999999999995  899999999999999999999999999987652


Q ss_pred             CCCcccccccccccccCccccC----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQ----TWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                        +...+...|...|||||.+.    ...|+-++||||+|+.+.||.+++.||+....
T Consensus       202 --SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  202 --SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             --hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence              22233356788999999765    34789999999999999999999999987644

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=230.91  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=192.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +|...++||+|.||+||+|+.+ +++.||+|+++-+...  -.....+|+-+++.    ++|+|||+++++...+...-+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllke----lkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----LKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHH----hhhcceeehhhhhccCceeEE
Confidence            4666789999999999999965 5788999999865322  22456789999886    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |+|||.. +|..+... ++.++.+.++.++.|+++|+.+.|++   ++.|||+||+|.+|..+|++|++|||+++.+.-.
T Consensus        79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            9999955 88888865 56799999999999999999999999   9999999999999999999999999999877532


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh--hh--ccCCCCCCcccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR--VM--GYGRHGPGRAVI 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~ 1036 (1088)
                      -. -....+-|..|.+|.++.+ .-|+...|+||.||++.|+....+|...+.+-..+..+.  ..  .-...++.....
T Consensus       155 vr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             eE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            21 1233456889999997655 568899999999999999998666644433322222211  11  111112222111


Q ss_pred             chhhcCCCcccc---H----HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEG---A----EEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~---~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +........+..   .    +....=.+++.+.+.-+|..|.++++.++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111110000000   1    11112346677888889999999998765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=4.3e-28  Score=262.30  Aligned_cols=238  Identities=32%  Similarity=0.475  Sum_probs=194.4

Q ss_pred             CceEEEEEEeC-CCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHH
Q 001384          817 GFGTVYRGVLP-DGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED  894 (1088)
Q Consensus       817 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  894 (1088)
                      +||.||+|+.. +++.+|+|++....... .+.+.+|++.+++    ++|+|++++++++......+++|||+++++|.+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~----l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKK----LKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHh----CCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            58999999987 48999999998765444 6789999999986    589999999999999999999999999999999


Q ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccccccccc
Q 001384          895 IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG  974 (1088)
Q Consensus       895 ~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~  974 (1088)
                      ++.....+++..++.++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+.......  ......++..
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            998776689999999999999999999999   99999999999999999999999999998765432  2334567889


Q ss_pred             ccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHH
Q 001384          975 YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSE 1054 (1088)
Q Consensus       975 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1088)
                      |+|||......++.++||||+|+++|++++|..||...... ............     ....         .......+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~-----~~~~---------~~~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKP-----PFPP---------PEWKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCC-----CCcc---------ccccCCHH
Confidence            99999988888899999999999999999999999763221 111111110000     0000         00003467


Q ss_pred             HHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1055 LLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1055 l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.1e-28  Score=282.91  Aligned_cols=256  Identities=19%  Similarity=0.239  Sum_probs=176.0

Q ss_pred             cCCCCccceecccCceEEEEEEe-----------------CCCcEEEEEEccccCccchHHH--------------HHHH
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-----------------PDGREVAVKKLQREGLEGEREF--------------RAEM  852 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  852 (1088)
                      .++|++.++||+|+||+||+|.+                 ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 2356899999875432222222              2345


Q ss_pred             HHHhCCCC-CCCCCceeEEeeEEec--------CCeEEEEEEecCCCCHHHHHhhcC-----------------------
Q 001384          853 EVLSGNGF-GWPHPNLVTLYGWCLD--------GSEKILVYEYMEGGSLEDIISDRT-----------------------  900 (1088)
Q Consensus       853 ~~l~~~~~-~l~h~niv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-----------------------  900 (1088)
                      .++.++.. .+.++++++++++|..        +...++||||+++|+|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            55444210 0123345677777653        356799999999999999986421                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCcc
Q 001384          901 -RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE  979 (1088)
Q Consensus       901 -~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE  979 (1088)
                       .+++..++.++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+++..............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence             246778899999999999999999   9999999999999999999999999999765433222222234578999999


Q ss_pred             ccCCCC--------------------C--CcchhHHHHHHHHHHHHhCCc-CCCCCch----------hHHHHHHhhhcc
Q 001384          980 YGQTWQ--------------------A--TTKGDVYSFGVLAMELATGRR-ALEGGEE----------CLVEWGRRVMGY 1026 (1088)
Q Consensus       980 ~~~~~~--------------------~--~~~~DvwslG~~l~elltg~~-p~~~~~~----------~~~~~~~~~~~~ 1026 (1088)
                      .+....                    |  ..+.||||+||++|+|++|.. ||.....          ....|.....  
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~--  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG--  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc--
Confidence            764322                    1  234799999999999999885 6653211          1111211000  


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCC---CCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAP---NARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~ 1078 (1088)
                           ..  .+       .+..........+++.+++..+|   .+|+|++|+++
T Consensus       459 -----~~--~~-------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 -----QK--YD-------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -----cC--CC-------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                 00  00       00112234567788889998765   78999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=2e-28  Score=238.34  Aligned_cols=258  Identities=19%  Similarity=0.273  Sum_probs=193.7

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--eE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--EK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--~~  880 (1088)
                      .++|++.+++|+|.|+.||.|.. .+.+.++||+++.-   .++.+.+|+.++..+.   .||||+++++...+..  ..
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~---gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLR---GGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhcc---CCCCeeehhhhhcCccccCc
Confidence            36799999999999999999994 46788999999753   5678999999999754   6999999999988754  56


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~~  959 (1088)
                      .+|+||+.+.+...+-   ..++..+++.++.+++.||+|+|++   ||+|||+||+|||||. .-.++++|+|+|..+.
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            7999999886665554   3478899999999999999999999   9999999999999985 4679999999999886


Q ss_pred             CCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh------------hcc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV------------MGY 1026 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~------------~~~ 1026 (1088)
                      ++..  ....+.+..|.-||.+- ...|+..-|+|||||++..|+..+.||..+.++..+.++-.            ..|
T Consensus       185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            5432  23345566788999654 45789999999999999999999999987654333322211            111


Q ss_pred             CCC--CCCcccc--------chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRH--GPGRAVI--------PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...  .....++        ...+....   ..-...+.++++.+.+..|-.+|||++|.+.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n---~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSEN---QHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccc---cccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            110  0000000        00000000   0111256788888999999999999999864

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-29  Score=252.34  Aligned_cols=262  Identities=26%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEcccc--CccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-----eE
Q 001384          809 EDRIIGKGGFGTVYRGVLP-DGREVAVKKLQRE--GLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-----EK  880 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-----~~  880 (1088)
                      -.+.||.|+||+||.+.+. +|+.||.|++..-  .....+.+.+|++++..    ++|.|++..++...-..     +.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcf----FkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSS----FRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHh----hccccHHHHHHhcCCCCchHHHHH
Confidence            3578999999999999975 7999999998753  23455788899999986    78999999888765432     45


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+++|.|.. +|..++-....++...+..+.+||++||.|||+.   +|.||||||-|.+++++..+||+|||+|+....
T Consensus       133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            788999966 8999888888899999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhh--------ccCCCC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVM--------GYGRHG 1030 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~--------~~~~~~ 1030 (1088)
                      .+..-.+..+-|..|.|||++.+ ..|+.+.||||.||++.|++..+..|....+ .-.+.....+        .+.-++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            55555555677899999998765 5799999999999999999999988876543 0001100000        000000


Q ss_pred             CCccccc------hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIP------VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .-..+..      ....-.....+...-.+.+.+...++..||++|.+..+.+.
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            0000000      00000011112233345667778999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=269.74  Aligned_cols=200  Identities=25%  Similarity=0.335  Sum_probs=174.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc--------hHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG--------EREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      -..|...+.+|+|+||.|+.|.++ +..+|+||.+.++..-.        -..+-.|+++|..+. .-.|+||++++++|
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~-~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLN-KHSHENILKLLDFF  638 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhh-hcCccchhhhhhee
Confidence            356888999999999999999987 46789999998764221        134667899998754 23599999999999


Q ss_pred             ecCCeEEEEEEecC-CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          875 LDGSEKILVYEYME-GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~-~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                      ++++.+|++||-.. +-+|.|+|+.+.++++.++..|++||+.|+++||++   +|||||||-+||.++.+|-+|++|||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence            99999999999864 559999999999999999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      .|.....   .+...++||..|.|||++.+..| +..-|||++|+++|-++....||.
T Consensus       716 saa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9987653   34567899999999999999887 566899999999999998888875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-27  Score=252.82  Aligned_cols=135  Identities=28%  Similarity=0.382  Sum_probs=114.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCC----CCCCceeEEeeEEec--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG----WPHPNLVTLYGWCLD--  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~----l~h~niv~l~~~~~~--  876 (1088)
                      .++|.+.++||-|.|++||+|.+. ..+.||+|+++... ...+....|++++++++..    ..-.+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            378999999999999999999975 57889999998652 3345678899999887632    233579999999874  


Q ss_pred             --CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          877 --GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       877 --~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                        +.++|||+|++ |.+|..+|+..  +.++...+.+|++||+.||.|||.+|  +|||.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              56899999999 55999999764  35999999999999999999999999  999999999999983

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=245.35  Aligned_cols=260  Identities=24%  Similarity=0.299  Sum_probs=197.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      .+|.-.+.+|.|+- .|..|.+. .++.||+|++....  ....+...+|..++..    +.|+|+++++.++.-.    
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~----v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKC----VNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhh----hcccceeeeeeccCccccHH
Confidence            46777788999998 67777755 78999999987652  2233566778888775    6899999999998754    


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 --SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                        ...|+|||+|.. +|...++  -.++-..+.++..|+++|+.|||+.   +|+||||||+||++..++.+||.|||+|
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence              356999999965 9998887  3467788899999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC------
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH------ 1029 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1029 (1088)
                      +.-...  ...+.++.|..|.|||++-+..|.+.+||||.||++.||++|+..|.+. +.+.+|.+.....+..      
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-DHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-hHHHHHHHHHHHhcCCCHHHHH
Confidence            865432  4566788899999999988888999999999999999999999999853 4456664433211110      


Q ss_pred             ------------------CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 ------------------GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                        ....+.++...-......+......+.+++.+|+..+|++|.+++|+++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                              0111111111111111112234456778888999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-28  Score=267.73  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=206.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|+....+|.|.||.||||+++ +++..|||+++-.....-...++|+-+++.    .+|||||.+++.+...+..++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~d----c~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRD----CRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeec----CCCcChHHHHhhhhhhcCcEE
Confidence            357889999999999999999976 689999999998755555667788888875    689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      .||||.||+|.|.-+--+++++.++..+.+...+|++|||++   +-+|||||-.||++++.|.+|++|||.+..+... 
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-
Confidence            999999999999988888999999999999999999999999   8899999999999999999999999998765432 


Q ss_pred             CcccccccccccccCccc---cCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          963 SHVSTTIAGTVGYVAPEY---GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      -.....+.||+.|||||+   -..+.|..++|||+.|+...|+-.-+.|..+..+.-..+...          +.-.   
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT----------kS~~---  232 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT----------KSGF---  232 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh----------ccCC---
Confidence            223456789999999995   445688999999999999999998888866543321111110          1111   


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ..............+-++++.|+..+|.+||+++..+.
T Consensus       233 -qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  233 -QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             11112234455667888999999999999999987654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.7e-25  Score=236.13  Aligned_cols=209  Identities=38%  Similarity=0.637  Sum_probs=182.8

Q ss_pred             ecccCceEEEEEEeCC-CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCC
Q 001384          813 IGKGGFGTVYRGVLPD-GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG  890 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  890 (1088)
                      ||+|++|.||++.... ++++++|++...... ....+.+|++.++.    +.|++++++++++......+++|||++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~----l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKK----LNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHh----cCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            6899999999999864 899999999876332 24678899999987    57899999999999999999999999999


Q ss_pred             CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceeecCCCCccccc
Q 001384          891 SLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       891 sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      +|.+++... ..+++..++.++.+++++++|||+.   +++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT  152 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence            999999876 5789999999999999999999999   9999999999999999 89999999999987654321 2233


Q ss_pred             ccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccc
Q 001384          969 IAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1088)
                      ..+...|++||..... .++.+.|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            5577899999988877 888999999999999999                                             


Q ss_pred             cHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1048 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                           ..+.+++.+|++.+|++||++.++++.
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                 357788889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=9.9e-27  Score=250.87  Aligned_cols=276  Identities=21%  Similarity=0.213  Sum_probs=205.3

Q ss_pred             cCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCC--CCCCceeEEe
Q 001384          795 FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG--WPHPNLVTLY  871 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~--l~h~niv~l~  871 (1088)
                      +.+.-......+|.+....|+|-|++|..|.+. .|..||||++..... ..+.=..|+++|.++...  -.--|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334444456688999999999999999999976 588999999987632 234446788998876521  1234789999


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCE
Q 001384          872 GWCLDGSEKILVYEYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKA  947 (1088)
Q Consensus       872 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~  947 (1088)
                      ..|...++.|+|+|-+.- +|.+.++..+   .+....++.++.|+.-||..|-..   +|+|.||||.||||.+. ..+
T Consensus       501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence            999999999999999854 9999998765   488999999999999999999997   99999999999999865 468


Q ss_pred             EEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH--HHHH----
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV--EWGR---- 1021 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~~---- 1021 (1088)
                      ||||||.|......+   -+.+.-+..|.|||++.+.+|+...|+||.||+|||+.||+..|.+...+-+  -+..    
T Consensus       577 KLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  577 KLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            999999998765433   2334456689999999999999999999999999999999999988643211  1111    


Q ss_pred             ---hhhccCCC------------------CCCcccc------------chhhcCC--CccccHHHHHHHHHHHhhhcccC
Q 001384         1022 ---RVMGYGRH------------------GPGRAVI------------PVVLLGS--GLAEGAEEMSELLRIGVRCTAEA 1066 (1088)
Q Consensus      1022 ---~~~~~~~~------------------~~~~~~~------------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~d 1066 (1088)
                         .++.-...                  ....+..            ...+.+.  ..........++.+|+..|+..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence               00000000                  0000000            0011111  11223455678899999999999


Q ss_pred             CCCCCCHHHHHH
Q 001384         1067 PNARPNVKEVLA 1078 (1088)
Q Consensus      1067 P~~RPs~~eil~ 1078 (1088)
                      |++|.+..++++
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=229.74  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=186.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE-EecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW-CLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~-~~~~~~~~l  882 (1088)
                      +.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+.+. ....++|.+|..---.+.   .|.||+.-|++ |+..+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls---~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLS---PHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeec---cchhhhHHHHHHhhcCceEEE
Confidence            46889999999999999999987 5678999999876 345678999887544332   79999988874 566778889


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~--~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||++.|+|..-+...+ +.+....+++.|++.|+.|||++   ++||||||.+||||-  +..++|++|||.++..+.
T Consensus       100 ~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999999887644 78888999999999999999999   999999999999994  335899999999876542


Q ss_pred             CCCcccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCc---hhHHHHHHhhhccCCCCCC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGE---ECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .-    .....+..|.|||....     ....+.+|||.||+++|.++||..||+...   ....+|..+..  ....  
T Consensus       176 tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--rk~~--  247 (378)
T KOG1345|consen  176 TV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--RKNP--  247 (378)
T ss_pred             ee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--ccCc--
Confidence            21    12234567899996432     234678999999999999999999998542   23334433322  1111  


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1080 (1088)
                        ..+..        -......+.++.++-+.++|++|=...++.++.
T Consensus       248 --~~P~~--------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 --ALPKK--------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             --cCchh--------hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence              11111        112335677788899999999995555544443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=4.1e-25  Score=236.08  Aligned_cols=198  Identities=36%  Similarity=0.516  Sum_probs=174.4

Q ss_pred             CCccceecccCceEEEEEEeCC-CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      |++.+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+.+    ++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~----~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKK----LKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHh----CCCCChhhheeeeecCCceEEEE
Confidence            5667899999999999999874 889999999876544 56688899998886    57999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++++|.+++..... +++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++++|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            99999999999988766 89999999999999999999999   999999999999999999999999999987754321


Q ss_pred             cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCcCCCC
Q 001384          964 HVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELATGRRALEG 1011 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~ 1011 (1088)
                      .......++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122345677889999988 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.2e-25  Score=239.88  Aligned_cols=269  Identities=26%  Similarity=0.327  Sum_probs=198.2

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ++....+.|..+++||+|.|++||+|.+.    ..+.||+|.+...  ..-..+.+|++++..++   .+.||+++.+++
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~g---G~~ni~~~~~~~  104 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLG---GSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhc---cchhhhcchhhh
Confidence            34455678999999999999999999964    3678999999765  23356889999998865   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeecc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFG  953 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Dfg  953 (1088)
                      ...+...+|+||++.....++...   ++..++..+++.+..||+++|.+   |||||||||+|++.+ ..++-.|.|||
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            999999999999999888888754   67899999999999999999999   999999999999998 55788999999


Q ss_pred             cceeecC--------C-------------------------CCc----------ccccccccccccCccccC-CCCCCcc
Q 001384          954 LARVVSA--------G-------------------------DSH----------VSTTIAGTVGYVAPEYGQ-TWQATTK  989 (1088)
Q Consensus       954 ~a~~~~~--------~-------------------------~~~----------~~~~~~gt~~y~aPE~~~-~~~~~~~  989 (1088)
                      +|..+..        .                         ..+          ......||++|.|||++. ....+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9862110        0                         000          011346999999999754 5567889


Q ss_pred             hhHHHHHHHHHHHHhCCcCCCCCch---hHHHHHH---------hhhccCC--CCC---C---------ccccc-hhhcC
Q 001384          990 GDVYSFGVLAMELATGRRALEGGEE---CLVEWGR---------RVMGYGR--HGP---G---------RAVIP-VVLLG 1042 (1088)
Q Consensus       990 ~DvwslG~~l~elltg~~p~~~~~~---~~~~~~~---------~~~~~~~--~~~---~---------~~~~~-~~~~~ 1042 (1088)
                      +||||.||++..+++++.||....+   .+.+.+.         .....+.  .+.   .         .+... ..+..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999975432   2222211         1111111  000   0         00000 00001


Q ss_pred             CCc------cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGL------AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...      ......+..+++++.+|+..||.+|.+++|.++
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            000      011122346889999999999999999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=7.8e-27  Score=244.87  Aligned_cols=295  Identities=22%  Similarity=0.218  Sum_probs=215.7

Q ss_pred             cccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc---cccccCcccceecccC-ccccccccccc
Q 001384          164 EISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSE-NVLSGVVSSSV  239 (1088)
Q Consensus       164 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~---~~~~~l~~L~~L~L~~-n~l~~~~~~~~  239 (1088)
                      ++|..++   ..-+++.|..|+|+.+++.+|..+++|+.|||++|+|+.   ..+.+++++..|.+.+ |.|+ .++...
T Consensus        60 eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~  135 (498)
T KOG4237|consen   60 EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGA  135 (498)
T ss_pred             cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhH
Confidence            4455544   457788999999999999999999999999999998775   5567788888887777 7887 578899


Q ss_pred             ccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCc
Q 001384          240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE  319 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  319 (1088)
                      |.++.+|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+--..|..+..++.+.+..|.+..     .++++.+.
T Consensus       136 F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla  210 (498)
T KOG4237|consen  136 FGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLA  210 (498)
T ss_pred             hhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhh
Confidence            9999999999999999988888899999999999999999984433488889999999998887432     23333322


Q ss_pred             EEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccc-cCCCCcCEEEccCCccCCCCC-ccccCCcCcceeecc
Q 001384          320 VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI-LKLPNISRLDLSHNNFTGPLP-VEISQMRSLKFLILA  397 (1088)
Q Consensus       320 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~  397 (1088)
                      .- +.-      .+..++.........+.++++- ......| ..+..+..=..+.+...+.-| ..|..+++|+.|+|+
T Consensus       211 ~~-~a~------~~ietsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnls  282 (498)
T KOG4237|consen  211 DD-LAM------NPIETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLS  282 (498)
T ss_pred             hH-Hhh------chhhcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccC
Confidence            21 111      1222333333333333333221 1111111 112222221222333333444 458889999999999


Q ss_pred             ccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       398 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      +|+|+++-+.+|..+..+++|.|..|+|...-...|.++..|+.|+|.+|+|+..-|..|..+.+|..|+|-.|++..
T Consensus       283 nN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  283 NNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC  360 (498)
T ss_pred             CCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence            999998889999999999999999999985555678889999999999999998889999999999999999999874

>PLN03210 Resistant to P

Probab=99.90  E-value=1.1e-22  Score=264.10  Aligned_cols=307  Identities=21%  Similarity=0.240  Sum_probs=179.9

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +|+.|++.++.+. .+|..+ ...+|++|+|.+|++. .++..+..+++|+.|+|++|.....+|. +..+++|+.|+|+
T Consensus       590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~  665 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS  665 (1153)
T ss_pred             ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence            5677777766654 556555 4567777777777776 5666666777777777776654455553 6667777777777


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|.....+|..++.+++|+.|++++|..+..++...  ++++|+.|++++|...+.+|..   .++|+.|++++|.+. .
T Consensus       666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~  739 (1153)
T PLN03210        666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-E  739 (1153)
T ss_pred             CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-c
Confidence            766555666666666666666666554443333221  4556666666665544344432   235556666666655 4


Q ss_pred             CCcccCCCCCCcEEEccCCcCC-------CCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCC
Q 001384          405 IPAVYGNMPNLQTLDLSFNELT-------GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI  477 (1088)
Q Consensus       405 ~p~~~~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i  477 (1088)
                      +|..+ .+++|+.|++.++...       ...|......++|+.|+|++|...+.+|..++++++|+.|+|++|...+  
T Consensus       740 lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~--  816 (1153)
T PLN03210        740 FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE--  816 (1153)
T ss_pred             ccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC--
Confidence            55443 3555555555543221       0011111223445555555554444555555555555555555543322  


Q ss_pred             CchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCc
Q 001384          478 PPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLA  557 (1088)
Q Consensus       478 p~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  557 (1088)
                                                                                                      
T Consensus       817 --------------------------------------------------------------------------------  816 (1153)
T PLN03210        817 --------------------------------------------------------------------------------  816 (1153)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             ccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcE
Q 001384          558 SRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQN  637 (1088)
Q Consensus       558 ~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~  637 (1088)
                                         .+|..+ ++++|+.|+|++|..-..+|....  .++.|+|++|.++ .+|.+++.+++|+.
T Consensus       817 -------------------~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~--nL~~L~Ls~n~i~-~iP~si~~l~~L~~  873 (1153)
T PLN03210        817 -------------------TLPTGI-NLESLESLDLSGCSRLRTFPDIST--NISDLNLSRTGIE-EVPWWIEKFSNLSF  873 (1153)
T ss_pred             -------------------eeCCCC-CccccCEEECCCCCcccccccccc--ccCEeECCCCCCc-cChHHHhcCCCCCE
Confidence                               334333 345555666665544334444322  3567777777777 78888888888888


Q ss_pred             EEccc-cccCCcCCcccccccccceeeccCCC
Q 001384          638 LDLSY-NNFSGPFPASFNNLTELSKLNISYNP  668 (1088)
Q Consensus       638 L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~  668 (1088)
                      |+|++ |+|. .+|..+..+++|+.++++++.
T Consensus       874 L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        874 LDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             EECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            88887 5565 578888888888888888764

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=8.9e-26  Score=236.98  Aligned_cols=383  Identities=24%  Similarity=0.196  Sum_probs=259.7

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECcc-ccccCcc--cCCCCCCCceeec
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSH-NILSGDL--NLSGLRSLEILDL  156 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-n~l~~~~--~l~~l~~L~~L~L  156 (1088)
                      ..+.|+|..|+|+...+.+|+.+.+|+.||||+|+|+.+-|++|.++++|..|-+-+ |+|+...  .|.+|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            468999999999998889999999999999999999999999999999998887766 9999754  5999999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc---------------cccccCccc
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---------------NIWNGLAQL  221 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~---------------~~~~~l~~L  221 (1088)
                      .-|++..... ...+.+++|..|.+.+|.+..+....|..+..++.+.+..|.+-.               .-.++....
T Consensus       148 Nan~i~Cir~-~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  148 NANHINCIRQ-DALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             ChhhhcchhH-HHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence            9999985444 444567899999999999998888899999999999999987321               112222333


Q ss_pred             ceecccCcccccccccccccCC-CccCEEEcCCCcccccCc-ccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeC
Q 001384          222 VEFSVSENVLSGVVSSSVFKEN-CSLEIFDLSENEFIGDFP-GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL  299 (1088)
Q Consensus       222 ~~L~L~~n~l~~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  299 (1088)
                      .-..+..+.+.. +.+..|... .++..--.+.+...+..| ..|..+++|+.|+|++|+|+++-+.+|.++..+++|.|
T Consensus       227 ~p~rl~~~Ri~q-~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  227 SPYRLYYKRINQ-EDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             chHHHHHHHhcc-cchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence            333333333332 222233221 122111122222333333 45778888888888888888888888888888888888


Q ss_pred             CCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccc---------------cCC
Q 001384          300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI---------------LKL  364 (1088)
Q Consensus       300 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~---------------~~l  364 (1088)
                      ..|++..+-...|.++..|+.|+|.+|+|+...|..|..+..|..|.+-.|.+.-.-...++               .+-
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p  385 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSP  385 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCC
Confidence            88888777667788888888888888888888888888888888888877765332211111               111


Q ss_pred             CCcCEEEccCCccC---CCCCccccCC---------cCcce-eeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCc
Q 001384          365 PNISRLDLSHNNFT---GPLPVEISQM---------RSLKF-LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP  431 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~---~~~p~~l~~l---------~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  431 (1088)
                      ..++.++++++.+.   ...|++.+-.         +-+.+ ...|++.++ .+|..+  -..-.+|++.+|.++ .+|.
T Consensus       386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~~~-~vp~  461 (498)
T KOG4237|consen  386 GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNAIT-SVPD  461 (498)
T ss_pred             chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccchhc-ccCH
Confidence            23445555555433   1223332211         11222 223333333 444433  124456777777777 5666


Q ss_pred             cccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          432 SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       432 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      .  .+.+| .+|+++|+++-.--..|.++++|.+|.|+.|
T Consensus       462 ~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  462 E--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             H--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            5  55666 7777777776444456777777777777665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=3.5e-24  Score=270.23  Aligned_cols=192  Identities=18%  Similarity=0.206  Sum_probs=137.8

Q ss_pred             CC-CceeEEeeEE-------ecCCeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 001384          863 PH-PNLVTLYGWC-------LDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRD  933 (1088)
Q Consensus       863 ~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~D  933 (1088)
                      .| +||+++++++       ......+.++||+ +++|+++++. ...+++.+++.++.||++||+|||++   +|+|||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrD  105 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHN  105 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            45 5777777776       2334567889988 5599999975 34699999999999999999999999   999999


Q ss_pred             CCCCCEEEcCCC-------------------CEEEeecccceeecCCCC---------------cccccccccccccCcc
Q 001384          934 VKASNVLLDKEG-------------------KALVTDFGLARVVSAGDS---------------HVSTTIAGTVGYVAPE  979 (1088)
Q Consensus       934 Lkp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~y~aPE  979 (1088)
                      |||+||||+..+                   .+|++|||+++.......               .......||+.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            999999996544                   455666666543211000               0011235788899999


Q ss_pred             ccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHH
Q 001384          980 YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIG 1059 (1088)
Q Consensus       980 ~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1059 (1088)
                      ++.+..|+.++|||||||++|||++|..|+...............            +..        .........+++
T Consensus       186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~------------~~~--------~~~~~~~~~~~~  245 (793)
T PLN00181        186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVL------------PPQ--------ILLNWPKEASFC  245 (793)
T ss_pred             hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhc------------Chh--------hhhcCHHHHHHH
Confidence            999889999999999999999999998887643222111111110            000        011123456778


Q ss_pred             hhhcccCCCCCCCHHHHHH
Q 001384         1060 VRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1060 ~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+|++++|.+||++.|+++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8999999999999999975

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.7e-23  Score=248.11  Aligned_cols=174  Identities=25%  Similarity=0.316  Sum_probs=92.2

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      .-..|+|++|+++ .+|..+.  ++|+.|++++|+++ .+|..   .++|++|+|++|+++. +|..   .++|+.|+|+
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls  270 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF  270 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence            3556778887777 5666664  36778888888777 45532   4566777777776664 3432   2456666666


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|.++..+ ..                            .++|+.|+|++|+++ .+|..   +++|+.|+|++|+|+ .
T Consensus       271 ~N~L~~Lp-~l----------------------------p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~  316 (788)
T PRK15387        271 SNPLTHLP-AL----------------------------PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA-S  316 (788)
T ss_pred             CCchhhhh-hc----------------------------hhhcCEEECcCCccc-ccccc---ccccceeECCCCccc-c
Confidence            66655321 11                            123445555555555 33331   245555555555555 2


Q ss_pred             CCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          405 IPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       405 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      +|...   .+|+.|++++|+|+ .+|...   .+|++|+|++|+|+ .+|..   .++|+.|++++|+|+
T Consensus       317 Lp~lp---~~L~~L~Ls~N~L~-~LP~lp---~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~  375 (788)
T PRK15387        317 LPALP---SELCKLWAYNNQLT-SLPTLP---SGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT  375 (788)
T ss_pred             CCCCc---ccccccccccCccc-cccccc---cccceEecCCCccC-CCCCC---Ccccceehhhccccc
Confidence            33321   23445555555555 244311   34555555555555 34432   134445555555554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=6.1e-23  Score=210.39  Aligned_cols=164  Identities=22%  Similarity=0.207  Sum_probs=127.3

Q ss_pred             CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCccccc
Q 001384          890 GSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT  968 (1088)
Q Consensus       890 gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  968 (1088)
                      |+|.++++.+ ..+++.+++.++.|++.||+|||++   +      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999874 4599999999999999999999998   5      999999999999999  99988764321      


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh---HHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          969 IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC---LVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       969 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...+.....   . ....          ..
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~-~~~~----------~~  129 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---A-DDPR----------DR  129 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---c-CCcc----------cc
Confidence            25789999999999999999999999999999999999999764331   111111111   0 0000          00


Q ss_pred             cccHHHHH--HHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1046 AEGAEEMS--ELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1046 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+.....  ++.+++.+|++.+|++||++.|+++.+..+.
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            00112222  6899999999999999999999999887664

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.89  E-value=3.3e-22  Score=259.65  Aligned_cols=223  Identities=26%  Similarity=0.255  Sum_probs=125.6

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +|+.|++++|++. .+|..+..+++|+.|+|++|.....+| .++.+++|+.|+|++|.....+|..+.++++|+.|+++
T Consensus       612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            3334444443333 233333444444444444433222333 23344444444444443333344444444444444444


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccC--
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN--  402 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--  402 (1088)
                      +|..-+.+|..+ ++++|+.|++++|..+...+.    ...+|++|+|++|.++ .+|..+ .+++|+.|++.++...  
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l  762 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL  762 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccc-cccccccccccccchhhc
Confidence            432222222222 344444444444432222111    1356788888888877 567655 5777888887764322  


Q ss_pred             -----CcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCC
Q 001384          403 -----GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI  477 (1088)
Q Consensus       403 -----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i  477 (1088)
                           ...|..+...++|+.|+|++|...+.+|.+++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+
T Consensus       763 ~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~  841 (1153)
T PLN03210        763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTF  841 (1153)
T ss_pred             cccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccc
Confidence                 1122223345789999999998877899999999999999999986555888776 7999999999988654333

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=9.6e-23  Score=244.60  Aligned_cols=267  Identities=25%  Similarity=0.262  Sum_probs=168.9

Q ss_pred             cCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccC
Q 001384          104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSL  183 (1088)
Q Consensus       104 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~  183 (1088)
                      .-..|||++|.++ .+|..+.  ++|+.|+|++|+|+....  .+++|++|+|++|+|+                     
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~--lp~~Lk~LdLs~N~Lt---------------------  255 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA--LPPELRTLEVSGNQLT---------------------  255 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC--CCCCCcEEEecCCccC---------------------
Confidence            3556778888777 5676664  367777777777665332  1345555555555554                     


Q ss_pred             ccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCccc
Q 001384          184 NNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE  263 (1088)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~  263 (1088)
                          .. |.   ..++|+.|++++|.++. ++..                         ..+|+.|++++|+++ .+|..
T Consensus       256 ----sL-P~---lp~sL~~L~Ls~N~L~~-Lp~l-------------------------p~~L~~L~Ls~N~Lt-~LP~~  300 (788)
T PRK15387        256 ----SL-PV---LPPGLLELSIFSNPLTH-LPAL-------------------------PSGLCKLWIFGNQLT-SLPVL  300 (788)
T ss_pred             ----cc-cC---cccccceeeccCCchhh-hhhc-------------------------hhhcCEEECcCCccc-ccccc
Confidence                22 11   12345555555555441 1111                         123445555555554 23331


Q ss_pred             ccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccc
Q 001384          264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK  343 (1088)
Q Consensus       264 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  343 (1088)
                         .++|+.|+|++|++++ +|...   .+|+.|++++|++++ +|..   ..+|++|+|++|+|++.++ .        
T Consensus       301 ---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~-l--------  360 (788)
T PRK15387        301 ---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLPT-L--------  360 (788)
T ss_pred             ---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCCCCC-C--------
Confidence               3456666666666663 33322   345666677776654 3431   1367777777777764321 1        


Q ss_pred             eeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCC
Q 001384          344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN  423 (1088)
Q Consensus       344 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  423 (1088)
                                          .++|+.|++++|+++ .+|..   ..+|+.|++++|+|+ .+|..   .++|+.|++++|
T Consensus       361 --------------------p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N  412 (788)
T PRK15387        361 --------------------PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGN  412 (788)
T ss_pred             --------------------Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCC
Confidence                                134667777778777 45643   246888888999888 56654   357889999999


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhcc
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI  484 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~  484 (1088)
                      +|+ .+|...   .+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|+|.+|..+..+
T Consensus       413 ~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        413 RLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             cCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            998 577643   46788999999998 799999999999999999999999888876544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=209.87  Aligned_cols=248  Identities=22%  Similarity=0.358  Sum_probs=190.9

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          808 SEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      ....+|.+...|..|+|+++ |..+++|++....  ....++|..|.-.++-    +.||||+++++.|..+....++..
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lri----fshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRI----FSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceee----ecCCchhhhhhhccCCCCceEeee
Confidence            34467889999999999996 5667778776443  2334688888887775    679999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          886 YMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+.|+|+..+++...  .+..++.+++.++|+|++|||+. .+-|----+....|+||++.+++|. ++-++.     +
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kf-----s  340 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----S  340 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-ccccee-----e
Confidence            9999999999998764  67889999999999999999997 3233344688999999999988874 222221     1


Q ss_pred             cccccccccccccCccccCCCCCC---cchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQAT---TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........+.||+||.++..+.+   .++|+|||++++||+.|...||.+..+...                 -+...+
T Consensus       341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------------gmkial  403 (448)
T KOG0195|consen  341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------------GMKIAL  403 (448)
T ss_pred             eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------------hhhhhh
Confidence            112223456899999988776543   578999999999999999999987544111                 111122


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .+.+...|+.....+.+++.-|++.||.+||.++.|+-.||++.
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            23333345666778888999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2e-21  Score=200.06  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=196.6

Q ss_pred             CCCCccceecccCceEEEEEE-eCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      -.|+++++||+|+||+.+.|+ +-++++||||.-.....  .-+++.|.+..+.+.   ..+.|...|.|..++.+..+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~---g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLG---GTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHc---CCCCCCceeeeccccchhhhh
Confidence            368999999999999999999 34799999998765432  235667777666543   688999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-----CEEEeeccccee
Q 001384          884 YEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-----KALVTDFGLARV  957 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-----~~kl~Dfg~a~~  957 (1088)
                      +|.+ |-+|+|++.=. ++++.+++..+|.|++.-++|+|++   .+|+|||||+|+||...+     .+.++|||+|+.
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999 66999988654 4699999999999999999999999   999999999999997443     588999999998


Q ss_pred             ecCCCCcc------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          958 VSAGDSHV------STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       958 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      +.+.....      .....||.+||+-....+.+.+.+.|+-|+|-++++++.|..||++........     .|+..++
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-----kYeKIGe  253 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-----KYEKIGE  253 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-----HHHHhcc
Confidence            87654332      334679999999999999999999999999999999999999999864321111     1111222


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .+..-+.....      ...+.++..-++-.-..+-.+-|..+-+...+..+++
T Consensus       254 ~Kr~T~i~~Lc------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  254 TKRSTPIEVLC------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             ccccCCHHHHH------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            22222211111      1123344444444445577778888888777777654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.9e-21  Score=217.25  Aligned_cols=260  Identities=22%  Similarity=0.264  Sum_probs=192.6

Q ss_pred             CCCccceecccCceEEEEEEeCCC--cEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE-ecCCeEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDG--REVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC-LDGSEKIL  882 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~-~~~~~~~l  882 (1088)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|..++..+.....-+++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  478888887653332226677777777643211236888888888 47788999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-----CCEEEeecccc
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-----GKALVTDFGLA  955 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-----~~~kl~Dfg~a  955 (1088)
                      ||+.+ |.+|.++.+..  ++++..++.+++.|++.+|+++|+.   |++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 66999988544  4799999999999999999999999   99999999999999865     36899999999


Q ss_pred             e--eecCCCC----cc---cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhh
Q 001384          956 R--VVSAGDS----HV---STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVM 1024 (1088)
Q Consensus       956 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~ 1024 (1088)
                      +  .+.....    ..   .....||.+|.+++...+.+.+.+.|+||++.++.|+..|..||......  .........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  3322211    11   22456999999999999999999999999999999999999999765431  111111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .        .....     .   ....+..+.++...+-..+...+|....+...++.+..
T Consensus       255 ~--------~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  255 K--------LLTDR-----F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h--------hcccc-----c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0        00000     0   11122344444445555899999999999999887754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.6e-21  Score=217.37  Aligned_cols=164  Identities=25%  Similarity=0.248  Sum_probs=127.8

Q ss_pred             HcCCCCccceecccCceEEEEEEeC--CCcEEEEEEccccC-----ccchHHHHHHHHHHhCCCCCCCCCceeE-EeeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP--DGREVAVKKLQREG-----LEGEREFRAEMEVLSGNGFGWPHPNLVT-LYGWC  874 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~~l~h~niv~-l~~~~  874 (1088)
                      ..++|.+.+.||+|+||+||+|.++  +++.||||+.....     ......+.+|++++.+    +.|+|+++ ++++ 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~----L~h~~iv~~l~~~-   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKT----VRGIGVVPQLLAT-   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHh----ccCCCCCcEEEEc-
Confidence            4567999999999999999999865  47778999875331     1224568999999997    67999985 4432 


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEEcCCCCEEEeecc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV-KASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL-kp~NIll~~~~~~kl~Dfg  953 (1088)
                         +..|+||||++|++|... ...   .   ...++.|+++||+|+|++   +|+|||| ||+||+++.++.+||+|||
T Consensus        91 ---~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence               457999999999999732 111   1   246889999999999999   9999999 9999999999999999999


Q ss_pred             cceeecCCCCcc-------cccccccccccCccccCCC
Q 001384          954 LARVVSAGDSHV-------STTIAGTVGYVAPEYGQTW  984 (1088)
Q Consensus       954 ~a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  984 (1088)
                      +|+.+.......       -....++..|+|||++...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999775432111       1345678889999986643

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=2e-21  Score=235.30  Aligned_cols=42  Identities=7%  Similarity=-0.043  Sum_probs=32.9

Q ss_pred             hcccCCCchhhHHHHHHHHhhcccCCCCCcccccc----cCCCCCCcccCC
Q 001384           25 THVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQ----WNQSSSPCEWPG   71 (1088)
Q Consensus        25 ~~~~~~~~~~d~~~l~~~~~~~~~~~~~~~~~~~s----W~~~~~~C~W~g   71 (1088)
                      ||..+.+...+.+.++.+++.+..     ++.+++    |+.++|+|-=..
T Consensus        54 ~~~~~~~~~~~~~~~~~~~~~l~~-----p~~~~~~~~~~~~~~~fc~~~~   99 (754)
T PRK15370         54 CHPPETASPEEIKSKFECLRMLAF-----PAYADNIQYSRGGADQYCILSE   99 (754)
T ss_pred             hCCCCCCCHHHHHHHHHHHHHhcC-----CchhhccccccCCCCcccccCC
Confidence            677888888899999999999964     234555    999999997544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-21  Score=191.62  Aligned_cols=259  Identities=21%  Similarity=0.293  Sum_probs=190.0

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|.++++||.|+||.+|.|.. .+|++||||+-.....  .-++..|.++...++   .-..|..+..+..+.....+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~---~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQ---GGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhc---cCCCCchhhhhcccccccee
Confidence            47899999999999999999994 5899999998876532  234555666655543   34456666777788888999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE---GKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~---~~~kl~Dfg~a~~~  958 (1088)
                      |||.. |.+|.+++.- .+.++..+++-+|-|++.-++|+|.+   ++|||||||+|+|..-+   ..+.++|||+|+.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999 6699998864 34699999999999999999999999   89999999999999643   46889999999987


Q ss_pred             cCCCCcc------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCC
Q 001384          959 SAGDSHV------STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGP 1031 (1088)
Q Consensus       959 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 1031 (1088)
                      .+.....      .....||.+|.+-....+.+.+.+.|+-|+|.++..+-.|..||++.....- +-+..+.. ..   
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E-kK---  240 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE-KK---  240 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH-hh---
Confidence            6533221      3456799999988877777888999999999999999999999998644211 11111110 00   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                       .......+.       ...+.++...+.-|-...-++-|+..-+-+.+.-+
T Consensus       241 -~s~~ie~LC-------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  241 -MSTPIEVLC-------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             -cCCCHHHHh-------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence             000111111       12245666666677777777778777666665544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=2.9e-22  Score=234.60  Aligned_cols=254  Identities=22%  Similarity=0.226  Sum_probs=188.1

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      +|...+.+|++.|=+|.+|++++|. |+||++-+.... .-+.+.++++-.+..  .++|||++++.-+-..+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~--l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFA--LMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHH--hhcCCcccchHHHHHhhHHHHHHH
Confidence            5677789999999999999998887 999998765422 234444444433321  268999999999888888889999


Q ss_pred             EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc
Q 001384          885 EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH  964 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  964 (1088)
                      +|..+ +|+|.+..+..+..-+.+.|+.|++.|+.-+|..   ||+|||||.+||||++-.-+.|+||..-+...-.+..
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            99977 9999999988899999999999999999999999   9999999999999999999999999876543222222


Q ss_pred             c--cccc----cccccccCccccCCC----------C-CCcchhHHHHHHHHHHHHhC-CcCCCCCchhHHHHHHhhhcc
Q 001384          965 V--STTI----AGTVGYVAPEYGQTW----------Q-ATTKGDVYSFGVLAMELATG-RRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       965 ~--~~~~----~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      +  ...+    ..-..|.|||.+...          . .+++.||||+||+++|+++- ++||.-         .+...|
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aY  247 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAY  247 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhH
Confidence            1  1222    223479999965431          2 56789999999999999984 666652         112222


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ....  . ..+..+...      -+...+.+++..|++.||++|.+++|.++....+.
T Consensus       248 r~~~--~-~~~e~~Le~------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  248 RSGN--A-DDPEQLLEK------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             hccC--c-cCHHHHHHh------CcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            2221  1 111111111      11126888999999999999999999999876553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=7.7e-22  Score=234.77  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=187.3

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEcccc--CccchHH----HHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          809 EDRIIGKGGFGTVYRGVLP-DGREVAVKKLQRE--GLEGERE----FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~----~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ..+++|.|++|.|+.+... ..+.++.|.+...  ....+..    +..|+-+-.    .++|||++..+..+.+....+
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~----~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGS----SLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecc----cccCCchhhhHHHHhhcccch
Confidence            3578999999988887754 3444455444311  1122222    233333332    488999988887777766666


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      -+||||++ +|..++....+++..++..+++|+..|++|+|.+   ||.|||+|++|++++.+|.+||+|||.+..+...
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            66999999 9999999888899999999999999999999999   9999999999999999999999999999887654


Q ss_pred             CC---cccccccccccccCccccCCCCCCc-chhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          962 DS---HVSTTIAGTVGYVAPEYGQTWQATT-KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       962 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ..   ......+|+..|+|||++...+|++ ..||||.|++++.|.+|+.||........++  ....+..+..      
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~~~------  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQRN------  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccccc------
Confidence            33   4456678999999999999988876 5799999999999999999998764432222  0000111010      


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ............+.+-..++.+|++.||.+|.++++|++
T Consensus       546 --~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 --IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              001111123344567788899999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=3.6e-19  Score=202.52  Aligned_cols=256  Identities=30%  Similarity=0.441  Sum_probs=197.8

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCC-ceeEEeeEEecCCeEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHP-NLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~-niv~l~~~~~~~~~~~l  882 (1088)
                      |...+.||.|+||.||++.+.  ..+++|.+.......   ...+.+|+..+..    +.|+ +++++++++......++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~----~~~~~~i~~~~~~~~~~~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILAS----LNHPPNIVKLYDFFQDEGSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHH----ccCCcceeeEEEEEecCCEEEE
Confidence            667789999999999999986  789999998764332   5678889888876    5566 79999999987788899


Q ss_pred             EEEecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~  958 (1088)
                      ++||+.++++.+++....   .++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.+
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            999999999998887765   799999999999999999999999   999999999999999998 7999999999866


Q ss_pred             cCCCCc-----ccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCC
Q 001384          959 SAGDSH-----VSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGR 1028 (1088)
Q Consensus       959 ~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~ 1028 (1088)
                      ......     ......++..|+|||....   ..+....|+|++|++++++++|..||......  ..+..........
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            543322     2456789999999998887   58889999999999999999999998765420  1111111110000


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       ..........       ........+.+++.+|+..+|..|.++.+....
T Consensus       233 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 -PSLASPLSPS-------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -cccccccCcc-------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             0000000000       001223567788889999999999998887653

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=8.9e-21  Score=229.64  Aligned_cols=96  Identities=27%  Similarity=0.436  Sum_probs=48.9

Q ss_pred             cCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccc
Q 001384          367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN  446 (1088)
Q Consensus       367 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  446 (1088)
                      |+.|+|++|+++ .+|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|++++
T Consensus       243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~  313 (754)
T PRK15370        243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQS  313 (754)
T ss_pred             ccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcC
Confidence            445555555554 3444432  34555555555555 3444332  35556666666655 3444332  3455556666


Q ss_pred             cccccCCCccccCCCCCCeEEccCCcCc
Q 001384          447 NSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       447 N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      |+++ .+|..+.  ++|+.|++++|.++
T Consensus       314 N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt  338 (754)
T PRK15370        314 NSLT-ALPETLP--PGLKTLEAGENALT  338 (754)
T ss_pred             Cccc-cCCcccc--ccceeccccCCccc
Confidence            6665 3444332  45566666666555

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.1e-19  Score=186.77  Aligned_cols=139  Identities=20%  Similarity=0.239  Sum_probs=106.3

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCcc--c-------h-----------------HHHHHHHHHHhCCCCCCC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--G-------E-----------------REFRAEMEVLSGNGFGWP  863 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~~~~~l~  863 (1088)
                      ...||+|+||.||+|.+.+|+.||||+++.....  .       .                 .....|++.+.++    .
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~   77 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL----V   77 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH----H
Confidence            4679999999999999888999999999764221  1       0                 1123477777763    3


Q ss_pred             CCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEEc
Q 001384          864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       864 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ++++.....+..  ...++||||++++++........++++.++..++.|++.+|+|+ |+.   +|+||||||+||+++
T Consensus        78 ~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          78 TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            444422222111  22389999999988776544456789999999999999999999 687   999999999999998


Q ss_pred             CCCCEEEeecccceee
Q 001384          943 KEGKALVTDFGLARVV  958 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~  958 (1088)
                       ++.++++|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=1.4e-19  Score=187.14  Aligned_cols=172  Identities=16%  Similarity=0.171  Sum_probs=133.0

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHH---------HHHHHHHHhCCCCCCCCCceeEEee
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE---------FRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      -..++|+..+++|.|+||.||.+.. ++..+|||.+.......++.         +.+|+..+.+    +.|++|..+.+
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~r----L~~~GI~~~~d  102 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDR----VRSEGLASLND  102 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHH----HHHCCCCcceE
Confidence            3468999999999999999999766 57789999998654333332         5788887776    57999999988


Q ss_pred             EEecC--------CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          873 WCLDG--------SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       873 ~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++...        ...++||||++|.+|.++..    +++    ....+++.++..+|+.   |++|||++|+||+++.+
T Consensus       103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            86533        35789999999999988742    233    2456999999999999   99999999999999998


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELA 1003 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 1003 (1088)
                      + ++++|||...........  .           .+.....|..++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence            8 999999988654211110  0           0333445667999999999887664

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.4e-18  Score=175.40  Aligned_cols=186  Identities=18%  Similarity=0.143  Sum_probs=140.4

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEccccCccch----HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE----REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      +...|++|+||+||.+.. .+.+++.+.+.......+    ..+.+|++++.++.   +|+++.+++++    ...+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~---~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD---GLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC---CCCCCCEEEEE----cCEEEEE
Confidence            457899999999997776 678888887776533211    24789999999853   46888888886    3468999


Q ss_pred             EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV-KASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+.|.+|......       ....++.|++.+++++|++   ||+|||| ||+||+++.++.++|+|||+|........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99999999765421       1245788999999999999   9999999 79999999999999999999986543221


Q ss_pred             c----c--------cccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCcCCCCC
Q 001384          964 H----V--------STTIAGTVGYVAPEYGQ--TWQATTKGDVYSFGVLAMELATGRRALEGG 1012 (1088)
Q Consensus       964 ~----~--------~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~ 1012 (1088)
                      .    .        ......++.|++|+...  ...--...++++-|+.+|.++|++.++-+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0    0        11123577788887322  222235679999999999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.8e-18  Score=178.82  Aligned_cols=140  Identities=21%  Similarity=0.207  Sum_probs=108.9

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccc--------------------------hHHHHHHHHHHhCCCCCCC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG--------------------------EREFRAEMEVLSGNGFGWP  863 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~~~~~l~  863 (1088)
                      .+.||+|++|.||+|.+.+|+.||||+++......                          ......|.+.+.+    +.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~   77 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR----LY   77 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH----HH
Confidence            47899999999999998789999999988652110                          1123467777765    45


Q ss_pred             CCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEc
Q 001384          864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       864 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~  942 (1088)
                      |+++.....+...  ..++||||++|+++........+++..++.+++.|++.++.|+|+ .   ||+||||||+||+++
T Consensus        78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            7766433333322  248999999988655433344568889999999999999999999 8   999999999999998


Q ss_pred             CCCCEEEeecccceeec
Q 001384          943 KEGKALVTDFGLARVVS  959 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~  959 (1088)
                       ++.++++|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             8999999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=8.9e-20  Score=205.11  Aligned_cols=226  Identities=28%  Similarity=0.332  Sum_probs=182.5

Q ss_pred             eecccCceEEEEEEe----CCCcEEEEEEccccCccch--HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          812 IIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      ++|+|+||.|+.++.    ..|.-+|.|+.++......  .....|..++....   .||.+|++...+..+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~---~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH---NTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc---CCCceeeeeeeeccccchhHhhh
Confidence            379999999998763    2467788888876543222  13444555555432   59999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |..||.+...+.....+++.....+...++-+++++|+.   +|+|||+|++||+++.+|++++.|||+++..-....  
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999999999998888899999999999999999999999   999999999999999999999999999886543222  


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                         .+||..|||||++.  .....+|+||||++++||+||..||..      +..+.+.                 ....
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il-----------------~~~~  204 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRIL-----------------KAEL  204 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHh-----------------hhcc
Confidence               28999999999998  567889999999999999999999986      2222222                 1112


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      ..+......+.+++.++...+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2355666778888889999999999855

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.7e-18  Score=208.84  Aligned_cols=249  Identities=19%  Similarity=0.178  Sum_probs=188.3

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-.   -.+++..++ .      .--+-|.++..++...+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~------~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-P------QMLPSIMHISSAHVFQN  767 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-h------hhhcchHHHHHHHccCC
Confidence            3456788999999999999999998889999999987653221   122222222 1      12355667777777788


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-------CCCCEEEee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-------KEGKALVTD  951 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-------~~~~~kl~D  951 (1088)
                      ..++|+||.+.|+|.|++...+.++|.-++.++.|+++.+++||..   +||||||||+|.|+.       ....++|+|
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            8899999999999999999888899999999999999999999999   999999999999995       344699999


Q ss_pred             cccceeecCC-CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC
Q 001384          952 FGLARVVSAG-DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       952 fg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1088)
                      ||.+..+..- +.......++|..+-.+|+..++++++.+|.|.++.+++-|+.|++--...              +..+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~--------------g~~~  910 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKN--------------GSSW  910 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcC--------------Ccce
Confidence            9998765432 233455678899999999999999999999999999999999988542000              0000


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .....++..          .......+++..+|++|-..=|...++...|++++
T Consensus       911 ~~~~~~~Ry----------~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  911 MVKTNFPRY----------WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             eccccchhh----------hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence            001001110          11123445666788888888889999999888875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.9e-18  Score=181.85  Aligned_cols=196  Identities=20%  Similarity=0.268  Sum_probs=141.1

Q ss_pred             CCCCceeEEeeEEec---------------------------CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHH
Q 001384          862 WPHPNLVTLYGWCLD---------------------------GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDV  914 (1088)
Q Consensus       862 l~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi  914 (1088)
                      -+|||||++.++|.+                           +...|+||...+. +|..++..+. .+....+-+..|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence            379999999988753                           2356899999876 9999997766 4666677799999


Q ss_pred             HHHHHHHHhcCCCCeEecCCCCCCEEEc--CCC--CEEEeecccceeecCCC---Ccc--cccccccccccCccccCCCC
Q 001384          915 ARALVFLHHECYPPIVHRDVKASNVLLD--KEG--KALVTDFGLARVVSAGD---SHV--STTIAGTVGYVAPEYGQTWQ  985 (1088)
Q Consensus       915 ~~~L~yLH~~~~~~ivH~DLkp~NIll~--~~~--~~kl~Dfg~a~~~~~~~---~~~--~~~~~gt~~y~aPE~~~~~~  985 (1088)
                      ++|+.|||.+   ||.|||+|.+||++.  +|+  .+.|+|||.+---....   .+.  .-...|...-||||+....+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999   999999999999995  333  46789999864321100   011  11234667789999865432


Q ss_pred             C------CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHH
Q 001384          986 A------TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIG 1059 (1088)
Q Consensus       986 ~------~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1059 (1088)
                      -      -.|+|.|+.|.+.||+++...||.+..+...+-..         ......        ..-++.++..+.+++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---------Yqe~qL--------Palp~~vpp~~rqlV  490 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---------YQESQL--------PALPSRVPPVARQLV  490 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---------hhhhhC--------CCCcccCChHHHHHH
Confidence            1      35899999999999999999999875543222211         011111        122455667788899


Q ss_pred             hhhcccCCCCCCCHHHHHHH
Q 001384         1060 VRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1060 ~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                      ...+++||.+|++..-....
T Consensus       491 ~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHhcCCccccCCccHHHhH
Confidence            99999999999987654443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=1.5e-20  Score=175.67  Aligned_cols=179  Identities=28%  Similarity=0.496  Sum_probs=128.2

Q ss_pred             ccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCC
Q 001384          385 ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLL  464 (1088)
Q Consensus       385 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  464 (1088)
                      +.++..++.|.|++|+++ .+|..+..+.+|+.|++++|+++ .+|.++..+++|+.|+++-|++. .+|..||.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            335667788888888888 77778888889999999999998 78889999999999999999998 7899999999999


Q ss_pred             eEEccCCcCcc-CCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcc
Q 001384          465 WLNLSNNKLSG-NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLL  543 (1088)
Q Consensus       465 ~L~L~~N~l~g-~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  543 (1088)
                      +|||..|++.. .+|..++.+                                                           
T Consensus       106 vldltynnl~e~~lpgnff~m-----------------------------------------------------------  126 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYM-----------------------------------------------------------  126 (264)
T ss_pred             hhhccccccccccCCcchhHH-----------------------------------------------------------
Confidence            99999998862 122211111                                                           


Q ss_pred             cCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccc
Q 001384          544 KGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSG  623 (1088)
Q Consensus       544 ~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~  623 (1088)
                                        ..++.|+|+.|.|. .+|+++|++++|+.|.+..|.+-                        
T Consensus       127 ------------------~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll------------------------  163 (264)
T KOG0617|consen  127 ------------------TTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL------------------------  163 (264)
T ss_pred             ------------------HHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh------------------------
Confidence                              01223455555555 56666666666555555555544                        


Q ss_pred             cCCccccCCccCcEEEccccccCCcCCccccccccc---ceeeccCCCC
Q 001384          624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTEL---SKLNISYNPL  669 (1088)
Q Consensus       624 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L---~~l~l~~N~l  669 (1088)
                      .+|.+++.|++|++|.+.+|+++ .+|.+++++.-.   +.+.+..|||
T Consensus       164 ~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  164 SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCC
Confidence            67888888888888888888887 677777766422   3445566666

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=5e-18  Score=180.96  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=144.1

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCC-------CCceeEEeeEEe
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWP-------HPNLVTLYGWCL  875 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~-------h~niv~l~~~~~  875 (1088)
                      +...+.||.|+++.||.+.+. +++++|||++......   ..+++++|.-...... ..+       |-.++-.++...
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~-~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFP-GVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGST-T--SHHHHHHHH-B---SEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhc-cCCCHHHHHHhceEEeeeEEEE
Confidence            445688999999999999987 5899999998754322   2245566554443311 000       112222222111


Q ss_pred             ---------cC---Ce-----EEEEEEecCCCCHHHHHh---hcCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001384          876 ---------DG---SE-----KILVYEYMEGGSLEDIIS---DRTR----LTWRRRLDIAIDVARALVFLHHECYPPIVH  931 (1088)
Q Consensus       876 ---------~~---~~-----~~lv~e~~~~gsL~~~l~---~~~~----l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  931 (1088)
                               ..   ..     .+++|+-+.+ +|.+++.   ....    +....+..+..|+++.+++||+.   |+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     11   12     2577888854 8888764   2221    33444566779999999999999   9999


Q ss_pred             cCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCC--------CCCCcchhHHHHHHHHHHHH
Q 001384          932 RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT--------WQATTKGDVYSFGVLAMELA 1003 (1088)
Q Consensus       932 ~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ell 1003 (1088)
                      +||+|+|++++.+|.+.++||+.....+.  ....  ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999988765432  1111  334578999996533        35788999999999999999


Q ss_pred             hCCcCCCCCchh-HHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCC
Q 001384         1004 TGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNAR 1070 (1088)
Q Consensus      1004 tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1070 (1088)
                      +|+.||...... ..+|                   ....+    . +.++.+..+|..+++++|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~~C----~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFSRC----R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGTTS----S----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cchhc----C-CcCHHHHHHHHHHccCCcccC
Confidence            999999865331 1111                   11111    2 556778889999999999988

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=5e-20  Score=172.10  Aligned_cols=185  Identities=31%  Similarity=0.488  Sum_probs=133.9

Q ss_pred             cCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccce
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKI  344 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  344 (1088)
                      .++.+.+.|.|++|+++ .+|+.+..+.+|+.|++++|++.. +|.++..+++|+.|+++-|++. ..            
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~l------------   94 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-IL------------   94 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cC------------
Confidence            34555666666666666 566666666666666666666654 5666667777777776666654 22            


Q ss_pred             eecCcCcccCCCCCccccCCCCcCEEEccCCccC-CCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCC
Q 001384          345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT-GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN  423 (1088)
Q Consensus       345 L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  423 (1088)
                                   +.+|+.+|.|+.|||++|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|
T Consensus        95 -------------prgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen   95 -------------PRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             -------------ccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence                         233444555555555555553 367788888899999999999998 88889999999999999999


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCC---CeEEccCCcCccCCCch
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSL---LWLNLSNNKLSGNIPPE  480 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L---~~L~L~~N~l~g~ip~~  480 (1088)
                      .+- .+|..++.++.|++|++.+|+++ .+|++++++.-+   +++.+.+|++...|-+.
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQ  218 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQ  218 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHH
Confidence            988 79999999999999999999998 788888876432   55677788876554443

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=5.2e-17  Score=168.18  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=107.6

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCceeEEeeEEecCC---e-EEE
Q 001384          808 SEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVTLYGWCLDGS---E-KIL  882 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~niv~l~~~~~~~~---~-~~l  882 (1088)
                      .-.+.||+|+||.||.  +.+....+||++........+++.+|+++++.+.. ...||||+++++++.++.   . +.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  44333347998876544556789999999987421 126899999999998864   3 337


Q ss_pred             EEEe--cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCEEEcC----CCCEEEeecccc
Q 001384          883 VYEY--MEGGSLEDIISDRTRLTWRRRLDIAIDVARAL-VFLHHECYPPIVHRDVKASNVLLDK----EGKALVTDFGLA  955 (1088)
Q Consensus       883 v~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~ivH~DLkp~NIll~~----~~~~kl~Dfg~a  955 (1088)
                      |+||  +.+|+|.+++++. .+++.  ..++.|++.++ +|||++   +||||||||+||+++.    ++.++|+||+.+
T Consensus        83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            8999  5579999999764 46655  35678888777 999999   9999999999999974    347999994433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.71  E-value=4e-17  Score=184.90  Aligned_cols=212  Identities=30%  Similarity=0.429  Sum_probs=161.1

Q ss_pred             CCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCCCCCE
Q 001384          862 WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPI-VHRDVKASNV  939 (1088)
Q Consensus       862 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-vH~DLkp~NI  939 (1088)
                      +.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. .-++++.-...+.++|+.||+|+|..   +| .|+.++++|+
T Consensus         4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSSNC   80 (484)
T ss_pred             cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccccc
Confidence            6899999999999999999999999999999999977 44689999999999999999999998   44 9999999999


Q ss_pred             EEcCCCCEEEeecccceeecCC-CCcccccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHhCCcCCCC
Q 001384          940 LLDKEGKALVTDFGLARVVSAG-DSHVSTTIAGTVGYVAPEYGQTW-------QATTKGDVYSFGVLAMELATGRRALEG 1011 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~elltg~~p~~~ 1011 (1088)
                      ++|..+.+|++|||+....... +........-..-|.|||.+...       ..+.+.||||||++++|+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421 11112222345679999987653       146779999999999999999999986


Q ss_pred             Cch--hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1012 GEE--CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1012 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ...  ...+...+...     .......+.+..     ..+...++..++.+||..+|.+||+++.|-..++.+.+.
T Consensus       161 ~~~~~~~~eii~~~~~-----~~~~~~rP~i~~-----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKK-----GGSNPFRPSIEL-----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccCChHHHHHHHHh-----cCCCCcCcchhh-----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            432  21222222221     011111111100     012333688899999999999999999999999887653

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.70  E-value=5.3e-19  Score=200.02  Aligned_cols=277  Identities=25%  Similarity=0.239  Sum_probs=132.6

Q ss_pred             EEeccCccCC-CCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcc
Q 001384          178 VANLSLNNLT-GRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF  256 (1088)
Q Consensus       178 ~L~L~~n~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  256 (1088)
                      .|+|..+.++ ......+..+.+|+.|+++++.+++.....+                  ...+...+++++|+++++.+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i------------------~~~l~~~~~l~~l~l~~~~~   63 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKAL------------------ASALRPQPSLKELCLSLNET   63 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHH------------------HHHHhhCCCceEEecccccc
Confidence            3566667776 3344555666677777777777654211110                  11122333455555555544


Q ss_pred             c------ccCcccccCCCCCcEEEccCccccCCCccccCCCCC---CCEEeCCCCcCCc----cCcccccCC-CCCcEEE
Q 001384          257 I------GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG---LEALFLGKNNFLS----VIPESLLNL-SKLEVLD  322 (1088)
Q Consensus       257 ~------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~  322 (1088)
                      .      ..++..+.++++|+.|++++|.+.+..+..+..+.+   |++|++++|++.+    .+...+..+ ++|+.|+
T Consensus        64 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~  143 (319)
T cd00116          64 GRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV  143 (319)
T ss_pred             CCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence            3      122344555566666666666665444444444333   6666666666552    222334444 5666666


Q ss_pred             cCCCcCCCchh----HhhhcccccceeecCcCcccCCCC---CccccCCCCcCEEEccCCccCCCC----CccccCCcCc
Q 001384          323 LSSNNFGGEVQ----KIFGRFTQVKILALHSNSYIDGMN---SSGILKLPNISRLDLSHNNFTGPL----PVEISQMRSL  391 (1088)
Q Consensus       323 L~~N~l~~~~~----~~~~~l~~L~~L~L~~n~~~~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L  391 (1088)
                      +++|.+++...    ..+..+++|+.|++++|.+.+...   ...+..+++|+.|+|++|.+++..    +..+..+++|
T Consensus       144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            66666664322    223333444444444444322110   111223345566666665554321    2233445556


Q ss_pred             ceeeccccccCCcCCcccC-----CCCCCcEEEccCCcCCC----CCCccccCCCCCcEEEccccccccC----CCcccc
Q 001384          392 KFLILAHNRFNGSIPAVYG-----NMPNLQTLDLSFNELTG----PIPPSIGNLTSLLWLMLANNSLSGE----IPGEIG  458 (1088)
Q Consensus       392 ~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~  458 (1088)
                      ++|++++|.+++..+..+.     ..+.|+.|++++|.+++    .+...+..+++|+++++++|.++..    +...+.
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~  303 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL  303 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence            6666666655532111111     12456666666665541    2233344445566666666665532    222333


Q ss_pred             CC-CCCCeEEccCCc
Q 001384          459 NC-TSLLWLNLSNNK  472 (1088)
Q Consensus       459 ~l-~~L~~L~L~~N~  472 (1088)
                      .. +.|++|++.+|+
T Consensus       304 ~~~~~~~~~~~~~~~  318 (319)
T cd00116         304 EPGNELESLWVKDDS  318 (319)
T ss_pred             hcCCchhhcccCCCC
Confidence            33 455555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.69  E-value=1.3e-18  Score=196.88  Aligned_cols=252  Identities=21%  Similarity=0.244  Sum_probs=189.5

Q ss_pred             cccCcccccccccccccCCCccCEEEcCCCcccc----cCcccccCCCCCcEEEccCccccC------CCccccCCCCCC
Q 001384          225 SVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG----DFPGEVSNCRNLVVLNLFGNNFSG------PIPAEIGSISGL  294 (1088)
Q Consensus       225 ~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L  294 (1088)
                      +|..+.+++.-....|..+.+|++|+++++.++.    .++..+...++|++|+++++.+.+      .++..+..+++|
T Consensus         4 ~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L   83 (319)
T cd00116           4 SLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGL   83 (319)
T ss_pred             ccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCce
Confidence            3444444433334455666678899999988753    356677788999999999998872      234567788999


Q ss_pred             CEEeCCCCcCCccCcccccCCCC---CcEEEcCCCcCCCc----hhHhhhcc-cccceeecCcCcccCCC---CCccccC
Q 001384          295 EALFLGKNNFLSVIPESLLNLSK---LEVLDLSSNNFGGE----VQKIFGRF-TQVKILALHSNSYIDGM---NSSGILK  363 (1088)
Q Consensus       295 ~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~n~~~~~~---~~~~~~~  363 (1088)
                      +.|++++|.+.+..+..+..+.+   |++|++++|++++.    +...+..+ ++|+.|++++|.+....   ....+..
T Consensus        84 ~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~  163 (319)
T cd00116          84 QELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRA  163 (319)
T ss_pred             eEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHh
Confidence            99999999998777777766665   99999999999843    33445667 89999999999876321   2234556


Q ss_pred             CCCcCEEEccCCccCCC----CCccccCCcCcceeeccccccCCc----CCcccCCCCCCcEEEccCCcCCCCCCcccc-
Q 001384          364 LPNISRLDLSHNNFTGP----LPVEISQMRSLKFLILAHNRFNGS----IPAVYGNMPNLQTLDLSFNELTGPIPPSIG-  434 (1088)
Q Consensus       364 l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-  434 (1088)
                      +++|++|++++|.+++.    ++..+..+++|+.|++++|.+++.    ++..+..+++|++|++++|++++.....+. 
T Consensus       164 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~  243 (319)
T cd00116         164 NRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS  243 (319)
T ss_pred             CCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHH
Confidence            78999999999999853    333455667999999999999753    345567789999999999999863333332 


Q ss_pred             ----CCCCCcEEEccccccc----cCCCccccCCCCCCeEEccCCcCccC
Q 001384          435 ----NLTSLLWLMLANNSLS----GEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       435 ----~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                          ..+.|++|++++|.++    ..+...+..+++|+++++++|.++..
T Consensus       244 ~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         244 ALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             HHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence                2479999999999997    23455677779999999999999843

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.6e-16  Score=168.98  Aligned_cols=144  Identities=21%  Similarity=0.231  Sum_probs=111.6

Q ss_pred             CCCCccceecccCceEEEEEE--eCCCcEEEEEEccccCcc------------------------chHHHHHHHHHHhCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGV--LPDGREVAVKKLQREGLE------------------------GEREFRAEMEVLSGN  858 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~~  858 (1088)
                      .-|++.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  458999999998754211                        012356788888764


Q ss_pred             CCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCC
Q 001384          859 GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP-IVHRDVKAS  937 (1088)
Q Consensus       859 ~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-ivH~DLkp~  937 (1088)
                      ..  .+..+.+++++    ...++||||++++++..+..........++..++.|++.+++|||+.   + |+||||||+
T Consensus       108 ~~--~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      108 YE--AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             Hh--cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            31  12333444443    23489999999988877654445567777889999999999999999   8 999999999


Q ss_pred             CEEEcCCCCEEEeecccceee
Q 001384          938 NVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       938 NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ||+++ ++.++++|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=1.5e-16  Score=187.45  Aligned_cols=212  Identities=21%  Similarity=0.296  Sum_probs=147.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..+|+.++.|-.|+||.||.++++ ..+.+|.| +.+..     -+.+-  ++..    -..|.+|              
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~----a~npfvv--------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTF----AGNPFVV--------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccc----cCCccee--------------
Confidence            357888999999999999999987 46678884 33321     11110  1111    1233333              


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC-
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~-  961 (1088)
                             |+-.+.++.-++++...        +.+++|+|+.   +|+|||+||+|.+|+.-|++|++|||++++-... 
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                   45556666555555443        7899999999   9999999999999999999999999987642110 


Q ss_pred             -----CC--------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhcc
Q 001384          962 -----DS--------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGY 1026 (1088)
Q Consensus       962 -----~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~ 1026 (1088)
                           +.        .....++||+.|+|||++....|...+|+|++|+++||++-|..||.+..+.  +.........+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                 00        1123568999999999999999999999999999999999999999987441  21221111111


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      ..    .              ......++.+++.+.++..|..|--....+
T Consensus       278 pE----~--------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  278 PE----E--------------DEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             cc----c--------------CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            10    0              112234677778899999999998544433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.3e-15  Score=161.02  Aligned_cols=134  Identities=27%  Similarity=0.439  Sum_probs=111.2

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCccc--------hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG--------EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.||+|++|.||+|.. .|..|++|+........        ...+.+|++++..    +.|+++.....++......++
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~~~~i~~p~~~~~~~~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSR----ARKAGVNVPAVYFVDPENFII   76 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHH----HHHCCCCCCeEEEEeCCCCEE
Confidence            5799999999999987 67889999866432211        2356778888876    568887766666667778899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ||||++|++|.+++.....    ++..++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999999865432    8889999999999999999   999999999999999 88999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=1e-15  Score=159.61  Aligned_cols=145  Identities=21%  Similarity=0.263  Sum_probs=110.4

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc----------------------chHHHHHHHHHHh
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE----------------------GEREFRAEMEVLS  856 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  856 (1088)
                      ++.+....|.+.+.||+|+||.||+|..++|+.||||++......                      .......|+..+.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444458888999999999999999888999999987643210                      0113556777776


Q ss_pred             CCCCCCCCC--ceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          857 GNGFGWPHP--NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       857 ~~~~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      .    +.|+  .+.+.++.    ...++||||++|++|.+....      .....++.+++.++.++|+.   +|+||||
T Consensus        89 ~----l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 A----LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             H----HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            5    3455  34444432    345899999999999876431      34567899999999999998   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||+||++++++.++|+|||++.....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=7.1e-17  Score=178.54  Aligned_cols=189  Identities=21%  Similarity=0.252  Sum_probs=134.3

Q ss_pred             CCccceecccCceEEEEEEeCC----CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEe------eEEe-
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY------GWCL-  875 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~------~~~~-  875 (1088)
                      ..+.+..+..+++.++..+...    ...++.+....+....-....+++-.+...   .+|+..+..-      ..+. 
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~---~~~~~s~~~d~~~s~~~~~~~  322 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDS---SHSNRSILEDLRPSLFESSKR  322 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheecc---ccCCcccccCCCCchhhhccc
Confidence            3445566777777777665432    233444544444312222223333333221   2344433211      0111 


Q ss_pred             ----cCCeEEEEEEecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          876 ----DGSEKILVYEYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       876 ----~~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                          .....|+.|++|+-.+|.+|+.++.   ..++.....++.|++.|++|   +   +.+|+|+||.||+...+..+|
T Consensus       323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhh
Confidence                1235689999999999999997544   46788889999999999999   5   899999999999999999999


Q ss_pred             EeecccceeecCCC-----CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 001384          949 VTDFGLARVVSAGD-----SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt 1004 (1088)
                      |.|||+........     ....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99999988766544     233456789999999999999999999999999999999986

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.61  E-value=2.5e-15  Score=157.26  Aligned_cols=131  Identities=27%  Similarity=0.449  Sum_probs=103.7

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          812 IIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .||+|+||.||+|.+ ++..|++|+.......        ...++.+|++++..    +.|+++.....++......++|
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~~~~i~~p~~~~~~~~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSR----ARKAGVNTPVVYDVDPDNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHH----HHHCCCCCCEEEEEECCCCEEE
Confidence            489999999999996 5788999986543211        12456778888876    4566554444444556667899


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      |||++|++|.+++.....       .++.+++.+|.++|+.   +++|||++|.||+++ ++.++++|||.+...
T Consensus        76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999999998755321       7899999999999999   999999999999999 899999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.60  E-value=4.1e-15  Score=178.94  Aligned_cols=137  Identities=26%  Similarity=0.396  Sum_probs=110.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEc-cccCc-------cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL-QREGL-------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ...|...+.||+|+||+||+|.+... .+++|+. .+...       .....+.+|++++..    ++|++++..+.++.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~~~~i~~p~~~~~  406 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSE----ARRAGVPTPVIYDV  406 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHh----hcccCCCeeEEEEE
Confidence            34456679999999999999997544 3444432 22111       112457889999987    67999888877777


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      .+...++||||+++++|.+++.        ....++.|++++++|||+.   +++||||||+||++ +++.++|+|||++
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            7777899999999999999885        4578999999999999999   99999999999999 6789999999998


Q ss_pred             ee
Q 001384          956 RV  957 (1088)
Q Consensus       956 ~~  957 (1088)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            65

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=2.3e-16  Score=173.89  Aligned_cols=189  Identities=30%  Similarity=0.466  Sum_probs=138.6

Q ss_pred             ceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       392 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      ...||+.|++. ++|..+..+-.|+.+.|++|.+. .+|+.++++..|++|||+.|+++ .+|..++.|+ |+.|-+++|
T Consensus        78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN  153 (722)
T KOG0532|consen   78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN  153 (722)
T ss_pred             hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence            45566666666 66666666666666666666666 66777777777777777777776 6666666664 677777777


Q ss_pred             cCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCccccc
Q 001384          472 KLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPV  551 (1088)
Q Consensus       472 ~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  551 (1088)
                      +++ .+|++++...                                                                  
T Consensus       154 kl~-~lp~~ig~~~------------------------------------------------------------------  166 (722)
T KOG0532|consen  154 KLT-SLPEEIGLLP------------------------------------------------------------------  166 (722)
T ss_pred             ccc-cCCcccccch------------------------------------------------------------------
Confidence            776 5666554111                                                                  


Q ss_pred             ccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccC
Q 001384          552 CLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGN  631 (1088)
Q Consensus       552 ~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~  631 (1088)
                                 .+..|+.+.|++. .+|..++.+.+|+.|.+..|++. .+|+++..|+|..||+|.|+++ .||-.|.+
T Consensus       167 -----------tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~  232 (722)
T KOG0532|consen  167 -----------TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRK  232 (722)
T ss_pred             -----------hHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ecchhhhh
Confidence                       1123566666666 67888888889999999999998 8888889999999999999999 99999999


Q ss_pred             CccCcEEEccccccCCcCCcccccccc---cceeeccC
Q 001384          632 IKCLQNLDLSYNNFSGPFPASFNNLTE---LSKLNISY  666 (1088)
Q Consensus       632 l~~L~~L~l~~N~l~g~~p~~~~~l~~---L~~l~l~~  666 (1088)
                      |+.|++|-|.+|.|. ..|..+...-+   .++|+.+-
T Consensus       233 m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA  269 (722)
T KOG0532|consen  233 MRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQA  269 (722)
T ss_pred             hhhheeeeeccCCCC-CChHHHHhccceeeeeeecchh
Confidence            999999999999998 67877655444   34444443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=3.7e-14  Score=146.71  Aligned_cols=138  Identities=22%  Similarity=0.274  Sum_probs=96.1

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccch--HHH----------------------HHHHHHHhCCCCCCCCC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REF----------------------RAEMEVLSGNGFGWPHP  865 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~E~~~l~~~~~~l~h~  865 (1088)
                      .+.||+|+||+||+|.+.+++.||||++........  ..+                      ..|.+.+.+..  -.+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY--EAGV   79 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH--HcCC
Confidence            467999999999999988899999999875422111  111                      23444443321  0112


Q ss_pred             ceeEEeeEEecCCeEEEEEEecCCCCHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcC
Q 001384          866 NLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLDK  943 (1088)
Q Consensus       866 niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~~  943 (1088)
                      .+.+.+++    ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. .   +|+||||||+||+++ 
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            23344432    24589999999954321 111111 11 6778999999999999999 7   999999999999999 


Q ss_pred             CCCEEEeecccceeec
Q 001384          944 EGKALVTDFGLARVVS  959 (1088)
Q Consensus       944 ~~~~kl~Dfg~a~~~~  959 (1088)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            9999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=3.4e-16  Score=172.52  Aligned_cols=191  Identities=32%  Similarity=0.499  Sum_probs=165.4

Q ss_pred             eeccccccCCcCCccc--CCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          394 LILAHNRFNGSIPAVY--GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       394 L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      |.|++-++. ..|..-  ..+.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..++++..|++|||+.|
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            445555554 333211  23455667899999999 89999999999999999999998 89999999999999999999


Q ss_pred             cCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCccccc
Q 001384          472 KLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPV  551 (1088)
Q Consensus       472 ~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  551 (1088)
                      +++ .+|..++.++                                                                  
T Consensus       132 qlS-~lp~~lC~lp------------------------------------------------------------------  144 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP------------------------------------------------------------------  144 (722)
T ss_pred             hhh-cCChhhhcCc------------------------------------------------------------------
Confidence            999 7888775431                                                                  


Q ss_pred             ccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCcccc
Q 001384          552 CLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFG  630 (1088)
Q Consensus       552 ~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~  630 (1088)
                                  |..|-+++|+++ .+|+.|+.++.|..||.+.|++. .+|+.++.+ +|+.|++.+|++. .+|++++
T Consensus       145 ------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~  209 (722)
T KOG0532|consen  145 ------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC  209 (722)
T ss_pred             ------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh
Confidence                        245889999999 89999999999999999999999 788888888 8999999999999 8999999


Q ss_pred             CCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          631 NIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       631 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      .| .|..||+|.|+++ .||.+|.+|+.|++|-|.+|||.+
T Consensus       210 ~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  210 SL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             CC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence            55 5899999999999 899999999999999999999964

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=2.8e-15  Score=178.86  Aligned_cols=253  Identities=21%  Similarity=0.231  Sum_probs=186.7

Q ss_pred             CCCCccceecccCceEEEEEEeCC--CcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD--GREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..|...+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-....   .|+|++++++...+....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s---~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS---KHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc---ccccccccCCccCCCccc
Confidence            356777889999999999988643  3456666665442  112233334555444322   399999999999999999


Q ss_pred             EEEEEecCCCCHHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCEEEcCCC-CEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDII-SDRT-RLTWRRRLDIAIDVARALVFLH-HECYPPIVHRDVKASNVLLDKEG-KALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~  956 (1088)
                      ++++||..++++.+.+ +... ..+...+-.++.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999999999988 6554 6788888999999999999999 76   999999999999999999 99999999998


Q ss_pred             eecC--CCCcccccccc-cccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          957 VVSA--GDSHVSTTIAG-TVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .+..  +........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.........+..+..        
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~--------  245 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS--------  245 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc--------
Confidence            8765  22333445677 9999999987774 5567899999999999999999999865432211111110        


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                           .... ..............++..+++..+|..|.+.+++.
T Consensus       246 -----~~~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  246 -----NKGR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----cccc-cccCccccCChhhhhcccccccCCchhcccccccc
Confidence                 0000 00011222334566777789999999999988764

>PLN03150 hypothetical protein; Provisional

Probab=99.49  E-value=8.2e-14  Score=169.19  Aligned_cols=151  Identities=31%  Similarity=0.437  Sum_probs=123.0

Q ss_pred             CCCchhhHHHHHHHHhhcccCCCCCcccccccCCCCCCc----ccCCceeCCC--C--ceeEEecccccccccccccccc
Q 001384           29 GDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPC----EWPGIICSPD--K--ARVNGLNLTDWNISGDIFNNFS  100 (1088)
Q Consensus        29 ~~~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C----~W~gv~C~~~--~--~~v~~L~L~~~~l~~~~~~~l~  100 (1088)
                      ..+.+.|.+||+++|+.+...    .  ..+|+. ..||    .|.||+|+.+  .  .+|+.|+|+++++.|.+|..++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~----~--~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~  439 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLP----L--RFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDIS  439 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCc----c--cCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHh
Confidence            445678999999999988531    1  147964 2342    6999999532  2  3699999999999999999999


Q ss_pred             CCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceE
Q 001384          101 ALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVV  178 (1088)
Q Consensus       101 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~  178 (1088)
                      .+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++..  .++++++|++|+|++|++++.+|..+.....++..
T Consensus       440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~  519 (623)
T PLN03150        440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS  519 (623)
T ss_pred             CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence            9999999999999999999999999999999999999999754  48889999999999999998888777654445556


Q ss_pred             EeccCccC
Q 001384          179 ANLSLNNL  186 (1088)
Q Consensus       179 L~L~~n~l  186 (1088)
                      +++.+|..
T Consensus       520 l~~~~N~~  527 (623)
T PLN03150        520 FNFTDNAG  527 (623)
T ss_pred             EEecCCcc
Confidence            66666543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.49  E-value=1.7e-13  Score=136.32  Aligned_cols=137  Identities=19%  Similarity=0.189  Sum_probs=112.7

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..+..+...  ..++.+++++....+..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~--~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARK--GLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHc--CCCCCeEEEEcCCCCccEEEEEecC
Confidence            35789999999999999854 7899999876533  45788888888864310  2578888888887788999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ++.+..+       +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777654       5677788999999999999996434799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.47  E-value=2e-13  Score=145.64  Aligned_cols=136  Identities=22%  Similarity=0.323  Sum_probs=104.5

Q ss_pred             cceec-ccCceEEEEEEeCCCcEEEEEEccccCc-------------cchHHHHHHHHHHhCCCCCCCCCc--eeEEeeE
Q 001384          810 DRIIG-KGGFGTVYRGVLPDGREVAVKKLQREGL-------------EGEREFRAEMEVLSGNGFGWPHPN--LVTLYGW  873 (1088)
Q Consensus       810 ~~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~~~~~l~h~n--iv~l~~~  873 (1088)
                      ...|| .|+.|+||.+... +..+|||++.....             .....+.+|++++..    +.|++  +++.+++
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~----L~~~gi~vP~pl~~  110 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQ----LYEAGLPVPRPIAA  110 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHH----HHhCCCCCceeEee
Confidence            36788 8999999999884 77899998854211             123457789998886    45666  4666666


Q ss_pred             EecC-C---eEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          874 CLDG-S---EKILVYEYMEG-GSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       874 ~~~~-~---~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                      ...+ .   ..++||||++| .+|.+++... ++++.    .+.+++.++.+||+.   ||+||||||+|||++.++.++
T Consensus       111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        111 RVVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             eeeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            4432 2   22599999997 6999988653 45544    356899999999999   999999999999999999999


Q ss_pred             Eeecccceee
Q 001384          949 VTDFGLARVV  958 (1088)
Q Consensus       949 l~Dfg~a~~~  958 (1088)
                      ++|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988764

>PLN03150 hypothetical protein; Provisional

Probab=99.43  E-value=1.6e-13  Score=166.78  Aligned_cols=106  Identities=30%  Similarity=0.509  Sum_probs=74.9

Q ss_pred             eceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccc
Q 001384          564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSY  642 (1088)
Q Consensus       564 l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~  642 (1088)
                      +..|+|++|.++|.+|..++++++|+.|+|++|+|+|.+|..++.+ .|+.|+|++|+++|.+|+.+++|++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            4567788888888888888888888888887777777777777766 577777777777777777777777777777777


Q ss_pred             cccCCcCCcccccc-cccceeeccCCCC
Q 001384          643 NNFSGPFPASFNNL-TELSKLNISYNPL  669 (1088)
Q Consensus       643 N~l~g~~p~~~~~l-~~L~~l~l~~N~l  669 (1088)
                      |+++|.+|..++.+ .++..+++++|+.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~  527 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAG  527 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCcc
Confidence            77777777766543 2344444444443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.35  E-value=2.7e-12  Score=149.02  Aligned_cols=144  Identities=28%  Similarity=0.372  Sum_probs=101.2

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccc----------------------------------------hHHHH
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG----------------------------------------EREFR  849 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  849 (1088)
                      .+.||+|++|.||+|++++|+.||||+.+......                                        +-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986431000                                        01234


Q ss_pred             HHHHHHhCCCCCCCCCceeEEeeEEe-cCCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 001384          850 AEMEVLSGNGFGWPHPNLVTLYGWCL-DGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVAR-ALVFLHHECY  926 (1088)
Q Consensus       850 ~E~~~l~~~~~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~-~L~yLH~~~~  926 (1088)
                      .|.+.+.+....++|.+-+.+-.++. .....++||||++|++|.++.... ...   .+..++.+++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence            44444433322233333333333332 244579999999999999876532 112   23456676666 46788988  


Q ss_pred             CCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          927 PPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                       |++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.32  E-value=1.9e-12  Score=150.74  Aligned_cols=105  Identities=40%  Similarity=0.576  Sum_probs=50.8

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcc
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA  445 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  445 (1088)
                      +|+.|++++|.+. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|..+..+..|++|+++
T Consensus       141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~  217 (394)
T COG4886         141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS  217 (394)
T ss_pred             hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence            3444444444444 33344445555555555555555 44443334455555555555555 444444444445555555


Q ss_pred             ccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       446 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      +|.+. .++..+.+++++..+.+.+|++.
T Consensus       218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~  245 (394)
T COG4886         218 NNSII-ELLSSLSNLKNLSGLELSNNKLE  245 (394)
T ss_pred             CCcce-ecchhhhhcccccccccCCceee
Confidence            55332 34444555555555555555544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.8e-12  Score=145.64  Aligned_cols=247  Identities=23%  Similarity=0.238  Sum_probs=182.9

Q ss_pred             CCCccceecc--cCceEEEEEEe--C-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGK--GGFGTVYRGVL--P-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .|...+.+|+  |.+|.||.+..  + ++..+|+|+-+....  .....=.+|+......   -.|++.++.+..+.+.+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i---~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI---DSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc---CccccccccCcccccCC
Confidence            4666788999  99999999986  3 678899998554322  2222223444444333   36999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeec
Q 001384          879 EKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVAR----ALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDF  952 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~----~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Df  952 (1088)
                      ..++-+|++. .+|.++.+.... ++...++.+..+..+    |+.++|..   +++|-|+||.||+..++ ...+++||
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999999995 699988887665 888899999999999    99999999   99999999999999999 88999999


Q ss_pred             ccceeecCCCCcc----cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          953 GLARVVSAGDSHV----STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       953 g~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      |+...+...+-..    .....|...|++||..++ .++...|||++|.+..+-.+|..++....  ...|..-.     
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~~~r-----  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK--NSSWSQLR-----  339 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC--CCCccccc-----
Confidence            9998877554221    122357788999999887 78899999999999999999888876531  11121110     


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ...  ++.....       .-..++...+..|++.+|..|++++++..
T Consensus       340 --~~~--ip~e~~~-------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 --QGY--IPLEFCE-------GGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccc--Cchhhhc-------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              000  1111110       11134444778999999999999988754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=2.6e-12  Score=133.17  Aligned_cols=193  Identities=25%  Similarity=0.393  Sum_probs=136.3

Q ss_pred             CCCCceeEEeeEEecCC-----eEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 001384          862 WPHPNLVTLYGWCLDGS-----EKILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHR  932 (1088)
Q Consensus       862 l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~  932 (1088)
                      +.|.|+|++..|+.+.+     ...++.|||..|++..++++-    ..+......+|.-||..||.|||+ |.|.|+|+
T Consensus       124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppiihg  202 (458)
T KOG1266|consen  124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccC
Confidence            46999999999987643     467899999999999999763    347888889999999999999999 58899999


Q ss_pred             CCCCCCEEEcCCCCEEEeecccceeecC----CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcC
Q 001384          933 DVKASNVLLDKEGKALVTDFGLARVVSA----GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008 (1088)
Q Consensus       933 DLkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 1008 (1088)
                      ++..+-|++..+|-+|++- +.-..+..    ........-.+-++|.|||+......+.++|||+||.+..||.-|..-
T Consensus       203 nlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             CcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence            9999999999999888742 11111110    011111223456899999998888888999999999999999987765


Q ss_pred             CCCCch-hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1009 LEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1009 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      -...+. ...+-.-.               ....+..    .   ..=..++..|++..|..||+|++.+.
T Consensus       282 ~tnseS~~~~ee~ia---------------~~i~~le----n---~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  282 STNSESKVEVEENIA---------------NVIIGLE----N---GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             cCCCcceeehhhhhh---------------hheeecc----C---ccccCcCcccccCCCCCCcchhhhhc
Confidence            332211 11110000               0000000    0   01124667999999999999998753

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.28  E-value=3.8e-12  Score=148.30  Aligned_cols=199  Identities=38%  Similarity=0.493  Sum_probs=155.8

Q ss_pred             EEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCC-CCCEEeCCCCcCCccCcccccCCCCCcEEEcCCC
Q 001384          248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSIS-GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       248 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      .++++.|.+.. .+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+.. +|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCc
Confidence            46666666532 2333445577888888888888 6677777774 88888888888765 4567788888888888888


Q ss_pred             cCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCC
Q 001384          327 NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP  406 (1088)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  406 (1088)
                      +++...+..                          ..+++|+.|++++|+++ .+|..+.....|++|++++|++. ..+
T Consensus       174 ~l~~l~~~~--------------------------~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~  225 (394)
T COG4886         174 DLSDLPKLL--------------------------SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL  225 (394)
T ss_pred             hhhhhhhhh--------------------------hhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecc
Confidence            887544321                          14568888999999998 78877777777999999999755 577


Q ss_pred             cccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCch
Q 001384          407 AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE  480 (1088)
Q Consensus       407 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~  480 (1088)
                      ..+.++.++..+.+.+|++. .++..+++++++++|++++|+++ .++. ++.+.+|+.|++++|.++..+|..
T Consensus       226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence            78899999999999999998 56888999999999999999998 5665 899999999999999999665554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.24  E-value=1.6e-11  Score=143.66  Aligned_cols=145  Identities=22%  Similarity=0.275  Sum_probs=97.5

Q ss_pred             CCCCccceecccCceEEEEEEeCC-CcEEEEEEccccCcc----------------------------------ch----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLE----------------------------------GE----  845 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~----  845 (1088)
                      ..|+. +.||+|++|.||+|++++ |++||||+.+..-..                                  ..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999987 999999999743100                                  01    


Q ss_pred             --HHHHHHHHHHhCCCCCCCCCceeEEeeEEec-CCeEEEEEEecCCCCHHHH--HhhcC----CCCHHHHHHHHHHHHH
Q 001384          846 --REFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDI--ISDRT----RLTWRRRLDIAIDVAR  916 (1088)
Q Consensus       846 --~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~----~l~~~~~~~i~~qi~~  916 (1088)
                        -++..|+.-+.+....+.+...+.+-.++.+ ....++||||++|+.+.++  ++..+    .+....+..++.|+. 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence              1233444433332222334444443343332 4567899999999999875  33322    233344444455543 


Q ss_pred             HHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeecccceeecC
Q 001384          917 ALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDFGLARVVSA  960 (1088)
Q Consensus       917 ~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Dfg~a~~~~~  960 (1088)
                            ..   |++|+|++|.||+++.++    +++++|||++..+..
T Consensus       278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  35   999999999999999888    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.23  E-value=1.2e-10  Score=133.09  Aligned_cols=165  Identities=21%  Similarity=0.261  Sum_probs=127.4

Q ss_pred             CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHH
Q 001384          827 PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRR  906 (1088)
Q Consensus       827 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~  906 (1088)
                      .++.+|.|+..+...........+-++.++.    ++||+|+++++.+..+++.|+|+|.+.  .|..++++.+   ...
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKt----lRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKT----LRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhh----ccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHH
Confidence            3688899988877644223345566666664    789999999999999999999999985  6777777643   677


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCC
Q 001384          907 RLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA  986 (1088)
Q Consensus       907 ~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  986 (1088)
                      +..-+.||+.||.|||..|  +++|++|.-.-|+|++.|+.||++|.++.....-.. ......--..|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            7788999999999999887  899999999999999999999999998765443221 111222233566777554433 


Q ss_pred             CcchhHHHHHHHHHHHHhC
Q 001384          987 TTKGDVYSFGVLAMELATG 1005 (1088)
Q Consensus       987 ~~~~DvwslG~~l~elltg 1005 (1088)
                       -..|.|.||++++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             357999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=1.5e-10  Score=117.66  Aligned_cols=138  Identities=20%  Similarity=0.232  Sum_probs=97.8

Q ss_pred             cceecccCceEEEEEEeCC-------CcEEEEEEccccCc----------------------cchHHHH----HHHHHHh
Q 001384          810 DRIIGKGGFGTVYRGVLPD-------GREVAVKKLQREGL----------------------EGEREFR----AEMEVLS  856 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~  856 (1088)
                      ...||.|..+.||.|...+       +..+|||+.+....                      ...+.+.    +|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998653       47999998853210                      0012222    6777776


Q ss_pred             CCCC-CCCCCceeEEeeEEecCCeEEEEEEecCCCCHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 001384          857 GNGF-GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRD  933 (1088)
Q Consensus       857 ~~~~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~D  933 (1088)
                      ++.. .+..|.   ++++    ...++||||+.++.+.. .+++ ..++..+...+..+++.+|.++ |..   ++||||
T Consensus        82 rl~~~Gv~vP~---pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPE---VVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCe---EEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            6442 234444   4443    45689999997754422 2322 2355667778889999999999 777   999999


Q ss_pred             CCCCCEEEcCCCCEEEeecccceeec
Q 001384          934 VKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       934 Lkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      |+++||+++ ++.+.++|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999996 5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.15  E-value=1.1e-10  Score=118.68  Aligned_cols=131  Identities=20%  Similarity=0.146  Sum_probs=94.3

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCc-eeEEeeEEecCCeEEEEEEecC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN-LVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      .+.++.|.++.||++... ++.|++|....... ....+..|++++..+.    +.+ +.+++.+.  ....++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~----~~~~~P~~~~~~--~~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAA----EAGIGPKLYYFD--PETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHH----HhCCCCceEEEe--CCCCeEEEEecC
Confidence            367899999999999975 77899999865531 2234567777777532    223 33444443  234579999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC--YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      |.++.+.        ......++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9887653        0112346789999999999982  11259999999999998 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=3.8e-12  Score=133.76  Aligned_cols=237  Identities=23%  Similarity=0.265  Sum_probs=142.4

Q ss_pred             ceeEEeccccccccc----cccccccCCccCCeeeCCCCCCCC----CcCcc-------CCCCCCCcEEECccccccC--
Q 001384           79 ARVNGLNLTDWNISG----DIFNNFSALTQLSYLDLSRNTFSG----SIPDD-------LSSCRSLKYLNLSHNILSG--  141 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~----~~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~-------l~~l~~L~~L~Ls~n~l~~--  141 (1088)
                      ..++.|+|++|.+.-    .+.+.+.+.++|+..++|+ -++|    .+|+.       +..+++|++|+||.|.+..  
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g  108 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG  108 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence            457788888887643    3456677778888888876 3333    34433       3566788888888888763  


Q ss_pred             ccc----CCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc-----
Q 001384          142 DLN----LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG-----  212 (1088)
Q Consensus       142 ~~~----l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-----  212 (1088)
                      ...    +.++..|++|.|.+|.+.-.....+...   |.+|.  .|+.       ...-++|+++...+|++..     
T Consensus       109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~a---l~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~  176 (382)
T KOG1909|consen  109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRA---LFELA--VNKK-------AASKPKLRVFICGRNRLENGGATA  176 (382)
T ss_pred             hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHH---HHHHH--HHhc-------cCCCcceEEEEeeccccccccHHH
Confidence            221    5567888888888887653333332221   11111  1111       2334578888888888764     


Q ss_pred             --cccccCcccceecccCcccccc---cccccccCCCccCEEEcCCCcccc----cCcccccCCCCCcEEEccCccccCC
Q 001384          213 --NIWNGLAQLVEFSVSENVLSGV---VSSSVFKENCSLEIFDLSENEFIG----DFPGEVSNCRNLVVLNLFGNNFSGP  283 (1088)
Q Consensus       213 --~~~~~l~~L~~L~L~~n~l~~~---~~~~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~  283 (1088)
                        .+++..+.|+++.+..|.|...   .....|..+++|++|||.+|-++.    .+...+..+++|++|++++|.+...
T Consensus       177 ~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~  256 (382)
T KOG1909|consen  177 LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENE  256 (382)
T ss_pred             HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccc
Confidence              2344556667777766655421   223446667777777777777652    3345556667777777777777644


Q ss_pred             Ccccc-----CCCCCCCEEeCCCCcCCcc----CcccccCCCCCcEEEcCCCcC
Q 001384          284 IPAEI-----GSISGLEALFLGKNNFLSV----IPESLLNLSKLEVLDLSSNNF  328 (1088)
Q Consensus       284 ~p~~~-----~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l  328 (1088)
                      ...+|     ...++|+.|.|.+|.++..    +...+...+.|..|+|++|.+
T Consensus       257 Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  257 GAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            33332     2356677777777766532    223344556677777777766

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=4.9e-11  Score=135.60  Aligned_cols=250  Identities=19%  Similarity=0.111  Sum_probs=181.1

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC--CCcEEEEEEccccCccchHHH--HHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP--DGREVAVKKLQREGLEGEREF--RAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ....+|..+..||.|.|+.|+++..+  ++..+++|.+.+.......++  ..|+.+...+   ..|.++++.+..|...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l---~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAIL---GSHLPSVGKNSSWSQL  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHh---hcccccCCCCCCcccc
Confidence            34568899999999999999998744  577899999887643333222  2344444332   2588888888777777


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Dfg~a~  956 (1088)
                      ...|+--||++++++...+.-...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||.++
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence            77889999999999988775555688899999999999999999998   99999999999999886 778899999886


Q ss_pred             eecCCCCccccccccccccc--CccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSHVSTTIAGTVGYV--APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .+.-    .........+++  +|+......+-.+.|++|||.-+++..+|...-....    +|.....          
T Consensus       416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~----------  477 (524)
T KOG0601|consen  416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRS----------  477 (524)
T ss_pred             ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeec----------
Confidence            4321    111122333444  5556667788899999999999999998776544321    2211110          


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                              ...+........+..+.+.+..+|+..||.+.+.....+..
T Consensus       478 --------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  478 --------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                    00011122225677778899999999999999887655443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.11  E-value=1e-11  Score=133.84  Aligned_cols=187  Identities=25%  Similarity=0.271  Sum_probs=92.0

Q ss_pred             cccCCCccCEEEcCCCcccc--cCcccccCCCCCcEEEccCccccCCCcccc-CCCCCCCEEeCCCCcCCccCcccccCC
Q 001384          239 VFKENCSLEIFDLSENEFIG--DFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNL  315 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l  315 (1088)
                      ..+.+++++.||||.|-+..  .+-.....+++|+.|+|+.|++........ ..++.|+.|.|+.|.++..        
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k--------  212 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWK--------  212 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHH--------
Confidence            34445555555555554442  122333455556666666665542222211 1234444444444444321        


Q ss_pred             CCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCC--ccccCCcCcce
Q 001384          316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP--VEISQMRSLKF  393 (1088)
Q Consensus       316 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~  393 (1088)
                                     .+......+++|+.|+|..|..+ .........+..|+.|||++|++-. .+  ...+.++.|+.
T Consensus       213 ---------------~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  213 ---------------DVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQ  275 (505)
T ss_pred             ---------------HHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCcccc-cccccccccccchhh
Confidence                           12233344444555555444311 1111112234455666666665542 22  33455666666


Q ss_pred             eeccccccCCc-CCcc-----cCCCCCCcEEEccCCcCCCCCC--ccccCCCCCcEEEcccccccc
Q 001384          394 LILAHNRFNGS-IPAV-----YGNMPNLQTLDLSFNELTGPIP--PSIGNLTSLLWLMLANNSLSG  451 (1088)
Q Consensus       394 L~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~  451 (1088)
                      |+++.+.+... .|+.     ...+++|++|+++.|++. ..+  ..+..+.+|+.|....|.++.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence            66666666532 2332     345677888888888875 222  244556777777777777763

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.10  E-value=4.3e-12  Score=133.35  Aligned_cols=40  Identities=38%  Similarity=0.532  Sum_probs=25.0

Q ss_pred             ccccCCccCCeeeCCCCCCCC----CcCccCCCCCCCcEEECcc
Q 001384           97 NNFSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSH  136 (1088)
Q Consensus        97 ~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~  136 (1088)
                      +.+-....++.|+||+|.|..    .+...+.+.++|+.-++|+
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd   67 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD   67 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh
Confidence            344556677777777777753    2444556666677666664

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.08  E-value=2.1e-11  Score=131.54  Aligned_cols=190  Identities=24%  Similarity=0.218  Sum_probs=115.5

Q ss_pred             ccCCCCCcEEEccCccccc-----cccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccc-cCcccccCC
Q 001384          194 FDGCLNLRYLDLSSNNFRG-----NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNC  267 (1088)
Q Consensus       194 l~~l~~L~~L~Ls~N~l~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~p~~l~~l  267 (1088)
                      ...|++++.|||+.|-+..     .+.+.|++|+.|+|+.|.+........-..++.|+.|.|+.|.++- .+...+..+
T Consensus       142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f  221 (505)
T KOG3207|consen  142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF  221 (505)
T ss_pred             hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence            4456666677777666554     3455666666666666666554444444455677777777777762 233334466


Q ss_pred             CCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccC-cccccCCCCCcEEEcCCCcCCCchhHhhhcccccceee
Q 001384          268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI-PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILA  346 (1088)
Q Consensus       268 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  346 (1088)
                      |+|+.|+|..|.....-.....-+..|++|+|++|++.... -...+.++.|+.|+++.|.+...-....+         
T Consensus       222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~---------  292 (505)
T KOG3207|consen  222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVE---------  292 (505)
T ss_pred             CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCcc---------
Confidence            77778888777533333334445667777777777765431 13456677777777777766533111000         


Q ss_pred             cCcCcccCCCCCccccCCCCcCEEEccCCccCCCCC--ccccCCcCcceeeccccccCC
Q 001384          347 LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP--VEISQMRSLKFLILAHNRFNG  403 (1088)
Q Consensus       347 L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~  403 (1088)
                                .......+++|++|+++.|++.. .+  ..+..+++|+.|.+..|.++.
T Consensus       293 ----------s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  293 ----------SLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             ----------chhhhcccccceeeecccCcccc-ccccchhhccchhhhhhcccccccc
Confidence                      00112356788899999998852 22  345556788888888888874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=2.3e-10  Score=113.96  Aligned_cols=112  Identities=29%  Similarity=0.315  Sum_probs=43.1

Q ss_pred             cccCCccCCeeeCCCCCCCCCcCccCC-CCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccc
Q 001384           98 NFSALTQLSYLDLSRNTFSGSIPDDLS-SCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKL  176 (1088)
Q Consensus        98 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L  176 (1088)
                      .+.+...+++|+|++|.|+. | +.++ .+.+|+.|+|++|.|+....+..++.|++|++++|+|+... ..+...+++|
T Consensus        14 ~~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L   90 (175)
T PF14580_consen   14 QYNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNL   90 (175)
T ss_dssp             ------------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS---S-C-HHHHHH-TT-
T ss_pred             cccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCccc-cchHHhCCcC
Confidence            34556678999999999983 3 3565 57899999999999998888889999999999999998543 2344557889


Q ss_pred             eEEeccCccCCCCCC-ccccCCCCCcEEEccCccccc
Q 001384          177 VVANLSLNNLTGRID-TCFDGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       177 ~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ++|+|++|+|..... ..+..+++|+.|+|.+|.++.
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            999999999886433 567788999999999998764

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=3.3e-10  Score=112.74  Aligned_cols=110  Identities=30%  Similarity=0.380  Sum_probs=32.0

Q ss_pred             cCCCCCcEEEccCccccCCCccccC-CCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccc
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIG-SISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK  343 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  343 (1088)
                      .+..++++|+|++|+|+ .+ +.++ .+.+|+.|+|++|.|+..  +.+..+++|++|++++|+|+...+.....+++|+
T Consensus        16 ~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ   91 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred             ccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence            34456677777777776 33 2444 466777777777777664  3466677777777777777755433333455555


Q ss_pred             eeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       344 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      .|++++|++.+......+..+++|+.|+|.+|.++
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            55555555444333344455566666666666555

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.02  E-value=5.5e-11  Score=121.64  Aligned_cols=138  Identities=27%  Similarity=0.289  Sum_probs=106.5

Q ss_pred             ccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCc
Q 001384          310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMR  389 (1088)
Q Consensus       310 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  389 (1088)
                      ..+.....|++||||+|.|+....                          ...-+|.++.|++|+|.+.. + ..+..++
T Consensus       278 ~~~dTWq~LtelDLS~N~I~~iDE--------------------------SvKL~Pkir~L~lS~N~i~~-v-~nLa~L~  329 (490)
T KOG1259|consen  278 VSADTWQELTELDLSGNLITQIDE--------------------------SVKLAPKLRRLILSQNRIRT-V-QNLAELP  329 (490)
T ss_pred             EecchHhhhhhccccccchhhhhh--------------------------hhhhccceeEEeccccceee-e-hhhhhcc
Confidence            344445567777777777653221                          12236788899999999873 3 3488889


Q ss_pred             CcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC-CCccccCCCCCCeEEc
Q 001384          390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE-IPGEIGNCTSLLWLNL  468 (1088)
Q Consensus       390 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L  468 (1088)
                      +|+.||||+|.++ .+..+-.++.++++|.|+.|.|..  -..+++|-+|..||+++|+|... --..+|+|+-|+.|.|
T Consensus       330 ~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L  406 (490)
T KOG1259|consen  330 QLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRL  406 (490)
T ss_pred             cceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhh
Confidence            9999999999998 777777788899999999999872  34678889999999999999842 1357999999999999


Q ss_pred             cCCcCccCCCc
Q 001384          469 SNNKLSGNIPP  479 (1088)
Q Consensus       469 ~~N~l~g~ip~  479 (1088)
                      .+|++.+ +|+
T Consensus       407 ~~NPl~~-~vd  416 (490)
T KOG1259|consen  407 TGNPLAG-SVD  416 (490)
T ss_pred             cCCCccc-cch
Confidence            9999984 454

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.96  E-value=3.6e-09  Score=112.68  Aligned_cols=144  Identities=24%  Similarity=0.298  Sum_probs=108.9

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---CeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---SEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---~~~~lv~e~  886 (1088)
                      +.|+.|..+.||++...+|+.+++|+...... ....++..|.+++..+..  .+..+.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~--~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAG--TGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhC--CCCCCCCEEEECCCCCccCCceEEEEE
Confidence            67899999999999987678999999876432 134567888888887542  123455566665553   256899999


Q ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 001384          887 MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-----------------------------------------  925 (1088)
Q Consensus       887 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----------------------------------------  925 (1088)
                      ++|+++.+.+.. ..++..+...++.++++++.+||+..                                         
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888776532 35777888888899999999998531                                         


Q ss_pred             ------------CCCeEecCCCCCCEEEcC--CCCEEEeeccccee
Q 001384          926 ------------YPPIVHRDVKASNVLLDK--EGKALVTDFGLARV  957 (1088)
Q Consensus       926 ------------~~~ivH~DLkp~NIll~~--~~~~kl~Dfg~a~~  957 (1088)
                                  ...++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        146799999999999998  56789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=6.6e-09  Score=101.25  Aligned_cols=131  Identities=26%  Similarity=0.387  Sum_probs=95.0

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccC-cc-------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREG-LE-------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..+++|+.+.+|.+.+. |.++++|.-.... ..       ......+|+.++.++.    --.|...+=+..+.....+
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~----~~GV~~P~v~dvD~~~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR----EAGVPVPIVYDVDPDNGLI   76 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH----HcCCCCCeEEEEcCCCCEE
Confidence            45889999999999774 4456666433221 11       1234567888777543    2222222334456677789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      +|||++|..|.+.+...       ...++..+-.-+.-||..   +|||+||.++||++..+. +.++|||++..
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999998765       256777888888899999   999999999999997655 99999999874

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.92  E-value=1.6e-10  Score=134.80  Aligned_cols=212  Identities=29%  Similarity=0.312  Sum_probs=103.6

Q ss_pred             EeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccccccc
Q 001384           83 GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIH  162 (1088)
Q Consensus        83 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~  162 (1088)
                      .++++.+.|+. +-..+..+++|+.|+|.+|.|. .+...+..+++|++|+|++|.|+....+..++.|+.|++++|.|+
T Consensus        76 ~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~  153 (414)
T KOG0531|consen   76 ELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLIS  153 (414)
T ss_pred             hhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchhhccchhhheeccCcch
Confidence            33444444443 2233556666666666666666 333335566666666666666666666666666666666666665


Q ss_pred             ccccCchhhhcccceEEeccCccCCCCCC-ccccCCCCCcEEEccCccccccccccCcccceecccCccccccccccccc
Q 001384          163 GEISFSFPAICEKLVVANLSLNNLTGRID-TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFK  241 (1088)
Q Consensus       163 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  241 (1088)
                      .......   +..|+.+++++|.+....+ . ...+.+++.+++.+|                     .+...-.   +.
T Consensus       154 ~~~~~~~---l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n---------------------~i~~i~~---~~  205 (414)
T KOG0531|consen  154 DISGLES---LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGN---------------------SIREIEG---LD  205 (414)
T ss_pred             hccCCcc---chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCC---------------------chhcccc---hH
Confidence            3222111   3445555555555544433 2 334444444555544                     4432211   11


Q ss_pred             CCCccCEEEcCCCcccccCcccccCCC--CCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCc
Q 001384          242 ENCSLEIFDLSENEFIGDFPGEVSNCR--NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE  319 (1088)
Q Consensus       242 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  319 (1088)
                      ....+..+++..|.++..-+  +..+.  .|+.+++++|.+. .++..+..+..+..|++.+|++...  ..+.....+.
T Consensus       206 ~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~  280 (414)
T KOG0531|consen  206 LLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLS  280 (414)
T ss_pred             HHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHH
Confidence            12233333555555442211  11111  2555666666555 3334445555566666665555443  2233444555


Q ss_pred             EEEcCCCcCC
Q 001384          320 VLDLSSNNFG  329 (1088)
Q Consensus       320 ~L~L~~N~l~  329 (1088)
                      .+.+..|.+.
T Consensus       281 ~~~~~~~~~~  290 (414)
T KOG0531|consen  281 ELWLNDNKLA  290 (414)
T ss_pred             HhccCcchhc
Confidence            5555555544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=3.3e-10  Score=134.85  Aligned_cols=247  Identities=20%  Similarity=0.208  Sum_probs=173.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch---HHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      +.+.+.+-+-+|+++.++.+.-. .|...+.|.......-..   +....+-.+..    ..++|-+++...-+.-....
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i----~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI----TPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc----cCCCCceecccCCCCCCCCc
Confidence            45667778899999999998744 454555555443211111   11122211111    13567777666655566788


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++|++|..+++|...++..+..+...++.+...+.++.+|||..   .+.|+|++|.|.++..+++.+++|||.......
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence            99999999999999999888788888888999999999999998   799999999999999999999999984432211


Q ss_pred             C---------------------C---------CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCC
Q 001384          961 G---------------------D---------SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       961 ~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      .                     .         ........+|+.|.|||...+......+|+|+.|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                     0         011223568999999999999999999999999999999999999998


Q ss_pred             CCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHH
Q 001384         1011 GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVK 1074 (1088)
Q Consensus      1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1074 (1088)
                      .....-..  +.+.....       -.       ...+.....+..+++.+.+..+|.+|-.+.
T Consensus      1037 a~tpq~~f--~ni~~~~~-------~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF--ENILNRDI-------PW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh--hccccCCC-------CC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            76441111  11110000       00       011233345566777788899999998765

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.90  E-value=2.7e-10  Score=132.78  Aligned_cols=246  Identities=30%  Similarity=0.328  Sum_probs=155.3

Q ss_pred             cCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCccc-CCCCCCCceeecccccccccccCchhhhcccceE
Q 001384          100 SALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN-LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVV  178 (1088)
Q Consensus       100 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~  178 (1088)
                      ..+..++.++++.|.+.. +-..+..+.+|..|++.+|+|..... +..+++|++|+|++|+|+...+.           
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~l-----------  136 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEGL-----------  136 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccch-----------
Confidence            456677777788887763 34457778888888888888887777 77788888888888887754432           


Q ss_pred             EeccCccCCCCCCccccCCCCCcEEEccCccccc-cccccCcccceecccCcccccccccccccCCCccCEEEcCCCccc
Q 001384          179 ANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI  257 (1088)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  257 (1088)
                                      ..++.|+.|++++|.++. ..+..+..|+.+++++|.++..-... ...+.+++.+++.+|.+.
T Consensus       137 ----------------~~l~~L~~L~l~~N~i~~~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  137 ----------------STLTLLKELNLSGNLISDISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             ----------------hhccchhhheeccCcchhccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence                            333334445555554443 22233445555555555554332211 356678999999999886


Q ss_pred             ccCcccccCCCCCcEEEccCccccCCCccccCCCCC--CCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHh
Q 001384          258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG--LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI  335 (1088)
Q Consensus       258 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  335 (1088)
                      .  ...+..+..+..+++..|.++..-+  +..+..  |+.+++++|.+... +..+..+.++..|++.+|++...-.  
T Consensus       200 ~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~~~--  272 (414)
T KOG0531|consen  200 E--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNLEG--  272 (414)
T ss_pred             c--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccccc--
Confidence            3  3334555667777999999883322  223333  89999999998763 3667788899999999998874321  


Q ss_pred             hhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCC---CCCcc-ccCCcCcceeeccccccCCcCC
Q 001384          336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG---PLPVE-ISQMRSLKFLILAHNRFNGSIP  406 (1088)
Q Consensus       336 ~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~-l~~l~~L~~L~L~~N~l~~~~p  406 (1088)
                      +                         ...+.+..+.+..|.+..   ..... ....+.++.+.+..|.+....+
T Consensus       273 ~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  273 L-------------------------ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             c-------------------------cccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            1                         123344444455554431   11111 4556777888888887775444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.90  E-value=1.9e-10  Score=117.68  Aligned_cols=130  Identities=32%  Similarity=0.369  Sum_probs=81.1

Q ss_pred             CccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEec
Q 001384          102 LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL  181 (1088)
Q Consensus       102 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L  181 (1088)
                      -..|+.||||+|.|+ .|..++.-++.++.|+||+|.|....++..+++|++||||+|.++....  +            
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~~~G--w------------  347 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAECVG--W------------  347 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHhhhh--h------------
Confidence            356777888888887 6666777777888888888887776677777777777777777753211  1            


Q ss_pred             cCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccc-cC
Q 001384          182 SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DF  260 (1088)
Q Consensus       182 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~  260 (1088)
                                  =..+.+.+.|.|++|.+..     +                   +-+..+-+|..||+++|+|.. .-
T Consensus       348 ------------h~KLGNIKtL~La~N~iE~-----L-------------------SGL~KLYSLvnLDl~~N~Ie~lde  391 (490)
T KOG1259|consen  348 ------------HLKLGNIKTLKLAQNKIET-----L-------------------SGLRKLYSLVNLDLSSNQIEELDE  391 (490)
T ss_pred             ------------HhhhcCEeeeehhhhhHhh-----h-------------------hhhHhhhhheeccccccchhhHHH
Confidence                        1233444555555554431     1                   112223356666666666542 11


Q ss_pred             cccccCCCCCcEEEccCccccC
Q 001384          261 PGEVSNCRNLVVLNLFGNNFSG  282 (1088)
Q Consensus       261 p~~l~~l~~L~~L~L~~N~l~~  282 (1088)
                      -..++++|.|++|.|.+|.+.+
T Consensus       392 V~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  392 VNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hcccccccHHHHHhhcCCCccc
Confidence            2457788888888888888874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.87  E-value=2.3e-08  Score=96.65  Aligned_cols=141  Identities=22%  Similarity=0.360  Sum_probs=99.5

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEcc-cc----Ccc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQ-RE----GLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~-~~----~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ....+-+|+.+.|+++.+. |+.++||.-. +.    ...   ..+...+|++.+.++.    --.|.-..=++.+...-
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~----~~GI~~P~l~~~D~~~~   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR----ALGIPAPRLIFIDTYGG   85 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH----HhCCCCceEEEEecCCC
Confidence            4578999999999999984 7776766432 21    111   2356678888877643    11222222234455566


Q ss_pred             EEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---CEEEeeccc
Q 001384          881 ILVYEYMEG-GSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---KALVTDFGL  954 (1088)
Q Consensus       881 ~lv~e~~~~-gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~~kl~Dfg~  954 (1088)
                      .++|||++| -++.+++....  .........++.+|-+.+.-||..   +||||||..+||++..++   .+.++|||+
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence            789999976 47888876532  223333378999999999999999   999999999999997654   458999999


Q ss_pred             cee
Q 001384          955 ARV  957 (1088)
Q Consensus       955 a~~  957 (1088)
                      +..
T Consensus       163 s~~  165 (229)
T KOG3087|consen  163 SSV  165 (229)
T ss_pred             hhc
Confidence            865

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.86  E-value=6.8e-08  Score=104.34  Aligned_cols=256  Identities=18%  Similarity=0.220  Sum_probs=159.4

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe------cC-CeEE
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL------DG-SEKI  881 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~------~~-~~~~  881 (1088)
                      ..+.||+|+.+.+|-.--  -...+.|++.......+.+...|+   ...   -.||-+-.-+.|=.      ++ ....
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk~a~l---a~~---p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQKVAEL---AAT---PDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHHHHHHh---ccC---CCCcchhhhhcccHHHhhCCCccceeE
Confidence            357799999999997542  233567888876555444433333   221   35664433222211      12 2256


Q ss_pred             EEEEecCCC-CHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          882 LVYEYMEGG-SLEDIISD------RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       882 lv~e~~~~g-sL~~~l~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      +.|..+++. ...++...      .....|.-++++++.+|.+.+.||..   |.+-+|+.++|+|+++++.+.+.|=+.
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            778887764 23333321      12378999999999999999999999   999999999999999999999998654


Q ss_pred             ceeecCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhC-CcCCCCCc-----h--hHHHHHH
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATG-RRALEGGE-----E--CLVEWGR 1021 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg-~~p~~~~~-----~--~~~~~~~ 1021 (1088)
                      -....  +.......+|...|.+||.-.     +..-+...|.|.+|+++++++.| ++||.+--     +  ..-..+.
T Consensus       164 fqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         164 FQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             eeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            43322  223344567889999999643     34557789999999999998886 99997531     1  1111222


Q ss_pred             hhhccCCCCCCccccchhhcCCCccc-cHHHHHHHHHHHhhhccc--CCCCCCCHHHHHHHHHhh
Q 001384         1022 RVMGYGRHGPGRAVIPVVLLGSGLAE-GAEEMSELLRIGVRCTAE--APNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~i 1083 (1088)
                      ....|...... .     ........ ..-.+..+.-+..+|+..  .|.-||+++.++..|.++
T Consensus       242 g~f~ya~~~~~-g-----~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         242 GRFAYASDQRR-G-----LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             ceeeechhccC-C-----CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            22211111000 0     00000000 112234555566688865  367899999988777654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.81  E-value=2e-07  Score=103.63  Aligned_cols=166  Identities=19%  Similarity=0.273  Sum_probs=124.9

Q ss_pred             ceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CCeEEEEEEecCC-CC
Q 001384          818 FGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GSEKILVYEYMEG-GS  891 (1088)
Q Consensus       818 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gs  891 (1088)
                      -.+.|++... +|..|++|++..........-..-++.+++    +.|+|+|++.+++..    +...++||+|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkk----l~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKK----LCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHH----hccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            3578999864 899999999954332222122233455554    579999999998873    4578999999885 57


Q ss_pred             HHHHHh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          892 LEDIIS---------------DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       892 L~~~l~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      |.++--               ...+.++..+|.++.|+..||.++|+.   |+..+-|.+.+|+++.+.+++|...|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            776541               122478899999999999999999999   99999999999999999999999888877


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcC
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 1008 (1088)
                      .+.....               |-+   +-..+-|.-.+|.++..+.||..-
T Consensus       442 vl~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  442 VLQEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eecCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            6543220               111   123467999999999999998644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.75  E-value=4.5e-08  Score=101.25  Aligned_cols=138  Identities=25%  Similarity=0.308  Sum_probs=98.5

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccC----------------------ccchHHHHHHHHHHhCCCCCCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG----------------------LEGEREFRAEMEVLSGNGFGWP  863 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~~~~~l~  863 (1088)
                      -+.+...||.|..+.||.|.+.+|.++|||.=+...                      .......++|+++|.++.   .
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~---~  168 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY---P  168 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh---h
Confidence            355678999999999999999999999999643111                      011234567888887642   1


Q ss_pred             C-CceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          864 H-PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       864 h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      + -.+.+.+++    +...+||||++|-.|+..-     ++......++..|++-+.-+-..   ||||+|+.+-||+++
T Consensus       169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             cCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            1 134455544    4567999999996666532     23444555666666666666666   999999999999999


Q ss_pred             CCCCEEEeecccceee
Q 001384          943 KEGKALVTDFGLARVV  958 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~  958 (1088)
                      ++|.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999766543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=6.4e-08  Score=98.22  Aligned_cols=128  Identities=26%  Similarity=0.351  Sum_probs=82.1

Q ss_pred             EEEEEEeCCCcEEEEEEccccCc-------------c-------------chHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          820 TVYRGVLPDGREVAVKKLQREGL-------------E-------------GEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       820 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      .||.|...+|..+|||+.+....             .             .....++|++.|.++...  --++.+++++
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~--Gv~vP~p~~~   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEA--GVPVPKPYDY   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCT--T-SS--EEEE
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHC--CccCCcEEEE
Confidence            48999998899999998853210             0             013467788988875421  1234455544


Q ss_pred             EecCCeEEEEEEecC--CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEEcCCCCEEEe
Q 001384          874 CLDGSEKILVYEYME--GGSLEDIISDRTRLTWRRRLDIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVT  950 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~DLkp~NIll~~~~~~kl~  950 (1088)
                      .    ..++||||++  |..+..+....  ++..+...++.+++..+..+ |..   ||||||+.+.||+++++ .+.++
T Consensus        79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence            2    3479999998  65554433221  22455677888888866665 576   99999999999999887 99999


Q ss_pred             ecccceeec
Q 001384          951 DFGLARVVS  959 (1088)
Q Consensus       951 Dfg~a~~~~  959 (1088)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.69  E-value=1.8e-08  Score=125.19  Aligned_cols=273  Identities=20%  Similarity=0.211  Sum_probs=166.0

Q ss_pred             CCCcEEEccCccccc-cccccCcccceecccCccc-ccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEc
Q 001384          198 LNLRYLDLSSNNFRG-NIWNGLAQLVEFSVSENVL-SGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNL  275 (1088)
Q Consensus       198 ~~L~~L~Ls~N~l~~-~~~~~l~~L~~L~L~~n~l-~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  275 (1088)
                      ...+...+-+|++.. ......++|+.|-+..|.. -..++...|..++.|++|||++|.-.+.+|..++++-+|++|+|
T Consensus       523 ~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L  602 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDL  602 (889)
T ss_pred             hheeEEEEeccchhhccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccc
Confidence            455666666665432 1122334677777777752 23456677888999999999998877899999999999999999


Q ss_pred             cCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCC--CchhHhhhcccccceeecCcCccc
Q 001384          276 FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFG--GEVQKIFGRFTQVKILALHSNSYI  353 (1088)
Q Consensus       276 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~n~~~  353 (1088)
                      ++..+. .+|..++++..|.+|++..+.....+|..+..+++|++|.+..-...  ...-..+..+.+|+.+....... 
T Consensus       603 ~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~-  680 (889)
T KOG4658|consen  603 SDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV-  680 (889)
T ss_pred             cCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh-
Confidence            999998 88999999999999999988776667777778999999998776522  22233345555555555433221 


Q ss_pred             CCCCCccccCCCCcC----EEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCC------CCCcEEEccCC
Q 001384          354 DGMNSSGILKLPNIS----RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNM------PNLQTLDLSFN  423 (1088)
Q Consensus       354 ~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N  423 (1088)
                        .....+..+..|.    .+.+..+... ..+..++.+.+|+.|.+.++.+...........      +++..+...++
T Consensus       681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~  757 (889)
T KOG4658|consen  681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC  757 (889)
T ss_pred             --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence              0011112222222    2333333333 445566677777777777777753222221111      11222222222


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      ..- ..+.+.--.++|+.|++..+.....+.+....+..+..+.+..+.+.|.
T Consensus       758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence            211 2333333456777777777766655555566666666666666666543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.67  E-value=3.1e-07  Score=99.17  Aligned_cols=143  Identities=20%  Similarity=0.105  Sum_probs=97.5

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCc-----------cchHHHHHHHHHHhCCC-CCCCCCceeEEeeEEec--
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGL-----------EGEREFRAEMEVLSGNG-FGWPHPNLVTLYGWCLD--  876 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~~~-~~l~h~niv~l~~~~~~--  876 (1088)
                      +.+-+-....|+++.. +|+.+.||+......           .....+.+|...+.++. ..+..|.+|-+...-..  
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444445667665 578899997754321           11123566766554432 12455555444321111  


Q ss_pred             CCeEEEEEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-------CCC
Q 001384          877 GSEKILVYEYMEGG-SLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-------EGK  946 (1088)
Q Consensus       877 ~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-------~~~  946 (1088)
                      ....++|||++++. +|.+++..  ..+.+...+..++.+++..+.-||..   ||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23568999999886 89999864  23456677889999999999999999   9999999999999985       468


Q ss_pred             EEEeeccccee
Q 001384          947 ALVTDFGLARV  957 (1088)
Q Consensus       947 ~kl~Dfg~a~~  957 (1088)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.64  E-value=2.2e-08  Score=74.81  Aligned_cols=40  Identities=38%  Similarity=0.891  Sum_probs=30.1

Q ss_pred             hhhHHHHHHHHhhcccCCCCCcccccccCCC--CCCcccCCceeC
Q 001384           33 ETDREVLSNLRSFLENNNPVNEGHYMQWNQS--SSPCEWPGIICS   75 (1088)
Q Consensus        33 ~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~--~~~C~W~gv~C~   75 (1088)
                      ++|++||++||+.+...   +.+.+.+|+.+  ++||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~---~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNND---PSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-S---C-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccc---cCcccccCCCcCCCCCeeeccEEeC
Confidence            57999999999999752   24689999987  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.59  E-value=3.2e-08  Score=80.93  Aligned_cols=60  Identities=47%  Similarity=0.576  Sum_probs=33.4

Q ss_pred             CCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcC
Q 001384          414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL  473 (1088)
Q Consensus       414 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  473 (1088)
                      +|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555533334555555566666666655544445555666666666665553

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.57  E-value=3.7e-08  Score=80.56  Aligned_cols=59  Identities=42%  Similarity=0.613  Sum_probs=27.2

Q ss_pred             CcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccc
Q 001384          390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS  448 (1088)
Q Consensus       390 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  448 (1088)
                      +|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444443333344444444444444444443333444444445555554444

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.54  E-value=4.4e-08  Score=121.78  Aligned_cols=102  Identities=23%  Similarity=0.245  Sum_probs=49.3

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECcccc--ccCcc--cCCCCCCCceeecccccccccccCchhhhcccceE
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNI--LSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVV  178 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~--l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~  178 (1088)
                      ...+...+.+|.+. .++... .+++|++|-+..|.  +....  .|..++.|+.|||++|.=.+..|..+... -+|++
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L-i~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL-VHLRY  599 (889)
T ss_pred             hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh-hhhhc
Confidence            45566666666664 333332 23356666666664  22221  15556666666666554444444443322 34445


Q ss_pred             EeccCccCCCCCCccccCCCCCcEEEccCc
Q 001384          179 ANLSLNNLTGRIDTCFDGCLNLRYLDLSSN  208 (1088)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N  208 (1088)
                      |+|++..++ .+|..+.++.+|.+|++..+
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~  628 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVT  628 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccc
Confidence            555555544 33444455555555554443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=3.2e-08  Score=114.24  Aligned_cols=150  Identities=19%  Similarity=0.279  Sum_probs=103.7

Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccc--------cccccccccCccccCC
Q 001384          912 IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST--------TIAGTVGYVAPEYGQT  983 (1088)
Q Consensus       912 ~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~  983 (1088)
                      .+++.|+.|+|..  .++||++|.|++|.++.++..|++.|+.+........+...        .......|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999998  49999999999999999999999999988765442222211        1233457999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhh
Q 001384          984 WQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRC 1062 (1088)
Q Consensus       984 ~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1062 (1088)
                      ...+.++|+||+|+++|.+.. |+.-+... .....+............              ......+.++.+=+.++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~~~~~~~~~~~~~--------------~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSYSFSRNLLNAGAF--------------GYSNNLPSELRESLKKL  248 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhcc-CCcchhhhhhcccccccc--------------cccccCcHHHHHHHHHH
Confidence            899999999999999999994 55444433 222222222111111000              01133445677777789


Q ss_pred             cccCCCCCCCHHHHHH
Q 001384         1063 TAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1063 l~~dP~~RPs~~eil~ 1078 (1088)
                      +..++..||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            9999999997776643

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.51  E-value=5.4e-09  Score=107.48  Aligned_cols=176  Identities=25%  Similarity=0.210  Sum_probs=111.9

Q ss_pred             CCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCc-cccc----cccccCccccee
Q 001384          150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN-NFRG----NIWNGLAQLVEF  224 (1088)
Q Consensus       150 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~----~~~~~l~~L~~L  224 (1088)
                      .|++||||+..|+-.--..+..-|++|+.|+|.++++.+.+...++...+|+.|+|+.+ .++.    .++.+++.|.+|
T Consensus       186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L  265 (419)
T KOG2120|consen  186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL  265 (419)
T ss_pred             hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence            36666666666554333344455677777777777777777777778888888888775 3554    345667777777


Q ss_pred             cccCccccccccc-ccccCCCccCEEEcCCCcc---cccCcccccCCCCCcEEEccCcc-ccCCCccccCCCCCCCEEeC
Q 001384          225 SVSENVLSGVVSS-SVFKENCSLEIFDLSENEF---IGDFPGEVSNCRNLVVLNLFGNN-FSGPIPAEIGSISGLEALFL  299 (1088)
Q Consensus       225 ~L~~n~l~~~~~~-~~~~~l~~L~~L~Ls~n~l---~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L  299 (1088)
                      +++.+.++...-. .+-.--.+|+.|+|++++=   ...+..-...+++|.+|||++|. ++.....+|..++.|++|.|
T Consensus       266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSl  345 (419)
T KOG2120|consen  266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSL  345 (419)
T ss_pred             CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeeh
Confidence            7777766543222 2222234778888877631   11222234567888888888765 45444456677888888888


Q ss_pred             CCCcCCccCccc---ccCCCCCcEEEcCCCc
Q 001384          300 GKNNFLSVIPES---LLNLSKLEVLDLSSNN  327 (1088)
Q Consensus       300 ~~N~l~~~~p~~---l~~l~~L~~L~L~~N~  327 (1088)
                      +.|.  +++|..   +...++|.+|+..++-
T Consensus       346 sRCY--~i~p~~~~~l~s~psl~yLdv~g~v  374 (419)
T KOG2120|consen  346 SRCY--DIIPETLLELNSKPSLVYLDVFGCV  374 (419)
T ss_pred             hhhc--CCChHHeeeeccCcceEEEEecccc
Confidence            7775  345553   4556778888877763

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.50  E-value=1e-08  Score=105.45  Aligned_cols=86  Identities=29%  Similarity=0.265  Sum_probs=40.7

Q ss_pred             CCCCCCcEEECccccccCccc---C-CCCCCCceeeccccccccccc-CchhhhcccceEEeccCccCCCCCCccccCCC
Q 001384          124 SSCRSLKYLNLSHNILSGDLN---L-SGLRSLEILDLSVNRIHGEIS-FSFPAICEKLVVANLSLNNLTGRIDTCFDGCL  198 (1088)
Q Consensus       124 ~~l~~L~~L~Ls~n~l~~~~~---l-~~l~~L~~L~Ls~N~l~~~~~-~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~  198 (1088)
                      ..+.-+..|.|.++.|.....   + +.++.+++|||.+|+|++... .++...++.|+.|+|+.|++...+...=..+.
T Consensus        42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~  121 (418)
T KOG2982|consen   42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLK  121 (418)
T ss_pred             ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCccccc
Confidence            334455566666666654321   2 235566677777776664321 12233334455555555555443332112334


Q ss_pred             CCcEEEccCcc
Q 001384          199 NLRYLDLSSNN  209 (1088)
Q Consensus       199 ~L~~L~Ls~N~  209 (1088)
                      +|+.|-|.+..
T Consensus       122 nl~~lVLNgT~  132 (418)
T KOG2982|consen  122 NLRVLVLNGTG  132 (418)
T ss_pred             ceEEEEEcCCC
Confidence            44444444443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=1.3e-06  Score=91.29  Aligned_cols=109  Identities=25%  Similarity=0.345  Sum_probs=80.7

Q ss_pred             HHHHHHHHHhCCC-CCCCCCceeEEeeEEec-CCeEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 001384          847 EFRAEMEVLSGNG-FGWPHPNLVTLYGWCLD-GSEKILVYEYMEGG-SLEDIISDRTRLTWRRRLDIAIDVARALVFLHH  923 (1088)
Q Consensus       847 ~~~~E~~~l~~~~-~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~  923 (1088)
                      ...+|...+.++. ..+.-|..+-+...-.. ....++|+|++++. +|.+++......+......++.+++..++-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            4555655443321 12455555544322111 13458999999874 899999875557778889999999999999999


Q ss_pred             cCCCCeEecCCCCCCEEEcCCC---CEEEeecccceee
Q 001384          924 ECYPPIVHRDVKASNVLLDKEG---KALVTDFGLARVV  958 (1088)
Q Consensus       924 ~~~~~ivH~DLkp~NIll~~~~---~~kl~Dfg~a~~~  958 (1088)
                      .   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       137 ~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  137 A---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             C---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.40  E-value=1.7e-06  Score=88.97  Aligned_cols=157  Identities=22%  Similarity=0.256  Sum_probs=101.8

Q ss_pred             CccCHHHHHHHcCCCCccceec---ccCceEEEEEEeCCCcEEEEEEccccCccchH-------------------H---
Q 001384          793 TAFTYSDILKATGKFSEDRIIG---KGGFGTVYRGVLPDGREVAVKKLQREGLEGER-------------------E---  847 (1088)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~LG---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------~---  847 (1088)
                      ...++..+.+...+..+....|   .|..+.||+|...++..+|||+++......++                   +   
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            4456666777777776666554   67778899999888999999999754322110                   0   


Q ss_pred             --HHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCC-HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 001384          848 --FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGS-LEDIISDRTRLTWRRRLDIAIDVARALVFLHHE  924 (1088)
Q Consensus       848 --~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~  924 (1088)
                        ...|+.-|.++..  -+-.+.+.+++    ....+||||+.... -.-.+++- ++...++..+..++++.+.-|-..
T Consensus       113 ~W~~kEf~NL~R~~e--AGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         113 AWARKEFRNLKRAYE--AGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHH--cCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHh
Confidence              1234333332210  11122222322    24579999996531 11122222 233346788888999999988874


Q ss_pred             CCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          925 CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       925 ~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +  ++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            3  999999999999999 8899999999987654

>PRK09902 hypothetical protein; Provisional

Probab=98.39  E-value=5.6e-06  Score=84.38  Aligned_cols=140  Identities=21%  Similarity=0.179  Sum_probs=101.3

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEEcccc---C---ccchHHHHHHHHHHhCCCC-CCCCCceeEEeeEEecC--CeEEEE
Q 001384          813 IGKGGFGTVYRGVLPDGREVAVKKLQRE---G---LEGEREFRAEMEVLSGNGF-GWPHPNLVTLYGWCLDG--SEKILV  883 (1088)
Q Consensus       813 LG~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~~~~-~l~h~niv~l~~~~~~~--~~~~lv  883 (1088)
                      -|+||.+.|+..... |+.+-+|+-...   .   +-.+..|.+|+..+.++.. .+.-|-++ +.+....+  ..-++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467899999998764 556888876511   1   3356789999887776442 12333333 22221122  235799


Q ss_pred             EEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC--EEEeeccccee
Q 001384          884 YEYMEG-GSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK--ALVTDFGLARV  957 (1088)
Q Consensus       884 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~--~kl~Dfg~a~~  957 (1088)
                      +|-++| .+|.+++.+.  .+.+..+...+..+++.++.-||..   |+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998764 4899998663  3567888889999999999999999   9999999999999986677  99999986653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.33  E-value=1.5e-08  Score=115.71  Aligned_cols=180  Identities=24%  Similarity=0.235  Sum_probs=89.9

Q ss_pred             CccccCCCCCcEEEccCccccc-cccccC-cccceecccCcccc---ccccc--ccccCC---CccCEEEcCCCcccccC
Q 001384          191 DTCFDGCLNLRYLDLSSNNFRG-NIWNGL-AQLVEFSVSENVLS---GVVSS--SVFKEN---CSLEIFDLSENEFIGDF  260 (1088)
Q Consensus       191 ~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l-~~L~~L~L~~n~l~---~~~~~--~~~~~l---~~L~~L~Ls~n~l~~~~  260 (1088)
                      |-.+....+|++|.|.++.|.. .....+ .+|+.|..+ |.+.   .++..  +.+.+-   -.|...+.+.|.+. ..
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~m  179 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LM  179 (1096)
T ss_pred             CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hH
Confidence            4445667778888888877653 111111 233333222 2111   11110  011110   14555556666655 44


Q ss_pred             cccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhccc
Q 001384          261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT  340 (1088)
Q Consensus       261 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  340 (1088)
                      ..++.-++.|+.|||++|+++..  +.+..++.|++|||++|.+..+.--....+ +|+.|.+++|.++..         
T Consensus       180 D~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrnN~l~tL---------  247 (1096)
T KOG1859|consen  180 DESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRNNALTTL---------  247 (1096)
T ss_pred             HHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeecccHHHhh---------
Confidence            55555566666666666666532  255566666666666666554322222223 266666666655422         


Q ss_pred             ccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCC-ccccCCcCcceeeccccccC
Q 001384          341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP-VEISQMRSLKFLILAHNRFN  402 (1088)
Q Consensus       341 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~  402 (1088)
                                        .++.++.+|+.|||++|-|.+.-. ..++.+..|+.|+|.+|.+.
T Consensus       248 ------------------~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  248 ------------------RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ------------------hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence                              233455666666666666654211 12344566666777776664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1088
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-52
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-51
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-09
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		8e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		9e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-06
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		3e-06
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		6e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-06
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		4e-06
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		4e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-06
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		5e-06
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		5e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		6e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-06
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		7e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-05
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		8e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		9e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  203 bits (516), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 212/744 (28%), Positives = 318/744 (42%), Gaps = 147/744 (19%)
Query: 59  QWNQSSSPCEWPGIICSPDKARVNGLN-------------------------LTDWNISG 93
            W+ + +PC + G+ C  DK     L+                         L++ +I+G
Sbjct: 29  DWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING 88
Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILSGDLNLSG---L 148
            + + F     L+ LDLSRN+ SG +     L SC  LK+LN+S N L     +SG   L
Sbjct: 89  SV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 147
Query: 149 RSLEILDLSVNRIHGE--ISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS 206
            SLE+LDLS N I G   + +     C +L    +S N ++G +D     C+NL +LD+S
Sbjct: 148 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVS 205
Query: 207 SNNFRGNI--WNGLAQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLSENEFIGDFP-- 261
           SNNF   I      + L    +S N LSG  S ++    C+ L++ ++S N+F+G  P  
Sbjct: 206 SNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAI--STCTELKLLNISSNQFVGPIPPL 263
Query: 262 ----------------GEVSN-----CRXXXXXXXXXXXXSGPIPAEIG----------- 289
                           GE+ +     C              G +P   G           
Sbjct: 264 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 323
Query: 290 --------------SISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDLSSNNFGGEV-- 332
                          + GL+ L L  N F   +PESL NLS  L  LDLSSNNF G +  
Sbjct: 324 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 383
Query: 333 ----------QKIF-------GRFTQV-----KILALH-SNSYIDGMNSSGILKLPNISR 369
                     Q+++       G+         ++++LH S +Y+ G   S +  L  +  
Sbjct: 384 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 443
Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
           L L  N   G +P E+  +++L+ LIL  N   G IP+   N  NL  + LS N LTG I
Sbjct: 444 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 503
Query: 430 PPSIGNLTSLLWLMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNAR 489
           P  IG L +L  L L+NNS SG IP E+G                  IP  +        
Sbjct: 504 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM-------- 555
Query: 490 PTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIF 549
             F+ + +     IAG       KR++        ++     +K C    + LL+  GI 
Sbjct: 556 --FKQSGKIAANFIAG-------KRYV--------YIKNDGMKKECHGAGN-LLEFQGIR 597
Query: 550 PVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL 609
              L  L++R         ++     G  SP      +   + + +N   G +P +   +
Sbjct: 598 SEQLNRLSTRN-----PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 652
Query: 610 P-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
           P L +LNL  N+ SG IP E G+++ L  LDLS N   G  P + + LT L+++++S N 
Sbjct: 653 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 712
Query: 669 LVSGTIPSTGQLATFEKTSYLGDP 692
           L SG IP  GQ  TF    +L +P
Sbjct: 713 L-SGPIPEMGQFETFPPAKFLNNP 735

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  202 bits (513), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 212/744 (28%), Positives = 318/744 (42%), Gaps = 147/744 (19%)
Query: 59  QWNQSSSPCEWPGIICSPDKARVNGLN-------------------------LTDWNISG 93
            W+ + +PC + G+ C  DK     L+                         L++ +I+G
Sbjct: 32  DWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING 91
Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILSGDLNLSG---L 148
            + + F     L+ LDLSRN+ SG +     L SC  LK+LN+S N L     +SG   L
Sbjct: 92  SV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150
Query: 149 RSLEILDLSVNRIHGE--ISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS 206
            SLE+LDLS N I G   + +     C +L    +S N ++G +D     C+NL +LD+S
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVS 208
Query: 207 SNNFRGNI--WNGLAQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLSENEFIGDFP-- 261
           SNNF   I      + L    +S N LSG  S ++    C+ L++ ++S N+F+G  P  
Sbjct: 209 SNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAI--STCTELKLLNISSNQFVGPIPPL 266
Query: 262 ----------------GEVSN-----CRXXXXXXXXXXXXSGPIPAEIG----------- 289
                           GE+ +     C              G +P   G           
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 290 --------------SISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDLSSNNFGGEV-- 332
                          + GL+ L L  N F   +PESL NLS  L  LDLSSNNF G +  
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 333 ----------QKIF-------GRFTQV-----KILALH-SNSYIDGMNSSGILKLPNISR 369
                     Q+++       G+         ++++LH S +Y+ G   S +  L  +  
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
           L L  N   G +P E+  +++L+ LIL  N   G IP+   N  NL  + LS N LTG I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 430 PPSIGNLTSLLWLMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNAR 489
           P  IG L +L  L L+NNS SG IP E+G                  IP  +        
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM-------- 558
Query: 490 PTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIF 549
             F+ + +     IAG       KR++        ++     +K C    + LL+  GI 
Sbjct: 559 --FKQSGKIAANFIAG-------KRYV--------YIKNDGMKKECHGAGN-LLEFQGIR 600
Query: 550 PVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL 609
              L  L++R         ++     G  SP      +   + + +N   G +P +   +
Sbjct: 601 SEQLNRLSTRN-----PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
Query: 610 P-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
           P L +LNL  N+ SG IP E G+++ L  LDLS N   G  P + + LT L+++++S N 
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 669 LVSGTIPSTGQLATFEKTSYLGDP 692
           L SG IP  GQ  TF    +L +P
Sbjct: 716 L-SGPIPEMGQFETFPPAKFLNNP 738

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  198 bits (504), Expect = 1e-50,   Method: Composition-based stats.
 Identities = 112/297 (37%), Positives = 175/297 (58%), Gaps = 21/297 (7%)
Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-EREFRAEME 853
            F+  ++  A+  FS   I+G+GGFG VY+G L DG  VAVK+L+ E  +G E +F+ E+E
Sbjct: 28   FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXX----XXXX 909
            ++S       H NL+ L G+C+  +E++LVY YM  GS+   +                 
Sbjct: 88   MISMA----VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            IA+  AR L +LH  C P I+HRDVKA+N+LLD+E +A+V DFGLA+++   D HV   +
Sbjct: 144  IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE------GGEECLVEWGRRV 1023
             GT+G++APEY  T +++ K DV+ +GV+ +EL TG+RA +        +  L++W   V
Sbjct: 204  RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW---V 260
Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             G  +     A++ V L G+      EE+ +L+++ + CT  +P  RP + EV+ ML
Sbjct: 261  KGLLKEKKLEALVDVDLQGN---YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  194 bits (493), Expect = 2e-49,   Method: Composition-based stats.
 Identities = 110/297 (37%), Positives = 173/297 (58%), Gaps = 21/297 (7%)
Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-EREFRAEME 853
            F+  ++  A+  F    I+G+GGFG VY+G L DG  VAVK+L+ E  +G E +F+ E+E
Sbjct: 20   FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXX----XXXX 909
            ++S       H NL+ L G+C+  +E++LVY YM  GS+   +                 
Sbjct: 80   MISMA----VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            IA+  AR L +LH  C P I+HRDVKA+N+LLD+E +A+V DFGLA+++   D HV   +
Sbjct: 136  IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE------GGEECLVEWGRRV 1023
             G +G++APEY  T +++ K DV+ +GV+ +EL TG+RA +        +  L++W   V
Sbjct: 196  RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW---V 252
Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             G  +     A++ V L G+      EE+ +L+++ + CT  +P  RP + EV+ ML
Sbjct: 253  KGLLKEKKLEALVDVDLQGN---YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 85/216 (39%), Positives = 122/216 (56%), Gaps = 12/216 (5%)
Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGN 858
            D+ +AT  F    +IG G FG VY+GVL DG +VA+K+   E  +G  EF  E+E LS  
Sbjct: 33   DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS-- 90
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----XXXXXXXXXXXIAIDV 914
                 HP+LV+L G+C + +E IL+Y+YME G+L+  +                 I I  
Sbjct: 91   --FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTV 973
            AR L +LH      I+HRDVK+ N+LLD+     +TDFG+++     G +H+   + GT+
Sbjct: 149  ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTL 205
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009
            GY+ PEY    + T K DVYSFGV+  E+   R A+
Sbjct: 206  GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  131 bits (330), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 101/293 (34%), Positives = 149/293 (50%), Gaps = 26/293 (8%)
Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGN 858
            D+ +AT  F    +IG G FG VY+GVL DG +VA+K+   E  +G  EF  E+E LS  
Sbjct: 33   DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS-- 90
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----XXXXXXXXXXXIAIDV 914
                 HP+LV+L G+C + +E IL+Y+YME G+L+  +                 I I  
Sbjct: 91   --FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTV 973
            AR L +LH      I+HRDVK+ N+LLD+     +TDFG+++  +  D +H+   + GT+
Sbjct: 149  ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTL 205
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA----LEGGEECLVEWGRRVMGYGRH 1029
            GY+ PEY    + T K DVYSFGV+  E+   R A    L      L EW       G+ 
Sbjct: 206  GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 1030 GPGRAVIPVVLLGSGLAEGA--EEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                      ++   LA+    E + +     V+C A +   RP++ +VL  L
Sbjct: 266  EQ--------IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 27/301 (8%)
Query: 794  AFTYSDILKATGKFSEDRI------IGKGGFGTVYRGVLPDGREVAVKKLQR----EGLE 843
            +F++ ++   T  F E  I      +G+GGFG VY+G + +   VAVKKL         E
Sbjct: 14   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX- 902
             +++F  E++V++       H NLV L G+  DG +  LVY YM  GSL D +S      
Sbjct: 73   LKQQFDQEIKVMAK----CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                     IA   A  + FLH   +   +HRD+K++N+LLD+   A ++DFGLAR    
Sbjct: 129  PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 961  -GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
               + + + I GT  Y+APE     + T K D+YSFGV+ +E+ TG  A++   E  +  
Sbjct: 186  FAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
              +             I   +  +     +  +  +  +  +C  E  N RP++K+V  +
Sbjct: 245  DIKEEIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 1080 L 1080
            L
Sbjct: 301  L 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 144/301 (47%), Gaps = 27/301 (8%)
Query: 794  AFTYSDILKATGKFSEDRI------IGKGGFGTVYRGVLPDGREVAVKKLQR----EGLE 843
            +F++ ++   T  F E  I      +G+GGFG VY+G + +   VAVKKL         E
Sbjct: 14   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX- 902
             +++F  E++V++       H NLV L G+  DG +  LVY YM  GSL D +S      
Sbjct: 73   LKQQFDQEIKVMAK----CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                     IA   A  + FLH   +   +HRD+K++N+LLD+   A ++DFGLAR    
Sbjct: 129  PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 961  -GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
               + +   I GT  Y+APE     + T K D+YSFGV+ +E+ TG  A++   E  +  
Sbjct: 186  FAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
              +             I   +  +     +  +  +  +  +C  E  N RP++K+V  +
Sbjct: 245  DIKEEIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 1080 L 1080
            L
Sbjct: 301  L 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 143/301 (47%), Gaps = 27/301 (8%)
Query: 794  AFTYSDILKATGKFSEDRI------IGKGGFGTVYRGVLPDGREVAVKKLQR----EGLE 843
            +F++ ++   T  F E  I      +G+GGFG VY+G + +   VAVKKL         E
Sbjct: 8    SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX- 902
             +++F  E++V++       H NLV L G+  DG +  LVY YM  GSL D +S      
Sbjct: 67   LKQQFDQEIKVMAK----CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                     IA   A  + FLH   +   +HRD+K++N+LLD+   A ++DFGLAR    
Sbjct: 123  PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 179
Query: 961  GDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
                V    I GT  Y+APE     + T K D+YSFGV+ +E+ TG  A++   E  +  
Sbjct: 180  FAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
              +             I   +  +     +  +  +  +  +C  E  N RP++K+V  +
Sbjct: 239  DIKEEIEDEEKTIEDYIDKKMNDA----DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 294
Query: 1080 L 1080
            L
Sbjct: 295  L 295

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 74/197 (37%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGWPHPNLVTL 870
            IG G FGTV+R     G +VAVK L  +    ER  EF  E+ ++        HPN+V  
Sbjct: 45   IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR----HPNIVLF 99
Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---XXXXXIAIDVARALVFLHHECYP 927
             G         +V EY+  GSL  ++                +A DVA+ + +LH+   P
Sbjct: 100  MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            PIVHRD+K+ N+L+DK+    V DFGL+R + A     S   AGT  ++APE  +   + 
Sbjct: 159  PIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 988  TKGDVYSFGVLAMELAT 1004
             K DVYSFGV+  ELAT
Sbjct: 218  EKSDVYSFGVILWELAT 234

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/235 (35%), Positives = 119/235 (50%), Gaps = 23/235 (9%)
Query: 794  AFTYSDILKATGKFSEDRI------IGKGGFGTVYRGVLPDGREVAVKKLQR----EGLE 843
            +F++ ++   T  F E  I       G+GGFG VY+G + +   VAVKKL         E
Sbjct: 5    SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX- 902
             +++F  E++V +       H NLV L G+  DG +  LVY Y   GSL D +S      
Sbjct: 64   LKQQFDQEIKVXAK----CQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                     IA   A  + FLH   +   +HRD+K++N+LLD+   A ++DFGLAR    
Sbjct: 120  PLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 961  GDSHVSTT-IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                V  + I GT  Y APE     + T K D+YSFGV+ +E+ TG  A++   E
Sbjct: 177  FAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/197 (37%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGWPHPNLVTL 870
            IG G FGTV+R     G +VAVK L  +    ER  EF  E+ ++        HPN+V  
Sbjct: 45   IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR----HPNIVLF 99
Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---XXXXXIAIDVARALVFLHHECYP 927
             G         +V EY+  GSL  ++                +A DVA+ + +LH+   P
Sbjct: 100  MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            PIVHR++K+ N+L+DK+    V DFGL+R + A     S + AGT  ++APE  +   + 
Sbjct: 159  PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 988  TKGDVYSFGVLAMELAT 1004
             K DVYSFGV+  ELAT
Sbjct: 218  EKSDVYSFGVILWELAT 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 113/230 (49%), Gaps = 25/230 (10%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGF 860
             + + + IIG GGFG VYR     G EVAVK  + +  E   +     R E ++ +    
Sbjct: 7    AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK- 64
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVF 920
               HPN++ L G CL      LV E+  GG L  ++S             A+ +AR + +
Sbjct: 65   ---HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIARGMNY 120
Query: 921  LHHECYPPIVHRDVKASNVLL-------DKEGKAL-VTDFGLARVVSAGDSHVSTTI--A 970
            LH E   PI+HRD+K+SN+L+       D   K L +TDFGLAR     + H +T +  A
Sbjct: 121  LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAA 175
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020
            G   ++APE  +    +   DV+S+GVL  EL TG     G +   V +G
Sbjct: 176  GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV LYG
Sbjct: 15   IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 69
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV+E+ME G L D + +            + +DV   + +L   C   ++H
Sbjct: 70   VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 127  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 187  VWSFGVLMWEV 197

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV LYG
Sbjct: 13   IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 67
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV+E+ME G L D + +            + +DV   + +L   C   ++H
Sbjct: 68   VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 125  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 185  VWSFGVLMWEV 195

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV LYG
Sbjct: 18   IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 72
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV+E+ME G L D + +            + +DV   + +L   C   ++H
Sbjct: 73   VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 130  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 190  VWSFGVLMWEV 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV LYG
Sbjct: 16   IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 70
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV E+ME G L D + +            + +DV   + +L   C   ++H
Sbjct: 71   VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 128  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 188  VWSFGVLMWEV 198

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + +EG   E +F  E EV+        HP LV LYG
Sbjct: 35   IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVM----MKLSHPKLVQLYG 89
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV+E+ME G L D + +            + +DV   + +L   C   ++H
Sbjct: 90   VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 147  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 207  VWSFGVLMWEV 217

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV LYG
Sbjct: 15   IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 69
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             CL+ +   LV+E+ME G L D + +            + +DV   + +L       ++H
Sbjct: 70   VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L+ +     V+DFG+ R V       ST     V + +PE     + ++K D
Sbjct: 127  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 992  VYSFGVLAMEL 1002
            V+SFGVL  E+
Sbjct: 187  VWSFGVLMWEV 197

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 127/274 (46%), Gaps = 28/274 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 21   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----N 76
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D+++            +  +  +AL FLH  
Sbjct: 77   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN 135
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  ST + GT  ++APE     
Sbjct: 136  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 192  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 234
Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE+L
Sbjct: 235  ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 36   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 91
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 92   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 151  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 208  ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 94   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 149
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 150  PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 209  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 266  ESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 40   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 95
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 96   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 155  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 212  ESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 33   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 88
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 89   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 148  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 205  ESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/206 (36%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 36   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 91
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 92   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDS-HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +     DS H  T     V ++A 
Sbjct: 151  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 208  ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 90
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 91   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 150  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 207  ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 90
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + FL
Sbjct: 91   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD---SHVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 150  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 207  ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 28/274 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 21   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----N 76
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D+++            +  +  +AL FLH  
Sbjct: 77   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN 135
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  S  + GT  ++APE     
Sbjct: 136  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRK 191
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 192  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 234
Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE+L
Sbjct: 235  ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 34   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 89
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 90   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 149  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 206  ESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 54   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 109
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 110  PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 169  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 226  ESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 28/274 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 21   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----N 76
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D+++            +  +  +AL FLH  
Sbjct: 77   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN 135
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  S  + GT  ++APE     
Sbjct: 136  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRK 191
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 192  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 234
Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE+L
Sbjct: 235  ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 53   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 108
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 109  PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 168  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 225  ESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 28/274 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 22   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----N 77
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D+++            +  +  +AL FLH  
Sbjct: 78   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN 136
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HR++K+ N+LL  +G   +TDFG    ++   S  ST + GT  ++APE     
Sbjct: 137  ---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 192
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 193  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 235
Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE++
Sbjct: 236  ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 90
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 91   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 150  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 207  ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 27   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 82
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 83   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 142  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 199  ESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 32   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 87
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 88   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 147  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 204  ESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 28/274 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N     +
Sbjct: 22   KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----N 77
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            PN+V      L G E  +V EY+ GGSL D+++            +  +  +AL FLH  
Sbjct: 78   PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN 136
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                ++HRD+K+ N+LL  +G   +TDFG    ++   S  S  + GT  ++APE     
Sbjct: 137  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRK 192
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
                K D++S G++A+E+  G                    Y    P RA+  +   G+ 
Sbjct: 193  AYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATNGTP 235
Query: 1045 LAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVL 1077
              +  E++S + R  + RC       R + KE++
Sbjct: 236  ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 34   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 89
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 90   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 149  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 206  ESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 35   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 90
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 91   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 150  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 207  ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 30   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 85
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 86   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 145  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 202  ESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG+++  AVK L R    GE  +F  E  ++      + H
Sbjct: 33   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 88
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
            PN+++L G CL  +GS  ++V  YM+ G L + I +              + VA+ + +L
Sbjct: 89   PNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAP 978
              + +   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A 
Sbjct: 148  ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT + TTK DV+SFGVL  EL T
Sbjct: 205  ESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 37/281 (13%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            + ++G+G FG V +      ++VA+K+++ E     + F  E+  LS       HPN+V 
Sbjct: 13   EEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVN----HPNIVK 65
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXX---XXXXXXXXXIAIDVARALVFLHHECY 926
            LYG CL+     LV EY EGGSL +++                  +  ++ + +LH    
Sbjct: 66   LYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 927  PPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              ++HRD+K  N+LL   G  L + DFG A  +    +H+ T   G+  ++APE  +   
Sbjct: 124  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THM-TNNKGSAAWMAPEVFEGSN 179
Query: 986  ATTKGDVYSFGVLAMELATGRRALE--GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
             + K DV+S+G++  E+ T R+  +  GG    + W    +  G   P         L  
Sbjct: 180  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRPP---------LIK 227
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             L +  E +        RC ++ P+ RP+++E++ ++  ++
Sbjct: 228  NLPKPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 37/281 (13%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            + ++G+G FG V +      ++VA+K+++ E     + F  E+  LS       HPN+V 
Sbjct: 14   EEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVN----HPNIVK 66
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXX---XXXXXXXXXIAIDVARALVFLHHECY 926
            LYG CL+     LV EY EGGSL +++                  +  ++ + +LH    
Sbjct: 67   LYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 927  PPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              ++HRD+K  N+LL   G  L + DFG A  +    +H+ T   G+  ++APE  +   
Sbjct: 125  KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHM-TNNKGSAAWMAPEVFEGSN 180
Query: 986  ATTKGDVYSFGVLAMELATGRRALE--GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
             + K DV+S+G++  E+ T R+  +  GG    + W    +  G   P         L  
Sbjct: 181  YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRPP---------LIK 228
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             L +  E +        RC ++ P+ RP+++E++ ++  ++
Sbjct: 229  NLPKPIESLM------TRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 811  RIIGKGGFGTVYR-GVLPDGREVAVKKLQRE------GLEGEREFRAEMEVLSGNGFGWP 863
            R +G G FG V+      +GR  A+K L++E       +E   + R  + +++       
Sbjct: 12   RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------- 64
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HP ++ ++G   D  +  ++ +Y+EGG L  ++              A +V  AL +LH 
Sbjct: 65   HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
            +    I++RD+K  N+LLDK G   +TDFG A+ V      V+  + GT  Y+APE   T
Sbjct: 125  K---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVST 177
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
                   D +SFG+L  E+  G
Sbjct: 178  KPYNKSIDWWSFGILIYEMLAG 199

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L D R+VAVK L R  L  +  F       + N    
Sbjct: 11   SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 863  PHPNLVTLY----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 70   NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+L+       V DFG+AR ++   + V  T A  GT  Y+
Sbjct: 130  NFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 187  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L D R+VAVK L R  L  +  F       + N    
Sbjct: 11   SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 863  PHPNLVTLY----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 70   NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+++       V DFG+AR ++   + V+ T A  GT  Y+
Sbjct: 130  NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 187  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L D R+VAVK L R  L  +  F       + N    
Sbjct: 11   SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 863  PHPNLVTLY----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 70   NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+++       V DFG+AR ++   + V+ T A  GT  Y+
Sbjct: 130  NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 187  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 90
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 91   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 148  SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 201
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 202  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 69
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G +   +                ++A AL
Sbjct: 70   ---LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 127  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 180
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 181  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 23   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 81
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 82   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 138
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 139  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 192
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 193  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 125  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 69
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 70   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 127  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 180
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 181  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 65
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 66   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +       S   TT++GT+ Y+ P
Sbjct: 123  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPP 176
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 177  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 5    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 63
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 64   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 121  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 174
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 175  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 125  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGW 862
            F   +++GKG FG V+        +  A+K L+++ +  + +    M    VLS     W
Sbjct: 20   FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS---LAW 76
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP L  ++           V EY+ GG L   I              A ++   L FLH
Sbjct: 77   EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--Y 980
             +    IV+RD+K  N+LLDK+G   + DFG+ +    GD+  +    GT  Y+APE   
Sbjct: 137  SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYIAPEILL 192
Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            GQ +  +   D +SFGVL  E+  G+    G +E
Sbjct: 193  GQKYNHSV--DWWSFGVLLYEMLIGQSPFHGQDE 224

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 10   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 68
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 69   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 126  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 179
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 180  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 39/278 (14%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGNGFGW 862
            F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S      
Sbjct: 15   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----L 70
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN++ LYG+  D +   L+ EY   G++   +                ++A AL + H
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 130
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ PE  +
Sbjct: 131  SK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPPEXIE 184
Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGG--EECLVEWGRRVMGYGRHGPGRAVIPVVL 1040
                  K D++S GVL  E   G+   E    +E           Y R        P   
Sbjct: 185  GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET----------YKRISRVEFTFP--- 231
Query: 1041 LGSGLAEGAEEM-SELLRIGVRCTAEAPNARPNVKEVL 1077
                + EGA ++ S LL+         P+ RP ++EVL
Sbjct: 232  --DFVTEGARDLISRLLK-------HNPSQRPXLREVL 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 3    ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 61
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 62   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ P
Sbjct: 119  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPP 172
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 173  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 25/230 (10%)
Query: 796  TYSDILKATGKFSED---------RIIGKGGFGTVYRG--VLPDGREVAV--KKLQREGL 842
            TY D  +A  +F+++         R+IG G FG V  G   LP  R+VAV  K L+    
Sbjct: 25   TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 843  EGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXX 901
            E +R +F  E  ++      + HPN+V L G    G   ++V E+ME G+L+  +     
Sbjct: 85   EKQRRDFLCEASIMGQ----FDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG 140
Query: 902  XXXXXXXXIAI-DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                      +  +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+  
Sbjct: 141  QFTVIQLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIED 197
Query: 961  GDSHVSTTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAME-LATGRR 1007
                V TT  G   V + APE  Q  + T+  DV+S+G++  E ++ G R
Sbjct: 198  DPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPN 866
            +++GKG FG V+        +  A+K L+++ +  + +    M    VLS     W HP 
Sbjct: 23   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS---LAWEHPF 79
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            L  ++           V EY+ GG L   I              A ++   L FLH +  
Sbjct: 80   LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-- 137
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTW 984
              IV+RD+K  N+LLDK+G   + DFG+ +    GD+  +    GT  Y+APE   GQ +
Sbjct: 138  -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAPEILLGQKY 195
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
              +   D +SFGVL  E+  G+    G +E
Sbjct: 196  NHSV--DWWSFGVLLYEMLIGQSPFHGQDE 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 66
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 67   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + +FG +  V A  S   TT+ GT+ Y+ P
Sbjct: 124  SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSR-RTTLCGTLDYLPP 177
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 178  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGLARV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQ-REGLEGEREFRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +   E  +   + + E+ VLS     +
Sbjct: 25   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
                +   YG  L GS+  ++ EY+ GGS  D++             +  ++ + L +LH
Sbjct: 83   ----VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH 137
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYG 981
             E     +HRD+KA+NVLL ++G   + DFG+A  ++  D+ +   T  GT  ++APE  
Sbjct: 138  SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 192
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            Q     +K D++S G+ A+ELA G 
Sbjct: 193  QQSAYDSKADIWSLGITAIELAKGE 217

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L   R+VAVK L R  L  +  F       + N    
Sbjct: 28   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 86
Query: 863  PHPNLVTLY----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 87   NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+++       V DFG+AR ++   + V+ T A  GT  Y+
Sbjct: 147  NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 204  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + +FG +  V A  S   TT+ GT+ Y+ P
Sbjct: 125  SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSR-RTTLCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTELCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 41/306 (13%)
Query: 796  TYSDILKATGKFSED---------RIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGL 842
            TY D  +A  +F+++         R+IG G FG V  G   LP  RE  VA+K L+    
Sbjct: 4    TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 843  EGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXX 901
            E +R +F  E  ++      + HPN++ L G        ++V EYME GSL+  +     
Sbjct: 64   EKQRRDFLGEASIMGQ----FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG 119
Query: 902  XXXXXXXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                     +   ++  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+  
Sbjct: 120  QFTVIQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 961  GDSHVSTTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
                  TT  G   + + APE     + T+  DV+S+G++  E              +V 
Sbjct: 177  DPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWE--------------VVS 222
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            +G R          + VI  V  G  L    +  + L ++ + C  +  N+RP   E++ 
Sbjct: 223  YGERPYW---EMTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVN 279
Query: 1079 MLIKIL 1084
            ML K++
Sbjct: 280  MLDKLI 285

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 69
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 70   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 127  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYLPP 180
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 181  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 65
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 66   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S    T+ GT+ Y+ P
Sbjct: 123  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RDTLCGTLDYLPP 176
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 177  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L   R+VAVK L R  L  +  F       + N    
Sbjct: 11   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 863  PHPNLVTLYGW----CLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 70   NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+++       V DFG+AR ++   + V+ T A  GT  Y+
Sbjct: 130  NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 187  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 65
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 66   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 123  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYLPP 176
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 177  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S   T + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTXLCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            + ++    I+G GG   V+    L   R+VAVK L R  L  +  F       + N    
Sbjct: 11   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLRFRREAQNAAAL 69
Query: 863  PHPNLVTLY----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
             HP +V +Y         G    +V EY++G +L DI+             +  D  +AL
Sbjct: 70   NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYV 976
             F H      I+HRDVK +N+++       V DFG+AR ++   + V+ T A  GT  Y+
Sbjct: 130  NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +PE  +      + DVYS G +  E+ TG     G
Sbjct: 187  SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGNGFGW 862
            F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S      
Sbjct: 14   FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH----L 69
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN++ LYG+  D +   L+ EY   G++   +                ++A AL + H
Sbjct: 70   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    ++HRD+K  N+LL   G+  + DFG +  V A  S   TT+ GT+ Y+ PE  +
Sbjct: 130  SK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSR-RTTLCGTLDYLPPEMIE 183
Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
                  K D++S GVL  E   G
Sbjct: 184  GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 31   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 89
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 90   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 145
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 146  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 203  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 241
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 242  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 1080 LIKIL 1084
            L K++
Sbjct: 302  LDKLI 306

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY     + + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 122  SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RAALCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V        G++VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 53   IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRD----YHHDNVVDMY 108
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V RAL +LH++    ++H
Sbjct: 109  SSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE        T+ D
Sbjct: 165  RDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 224  IWSLGIMVIEMIDG 237

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 4    QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 63   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 118
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 119  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 176  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 214
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 215  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 1080 LIKIL 1084
            L K++
Sbjct: 275  LDKLI 279

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 21   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 79
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 80   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 135
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 136  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 193  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 231
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 232  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 291
Query: 1080 LIKIL 1084
            L K++
Sbjct: 292  LDKLI 296

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 90
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 91   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 147
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 148  SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RDDLCGTLDYLPP 201
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 202  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 125  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RAALCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 66
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 67   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 123
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 124  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RXXLCGTLDYLPP 177
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 178  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RAALCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 69
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G +   +                ++A AL
Sbjct: 70   ---LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANAL 126
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 127  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RXXLXGTLDYLPP 180
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 181  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 135/305 (44%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V EYME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    +   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 125  SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RDDLCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 64
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 65   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 122  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RXXLCGTLDYLPP 175
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 176  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGN 858
            A   F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S  
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH- 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +                ++A AL
Sbjct: 68   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +  V A  S     + GT+ Y+ P
Sbjct: 125  SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RXXLCGTLDYLPP 178
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      K D++S GVL  E   G+   E 
Sbjct: 179  EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKL-QREGLEGEREFRAEME 853
            ILK T +    +++G G FGTVY+G+ +P+G  V    A+K L +  G +   EF  E  
Sbjct: 11   ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID 913
            +++       HP+LV L G CL  + +++      G  LE +                + 
Sbjct: 70   IMASMD----HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 125
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A+ +++L       +VHRD+ A NVL+       +TDFGLAR++  GD        G  
Sbjct: 126  IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKM 181
Query: 973  -VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHG 1030
             + ++A E     + T + DV+S+GV   EL T G +  +G                   
Sbjct: 182  PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG------------------I 223
Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            P R +  ++  G  L +      ++  + V+C     ++RP  KE+ A
Sbjct: 224  PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEG---EREFRAEMEVLSGNGFGW 862
            F   R +GKG FG VY       + + A+K L +  LE    E + R E+E+ S      
Sbjct: 14   FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH----L 69
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN++ LYG+  D +   L+ EY   G++   +                ++A AL + H
Sbjct: 70   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    ++HRD+K  N+LL   G+  + DFG +  V A  S    T+ GT+ Y+ PE  +
Sbjct: 130  SK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSR-RDTLCGTLDYLPPEMIE 183
Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
                  K D++S GVL  E   G
Sbjct: 184  GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQ-REGLEGEREFRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +   E  +   + + E+ VLS      
Sbjct: 29   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--- 83
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
              P +   YG  L  ++  ++ EY+ GGS  D++             I  ++ + L +LH
Sbjct: 84   -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLH 141
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYG 981
             E     +HRD+KA+NVLL + G+  + DFG+A  ++  D+ +   T  GT  ++APE  
Sbjct: 142  SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 196
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +     +K D++S G+ A+ELA G 
Sbjct: 197  KQSAYDSKADIWSLGITAIELARGE 221

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGERE-FRAEMEVLSGNG 859
            +  G +     +G GGFG V R +  D G +VA+K+ ++E     RE +  E++++    
Sbjct: 11   QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-------LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
                HPN+V+      DG +K+       L  EY EGG L   ++            I  
Sbjct: 71   ----HPNVVSARE-VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 913  ---DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV---TDFGLARVVSAGDSHVS 966
               D++ AL +LH      I+HRD+K  N++L    + L+    D G A+ +  G+  + 
Sbjct: 126  LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LC 180
Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR 1007
            T   GT+ Y+APE  +  + T   D +SFG LA E  TG R
Sbjct: 181  TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 810  DRIIGKGGFGTVYRGVLPDGRE----VAVKKLQR-EGLEGEREFRAEMEVLSGNGFGWPH 864
            DR+IGKG FG VY G   D  +     A+K L R   ++    F  E  ++ G      H
Sbjct: 26   DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG----LNH 81
Query: 865  PNLVTLYGWCL--DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            PN++ L G  L  +G   +L+     G  L+ I S              + VAR + +L 
Sbjct: 82   PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV-----SAGDSHVSTTIAGTVGYVA 977
             + +   VHRD+ A N +LD+     V DFGLAR +      +   H    +   V + A
Sbjct: 142  EQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTA 196
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELAT 1004
             E  QT++ TTK DV+SFGVL  EL T
Sbjct: 197  LESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGERE-FRAEMEVLSGNG 859
            +  G +     +G GGFG V R +  D G +VA+K+ ++E     RE +  E++++    
Sbjct: 12   QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-------LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
                HPN+V+      DG +K+       L  EY EGG L   ++            I  
Sbjct: 72   ----HPNVVSARE-VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 126
Query: 913  ---DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV---TDFGLARVVSAGDSHVS 966
               D++ AL +LH      I+HRD+K  N++L    + L+    D G A+ +  G+  + 
Sbjct: 127  LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LC 181
Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR 1007
            T   GT+ Y+APE  +  + T   D +SFG LA E  TG R
Sbjct: 182  TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 62/194 (31%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VAVK + +EG   E EF  E + +        HP LV  YG
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTM----MKLSHPKLVKFYG 70
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       +V EY+  G L + + S            +  DV   + FL    +   +H
Sbjct: 71   VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF---IH 127
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQATT 988
            RD+ A N L+D++    V+DFG+ R V   D +VS+   GT   V + APE    ++ ++
Sbjct: 128  RDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSV--GTKFPVKWSAPEVFHYFKYSS 184
Query: 989  KGDVYSFGVLAMEL 1002
            K DV++FG+L  E+
Sbjct: 185  KSDVWAFGILMWEV 198

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 13/217 (5%)
Query: 801  LKATGKFSEDRIIGKGGFG-TVYRGVLPDGREVAVKKL--QREGLEGEREFRAEMEVLSG 857
             ++  K+   + IG+G FG  +      DGR+  +K++   R   +   E R E+ VL+ 
Sbjct: 20   FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIA--IDVA 915
                  HPN+V       +     +V +Y EGG L   I+            +   + + 
Sbjct: 80   ----MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             AL  +H      I+HRD+K+ N+ L K+G   + DFG+ARV+++    ++    GT  Y
Sbjct: 136  LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYY 191
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
            ++PE  +      K D+++ G +  EL T + A E G
Sbjct: 192  LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQ-REGLEGEREFRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +   E  +   + + E+ VLS      
Sbjct: 9    FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--- 63
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
              P +   YG  L  ++  ++ EY+ GGS  D++             I  ++ + L +LH
Sbjct: 64   -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLH 121
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYG 981
             E     +HRD+KA+NVLL + G+  + DFG+A  ++  D+ +   T  GT  ++APE  
Sbjct: 122  SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +     +K D++S G+ A+ELA G 
Sbjct: 177  KQSAYDSKADIWSLGITAIELARGE 201

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
            R IGKG FG V      D +++ A+K + ++      E R    E++++ G      HP 
Sbjct: 21   RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG----LEHPF 76
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            LV L+    D  +  +V + + GG L   +                ++  AL +L ++  
Sbjct: 77   LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ-- 134
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I+HRD+K  N+LLD+ G   +TDF +A ++        TT+AGT  Y+APE      +
Sbjct: 135  -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMF----S 187
Query: 987  TTKGDVYSF-------GVLAMELATGRR 1007
            + KG  YSF       GV A EL  GRR
Sbjct: 188  SRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 11   PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 54
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 55   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 109
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 110  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 166
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 167  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 226
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 227  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 266
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 267  DYLRSVL 273

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKL-QREGLEGEREFRAEME 853
            ILK T +    +++G G FGTVY+G+ +P+G  V    A+K L +  G +   EF  E  
Sbjct: 34   ILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID 913
            +++       HP+LV L G CL  + +++      G  LE +                + 
Sbjct: 93   IMASMD----HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ 148
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A+ +++L       +VHRD+ A NVL+       +TDFGLAR++  GD        G  
Sbjct: 149  IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKM 204
Query: 973  -VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHG 1030
             + ++A E     + T + DV+S+GV   EL T G +  +G                   
Sbjct: 205  PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG------------------I 246
Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            P R +  ++  G  L +      ++  + V+C     ++RP  KE+ A
Sbjct: 247  PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 294

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 812  IIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVT 869
            +IG G    V      P   +VA+K++  E  +    E   E++ +S       HPN+V+
Sbjct: 22   VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH----HPNIVS 77
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX--------XXXXXXXIAIDVARALVFL 921
             Y   +   E  LV + + GGS+ DII                     I  +V   L +L
Sbjct: 78   YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG----DSHVSTTIAGTVGYVA 977
            H       +HRDVKA N+LL ++G   + DFG++  ++ G     + V  T  GT  ++A
Sbjct: 138  HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 978  PEYGQTWQATT-KGDVYSFGVLAMELATG 1005
            PE  +  +    K D++SFG+ A+ELATG
Sbjct: 195  PEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 8    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 51
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 52   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 106
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 107  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 163
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 164  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 223
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 224  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 263
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 264  DYLRSVL 270

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 10   PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 53
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 54   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 108
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 109  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 165
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 166  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 225
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 226  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 265
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 266  DYLRSVL 272

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V E ME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 4    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 47
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 48   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 102
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 103  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 159
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 160  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 219
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 220  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 259
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 260  DYLRSVL 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 2    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 45
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 46   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 100
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 101  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 158  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 218  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 257
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 258  DYLRSVL 264

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 807  FSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +    +IG G    V      P   +VA+K++  E  +    E   E++ +S       H
Sbjct: 12   YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH----H 67
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX--------XXXXXXXIAIDVAR 916
            PN+V+ Y   +   E  LV + + GGS+ DII                     I  +V  
Sbjct: 68   PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG----DSHVSTTIAGT 972
             L +LH       +HRDVKA N+LL ++G   + DFG++  ++ G     + V  T  GT
Sbjct: 128  GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 973  VGYVAPEYGQTWQATT-KGDVYSFGVLAMELATG 1005
              ++APE  +  +    K D++SFG+ A+ELATG
Sbjct: 185  PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 806  KFSEDRIIGKGGFGTVY---RGVLPDGREV-AVKKLQREGLEGEREFRAEME---VLSGN 858
            +F   +++G+G FG V+   +    D R++ A+K L++  L+     R +ME   ++  N
Sbjct: 26   QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 859  GFGWPHPNLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                 HP +V L Y +  +G +  L+ +++ GG L   +S               ++A A
Sbjct: 86   -----HPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 139
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH      I++RD+K  N+LLD+EG   +TDFGL++  S      + +  GTV Y+A
Sbjct: 140  LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 195
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            PE       T   D +SFGVL  E+ TG    +G
Sbjct: 196  PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 229

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 806  KFSEDRIIGKGGFGTVY---RGVLPDGREV-AVKKLQREGLEGEREFRAEME---VLSGN 858
            +F   +++G+G FG V+   +    D R++ A+K L++  L+     R +ME   ++  N
Sbjct: 25   QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 859  GFGWPHPNLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                 HP +V L Y +  +G +  L+ +++ GG L   +S               ++A A
Sbjct: 85   -----HPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH      I++RD+K  N+LLD+EG   +TDFGL++  S      + +  GTV Y+A
Sbjct: 139  LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            PE       T   D +SFGVL  E+ TG    +G
Sbjct: 195  PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 806  KFSEDRIIGKGGFGTVY---RGVLPDGREV-AVKKLQREGLEGEREFRAEME---VLSGN 858
            +F   +++G+G FG V+   +    D R++ A+K L++  L+     R +ME   ++  N
Sbjct: 25   QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 859  GFGWPHPNLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                 HP +V L Y +  +G +  L+ +++ GG L   +S               ++A A
Sbjct: 85   -----HPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH      I++RD+K  N+LLD+EG   +TDFGL++  S      + +  GTV Y+A
Sbjct: 139  LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            PE       T   D +SFGVL  E+ TG    +G
Sbjct: 195  PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 2    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 45
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 46   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 100
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 101  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 158  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 218  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 257
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 258  DYLRSVL 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 3    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 46
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 47   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 101
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 102  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 158
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 159  LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 218
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 219  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 258
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 259  DYLRSVL 265

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 12   PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 55
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 56   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 110
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 111  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 167
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 168  LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 227
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 228  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 267
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 268  DYLRSVL 274

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 19   LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 73
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 74   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 130
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD+   T  AG    + + APE     + 
Sbjct: 131  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDT--XTAHAGAKFPIKWTAPESLAYNKF 187
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 188  SIKSDVWAFGVLLWEIAT 205

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 4    QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V E ME GSL+  +          
Sbjct: 63   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 118
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 119  QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 176  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 214
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 215  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 1080 LIKIL 1084
            L K++
Sbjct: 275  LDKLI 279

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 806  KFSEDRIIGKGGFGTVYRG-VLPDG--REVAVKKLQREGLEGE-REFRAEMEVLSGNGFG 861
            KF +  +IG+G FG V +  +  DG   + A+K+++    + + R+F  E+EVL   G  
Sbjct: 18   KFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH- 74
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SXXXXXXXX 905
              HPN++ L G C       L  EY   G+L D +                S        
Sbjct: 75   --HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                 A DVAR + +L  + +   +HRD+ A N+L+ +   A + DFGL+R     + +V
Sbjct: 133  QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 186
Query: 966  STTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
              T+    V ++A E       TT  DV+S+GVL  E+ +       G  C   + +   
Sbjct: 187  KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 246
Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            GY    P                  +E+ +L+R   +C  E P  RP+  ++L  L ++L
Sbjct: 247  GYRLEKP--------------LNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 289

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 8    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 51
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 52   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 106
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 107  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 163
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 164  LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 223
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 224  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 263
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 264  DYLRSVL 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 2    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 45
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 46   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 100
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 101  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 158  LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 218  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 257
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 258  DYLRSVL 264

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 806  KFSEDRIIGKGGFGTVYRG-VLPDG--REVAVKKLQREGLEGE-REFRAEMEVLSGNGFG 861
            KF +  +IG+G FG V +  +  DG   + A+K+++    + + R+F  E+EVL   G  
Sbjct: 28   KFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH- 84
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SXXXXXXXX 905
              HPN++ L G C       L  EY   G+L D +                S        
Sbjct: 85   --HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                 A DVAR + +L  + +   +HRD+ A N+L+ +   A + DFGL+R     + +V
Sbjct: 143  QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 196
Query: 966  STTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
              T+    V ++A E       TT  DV+S+GVL  E+ +       G  C   + +   
Sbjct: 197  KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            GY    P                  +E+ +L+R   +C  E P  RP+  ++L  L ++L
Sbjct: 257  GYRLEKP--------------LNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 299

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 125/307 (40%), Gaps = 49/307 (15%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G FG V+ G      +VAVK L 
Sbjct: 7    PWWEDEWEVPR---------ETLKLVER------LGAGQFGEVWMGYYNGHTKVAVKSL- 50
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 51   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 105
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 106  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 162
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GE 1013
            ++   +          + + APE       T K DV+SFG+L  E+ T GR    G    
Sbjct: 163  LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 222
Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
            E +    R   GY      R V P            EE+ +L+R+   C  E P  RP  
Sbjct: 223  EVIQNLER---GY------RMVRP--------DNCPEELYQLMRL---CWKERPEDRPTF 262
Query: 1074 KEVLAML 1080
              + ++L
Sbjct: 263  DYLRSVL 269

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 7/206 (3%)
Query: 811  RIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            R++GKG FG V    V   G   AVK L+++ +  + +    M           HP L  
Sbjct: 29   RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 870  LYGWCLDGSEKIL-VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
            L+  C    +++  V E++ GG L   I              A ++  AL+FLH +    
Sbjct: 89   LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--- 144
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            I++RD+K  NVLLD EG   + DFG+ +     +   + T  GT  Y+APE  Q      
Sbjct: 145  IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 989  KGDVYSFGVLAMELATGRRALEGGEE 1014
              D ++ GVL  E+  G    E   E
Sbjct: 204  AVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 22   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 76
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 77   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 133
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HRD+ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 134  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 193  KSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 23   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 77
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 78   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HRD+ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 194  KSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 189
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 190  SIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 189
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 190  SIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 26   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 80
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 81   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 194
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 195  SIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 26   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 80
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 81   GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 194
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 195  SIKSDVWAFGVLLWEIAT 212

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRG-VLPDGREVAVKKL-------QREGLEGEREFRAEMEV 854
            A  +   ++ IGKGGFG V++G ++ D   VA+K L       + E +E  +EF+ E+ +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAID 913
            +S       HPN+V LYG  L  +   +V E++  G L   ++             + +D
Sbjct: 77   MSNLN----HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----ALVTDFGLARVVSAGDSHVSTT 968
            +A  + ++ ++  PPIVHRD+++ N+ L    +     A V DFGL    S    H  + 
Sbjct: 131  IALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----SQQSVHSVSG 185
Query: 969  IAGTVGYVAPEY--GQTWQATTKGDVYSFGVLAMELATG 1005
            + G   ++APE    +    T K D YSF ++   + TG
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 26   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 80
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 81   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 194
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 195  SIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 34   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 88
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 89   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 145
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 146  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 202
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 203  SIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 26   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 80
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 81   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 194
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 195  SIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 189
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 190  SIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 25   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 79
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 80   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 136
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 137  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 193
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 194  SIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 189
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 190  SIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 23   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 77
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 78   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 191
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 192  SIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 23   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 77
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 78   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE     + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNKF 191
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 192  SIKSDVWAFGVLLWEIAT 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 34/273 (12%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VAVK L ++G      F AE  ++        H  LV LY 
Sbjct: 16   LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ----LQHQRLVRLYA 70
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXX--XXXXXXXXXIAIDVARALVFLHHECYPPIV 930
              +      ++ EYME GSL D +               +A  +A  + F+    Y   +
Sbjct: 71   -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 126
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+       + DFGLAR++   +          + + APE       T K 
Sbjct: 127  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 991  DVYSFGVLAMELAT-GRRALEG--GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047
            DV+SFG+L  E+ T GR    G    E +    R   GY      R V P          
Sbjct: 187  DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GY------RMVRP--------DN 229
Query: 1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
              EE+ +L+R+   C  E P  RP    + ++L
Sbjct: 230  CPEELYQLMRL---CWKERPEDRPTFDYLRSVL 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQ-REGLEGEREFRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +   E  +   + + E+ VLS      
Sbjct: 24   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--- 78
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
              P +   YG  L  ++  ++ EY+ GGS  D++             I  ++ + L +LH
Sbjct: 79   -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLH 136
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYG 981
             E     +HRD+KA+NVLL + G+  + DFG+A  ++  D+ +      GT  ++APE  
Sbjct: 137  SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +     +K D++S G+ A+ELA G 
Sbjct: 192  KQSAYDSKADIWSLGITAIELARGE 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 39   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 94
Query: 863  PHPNLVTLYGWCLDGSEKILV-YEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
             HP  V LY +C    EK+     Y + G L   I                ++  AL +L
Sbjct: 95   DHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 153
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEY 980
            H +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE 
Sbjct: 154  HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                 A    D+++ G +  +L  G      G E L+
Sbjct: 211  LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 247

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKL--QREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            DRI GKG FG VY+G+    +EV   K+    E  +   + + E+ VLS        P +
Sbjct: 25   DRI-GKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD----SPYI 79
Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
               +G  L  ++  ++ EY+ GGS  D++             I  ++ + L +LH E   
Sbjct: 80   TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT-ILREILKGLDYLHSERK- 137
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQA 986
              +HRD+KA+NVLL ++G   + DFG+A  ++  D+ +      GT  ++APE  +    
Sbjct: 138  --IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 987  TTKGDVYSFGVLAMELATG 1005
              K D++S G+ A+ELA G
Sbjct: 194  DFKADIWSLGITAIELAKG 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQ-REGLEGEREFRAEMEVLSGNGFGW 862
            F++   IGKG FG V++G+  D R    VA+K +   E  +   + + E+ VLS      
Sbjct: 9    FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--- 63
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
              P +   YG  L  ++  ++ EY+ GGS  D++             I  ++ + L +LH
Sbjct: 64   -SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLH 121
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-TTIAGTVGYVAPEYG 981
             E     +HRD+KA+NVLL + G+  + DFG+A  ++  D+ +      GT  ++APE  
Sbjct: 122  SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +     +K D++S G+ A+ELA G 
Sbjct: 177  KQSAYDSKADIWSLGITAIELARGE 201

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 40   LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 94
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       +V EYM  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 95   GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNF--- 151
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD++  T  AG    + + APE       
Sbjct: 152  IHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAPESLAYNTF 208
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 209  SIKSDVWAFGVLLWEIAT 226

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G+G +G+VY+ +  + G+ VA+K++  E     +E   E+ ++         P++V  Y
Sbjct: 37   LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD----SPHVVKYY 90
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXX-XXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
            G     ++  +V EY   GS+ DII              I     + L +LH   +   +
Sbjct: 91   GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD+KA N+LL+ EG A + DFG+A  ++   +  +  I GT  ++APE  Q        
Sbjct: 148  HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVA 206
Query: 991  DVYSFGVLAMELATGR 1006
            D++S G+ A+E+A G+
Sbjct: 207  DIWSLGITAIEMAEGK 222

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 16   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 70
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 71   --VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY--- 125
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 126  VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 186  SDVWSFGILLTELTTKGR 203

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 37   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 92
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 93   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 149  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 208  IWSLGIMVIEMVDG 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 28   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 83
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 84   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 140  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 199  IWSLGIMVIEMVDG 212

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 32   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 87
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 88   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 144  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 203  IWSLGIMVIEMVDG 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 26   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 80
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 81   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD+   T  AG    + + APE     + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDT--XTAHAGAKFPIKWTAPESLAYNKF 194
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 195  SIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI----KHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HRD+ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 192  KSDVWAFGVLLWEIAT 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 39   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 94
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 95   NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 151  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 210  IWSLGIMVIEMVDG 223

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 21   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI----KHPNLVQLL 75
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 76   GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HRD+ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 192  KSDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 19   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKHPNLVQLL 73
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIIS--XXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 74   GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 130
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTWQA 986
            +HRD+ A N L+ +     V DFGL+R+++ GD+   T  AG    + + APE     + 
Sbjct: 131  IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTF--TAHAGAKFPIKWTAPESLAYNKF 187
Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 188  SIKSDVWAFGVLLWEIAT 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 113/277 (40%), Gaps = 36/277 (12%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            ++ +G G FG V+        +VAVK ++   +  E  F AE  V+        H  LV 
Sbjct: 193  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT----LQHDKLVK 247
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYP 927
            L+   +      ++ E+M  GSL D +             I  +  +A  + F+    Y 
Sbjct: 248  LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              +HRD++A+N+L+       + DFGLARV+   +          + + APE       T
Sbjct: 306  --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 988  TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR-HGPGRA---VIPVVLLGS 1043
             K DV+SFG+L ME+ T                     YGR   PG +   VI  +  G 
Sbjct: 364  IKSDVWSFGILLMEIVT---------------------YGRIPYPGMSNPEVIRALERGY 402
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +        EL  I +RC    P  RP  + + ++L
Sbjct: 403  RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 19   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 73
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 74   --VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY--- 128
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 129  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 189  SDVWSFGILLTELTTKGR 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 82   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 137
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 138  NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 194  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 253  IWSLGIMVIEMVDG 266

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 15   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 69
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 70   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 124
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 125  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 185  SDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 17   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 71
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 72   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 126
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 127  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 187  SDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 812  IIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPN 866
            ++G G F  V   +L + +     VA+K + +E LEG E     E+ VL        HPN
Sbjct: 25   VLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK----IKHPN 77
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +V L      G    L+ + + GG L D I             +   V  A+ +LH    
Sbjct: 78   IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 927  PPIVHRDVKASNVL---LDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              IVHRD+K  N+L   LD++ K +++DFGL+++   G   V +T  GT GYVAPE    
Sbjct: 136  -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ 192
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
               +   D +S GV+A  L  G
Sbjct: 193  KPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 812  IIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPN 866
            ++G G F  V   +L + +     VA+K + +E LEG E     E+ VL        HPN
Sbjct: 25   VLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK----IKHPN 77
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +V L      G    L+ + + GG L D I             +   V  A+ +LH    
Sbjct: 78   IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 927  PPIVHRDVKASNVL---LDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              IVHRD+K  N+L   LD++ K +++DFGL+++   G   V +T  GT GYVAPE    
Sbjct: 136  -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ 192
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
               +   D +S GV+A  L  G
Sbjct: 193  KPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 812  IIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPN 866
            ++G G F  V   +L + +     VA+K + +E LEG E     E+ VL        HPN
Sbjct: 25   VLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK----IKHPN 77
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +V L      G    L+ + + GG L D I             +   V  A+ +LH    
Sbjct: 78   IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 927  PPIVHRDVKASNVL---LDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              IVHRD+K  N+L   LD++ K +++DFGL+++   G   V +T  GT GYVAPE    
Sbjct: 136  -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ 192
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
               +   D +S GV+A  L  G
Sbjct: 193  KPYSKAVDCWSIGVIAYILLCG 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 86
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 87   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 143
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 204  IWAFGVLMWEIYS 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 806  KFSEDRIIGKGGFGTVYRG-VLPDG--REVAVKKLQREGLEGE-REFRAEMEVLSGNGFG 861
            KF +  +IG+G FG V +  +  DG   + A+K+++    + + R+F  E+EVL   G  
Sbjct: 25   KFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH- 81
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SXXXXXXXX 905
              HPN++ L G C       L  EY   G+L D +                S        
Sbjct: 82   --HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                 A DVAR + +L  + +   +HR++ A N+L+ +   A + DFGL+R     + +V
Sbjct: 140  QLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSR---GQEVYV 193
Query: 966  STTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
              T+    V ++A E       TT  DV+S+GVL  E+ +       G  C   + +   
Sbjct: 194  KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 253
Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            GY    P                  +E+ +L+R   +C  E P  RP+  ++L  L ++L
Sbjct: 254  GYRLEKP--------------LNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 296

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V    V   G+ VAVKK+     +       E+ ++      + H N+V +Y
Sbjct: 159  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMY 214
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  +V E++EGG+L DI++            + + V +AL  LH +    ++H
Sbjct: 215  NSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    VS  +      + GT  ++APE         + D
Sbjct: 271  RDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 330  IWSLGIMVIEMVDG 343

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRG-VLPDGREVAVKKL-------QREGLEGEREFRAEMEV 854
            A  +   ++ IGKGGFG V++G ++ D   VA+K L       + E +E  +EF+ E+ +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAID 913
            +S       HPN+V LYG  L  +   +V E++  G L   ++             + +D
Sbjct: 77   MSNLN----HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----ALVTDFGLARVVSAGDSHVSTT 968
            +A  + ++ ++  PPIVHRD+++ N+ L    +     A V DFG     S    H  + 
Sbjct: 131  IALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVHSVSG 185
Query: 969  IAGTVGYVAPEY--GQTWQATTKGDVYSFGVLAMELATG 1005
            + G   ++APE    +    T K D YSF ++   + TG
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       + +  GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A+   D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 790  LDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREF 848
            LDK     +DI       +    +G G +G VY GV       VAVK L+ + +E E EF
Sbjct: 3    LDKWEMERTDI-------TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF 54
Query: 849  RAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXX 906
              E  V+        HPNLV L G C       ++ E+M  G+L D +            
Sbjct: 55   LKEAAVMKEI----KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV 110
Query: 907  XXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
               +A  ++ A+ +L  + +   +HRD+ A N L+ +     V DFGL+R+++       
Sbjct: 111  LLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 167
Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                  + + APE     + + K DV++FGVL  E+AT
Sbjct: 168  AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----IRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 246
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  +A  + ++    Y   V
Sbjct: 247  -VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 363  DVWSFGILLTELTTKGR 379

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 31   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 86
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 87   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       + +  GT  YV+PE  
Sbjct: 147  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 204  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 239

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 71
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 72   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 128
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 129  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 189  IWAFGVLMWEIYS 201

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 246
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  +A  + ++    Y   V
Sbjct: 247  -VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 363  DVWSFGILLTELTTKGR 379

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 115/273 (42%), Gaps = 34/273 (12%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VAVK L ++G      F AE  ++        H  LV LY 
Sbjct: 17   LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ----LQHQRLVRLYA 71
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXX--XXXXXXXXXIAIDVARALVFLHHECYPPIV 930
              +      ++ EYME GSL D +               +A  +A  + F+    Y   +
Sbjct: 72   -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 127
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HR+++A+N+L+       + DFGLAR++   +          + + APE       T K 
Sbjct: 128  HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 991  DVYSFGVLAMELAT-GRRALEG--GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAE 1047
            DV+SFG+L  E+ T GR    G    E +    R   GY      R V P          
Sbjct: 188  DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GY------RMVRP--------DN 230
Query: 1048 GAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
              EE+ +L+R+   C  E P  RP    + ++L
Sbjct: 231  CPEELYQLMRL---CWKERPEDRPTFDYLRSVL 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 22   LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK----HPNLVQLL 76
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 77   GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 133
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            +HRD+ A N L+ +     V DFGL+R+++             + + APE     + + K
Sbjct: 134  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 990  GDVYSFGVLAMELAT 1004
             DV++FGVL  E+AT
Sbjct: 194  SDVWAFGVLLWEIAT 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 66
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 67   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 123
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 124  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 184  IWAFGVLMWEIYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 16   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 70
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 71   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 127
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 128  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 188  IWAFGVLMWEIYS 200

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 795  FTYSDILKATGKFSED---------RIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREG 841
            FT+ D  +A  +F+++         ++IG G FG V  G   LP  RE  VA+K L+   
Sbjct: 14   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 842  LEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXX 900
             E +R +F +E  ++      + HPN++ L G     +  +++ E+ME GSL+  +    
Sbjct: 74   TEKQRRDFLSEASIMGQ----FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 129
Query: 901  XXXXXXXXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV- 958
                      +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL+R + 
Sbjct: 130  GQFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLE 186
Query: 959  -SAGDSHVSTTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAME-LATGRR 1007
                D   ++ + G   + + APE  Q  + T+  DV+S+G++  E ++ G R
Sbjct: 187  DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 86
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 87   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 143
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 144  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 204  IWAFGVLMWEIYS 216

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 72/277 (25%), Positives = 113/277 (40%), Gaps = 36/277 (12%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            ++ +G G FG V+        +VAVK ++   +  E  F AE  V+        H  LV 
Sbjct: 20   EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT----LQHDKLVK 74
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYP 927
            L+   +      ++ E+M  GSL D +             I  +  +A  + F+    Y 
Sbjct: 75   LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 132
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              +HRD++A+N+L+       + DFGLARV+   +          + + APE       T
Sbjct: 133  --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 988  TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR-HGPGRA---VIPVVLLGS 1043
             K DV+SFG+L ME+ T                     YGR   PG +   VI  +  G 
Sbjct: 191  IKSDVWSFGILLMEIVT---------------------YGRIPYPGMSNPEVIRALERGY 229
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +        EL  I +RC    P  RP  + + ++L
Sbjct: 230  RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRG-VLPDGREVAVKKL-------QREGLEGEREFRAEMEV 854
            A  +   ++ IGKGGFG V++G ++ D   VA+K L       + E +E  +EF+ E+ +
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAID 913
            +S       HPN+V LYG  L  +   +V E++  G L   ++             + +D
Sbjct: 77   MSNLN----HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----ALVTDFGLARVVSAGDSHVSTT 968
            +A  + ++ ++  PPIVHRD+++ N+ L    +     A V DF L    S    H  + 
Sbjct: 131  IALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL----SQQSVHSVSG 185
Query: 969  IAGTVGYVAPEY--GQTWQATTKGDVYSFGVLAMELATG 1005
            + G   ++APE    +    T K D YSF ++   + TG
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 12   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 65
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   + +            IA   AR + +L
Sbjct: 66   RHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 125  HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +   +   + + DVY+FG++  EL TG+
Sbjct: 182  IRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 41/305 (13%)
Query: 792  KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER- 846
            +T   ++  L AT   S D+++G G FG V  G   LP  +E  VA+K L+    E +R 
Sbjct: 33   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 847  EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX 906
            +F  E  ++      + HPN++ L G        ++V E ME GSL+  +          
Sbjct: 92   DFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 147
Query: 907  XXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
                +   +A  + +L        VHRD+ A N+L++      V+DFGL+RV+       
Sbjct: 148  QLVGMLRGIASGMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 966  STTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
             TT  G   + + +PE     + T+  DV+S+G++  E                     V
Sbjct: 205  YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE---------------------V 243
Query: 1024 MGYGRHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            M YG         + VI  V  G  L    +  + L ++ + C  +  N RP  ++++++
Sbjct: 244  MSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 1080 LIKIL 1084
            L K++
Sbjct: 304  LDKLI 308

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 812  IIGKGGFGTVYRGVLPDGREVAV-KKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            ++GKG FG   +    +  EV V K+L R   E +R F  E++V+        HPN++  
Sbjct: 17   VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC----LEHPNVLKF 72
Query: 871  YGWCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
             G          + EY++GG+L  II S             A D+A  + +LH      I
Sbjct: 73   IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVV-------------SAGDSHVSTTIAGTVGYV 976
            +HRD+ + N L+ +    +V DFGLAR++                D     T+ G   ++
Sbjct: 130  IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 977  APEYGQTWQATTKGDVYSFGVLAMEL 1002
            APE         K DV+SFG++  E+
Sbjct: 190  APEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 802  KATGKFSEDRI------IGKGGFGTVYRGVLPDGR-EVAVKKLQ-REGLEGERE-FRAEM 852
            KA G  ++ R       IG+G F TVY+G+  +   EVA  +LQ R+  + ER+ F+ E 
Sbjct: 17   KAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 853  EVLSGNGFGWPHPNLVTLY-GW--CLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXX 908
            E L G      HPN+V  Y  W   + G + I LV E    G+L+  +            
Sbjct: 77   EXLKG----LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLR 132
Query: 909  XIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVST 967
                 + + L FLH    PPI+HRD+K  N+ +    G   + D GLA +  A     + 
Sbjct: 133  SWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAK 188
Query: 968  TIAGTVGYVAPE-YGQTWQATTKGDVYSFGVLAMELAT 1004
             + GT  + APE Y + +  +   DVY+FG   +E AT
Sbjct: 189  AVIGTPEFXAPEXYEEKYDESV--DVYAFGXCXLEXAT 224

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 9    FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 64
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 65   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 125  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 182  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 864  HPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
            HPN+V  Y   +D +   L  V EY EGG L  +I+              + V   L   
Sbjct: 64   HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 922  HHECYP------PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              EC+        ++HRD+K +NV LD +    + DFGLAR+++  D+  + T  GT  Y
Sbjct: 124  LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTPYY 182
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELA 1003
            ++PE         K D++S G L  EL 
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELC 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 10   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 65
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 66   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 126  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 183  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 26/231 (11%)
Query: 779  PWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQ 838
            PW  D  +V R         + LK   +      +G G  G V+ G      +VAVK L 
Sbjct: 2    PWWEDAWEVPR---------ETLKLVER------LGAGQAGEVWMGYYNGHTKVAVKSL- 45
Query: 839  REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX 898
            ++G      F AE  ++        H  LV LY   +      ++ EYME GSL D +  
Sbjct: 46   KQGSMSPDAFLAEANLMKQLQ----HQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKT 100
Query: 899  XX--XXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +A  +A  + F+    Y   +HRD++A+N+L+       + DFGLAR
Sbjct: 101  PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 957  VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR 1007
            ++   +          + + APE       T K DV+SFG+L  E+ T  R
Sbjct: 158  LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 73
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 74   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 134  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 191  ESKFSVASDVWSFGVVLYELFT 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 71
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 72   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 128
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 129  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 189  IWAFGVLMWEIYS 201

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 17   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 72
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 73   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 132
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 133  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 190  ESKFSVASDVWSFGVVLYELFT 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 35   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 90
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 91   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       + +  GT  YV+PE  
Sbjct: 151  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 208  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 243

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V R L +L  +
Sbjct: 74   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y+APE  Q 
Sbjct: 134  HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERLQG 187
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +ELA GR
Sbjct: 188  THYSVQSDIWSMGLSLVELAVGR 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 73
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 74   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 134  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 191  ESKFSVASDVWSFGVVLYELFT 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 77
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  +  +A  + ++    Y   
Sbjct: 78   --VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 133  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 193  SDVWSFGILLTELTTKGR 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 22   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 77
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 78   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 137
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 138  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 195  ESKFSVASDVWSFGVVLYELFT 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 329
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  +A  + ++    Y   V
Sbjct: 330  -VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 385
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K 
Sbjct: 386  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 446  DVWSFGILLTELTTKGR 462

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD+ A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 31   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 86
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 87   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 147  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 204  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G   +  +VAVK L + G    + F  E  ++        H  LV LY 
Sbjct: 21   LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKT----LQHDKLVRLYA 75
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
                     ++ EYM  GSL D +             I  +  +A  + ++  + Y   +
Sbjct: 76   VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---I 132
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+NVL+ +     + DFGLARV+   +          + + APE       T K 
Sbjct: 133  HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 991  DVYSFGVLAMELAT 1004
            DV+SFG+L  E+ T
Sbjct: 193  DVWSFGILLYEIVT 206

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 228  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI----KHPNLVQLL 282
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 283  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 339
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HR++ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 340  IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 399  KSDVWAFGVLLWEIAT 414

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 91
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 92   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 152  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 209  ESKFSVASDVWSFGVVLYELFT 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 9/193 (4%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV LYG
Sbjct: 23   LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 77
Query: 873  WCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
             C       ++ EYM  G L + +              +  DV  A+ +L  + +   +H
Sbjct: 78   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF---LH 134
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     + ++K D
Sbjct: 135  RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 992  VYSFGVLAMELAT 1004
            +++FGVL  E+ +
Sbjct: 195  IWAFGVLMWEIYS 207

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 16   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 71
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 72   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 132  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 189  ESKFSVASDVWSFGVVLYELFT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 246
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  +A  + ++    Y   V
Sbjct: 247  -VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 363  DVWSFGILLTELTTKGR 379

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 55/297 (18%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V+           D   VAVK L+   L   ++F+ E E+L+       H
Sbjct: 21   RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN----LQH 76
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SXXXXXXXXXXX 908
             ++V  YG C DG   I+V+EYM+ G L   +                            
Sbjct: 77   EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 909  XIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VST 967
             IA  +A  +V+L  + +   VHRD+   N L+       + DFG++R V + D + V  
Sbjct: 137  HIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 968  TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG 1027
                 + ++ PE     + TT+ DV+SFGV+  E+ T                     YG
Sbjct: 194  HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------------YG 232
Query: 1028 RHG----PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            +          VI  +  G  L        E+  + + C    P  R N+KE+  +L
Sbjct: 233  KQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 16   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 71
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 72   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 131
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 132  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 189  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 49   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 104
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 105  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 165  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 222  ESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 73
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 74   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 134  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 191  ESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 23   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 78
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 79   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 138
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 139  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 196  ESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 76
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 77   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 137  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 194  ESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 76
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D + +                + + + +L  +
Sbjct: 77   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 137  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 194  ESKFSVASDVWSFGVVLYELFT 215

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G +G VY GV       VAVK L+ + +E E EF  E  V+        HPNLV L 
Sbjct: 267  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI----KHPNLVQLL 321
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISX--XXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G C       ++ E+M  G+L D +               +A  ++ A+ +L  + +   
Sbjct: 322  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 378
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATT 988
            +HR++ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + + 
Sbjct: 379  IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 989  KGDVYSFGVLAMELAT 1004
            K DV++FGVL  E+AT
Sbjct: 438  KSDVWAFGVLLWEIAT 453

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 811  RIIGKGGFGTVY---RGVLPD-GREVAVKKLQREGLEGEREFRAEME--VLSGNGFGWPH 864
            +++G+G FG V+   +   PD G   A+K L++  L+     R +ME  +L+       H
Sbjct: 34   KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN----H 89
Query: 865  PNLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            P +V L Y +  +G +  L+ +++ GG L   +S               ++A  L  LH 
Sbjct: 90   PFVVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 I++RD+K  N+LLD+EG   +TDFGL++     +   + +  GTV Y+APE    
Sbjct: 149  L---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK-AYSFCGTVEYMAPEVVNR 204
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEG 1011
               +   D +S+GVL  E+ TG    +G
Sbjct: 205  QGHSHSADWWSYGVLMFEMLTGSLPFQG 232

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 77
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  GSL D +             +  +  +A  + ++    Y   
Sbjct: 78   --VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY--- 132
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 133  VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 193  SDVWSFGILLTELTTKGR 210

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 32   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 87
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 88   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 148  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 37   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 92
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 93   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 152
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 153  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 210  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 245

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 32   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 87
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 88   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 148  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 91
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 92   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 152  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 209  ESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 25   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 80
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 81   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 140
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 141  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 198  ESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 24   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 79
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 80   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 139
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE   
Sbjct: 140  RY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 197  ESKFSVASDVWSFGVVLYELFT 218

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  G L D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 812  IIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPN 866
            ++G G F  V   +L + +     VA+K + ++ LEG E     E+ VL        HPN
Sbjct: 25   VLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK----IKHPN 77
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +V L      G    L+ + + GG L D I             +   V  A+ +LH    
Sbjct: 78   IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-- 135
Query: 927  PPIVHRDVKASNVL---LDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              IVHRD+K  N+L   LD++ K +++DFGL+++   G   V +T  GT GYVAPE    
Sbjct: 136  -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ 192
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
               +   D +S GV+A  L  G
Sbjct: 193  KPYSKAVDCWSIGVIAYILLCG 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 32   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 87
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 88   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 148  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 35   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 90
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 91   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 151  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 208  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 243

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV LY 
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQLYA 80
Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPI 929
              +   E I +V EYM  G L D +             +  A  +A  + ++    Y   
Sbjct: 81   --VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 135
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTK 989
            VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T K
Sbjct: 136  VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 990  GDVYSFGVLAMELATGRR 1007
             DV+SFG+L  EL T  R
Sbjct: 196  SDVWSFGILLTELTTKGR 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 808  SEDRIIGKGGFGTVYRGVLP--DGRE---VAVKKLQREGLEGER-EFRAEMEVLSGNGFG 861
            +  ++IG G FG VY+G+L    G++   VA+K L+    E +R +F  E  ++      
Sbjct: 47   TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ---- 102
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX-IAIDVARALVF 920
            + H N++ L G        +++ EYME G+L+  +              +   +A  + +
Sbjct: 103  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAP 978
            L +  Y   VHRD+ A N+L++      V+DFGL+RV+        TT  G   + + AP
Sbjct: 163  LANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E     + T+  DV+SFG++  E+ T
Sbjct: 220  EAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            ++IIG G  G V  G L  P  R+V  A+K L+    E +R +F +E  ++      + H
Sbjct: 54   EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ----FDH 109
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHH 923
            PN++ L G    G   ++V EYME GSL+  + +            +   V   + +L  
Sbjct: 110  PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              Y   VHRD+ A NVL+D      V+DFGL+RV+        TT  G   + + APE  
Sbjct: 170  LGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 982  QTWQATTKGDVYSFGVLAME-LATGRR 1007
                 ++  DV+SFGV+  E LA G R
Sbjct: 227  AFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGT-VYRGVLPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F T V    L   RE A+K L++  +  E +      E +V+S      
Sbjct: 32   FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 87
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 88   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 148  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H N+
Sbjct: 19   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNI 74
Query: 868  VTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLHHE 924
            V   G C     +   L+ EY+  GSL D +                  + + + +L  +
Sbjct: 75   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             Y   +HR++   N+L++ E +  + DFGL +V+     +      G   + + APE   
Sbjct: 135  RY---IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 983  TWQATTKGDVYSFGVLAMELAT 1004
              + +   DV+SFGV+  EL T
Sbjct: 192  ESKFSVASDVWSFGVVLYELFT 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 11   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 66
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 67   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 127  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 184  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 219

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 12   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 67
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 68   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 128  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 185  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGREV--AVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            ++IIG G  G V  G L  P  R+V  A+K L+    E +R +F +E  ++      + H
Sbjct: 54   EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ----FDH 109
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHH 923
            PN++ L G    G   ++V EYME GSL+  + +            +   V   + +L  
Sbjct: 110  PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              Y   VHRD+ A NVL+D      V+DFGL+RV+        TT  G   + + APE  
Sbjct: 170  LGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 982  QTWQATTKGDVYSFGVLAME-LATGRR 1007
                 ++  DV+SFGV+  E LA G R
Sbjct: 227  AFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 805  GKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------REFRAEMEVLS 856
            G +   + IGKG F  V   R VL  GREVAVK + +  L         RE R  M++L+
Sbjct: 15   GNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRI-MKILN 72
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HPN+V L+          LV EY  GG + D +                 +  
Sbjct: 73   -------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 125
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     T  G+  Y 
Sbjct: 126  AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK--LDTFCGSPPYA 180
Query: 977  APEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 181  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 12/216 (5%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGW 862
            F   +I+G+G F TV     L   RE A+K L++  +  E +      E +V+S      
Sbjct: 34   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----L 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP  V LY    D  +      Y + G L   I                ++  AL +LH
Sbjct: 90   DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV-STTIAGTVGYVAPEYG 981
             +    I+HRD+K  N+LL+++    +TDFG A+V+S       +    GT  YV+PE  
Sbjct: 150  GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                A    D+++ G +  +L  G      G E L+
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG+G  G V        GR+VAVK +     +       E+ ++      + H N+V +Y
Sbjct: 53   IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD----YQHFNVVEMY 108
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
               L G E  ++ E+++GG+L DI+S            +   V +AL +LH +    ++H
Sbjct: 109  KSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQ---GVIH 164
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGD 991
            RD+K+ ++LL  +G+  ++DFG    +S  D      + GT  ++APE        T+ D
Sbjct: 165  RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 992  VYSFGVLAMELATG 1005
            ++S G++ +E+  G
Sbjct: 224  IWSLGIMVIEMVDG 237

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 109/275 (39%), Gaps = 71/275 (25%)
Query: 375 NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIG 434
           NN  GP+P  I+++  L +L + H   +G+IP     +  L TLD S+N L+G +PPSI 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 435 NLTSLLWLMLANNSLSGEIPGEIGXXXXXXXXXXXXXXXXXXIPPEVMTIGRNARPTFEA 494
           +L +L+ +    N +SG IP   G                       MTI RN       
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTS---------------MTISRN------- 184
Query: 495 NQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLP 554
                            +   IP  +   +  +  L+R                    L 
Sbjct: 185 ----------------RLTGKIPPTFANLNLAFVDLSRN------------------MLE 210
Query: 555 GLASRTF---QITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPL 611
           G AS  F   + T  + L+ N L+ +L   +G  +N + + L  N+  G LP    QL  
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 612 I-VLNLTRNNFSGEIP----------SEFGNIKCL 635
           +  LN++ NN  GEIP          S + N KCL
Sbjct: 270 LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 64/160 (40%), Gaps = 33/160 (20%)
Query: 553 LPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQN-FSMVHLGFNQFDGKLPSQFDQLPL 611
           LP L   TF         GN++SG +    G     F+ + +  N+  GK+P  F  L L
Sbjct: 148 LPNLVGITFD--------GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL 199
Query: 612 IVLNLTRNNFSGEIPSEFGNIKCLQN-----------------------LDLSYNNFSGP 648
             ++L+RN   G+    FG+ K  Q                        LDL  N   G 
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 649 FPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSY 688
            P     L  L  LN+S+N L  G IP  G L  F+ ++Y
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLC-GEIPQGGNLQRFDVSAY 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 811  RIIGKGGFGTVYRGVLPDGREV--AVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            ++IGKG FG V         EV  AVK LQ++ +   + E+   +E  VL  N     HP
Sbjct: 44   KVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHP 99
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
             LV L+       +   V +Y+ GG L   +              A ++A AL +LH   
Sbjct: 100  FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
               IV+RD+K  N+LLD +G  ++TDFGL +     +S  ++T  GT  Y+APE  + Q 
Sbjct: 160  ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHKQP 215
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
            +  T   D +  G +  E+  G
Sbjct: 216  YDRTV--DWWCLGAVLYEMLYG 235

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G+G FG V+ G       VA+K L+   +  E  F  E +V+        H  LV LY 
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-AFLQEAQVMKK----LRHEKLVQLYA 247
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  +A  + ++    Y   V
Sbjct: 248  -VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---V 303
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+N+L+ +     V DFGL R++   +          + + APE     + T K 
Sbjct: 304  HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 364  DVWSFGILLTELTTKGR 380

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 864  HPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
            HPN+V  Y   +D +   L  V EY EGG L  +I+              + V   L   
Sbjct: 64   HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 922  HHECYP------PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              EC+        ++HRD+K +NV LD +    + DFGLAR+++  D+  +    GT  Y
Sbjct: 124  LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYY 182
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELA 1003
            ++PE         K D++S G L  EL 
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELC 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 11/197 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G      +VA+K L + G      F  E +++        H  LV LY 
Sbjct: 17   LGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKK----LKHDKLVQLYA 71
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
              +      +V EYM  GSL D +             +  A  VA  + ++    Y   +
Sbjct: 72   -VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 127
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++++N+L+       + DFGLAR++   +          + + APE     + T K 
Sbjct: 128  HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 991  DVYSFGVLAMELATGRR 1007
            DV+SFG+L  EL T  R
Sbjct: 188  DVWSFGILLTELVTKGR 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 56/296 (18%)
Query: 811  RIIGKGGFGTVYRG----VLPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V+      + P+  +  VAVK L+       ++F  E E+L+       H
Sbjct: 19   RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN----LQH 74
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX-------------XXXXXXXXXXIA 911
             ++V  YG C++G   I+V+EYM+ G L   +                          IA
Sbjct: 75   EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              +A  +V+L  + +   VHRD+   N L+ +     + DFG++R V + D + V     
Sbjct: 135  QQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRR---ALEGGE--ECLVEWGRRVM 1024
              + ++ PE     + TT+ DV+S GV+  E+ T G++    L   E  EC+ +   RV+
Sbjct: 192  LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ--GRVL 249
Query: 1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
               R  P                  +E+ EL+   + C    P+ R N+K +  +L
Sbjct: 250  QRPRTCP------------------QEVYELM---LGCWQREPHMRKNIKGIHTLL 284

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 811  RIIGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            R +GKG FG+V       L D  G  VAVKKLQ    E  R+F  E+E+L        H 
Sbjct: 19   RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHD 74
Query: 866  NLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXX-XIAIDVARALVFLH 922
            N+V   G C     +   L+ E++  GSL + +                  + + + +L 
Sbjct: 75   NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HRD+   N+L++ E +  + DFGL +V+            G   + + APE 
Sbjct: 135  TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
                + +   DV+SFGV+  EL T
Sbjct: 192  LTESKFSVASDVWSFGVVLYELFT 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 864  HPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
            HPN+V  Y   +D +   L  V EY EGG L  +I+              + V   L   
Sbjct: 64   HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 922  HHECYP------PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              EC+        ++HRD+K +NV LD +    + DFGLAR+++  D   +    GT  Y
Sbjct: 124  LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFVGTPYY 182
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            ++PE         K D++S G L  EL  
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 24   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 77
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   + +            IA   AR + +L
Sbjct: 78   RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE 
Sbjct: 137  HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +   +   + + DVY+FG++  EL TG+
Sbjct: 194  IRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 24   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 77
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   + +            IA   AR + +L
Sbjct: 78   RHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE 
Sbjct: 137  HAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +   +   + + DVY+FG++  EL TG+
Sbjct: 194  IRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAVK + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R  M+VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-MKVLN-------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            T  G+  Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 83   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 143  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 196
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGG 1012
               + + D++S G+  +E+A GR  +  G
Sbjct: 197  THYSVQSDIWSMGLSLVEMAVGRYPIGSG 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAVK + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R  M+VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-MKVLN-------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            T  G+  Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 126  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 186  HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 239
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 240  THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 91   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 151  H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 204
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 205  THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 10/194 (5%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +G G FG V+ G   +  +VAVK L + G    + F  E  ++        H  LV LY 
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKT----LQHDKLVRLYA 74
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIV 930
                     ++ E+M  GSL D +             I  +  +A  + ++  + Y   +
Sbjct: 75   VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---I 131
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG 990
            HRD++A+NVL+ +     + DFGLARV+   +          + + APE       T K 
Sbjct: 132  HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 991  DVYSFGVLAMELAT 1004
            +V+SFG+L  E+ T
Sbjct: 192  NVWSFGILLYEIVT 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 124  HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 124  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 124  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGE---REFRAEMEVLSGNGFGW 862
            F   R +GKG FG VY          VA+K L +  +E E    + R E+E+ +      
Sbjct: 25   FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAH----L 80
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN++ LY +  D     L+ EY   G L   +             I  ++A AL++ H
Sbjct: 81   HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    ++HRD+K  N+LL  +G+  + DFG +       S    T+ GT+ Y+ PE  +
Sbjct: 141  GK---KVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGG 1012
                  K D++  GVL  EL  G    E  
Sbjct: 195  GRMHNEKVDLWCIGVLCYELLVGNPPFESA 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 124  H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 77/143 (53%), Gaps = 7/143 (4%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                I+HRDVK SN+L++  G+  + DFG++ +++ +    ++ +  GT  Y++PE  Q 
Sbjct: 124  H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177
Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
               + + D++S G+  +E+A GR
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAV+ + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R  M+VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-MKVLN-------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            T  G+  Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 805  GKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------REFRAEMEVLS 856
            G +   + IGKG F  V   R +L  G+EVAVK + +  L         RE R  M+VL+
Sbjct: 7    GNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRI-MKVLN 64
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HPN+V L+          LV EY  GG + D +                 +  
Sbjct: 65   -------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS 117
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     T  G+  Y 
Sbjct: 118  AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYA 172
Query: 977  APEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
            APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 173  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 219

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 62
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 63   -HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 121  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 178  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 10   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 64
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 65   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 123  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 180  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P +V  YG      E  +  E+M+GGSL+ ++             ++I V + L +L  +
Sbjct: 67   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRDVK SN+L++  G+  + DFG++  +      ++    GT  Y++PE  Q  
Sbjct: 127  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DEMANEFVGTRSYMSPERLQGT 181
Query: 985  QATTKGDVYSFGVLAMELATGR 1006
              + + D++S G+  +E+A GR
Sbjct: 182  HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 62
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 63   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 121  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 178  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 13   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 67
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 68   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 126  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 183  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 13   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 67
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 68   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 126  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 183  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 114/260 (43%), Gaps = 46/260 (17%)
Query: 781  LSDTVKVIRLDKTAFTYSDILKATGKFSEDR--------IIGKGGFGTVYRGVLPDGREV 832
            L D  KVI+          +L + GK  E R        +IG G FG V++  L +  EV
Sbjct: 18   LDDPNKVIK----------VLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67
Query: 833  AVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI------LVYEY 886
            A+KK+ ++     RE +  M ++        HPN+V L  +     +K       LV EY
Sbjct: 68   AIKKVLQDKRFKNRELQI-MRIVK-------HPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 887  MEGGSLEDIISXXXXXXXXXXXXIAI---DVARALVFLHHECYPPIVHRDVKASNVLLDK 943
            +                      I +    + R+L ++H      I HRD+K  N+LLD 
Sbjct: 120  VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDP 176
Query: 944  EGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAM 1000
                L + DFG A+++ AG+ +VS   +    Y APE  +G T   TT  D++S G +  
Sbjct: 177  PSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAPELIFGAT-NYTTNIDIWSTGCVMA 233
Query: 1001 ELATGRRAL--EGGEECLVE 1018
            EL  G+     E G + LVE
Sbjct: 234  ELMQGQPLFPGESGIDQLVE 253

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H NLV L
Sbjct: 12   QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQ----LRHSNLVQL 64
Query: 871  YGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXX--XXXXXIAIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D +                ++DV  A+ +L    + 
Sbjct: 65   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 123
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVL+ ++  A V+DFGL +  S      ST   G   V + APE  +  +
Sbjct: 124  --VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 175
Query: 986  ATTKGDVYSFGVLAMEL 1002
             +TK DV+SFG+L  E+
Sbjct: 176  FSTKSDVWSFGILLWEI 192

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            F  ++ IG+G F  VYR   L DG  VA+KK+Q   L   +   +   E+++L       
Sbjct: 34   FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--- 90
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIA----IDVARAL 918
             HPN++  Y   ++ +E  +V E  + G L  +I                   + +  AL
Sbjct: 91   -HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H      ++HRD+K +NV +   G   + D GL R  S+  +  + ++ GT  Y++P
Sbjct: 150  EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSP 205
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
            E         K D++S G L  E+A  +    G +  L    +++
Sbjct: 206  ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 35   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 88
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 89   RHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 148  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 204
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 205  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 36   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 90   RHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE 
Sbjct: 149  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 206  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +++IG G FG V  G L  P  RE  VA+K L+    + +R +F +E  ++      + H
Sbjct: 13   EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ----FDH 68
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX-IAIDVARALVFLHH 923
            PN++ L G        +++ EYME GSL+  +              +   +   + +L  
Sbjct: 69   PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD 128
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              Y   VHRD+ A N+L++      V+DFG++RV+        TT  G   + + APE  
Sbjct: 129  MSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 982  QTWQATTKGDVYSFGVLAMELAT 1004
               + T+  DV+S+G++  E+ +
Sbjct: 186  AYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H NLV L
Sbjct: 27   QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQ----LRHSNLVQL 79
Query: 871  YGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXX--XXXXXIAIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D +                ++DV  A+ +L    + 
Sbjct: 80   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVL+ ++  A V+DFGL +  S      ST   G   V + APE  +  +
Sbjct: 139  --VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 190
Query: 986  ATTKGDVYSFGVLAMEL 1002
             +TK DV+SFG+L  E+
Sbjct: 191  FSTKSDVWSFGILLWEI 207

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 11/219 (5%)
Query: 791  DKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR--EGLEGERE 847
            +K     + I K T +  + +++G G FGTV++GV +P+G  + +    +  E   G + 
Sbjct: 18   EKANKVLARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 76
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXX 906
            F+A  + +   G    H ++V L G C  GS   LV +Y+  GSL D +           
Sbjct: 77   FQAVTDHMLAIG-SLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 134
Query: 907  XXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
                 + +A+ + +L       +VHR++ A NVLL    +  V DFG+A ++   D  + 
Sbjct: 135  LLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 967  TTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             + A T + ++A E     + T + DV+S+GV   EL T
Sbjct: 192  YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +++IG G FG V  G L  P  RE  VA+K L+    + +R +F +E  ++      + H
Sbjct: 19   EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ----FDH 74
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX-IAIDVARALVFLHH 923
            PN++ L G        +++ EYME GSL+  +              +   +   + +L  
Sbjct: 75   PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD 134
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              Y   VHRD+ A N+L++      V+DFG++RV+        TT  G   + + APE  
Sbjct: 135  MSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 982  QTWQATTKGDVYSFGVLAMELAT 1004
               + T+  DV+S+G++  E+ +
Sbjct: 192  AYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 811  RIIGKGGFGTVYRGVLP--DGR--EVAVK--KLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            +I+G+G FG+V  G L   DG   +VAVK  KL         EF +E   +      + H
Sbjct: 40   KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD----FSH 95
Query: 865  PNLVTLYGWCLDGSEK-----ILVYEYMEGGSLEDII------SXXXXXXXXXXXXIAID 913
            PN++ L G C++ S +     +++  +M+ G L   +      +              +D
Sbjct: 96   PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A  + +L +  +   +HRD+ A N +L  +    V DFGL++ + +GD +    IA   
Sbjct: 156  IALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++A E       T+K DV++FGV   E+AT                R +  Y    PG
Sbjct: 213  VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------------RGMTPY----PG 252
Query: 1033 ---RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                 +   +L G  L +  + + EL  I   C    P  RP    +   L K+L
Sbjct: 253  VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 810  DRIIGKGGFGTVYRG--VLPDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +++IG G FG V  G   LP  RE  VA+K L+    E +R +F +E  ++      + H
Sbjct: 12   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ----FDH 67
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXX-XXXXXXXXXIAIDVARALVFLHH 923
            PN++ L G     +  +++ E+ME GSL+  +              +   +A  + +L  
Sbjct: 68   PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 127
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS--AGDSHVSTTIAGT--VGYVAPE 979
              Y   VHR + A N+L++      V+DFGL+R +     D   ++ + G   + + APE
Sbjct: 128  MNY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 980  YGQTWQATTKGDVYSFGVLAME-LATGRR 1007
              Q  + T+  DV+S+G++  E ++ G R
Sbjct: 185  AIQYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H NLV L
Sbjct: 199  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQ----LRHSNLVQL 251
Query: 871  YGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXX--XXXXXIAIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D +                ++DV  A+ +L    + 
Sbjct: 252  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVL+ ++  A V+DFGL +  S      ST   G   V + APE  +  +
Sbjct: 311  --VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK 362
Query: 986  ATTKGDVYSFGVLAMEL 1002
             +TK DV+SFG+L  E+
Sbjct: 363  FSTKSDVWSFGILLWEI 379

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 46/277 (16%)
Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            ++ +G G FG V+        +VAVK ++   +  E  F AE  V+        H  LV 
Sbjct: 187  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKT----LQHDKLVK 241
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYP 927
            L+   +      ++ E+M  GSL D +             I  +  +A  + F+    Y 
Sbjct: 242  LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 299
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
              +HRD++A+N+L+       + DFGLARV +             + + APE       T
Sbjct: 300  --IHRDLRAANILVSASLVCKIADFGLARVGA----------KFPIKWTAPEAINFGSFT 347
Query: 988  TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR-HGPGRA---VIPVVLLGS 1043
             K DV+SFG+L ME+ T                     YGR   PG +   VI  +  G 
Sbjct: 348  IKSDVWSFGILLMEIVT---------------------YGRIPYPGMSNPEVIRALERGY 386
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +        EL  I +RC    P  RP  + + ++L
Sbjct: 387  RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAVK + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R  M+VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-MKVLN-------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
               G   Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 34/287 (11%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK---KLQREGL--EGEREFRAEME 853
            ILK T +  + +++G G FGTVY+G+ +PDG  V +    K+ RE    +  +E   E  
Sbjct: 13   ILKET-ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID 913
            V++G G     P +  L G CL  + +++      G  L+ +                + 
Sbjct: 72   VMAGVG----SPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ 127
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A+ + +L       +VHRD+ A NVL+       +TDFGLAR++   ++          
Sbjct: 128  IAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGP 1031
            + ++A E     + T + DV+S+GV   EL T G +  +G                   P
Sbjct: 185  IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG------------------IP 226
Query: 1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
             R +  ++  G  L +      ++  I V+C       RP  +E+++
Sbjct: 227  AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 24/227 (10%)
Query: 795  FTYSDILKATGKFSED---------RIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREG 841
            FT+ D  +A  +F+++         ++IG G FG V  G L  P  RE  VA+K L+   
Sbjct: 10   FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 842  LEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXX 900
             + +R +F +E  ++      + HPN++ L G        +++ EYME GSL+  +    
Sbjct: 70   TDKQRRDFLSEASIMGQ----FDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKND 125
Query: 901  XXXXXXXXX-IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                      +   +   + +L        VHRD+ A N+L++      V+DFG++RV+ 
Sbjct: 126  GRFTVIQLVGMLRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 960  AGDSHVSTTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                   TT  G   + + APE     + T+  DV+S+G++  E+ +
Sbjct: 183  DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 25/236 (10%)
Query: 798  SDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------REFR 849
            SD     G +   + IGKG F  V   R +L  GREVA+K + +  L         RE R
Sbjct: 5    SDEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVR 63
Query: 850  AEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX 909
              M++L+       HPN+V L+          L+ EY  GG + D +             
Sbjct: 64   I-MKILN-------HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 115
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
                +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G      T 
Sbjct: 116  KFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDTF 170
Query: 970  AGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
             G+  Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 224

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G  VAVK L+ + G +    ++ E+++L        H
Sbjct: 20   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT----LYH 75
Query: 865  PNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             +++   G C D  EK   LV EY+  GSL D +              A  +   + +LH
Sbjct: 76   EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLH 134
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HR++ A NVLLD +    + DFGLA+ V  G  +      G   V + APE 
Sbjct: 135  SQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             + ++     DV+SFGV   EL T
Sbjct: 192  LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H NLV L
Sbjct: 18   QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQ----LRHSNLVQL 70
Query: 871  YGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D +             +  ++DV  A+ +L    + 
Sbjct: 71   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 129
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQ 985
              VHRD+ A NVL+ ++  A V+DFGL +  S      ST   G   V + APE  +   
Sbjct: 130  --VHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREAA 181
Query: 986  ATTKGDVYSFGVLAMEL 1002
             +TK DV+SFG+L  E+
Sbjct: 182  FSTKSDVWSFGILLWEI 198

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            + +IG G FG V RG L  P  +E  VA+K L+    E +R EF +E  ++      + H
Sbjct: 19   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQ----FEH 74
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX-IAIDVARALVFLHH 923
            PN++ L G   +    +++ E+ME G+L+  +              +   +A  + +L  
Sbjct: 75   PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVSTTIAGT--VGYVAPE 979
              Y   VHRD+ A N+L++      V+DFGL+R +  ++ D   ++++ G   + + APE
Sbjct: 135  MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG----PGRAV 1035
                 + T+  D +S+G++  E                     VM +G         + V
Sbjct: 192  AIAFRKFTSASDAWSYGIVMWE---------------------VMSFGERPYWDMSNQDV 230
Query: 1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            I  +     L    +  + L ++ + C  +  NARP   +V++ L K++
Sbjct: 231  INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     +   ++ ++ L  + E     + E  V         HP 
Sbjct: 58   RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS---NHPF 114
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            LV L+      S    V EY+ GG L   +              + +++ AL +LH    
Sbjct: 115  LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 173
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++T  GT  Y+APE  +   
Sbjct: 174  --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 229
Query: 986  ATTKGDVYSFGVLAMELATGRRALE 1010
                 D ++ GVL  E+  GR   +
Sbjct: 230  YGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 104/238 (43%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAV+ + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R  M+VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-MKVLN-------HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
               G+  Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  EFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 798  SDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR--EGLEGEREFRAEMEV 854
            + I K T +  + +++G G FGTV++GV +P+G  + +    +  E   G + F+A  + 
Sbjct: 7    ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIAID 913
            +   G    H ++V L G C  GS   LV +Y+  GSL D +                + 
Sbjct: 66   MLAIG-SLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A+ + +L       +VHR++ A NVLL    +  V DFG+A ++   D  +  + A T 
Sbjct: 124  IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            + ++A E     + T + DV+S+GV   EL T
Sbjct: 181  IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     +   K+ ++ L  + E     + E  V         HP 
Sbjct: 15   RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS---NHPF 71
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            LV L+      S    V EY+ GG L   +              + +++ AL +LH    
Sbjct: 72   LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 130
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++   GT  Y+APE  +   
Sbjct: 131  --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGED 186
Query: 986  ATTKGDVYSFGVLAMELATGRRALE 1010
                 D ++ GVL  E+  GR   +
Sbjct: 187  YGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 811  RIIGKGGFGTVY--RGVLP--DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGW 862
            R++GKGG+G V+  R V     G+  A+K L++  +    +     +AE  +L       
Sbjct: 23   RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE----V 78
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP +V L      G +  L+ EY+ GG L   +                +++ AL  LH
Sbjct: 79   KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    I++RD+K  N++L+ +G   +TDFGL +  S  D  V+ T  GT+ Y+APE   
Sbjct: 139  QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
                    D +S G L  ++ TG
Sbjct: 195  RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     +   K+ ++ L  + E     + E  V         HP 
Sbjct: 11   RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS---NHPF 67
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            LV L+      S    V EY+ GG L   +              + +++ AL +LH    
Sbjct: 68   LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 126
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++   GT  Y+APE  +   
Sbjct: 127  --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGED 182
Query: 986  ATTKGDVYSFGVLAMELATGRRALE 1010
                 D ++ GVL  E+  GR   +
Sbjct: 183  YGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            + +IG G FG V RG L  P  +E  VA+K L+    E +R EF +E  ++      + H
Sbjct: 21   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQ----FEH 76
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXX-IAIDVARALVFLHH 923
            PN++ L G   +    +++ E+ME G+L+  +              +   +A  + +L  
Sbjct: 77   PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE 136
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVSTTIAGT--VGYVAPE 979
              Y   VHRD+ A N+L++      V+DFGL+R +  ++ D   ++++ G   + + APE
Sbjct: 137  MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
                 + T+  D +S+G++  E+ +
Sbjct: 194  AIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ AVK L+++ +  + +    M    VL+  G     P  
Sbjct: 348  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPF 403
Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +T    C    +++  V EY+ GG L   I              A ++A  L FL  +  
Sbjct: 404  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG- 462
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  NV+LD EG   + DFG+ +  +  D   +    GT  Y+APE       
Sbjct: 463  --IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEE 1014
                D ++FGVL  E+  G+   EG +E
Sbjct: 520  GKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ AVK L+++ +  + +    M    VL+  G     P  
Sbjct: 27   VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPF 82
Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +T    C    +++  V EY+ GG L   I              A ++A  L FL  +  
Sbjct: 83   LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  NV+LD EG   + DFG+ +  +  D   +    GT  Y+APE       
Sbjct: 142  --IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEE 1014
                D ++FGVL  E+  G+   EG +E
Sbjct: 199  GKSVDWWAFGVLLYEMLAGQAPFEGEDE 226

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEG-EREFRAEMEVLSGNGFG 861
            F     +G G F  V   VL +    G+  AVK + ++ L+G E     E+ VL      
Sbjct: 24   FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRK---- 76
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              H N+V L       +   LV + + GG L D I             +   V  A+ +L
Sbjct: 77   IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 922  HHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
            H      IVHRD+K  N+L    D+E K +++DFGL+++   GD  V +T  GT GYVAP
Sbjct: 137  HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMSTACGTPGYVAP 191
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATG 1005
            E       +   D +S GV+A  L  G
Sbjct: 192  EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG+G FG V+ G L  D   VAVK   RE L  + + +F  E  +L      + HPN+V 
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQ----YSHPNIVR 176
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHHECYPP 928
            L G C       +V E ++GG     +               + D A  + +L  +C   
Sbjct: 177  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYGQTWQAT 987
             +HRD+ A N L+ ++    ++DFG++R  + G    S  +    V + APE     + +
Sbjct: 234  CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 988  TKGDVYSFGVLAME 1001
            ++ DV+SFG+L  E
Sbjct: 294  SESDVWSFGILLWE 307

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE----FRAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     +   K+ ++ L  + E     + E  V         HP 
Sbjct: 26   RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS---NHPF 82
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            LV L+      S    V EY+ GG L   +              + +++ AL +LH    
Sbjct: 83   LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG- 141
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARV-VSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
              I++RD+K  NVLLD EG   +TD+G+ +  +  GD+  ++   GT  Y+APE  +   
Sbjct: 142  --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEILRGED 197
Query: 986  ATTKGDVYSFGVLAMELATGR 1006
                 D ++ GVL  E+  GR
Sbjct: 198  YGFSVDWWALGVLMFEMMAGR 218

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            IG G FGTVY+G       V + K+     E  + FR E+ VL        H N++   G
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR----HVNILLFMG 99
Query: 873  WCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
            +    +  I V ++ EG SL + +              IA   A+ + +LH +    I+H
Sbjct: 100  YMTKDNLAI-VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIH 155
Query: 932  RDVKASNVLLDKEGKALVTDFGLARVVS--AGDSHVSTTIAGTVGYVAPEYGQTWQA--- 986
            RD+K++N+ L +     + DFGLA V S  +G   V     G+V ++APE  +       
Sbjct: 156  RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP-TGSVLWMAPEVIRMQDNNPF 214
Query: 987  TTKGDVYSFGVLAMELATG 1005
            + + DVYS+G++  EL TG
Sbjct: 215  SFQSDVYSYGIVLYELMTG 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG+G FG V+ G L  D   VAVK   RE L  + + +F  E  +L      + HPN+V 
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQ----YSHPNIVR 176
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHHECYPP 928
            L G C       +V E ++GG     +               + D A  + +L  +C   
Sbjct: 177  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYGQTWQAT 987
             +HRD+ A N L+ ++    ++DFG++R  + G    S  +    V + APE     + +
Sbjct: 234  CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 988  TKGDVYSFGVLAME 1001
            ++ DV+SFG+L  E
Sbjct: 294  SESDVWSFGILLWE 307

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQRE---GLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G FG V  G     G +VAVK L R+    L+   + R E++ L      + HP+++
Sbjct: 24   LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL----FRHPHII 79
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             LY      S+  +V EY+ GG L D I             +   +   + + H      
Sbjct: 80   KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQA 986
            +VHRD+K  NVLLD    A + DFGL+ ++S G+        G+  Y APE   G+ + A
Sbjct: 137  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPEVISGRLY-A 193
Query: 987  TTKGDVYSFGVLAMELATG 1005
              + D++S GV+   L  G
Sbjct: 194  GPEVDIWSSGVILYALLCG 212

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 12   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 69
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 70   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 124
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 125  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 182  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 223
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 224  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 62
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 63   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE 
Sbjct: 121  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 178  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQRE---GLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G FG V  G     G +VAVK L R+    L+   + + E++ L      + HP+++
Sbjct: 19   LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL----FRHPHII 74
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             LY      ++  +V EY+ GG L D I             +   +  A+ + H      
Sbjct: 75   KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--- 131
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQA 986
            +VHRD+K  NVLLD    A + DFGL+ ++S G+     T  G+  Y APE   G+ + A
Sbjct: 132  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY-A 188
Query: 987  TTKGDVYSFGVLAMELATG 1005
              + D++S GV+   L  G
Sbjct: 189  GPEVDIWSCGVILYALLCG 207

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 222
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 223  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 15   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 72
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 73   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 127
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 128  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 185  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 226
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 227  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 36   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 93
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 94   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 148
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 149  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 206  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 247
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 248  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 14   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 71
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 72   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 126
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 127  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 184  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 225
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 226  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 28   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--- 82
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 83   -HVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE 
Sbjct: 141  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 197
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 198  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 84/311 (27%), Positives = 129/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++TL G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 12   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 69
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 70   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC 124
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 125  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 182  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 223
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 224  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 13   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 70
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 71   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 125
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 126  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 183  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 224
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 225  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 222
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 223  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 5    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 62
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 63   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 118  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 175  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 216
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 217  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGW 862
            G+ +  + IG G FGTVY+G      +VAVK L       ++   F+ E+ VL       
Sbjct: 36   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT---- 89
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX-XXXXXXXIAIDVARALVFL 921
             H N++   G+     +  +V ++ EG SL   +              IA   A+ + +L
Sbjct: 90   RHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPEY 980
            H +    I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE 
Sbjct: 149  HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 205
Query: 981  GQTWQA---TTKGDVYSFGVLAMELATGR 1006
             +       + + DVY+FG++  EL TG+
Sbjct: 206  IRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 13   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 70
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 71   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 125
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 126  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 183  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 224
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 225  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G  VAVK L+ + G +    ++ E+++L        H
Sbjct: 20   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT----LYH 75
Query: 865  PNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             +++   G C D  EK L  V EY+  GSL D +              A  +   + +LH
Sbjct: 76   EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLH 134
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HR++ A NVLLD +    + DFGLA+ V  G  +      G   V + APE 
Sbjct: 135  AQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             + ++     DV+SFGV   EL T
Sbjct: 192  LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 21   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 78
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 79   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 133
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 134  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 191  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G 
Sbjct: 191  FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 249
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              P +V +  +     +K+  + + M GG L   +S             A ++   L  +
Sbjct: 250  DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  
Sbjct: 309  HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 362
Query: 982  QTWQA-TTKGDVYSFGVLAMELATG 1005
            Q   A  +  D +S G +  +L  G
Sbjct: 363  QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G 
Sbjct: 191  FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 249
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              P +V +  +     +K+  + + M GG L   +S             A ++   L  +
Sbjct: 250  DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  
Sbjct: 309  HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 362
Query: 982  QTWQA-TTKGDVYSFGVLAMELATG 1005
            Q   A  +  D +S G +  +L  G
Sbjct: 363  QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 17   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 74
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 75   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 129
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 130  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 187  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 228
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 229  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 222
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 223  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 14   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 71
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 72   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 126
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 127  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 184  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 225
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 226  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G 
Sbjct: 190  FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 248
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              P +V +  +     +K+  + + M GG L   +S             A ++   L  +
Sbjct: 249  DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  
Sbjct: 308  HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 361
Query: 982  QTWQA-TTKGDVYSFGVLAMELATG 1005
            Q   A  +  D +S G +  +L  G
Sbjct: 362  QKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G 
Sbjct: 191  FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 249
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              P +V +  +     +K+  + + M GG L   +S             A ++   L  +
Sbjct: 250  DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  
Sbjct: 309  HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 362
Query: 982  QTWQA-TTKGDVYSFGVLAMELATG 1005
            Q   A  +  D +S G +  +L  G
Sbjct: 363  QKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------RE 847
            T +D     G +   + IGKG F  V   R +L  G+EVAVK + +  L         RE
Sbjct: 5    TSADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFRE 63
Query: 848  FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX 907
             R   +VL+       HPN+V L+          LV EY  GG + D +           
Sbjct: 64   VRI-XKVLN-------HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA 115
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +  A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G+     
Sbjct: 116  RAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LD 170
Query: 968  TIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
               G   Y APE  Q  +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 171  AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
             G F    ++G G +G VY+G  +  G+  A+K +   G E E E + E+ +L       
Sbjct: 23   AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSH-- 79
Query: 863  PHPNLVTLYGWCLDGS------EKILVYEYMEGGSLEDIISXXXXXXXXXX--XXIAIDV 914
             H N+ T YG  +  +      +  LV E+   GS+ D+I               I  ++
Sbjct: 80   -HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
             R L  LH      ++HRD+K  NVLL +  +  + DFG++  +       +T I GT  
Sbjct: 139  LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 194
Query: 975  YVAPEY---GQTWQATT--KGDVYSFGVLAMELATG 1005
            ++APE     +   AT   K D++S G+ A+E+A G
Sbjct: 195  WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 97/223 (43%), Gaps = 25/223 (11%)
Query: 811  RIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGE------REFRAEMEVLSGNGFGW 862
            + IGKG F  V   R +L  GREVA+K + +  L         RE R  M++L+      
Sbjct: 21   KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRI-MKILN------ 72
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN+V L+          L+ EY  GG + D +                 +  A+ + H
Sbjct: 73   -HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    IVHRD+KA N+LLD +    + DFG +   + G         G   Y APE  Q
Sbjct: 132  QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPELFQ 186
Query: 983  TWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
              +    + DV+S GV+   L +G    +G  + L E   RV+
Sbjct: 187  GKKYDGPEVDVWSLGVILYTLVSGSLPFDG--QNLKELRERVL 227

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 14   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 71
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 72   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 126
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 127  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 184  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 14   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 71
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 72   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 126
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 127  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 184  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 18   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 75
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 76   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 130
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 131  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 188  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 811  RIIGKGGFGTVY--RGVLP--DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGW 862
            R++GKGG+G V+  R V     G+  A+K L++  +    +     +AE  +L       
Sbjct: 23   RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE----V 78
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP +V L      G +  L+ EY+ GG L   +                +++ AL  LH
Sbjct: 79   KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    I++RD+K  N++L+ +G   +TDFGL +  S  D  V+    GT+ Y+APE   
Sbjct: 139  QKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 983  TWQATTKGDVYSFGVLAMELATG 1005
                    D +S G L  ++ TG
Sbjct: 195  RSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 44/282 (15%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVK+LQ  G + +R+F+ E+++L        H + 
Sbjct: 18   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-----LHSDF 72
Query: 868  VTLYGWCLDGSEKI---LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            +  Y     G  +    LV EY+  G L D +               +D +R L++    
Sbjct: 73   IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQI 123
Query: 925  C-------YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGY 975
            C           VHRD+ A N+L++ E    + DFGLA+++     +      G   + +
Sbjct: 124  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034
             APE       + + DV+SFGV+  EL T   ++     E L     R+MG  R  P  +
Sbjct: 184  YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGSERDVPALS 238
Query: 1035 -VIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPN 1072
             ++ ++  G  L        E+ EL+++   C A +P  RP+
Sbjct: 239  RLLELLEEGQRLPAPPACPAEVHELMKL---CWAPSPQDRPS 277

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 119/293 (40%), Gaps = 30/293 (10%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVK---KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IGKG +G V+ G    G +VAVK     +      E E    + +   N  G+   ++  
Sbjct: 45   IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY--- 926
               W    ++  L+ +Y E GSL D +             +A      L  LH E +   
Sbjct: 104  TGSW----TQLYLITDYHENGSLYDYLKSTTLDAKSMLK-LAYSSVSGLCHLHTEIFSTQ 158
Query: 927  --PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS---TTIAGTVGYVAPEY- 980
              P I HRD+K+ N+L+ K G   + D GLA    +  + V     T  GT  Y+ PE  
Sbjct: 159  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 981  -----GQTWQATTKGDVYSFGVLAMELATGRRALEGG--EECLVEWGRRVMGYGRHGPGR 1033
                    +Q+    D+YSFG++  E+A  RR + GG  EE  + +   V     +   R
Sbjct: 219  DESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 1034 AVIPVVLLGSGLA---EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             ++ +  L           E + ++ ++   C A  P +R     V   L K+
Sbjct: 277  EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVT 869
            +GKG +G V+RG    G  VAVK       +    E E    + +   N  G+   ++ +
Sbjct: 16   VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY--- 926
             +      ++  L+  Y E GSL D +             I + +A  L  LH E +   
Sbjct: 75   RHS----STQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIFGTQ 129
Query: 927  --PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST---TIAGTVGYVAPEY- 980
              P I HRD+K+ N+L+ K G+  + D GLA + S   + +        GT  Y+APE  
Sbjct: 130  GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 981  GQTWQ-----ATTKGDVYSFGVLAMELATGRRALEGG 1012
             +T Q     +  + D+++FG++  E+A  RR +  G
Sbjct: 190  DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNG 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-------KLQREGLEGEREF-RAEMEVLS 856
            K+    +IG+G    V R V    G E AVK       +L  E LE  RE  R E  +L 
Sbjct: 95   KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HP+++TL       S   LV++ M  G L D ++            I   +  
Sbjct: 155  QVA---GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            A+ FLH      IVHRD+K  N+LLD   +  ++DFG +  +  G+      + GT GY+
Sbjct: 212  AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYL 266
Query: 977  APEYGQTWQATT------KGDVYSFGVLAMELATG 1005
            APE  +     T      + D+++ GV+   L  G
Sbjct: 267  APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVK+LQ  G + +R+F+ E+++L        H + 
Sbjct: 31   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-----LHSDF 85
Query: 868  VTLYGWCLDGSEKI---LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            +  Y     G  +    LV EY+  G L D +               +D +R L++    
Sbjct: 86   IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQI 136
Query: 925  C-------YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGY 975
            C           VHRD+ A N+L++ E    + DFGLA+++     +      G   + +
Sbjct: 137  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             APE       + + DV+SFGV+  EL T
Sbjct: 197  YAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVT 869
            +GKG +G V+RG    G  VAVK       +    E E    + +   N  G+   ++ +
Sbjct: 16   VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY--- 926
             +      ++  L+  Y E GSL D +             I + +A  L  LH E +   
Sbjct: 75   RHS----STQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIFGTQ 129
Query: 927  --PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST---TIAGTVGYVAPEY- 980
              P I HRD+K+ N+L+ K G+  + D GLA + S   + +        GT  Y+APE  
Sbjct: 130  GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 981  GQTWQ-----ATTKGDVYSFGVLAMELATGRRALEGG 1012
             +T Q     +  + D+++FG++  E+A  RR +  G
Sbjct: 190  DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNG 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVK+LQ  G + +R+F+ E+++L        H + 
Sbjct: 19   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-----LHSDF 73
Query: 868  VTLYGWCLDGSEKI---LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            +  Y     G  +    LV EY+  G L D +               +D +R L++    
Sbjct: 74   IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQI 124
Query: 925  C-------YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGY 975
            C           VHRD+ A N+L++ E    + DFGLA+++     +      G   + +
Sbjct: 125  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             APE       + + DV+SFGV+  EL T
Sbjct: 185  YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVT 869
            +GKG +G V+RG    G  VAVK       +    E E    + +   N  G+   ++ +
Sbjct: 45   VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 103
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY--- 926
             +      ++  L+  Y E GSL D +             I + +A  L  LH E +   
Sbjct: 104  RHS----STQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-IVLSIASGLAHLHIEIFGTQ 158
Query: 927  --PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST---TIAGTVGYVAPEY- 980
              P I HRD+K+ N+L+ K G+  + D GLA + S   + +        GT  Y+APE  
Sbjct: 159  GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 981  GQTWQ-----ATTKGDVYSFGVLAMELATGRRALEGG 1012
             +T Q     +  + D+++FG++  E+A  RR +  G
Sbjct: 219  DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNG 253

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 50   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 102
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 103  AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 157
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDS--HVSTTIAGTVGY 975
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D+         GT  Y
Sbjct: 158  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 976  VAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
            +APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 218  MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 77   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 133
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 134  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLAR-VVSAGDSHVSTTIAGTV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +  AG           V
Sbjct: 194  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 251  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 290
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 291  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 343

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 11   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 63
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 64   AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 118
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIA-----GT 972
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D   +  IA     GT
Sbjct: 119  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGT 175
Query: 973  VGYVAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
              Y+APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 176  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 219

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 813  IGKGGFGTVYRG---VLPDGREVAVKKL---QREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G GG  TVY     +L    +VA+K +    RE  E  + F  E+     N     H N
Sbjct: 19   LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVH----NSSQLSHQN 72
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVA-----RALVFL 921
            +V++     +     LV EY+EG +L + I             +++D A     + L  +
Sbjct: 73   IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--------LSVDTAINFTNQILDGI 124
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
             H     IVHRD+K  N+L+D      + DFG+A+ +S      +  + GTV Y +PE  
Sbjct: 125  KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +        D+YS G++  E+  G     G
Sbjct: 185  KGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G            V + K +      + E  AE  V+        
Sbjct: 373  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 428
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 429  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 487
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 488  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 545  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 591

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 12   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 64
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 65   AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 119
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIA-----GT 972
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D   +  IA     GT
Sbjct: 120  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGT 176
Query: 973  VGYVAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
              Y+APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 177  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 37   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 89
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 90   AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 144
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIA-----GT 972
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D   +  IA     GT
Sbjct: 145  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGT 201
Query: 973  VGYVAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
              Y+APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 202  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 31   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 86
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 87   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 146  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 203  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 31   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 86
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 87   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 146  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 203  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 249

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 21   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 76
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 77   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 136  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 193  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 29   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 84
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 85   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 144  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 201  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 247

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 14   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 66
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 67   AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 121
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIA-----GT 972
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D   +  IA     GT
Sbjct: 122  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGT 178
Query: 973  VGYVAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
              Y+APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 179  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 222

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G            V + K +      + E  AE  V+        
Sbjct: 9    EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 64
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 65   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 124  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 181  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 15   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 70
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 71   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 130  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 187  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 8    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 65
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 66   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A  + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 121  VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 178  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 219
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 220  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G            V + K +      + E  AE  V+        
Sbjct: 11   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 66
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 67   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 126  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 183  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 813  IGKGGFGTV---YRGVLPD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            +GKG FG+V       L D  G  VAVK+LQ  G + +R+F+ E+++L        H + 
Sbjct: 15   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA-----LHSDF 69
Query: 868  VTLYGWCLDGS---EKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            +  Y     G    E  LV EY+  G L D +               +D +R L++    
Sbjct: 70   IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQI 120
Query: 925  C-------YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGY 975
            C           VHRD+ A N+L++ E    + DFGLA+++            G   + +
Sbjct: 121  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             APE       + + DV+SFGV+  EL T
Sbjct: 181  YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG FG V+RG    G EVAVK    RE    ER +  E E+         H N++   
Sbjct: 17   IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVML--RHENILGFI 69
Query: 872  G--------WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
                     W    ++  LV +Y E GSL D ++            +A+  A  L  LH 
Sbjct: 70   AADNKDNGTW----TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM 124
Query: 924  ECY-----PPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIA-----GT 972
            E       P I HRD+K+ N+L+ K G   + D GLA R  SA D   +  IA     GT
Sbjct: 125  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---TIDIAPNHRVGT 181
Query: 973  VGYVAPEY------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
              Y+APE        + +++  + D+Y+ G++  E+A  RR   GG
Sbjct: 182  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGG 225

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 54   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 110
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 111  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLAR-VVSAGDSHVSTTIAGTV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +  AG           V
Sbjct: 171  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 228  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 267
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 268  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 320

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 129/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D + +TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL        
Sbjct: 11   KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---- 63
Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            HP L  L  +     +++  V EY  GG L   +S               ++  AL +LH
Sbjct: 64   HPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  +
Sbjct: 123  SR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +  GV+  E+  GR
Sbjct: 179  DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 15   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 72
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 73   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 127
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 128  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 185  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 226
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 227  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G            V + K +      + E  AE  V+        
Sbjct: 374  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 429
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 430  NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 488
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE  
Sbjct: 489  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 546  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 592

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQRE---GLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G FG V  G     G +VAVK L R+    L+   + + E++ L      + HP+++
Sbjct: 19   LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL----FRHPHII 74
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             LY      ++  +V EY+ GG L D I             +   +  A+ + H      
Sbjct: 75   KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--- 131
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQA 986
            +VHRD+K  NVLLD    A + DFGL+ ++S G+    +   G+  Y APE   G+ + A
Sbjct: 132  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVISGRLY-A 188
Query: 987  TTKGDVYSFGVLAMELATG 1005
              + D++S GV+   L  G
Sbjct: 189  GPEVDIWSCGVILYALLCG 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL        
Sbjct: 14   KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---- 66
Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            HP L  L  +     +++  V EY  GG L   +S               ++  AL +LH
Sbjct: 67   HPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  +
Sbjct: 126  SR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 181
Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +  GV+  E+  GR
Sbjct: 182  DNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 811  RIIGKGGFGTVY--RGVL--PDGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGW 862
            +++G G +G V+  R +     G+  A+K L++  +    +     R E +VL       
Sbjct: 60   KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--- 116
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              P LVTL+ +      K+ L+ +Y+ GG L    +            + I V   ++ L
Sbjct: 117  QSPFLVTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY- 980
             H     I++RD+K  N+LLD  G  ++TDFGL++   A ++  +    GT+ Y+AP+  
Sbjct: 173  EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 981  -GQTWQATTKGDVYSFGVLAMELATGRR--ALEGGEECLVEWGRRVM 1024
             G         D +S GVL  EL TG     ++G +    E  RR++
Sbjct: 233  RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVY----RGVLP--DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G+G FG V+      +LP  D   VAVK L+       ++F+ E E+L+       H +
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM----LQHQH 81
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX---------------XXIA 911
            +V  +G C +G   ++V+EYM  G L   +                            +A
Sbjct: 82   IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              VA  +V+L    +   VHRD+   N L+ +     + DFG++R + + D + V     
Sbjct: 142  SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
              + ++ PE     + TT+ DV+SFGV+  E+ T
Sbjct: 199  LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVY----RGVLP--DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G+G FG V+      +LP  D   VAVK L+       ++F+ E E+L+       H +
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM----LQHQH 75
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX---------------XXIA 911
            +V  +G C +G   ++V+EYM  G L   +                            +A
Sbjct: 76   IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              VA  +V+L    +   VHRD+   N L+ +     + DFG++R + + D + V     
Sbjct: 136  SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
              + ++ PE     + TT+ DV+SFGV+  E+ T
Sbjct: 193  LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 74/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 790  LDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKK------LQREGLE 843
            + K  FT  D       F   R +GKG FG VY       + +   K      L++EG+E
Sbjct: 7    MPKRKFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE 59
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX 903
               + R E+E+ S       HPN++ +Y +  D     L+ E+   G L   +       
Sbjct: 60   --HQLRREIEIQSH----LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 904  XXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                     ++A AL + H      ++HRD+K  N+L+  +G+  + DFG +       S
Sbjct: 114  EQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPS 167
Query: 964  HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
                 + GT+ Y+ PE  +      K D++  GVL  E   G    +       E  RR+
Sbjct: 168  LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRI 225
Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEM-SELL------RIGVRCTAEAPNARPNVKEV 1076
            +      P     P       L++G++++ S+LL      R+ ++   E P  + N + V
Sbjct: 226  VNVDLKFP-----PF------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 274
Query: 1077 L 1077
            L
Sbjct: 275  L 275

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 106/262 (40%), Gaps = 43/262 (16%)
Query: 781  LSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQR 839
             +  VK +RL +  F   +ILK         +IG+G FG V    L +  +V A+K L +
Sbjct: 62   FTSKVKQMRLHREDF---EILK---------VIGRGAFGEVAVVKLKNADKVFAMKILNK 109
Query: 840  EGLEGERE---FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL---- 892
              +    E   FR E +VL      W    + TL+    D +   LV +Y  GG L    
Sbjct: 110  WEMLKRAETACFREERDVLVNGDSKW----ITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 893  ---EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV 949
               ED +             IAID    L +         VHRD+K  N+L+D  G   +
Sbjct: 166  SKFEDRLPEEMARFYLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRL 216
Query: 950  TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT-----KGDVYSFGVLAMELAT 1004
             DFG    +    +  S+   GT  Y++PE  Q  +        + D +S GV   E+  
Sbjct: 217  ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 1005 GRRALEGGEECLVEWGRRVMGY 1026
            G        E LVE   ++M +
Sbjct: 277  GETPFYA--ESLVETYGKIMNH 296

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 25   KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 84
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 85   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 142  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 198
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 199  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 243
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 244  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 295
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 296  KQLVEDLDRIL 306

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +    R +      E AVK + +     +R+   E+E+L   G    HPN++TL 
Sbjct: 30   IGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPTEEIEILLRYG---QHPNIITLK 82
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
                DG    +V E M+GG L D I             +   + + + +LH +    +VH
Sbjct: 83   DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVH 139
Query: 932  RDVKASNVL-LDKEG---KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            RD+K SN+L +D+ G      + DFG A+ + A ++ +  T   T  +VAPE  +     
Sbjct: 140  RDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTANFVAPEVLERQGYD 198
Query: 988  TKGDVYSFGVLAMELATGRRALEGG-----EECLVEWG 1020
               D++S GVL   + TG      G     EE L   G
Sbjct: 199  AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   +++GKG FG V        GR  A+K L++E +  + E      E  VL  +   
Sbjct: 149  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-- 206
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              HP L  L            V EY  GG L   +S               ++  AL +L
Sbjct: 207  --HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H E    +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  
Sbjct: 265  HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL 321
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +        D +  GV+  E+  GR
Sbjct: 322  EDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++  G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 222
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 223  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 129/312 (41%), Gaps = 63/312 (20%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 82   KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 142  MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 911  ----------AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                         +AR + +L   +C    +HRD+ A NVL+ +     + DFGLAR ++
Sbjct: 199  QMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
              D +  TT     V ++APE       T + DV+SFGVL  E+ T              
Sbjct: 255  NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------------- 300
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPN 1072
                 +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP 
Sbjct: 301  -----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT 351
Query: 1073 VKEVLAMLIKIL 1084
             K+++  L +IL
Sbjct: 352  FKQLVEDLDRIL 363

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 38/288 (13%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++  G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 18   ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 75
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 76   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 130
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 131  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 188  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 229
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++
Sbjct: 230  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 43   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 99
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 100  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 160  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 217  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 256
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 257  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 309

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 37   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 93
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 94   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 154  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 211  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 250
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 251  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 303

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 11/200 (5%)
Query: 811  RIIGKGGFGTV-YRGVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
            +++GKG FG V        GR  A+K L++E +  + E      E  VL  +     HP 
Sbjct: 157  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR----HPF 212
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            L  L            V EY  GG L   +S               ++  AL +LH E  
Sbjct: 213  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE-- 270
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE  +    
Sbjct: 271  KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDY 329
Query: 987  TTKGDVYSFGVLAMELATGR 1006
                D +  GV+  E+  GR
Sbjct: 330  GRAVDWWGLGVVMYEMMCGR 349

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 13   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 70
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 71   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 125
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 126  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 183  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 224
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 225  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +  +G FG V++  L +   VAVK      ++ ++ ++ E EV S  G    H N++   
Sbjct: 31   VKARGRFGCVWKAQLLN-EYVAVKIFP---IQDKQSWQNEYEVYSLPGM--KHENILQFI 84
Query: 872  GWCLDGS----EKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC-- 925
            G    G+    +  L+  + E GSL D +             IA  +AR L +LH +   
Sbjct: 85   GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH-IAETMARGLAYLHEDIPG 143
Query: 926  -----YPPIVHRDVKASNVLLDKEGKALVTDFGLARVV----SAGDSHVSTTIAGTVGYV 976
                  P I HRD+K+ NVLL     A + DFGLA       SAGD+H      GT  Y+
Sbjct: 144  LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV---GTRRYM 200
Query: 977  APEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEG 1011
            APE  +        A  + D+Y+ G++  ELA+   A +G
Sbjct: 201  APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 11   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 68
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 69   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 124  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 181  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 222
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 223  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 13   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 70
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 71   YVMASVD----NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC 125
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 126  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 183  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 77   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 132
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 133  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 191  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 247  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 288
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 289  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 344  VEDLDRIV 351

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 36   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 92
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 93   QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 153  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 210  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 249
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 250  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 302

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 36   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 92
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 93   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 153  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 210  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 249
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 250  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 302

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 807  FSEDRIIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG---- 861
            F    ++GKG F  VYR   +  G EVA+K + ++ +     ++A M     N       
Sbjct: 13   FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQ 67
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXX-XXXXXXXXIAIDVARALVF 920
              HP+++ LY +  D +   LV E    G +   +                  +   +++
Sbjct: 68   LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPE 979
            LH      I+HRD+  SN+LL +     + DFGLA ++    + H   T+ GT  Y++PE
Sbjct: 128  LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPE 182
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
                     + DV+S G +   L  GR
Sbjct: 183  IATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 38/294 (12%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++  G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 18   ILKET-EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 75
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 76   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 130
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 131  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
              + ++A E       T + DV+S+GV   EL T G +  +G                  
Sbjct: 188  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------------ 229
Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
             P   +  ++  G  L +      ++  I V+C     ++RP  +E++    K+
Sbjct: 230  IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+ +L RE    +  +E   E 
Sbjct: 45   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMEL-REATSPKANKEILDEA 102
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 103  YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 157
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +         
Sbjct: 158  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 215  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 53   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 109
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 110  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 170  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 227  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 266
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 267  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 319

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 51   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 107
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 108  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 168  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 225  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 264
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 265  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 317

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 84/311 (27%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D    TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 809  EDRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G   +    + VAVK L+ E  +   + E  AE  V+        
Sbjct: 15   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 70
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +             +   V+  + +L  
Sbjct: 71   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
              +   VHRD+ A NVLL  +  A ++DFGL++ + A ++       G   V + APE  
Sbjct: 130  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 982  QTWQATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
              ++ ++K DV+SFGVL  E  + G+   R ++G E   ++E G R+
Sbjct: 187  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 807  FSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNG 859
            F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL    
Sbjct: 7    FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                HP L  L  +     +++  V EY  GG L   +S               ++  AL
Sbjct: 63   ---RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH      +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+AP
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 175  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D    TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 28   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 84
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 85   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 145  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 202  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 241
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 242  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 294

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G  VAVK L+ + G +    ++ E+++L        H
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT----LYH 92
Query: 865  PNLVTLYGWCLD-GSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             +++   G C D G+  + LV EY+  GSL D +              A  +   + +LH
Sbjct: 93   EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL-FAQQICEGMAYLH 151
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HRD+ A NVLLD +    + DFGLA+ V  G         G   V + APE 
Sbjct: 152  AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             + ++     DV+SFGV   EL T
Sbjct: 209  LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 74/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 790  LDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKK------LQREGLE 843
            + K  FT  D       F   R +GKG FG VY       + +   K      L++EG+E
Sbjct: 6    MPKRKFTIDD-------FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE 58
Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX 903
               + R E+E+ S       HPN++ +Y +  D     L+ E+   G L   +       
Sbjct: 59   --HQLRREIEIQSH----LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 904  XXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                     ++A AL + H      ++HRD+K  N+L+  +G+  + DFG +       S
Sbjct: 113  EQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPS 166
Query: 964  HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023
                 + GT+ Y+ PE  +      K D++  GVL  E   G    +       E  RR+
Sbjct: 167  LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--TETHRRI 224
Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEM-SELL------RIGVRCTAEAPNARPNVKEV 1076
            +      P     P       L++G++++ S+LL      R+ ++   E P  + N + V
Sbjct: 225  VNVDLKFP-----PF------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273
Query: 1077 L 1077
            L
Sbjct: 274  L 274

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 800  ILKATGKFSED----RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEV 854
            ++ A+ KFS++      +GKG F  V R V    G E A K +  + L   R+F+ ++E 
Sbjct: 20   MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQ-KLER 77
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAID 913
             +       HPN+V L+    + S   LV++ + GG L EDI++            I   
Sbjct: 78   EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-Q 136
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIA 970
            +  ++ + H      IVHR++K  N+LL  + K     + DFGLA  +   DS      A
Sbjct: 137  ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 191
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
            GT GY++PE  +    +   D+++ GV+   L  G
Sbjct: 192  GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 51   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVYSEQDELDFLMEALIISKFN--H 107
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 108  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 168  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 225  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 264
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 265  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 317

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 813  IGKGGFGTVYR----GVLPDG----REVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            +G+G FG V      G+  D      +VAVK L+ +  E +  +  +EME++   G    
Sbjct: 21   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---K 77
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXX----------------XXXXXXX 907
            H N++ L G C       ++ EY   G+L + +                           
Sbjct: 78   HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
               A  VAR + +L  +     +HRD+ A NVL+ ++    + DFGLAR +   D +  T
Sbjct: 138  VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 968  TIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
            T     V ++APE       T + DV+SFGVL  E+ T                   +G 
Sbjct: 195  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-------------------LG- 234
Query: 1027 GRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K+++  L
Sbjct: 235  GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 1081 IKIL 1084
             +I+
Sbjct: 292  DRIV 295

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 807  FSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GW 862
            FS+ R IG G FG VY  R V  +   VA+KK+   G +   +++   +++    F    
Sbjct: 56   FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKL 111
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN +   G  L      LV EY  G + + +              +     + L +LH
Sbjct: 112  RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                  ++HRDVKA N+LL + G   + DFG A +++  +  V     GT  ++APE   
Sbjct: 172  SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 223
Query: 981  -GQTWQATTKGDVYSFGVLAMELATGRRAL 1009
                 Q   K DV+S G+  +ELA  +  L
Sbjct: 224  AMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 13   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 70
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 71   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 125
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 126  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 183  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 813  IGKGGFGTVYR----GVLPDG----REVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            +G+G FG V      G+  D      +VAVK L+ +  E +  +  +EME++   G    
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---K 92
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXXXXX 907
            H N++ L G C       ++ EY   G+L + +                           
Sbjct: 93   HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
               A  VAR + +L  +     +HRD+ A NVL+ ++    + DFGLAR +   D +  T
Sbjct: 153  VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 968  TIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
            T     V ++APE       T + DV+SFGVL  E+ T                   +G 
Sbjct: 210  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-------------------LG- 249
Query: 1027 GRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K+++  L
Sbjct: 250  GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306
Query: 1081 IKIL 1084
             +I+
Sbjct: 307  DRIV 310

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 63   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 119
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 120  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   V
Sbjct: 180  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 237  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 276
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 277  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 329

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 23   KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 82
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 83   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 140  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINN 196
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 197  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 241
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 242  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 293
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 294  KQLVEDLDRIL 304

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLVTL 870
            IG+G +G+V + V  P G+ +AVK+++    E E ++   +++V+  +      P +V  
Sbjct: 30   IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS---DCPYIVQF 86
Query: 871  YG--------W-CLD----GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
            YG        W C++      +K   Y Y     L+D+I             I +   +A
Sbjct: 87   YGALFREGDCWICMELMSTSFDKFYKYVY---SVLDDVIPEEILGK------ITLATVKA 137
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  L       I+HRD+K SN+LLD+ G   + DFG++  +   DS   T  AG   Y+A
Sbjct: 138  LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMA 193
Query: 978  PEY----GQTWQATTKGDVYSFGVLAMELATGR 1006
            PE             + DV+S G+   ELATGR
Sbjct: 194  PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREV----AVKKLQREGL--EGEREFRAEM 852
            ILK T +F + +++G G FGTVY+G+ +P+G +V    A+K+L RE    +  +E   E 
Sbjct: 18   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEA 75
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-XXXXXXIA 911
             V++       +P++  L G CL  + + L+ + M  G L D +                
Sbjct: 76   YVMASVD----NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 130
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            + +A+ + +L       +VHRD+ A NVL+       +TDFG A+++ A +         
Sbjct: 131  VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 972  T-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG 1011
              + ++A E       T + DV+S+GV   EL T G +  +G
Sbjct: 188  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 28   KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 87
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++ EY   G+L + +             I      
Sbjct: 88   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 145  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 201
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 202  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 246
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 247  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 298
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 299  KQLVEDLDRIL 309

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 811  RIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLV 868
            R +G G FG V+       G E  +K + ++  +   E   AE+EVL        HPN++
Sbjct: 28   RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS----LDHPNII 83
Query: 869  TLYGWCLDGSEKILVYEYMEGGS-LEDIISXXXXXXXXXXXXIA---IDVARALVFLHHE 924
             ++    D     +V E  EGG  LE I+S            +A     +  AL + H +
Sbjct: 84   KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 925  CYPPIVHRDVKASNVLLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
                +VH+D+K  N+L           + DFGLA +  + D H ST  AGT  Y+APE  
Sbjct: 144  ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEH-STNAAGTALYMAPEVF 198
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
            +    T K D++S GV+   L TG
Sbjct: 199  KR-DVTFKCDIWSAGVVMYFLLTG 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 29   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 84
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 85   --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 143  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 198
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 199  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 240
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 241  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 295
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 296  VEDLDRIV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 25   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 80
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 81   --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 139  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 194
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 195  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 236
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 237  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 291
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 292  VEDLDRIV 299

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 807  FSEDRIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GW 862
            FS+ R IG G FG VY  R V  +   VA+KK+   G +   +++   +++    F    
Sbjct: 17   FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQKL 72
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HPN +   G  L      LV EY  G + + +              +     + L +LH
Sbjct: 73   RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                  ++HRDVKA N+LL + G   + DFG A +++  +  V     GT  ++APE   
Sbjct: 133  SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 981  -GQTWQATTKGDVYSFGVLAMELATGRRAL 1009
                 Q   K DV+S G+  +ELA  +  L
Sbjct: 185  AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 36   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 91
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 92   --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 150  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 206  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 248  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 303  VEDLDRIV 310

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 36   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 91
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 92   --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 150  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 205
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 206  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 248  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 303  VEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 125/308 (40%), Gaps = 69/308 (22%)
Query: 813  IGKGGFGTVYRGVLPDG-----------REVAVKKLQREGLEGE-REFRAEMEVLSGNGF 860
            +G+G FG V   VL +             +VAVK L+ +  E +  +  +EME++   G 
Sbjct: 28   LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG- 83
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXX 904
               H N++ L G C       ++ EY   G+L + +                        
Sbjct: 84   --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 905  XXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
                  A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D 
Sbjct: 142  KDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 197
Query: 964  HVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
            +  TT     V ++APE       T + DV+SFGVL  E+ T                  
Sbjct: 198  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 239
Query: 1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEV 1076
             +G G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K++
Sbjct: 240  -LG-GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 294
Query: 1077 LAMLIKIL 1084
            +  L +I+
Sbjct: 295  VEDLDRIV 302

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQ---REGLEGEREFRAEMEVLSGNGFGWP---HP 865
            +IG+G +G VY+G L D R VAVK      R+    E+           N +  P   H 
Sbjct: 20   LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-----------NIYRVPLMEHD 67
Query: 866  NLVTLY----GWCLDGS-EKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVF 920
            N+            DG  E +LV EY   GSL   +S            +A  V R L +
Sbjct: 68   NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAY 126
Query: 921  LHHEC------YPPIVHRDVKASNVLLDKEGKALVTDFGLA------RVVSAGDS-HVST 967
            LH E        P I HRD+ + NVL+  +G  +++DFGL+      R+V  G+  + + 
Sbjct: 127  LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 968  TIAGTVGYVAPEYGQ-------TWQATTKGDVYSFGVLAMEL 1002
            +  GT+ Y+APE  +          A  + D+Y+ G++  E+
Sbjct: 187  SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 124/305 (40%), Gaps = 63/305 (20%)
Query: 813  IGKGGFGTVYR----GVLPDG----REVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            +G+G FG V      G+  D      +VAVK L+ +  E +  +  +EME++   G    
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---K 92
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISX----------------XXXXXXXXX 907
            H N++ L G C       ++ EY   G+L + +                           
Sbjct: 93   HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 908  XXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
               A  VAR + +L   +C    +HRD+ A NVL+ ++    + DFGLAR +   D    
Sbjct: 153  VSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 967  TTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025
            TT     V ++APE       T + DV+SFGVL  E+ T                   +G
Sbjct: 209  TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-------------------LG 249
Query: 1026 YGRHGPGRAVIPVVLLGSGLAEGAEE------MSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             G   PG   +PV  L   L EG          +EL  +   C    P+ RP  K+++  
Sbjct: 250  -GSPYPG---VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 305
Query: 1080 LIKIL 1084
            L +I+
Sbjct: 306  LDRIV 310

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 11/205 (5%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   +++GKG FG V        GR  A+K L++E +  + E      E  VL  +   
Sbjct: 9    EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-- 66
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              HP L  L            V EY  GG L   +S               ++  AL +L
Sbjct: 67   --HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H E    +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+APE  
Sbjct: 125  HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAPEVL 181
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            +        D +  GV+  E+  GR
Sbjct: 182  EDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFGWP 863
            +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL        
Sbjct: 11   KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---- 63
Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            HP L  L  +     +++  V EY  GG L   +S               ++  AL +LH
Sbjct: 64   HPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+APE  +
Sbjct: 123  SR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +  GV+  E+  GR
Sbjct: 179  DNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 806  KFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGN 858
            +F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL  +
Sbjct: 10   EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HP L  L            V EY  GG L   +S               ++  AL
Sbjct: 67   ----RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 122
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH E    +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+AP
Sbjct: 123  DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAP 179
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 180  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 806  KFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGN 858
            +F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL  +
Sbjct: 11   EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HP L  L            V EY  GG L   +S               ++  AL
Sbjct: 68   ----RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 123
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH E    +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+AP
Sbjct: 124  DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLAP 180
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 181  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEV-LSGNGFGWPHPNLVTL 870
            +G+G +G V +   +P G+ +AVK++ R  +  + + R  M++ +S      P    VT 
Sbjct: 59   LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF--TVTF 115
Query: 871  YGWCLDGSEKILVYEYMEGG---SLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
            YG      +  +  E M+       + +I             IA+ + +AL  LH +   
Sbjct: 116  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 174
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQ 985
             ++HRDVK SNVL++  G+  + DFG++  +   DS   T  AG   Y+APE    +  Q
Sbjct: 175  -VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 986  A--TTKGDVYSFGVLAMELATGR 1006
               + K D++S G+  +ELA  R
Sbjct: 232  KGYSVKSDIWSLGITMIELAILR 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 50/297 (16%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            R +G G FG VY G +      P   +VAVK L  E    + E    ME L  + F   H
Sbjct: 37   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFN--H 93
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVARA 917
             N+V   G  L    + ++ E M GG L+  +       S            +A D+A  
Sbjct: 94   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-TV 973
              +L    +   +HRD+ A N LL   G    A + DFG+A+ +     +     A   V
Sbjct: 154  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             ++ PE       T+K D +SFGVL  E+ +                   +GY  + P +
Sbjct: 211  KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PSK 250
Query: 1034 A---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            +   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 251  SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 303

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +    R V      E AVK + +     +R+   E+E+L   G    HPN++TL 
Sbjct: 35   IGVGSYSECKRCVHKATNMEYAVKVIDK----SKRDPSEEIEILLRYG---QHPNIITLK 87
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
                DG    LV E M GG L D I             +   + + + +LH +    +VH
Sbjct: 88   DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 932  RDVKASNVL-LDKEGKA---LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            RD+K SN+L +D+ G      + DFG A+ + A ++ +  T   T  +VAPE  +     
Sbjct: 145  RDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 988  TKGDVYSFGVLAMELATGRRALEGG-----EECLVEWG 1020
               D++S G+L   +  G      G     EE L   G
Sbjct: 204  EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA---EMEVLSG 857
            + ++   R++GKG FG V   +  D   G+E AVK + +  ++ + +  +   E+++L  
Sbjct: 31   SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                  HPN++ LY +  D     LV E   GG L D I             I   V   
Sbjct: 89   ----LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 144
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + ++H      IVHRD+K  N+LL+   K+    + DFGL+    A  S       GT  
Sbjct: 145  ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAY 199
Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            Y+APE         K DV+S GV+   L +G     G  E
Sbjct: 200  YIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 25   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 85   FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 141
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D     T+ GT  Y+APE       + + DV
Sbjct: 142  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 201  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 248
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 249  QKMLQTD-------PTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 25   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 85   FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 141
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D     T+ GT  Y+APE       + + DV
Sbjct: 142  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 201  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 248
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 249  QKMLQTD-------PTARPTINELL 266

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G  VAVK L+   G +    ++ E+E+L        H
Sbjct: 14   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT----LYH 69
Query: 865  PNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             ++V   G C D  EK   LV EY+  GSL D +              A  +   + +LH
Sbjct: 70   EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLH 128
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HR + A NVLLD +    + DFGLA+ V  G  +      G   V + APE 
Sbjct: 129  AQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             +  +     DV+SFGV   EL T
Sbjct: 186  LKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 64/204 (31%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G  VAVK L+   G +    ++ E+E+L        H
Sbjct: 15   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRT----LYH 70
Query: 865  PNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             ++V   G C D  EK   LV EY+  GSL D +              A  +   + +LH
Sbjct: 71   EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLH 129
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + Y   +HR + A NVLLD +    + DFGLA+ V  G  +      G   V + APE 
Sbjct: 130  AQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 981  GQTWQATTKGDVYSFGVLAMELAT 1004
             +  +     DV+SFGV   EL T
Sbjct: 187  LKECKFYYASDVWSFGVTLYELLT 210

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +    R V      E AVK + +     +R+   E+E+L   G    HPN++TL 
Sbjct: 35   IGVGSYSECKRCVHKATNMEYAVKVIDK----SKRDPSEEIEILLRYG---QHPNIITLK 87
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
                DG    LV E M GG L D I             +   + + + +LH +    +VH
Sbjct: 88   DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 932  RDVKASNVL-LDKEGKA---LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            RD+K SN+L +D+ G      + DFG A+ + A ++ +  T   T  +VAPE  +     
Sbjct: 145  RDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 988  TKGDVYSFGVLAMELATGRRALEGG-----EECLVEWG 1020
               D++S G+L   +  G      G     EE L   G
Sbjct: 204  EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 29   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 89   FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 145
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D     T+ GT  Y+APE       + + DV
Sbjct: 146  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 205  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 252
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 253  QKMLQTD-------PTARPTINELL 270

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++  Y   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVY----RGVLP--DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G+G FG V+      +LP  D   VAVK L+       ++F+ E E+L+       H +
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM----LQHQH 104
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXX---------------XXIA 911
            +V  +G C +G   ++V+EYM  G L   +                            +A
Sbjct: 105  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIA 970
              VA  +V+L    +   VHRD+   N L+ +     + DFG++R + + D + V     
Sbjct: 165  SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
              + ++ PE     + TT+ DV+SFGV+  E+ T
Sbjct: 222  LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    + G   A K ++ +  E   ++  E+E+L+       HP +V L 
Sbjct: 19   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT----CDHPYIVKLL 74
Query: 872  G-WCLDGSEKILVYEYMEGGSLEDI-ISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G +  DG   I++ E+  GG+++ I +             +   +  AL FLH +    I
Sbjct: 75   GAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
            +HRD+KA NVL+  EG   + DFG++    + +   DS +     GT  ++APE    +T
Sbjct: 131  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCET 185
Query: 984  WQATT---KGDVYSFGVLAMELA 1003
             + T    K D++S G+  +E+A
Sbjct: 186  MKDTPYDYKADIWSLGITLIEMA 208

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    + G   A K ++ +  E   ++  E+E+L+       HP +V L 
Sbjct: 27   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT----CDHPYIVKLL 82
Query: 872  G-WCLDGSEKILVYEYMEGGSLEDI-ISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            G +  DG   I++ E+  GG+++ I +             +   +  AL FLH +    I
Sbjct: 83   GAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 930  VHRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
            +HRD+KA NVL+  EG   + DFG++    + +   DS +     GT  ++APE    +T
Sbjct: 139  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCET 193
Query: 984  WQATT---KGDVYSFGVLAMELA 1003
             + T    K D++S G+  +E+A
Sbjct: 194  MKDTPYDYKADIWSLGITLIEMA 216

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 23/277 (8%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +   ++   R +GKGGF   Y     D +EV   K+  + +  +   + +M         
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              +P++V  +G+  D     +V E     SL ++                    + + +L
Sbjct: 99   LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     ++HRD+K  N+ L+ +    + DFGLA  +   D     T+ GT  Y+APE  
Sbjct: 159  HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKTLCGTPNYIAPEVL 214
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
                 + + D++S G +   L  G+   E    CL E   R+       P R + PV   
Sbjct: 215  CKKGHSFEVDIWSLGCILYTLLVGKPPFETS--CLKETYIRIKKNEYSVP-RHINPVA-- 269
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                       S L+R   R     P  RP+V E+L 
Sbjct: 270  -----------SALIR---RMLHADPTLRPSVAELLT 292

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 41/276 (14%)
Query: 812  IIGKGGFGTVYRG-VLPDGREVAVKKLQREGLEGEREFRA------EMEVLSGNGFGWPH 864
            ++GKGGFGTV+ G  L D  +VA+K + R  + G            E+ +L   G G  H
Sbjct: 38   LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 865  PNLVTLYGWCLDGSEKILVYEY-MEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            P ++ L  W       +LV E  +    L D I+                V  A+   H 
Sbjct: 98   PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 924  ECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                 +VHRD+K  N+L+D + G A + DFG   ++        T   GT  Y  PE+  
Sbjct: 158  RG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYSPPEWIS 211
Query: 983  TWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
              Q       V+S G+L  ++  G    E  +E        ++    H P          
Sbjct: 212  RHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILEAELHFP---------- 253
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                A  + +   L+R   RC A  P++RP+++E+L
Sbjct: 254  ----AHVSPDCCALIR---RCLAPKPSSRPSLEEIL 282

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGW 862
            G +   + +G+G FG V        G++VA+K + ++ L + + + R E E+        
Sbjct: 4    GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR- 62
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP+++ LY       E I+V EY  G  L D I                 +  A+ + H
Sbjct: 63   -HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                  IVHRD+K  N+LLD+     + DFGL+ +++ G+     T  G+  Y APE   
Sbjct: 121  RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVIS 175
Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
            G+ + A  + DV+S GV+   +   R
Sbjct: 176  GKLY-AGPEVDVWSCGVILYVMLCRR 200

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R + +P G+E A K +  + L      + E E          HPN+V L+
Sbjct: 12   LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK--HPNIVRLH 69
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                +     LV++ + GG L EDI++            I     + L  ++H     IV
Sbjct: 70   DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ----QILESVNHCHLNGIV 125
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HRD+K  N+LL  + K     + DFGLA  V  GD       AGT GY++PE  +     
Sbjct: 126  HRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 185  KPVDMWACGVILYILLVG 202

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 127/315 (40%), Gaps = 43/315 (13%)
Query: 791  DKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP--DGR--EVAVKKLQREGLEGE- 845
            D+      D+L    +F+  R++GKG FG+V    L   DG   +VAVK L+ + +    
Sbjct: 9    DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 846  -REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK------ILVYEYMEGGSLEDIISX 898
              EF  E   +      + HP++  L G  L    K      +++  +M+ G L   +  
Sbjct: 69   IEEFLREAACMKE----FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 899  XXXXX------XXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF 952
                               +D+A  + +L    +   +HRD+ A N +L ++    V DF
Sbjct: 125  SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADF 181
Query: 953  GLARVVSAGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            GL+R + +GD +     +   V ++A E       T   DV++FGV   E+ T  +    
Sbjct: 182  GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 1012 GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP 1071
            G E                    +   ++ G+ L +  E M E+  +  +C +  P  RP
Sbjct: 242  GIE-----------------NAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
Query: 1072 NVKEVLAMLIKILPH 1086
            +   +   L  IL H
Sbjct: 285  SFTCLRMELENILGH 299

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 118/298 (39%), Gaps = 52/298 (17%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWP 863
            R +G G FG VY G +      P   +VAVK L     E  E +F  E  ++S       
Sbjct: 37   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN---- 92
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVAR 916
            H N+V   G  L    + ++ E M GG L+  +       S            +A D+A 
Sbjct: 93   HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-T 972
               +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   
Sbjct: 153  GCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 209
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++ PE       T+K D +SFGVL  E+ +                   +GY  + P 
Sbjct: 210  VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PS 249
Query: 1033 RA---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            ++   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 250  KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 303

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 807  FSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNG 859
            F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL    
Sbjct: 7    FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                HP L  L  +     +++  V EY  GG L   +S               ++  AL
Sbjct: 63   ---RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH      +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+AP
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 174
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 175  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGW 862
           G +   + +G+G FG V        G++VA+K + ++ L + + + R E E+        
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR- 71
Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            HP+++ LY       E I+V EY  G  L D I                 +  A+ + H
Sbjct: 72  -HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 923 HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                 IVHRD+K  N+LLD+     + DFGL+ +++ G+     T  G+  Y APE   
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVIS 184
Query: 981 GQTWQATTKGDVYSFGVL 998
           G+ + A  + DV+S GV+
Sbjct: 185 GKLY-AGPEVDVWSCGVI 201

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 807  FSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNG 859
            F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL    
Sbjct: 12   FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 67
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                HP L  L  +     +++  V EY  GG L   +S               ++  AL
Sbjct: 68   ---RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 123
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH      +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+AP
Sbjct: 124  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 179
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 180  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 807  FSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFR---AEMEVLSGNG 859
            F   +++GKG FG V   +L      GR  A+K L++E +  + E      E  VL    
Sbjct: 7    FDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                HP L  L  +     +++  V EY  GG L   +S               ++  AL
Sbjct: 63   ---RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             +LH      +V+RD+K  N++LDK+G   +TDFGL +     D        GT  Y+AP
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 174
Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGR 1006
            E  +        D +  GV+  E+  GR
Sbjct: 175  EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTL 870
            +G+G FG V         ++VA+K + R+ L+  +   R E E+         HP+++ L
Sbjct: 17   LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR--HPHIIKL 74
Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
            Y      ++ ++V EY  GG L D I                 +  A+ + H      IV
Sbjct: 75   YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIV 130
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQATT 988
            HRD+K  N+LLD      + DFGL+ +++ G+     T  G+  Y APE   G+ + A  
Sbjct: 131  HRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLY-AGP 187
Query: 989  KGDVYSFGVLAMELATGR 1006
            + DV+S G++   +  GR
Sbjct: 188  EVDVWSCGIVLYVMLVGR 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 806  KFSEDRIIGKGGFGTVYR----GVLPDGRE----VAVKKLQREGLEGE-REFRAEMEVLS 856
            K +  + +G+G FG V      G+  D  +    VAVK L+ +  E +  +  +EME++ 
Sbjct: 36   KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI------ 910
              G    H N++ L G C       ++  Y   G+L + +             I      
Sbjct: 96   MIG---KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         +AR + +L  +     +HRD+ A NVL+ +     + DFGLAR ++ 
Sbjct: 153  QMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  TT     V ++APE       T + DV+SFGVL  E+ T               
Sbjct: 210  IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------------- 254
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEG------AEEMSELLRIGVRCTAEAPNARPNV 1073
                +G G   PG   IPV  L   L EG      A   +EL  +   C    P+ RP  
Sbjct: 255  ----LG-GSPYPG---IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 1074 KEVLAMLIKIL 1084
            K+++  L +IL
Sbjct: 307  KQLVEDLDRIL 317

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 118/298 (39%), Gaps = 52/298 (17%)
Query: 811  RIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWP 863
            R +G G FG VY G +      P   +VAVK L     E  E +F  E  ++S       
Sbjct: 51   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN---- 106
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-------SXXXXXXXXXXXXIAIDVAR 916
            H N+V   G  L    + ++ E M GG L+  +       S            +A D+A 
Sbjct: 107  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVSTTIAG-T 972
               +L    +   +HRD+ A N LL   G    A + DFG+AR +     +     A   
Sbjct: 167  GCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 223
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++ PE       T+K D +SFGVL  E+ +                   +GY  + P 
Sbjct: 224  VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPY-PS 263
Query: 1033 RA---VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
            ++   V+  V  G  +         + RI  +C    P  RPN     A++++ + +C
Sbjct: 264  KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 317

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGW 862
           G +   + +G+G FG V        G++VA+K + ++ L + + + R E E+        
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR- 72
Query: 863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            HP+++ LY       E I+V EY  G  L D I                 +  A+ + H
Sbjct: 73  -HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 923 HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                 IVHRD+K  N+LLD+     + DFGL+ +++ G+     T  G+  Y APE   
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVIS 185
Query: 981 GQTWQATTKGDVYSFGVL 998
           G+ + A  + DV+S GV+
Sbjct: 186 GKLY-AGPEVDVWSCGVI 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R + +P G+E A K +  + L      + E E          HPN+V L+
Sbjct: 12   LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK--HPNIVRLH 69
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                +     LV++ + GG L EDI++            I     + L  ++H     IV
Sbjct: 70   DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ----QILESVNHCHLNGIV 125
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HRD+K  N+LL  + K     + DFGLA  V  GD       AGT GY++PE  +     
Sbjct: 126  HRDLKPENLLLASKSKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 185  KPVDMWACGVILYILLVG 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA---EMEVLSG 857
            + ++   R++GKG FG V   +  D   G+E AVK + +  ++ + +  +   E+++L  
Sbjct: 25   SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                  HPN++ LY +  D     LV E   GG L D I             I   V   
Sbjct: 83   ----LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + ++H      IVHRD+K  N+LL+   K+    + DFGL+    A  S       GT  
Sbjct: 139  ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAY 193
Query: 975  YVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
            Y+APE  +G T+    K DV+S GV+   L +G
Sbjct: 194  YIAPEVLHG-TYDE--KCDVWSTGVILYILLSG 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K +VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 811  RIIGKGGFGTVYRGVL-PDG----REVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V      P+G     +VAVK L+ E G     + + E+E+L        H
Sbjct: 15   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----LYH 70
Query: 865  PNLVTLYGWCL-DGSEKI-LVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
             N+V   G C  DG   I L+ E++  GSL++ +               A+ + + + +L
Sbjct: 71   ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPE 979
                Y   VHRD+ A NVL++ E +  + DFGL + +        V       V + APE
Sbjct: 131  GSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
                 +     DV+SFGV   EL T
Sbjct: 188  CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 811  RIIGKGGFGTVYR----GVLPDGR--EVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            +++G G FG V      G+   G   +VAVK L+ +    ERE   +E+++++  G    
Sbjct: 51   KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG---S 107
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL------------EDIISXXXXXXXXXXXXI- 910
            H N+V L G C       L++EY   G L            ED I             + 
Sbjct: 108  HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 911  ----------AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                      A  VA+ + FL    +   VHRD+ A NVL+       + DFGLAR + +
Sbjct: 168  VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 961  GDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
              ++V    A   V ++APE       T K DV+S+G+L  E+
Sbjct: 225  DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 812  IIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFRAEM---EVLSGNGFGWPHPNL 867
            ++GKG FG V         E+ A+K L+++ +  + +    M    VL+        P  
Sbjct: 26   VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL----LDKPPF 81
Query: 868  VTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +T    C    +++  V EY+ GG L   I              A +++  L FLH    
Sbjct: 82   LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR-- 139
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  NV+LD EG   + DFG+ +     D   +    GT  Y+APE       
Sbjct: 140  -GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAYQPY 197
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEE 1014
                D +++GVL  E+  G+   +G +E
Sbjct: 198  GKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGW 862
            G +   + +G+G FG V        G++VA+K + ++ L + + + R E E+        
Sbjct: 8    GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR- 66
Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
             HP+++ LY       E I+V EY  G  L D I                 +  A+ + H
Sbjct: 67   -HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY-- 980
                  IVHRD+K  N+LLD+     + DFGL+ +++  D +   T  G+  Y APE   
Sbjct: 125  RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIS 179
Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
            G+ + A  + DV+S GV+   +   R
Sbjct: 180  GKLY-AGPEVDVWSCGVILYVMLCRR 204

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 56/306 (18%)
Query: 811  RIIGKGGFGTVYRGVL--PDGRE----VAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            + +G+G FG V +       GR     VAVK L+      E R+  +E  VL        
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---- 84
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX--------------------- 902
            HP+++ LYG C      +L+ EY + GSL   +                           
Sbjct: 85   HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 903  ---XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                       A  +++ + +L       +VHRD+ A N+L+ +  K  ++DFGL+R V 
Sbjct: 145  RALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 960  AGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
              DS+V  +     V ++A E       TT+ DV+SFGVL  E+ T    L G     + 
Sbjct: 202  EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGI- 256
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                        P   +  ++  G  +        E+ R+ ++C  + P+ RP   ++  
Sbjct: 257  ------------PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 1079 MLIKIL 1084
             L K++
Sbjct: 305  DLEKMM 310

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 811  RIIGKGGFGTVYRG-VLPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 44   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 100
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID---------- 913
            H N+V L G C  G   +++ EY   G L + +               ++          
Sbjct: 101  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++    A   
Sbjct: 161  VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            V ++APE       T + DV+S+G+L  E+
Sbjct: 218  VKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 34/228 (14%)
Query: 797  YSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQRE-GLEGEREFRAEMEV 854
            + D+ K T +     ++G+G +  V   V L +G+E AVK ++++ G    R FR E+E 
Sbjct: 10   FEDMYKLTSE-----LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVET 63
Query: 855  L---SGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIA 911
            L    GN       N++ L  +  D +   LV+E ++GGS+   I             + 
Sbjct: 64   LYQCQGN------KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVV 117
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSAGDSHVS-- 966
             DVA AL FLH +    I HRD+K  N+L +   K     + DF L   +   +S     
Sbjct: 118  RDVAAALDFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 967  ----TTIAGTVGYVAPEYGQTW--QAT---TKGDVYSFGVLAMELATG 1005
                TT  G+  Y+APE  + +  QAT    + D++S GV+   + +G
Sbjct: 175  TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 810  DRIIGKGGFGTVYRGVLPDGR----EVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            +RI+G+G FG VY GV  + +     VAVK  +++  L+ + +F +E  ++        H
Sbjct: 13   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD----H 68
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHH 923
            P++V L G  ++     ++ E    G L   +             + ++ + +A+ +L  
Sbjct: 69   PHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 924  -ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
              C    VHRD+   N+L+       + DFGL+R +   D + ++     + +++PE   
Sbjct: 128  INC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 983  TWQATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
              + TT  DV+ F V   E L+ G++     E                   + VI V+  
Sbjct: 184  FRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------------NKDVIGVLEK 225
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G  L +       L  +  RC    P+ RP   E++  L
Sbjct: 226  GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 811  RIIGKGGFGTVYRGVL-PDG----REVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V      P+G     +VAVK L+ E G     + + E+E+L        H
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----LYH 82
Query: 865  PNLVTLYGWCL-DGSEKI-LVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFL 921
             N+V   G C  DG   I L+ E++  GSL++ +               A+ + + + +L
Sbjct: 83   ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPE 979
                Y   VHRD+ A NVL++ E +  + DFGL + +        V       V + APE
Sbjct: 143  GSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
                 +     DV+SFGV   EL T
Sbjct: 200  CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 798  SDILKATGKFSE--DRII-GKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEME 853
            SD+L+   ++ E  DR++ GKG +G VY G  L +   +A+K++        +    E+ 
Sbjct: 12   SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 71
Query: 854  VLSGNGFGWPHPNLVTLYG-WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +         H N+V   G +  +G  KI + E + GGSL  ++             I  
Sbjct: 72   LHKH----LKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 913  ---DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTT 968
                +   L +LH      IVHRD+K  NVL++     L ++DFG ++ + AG +  + T
Sbjct: 127  YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTET 182
Query: 969  IAGTVGYVAPE--------YGQTWQATTKGDVYSFGVLAMELATGR 1006
              GT+ Y+APE        YG+        D++S G   +E+ATG+
Sbjct: 183  FTGTLQYMAPEIIDKGPRGYGKA------ADIWSLGCTIIEMATGK 222

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R V    G E A K +  + L   R+F+ ++E  +       HPN+V L+
Sbjct: 14   LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQ-KLEREARICRKLQHPNIVRLH 71
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                + S   LV++ + GG L EDI++            I   +  ++ + H      IV
Sbjct: 72   DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSN---GIV 127
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HR++K  N+LL  + K     + DFGLA  +   DS      AGT GY++PE  +    +
Sbjct: 128  HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 186  KPVDIWACGVILYILLVG 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 811  RIIGKGGFGTVYRG-VLPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 52   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 108
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID---------- 913
            H N+V L G C  G   +++ EY   G L + +               ++          
Sbjct: 109  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++    A   
Sbjct: 169  VAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            V ++APE       T + DV+S+G+L  E+
Sbjct: 226  VKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKG +G V+RG L  G  VAVK         E+ +  E E+   N     H N++    
Sbjct: 16   VGKGRYGEVWRG-LWHGESVAVKIFSSRD---EQSWFRETEIY--NTVLLRHDNILGFIA 69
Query: 873  WCL----DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY-- 926
              +      ++  L+  Y E GSL D +             +A+  A  L  LH E +  
Sbjct: 70   SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR-LAVSAACGLAHLHVEIFGT 128
Query: 927  ---PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVGYVAPEY 980
               P I HRD K+ NVL+    +  + D GLA + S G  ++   +    GT  Y+APE 
Sbjct: 129  QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 981  ------GQTWQATTKGDVYSFGVLAMELATGRRALEGG 1012
                     +++    D+++FG++  E+A  RR +  G
Sbjct: 189  LDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTIVNG 224

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA---EMEVLSG 857
            + ++   R++GKG FG V   +  D   G+E AVK + +  ++ + +  +   E+++L  
Sbjct: 48   SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                  HPN++ LY +  D     LV E   GG L D I             I   V   
Sbjct: 106  ----LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 161
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + ++H      IVHRD+K  N+LL+   K+    + DFGL+    A  S       GT  
Sbjct: 162  ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAY 216
Query: 975  YVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
            Y+APE  +G T+    K DV+S GV+   L +G
Sbjct: 217  YIAPEVLHG-TYDE--KCDVWSTGVILYILLSG 246

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            K+ +   +G+G +G VY+     GR VA+K++    + EG+     RE     E+     
Sbjct: 22   KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL----- 76
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARAL 918
                HPN+V+L           LV+E+ME   L+ ++             I +  + R +
Sbjct: 77   ---HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
               H      I+HRD+K  N+L++ +G   + DFGLAR         +  +  T+ Y AP
Sbjct: 133  AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 979  EYGQ-TWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +    + + +T  D++S G +  E+ TG+    G
Sbjct: 189  DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 810  DRIIGKGGFGTVYRGVLPDGR----EVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            +RI+G+G FG VY GV  + +     VAVK  +++  L+ + +F +E  ++        H
Sbjct: 29   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD----H 84
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHH 923
            P++V L G  ++     ++ E    G L   +             + ++ + +A+ +L  
Sbjct: 85   PHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 924  -ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
              C    VHRD+   N+L+       + DFGL+R +   D + ++     + +++PE   
Sbjct: 144  INC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 199
Query: 983  TWQATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
              + TT  DV+ F V   E L+ G++     E                   + VI V+  
Sbjct: 200  FRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------------NKDVIGVLEK 241
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G  L +       L  +  RC    P+ RP   E++  L
Sbjct: 242  GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 21/218 (9%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IG G +    R +      E AVK + +     +R+   E+E+L   G    HPN++TL 
Sbjct: 30   IGVGSYSVCKRCIHKATNXEFAVKIIDK----SKRDPTEEIEILLRYG---QHPNIITLK 82
Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVH 931
                DG    +V E  +GG L D I             +   + + + +LH +    +VH
Sbjct: 83   DVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVH 139
Query: 932  RDVKASNVL-LDKEGKA---LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            RD+K SN+L +D+ G      + DFG A+ + A +  + T    T  +VAPE  +     
Sbjct: 140  RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANFVAPEVLERQGYD 198
Query: 988  TKGDVYSFGVLAMELATGRRALEGG-----EECLVEWG 1020
               D++S GVL     TG      G     EE L   G
Sbjct: 199  AACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIG 236

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R V    G E A K +  + L   R+F+ ++E  +       HPN+V L+
Sbjct: 14   LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQ-KLEREARICRKLQHPNIVRLH 71
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                + S   LV++ + GG L EDI++            I   +  ++ + H      IV
Sbjct: 72   DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSN---GIV 127
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HR++K  N+LL  + K     + DFGLA  +   DS      AGT GY++PE  +    +
Sbjct: 128  HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 186  KPVDIWACGVILYILLVG 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA---EMEVLSG 857
            + ++   R++GKG FG V   +  D   G+E AVK + +  ++ + +  +   E+++L  
Sbjct: 49   SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                  HPN++ LY +  D     LV E   GG L D I             I   V   
Sbjct: 107  ----LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 162
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + ++H      IVHRD+K  N+LL+   K+    + DFGL+    A  S       GT  
Sbjct: 163  ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAY 217
Query: 975  YVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
            Y+APE  +G T+    K DV+S GV+   L +G
Sbjct: 218  YIAPEVLHG-TYDE--KCDVWSTGVILYILLSG 247

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            K+ +   +G+G +G VY+     GR VA+K++    + EG+     RE     E+     
Sbjct: 22   KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL----- 76
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARAL 918
                HPN+V+L           LV+E+ME   L+ ++             I +  + R +
Sbjct: 77   ---HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
               H      I+HRD+K  N+L++ +G   + DFGLAR         +  +  T+ Y AP
Sbjct: 133  AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAP 188
Query: 979  EYGQ-TWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +    + + +T  D++S G +  E+ TG+    G
Sbjct: 189  DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 26   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 80
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 81   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    +AG V    Y APE 
Sbjct: 140  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 189
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 190  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 811  RIIGKGGFGTVYR----GVLP--DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWP 863
            R IG+G FG V++    G+LP      VAVK L+ E   + + +F+ E  +++     + 
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE----FD 108
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX------------------- 904
            +PN+V L G C  G    L++EYM  G L + +                           
Sbjct: 109  NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 905  -----XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                      IA  VA  + +L    +   VHRD+   N L+ +     + DFGL+R + 
Sbjct: 169  PPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 960  AGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            + D + +    A  + ++ PE     + TT+ DV+++GV+  E+
Sbjct: 226  SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 28/225 (12%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-----REFRAEMEV 854
            + ++ +F +   +G G + TVY+G+    G  VA+K+++ +  EG      RE     E+
Sbjct: 1    MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXX-----XXXXXX 909
                     H N+V LY      ++  LV+E+M+    + + S                 
Sbjct: 61   --------KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
                + + L F H      I+HRD+K  N+L++K G+  + DFGLAR      +  S+ +
Sbjct: 113  FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 970  AGTVGYVAPEY---GQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
              T+ Y AP+     +T+  +T  D++S G +  E+ TG+    G
Sbjct: 170  V-TLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGKPLFPG 211

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 811  RIIGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
             ++G G F  V+  +  L  G+  A+K +++     +     E+ VL        H N+V
Sbjct: 15   EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKK----IKHENIV 69
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
            TL       +   LV + + GG L D I             +   V  A+ +LH      
Sbjct: 70   TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---G 126
Query: 929  IVHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            IVHRD+K  N+L    ++  K ++TDFGL+++   G   + +T  GT GYVAPE      
Sbjct: 127  IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKP 183
Query: 986  ATTKGDVYSFGVLAMELATG 1005
             +   D +S GV+   L  G
Sbjct: 184  YSKAVDCWSIGVITYILLCG 203

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 28   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 86
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 87   ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       + T+ GT  Y+APE  
Sbjct: 144  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEII 196
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 197  LSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    +AG V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    +AG V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 810  DRIIGKGGFGTVYRGVLPDGR----EVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            +RI+G+G FG VY GV  + +     VAVK  +++  L+ + +F +E  ++        H
Sbjct: 17   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD----H 72
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHH 923
            P++V L G  ++     ++ E    G L   +             + ++ + +A+ +L  
Sbjct: 73   PHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 924  -ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
              C    VHRD+   N+L+       + DFGL+R +   D + ++     + +++PE   
Sbjct: 132  INC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 983  TWQATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
              + TT  DV+ F V   E L+ G++     E                   + VI V+  
Sbjct: 188  FRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------------NKDVIGVLEK 229
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G  L +       L  +  RC    P+ RP   E++  L
Sbjct: 230  GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 23/277 (8%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +   ++   R +GKGGF   Y     D +EV   K+  + +  +   + +M         
Sbjct: 23   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              +P++V  +G+  D     +V E     SL ++                    + + +L
Sbjct: 83   LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     ++HRD+K  N+ L+ +    + DFGLA  +   D      + GT  Y+APE  
Sbjct: 143  HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEVL 198
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
                 + + D++S G +   L  G+   E    CL E   R+       P R + PV   
Sbjct: 199  CKKGHSFEVDIWSLGCILYTLLVGKPPFETS--CLKETYIRIKKNEYSVP-RHINPVA-- 253
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                       S L+R   R     P  RP+V E+L 
Sbjct: 254  -----------SALIR---RMLHADPTLRPSVAELLT 276

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 47   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 107  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 163
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D      + GT  Y+APE       + + DV
Sbjct: 164  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 223  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 270
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 271  QKMLQTD-------PTARPTINELL 288

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 22/224 (9%)
Query: 813  IGKGGFGTVYRGVLPDGR---EVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNL 867
            +G G FG+V +GV    +   +VA+K L ++G E     E   E +++        +P +
Sbjct: 18   LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQ----LDNPYI 72
Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLED-IISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            V L G C      +LV E   GG L   ++             +   V+  + +L  + +
Sbjct: 73   VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTW 984
               VHRD+ A NVLL     A ++DFGL++ + A DS+ +   AG   + + APE     
Sbjct: 132  ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 985  QATTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
            + +++ DV+S+GV   E L+ G+   + ++G E    +E G+R+
Sbjct: 189  KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 31/227 (13%)
Query: 800  ILKATGKFSED----RIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGER-------- 846
            + K  GK  E     R +G G +G V      +G  E A+K +++   +  R        
Sbjct: 27   VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 847  -----EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXX 901
                 E   E+ +L        HPN++ L+    D     LV E+ EGG L + I     
Sbjct: 87   EKFHEEIYNEISLLKS----LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 902  XXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVV 958
                    I   +   + +LH      IVHRD+K  N+LL+ +   L   + DFGL+   
Sbjct: 143  FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
            S  D  +   + GT  Y+APE  +  +   K DV+S GV+   L  G
Sbjct: 200  SK-DYKLRDRL-GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 806  KFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF 860
            KFS++      +GKG F  V R V    G E A K +  + L   R+F+ ++E  +    
Sbjct: 2    KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQ-KLEREARICR 59
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALV 919
               HPN+V L+    + S   LV++ + GG L EDI++            I   +  ++ 
Sbjct: 60   KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIA 118
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            + H      IVHR++K  N+LL  + K     + DFGLA  +   DS      AGT GY+
Sbjct: 119  YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 173
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATG 1005
            +PE  +    +   D+++ GV+   L  G
Sbjct: 174  SPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 808  SEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            S+  I+G G FG V++      G ++A K ++  G++ + E + E+ V++       H N
Sbjct: 92   SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ----LDHAN 147
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLED-IISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            L+ LY      ++ +LV EY++GG L D II                 +   +  + H+ 
Sbjct: 148  LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM-HQM 206
Query: 926  YPPIVHRDVKASNVL-LDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
            Y  I+H D+K  N+L ++++ K + + DFGLAR     +        GT  ++APE    
Sbjct: 207  Y--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNY 262
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
               +   D++S GV+A  L +G
Sbjct: 263  DFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 49   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 109  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 165
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D      + GT  Y+APE       + + DV
Sbjct: 166  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 225  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 272
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 273  QKMLQTD-------PTARPTINELL 290

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 811  RIIGKGGFGTVYRGVL--PDGRE----VAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            + +G+G FG V +       GR     VAVK L+      E R+  +E  VL        
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---- 84
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX--------------------- 902
            HP+++ LYG C      +L+ EY + GSL   +                           
Sbjct: 85   HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 903  ---XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                       A  +++ + +L       +VHRD+ A N+L+ +  K  ++DFGL+R V 
Sbjct: 145  RALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 960  AGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
              DS V  +     V ++A E       TT+ DV+SFGVL  E+ T    L G     + 
Sbjct: 202  EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGI- 256
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                        P   +  ++  G  +        E+ R+ ++C  + P+ RP   ++  
Sbjct: 257  ------------PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 1079 MLIKIL 1084
             L K++
Sbjct: 305  DLEKMM 310

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       + T+ GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG V+R      G   A K +       +   R E++ +S       HP LV L+
Sbjct: 59   LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRHPTLVNLH 114
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                D +E +++YE+M GG L E +                  V + L  +H   Y   V
Sbjct: 115  DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY---V 171
Query: 931  HRDVKASNVLL--DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            H D+K  N++    +  +  + DFGL   +    S   TT  GT  + APE  +      
Sbjct: 172  HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 229
Query: 989  KGDVYSFGVLAMELATG 1005
              D++S GVL+  L +G
Sbjct: 230  YTDMWSVGVLSYILLSG 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 63   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 121
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 122  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       + T+ GT  Y+APE  
Sbjct: 179  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA----TWTLCGTPEYLAPEII 231
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 232  LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 811  RIIGKGGFGTVYRGVL--PDGRE----VAVKKLQREGLEGE-REFRAEMEVLSGNGFGWP 863
            + +G+G FG V +       GR     VAVK L+      E R+  +E  VL        
Sbjct: 29   KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN---- 84
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXX--------------------- 902
            HP+++ LYG C      +L+ EY + GSL   +                           
Sbjct: 85   HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 903  ---XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                       A  +++ + +L       +VHRD+ A N+L+ +  K  ++DFGL+R V 
Sbjct: 145  RALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 960  AGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
              DS V  +     V ++A E       TT+ DV+SFGVL  E+ T    L G     + 
Sbjct: 202  EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGI- 256
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                        P   +  ++  G  +        E+ R+ ++C  + P+ RP   ++  
Sbjct: 257  ------------PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 1079 MLIKIL 1084
             L K++
Sbjct: 305  DLEKMM 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 23   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 74
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 75   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 135  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 189
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 190  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 235

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 23/277 (8%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +   ++   R +GKGGF   Y     D +EV   K+  + +  +   + +M         
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              +P++V  +G+  D     +V E     SL ++                    + + +L
Sbjct: 99   LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     ++HRD+K  N+ L+ +    + DFGLA  +   D      + GT  Y+APE  
Sbjct: 159  HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTPNYIAPEVL 214
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
                 + + D++S G +   L  G+   E    CL E   R+       P R + PV   
Sbjct: 215  CKKGHSFEVDIWSLGCILYTLLVGKPPFETS--CLKETYIRIKKNEYSVP-RHINPVA-- 269
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                       S L+R   R     P  RP+V E+L 
Sbjct: 270  -----------SALIR---RMLHADPTLRPSVAELLT 292

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 811  RIIGKGGFGTVYRG-VLPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 52   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 108
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX--------------XXXXXXXXXX 909
            H N+V L G C  G   +++ EY   G L + +                           
Sbjct: 109  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
             +  VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++    
Sbjct: 169  FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   V ++APE       T + DV+S+G+L  E+
Sbjct: 226  ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 23/277 (8%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +   ++   R +GKGGF   Y     D +EV   K+  + +  +   + +M         
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              +P++V  +G+  D     +V E     SL ++                    + + +L
Sbjct: 99   LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     ++HRD+K  N+ L+ +    + DFGLA  +   D      + GT  Y+APE  
Sbjct: 159  HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEVL 214
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
                 + + D++S G +   L  G+   E    CL E   R+       P R + PV   
Sbjct: 215  CKKGHSFEVDIWSLGCILYTLLVGKPPFETS--CLKETYIRIKKNEYSVP-RHINPVA-- 269
Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                       S L+R   R     P  RP+V E+L 
Sbjct: 270  -----------SALIR---RMLHADPTLRPSVAELLT 292

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGE----------REFRAEMEV 854
            K+ +   IG+G +G V++    D G+ VA+KK     LE E          RE R   ++
Sbjct: 4    KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQL 59
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDV 914
                     HPNLV L           LV+EY +   L ++              I    
Sbjct: 60   --------KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 915  ARALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
             +A+ F H H C    +HRDVK  N+L+ K     + DFG AR+++    +    +A T 
Sbjct: 112  LQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TR 166
Query: 974  GYVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
             Y +PE   G T Q     DV++ G +  EL +G
Sbjct: 167  WYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSG 199

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG V+R      G   A K +       +   R E++ +S       HP LV L+
Sbjct: 165  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRHPTLVNLH 220
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                D +E +++YE+M GG L E +                  V + L  +H   Y   V
Sbjct: 221  DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY---V 277
Query: 931  HRDVKASNVLL--DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            H D+K  N++    +  +  + DFGL   +    S   TT  GT  + APE  +      
Sbjct: 278  HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 335
Query: 989  KGDVYSFGVLAMELATGRRALEGGE 1013
              D++S GVL+  L +G     GGE
Sbjct: 336  YTDMWSVGVLSYILLSGLSPF-GGE 359

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 23/265 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            +GKGGF   +     D +EV   K+  + L  +   R +M +         H ++V  +G
Sbjct: 23   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 873  WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHR 932
            +  D     +V E     SL ++                  +     +LH      ++HR
Sbjct: 83   FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 139
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDV 992
            D+K  N+ L+++ +  + DFGLA  V   D      + GT  Y+APE       + + DV
Sbjct: 140  DLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 993  YSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEM 1052
            +S G +   L  G+   E    CL E   R+       P + + PV          A  +
Sbjct: 199  WSIGCIMYTLLVGKPPFETS--CLKETYLRIKKNEYSIP-KHINPV---------AASLI 246
Query: 1053 SELLRIGVRCTAEAPNARPNVKEVL 1077
             ++L+         P ARP + E+L
Sbjct: 247  QKMLQTD-------PTARPTINELL 264

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 34   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 85
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 86   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 146  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 200
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 201  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 811  RIIGKGGFGTVYRGV-LPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 52   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 108
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXX--------------XXXXXXXXX 909
            H N+V L G C  G   +++ EY   G L + +                           
Sbjct: 109  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
             +  VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++    
Sbjct: 169  FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   V ++APE       T + DV+S+G+L  E+
Sbjct: 226  ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 26   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 77
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 78   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 138  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 192
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 193  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 30   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 81
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 82   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 142  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 196
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 197  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 242

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 41   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 92
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 93   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 153  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 207
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 208  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 253

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA---EMEVLSG 857
            + ++   R++GKG FG V   +  D   G+E AVK + +  ++ + +  +   E+++L  
Sbjct: 25   SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                  HPN+  LY +  D     LV E   GG L D I             I   V   
Sbjct: 83   ----LDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + + H      IVHRD+K  N+LL+   K+    + DFGL+    A  S       GT  
Sbjct: 139  ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKIGTAY 193
Query: 975  YVAPE--YGQTWQATTKGDVYSFGVLAMELATG 1005
            Y+APE  +G T+    K DV+S GV+   L +G
Sbjct: 194  YIAPEVLHG-TYDE--KCDVWSTGVILYILLSG 223

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            I  +G FG V++  L +   VAVK      L+ ++ +++E E+ S  G    H NL+   
Sbjct: 22   IKARGRFGCVWKAQLMNDF-VAVKIFP---LQDKQSWQSEREIFSTPGM--KHENLLQFI 75
Query: 872  GWCLDGS----EKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC-- 925
                 GS    E  L+  + + GSL D +             +A  ++R L +LH +   
Sbjct: 76   AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCH-VAETMSRGLSYLHEDVPW 134
Query: 926  ------YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS----AGDSHVSTTIAGTVGY 975
                   P I HRD K+ NVLL  +  A++ DFGLA         GD+H      GT  Y
Sbjct: 135  CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRY 191
Query: 976  VAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +APE  +        A  + D+Y+ G++  EL +  +A +G
Sbjct: 192  MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 35   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 86
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 87   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 147  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 201
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 202  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 247

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 26   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 80
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 81   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 140  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 190  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 34   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 85
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 86   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 146  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 200
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 201  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 806  KFSEDRIIGKGGFG-----TVYRGVLPDGR-EVAVKKLQREGLEGERE-FRAEMEVLSGN 858
            + S  + +G G FG     T Y  +  D    VAVK L+      ERE   +E++VLS  
Sbjct: 24   RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI------ 912
            G    H N+V L G C  G   +++ EY   G L + +              AI      
Sbjct: 84   G---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 913  ------------DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         VA+ + FL  +     +HRD+ A N+LL       + DFGLAR +  
Sbjct: 141  ALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
              ++V    A   V ++APE       T + DV+S+G+   EL
Sbjct: 198  DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + IG G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EYM GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   V DFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   +E      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFGLA+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGF 860
            AT ++     IG G +GTVY+   P  G  VA+K ++   G EG          L     
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 861  GWPHPNLVTLYGWC----LDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--- 912
             + HPN+V L   C     D   K+ LV+E+++    +D+ +              I   
Sbjct: 62   AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 913  --DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
                 R L FLH  C   IVHRD+K  N+L+   G   + DFGLAR+ S   +     + 
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV- 173
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             T+ Y APE        T  D++S G +  E+
Sbjct: 174  -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 26   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 80
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 81   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 140  A---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 190  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 56   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 107
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 108  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 168  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 222
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 223  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +IGKG FG VY G       + +  ++R+  +  + F+ E+           H N+V   
Sbjct: 40   LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR----HENVVLFM 95
Query: 872  GWCLDGSEKILVYEYMEGGSLEDII-SXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
            G C+      ++    +G +L  ++              IA ++ + + +LH +    I+
Sbjct: 96   GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 931  HRDVKASNVLLDKEGKALVTDFGL---ARVVSAGDSHVSTTIA-GTVGYVAPEYGQTWQA 986
            H+D+K+ NV  D  GK ++TDFGL   + V+ AG       I  G + ++APE  +    
Sbjct: 153  HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 987  TTK---------GDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
             T+          DV++ G +  EL               EW  +        P  A+I 
Sbjct: 212  DTEEDKLPFSKHSDVFALGTIWYELHAR------------EWPFKTQ------PAEAII- 252
Query: 1038 VVLLGSGLAEGAEEM---SELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
               +G+G+     ++    E+  I + C A     RP   +++ ML K+
Sbjct: 253  -WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 100/242 (41%), Gaps = 33/242 (13%)
Query: 788  IRLDKTAFTYSDILK-ATGKFSEDRIIGKGGFG-----TVYRGVLPDGR-EVAVKKLQRE 840
            + +D T   Y    +    + S  + +G G FG     T Y  +  D    VAVK L+  
Sbjct: 21   VXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 80
Query: 841  GLEGERE-FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX 899
                ERE   +E++VLS  G    H N+V L G C  G   +++ EY   G L + +   
Sbjct: 81   AHLTEREALMSELKVLSYLG---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 137
Query: 900  XXXXXXXXXXIAI------------------DVARALVFLHHECYPPIVHRDVKASNVLL 941
                       AI                   VA+ + FL  +     +HRD+ A N+LL
Sbjct: 138  RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 194
Query: 942  DKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAM 1000
                   + DFGLAR +    ++V    A   V ++APE       T + DV+S+G+   
Sbjct: 195  THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 254
Query: 1001 EL 1002
            EL
Sbjct: 255  EL 256

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   +E      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFGLA+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+G+     E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 9/145 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++ LY +  D     LV E  +GG L D I             I   V   + +LH 
Sbjct: 95   HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 924  ECYPPIVHRDVKASNVLLD-KEGKAL--VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
                 IVHRD+K  N+LL+ KE  AL  + DFGL+ V    +        GT  Y+APE 
Sbjct: 155  H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEV 209
Query: 981  GQTWQATTKGDVYSFGVLAMELATG 1005
             +  +   K DV+S GV+   L  G
Sbjct: 210  LRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGF 860
            AT ++     IG G +GTVY+   P  G  VA+K ++   G EG          L     
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 861  GWPHPNLVTLYGWC----LDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--- 912
             + HPN+V L   C     D   K+ LV+E+++    +D+ +              I   
Sbjct: 62   AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 913  --DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
                 R L FLH  C   IVHRD+K  N+L+   G   + DFGLAR+ S   +     + 
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV- 173
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             T+ Y APE        T  D++S G +  E+
Sbjct: 174  -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 50   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 104
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 105  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 164  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEI 213
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 214  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+G+     E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMR----KLDHC 73
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 40   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 94
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 95   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 153
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 154  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 203
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 204  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 238

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 813  IGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G FG V+R  + D   G + AVKK++ E       FRAE E+++  G     P +V 
Sbjct: 82   LGRGSFGEVHR--MEDKQTGFQCAVKKVRLE------VFRAE-ELMACAGL--TSPRIVP 130
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            LYG   +G    +  E +EGGSL  ++                     L +LH      I
Sbjct: 131  LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 187
Query: 930  VHRDVKASNVLLDKEGK-ALVTDFGLARVVS----AGDSHVSTTIAGTVGYVAPEYGQTW 984
            +H DVKA NVLL  +G  A + DFG A  +       D      I GT  ++APE     
Sbjct: 188  LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K DV+S   + + +  G
Sbjct: 248  SCDAKVDVWSSCCMMLHMLNG 268

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 27   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 78
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 79   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 139  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 193
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 194  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            IG G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 35   IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 89
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 90   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 149  ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 199  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 813  IGKGGFGTVYRGV--LPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            +G+G + TVY+G   L D   VA+K+++ E  EG      R E+ +L        H N+V
Sbjct: 10   LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKD----LKHANIV 63
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
            TL+          LV+EY++    + +                  + R L + H +    
Sbjct: 64   TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQA 986
            ++HRD+K  N+L+++ G+  + DFGLAR  S         +  T+ Y  P+   G T   
Sbjct: 121  VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST-DY 178
Query: 987  TTKGDVYSFGVLAMELATGR 1006
            +T+ D++  G +  E+ATGR
Sbjct: 179  STQIDMWGVGCIFYEMATGR 198

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 36   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 90
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 91   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 150  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 199
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 200  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 806  KFSEDRIIGKGGFG-----TVYRGVLPDGR-EVAVKKLQREGLEGERE-FRAEMEVLSGN 858
            + S  + +G G FG     T Y  +  D    VAVK L+      ERE   +E++VLS  
Sbjct: 42   RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 101
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI------ 912
            G    H N+V L G C  G   +++ EY   G L + +              AI      
Sbjct: 102  G---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 913  ------------DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         VA+ + FL  +     +HRD+ A N+LL       + DFGLAR +  
Sbjct: 159  ALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
              ++V    A   V ++APE       T + DV+S+G+   EL
Sbjct: 216  DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 50   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 104
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 105  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 164  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 213
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 214  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 101  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 152
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 153  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 213  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 267
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 268  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 313

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 101/243 (41%), Gaps = 35/243 (14%)
Query: 788  IRLDKTAFTYSDILK-ATGKFSEDRIIGKGGFG-----TVYRGVLPDGR-EVAVKKLQRE 840
            + +D T   Y    +    + S  + +G G FG     T Y  +  D    VAVK L+  
Sbjct: 28   VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 841  GLEGERE-FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX 899
                ERE   +E++VLS  G    H N+V L G C  G   +++ EY   G L + +   
Sbjct: 88   AHLTEREALMSELKVLSYLG---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 144
Query: 900  XXXXXXXXXXIAI------------------DVARALVFLHHE-CYPPIVHRDVKASNVL 940
                       AI                   VA+ + FL  + C    +HRD+ A N+L
Sbjct: 145  RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNIL 200
Query: 941  LDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLA 999
            L       + DFGLAR +    ++V    A   V ++APE       T + DV+S+G+  
Sbjct: 201  LTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 260
Query: 1000 MEL 1002
             EL
Sbjct: 261  WEL 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 90
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 91   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 150  ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 199
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 200  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 62   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 122  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 179  RREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 91
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 92   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H +  + G V    Y APE 
Sbjct: 151  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEI 200
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 201  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 49   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 103
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 104  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 163  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 212
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 213  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT 869
            IG+G +G V+  R +   GR VA+K+++ +  E         EV        + HPN+V 
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 870  LYGWCL----DGSEKI-LVYEYMEGGSLEDIISXXXXXX-----XXXXXXIAIDVARALV 919
            L+  C     D   K+ LV+E+++    +D+ +                 +   + R L 
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            FLH      +VHRD+K  N+L+   G+  + DFGLAR+ S       T++  T+ Y APE
Sbjct: 135  FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                    T  D++S G +  E+   +    G  +
Sbjct: 190  VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        R+V   KL           + EM   S + F W        
Sbjct: 80   KVIGRGAFGEVQLVRHKSTRKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 130
Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P +V L+    D     +V EYM GG L +++S             A +V  AL  +
Sbjct: 131  ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAI 189
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H   +   +HRDVK  N+LLDK G   + DFG    ++        T  GT  Y++PE  
Sbjct: 190  HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 980  --YGQTWQATTKGDVYSFGVLAMELATG 1005
               G       + D +S GV   E+  G
Sbjct: 247  KSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 58   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 109
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 110  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 170  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 224
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 225  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 270

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 50   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 101
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 102  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 162  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 216
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 217  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 262

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 813  IGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G FG V+R  + D   G + AVKK++ E       FR E  V      G   P +V 
Sbjct: 82   VGRGSFGEVHR--MKDKQTGFQCAVKKVRLE------VFRVEELVACA---GLSSPRIVP 130
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            LYG   +G    +  E +EGGSL  +I                     L +LH      I
Sbjct: 131  LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 930  VHRDVKASNVLLDKEG-KALVTDFGLARVVSA---GDSHVSTT-IAGTVGYVAPEYGQTW 984
            +H DVKA NVLL  +G +A + DFG A  +     G S ++   I GT  ++APE     
Sbjct: 188  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K D++S   + + +  G
Sbjct: 248  PCDAKVDIWSSCCMMLHMLNG 268

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 806  KFSEDRIIGKGGFG-----TVYRGVLPDGR-EVAVKKLQREGLEGERE-FRAEMEVLSGN 858
            + S  + +G G FG     T Y  +  D    VAVK L+      ERE   +E++VLS  
Sbjct: 47   RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI------ 912
            G    H N+V L G C  G   +++ EY   G L + +              AI      
Sbjct: 107  G---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 913  ------------DVARALVFLHHE-CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                         VA+ + FL  + C    +HRD+ A N+LL       + DFGLAR + 
Sbjct: 164  ALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
               ++V    A   V ++APE       T + DV+S+G+   EL
Sbjct: 220  NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 91
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 92   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H +  + G V    Y APE 
Sbjct: 151  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEI 200
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 201  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 807  FSED----RIIGKGGFGTVYRGVLPDGRE-VAVKKLQ-REGLEGEREFRAEMEVLSGNGF 860
            F ED    + +G+G +G V   V     E VAVK +  +  ++     + E+ +      
Sbjct: 4    FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN- 62
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVF 920
               H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+
Sbjct: 63   ---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPE 979
            LH      I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE
Sbjct: 120  LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 980  YGQTWQATTKG-DVYSFGVLAMELATG 1005
              +  +   +  DV+S G++   +  G
Sbjct: 177  LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 86
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 87   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 146  ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 196  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 60   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 111
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 112  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 172  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 226
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 227  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 272

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+ +R    E++++        H 
Sbjct: 56   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMR----KLDHC 107
Query: 866  NLVTL-YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--------DVAR 916
            N+V L Y +   G +K  VY  +    + + +             + +         + R
Sbjct: 108  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 168  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--Y 222
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 223  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPHPNLVTL 870
            +G G  G V++      G  +AVK+++R G + E +    +++V+  +      P +V  
Sbjct: 33   MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS---HDCPYIVQC 89
Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
            +G  +  ++  +  E M   + +                + + + +AL +L  +    ++
Sbjct: 90   FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVI 147
Query: 931  HRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT- 988
            HRDVK SN+LLD+ G+  + DFG++ R+V   D       AG   Y+APE       T  
Sbjct: 148  HRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 989  ----KGDVYSFGVLAMELATGR 1006
                + DV+S G+  +ELATG+
Sbjct: 205  DYDIRADVWSLGISLVELATGQ 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 91
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 92   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H +  + G V    Y APE 
Sbjct: 151  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEI 200
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 201  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 811  RIIGKGGFGTVYRG-VLPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 52   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 108
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX----------------XXXXXXXX 907
            H N+V L G C  G   +++ EY   G L + +                           
Sbjct: 109  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 908  XXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
               +  VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++  
Sbjct: 169  LHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 968  TIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
              A   V ++APE       T + DV+S+G+L  E+
Sbjct: 226  GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 89
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 90   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 149  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 199  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 807  FSED----RIIGKGGFGTVYRGVLPDGRE-VAVKKLQ-REGLEGEREFRAEMEVLSGNGF 860
            F ED    + +G+G +G V   V     E VAVK +  +  ++     + E+ +      
Sbjct: 5    FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN- 63
Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVF 920
               H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+
Sbjct: 64   ---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPE 979
            LH      I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE
Sbjct: 121  LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 980  YGQTWQATTKG-DVYSFGVLAMELATG 1005
              +  +   +  DV+S G++   +  G
Sbjct: 178  LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        R+V   KL           + EM   S + F W        
Sbjct: 75   KVIGRGAFGEVQLVRHKSTRKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 125
Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P +V L+    D     +V EYM GG L +++S             A +V  AL  +
Sbjct: 126  ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAI 184
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H   +   +HRDVK  N+LLDK G   + DFG    ++        T  GT  Y++PE  
Sbjct: 185  HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 980  --YGQTWQATTKGDVYSFGVLAMELATG 1005
               G       + D +S GV   E+  G
Sbjct: 242  KSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 64   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 124  ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 26   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 80
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 81   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 140  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 189
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 190  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
               W    +  D++S G +  EL TGR    G +
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGF 860
            AT ++     IG G +GTVY+   P  G  VA+K ++   G EG          L     
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 861  GWPHPNLVTLYGWC----LDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--- 912
             + HPN+V L   C     D   K+ LV+E+++    +D+ +              I   
Sbjct: 62   AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 117
Query: 913  --DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
                 R L FLH  C   IVHRD+K  N+L+   G   + DFGLAR+ S         + 
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALDPVV 172
Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             T+ Y APE        T  D++S G +  E+
Sbjct: 173  VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 813  IGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G FG V+R  + D   G + AVKK++ E       FR E  V      G   P +V 
Sbjct: 66   VGRGSFGEVHR--MKDKQTGFQCAVKKVRLE------VFRVEELVACA---GLSSPRIVP 114
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            LYG   +G    +  E +EGGSL  +I                     L +LH      I
Sbjct: 115  LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 930  VHRDVKASNVLLDKEG-KALVTDFGLARVVSA---GDSHVSTT-IAGTVGYVAPEYGQTW 984
            +H DVKA NVLL  +G +A + DFG A  +     G S ++   I GT  ++APE     
Sbjct: 172  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K D++S   + + +  G
Sbjct: 232  PCDAKVDIWSSCCMMLHMLNG 252

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 89
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 90   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 149  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 199  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 29   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 83
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 84   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 142
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 143  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 192
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 193  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 227

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 84/208 (40%), Gaps = 26/208 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        R+V   KL           + EM   S + F W        
Sbjct: 80   KVIGRGAFGEVQLVRHKSTRKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 130
Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P +V L+    D     +V EYM GG L +++S             A +V  AL  +
Sbjct: 131  ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAI 189
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
            H   +   +HRDVK  N+LLDK G   + DFG    ++        T  GT  Y++PE  
Sbjct: 190  HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 980  --YGQTWQATTKGDVYSFGVLAMELATG 1005
               G       + D +S GV   E+  G
Sbjct: 247  KSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 5/144 (3%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N+V  YG   +G+ + L  EY  GG L D I                 +   +V+LH 
Sbjct: 63   HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE  +
Sbjct: 123  IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 983  TWQATTKG-DVYSFGVLAMELATG 1005
              +   +  DV+S G++   +  G
Sbjct: 180  RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEEC 1015
               W    +  D++S G +  EL TGR    G +  
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 27   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 81
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 82   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 141  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 190
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 191  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 810  DRII-GKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNL 867
            DR++ GKG +G VY G  L +   +A+K++        +    E+ +         H N+
Sbjct: 12   DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH----LKHKNI 67
Query: 868  VTLYG-WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI---DVARALVFLHH 923
            V   G +  +G  KI + E + GGSL  ++             I      +   L +LH 
Sbjct: 68   VQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 924  ECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
                 IVHRD+K  NVL++     L ++DFG ++ + AG +  + T  GT+ Y+APE   
Sbjct: 127  N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIID 182
Query: 980  -----YGQTWQATTKGDVYSFGVLAMELATGR 1006
                 YG+        D++S G   +E+ATG+
Sbjct: 183  KGPRGYGKA------ADIWSLGCTIIEMATGK 208

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 91
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 92   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 151  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 200
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 201  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 53   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 107
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 108  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 167  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPEI 216
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 217  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 251

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 27   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 81
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 82   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 141  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 190
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 191  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 89
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 90   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 149  ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 198
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 199  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 86
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 87   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 146  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 196  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 16   RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 72
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 73   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 189  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 230
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 231  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 28   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 82
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 83   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 141
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 142  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 191
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 192  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+    L+G+     E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRK----LDHC 73
Query: 866  NLVTLYGWCLDGSEKI------LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI---DVAR 916
            N+V L  +     EK       LV +Y+                      + +    + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   +    Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--Y 188
Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG--GEECLVE 1018
             APE  +G T   T+  DV+S G +  EL  G+    G  G + LVE
Sbjct: 189  RAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 86
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 87   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 146  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 196  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 86
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 87   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 146  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 195
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 196  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 230

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 53   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 107
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 108  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 167  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 216
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 217  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 251

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 16   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 72
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 73   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 189  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 230
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 231  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 28/209 (13%)
Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH------ 864
            ++IG+G FG V        ++V   KL           + EM   S + F W        
Sbjct: 81   KVIGRGAFGEVQLVRHKASQKVYAMKLLS---------KFEMIKRSDSAFFWEERDIMAF 131
Query: 865  ---PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P +V L+    D     +V EYM GG L +++S             A +V  AL  +
Sbjct: 132  ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLALDAI 190
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPE- 979
            H      ++HRDVK  N+LLDK G   + DFG   ++   G  H  T + GT  Y++PE 
Sbjct: 191  HSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEV 246
Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATG 1005
                G       + D +S GV   E+  G
Sbjct: 247  LKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 50   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 104
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 105  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 164  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 213
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 214  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 248

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 41   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 95
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 96   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 155  ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 204
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 205  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 96
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 97   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 156  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 206  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 90
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 91   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 150  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 199
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 200  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 96
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 97   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 156  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 206  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEV-LSGNGFGWPHPNLVTL 870
            +G+G +G V +   +P G+ +AVK++ R  +  + + R  M++ +S      P    VT 
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF--TVTF 71
Query: 871  YGWCLDGSEKILVYEYMEGG---SLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
            YG      +  +  E M+       + +I             IA+ + +AL  LH +   
Sbjct: 72   YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQ 985
             ++HRDVK SNVL++  G+  + DFG++  +   D       AG   Y+APE    +  Q
Sbjct: 130  SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 986  A--TTKGDVYSFGVLAMELATGR 1006
               + K D++S G+  +ELA  R
Sbjct: 188  KGYSVKSDIWSLGITMIELAILR 210

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 90
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 91   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 150  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 199
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 200  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 234

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 813  IGKGGFGTVYRGVLPDGR---EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G G FG+V +GV    +   +VA+K L++   + + E   EM   +       +P +V 
Sbjct: 344  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIVR 400
Query: 870  LYGWCLDGSEKILVYEYMEGGSLED-IISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
            L G C      +LV E   GG L   ++             +   V+  + +L  + +  
Sbjct: 401  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 457
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQTWQA 986
             VHR++ A NVLL     A ++DFGL++ + A DS+ +   AG   + + APE     + 
Sbjct: 458  -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 987  TTKGDVYSFGVLAME-LATGR---RALEGGE-ECLVEWGRRV 1023
            +++ DV+S+GV   E L+ G+   + ++G E    +E G+R+
Sbjct: 517  SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 558

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 136/307 (44%), Gaps = 40/307 (13%)
Query: 152 EILDLSVNRIH--GEISF-SFPAICEKLVVANLSLN-NLTGRIDT-CFDGCLNLRYLDLS 206
            +LDL  NRI    +  F SFP + E      L LN N+   ++   F+   NLR L L 
Sbjct: 35  RLLDLGKNRIKTLNQDEFASFPHLEE------LELNENIVSAVEPGAFNNLFNLRTLGLR 88
Query: 207 SNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE 263
           SN  +     ++ GL+ L +  +SEN +  ++   +F++  +L+  ++ +N+ +      
Sbjct: 89  SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-----Y 142
Query: 264 VSNCRXXXXXXXXXXXXSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
           +S+                        ++ LE L L K N  S+  E+L +L  L VL L
Sbjct: 143 ISH-------------------RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183
Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
              N        F R  ++K+L +    Y+D M  + +  L N++ L ++H N T    +
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-NLTSLSITHCNLTAVPYL 242
Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
            +  +  L+FL L++N  +    ++   +  LQ + L   +L    P +   L  L  L 
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302
Query: 444 LANNSLS 450
           ++ N L+
Sbjct: 303 VSGNQLT 309

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 813  IGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G FG V+R  + D   G + AVKK++ E       FR E  V      G   P +V 
Sbjct: 80   LGRGSFGEVHR--MKDKQTGFQCAVKKVRLE------VFRVEELVACA---GLSSPRIVP 128
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            LYG   +G    +  E +EGGSL  +I                     L +LH      I
Sbjct: 129  LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 185
Query: 930  VHRDVKASNVLLDKEG-KALVTDFGLARVVSA---GDSHVSTT-IAGTVGYVAPEYGQTW 984
            +H DVKA NVLL  +G +A + DFG A  +     G S ++   I GT  ++APE     
Sbjct: 186  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K D++S   + + +  G
Sbjct: 246  PCDAKVDIWSSCCMMLHMLNG 266

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 49   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 103
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 104  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 163  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 212
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 213  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 44   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 100
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 101  IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 159
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 160  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 217  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 258
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 259  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 298

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 41   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 95
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 96   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 155  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 204
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 205  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 35   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 93
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 94   ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 151  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 203
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 204  LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 16   RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 72
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 73   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 132  F---VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 189  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 230
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 231  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V     +  G ++AVKKL R     +  +R +R E+ +L        H N++
Sbjct: 59   VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 113
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 114  GLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 172
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 173  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 222
Query: 981  GQTW-QATTKGDVYSFGVLAMELATGRRALEGGE 1013
               W       D++S G +  EL TGR    G +
Sbjct: 223  MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 23/244 (9%)
Query: 797  YSDILKATGKFSED----RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---F 848
            ++ ++K      ED    ++IG+G FG V    + +   + A+K L +  +    E   F
Sbjct: 62   FTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 121
Query: 849  RAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXX 908
            R E +VL      W    +  L+    D +   LV +Y  GG L  ++S           
Sbjct: 122  REERDVLVNGDCQW----ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 909  XIAI-DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
               I ++  A+  +H   Y   VHRD+K  NVLLD  G   + DFG    ++   +  S+
Sbjct: 178  RFYIGEMVLAIDSIHQLHY---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 968  TIAGTVGYVAPEYGQTWQATT-----KGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
               GT  Y++PE  Q  +        + D +S GV   E+  G        E LVE   +
Sbjct: 235  VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK 292
Query: 1023 VMGY 1026
            +M +
Sbjct: 293  IMNH 296

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 35   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 93
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 94   ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 150
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 151  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 203
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 204  LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 23/244 (9%)
Query: 797  YSDILKATGKFSED----RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---F 848
            ++ ++K      ED    ++IG+G FG V    + +   + A+K L +  +    E   F
Sbjct: 78   FTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 137
Query: 849  RAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXX 908
            R E +VL      W    +  L+    D +   LV +Y  GG L  ++S           
Sbjct: 138  REERDVLVNGDCQW----ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 193
Query: 909  XIAI-DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
               I ++  A+  +H   Y   VHRD+K  NVLLD  G   + DFG    ++   +  S+
Sbjct: 194  RFYIGEMVLAIDSIHQLHY---VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 968  TIAGTVGYVAPEYGQTWQATT-----KGDVYSFGVLAMELATGRRALEGGEECLVEWGRR 1022
               GT  Y++PE  Q  +        + D +S GV   E+  G        E LVE   +
Sbjct: 251  VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK 308
Query: 1023 VMGY 1026
            +M +
Sbjct: 309  IMNH 312

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 13/197 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    +   +A  K+     E E E +  E+++L+       HPN+V L 
Sbjct: 45   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD----HPNIVKLL 100
Query: 872  GWCLDGSEKILVYEYMEGGSLEDI-ISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                  +   ++ E+  GG+++ + +             +      AL +LH      I+
Sbjct: 101  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 931  HRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
            HRD+KA N+L   +G   + DFG++    R +   DS + T        V  E  +    
Sbjct: 158  HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 987  TTKGDVYSFGVLAMELA 1003
              K DV+S G+  +E+A
Sbjct: 218  DYKADVWSLGITLIEMA 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 813  IGKGGFGTVYRGVLPD-GREVAVK--KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G F  V + +    G+E A K  K +R G +   E   E+ VL         P ++ 
Sbjct: 37   LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE---LAKSCPRVIN 93
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI--DVARALVFLHHECYP 927
            L+    + SE IL+ EY  GG +  +              I +   +   + +LH     
Sbjct: 94   LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--- 150
Query: 928  PIVHRDVKASNVLLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
             IVH D+K  N+LL      G   + DFG++R +  G +     I GT  Y+APE     
Sbjct: 151  NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNYD 208
Query: 985  QATTKGDVYSFGVLAMELAT 1004
              TT  D+++ G++A  L T
Sbjct: 209  PITTATDMWNIGIIAYMLLT 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 13   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 69
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 70   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 129  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 186  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 227
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 228  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 813  IGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            +G+G FG V+R  + D   G + AVKK++ E       FRAE E+++  G     P +V 
Sbjct: 101  LGRGSFGEVHR--MEDKQTGFQCAVKKVRLE------VFRAE-ELMACAGLT--SPRIVP 149
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            LYG   +G    +  E +EGGSL  ++                     L +LH      I
Sbjct: 150  LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 206
Query: 930  VHRDVKASNVLLDKEG-KALVTDFGLARVVSA---GDSHVS-TTIAGTVGYVAPEYGQTW 984
            +H DVKA NVLL  +G  A + DFG A  +     G S ++   I GT  ++APE     
Sbjct: 207  LHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 985  QATTKGDVYSFGVLAMELATG 1005
                K DV+S   + + +  G
Sbjct: 267  SCDAKVDVWSSCCMMLHMLNG 287

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+    F E  ++G+G FG V +     D R  A+KK+ R   E      +E+ +L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS-- 58
Query: 860  FGWPHPNLVTLYGWCLD-------------GSEKILVYEYMEGGSLEDII-SXXXXXXXX 905
                H  +V  Y   L+              S   +  EY E G+L D+I S        
Sbjct: 59   --LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA----- 960
                +   +  AL ++H +    I+HRD+K  N+ +D+     + DFGLA+ V       
Sbjct: 117  EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 961  --------GDSHVSTTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAMEL 1002
                    G S   T+  GT  YVA E    T     K D+YS G++  E+
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + IG G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EYM GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   V DFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT 869
            IG+G +G V+  R +   GR VA+K+++ +  E         EV        + HPN+V 
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 870  LYGWCL----DGSEKI-LVYEYMEGGSLEDIISXXXXXX-----XXXXXXIAIDVARALV 919
            L+  C     D   K+ LV+E+++    +D+ +                 +   + R L 
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            FLH      +VHRD+K  N+L+   G+  + DFGLAR+ S       T++  T+ Y APE
Sbjct: 135  FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 980  YGQTWQATTKGDVYSFGVLAMEL 1002
                    T  D++S G +  E+
Sbjct: 190  VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 813  IGKGGFGTVY--RGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT 869
            IG+G +G V+  R +   GR VA+K+++ +  E         EV        + HPN+V 
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 870  LYGWCL----DGSEKI-LVYEYMEGGSLEDIISXXXXXX-----XXXXXXIAIDVARALV 919
            L+  C     D   K+ LV+E+++    +D+ +                 +   + R L 
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            FLH      +VHRD+K  N+L+   G+  + DFGLAR+ S       T++  T+ Y APE
Sbjct: 135  FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 189
Query: 980  YGQTWQATTKGDVYSFGVLAMEL 1002
                    T  D++S G +  E+
Sbjct: 190  VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 13/197 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    +   +A  K+     E E E +  E+++L+       HPN+V L 
Sbjct: 45   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD----HPNIVKLL 100
Query: 872  GWCLDGSEKILVYEYMEGGSLEDI-ISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                  +   ++ E+  GG+++ + +             +      AL +LH      I+
Sbjct: 101  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 931  HRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
            HRD+KA N+L   +G   + DFG++    R +   DS + T        V  E  +    
Sbjct: 158  HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 987  TTKGDVYSFGVLAMELA 1003
              K DV+S G+  +E+A
Sbjct: 218  DYKADVWSLGITLIEMA 234

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 75
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 76   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 135
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 136  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               +   D + FGV   E+ T       G+E  +         G +G  + +  +   G 
Sbjct: 193  RTFSHASDTWMFGVTLWEMFT------YGQEPWI---------GLNG-SQILHKIDKEGE 236
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
             L    +   ++  + V+C A  P  RP    +   L++  P
Sbjct: 237  RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 278

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + IG G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   V DFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGL R       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 29   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 87
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 88   ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 145  HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 197
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 198  LSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 811  RIIGKGGFGTVYRG-VLPDGRE-----VAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            + +G G FG V        G+E     VAVK L+      E+E   +E++++S  G    
Sbjct: 37   KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---Q 93
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID---------- 913
            H N+V L G C  G   +++ EY   G L + +                D          
Sbjct: 94   HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 914  -------------VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                         VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +  
Sbjct: 154  PLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
              +++    A   V ++APE       T + DV+S+G+L  E+
Sbjct: 211  DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 71
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 72   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 132  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               +   D + FGV   E+ T       G+E  +         G +G  + +  +   G 
Sbjct: 189  RTFSHASDTWMFGVTLWEMFT------YGQEPWI---------GLNG-SQILHKIDKEGE 232
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
             L    +   ++  + V+C A  P  RP    +   L++  P
Sbjct: 233  RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 71
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 72   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 132  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               +   D + FGV   E+ T       G+E  +         G +G  + +  +   G 
Sbjct: 189  RTFSHASDTWMFGVTLWEMFT------YGQEPWI---------GLNG-SQILHKIDKEGE 232
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
             L    +   ++  + V+C A  P  RP    +   L++  P
Sbjct: 233  RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 60/198 (30%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            IGKG F  V R V L  G E A K +  + L      + E E          H N+V L+
Sbjct: 12   IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL--KHSNIVRLH 69
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                +     LV++ + GG L EDI++            I   +  A++  H      +V
Sbjct: 70   DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCHQM---GVV 125
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HRD+K  N+LL  + K     + DFGLA  V  GD       AGT GY++PE  +     
Sbjct: 126  HRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKEAYG 184
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 185  KPVDIWACGVILYILLVG 202

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  +AGT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 16/214 (7%)
Query: 809  EDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWPHPN 866
            +D+ +G+G F    + V     +    K+  + +E   ++E  A +++  G      HPN
Sbjct: 15   KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITA-LKLCEG------HPN 67
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            +V L+    D     LV E + GG L + I             I   +  A+  +H    
Sbjct: 68   IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--- 124
Query: 927  PPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              +VHRD+K  N+L   E   L   + DFG AR +   D+    T   T+ Y APE    
Sbjct: 125  VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-LKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                   D++S GV+   + +G+   +  +  L 
Sbjct: 184  NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 21   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 77
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 78   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 137  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 194  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 235
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 236  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 23   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 81
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 82   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 138  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 195  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 16   RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 72
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G  +  +   ++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 73   IVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +       ++     + ++APE     +
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 189  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 230
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 231  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + D+GLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 791 DKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFR 849
           D++ F    +     +    R++ +GGF  VY    +  GRE A+K+L     E  R   
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 850 AE---MEVLSGNGFGWPHPNLVTLYGWCLDGSEK--------ILVYEYMEGGSLEDIISX 898
            E   M+ LSG      HPN+V        G E+        +L+ E  +G  +E +   
Sbjct: 74  QEVCFMKKLSG------HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 899 XXXXXXXXXXXIAI--DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                      + I     RA+  +H +  PPI+HRD+K  N+LL  +G   + DFG A 
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 957 VVS 959
            +S
Sbjct: 187 TIS 189

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 48/305 (15%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 23   EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXX---------- 902
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 83   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                      +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR +  
Sbjct: 140  FLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
               +V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   E+
Sbjct: 197  DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             RR+    R        P                E+ +  + C    P+ RP   E++  
Sbjct: 257  CRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELVEH 300
Query: 1080 LIKIL 1084
            L  +L
Sbjct: 301  LGNLL 305

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            ++ +  IG+G +G V   V    R   A KK+ +  +E    F+ E+E++        HP
Sbjct: 28   YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS----LDHP 83
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            N++ LY    D ++  LV E   GG L + +             I  DV  A+ + H   
Sbjct: 84   NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 143
Query: 926  YPPIVHRDVKASNVLL--DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
               + HRD+K  N L   D     L + DFGLA     G   +  T  GT  YV+P+   
Sbjct: 144  ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLE 198
Query: 980  --YGQTWQATTKGDVYSFGVLAMELATG 1005
              YG       + D +S GV+   L  G
Sbjct: 199  GLYG------PECDEWSAGVMMYVLLCG 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 63   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 121
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 122  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 178
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 179  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 231
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 232  LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 63   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 121
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 122  ---PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 179  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 231
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 232  LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 122/305 (40%), Gaps = 48/305 (15%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 23   EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXX---------- 902
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 83   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 903  --XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
                      +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR +  
Sbjct: 140  FLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 961  GDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
               +V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   E+
Sbjct: 197  DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 256
Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             RR+                  G+ +        E+ +  + C    P+ RP   E++  
Sbjct: 257  XRRLKE----------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300
Query: 1080 LIKIL 1084
            L  +L
Sbjct: 301  LGNLL 305

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 16   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 74
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 75   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 131  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 188  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVT 869
            +G G F  V +      G+E A K +++  L   R    R E+E          HPN++T
Sbjct: 20   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            L+    + ++ +L+ E + GG L D ++                +   + +LH +    I
Sbjct: 80   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RI 136
Query: 930  VHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
             H D+K  N+ LLDK     +  + DFG+A  + AG+      I GT  +VAPE      
Sbjct: 137  AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEP 194
Query: 986  ATTKGDVYSFGVLAMELATG 1005
               + D++S GV+   L +G
Sbjct: 195  LGLEADMWSIGVITYILLSG 214

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 45   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 103
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 104  M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 160  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 217  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVT 869
            +G G F  V +      G+E A K +++  L   R    R E+E          HPN++T
Sbjct: 13   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            L+    + ++ +L+ E + GG L D ++                +   + +LH +    I
Sbjct: 73   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RI 129
Query: 930  VHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
             H D+K  N+ LLDK     +  + DFG+A  + AG+      I GT  +VAPE      
Sbjct: 130  AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEP 187
Query: 986  ATTKGDVYSFGVLAMELATG 1005
               + D++S GV+   L +G
Sbjct: 188  LGLEADMWSIGVITYILLSG 207

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 396  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 452
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 453  IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 512  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 569  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 610
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 611  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 23   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 81
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 82   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 138  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 195  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 18   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 74
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 75   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 133
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 134  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 191  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 232
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 233  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 272

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 19   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 75
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 76   IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 134
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 135  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 192  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 233
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 234  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            ++ +  IG+G +G V   V    R   A KK+ +  +E    F+ E+E++        HP
Sbjct: 11   YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD----HP 66
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            N++ LY    D ++  LV E   GG L + +             I  DV  A+ + H   
Sbjct: 67   NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 926  YPPIVHRDVKASNVLL--DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
               + HRD+K  N L   D     L + DFGLA     G   +  T  GT  YV+P+   
Sbjct: 127  ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQVLE 181
Query: 980  --YGQTWQATTKGDVYSFGVLAMELATG 1005
              YG       + D +S GV+   L  G
Sbjct: 182  GLYG------PECDEWSAGVMMYVLLCG 203

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 71
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 72   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 132  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 984  WQATTKGDVYSFGVLAMELAT 1004
               +   D + FGV   E+ T
Sbjct: 189  RTFSHASDTWMFGVTLWEMFT 209

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL +     +  +R +R E+ +L        H N++
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKH----MKHENVI 96
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 97   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 156  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 205
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 206  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 240

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 813  IGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVT 869
            +G G F  V +      G+E A K +++  L   R    R E+E          HPN++T
Sbjct: 34   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            L+    + ++ +L+ E + GG L D ++                +   + +LH +    I
Sbjct: 94   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RI 150
Query: 930  VHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
             H D+K  N+ LLDK     +  + DFG+A  + AG+      I GT  +VAPE      
Sbjct: 151  AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEP 208
Query: 986  ATTKGDVYSFGVLAMELATG 1005
               + D++S GV+   L +G
Sbjct: 209  LGLEADMWSIGVITYILLSG 228

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 75
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 76   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 135
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 136  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 984  WQATTKGDVYSFGVLAMELAT 1004
               +   D + FGV   E+ T
Sbjct: 193  RTFSHASDTWMFGVTLWEMFT 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 8    AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 66
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 67   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D  
Sbjct: 123  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 180  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 81
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 82   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 142  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               +   D + FGV   E+ T       G+E  +         G +G  + +  +   G 
Sbjct: 199  RTFSHASDTWMFGVTLWEMFT------YGQEPWI---------GLNG-SQILHKIDKEGE 242
Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
             L    +   ++  + V+C A  P  RP    +   L++  P
Sbjct: 243  RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 10   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 68
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 69   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 125  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 182  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 813  IGKGGFGTVYRGVL--PDGR--EVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHP 865
            +G G FG V RG    P G+   VAVK L+ + L   E   +F  E+  +        H 
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD----HR 81
Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            NL+ LYG  L    K++      G  L+ +               A+ VA  + +L  + 
Sbjct: 82   NLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--GYVAPEYGQT 983
            +   +HRD+ A N+LL       + DFGL R +   D H        V   + APE  +T
Sbjct: 142  F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 984  WQATTKGDVYSFGVLAMELAT 1004
               +   D + FGV   E+ T
Sbjct: 199  RTFSHASDTWMFGVTLWEMFT 219

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 14   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 72
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 73   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 129  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 186  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 811  RIIGKGGFGTVYRGVL--PD--GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            R IG+G FG V++G+   P+     VA+K  +    +  RE +   E L+   F   HP+
Sbjct: 396  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFD--HPH 452
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI-AIDVARALVFLHHEC 925
            +V L G   +    I++ E    G L   +             + A  ++ AL +L  + 
Sbjct: 453  IVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
            +   VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE     +
Sbjct: 512  F---VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 986  ATTKGDVYSFGVLAME-LATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSG 1044
             T+  DV+ FGV   E L  G +  +G +                     VI  +  G  
Sbjct: 569  FTSASDVWMFGVCMWEILMHGVKPFQGVK------------------NNDVIGRIENGER 610
Query: 1045 LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            L         L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 611  LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 13   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 71
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 72   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 128  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 185  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 17   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 75
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 76   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 132  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 189  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 17   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 75
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 76   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D  
Sbjct: 132  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 189  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 16   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 74
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 75   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +
Sbjct: 131  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 188  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + DF LAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 117/306 (38%), Gaps = 46/306 (15%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 23   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 83   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 140  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
                +V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   E
Sbjct: 200  KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            + RR+    R        P                E+ +  + C    P+ RP   E++ 
Sbjct: 260  FCRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 1079 MLIKIL 1084
             L  +L
Sbjct: 304  HLGNLL 309

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---------LEGEREFRAEM 852
            AT ++     IG G +GTVY+   P  G  VA+K ++            +   RE  A +
Sbjct: 7    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-ALL 65
Query: 853  EVLSGNGFGWPHPNLVTLYGWC----LDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXX 907
              L      + HPN+V L   C     D   K+ LV+E+++    +D+ +          
Sbjct: 66   RRLEA----FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGL 117
Query: 908  XXIAI-----DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
                I        R L FLH  C   IVHRD+K  N+L+   G   + DFGLAR+ S   
Sbjct: 118  PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172
Query: 963  SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC 1015
                T +  T+ Y APE        T  D++S G +  E+   +    G  E 
Sbjct: 173  QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R V +  G+E A K +  + L      + E E          HPN+V L+
Sbjct: 30   LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLL--KHPNIVRLH 87
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                +     L+++ + GG L EDI++            I   +  A++  H      +V
Sbjct: 88   DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCHQM---GVV 143
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HRD+K  N+LL  + K     + DFGLA  V  G+       AGT GY++PE  +     
Sbjct: 144  HRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 203  KPVDLWACGVILYILLVG 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F E  +IG GGFG V++     DG+   +K+++    + ERE +A  ++         H 
Sbjct: 13   FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKL--------DHV 64
Query: 866  NLVTLYGWCLDG-------SEK----------ILVYEYMEGGSLEDIISXXXXXXXXXXX 908
            N+V  Y  C DG       S K           +  E+ + G+LE  I            
Sbjct: 65   NIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 909  XIAI--DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
             + +   + + + ++H +    +++RD+K SN+ L    +  + DFGL  V S  +    
Sbjct: 124  ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKR 178
Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                GT+ Y++PE   +     + D+Y+ G++  EL
Sbjct: 179  XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  ISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  ++A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTLY 871
            +G G FG VY+    +   +A  K+     E E E +  E+++L+       HPN+V L 
Sbjct: 45   LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD----HPNIVKLL 100
Query: 872  GWCLDGSEKILVYEYMEGGSLEDI-ISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                  +   ++ E+  GG+++ + +             +      AL +LH      I+
Sbjct: 101  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 931  HRDVKASNVLLDKEGKALVTDFGLA----RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
            HRD+KA N+L   +G   + DFG++    R +   D  + T        V  E  +    
Sbjct: 158  HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 987  TTKGDVYSFGVLAMELA 1003
              K DV+S G+  +E+A
Sbjct: 218  DYKADVWSLGITLIEMA 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 16/218 (7%)
Query: 797  YSDILKATGKFSED----RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAE 851
            Y   +    +F++D      +GKG F  V R V     +E A K +  + L      + E
Sbjct: 19   YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 852  MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXI 910
             E          HPN+V L+    +     LV++ + GG L EDI++            I
Sbjct: 79   REARICRLLK--HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI 136
Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVST 967
                 + L  ++H     IVHRD+K  N+LL  + K     + DFGLA  V  G+     
Sbjct: 137  H----QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GEQQAWF 191
Query: 968  TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
              AGT GY++PE  +        D+++ GV+   L  G
Sbjct: 192  GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 117/306 (38%), Gaps = 46/306 (15%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 25   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 84
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 85   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 142  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
                +V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   E
Sbjct: 202  KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 261
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            + RR+    R        P                E+ +  + C    P+ RP   E++ 
Sbjct: 262  FCRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELVE 305
Query: 1079 MLIKIL 1084
             L  +L
Sbjct: 306  HLGNLL 311

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-----FRAEMEVLSGNGFGWPHPNL 867
            IG+G +G VY+     G   A+KK++   LE E E        E+ +L        H N+
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE----LKHSNI 62
Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
            V LY         +LV+E+++    + +                + +   + + H     
Sbjct: 63   VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQA 986
             ++HRD+K  N+L+++EG+  + DFGLAR         +  I  T+ Y AP+    + + 
Sbjct: 120  RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEEC 1015
            +T  D++S G +  E+  G     G  E 
Sbjct: 179  STTIDIWSVGCIFAEMVNGTPLFPGVSEA 207

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F + R++GKGGFG V    V   G+  A KKL+++ ++   GE     E ++L       
Sbjct: 186  FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV---- 241
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALV 919
             +   V    +  +  + + LV   M GG L+  I             +  A ++   L 
Sbjct: 242  -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             LH E    IV+RD+K  N+LLD  G   ++D GLA  V  G +       GTVGY+APE
Sbjct: 301  DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
              +  + T   D ++ G L  E+  G+
Sbjct: 356  VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 60   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 119
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 120  ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 177  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                +V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 237  KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 807  FSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGW 862
            F + R++GKGGFG V    V   G+  A KKL+++ ++   GE     E ++L       
Sbjct: 186  FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV---- 241
Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALV 919
             +   V    +  +  + + LV   M GG L+  I             +  A ++   L 
Sbjct: 242  -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             LH E    IV+RD+K  N+LLD  G   ++D GLA  V  G +       GTVGY+APE
Sbjct: 301  DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
              +  + T   D ++ G L  E+  G+
Sbjct: 356  VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 53/309 (17%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 24   EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 83
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXX---------- 902
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 84   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 903  -----XXXXXXXIAIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
                         +  VA+ + FL   +C    +HRD+ A N+LL ++    + DFGLAR
Sbjct: 141  YKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 957  VVSAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC 1015
             +      V    A   + ++APE       T + DV+SFGVL  E+ +   +   G + 
Sbjct: 197  DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075
              E+ RR+    R        P                E+ +  + C    P+ RP   E
Sbjct: 257  DEEFCRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSE 300
Query: 1076 VLAMLIKIL 1084
            ++  L  +L
Sbjct: 301  LVEHLGNLL 309

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 15   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E ME    L D I+                V  A+   H+ C
Sbjct: 75   VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 133
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 134  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 188
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 189  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 221

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGF 860
            +  F    ++G+G +G V      P G  VA+KK++   + L   R  R E+++L     
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKH--- 65
Query: 861  GWPHPNLVTLYGW----CLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             + H N++T++        +   ++ + + +    L  +IS            I     R
Sbjct: 66   -FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLR 123
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVST------- 967
            A+  LH      ++HRD+K SN+L++      V DFGLAR++  SA D+   T       
Sbjct: 124  AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 968  TIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
                T  Y APE   T    ++  DV+S G +  EL   R    G +
Sbjct: 181  EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ---REGLEGEREFRAEMEVLSGNGFG 861
            K+   + +GKG +G V++ +    G  VAVKK+    +   + +R FR  M +   +G  
Sbjct: 10   KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG-- 67
Query: 862  WPHPNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALV 919
              H N+V L       +++   LV++YME   L  +I             +   + + + 
Sbjct: 68   --HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY-VVYQLIKVIK 123
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS-------------------- 959
            +LH      ++HRD+K SN+LL+ E    V DFGL+R                       
Sbjct: 124  YLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 960  AGDSHVSTTIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGG 1012
              D  + T    T  Y APE        TKG D++S G +  E+  G+    G 
Sbjct: 181  DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 14   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 74   ILIHIGH---HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 131  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                +V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 191  KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P L  L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 102  ---PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 14   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 74   ILIHIGH---HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 131  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                +V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 191  KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 803  ATGKFSEDRIIGKGGFGTVYRGVL-------PDGREVAVKKLQREGLEGER-EFRAEMEV 854
            A  K +  R +G+G FG VY GV        P+ R VA+K +       ER EF  E  V
Sbjct: 10   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASV 68
Query: 855  LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX---------- 904
            +    F   H  +V L G    G   +++ E M  G L+  +                  
Sbjct: 69   M--KEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 905  XXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
                 +A ++A  + +L+   +   VHRD+ A N  + ++    + DFG+ R +   D +
Sbjct: 125  SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 965  VSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                     V +++PE  +    TT  DV+SFGV+  E+AT
Sbjct: 182  RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 37   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 95
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 96   ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 152
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 153  HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 205
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 206  LSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 48/291 (16%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 23   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 80
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 81   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA-GT 972
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D           
Sbjct: 139  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++APE  +    TT  D++SFGV+  E+ +           L E   + +        
Sbjct: 196  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQPYQGLS------N 238
Query: 1033 RAVIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
              V+  V+ G  L +     E +++L+R+   C    PN RP   E++ +L
Sbjct: 239  EQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 286

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 23   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 83   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 140  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                 V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 200  KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 812  IIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            ++GKG FG V +       +E AVK + +   + +       E+E+L        HPN++
Sbjct: 29   MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK----LDHPNIM 84
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             L+    D S   +V E   GG L D I             I   V   + ++H      
Sbjct: 85   KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 929  IVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TW 984
            IVHRD+K  N+LL+ + K     + DFGL+      ++ +   I GT  Y+APE  + T+
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLRGTY 199
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                K DV+S GV+   L +G     G  E
Sbjct: 200  DE--KCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGR---EVAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHP 865
            R +G G +G+V      D R   +VAVKKL R  + L   R    E+ +L        H 
Sbjct: 34   RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH----LKHE 87
Query: 866  NLVTLYGWCL------DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALV 919
            N++ L           D SE  LV   M G  L +I+             +   + R L 
Sbjct: 88   NVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQFLV-YQLLRGLK 145
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            ++H      I+HRD+K SNV ++++ +  + DFGLAR     D  ++  +A T  Y APE
Sbjct: 146  YIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVA-TRWYRAPE 198
Query: 980  YGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
                W    +  D++S G +  EL  G+    G +   ++  +R+M
Sbjct: 199  IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD--YIDQLKRIM 242

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 120/307 (39%), Gaps = 50/307 (16%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 25   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 84
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXX---------- 902
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 85   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 903  ----XXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
                        +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR +
Sbjct: 142  KDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 959  SAGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV 1017
                  V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   
Sbjct: 199  XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            E+ RR+    R        P                E+ +  + C    P+ RP   E++
Sbjct: 259  EFCRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELV 302
Query: 1078 AMLIKIL 1084
              L  +L
Sbjct: 303  EHLGNLL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGF 860
            +  F    ++G+G +G V      P G  VA+KK++   + L   R  R E+++L     
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKH--- 65
Query: 861  GWPHPNLVTLYGW----CLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             + H N++T++        +   ++ + + +    L  +IS            I     R
Sbjct: 66   -FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLR 123
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVS-------T 967
            A+  LH      ++HRD+K SN+L++      V DFGLAR++  SA D+          T
Sbjct: 124  AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 968  TIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
                T  Y APE   T    ++  DV+S G +  EL   R    G +
Sbjct: 181  EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  +  FGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-----FRAEMEVLSGNGFGWPHPNL 867
            IG+G +G VY+     G   A+KK++   LE E E        E+ +L        H N+
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE----LKHSNI 62
Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
            V LY         +LV+E+++    + +                + +   + + H     
Sbjct: 63   VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQA 986
             ++HRD+K  N+L+++EG+  + DFGLAR         +  +  T+ Y AP+    + + 
Sbjct: 120  RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEEC 1015
            +T  D++S G +  E+  G     G  E 
Sbjct: 179  STTIDIWSVGCIFAEMVNGTPLFPGVSEA 207

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGF 860
            +  F    ++G+G +G V      P G  VA+KK++   + L   R  R E+++L     
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKH--- 65
Query: 861  GWPHPNLVTLYGW----CLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             + H N++T++        +   ++ + + +    L  +IS            I     R
Sbjct: 66   -FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLR 123
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV--SAGDSHVS-------T 967
            A+  LH      ++HRD+K SN+L++      V DFGLAR++  SA D+          T
Sbjct: 124  AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 968  TIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
                T  Y APE   T    ++  DV+S G +  EL   R    G +
Sbjct: 181  EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + D GLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH----MKHENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPE- 979
                 I+HRD+K SN+ ++++ +  + DFGLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 980  ------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                  Y QT       D++S G +  EL TGR    G + 
Sbjct: 194  MLNAMHYNQT------VDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + D GLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            ++GKG FG V +       +E AVK + +   + +       E+E+L        HPN++
Sbjct: 29   MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK----LDHPNIM 84
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             L+    D S   +V E   GG L D I             I   V   + ++H      
Sbjct: 85   KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 929  IVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TW 984
            IVHRD+K  N+LL+ + K     + DFGL+      ++ +   I GT  Y+APE  + T+
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLRGTY 199
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                K DV+S GV+   L +G     G  E
Sbjct: 200  DE--KCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 23   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 80
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 81   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D +         
Sbjct: 139  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            V ++APE  +    TT  D++SFGV+  E+ +
Sbjct: 196  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 37/231 (16%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+    F E  ++G+G FG V +     D R  A+KK+ R   E      +E+ +L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS-- 58
Query: 860  FGWPHPNLVTLYGWCLD-------------GSEKILVYEYMEGGSLEDII-SXXXXXXXX 905
                H  +V  Y   L+              S   +  EY E  +L D+I S        
Sbjct: 59   --LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA----- 960
                +   +  AL ++H +    I+HRD+K  N+ +D+     + DFGLA+ V       
Sbjct: 117  EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 961  --------GDSHVSTTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAMEL 1002
                    G S   T+  GT  YVA E    T     K D+YS G++  E+
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 158  HSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            ++GKG FG V +       +E AVK + +   + +       E+E+L        HPN++
Sbjct: 29   MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK----LDHPNIM 84
Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPP 928
             L+    D S   +V E   GG L D I             I   V   + ++H      
Sbjct: 85   KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 929  IVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TW 984
            IVHRD+K  N+LL+ + K     + DFGL+      ++ +   I GT  Y+APE  + T+
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYIAPEVLRGTY 199
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEE 1014
                K DV+S GV+   L +G     G  E
Sbjct: 200  DE--KCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 116/306 (37%), Gaps = 46/306 (15%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 23   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 83   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 140  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
                 V    A   + ++APE       T + DV+SFGVL  E+ +   +   G +   E
Sbjct: 200  KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            + RR+    R        P                E+ +  + C    P+ RP   E++ 
Sbjct: 260  FCRRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 1079 MLIKIL 1084
             L  +L
Sbjct: 304  HLGNLL 309

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE-----FRAEMEVLSGNGFGWPHPNL 867
            IG+G +G VY+     G   A+KK++   LE E E        E+ +L        H N+
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE----LKHSNI 62
Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYP 927
            V LY         +LV+E+++    + +                + +   + + H     
Sbjct: 63   VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQA 986
             ++HRD+K  N+L+++EG+  + DFGLAR         +  +  T+ Y AP+    + + 
Sbjct: 120  RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEEC 1015
            +T  D++S G +  E+  G     G  E 
Sbjct: 179  STTIDIWSVGCIFAEMVNGAPLFPGVSEA 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGR---EVAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHP 865
            R +G G +G+V      D R   +VAVKKL R  + L   R    E+ +L        H 
Sbjct: 34   RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH----LKHE 87
Query: 866  NLVTLYGWCL------DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALV 919
            N++ L           D SE  LV   M G  L +I+             +   + R L 
Sbjct: 88   NVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLV-YQLLRGLK 145
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            ++H      I+HRD+K SNV ++++ +  + DFGLAR     D  ++  +A T  Y APE
Sbjct: 146  YIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVA-TRWYRAPE 198
Query: 980  YGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
                W    +  D++S G +  EL  G+    G +   ++  +R+M
Sbjct: 199  IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD--YIDQLKRIM 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/229 (22%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F E  +IG GGFG V++     DG+   +++++    + ERE +A  ++         H 
Sbjct: 14   FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKL--------DHV 65
Query: 866  NLVTLYGWCLDGSEK------------------------------ILVYEYMEGGSLEDI 895
            N+V  Y  C DG +                                +  E+ + G+LE  
Sbjct: 66   NIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 896  ISXXXXXXXXXXXXIAI--DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG 953
            I             + +   + + + ++H +    ++HRD+K SN+ L    +  + DFG
Sbjct: 125  IEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 954  LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            L  V S  +    T   GT+ Y++PE   +     + D+Y+ G++  EL
Sbjct: 182  L--VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 23   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 80
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 81   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA-GT 972
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D           
Sbjct: 139  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            V ++APE  +    TT  D++SFGV+  E+ +
Sbjct: 196  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 14   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 74   ILIHIGH---HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 131  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                 V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 191  KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT  Y+AP   
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            F  +  +G+G    VYR      ++    K+ ++ ++ ++  R E+ VL        HPN
Sbjct: 55   FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVL----LRLSHPN 109
Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            ++ L       +E  LV E + GG L D I                 +  A+ +LH    
Sbjct: 110  IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG- 168
Query: 927  PPIVHRDVKASNVLLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
              IVHRD+K  N+L      +    + DFGL+++V      +  T+ GT GY APE  + 
Sbjct: 169  --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRG 224
Query: 984  WQATTKGDVYSFGVLAMELATG 1005
                 + D++S G++   L  G
Sbjct: 225  CAYGPEVDMWSVGIITYILLCG 246

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 22   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 79
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 80   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D +         
Sbjct: 138  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            V ++APE  +    TT  D++SFGV+  E+ +
Sbjct: 195  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 20   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 77
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 78   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA-GT 972
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +   D           
Sbjct: 136  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
            V ++APE  +    TT  D++SFGV+  E+ +
Sbjct: 193  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 811  RIIGKGGFGTVYRGVLPDGR---EVAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHP 865
            R +G G +G+V      D R   +VAVKKL R  + L   R    E+ +L        H 
Sbjct: 26   RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH----LKHE 79
Query: 866  NLVTLYGWCL------DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALV 919
            N++ L           D SE  LV   M G  L +I+             +   + R L 
Sbjct: 80   NVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLV-YQLLRGLK 137
Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            ++H      I+HRD+K SNV ++++ +  + DFGLAR     D  ++  +A T  Y APE
Sbjct: 138  YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYVA-TRWYRAPE 190
Query: 980  YGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
                W    +  D++S G +  EL  G+    G +   ++  +R+M
Sbjct: 191  IMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD--YIDQLKRIM 234

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 35/260 (13%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK----KLQREGLEGEREFRAEMEVL 855
            L+   K+   R IG G FG +Y G  +  G EVA+K    K +   L  E +F   M+  
Sbjct: 5    LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ-- 62
Query: 856  SGNGFGWPHPNLVTLYGWC-LDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID- 913
               G G P         WC  +G   ++V E + G SLED+ +            +  D 
Sbjct: 63   --GGVGIPSIK------WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQ 113
Query: 914  VARALVFLHHECYPPIVHRDVKASNVL--LDKEGK-ALVTDFGLARVVSAGDSHV----- 965
            +   + ++H + +   +HRDVK  N L  L K+G    + DFGLA+      +H      
Sbjct: 114  MISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
Query: 966  -STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024
             +  + GT  Y +       + + + D+ S G + M    G    +G     ++   +  
Sbjct: 171  ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG-----LKAATKRQ 225
Query: 1025 GYGRHGPGRAVIPVVLLGSG 1044
             Y R    +   P+ +L  G
Sbjct: 226  KYERISEKKMSTPIEVLCKG 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 806  KFSEDRI-----IGKGGFGTVYRG------VLPDGREVAVKKLQREGLEGE-REFRAEME 853
            +F  DR+     +G+G FG V              R VAVK L+      E R   +E++
Sbjct: 14   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 73
Query: 854  VLSGNGFGWPHPNLVTLYGWCLD-GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            +L   G    H N+V L G C   G   +++ E+ + G+L   +                
Sbjct: 74   ILIHIGH---HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 913  DVARALVFLHHECYP-------------PIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                 L   H  CY                +HRD+ A N+LL ++    + DFGLAR + 
Sbjct: 131  LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 960  AGDSHVSTTIAG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                 V    A   + ++APE       T + DV+SFGVL  E+
Sbjct: 191  KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            +G G +G+V        G  VAVKKL R     +  +R +R E+ +L        H N++
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK----HENVI 84
Query: 869  TLY-----GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
             L         L+    + +  ++ G  L +I+             I   + R L ++H 
Sbjct: 85   GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEY 980
                 I+HRD+K SN+ ++++ +  + D GLAR       H    + G V    Y APE 
Sbjct: 144  ---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEMTGYVATRWYRAPEI 193
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
               W    +  D++S G +  EL TGR    G + 
Sbjct: 194  MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 228

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++ LY +  D     LV E   GG L D I             I   V     +LH 
Sbjct: 80   HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 139
Query: 924  ECYPPIVHRDVKASNVLLDKEGK-AL--VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
                 IVHRD+K  N+LL+ + + AL  + DFGL+     G         GT  Y+APE 
Sbjct: 140  H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEV 194
Query: 981  GQTWQATTKGDVYSFGVLAMELATG 1005
             +  +   K DV+S GV+   L  G
Sbjct: 195  LRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 48/291 (16%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 23   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 80
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 81   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            +A  + +L+ + +   VHR++ A N ++  +    + DFG+ R +   D +         
Sbjct: 139  IADGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++APE  +    TT  D++SFGV+  E+ +           L E   + +        
Sbjct: 196  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQPYQGLS------N 238
Query: 1033 RAVIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
              V+  V+ G  L +     E +++L+R+   C    PN RP   E++ +L
Sbjct: 239  EQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 286

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA------EMEVLSGN 858
            K+    ++G+G +G V +    D GR VA+KK     LE + +         E+++L   
Sbjct: 26   KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQ- 80
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 H NLV L   C       LV+E+++   L+D+                  +   +
Sbjct: 81   ---LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             F H      I+HRD+K  N+L+ + G   + DFG AR ++A        +A T  Y AP
Sbjct: 138  GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAP 193
Query: 979  E-------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            E       YG+        DV++ G L  E+  G     G  +
Sbjct: 194  ELLVGDVKYGKAV------DVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 48/291 (16%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 24   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 81
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 82   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-T 972
            +A  + +L+ + +   VHR++ A N ++  +    + DFG+ R +   D +         
Sbjct: 140  IADGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            V ++APE  +    TT  D++SFGV+  E+ +           L E   + +        
Sbjct: 197  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQPYQGLS------N 239
Query: 1033 RAVIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
              V+  V+ G  L +     E +++L+R+   C    PN RP   E++ +L
Sbjct: 240  EQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLL 287

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 19/192 (9%)
Query: 827  PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
            P G  V V+++  E    E     + E+     F   HPN+V      +  +E  +V  +
Sbjct: 50   PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTSF 107
Query: 887  MEGGSLEDIISXXXX--XXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE 944
            M  GS +D+I               I   V +AL ++HH  Y   VHR VKAS++L+  +
Sbjct: 108  MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVD 164
Query: 945  GK----------ALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYS 994
            GK          ++++     RVV     +    +      V  +  Q + A  K D+YS
Sbjct: 165  GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA--KSDIYS 222
Query: 995  FGVLAMELATGR 1006
             G+ A ELA G 
Sbjct: 223  VGITACELANGH 234

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+D +  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 210

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 19/192 (9%)
Query: 827  PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEY 886
            P G  V V+++  E    E     + E+     F   HPN+V      +  +E  +V  +
Sbjct: 34   PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTSF 91
Query: 887  MEGGSLEDIISXXXX--XXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE 944
            M  GS +D+I               I   V +AL ++HH  Y   VHR VKAS++L+  +
Sbjct: 92   MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVD 148
Query: 945  GK----------ALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYS 994
            GK          ++++     RVV     +    +      V  +  Q + A  K D+YS
Sbjct: 149  GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA--KSDIYS 206
Query: 995  FGVLAMELATGR 1006
             G+ A ELA G 
Sbjct: 207  VGITACELANGH 218

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   + +G G FG V      + G   A+K L ++ +   ++      E  +L    F 
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +              A  +     +L
Sbjct: 101  ---PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+ V       +  + GT   +APE  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEII 210
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            K+TG     + I K    +  RGV             RE +E E     E++        
Sbjct: 33   KSTGLQYAAKFIKKRRTKSSRRGV------------SREDIEREVSILKEIQ-------- 72
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              HPN++TL+    + ++ IL+ E + GG L D ++                +   + +L
Sbjct: 73   --HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 922  HHECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            H      I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VA
Sbjct: 131  HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAFVA 185
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATG 1005
            PE         + D++S GV+   L +G
Sbjct: 186  PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P L  L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 102  ---PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRA---EMEVLSGNGFG 861
            +F   R +G G FG V      + G   A+K L ++ +   ++      E  +     F 
Sbjct: 43   QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P LV L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 102  ---PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   V DFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 7    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 61
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+D +  S                + + 
Sbjct: 62   ---NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 118  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 174  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 209

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++ LY +  D     LV E   GG L D I             I   V     +LH 
Sbjct: 63   HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 122
Query: 924  ECYPPIVHRDVKASNVLLDKEGK-AL--VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
                 IVHRD+K  N+LL+ + + AL  + DFGL+     G         GT  Y+APE 
Sbjct: 123  H---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEV 177
Query: 981  GQTWQATTKGDVYSFGVLAMELATG 1005
             +  +   K DV+S GV+   L  G
Sbjct: 178  LRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+D +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 806  KFSEDRIIGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGEREFR---AEMEVLSGNGFG 861
            +F   + +G G FG V     +  G   A+K L ++ +   ++      E  +L    F 
Sbjct: 43   QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 101
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
               P L  L     D S   +V EY  GG +   +              A  +     +L
Sbjct: 102  ---PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL 158
Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+++D++G   VTDFG A+ V       +  + GT  Y+APE  
Sbjct: 159  HSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 982  QTWQATTKGDVYSFGVLAMELATG 1005
             +       D ++ GVL  E+A G
Sbjct: 212  LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 28/244 (11%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQRE-GLEGEREFRAEME 853
            ++S   +   +  ED ++G+G    V   + L   +E AVK ++++ G    R FR    
Sbjct: 5    SFSGRFEDVYQLQED-VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID 913
            +    G    H N++ L  +  +     LV+E M GGS+   I             +  D
Sbjct: 64   LYQCQG----HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD 119
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSA-GD-SHVST- 967
            VA AL FLH++    I HRD+K  N+L +   +     + DFGL   +   GD S +ST 
Sbjct: 120  VASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 968  ---TIAGTVGYVAPEYGQTWQATT-----KGDVYSFGVLAMELATGRRALEG--GEECLV 1017
               T  G+  Y+APE  + +         + D++S GV+   L +G     G  G +C  
Sbjct: 177  ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC-- 234
Query: 1018 EWGR 1021
             W R
Sbjct: 235  GWDR 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 20/225 (8%)
Query: 793  TAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEM 852
            + + Y DIL+          +G G FG V+R V      V V K        ++ +  + 
Sbjct: 48   SVYDYYDILEE---------LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKN 97
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAI 912
            E+   N     HP L+ L+    D  E +L+ E++ GG L D I+              I
Sbjct: 98   EISIMNQLH--HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VI 152
Query: 913  DVAR-ALVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  R A   L H     IVH D+K  N++ +  K     + DFGLA  ++  D  V  T 
Sbjct: 153  NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTT 211
Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            A T  + APE           D+++ GVL   L +G     G ++
Sbjct: 212  A-TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 33/235 (14%)
Query: 785  VKVIRLDKTAFTYSDILKATGK--FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL 842
            +K +RL +  F   +ILK  G+  FSE  ++     G VY          A+K + +  +
Sbjct: 53   LKEVRLQRDDF---EILKVIGRGAFSEVAVVKMKQTGQVY----------AMKIMNKWDM 99
Query: 843  EGERE---FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXX 899
                E   FR E +VL      W    +  L+    D +   LV EY  GG L  ++S  
Sbjct: 100  LKRGEVSCFREERDVLVNGDRRW----ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF 155
Query: 900  XXXXXXXXXXIAI-DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
                        + ++  A+  +H   Y   VHRD+K  N+LLD+ G   + DFG    +
Sbjct: 156  GERIPAEMARFYLAEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQT-------WQATTKGDVYSFGVLAMELATGR 1006
             A  +  S    GT  Y++PE  Q             + D ++ GV A E+  G+
Sbjct: 213  RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 44   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 104  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 162
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 163  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 217
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 218  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 43   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 103  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 161
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 162  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 216
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 217  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 58   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 118  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 176
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 177  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 231
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 232  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 264

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 44   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 104  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 162
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 163  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 217
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 218  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 43   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 103  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 161
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 162  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 216
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 217  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 804  TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKK--LQREGLEGEREFRAEMEVLSGNGFG 861
            +GKF+  +   +   G  Y       R     +  + RE +E E     E++        
Sbjct: 21   SGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-------- 72
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              HPN++TL+    + ++ IL+ E + GG L D ++                +   + +L
Sbjct: 73   --HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 922  HHECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            H      I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VA
Sbjct: 131  HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVA 185
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATG 1005
            PE         + D++S GV+   L +G
Sbjct: 186  PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 44   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 104  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 162
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 163  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 217
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 218  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 43   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 103  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 161
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 162  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 216
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 217  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 44   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 104  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 162
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 163  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 217
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 218  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 58   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 118  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 176
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 177  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 231
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 232  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 264

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 43   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 103  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 161
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 162  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 216
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 217  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 16   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 76   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 134
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 135  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 189
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 190  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 12   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 66
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 67   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 123  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 179  PEILLGXKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREG-----LEGEREFR----AEMEVLS 856
            +    I+G+G    V R +  P  +E AVK +   G      E  +E R     E+++L 
Sbjct: 19   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HPN++ L       +   LV++ M+ G L D ++            I   +  
Sbjct: 79   KVS---GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             +  LH      IVHRD+K  N+LLD +    +TDFG +  +  G+   S  + GT  Y+
Sbjct: 136  VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYL 190
Query: 977  APE------------YGQTWQATTKGDVYSFGVLAMELATG 1005
            APE            YG+      + D++S GV+   L  G
Sbjct: 191  APEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAG 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 10/139 (7%)
Query: 864 HPNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
           HPN+V L     D +E    +V+E +  G + ++ +               D+ + + +L
Sbjct: 95  HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ-DLIKGIEYL 153
Query: 922 HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
           H   Y  I+HRD+K SN+L+ ++G   + DFG++      D+ +S T+ GT  ++APE  
Sbjct: 154 H---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESL 209
Query: 982 QTWQATTKG---DVYSFGV 997
              +    G   DV++ GV
Sbjct: 210 SETRKIFSGKALDVWAMGV 228

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 30   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 90   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 148
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 149  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 203
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 204  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 236

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+  
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXG 130
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 131  ---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 184
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 185  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 129
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 130  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 184
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 185  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 63   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 123  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 181
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 182  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 236
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 237  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 269

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGXKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 30   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 90   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 148
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 149  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 203
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 204  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 236

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            K+TG     + I K    +  RGV             RE +E E     E++        
Sbjct: 33   KSTGLQYAAKFIKKRRTKSSRRGV------------SREDIEREVSILKEIQ-------- 72
Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFL 921
              HPN++TL+    + ++ IL+ E + GG L D ++                +   + +L
Sbjct: 73   --HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 922  HHECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            H      I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VA
Sbjct: 131  HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVA 185
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATG 1005
            PE         + D++S GV+   L +G
Sbjct: 186  PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 16   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 76   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 134
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 135  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 189
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 190  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 15   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 75   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 133
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 134  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 188
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 189  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 221

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 31   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 91   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 149
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 150  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 204
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 205  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 50   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 110  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 168
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 169  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 223
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 224  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 256

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 31   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 91   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 149
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 150  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 204
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 205  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREG-----LEGEREFR----AEMEVLS 856
            +    I+G+G    V R +  P  +E AVK +   G      E  +E R     E+++L 
Sbjct: 6    YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HPN++ L       +   LV++ M+ G L D ++            I   +  
Sbjct: 66   KVS---GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 122
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             +  LH      IVHRD+K  N+LLD +    +TDFG +  +  G+      + GT  Y+
Sbjct: 123  VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 177
Query: 977  APE------------YGQTWQATTKGDVYSFGVLAMELATG 1005
            APE            YG+      + D++S GV+   L  G
Sbjct: 178  APEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAG 212

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 129
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 130  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 184
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 185  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 811  RIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY G   D         VAVK +       ER EF  E  V+   GF   
Sbjct: 23   RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM--KGFTCH 80
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX----------XXXXXIAID 913
            H  +V L G    G   ++V E M  G L+  +                       +A +
Sbjct: 81   H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-- 971
            +A  + +L+ + +   VHRD+ A N ++  +    + DFG+ R +    ++      G  
Sbjct: 139  IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TAYYRKGGKGLL 194
Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
             V ++APE  +    TT  D++SFGV+  E+ +
Sbjct: 195  PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+    F E  ++G+G FG V +     D R  A+KK+ R   E      +E+ +L+   
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS-- 58
Query: 860  FGWPHPNLVTLYGWCLD-------------GSEKILVYEYMEGGSLEDII-SXXXXXXXX 905
                H  +V  Y   L+              S   +  EY E  +L D+I S        
Sbjct: 59   --LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 906  XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA----- 960
                +   +  AL ++H +    I+HR++K  N+ +D+     + DFGLA+ V       
Sbjct: 117  EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 961  --------GDSHVSTTIAGTVGYVAPEY-GQTWQATTKGDVYSFGVLAME 1001
                    G S   T+  GT  YVA E    T     K D YS G++  E
Sbjct: 174  KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 31   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 91   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 149
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 150  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 204
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 205  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 14   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 74   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 132
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 133  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 187
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 188  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 38   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 98   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 156
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 157  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 211
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 212  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 244

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 12   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 66
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 67   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 123  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 179  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 214

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPN 866
            ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+           
Sbjct: 16   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 867  LVTLYGWCLDGSEKILVYEYMEG-GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHEC 925
            ++ L  W       +L+ E  E    L D I+                V  A+   H+ C
Sbjct: 76   VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 134
Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
               ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  PE+ +  
Sbjct: 135  --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 189
Query: 985  QATTK-GDVYSFGVLAMELATGRRALEGGEECL 1016
            +   +   V+S G+L  ++  G    E  EE +
Sbjct: 190  RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 132  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 187  IVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +GKG F  V R V +  G+E A   +  + L      + E E          HPN+V L+
Sbjct: 19   LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL--KHPNIVRLH 76
Query: 872  GWCLDGSEKILVYEYMEGGSL-EDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIV 930
                +     L+++ + GG L EDI++            I   +  A++  H      +V
Sbjct: 77   DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCHQM---GVV 132
Query: 931  HRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQAT 987
            HR++K  N+LL  + K     + DFGLA  V  G+       AGT GY++PE  +     
Sbjct: 133  HRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDPYG 191
Query: 988  TKGDVYSFGVLAMELATG 1005
               D+++ GV+   L  G
Sbjct: 192  KPVDLWACGVILYILLVG 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 60
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 61   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 117  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 172
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 173  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 132  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 187  IVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 115  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 171  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 115  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 171  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREG-----LEGEREFR----AEMEVLS 856
            +    I+G+G    V R +  P  +E AVK +   G      E  +E R     E+++L 
Sbjct: 19   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
                   HPN++ L       +   LV++ M+ G L D ++            I   +  
Sbjct: 79   KVS---GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             +  LH      IVHRD+K  N+LLD +    +TDFG +  +  G+      + GT  Y+
Sbjct: 136  VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 190
Query: 977  APE------------YGQTWQATTKGDVYSFGVLAMELATG 1005
            APE            YG+      + D++S GV+   L  G
Sbjct: 191  APEIIECSMNDNHPGYGK------EVDMWSTGVIMYTLLAG 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 9    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 63
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 64   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 120  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 175
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 176  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 211

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 12/225 (5%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K+ +   IG+G +GTV++    +  E VA+K+++ +  +      A  E+         H
Sbjct: 3    KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--H 60
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
             N+V L+       +  LV+E+ +    +   S                + + L F H  
Sbjct: 61   KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                ++HRD+K  N+L+++ G+  + DFGLAR         S  +  T+ Y  P+  +G 
Sbjct: 121  ---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR--RVMG 1025
               +T+  D++S G +  ELA   R L  G +   +  R  R++G
Sbjct: 177  KLYSTS-IDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLG 220

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 9    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 63
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 64   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 120  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 175
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 176  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 211

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEY--MEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E+  M+     D  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 210

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 7    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 61
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 62   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 118  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 174  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 116  LSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 7    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 61
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 62   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 118  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 174  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 210

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 60
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEY--MEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E+  M+     D  S                + + 
Sbjct: 61   ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQG 116
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 117  LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 173  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 208

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 199 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 311

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 115  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 171  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 213 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 271
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 272 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 325

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 799  DILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQ----REGLEG-EREFRAEM 852
            D+     ++ +   +G+G F TVY+    +  + VA+KK++     E  +G  R    E+
Sbjct: 4    DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXX-XXXXXIA 911
            ++L        HPN++ L       S   LV+++ME   LE II                
Sbjct: 64   KLLQE----LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            +   + L +LH      I+HRD+K +N+LLD+ G   + DFGLA+   + +      +  
Sbjct: 119  LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV- 174
Query: 972  TVGYVAPEYGQTWQATTKG---DVYSFGVLAMEL 1002
            T  Y APE    + A   G   D+++ G +  EL
Sbjct: 175  TRWYRAPEL--LFGARMYGVGVDMWAVGCILAEL 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 60
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 61   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 117  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 173  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 115  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 171  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + LV + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLVGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S GV+  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGVIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 60
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 61   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 117  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 173  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 7    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 61
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 62   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 118  LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 174  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 60
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 61   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 117  LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 173  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            HPN++TL+    + ++ IL+ E + GG L D ++                +   + +LH 
Sbjct: 73   HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 924  ECYPPIVHRDVKASNV-LLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                 I H D+K  N+ LLD+   + +  + DFGLA  +  G+      I GT  +VAPE
Sbjct: 133  ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 188  IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + LV + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLVGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S GV+  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGVIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYE--------YMEGGSLEDIISXXXXXXXXXXXXIA 911
                HPN+V L       ++  LV+E        +M+  +L  I                
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGI-------PLPLIKSYL 108
Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
              + + L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  
Sbjct: 109  FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 164
Query: 972  TVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            T+ Y APE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 165  TLWYRAPEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 28/244 (11%)
Query: 796  TYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQRE-GLEGEREFRAEME 853
            ++S   +   +  ED ++G+G    V   + L   +E AVK ++++ G    R FR    
Sbjct: 5    SFSGRFEDVYQLQED-VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63
Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID 913
            +    G    H N++ L  +  +     LV+E M GGS+   I             +  D
Sbjct: 64   LYQCQG----HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD 119
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVVSA-GD-SHVST- 967
            VA AL FLH++    I HRD+K  N+L +   +     + DF L   +   GD S +ST 
Sbjct: 120  VASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 968  ---TIAGTVGYVAPEYGQTWQATT-----KGDVYSFGVLAMELATGRRALEG--GEECLV 1017
               T  G+  Y+APE  + +         + D++S GV+   L +G     G  G +C  
Sbjct: 177  ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC-- 234
Query: 1018 EWGR 1021
             W R
Sbjct: 235  GWDR 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 40/199 (20%)
Query: 828 DGREVAVKKLQREGLEGEREF-----------------RAEMEVLSG--NGFGWPHPNLV 868
           D +  A+KK ++  LE +R+F                 + E+++++   N +      ++
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 869 TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALV--------F 920
           T Y       E  ++YEYME  S+                 I I V + ++        +
Sbjct: 113 TNY------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166
Query: 921 LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
           +H+E    I HRDVK SN+L+DK G+  ++DFG +  +   D  +  +  GT  ++ PE+
Sbjct: 167 IHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGS-RGTYEFMPPEF 221
Query: 981 --GQTWQATTKGDVYSFGV 997
              ++     K D++S G+
Sbjct: 222 FSNESSYNGAKVDIWSLGI 240

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGF 860
            +++    IG+G +G V   Y  V  +   VA+KK+         +R  R E+++L     
Sbjct: 44   RYTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKIL----L 96
Query: 861  GWPHPNLV----TLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             + H N++     +    ++  + + +  ++ G  L  ++             +   + R
Sbjct: 97   RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL-YQILR 155
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAGTVG 974
             L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    T  
Sbjct: 156  GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 975  YVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 213  YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 73  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 131
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 132 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 185

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+KK+    + EG+     RE     E+     
Sbjct: 8    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL----- 62
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E+++   L+  +  S                + + 
Sbjct: 63   ---NHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR            +  T+ Y A
Sbjct: 119  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 175  PEILLGCKYYSTAV-DIWSLGCIFAEMVT-RRALFPGD 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 186

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 186

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 135  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 192  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 133 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 186

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 9/119 (7%)
Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
           HP ++ +  +  D  +  +V E MEGG L D +                 +  A+ +LH 
Sbjct: 80  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 138
Query: 924 ECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                I+HRD+K  NVLL  + +     +TDFG ++++  G++ +  T+ GT  Y+APE
Sbjct: 139 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPE 192

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 137  ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 137  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 137  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 138  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 195  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 139  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 196  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 130  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 187  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 137  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 133  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 190  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 137  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 131  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 188  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 131  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 188  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 133  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 190  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 133  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 190  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 20/182 (10%)
Query: 807 FSEDRIIGKGGFGT-VYRGVLPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPH 864
           F    ++G G  GT VYRG+  D R+VAVK++  E     +RE +   E          H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRE-------SDEH 77
Query: 865 PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
           PN++  +    D   + +  E       E +              +       L  LH  
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-- 135
Query: 925 CYPPIVHRDVKASNVLLDKEG-----KALVTDFGLARVVSAGDSHVS--TTIAGTVGYVA 977
               IVHRD+K  N+L+         KA+++DFGL + ++ G    S  + + GT G++A
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 978 PE 979
           PE
Sbjct: 195 PE 196

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 141  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 198  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 133  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 190  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 133  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 190  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 135  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 192  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 153  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 210  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 135  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 192  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+ K+    + EG+     RE     E+     
Sbjct: 5    FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL----- 59
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 60   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 116  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 172  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKL----QREGLEGE--REFRAEMEVLSGNG 859
            F +   IG+G +G VY+      G  VA+ K+    + EG+     RE     E+     
Sbjct: 4    FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL----- 58
Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SXXXXXXXXXXXXIAIDVARA 917
                HPN+V L       ++  LV+E++    L+  +  S                + + 
Sbjct: 59   ---NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L F H      ++HRD+K  N+L++ EG   + DFGLAR         +  +  T+ Y A
Sbjct: 115  LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            PE   G  + +T   D++S G +  E+ T RRAL  G+
Sbjct: 171  PEILLGCKYYSTA-VDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEV-LSGNGFGWPHPNLVTL 870
            +G+G +G V +   +P G+  AVK++ R  +  + + R   ++ +S      P    VT 
Sbjct: 42   LGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQKRLLXDLDISXRTVDCPFT--VTF 98
Query: 871  YGWCLDGSEKILVYEYMEGGSLE----DIISXXXXXXXXXXXXIAIDVARALVFLHHECY 926
            YG      +  +  E +   SL+     +I             IA+ + +AL  LH +  
Sbjct: 99   YGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 156
Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA-----PEYG 981
              ++HRDVK SNVL++  G+    DFG++  +   D       AG   Y A     PE  
Sbjct: 157  -SVIHRDVKPSNVLINALGQVKXCDFGISGYLV--DDVAKDIDAGCKPYXAPERINPELN 213
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            Q    + K D++S G+  +ELA  R
Sbjct: 214  QK-GYSVKSDIWSLGITXIELAILR 237

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 27/256 (10%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+   ++   R IG G FG +Y G  +  G EVA+K    +    +    +++  +   G
Sbjct: 5    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 860  FGWPHPNLVTLYGWC-LDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID-VARA 917
             G P         WC  +G   ++V E + G SLED+ +            +  D +   
Sbjct: 65   VGIPTIR------WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 918  LVFLHHECYPPIVHRDVKASNVL--LDKEGK-ALVTDFGLARVVSAGDSHV------STT 968
            + ++H + +   +HRDVK  N L  L K+G    + DFGLA+      +H       +  
Sbjct: 118  IEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 969  IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028
            + GT  Y +       + + + D+ S G + M    G    +G     ++   +   Y R
Sbjct: 175  LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG-----LKAATKRQKYER 229
Query: 1029 HGPGRAVIPVVLLGSG 1044
                +   P+ +L  G
Sbjct: 230  ISEKKMSTPIEVLCKG 245

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 10/174 (5%)
Query: 102 LTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN-ILSGDLNLSGLRSLEILDLSV 158
           L  L +LDLSRN  +F G          SLKYL+LS N +++   N  GL  LE LD   
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405
Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN----I 214
           + +     FS       L+  ++S  +     +  F+G  +L  L ++ N+F+ N    I
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 215 WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF--IGDFPGEVSN 266
           +  L  L    +S+  L   +S + F    SL++ ++S N F  +  FP +  N
Sbjct: 466 FTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 62/140 (44%), Gaps = 1/140 (0%)
Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
            L+L  L  LD+S  +       IF   + +++L +  NS+ +        +L N++ LD
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP 431
           LS        P   + + SL+ L ++HN F       Y  + +LQ LD S N +      
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 432 SIGNL-TSLLWLMLANNSLS 450
            + +  +SL +L L  N  +
Sbjct: 537 ELQHFPSSLAFLNLTQNDFA 556

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 807  FSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F + R++G+GGFG V+   +   G+  A KKL ++ L+  + ++  M  +        H 
Sbjct: 187  FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM--VEKKILAKVHS 244
Query: 866  NLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHH 923
              +    +  +    + LV   M GG +   I              AI   A+ +  L H
Sbjct: 245  RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YG 981
                 I++RD+K  NVLLD +G   ++D GLA  + AG +  +   AGT G++APE   G
Sbjct: 305  LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            + +  +   D ++ GV   E+   R
Sbjct: 364  EEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 27/256 (10%)
Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+   ++   R IG G FG +Y G  +  G EVA+K    +    +    +++  +   G
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 62
Query: 860  FGWPHPNLVTLYGWC-LDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID-VARA 917
             G P         WC  +G   ++V E + G SLED+ +            +  D +   
Sbjct: 63   VGIPTIR------WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 918  LVFLHHECYPPIVHRDVKASNVL--LDKEGK-ALVTDFGLARVVSAGDSHV------STT 968
            + ++H + +   +HRDVK  N L  L K+G    + DFGLA+      +H       +  
Sbjct: 116  IEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 969  IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028
            + GT  Y +       + + + D+ S G + M    G    +G     ++   +   Y R
Sbjct: 173  LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG-----LKAATKRQKYER 227
Query: 1029 HGPGRAVIPVVLLGSG 1044
                +   P+ +L  G
Sbjct: 228  ISEKKMSTPIEVLCKG 243

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F + R++G+GGFG V+   +   G+  A KKL ++ L+  + ++  M  +        H 
Sbjct: 187  FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM--VEKKILAKVHS 244
Query: 866  NLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHH 923
              +    +  +    + LV   M GG +   I              AI   A+ +  L H
Sbjct: 245  RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YG 981
                 I++RD+K  NVLLD +G   ++D GLA  + AG +  +   AGT G++APE   G
Sbjct: 305  LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            + +  +   D ++ GV   E+   R
Sbjct: 364  EEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F + R++G+GGFG V+   +   G+  A KKL ++ L+  + ++  M  +        H 
Sbjct: 187  FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM--VEKKILAKVHS 244
Query: 866  NLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHH 923
              +    +  +    + LV   M GG +   I              AI   A+ +  L H
Sbjct: 245  RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YG 981
                 I++RD+K  NVLLD +G   ++D GLA  + AG +  +   AGT G++APE   G
Sbjct: 305  LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            + +  +   D ++ GV   E+   R
Sbjct: 364  EEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 807  FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            F + R++G+GGFG V+   +   G+  A KKL ++ L+  + ++  M  +        H 
Sbjct: 187  FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM--VEKKILAKVHS 244
Query: 866  NLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAI-DVARALVFLHH 923
              +    +  +    + LV   M GG +   I              AI   A+ +  L H
Sbjct: 245  RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YG 981
                 I++RD+K  NVLLD +G   ++D GLA  + AG +  +   AGT G++APE   G
Sbjct: 305  LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLG 363
Query: 982  QTWQATTKGDVYSFGVLAMELATGR 1006
            + +  +   D ++ GV   E+   R
Sbjct: 364  EEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + LV + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLVGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 12/225 (5%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K+ +   IG+G +GTV++    +  E VA+K+++ +  +      A  E+         H
Sbjct: 3    KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--H 60
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
             N+V L+       +  LV+E+ +    +   S                + + L F H  
Sbjct: 61   KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                ++HRD+K  N+L+++ G+  + +FGLAR         S  +  T+ Y  P+  +G 
Sbjct: 121  ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR--RVMG 1025
               +T+  D++S G +  ELA   R L  G +   +  R  R++G
Sbjct: 177  KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 58/119 (48%), Gaps = 18/119 (15%)
Query: 886  YMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH-HECYPPIVHRDVKASNVLLDKE 944
            Y E  ++ED+IS             +  VAR + FL   +C    +HRD+ A N+LL + 
Sbjct: 192  YKEPITMEDLIS------------YSFQVARGMEFLSSRKC----IHRDLAARNILLSEN 235
Query: 945  GKALVTDFGLARVVSAGDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                + DFGLAR +     +V        + ++APE       +TK DV+S+GVL  E+
Sbjct: 236  NVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 25   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN- 81
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+  +L  +I             ++  + +
Sbjct: 82   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHER-----MSYLLYQ 134
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 135  MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 193  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 18   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 74
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 75   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 127
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 128  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 186  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 239

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 10/174 (5%)
Query: 102 LTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN-ILSGDLNLSGLRSLEILDLSV 158
           L  L +LDLSRN  +F G          SLKYL+LS N +++   N  GL  LE LD   
Sbjct: 370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 429
Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN----I 214
           + +     FS       L+  ++S  +     +  F+G  +L  L ++ N+F+ N    I
Sbjct: 430 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 489
Query: 215 WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF--IGDFPGEVSN 266
           +  L  L    +S+  L   +S + F    SL++ ++S N F  +  FP +  N
Sbjct: 490 FTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 542

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 62/140 (44%), Gaps = 1/140 (0%)
Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
            L+L  L  LD+S  +       IF   + +++L +  NS+ +        +L N++ LD
Sbjct: 441 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500
Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP 431
           LS        P   + + SL+ L ++HN F       Y  + +LQ LD S N +      
Sbjct: 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 560
Query: 432 SIGNL-TSLLWLMLANNSLS 450
            + +  +SL +L L  N  +
Sbjct: 561 ELQHFPSSLAFLNLTQNDFA 580

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 22/228 (9%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  VL   R VA+KKL R         RA  E++        H N+++
Sbjct: 32   IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN--HKNIIS 87
Query: 870  LYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            L         L+  + + LV E M+  +L  +I             ++  + + L  + H
Sbjct: 88   LLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHER-----MSYLLYQMLCGIKH 141
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE    
Sbjct: 142  LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                   D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 200  MGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 18   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 74
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+  +L  +I             ++  + +
Sbjct: 75   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHER-----MSYLLYQ 127
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 128  MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 186  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 239

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 44/277 (15%)
Query: 819  GTVYRGVLPDGREVAVK--KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD 876
            G +++G    G ++ VK  K++       R+F  E   L        HPN++ + G C  
Sbjct: 24   GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS----HPNVLPVLGACQS 78
Query: 877  --GSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI--AIDVARALVFLHHECYPPIVHR 932
                   L+  +M  GSL +++             +  A+D+AR + FL H   P I   
Sbjct: 79   PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL-HTLEPLIPRH 137
Query: 933  DVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV---GYVAPEYGQTWQATT- 988
             + + +V++D++  A          +S  D   S    G +    +VAPE  Q     T 
Sbjct: 138  ALNSRSVMIDEDMTAR---------ISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 989  --KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046
                D++SF VL  EL T  R +   +   +E G +V   G     R  IP      G+ 
Sbjct: 189  RRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKVALEGL----RPTIP-----PGI- 236
Query: 1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
              +  +S+L++I   C  E P  RP    ++ +L K+
Sbjct: 237  --SPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKM 268

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 20/234 (8%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 63   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 119
Query: 863  PHPNLVTLYGWCLDGSEKIL-----VYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
             H N+++L    +   +K L     VY  ME   L D               ++  + + 
Sbjct: 120  -HKNIISLLN--VFTPQKTLEEFQDVYLVME---LMDANLCQVIQMELDHERMSYLLYQM 173
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y A
Sbjct: 174  LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 231
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            PE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 232  PEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 284

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 19   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 75
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 76   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 128
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 129  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 187  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 240

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 19/219 (8%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQ------REGLEGEREFRAEMEVLSGNGFGWPH 864
            +IGKG F  V R +    G++ AVK +         GL  E + + E  +         H
Sbjct: 31   VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHM----LKH 85
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P++V L           +V+E+M+G  L   I             +A    R ++     
Sbjct: 86   PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 925  CYPP-IVHRDVKASNVLL-DKEGKALVT--DFGLARVVSAGDSH-VSTTIAGTVGYVAPE 979
            C+   I+HRDVK  NVLL  KE  A V   DFG+A  +  G+S  V+    GT  ++APE
Sbjct: 146  CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPE 203
Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
              +        DV+  GV+   L +G     G +E L E
Sbjct: 204  VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 24   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 80
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 81   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 133
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 134  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 191
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 192  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 245

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 19   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 75
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 76   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 128
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 129  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 186
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 187  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 240

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 12/200 (6%)
Query: 813  IGKGGFGTVYR-GVLPDGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVT 869
            +G G F  V +      G E A K +++      R    R E+E          HPN++T
Sbjct: 20   LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPI 929
            L+    + ++ +L+ E + GG L D ++                +   + +LH +    I
Sbjct: 80   LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KI 136
Query: 930  VHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
             H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE      
Sbjct: 137  AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEP 194
Query: 986  ATTKGDVYSFGVLAMELATG 1005
               + D++S GV+   L +G
Sbjct: 195  LGLEADMWSIGVITYILLSG 214

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 25   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 81
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 82   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 134
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 135  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 193  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 22/228 (9%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  VL   R VA+KKL R         RA  E++        H N+++
Sbjct: 32   IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN--HKNIIS 87
Query: 870  LYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            L         L+  + + LV E M+    + I              ++  + + L  + H
Sbjct: 88   LLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKH 141
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE    
Sbjct: 142  LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                   D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 200  MGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 10/177 (5%)
Query: 99  FSALTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN-ILSGDLNLSGLRSLEILD 155
           F  LTQL+ L LS N  +F G          SLKYL+LS N +++   N  GL  LE LD
Sbjct: 48  FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLD 107
Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN-- 213
              + +     FS       L+  ++S  +     +  F+G  +L  L ++ N+F+ N  
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 214 --IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF--IGDFPGEVSN 266
             I+  L  L    +S+  L   +S + F    SL++ ++S N F  +  FP +  N
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 33/255 (12%)
Query: 203 LDLSSNNFRG---NIWNGLAQLVEFSVSENVLS--GVVSSSVFKENCSLEIFDLSENEFI 257
           L+L SN  +     +++ L QL + S+S N LS  G  S S F    SL+  DLS N  I
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVI 91
Query: 258 GDFPGEVSNCRXXXXXXXXXXXXSGPIPAEIGSISGLEALFLGKNNFLSVIPESL-LNLS 316
                                     + +    +  LE L    +N   +   S+ L+L 
Sbjct: 92  -------------------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 317 KLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNN 376
            L  LD+S  +       IF   + +++L +  NS+ +        +L N++ LDLS   
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 377 FTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL 436
                P   + + SL+ L ++HN F       Y  + +LQ LD S N +       + + 
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246
Query: 437 -TSLLWLMLANNSLS 450
            +SL +L L  N  +
Sbjct: 247 PSSLAFLNLTQNDFA 261

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 25   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 81
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 82   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 134
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 135  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 193  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 26   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 82
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 83   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 135
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 136  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 194  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 247

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 25   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 81
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+  +L  +I             ++  + +
Sbjct: 82   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHER-----MSYLLYQ 134
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 135  MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 193  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 246

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 63   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 119
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 120  -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 172
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 173  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 231  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 284

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 22/235 (9%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  VL   R VA+KKL R         RA  E++       
Sbjct: 26   RYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 82
Query: 863  PHPNLVTLYG-----WCLDGSEKI-LVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVAR 916
             H N+++L         L+  + + LV E M+    + I              ++  + +
Sbjct: 83   -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQ 135
Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y 
Sbjct: 136  MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            APE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 194  APEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCP 247

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 14/219 (6%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRAEMEVLSGN 858
            I+  + ++   + IG G FG          +E VAVK ++R     E     + E++  N
Sbjct: 15   IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREII--N 69
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN+V      L  +   ++ EY  GG L + I                 +   +
Sbjct: 70   HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 919  VFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             + H      I HRD+K  N LLD     +  + DFG ++  S   S   +T+ GT  Y+
Sbjct: 130  SYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPAYI 184
Query: 977  APEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 185  APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 802  KATGKFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFR--AEMEVLSGN 858
            K   +F  +R+ G+G FGTV  G     G  VA+KK+ ++     RE +   ++ VL   
Sbjct: 20   KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-- 77
Query: 859  GFGWPHPNLVTL--YGWCLDGSEKILVY-----EYMEGG---SLEDIISXXXXXXXXXXX 908
                 HPN+V L  Y + L   ++  +Y     EY+         +              
Sbjct: 78   -----HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 909  XIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVSAGDSHVST 967
                 + R++  LH      + HRD+K  NVL+++ +G   + DFG A+ +S  + +V+ 
Sbjct: 133  VFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
              +    Y APE  +G     TT  D++S G +  E+  G     G
Sbjct: 192  ICSRY--YRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGEPIFRG 234

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 101 ALTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN---ILSGDLNLSGLRSLEILD 155
           AL  LSYLDLSRN  +FSG          SL++L+LS N   I+S   N  GL  L+ LD
Sbjct: 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA--NFMGLEELQHLD 405
Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---- 211
              + +     FS     EKL+  ++S  N     D  F G  +L  L ++ N+F+    
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
            N++     L    +S+  L   +S  VF     L++ ++S N  +
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLL 510

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H         
Sbjct: 137  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 194  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H         
Sbjct: 138  ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 195  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 12/166 (7%)
Query: 101 ALTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN---ILSGDLNLSGLRSLEILD 155
           AL  LSYLDLSRN  +FSG          SL++L+LS N   I+S   N  GL  L+ LD
Sbjct: 343 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA--NFMGLEELQHLD 400
Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---- 211
              + +     FS     EKL+  ++S  N     D  F G  +L  L ++ N+F+    
Sbjct: 401 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 460
Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
            N++     L    +S+  L   +S  VF     L++ ++S N  +
Sbjct: 461 SNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLL 505

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 16/220 (7%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGER-EFRAEMEVLSG 857
            I+  + ++   + IG G FG           E VAVK ++R    GE+ +   + E++  
Sbjct: 13   IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER----GEKIDENVKREII-- 66
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
            N     HPN+V      L  +   +V EY  GG L + I                 +   
Sbjct: 67   NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 126
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + + H      + HRD+K  N LLD     +  + DFG ++  S   S   +T+ GT  Y
Sbjct: 127  VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPAY 181
Query: 976  VAPEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            +APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 182  IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 813  IGKGGFGTVYRGVLPDGR---EVAVKKLQR---EGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G G +G V   V  DGR   +VA+KKL R     L  +R +R E+ +L        H N
Sbjct: 33   VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR----HEN 85
Query: 867  LVTLYGWCL------DGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVF 920
            ++ L           D ++  LV  +M G  L  ++             +   + + L +
Sbjct: 86   VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLV-YQMLKGLRY 143
Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            +H      I+HRD+K  N+ ++++ +  + DFGLAR     DS +   +  T  Y APE 
Sbjct: 144  IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV-TRWYRAPEV 196
Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
               W   T+  D++S G +  E+ TG+   +G +
Sbjct: 197  ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 38/114 (33%), Positives = 52/114 (45%), Gaps = 10/114 (8%)
Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
            D   AL  LH +    +VH DVK +N+ L   G+  + DFGL  +V  G +       G 
Sbjct: 165  DTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGD 219
Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
              Y+APE  Q    T   DV+S G+  +E+A       GGE     W +   GY
Sbjct: 220  PRYMAPELLQGSYGTA-ADVFSLGLTILEVACNMELPHGGE----GWQQLRQGY 268

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPH 864
            F   + +G+GGFG V+      D    A+K+++    E  RE    E++ L+       H
Sbjct: 7    FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK----LEH 62
Query: 865  PNLVTLYGWCLD---------GSEKILVYEYMEGGSLEDIIS------XXXXXXXXXXXX 909
            P +V  +   L+          S K+ +Y  M+    E++                    
Sbjct: 63   PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--- 966
            I + +A A+ FLH +    ++HRD+K SN+    +    V DFGL   +   +   +   
Sbjct: 123  IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 967  --------TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
                    T   GT  Y++PE       + K D++S G++  EL
Sbjct: 180  PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 14/219 (6%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGEREFRAEMEVLSGN 858
            I+  + ++   + IG G FG           E VAVK ++R    GE+   A ++    N
Sbjct: 14   IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER----GEK-IAANVKREIIN 68
Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARAL 918
                 HPN+V      L  +   +V EY  GG L + I                 +   +
Sbjct: 69   HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 919  VFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             + H      + HRD+K  N LLD     +  + DFG ++  S   S   +T+ GT  Y+
Sbjct: 129  SYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPAYI 183
Query: 977  APEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 184  APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + L  + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLCGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 55/232 (23%)
Query: 806  KFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQ-------REGLEGEREFRAEM 852
            +F E+  +G+  FG VY+G L         + VA+K L+       RE    E   RA +
Sbjct: 29   RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 86
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII---------------- 896
            +          HPN+V L G         +++ Y   G L + +                
Sbjct: 87   Q----------HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 897  SXXXXXXXXXXXXIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            +            +   +A  + +L  HH     +VH+D+   NVL+  +    ++D GL
Sbjct: 137  TVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL 191
Query: 955  ARVVSAGDSHVSTTIAGT----VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             R V A D +    + G     + ++APE     + +   D++S+GV+  E+
Sbjct: 192  FREVYAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 6/86 (6%)
Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG---YVAPEYGQTWQAT 987
            HRDVK  N+L+  +  A + DFG+A   SA      T +  TVG   Y APE      AT
Sbjct: 157  HRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYXAPERFSESHAT 213
Query: 988  TKGDVYSFGVLAMELATGRRALEGGE 1013
             + D+Y+   +  E  TG    +G +
Sbjct: 214  YRADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+L++      + DFGLAR+      H    T    
Sbjct: 153  ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 972  TVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEG 1011
            T  Y APE     +  TK  D++S G +  E+ + R    G
Sbjct: 210  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + L  + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLCGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 55/232 (23%)
Query: 806  KFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQ-------REGLEGEREFRAEM 852
            +F E+  +G+  FG VY+G L         + VA+K L+       RE    E   RA +
Sbjct: 12   RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL 69
Query: 853  EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII---------------- 896
            +          HPN+V L G         +++ Y   G L + +                
Sbjct: 70   Q----------HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 897  SXXXXXXXXXXXXIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
            +            +   +A  + +L  HH     +VH+D+   NVL+  +    ++D GL
Sbjct: 120  TVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 955  ARVVSAGDSHVSTTIAGT----VGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
             R V A D +    + G     + ++APE     + +   D++S+GV+  E+
Sbjct: 175  FREVYAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 20/227 (8%)
Query: 813  IGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            IG G  G V   Y  +L   R VA+KKL R         RA  E++        H N++ 
Sbjct: 32   IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIG 87
Query: 870  LYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            L         L+  + + +   +   +L  +I             ++  + + L  + H 
Sbjct: 88   LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER-----MSYLLYQMLCGIKHL 142
Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE     
Sbjct: 143  HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 985  QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
                  D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 201  GYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 8/161 (4%)
Query: 102 LTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN-ILSGDLNLSGLRSLEILDLSV 158
           L  L +LDLSRN  +F G          SLKYL+LS N +++   N  GL  LE LD   
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405
Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN----I 214
           + +     FS       L+  ++S  +     +  F+G  +L  L ++ N+F+ N    I
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 215 WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
           +  L  L    +S+  L   +S + F    SL++ +++ N+
Sbjct: 466 FTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQ 505

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 30/239 (12%)
Query: 790  LDKTAFTYSDILKATGKFSEDRI----IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG 844
            + K  F   D+ K   +  +  +    +G G +G+V   +    G +VA+KKL R     
Sbjct: 23   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 82
Query: 845  EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS------EKILVYEYMEGGSLEDIISX 898
                RA  E+L        H N++ L       S      +  LV  +M+   L+ I+  
Sbjct: 83   IFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM 139
Query: 899  XXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
                       +   + + L ++H      +VHRD+K  N+ ++++ +  + DFGLAR  
Sbjct: 140  EFSEEKIQY--LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-- 192
Query: 959  SAGDSHVSTTIAGTV---GYVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGE 1013
                 H    + G V    Y APE   +W    +  D++S G +  E+ TG+   +G +
Sbjct: 193  -----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 911  AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  VA+ + FL   +C    +HRD+ A N+LL ++    + DFGLAR +     +V    
Sbjct: 204  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 259
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   + ++APE       T + DV+SFGVL  E+
Sbjct: 260  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 911  AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  VA+ + FL   +C    +HRD+ A N+LL ++    + DFGLAR +     +V    
Sbjct: 199  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   + ++APE       T + DV+SFGVL  E+
Sbjct: 255  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLS----GLRSLEILDLSV 158
           +  ++L+ ++N F+ S+    S+ + L+ L L  N L     ++     + SLE LD+S+
Sbjct: 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412
Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG--NIWN 216
           N ++        A  E ++V NLS N LTG +  C      ++ LDL +N          
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMSIPKDVT 470
Query: 217 GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
            L  L E +V+ N L   V   VF    SL+   L +N +    PG
Sbjct: 471 HLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 911  AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  VA+ + FL   +C    +HRD+ A N+LL ++    + DFGLAR +     +V    
Sbjct: 206  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 261
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   + ++APE       T + DV+SFGVL  E+
Sbjct: 262  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 911  AIDVARALVFL-HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            +  VA+ + FL   +C    +HRD+ A N+LL ++    + DFGLAR +     +V    
Sbjct: 197  SFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 252
Query: 970  AG-TVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002
            A   + ++APE       T + DV+SFGVL  E+
Sbjct: 253  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 16/220 (7%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGER-EFRAEMEVLSG 857
            I+  + ++   + IG G FG           E VAVK ++R    GE+ +   + E++  
Sbjct: 14   IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER----GEKIDENVKREII-- 67
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
            N     HPN+V      L  +   +V EY  GG L + I                 +   
Sbjct: 68   NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + + H      + HRD+K  N LLD     +  + DFG ++  S   S   + + GT  Y
Sbjct: 128  VSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSK-ASVLHSQPKSAV-GTPAY 182
Query: 976  VAPEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            +APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 183  IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 32/174 (18%)
Query: 804 TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKL----QREG--LEGEREFRAEMEVLS 856
             K+ +   IG+G FG V++      G++VA+KK+    ++EG  +   RE +  +++L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 75
Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISXXXXXXXX 905
                  H N+V L   C   +           LV+++ E    G L +++         
Sbjct: 76  -------HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 906 XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
               + ++    L ++H      I+HRD+KA+NVL+ ++G   + DFGLAR  S
Sbjct: 129 RVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 59/246 (23%), Positives = 107/246 (43%), Gaps = 38/246 (15%)
Query: 784  TVKVIRLDKTAFTYSDILKATGKFSEDRI----IGKGGFGTVYRGV-LPDGREVAVKKLQ 838
            ++ +IR  K  F   D+ K   +  +  +    +G G +G+V   +    G +VA+KKL 
Sbjct: 1    SLSLIR--KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS 58
Query: 839  R---EGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS------EKILVYEYMEG 889
            R     +  +R +R E+ +L        H N++ L       S      +  LV  +M+ 
Sbjct: 59   RPFQSEIFAKRAYR-ELLLLKH----MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113
Query: 890  GSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV 949
              L+ I+             +   + + L ++H      +VHRD+K  N+ ++++ +  +
Sbjct: 114  -DLQKIMGLKFSEEKIQY--LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKI 167
Query: 950  TDFGLARVVSAGDSHVSTTIAGTV---GYVAPEYGQTWQATTKG-DVYSFGVLAMELATG 1005
             DFGLAR       H    + G V    Y APE   +W    +  D++S G +  E+ TG
Sbjct: 168  LDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 1006 RRALEG 1011
            +   +G
Sbjct: 221  KTLFKG 226

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE         
Sbjct: 147  IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 989  KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
              D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 205  NVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPSP 246

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 32/174 (18%)
Query: 804 TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKL----QREG--LEGEREFRAEMEVLS 856
             K+ +   IG+G FG V++      G++VA+KK+    ++EG  +   RE +  +++L 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 74
Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISXXXXXXXX 905
                  H N+V L   C   +           LV+++ E    G L +++         
Sbjct: 75  -------HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 906 XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
               + ++    L ++H      I+HRD+KA+NVL+ ++G   + DFGLAR  S
Sbjct: 128 RVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 32/174 (18%)
Query: 804 TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKL----QREG--LEGEREFRAEMEVLS 856
             K+ +   IG+G FG V++      G++VA+KK+    ++EG  +   RE +  +++L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 75
Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISXXXXXXXX 905
                  H N+V L   C   +           LV+++ E    G L +++         
Sbjct: 76  -------HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 906 XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
               + ++    L ++H      I+HRD+KA+NVL+ ++G   + DFGLAR  S
Sbjct: 129 RVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 32/174 (18%)
Query: 804 TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKL----QREG--LEGEREFRAEMEVLS 856
             K+ +   IG+G FG V++      G++VA+KK+    ++EG  +   RE +  +++L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI-LQLLK 75
Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISXXXXXXXX 905
                  H N+V L   C   +           LV+++ E    G L +++         
Sbjct: 76  -------HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 906 XXXXIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
               + ++    L ++H      I+HRD+KA+NVL+ ++G   + DFGLAR  S
Sbjct: 129 RVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 20/234 (8%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  +L   R VA+KKL R         RA  E++       
Sbjct: 19   RYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 75
Query: 863  PHPNLVTLYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
             H N++ L         L+  + + +   +   +L  +I             ++  + + 
Sbjct: 76   -HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER-----MSYLLYQM 129
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y A
Sbjct: 130  LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 187
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            PE           D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 188  PEVILGMGYKENVDLWSVGCIMGEMVC-HKILFPGRDYIDQWNKVIEQLGTPCP 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 813  IGKGGFGTV--YRGVLPDGREVAVKKL----QREGLEGEREFRAEMEVLSGNGFGWPHPN 866
            +G+GGF  V    G L DG   A+K++    Q++  E +RE  A+M  L      + HPN
Sbjct: 37   LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQRE--ADMHRL------FNHPN 87
Query: 867  LVTLYGWCLD----GSEKILVYEYMEGGSL----EDIISXXXXXXXXXXXXIAIDVARAL 918
            ++ L  +CL       E  L+  + + G+L    E +              + + + R L
Sbjct: 88   ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR--VVSAGDSHVSTTIAG----- 971
              +H + Y    HRD+K +N+LL  EG+ ++ D G      +    S  + T+       
Sbjct: 148  EAIHAKGY---AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 972  -TVGYVAPEYGQTWQATT---KGDVYSFGVLAMELATG 1005
             T+ Y APE            + DV+S G +   +  G
Sbjct: 205  CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE         
Sbjct: 147  IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 989  KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
              D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 205  NVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCP 246

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE         
Sbjct: 148  IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 205
Query: 989  KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
              D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 206  NVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCP 247

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 3/103 (2%)
Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
            I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y APE         
Sbjct: 152  IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 209
Query: 989  KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
              D++S G +  E+    + L  G + + +W + +   G   P
Sbjct: 210  NVDLWSVGCIMGEMVC-HKILFPGRDYIDQWNKVIEQLGTPCP 251

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 813  IGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            +G+G F  +++GV  +          EV +K L +        F     ++S       H
Sbjct: 16   LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK----LSH 71
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX-XXXIAIDVARALVFLHH 923
             +LV  YG C+ G E ILV E+++ GSL+  +              +A  +A A+ FL  
Sbjct: 72   KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI------AGTVGYVA 977
                 ++H +V A N+LL +E        G    +   D  +S T+         + +V 
Sbjct: 132  NT---LIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 978  PEYGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECL--VEWGRRVMGYGRHGPGRA 1034
            PE  +  +      D +SFG    E+ +      GG++ L  ++  R++  Y      R 
Sbjct: 186  PECIENPKNLNLATDKWSFGTTLWEICS------GGDKPLSALDSQRKLQFY----EDRH 235
Query: 1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +P        A  A E++ L+     C    P+ RP+ + ++  L
Sbjct: 236  QLP--------APKAAELANLIN---NCMDYEPDHRPSFRAIIRDL 270

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N++TL+    + ++ +L+ E + GG L D ++                +   + +LH 
Sbjct: 74   HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 924  ECYPPIVHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +    I H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE
Sbjct: 134  K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 189  IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 20/234 (8%)
Query: 806  KFSEDRIIGKGGFGTV---YRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
            ++   + IG G  G V   Y  +L   R VA+KKL R         RA  E++       
Sbjct: 25   RYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN- 81
Query: 863  PHPNLVTLYG-----WCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
             H N++ L         L+  + + +   +   +L  +I             ++  + + 
Sbjct: 82   -HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER-----MSYLLYQM 135
Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  + H     I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y A
Sbjct: 136  LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRA 193
Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            PE           D++S G +  E+  G   L  G + + +W + +   G   P
Sbjct: 194  PEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCP 246

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N++TL+    + ++ +L+ E + GG L D ++                +   + +LH 
Sbjct: 74   HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 924  ECYPPIVHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +    I H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE
Sbjct: 134  K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 189  IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N++TL+    + ++ +L+ E + GG L D ++                +   + +LH 
Sbjct: 74   HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 924  ECYPPIVHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +    I H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE
Sbjct: 134  K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 189  IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 16/220 (7%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGER-EFRAEMEVLSG 857
            I+  + ++   + IG G FG           E VAVK ++R    GE+ +   + E++  
Sbjct: 14   IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER----GEKIDENVKREII-- 67
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
            N     HPN+V      L  +   +V EY  GG L + I                 +   
Sbjct: 68   NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + + H      + HRD+K  N LLD     +  +  FG ++  S   S   +T+ GT  Y
Sbjct: 128  VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK-SSVLHSQPKSTV-GTPAY 182
Query: 976  VAPEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            +APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 183  IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 48/246 (19%)
Query: 811  RIIGKGGFGTVYRGVLPDG-REVAVKKLQR--EGLEGEREFRAEMEVLSGNGFGWPHPNL 867
             +IG+G +G VY     +  + VA+KK+ R  E L   +    E+ +L+     +    +
Sbjct: 32   HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY----I 87
Query: 868  VTLYGWC-----LDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLH 922
            + LY        L   E  +V E +    L+ +              I  ++     F+H
Sbjct: 88   IRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV-SAGDSHVS--------------- 966
                  I+HRD+K +N LL+++    V DFGLAR + S  D+++                
Sbjct: 147  ESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 967  -----TTIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMEL----------ATGRRALE 1010
                 T+   T  Y APE     +  TK  D++S G +  EL           T R  L 
Sbjct: 204  LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 1011 GGEECL 1016
             G  C 
Sbjct: 264  PGSSCF 269

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N++TL+    + ++ +L+ E + GG L D ++                +   + +LH 
Sbjct: 74   HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 924  ECYPPIVHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +    I H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE
Sbjct: 134  K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 189  IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 88/322 (27%), Positives = 127/322 (39%), Gaps = 57/322 (17%)
Query: 119 IPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICE-- 174
           IPDDL S  ++  LNL+HN L      N +    L ILD   N     IS   P +C+  
Sbjct: 19  IPDDLPS--NITVLNLTHNQLRRLPPTNFTRYSQLAILDAGFN----SISKLEPELCQIL 72
Query: 175 -KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF---RGNIWNGLAQLVEFSVSENV 230
             L V NL  N L+   D  F  C NL  LDL SN+    + N +     L++  +S N 
Sbjct: 73  PLLKVLNLQHNELSQISDQTFVFCTNLTELDLMSNSIHKIKSNPFKNQKNLIKLDLSHNG 132
Query: 231 LSGV-------VSSSVFKENCSLEIFDL--SENEFIGDFPGEVSNCRXXXXXXXXXXXXS 281
           LS         + +         +I  L   E EF+G+     S+ R            S
Sbjct: 133 LSSTKLGTGVQLENLQELLLAKNKILALRSEELEFLGN-----SSLRKLDLSSNPLKEFS 187
Query: 282 GPIPAEIGSISGLEALFLGKNNFLSVIPESL---LNLSKLEVLDLSSNNFGGEVQKIFGR 338
              P    +I  L AL L        + E L   L+ + ++ L L++N      +  F  
Sbjct: 188 ---PGCFQTIGKLFALLLNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATSESTF-- 242
Query: 339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH 398
                               SG LK  N+++LDLS+NN         S + SL++L L +
Sbjct: 243 --------------------SG-LKWTNLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEY 281
Query: 399 NRFNGSIPAVYGNMPNLQTLDL 420
           N      P  +  + NL+ L L
Sbjct: 282 NNIQRLSPRSFYGLSNLRYLSL 303

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 49/286 (17%)
Query: 813  IGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            +G+G F  +++GV  +          EV +K L +        F     ++S       H
Sbjct: 16   LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK----LSH 71
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXX-XXXIAIDVARALVFLHH 923
             +LV  YG C  G E ILV E+++ GSL+  +              +A  +A A+ FL  
Sbjct: 72   KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEE 131
Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI------AGTVGYVA 977
                 ++H +V A N+LL +E        G    +   D  +S T+         + +V 
Sbjct: 132  NT---LIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 978  PEYGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECL--VEWGRRVMGYGRHGPGRA 1034
            PE  +  +      D +SFG    E+ +      GG++ L  ++  R++  Y      R 
Sbjct: 186  PECIENPKNLNLATDKWSFGTTLWEICS------GGDKPLSALDSQRKLQFY----EDRH 235
Query: 1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +P        A  A E++ L+     C    P+ RP+ + ++  L
Sbjct: 236  QLP--------APKAAELANLIN---NCMDYEPDHRPSFRAIIRDL 270

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHH 923
            H N++TL+    + ++ +L+ E + GG L D ++                +   + +LH 
Sbjct: 74   HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 924  ECYPPIVHRDVKASNV-LLDKE---GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +    I H D+K  N+ LLDK        + DFGLA  +  G       I GT  +VAPE
Sbjct: 134  K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     + D++S GV+   L +G
Sbjct: 189  IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 47/231 (20%)
Query: 810  DRIIGKGGFGT-VYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            ++I+G G  GT V++G    GR VAVK++  +  +       E+++L+ +     HPN++
Sbjct: 20   EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA---LMEIKLLTESD---DHPNVI 72
Query: 869  TLYGWCLDGSEKILVYEYME--GGSLEDI-----ISXXXXXXXXXXXXIAI--DVARALV 919
              Y  C + +++ L Y  +E    +L+D+     +S            I++   +A  + 
Sbjct: 73   RYY--CSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 920  FLHHECYPPIVHRDVKASNVLL--------DKEGKA-----LVTDFGLARVVSAGDSHVS 966
             LH      I+HRD+K  N+L+        D++  A     L++DFGL + + +G S   
Sbjct: 130  HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 967  TTI---AGTVGYVAPEY------GQTWQATTKG-DVYSFG-VLAMELATGR 1006
            T +   +GT G+ APE        QT +  T+  D++S G V    L+ G+
Sbjct: 187  TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            KF   R IG G FG +Y G  +    EVA+K    +    +  + +++  +   G G P+
Sbjct: 8    KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN 67
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAID-VARALVFLHH 923
               V  +G  ++G   +LV + + G SLED+ +            +  D +   + F+H 
Sbjct: 68   ---VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 924  ECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHV------STTIAGTVG 974
            + +   +HRD+K  N L+    +  +  + DFGLA+      +H       +  + GT  
Sbjct: 122  KSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            Y +       + + + D+ S G + M    G    +G
Sbjct: 179  YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            ++ + + +G GG G V+  V  D  + VA+KK+     +  +    E++++        H
Sbjct: 12   RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR----LDH 67
Query: 865  PNLVTLY--------------GWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXI 910
             N+V ++              G   + +   +V EYME   L +++             +
Sbjct: 68   DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFM 126
Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTI 969
               + R L ++H      ++HRD+K +N+ ++ E   L + DFGLAR++    SH     
Sbjct: 127  -YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 970  AGTVG--YVAPEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEE 1014
             G V   Y +P    +    TK  D+++ G +  E+ TG+    G  E
Sbjct: 183  EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 16/220 (7%)
Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE-VAVKKLQREGLEGER-EFRAEMEVLSG 857
            I+  + ++   + IG G FG           E VAVK ++R    GE+ +   + E++  
Sbjct: 14   IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER----GEKIDENVKREII-- 67
Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARA 917
            N     HPN+V      L  +   +V EY  GG L + I                 +   
Sbjct: 68   NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 918  LVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + + H      + HRD+K  N LLD     +  +  FG ++  S   S    T+ GT  Y
Sbjct: 128  VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSK-SSVLHSQPKDTV-GTPAY 182
Query: 976  VAPEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE 1014
            +APE     +   K  DV+S GV    +  G    E  EE
Sbjct: 183  IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 15/217 (6%)
Query: 812  IIGKGGFGTVYRGV-LPDGREVAVKKLQ------REGLEGEREFRAEMEVLSGNGFGWPH 864
            +IGKG F  V R +    G++ AVK +         GL  E + + E  +         H
Sbjct: 31   VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHM----LKH 85
Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISXXXXXXXXXXXXIAIDVARALVFLHHE 924
            P++V L           +V+E+M+G  L   I             +A    R ++     
Sbjct: 86   PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 925  CYP-PIVHRDVKASNVLL-DKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYG 981
            C+   I+HRDVK   VLL  KE  A V   G    +  G+S  V+    GT  ++APE  
Sbjct: 146  CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
            +        DV+  GV+   L +G     G +E L E
Sbjct: 206  KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1088
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-152
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-132
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-81
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-117
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-108
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-101
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-74
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-51
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-73
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-68
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-44
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-42
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-67
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-47
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-69
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-54
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-68
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-66
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-57
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-44
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-50
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-09
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-61
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-60
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-05
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-27
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-55
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-06
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-53
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-53
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-44
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-09
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-52
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-48
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-48
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-47
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-46
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-04
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-43
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-43
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-40
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-41
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-08
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-17
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-36
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-31
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-07
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-34
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-33
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-31
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-30
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-05
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-29
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-05
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-07
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-25
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-24
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-04
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-22
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-19
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-19
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-19
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-07
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-15
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-14
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-13
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-12
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	8e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-11
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-08
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	6e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	5e-05
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	1e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	3e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	5e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  471 bits (1214), Expect = e-152
 Identities = 193/622 (31%), Positives = 288/622 (46%), Gaps = 75/622 (12%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L ++   ISGD+  + S    L +LD+S N FS  IP  L  C +L++L++S N LSGD 
Sbjct: 183 LAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239

Query: 144 --NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDG-CLNL 200
              +S    L++L++S N+  G I    P   + L   +L+ N  TG I     G C  L
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGACDTL 296

Query: 201 RYLDLSSNNFRGNI----WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF 256
             LDLS N+F G +     +  + L   ++S N  SG +      +   L++ DLS NEF
Sbjct: 297 TGLDLSGNHFYGAVPPFFGS-CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355

Query: 257 IGDFPGEVSNCR-NLVVLNLFGNNFSGPIPAEIGSI--SGLEALFLGKNNFLSVIPESLL 313
            G+ P  ++N   +L+ L+L  NNFSGPI   +     + L+ L+L  N F   IP +L 
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415

Query: 314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
           N S+L  L LS N   G +                          S +  L  +  L L 
Sbjct: 416 NCSELVSLHLSFNYLSGTI-------------------------PSSLGSLSKLRDLKLW 450

Query: 374 HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI 433
            N   G +P E+  +++L+ LIL  N   G IP+   N  NL  + LS N LTG IP  I
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510

Query: 434 GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFE 493
           G L +L  L L+NNS SG IP E+G+C SL+WL+L+ N  +G IP  +            
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM------------ 558

Query: 494 ANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCL 553
                 +++   ++  ++ K                            LL+  GI    L
Sbjct: 559 -----FKQSGKIAANFIAGK--RYVYIKNDGMKKEC-------HGAGNLLEFQGIRSEQL 604

Query: 554 PGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LI 612
             L++R         ++     G  SP      +   + + +N   G +P +   +P L 
Sbjct: 605 NRLSTRN-----PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF 659

Query: 613 VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSG 672
           +LNL  N+ SG IP E G+++ L  LDLS N   G  P + + LT L+++++S N L SG
Sbjct: 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL-SG 718

Query: 673 TIPSTGQLATFEKTSYLGDPLL 694
            IP  GQ  TF    +L +P L
Sbjct: 719 PIPEMGQFETFPPAKFLNNPGL 740

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  419 bits (1079), Expect = e-132
 Identities = 175/681 (25%), Positives = 282/681 (41%), Gaps = 108/681 (15%)

Query: 31  SLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWN 90
           SL  +   L + +  L + N         W+ + +PC + G+ C  D  +V  ++L+   
Sbjct: 9   SLYREIHQLISFKDVLPDKN-----LLPDWSSNKNPCTFDGVTCRDD--KVTSIDLSSKP 61

Query: 91  IS---GDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL---- 143
           ++     + ++  +LT L  L LS +  +GS+        SL  L+LS N LSG +    
Sbjct: 62  LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLT 120

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI---DTCFDGCLNL 200
           +L     L+ L++S N +      S       L V +LS N+++G         DGC  L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
           ++L +S N   G++   +++ V                      +LE  D+S N F    
Sbjct: 181 KHLAISGNKISGDV--DVSRCV----------------------NLEFLDVSSNNFSTGI 216

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
           P  + +C  L  L++ GN  SG     I + + L+ L +  N F+  IP     L  L+ 
Sbjct: 217 P-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQY 273

Query: 321 LDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGP 380
           L L+ N F GE+                                  ++ LDLS N+F G 
Sbjct: 274 LSLAENKFTGEIP------------------------DFLSGACDTLTGLDLSGNHFYGA 309

Query: 381 LPVEISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLSFNELTGPIPPSIGNLT-S 438
           +P        L+ L L+ N F+G +P      M  L+ LDLSFNE +G +P S+ NL+ S
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369

Query: 439 LLWLMLANNSLSGEIPGEIGNC--TSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQ 496
           LL L L++N+ SG I   +      +L  L L NN  +G IPP +             N 
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429

Query: 497 RNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGL 556
            +G                IP+     S +  +        LW  +L   G  P  L  +
Sbjct: 430 LSGT---------------IPSSLGSLSKLRDL-------KLWLNML--EGEIPQELMYV 465

Query: 557 ASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLN 615
            +        L L  N L+GE+   +    N + + L  N+  G++P    +L  L +L 
Sbjct: 466 KTLET-----LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 616 LTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIP 675
           L+ N+FSG IP+E G+ + L  LDL+ N F+G  PA+    +     N      ++G   
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN-----FIAGKRY 575

Query: 676 STGQLATFEKTSYLGDPLLDL 696
              +    +K  +    LL+ 
Sbjct: 576 VYIKNDGMKKECHGAGNLLEF 596

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  281 bits (722), Expect = 1e-81
 Identities = 112/411 (27%), Positives = 167/411 (40%), Gaps = 76/411 (18%)

Query: 70  PGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSL 129
              +C   K  +  L L +   +G I    S  ++L  L LS N  SG+IP  L S   L
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444

Query: 130 KYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLT 187
           + L L  N+L G++   L  +++LE L L  N + GEI     + C  L   +LS N LT
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL-SNCTNLNWISLSNNRLT 503

Query: 188 GRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLE 247
           G I        NL  L LS+N+F GNI                                 
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNI--------------------------------- 530

Query: 248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV 307
                        P E+ +CR+L+ L+L  N F+G IPA +   SG     +  N     
Sbjct: 531 -------------PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGK 573

Query: 308 IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
               + N    +    + N                            G+ S  + +L   
Sbjct: 574 RYVYIKNDGMKKECHGAGNLL-----------------------EFQGIRSEQLNRLSTR 610

Query: 368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG 427
           +  +++   + G          S+ FL +++N  +G IP   G+MP L  L+L  N+++G
Sbjct: 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670

Query: 428 PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
            IP  +G+L  L  L L++N L G IP  +   T L  ++LSNN LSG IP
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  363 bits (934), Expect = e-117
 Identities = 112/299 (37%), Positives = 181/299 (60%), Gaps = 25/299 (8%)

Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-EREFRAEME 853
            F+  ++  A+  FS   I+G+GGFG VY+G L DG  VAVK+L+ E  +G E +F+ E+E
Sbjct: 20   FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLE----DIISDRTRLTWRRRLD 909
            ++S       H NL+ L G+C+  +E++LVY YM  GS+     +    +  L W +R  
Sbjct: 80   MISM----AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            IA+  AR L +LH  C P I+HRDVKA+N+LLD+E +A+V DFGLA+++   D+HV+T +
Sbjct: 136  IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE----GGEE--CLVEWGRRV 1023
             GT+G++APEY  T +++ K DV+ +GV+ +EL TG+RA +      ++   L++W + +
Sbjct: 196  RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 1024 MGYGRHGPGRAVIPVVLLGSGLAEG--AEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            +   +           L+   L      EE+ +L+++ + CT  +P  RP + EV+ ML
Sbjct: 256  LKEKKL--------EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  340 bits (874), Expect = e-108
 Identities = 107/318 (33%), Positives = 163/318 (51%), Gaps = 22/318 (6%)

Query: 772  SSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGRE 831
            S +  S      +  ++  +       D+ +AT  F    +IG G FG VY+GVL DG +
Sbjct: 6    SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65

Query: 832  VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGS 891
            VA+K+   E  +G  EF  E+E LS       HP+LV+L G+C + +E IL+Y+YME G+
Sbjct: 66   VALKRRTPESSQGIEEFETEIETLS----FCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 892  LEDIISDRTR----LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA 947
            L+  +         ++W +RL+I I  AR L +LH      I+HRDVK+ N+LLD+    
Sbjct: 122  LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178

Query: 948  LVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
             +TDFG+++  +  D +H+ST + GT+GY+ PEY    + T K DVYSFGV+  E+   R
Sbjct: 179  KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 1007 RA----LEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRC 1062
             A    L      L EW       G+      ++   L      E   +  +     V+C
Sbjct: 239  SAIVQSLPREMVNLAEWAVESHNNGQL---EQIVDPNLADKIRPESLRKFGD---TAVKC 292

Query: 1063 TAEAPNARPNVKEVLAML 1080
             A +   RP++ +VL  L
Sbjct: 293  LALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  321 bits (825), Expect = e-101
 Identities = 94/305 (30%), Positives = 151/305 (49%), Gaps = 35/305 (11%)

Query: 794  AFTYSDILKATGKFSEDR------IIGKGGFGTVYRGVLPDGREVAVKKL----QREGLE 843
            +F++ ++   T  F E         +G+GGFG VY+G + +   VAVKKL         E
Sbjct: 14   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 844  GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-- 901
             +++F  E++V++       H NLV L G+  DG +  LVY YM  GSL D +S      
Sbjct: 73   LKQQFDQEIKVMAK----CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 902  -LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
             L+W  R  IA   A  + FLH       +HRD+K++N+LLD+   A ++DFGLAR    
Sbjct: 129  PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 961  GD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE--GGEECLV 1017
               + +++ I GT  Y+APE     + T K D+YSFGV+ +E+ TG  A++     + L+
Sbjct: 186  FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 1018 EWGRRVMGYGRHGPGRAVIPVV--LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075
            +    +         + +   +   +    +   E M     +  +C  E  N RP++K+
Sbjct: 245  DIKEEI-----EDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKK 296

Query: 1076 VLAML 1080
            V  +L
Sbjct: 297  VQQLL 301

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  258 bits (662), Expect = 3e-74
 Identities = 123/593 (20%), Positives = 194/593 (32%), Gaps = 106/593 (17%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNR 160
                 D S    +  +PDDL +  ++  LNL+HN L      N +    L  LD+  N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 161 IHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQ 220
           I              L V NL  N L+   D  F  C NL  L L SN+ +         
Sbjct: 61  ISKLEPELC-QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-------- 111

Query: 221 LVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNF 280
                         + ++ F +  +L   DLS N       G      NL  L L  N  
Sbjct: 112 --------------IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157

Query: 281 SGPIPAEIGSI--SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR 338
                 E+     S L+ L L  N      P     + +L  L L++   G  + +    
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217

Query: 339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMR--SLKFLIL 396
                                  L   +I  L LS++  +         ++  +L  L L
Sbjct: 218 E----------------------LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 397 AHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE 456
           ++N  N      +  +P L+   L +N +      S+  L ++ +L L  +         
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS--------- 306

Query: 457 IGNCTSLLWLNLSNNKLSGNIPP---------EVMTIGRNARPTFEANQRNGERTIAGSS 507
                     ++S   L   I           E + +  N  P  ++N         G  
Sbjct: 307 ------FTKQSISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLI 353

Query: 508 EC----LSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQI 563
                 LS            +FV   L       L    L    I       + S  F  
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVS--LAHSPLHILN---LTKNKIS-----KIESDAFSW 403

Query: 564 TGYLQ---LSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTR 618
            G+L+   L  N++  EL+      L+N   ++L +N++     + F  +P L  L L R
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 619 NNFSG--EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
                    PS F  ++ L  LDLS NN +         L +L  L++ +N L
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  255 bits (653), Expect = 6e-73
 Identities = 93/428 (21%), Positives = 157/428 (36%), Gaps = 34/428 (7%)

Query: 84  LNLTDWNISGDIFNNFS---ALTQLSYLDLSRNTFSGSIPDDLSSCR--SLKYLNLSHNI 138
           L L +  +   +        A T +  L LS +  S +        +  +L  L+LS+N 
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259

Query: 139 LSG--DLNLSGLRSLEILDLSVNRIHGEISFSFP--------AICEKLVVANLSLNNLTG 188
           L+   + + + L  LE   L  N I    S S           +       ++SL +L  
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319

Query: 189 RIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGV-VSSSVFK--E 242
             D  F     L +L++  N+  G   N++ GL  L   S+S +  S   +++  F    
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA-EIGSISGLEALFLGK 301
           +  L I +L++N+         S   +L VL+L  N     +   E   +  +  ++L  
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGG--EVQKIFGRFTQVKILALHSNSYIDGMNSS 359
           N +L +   S   +  L+ L L              F     + IL L +N+ I  +N  
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN-IANINDD 498

Query: 360 GILKLPNISRLDLSHNNFT--------GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
            +  L  +  LDL HNN          G     +  +  L  L L  N F+     V+ +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG-NCTSLLWLNLSN 470
           +  L+ +DL  N L         N  SL  L L  N ++       G    +L  L++  
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 471 NKLSGNIP 478
           N       
Sbjct: 619 NPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (650), Expect = 2e-72
 Identities = 88/432 (20%), Positives = 154/432 (35%), Gaps = 34/432 (7%)

Query: 74  CSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLN 133
            S + A  + L LT   +  D+  N      ++ L+L+ N        + +    L  L+
Sbjct: 4   VSHEVADCSHLKLTQ--VPDDLPTN------ITVLNLTHNQLRRLPAANFTRYSQLTSLD 55

Query: 134 LSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
           +  N +S         L  L++L+L  N +      +F A C  L   +L  N++    +
Sbjct: 56  VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF-AFCTNLTELHLMSNSIQKIKN 114

Query: 192 TCFDGCLNLRYLDLSSNNFRGNIWN---GLAQLVEFSVSENVLSGVVSSSV-FKENCSLE 247
             F    NL  LDLS N            L  L E  +S N +  + S  +    N SL+
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174

Query: 248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIG---SISGLEALFLGKNNF 304
             +LS N+     PG       L  L L        +  ++    + + +  L L  +  
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 305 LSVIPESL--LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
            +    +   L  + L +LDLS NN        F    Q++   L  N  I  + S  + 
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN-NIQHLFSHSLH 293

Query: 363 KLPNISRLDLSHNNFTGPL---------PVEISQMRSLKFLILAHNRFNGSIPAVYGNMP 413
            L N+  L+L  +     +               ++ L+ L +  N   G    ++  + 
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353

Query: 414 NLQTLDLSFNELTGPIPPSIG----NLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLS 469
           NL+ L LS +  +     +        + L  L L  N +S            L  L+L 
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 470 NNKLSGNIPPEV 481
            N++   +  + 
Sbjct: 414 LNEIGQELTGQE 425

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  193 bits (492), Expect = 1e-51
 Identities = 80/354 (22%), Positives = 139/354 (39%), Gaps = 31/354 (8%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSI---------PDDLSSCRSLKYLNL 134
             L   NI     ++   L  + YL+L R+    SI                + L++LN+
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 135 SHNILSGDLN--LSGLRSLEILDLSVNR--IHGEISFSFPAICE-KLVVANLSLNNLTGR 189
             N + G  +   +GL +L+ L LS +   +    + +F ++    L + NL+ N ++  
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396

Query: 190 IDTCFDGCLNLRYLDLSSNNFRGNI----WNGLAQLVEFSVSENVLSGVVSSSVFKENCS 245
               F    +L  LDL  N     +    W GL  + E  +S N    + + + F    S
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL-TRNSFALVPS 455

Query: 246 LEIFDLSENEF--IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN 303
           L+   L       +   P      RNL +L+L  NN +      +  +  LE L L  NN
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 304 --------FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDG 355
                           L  LS L +L+L SN F     ++F    ++KI+ L  N+ ++ 
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN-LNT 574

Query: 356 MNSSGILKLPNISRLDLSHNNFTGPLPVEIS-QMRSLKFLILAHNRFNGSIPAV 408
           + +S      ++  L+L  N  T           R+L  L +  N F+ +  ++
Sbjct: 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  164 bits (418), Expect = 3e-42
 Identities = 56/240 (23%), Positives = 88/240 (36%), Gaps = 30/240 (12%)

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
             S E+ D S  + +   P ++    N+ VLNL  N       A     S L +L +G N
Sbjct: 3   TVSHEVADCSHLK-LTQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
               + PE    L  L+VL+L  N       K F                          
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF------------------------ 95

Query: 363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSF 422
              N++ L L  N+          + ++L  L L+HN  + +       + NLQ L LS 
Sbjct: 96  -CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154

Query: 423 NELTGPIPP--SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           N++         I   +SL  L L++N +    PG       L  L L+N +L  ++  +
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 2e-16
 Identities = 32/113 (28%), Positives = 44/113 (38%), Gaps = 2/113 (1%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L L+ NQL    + +  +    + + +GFN      P    +LP L VLNL  N  S  
Sbjct: 29  VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
               F     L  L L  N+        F     L  L++S+N L S T   T
Sbjct: 89  SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL-SSTKLGT 140

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.8 bits (200), Expect = 1e-15
 Identities = 25/130 (19%), Positives = 41/130 (31%), Gaps = 5/130 (3%)

Query: 85  NLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--D 142
            L      G        L+ L  L+L  N F     +       LK ++L  N L+    
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 143 LNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRY 202
              +   SL+ L+L  N I       F      L   ++  N       TC      + +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC---TCESIAWFVNW 634

Query: 203 LDLSSNNFRG 212
           ++ +  N   
Sbjct: 635 INETHTNIPE 644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.0 bits (198), Expect = 2e-15
 Identities = 28/121 (23%), Positives = 44/121 (36%), Gaps = 10/121 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQ--------FDGKLPSQFDQLP-LIVLNL 616
            L LS N ++      +  L+   ++ L  N           G        L  L +LNL
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

Query: 617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             N F       F ++  L+ +DL  NN +    + FNN   L  LN+  N + +     
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI-TSVEKK 602

Query: 677 T 677
            
Sbjct: 603 V 603

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.1 bits (193), Expect = 7e-15
 Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 1/107 (0%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +  N +S        KL    +++L  N+        F     L  L+L  N+    
Sbjct: 53  SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             + F   K L  LDLS+N  S     +   L  L +L +S N + +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.7 bits (192), Expect = 1e-14
 Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 11/139 (7%)

Query: 566 YLQLSGNQLS--------GELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNL 616
            L L  N L+        G     +  L +  +++L  N FD      F  L  L +++L
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567

Query: 617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASF-NNLTELSKLNISYNPLVSGTIP 675
             NN +    S F N   L++L+L  N  +      F      L++L++ +NP    T  
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF-DCTCE 626

Query: 676 STGQLATFEKTSYLGDPLL 694
           S      +   ++   P L
Sbjct: 627 SIAWFVNWINETHTNIPEL 645

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.0 bits (190), Expect = 2e-14
 Identities = 22/121 (18%), Positives = 40/121 (33%), Gaps = 10/121 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP----------LIVLN 615
            L LS N L+   +     L       L +N            L               +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 616 LTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIP 675
           ++  +        F  +KCL++L++  N+  G     F  L  L  L++S +     T+ 
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 676 S 676
           +
Sbjct: 372 N 372

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 3e-14
 Identities = 25/117 (21%), Positives = 41/117 (35%), Gaps = 11/117 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG--KLPSQFDQLP-LIVLNLTRNNFS 622
            + LS N+           + +   + L           PS F  L  L +L+L+ NN +
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIA 493

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFS--------GPFPASFNNLTELSKLNISYNPLVS 671
                    ++ L+ LDL +NN +        G        L+ L  LN+  N    
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 3e-14
 Identities = 29/126 (23%), Positives = 44/126 (34%), Gaps = 6/126 (4%)

Query: 552 CLPGLASRTFQITGYLQ---LSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQ 608
            +  L     Q    L+   L  N+LS           N + +HL  N       + F +
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 609 LP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN--NLTELSKLNIS 665
              LI L+L+ N  S         ++ LQ L LS N          +    + L KL +S
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 666 YNPLVS 671
            N +  
Sbjct: 180 SNQIKE 185

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.2 bits (188), Expect = 3e-14
 Identities = 23/107 (21%), Positives = 46/107 (42%), Gaps = 4/107 (3%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
               S  +L+ ++  D+    N ++++L  NQ      + F +   L  L++  N  S  
Sbjct: 8   VADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            P     +  L+ L+L +N  S     +F   T L++L++  N +  
Sbjct: 65  EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.7 bits (184), Expect = 1e-13
 Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 7/118 (5%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK--LPSQFDQLP---LIVLNLTRNN 620
           +L +  N + G  S     L N   + L  +    +      F  L    L +LNLT+N 
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392

Query: 621 FSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS-FNNLTELSKLNISYNPLVSGTIPST 677
            S      F  +  L+ LDL  N          +  L  + ++ +SYN        ++
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY-LQLTRNS 449

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.3 bits (183), Expect = 1e-13
 Identities = 28/118 (23%), Positives = 40/118 (33%), Gaps = 7/118 (5%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP---LIVLNLTRNNFS 622
            L LS N LS        +L+N   + L  N+       + D      L  L L+ N   
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFSGPFPASF---NNLTELSKLNISYNPLVSGTIPST 677
              P  F  I  L  L L+                  T +  L++S + L S T  +T
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL-STTSNTT 241

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  254 bits (650), Expect = 5e-73
 Identities = 66/455 (14%), Positives = 146/455 (32%), Gaps = 67/455 (14%)

Query: 60  WNQSSSPCEW---PGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFS 116
           WN +     W   PG+  +                         +  +++ L L     S
Sbjct: 60  WNFNKELDMWGAQPGVSLN-------------------------SNGRVTGLSLEGFGAS 94

Query: 117 GSIPDDLSSCRSLKYLNLSHNILSGDL------NLSGLRSLEILDLSVNRIHGEISFSFP 170
           G +PD +     L+ L L  +    +        +S   S E                 P
Sbjct: 95  GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154

Query: 171 A-ICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSV 226
                 L+   ++ +     I       L    +   SNN       +   L +L +F +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMR-LTKLRQFYM 213

Query: 227 SENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA 286
             +               + E  +    +       +  N ++L  + ++       +P 
Sbjct: 214 GNSPFVAENICE------AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267

Query: 287 EIGSISGLEALFLGKNNFLSV--------IPESLLNLSKLEVLDLSSNNF-GGEVQKIFG 337
            + ++  ++ + +  N  +S                  K++++ +  NN     V+    
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327

Query: 338 RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILA 397
           +  ++ +L    N     + +        ++ L+L++N  T            ++ L  A
Sbjct: 328 KMKKLGMLECLYNQLEGKLPA--FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385

Query: 398 HNRFNGSIPAVY--GNMPNLQTLDLSFNELTG-------PIPPSIGNLTSLLWLMLANNS 448
           HN+    IP ++   ++  +  +D S+NE+         P+ P+     ++  + L+NN 
Sbjct: 386 HNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444

Query: 449 LSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           +S          + L  +NL  N L+  IP   + 
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLK 478

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  253 bits (648), Expect = 1e-72
 Identities = 62/428 (14%), Positives = 128/428 (29%), Gaps = 63/428 (14%)

Query: 84  LNLTDWNISGDIFNNFSAL--TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
                 +      +       + L    ++ +    SI            +    N ++ 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 142 -DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
               +  L  L    +  +    E       ICE     N          D  +D   +L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAEN------ICEAWENENSEYAQQYKTEDLKWDNLKDL 251

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI--- 257
             +++ +      +   L  L                        +++ +++ N  I   
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALP----------------------EMQLINVACNRGISGE 289

Query: 258 -----GDFPGEVSNCRNLVVLNLFGNNF-SGPIPAEIGSISGLEALFLGKNNFLSVIPES 311
                     +      + ++ +  NN  + P+   +  +  L  L    N  L     +
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ-LEGKLPA 348

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN--SYIDGMNSSGILKLPNISR 369
             +  KL  L+L+ N          G   QV+ L+   N   YI   N      +  +S 
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIP--NIFDAKSVSVMSA 406

Query: 370 LDLSHNNFTG-------PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSF 422
           +D S+N           PL     +  ++  + L++N+ +     ++     L +++L  
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466

Query: 423 NELTG-------PIPPSIGNLTSLLWLMLANNSLSGEIPGEI--GNCTSLLWLNLSNNKL 473
           N LT            +  N   L  + L  N L+  +  +        L+ ++LS N  
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF 525

Query: 474 SGNIPPEV 481
           S   P + 
Sbjct: 526 SK-FPTQP 532

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  251 bits (643), Expect = 4e-72
 Identities = 63/434 (14%), Positives = 129/434 (29%), Gaps = 44/434 (10%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
             +        I  +     + + +    N  +  +   +     L+   + ++    + 
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAEN 222

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
                 + E  +    + +      +    + L    +       ++ T       ++ +
Sbjct: 223 ICE---AWENENSEYAQQYKTEDLKW-DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278

Query: 204 DLSSNNFRG-----NIWNGLA------QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
           +++ N         + W  LA      ++    +  N L      +  ++   L + +  
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338

Query: 253 ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
            N+  G       +   L  LNL  N  +       G    +E L    +N L  IP   
Sbjct: 339 YNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA-HNKLKYIPNIF 396

Query: 313 L--NLSKLEVLDLSSNNFGGEVQKIF-------GRFTQVKILALHSNSYIDGMNSSGILK 363
              ++S +  +D S N  G    K F        +   V  + L +N  I          
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ-ISKFPKELFST 455

Query: 364 LPNISRLDLSHNNFTG-------PLPVEISQMRSLKFLILAHNRFNGSIPAV-YGNMPNL 415
              +S ++L  N  T                   L  + L  N+            +P L
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL 515

Query: 416 QTLDLSFNELTGPIPPSIGNLTSLLWL------MLANNSLSGEIPGEIGNCTSLLWLNLS 469
             +DLS+N  +   P    N ++L             N    E P  I  C SL  L + 
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574

Query: 470 NNKLSGNIPPEVMT 483
           +N +   +  ++  
Sbjct: 575 SNDIRK-VNEKITP 587

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  239 bits (613), Expect = 6e-68
 Identities = 57/428 (13%), Positives = 120/428 (28%), Gaps = 76/428 (17%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
              N             +  L  L+ +++        +P  L +   ++ +N++ N    
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

Query: 142 D----------LNLSGLRSLEILDLSVNRI-HGEISFSFPAICEKLVVANLSLNNLTGRI 190
                       +      ++I+ +  N +    +  S     +KL +     N L G++
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK-MKKLGMLECLYNQLEGKL 346

Query: 191 DTCFDGCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLE 247
              F   + L  L+L+ N       N      Q+   S + N L  + +           
Sbjct: 347 PA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIF--------- 396

Query: 248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSG-------PIPAEIGSISGLEALFLG 300
                          +  +   +  ++   N           P+         + ++ L 
Sbjct: 397 ---------------DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441

Query: 301 KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSG 360
            N       E     S L  ++L  N      +                        +  
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE------------------NEN 483

Query: 361 ILKLPNISRLDLSHNNFTG-PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL- 418
                 ++ +DL  N  T        + +  L  + L++N F+   P    N   L+   
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542

Query: 419 -----DLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
                D   N      P  I    SL  L + +N +   +  +I    ++  L++ +N  
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPN 599

Query: 474 SGNIPPEV 481
                  V
Sbjct: 600 ISIDLSYV 607

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  170 bits (434), Expect = 1e-44
 Identities = 51/292 (17%), Positives = 91/292 (31%), Gaps = 30/292 (10%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           L      + G     F +  +L+ L+L+ N  +    +       ++ L+ +HN L    
Sbjct: 335 LECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIP 393

Query: 142 -DLNLSGLRSLEILDLSVNRIHGEISFSFPAI------CEKLVVANLSLNNLTGRIDTCF 194
              +   +  +  +D S N I      +F  +         +   NLS N ++      F
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

Query: 195 DGCLNLRYLDLSSNNFRG----------NIWNGLAQLVEFSVSENVLSGVVSSSVFKENC 244
                L  ++L  N                +     L    +  N L+ +          
Sbjct: 454 STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVL------NLFGNNFSGPIPAEIGSISGLEALF 298
            L   DLS N F   FP +  N   L         +  GN      P  I     L  L 
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572

Query: 299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
           +G N+ +  + E +     + VLD+  N            + +  +  L  +
Sbjct: 573 IGSND-IRKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  162 bits (412), Expect = 9e-42
 Identities = 49/386 (12%), Positives = 104/386 (26%), Gaps = 79/386 (20%)

Query: 311 SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRL 370
           SL +  ++  L L      G V                            I +L  +  L
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRV-------------------------PDAIGQLTELEVL 110

Query: 371 DLSHNNFTGP----LPVEISQMRSLKFLILAHNRFNGSIPAVYG--NMPNLQTLDLSFNE 424
            L  +          P  IS   S +        +  +        +  +L    ++ + 
Sbjct: 111 ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP 170

Query: 425 LTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI 484
               I  S         +   +N+++  +   +   T L    + N+        E    
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229

Query: 485 GRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLK 544
                                +SE     +                  K    +      
Sbjct: 230 E--------------------NSEYAQQYKTEDL---------KWDNLKDLTDVEVYNCP 260

Query: 545 GTGIFPVCLPGLASRTFQITGYLQLSGNQL--------SGELSPDIGKLQNFSMVHLGFN 596
                P  L  L          + ++ N+           +   D    +   ++++G+N
Sbjct: 261 NLTKLPTFLKALPEMQ-----LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315

Query: 597 QF-DGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN 654
                 + +   ++  L +L    N   G++P  FG+   L +L+L+YN  +        
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCG 374

Query: 655 NLTELSKLNISYNPLVSGTIPSTGQL 680
              ++  L+ ++N L    IP+    
Sbjct: 375 FTEQVENLSFAHNKL--KYIPNIFDA 398

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (275), Expect = 9e-25
 Identities = 38/254 (14%), Positives = 73/254 (28%), Gaps = 47/254 (18%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
           N +   D      +         +S ++LS N  S    +  S+   L  +NL  N+L+ 
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 142 ---------DLNLSGLRSLEILDLSVNRIHG---EISFSFPAICEKLVVANLSLNNLTGR 189
                    + N      L  +DL  N++     +   +       LV  +LS N+ +  
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT---LPYLVGIDLSYNSFSK- 527

Query: 190 IDTCFDGCLNLRYL------DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKEN 243
             T       L+        D   N        G+                         
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP--------------------- 566

Query: 244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN 303
            SL    +  N+ I     ++    N+ VL++  N       + +          L  + 
Sbjct: 567 -SLTQLQIGSND-IRKVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

Query: 304 FLSVIPESLLNLSK 317
              +     L++ +
Sbjct: 623 TQDIRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.6 bits (207), Expect = 2e-16
 Identities = 23/140 (16%), Positives = 45/140 (32%), Gaps = 18/140 (12%)

Query: 566 YLQLSGNQLSG-ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP--------LIVLNL 616
            L  + N+L       D   +   S +   +N+        FD L         +  +NL
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440

Query: 617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG-------PFPASFNNLTELSKLNISYNPL 669
           + N  S      F     L +++L  N  +            +F N   L+ +++ +N L
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500

Query: 670 VSGTIPSTGQLATFEKTSYL 689
               +    +  T      +
Sbjct: 501 TK--LSDDFRATTLPYLVGI 518

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.2 bits (206), Expect = 2e-16
 Identities = 26/142 (18%), Positives = 41/142 (28%), Gaps = 14/142 (9%)

Query: 566 YLQLSGNQLSGELSPDI--GKLQNFSMVHLGFNQFDGKLPSQFDQLP-------LIVLNL 616
            + L  N+L+  LS D     L     + L +N F    P+Q                + 
Sbjct: 492 SIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549

Query: 617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             N    E P        L  L +  N+          N++    L+I  NP +S  +  
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIKDNPNISIDLSY 606

Query: 677 TGQLATFEKTSYLGDPLLDLPD 698
                         D   D+  
Sbjct: 607 VCPYIEAGMYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 2e-13
 Identities = 24/137 (17%), Positives = 45/137 (32%), Gaps = 34/137 (24%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD-------GKLPS---------QFDQL 609
            L+   NQL G+L P  G     + ++L +NQ         G             +   +
Sbjct: 334 MLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYI 392

Query: 610 P----------LIVLNLTRNNFSG-------EIPSEFGNIKCLQNLDLSYNNFSGPFPAS 652
           P          +  ++ + N            +         + +++LS N  S      
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

Query: 653 FNNLTELSKLNISYNPL 669
           F+  + LS +N+  N L
Sbjct: 453 FSTGSPLSSINLMGNML 469

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 6e-10
 Identities = 14/120 (11%), Positives = 25/120 (20%), Gaps = 8/120 (6%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGP----FPASFNNLTELSKLNISY 666
           +  L+L     SG +P   G +  L+ L L  +          P   +      +     
Sbjct: 83  VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142

Query: 667 NPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTII 726
                 T         F                I                   +  +T +
Sbjct: 143 MHY-QKTFVDYDPREDFSDLIKDCINSDPQQKSI---KKSSRITLKDTQIGQLSNNITFV 198

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 6e-08
 Identities = 14/111 (12%), Positives = 26/111 (23%), Gaps = 26/111 (23%)

Query: 559 RTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTR 618
           + F I       GN+   E    I    +                       L  L +  
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPS-----------------------LTQLQIGS 575

Query: 619 NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           N+    +  +      +  LD+  N       +      E     + Y+  
Sbjct: 576 NDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.5 bits (116), Expect = 1e-05
 Identities = 11/62 (17%), Positives = 19/62 (30%)

Query: 615 NLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTI 674
           N   + +  +      +   +  L L     SG  P +   LTEL  L +  +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 675 PS 676
             
Sbjct: 123 LF 124

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  237 bits (606), Expect = 2e-70
 Identities = 77/318 (24%), Positives = 127/318 (39%), Gaps = 34/318 (10%)

Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEV 854
                ++   +       +  +G FG V++        VAVK    +    ++ ++ E EV
Sbjct: 14   LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQD---KQSWQNEYEV 69

Query: 855  LSGNGFGWPHPNLVTLYGWCLDGS----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDI 910
             S  G    H N++   G    G+    +  L+  + E GSL D +     ++W     I
Sbjct: 70   YSLPG--MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126

Query: 911  AIDVARALVFLHHECY-------PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS 963
            A  +AR L +LH +         P I HRD+K+ NVLL     A + DFGLA    AG S
Sbjct: 127  AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 964  HVSTT-IAGTVGYVAPEY-----GQTWQATTKGDVYSFGVLAMELATGRRALEG-GEECL 1016
               T    GT  Y+APE           A  + D+Y+ G++  ELA+   A +G  +E +
Sbjct: 187  AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 1017 VEWGRRVMGYGRHGPGRAVIPVVLLG------SGLAEGAEEMSELLRIGVRCTAEAPNAR 1070
            + +   +   G+H     +  VV+            +    M+ L      C      AR
Sbjct: 247  LPFEEEI---GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 1071 PNVKEVLAMLIKILPHCD 1088
             +   V   + ++    +
Sbjct: 304  LSAGCVGERITQMQRLTN 321

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  235 bits (603), Expect = 3e-70
 Identities = 86/404 (21%), Positives = 127/404 (31%), Gaps = 119/404 (29%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
           N   L+ W  +                D    T+ G + D  +    +  L+LS   L  
Sbjct: 20  NPTTLSSWLPT---------------TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 142 DLN----LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC 197
                  L+ L  L  L +                          +NNL G I       
Sbjct: 65  PYPIPSSLANLPYLNFLYIG------------------------GINNLVGPIPPAIAKL 100

Query: 198 LNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
             L YL ++  N  G I                                           
Sbjct: 101 TQLHYLYITHTNVSGAI------------------------------------------- 117

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK 317
              P  +S  + LV L+   N  SG +P  I S+  L  +    N     IP+S  + SK
Sbjct: 118 ---PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 318 L-EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNN 376
           L   + +S N   G++   F                             N++ +DLS N 
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL--------------------------NLAFVDLSRNM 208

Query: 377 FTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL 436
             G   V     ++ + + LA N     +  V G   NL  LDL  N + G +P  +  L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 437 TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK-LSGNIPP 479
             L  L ++ N+L GEIP + GN         +NNK L G+  P
Sbjct: 268 KFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  228 bits (585), Expect = 1e-67
 Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 36/285 (12%)

Query: 206 SSNNFRGNIWNG--------LAQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLS-ENE 255
            + +     W G          ++    +S   L           N   L    +   N 
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 256 FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL 315
            +G  P  ++    L  L +   N SG IP  +  I  L  L    N     +P S+ +L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
             L  +    N   G +   +G F++                          + + +S N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSK------------------------LFTSMTISRN 184

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
             TG +P   + + +L F+ L+ N   G    ++G+  N Q + L+ N L   +   +G 
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGL 242

Query: 436 LTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
             +L  L L NN + G +P  +     L  LN+S N L G IP  
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  209 bits (535), Expect = 7e-61
 Identities = 78/329 (23%), Positives = 134/329 (40%), Gaps = 41/329 (12%)

Query: 33  ETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCE--WPGIICSPD--KARVNGLNLTD 88
             D++ L  ++  L N   ++      W  ++  C   W G++C  D    RVN L+L+ 
Sbjct: 5   PQDKQALLQIKKDLGNPTTLS-----SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 89  WNISG--DIFNNFSALTQLSYLDLS-RNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL-- 143
            N+     I ++ + L  L++L +   N   G IP  ++    L YL ++H  +SG +  
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL-RY 202
            LS +++L  LD S N + G +  S  +    LV      N ++G I   +     L   
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 203 LDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           + +S N   G I                       +    N +L   DLS N   GD   
Sbjct: 179 MTISRNRLTGKI---------------------PPTFA--NLNLAFVDLSRNMLEGDASV 215

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
              + +N   ++L  N+ +  +  ++G    L  L L  N     +P+ L  L  L  L+
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 323 LSSNNFGGEVQKIFGRFTQVKILALHSNS 351
           +S NN  GE+ +  G   +  + A  +N 
Sbjct: 275 VSFNNLCGEIPQG-GNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  170 bits (433), Expect = 4e-47
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 25/182 (13%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
             +L V+ ++     ++  LDLS  N                I              S +
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPK----------PYPI-------------PSSL 72

Query: 362 LKLPNISRLDLSH-NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
             LP ++ L +   NN  GP+P  I+++  L +L + H   +G+IP     +  L TLD 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLL-WLNLSNNKLSGNIPP 479
           S+N L+G +PPSI +L +L+ +    N +SG IP   G+ + L   + +S N+L+G IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 480 EV 481
             
Sbjct: 193 TF 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  113 bits (286), Expect = 1e-27
 Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 25/153 (16%)

Query: 566 YLQLSGNQLSGELSPDIGKLQN-FSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            +   GN++SG +    G     F+ + +  N+  GK+P  F  L L  ++L+RN   G+
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV-------------- 670
               FG+ K  Q + L+ N+ +            L+ L++  N +               
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 671 ---------SGTIPSTGQLATFEKTSYLGDPLL 694
                     G IP  G L  F+ ++Y  +  L
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  113 bits (284), Expect = 2e-27
 Identities = 38/115 (33%), Positives = 52/115 (45%), Gaps = 5/115 (4%)

Query: 567 LQLSGNQLSGE--LSPDIGKLQNFSMVHL-GFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
           L LSG  L     +   +  L   + +++ G N   G +P    +L  L  L +T  N S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
           G IP     IK L  LD SYN  SG  P S ++L  L  +    N + SG IP +
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI-SGAIPDS 168

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  111 bits (280), Expect = 7e-27
 Identities = 38/144 (26%), Positives = 59/144 (40%), Gaps = 9/144 (6%)

Query: 537 SLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSG-NQLSGELSPDIGKLQNFSMVHLGF 595
            L    L      P  L  L         +L + G N L G + P I KL     +++  
Sbjct: 56  DLSGLNLPKPYPIPSSLANLPYLN-----FLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 596 NQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN 654
               G +P    Q+  L+ L+ + N  SG +P    ++  L  +    N  SG  P S+ 
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 655 NLTELSK-LNISYNPLVSGTIPST 677
           + ++L   + IS N L +G IP T
Sbjct: 171 SFSKLFTSMTISRNRL-TGKIPPT 193

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 18/66 (27%), Positives = 25/66 (37%), Gaps = 2/66 (3%)

Query: 614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG--PFPASFNNLTELSKLNISYNPLVS 671
            +     + G +         + NLDLS  N     P P+S  NL  L+ L I     + 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 672 GTIPST 677
           G IP  
Sbjct: 91  GPIPPA 96

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  242 bits (619), Expect = 5e-69
 Identities = 110/590 (18%), Positives = 183/590 (31%), Gaps = 72/590 (12%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEI 165
                   S  +PDD+ S  S K ++LS N L      + S    L+ LDLS   I    
Sbjct: 16  YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 166 SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFS 225
             ++      L    L+ N +       F G  +L  L                      
Sbjct: 73  DKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS------------- 118

Query: 226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNLVVLNLFGNNFSGPI 284
                    + S    +  +L+  +++ N       P   SN  NLV ++L  N      
Sbjct: 119 ---------LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169

Query: 285 PAEIGSISGLEALFLG---KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK-IFGRFT 340
             ++  +     + L      N +  I +      KL  L L  N     + K       
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229

Query: 341 QVKILALHSNSYIDGMNSSGI-------LKLPNISRLDLSHNNFTGPLPVEISQMRSLKF 393
            + +  L    + D  N           L    I    L++ N      V+   + ++  
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289

Query: 394 LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEI 453
           + LA                  Q+L +   +L    P    +L  L  L L  N  S  I
Sbjct: 290 MSLAGVSIKYLEDVP--KHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGS--I 342

Query: 454 PGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMK 513
             +     SL +L+LS N LS        +              NG   ++ +   L   
Sbjct: 343 SFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEEL 401

Query: 514 RWIPADYPPFSFVYTILTRKSCRSLWDRL--LKG--------TGIFPVCLPGLASRTFQI 563
           + +        F ++ L R +  S +  L  L             F     GL S     
Sbjct: 402 QHL-------DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN--- 451

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
              L+++GN        ++     N + + L   Q +      FD L  L +LN++ NN 
Sbjct: 452 --TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                S +  +  L  LD S+N          +    L+  N++ N +  
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  205 bits (523), Expect = 3e-56
 Identities = 86/416 (20%), Positives = 145/416 (34%), Gaps = 31/416 (7%)

Query: 84  LNLTDWNISG-DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLK----YLNLSHNI 138
           LN+    I    +   FS LT L ++DLS N       +DL   R        L++S N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 139 LSG-DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS------LNNLTGRID 191
           +            L  L L  N     I  +       L V  L         NL     
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252

Query: 192 TCFDGCLNLRY--LDLSSNNFRGNI---WNGLAQLVEFSVSENVLSGVVSSSVFKENCSL 246
           +  +G  ++      L+  N   +    ++ LA +   S++   +  +       ++   
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED---VPKHFKW 309

Query: 247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN--NF 304
           +   +   + +  FP    +   L  L L  N  S        ++  L  L L +N  +F
Sbjct: 310 QSLSIIRCQ-LKQFPT--LDLPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSF 364

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK- 363
                 S L  + L  LDLS N     +   F    +++ L    ++ +  +        
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHST-LKRVTEFSAFLS 422

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSF 422
           L  +  LD+S+ N           + SL  L +A N F  +  + V+ N  NL  LDLS 
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482

Query: 423 NELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
            +L          L  L  L +++N+L            SL  L+ S N++  +  
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  199 bits (508), Expect = 2e-54
 Identities = 84/419 (20%), Positives = 131/419 (31%), Gaps = 39/419 (9%)

Query: 83  GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG- 141
              L+   +  DI ++         +DLS N          S+   L++L+LS   +   
Sbjct: 20  DQKLSK--VPDDIPSS------TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71

Query: 142 -DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
            D    GL  L  L L+ N I      SF +    L         L           + L
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSF-SGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 201 RYLDLSSNNFRGNIWN----GLAQLVEFSVSENVLSGVVS---SSVFKENCSLEIFDLSE 253
           + L+++ N             L  LV   +S N +  +       + +        D+S 
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 254 NEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAE-IGSISGLEALFLGKNNFLSVIPESL 312
           N  I     +      L  L L GN  S  I    + +++GL    L    F       +
Sbjct: 191 N-PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 313 LNLSKLE--------VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL 364
              S +E           L+  N   +    F     V  ++L   S I  +    + K 
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS-IKYLED--VPKH 306

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
                L +               +  LK L L  N+  GSI      +P+L  LDLS N 
Sbjct: 307 FKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNA 361

Query: 425 LT--GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
           L+  G    S     SL  L L+ N     +         L  L+  ++ L        
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  195 bits (498), Expect = 5e-53
 Identities = 81/405 (20%), Positives = 127/405 (31%), Gaps = 39/405 (9%)

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSGDLNLSGL 148
            I    F        L  L L  N  S +I    L +   L    L       + NL   
Sbjct: 195 FIQDQAFQGIK----LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 149 R----------SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCL 198
                      +++   L+      +    F      +   +L+  ++    D       
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC-LANVSAMSLAGVSIKYLEDVPK--HF 307

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN--EF 256
             + L +     +      L  L   +++ N  S            SL   DLS N   F
Sbjct: 308 KWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP---SLSYLDLSRNALSF 364

Query: 257 IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL-NL 315
            G          +L  L+L  N     + A    +  L+ L    +    V   S   +L
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
            KL  LD+S  N   +   IF   T +  L +  NS+ D   S+      N++ LDLS  
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
                       +  L+ L ++HN       + Y  + +L TLD SFN +          
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

Query: 436 LTSLLWLMLANNSLSGEIPGEIGNCTS-----LLWLNLSNNKLSG 475
             SL +  L NNS++         C       L W+      L  
Sbjct: 544 PKSLAFFNLTNNSVA---------CICEHQKFLQWVKEQKQFLVN 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  175 bits (446), Expect = 3e-46
 Identities = 86/466 (18%), Positives = 151/466 (32%), Gaps = 36/466 (7%)

Query: 242 ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK 301
           E      +   + + +   P ++    +   ++L  N           + S L+ L L +
Sbjct: 9   EVVPNITYQCMDQK-LSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSR 65

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
               ++  ++   L  L  L L+ N         F   T ++ L       +  + S  I
Sbjct: 66  CEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK-LASLESFPI 124

Query: 362 LKLPNISRLDLSHNNFTG-PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNL----Q 416
            +L  + +L+++HN      LP   S + +L  + L++N            +        
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184

Query: 417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE-IGNCTSLLWLNLSNNKLSG 475
           +LD+S N +   I         L  L L  N  S  I    + N   L    L   +   
Sbjct: 185 SLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

Query: 476 NIPPEV------MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTI 529
               E+        +       F     N          CL+    +        ++  +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV 303

Query: 530 LTRKSCRSLWDRLLKGTGIFPVCLPGLA---------SRTFQITG-----YLQLSGNQLS 575
                 +SL     +      + LP L          S +F+        YL LS N LS
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALS 363

Query: 576 --GELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIP-SEFGN 631
             G  S       +   + L FN     + + F  L  L  L+   +        S F +
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 632 IKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
           ++ L  LD+SY N    F   F  LT L+ L ++ N     T+ + 
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  174 bits (443), Expect = 7e-46
 Identities = 87/426 (20%), Positives = 138/426 (32%), Gaps = 51/426 (11%)

Query: 261 PGEVSNCR---NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK 317
           PG ++ C      +         S  +P +I S    + + L  N    +   S  N S+
Sbjct: 1   PGSLNPCIEVVPNITYQCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
           L+ LDLS         K +     +  L L  N  I   +      L ++  L       
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP-IQSFSPGSFSGLTSLENLVAVETKL 116

Query: 378 TGPLPVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL 436
                  I Q+ +LK L +AHN  +   +PA + N+ NL  +DLS+N +       +  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 437 T----SLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTF 492
                  L L ++ N +   I  +      L  L L  N  S NI               
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT----------CL 225

Query: 493 EANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRL----LKGTGI 548
           +                  +      D          +    C    D            
Sbjct: 226 QNLA---------GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276

Query: 549 FPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQ 608
             V    LA+ +      + L+G  +      D+ K   +  + +   Q     P     
Sbjct: 277 DIVKFHCLANVS-----AMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FP--TLD 326

Query: 609 LP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNL--TELSKLNIS 665
           LP L  L LT N  S  I  +   +  L  LDLS N  S     S+++L    L  L++S
Sbjct: 327 LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384

Query: 666 YNPLVS 671
           +N  + 
Sbjct: 385 FNGAII 390

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  103 bits (260), Expect = 6e-23
 Identities = 44/179 (24%), Positives = 68/179 (37%), Gaps = 8/179 (4%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIP-DDLSSCRSLKYLNLSHNILSGD 142
           L+L+  N +  +  NF  L +L +LD   +T           S   L YL++S+     D
Sbjct: 381 LDLSF-NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 143 LN--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
            +    GL SL  L ++ N        +  A    L   +LS   L       FD    L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 201 RYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF 256
           + L++S NN      + +N L  L     S N +       +     SL  F+L+ N  
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.7 bits (223), Expect = 2e-18
 Identities = 27/131 (20%), Positives = 55/131 (41%), Gaps = 4/131 (3%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSG- 141
           L+++  N   D    F  LT L+ L ++ N+F  +   +  ++  +L +L+LS   L   
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488

Query: 142 -DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
                  L  L++L++S N +    S  +      L   + S N +            +L
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ-LYSLSTLDCSFNRIETSKGILQHFPKSL 547

Query: 201 RYLDLSSNNFR 211
            + +L++N+  
Sbjct: 548 AFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.1 bits (167), Expect = 9e-12
 Identities = 24/138 (17%), Positives = 38/138 (27%), Gaps = 8/138 (5%)

Query: 566 YLQLSGNQLSG-ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-----LIVLNLTRN 619
            L ++ N +   +L      L N   V L +N       +    L       + L+++ N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 620 NFSGEIPSEFGNIKCLQNLDLSYNNFSG-PFPASFNNLTELSKLNISYNPLVSGTIPSTG 678
                    F  IK L  L L  N  S         NL  L    +              
Sbjct: 192 PIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 679 QLATFEKTSYLGDPLLDL 696
           + +  E    +      L
Sbjct: 251 EPSIMEGLCDVTIDEFRL 268

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  238 bits (610), Expect = 7e-68
 Identities = 88/417 (21%), Positives = 147/417 (35%), Gaps = 31/417 (7%)

Query: 92  SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY----LNLSHNILSG-DLNLS 146
           S  +   FS LT L +LDLS N        DL     +      L+LS N ++       
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 147 GLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI---DTCFDGCLNLRYL 203
               L  L L  N     +  +       L V  L L                   L  L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 204 DLSSNNFRGN---------IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
            +                 ++N L  +  FS+    +  V   S    N   +  +L   
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNC 314

Query: 255 EFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN--NFLSVIPESL 312
           +F     G+    +   +  L   +  G        +  LE L L +N  +F     +S 
Sbjct: 315 KF-----GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 313 LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK-LPNISRLD 371
              + L+ LDLS N     +   F    Q++ L    ++ +  M+   +   L N+  LD
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN-LKQMSEFSVFLSLRNLIYLD 427

Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSI-PAVYGNMPNLQTLDLSFNELTGPIP 430
           +SH +         + + SL+ L +A N F  +  P ++  + NL  LDLS  +L    P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 431 PSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRN 487
            +  +L+SL  L +++N+             SL  L+ S N +  +   E+     +
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  234 bits (599), Expect = 2e-66
 Identities = 84/418 (20%), Positives = 144/418 (34%), Gaps = 35/418 (8%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           L+L+   +      +F +  +L  LDLSR            S   L  L L+ N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNL 200
               SGL SL+ L      +    +F      + L   N++ N +   ++   F    NL
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGH-LKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 201 RYLDLSSNNFRGNIWNGLAQL-------VEFSVSENVLSGVVSSSVFKENCSLEIFDLSE 253
            +LDLSSN  +      L  L       +   +S N ++  +    FK    L    L  
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK-EIRLHKLTLRN 209

Query: 254 NEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPI---PAEIGSISGLEALFLGKNN------ 303
           N    +           L V  L    F         +  ++ GL  L + +        
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK 363
           +L  I +    L+ +    L S          F      + L L +  +         LK
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF----GQFPTLK 323

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN--GSIPAVYGNMPNLQTLDLS 421
           L ++ RL  + N            + SL+FL L+ N  +  G          +L+ LDLS
Sbjct: 324 LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGNIP 478
           FN +   +  +   L  L  L   +++L       +  +  +L++L++S+        
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  226 bits (579), Expect = 1e-63
 Identities = 108/590 (18%), Positives = 169/590 (28%), Gaps = 145/590 (24%)

Query: 102 LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVN 159
           +  ++Y  +  N +   IPD+L    S K L+LS N L      +      L++LDLS  
Sbjct: 7   VPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62

Query: 160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLA 219
            I      ++ +    L    L+ N +       F G  +L+ L     N        + 
Sbjct: 63  EIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNLVVLNLFGN 278
            L                       +L+  +++ N       P   SN  NL  L+L  N
Sbjct: 122 HLK----------------------TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 279 NFSGPIPAEIGSISGLEALFLG---KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI 335
                   ++  +  +  L L      N ++ I        +L  L L +N     V K 
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219

Query: 336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG---PLPVEISQMRSLK 392
                                    I  L  +    L    F         + S +  L 
Sbjct: 220 C------------------------IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 393 FLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE 452
            L +   R                 LD   ++    I      LT++    L + ++   
Sbjct: 256 NLTIEEFRLA--------------YLDYYLDD----IIDLFNCLTNVSSFSLVSVTIERV 297

Query: 453 IPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSM 512
                        L L N K     P   +                              
Sbjct: 298 KD--FSYNFGWQHLELVNCKFGQ-FPTLKL------------------------------ 324

Query: 513 KRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFP-VCLPGLASRTFQITGYLQLSG 571
                               KS + L     KG   F  V LP L         +L LS 
Sbjct: 325 --------------------KSLKRLTFTSNKGGNAFSEVDLPSLE--------FLDLSR 356

Query: 572 NQLS--GELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIP-S 627
           N LS  G  S       +   + L FN     + S F  L  L  L+   +N       S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415

Query: 628 EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
            F +++ L  LD+S+ +    F   FN L+ L  L ++ N      +P  
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  226 bits (577), Expect = 2e-63
 Identities = 83/415 (20%), Positives = 149/415 (35%), Gaps = 26/415 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSGD 142
           L+L+   ++      F  + +L  L L  N  S ++    +     L+   L       +
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 143 LN--------LSGLRSLEILDLSVNRI---HGEISFSFPAICEKLVVANLSLNNLTGRID 191
            N        L GL +L I +  +  +     +I   F      +   +L    +    D
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC-LTNVSSFSLVSVTIERVKD 299

Query: 192 TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
             F      ++L+L +  F       L  L   + + N      S     +  SLE  DL
Sbjct: 300 --FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDL 354

Query: 252 SEN--EFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
           S N   F G          +L  L+L  N     + +    +  LE L    +N   +  
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 310 ESLL-NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNIS 368
            S+  +L  L  LD+S  +       IF   + +++L +  NS+ +        +L N++
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP 428
            LDLS        P   + + SL+ L ++HN F       Y  + +LQ LD S N +   
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 429 IPPSIGNL-TSLLWLMLANNSLSGEIPGE--IGNCTSLLWLNLSNNKLSGNIPPE 480
               + +  +SL +L L  N  +     +  +        L +   ++    P +
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  206 bits (527), Expect = 9e-57
 Identities = 82/414 (19%), Positives = 126/414 (30%), Gaps = 55/414 (13%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
             LN     I  ++  +         LDLS N           S   L+ L+LS   +  
Sbjct: 15  MELNFY--KIPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 142 --DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
             D     L  L  L L+ N I      +F +    L        NL    +        
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 200 LRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
           L+ L+++ N                      +        F    +LE  DLS N+    
Sbjct: 126 LKELNVAHNL---------------------IQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 260 FPGEVSNCRNL----VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF-LSVIPESLLN 314
           +  ++     +    + L+L  N  +   P     I  L  L L  N   L+V+   +  
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQG 223

Query: 315 LSKLEVLDLSSNNFGGEVQKIFGRFT--------QVKILALHSNSYIDGMNSSGILKLPN 366
           L+ LEV  L    F  E        +         ++   L    Y           L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT 426
           +S   L             S     + L L + +F         ++       L+F    
Sbjct: 284 VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKR-----LTFTSNK 336

Query: 427 GPIPPSIGNLTSLLWLMLANNSLS--GEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           G    S  +L SL +L L+ N LS  G         TSL +L+LS N +     
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS 390

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  177 bits (450), Expect = 8e-47
 Identities = 80/421 (19%), Positives = 133/421 (31%), Gaps = 63/421 (14%)

Query: 264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
           V    N+        NF   IP  +      + L L  N    +   S  +  +L+VLDL
Sbjct: 4   VEVVPNITY-QCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
           S           +   + +  L L  N  I  +       L ++ +L     N       
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 384 EISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL--- 439
            I  +++LK L +AHN      +P  + N+ NL+ LDLS N++       +  L  +   
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 440 -LWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRN 498
            L L L+ N ++   PG       L  L L NN  S N+    +                
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCI---------------- 221

Query: 499 GERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLAS 558
                      L + R +  ++     +                          L GL +
Sbjct: 222 ------QGLAGLEVHRLVLGEFRNEGNL-------------------EKFDKSALEGLCN 256

Query: 559 RTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLT 617
            T +     +L+      +   D+   L N S   L     +      ++      L L 
Sbjct: 257 LTIE---EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN-FGWQHLELV 312

Query: 618 RNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL-VSGTIPS 676
              F      +  +   L+ L  + N     F  S  +L  L  L++S N L   G    
Sbjct: 313 NCKFGQFPTLKLKS---LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 677 T 677
           +
Sbjct: 368 S 368

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (434), Expect = 1e-44
 Identities = 73/351 (20%), Positives = 124/351 (35%), Gaps = 75/351 (21%)

Query: 76  PDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLN 133
           P     +   LT  +  G    +   L  L +LDLSRN  +F G          SLKYL+
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 134 LSHNILSG-DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDT 192
           LS N +     N  GL  LE LD   + +     FS       L+  ++S  +     + 
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 193 CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
            F+G  +L  L ++ N+F+ N                                       
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENF-------------------------------------- 461

Query: 253 ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
                   P   +  RNL  L+L         P    S+S L+ L +  NNF S+     
Sbjct: 462 -------LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514

Query: 313 LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL 372
             L+ L+VLD S N+     ++    F                          +++ L+L
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHF------------------------PSSLAFLNL 550

Query: 373 SHNNFTGPLPVE--ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
           + N+F      +  +  ++  + L++   R   + P+    MP + +L+++
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 86.2 bits (214), Expect = 2e-17
 Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 3/114 (2%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKL-PSQFDQLP-LIVLNLTRNNFSG 623
           YL +S        +     L +  ++ +  N F     P  F +L  L  L+L++     
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
             P+ F ++  LQ L++S+NNF       +  L  L  L+ S N +   +    
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.5 bits (207), Expect = 1e-16
 Identities = 26/121 (21%), Positives = 44/121 (36%), Gaps = 7/121 (5%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF-SG 623
            L L+GN +          L +   +                 L  L  LN+  N   S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS----KLNISYNPLVSGTIPSTGQ 679
           ++P  F N+  L++LDLS N     +      L ++      L++S NP+ +   P   +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFK 198

Query: 680 L 680
            
Sbjct: 199 E 199

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 59.3 bits (144), Expect = 5e-09
 Identities = 23/128 (17%), Positives = 42/128 (32%), Gaps = 29/128 (22%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           +L LS  QL          L +  ++++  N F       +  L  L VL+ + N+    
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533

Query: 625 IPSEFGNI-KCLQNLDLSYNNFSG--------------------------PFPASFNNLT 657
              E  +    L  L+L+ N+F+                             P+    + 
Sbjct: 534 KKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

Query: 658 ELSKLNIS 665
            +  LNI+
Sbjct: 594 -VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.5 bits (142), Expect = 9e-09
 Identities = 20/127 (15%), Positives = 38/127 (29%), Gaps = 12/127 (9%)

Query: 566 YLQLSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKL------PSQFDQLP---LIVLN 615
            L L  N  S  +    I  L    +  L   +F  +        S  + L    +    
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 616 LTRNNFS-GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN-NLTELSKLNISYNPLVSGT 673
           L   ++   +I   F  +  + +  L           S+N     L  +N  +    +  
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLK 323

Query: 674 IPSTGQL 680
           + S  +L
Sbjct: 324 LKSLKRL 330

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  235 bits (602), Expect = 1e-66
 Identities = 89/407 (21%), Positives = 146/407 (35%), Gaps = 14/407 (3%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           L+LT   I     + F +  +L  L L+ N         LS  ++LK+L      +S   
Sbjct: 62  LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLR 201
            + L   ++LE L L  N I            EKL V +   N +               
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180

Query: 202 --YLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF 256
              L+L+ N+  G     ++              L  +          SL +    + + 
Sbjct: 181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240

Query: 257 IGDFPGEVSNCR--NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN 314
               P         ++  +NL  + F           SGL+ L L   + LS +P  L+ 
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH-LSELPSGLVG 299

Query: 315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSH 374
           LS L+ L LS+N F    Q     F  +  L++  N+    + +  +  L N+  LDLSH
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359

Query: 375 NNFT--GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS 432
           ++        +++  +  L+ L L++N         +   P L+ LDL+F  L      S
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419

Query: 433 I-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
              NL  L  L L+++ L            +L  LNL  N       
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  222 bits (568), Expect = 3e-62
 Identities = 85/421 (20%), Positives = 161/421 (38%), Gaps = 23/421 (5%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLK--YLNLSHNILSG 141
           L L   +IS           +L  LD   N       +D+SS +      LNL+ N ++G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 142 -DLNLSGLRSLEILDLSVNRIHGEI--SFSFPAICEKLVVANLSLNNLTGRIDTCFDGC- 197
            +         + L+    +    I        I + L +      +        F+G  
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI-QSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 198 -LNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSE 253
            +++  ++L  + F     N ++  + L E  ++   LS +   S      +L+   LS 
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL--PSGLVGLSTLKKLVLSA 310

Query: 254 NEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAE-IGSISGLEALFLGKNN--FLSVIPE 310
           N+F        SN  +L  L++ GN     +    + ++  L  L L  ++         
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 311 SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK-LPNISR 369
            L NLS L+ L+LS N       + F    Q+++L L     +   ++    + L  +  
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR-LKVKDAQSPFQNLHLLKV 429

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSI---PAVYGNMPNLQTLDLSFNELT 426
           L+LSH+            + +L+ L L  N F             +  L+ L LSF +L+
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 427 GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGR 486
                +  +L  +  + L++N L+      + +    ++LNL++N +S  I P ++ I  
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISI-ILPSLLPILS 547

Query: 487 N 487
            
Sbjct: 548 Q 548

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  222 bits (568), Expect = 4e-62
 Identities = 83/401 (20%), Positives = 155/401 (38%), Gaps = 19/401 (4%)

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG----DLNL 145
            +S +  ++    T L  L+L+ N  +  I          + LN             L  
Sbjct: 167 YLSKEDMSSLQQATNL-SLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224

Query: 146 SGLRSLEILDLSVNRIHGEISFSFPAICE-KLVVANLSLNNLTGRIDTCFDGCLNLRYLD 204
           S ++SL +               F  +CE  +   NL  +         F     L+ LD
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284

Query: 205 LSSNNFRG--NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD-FP 261
           L++ +     +   GL+ L +  +S N    +          SL    +  N    +   
Sbjct: 285 LTATHLSELPSGLVGLSTLKKLVLSANKFENL-CQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 262 GEVSNCRNLVVLNLFGNN--FSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE 319
           G + N  NL  L+L  ++   S     ++ ++S L++L L  N  LS+  E+     +LE
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 320 VLDLSSNNFGG-EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT 378
           +LDL+       + Q  F     +K+L L  +  +D  +      LP +  L+L  N+F 
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL-LDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 379 GPLPVE---ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
                +   +  +  L+ L+L+    +      + ++  +  +DLS N LT     ++ +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522

Query: 436 LTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           L  + +L LA+N +S  +P  +   +    +NL  N L   
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  215 bits (550), Expect = 9e-60
 Identities = 70/409 (17%), Positives = 138/409 (33%), Gaps = 42/409 (10%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
             L L    I G + N+         L+ S N          S   +L +L+L+   +  
Sbjct: 20  ENLGLN--EIPGTLPNS------TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 142 --DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
             +        L+ L L+ N +      +  +  + L         ++            
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETAL-SGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 200 LRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
           L  L L SN+                         +          L++ D   N     
Sbjct: 131 LESLYLGSNHISS----------------------IKLPKGFPTEKLKVLDFQNNAIHYL 168

Query: 260 FPGEVSNCRNLVVLNL-FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL--LNLS 316
              ++S+ +    L+L    N    I       +  ++L  G    L VI + L    + 
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228

Query: 317 KLEVLDLSSNNFGGEVQKIFGRFTQVKILALH-SNSYIDGMNSSGILKLPNISRLDLSHN 375
            L +      +       +F    ++ + +++    Y   ++S+       +  LDL+  
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP-SIG 434
           + +  LP  +  + +LK L+L+ N+F         N P+L  L +  N     +    + 
Sbjct: 289 HLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347

Query: 435 NLTSLLWLMLANNSL--SGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
           NL +L  L L+++ +  S     ++ N + L  LNLS N+   ++  E 
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEA 395

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  186 bits (475), Expect = 6e-50
 Identities = 73/354 (20%), Positives = 119/354 (33%), Gaps = 19/354 (5%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           +NL          N F   + L  LDL+    S  +P  L    +LK L LS N      
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLT--GRIDTCFDGCLN 199
            ++ S   SL  L +  N    E+        E L   +LS +++      +       +
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377

Query: 200 LRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF 256
           L+ L+LS N         +    QL    ++   L    + S F+    L++ +LS +  
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437

Query: 257 IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG---LEALFLGKNNFLSVIPESLL 313
                        L  LNL GN+F      +  S+     LE L L   +  S+   +  
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497

Query: 314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
           +L  +  +DLS N       +       +  L L SN  I  +  S +  L     ++L 
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH-ISIILPSLLPILSQQRTINLR 555

Query: 374 HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLSFNELT 426
            N                      + +           N P L+ + LS   L+
Sbjct: 556 QNPLDC-----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  180 bits (458), Expect = 9e-48
 Identities = 77/408 (18%), Positives = 129/408 (31%), Gaps = 41/408 (10%)

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
             N      +  IP  + +    E L    N   ++   +   L  L  LDL+       
Sbjct: 16  TYNCENLGLNE-IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSL 391
            +  F    ++  L L +N  +  M  + +     +  L       +    + +   ++L
Sbjct: 73  HEDTFQSQHRLDTLVLTANP-LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL--LWLMLANNSL 449
           + L L  N  +            L+ LD   N +       + +L     L L L  N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 450 SGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVM--TIGRNARPTFEANQRNGERTIAGSS 507
           +  I     +      LN    +    I   +   TI      TFE              
Sbjct: 192 A-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE--------- 241

Query: 508 ECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYL 567
                      D  P  F    L   S  S+  +      I        +         L
Sbjct: 242 -----------DISPAVF--EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ-----EL 283

Query: 568 QLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIP 626
            L+   LS EL   +  L     + L  N+F+          P L  L++  N    E+ 
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

Query: 627 SE-FGNIKCLQNLDLSYNN--FSGPFPASFNNLTELSKLNISYNPLVS 671
           +    N++ L+ LDLS+++   S        NL+ L  LN+SYN  +S
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  166 bits (422), Expect = 4e-43
 Identities = 63/335 (18%), Positives = 114/335 (34%), Gaps = 34/335 (10%)

Query: 152 EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           +  +     ++ EI  + P   E L     S N L    +T F   +NL +LDL+     
Sbjct: 15  KTYNCENLGLN-EIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV 271
                                  +    F+    L+   L+ N  I      +S  + L 
Sbjct: 71  W----------------------IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
            L       S      + +   LE+L+LG N+  S+         KL+VLD  +N     
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168

Query: 332 VQKIFGRFTQVKILALH-SNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEIS--QM 388
            ++      Q   L+L+ + + I G+   G         L+         +   +    +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMP--NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN 446
           +SL              PAV+  +   ++++++L  +        +    + L  L L  
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287

Query: 447 NSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
             LS E+P  +   ++L  L LS NK    +    
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQIS 320

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (400), Expect = 2e-40
 Identities = 62/330 (18%), Positives = 103/330 (31%), Gaps = 32/330 (9%)

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
             +   L+ S N          S++ +L FL L   +        + +   L TL L+ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP---- 479
            L      ++    +L  L      +S      + N  +L  L L +N +S    P    
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 480 ----EVMTIGRNA-----RPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
               +V+    NA     +    + Q+    ++  +   ++          P +F     
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-------GIEPGAF----- 199

Query: 531 TRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSM 590
                         GT    V   GL + T Q                      L   S+
Sbjct: 200 ---DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 591 V--HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG 647
              +L  + F     + F     L  L+LT  + S E+PS    +  L+ L LS N F  
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315

Query: 648 PFPASFNNLTELSKLNISYNPLVSGTIPST 677
               S +N   L+ L+I  N          
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGC 345

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.9 bits (195), Expect = 4e-15
 Identities = 24/116 (20%), Positives = 36/116 (31%), Gaps = 1/116 (0%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L+ S N L    +    +L N + + L   Q        F     L  L LT N     
Sbjct: 37  CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
             +     K L++L       S       +N   L  L +  N + S  +P     
Sbjct: 97  AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 73.9 bits (182), Expect = 1e-13
 Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 4/128 (3%)

Query: 566 YLQLSGNQL--SGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
            L LS + +  S   +  +  L +   ++L +N+        F + P L +L+L      
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413

Query: 623 G-EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLA 681
             +  S F N+  L+ L+LS++         F+ L  L  LN+  N    G I  T  L 
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473

Query: 682 TFEKTSYL 689
           T  +   L
Sbjct: 474 TLGRLEIL 481

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.0 bits (177), Expect = 6e-13
 Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 5/108 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMV---HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           +L L GN            LQ    +    L F          F  L  +  ++L+ N  
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           +        ++K +  L+L+ N+ S   P+    L++   +N+  NPL
Sbjct: 513 TSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 1e-10
 Identities = 23/110 (20%), Positives = 46/110 (41%), Gaps = 5/110 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQF---DGKLPSQFDQLP-LIVLNLTRNNF 621
            L LS + L          L     ++L  N F   + +  +    L  L +L L+  + 
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           S      F ++K + ++DLS+N  +     + ++L  +  LN++ N +  
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI 537

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 61.2 bits (149), Expect = 1e-09
 Identities = 20/82 (24%), Positives = 29/82 (35%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
            L LS   LS         L+  + V L  N+           L  I LNL  N+ S  +
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIIL 539

Query: 626 PSEFGNIKCLQNLDLSYNNFSG 647
           PS    +   + ++L  N    
Sbjct: 540 PSLLPILSQQRTINLRQNPLDC 561

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 3e-61
 Identities = 94/328 (28%), Positives = 148/328 (45%), Gaps = 38/328 (11%)

Query: 764  MKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFT--YSDILKATGKFSEDRIIGKGGFGTV 821
            MK+ H     S    P   +      +D       + D+       +    IG G FGTV
Sbjct: 1    MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDL-------NIKEKIGAGSFGTV 53

Query: 822  YRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE 879
            +R     G +VAVK L  +    E   EF  E+ ++        HPN+V   G       
Sbjct: 54   HRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL----RHPNIVLFMGAVTQPPN 108

Query: 880  KILVYEYMEGGSLEDII---SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKA 936
              +V EY+  GSL  ++     R +L  RRRL +A DVA+ + +LH+   PPIVHR++K+
Sbjct: 109  LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKS 167

Query: 937  SNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFG 996
             N+L+DK+    V DFGL+R+ ++     S + AGT  ++APE  +   +  K DVYSFG
Sbjct: 168  PNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226

Query: 997  VLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELL 1056
            V+  ELAT ++         +   + V   G     R  IP             +++ ++
Sbjct: 227  VILWELATLQQPWGN-----LNPAQVVAAVGFKC-KRLEIP--------RNLNPQVAAII 272

Query: 1057 RIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                 C    P  RP+   ++ +L  ++
Sbjct: 273  E---GCWTNEPWKRPSFATIMDLLRPLI 297

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  209 bits (533), Expect = 4e-61
 Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 38/285 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKL----QREGLEGEREFRAEMEVLSGNGFGWPHPN 866
             IIG GGFG VYR     G EVAVK        +  +     R E ++ +       HPN
Sbjct: 13   EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM----LKHPN 67

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            ++ L G CL      LV E+  GG L  ++S + R+     ++ A+ +AR + +LH E  
Sbjct: 68   IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 927  PPIVHRDVKASNVLLDKEGKAL--------VTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             PI+HRD+K+SN+L+ ++ +          +TDFGLAR           + AG   ++AP
Sbjct: 127  VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAP 183

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038
            E  +    +   DV+S+GVL  EL TG     G +   V +G  +            IP 
Sbjct: 184  EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------ALPIP- 236

Query: 1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                   +   E  ++L+     C    P++RP+   +L  L  I
Sbjct: 237  -------STCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  223 bits (569), Expect = 1e-60
 Identities = 69/432 (15%), Positives = 125/432 (28%), Gaps = 90/432 (20%)

Query: 75  SPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL 134
                     N        +   ++S L  L+ ++L        +PD L     L+ LN+
Sbjct: 463 DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522

Query: 135 SHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCF 194
           + N                L     R+  +                              
Sbjct: 523 ACNRGIS---------AAQLKADWTRLADDED------------------TGP------- 548

Query: 195 DGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
                ++   +  NN                     L    +S+  ++   L + D   N
Sbjct: 549 ----KIQIFYMGYNN---------------------LEEFPASASLQKMVKLGLLDCVHN 583

Query: 255 EFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGS-ISGLEALFLGKNNFLSVIPE--S 311
           + +            L  L L  N     IP +  +    +E L    +N L  IP   +
Sbjct: 584 K-VRHLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFS-HNKLKYIPNIFN 639

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFG-----RFTQVKILALHSNSYIDGMNSSGILKLPN 366
             ++  +  +D S N  G E + I       +      + L  N  I    +        
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE-IQKFPTELFATGSP 698

Query: 367 ISRLDLSHNNFT-------GPLPVEISQMRSLKFLILAHNRFNGSIPA--VYGNMPNLQT 417
           IS + LS+N  T        P          L  + L  N+   S+        +P L  
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSN 757

Query: 418 LDLSFNELTGPIPPSIGNLTSLLWLML------ANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           +D+S+N  +   P    N + L    +        N +  + P  I  C SL+ L + +N
Sbjct: 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816

Query: 472 KLSGNIPPEVMT 483
            +   +  ++  
Sbjct: 817 DIR-KVDEKLTP 827

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  213 bits (543), Expect = 2e-57
 Identities = 69/462 (14%), Positives = 142/462 (30%), Gaps = 78/462 (16%)

Query: 30  DSLETDREVLSNLRSFLENNN-------PVNEGHYMQWNQSSSPCEWPGIICSPDKARVN 82
                D + L  +   L+  N         N  H + WN +     W             
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV------- 317

Query: 83  GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD 142
                          +     +++ L L+     G +PD +     LK L+   +  +  
Sbjct: 318 ---------------DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 143 LNLSGLRSL--EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
             L G   L  ++ +   +RI       F    ++L +++L  + +    +         
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE--MKPIKKD 420

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
             + L      GN+ N +  +               S   +    L+I   + + F    
Sbjct: 421 SRISLKDTQI-GNLTNRITFI---------------SKAIQRLTKLQIIYFANSPFTY-- 462

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
               +   +    N               ++  L  + L     ++ +P+ L +L +L+ 
Sbjct: 463 ---DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519

Query: 321 LDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG- 379
           L+++ N       ++   +T++               +      P I    + +NN    
Sbjct: 520 LNIACNRGIS-AAQLKADWTRL---------------ADDEDTGPKIQIFYMGYNNLEEF 563

Query: 380 PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIG-NLTS 438
           P    + +M  L  L   HN+    + A  G    L  L L +N++   IP         
Sbjct: 564 PASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQ 620

Query: 439 LLWLMLANNSLSGEIP--GEIGNCTSLLWLNLSNNKLSGNIP 478
           +  L  ++N L   IP      +   +  ++ S NK+     
Sbjct: 621 VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  151 bits (382), Expect = 2e-37
 Identities = 52/253 (20%), Positives = 84/253 (33%), Gaps = 29/253 (11%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDL-SSCRSLKYLNLSHNILSG---DLNLSGLRSLEIL 154
           F    +L+ L L  N     IP+D  +    ++ L  SHN L       N   +  +  +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSV 649

Query: 155 DLSVNRIHGEISFSFPAI----CEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF 210
           D S N+I  E      ++            LS N +       F     +  + LS+N  
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709

Query: 211 RG----------NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
                         +     L    +  N L+ +           L   D+S N F   F
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-F 768

Query: 261 PGEVSNCRNLVVLNL------FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN 314
           P +  N   L    +       GN      P  I +   L  L +G N+ +  + E L  
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND-IRKVDEKL-- 825

Query: 315 LSKLEVLDLSSNN 327
             +L +LD++ N 
Sbjct: 826 TPQLYILDIADNP 838

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  133 bits (337), Expect = 6e-32
 Identities = 50/396 (12%), Positives = 98/396 (24%), Gaps = 81/396 (20%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
           + +       L N  ++  L L+     G V    G                        
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG------------------------ 344

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMP-NLQTLDL 420
            +L  +  L    ++ T    +   +  +        +R       ++ +    L   DL
Sbjct: 345 -QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403

Query: 421 SFNELT-----GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG 475
             + +       PI            +    N ++  I   I   T L  +  +N+  + 
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY 462

Query: 476 NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC 535
           +                 ++          S   L                      K  
Sbjct: 463 DNIAVDWE-------DANSDYAKQYENEELSWSNL----------------------KDL 493

Query: 536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG---------ELSPDIGKLQ 586
             +           P  L  L          L ++ N+             L+ D     
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQ-----SLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 587 NFSMVHLGFNQFDG-KLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN 644
              + ++G+N  +     +   ++  L +L+   N         FG    L +L L YN 
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQ 606

Query: 645 FSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
                        ++  L  S+N L    IP+    
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKL--KYIPNIFNA 640

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  129 bits (326), Expect = 1e-30
 Identities = 43/323 (13%), Positives = 89/323 (27%), Gaps = 44/323 (13%)

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
            +   + +     V++     +  L LA     G +P   G +  L+ L    +  T   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 430 PPSIGNLTSLLWLMLANNSLSGEIPGE-IGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNA 488
                   +        + +        +     L   +L  + ++ N  PE+  I +++
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDS 421

Query: 489 RPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGI 548
           R + +  Q      I   +  ++    I                +    L       +  
Sbjct: 422 RISLKDTQ------IGNLTNRITF---ISKAI------------QRLTKLQIIYFANS-- 458

Query: 549 FPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQ 608
                                   +           L++ + V L       +LP     
Sbjct: 459 ---PFTYDNIAVDWED--ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513

Query: 609 LP-LIVLNLTRNNFSG---------EIPSEFGNIKCLQNLDLSYNNFSG-PFPASFNNLT 657
           LP L  LN+  N              +  +      +Q   + YNN    P  AS   + 
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573

Query: 658 ELSKLNISYNPLVSGTIPSTGQL 680
           +L  L+  +N +    + + G  
Sbjct: 574 KLGLLDCVHNKVRH--LEAFGTN 594

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  111 bits (280), Expect = 3e-25
 Identities = 41/273 (15%), Positives = 81/273 (29%), Gaps = 29/273 (10%)

Query: 399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
            R+         +  N    +   +         + N   +  L LA     G +P  IG
Sbjct: 286 WRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344

Query: 459 NCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPA 518
             T L  L+   +  + +             P     +++                 I  
Sbjct: 345 QLTELKVLSFGTHSETVSGRL---FGDEELTPDMSEERKHR----------------IRM 385

Query: 519 DYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGEL 578
            Y      Y      S   L D + +   + P  +   +  + + T  +    N+++  +
Sbjct: 386 HYKKMFLDYDQRLNLS-DLLQDAINRNPEMKP--IKKDSRISLKDT-QIGNLTNRITF-I 440

Query: 579 SPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNL 638
           S  I +L    +++   + F     +          N             + N+K L ++
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQYENEELSWSNLKDLTDV 496

Query: 639 DLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +L         P    +L EL  LNI+ N  +S
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 1e-15
 Identities = 28/142 (19%), Positives = 46/142 (32%), Gaps = 14/142 (9%)

Query: 566 YLQLSGNQLSGELSPDI--GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTR---- 618
            + L  N+L+  LS D     L   S + + +N F    P+Q      L    +      
Sbjct: 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789

Query: 619 --NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             N    + P+       L  L +  N+             +L  L+I+ NP +S  + S
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTS 846

Query: 677 TGQLATFEKTSYLGDPLLDLPD 698
                       L D   D+  
Sbjct: 847 VCPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 75.3 bits (185), Expect = 7e-14
 Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 17/127 (13%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD-------GKLPSQFDQLP-LIVLNLT 617
            + LS N++    +         S + L  N                +     L  ++L 
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736

Query: 618 RNNFSGEIPSE--FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS---- 671
            N  +  +  +     +  L N+D+SYN FS  FP    N ++L    I +         
Sbjct: 737 FNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI 794

Query: 672 -GTIPST 677
               P+ 
Sbjct: 795 LRQWPTG 801

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.1 bits (169), Expect = 5e-12
 Identities = 38/342 (11%), Positives = 83/342 (24%), Gaps = 80/342 (23%)

Query: 367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG------SIPAVYGNMPNLQTLDL 420
           +        +      +E   +R   F  +  N+          +      + + + L  
Sbjct: 218 VVAYTTYSQSGIKRSELETQSVRGESF-TVIDNKLTKDANVPIQLKETAEYIKDYKALKA 276

Query: 421 SFNELTGP---IPPSIGNLTSLL--WLMLANNSLSGEIPG-EIGNCTSLLWLNLSNNKLS 474
            +  L G          N T     W       + G+ PG ++ N   +  L+L+     
Sbjct: 277 IWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAK 336

Query: 475 GNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKS 534
           G +P  +                          + LS                 +    S
Sbjct: 337 GRVPDAI------------GQLTE--------LKVLSFGTHSETVSGRLFGDEELTPDMS 376

Query: 535 CRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLG 594
                   +            +     Q      L  + ++   +P++  ++  S + L 
Sbjct: 377 EERKHRIRM--------HYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLK 426

Query: 595 FNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGP------ 648
             Q                      N    I      +  LQ +  + + F+        
Sbjct: 427 DTQIGN-----------------LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469

Query: 649 -------------FPASFNNLTELSKLNISYNPLVSGTIPST 677
                           S++NL +L+ + +   P     +P  
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPN-MTQLPDF 510

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.4 bits (162), Expect = 3e-11
 Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 13/120 (10%)

Query: 566 YLQLSGNQLSGELSPDIGK-LQNFSMVHLGFNQFDGKLPSQFD--QLP-LIVLNLTRNNF 621
            L+L  NQ+  E+  D          +    N+    +P+ F+   +  +  ++ + N  
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI 656

Query: 622 SGEIPSEFGNIKC-----LQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             E  +   ++          + LSYN         F   + +S + +S N +   +IP 
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM--TSIPE 714

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.7 bits (142), Expect = 9e-09
 Identities = 13/117 (11%), Positives = 31/117 (26%), Gaps = 2/117 (1%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
           +  L+L      G +P   G +  L+ L    ++ +       +            + + 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 671 SGTIPSTGQ-LATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTKLTII 726
                           +  L D +   P+             ++      N ++T I
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN-RITFI 440

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 17/123 (13%), Positives = 36/123 (29%), Gaps = 5/123 (4%)

Query: 614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGT 673
            N   + +  +   +  N   +  L L+     G  P +   LTEL  L+   +   + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSE-TVS 362

Query: 674 IPSTGQLATFEKTSYLGDPLLDL---PDFIENGPHHGHKYPNSNGRTGNNTKLTI-ILAF 729
               G        S      + +     F++            +    N     I   + 
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 730 LAL 732
           ++L
Sbjct: 423 ISL 425

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.0 bits (109), Expect = 7e-05
 Identities = 19/127 (14%), Positives = 35/127 (27%), Gaps = 29/127 (22%)

Query: 549 FPVCLPGLAS-RTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFD 607
           FP      +  + F I       GN++  +    I    +                    
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS-------------------- 807

Query: 608 QLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN-NFSGPFPASFNNLTELS-KLNIS 665
              LI L +  N+   ++  +      L  LD++ N N S    +    +      L   
Sbjct: 808 ---LIQLQIGSNDIR-KVDEKLTPQ--LYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861

Query: 666 YNPLVSG 672
               + G
Sbjct: 862 KTQDIRG 868

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  208 bits (531), Expect = 1e-60
 Identities = 73/294 (24%), Positives = 131/294 (44%), Gaps = 42/294 (14%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-------REFRAEMEVLSG 857
            +   ++ IGKGGFG V++G  + D   VA+K L     EGE       +EF+ E+ ++S 
Sbjct: 20   EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVAR 916
                  HPN+V LYG   +     +V E++  G L   + D+   + W  +L + +D+A 
Sbjct: 80   LN----HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-----VTDFGLARVVSAGDSHVSTTIAG 971
             + ++ +   PPIVHRD+++ N+ L    +       V DFGL++       H  + + G
Sbjct: 134  GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLG 188

Query: 972  TVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029
               ++APE    +    T K D YSF ++   + TG    +      +++   +   G  
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
               R  IP         +    +  ++     C +  P  RP+   ++  L ++
Sbjct: 248  ---RPTIP--------EDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (529), Expect = 4e-60
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 37/285 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +   + ++G+G FG V +      ++VA+K+++ E     + F  E+  LS       HP
Sbjct: 9    EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVN----HP 61

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFLH 922
            N+V LYG CL+     LV EY EGGSL +++         T    +   +  ++ + +LH
Sbjct: 62   NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 923  HECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-- 979
                  ++HRD+K  N+LL   G  L + DFG A  +        T   G+  ++APE  
Sbjct: 120  SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVF 175

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
             G  +  + K DV+S+G++  E+ T R+  +     +     R+M    +G  R  +   
Sbjct: 176  EGSNY--SEKCDVFSWGIILWEVITRRKPFDE----IGGPAFRIMWAVHNG-TRPPLI-- 226

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                      + +  L+    RC ++ P+ RP+++E++ ++  ++
Sbjct: 227  ------KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLM 262

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  203 bits (519), Expect = 2e-58
 Identities = 73/325 (22%), Positives = 120/325 (36%), Gaps = 45/325 (13%)

Query: 795  FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEV 854
               S+            +IG+G +G VY+G L D R VAVK          + F  E  +
Sbjct: 3    AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58

Query: 855  LSGNGFGWPHPNLVTLYGWCLDGS-----EKILVYEYMEGGSLEDIISDRTRLTWRRRLD 909
                     H N+          +     E +LV EY   GSL   +S  T   W     
Sbjct: 59   YRVPLM--EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCR 115

Query: 910  IAIDVARALVFLHHE------CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-- 961
            +A  V R L +LH E        P I HRD+ + NVL+  +G  +++DFGL+  ++    
Sbjct: 116  LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 962  -----DSHVSTTIAGTVGYVAPEY-------GQTWQATTKGDVYSFGVLAMELATGRRAL 1009
                 + + + +  GT+ Y+APE             A  + D+Y+ G++  E+      L
Sbjct: 176  VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 1010 ---EGGEECLVEWGRRVMGYGRHGPGRAVIPVVL-------LGSGLAEGAEEMSELLRIG 1059
               E   E  + +   V   G H     +  +V              E +  +  L    
Sbjct: 236  FPGESVPEYQMAFQTEV---GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 1060 VRCTAEAPNARPNVKEVLAMLIKIL 1084
              C  +   AR   +     + +++
Sbjct: 293  EDCWDQDAEARLTAQXAEERMAELM 317

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (506), Expect = 2e-57
 Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 38/282 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
              + +   G +++G    G ++ VK L+         R+F  E   L      + HPN++
Sbjct: 16   TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI----FSHPNVL 70

Query: 869  TLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHE 924
             + G C          +  +M  GSL +++ + T   +   + +  A+D+AR + FLH  
Sbjct: 71   PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE---YG 981
              P I    + + +V++D++  A ++   +        S  S        +VAPE     
Sbjct: 130  LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
                     D++SF VL  EL T            +      M     G  R  IP    
Sbjct: 184  PEDTNRRSADMWSFAVLLWELVTREVPFAD-----LSNMEIGMKVALEG-LRPTIP---- 233

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                   +  +S+L++    C  E P  RP    ++ +L K+
Sbjct: 234  ----PGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKM 268

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  197 bits (503), Expect = 2e-56
 Identities = 78/303 (25%), Positives = 119/303 (39%), Gaps = 34/303 (11%)

Query: 810  DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
             + IGKG +G V+ G    G +VAVK         E  +  E E+         H N++ 
Sbjct: 42   VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMR--HENILG 95

Query: 870  LYGWCLDGSEKI----LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
                 + G+       L+ +Y E GSL D +   T L  +  L +A      L  LH E 
Sbjct: 96   FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 926  Y-----PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVGYVA 977
            +     P I HRD+K+ N+L+ K G   + D GLA    +  + V     T  GT  Y+ 
Sbjct: 155  FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 978  PE------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            PE          +Q+    D+YSFG++  E+A    +    EE  + +   V     +  
Sbjct: 215  PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 1032 GRAVI------PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
             R ++      P         E   +M +L+     C A  P +R     V   L K+  
Sbjct: 275  MREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMSE 331

Query: 1086 HCD 1088
              D
Sbjct: 332  SQD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  196 bits (499), Expect = 4e-56
 Identities = 73/303 (24%), Positives = 122/303 (40%), Gaps = 46/303 (15%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
              +GKG +G V+RG    G  VAVK         E+ +  E E+ +       H N++  
Sbjct: 14   ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLR--HENILGF 67

Query: 871  YGWCLDGSEKI----LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
                +          L+  Y E GSL D +   T L     L I + +A  L  LH E +
Sbjct: 68   IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 927  -----PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVGYVAP 978
                 P I HRD+K+ N+L+ K G+  + D GLA + S   + +   +    GT  Y+AP
Sbjct: 127  GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 979  E------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG------------ 1020
            E          + +  + D+++FG++  E+A    +    E+    +             
Sbjct: 187  EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            R+V+   +    R  IP              +++L++    C  + P+AR     +   L
Sbjct: 247  RKVVCVDQQ---RPNIPNRWFSD---PTLTSLAKLMK---ECWYQNPSARLTALRIKKTL 297

Query: 1081 IKI 1083
             KI
Sbjct: 298  TKI 300

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (509), Expect = 1e-55
 Identities = 97/399 (24%), Positives = 163/399 (40%), Gaps = 34/399 (8%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
             L   N++  +  + + L Q++ L   R        D +    +L  +N S+N L+   
Sbjct: 29  TVLGKTNVTDTV--SQTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNNQLTDIT 84

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L  L  L  + ++ N+I      +       L    L  N +T  ID       NL  L
Sbjct: 85  PLKNLTKLVDILMNNNQIADITPLAN---LTNLTGLTLFNNQITD-IDP-LKNLTNLNRL 139

Query: 204 DLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           +LSSN     +  +GL  L + S    V              +LE  D+S N+ + D   
Sbjct: 140 ELSSNTISDISALSGLTSLQQLSFGNQVT----DLKPLANLTTLERLDISSNK-VSDISV 194

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            ++   NL  L    N  S   P  +G ++ L+ L L  N  L  I  +L +L+ L  LD
Sbjct: 195 -LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ-LKDIG-TLASLTNLTDLD 249

Query: 323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP 382
           L++N             T++  L L +N   +    S +  L  ++ L+L+ N      P
Sbjct: 250 LANNQISNL--APLSGLTKLTELKLGANQISN---ISPLAGLTALTNLELNENQLEDISP 304

Query: 383 VEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL 442
             IS +++L +L L  N  +   P    ++  LQ L    N+++     S+ NLT++ WL
Sbjct: 305 --ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358

Query: 443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
              +N +S   P  + N T +  L L++   + N P   
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNY 394

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  195 bits (498), Expect = 4e-54
 Identities = 84/402 (20%), Positives = 150/402 (37%), Gaps = 36/402 (8%)

Query: 80  RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL 139
            +    +T       IF   +AL +     L +   + ++    +    +  L      +
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 140 SGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
                +  L +L  ++ S N++             KLV   ++ N +            N
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQLTDITPLKN---LTKLVDILMNNNQIADITP--LANLTN 113

Query: 200 LRYLDLSSNNFRGNIW-NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
           L  L L +N          L  L    +S N +S +   S      SL+      N+   
Sbjct: 114 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI---SALSGLTSLQQLSFG-NQVTD 169

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
             P  ++N   L  L++  N  S      +  ++ LE+L    N    + P  L  L+ L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNL 223

Query: 319 EVLDLSSNNFGGEVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNN 376
           + L L+ N     ++ I      T +  L L +N  I  +  + +  L  ++ L L  N 
Sbjct: 224 DELSLNGNQ----LKDIGTLASLTNLTDLDLANNQ-ISNL--APLSGLTKLTELKLGANQ 276

Query: 377 FTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL 436
            +   P  ++ + +L  L L  N+     P    N+ NL  L L FN ++   P  + +L
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSL 330

Query: 437 TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           T L  L   NN +S      + N T++ WL+  +N++S   P
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  190 bits (485), Expect = 2e-52
 Identities = 80/394 (20%), Positives = 149/394 (37%), Gaps = 31/394 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           +N ++  ++         LT+L  + ++ N  +   P  L++  +L  L L +N ++   
Sbjct: 73  INFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 128

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L  L +L  L+LS N I    + S       L   +   N +T            L  L
Sbjct: 129 PLKNLTNLNRLELSSNTISDISALSG---LTSLQQLSFG-NQVTDLKP--LANLTTLERL 182

Query: 204 DLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           D+SSN     ++   L  L     + N +S +   +      +L+   L+ N+      G
Sbjct: 183 DISSNKVSDISVLAKLTNLESLIATNNQISDI---TPLGILTNLDELSLNGNQLKD--IG 237

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            +++  NL  L+L  N  S   P  +  ++ L  L LG N   ++ P  L  L+ L  L+
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293

Query: 323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP 382
           L+ N               +  L L+ N+  D    S +  L  + RL   +N  +    
Sbjct: 294 LNENQLEDI--SPISNLKNLTYLTLYFNNISD---ISPVSSLTKLQRLFFYNNKVSDVSS 348

Query: 383 VEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL 442
             ++ + ++ +L   HN+ +   P    N+  +  L L+    T   P +     S+   
Sbjct: 349 --LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNT 403

Query: 443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           +          P  I +  S    +++ N  S  
Sbjct: 404 VKNVTGAL-IAPATISDGGSYTEPDITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  114 bits (287), Expect = 9e-27
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 23/241 (9%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
            L    ++++  I       +     +   L   N +  +      +  +  L   +   
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKI--FGRFTQVKILALHSNSYIDGMNSSGIL 362
            S   + +  L+ L  ++ S+N     +  I      T++  + +++N   D    + + 
Sbjct: 59  KS--IDGVEYLNNLTQINFSNNQ----LTDITPLKNLTKLVDILMNNNQIAD---ITPLA 109

Query: 363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSF 422
            L N++ L L +N  T   P  +  + +L  L L+ N  +  I A+   + +LQ L    
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISAL-SGLTSLQQLSFG- 164

Query: 423 NELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVM 482
           N++T   P  + NLT+L  L +++N +S      +   T+L  L  +NN++S   P  ++
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGIL 220

Query: 483 T 483
           T
Sbjct: 221 T 221

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  113 bits (285), Expect = 1e-26
 Identities = 56/273 (20%), Positives = 87/273 (31%), Gaps = 40/273 (14%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L  T+  IS         LT L  L L+ N         L+S  +L  L+L++N +S   
Sbjct: 204 LIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 259

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            LSGL  L  L L  N+I      +       L    L+ N L            NL YL
Sbjct: 260 PLSGLTKLTELKLGANQISNISPLAG---LTALTNLELNENQLEDISP--ISNLKNLTYL 314

Query: 204 DLSSNNFRGNI-WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
            L  NN       + L +L       N +S V   S      ++       N+ I D   
Sbjct: 315 TLYFNNISDISPVSSLTKLQRLFFYNNKVSDV---SSLANLTNINWLSAGHNQ-ISDLT- 369

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            ++N   +  L L    ++        ++S    +         + P ++ +       D
Sbjct: 370 PLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN--VTGALIAPATISDGGSYTEPD 427

Query: 323 LSSN-----------------------NFGGEV 332
           ++ N                        F G V
Sbjct: 428 ITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.3 bits (191), Expect = 7e-15
 Identities = 41/203 (20%), Positives = 71/203 (34%), Gaps = 34/203 (16%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L L +  +     +  S L  L+YL L  N  S   P  +SS   L+ L   +N +S   
Sbjct: 292 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVS 347

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
           +L+ L ++  L    N+I      +                NLT            +  L
Sbjct: 348 SLANLTNINWLSAGHNQISDLTPLA----------------NLT-----------RITQL 380

Query: 204 DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE 263
            L+   +     N  A +   +  +NV   +++ +   +  S    D++ N     +  E
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP--SYTNE 438

Query: 264 VS-NCRNLVVLNLFGNNFSGPIP 285
           VS      V +      FSG + 
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 31/105 (29%), Positives = 43/105 (40%), Gaps = 9/105 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L L+ NQ+S      +  L   + + LG NQ      S    L  L  L L  N     
Sbjct: 247 DLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED- 301

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             S   N+K L  L L +NN S   P   ++LT+L +L    N +
Sbjct: 302 -ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.1 bits (136), Expect = 4e-08
 Identities = 29/116 (25%), Positives = 42/116 (36%), Gaps = 12/116 (10%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L L  NQ++      +  L N + + L  N       S    L  L  L+   N  +  
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
            P    N+  L+ LD+S N  S    +    LT L  L  + N +    I   G L
Sbjct: 171 KP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGIL 220

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.0 bits (133), Expect = 8e-08
 Identities = 27/105 (25%), Positives = 43/105 (40%), Gaps = 9/105 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +S N++S      + KL N   +    NQ     P     L  L  L+L  N     
Sbjct: 181 RLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
                 ++  L +LDL+ N  S   P   + LT+L++L +  N +
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 18/107 (16%), Positives = 35/107 (32%), Gaps = 7/107 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL L  N +S      +  L     +    N+      S    L  +  L+   N  S  
Sbjct: 313 YLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL 368

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            P    N+  +  L L+   ++        N++  + +      L++
Sbjct: 369 TP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA 413

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.5 bits (124), Expect = 1e-06
 Identities = 19/104 (18%), Positives = 37/104 (35%), Gaps = 9/104 (8%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEI 625
             L    ++  +S     L   + +         K     + L  L  +N + N  +   
Sbjct: 29  TVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 84

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           P    N+  L ++ ++ N  +   P    NLT L+ L +  N +
Sbjct: 85  P--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 47.7 bits (114), Expect = 2e-05
 Identities = 21/113 (18%), Positives = 42/113 (37%), Gaps = 11/113 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           +L    NQ+S  L+P +  L   + + L    +     +    + +   N  +N     I
Sbjct: 357 WLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSI--PNTVKNVTGALI 412

Query: 626 -PSEFGNIKCLQNLDLSYNNFSGPFPAS--FNNLTELSKLNISYNPLVSGTIP 675
            P+   +       D+++N  S     S  F+    + K   ++    SGT+ 
Sbjct: 413 APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTF----SGTVT 461

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  196 bits (500), Expect = 1e-55
 Identities = 77/391 (19%), Positives = 142/391 (36%), Gaps = 49/391 (12%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L      I+  IF   + L +     L + + +  +        S+  L ++   ++   
Sbjct: 5   LATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQ 60

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            +  L +LE L+L+ N+I      S      KL    +  N +T  I        NLR L
Sbjct: 61  GIEYLTNLEYLNLNGNQITDISPLSN---LVKLTNLYIGTNKIT-DISA-LQNLTNLREL 115

Query: 204 DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE 263
            L+ +N        LA L                        +   +L  N  + D    
Sbjct: 116 YLNEDNISDIS--PLANLT----------------------KMYSLNLGANHNLSD-LSP 150

Query: 264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
           +SN   L  L +  +      P  I +++ L +L L  N    + P  L +L+ L     
Sbjct: 151 LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206

Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
             N             T++  L + +N   D    S +  L  ++ L++  N  +     
Sbjct: 207 YVNQITDI--TPVANMTRLNSLKIGNNKITD---LSPLANLSQLTWLEIGTNQISDINA- 260

Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
            +  +  LK L +  N+ +  I  +  N+  L +L L+ N+L       IG LT+L  L 
Sbjct: 261 -VKDLTKLKMLNVGSNQIS-DISVL-NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317

Query: 444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           L+ N ++   P  + + + +   + +N  + 
Sbjct: 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.0 bits (162), Expect = 2e-11
 Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 7/105 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L++  N+++      +  L   + + +G NQ      +    L  L +LN+  N  S  
Sbjct: 225 SLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD- 279

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             S   N+  L +L L+ N            LT L+ L +S N +
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 65.3 bits (160), Expect = 3e-11
 Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 7/105 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           +L++  NQ+S  ++  +  L    M+++G NQ      S  + L  L  L L  N    E
Sbjct: 247 WLEIGTNQISD-INA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNE 302

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
                G +  L  L LS N+ +   P    +L+++   + +   +
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 60.2 bits (147), Expect = 1e-09
 Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 11/116 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL ++ +++       I  L +   + L +NQ +    S    L  L       N  +  
Sbjct: 159 YLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDI 214

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
            P    N+  L +L +  N  +   P    NL++L+ L I  N +    I +   L
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDL 264

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.9 bits (133), Expect = 6e-08
 Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 8/105 (7%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +  N+++ ++S  +  L N   ++L  +       S    L  +  LNL  N+    
Sbjct: 92  NLYIGTNKIT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS- 146

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             S   N+  L  L ++ +      P    NLT+L  L+++YN +
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.4 bits (124), Expect = 8e-07
 Identities = 21/116 (18%), Positives = 42/116 (36%), Gaps = 11/116 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
              L    ++        +L++ + + +   +         + L  L  LNL  N  +  
Sbjct: 26  RAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDI 81

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
            P    N+  L NL +  N  +    ++  NLT L +L ++ + +    I     L
Sbjct: 82  SP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANL 131

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 49.1 bits (118), Expect = 4e-06
 Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 5/82 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +  NQ+S ++S  +  L   + + L  NQ   +       L  L  L L++N+ +  
Sbjct: 269 MLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326

Query: 625 IPSEFGNIKCLQNLDLSYNNFS 646
            P    ++  + + D +     
Sbjct: 327 RP--LASLSKMDSADFANQVIK 346

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  190 bits (486), Expect = 1e-54
 Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 34/279 (12%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKL--QREGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
            + IG G FGTVY+G      +VAVK L       +  + F+ E+ VL        H N++
Sbjct: 30   QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRK----TRHVNIL 83

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
               G+       I V ++ EG SL   + +  T+   ++ +DIA   AR + +LH     
Sbjct: 84   LFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---K 139

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSA-GDSHVSTTIAGTVGYVAPE---YGQT 983
             I+HRD+K++N+ L ++    + DFGLA   S    SH    ++G++ ++APE      +
Sbjct: 140  SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEG--GEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
               + + DVY+FG++  EL TG+         + ++E    ++G G   P  + +     
Sbjct: 200  NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE----MVGRGSLSPDLSKVR---- 251

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
                +   + M  L+     C  +  + RP+   +LA +
Sbjct: 252  ----SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  190 bits (484), Expect = 1e-53
 Identities = 74/301 (24%), Positives = 117/301 (38%), Gaps = 34/301 (11%)

Query: 812  IIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
             IGKG FG V+RG    G EVAVK         ER +  E E+         H N++   
Sbjct: 49   SIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVML--RHENILGFI 102

Query: 872  GWCLDGSEKI----LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE--- 924
                  +       LV +Y E GSL D ++  T +T    + +A+  A  L  LH E   
Sbjct: 103  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 925  --CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV---STTIAGTVGYVAPE 979
                P I HRD+K+ N+L+ K G   + D GLA    +    +        GT  Y+APE
Sbjct: 162  TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 980  ------YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
                    + +++  + D+Y+ G++  E+A         E+  + +   V         R
Sbjct: 222  VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 1034 AVI------PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087
             V+      P +       E    M++++R    C      AR     +   L ++    
Sbjct: 282  KVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQLSQQE 338

Query: 1088 D 1088
             
Sbjct: 339  G 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  200 bits (509), Expect = 3e-53
 Identities = 111/642 (17%), Positives = 194/642 (30%), Gaps = 102/642 (15%)

Query: 106 SYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHG 163
                     +  +P  L++    + L LS N +      +   L  L++L+L       
Sbjct: 7   RIAFYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 164 EISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVE 223
            I          L + +L  + +       F G  +L  L L                  
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS------------ 110

Query: 224 FSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNLVVLNLFGNNFSG 282
                     V+    F+   +L   DLS+N+              +L  ++   N    
Sbjct: 111 --------DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162

Query: 283 PIPAEIGSISG--LEALFLGKNNFLSVIPESLLNLSK------LEVLDLSSNNFGGEVQK 334
               E+  + G  L    L  N+  S +               LE+LD+S N +  ++  
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

Query: 335 IF-GRFTQVKILALHSNSYIDGMNSSG------------ILKLPNISRLDLSHNNFTGPL 381
            F    ++ +  +L    +I G                  L   ++  LDLSH       
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 382 PVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW 441
                 ++ LK L LA+N+ N      +  + NLQ L+LS+N L      +   L  + +
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342

Query: 442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGER 501
           + L  N ++            L  L+L +N L+                           
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-------------------------TI 377

Query: 502 TIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTF 561
               S   + +        P  +    ++            L     F + +P L     
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINLTANLI---HLSENRLENLD-ILYFLLRVPHLQ---- 429

Query: 562 QITGYLQLSGNQLSGELSPD--IGKLQNFSMVHLGFNQFDGKLPSQ-----FDQLP-LIV 613
                L L+ N+ S   S D    +  +   + LG N       ++     F+ L  L V
Sbjct: 430 ----ILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484

Query: 614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGT 673
           L L  N  +   P  F ++  L+ L L+ N  +            L  L+IS N L    
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL---L 539

Query: 674 IPSTGQLATFEKTSYLGDPLL---DLPDFIENGPHHGHKYPN 712
            P+     +        +  +   +L  FI    H       
Sbjct: 540 APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAG 581

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  193 bits (491), Expect = 7e-51
 Identities = 132/690 (19%), Positives = 220/690 (31%), Gaps = 91/690 (13%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILD 155
              L     L LS N               L+ L L        ++      L +L ILD
Sbjct: 20  PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79

Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI--DTCFDGCLNLRYLDLSSNNFR-- 211
           L  ++I+  +          L    L    L+  +  D  F     L  LDLS N  R  
Sbjct: 80  LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 212 --GNIWNGLAQLVEFSVSENVLSGVVSSSVFK--ENCSLEIFDLSENEFIGDFPGEVSNC 267
                +  L  L     S N +  +V     +  +  +L  F L+ N        +   C
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197

Query: 268 RN------LVVLNLFGNNFSGPIPAE-IGSISGLEA-----------LFLGKNNFLSVIP 309
            N      L +L++ GN ++  I      +IS  +A              G +N      
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257

Query: 310 ESLLNL--SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
            +   L  S +  LDLS         ++F     +K+L L  N  I+ +       L N+
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN-KINKIADEAFYGLDNL 316

Query: 368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG 427
             L+LS+N            +  + ++ L  N         +  +  LQTLDL  N LT 
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT- 375

Query: 428 PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRN 487
               +I  + S+  + L+ N L   +P       +   ++LS N+L  N+      +   
Sbjct: 376 ----TIHFIPSIPDIFLSGNKLV-TLP---KINLTANLIHLSENRLE-NLDILYFLLR-- 424

Query: 488 ARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTG 547
                                 +   + +  +   FS      T     SL    L    
Sbjct: 425 ----------------------VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462

Query: 548 IFPVCLPGLASRTFQITGYLQ---LSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLP 603
           +       L    F+   +LQ   L+ N L+  L P +   L     + L  N+    L 
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRL-TVLS 520

Query: 604 SQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFP-ASFNNLTELSKL 662
                  L +L+++RN      P  F +   L  LD+++N F      ++F N    + +
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELSTFINWLNHTNV 577

Query: 663 NISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSNGRTGNNTK 722
            I+  P           +      S+ G  L  L            +   S   +     
Sbjct: 578 TIAGPP---------ADIYCVYPDSFSGVSLFSLSTE----GCDEEEVLKSLKFSLFIVC 624

Query: 723 LTIILAFLALLMACLICGVLSIIIYMLVKR 752
              +  FL  ++          I Y   +R
Sbjct: 625 TVTLTLFLMTILTVTKFRGFCFICYKTAQR 654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  172 bits (437), Expect = 3e-44
 Identities = 86/433 (19%), Positives = 164/433 (37%), Gaps = 46/433 (10%)

Query: 84  LNLTDWNISG-DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCR--SLKYLNLSHNILS 140
           L+L+   I    +  +F  L  L  +D S N        +L   +  +L + +L+ N L 
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187

Query: 141 --------GDLNLSGLRSLEILDLSVNRIHGEISFSFP-----------AICEKLVVANL 181
                     +N      LEILD+S N    +I+ +F             +   ++ A  
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247

Query: 182 SLNNLTGRIDTCFDG--CLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVS 236
             +N+       F G    ++R+LDLS          ++  L  L   +++ N ++ + +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI-A 306

Query: 237 SSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEA 296
              F    +L++ +LS N     +         +  ++L  N+ +         +  L+ 
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366

Query: 297 LFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM 356
           L L  N        ++  +  +  + LS N        +        ++ L  N   +  
Sbjct: 367 LDLRDNAL-----TTIHFIPSIPDIFLSGNKL----VTLPKINLTANLIHLSENRLENLD 417

Query: 357 NSSGILKLPNISRLDLSHNNFTG-PLPVEISQMRSLKFLILAHNRFNGSI-----PAVYG 410
               +L++P++  L L+ N F+        S+  SL+ L L  N    +        V+ 
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            + +LQ L L+ N L    P    +LT+L  L L +N L+  +        +L  L++S 
Sbjct: 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISR 535

Query: 471 NKLSGNIPPEVMT 483
           N+L     P+V  
Sbjct: 536 NQLL-APNPDVFV 547

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  153 bits (388), Expect = 4e-38
 Identities = 84/438 (19%), Positives = 150/438 (34%), Gaps = 68/438 (15%)

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSC------RSLKYLNLSHNILSGDL 143
            +           T LS+  L+ N+    +  D   C        L+ L++S N  + D+
Sbjct: 162 LVCEHELEPLQGKT-LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220

Query: 144 --------------NLSGLRSLEILDLSVNRIHGEISFSFPAICE-KLVVANLSLNNLTG 188
                         +L     +       + I      +F  +    +   +LS   +  
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280

Query: 189 RIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCS 245
                F+   +L+ L+L+ N         + GL  L   ++S N+L   + SS F     
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPK 339

Query: 246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFL 305
           +   DL +N               L  L+L  N  +      I  I  +  +FL  N  +
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394

Query: 306 SVIPESL---------------------LNLSKLEVLDLSSNNFGG-EVQKIFGRFTQVK 343
           ++   +L                     L +  L++L L+ N F      +       ++
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454

Query: 344 ILALHSNSYIDGMNSSGILK-----LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH 398
            L L  N  +     + +       L ++  L L+HN      P   S + +L+ L L  
Sbjct: 455 QLFLGENM-LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513

Query: 399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
           NR    +        NL+ LD+S N+L  P P    +L+    L + +N    E      
Sbjct: 514 NRLT-VLSH-NDLPANLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECE---- 564

Query: 459 NCTSLLWLNLSNNKLSGN 476
             T + WLN +N  ++G 
Sbjct: 565 LSTFINWLNHTNVTIAGP 582

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  127 bits (321), Expect = 5e-30
 Identities = 83/462 (17%), Positives = 146/462 (31%), Gaps = 73/462 (15%)

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
            F G ++  R          N +  +P     ++  E L L  N   +V   S   L +L
Sbjct: 3   SFDGRIAFYRF--------CNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQL 50

Query: 319 EVLDLSSNNFGGEVQK-IFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
           ++L+L S      + K  F     ++IL L S+  I  ++      L ++  L L     
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGL 109

Query: 378 TGPL--PVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLSFNELTGPIPPSIG 434
           +  +        +++L  L L+ N+     +   +G + +L+++D S N++       + 
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169

Query: 435 NLT--SLLWLMLANNSLSGEIPGEIGNC------TSLLWLNLSNNKLSGNIPPEVMTIGR 486
            L   +L +  LA NSL   +  + G C        L  L++S N  + +I         
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229

Query: 487 NARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKG- 545
            ++        +      G        +   A     S  +  L+     SL  R+ +  
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 546 -------------TGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMV 591
                          I      GL +        L LS N L  EL       L   + +
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQ-----VLNLSYNLLG-ELYSSNFYGLPKVAYI 343

Query: 592 HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG--- 647
            L  N         F  L  L  L+L  N  +         I  + ++ LS N       
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPK 398

Query: 648 ------------------PFPASFNNLTELSKLNISYNPLVS 671
                                     +  L  L ++ N   S
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  113 bits (284), Expect = 1e-25
 Identities = 59/255 (23%), Positives = 107/255 (41%), Gaps = 24/255 (9%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           LNL+   +     +NF  L +++Y+DL +N  +            L+ L+L  N L+   
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNLRY 202
            +  + S+  + LS N++      + P I     + +LS N L    I        +L+ 
Sbjct: 376 TIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQI 430

Query: 203 LDLSSNNFRG----NIWNGLAQLVEFSVSENVLSGVVSSS----VFKENCSLEIFDLSEN 254
           L L+ N F         +    L +  + EN+L     +     VF+    L++  L+ N
Sbjct: 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490

Query: 255 EFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL 313
            ++   P  V S+   L  L+L  N  +  +       + LE L + +N  L+  P+  +
Sbjct: 491 -YLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLP-ANLEILDISRNQLLAPNPDVFV 547

Query: 314 NLSKLEVLDLSSNNF 328
           +LS    LD++ N F
Sbjct: 548 SLSV---LDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 4/112 (3%)

Query: 80  RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL 139
            +    L     +   ++ F  L+ L  L L+ N  +   P   S   +L+ L+L+ N L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 140 SGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
           +   +     +LEILD+S N++       F      L V +++ N      +
Sbjct: 517 TVLSHNDLPANLEILDISRNQLLAPNPDVFV----SLSVLDITHNKFICECE 564

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (476), Expect = 7e-53
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 43/286 (15%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
             +IGKG FG VY G      EVA++ +  E    +  + F+ E+           H N+V
Sbjct: 39   ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR----HENVV 92

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYP 927
               G C+      ++    +G +L  ++ D    L   +   IA ++ + + +LH     
Sbjct: 93   LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVS----AGDSHVSTTIAGTVGYVAPE---- 979
             I+H+D+K+ NV  D  GK ++TDFGL  +                 G + ++APE    
Sbjct: 150  GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 980  -----YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034
                        +   DV++ G +  EL       +      + W    MG G     + 
Sbjct: 209  LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW---QMGTGM----KP 261

Query: 1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +  + +G       +E+S++L     C A     RP   +++ ML
Sbjct: 262  NLSQIGMG-------KEISDILL---FCWAFEQEERPTFTKLMDML 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  185 bits (472), Expect = 2e-52
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 38/291 (13%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
             ++GKG FG   +      G  + +K+L R   E +R F  E++V+        HPN++ 
Sbjct: 16   EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC----LEHPNVLK 71

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPP 928
              G          + EY++GG+L  II    ++  W +R+  A D+A  + +LH      
Sbjct: 72   FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---N 128

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-------------VSTTIAGTVGY 975
            I+HRD+ + N L+ +    +V DFGLAR++    +                 T+ G   +
Sbjct: 129  IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035
            +APE         K DV+SFG++  E+     A        +++G  V G+         
Sbjct: 189  MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086
             P                    I VRC    P  RP+  ++   L  +  H
Sbjct: 249  PP----------------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  180 bits (458), Expect = 1e-48
 Identities = 75/404 (18%), Positives = 145/404 (35%), Gaps = 23/404 (5%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
             +TD ++   + +   +   +  LDLS N  S     DL+    L+ LNLS N+L   L
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
           +L  L +L  LDL+ N +  E+      +   +   + + NN++    +        + +
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSRGQ---GKKNI 125

Query: 204 DLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
            L++N             +++    +  N +  V  + +   + +LE  +L  N  I D 
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF-IYDV 184

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
            G+V     L  L+L  N  +  +  E  S +G+  + L  NN L +I ++L     LE 
Sbjct: 185 KGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR-NNKLVLIEKALRFSQNLEH 241

Query: 321 LDLSSNNF-GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG 379
            DL  N F  G ++  F +  +V+ +A  +   + G N                  +   
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 380 PLPVEISQMRS--LKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLT 437
           P    +  ++      L    +     +     N    + +D    +    I        
Sbjct: 302 PFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360

Query: 438 SLLWLMLANNSLSGEIPGEIGNCTSL---LWLNLSNNKLSGNIP 478
           + + L     +L  ++         L   L   +   +L     
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  161 bits (410), Expect = 2e-42
 Identities = 52/388 (13%), Positives = 118/388 (30%), Gaps = 25/388 (6%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSL 151
           +I  N     +     ++ ++   ++     S  ++K L+LS N LS     +L+    L
Sbjct: 4   EIKQN---GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 152 EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           E+L+LS N ++  +          L   +L+ N +            ++  L  ++NN  
Sbjct: 61  ELLNLSSNVLYETLDLES---LSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS 112

Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNL 270
               +         ++ N ++  +          ++  DL  NE    +F    ++   L
Sbjct: 113 RVSCSRGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 271 VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG 330
             LNL  N     +  ++   + L+ L L  +N L+ +     + + +  + L +N    
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLS-SNKLAFMGPEFQSAAGVTWISLRNNKL-V 227

Query: 331 EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS 390
            ++K       ++   L  N +  G       K   +    ++             +   
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTV 285

Query: 391 LKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG----PIPPSIGNLTSLLWLMLAN 446
                                +  L+  + +     G     +     N      +    
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 447 NSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
                 I        + + L      L 
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  156 bits (397), Expect = 7e-41
 Identities = 61/449 (13%), Positives = 140/449 (31%), Gaps = 51/449 (11%)

Query: 237 SSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEA 296
             + +     +I  ++++           +  N+  L+L GN  S    A++   + LE 
Sbjct: 3   HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62

Query: 297 LFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM 356
           L L  +N L    + L +LS L  LDL++N       +       ++ L   +N+    +
Sbjct: 63  LNLS-SNVLYETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN----I 111

Query: 357 NSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNL 415
           +     +      + L++N  T    ++      +++L L  N  +  +   +  +   L
Sbjct: 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 416 QTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG 475
           + L+L +N +   +   +     L  L L++N L+  +  E  +   + W++L NNKL  
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227

Query: 476 NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC 535
            I   +             N  +          C +++ +                    
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH----------CGTLRDFF------------------- 258

Query: 536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKL-----QNFSM 590
            S   R+          L G       +               +P   +L     +  ++
Sbjct: 259 -SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317

Query: 591 VHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFP 650
           +    ++ +     + +Q     ++  +  +   I       +    L+           
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

Query: 651 ASFNNLTELSKLNISYNPLVSGTIPSTGQ 679
                  EL          +     +  Q
Sbjct: 378 NGRRAHAELDGTLQQAVGQIELQHATEEQ 406

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  133 bits (337), Expect = 5e-33
 Identities = 58/423 (13%), Positives = 119/423 (28%), Gaps = 48/423 (11%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+L+   +S     + +  T+L  L+LS N       D L S  +L+ L+L++N +    
Sbjct: 39  LDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ--- 93

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L    S+E L  + N I   +S    +  +      L+ N +T   D        ++YL
Sbjct: 94  ELLVGPSIETLHAANNNIS-RVS---CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 204 DLSSNNFR----GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
           DL  N         +      L   ++  N +   V   V      L+  DLS N+ +  
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK--LKTLDLSSNK-LAF 205

Query: 260 FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE 319
              E  +   +  ++L  N     I   +     LE   L   N                
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLR-GNGFHCGTLRDFFSKNQR 263

Query: 320 VLDLSSNNFGGEVQKIFGRFTQVKILALHSN-------SYIDGMN--------------- 357
           V  ++         +     T   +    +         + D +                
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

Query: 358 -----SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNM 412
                            +D     +   +     + ++   L       +  +       
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

Query: 413 PNLQTLDLSFNELTGPIPPSIGNLTSLLWL-MLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
             L             +  +    + L  L  +        +  +     ++   ++  +
Sbjct: 384 AELDGTLQQAVGQIE-LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442

Query: 472 KLS 474
           K +
Sbjct: 443 KET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (279), Expect = 9e-26
 Identities = 30/167 (17%), Positives = 71/167 (42%), Gaps = 11/167 (6%)

Query: 308 IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
           I E   N ++ ++  ++ ++    +  +      VK L L  N  +  ++++ +     +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-LSQISAADLAPFTKL 60

Query: 368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG 427
             L+LS N     L   +  + +L+ L L +N     +       P+++TL  + N ++ 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISR 113

Query: 428 PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
            +  S         + LANN ++     + G  + + +L+L  N++ 
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSL 463
           +I  +  N    +   ++ + L   +     +  ++  L L+ N LS     ++   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 464 LWLNLSNNKLSGNIPP 479
             LNLS+N L      
Sbjct: 61  ELLNLSSNVLY-ETLD 75

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.8 bits (137), Expect = 3e-08
 Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 2/70 (2%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
             +  +T ++    + S   +   ++ LDLS N  S    A     T+L  LN+S N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 671 SGTIPSTGQL 680
                    L
Sbjct: 72  E--TLDLESL 79

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 16/156 (10%), Positives = 39/156 (25%), Gaps = 8/156 (5%)

Query: 552 CLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPL 611
            L    S+  ++     ++   +      +  +    ++ H G    +       D+L  
Sbjct: 253 TLRDFFSKNQRV---QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309

Query: 612 I-----VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISY 666
           +      L   + + +  +  E  N    + +D     +                L    
Sbjct: 310 LKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369

Query: 667 NPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIEN 702
             L           A  + T       ++L    E 
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  179 bits (457), Expect = 7e-48
 Identities = 82/419 (19%), Positives = 152/419 (36%), Gaps = 31/419 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           L+L+   I       + +L+ LS L L+ N          S   SL+ L      L+   
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLR 201
           +  +  L++L+ L+++ N I       + +    L   +LS N +     T       + 
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 202 Y----LDLSSNNFRGNIWNGLA--QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
                LDLS N             +L + ++  N  S  V  +  +    LE+  L   E
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 256 FIGD------FPGEVSNCRNLVVLNL---FGNNFSGPIPAEIGSISGLEALFLGKNNFLS 306
           F  +          +    NL +      + + +   I      ++ + +  L       
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 307 VIPES-LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP 365
           V   S       LE+++     F         +   +K L   SN    G N+   + LP
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFP------TLKLKSLKRLTFTSNK---GGNAFSEVDLP 347

Query: 366 NISRLDLSHNNFT--GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
           ++  LDLS N  +  G          SLK+L L+ N    ++ + +  +  L+ LD   +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406

Query: 424 ELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            L      S+  +L +L++L +++        G     +SL  L ++ N    N  P++
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  176 bits (449), Expect = 6e-47
 Identities = 83/421 (19%), Positives = 143/421 (33%), Gaps = 43/421 (10%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
             LN     I  ++  +         LDLS N           S   L+ L+LS   +  
Sbjct: 15  MELNFYK--IPDNLPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 142 --DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
             D     L  L  L L+ N I      +F +    L        NL    +        
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 200 LRYLDLSSNNFR----GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIF----DL 251
           L+ L+++ N  +       ++ L  L    +S N +   +  +  +    + +     DL
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDL 184

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAE-IGSISGLEALFLGKNNF-----L 305
           S N  +            L  L L  N  S  +    I  ++GLE   L    F     L
Sbjct: 185 SLN-PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 306 SVIPESLL-NLSKLEVLDLSSN---NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
               +S L  L  L + +        +  ++  +F   T V   +L S +     + S  
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
               ++  ++     F         +++SLK L    N+   +   V  ++P+L+ LDLS
Sbjct: 304 FGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLS 355

Query: 422 FNELT--GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
            N L+  G    S    TSL +L L+ N +   +         L  L+  ++ L   +  
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 413

Query: 480 E 480
            
Sbjct: 414 F 414

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  171 bits (436), Expect = 3e-45
 Identities = 97/417 (23%), Positives = 155/417 (37%), Gaps = 32/417 (7%)

Query: 84  LNLTDWNI-SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY----LNLSHN- 137
           LN+    I S  +   FS LT L +LDLS N        DL     +      L+LS N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 138 ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSL------NNLTGRID 191
           +            L  L L  N     +  +       L V  L L       NL     
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 192 TCFDGC--LNLRYLDLSSNNFRGNIW----NGLAQLVEFSVSENVLSGVVSSSVFKENCS 245
           +  +G   L +    L+  ++  +      N L  +  FS+    +  V   S       
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308

Query: 246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN--N 303
           LE+ +    +F           ++L  L    N       +E+  +  LE L L +N  +
Sbjct: 309 LELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLS 360

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK 363
           F     +S    + L+ LDLS N     +   F    Q++ L    ++ +  M+   +  
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-LKQMSEFSVFL 418

Query: 364 -LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLS 421
            L N+  LD+SH +         + + SL+ L +A N F  +    ++  + NL  LDLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
             +L    P +  +L+SL  L +A+N L     G     TSL  + L  N    + P
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  159 bits (403), Expect = 5e-41
 Identities = 103/586 (17%), Positives = 173/586 (29%), Gaps = 113/586 (19%)

Query: 109 DLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEIS 166
                 F   IPD+L    S K L+LS N L      +      L++LDLS   I     
Sbjct: 13  QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 167 FSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSV 226
            ++      L    L+ N +       F G  +L+ L     N                 
Sbjct: 70  GAY-QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-------------- 114

Query: 227 SENVLSGVVSSSVFKENCSLEIFDLSENEF-IGDFPGEVSNCRNLVVLNLFGNNFSGPIP 285
                   + +       +L+  +++ N       P   SN  NL  L+L  N       
Sbjct: 115 --------LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 286 AEIGSISGLEALFLG---KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV-QKIFGRFTQ 341
            ++  +  +  L L      N ++ I        +L  L L +N     V +        
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226

Query: 342 VKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRF 401
           +++  L    + +           N+ + D S              +  L  L +   R 
Sbjct: 227 LEVHRLVLGEFRN---------EGNLEKFDKSA-------------LEGLCNLTIEEFR- 263

Query: 402 NGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNC- 460
                        L  LD   ++    I      LT++    L + ++   +     N  
Sbjct: 264 -------------LAYLDYYLDD----IIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFG 305

Query: 461 -TSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAG---------SSECL 510
              L  +N    +        +  +      TF +N+     +            S   L
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRL------TFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 511 SMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGI--FPVCLPGLASRTFQITGYLQ 568
           S K          S            SL    L   G+        GL         +L 
Sbjct: 360 SFK-----GCCSQSD-------FGTTSLKYLDLSFNGVITMSSNFLGLEQLE-----HLD 402

Query: 569 LSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIP 626
              + L       +   L+N   + +            F+ L  L VL +  N+F     
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 627 SE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            + F  ++ L  LDLS        P +FN+L+ L  LN++ N L S
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  155 bits (394), Expect = 8e-40
 Identities = 85/442 (19%), Positives = 141/442 (31%), Gaps = 36/442 (8%)

Query: 268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN 327
            +   L+L  N           S   L+ L L +    ++   +  +LS L  L L+ N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT-GPLPVEIS 386
                   F   + ++ L     + +  + +  I  L  +  L+++HN      LP   S
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 387 QMRSLKFLILAHNRFNGSIPAVYGNMPNLQ----TLDLSFNELTGPIPPSIGNLTSLLWL 442
            + +L+ L L+ N+           +  +     +LDLS N +   I P       L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205

Query: 443 MLANNSLSGEIP-GEIGNCTSLLWLNLSNNKLSGN---IPPEVMTIGRNARPTFEANQRN 498
            L NN  S  +    I     L    L   +          +   +      T E  +  
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 499 G----ERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLP 554
                   I     CL+              V         + L     K      + L 
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325

Query: 555 GLASRTF---QITG-----------YLQLSGNQLS--GELSPDIGKLQNFSMVHLGFNQF 598
            L   TF   +              +L LS N LS  G  S       +   + L FN  
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 599 DGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE--FGNIKCLQNLDLSYNNFSGPFPASFNN 655
              + S F  L  L  L+   +N   ++     F +++ L  LD+S+ +    F   FN 
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 656 LTELSKLNISYNPLVSGTIPST 677
           L+ L  L ++ N      +P  
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  137 bits (347), Expect = 6e-34
 Identities = 79/417 (18%), Positives = 130/417 (31%), Gaps = 62/417 (14%)

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
              N+        NF   IP  +      + L L  N    +   S  +  +L+VLDLS 
Sbjct: 6   VVPNITY-QCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61

Query: 326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI 385
                     +   + +  L L  N  I  +       L ++ +L     N        I
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 386 SQMRSLKFLILAHNRFN-GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL----L 440
             +++LK L +AHN      +P  + N+ NL+ LDLS N++       +  L  +    L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 441 WLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGE 500
            L L+ N ++  I         L  L L NN  S N+                       
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVM---------------------- 217

Query: 501 RTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRT 560
           +T       L + R +  ++                                L GL + T
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEG-------------------NLEKFDKSALEGLCNLT 258

Query: 561 FQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRN 619
            +     +L+      +   D+   L N S   L     + ++           L L   
Sbjct: 259 IE---EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNC 314

Query: 620 NFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
            F      +  +   L+ L  + N     F  S  +L  L  L++S N L      S
Sbjct: 315 KFGQFPTLKLKS---LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCS 366

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 64.4 bits (157), Expect = 1e-10
 Identities = 24/106 (22%), Positives = 43/106 (40%), Gaps = 2/106 (1%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSG 623
           YL +S        +     L +  ++ +  N F        F +L  L  L+L++     
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             P+ F ++  LQ L+++ N         F+ LT L K+ +  NP 
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.3 bits (136), Expect = 5e-08
 Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 8/138 (5%)

Query: 566 YLQLSGNQL-SGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-----LIVLNLTRN 619
            L ++ N + S +L      L N   + L  N+      +    L       + L+L+ N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 620 NFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPA-SFNNLTELSKLNISYNPLVSGTIPSTG 678
             +   P  F  I+ L  L L  N  S          L  L    +      +       
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246

Query: 679 QLATFEKTSYLGDPLLDL 696
             +  E    L      L
Sbjct: 247 DKSALEGLCNLTIEEFRL 264

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 2/83 (2%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L+++GN       PDI  +L+N + + L   Q +   P+ F+ L  L VLN+  N    
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508

Query: 624 EIPSEFGNIKCLQNLDLSYNNFS 646
                F  +  LQ + L  N + 
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPWD 531

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  168 bits (429), Expect = 8e-47
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 13/207 (6%)

Query: 810  DRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPH 864
               +G GG  TVY     D     +VA+K +       + E     E EV + +     H
Sbjct: 16   VDKLGGGGMSTVYLAE--DTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLS--H 70

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
             N+V++     +     LV EY+EG +L + I     L+    ++    +   +   H  
Sbjct: 71   QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                IVHRD+K  N+L+D      + DFG+A+ +S      +  + GTV Y +PE  +  
Sbjct: 131  ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 985  QATTKGDVYSFGVLAMELATGRRALEG 1011
                  D+YS G++  E+  G     G
Sbjct: 188  ATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  167 bits (426), Expect = 3e-46
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)

Query: 810  DRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGEREFRA--EMEVLSGNGFGWPH 864
              I+G GG   V+     D    R+VAVK L R  L  +  F      E  +       H
Sbjct: 17   GEILGFGGMSEVHLAR--DLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALN--H 71

Query: 865  PNLVTLY--GWCLDGSEKI--LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
            P +V +Y  G     +  +  +V EY++G +L DI+     +T +R +++  D  +AL F
Sbjct: 72   PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT--IAGTVGYVAP 978
             H      I+HRDVK +N+++       V DFG+AR ++   + V+ T  + GT  Y++P
Sbjct: 132  SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 979  EYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            E  +      + DVYS G +  E+ TG     G
Sbjct: 189  EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  167 bits (425), Expect = 4e-46
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 27/214 (12%)

Query: 810  DRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEGEREFRAEME-------VLSGNG 859
             R++G+GG G VY     V    R VA+K +  E L  +  FR  M+        L    
Sbjct: 39   RRLVGRGGMGDVYEAEDTVR--ERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQ--- 92

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
                 P++V ++ +     +  +    + G  L  ++  +  L   R + I   +  AL 
Sbjct: 93   ----EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT--IAGTVGYVA 977
              H        HRDVK  N+L+  +  A + DFG+A   +  D  ++      GT+ Y+A
Sbjct: 149  AAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMA 203

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            PE      AT + D+Y+   +  E  TG    +G
Sbjct: 204  PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  169 bits (431), Expect = 4e-46
 Identities = 78/418 (18%), Positives = 144/418 (34%), Gaps = 82/418 (19%)

Query: 70  PGIICSPDKARVNG--LNLTDWNISGDIFNNFSA--LTQLSYLDLSRNTFSGSIPDD-LS 124
           P   C     + +    ++     + D++  F    L     +    +T    +P   L 
Sbjct: 8   PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD 66

Query: 125 SCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS 182
           S R ++ LNL+   +        +   +++ L +  N I        P            
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-----YLPP----------- 110

Query: 183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSV 239
                      F     L  L L  N+       I++   +L   S+S N L   +    
Sbjct: 111 ---------HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL 299
           F+   SL+   LS N  +      +S   +L   N+  N  S      +     +E L  
Sbjct: 161 FQATTSLQNLQLSSNR-LTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212

Query: 300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSS 359
             +N ++V+   +    +L +L L  NN                             +++
Sbjct: 213 S-HNSINVVRGPV--NVELTILKLQHNNL---------------------------TDTA 242

Query: 360 GILKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL 418
            +L  P +  +DLS+N     +      +M+ L+ L +++NR   ++      +P L+ L
Sbjct: 243 WLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 419 DLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           DLS N L   +  +      L  L L +NS+   +   +    +L  L LS+N    N
Sbjct: 301 DLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (372), Expect = 2e-38
 Identities = 64/315 (20%), Positives = 115/315 (36%), Gaps = 30/315 (9%)

Query: 176 LVVANLSLNNLTGRIDTCFDGC--LNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENV 230
            V  ++ ++  T  +   F+     N + +   ++  R     + +   Q+   ++++  
Sbjct: 21  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80

Query: 231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI- 288
           +   + +  F    +++   +  N  I   P  V  N   L VL L  N+ S  +P  I 
Sbjct: 81  IE-EIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIF 137

Query: 289 GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI-FGRFTQVKILAL 347
            +   L  L +  NN   +  ++    + L+ L LSSN        +       +    +
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL----THVDLSLIPSLFHANV 193

Query: 348 HSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA 407
             N        S +     +  LD SHN+      V       L  L L HN        
Sbjct: 194 SYN------LLSTLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTAW 243

Query: 408 VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWL 466
           +  N P L  +DLS+NEL   I       +  L  L ++NN L   +        +L  L
Sbjct: 244 L-LNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 467 NLSNNKLSGNIPPEV 481
           +LS+N L  ++    
Sbjct: 301 DLSHNHLL-HVERNQ 314

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 18/125 (14%), Positives = 44/125 (35%), Gaps = 5/125 (4%)

Query: 359 SGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL 418
           S +        + +           E   + + K +   ++       A+  +   ++ L
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 419 DLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGN 476
           +L+  ++   I         ++  L +  N++   +P  +  N   L  L L  N LS +
Sbjct: 75  NLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-S 131

Query: 477 IPPEV 481
           +P  +
Sbjct: 132 LPRGI 136

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 64.3 bits (157), Expect = 9e-11
 Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L+L  N L+   +  +        V L +N+ +  +   F ++  L  L ++ N     
Sbjct: 230 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +      I  L+ LDLS+N+       +      L  L + +N +V+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 332

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 8/106 (7%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            + LS N+L  ++      K+Q    +++  N+    L      +P L VL+L+ N+   
Sbjct: 252 EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 308

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            +         L+NL L +N+         +    L  L +S+N  
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 11/103 (10%), Positives = 33/103 (32%), Gaps = 5/103 (4%)

Query: 381 LPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSL 439
           +   +        + +     +         + N + +    + +   +P ++  +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQV 71

Query: 440 LWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGNIPPEV 481
             L L +  +  EI         ++  L +  N +   +PP V
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 112

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 5/109 (4%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            +    + +  +L   +    +   +++L   Q +      F     +  L +  N    
Sbjct: 49  IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 106

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            +P   F N+  L  L L  N+ S      F+N  +L+ L++S N L  
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 155

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.7 bits (132), Expect = 9e-08
 Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 9/105 (8%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIP 626
             +S N LS      +        +    N  +        +L   +L L  NN + +  
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT--ILKLQHNNLT-DTA 242

Query: 627 SEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               N   L  +DLSYN         F  +  L +L IS N LV+
Sbjct: 243 W-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 286

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 21/107 (19%), Positives = 36/107 (33%), Gaps = 3/107 (2%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEI 625
           + +           +   L N  +V    +       +  D    + +LNL       EI
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84

Query: 626 PSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            +  F     +Q L + +N      P  F N+  L+ L +  N L S
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 21/107 (19%), Positives = 35/107 (32%), Gaps = 12/107 (11%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            L +S N L   +  D      +   + L  N+      S    L     N++ N  S  
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL--FHANVSYNLLS-- 199

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                     ++ LD S+N+ +         LT    L + +N L  
Sbjct: 200 ---TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLTD 240

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.4 bits (108), Expect = 7e-05
 Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 8/105 (7%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +S N+L   L+     +    ++ L  N     +     Q   L  L L  N+    
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           +         L+NL LS+N++      +      +++  +     
Sbjct: 333 LK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 8/79 (10%), Positives = 25/79 (31%), Gaps = 3/79 (3%)

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI-GNCTS 462
            I +          + +               L +   +   N+++  ++P  +  +   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 463 LLWLNLSNNKLSGNIPPEV 481
           +  LNL++ ++   I    
Sbjct: 71  VELLNLNDLQIE-EIDTYA 88

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  173 bits (441), Expect = 5e-46
 Identities = 68/411 (16%), Positives = 132/411 (32%), Gaps = 21/411 (5%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           L+L+   I+     +  A   L  L L  +  +    D   S  SL++L+LS N LS   
Sbjct: 31  LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID-TCFDGCLNL 200
                 L SL+ L+L  N        S       L    +        I    F G  +L
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 201 RYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
             L++ + + R         +  +   ++  +  +  +         S+   +L +    
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLA 209

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK 317
                 +        +       S         +  L    L  +           + + 
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTL 263

Query: 318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
             + D + +      +        ++ L +    Y+    S+    L  + R+ + ++  
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQF-YLFYDLSTVYSLLEKVKRITVENSKV 322

Query: 378 TGPLPVEISQMRSLKFLILAHNRFNGSI---PAVYGNMPNLQTLDLSFNELT--GPIPPS 432
                     ++SL+FL L+ N          A  G  P+LQTL LS N L         
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           +  L +L  L ++ N+    +P        + +LNLS+  +   +   +  
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ 431

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  159 bits (404), Expect = 3e-41
 Identities = 71/397 (17%), Positives = 139/397 (35%), Gaps = 48/397 (12%)

Query: 101 ALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSV 158
           +       D    +F+ SIP  L++  ++K L+LS N ++  G  +L    +L++L L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGL 218
           +RI+     +F ++   L   +LS N+L+    + F    +L+YL+L  N          
Sbjct: 60  SRINTIEGDAFYSL-GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP--------- 109

Query: 219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFG 277
                          +  +S+F    +L+   +   E   +      +   +L  L +  
Sbjct: 110 ------------YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157

Query: 278 NNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG 337
            +        + SI  +  L L  +    ++      LS +  L+L   N          
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217

Query: 338 RFTQVKILALHSNSYIDGMNSS---------GILKLPNISRLDLSHNNFTGPLPVEISQM 388
                  +   +       + S          IL+L  +   D + N      P E   +
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277

Query: 389 R--------SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLL 440
                    +++ L +        +  VY  +  ++ + +  +++         +L SL 
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337

Query: 441 WLMLANNSLSGEI---PGEIGNCTSLLWLNLSNNKLS 474
           +L L+ N +  E        G   SL  L LS N L 
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  157 bits (400), Expect = 1e-40
 Identities = 70/414 (16%), Positives = 140/414 (33%), Gaps = 23/414 (5%)

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
           +C    V +    +F+  IP+ +   + +++L L  N    +    L   + L+VL L S
Sbjct: 3   SCDASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG-PLPVE 384
           +         F     ++ L L  N  +  ++SS    L ++  L+L  N +    +   
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNH-LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 385 ISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
              + +L+ L + +      I  +    + +L  L++    L      S+ ++  +  L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTI 503
           L  +  +  +       +S+ +L L +  L+       + +   + P  +   R    T 
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLT- 236

Query: 504 AGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQI 563
                  S    +                 +   L D     + +    L  + + T + 
Sbjct: 237 -----DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS-ELGKVETVTIR- 289

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
              L +    L  +LS     L+    + +  ++      S    L  L  L+L+ N   
Sbjct: 290 --RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 623 GEI---PSEFGNIKCLQNLDLSYNNFS--GPFPASFNNLTELSKLNISYNPLVS 671
            E     +  G    LQ L LS N+             L  L+ L+IS N    
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP 401

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  155 bits (394), Expect = 5e-40
 Identities = 73/431 (16%), Positives = 144/431 (33%), Gaps = 45/431 (10%)

Query: 84  LNLTDWNISGDIFNN-FSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS-- 140
           L + +     +I    F+ LT L+ L++   +        L S R + +L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 141 GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLT------GRIDTCF 194
            ++    L S+  L+L    +        P       +  L+             +    
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 195 DGCLNLRYLDLSSNNFRG---------NIWNGLAQLVEFSVSENVLSG----VVSSSVFK 241
              L L  ++       G         ++ + L ++   ++    +         S+V+ 
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 242 ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS---GPIPAEIGSISGLEALF 298
               ++   +  ++          + ++L  L+L  N          A  G+   L+ L 
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367

Query: 299 LGKNNF--LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM 356
           L +N+   +    E LL L  L  LD+S N F   +        +++ L L S      +
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG----I 422

Query: 357 NSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ 416
                     +  LD+S+NN      + +     L+ L ++ N+   ++P      P L 
Sbjct: 423 RVVKTCIPQTLEVLDVSNNNLDS-FSLFLP---RLQELYISRNKLK-TLPD-ASLFPVLL 476

Query: 417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
            + +S N+L          LTSL  + L  N           +C  + +L+   NK S  
Sbjct: 477 VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW-------DCSCPRIDYLSRWLNKNSQK 529

Query: 477 IPPEVMTIGRN 487
                   G  
Sbjct: 530 EQGSAKCSGSG 540

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  141 bits (357), Expect = 3e-35
 Identities = 71/455 (15%), Positives = 139/455 (30%), Gaps = 43/455 (9%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
           +  + D     F    P  ++    +  L+L  N  +     ++ + + L+ L L  +  
Sbjct: 6   ASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL 364
            ++  ++  +L  LE LDLS N+        FG  + +K L L  N Y     +S    L
Sbjct: 63  NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122

Query: 365 PNISRLDLSHNNFTGPLPVE-ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
            N+  L + +      +     + + SL  L +              ++ ++  L L  +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           E    +      L+S+ +L L + +L+      +        +     + S         
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS--------V 234

Query: 484 IGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTI--LTRKSCRSLWDR 541
           +   +        R          +  ++      +      V  +  +   + R L   
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294

Query: 542 LLKGTGIFPVCLPGLAS----------------RTFQITG---YLQLSGNQLSGELSPD- 581
                         L                     Q      +L LS N +  E   + 
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354

Query: 582 --IGKLQNFSMVHLGFNQFD--GKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQ 636
              G   +   + L  N      K       L  L  L+++RN F   +P      + ++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR 413

Query: 637 NLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            L+LS              L     L++S N L S
Sbjct: 414 FLNLSSTGIRVVKTCIPQTLEV---LDVSNNNLDS 445

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  124 bits (313), Expect = 9e-30
 Identities = 61/390 (15%), Positives = 131/390 (33%), Gaps = 38/390 (9%)

Query: 313 LNLSKLEVLDLSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
           L+     V D  S +F      I  G    +K L L  N  I  +    +    N+  L 
Sbjct: 2   LSCDASGVCDGRSRSF----TSIPSGLTAAMKSLDLSFN-KITYIGHGDLRACANLQVLI 56

Query: 372 LSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG-PI 429
           L  +     +  +    + SL+ L L+ N  +    + +G + +L+ L+L  N      +
Sbjct: 57  LKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115

Query: 430 PPSIGNLTSLLWLMLANNSLSGEIP-GEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNA 488
                NLT+L  L + N     EI   +    TSL  L +    L  N   +        
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQ-------- 166

Query: 489 RPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGI 548
             + ++ +     T+  S        ++   +     + ++   +   +   R       
Sbjct: 167 --SLKSIRDIHHLTLHLSE-----SAFLLEIF--ADILSSVRYLELRDTNLARFQFSPLP 217

Query: 549 FPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQ 608
                  +    F+ +     S N+L  +L   I +L          N      PS+ D 
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276

Query: 609 LP---------LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTEL 659
           +          +  L++ +     ++ + +  ++ ++ + +  +       +   +L  L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336

Query: 660 SKLNISYNPLVSGTIPSTGQLATFEKTSYL 689
             L++S N +V   + ++     +     L
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (277), Expect = 3e-25
 Identities = 50/311 (16%), Positives = 102/311 (32%), Gaps = 44/311 (14%)

Query: 25  THVAGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGL 84
           T  + + L      +  L     ++  +N       ++S    E   +        +  L
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV----TIRRL 291

Query: 85  NLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--- 141
           ++  + +  D+   +S L ++  + +  +             +SL++L+LS N++     
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 142 --DLNLSGLRSLEILDLSVNRIH--GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC 197
                     SL+ L LS N +    +         + L   ++S N     +       
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL-LTLKNLTSLDISRNTFH-PMPDSCQWP 409

Query: 198 LNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
             +R+L+LSS   R              V   +              +LE+ D+S N  +
Sbjct: 410 EKMRFLNLSSTGIR-------------VVKTCIPQ------------TLEVLDVSNNN-L 443

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK 317
             F         L  L +  N     +P        L  + + +N   SV       L+ 
Sbjct: 444 DSFS---LFLPRLQELYISRNKLKT-LPDASLFPV-LLVMKISRNQLKSVPDGIFDRLTS 498

Query: 318 LEVLDLSSNNF 328
           L+ + L +N +
Sbjct: 499 LQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.0 bits (151), Expect = 6e-10
 Identities = 21/136 (15%), Positives = 40/136 (29%), Gaps = 3/136 (2%)

Query: 566 YLQLSGNQLSG-ELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
           YL L GN      ++     L N   + +G  +   ++    F  L  L  L +   +  
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLAT 682
                   +I+ + +L L  +  +       + L+ +  L +    L             
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 683 FEKTSYLGDPLLDLPD 698
                 L      L D
Sbjct: 222 SSPMKKLAFRGSVLTD 237

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 22/105 (20%), Positives = 38/105 (36%), Gaps = 8/105 (7%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           +L LS   +   +   I   Q   ++ +  N  D        +L    L ++RN     +
Sbjct: 414 FLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRL--QELYISRNKLK-TL 466

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
           P +      L  + +S N         F+ LT L K+ +  NP  
Sbjct: 467 P-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 23/108 (21%), Positives = 35/108 (32%), Gaps = 13/108 (12%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP--LIVLNLTRNNFSG 623
            L +S N     +       +    ++L        +      +P  L VL+++ NN   
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG----IRVVKTCIPQTLEVLDVSNNNLD- 444

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                      LQ L +S N       AS      L  + IS N L S
Sbjct: 445 SFSLFLPR---LQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKS 487

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  169 bits (430), Expect = 2e-44
 Identities = 78/417 (18%), Positives = 144/417 (34%), Gaps = 80/417 (19%)

Query: 70  PGIICSPDKARVN--GLNLTDWNISGDIFNNFSA--LTQLSYLDLSRNTFSGSIPDD-LS 124
           P   C     + +    ++     + D++  F    L     +    +T    +P   L 
Sbjct: 14  PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD 72

Query: 125 SCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS 182
           S R ++ LNL+   +        +   +++ L +  N I        P            
Sbjct: 73  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-----YLPP----------- 116

Query: 183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSV 239
                      F     L  L L  N+       I++   +L   S+S N L   +    
Sbjct: 117 ---------HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL 299
           F+   SL+   LS N  +      +S   +L   N+  N  S      +     +E L  
Sbjct: 167 FQATTSLQNLQLSSNR-LTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218

Query: 300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSS 359
             +N ++V+   +    +L +L L  NN                             +++
Sbjct: 219 S-HNSINVVRGPV--NVELTILKLQHNNL---------------------------TDTA 248

Query: 360 GILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLD 419
            +L  P +  +DLS+N     +     +M+ L+ L +++NR   ++      +P L+ LD
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307

Query: 420 LSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           LS N L   +  +      L  L L +NS+   +   +    +L  L LS+N    N
Sbjct: 308 LSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 360

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  146 bits (369), Expect = 1e-36
 Identities = 63/314 (20%), Positives = 115/314 (36%), Gaps = 28/314 (8%)

Query: 176 LVVANLSLNNLTGRIDTCFD--GCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENV 230
            V  ++ ++  T  +   F+     N + +   ++  R     + +   Q+   ++++  
Sbjct: 27  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86

Query: 231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI- 288
           +   + +  F    +++   +  N  I   P  V  N   L VL L  N+ S  +P  I 
Sbjct: 87  IE-EIDTYAFAYAHTIQKLYMGFNA-IRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIF 143

Query: 289 GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI-FGRFTQVKILAL 347
            +   L  L +  NN   +  ++    + L+ L LSSN        +       +    +
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL----THVDLSLIPSLFHANV 199

Query: 348 HSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA 407
             N        S +     +  LD SHN+      V       L  L L HN        
Sbjct: 200 SYN------LLSTLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTAW 249

Query: 408 VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLN 467
           +  N P L  +DLS+NEL   +      +  L  L ++NN L   +        +L  L+
Sbjct: 250 L-LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307

Query: 468 LSNNKLSGNIPPEV 481
           LS+N L  ++    
Sbjct: 308 LSHNHLL-HVERNQ 320

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 89.2 bits (221), Expect = 2e-18
 Identities = 71/421 (16%), Positives = 134/421 (31%), Gaps = 48/421 (11%)

Query: 85  NLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN 144
           +L   N+S ++ +  +    +  LD S N+ +  +   +     L  L L HN L+    
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDTAW 249

Query: 145 LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLD 204
           L     L  +DLS N +  +I +      ++L    +S N L   ++        L+ LD
Sbjct: 250 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307

Query: 205 LSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
           LS N+      N      +L    +  N +   +  S      +L+   LS N++  +  
Sbjct: 308 LSHNHLLHVERNQPQ-FDRLENLYLDHNSIV-TLKLSTHH---TLKNLTLSHNDWDCNSL 362

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
             +   RN+    +   +    I  +      LE     K +    +   L  ++   V+
Sbjct: 363 RALF--RNVARPAVDDADQHCKIDYQ------LEHGLCCKESDKPYLDRLLQYIALTSVV 414

Query: 322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPL 381
           +        +VQ+  GR +    +     S    +   G + L    +L+   N     +
Sbjct: 415 E--------KVQRAQGRCSATDTIN-SVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465

Query: 382 PV----EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLT 437
                 +I Q + L+ L    +              NL+   L  + L           T
Sbjct: 466 QQLTNEQIQQEQLLQGLHAEIDT-------------NLRRYRLPKDGLARSSDNLNKVFT 512

Query: 438 SLLWLMLANNSLSGEIPGEIGN-CTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQ 496
            L          +     E          L   N  L   +  +        + T    Q
Sbjct: 513 HLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQ 572

Query: 497 R 497
           +
Sbjct: 573 K 573

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 2e-12
 Identities = 19/126 (15%), Positives = 46/126 (36%), Gaps = 7/126 (5%)

Query: 359 SGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQT 417
           S +        + +           E   + + K +   ++     +PA +  +   ++ 
Sbjct: 21  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 79

Query: 418 LDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSG 475
           L+L+  ++   I         ++  L +  N++   +P  +  N   L  L L  N LS 
Sbjct: 80  LNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 476 NIPPEV 481
           ++P  +
Sbjct: 137 SLPRGI 142

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.8 bits (155), Expect = 2e-10
 Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L+L  N L+   +  +        V L +N+ +  +   F ++  L  L ++ N     
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +      I  L+ LDLS+N+       +      L  L + +N +V+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 338

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 20/108 (18%), Positives = 42/108 (38%), Gaps = 9/108 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L  S N ++  +   +      +++ L  N       +     P L+ ++L+ N    +
Sbjct: 215 ELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-K 268

Query: 625 IPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           I    F  ++ L+ L +S N            +  L  L++S+N L+ 
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 315

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.1 bits (135), Expect = 5e-08
 Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 8/106 (7%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            + LS N+L  ++      K+Q    +++  N+    L      +P L VL+L+ N+   
Sbjct: 258 EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL- 314

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            +         L+NL L +N+         +    L  L +S+N  
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 9/105 (8%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIP 626
             +S N LS      +        +    N  +        +L   +L L  NN + +  
Sbjct: 197 ANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT--ILKLQHNNLT-DTA 248

Query: 627 SEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               N   L  +DLSYN         F  +  L +L IS N LV+
Sbjct: 249 W-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 292

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 53.8 bits (129), Expect = 3e-07
 Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 5/109 (4%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            +    + +  +L   +    +   +++L   Q +      F     +  L +  N    
Sbjct: 55  IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 112

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            +P   F N+  L  L L  N+ S      F+N  +L+ L++S N L  
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 3/86 (3%)

Query: 588 FSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNF 645
           F  VH+     D     +   L    ++    +    ++P+    + + ++ L+L+    
Sbjct: 29  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87

Query: 646 SGPFPASFNNLTELSKLNISYNPLVS 671
                 +F     + KL + +N +  
Sbjct: 88  EEIDTYAFAYAHTIQKLYMGFNAIRY 113

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 21/107 (19%), Positives = 35/107 (32%), Gaps = 12/107 (11%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            L +S N L   +  D      +   + L  N+      S    L     N++ N  S  
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL--FHANVSYNLLS-- 205

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                     ++ LD S+N+ +         LT    L + +N L  
Sbjct: 206 ---TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLTD 246

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 7/104 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L +S N+L   L+     +    ++ L  N     +     Q   L  L L  N+    
Sbjct: 282 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338

Query: 625 IPSEFGNIKCLQNLDLSYNNFSG-PFPASFNNLTELSKLNISYN 667
           +         L+NL LS+N++      A F N+   +  +   +
Sbjct: 339 LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (420), Expect = 6e-44
 Identities = 78/389 (20%), Positives = 135/389 (34%), Gaps = 62/389 (15%)

Query: 100 SALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN 159
                L  L  S N+ +  +P+   S +SL   N +   LS          LE L +S N
Sbjct: 88  ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-----LLEYLGVSNN 141

Query: 160 RIHGEISFSFPAI--CEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG--NIW 215
           ++        P +     L + ++  N+L        D   +L ++   +N       + 
Sbjct: 142 QLE-----KLPELQNSSFLKIIDVDNNSLK----KLPDLPPSLEFIAAGNNQLEELPELQ 192

Query: 216 NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNL 275
           N L  L       N L       +     SLE      N  + + P E+ N   L  +  
Sbjct: 193 N-LPFLTAIYADNNSL-----KKLPDLPLSLESIVAGNNI-LEELP-ELQNLPFLTTIYA 244

Query: 276 FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI 335
             N     +P    S+  L       +N+L+ +PE   +L+ L+V +   +        +
Sbjct: 245 DNNLLKT-LPDLPPSLEALNVR----DNYLTDLPELPQSLTFLDVSENIFS-------GL 292

Query: 336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLI 395
                 +  L   SN        S     P++  L++S+N     LP        L+ LI
Sbjct: 293 SELPPNLYYLNASSNE-----IRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLI 343

Query: 396 LAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPG 455
            + N     +P       NL+ L + +N L    P    ++  L      N+ L+ E+P 
Sbjct: 344 ASFNHLA-EVPE---LPQNLKQLHVEYNPLRE-FPDIPESVEDL----RMNSHLA-EVPE 393

Query: 456 EIGNCTSLLWLNLSNNKLSGNIPPEVMTI 484
              N      L++  N L    P    ++
Sbjct: 394 LPQNLKQ---LHVETNPLR-EFPDIPESV 418

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  163 bits (415), Expect = 3e-43
 Identities = 81/397 (20%), Positives = 142/397 (35%), Gaps = 62/397 (15%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSG-------- 147
               +   +    + + +  + P      R +    L   +     +L L+         
Sbjct: 29  EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88

Query: 148 -LRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS 206
               LE L  S N +  E+     +  + L+V N +L  L+            L YL +S
Sbjct: 89  LPPHLESLVASCNSLT-ELPELPQS-LKSLLVDNNNLKALSDLPP-------LLEYLGVS 139

Query: 207 SNNFRG--NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV 264
           +N       + N  + L    V  N L       +     SLE      N+ + + P E+
Sbjct: 140 NNQLEKLPELQN-SSFLKIIDVDNNSL-----KKLPDLPPSLEFIAAGNNQ-LEELP-EL 191

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
            N   L  +    N+    +P    S   LE++  G NN L  +PE L NL  L  +   
Sbjct: 192 QNLPFLTAIYADNNSLKK-LPDLPLS---LESIVAG-NNILEELPE-LQNLPFLTTIYAD 245

Query: 325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE 384
           +N      + +      ++ L +  N       +       +++ LD+S N F+G L   
Sbjct: 246 NNLL----KTLPDLPPSLEALNVRDNY-----LTDLPELPQSLTFLDVSENIFSG-LSEL 295

Query: 385 ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML 444
                +L +L  + N    S+       P+L+ L++S N+L   +P     L     L+ 
Sbjct: 296 PP---NLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLIE-LPALPPRLER---LIA 344

Query: 445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
           + N L+ E+P    N      L++  N L    P   
Sbjct: 345 SFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIP 376

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  143 bits (362), Expect = 2e-36
 Identities = 64/411 (15%), Positives = 129/411 (31%), Gaps = 73/411 (17%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L  +  +++ ++     +L  L   + +    S   P        L+YL +S+N L    
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKLP 147

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L     L+I+D+  N +        P +   L       N L   +         L  +
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-----KLPDLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAI 200

Query: 204 DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE 263
              +N+ +  + +    L       N+L  +      +    L       N  +   P  
Sbjct: 201 YADNNSLK-KLPDLPLSLESIVAGNNILEEL---PELQNLPFLTTIYADNNL-LKTLPDL 255

Query: 264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
             +   L V + +  +    +P    S++ L+       N  S + E   NL     L+ 
Sbjct: 256 PPSLEALNVRDNYLTD----LPELPQSLTFLDVS----ENIFSGLSELPPNL---YYLNA 304

Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP----NISRLDLSHNNFTG 379
           SSN      + +      ++ L + +N          +++LP     + RL  S N+   
Sbjct: 305 SSNEI----RSLCDLPPSLEELNVSNNK---------LIELPALPPRLERLIASFNHLAE 351

Query: 380 PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNM----------------PNLQTLDLSFN 423
            +P       +LK L + +N      P +  ++                 NL+ L +  N
Sbjct: 352 -VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
            L    P    ++  L    + +  +             L      ++   
Sbjct: 407 PLRE-FPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  120 bits (302), Expect = 8e-29
 Identities = 53/288 (18%), Positives = 97/288 (33%), Gaps = 44/288 (15%)

Query: 196 GCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
               L+     S+N         N +    E+  + +            E   + +  L 
Sbjct: 9   SNTFLQEPLRHSSNLTEMPVEAEN-VKSKTEYYNAWSEWERNAPPGNG-EQREMAVSRLR 66

Query: 253 ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
           +              R    L L     S  +P        LE+L    N+ L+ +PE  
Sbjct: 67  DC-----------LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNS-LTELPELP 110

Query: 313 LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL 372
            +L  L V + +          +      ++ L + +N          +     +  +D+
Sbjct: 111 QSLKSLLVDNNNLK-------ALSDLPPLLEYLGVSNNQLEK---LPELQNSSFLKIIDV 160

Query: 373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS 432
            +N+    LP       SL+F+   +N+    +P +  N+P L  +    N L   +P  
Sbjct: 161 DNNSLKK-LPDLPP---SLEFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLKK-LPDL 213

Query: 433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
             +L S+   +  NN L  E+P E+ N   L  +   NN L   +P  
Sbjct: 214 PLSLESI---VAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL 255

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  103 bits (259), Expect = 3e-23
 Identities = 45/240 (18%), Positives = 76/240 (31%), Gaps = 51/240 (21%)

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
           P  VSN   L       +N +  +P E  ++      +   + +    P       ++ V
Sbjct: 5   PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 321 LDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP----NISRLDLSHNN 376
             L                 Q   L L++          G+  LP    ++  L  S N+
Sbjct: 63  SRLRDC-----------LDRQAHELELNNL---------GLSSLPELPPHLESLVASCNS 102

Query: 377 FTGPLPVEISQMRSLKFLILAHNRFNG----------------SIPAVYGNMPNLQTLDL 420
            T  LP     ++SL          +                  +P +  N   L+ +D+
Sbjct: 103 LT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPEL-QNSSFLKIIDV 160

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
             N L   +P    +L  +      NN L  E+P E+ N   L  +   NN L   +P  
Sbjct: 161 DNNSLKK-LPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDL 213

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 42/259 (16%), Positives = 74/259 (28%), Gaps = 68/259 (26%)

Query: 429 IPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNA 488
           I P   + T L   +  +++L+ E+P E  N  S      + ++   N PP        A
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 489 RPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGI 548
                         +  ++  LS                                     
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSS------------------------------------ 85

Query: 549 FPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPS---- 604
            P   P L S        L  S N L+ EL      L++  + +          P     
Sbjct: 86  LPELPPHLES--------LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYL 136

Query: 605 -----QFDQLP-------LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS 652
                Q ++LP       L ++++  N+   ++P    +   L+ +    N      P  
Sbjct: 137 GVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE-LP-E 190

Query: 653 FNNLTELSKLNISYNPLVS 671
             NL  L+ +    N L  
Sbjct: 191 LQNLPFLTAIYADNNSLKK 209

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 27/171 (15%), Positives = 53/171 (30%), Gaps = 42/171 (24%)

Query: 308 IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
           I    ++ + L+     S+N            T++                     + + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSN-----------LTEM---------------PVEAENVKSK 36

Query: 368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG 427
           +    + + +    P    + R +    L                     L+L+   L+ 
Sbjct: 37  TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR-----------QAHELELNNLGLS- 84

Query: 428 PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
            +P    +L SL+    + NSL+ E+P    +  SLL  N +   LS   P
Sbjct: 85  SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 59.2 bits (144), Expect = 4e-09
 Identities = 19/113 (16%), Positives = 33/113 (29%), Gaps = 19/113 (16%)

Query: 381 LPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL---- 436
           +         L+  +   +     +P    N+ +      +++E     PP  G      
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 437 ---------TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
                         L L N  LS  +P    +  S   L  S N L+  +P  
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPEL 109

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.5 bits (129), Expect = 3e-07
 Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 11/106 (10%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           ++    NQL  EL P++  L   + ++   N    KLP     L    +    N      
Sbjct: 177 FIAAGNNQLE-EL-PELQNLPFLTAIYADNNSLK-KLPDLPLSL--ESIVAGNNILE--E 229

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             E  N+  L  +    N      P    +L     LN+  N L  
Sbjct: 230 LPELQNLPFLTTIYADNNLLKT-LPDLPPSLEA---LNVRDNYLTD 271

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 5e-07
 Identities = 30/153 (19%), Positives = 56/153 (36%), Gaps = 32/153 (20%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           YL  S N++   L      L+     ++  N+   +LP+   +L    L  + N+ + E+
Sbjct: 301 YLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALPPRL--ERLIASFNHLA-EV 352

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS----------------KLNISYNPL 669
           P    N   L+ L + YN     FP    ++ +L                 +L++  NPL
Sbjct: 353 PELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408

Query: 670 VSGTIPSTGQLATFEKTSYLGDPLLDLPDFIEN 702
                P      + E      + ++D  +F   
Sbjct: 409 RE--FPDI--PESVEDLRMNSERVVDPYEFAHE 437

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 17/121 (14%), Positives = 39/121 (32%), Gaps = 26/121 (21%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP--------------- 610
            L  S N L+ E+      L+    +H+ +N    + P   + +                
Sbjct: 341 RLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395

Query: 611 --LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
             L  L++  N    E P    +   +++L ++      P+  +     +L      ++ 
Sbjct: 396 QNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451

Query: 669 L 669
            
Sbjct: 452 H 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.6 bits (119), Expect = 4e-06
 Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 17/112 (15%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
            +    N L   L      L+  ++           LP     L    L+++ N FS  +
Sbjct: 241 TIYADNNLLK-TLPDLPPSLEALNVRDNYLTD----LPELPQSLT--FLDVSENIFS-GL 292

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
                N   L  L+ S N       +  +    L +LN+S N L+   +P+ 
Sbjct: 293 SELPPN---LYYLNASSNEIR----SLCDLPPSLEELNVSNNKLIE--LPAL 335

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  160 bits (407), Expect = 1e-43
 Identities = 56/305 (18%), Positives = 102/305 (33%), Gaps = 26/305 (8%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN--GLAQLVEFSVSENVLSGVVSS 237
           NL     T  +    D     +    +  N   + W           + +   L      
Sbjct: 16  NLYFQGST-ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL 74

Query: 238 SVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEAL 297
                       +L     +  FP +     +L  + +        +P  +   +GLE L
Sbjct: 75  LEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETL 132

Query: 298 FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMN 357
            L +N  L  +P S+ +L++L  L + +     E+ +                       
Sbjct: 133 TLARNP-LRALPASIASLNRLRELSIRACPELTELPEPLASTD----------------A 175

Query: 358 SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQT 417
           S     L N+  L L        LP  I+ +++LK L + ++  + ++     ++P L+ 
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233

Query: 418 LDLS-FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           LDL     L    PP  G    L  L+L + S    +P +I   T L  L+L        
Sbjct: 234 LDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292

Query: 477 IPPEV 481
           +P  +
Sbjct: 293 LPSLI 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  158 bits (402), Expect = 7e-43
 Identities = 61/377 (16%), Positives = 105/377 (27%), Gaps = 72/377 (19%)

Query: 117 GSIPDDLSSCRSLKYLNLSH--NILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICE 174
           GS           + L       +      LS  +     D +        + S      
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56

Query: 175 KLVVANLSLNNLTGRIDTCFDGCL-NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSG 233
              +   +   L    D   D        L+L S        +   +L            
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS----------- 104

Query: 234 VVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG 293
                       L+   +     + + P  +     L  L L  N     +PA I S++ 
Sbjct: 105 -----------HLQHMTIDAAG-LMELPDTMQQFAGLETLTLARNPLRA-LPASIASLNR 151

Query: 294 LEALFLGKNNFLSVIPESLLN---------LSKLEVLDLSSNNFGGEVQKIFGRFTQVKI 344
           L  L +     L+ +PE L +         L  L+ L L                    I
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT----------------GI 195

Query: 345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS 404
            +L           + I  L N+  L + ++  +  L   I  +  L+ L L       +
Sbjct: 196 RSL----------PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244

Query: 405 IPAVYGNMPNLQTLDLS-FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSL 463
            P ++G    L+ L L   + L   +P  I  LT L  L L        +P  I    + 
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 464 LWLNLSNNKLSGNIPPE 480
             + +  + L   +   
Sbjct: 304 CIILVPPH-LQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  149 bits (379), Expect = 7e-40
 Identities = 55/358 (15%), Positives = 102/358 (28%), Gaps = 63/358 (17%)

Query: 102 LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRI 161
            +    L    +T      D LS  +     + +    +     +   + +I   +    
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW--RQANSNNPQIETRT---- 64

Query: 162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQL 221
                         L      L + T               L+L S        +   +L
Sbjct: 65  -----------GRALKATADLLEDATQ---------PGRVALELRSVPLP-QFPDQAFRL 103

Query: 222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS 281
                                   L+   +     + + P  +     L  L L  N   
Sbjct: 104 S----------------------HLQHMTIDAAG-LMELPDTMQQFAGLETLTLARNPLR 140

Query: 282 GPIPAEIGSISGLEALFLGKNNFLSVIPESLLN---------LSKLEVLDLSSNNFGGEV 332
             +PA I S++ L  L +     L+ +PE L +         L  L+ L L        +
Sbjct: 141 A-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SL 198

Query: 333 QKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK 392
                    +K L + ++  +  +  + I  LP +  LDL         P        LK
Sbjct: 199 PASIANLQNLKSLKIRNSP-LSALGPA-IHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256

Query: 393 FLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS 450
            LIL       ++P     +  L+ LDL        +P  I  L +   +++  +  +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (289), Expect = 5e-28
 Identities = 29/225 (12%), Positives = 61/225 (27%), Gaps = 41/225 (18%)

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
           +      L   G+     +      +S  +  +    N          N +  ++   + 
Sbjct: 10  HSSGRENLYFQGST---ALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTG 65

Query: 326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI 385
                    +                             P    L+L         P + 
Sbjct: 66  RALKATADLL------------------------EDATQPGRVALELRSVPLPQ-FPDQA 100

Query: 386 SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA 445
            ++  L+ + +        +P        L+TL L+ N L   +P SI +L  L  L + 
Sbjct: 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIR 158

Query: 446 NNSLSGEIPGEIGNC---------TSLLWLNLSNNKLSGNIPPEV 481
                 E+P  + +           +L  L L    +  ++P  +
Sbjct: 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  110 bits (276), Expect = 3e-26
 Identities = 43/241 (17%), Positives = 75/241 (31%), Gaps = 61/241 (25%)

Query: 97  NNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHN-----------ILSGDLNL 145
           +       L  L L+RN    ++P  ++S   L+ L++                      
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 146 SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDL 205
            GL +L+ L L    I      S PA          S+ NL            NL+ L +
Sbjct: 180 QGLVNLQSLRLEWTGIR-----SLPA----------SIANLQ-----------NLKSLKI 213

Query: 206 SSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVS 265
            ++     +   +  L                        LE  DL     + ++P    
Sbjct: 214 RNSPLSA-LGPAIHHL----------------------PKLEELDLRGCTALRNYPPIFG 250

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
               L  L L   +    +P +I  ++ LE L L     LS +P  +  L    ++ +  
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310

Query: 326 N 326
           +
Sbjct: 311 H 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 20/116 (17%), Positives = 37/116 (31%), Gaps = 13/116 (11%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L+L    L  +      +L +   + +       +LP    Q   L  L L RN     
Sbjct: 85  ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-A 141

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNN---------LTELSKLNISYNPLVS 671
           +P+   ++  L+ L +         P    +         L  L  L + +  + S
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.0 bits (172), Expect = 7e-13
 Identities = 21/106 (19%), Positives = 34/106 (32%), Gaps = 4/106 (3%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHL-GFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L++  + LS  L P I  L     + L G        P  F     L  L L   +   
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL-RNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            +P +   +  L+ LDL         P+    L     + +  +  
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 32/225 (14%), Positives = 60/225 (26%), Gaps = 78/225 (34%)

Query: 92  SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLR 149
           S D       L  L  L L       S+P  +++ ++LK L + ++ LS  L   +  L 
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229

Query: 150 SLEILDLS-VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN 208
            LE LDL     +      ++P                             L+ L L   
Sbjct: 230 KLEELDLRGCTALR-----NYPP----------IFGGRA-----------PLKRLILKDC 263

Query: 209 NFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCR 268
           +           L+                                      P ++    
Sbjct: 264 S----------NLLT------------------------------------LPLDIHRLT 277

Query: 269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL 313
            L  L+L G      +P+ I  +     + +   +  + + +   
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHRP 321

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.0 bits (102), Expect = 3e-04
 Identities = 11/57 (19%), Positives = 23/57 (40%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS 140
           L L D +    +  +   LTQL  LDL        +P  ++   +   + +  ++ +
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (401), Expect = 4e-43
 Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 38/285 (13%)

Query: 804  TGKFSE-DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNG 859
             G+F + D  IG+G F TVY+G+      EVA  +LQ   L     + F+ E E+L G  
Sbjct: 24   DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83

Query: 860  FGWPHPNLVTLYGWCLDGSEK----ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                HPN+V  Y       +     +LV E M  G+L+  +     +  +        + 
Sbjct: 84   ----HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 139

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            + L FLH    PPI+HRD+K  N+ +    G   + D GLA +     +  +  + GT  
Sbjct: 140  KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPE 195

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034
            ++APE  +  +     DVY+FG+  +E+AT                     Y        
Sbjct: 196  FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP-----------------YSECQNAAQ 237

Query: 1035 VIPVVLLGSGLAEGAEEMSELLR--IGVRCTAEAPNARPNVKEVL 1077
            +   V  G   A   +     ++  I   C  +  + R ++K++L
Sbjct: 238  IYRRVTSGVKPASFDKVAIPEVKEIIE-GCIRQNKDERYSIKDLL 281

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  162 bits (411), Expect = 7e-43
 Identities = 77/398 (19%), Positives = 135/398 (33%), Gaps = 47/398 (11%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+  + +I+         LT L+ L  + N  + ++  DLS   +L YL    N L+ +L
Sbjct: 47  LDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TL--DLSQNTNLTYLACDSNKLT-NL 100

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
           +++ L  L  L+   N++  ++  S       L   N + N LT  ID        L  L
Sbjct: 101 DVTPLTKLTYLNCDTNKLT-KLDVS---QNPLLTYLNCARNTLT-EID--VSHNTQLTEL 153

Query: 204 DLSSNNFRGNIW-NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           D   N     +      QL     S N ++         +N  L   +   N  I     
Sbjct: 154 DCHLNKKITKLDVTPQTQLTTLDCSFNKIT----ELDVSQNKLLNRLNCDTNN-ITKLD- 207

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            ++    L  L+   N  +     ++  ++ L       N  L+ +  S   LSKL  L 
Sbjct: 208 -LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNP-LTELDVS--TLSKLTTLH 260

Query: 323 LSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPL 381
               +      +I     TQ+          I       +     +  LD      T   
Sbjct: 261 CIQTDL----LEIDLTHNTQLIYFQAEGCRKI---KELDVTHNTQLYLLDCQAAGIT--- 310

Query: 382 PVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW 441
            +++SQ   L +L L +      +     +   L++L      +       +G + +L  
Sbjct: 311 ELDLSQNPKLVYLYLNNTELT-ELDV--SHNTKLKSLSCVNAHIQD-FSS-VGKIPALNN 365

Query: 442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL--SGNI 477
              A       +P E     S L + +S + L   GN 
Sbjct: 366 NFEAEGQTI-TMPKETLTNNS-LTIAVSPDLLDQFGNP 401

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  153 bits (388), Expect = 8e-40
 Identities = 66/394 (16%), Positives = 121/394 (30%), Gaps = 43/394 (10%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
           N L         D F +                   +         +L  L+  ++ ++ 
Sbjct: 1   NTLKAGQTQSFNDWFPD-DNFASEVAAAFEMQ---ATDTISEEQLATLTSLDCHNSSITD 56

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLR 201
              +  L  L  L  + N I   +  S       L       N LT  +D        L 
Sbjct: 57  MTGIEKLTGLTKLICTSNNI-TTLDLS---QNTNLTYLACDSNKLT-NLD--VTPLTKLT 109

Query: 202 YLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
           YL+  +N       +    L   + + N L+ +        N  L   D   N+ I    
Sbjct: 110 YLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEI----DVSHNTQLTELDCHLNKKIT--K 163

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
            +V+    L  L+   N  +     ++     L  L    NN ++ +   L    +L  L
Sbjct: 164 LDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNN-ITKLD--LNQNIQLTFL 217

Query: 322 DLSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGP 380
           D SSN       +I     TQ+       N     +    +  L  ++ L     +    
Sbjct: 218 DCSSNKL----TEIDVTPLTQLTYFDCSVNP----LTELDVSTLSKLTTLHCIQTDLLE- 268

Query: 381 LPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLL 440
             ++++    L +      R    +     +   L  LD     +T  +   +     L+
Sbjct: 269 --IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLV 321

Query: 441 WLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           +L L N  L+ E+   + + T L  L+  N  + 
Sbjct: 322 YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 23/107 (21%), Positives = 38/107 (35%), Gaps = 12/107 (11%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL  + N L+     D+      + +    N+   KL         L  L+ + N  + E
Sbjct: 131 YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +       K L  L+   NN +       N   +L+ L+ S N L  
Sbjct: 185 LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE 226

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 6e-06
 Identities = 17/133 (12%), Positives = 45/133 (33%), Gaps = 6/133 (4%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLS 157
           + S   +L YL L+    +  +  D+S    LK L+  +  +    ++  + +L     +
Sbjct: 313 DLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEA 369

Query: 158 VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNG 217
             +    I+     +    +   +S + L    +       +    D ++N       + 
Sbjct: 370 EGQT---ITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426

Query: 218 LAQLVEFSVSENV 230
               V ++ +   
Sbjct: 427 DNPAVTYTFTSEN 439

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 26/132 (19%), Positives = 50/132 (37%), Gaps = 13/132 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L  S N+++     D+ + +  + ++   N    KL    +Q   L  L+ + N  + E
Sbjct: 174 TLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-E 226

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFE 684
           I      +  L   D S N  +       + L++L+ L+     L+   +    QL  F+
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281

Query: 685 KTSYLGDPLLDL 696
                    LD+
Sbjct: 282 AEGCRKIKELDV 293

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 12/105 (11%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL    N+L+     D+ +    + ++   N    ++         L  L+   N    +
Sbjct: 110 YLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           +         L  LD S+N  +       +    L++LN   N +
Sbjct: 164 LD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 18/107 (16%), Positives = 31/107 (28%), Gaps = 12/107 (11%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L    + ++      I KL   + +    N     L     Q   L  L    N  +  
Sbjct: 46  SLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-N 99

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +      +  L  L+   N  +       +    L+ LN + N L  
Sbjct: 100 LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTE 141

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 17/106 (16%), Positives = 30/106 (28%), Gaps = 10/106 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           Y   S N L+     D+  L   + +H           +   QL  I           E+
Sbjct: 237 YFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQL--IYFQAEGCRKIKEL 291

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +  +   L  LD      +       +   +L  L ++   L  
Sbjct: 292 --DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE 332

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 16/106 (15%), Positives = 30/106 (28%), Gaps = 10/106 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           +L  S N+L+     D+  L   +      N       S   +L    L+  + +   EI
Sbjct: 216 FLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTELDVSTLSKL--TTLHCIQTDLL-EI 269

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                +   L                   + T+L  L+     +  
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE 311

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 22/161 (13%), Positives = 45/161 (27%), Gaps = 15/161 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L      L  E+  D+              +   +L         L +L+      + E
Sbjct: 258 TLHCIQTDLL-EI--DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-E 311

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFE 684
           +         L  L L+    +     S  + T+L  L+     +      S G++    
Sbjct: 312 LD--LSQNPKLVYLYLNNTELTE-LDVS--HNTKLKSLSCVNAHIQD--FSSVGKIPALN 364

Query: 685 KTSYLGDPLLDLP-DFIENGPHHGHKYPNSNGRTGNNTKLT 724
                    + +P + + N        P+   + GN   + 
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  161 bits (408), Expect = 4e-41
 Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 54/286 (18%)

Query: 810  DRIIGKGGFGTVYRG---VLPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHP 865
               I  GG G +Y      + +GR V +K L   G    +    AE + L+       HP
Sbjct: 85   KGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAE----VVHP 139

Query: 866  NLVTLY--GWCLDGSEKILVY---EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
            ++V ++      D     + Y   EY+ G SL+       +L     +   +++  AL +
Sbjct: 140  SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 921  LHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            LH      +V+ D+K  N++L +E  K  + D G    +++        + GT G+ APE
Sbjct: 198  LHSI---GLVYNDLKPENIMLTEEQLK--LIDLGAVSRINS-----FGYLYGTPGFQAPE 247

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
              +T   T   D+Y+ G     L        G              Y    P    +   
Sbjct: 248  IVRT-GPTVATDIYTVGRTLAALTLDLPTRNG-------------RYVDGLPEDDPVLKT 293

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKIL 1084
                      +    LLR   R     P  R    +E+ A L  +L
Sbjct: 294  ---------YDSYGRLLR---RAIDPDPRQRFTTAEEMSAQLTGVL 327

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  147 bits (372), Expect = 5e-39
 Identities = 52/284 (18%), Positives = 98/284 (34%), Gaps = 40/284 (14%)

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
             +   ++ ++ +                         +S+ +   +++  DLS N    
Sbjct: 11  RYKIEKVTDSSLKQ----------------------ALASLRQSAWNVKELDLSGNPLSQ 48

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
               +++    L +LNL  N        ++ S+S L  L L  NN++  +         +
Sbjct: 49  ISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLN-NNYVQELL----VGPSI 101

Query: 319 EVLDLSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
           E L  ++NN      ++   R    K + L +N  I  +          +  LDL  N  
Sbjct: 102 ETLHAANNNI----SRVSCSRGQGKKNIYLANNK-ITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 378 TG-PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL 436
                    +   +L+ L L +N     +         L+TLDLS N+L   + P   + 
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSA 213

Query: 437 TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
             + W+ L NN L   I   +    +L   +L  N        +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  144 bits (365), Expect = 4e-38
 Identities = 67/299 (22%), Positives = 125/299 (41%), Gaps = 22/299 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
             +TD ++   + +   +   +  LDLS N  S     DL+    L+ LNLS N+L   L
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
           +L  L +L  LDL+ N +  E+      +   +   + + NN++ R+          + +
Sbjct: 75  DLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS-RVS--CSRGQGKKNI 125

Query: 204 DLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
            L++N             +++    +  N +  V  + +   + +LE  +L  N  I D 
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF-IYDV 184

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
            G+V     L  L+L  N  +  +  E  S +G+  + L  NN L +I ++L     LE 
Sbjct: 185 KGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR-NNKLVLIEKALRFSQNLEH 241

Query: 321 LDLSSNNF-GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT 378
            DL  N F  G ++  F +  +V+ +A  +   + G N      +P +      +  + 
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE-CTVPTL----GHYGAYC 295

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  143 bits (362), Expect = 1e-37
 Identities = 59/384 (15%), Positives = 116/384 (30%), Gaps = 100/384 (26%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSL 151
           +I  N     +     ++ ++   ++     S  ++K L+LS N LS     +L+    L
Sbjct: 4   EIKQN---GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 152 EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           E+L+LS N ++  +                   +L+            LR LDL++N  +
Sbjct: 61  ELLNLSSNVLYETLDLE----------------SLS-----------TLRTLDLNNNYVQ 93

Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV 271
                                                              E+    ++ 
Sbjct: 94  ---------------------------------------------------ELLVGPSIE 102

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG- 330
            L+   NN S  +    G   G + ++L  N    +        S+++ LDL  N     
Sbjct: 103 TLHAANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159

Query: 331 EVQKIFGRFTQVKILALHSN--SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
              ++      ++ L L  N    +      G +    +  LDLS N     +  E    
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDV-----KGQVVFAKLKTLDLSSNKLAF-MGPEFQSA 213

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT-GPIPPSIGNLTSLLWLMLANN 447
             + ++ L +N+    I        NL+  DL  N    G +         +  +     
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272

Query: 448 SLSGEIPGEIGNCTSLLWLNLSNN 471
               ++ G+     ++  L     
Sbjct: 273 K---KLTGQNEEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (353), Expect = 2e-36
 Identities = 47/238 (19%), Positives = 98/238 (41%), Gaps = 16/238 (6%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
             +I  ++++           +  N+  L+L GN  S    A++   + LE L L  +N 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS-SNV 69

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL 364
           L    + L +LS L  LDL++N       +       ++ L   +N+    ++     + 
Sbjct: 70  LYETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN----ISRVSCSRG 119

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLSFN 423
                + L++N  T    ++      +++L L  N  +  +   +  +   L+ L+L +N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            +   +   +     L  L L++N L+  +  E  +   + W++L NNKL   I   +
Sbjct: 180 FIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  132 bits (334), Expect = 6e-34
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 19/218 (8%)

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
           N     +  +  ++    + +   S   ++ L L  N    +    L   +KLE+L+LSS
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 326 NNFGGEVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
           N       +       + ++ L L++N          +L  P+I  L  ++NN +    V
Sbjct: 68  NVL----YETLDLESLSTLRTLDLNNN------YVQELLVGPSIETLHAANNNISR---V 114

Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG-PIPPSIGNLTSLLWL 442
             S+ +  K + LA+N+         G    +Q LDL  NE+          +  +L  L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
            L  N +  ++ G++     L  L+LS+NKL+  + PE
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (303), Expect = 6e-30
 Identities = 35/199 (17%), Positives = 75/199 (37%), Gaps = 13/199 (6%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           I     + +  +   +  ++    +     +   ++ LDLS N            FT+++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG 403
           +L L SN  +       +  L  +  LDL++N        E+    S++ L  A+N  + 
Sbjct: 62  LLNLSSNV-LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG-EIPGEIGNCTS 462
            +          + + L+ N++T       G  + + +L L  N +          +  +
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 463 LLWLNLSNNKLSGNIPPEV 481
           L  LNL  N +  ++  +V
Sbjct: 171 LEHLNLQYNFIY-DVKGQV 188

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 8/123 (6%)

Query: 361 ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
                      ++ ++    L        ++K L L+ N  +    A       L+ L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           S N L       + +L++L  L L NN +      E+    S+  L+ +NN +S  +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117

Query: 481 VMT 483
              
Sbjct: 118 RGQ 120

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSL 463
           +I  +  N    +   ++ + L   +     +  ++  L L+ N LS     ++   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 464 LWLNLSNNKLSGNIPP 479
             LNLS+N L      
Sbjct: 61  ELLNLSSNVLY-ETLD 75

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 19/112 (16%), Positives = 37/112 (33%), Gaps = 4/112 (3%)

Query: 566 YLQLSGNQLSG-ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
           YL L  N++     +           ++L +N     +  Q     L  L+L+ N  +  
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-F 205

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
           +  EF +   +  + L  N        +      L   ++  N    GT+  
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 11/112 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L LS N L    + D+  L     + L  N        +    P +  L+   NN S  
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
           +    G  +  +N+ L+ N  +          + +  L++  N + +     
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 8/105 (7%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
             +++ + L   L+       N   + L  N       +       L +LNL+ N    E
Sbjct: 14  IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-E 72

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
              +  ++  L+ LDL+ N               +  L+ + N +
Sbjct: 73  TL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 2/70 (2%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
             +  +T ++    + S   +   ++ LDLS N  S    A     T+L  LN+S N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 671 SGTIPSTGQL 680
                    L
Sbjct: 72  E--TLDLESL 79

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (367), Expect = 2e-38
 Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 33/284 (11%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEVLSG-NG 859
              F  ++ IG+G F  VYR   L DG  VA+KK+Q   L   +       E+++L   N 
Sbjct: 32   ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----SDRTRLTWRRRLDIAIDVA 915
                HPN++  Y   ++ +E  +V E  + G L  +I      +  +  R      + + 
Sbjct: 91   ----HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             AL  +H      ++HRD+K +NV +   G   + D GL R  S+  +   + + GT  Y
Sbjct: 147  SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 202

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035
            ++PE         K D++S G L  E+A  +    G +  L    +++     + P    
Sbjct: 203  MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPP---- 257

Query: 1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            +P     S      EE+ +L+     C    P  RP+V  V  +
Sbjct: 258  LPSDHY-S------EELRQLVN---MCINPDPEKRPDVTYVYDV 291

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (365), Expect = 5e-38
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 37/214 (17%)

Query: 811  RIIGKGGFGTVYRGV---LPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
              +GKG FG+V       L D     VAVK+LQ  G + +R+F+ E+++L          
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA----LHSD 84

Query: 866  NLVTLYGWCLDGSEK--ILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
             +V   G       +   LV EY+  G L D +   R RL   R L  +  + + + +L 
Sbjct: 85   FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                   VHRD+ A N+L++ E    + DFGLA+++     +          YV  E GQ
Sbjct: 145  SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----------YVVREPGQ 191

Query: 983  T---WQA---------TTKGDVYSFGVLAMELAT 1004
            +   W A         + + DV+SFGV+  EL T
Sbjct: 192  SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  146 bits (371), Expect = 2e-37
 Identities = 74/377 (19%), Positives = 154/377 (40%), Gaps = 49/377 (12%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEI 165
           +   R  F  ++P+ + +    + L+L  N +        +    LE L+L+ N +   +
Sbjct: 16  VLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71

Query: 166 SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLV 222
                                       F+   NLR L L SN  +     ++ GL+ L 
Sbjct: 72  E------------------------PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLT 107

Query: 223 EFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFS 281
           +  +SEN +  ++   +F++  +L+  ++ +N+ +        S   +L  L L   N +
Sbjct: 108 KLDISENKIV-ILLDYMFQDLYNLKSLEVGDND-LVYISHRAFSGLNSLEQLTLEKCNLT 165

Query: 282 GPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
             IP E    + GL  L L   N  ++   S   L +L+VL++S   +   +        
Sbjct: 166 S-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224

Query: 341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR 400
            +  L++   + +  +    +  L  +  L+LS+N  +      + ++  L+ + L   +
Sbjct: 225 NLTSLSITHCN-LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283

Query: 401 FNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGN 459
                P  +  +  L+ L++S N+LT  +  S+  ++ +L  L+L +N L+        +
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPLA-------CD 335

Query: 460 CTSLLWLNLSNNKLSGN 476
           C  LLW+     +L+ N
Sbjct: 336 C-RLLWVFRRRWRLNFN 351

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  142 bits (361), Expect = 3e-36
 Identities = 59/301 (19%), Positives = 112/301 (37%), Gaps = 12/301 (3%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILS-- 140
           L+L    I     + F++   L  L+L+ N  S ++     ++  +L+ L L  N L   
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLI 95

Query: 141 GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
                +GL +L  LD+S N+I   + + F  +   L    +  N+L       F G  +L
Sbjct: 96  PLGVFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISHRAFSGLNSL 154

Query: 201 RYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
             L L   N         + L  L+   +    ++  +    FK    L++ ++S   ++
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYL 213

Query: 258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAE-IGSISGLEALFLGKNNFLSVIPESLLNLS 316
                      NL  L++   N +  +P   +  +  L  L L  N   ++    L  L 
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272

Query: 317 KLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNN 376
           +L+ + L            F     +++L +  N  +  +  S    + N+  L L  N 
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ-LTTLEESVFHSVGNLETLILDSNP 331

Query: 377 F 377
            
Sbjct: 332 L 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  120 bits (303), Expect = 9e-29
 Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 36/289 (12%)

Query: 199 NLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
             R LDL  N  +    + +     L E  ++EN++S  V    F    +L    L  N 
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91

Query: 256 FIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLL 313
            +   P  V +   NL  L++  N     +   +   +  L++L +G N+ + +   +  
Sbjct: 92  -LKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149

Query: 314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
            L+ LE L L   N                + ++ + +            L  +  L L 
Sbjct: 150 GLNSLEQLTLEKCN----------------LTSIPTEALSH---------LHGLIVLRLR 184

Query: 374 HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP-S 432
           H N          ++  LK L ++H  +  ++        NL +L ++   LT  +P  +
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLA 243

Query: 433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
           + +L  L +L L+ N +S      +     L  + L   +L+  + P  
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYA 291

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  109 bits (275), Expect = 3e-25
 Identities = 46/215 (21%), Positives = 76/215 (35%), Gaps = 4/215 (1%)

Query: 268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN 327
               +L+L  N        E  S   LE L L +N   +V P +  NL  L  L L SN 
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQ 387
                  +F   + +  L +  N  I  +       L N+  L++  N+         S 
Sbjct: 92  LKLIPLGVFTGLSNLTKLDISENK-IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150

Query: 388 MRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN 446
           + SL+ L L       SIP     ++  L  L L    +      S   L  L  L +++
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209

Query: 447 NSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
                 +        +L  L++++  L+  +P   
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 73.2 bits (180), Expect = 2e-13
 Identities = 35/164 (21%), Positives = 57/164 (34%), Gaps = 31/164 (18%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDL 156
           F  L +L  L++S   +  ++  +     +L  L+++H  L+    L +  L  L  L+L
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255

Query: 157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GN 213
           S N I   I                          +     L L+ + L           
Sbjct: 256 SYNPIS-TIE------------------------GSMLHELLRLQEIQLVGGQLAVVEPY 290

Query: 214 IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
            + GL  L   +VS N L+  +  SVF    +LE   L  N   
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 59.3 bits (144), Expect = 4e-09
 Identities = 30/111 (27%), Positives = 40/111 (36%), Gaps = 5/111 (4%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           T  L L  N++   L+ D      +   + L  N      P  F+ L  L  L L  N  
Sbjct: 34  TRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
              IP   F  +  L  LD+S N         F +L  L  L +  N LV 
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY 142

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 21/107 (19%), Positives = 42/107 (39%), Gaps = 3/107 (2%)

Query: 567 LQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           L L    L+  +  +    L    ++ L     +      F +L  L VL ++   +   
Sbjct: 157 LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +         L +L +++ N +     +  +L  L  LN+SYNP+ +
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 55.1 bits (133), Expect = 8e-08
 Identities = 24/108 (22%), Positives = 45/108 (41%), Gaps = 3/108 (2%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L+L+ N +S  + P     L N   + L  N+        F  L  L  L+++ N    
Sbjct: 60  ELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI 118

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            +   F ++  L++L++  N+       +F+ L  L +L +    L S
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 5/109 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSG 623
            L++S       ++P+     N + + +        +P      L  L  LNL+ N  S 
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS- 261

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            I       +  LQ + L     +   P +F  L  L  LN+S N L +
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 53.6 bits (129), Expect = 3e-07
 Identities = 20/108 (18%), Positives = 42/108 (38%), Gaps = 5/108 (4%)

Query: 566 YLQLSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L ++   L+  +    +  L     ++L +N       S   +L  L  + L     + 
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA- 285

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
            +    F  +  L+ L++S N  +    + F+++  L  L +  NPL 
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  141 bits (358), Expect = 2e-37
 Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 55/302 (18%)

Query: 811  RIIGKGGFGTVYRGV---LPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            + +GKG FG+V       L D     VAVKKLQ    E  R+F  E+E+L        H 
Sbjct: 16   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHD 71

Query: 866  NLVTLYGWCLDGSEK--ILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            N+V   G C     +   L+ EY+  GSL D +   + R+   + L     + + + +L 
Sbjct: 72   NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             + Y   +HRD+   N+L++ E +  + DFGL +V+                +   E G+
Sbjct: 132  TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----------FKVKEPGE 178

Query: 983  T---WQA---------TTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
            +   W A         +   DV+SFGV+  EL T   ++     E +   G         
Sbjct: 179  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK--Q--- 233

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEM-------SELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082
                 V  ++ L   L      +        E+  I   C     N RP+ +++   + +
Sbjct: 234  -GQMIVFHLIEL---LKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288

Query: 1083 IL 1084
            I 
Sbjct: 289  IR 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  142 bits (359), Expect = 3e-37
 Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 43/300 (14%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
             +   + +G+GGF  V     L DG   A+K++     +   E + E ++         H
Sbjct: 30   HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----H 85

Query: 865  PNLVTLYGWCLD----GSEKILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVAR 916
            PN++ L  +CL       E  L+  + + G+L + I         LT  + L + + + R
Sbjct: 86   PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA------ 970
             L  +H        HRD+K +N+LL  EG+ ++ D G               +       
Sbjct: 146  GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 971  --GTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025
               T+ Y APE            + DV+S G +   +  G    +   +        V  
Sbjct: 203  QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085
                      IP     S        + +LL          P+ RP++  +L+ L  + P
Sbjct: 263  QLS-------IPQSPRHS------SALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQP 306

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (359), Expect = 3e-37
 Identities = 74/302 (24%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 811  RIIGKGGFGTVYRGV---LPDGRE--VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            + +GKG FG+V       L D     VAVKKLQ    E  R+F  E+E+L        H 
Sbjct: 47   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHD 102

Query: 866  NLVTLYGWCLDGSEK--ILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            N+V   G C     +   L+ EY+  GSL D +   + R+   + L     + + + +L 
Sbjct: 103  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             + Y   +HRD+   N+L++ E +  + DFGL +V+     +          Y   E G+
Sbjct: 163  TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----------YKVKEPGE 209

Query: 983  T---WQA---------TTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRH 1029
            +   W A         +   DV+SFGV+  EL T   ++     E +   G         
Sbjct: 210  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQ--- 264

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEM-------SELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082
                 V  ++ L   L      +        E+  I   C     N RP+ +++   + +
Sbjct: 265  -GQMIVFHLIEL---LKNN-GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319

Query: 1083 IL 1084
            I 
Sbjct: 320  IR 321

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (359), Expect = 6e-37
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 33/280 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREF-RAEMEVLSG-NGFG 861
            K+   + IG+G FG         DGR+  +K++    +   ERE  R E+ VL+      
Sbjct: 25   KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--- 81

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALV 919
              HPN+V       +     +V +Y EGG L   I+ +        + LD  + +  AL 
Sbjct: 82   --HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
             +H      I+HRD+K+ N+ L K+G   + DFG+ARV+++    ++    GT  Y++PE
Sbjct: 140  HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPE 195

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
              +      K D+++ G +  EL T + A E     +     +++  G   P    + + 
Sbjct: 196  ICENKPYNNKSDIWALGCVLYELCTLKHAFEA--GSMKNLVLKII-SGSFPP----VSLH 248

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
               S       ++  L+    +     P  RP+V  +L  
Sbjct: 249  Y--S------YDLRSLVS---QLFKRNPRDRPSVNSILEK 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (356), Expect = 8e-37
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE-----VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             +++G G FGTVY+G+     E     VA+K+L+         E   E  V++       
Sbjct: 20   IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VD 75

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            +P++  L G CL  + ++ + + M  G L D +   +  +  +  L+  + +A+ + +L 
Sbjct: 76   NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYG 981
                   VHRD+ A NVL+       +TDFGLA+++ A +           + ++A E  
Sbjct: 135  DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRR 1007
                 T + DV+S+GV   EL T G +
Sbjct: 192  LHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  139 bits (353), Expect = 8e-37
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  LV L
Sbjct: 30   KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMN----LSHEKLVQL 84

Query: 871  YGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            YG C       ++ EYM  G L + +   R R   ++ L++  DV  A+ +L  + +   
Sbjct: 85   YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE---YGQT 983
            +HRD+ A N L++ +G   V+DFGL+R V        T+  G+   V +  PE   Y + 
Sbjct: 142  LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 984  WQATTKGDVYSFGVLAMELAT-GRR 1007
               ++K D+++FGVL  E+ + G+ 
Sbjct: 199  ---SSKSDIWAFGVLMWEIYSLGKM 220

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 9e-37
 Identities = 67/277 (24%), Positives = 98/277 (35%), Gaps = 32/277 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQRE--GLEGEREFRAEMEVLSGNGFGW 862
             F     +G G +G V++     DGR  AVK+      G +      AE+      G   
Sbjct: 58   SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG--- 114

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP  V L     +G    L  E       +   +    L   +      D   AL  LH
Sbjct: 115  QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    +VH DVK +N+ L   G+  + DFGL   +    +       G   Y+APE  Q
Sbjct: 175  SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQ 229

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
                 T  DV+S G+  +E+A       GGE      G + +  G   P        L  
Sbjct: 230  G-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQGYLPP---EFTAGL-- 277

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
            S       E+  +L          P  R   + +LA+
Sbjct: 278  S------SELRSVLV---MMLEPDPKLRATAEALLAL 305

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  139 bits (352), Expect = 1e-36
 Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 59/299 (19%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKK--LQREGLEGEREFRAEMEVLSGNGFGW 862
            +F E   IG G FG+V++ V   DG   A+K+      G   E+    E+   +  G   
Sbjct: 12   EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG--- 68

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWR----RRLDIAIDVARAL 918
             H ++V  +    +    ++  EY  GGSL D IS+  R+          D+ + V R L
Sbjct: 69   QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVT-------------------DFGLARVVS 959
             ++H      +VH D+K SN+ + +                          D G    +S
Sbjct: 129  RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 960  AGDSHVSTTIAGTVGYVAPE-YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVE 1018
            +          G   ++A E   + +    K D+++  +  +  A        G+    +
Sbjct: 186  SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q 236

Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            W    +  GR       IP VL  S      +E +ELL+         P  RP+   ++
Sbjct: 237  W--HEIRQGRLPR----IPQVL--S------QEFTELLK---VMIHPDPERRPSAMALV 278

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 1e-36
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP LV L
Sbjct: 14   QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMK----LSHPKLVQL 68

Query: 871  YGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            YG CL+ +   LV E+ME G L D + + R        L + +DV   + +L   C    
Sbjct: 69   YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV--- 125

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE---YGQT 983
            +HRD+ A N L+ +     V+DFG+ R V        T+  GT   V + +PE   + + 
Sbjct: 126  IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 182

Query: 984  WQATTKGDVYSFGVLAMELAT-GRR 1007
               ++K DV+SFGVL  E+ + G+ 
Sbjct: 183  ---SSKSDVWSFGVLMWEVFSEGKI 204

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  139 bits (352), Expect = 2e-36
 Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 35/292 (11%)

Query: 811  RIIGKGGFGTVYRGVLP-----DGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V            G +VAVK L+ E G     + + E+E+L        H
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----LYH 82

Query: 865  PNLVTLYGWCLDGSEK--ILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFL 921
             N+V   G C +       L+ E++  GSL++ +  ++ ++  +++L  A+ + + + +L
Sbjct: 83   ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPE 979
                Y   VHRD+ A NVL++ E +  + DFGL + +     + +        V + APE
Sbjct: 143  GSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
                 +     DV+SFGV   EL T        +         +   G       V  +V
Sbjct: 200  CLMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 1040 LLGSGLAEGAEEM-------SELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                 L EG + +        E+ ++  +C    P+ R + + ++     +L
Sbjct: 254  NT---LKEG-KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  140 bits (354), Expect = 2e-36
 Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)

Query: 813  IGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREF-RAEMEVLSGNGFGWPHPNLVTL 870
            +G G  G V++    P G  +A K +  E     R     E++VL         P +V  
Sbjct: 41   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN----SPYIVGF 96

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIV 930
            YG      E  +  E+M+GGSL+ ++    R+  +    ++I V + L +L  +    I+
Sbjct: 97   YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 154

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAG--DSHVSTTIAGTVGYVAPEYGQTWQATT 988
            HRDVK SN+L++  G+  + DFG    VS    DS ++ +  GT  Y++PE  Q    + 
Sbjct: 155  HRDVKPSNILVNSRGEIKLCDFG----VSGQLIDS-MANSFVGTRSYMSPERLQGTHYSV 209

Query: 989  KGDVYSFGVLAMELATGR--RALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046
            + D++S G+  +E+A GR        +E  + +G +V G     P R   P   L     
Sbjct: 210  QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 1047 EGAEEMS--ELLRIGV---------------------RCTAEAPNARPNVKEVL 1077
            +    M+  ELL   V                     +C  + P  R ++K+++
Sbjct: 270  DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (355), Expect = 3e-36
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 33/209 (15%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVKKLQREGL--EGEREFRAE---MEVLSGNGFGWPH 864
              IG+G FG V+ G L  D   VAVK   RE L  + + +F  E   ++  S       H
Sbjct: 120  EQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYS-------H 171

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHH 923
            PN+V L G C       +V E ++GG     + ++  RL  +  L +  D A  + +L  
Sbjct: 172  PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV-----AP 978
            +C    +HRD+ A N L+ ++    ++DFG++R  + G        +G +  V     AP
Sbjct: 232  KCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAP 284

Query: 979  E---YGQTWQATTKGDVYSFGVLAMELAT 1004
            E   YG+    +++ DV+SFG+L  E  +
Sbjct: 285  EALNYGRY---SSESDVWSFGILLWETFS 310

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (347), Expect = 4e-36
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + +G G FG V  G      +VAVK + +EG   E EF  E + +        HP LV  
Sbjct: 14   KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMK----LSHPKLVKF 68

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
            YG C       +V EY+  G L + + S    L   + L++  DV   + FL    +   
Sbjct: 69   YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 930  VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE---YGQT 983
            +HRD+ A N L+D++    V+DFG+ R V   D +VS+   GT   V + APE   Y + 
Sbjct: 126  IHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSV--GTKFPVKWSAPEVFHYFKY 182

Query: 984  WQATTKGDVYSFGVLAMELAT-GRR 1007
               ++K DV++FG+L  E+ + G+ 
Sbjct: 183  ---SSKSDVWAFGILMWEVFSLGKM 204

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  137 bits (348), Expect = 5e-36
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 809  EDRIIGKGGFGTVYRGVLPDGR---EVAVKKLQREGLEGER--EFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G     +    VAVK L+ E  +     E  AE  V+        
Sbjct: 21   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 76

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            +P +V + G C   +E   LV E  E G L   +     +  +  +++   V+  + +L 
Sbjct: 77   NPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
               +   VHRD+ A NVLL  +  A ++DFGL++ + A +++      G   V + APE 
Sbjct: 135  ESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191

Query: 981  GQTWQATTKGDVYSFGVLAMELAT-GRR 1007
               ++ ++K DV+SFGVL  E  + G++
Sbjct: 192  INYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (346), Expect = 5e-36
 Identities = 73/290 (25%), Positives = 116/290 (40%), Gaps = 44/290 (15%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREF-RAEMEVLSG-NGFG 861
             +     IG G +G   +     DG+ +  K+L    + E E++   +E+ +L       
Sbjct: 7    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--- 63

Query: 862  WPHPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVA 915
              HPN+V  Y   +D +   L  V EY EGG L  +I+    +R  L     L +   + 
Sbjct: 64   --HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 916  RALVFLHHECYPP--IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
             AL   H        ++HRD+K +NV LD +    + DFGLAR+++  D+  + T  GT 
Sbjct: 122  LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVGTP 180

Query: 974  GYVAPEYGQTWQA---TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030
             Y++PE            K D++S G L  EL               E   ++   G+  
Sbjct: 181  YYMSPE---QMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIR-EGKFR 234

Query: 1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVLAM 1079
                 IP               S+ L   + R        RP+V+E+L  
Sbjct: 235  R----IP------------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  137 bits (348), Expect = 7e-36
 Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 55/301 (18%)

Query: 811  RIIGKGGFGTVYRGVL---PDGRE--VAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWPH 864
            R +G+G FG V         DG    VAVK L+ + G +    ++ E+++L        H
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT----LYH 92

Query: 865  PNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             +++   G C D       LV EY+  GSL D +     +   + L  A  +   + +LH
Sbjct: 93   EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH 151

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             + Y   +HRD+ A NVLLD +    + DFGLA+ V  G  +          Y   E G 
Sbjct: 152  AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----------YRVREDGD 198

Query: 983  T---WQA---------TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030
            +   W A             DV+SFGV   EL T        +       + +   G   
Sbjct: 199  SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQ 252

Query: 1031 PGRAVIPVVLLGSGLAEGAEEM-------SELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                V+ +  L   L  G E +       +E+  +   C     + RP  + ++ +L  +
Sbjct: 253  GQMTVLRLTEL---LERG-ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

Query: 1084 L 1084
             
Sbjct: 309  H 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  136 bits (345), Expect = 2e-35
 Identities = 45/210 (21%), Positives = 83/210 (39%), Gaps = 21/210 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            + IG GG   V++ +    +  A+K +  E  + +    +R E+  L+          ++
Sbjct: 34   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN--KLQQHSDKII 91

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
             LY + +      +V E      L   +  +  +    R     ++  A+  +H      
Sbjct: 92   RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-DSHVSTTIAGTVGYVAPE-------- 979
            IVH D+K +N L+   G   + DFG+A  +     S V  +  GTV Y+ PE        
Sbjct: 148  IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATGR 1006
                    + + K DV+S G +   +  G+
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  141 bits (357), Expect = 2e-35
 Identities = 74/421 (17%), Positives = 139/421 (33%), Gaps = 55/421 (13%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS---GDLNLSGLRSLEILD 155
           F    +L YLDLS N     I        +LK+L+LS N             +  L+ L 
Sbjct: 65  FKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 156 LSVNRIHG---------------------EISFSFPAICEKLVVANLSLNNLTGRIDTCF 194
           LS   +                             P   +     +L +   T +     
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 195 DGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKE------------ 242
                    +L  +N +  + +         +++   +  +S+                 
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241

Query: 243 ----NCSLEIFDLSENEFIGDFPGEVSNC-----RNLVVLNLFGNNFSGPIPAEIGSISG 293
               + ++  F +S  +  G       +      + L +  +  + F  P        S 
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYI 353
           +       +    V       +S    LD S+N     V +  G  T+++ L L  N   
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

Query: 354 DGMNSSGI-LKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGN 411
           +    + +  ++ ++ +LD+S N+ +        S  +SL  L ++ N    +I      
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSN 470
            P ++ LDL  N++   IP  +  L +L  L +A+N L   +P  I    TSL  + L  
Sbjct: 420 PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477

Query: 471 N 471
           N
Sbjct: 478 N 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  128 bits (323), Expect = 4e-31
 Identities = 65/387 (16%), Positives = 125/387 (32%), Gaps = 50/387 (12%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEI 165
           +D S+N     +P DLS       LN+S N +S     ++  L  L IL +S NRI    
Sbjct: 5   VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ--- 58

Query: 166 SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFS 225
                            L+         F     L YLDLS N       +    L    
Sbjct: 59  ----------------YLDISV------FKFNQELEYLDLSHNKLVKISCHPTVNLKHLD 96

Query: 226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIP 285
           +S N    +     F     L+   LS           +++     VL + G  +     
Sbjct: 97  LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE- 155

Query: 286 AEIGSISGLEAL-----FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
            +   +           F     F  ++  S+  ++ LE+ ++       +         
Sbjct: 156 -DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214

Query: 341 QVKILALHSNSYIDGMNSSG--------ILKLPNISRLDLSHNNFTGPLPVEI-----SQ 387
           +++     SN  ++ + ++         ++    +    +S+    G L         + 
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274

Query: 388 MRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN 447
           +++L    +  + F      +Y    N+   + + +            ++  L L  +NN
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334

Query: 448 SLSGEIPGEIGNCTSLLWLNLSNNKLS 474
            L+  +    G+ T L  L L  N+L 
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  114 bits (288), Expect = 1e-26
 Identities = 70/375 (18%), Positives = 128/375 (34%), Gaps = 26/375 (6%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            N L  +P+ L    K  +L++S N             ++++IL +  N  I  ++ S  
Sbjct: 9   KNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNR-IQYLDISVF 65

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP--AVYGNMPNLQTLD 419
                +  LDLSHN     +        +LK L L+ N F+ ++P    +GNM  L+ L 
Sbjct: 66  KFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLG 121

Query: 420 LSFNELTGPIPPSIGNLTSL-LWLMLANNSLSGEIPGEIGNCTSL-LWLNLSNNKLSGNI 477
           LS   L       I +L    + L+L       E P  + +  +  L +    NK    I
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181

Query: 478 PPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRS 537
               +    N   +         +     S    ++              + LT  +  +
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK---------LSNLTLNNIET 232

Query: 538 LWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQ 597
            W+  ++        +       F I+  ++L G     +       L+  S+  +  + 
Sbjct: 233 TWNSFIR----ILQLVWHTTVWYFSISN-VKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287

Query: 598 FDGKLPSQFDQLPLI-VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNL 656
           F       ++    + + N T +            I    +LD S N  +     +  +L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347

Query: 657 TELSKLNISYNPLVS 671
           TEL  L +  N L  
Sbjct: 348 TELETLILQMNQLKE 362

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  102 bits (255), Expect = 1e-22
 Identities = 92/518 (17%), Positives = 170/518 (32%), Gaps = 112/518 (21%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV 239
           N+S N ++    +       LR L +S N  +                       +  SV
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQY----------------------LDISV 64

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNF-SGPIPAEIGSISGLEALF 298
           FK N  LE  DLS N+ +           NL  L+L  N F + PI  E G++S L+ L 
Sbjct: 65  FKFNQELEYLDLSHNK-LVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNS 358
           L   +        + +L+  +VL +    +G +              +LH     +    
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNK-EF 178

Query: 359 SGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL 418
             IL +   +  +L  +N                  +L  N+ +  +  +     N +  
Sbjct: 179 HFILDVSVKTVANLELSNIK---------------CVLEDNKCSYFLSILAKLQTNPKLS 223

Query: 419 DLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           +L+ N +      S   +  L+W                   T++ + ++SN KL G + 
Sbjct: 224 NLTLNNIETT-WNSFIRILQLVWH------------------TTVWYFSISNVKLQGQLD 264

Query: 479 PEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSL 538
                    +      +Q   +                     P S++Y I +  + ++ 
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVF-----------------GFPQSYIYEIFSNMNIKNF 307

Query: 539 WDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQF 598
              +     +  +C   ++        +L  S N L+  +  + G L     + L  NQ 
Sbjct: 308 T--VSGTRMVHMLCPSKISPFL-----HLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 599 D--GKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNF-SGPF---- 649
               K+     Q+  L  L++++N+ S +         K L +L++S N      F    
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420

Query: 650 ----------------PASFNNLTELSKLNISYNPLVS 671
                           P     L  L +LN++ N L S
Sbjct: 421 PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKS 458

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.2 bits (247), Expect = 1e-21
 Identities = 50/310 (16%), Positives = 99/310 (31%), Gaps = 27/310 (8%)

Query: 39  LSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLT------DWNIS 92
              +           E   ++     + C +   I +  +      NLT       WN  
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237

Query: 93  GDIFNNFSALTQLSYLDLSRNTFSGSIPDDL-----SSCRSLKYLNLSHNILSGDLNL-- 145
             I       T + Y  +S     G +         +S ++L    +  ++     +   
Sbjct: 238 IRILQLVW-HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296

Query: 146 SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDL 205
               ++ I + +V+     +    P+     +  + S N LT  +         L  L L
Sbjct: 297 EIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355

Query: 206 SSNNFR-----GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
             N  +       +   +  L +  +S+N +S            SL   ++S N      
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL---- 411

Query: 261 PGEVSNC--RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
              +  C    + VL+L  N     IP ++  +  L+ L +  N   SV       L+ L
Sbjct: 412 TDTIFRCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470

Query: 319 EVLDLSSNNF 328
           + + L +N +
Sbjct: 471 QKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.2 bits (229), Expect = 2e-19
 Identities = 53/308 (17%), Positives = 113/308 (36%), Gaps = 43/308 (13%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
           N  +     ++    N   +   L+ ++ + N+F   +   L    ++ Y ++S+  L G
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ--LVWHTTVWYFSISNVKLQG 261

Query: 142 -------DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCF 194
                  D + + L++L I  +  +      S+ +      + + N +++        C 
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF-SNMNIKNFTVSGTRMVHMLCP 320

Query: 195 DGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGV-VSSSVFKENCSLEIFD 250
                  +LD S+N            L +L    +  N L  +   + +  +  SL+  D
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 251 LSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
           +S+N    D      S  ++L+ LN+  N  +  I   +     ++ L L  N  +  IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNK-IKSIP 437

Query: 310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISR 369
           + ++ L  L+ L+++SN        IF R                         L ++ +
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDR-------------------------LTSLQK 472

Query: 370 LDLSHNNF 377
           + L  N +
Sbjct: 473 IWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.6 bits (165), Expect = 1e-11
 Identities = 34/138 (24%), Positives = 57/138 (41%), Gaps = 5/138 (3%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
           T  L +S N +S   + DI  L    ++ +  N+      S F     L  L+L+ N   
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 623 GEIPSEFGNIKCLQNLDLSYNNF-SGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLA 681
            +I         L++LDLS+N F + P    F N+++L  L +S   L   ++     L 
Sbjct: 83  -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 682 TFEKTSYLGDPLLDLPDF 699
             +    LG+   +  D 
Sbjct: 140 ISKVLLVLGETYGEKEDP 157

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 3/105 (2%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE 624
            L +S N +S +         ++   +++  N     +        + VL+L  N     
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-IKVLDLHSNKIK-S 435

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           IP +   ++ LQ L+++ N         F+ LT L K+ +  NP 
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  136 bits (345), Expect = 2e-35
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE-----VAVKKLQRE-GLEGEREFRAEMEVLSGNGFGWP 863
             +++G G FGTV++GV     E     V +K ++ + G +  +     M  +        
Sbjct: 18   LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS----LD 73

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            H ++V L G C   S ++ V +Y+  GSL D +   R  L  +  L+  + +A+ + +L 
Sbjct: 74   HAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYG 981
                   VHR++ A NVLL    +  V DFG+A ++   D  +  + A T + ++A E  
Sbjct: 133  EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRR 1007
               + T + DV+S+GV   EL T G  
Sbjct: 190  HFGKYTHQSDVWSYGVTVWELMTFGAE 216

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (343), Expect = 3e-35
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 49/235 (20%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
             F E  ++G+G FG V +     D R  A+KK++    +      +E+ +L+       H
Sbjct: 7    DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLAS----LNH 61

Query: 865  PNLVTLYG-WCLDGSEKI------------LVYEYMEGGSLEDIISDRTRLTWRRR-LDI 910
              +V  Y  W    +               +  EY E G+L D+I        R     +
Sbjct: 62   QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA---------- 960
               +  AL ++H +    I+HRD+K  N+ +D+     + DFGLA+ V            
Sbjct: 122  FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 961  ---GDSHVSTTIAGTVGYVAPE-------YGQTWQATTKGDVYSFGVLAMELATG 1005
               G S   T+  GT  YVA E       Y +      K D+YS G++  E+   
Sbjct: 179  NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE------KIDMYSLGIIFFEMIYP 227

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  139 bits (351), Expect = 3e-35
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
             F    ++G G  GT+    + D R+VAVK++  E          E+++L  +     HP
Sbjct: 25   SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESD---EHP 78

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHE 924
            N++  +    D   + +  E     +L++ +  +         + +       L  LH  
Sbjct: 79   NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 925  CYPPIVHRDVKASNVLLDKEG-----KALVTDFGLARVVSAGDS--HVSTTIAGTVGYVA 977
                IVHRD+K  N+L+         KA+++DFGL + ++ G       + + GT G++A
Sbjct: 138  N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 978  PEY---GQTWQATTKGDVYSFGVLAMELATG 1005
            PE          T   D++S G +   + + 
Sbjct: 195  PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 3e-35
 Identities = 80/281 (28%), Positives = 116/281 (41%), Gaps = 38/281 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
              +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV L
Sbjct: 190  VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQL 244

Query: 871  YGWCLDGSEKILVYEYMEGGSLED--IISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
            Y    +    I V EYM  GSL D         L   + +D+A  +A  + ++    Y  
Sbjct: 245  YAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
             VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T 
Sbjct: 302  -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 989  KGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
            K DV+SFG+L  EL T GR    G    E L  VE G R M      P            
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPECP------------ 407

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                  E + +L+    +C  + P  RP  + + A L    
Sbjct: 408  ------ESLHDLMC---QCWRKEPEERPTFEYLQAFLEDYF 439

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 4e-35
 Identities = 80/282 (28%), Positives = 127/282 (45%), Gaps = 38/282 (13%)

Query: 766  YRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFS-E--------DRIIGKG 816
            + H    SSG  + +    +   +      TY +  +A   F+ E        ++IIG G
Sbjct: 4    HHH---HSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 817  GFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHPNLVTLY 871
              G V  G L  P  R+  VA+K L+    E +R +F +E  ++      + HPN++ L 
Sbjct: 61   DSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ----FDHPNIIRLE 116

Query: 872  GWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIV 930
            G    G   ++V EYME GSL+  + +   + T  + + +   V   + +L    Y   V
Sbjct: 117  GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---V 173

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPE---YGQTWQ 985
            HRD+ A NVL+D      V+DFGL+RV+        TT  G   + + APE   +     
Sbjct: 174  HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-- 231

Query: 986  ATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWGRR 1022
             ++  DV+SFGV+  E+   G R        + +  VE G R
Sbjct: 232  -SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR 272

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  134 bits (340), Expect = 4e-35
 Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 19/209 (9%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGE---REFRAEMEVLSGNGFGW 862
               +G G FG V RG    P G+   VAVK L+ + L       +F  E+  +       
Sbjct: 23   LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS----L 78

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFL 921
             H NL+ LYG  L    K+ V E    GSL D +   +           A+ VA  + +L
Sbjct: 79   DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPE 979
              + +   +HRD+ A N+LL       + DFGL R +   D H            + APE
Sbjct: 138  ESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT-GRR 1007
              +T   +   D + FGV   E+ T G+ 
Sbjct: 195  SLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  135 bits (341), Expect = 4e-35
 Identities = 69/206 (33%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 809  EDRIIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             DR+IGKG FG VY G   D  +     A+K L R     +   F  E  ++ G      
Sbjct: 25   SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG----LN 80

Query: 864  HPNLVTLYGWCLDGSEKIL-VYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFL 921
            HPN++ L G  L        +  YM  G L   I S +   T +  +   + VAR + +L
Sbjct: 81   HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAP 978
              + +   VHRD+ A N +LD+     V DFGLAR +   + +           V + A 
Sbjct: 141  AEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 979  EYGQTWQATTKGDVYSFGVLAMELAT 1004
            E  QT++ TTK DV+SFGVL  EL T
Sbjct: 198  ESLQTYRFTTKSDVWSFGVLLWELLT 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (353), Expect = 5e-35
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
              +G G +G VY GV       VAVK L +E      EF  E  V+        HPNLV 
Sbjct: 226  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE----IKHPNLVQ 280

Query: 870  LYGWCLDGSEKILVYEYMEGGSLED--IISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            L G C       ++ E+M  G+L D     +R  ++    L +A  ++ A+ +L  + + 
Sbjct: 281  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF- 339

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG-TVGYVAPEYGQTWQA 986
              +HR++ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE     + 
Sbjct: 340  --IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 987  TTKGDVYSFGVLAMELAT 1004
            + K DV++FGVL  E+AT
Sbjct: 397  SIKSDVWAFGVLLWEIAT 414

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (339), Expect = 5e-35
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 51/244 (20%)

Query: 810  DRIIGKGGFGTVYRGVL--------PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFG 861
            +  +G+G F  +++GV             EV +K L +        F     ++S     
Sbjct: 13   NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK---- 68

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVF 920
              H +LV  YG C+ G E ILV E+++ GSL+  +  ++  +    +L++A  +A A+ F
Sbjct: 69   LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKAL--------VTDFGLARVVSAGDSHVSTTIAGT 972
            L        +H +V A N+LL +E            ++D G++  V   D          
Sbjct: 129  LEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------- 175

Query: 973  VGY------VAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VE 1018
                     V PE     +        D +SFG    E+ + G + L     +  L   E
Sbjct: 176  -ILQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232

Query: 1019 WGRR 1022
               +
Sbjct: 233  DRHQ 236

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 6e-35
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE-----VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             +++G G FGTVY+G+     E     VA+K+L+         E   E  V++       
Sbjct: 20   IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VD 75

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            +P++  L G CL  + ++ + + M  G L D +   +  +  +  L+  + +A+ + +L 
Sbjct: 76   NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPEYG 981
                   VHRD+ A NVL+       +TDFGLA+++ A +           + ++A E  
Sbjct: 135  DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRR 1007
                 T + DV+S+GV   EL T G +
Sbjct: 192  LHRIYTHQSDVWSYGVTVWELMTFGSK 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (342), Expect = 6e-35
 Identities = 65/249 (26%), Positives = 97/249 (38%), Gaps = 18/249 (7%)

Query: 765  KYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG 824
            K     ++      P   D   V+  +K      +  +     +    +G+G FG V+R 
Sbjct: 18   KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77

Query: 825  V-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV 883
                 G + AVKK++ E    E     E+   +G       P +V LYG   +G    + 
Sbjct: 78   KDKQTGFQCAVKKVRLEVFRVE-----ELVACAG----LSSPRIVPLYGAVREGPWVNIF 128

Query: 884  YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK 943
             E +EGGSL  +I     L   R L         L +LH      I+H DVKA NVLL  
Sbjct: 129  MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185

Query: 944  EGKAL-VTDFGLARVVSAGDSHVST----TIAGTVGYVAPEYGQTWQATTKGDVYSFGVL 998
            +G    + DFG A  +       S      I GT  ++APE         K D++S   +
Sbjct: 186  DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 999  AMELATGRR 1007
             + +  G  
Sbjct: 246  MLHMLNGCH 254

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (341), Expect = 1e-34
 Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 21/210 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            + IG GG   V++ +    +  A+K +  E  + +    +R E+  L  N        ++
Sbjct: 15   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--NKLQQHSDKII 72

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
             LY + +      +V E      L   +  +  +    R     ++  A+  +H      
Sbjct: 73   RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-DSHVSTTIAGTVGYVAPE-------- 979
            IVH D+K +N L+   G   + DFG+A  +     S V  +  GTV Y+ PE        
Sbjct: 129  IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATGR 1006
                    + + K DV+S G +   +  G+
Sbjct: 188  RENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  134 bits (340), Expect = 1e-34
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTL 870
            IG+G +G+V + V  P G+ +AVK+++    E E++    +++V+  +      P +V  
Sbjct: 30   IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS---DCPYIVQF 86

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------IAIDVARALVFLHHE 924
            YG      +  +  E M   S +        +     +       I +   +AL  L   
Sbjct: 87   YGALFREGDCWICMELM-STSFDKFYKYVYSVL-DDVIPEEILGKITLATVKALNHLKEN 144

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA--GDSHVSTTIAGTVGYVAPEYGQ 982
                I+HRD+K SN+LLD+ G   + DFG    +S    DS   T  AG   Y+APE   
Sbjct: 145  LK--IIHRDIKPSNILLDRSGNIKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERID 198

Query: 983  TWQA----TTKGDVYSFGVLAMELATGR 1006
               +      + DV+S G+   ELATGR
Sbjct: 199  PSASRQGYDVRSDVWSLGITLYELATGR 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 2e-34
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 11/196 (5%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
              +G+G FG V+ G       VA+K L + G      F  E +V+        H  LV L
Sbjct: 273  VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHEKLVQL 327

Query: 871  YGWCLDGSEKILVYEYMEGGSLED--IISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
            Y    +    I V EYM  GSL D         L   + +D+A  +A  + ++    Y  
Sbjct: 328  YAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
             VHRD++A+N+L+ +     V DFGLAR++   +          + + APE     + T 
Sbjct: 385  -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 989  KGDVYSFGVLAMELAT 1004
            K DV+SFG+L  EL T
Sbjct: 444  KSDVWSFGILLTELTT 459

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (338), Expect = 2e-34
 Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 27/230 (11%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE---VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
             ++IG G FG VY+G+L    G++   VA+K L+    E +R +F  E  ++      + 
Sbjct: 49   QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ----FS 104

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            H N++ L G        +++ EYME G+L+  +       +  + + +   +A  + +L 
Sbjct: 105  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPE- 979
            +  Y   VHRD+ A N+L++      V+DFGL+RV+        TT  G   + + APE 
Sbjct: 165  NMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

Query: 980  --YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWGRR 1022
              Y +    T+  DV+SFG++  E+ T G R        E +  +  G R
Sbjct: 222  ISYRKF---TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (334), Expect = 2e-34
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
              +G G FG V+ G      +VAVK L ++G      F AE  ++        H  LV L
Sbjct: 19   ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ----LQHQRLVRL 73

Query: 871  YGWCLDGSEKIL-VYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            Y       E I  + EYME GSL D +      +LT  + LD+A  +A  + F+    Y 
Sbjct: 74   YAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY- 130

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE---YG 981
              +HRD++A+N+L+       + DFGLAR++   + +  T   G    + + APE   YG
Sbjct: 131  --IHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRR 1007
                 T K DV+SFG+L  E+ T GR 
Sbjct: 186  TF---TIKSDVWSFGILLTEIVTHGRI 209

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  132 bits (335), Expect = 2e-34
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
            +G+G +G V +   +P G+ +AVK+++      E++ R  M+ L  +      P  VT Y
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMD-LDISMRTVDCPFTVTFY 72

Query: 872  GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD------IAIDVARALVFLHHEC 925
            G      +  +  E M   SL+            + +       IA+ + +AL  LH + 
Sbjct: 73   GALFREGDVWICMELM-DTSLDKFYKQVIDKG--QTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA--GDSHVSTTIAGTVGYVAPE---- 979
               ++HRDVK SNVL++  G+  + DFG    +S    D       AG   Y+APE    
Sbjct: 130  S--VIHRDVKPSNVLINALGQVKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
                   + K D++S G+  +ELA  R
Sbjct: 184  ELNQKGYSVKSDIWSLGITMIELAILR 210

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (336), Expect = 2e-34
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 34/215 (15%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTL 870
            IG G    V      P   +VA+K++  E  +   +    E++ +S       HPN+V+ 
Sbjct: 23   IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH----HPNIVSY 78

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLD---IAI---DVARALVFLH 922
            Y   +   E  LV + + GGS+ DII             LD   IA    +V   L +LH
Sbjct: 79   YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFG----LARVVSAGDSHVSTTIAGTVGYVAP 978
                   +HRDVKA N+LL ++G   + DFG    LA       + V  T  GT  ++AP
Sbjct: 139  KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 979  E-------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            E       Y        K D++SFG+ A+ELATG 
Sbjct: 196  EVMEQVRGYDF------KADIWSFGITAIELATGA 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (335), Expect = 2e-34
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 20/205 (9%)

Query: 811  RIIGKGGFGTVYRGVLPDGR-EVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
              +G G +G VY GV       VAVK L +E      EF  E  V+        HPNLV 
Sbjct: 19   HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE----IKHPNLVQ 73

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            L G C       ++ E+M  G+L D +   +R  ++    L +A  ++ A+ +L  + + 
Sbjct: 74   LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT-VGYVAPE---YGQT 983
              +HRD+ A N L+ +     V DFGL+R+++ GD++ +   A   + + APE   Y + 
Sbjct: 133  --IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 984  WQATTKGDVYSFGVLAMELAT-GRR 1007
               + K DV++FGVL  E+AT G  
Sbjct: 190  ---SIKSDVWAFGVLLWEIATYGMS 211

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  132 bits (334), Expect = 3e-34
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 809  EDRIIGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGE--REFRAEMEVLSGNGFGWP 863
             D  +G G FG+V +GV    ++   VA+K L ++G E     E   E +++        
Sbjct: 14   ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQ----LD 68

Query: 864  HPNLVTLYGWCLDGSEKI-LVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFL 921
            +P +V L G C   +E + LV E   GG L   ++  R  +      ++   V+  + +L
Sbjct: 69   NPYIVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPE 979
              + +   VHRD+ A NVLL     A ++DFGL++ + A DS+ +   AG   + + APE
Sbjct: 127  EEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT-GRR 1007
                 + +++ DV+S+GV   E  + G++
Sbjct: 184  CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (340), Expect = 3e-34
 Identities = 69/250 (27%), Positives = 118/250 (47%), Gaps = 29/250 (11%)

Query: 795  FTYSDILKATGKFS-E--------DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREG 841
             T+ D  +   +F+ E        D+++G G FG V  G L  P  +E  VA+K L+   
Sbjct: 26   HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85

Query: 842  LEGER-EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDR 899
             E +R +F  E  ++      + HPN++ L G        ++V EYME GSL+  +    
Sbjct: 86   TEKQRRDFLGEASIMGQ----FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141

Query: 900  TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
             + T  + + +   +A  + +L    Y   VHRD+ A N+L++      V+DFGL RV+ 
Sbjct: 142  AQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 960  AGDSHVSTTIAGT--VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEE 1014
                   TT  G   + + +PE     + T+  DV+S+G++  E+ + G R       ++
Sbjct: 199  DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

Query: 1015 CL--VEWGRR 1022
             +  V+ G R
Sbjct: 259  VIKAVDEGYR 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (332), Expect = 4e-34
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 30/207 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK + +      + F AE  V++       H NLV L
Sbjct: 27   QTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDAT-AQAFLAEASVMTQ----LRHSNLVQL 79

Query: 871  YGWCLDGSEKI-LVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D +    R+ L     L  ++DV  A+ +L    + 
Sbjct: 80   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE---YG 981
              VHRD+ A NVL+ ++  A V+DFGL +     ++  +         V + APE     
Sbjct: 139  --VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQD--TGKLPVKWTAPEALREK 189

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRR 1007
            +    +TK DV+SFG+L  E+ + GR 
Sbjct: 190  KF---STKSDVWSFGILLWEIYSFGRV 213

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (340), Expect = 4e-34
 Identities = 45/210 (21%), Positives = 82/210 (39%), Gaps = 21/210 (10%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLV 868
            + IG GG   V++ +    +  A+K +  E  + +    +R E+  L  N        ++
Sbjct: 62   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL--NKLQQHSDKII 119

Query: 869  TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
             LY + +      +V E      L   +  +  +    R     ++  A+  +H      
Sbjct: 120  RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAG-DSHVSTTIAGTVGYVAPE-------- 979
            IVH D+K +N L+   G   + DFG+A  +     S V  +  G V Y+ PE        
Sbjct: 176  IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 980  ---YGQTWQATTKGDVYSFGVLAMELATGR 1006
                    + + K DV+S G +   +  G+
Sbjct: 235  RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 5e-34
 Identities = 73/205 (35%), Positives = 107/205 (52%), Gaps = 17/205 (8%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG++   AVK L R    GE  +F  E  ++    F   H
Sbjct: 30   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD--FS--H 85

Query: 865  PNLVTLYGWCLDGSEKIL-VYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            PN+++L G CL      L V  YM+ G L + I ++    T +  +   + VA+ + +L 
Sbjct: 86   PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE 979
             + +   VHRD+ A N +LD++    V DFGLAR +   + +      G    V ++A E
Sbjct: 146  SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
              QT + TTK DV+SFGVL  EL T
Sbjct: 203  SLQTQKFTTKSDVWSFGVLLWELMT 227

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  134 bits (338), Expect = 9e-34
 Identities = 42/309 (13%), Positives = 75/309 (24%), Gaps = 64/309 (20%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVK--------------KLQREGLEGE--REFR 849
                 ++G+              G    V               +++ E L     R  +
Sbjct: 80   LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 850  AEMEVLSGNGFGWP-----HPNLVTLYGWCLDGS-----EKILVYEYMEG------GSLE 893
             + +      F +P      P    +    LD        +  +Y  M+         L 
Sbjct: 140  NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 894  DIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG 953
               S    L    RL + + V R L  LHH     +VH  ++  +++LD+ G   +T F 
Sbjct: 200  SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 954  LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG-----DVYSFGVLAMELATGRRA 1008
                  A                A       Q          D ++ G+    +      
Sbjct: 257  HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 1009 LEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPN 1068
                          + G          IP            + +  LL            
Sbjct: 317  NTDDAA--------LGGSEWIFRSCKNIP------------QPVRALLE---GFLRYPKE 353

Query: 1069 ARPNVKEVL 1077
             R    + +
Sbjct: 354  DRLLPLQAM 362

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (341), Expect = 9e-34
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + +G G FG V+        +VAVK + + G      F AE  V+        H  LV L
Sbjct: 194  KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKT----LQHDKLVKL 248

Query: 871  YGWCLDGSEKILVYEYMEGGSLED--IISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
            +         I + E+M  GSL D     + ++    + +D +  +A  + F+    Y  
Sbjct: 249  HAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT 988
             +HRD++A+N+L+       + DFGLARV+   +          + + APE       T 
Sbjct: 306  -IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 989  KGDVYSFGVLAMELAT-GRR 1007
            K DV+SFG+L ME+ T GR 
Sbjct: 365  KSDVWSFGILLMEIVTYGRI 384

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  131 bits (331), Expect = 1e-33
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 16/206 (7%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
                     IG+G  G V        GR+VAVK +     +       E+ ++       
Sbjct: 44   RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY---- 99

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALV 919
             H N+V +Y   L G E  ++ E+++GG+L DI+S + RL       IA     V +AL 
Sbjct: 100  QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLN---EEQIATVCEAVLQALA 155

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LH +    ++HRD+K+ ++LL  +G+  ++DFG    +S        ++ GT  ++APE
Sbjct: 156  YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPE 211

Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                    T+ D++S G++ +E+  G
Sbjct: 212  VISRSLYATEVDIWSLGIMVIEMVDG 237

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (334), Expect = 2e-33
 Identities = 74/205 (36%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L   DG++   AVK L R    GE  +F  E  ++    F   H
Sbjct: 94   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD--FS--H 149

Query: 865  PNLVTLYGWCLDGSEKIL-VYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            PN+++L G CL      L V  YM+ G L + I ++    T +  +   + VA+ + FL 
Sbjct: 150  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPE 979
             + +   VHRD+ A N +LD++    V DFGLAR +   +        G    V ++A E
Sbjct: 210  SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 980  YGQTWQATTKGDVYSFGVLAMELAT 1004
              QT + TTK DV+SFGVL  EL T
Sbjct: 267  SLQTQKFTTKSDVWSFGVLLWELMT 291

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (339), Expect = 2e-33
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
            + IGKG FG V  G    G +VAVK + +      + F AE  V++       H NLV L
Sbjct: 199  QTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDAT-AQAFLAEASVMTQ----LRHSNLVQL 251

Query: 871  YGWCLDGSEKI-LVYEYMEGGSLED--IISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
             G  ++    + +V EYM  GSL D      R+ L     L  ++DV  A+ +L    + 
Sbjct: 252  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT---VGYVAPEYGQTW 984
              VHRD+ A NVL+ ++  A V+DFGL +         S+T       V + APE  +  
Sbjct: 311  --VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361

Query: 985  QATTKGDVYSFGVLAMELAT-GRR 1007
            + +TK DV+SFG+L  E+ + GR 
Sbjct: 362  KFSTKSDVWSFGILLWEIYSFGRV 385

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (346), Expect = 2e-33
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)

Query: 802  KATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSG-N 858
            +  G +     +G GGFG V R +    G +VA+K+ ++E     RE +  E++++   N
Sbjct: 11   QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 859  GFGWPHPNLVTLY------GWCLDGSEKILVYEYMEGGSLEDIISDRTR---LTWRRRLD 909
                 HPN+V+                 +L  EY EGG L   ++       L       
Sbjct: 71   -----HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVVSAGDSHVS 966
            +  D++ AL +LH      I+HRD+K  N++L    + L   + D G A+ +      + 
Sbjct: 126  LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELC 180

Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR 1007
            T   GT+ Y+APE  +  + T   D +SFG LA E  TG R
Sbjct: 181  TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (328), Expect = 2e-33
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 16/206 (7%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
              K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N    
Sbjct: 19   KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN---- 74

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVARALV 919
             +PN+V      L G E  +V EY+ GGSL D+++  T +       IA    +  +AL 
Sbjct: 75   KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMD---EGQIAAVCRECLQALE 130

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            FLH      ++HRD+K+ N+LL  +G   +TDFG    ++   S   +T+ GT  ++APE
Sbjct: 131  FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPE 186

Query: 980  YGQTWQATTKGDVYSFGVLAMELATG 1005
                     K D++S G++A+E+  G
Sbjct: 187  VVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  129 bits (327), Expect = 3e-33
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 17/205 (8%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
             ++GKG +G VY G  L +   +A+K++        +    E+ +         H N+V 
Sbjct: 28   VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK----HKNIVQ 83

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAI---DVARALVFLHHEC 925
              G   +     +  E + GGSL  ++  +   L    +  I      +   L +LH   
Sbjct: 84   YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQ 142

Query: 926  YPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
               IVHRD+K  NVL++   G   ++DFG ++ ++  +   + T  GT+ Y+APE     
Sbjct: 143  ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETFTGTLQYMAPEIIDKG 198

Query: 983  TWQATTKGDVYSFGVLAMELATGRR 1007
                    D++S G   +E+ATG+ 
Sbjct: 199  PRGYGKAADIWSLGCTIIEMATGKP 223

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  130 bits (328), Expect = 3e-33
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPHPNLVTL 870
            +G G  G V++      G  +AVK+++R G + E +    +++V+  +      P +V  
Sbjct: 33   MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH---DCPYIVQC 89

Query: 871  YGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIV 930
            +G  +  ++  +  E M   + +     +  +  R    + + + +AL +L  +    ++
Sbjct: 90   FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VI 147

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSA--GDSHVSTTIAGTVGYVAPEYGQTWQA-- 986
            HRDVK SN+LLD+ G+  + DFG    +S    D       AG   Y+APE         
Sbjct: 148  HRDVKPSNILLDERGQIKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 987  ---TTKGDVYSFGVLAMELATGR 1006
                 + DV+S G+  +ELATG+
Sbjct: 204  PDYDIRADVWSLGISLVELATGQ 226

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (342), Expect = 4e-33
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 20/225 (8%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE---VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHP 865
            D  +G G FG+V +GV    ++   VA+K L++   + +  E   E +++        +P
Sbjct: 341  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----LDNP 396

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHHE 924
             +V L G C      +LV E   GG L   ++  R  +      ++   V+  + +L  +
Sbjct: 397  YIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYGQ 982
             +   VHR++ A NVLL     A ++DFGL++ + A DS+ +   AG   + + APE   
Sbjct: 456  NF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

Query: 983  TWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWGRR 1022
              + +++ DV+S+GV   E  + G++  +   G E +  +E G+R
Sbjct: 513  FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  129 bits (326), Expect = 5e-33
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 29/213 (13%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFG 861
               F++   IGKG FG V++G+     + VA+K +  E  E E E  + E+ VLS     
Sbjct: 21   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-- 78

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVA 915
               P +   YG  L  ++  ++ EY+ GGS  D++           LD   IA    ++ 
Sbjct: 79   --SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREIL 129

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS---TTIAGT 972
            + L +LH E     +HRD+KA+NVLL + G+  + DFG    V+   +       T  GT
Sbjct: 130  KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGT 182

Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATG 1005
              ++APE  +     +K D++S G+ A+ELA G
Sbjct: 183  PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (329), Expect = 6e-33
 Identities = 38/373 (10%), Positives = 81/373 (21%), Gaps = 67/373 (17%)

Query: 744  IIIYMLVKRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKA 803
              +  L+KR  E  GY  E           +  ++ W  +    +         S + + 
Sbjct: 9    SFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVD--------SLLSQG 60

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEVLSGNG 859
              K      +  G    V+    +    + A+K           E           +   
Sbjct: 61   ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL- 119

Query: 860  FGWPHPNLVTLYGWC----------LDGSEKI----------------LVYEYMEG---- 889
                  +                  +                      L+          
Sbjct: 120  ---LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176

Query: 890  --GSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA 947
               +L+ +   R          +   + R    L  +    +VH      N+ +  +G+ 
Sbjct: 177  LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRL 233

Query: 948  LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY--GQTWQATTKGDVYSFGVLAMELATG 1005
            ++ D      V           +  V Y   E+    T   T   + +  G+    +   
Sbjct: 234  MLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 1006 RRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAE 1065
                      +    +R                 L         + +  L+    R    
Sbjct: 290  FLPFGLVTPGIKGSWKRPSLRVPGTDS-------LAFGSCTPLPDFVKTLIG---RFLNF 339

Query: 1066 APNARPNVKEVLA 1078
                R    E + 
Sbjct: 340  DRRRRLLPLEAME 352

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (323), Expect = 7e-33
 Identities = 54/226 (23%), Positives = 100/226 (44%), Gaps = 23/226 (10%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPH 864
            +RI+G+G FG VY GV     G +  VAVK  +++     + +F +E  ++        H
Sbjct: 17   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN----LDH 72

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHH 923
            P++V L G   +    I + E    G L   +  ++  L     +  ++ + +A+ +L  
Sbjct: 73   PHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEYG 981
                  VHRD+   N+L+       + DFGL+R +   D            + +++PE  
Sbjct: 132  INC---VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPESI 186

Query: 982  QTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWGRR 1022
               + TT  DV+ F V   E+ + G++       ++ +  +E G R
Sbjct: 187  NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  128 bits (323), Expect = 7e-33
 Identities = 33/268 (12%), Positives = 71/268 (26%), Gaps = 57/268 (21%)

Query: 810  DRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGE---REFRAEMEVLSGNGFGWP 863
                G       ++ +  D    R+VA+  +  +G+  +   +E  +    LS       
Sbjct: 36   LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID---- 89

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
             P +  +       +  ++V E++ GGSL+++    T  +    +     +A A    H 
Sbjct: 90   KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 +       S V +  +G  ++                          +       
Sbjct: 148  A---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPD----- 178

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
              A  + D+   G     L   R  L           R  +           I    +  
Sbjct: 179  --ANPQDDIRGIGASLYALLVNRWPLPEAG------VRSGLAPAERDTAGQPIEPADIDR 230

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARP 1071
             +        ++  +  R        R 
Sbjct: 231  DIPF------QISAVAARSVQGDGGIRS 252

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  134 bits (339), Expect = 1e-32
 Identities = 69/373 (18%), Positives = 128/373 (34%), Gaps = 95/373 (25%)

Query: 102 LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNL-SGLRSLEILDLSVNR 160
               + L++  +  + ++PD L +   +  L +  N L+   +L +    L  L++S N+
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT---SLPALPPELRTLEVSGNQ 92

Query: 161 IHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQ 220
           +   +    P    +L + +  L +L             L  L +  N            
Sbjct: 93  LT-SLPVLPPG-LLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL---------- 133

Query: 221 LVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNF 280
                           +S+      L+   +S+N+ +   P   S    L  L  + N  
Sbjct: 134 ----------------TSLPVLPPGLQELSVSDNQ-LASLPALPS---ELCKLWAYNNQL 173

Query: 281 SGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
           +  +P        L+ L +  +N L+ +P     L KL   +               R T
Sbjct: 174 TS-LPMLPSG---LQELSVS-DNQLASLPTLPSELYKLWAYNN--------------RLT 214

Query: 341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR 400
            +  L                     +  L +S N  T  LPV  S+   LK L+++ NR
Sbjct: 215 SLPAL------------------PSGLKELIVSGNRLTS-LPVLPSE---LKELMVSGNR 252

Query: 401 FNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNC 460
              S+P        L +L +  N+LT  +P S+ +L+S   + L  N LS E   +    
Sbjct: 253 LT-SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQ--AL 304

Query: 461 TSLLWLNLSNNKL 473
             +      +  +
Sbjct: 305 REITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  130 bits (329), Expect = 2e-31
 Identities = 70/322 (21%), Positives = 119/322 (36%), Gaps = 52/322 (16%)

Query: 171 AICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENV 230
            +     V N+  + LT  +  C     ++  L +  NN   ++     +L    VS N 
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEVSGNQ 92

Query: 231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGS 290
           L+ +    +      L IF       +   P        L  L +FGN  +  +P     
Sbjct: 93  LTSL--PVLPPGLLELSIFSNPLTH-LPALPS------GLCKLWIFGNQLTS-LPVLPPG 142

Query: 291 ISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
              L+ L +  +N L+ +P     L K   L   +N        +    + ++ L++  N
Sbjct: 143 ---LQELSVS-DNQLASLPALPSELCK---LWAYNNQL----TSLPMLPSGLQELSVSDN 191

Query: 351 SYIDGMNSSGILKLP----NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP 406
                     +  LP     + +L   +N  T  LP   S    LK LI++ NR   S+P
Sbjct: 192 Q---------LASLPTLPSELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLP 237

Query: 407 AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWL 466
                   L+ L +S N LT  +P     L SL    +  N L+  +P  + + +S   +
Sbjct: 238 V---LPSELKELMVSGNRLTS-LPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTV 289

Query: 467 NLSNNKLSGNIPPEVMTIGRNA 488
           NL  N LS     + +    +A
Sbjct: 290 NLEGNPLS-ERTLQALREITSA 310

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  111 bits (280), Expect = 2e-25
 Identities = 61/358 (17%), Positives = 112/358 (31%), Gaps = 59/358 (16%)

Query: 85  NLTDWNISGDIFNNF-SALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-- 141
           ++T   I  +   +  +   +L  L++S N  + S+P        L   +     L    
Sbjct: 62  HITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP 120

Query: 142 ----DLNLSG---------LRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG 188
                L + G            L+ L +S N++      S PA+  +L       N LT 
Sbjct: 121 SGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-----SLPALPSELCKLWAYNNQLT- 174

Query: 189 RIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEI 248
            +         L+ L +S N    ++    ++L +     N L     +S+      L+ 
Sbjct: 175 SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRL-----TSLPALPSGLKE 225

Query: 249 FDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI 308
             +S N  +   P   S    L  L + GN  +  +P        L +L +   N L+ +
Sbjct: 226 LIVSGNR-LTSLPVLPS---ELKELMVSGNRLTS-LPMLPSG---LLSLSVY-RNQLTRL 276

Query: 309 PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNIS 368
           PESL++LS    ++L  N       +     T       +S   I    +         +
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITS---APGYSGPIIRFDMAGASAPRETRA 333

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT 426
               + +        E +                       G   N     L  + L+
Sbjct: 334 LHLAAADWLVPAREGEPAPADRWHMF---------------GQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 36/155 (23%), Positives = 54/155 (34%), Gaps = 35/155 (22%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
            L++SGNQL+  L      L   S+           LPS      L  L +  N  +  +
Sbjct: 85  TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSG-----LCKLWIFGNQLT-SL 136

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELS-----------------KLNISYNP 668
           P        LQ L +S N  +   PA  + L +L                  +L++S N 
Sbjct: 137 PVLPPG---LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQ 192

Query: 669 LVSGTIPST-GQLATFEKTSYLGDPLLDLPDFIEN 702
           L S  +P+   +L    K     + L  LP     
Sbjct: 193 LAS--LPTLPSEL---YKLWAYNNRLTSLPALPSG 222

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 23/138 (16%), Positives = 45/138 (32%), Gaps = 11/138 (7%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIP 626
           L +SGN+L+  L     +L+      +  N+    LP     L  + L++ RN  +  +P
Sbjct: 226 LIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSGL--LSLSVYRNQLT-RLP 277

Query: 627 SEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKT 686
               ++     ++L  N  S     +   +T     +    P++   +            
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS---GPIIRFDMAGASAPRETRAL 334

Query: 687 SYLGDPLLDLPDFIENGP 704
                  L      E  P
Sbjct: 335 HLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 18/136 (13%)

Query: 567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIP 626
           L +  + L+  L   +    + + + +  N     LP+   +L    L ++ N  +  +P
Sbjct: 45  LNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL--RTLEVSGNQLT-SLP 97

Query: 627 SEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKT 686
                +  L        +            + L KL I  N L S  +P        ++ 
Sbjct: 98  VLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS--LPV--LPPGLQEL 146

Query: 687 SYLGDPLLDLPDFIEN 702
           S   + L  LP     
Sbjct: 147 SVSDNQLASLPALPSE 162

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 31/143 (21%), Positives = 44/143 (30%), Gaps = 23/143 (16%)

Query: 102 LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRI 161
            + L  L + RN  +  +P+ L    S   +NL  N LS +  L  LR +         I
Sbjct: 260 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317

Query: 162 --HGEISFSFPAICEKL--VVANLSLNNLTGRIDTC-----FDGCLNLRYLDLSSN---- 208
                   S P     L    A+  +    G          F    N     L  +    
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSE 377

Query: 209 --------NFRGNIWNGLAQLVE 223
                    F+  I + LAQL E
Sbjct: 378 TENFIKDAGFKAQISSWLAQLAE 400

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  130 bits (328), Expect = 1e-32
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 810  DRIIGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGER-EFRAEMEVLSGNGF 860
             + +G+G FG V                 +VAVK L+ +  E +  +  +EME++     
Sbjct: 74   GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM--I 131

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLED----------------IISDRTRLTW 904
            G  H N++ L G C       ++ EY   G+L +                  +   +L+ 
Sbjct: 132  G-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 905  RRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
            +  +  A  VAR + +L  +     +HRD+ A NVL+ ++    + DFGLAR +   D +
Sbjct: 191  KDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247

Query: 965  VSTTIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
              TT     V ++APE          T + DV+SFGVL  E+ T
Sbjct: 248  KKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFT 288

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (324), Expect = 1e-32
 Identities = 75/304 (24%), Positives = 111/304 (36%), Gaps = 66/304 (21%)

Query: 811  RIIGKGGFGTVYRGVLPDGR------EVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G G FG VY G +          +VAVK L     E +  +F  E  ++S     + 
Sbjct: 36   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK----FN 91

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-------IISDRTRLTWRRRLDIAIDVAR 916
            H N+V   G  L    + ++ E M GG L+          S  + L     L +A D+A 
Sbjct: 92   HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALV---TDFGLARVVSAGDSHVSTTIAGTV 973
               +L    +   +HRD+ A N LL   G   V    DFG+AR +            G  
Sbjct: 152  GCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGC 204

Query: 974  GYV-----APE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWG 1020
              +      PE    G     T+K D +SFGVL  E+ + G         +E L  V  G
Sbjct: 205  AMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             R M   ++ P                    +  ++    +C    P  RPN   +L  +
Sbjct: 262  GR-MDPPKNCP------------------GPVYRIMT---QCWQHQPEDRPNFAIILERI 299

Query: 1081 IKIL 1084
                
Sbjct: 300  EYCT 303

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 1e-32
 Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 50/303 (16%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            +    R++ +GGF  VY    +  GRE A+K+L     E  R    E+  +        H
Sbjct: 29   RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS---GH 85

Query: 865  PNLVTLYGWCLDGSEK--------ILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDV 914
            PN+V        G E+        +L+ E  +G  +E +     R  L+    L I    
Sbjct: 86   PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST------- 967
             RA+  +H    PPI+HRD+K  N+LL  +G   + DFG A  +S    +  +       
Sbjct: 146  CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 968  ----TIAGTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020
                T   T  Y  PE    +       K D+++ G +   L   +   E G +      
Sbjct: 205  EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK------ 258

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             R++       G+  IP                 L+R         P  R ++ EV+  L
Sbjct: 259  LRIVN------GKYSIPPHDTQY------TVFHSLIR---AMLQVNPEERLSIAEVVHQL 303

Query: 1081 IKI 1083
             +I
Sbjct: 304  QEI 306

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (325), Expect = 1e-32
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 34/220 (15%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             + +G G FG V         +      VAVK L+      E+    +E++++S    G 
Sbjct: 51   GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH--LG- 107

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL--------------EDIISDRTRLTWRRRL 908
             H N+V L G C  G   +++ EY   G L                     +  + R  L
Sbjct: 108  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT 968
              +  VA+ + FL  +     +HRDV A NVLL     A + DFGLAR +    +++   
Sbjct: 168  HFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224

Query: 969  IAG-TVGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
             A   V ++APE          T + DV+S+G+L  E+ +
Sbjct: 225  NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFS 261

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  131 bits (331), Expect = 1e-32
 Identities = 79/407 (19%), Positives = 137/407 (33%), Gaps = 74/407 (18%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILDLSVN 159
             ++Y+DLS N+ +       S  + L++L +        +      GL SL IL L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR-----GNI 214
           +                                 F+G  NL  L L+  N       GN 
Sbjct: 90  QFL-----QLET--------------------GAFNGLANLEVLTLTQCNLDGAVLSGNF 124

Query: 215 WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNC--RNLVV 272
           +  L  L    + +N +  +  +S F       + DL+ N+       ++ N   ++  +
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184

Query: 273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV 332
           L L                       + +         +    + +  LDLS N F   +
Sbjct: 185 LRLSSITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228

Query: 333 QKIF---GRFTQVKILALHSNSYIDGMNSSGI-----------LKLPNISRLDLSHNNFT 378
            K F      T+++ L L ++  +                   L+   +   DLS +   
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288

Query: 379 GPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GN 435
             L   + S    L+ L LA N  N  I    +  + +L  L+LS N L   I   +  N
Sbjct: 289 A-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFEN 345

Query: 436 LTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGNIPPEV 481
           L  L  L L+ N +   +  +      +L  L L  N+L  ++P  +
Sbjct: 346 LDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  113 bits (284), Expect = 2e-26
 Identities = 80/397 (20%), Positives = 138/397 (34%), Gaps = 38/397 (9%)

Query: 292 SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK-IFGRFTQVKILALHSN 350
           + +  + L  N+   +   S   L  L+ L +     G  ++   F   + + IL L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 351 SYIDGMNSSGILKLPNISRLDLSHNNFTG-PLPVEI-SQMRSLKFLILAHNRFNGSIP-A 407
                + +     L N+  L L+  N  G  L       + SL+ L+L  N      P +
Sbjct: 90  Q-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 408 VYGNMPNLQTLDLSFNELTGPIPPSI---GNLTSLLWLMLANNSL--------SGEIPGE 456
            + NM     LDL+FN++   I               L L++ +L          E  G 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207

Query: 457 IGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWI 516
               TS+  L+LS N        +                 N     +            
Sbjct: 208 PFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD--- 263

Query: 517 PADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG 576
                P +F +  L     ++     L  + IF   L       F     L L+ N+++ 
Sbjct: 264 -----PDNFTFKGLEASGVKTCD---LSKSKIF--ALLKSVFSHFTDLEQLTLAQNEIN- 312

Query: 577 ELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSGEIPSE-FGNI 632
           ++  +    L +   ++L  N   G + S+ F+ L  L VL+L+ N+    +  + F  +
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL 370

Query: 633 KCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
             L+ L L  N         F+ LT L K+ +  NP 
Sbjct: 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 59/343 (17%), Positives = 102/343 (29%), Gaps = 71/343 (20%)

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFN 423
            +++ +DLS N+         S+++ L+FL +        I    +  + +L  L L +N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 424 ELTGPIPPSI-GNLTSLLWLMLANNSL-SGEIPGEI-GNCTSLLWLNLSNNKLSGNIPPE 480
           +    +       L +L  L L   +L    + G      TSL  L L +N +   I P 
Sbjct: 90  QFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPA 147

Query: 481 ----------VMTIGRNARPTFEANQRNGERTIAGSSECLSMKRW--IPADYPPFSFVYT 528
                     V+ +  N                          +   I  +         
Sbjct: 148 SFFLNMRRFHVLDLTFN--------------------------KVKSICEE------DLL 175

Query: 529 ILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTF---QITGYLQLSGNQLSGELSPDIGKL 585
               K    L    +    +    L                L LSGN     ++      
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235

Query: 586 QNFSMVH-------------LGFNQFDGKLPSQFDQLP---LIVLNLTRNNFSGEIPSE- 628
              + +               G   F       F  L    +   +L+++     +    
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV 294

Query: 629 FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           F +   L+ L L+ N  +     +F  LT L KLN+S N L S
Sbjct: 295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 91.0 bits (226), Expect = 3e-19
 Identities = 61/266 (22%), Positives = 101/266 (37%), Gaps = 24/266 (9%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDLSSCRS--LKYLNLSHNILSG----------DLNLS 146
           F  + +   LDL+ N       +DL + +      L LS   L              N  
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 147 GLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS 206
              S+  LDLS N     ++  F        + +L L+N      +           D  
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK----DPD 265

Query: 207 SNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-S 265
           +  F+G   +G+       +S++ +   +  SVF     LE   L++NE I         
Sbjct: 266 NFTFKGLEASGVKTC---DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE-INKIDDNAFW 320

Query: 266 NCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
              +L+ LNL  N     I + +  ++  LE L L  N+  ++  +S L L  L+ L L 
Sbjct: 321 GLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379

Query: 325 SNNFGGEVQKIFGRFTQVKILALHSN 350
           +N        IF R T ++ + LH+N
Sbjct: 380 TNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.1 bits (151), Expect = 5e-10
 Identities = 45/206 (21%), Positives = 70/206 (33%), Gaps = 22/206 (10%)

Query: 57  YMQWNQ-SSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
            +  N    S  +      +  K +   L+ +    S     NF      ++  L  +  
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS-- 275

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAIC 173
                        +K  +LS + +        S    LE L L+ N I+     +F    
Sbjct: 276 ------------GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF-WGL 322

Query: 174 EKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENV 230
             L+  NLS N L       F+    L  LDLS N+ R      + GL  L E ++  N 
Sbjct: 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQ 382

Query: 231 LSGVVSSSVFKENCSLEIFDLSENEF 256
           L   V   +F    SL+   L  N +
Sbjct: 383 LK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.2 bits (141), Expect = 8e-09
 Identities = 35/120 (29%), Positives = 46/120 (38%), Gaps = 13/120 (10%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILD 155
           FS  T L  L L++N  +  I D+       L  LNLS N L          L  LE+LD
Sbjct: 295 FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353

Query: 156 LSVNRIHGEISFSFPAI----CEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           LS N I      +           L    L  N L    D  FD   +L+ + L +N + 
Sbjct: 354 LSYNHIR-----ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 20/87 (22%), Positives = 30/87 (34%), Gaps = 2/87 (2%)

Query: 592 HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPF 649
            L  N       + F +L  L  L + +      I +  F  +  L  L L YN F    
Sbjct: 36  DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLE 95

Query: 650 PASFNNLTELSKLNISYNPLVSGTIPS 676
             +FN L  L  L ++   L    +  
Sbjct: 96  TGAFNGLANLEVLTLTQCNLDGAVLSG 122

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  128 bits (323), Expect = 2e-32
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
             G F    ++G G +G VY+G  +  G+  A+K +   G + E E + E+ +L       
Sbjct: 23   AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSH-- 79

Query: 863  PHPNLVTLYGWCLDGSEKI------LVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI- 912
             H N+ T YG  +  +         LV E+   GS+ D+I    + T    L    IA  
Sbjct: 80   -HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYI 134

Query: 913  --DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
              ++ R L  LH      ++HRD+K  NVLL +  +  + DFG++  +         T  
Sbjct: 135  CREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFI 190

Query: 971  GTVGYVAPE---YGQTWQAT--TKGDVYSFGVLAMELATG 1005
            GT  ++APE     +   AT   K D++S G+ A+E+A G
Sbjct: 191  GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  130 bits (327), Expect = 2e-32
 Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 30/213 (14%)

Query: 813  IGKG--GFGTVYRGV-LPDGREVAVKKLQREGLEGER--EFRAEMEVLSGNGFGWPHPNL 867
            IGKG     TV      P G  V V+++  E    E     + E+ V         HPN+
Sbjct: 33   IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF----NHPNI 88

Query: 868  VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVARALVFL 921
            V      +  +E  +V  +M  GS +D+I       +   ++   IA     V +AL ++
Sbjct: 89   VPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV----- 976
            HH  Y   VHR VKAS++L+  +GK  ++       + +               V     
Sbjct: 145  HHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 977  -APE-YGQTWQA-TTKGDVYSFGVLAMELATGR 1006
             +PE   Q  Q    K D+YS G+ A ELA G 
Sbjct: 202  LSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (323), Expect = 2e-32
 Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 63/308 (20%)

Query: 810  DRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             + +G+G FG V              R VAVK L+      E     +E+++L     G 
Sbjct: 32   GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH--IG- 88

Query: 863  PHPNLVTLYGWCLDGSEKILV-YEYMEGGSL----------------EDIISDRTRLTWR 905
             H N+V L G C      ++V  E+ + G+L                      +  LT  
Sbjct: 89   HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 906  RRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
              +  +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR +     +V
Sbjct: 149  HLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 966  STTIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRR---ALEGGEECLV 1017
                A   + ++APE          T + DV+SFGVL  E+ + G      ++  EE   
Sbjct: 206  RKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 259

Query: 1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVKEV 1076
                      + G  R   P         +    EM + +     C    P+ RP   E+
Sbjct: 260  -----FCRRLKEG-TRMRAP---------DYTTPEMYQTML---DCWHGEPSQRPTFSEL 301

Query: 1077 LAMLIKIL 1084
            +  L  +L
Sbjct: 302  VEHLGNLL 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  127 bits (321), Expect = 2e-32
 Identities = 75/308 (24%), Positives = 119/308 (38%), Gaps = 62/308 (20%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             + +G G FG V         +      VAVK L+      ER    +E++VLS    G 
Sbjct: 28   GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY--LG- 84

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL------------------EDIISDRTRLTW 904
             H N+V L G C  G   +++ EY   G L                    +  D   L  
Sbjct: 85   NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 905  RRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
               L  +  VA+ + FL  +     +HRD+ A N+LL       + DFGLAR +    ++
Sbjct: 145  EDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 965  VSTTIAGT---VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017
            V          V ++APE          T + DV+S+G+   EL + G     G     +
Sbjct: 202  VVKG--NARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPG-----M 251

Query: 1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVKEV 1076
                +     + G  R + P         E A  EM ++++    C    P  RP  K++
Sbjct: 252  PVDSKFYKMIKEG-FRMLSP---------EHAPAEMYDIMK---TCWDADPLKRPTFKQI 298

Query: 1077 LAMLIKIL 1084
            + ++ K +
Sbjct: 299  VQLIEKQI 306

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (319), Expect = 3e-32
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 41/233 (17%)

Query: 805  GKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSG- 857
            G++  D    + +G+GGFG V+      D    A+K+++    E  RE    E++ L+  
Sbjct: 1    GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60

Query: 858  NGFGWPHPNLVTLYGWCLDG---------SEKILVY---EYMEGGSLEDIISDRTRLTWR 905
                  HP +V  +   L+          S K+ +Y   +     +L+D ++ R  +  R
Sbjct: 61   E-----HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 906  RR---LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
             R   L I + +A A+ FLH +    ++HRD+K SN+    +    V DFGL   +   +
Sbjct: 116  ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 963  S-----------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT 1004
                           T   GT  Y++PE       + K D++S G++  EL  
Sbjct: 173  EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (322), Expect = 3e-32
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 42/226 (18%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE--------VAVKKLQREGLEGER-EFRAEMEVLSGNGF 860
             + +G+G FG V         +        VAVK L+ +  E +  +  +EME++     
Sbjct: 40   GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--I 97

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL----------------EDIISDRTRLTW 904
            G  H N++ L G C       ++ EY   G+L                +       ++T+
Sbjct: 98   G-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 905  RRRLDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
            +  +     +AR + +L          +HRD+ A NVL+ +     + DFGLAR ++  D
Sbjct: 157  KDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 963  SHVSTTIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
             +  TT     V ++APE          T + DV+SFGVL  E+ T
Sbjct: 212  YYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  128 bits (324), Expect = 4e-32
 Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 67/310 (21%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE--------VAVKKLQREGLEGER-EFRAEMEVLSGNGF 860
             + +G+G FG V         +        VAVK L+ +  E +  +  +EME++     
Sbjct: 86   GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--I 143

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL----------------EDIISDRTRLTW 904
            G  H N++ L G C       ++ EY   G+L                +       ++T+
Sbjct: 144  G-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 905  RRRLDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD 962
            +  +     +AR + +L          +HRD+ A NVL+ +     + DFGLAR ++  D
Sbjct: 203  KDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 963  SHVSTTIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEEC 1015
             +  TT     V ++APE          T + DV+SFGVL  E+ T G     G   EE 
Sbjct: 258  YYKKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313

Query: 1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVK 1074
                   +    + G  R   P              E+  ++R    C    P+ RP  K
Sbjct: 314  -------LFKLLKEG-HRMDKP---------ANCTNELYMMMR---DCWHAVPSQRPTFK 353

Query: 1075 EVLAMLIKIL 1084
            +++  L +IL
Sbjct: 354  QLVEDLDRIL 363

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (321), Expect = 5e-32
 Identities = 75/316 (23%), Positives = 119/316 (37%), Gaps = 73/316 (23%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             +++G G FG V         +      VAVK L+ +    ER    +E+++++    G 
Sbjct: 50   GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ--LG- 106

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL-----------------------EDIISDR 899
             H N+V L G C       L++EY   G L                        +   D 
Sbjct: 107  SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 900  TRLTWRRRLDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
              LT+   L  A  VA+ + FL          VHRD+ A NVL+       + DFGLAR 
Sbjct: 167  NVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 958  VSAGDSHVSTTIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRR---AL 1009
            + +  ++V    A   V ++APE    G     T K DV+S+G+L  E+ + G      +
Sbjct: 222  IMSDSNYVVRGNARLPVKWMAPESLFEGIY---TIKSDVWSYGILLWEIFSLGVNPYPGI 278

Query: 1010 EGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPN 1068
                              ++G  +   P           A EE+  +++    C A    
Sbjct: 279  PVDAN--------FYKLIQNG-FKMDQP---------FYATEEIYIIMQ---SCWAFDSR 317

Query: 1069 ARPNVKEVLAMLIKIL 1084
             RP+   + + L   L
Sbjct: 318  KRPSFPNLTSFLGCQL 333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  126 bits (319), Expect = 5e-32
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE----VAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPH 864
            +I+G+G FG+V  G L         VAVK ++ +        EF +E   +    F   H
Sbjct: 40   KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD--FS--H 95

Query: 865  PNLVTLYGWCLDG-----SEKILVYEYMEGGSLED------IISDRTRLTWRRRLDIAID 913
            PN++ L G C++       + +++  +M+ G L        + +    +  +  L   +D
Sbjct: 96   PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A  + +L +  +   +HRD+ A N +L  +    V DFGL++ + +GD +    IA   
Sbjct: 156  IALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 973  VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
            V ++A E          T+K DV++FGV   E+AT
Sbjct: 213  VKWIAIESLADRVY---TSKSDVWAFGVTMWEIAT 244

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (319), Expect = 6e-32
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 30/217 (13%)

Query: 810  DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSG-NGFGWPHPN 866
              I+G+G    V+RG     G   A+K           +    E EVL   N     H N
Sbjct: 14   SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-----HKN 68

Query: 867  LVTLYG--WCLDGSEKILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFL 921
            +V L+          K+L+ E+   GSL  ++ + +    L     L +  DV   +  L
Sbjct: 69   IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 922  HHECYPPIVHRDVKASNVLL----DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
                   IVHR++K  N++     D +    +TDFG AR +   D     ++ GT  Y+ 
Sbjct: 129  RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLH 183

Query: 978  PEYGQTWQATTKG--------DVYSFGVLAMELATGR 1006
            P+  +                D++S GV     ATG 
Sbjct: 184  PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (317), Expect = 7e-32
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
               +     +G G FG VY+      G   A K ++ +  E   ++  E+E+L+      
Sbjct: 18   NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC---- 73

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVAR 916
             HP +V L G      +  ++ E+  GG+++ I+ +       R L    I +    +  
Sbjct: 74   DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLE 128

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST---TIAGTV 973
            AL FLH +    I+HRD+KA NVL+  EG   + DFG    VSA +        +  GT 
Sbjct: 129  ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTP 181

Query: 974  GYVAPE-----YGQTWQATTKGDVYSFGVLAMELATG 1005
             ++APE       +      K D++S G+  +E+A  
Sbjct: 182  YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (315), Expect = 7e-32
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 811  RIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPH 864
            R IG+G FG V++G+   P+     VA+K   +         +F  E   +      + H
Sbjct: 21   RCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQ----FDH 75

Query: 865  PNLVTLYGWCLDGSEKI-LVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            P++V L G   +    + ++ E    G L   +   +  L     +  A  ++ AL +L 
Sbjct: 76   PHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + +   VHRD+ A NVL+       + DFGL+R +   DS       G   + ++APE 
Sbjct: 134  SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPES 188

Query: 981  GQTWQATTKGDVYSFGVLAMELAT-GRR 1007
                + T+  DV+ FGV   E+   G +
Sbjct: 189  INFRRFTSASDVWMFGVCMWEILMHGVK 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  125 bits (317), Expect = 8e-32
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 26/197 (13%)

Query: 811 RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            ++G G F  V+       G+  A+K +++     +     E+ VL        H N+VT
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK----IKHENIVT 70

Query: 870 LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI 929
           L       +   LV + + GG L D I +R   T +    +   V  A+ +LH      I
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---I 127

Query: 930 VHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
           VHRD+K  N+L    ++  K ++TDFGL+++     + + +T  GT GYVAPE      Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVLAQKPY 184

Query: 981 GQTWQATTKGDVYSFGV 997
            +        D +S GV
Sbjct: 185 SK------AVDCWSIGV 195

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  126 bits (318), Expect = 8e-32
 Identities = 71/409 (17%), Positives = 120/409 (29%), Gaps = 119/409 (29%)

Query: 74  CSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLN 133
           C     + + L L    +  D+  +       + LDL  N  +     D  + ++L  L 
Sbjct: 31  CHLRVVQCSDLGLEK--VPKDLPPD------TALLDLQNNKITEIKDGDFKNLKNLHTLI 82

Query: 134 LSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
           L +N +S       + L  LE L LS N++  E+    P   ++L    +  N +T    
Sbjct: 83  LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQEL---RVHENEITKVRK 138

Query: 192 TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
           + F+G   +  ++L +N            L    +      G                  
Sbjct: 139 SVFNGLNQMIVVELGTN-----------PLKSSGIENGAFQG------------------ 169

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPES 311
                           + L  + +   N +  IP   G    L  L L  N    V   S
Sbjct: 170 ---------------MKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKITKVDAAS 211

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
           L  L+ L  L LS N                 I A+ + S  +          P++  L 
Sbjct: 212 LKGLNNLAKLGLSFN----------------SISAVDNGSLAN---------TPHLRELH 246

Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG---- 427
           L++N                             +P    +   +Q + L  N ++     
Sbjct: 247 LNNNKLV-------------------------KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 428 --PIPPSIGNLTSLLWLMLANNSLS-GEIPGEIGNC-TSLLWLNLSNNK 472
               P       S   + L +N +   EI      C      + L N K
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (283), Expect = 4e-27
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 15/242 (6%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGS-ISGLEALFLGKNN 303
              + DL  N+      G+  N +NL  L L  N  S  I     + +  LE L+L KN 
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQ 111

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK 363
            L  +PE +     L+ L +  N      + +F    Q+ ++ L +N        +G  +
Sbjct: 112 -LKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 364 -LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLS 421
            +  +S + ++  N T  +P  +    SL  L L  N+    + A     + NL  L LS
Sbjct: 169 GMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224

Query: 422 FNELTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           FN ++  +   S+ N   L  L L NN L  ++PG + +   +  + L NN +S  I   
Sbjct: 225 FNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281

Query: 481 VM 482
             
Sbjct: 282 DF 283

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (282), Expect = 5e-27
 Identities = 52/294 (17%), Positives = 98/294 (33%), Gaps = 43/294 (14%)

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
           +   LDL +N                 + +     + +         L    L  N+   
Sbjct: 53  DTALLDLQNNKIT-------------EIKDGDFKNLKN---------LHTLILINNKISK 90

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
             PG  +    L  L L  N     +P        L+ L + +N    V       L+++
Sbjct: 91  ISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQM 147

Query: 319 EVLDLSSNNFGGEV--QKIFGRFTQVKILALHSN--SYIDGMNSSGILKLPNISRLDLSH 374
            V++L +N           F    ++  + +     + I           P+++ L L  
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL------PPSLTELHLDG 201

Query: 375 NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIG 434
           N  T      +  + +L  L L+ N  +        N P+L+ L L+ N+L   +P  + 
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 260

Query: 435 NLTSLLWLMLANNSLSG------EIPGEIGNCTSLLWLNLSNNKLS-GNIPPEV 481
           +   +  + L NN++S         PG      S   ++L +N +    I P  
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 9e-26
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 17/241 (7%)

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
            C L +   S+       P ++    +  +L+L  N  +     +  ++  L  L L  N
Sbjct: 30  QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMNSSGI 361
               + P +   L KLE L LS N      +++       ++ L +H N  I  +  S  
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQL----KELPEKMPKTLQELRVHENE-ITKVRKSVF 141

Query: 362 LKLPNISRLDLSHNNFT-GPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLD 419
             L  +  ++L  N      +       M+ L ++ +A      +IP   G  P+L  L 
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELH 198

Query: 420 LSFNELTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           L  N++T  +   S+  L +L  L L+ NS+S    G + N   L  L+L+NNKL   +P
Sbjct: 199 LDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 479 P 479
            
Sbjct: 257 G 257

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 60.8 bits (148), Expect = 8e-10
 Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 10/119 (8%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L L GN+++ ++       L N + + L FN             P L  L+L  N    
Sbjct: 196 ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSG------PFPASFNNLTELSKLNISYNPLVSGTIPS 676
           ++P    + K +Q + L  NN S         P         S +++  NP+    I  
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 26/122 (21%), Positives = 49/122 (40%), Gaps = 10/122 (8%)

Query: 553 LPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQF-DGKLPSQ-FDQL 609
           L  L  +  +    L++  N+++ ++   +   L    +V LG N      + +  F  +
Sbjct: 112 LKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 610 P-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYN 667
             L  + +   N +  IP     +   L  L L  N  +    AS   L  L+KL +S+N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226

Query: 668 PL 669
            +
Sbjct: 227 SI 228

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 30/116 (25%), Positives = 49/116 (42%), Gaps = 8/116 (6%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           T  L L  N+++ E+       L+N   + L  N+     P  F  L  L  L L++N  
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             E+P +       LQ L +  N  +    + FN L ++  + +  NPL S  I +
Sbjct: 113 K-ELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 24/70 (34%), Positives = 34/70 (48%), Gaps = 3/70 (4%)

Query: 413 PNLQTLDLSFNELTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           P+   LDL  N++T  I      NL +L  L+L NN +S   PG       L  L LS N
Sbjct: 52  PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 472 KLSGNIPPEV 481
           +L   +P ++
Sbjct: 111 QLK-ELPEKM 119

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 14/113 (12%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L LS N +S  +         +   +HL  N+   K+P        + V+ L  NN S 
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276

Query: 624 EIPSE-------FGNIKCLQNLDLSYNNFSGPF--PASFNNLTELSKLNISYN 667
            I S                 + L  N        P++F  +   + + +   
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (320), Expect = 1e-31
 Identities = 75/304 (24%), Positives = 111/304 (36%), Gaps = 66/304 (21%)

Query: 811  RIIGKGGFGTVYRGVLPDGR------EVAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G G FG VY G +          +VAVK L     E +  +F  E  ++S     + 
Sbjct: 77   RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK----FN 132

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-------IISDRTRLTWRRRLDIAIDVAR 916
            H N+V   G  L    + ++ E M GG L+          S  + L     L +A D+A 
Sbjct: 133  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALV---TDFGLARVVSAGDSHVSTTIAGTV 973
               +L    +   +HRD+ A N LL   G   V    DFG+AR +            G  
Sbjct: 193  GCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGC 245

Query: 974  GYV-----APE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECL--VEWG 1020
              +      PE    G     T+K D +SFGVL  E+ + G         +E L  V  G
Sbjct: 246  AMLPVKWMPPEAFMEGIF---TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             R M   ++ P                    +  ++    +C    P  RPN   +L  +
Sbjct: 303  GR-MDPPKNCP------------------GPVYRIMT---QCWQHQPEDRPNFAIILERI 340

Query: 1081 IKIL 1084
                
Sbjct: 341  EYCT 344

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (317), Expect = 1e-31
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 34/217 (15%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE----VAVKKLQREGLEGERE---FRAEMEVLSGNGFGWP 863
            R++GKG FG+V    L         VAVK L +  +    +   F  E   +    F   
Sbjct: 29   RMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKE--FD-- 83

Query: 864  HPNLVTLYGWCLDGSEKI------LVYEYMEGGSLED------IISDRTRLTWRRRLDIA 911
            HP++  L G  L    K       ++  +M+ G L        I  +   L  +  +   
Sbjct: 84   HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAG 971
            +D+A  + +L    +   +HRD+ A N +L ++    V DFGL+R + +GD +     + 
Sbjct: 144  VDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200

Query: 972  T-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
              V ++A E          T   DV++FGV   E+ T
Sbjct: 201  LPVKWLALESLADNLY---TVHSDVWAFGVTMWEIMT 234

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (314), Expect = 1e-31
 Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 34/221 (15%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSG-NGFGWPH 864
            F E  +IG GGFG V++     DG+   +K+++        +   E++ L+  +     H
Sbjct: 13   FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLD-----H 63

Query: 865  PNLVTLYG-------------WCLDGSEKILVY---EYMEGGSLEDIISDR--TRLTWRR 906
             N+V   G                  S+   ++   E+ + G+LE  I  R   +L    
Sbjct: 64   VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 907  RLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
             L++   + + + ++H +    +++RD+K SN+ L    +  + DFGL   +        
Sbjct: 124  ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178

Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR 1007
            T   GT+ Y++PE   +     + D+Y+ G++  EL     
Sbjct: 179  TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  125 bits (316), Expect = 1e-31
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
               F     +G+G +G+VY+ +    G+ VA+K++  E     +E   E+ ++       
Sbjct: 28   EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQC---- 81

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD---IAI---DVAR 916
              P++V  YG     ++  +V EY   GS+ DII  R      + L    IA       +
Sbjct: 82   DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-----NKTLTEDEIATILQSTLK 136

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L +LH       +HRD+KA N+LL+ EG A + DFG+A  ++   +    T+ GT  ++
Sbjct: 137  GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGTPFWM 192

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATG 1005
            APE  Q        D++S G+ A+E+A G
Sbjct: 193  APEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (311), Expect = 2e-31
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGEREFRAEMEVLSGN 858
              F   R +GKG FG VY          +A+K     +L++ G+E   + R E+E+ S  
Sbjct: 9    EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSH- 65

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARAL 918
                 HPN++ LYG+  D +   L+ EY   G++   +   ++   +R      ++A AL
Sbjct: 66   ---LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+LL   G+  + DFG +       S   T + GT+ Y+ P
Sbjct: 123  SYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPP 176

Query: 979  E------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            E      + +      K D++S GVL  E   G+
Sbjct: 177  EMIEGRMHDE------KVDLWSLGVLCYEFLVGK 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  128 bits (324), Expect = 3e-31
 Identities = 66/252 (26%), Positives = 97/252 (38%), Gaps = 29/252 (11%)

Query: 767  RHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV- 825
             H    SSG  + +    ++             + +    +   + +G G +G V     
Sbjct: 2    HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSE---MYQRVKKLGSGAYGEVLLCRD 58

Query: 826  LPDGREVAVKKLQREGLEGERE--FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV 883
                 E A+K +++  +          E+ VL        HPN++ LY +  D     LV
Sbjct: 59   KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD----HPNIMKLYDFFEDKRNYYLV 114

Query: 884  YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-D 942
             E  +GG L D I  R +        I   V   + +LH      IVHRD+K  N+LL  
Sbjct: 115  MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLES 171

Query: 943  KEGKALV--TDFGLARVVSAGDSHVSTTIAGTVGYVAPE-----YGQTWQATTKGDVYSF 995
            KE  AL+   DFGL+ V             GT  Y+APE     Y +      K DV+S 
Sbjct: 172  KEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRKKYDE------KCDVWSI 223

Query: 996  GVLAMELATGRR 1007
            GV+   L  G  
Sbjct: 224  GVILFILLAGYP 235

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  125 bits (316), Expect = 4e-31
 Identities = 37/267 (13%), Positives = 76/267 (28%), Gaps = 52/267 (19%)

Query: 784  TVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK------- 835
            +  +    +     S++ +         ++G+              G    V        
Sbjct: 52   STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER 111

Query: 836  -------KLQREGLEGE--REFRAEMEVLSGNGFGWP--------HPNLVTLYGWCLDGS 878
                   +++ E L     R  + + +      F +P           ++ +     D  
Sbjct: 112  PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW 171

Query: 879  EKILVYEYME--------GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIV 930
                 + Y          G  L    S    L    RL + + V R L  LHH     +V
Sbjct: 172  VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 228

Query: 931  HRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY---------- 980
            H  ++  +++LD+ G   +T F       A         + + G+  PE           
Sbjct: 229  HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYH 283

Query: 981  -GQTWQATTKGDVYSFGVLAMELATGR 1006
              +    T   D ++ G++   +    
Sbjct: 284  RDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (312), Expect = 4e-31
 Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 55/235 (23%)

Query: 810  DRIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
             + +G+G FG V +      +       VAVK L+      E  +  +E  VL       
Sbjct: 28   GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ--VN- 84

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSL------------------------EDIISD 898
             HP+++ LYG C      +L+ EY + GSL                             D
Sbjct: 85   -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 899  RTRLTWRRRLDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR 956
               LT    +  A  +++ + +L         +VHRD+ A N+L+ +  K  ++DFGL+R
Sbjct: 144  ERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 957  VVSAGDSHVSTTIAGT-VGYVAPE------YGQTWQATTKGDVYSFGVLAMELAT 1004
             V   DS+V  +     V ++A E      Y      TT+ DV+SFGVL  E+ T
Sbjct: 199  DVYEEDSYVKRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEIVT 247

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (312), Expect = 5e-31
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 56/299 (18%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG VY GV     +      VA+K +       ER EF  E  V+    F   
Sbjct: 31   RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE--FN-- 86

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL----------EDIISDRTRLTWRRRLDIAID 913
              ++V L G    G   +++ E M  G L                    +  + + +A +
Sbjct: 87   CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT- 972
            +A  + +L+   +   VHRD+ A N ++ ++    + DFG+ R +   D +         
Sbjct: 147  IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203

Query: 973  VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT-GRRALEG--GEECLVEWGRRVMGY 1026
            V +++PE    G     TT  DV+SFGV+  E+AT   +  +G   E+        V+ +
Sbjct: 204  VRWMSPESLKDGVF---TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRF 252

Query: 1027 GRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
               G G    P         +   + + EL+R    C    P  RP+  E+++ + + +
Sbjct: 253  VMEG-GLLDKP---------DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEM 298

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  123 bits (310), Expect = 5e-31
 Identities = 62/209 (29%), Positives = 88/209 (42%), Gaps = 30/209 (14%)

Query: 804 TGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE--FRAEMEVLS 856
            G F+E      ++GKG FG V +       +E AVK + +   + +       E+E+L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                  HPN++ L+    D S   +V E   GG L D I  R R +      I   V  
Sbjct: 77  KLD----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 917 ALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVSTTIAGTV 973
            + ++H      IVHRD+K  N+LL  KE    +   DFGL+               GT 
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187

Query: 974 GYVAPE-----YGQTWQATTKGDVYSFGV 997
            Y+APE     Y +      K DV+S GV
Sbjct: 188 YYIAPEVLRGTYDE------KCDVWSAGV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  122 bits (308), Expect = 6e-31
 Identities = 55/209 (26%), Positives = 85/209 (40%), Gaps = 28/209 (13%)

Query: 802 KATGKFSE----DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLS 856
              G  ++    +  IG+G +G V   V        A KK+ +  +E    F+ E+E++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                  HPN++ LY    D ++  LV E   GG L + +  +          I  DV  
Sbjct: 62  SLD----HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117

Query: 917 ALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL--VTDFGLARVVSAGDSHVSTTIAGTV 973
           A+ + H      + HRD+K  N L       +   + DFGLA     G   +  T  GT 
Sbjct: 118 AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTP 172

Query: 974 GYVAPE-----YGQTWQATTKGDVYSFGV 997
            YV+P+     YG       + D +S GV
Sbjct: 173 YYVSPQVLEGLYGP------ECDEWSAGV 195

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  126 bits (317), Expect = 8e-31
 Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 40/230 (17%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
                ++I+G G  GTV       GR VAVK++  +  +       E+++L+ +     HP
Sbjct: 16   LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESD---DHP 69

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-------TRLTWRRRLDIAIDVARAL 918
            N++  Y          +  E     +L+D++  +               + +   +A  +
Sbjct: 70   NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 919  VFLHHECYPPIVHRDVKASNVLLD-------------KEGKALVTDFGLARVVSAGDSHV 965
              LH      I+HRD+K  N+L+              +  + L++DFGL + + +G S  
Sbjct: 129  AHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 966  ST---TIAGTVGYVAPE-------YGQTWQATTKGDVYSFGVLAMELATG 1005
             T     +GT G+ APE            + T   D++S G +   + + 
Sbjct: 186  RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  124 bits (312), Expect = 8e-31
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 37/229 (16%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREF---------------- 848
              +   R + +G F  +      D +  A+KK ++  LE +R+F                
Sbjct: 31   NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 849  -RAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRR 907
             + E+++++       +   +T  G   +  E  ++YEYME  S+         L     
Sbjct: 90   FKNELQIITD----IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 908  LDIAIDVAR--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
              I I V +        +  ++H+E    I HRDVK SN+L+DK G+  ++DFG +  + 
Sbjct: 146  CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 960  AGDSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
                       GT  ++ PE    ++     K D++S G+    +    
Sbjct: 204  DKKIK---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (311), Expect = 8e-31
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 40/221 (18%)

Query: 810  DRIIGKGGFGTVYRGVL-PDGRE--VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWPHP 865
              +IG+G FG V +  +  DG     A+K+++    + +  +F  E+EVL     G  HP
Sbjct: 30   QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK--LG-HHP 86

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSL----------------EDIISDRTRLTWRRRLD 909
            N++ L G C       L  EY   G+L                    S  + L+ ++ L 
Sbjct: 87   NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
             A DVAR + +L  + +   +HRD+ A N+L+ +   A + DFGL+R        V    
Sbjct: 147  FAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKK 198

Query: 970  AGT---VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
                  V ++A E   Y      TT  DV+S+GVL  E+ +
Sbjct: 199  TMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIVS 236

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (314), Expect = 8e-31
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 30/217 (13%)

Query: 810  DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSG-NGFGWPHPN 866
              I+G+G    V+RG     G   A+K           +    E EVL   N     H N
Sbjct: 14   SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-----HKN 68

Query: 867  LVTLYGW--CLDGSEKILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFL 921
            +V L+          K+L+ E+   GSL  ++ + +    L     L +  DV   +  L
Sbjct: 69   IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 922  HHECYPPIVHRDVKASNVLL----DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
                   IVHR++K  N++     D +    +TDFG AR +   D     ++ GT  Y+ 
Sbjct: 129  RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLH 183

Query: 978  PEYGQTWQATTKG--------DVYSFGVLAMELATGR 1006
            P+  +                D++S GV     ATG 
Sbjct: 184  PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  123 bits (311), Expect = 9e-31
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 32/214 (14%)

Query: 800 ILKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEV 854
           + + + +F++       IG G +    R +      E AVK + +   +   E    +  
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI-EILLR 71

Query: 855 LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDV 914
                    HPN++TL     DG    +V E M+GG L D I  +   + R    +   +
Sbjct: 72  YGQ------HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 915 ARALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL---VTDFGLARVVSAGDSHVSTTIA 970
            + + +LH +    +VHRD+K SN+L  D+ G      + DFG A+ + A +  +  T  
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPC 181

Query: 971 GTVGYVAPE------YGQTWQATTKGDVYSFGVL 998
            T  +VAPE      Y          D++S GVL
Sbjct: 182 YTANFVAPEVLERQGYDA------ACDIWSLGVL 209

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 1e-30
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 39/285 (13%)

Query: 810  DRIIGKGGFGTVYRGVL--PDGRE--VAVKKLQREGL--EGEREFRAEMEVLSGNGFGWP 863
             R IG+G FG V++G+   P+     VA+K   +         +F  E   +    F   
Sbjct: 395  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQ--FD-- 449

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLH 922
            HP++V L G   +    I + E    G L   +   +  L     +  A  ++ AL +L 
Sbjct: 450  HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT--VGYVAPEY 980
             + +   VHRD+ A NVL+       + DFGL+R +   DS       G   + ++APE 
Sbjct: 509  SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPES 563

Query: 981  GQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
                + T+  DV+ FGV   E+   G +  +G +         V+G   +G  R  +P  
Sbjct: 564  INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENG-ERLPMP-- 614

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                           L  +  +C A  P+ RP   E+ A L  IL
Sbjct: 615  -------PNCPP--TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  121 bits (306), Expect = 3e-30
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 804 TGKFSED-----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVL-- 855
           +G+F +       ++G+G    V   + L   +E AVK ++++          E+E+L  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 856 -SGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDV 914
             G      H N++ L  +  +     LV+E M GGS+   I  R          +  DV
Sbjct: 67  CQG------HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV 120

Query: 915 ARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVS----- 966
           A AL FLH++    I HRD+K  N+L       + V   DF L   +             
Sbjct: 121 ASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 967 -TTIAGTVGYVAPEYGQTWQATTKG-----DVYSFGVL 998
             T  G+  Y+APE  + +           D++S GV+
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (304), Expect = 4e-30
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 38/221 (17%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R +G+G FG V+     +         VAVK L ++     R +F+ E E+L+       
Sbjct: 21   RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTN--LQ-- 75

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL----------------EDIISDRTRLTWRRR 907
            H ++V  YG C DG   I+V+EYM+ G L                      +  L   + 
Sbjct: 76   HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            L IA  +A  +V+L  + +   VHRD+   N L+       + DFG++R V + D +   
Sbjct: 136  LHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192

Query: 968  TIAGT-VGYVAPE---YGQTWQATTKGDVYSFGVLAMELAT 1004
                  + ++ PE   Y +    TT+ DV+SFGV+  E+ T
Sbjct: 193  GHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIFT 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (307), Expect = 4e-30
 Identities = 35/226 (15%), Positives = 68/226 (30%), Gaps = 34/226 (15%)

Query: 806  KFSEDRIIGKGGFGTVYRGV------LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
                  ++G+G F  VY           + ++  +K  +             ME L  + 
Sbjct: 66   LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRR-----RLDIAIDV 914
                    +  Y   L  +  +LV E    G+L + I+       +       +  A+ +
Sbjct: 126  ----QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLL-----------DKEGKALVTDFGLARVVSA-GD 962
               +  +H      I+H D+K  N +L           D      + D G +  +     
Sbjct: 182  LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 963  SHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
              + T    T G+   E    + W    + D +        +  G 
Sbjct: 239  GTIFTAKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGT 282

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (314), Expect = 4e-30
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 31/223 (13%)

Query: 800  ILKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAE 851
            +  +T  FS+     R++GKG FG V        G+E AVK + +  ++ + +      E
Sbjct: 17   VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 852  MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIA 911
            +++L        HPN++ LY +  D     LV E   GG L D I  R R +      I 
Sbjct: 77   VQLLKQLD----HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132

Query: 912  IDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHVSTT 968
              V   + ++H      IVHRD+K  N+LL    K+    + DFGL+    A        
Sbjct: 133  RQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KD 187

Query: 969  IAGTVGYVAPE-----YGQTWQATTKGDVYSFGVLAMELATGR 1006
              GT  Y+APE     Y +      K DV+S GV+   L +G 
Sbjct: 188  KIGTAYYIAPEVLHGTYDE------KCDVWSTGVILYILLSGC 224

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (303), Expect = 5e-30
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 46/225 (20%)

Query: 802 KATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVK--------KLQREGLEGERE- 847
            +T  F E+     I+G+G    V R +  P  +E AVK            E ++  RE 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 848 FRAEMEVL---SGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTW 904
              E+++L   SG      HPN++ L       +   LV++ M+ G L D ++++  L+ 
Sbjct: 70  TLKEVDILRKVSG------HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 905 RRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
           +    I   +   +  LH      IVHRD+K  N+LLD +    +TDFG +  +  G   
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--E 178

Query: 965 VSTTIAGTVGYVAPE------------YGQTWQATTKGDVYSFGV 997
               + GT  Y+APE            YG+      + D++S GV
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGK------EVDMWSTGV 217

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  124 bits (312), Expect = 8e-30
 Identities = 65/222 (29%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 801  LKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE--REFRAEME 853
            L   G F+E      ++GKG FG V +       +E AVK + +   + +       E+E
Sbjct: 14   LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
            +L        HPN++ L+    D S   +V E   GG L D I  R R +      I   
Sbjct: 74   LLKKLD----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL--VTDFGLARVVSAGDSHVSTTIA 970
            V   + ++H      IVHRD+K  N+LL  KE      + DFGL+               
Sbjct: 130  VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRI 184

Query: 971  GTVGYVAPE-----YGQTWQATTKGDVYSFGVLAMELATGRR 1007
            GT  Y+APE     Y +      K DV+S GV+   L +G  
Sbjct: 185  GTAYYIAPEVLRGTYDE------KCDVWSAGVILYILLSGTP 220

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (303), Expect = 9e-30
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 45/224 (20%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
              +G+G FG V+     +         VAVK L +E  E  R +F+ E E+L+       
Sbjct: 47   WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTM--LQ-- 101

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL---------------EDIISDRTRLTWRRRL 908
            H ++V  +G C +G   ++V+EYM  G L                        L   + L
Sbjct: 102  HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT 968
             +A  VA  +V+L    +   VHRD+   N L+ +     + DFG++R + + D      
Sbjct: 162  AVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YY 214

Query: 969  IAGTVGYV-----APE---YGQTWQATTKGDVYSFGVLAMELAT 1004
              G    +      PE   Y +    TT+ DV+SFGV+  E+ T
Sbjct: 215  RVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFT 255

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  121 bits (305), Expect = 1e-29
 Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 45/258 (17%)

Query: 768 HDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSE----DRIIGKGGFGTVYR 823
           + LA +   +      T  +               A  +F +      +IG+G    V R
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112

Query: 824 GV-LPDGREVAVK-------KLQREGLEGERE-FRAEMEVL---SGNGFGWPHPNLVTLY 871
            V    G E AVK       +L  E LE  RE  R E  +L   +G      HP+++TL 
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG------HPHIITLI 166

Query: 872 GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVH 931
                 S   LV++ M  G L D ++++  L+ +    I   +  A+ FLH      IVH
Sbjct: 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223

Query: 932 RDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------------ 979
           RD+K  N+LLD   +  ++DFG +  +  G       + GT GY+APE            
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPG 281

Query: 980 YGQTWQATTKGDVYSFGV 997
           YG+      + D+++ GV
Sbjct: 282 YGK------EVDLWACGV 293

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  119 bits (301), Expect = 1e-29
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 32/202 (15%)

Query: 810 DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVL---SGNGFGWPHP 865
           D+ +G+G F    + V     +  AVK + +      ++   E+  L    G      HP
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEG------HP 66

Query: 866 NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
           N+V L+    D     LV E + GG L + I  +   +      I   +  A+  +H   
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126

Query: 926 YPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
              +VHRD+K  N+L  D+     +   DFG AR+    D+    T   T+ Y APE   
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPELLN 182

Query: 980 ---YGQTWQATTKGDVYSFGVL 998
              Y +        D++S GV+
Sbjct: 183 QNGYDE------SCDLWSLGVI 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (298), Expect = 1e-29
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGEREFRAEMEVLSGN 858
              F   R +GKG FG VY      +   +A+K     +L++EG+E   + R E+E+ S  
Sbjct: 14   DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSH- 70

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARAL 918
                 HPN++ +Y +  D     L+ E+   G L   +    R   +R      ++A AL
Sbjct: 71   ---LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H      ++HRD+K  N+L+  +G+  + DFG +       S    T+ GT+ Y+ P
Sbjct: 128  HYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLDYLPP 181

Query: 979  E------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            E      + +      K D++  GVL  E   G 
Sbjct: 182  EMIEGKTHDE------KVDLWCAGVLCYEFLVGM 209

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  118 bits (298), Expect = 2e-29
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 31/210 (14%)

Query: 804 TGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE--FRAEMEVLS 856
           + KFS++      +GKG F  V R V    G E A K +  + L          E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                  HPN+V L+    + S   LV++ + GG L + I  R   +          +  
Sbjct: 61  K----LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116

Query: 917 ALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVSTTIAGTV 973
           ++ + H      IVHR++K  N+LL  K   A V   DFGLA  V+          AGT 
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTP 171

Query: 974 GYVAPE------YGQTWQATTKGDVYSFGV 997
           GY++PE      Y +        D+++ GV
Sbjct: 172 GYLSPEVLKKDPYSK------PVDIWACGV 195

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (304), Expect = 2e-29
 Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 29/237 (12%)

Query: 777 SSPWLSDTVKVIRLDKTAFTYSDILKATGKFSE----DRIIGKGGFGTVYRGV-LPDGRE 831
             P ++D  K        +    +    G   +       +G G FG V+R V    GR 
Sbjct: 19  DGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRV 78

Query: 832 VAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGS 891
              K +       +   + E+ +++       HP L+ L+    D  E +L+ E++ GG 
Sbjct: 79  FVAKFINTPYPLDKYTVKNEISIMNQ----LHHPKLINLHDAFEDKYEMVLILEFLSGGE 134

Query: 892 L-EDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL- 948
           L + I ++  +++    ++        L  +H      IVH D+K  N++   K+  ++ 
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVK 191

Query: 949 VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQTWQATTKGDVYSFGVLA 999
           + DFGLA  ++  +  +      T  + APE       G         D+++ GVL 
Sbjct: 192 IIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVG------FYTDMWAIGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  120 bits (302), Expect = 2e-29
 Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 19/259 (7%)

Query: 751 KRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSED 810
            + +       + +    DL       S   S     I      F +  +    G  +  
Sbjct: 29  DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88

Query: 811 ------RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP 863
                  I+G G FG V++      G ++A K ++  G++ + E + E+ V++       
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD---- 144

Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDVARALVFLH 922
           H NL+ LY      ++ +LV EY++GG L + II +   LT    +     +   +  +H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 923 HECYPPIVHRDVKASNVLL-DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
                 I+H D+K  N+L  +++ K + + DFGLAR     +        GT  ++APE 
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEV 259

Query: 981 GQTWQATTKGDVYSFGVLA 999
                 +   D++S GV+A
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  118 bits (297), Expect = 3e-29
 Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 14/244 (5%)

Query: 244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN 303
           CS      +        P  +    +   L L  N            ++ L  L L  N 
Sbjct: 7   CSGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 304 --FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
             F     +S    + L+ LDLS N     +   F    Q++ L    ++ +  M+   +
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN-LKQMSEFSV 121

Query: 362 LK-LPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTL 418
              L N+  LD+SH +        I + + SL+ L +A N F  +    ++  + NL  L
Sbjct: 122 FLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180

Query: 419 DLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI 477
           DLS  +L   + P+   +L+SL  L +++N+             SL  L+ S N +    
Sbjct: 181 DLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TS 238

Query: 478 PPEV 481
             + 
Sbjct: 239 KKQE 242

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  115 bits (291), Expect = 2e-28
 Identities = 58/274 (21%), Positives = 94/274 (34%), Gaps = 39/274 (14%)

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE--F 256
           +   L+L SN  +                       +   VF +   L    LS N   F
Sbjct: 29  SATRLELESNKLQ----------------------SLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 257 IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL-NL 315
            G          +L  L+L  N     + +    +  LE L    +N   +   S+  +L
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
             L  LD+S  +       IF   + +++L +  NS+ +        +L N++ LDLS  
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-- 433
                 P   + + SL+ L ++HN F       Y  + +LQ LD S N +          
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQ 244

Query: 434 GNLTSLLWLMLANNSLSGEIPGEIGNCT-SLLWL 466
              +SL +L L  N            CT      
Sbjct: 245 HFPSSLAFLNLTQNDF---------ACTCEHQSF 269

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 3e-24
 Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 27/250 (10%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRN--TFSGSIPDDLSSCRSLKYLNLSHN-ILS 140
           L L    +       F  LTQL+ L LS N  +F G          SLKYL+LS N +++
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 92

Query: 141 GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
              N  GL  LE LD   + +     FS       L+  ++S  +     +  F+G  +L
Sbjct: 93  MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
             L ++ N+F+ N               ++ + +          +L   DLS+ + +   
Sbjct: 153 EVLKMAGNSFQENF------------LPDIFTELR---------NLTFLDLSQCQ-LEQL 190

Query: 261 PGEVSNC-RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL-SKL 318
                N   +L VLN+  NNF          ++ L+ L    N+ ++   + L +  S L
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250

Query: 319 EVLDLSSNNF 328
             L+L+ N+F
Sbjct: 251 AFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 3/109 (2%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
           +L    + L       +   L+N   + +            F+ L  L VL +  N+F  
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               + F  ++ L  LDLS        P +FN+L+ L  LN+S+N   S
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 7/117 (5%)

Query: 566 YLQLSGNQLS-GELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
            L LS N LS             +   + L FN     + S F  L  L  L+   +N  
Sbjct: 56  KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK 114

Query: 623 GEIPSE--FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST 677
            ++     F +++ L  LD+S+ +    F   FN L+ L  L ++ N      +P  
Sbjct: 115 -QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 6/110 (5%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
           YL +S           I   L +  ++ +  N F        F +L  L  L+L++    
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            ++    F ++  LQ L++S+NNF       +  L  L  L+ S N +++
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 3/107 (2%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L+++GN       PDI  +L+N + + L   Q +   P+ F+ L  L VLN++ NNF  
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNL-TELSKLNISYNPL 669
                +  +  LQ LD S N+          +  + L+ LN++ N  
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 18/69 (26%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN--FSGPFPASFNNLTELSKLNISYNP 668
              L L  N         F  +  L  L LS N   F G    S    T L  L++S+N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 669 LVSGTIPST 677
           +++  + S 
Sbjct: 90  VIT--MSSN 96

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 6/76 (7%)

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHN---ILSGDLNLS 146
            +S   FN+   L+ L  L++S N F            SL+ L+ S N            
Sbjct: 189 QLSPTAFNS---LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245

Query: 147 GLRSLEILDLSVNRIH 162
              SL  L+L+ N   
Sbjct: 246 FPSSLAFLNLTQNDFA 261

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (298), Expect = 4e-29
 Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 30/215 (13%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGEREFRAEMEVLSGN 858
             ++   R +GKGGF   +           A K      L +     +     E+ +    
Sbjct: 41   RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRS- 97

Query: 859  GFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
                 H ++V  +G   + ++ + +V E     SL ++   R  LT          +   
Sbjct: 98   ---LAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 153

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
              +LH      ++HRD+K  N+ L+++ +  + DFGLA  V   D      + GT  Y+A
Sbjct: 154  CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIA 209

Query: 978  PE------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            PE      +        + DV+S G +   L  G+
Sbjct: 210  PEVLSKKGHSF------EVDVWSIGCIMYTLLVGK 238

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (298), Expect = 4e-29
 Identities = 76/410 (18%), Positives = 119/410 (29%), Gaps = 122/410 (29%)

Query: 74  CSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLN 133
           C     + + L L    +  +I  +       + LDL  N  S    DD    + L  L 
Sbjct: 33  CHLRVVQCSDLGLKA--VPKEISPD------TTLLDLQNNDISELRKDDFKGLQHLYALV 84

Query: 134 LSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
           L +N +S   +   S LR L+ L +S N +  EI  + P+    LV   +  N +     
Sbjct: 85  LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS---SLVELRIHDNRIRKVPK 140

Query: 192 TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
             F G  N+  +++  N            L           G+                 
Sbjct: 141 GVFSGLRNMNCIEMGGN-----------PLENSGFEPGAFDGL----------------- 172

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPES 311
                             L  L +     +G IP        L  L L  N   ++  E 
Sbjct: 173 -----------------KLNYLRISEAKLTG-IPK--DLPETLNELHLDHNKIQAIELED 212

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
           LL  SKL  L L  N                +I  + + S            LP +  L 
Sbjct: 213 LLRYSKLYRLGLGHN----------------QIRMIENGSLSF---------LPTLRELH 247

Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP 431
           L +N  +                          +PA   ++  LQ + L  N +T  +  
Sbjct: 248 LDNNKLS-------------------------RVPAGLPDLKLLQVVYLHTNNITK-VGV 281

Query: 432 SI-------GNLTSLLWLMLANNSLS-GEIPGEIGNC-TSLLWLNLSNNK 472
           +                + L NN +   E+      C T  L +   N K
Sbjct: 282 NDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (286), Expect = 1e-27
 Identities = 52/242 (21%), Positives = 90/242 (37%), Gaps = 14/242 (5%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNN 303
              + DL  N+       +    ++L  L L  N  S  I  +    +  L+ L++ KN+
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNH 113

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK 363
            L  IP +L   S L  L +  N      + +F     +  + +  N   +     G   
Sbjct: 114 -LVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLSF 422
              ++ L +S    TG +P ++    +L  L L HN+   +I          L  L L  
Sbjct: 171 GLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226

Query: 423 NELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
           N++   I       L +L  L L NN LS  +P  + +   L  + L  N ++  +    
Sbjct: 227 NQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283

Query: 482 MT 483
             
Sbjct: 284 FC 285

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  106 bits (267), Expect = 4e-25
 Identities = 66/359 (18%), Positives = 121/359 (33%), Gaps = 69/359 (19%)

Query: 140 SGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICE-KLVVANLSLNNLT---GRIDTCFD 195
           SG    SG+  L+ L  + + +        P  C   L V   S   L      I     
Sbjct: 5   SGAETTSGIPDLDSLPPTYSAMC-------PFGCHCHLRVVQCSDLGLKAVPKEISP--- 54

Query: 196 GCLNLRYLDLSSNNFRG---NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
              +   LDL +N+      + + GL  L    +  N +S  +    F     L+   +S
Sbjct: 55  ---DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYIS 110

Query: 253 ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNF-LSVIPE 310
           +N  + + P  +    +LV L +  N     +P  +   +  +  + +G N    S    
Sbjct: 111 KNH-LVEIPPNLP--SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

Query: 311 SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRL 370
              +  KL  L +S                   +  +  +                ++ L
Sbjct: 167 GAFDGLKLNYLRISEAK----------------LTGIPKDL------------PETLNEL 198

Query: 371 DLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGP 428
            L HN     + +E   +   L  L L HN+    I       +P L+ L L  N+L+  
Sbjct: 199 HLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR- 255

Query: 429 IPPSIGNLTSLLWLMLANNSLSGEIP-------GEIGNCTSLLWLNLSNNKLS-GNIPP 479
           +P  + +L  L  + L  N+++ ++        G          ++L NN +    + P
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 28/116 (24%), Positives = 44/116 (37%), Gaps = 8/116 (6%)

Query: 564 TGYLQLSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           T  L L  N +S EL  D    LQ+   + L  N+        F  L  L  L +++N+ 
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPS 676
             EIP     +   L  L +  N         F+ L  ++ + +  NPL +     
Sbjct: 115 V-EIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 26/131 (19%), Positives = 47/131 (35%), Gaps = 10/131 (7%)

Query: 553 LPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP- 610
           L G+     +    L L  N++   +  +   +      + LG NQ           LP 
Sbjct: 184 LTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASF------NNLTELSKLNI 664
           L  L+L  N  S  +P+   ++K LQ + L  NN +      F            + +++
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301

Query: 665 SYNPLVSGTIP 675
             NP+    + 
Sbjct: 302 FNNPVPYWEVQ 312

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (307), Expect = 4e-29
 Identities = 64/256 (25%), Positives = 96/256 (37%), Gaps = 42/256 (16%)

Query: 779  PWLSDTVKVIRLDKTAFTYSDIL-KATGKFSED----RIIGKGGFGTVYRGV-LPDGREV 832
               S   + +     A      + K  GK  E     R +G G +G V          E 
Sbjct: 5    HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64

Query: 833  AVKKLQREGL-------------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE 879
            A+K +++                +   E   E+ +L        HPN++ L+    D   
Sbjct: 65   AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD----HPNIIKLFDVFEDKKY 120

Query: 880  KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV 939
              LV E+ EGG L + I +R +       +I   +   + +LH      IVHRD+K  N+
Sbjct: 121  FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177

Query: 940  LL-DKEGKAL--VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE-----YGQTWQATTKGD 991
            LL +K       + DFGL+   S           GT  Y+APE     Y +      K D
Sbjct: 178  LLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKKYNE------KCD 229

Query: 992  VYSFGVLAMELATGRR 1007
            V+S GV+   L  G  
Sbjct: 230  VWSCGVIMYILLCGYP 245

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  119 bits (300), Expect = 4e-29
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 800 ILKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE--FRAEM 852
           ++ A+ KFS++      +GKG F  V R V    G E A K +  + L          E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 853 EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
            +         HPN+V L+    + S   LV++ + GG L + I  R   +         
Sbjct: 80  RICRK----LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135

Query: 913 DVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVSTTI 969
            +  ++ + H      IVHR++K  N+LL  K   A V   DFGLA  V   DS      
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 190

Query: 970 AGTVGYVAPE------YGQTWQATTKGDVYSFGV 997
           AGT GY++PE      Y +        D+++ GV
Sbjct: 191 AGTPGYLSPEVLKKDPYSK------PVDIWACGV 218

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (294), Expect = 7e-29
 Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 26/213 (12%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGER---EFRAEMEVLSGNGF 860
             ++   R +GKGGF   +           A K + +  L       +   E+ +      
Sbjct: 15   RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS--- 71

Query: 861  GWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
               H ++V  +G   + ++ + +V E     SL ++   R  LT          +     
Sbjct: 72   -LAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LH      ++HRD+K  N+ L+++ +  + DFGLA  V   D      + GT  Y+APE
Sbjct: 130  YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPE 185

Query: 980  ------YGQTWQATTKGDVYSFGVLAMELATGR 1006
                  +        + DV+S G +   L  G+
Sbjct: 186  VLSKKGHSF------EVDVWSIGCIMYTLLVGK 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  117 bits (295), Expect = 9e-29
 Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 26/199 (13%)

Query: 811 RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
             +G+G FG V+R V     +    K ++ +G +     + E+ +L+       H N++ 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIAR----HRNILH 65

Query: 870 LYGWCLDGSEKILVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
           L+       E ++++E++ G  + E I +    L  R  +     V  AL FLH      
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122

Query: 929 IVHRDVKASNVLL-DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
           I H D++  N++   +    + + +FG AR +  GD+     +     Y APE       
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVV 180

Query: 981 GQTWQATTKGDVYSFGVLA 999
                  T  D++S G L 
Sbjct: 181 S------TATDMWSLGTLV 193

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  121 bits (306), Expect = 9e-29
 Identities = 58/259 (22%), Positives = 98/259 (37%), Gaps = 28/259 (10%)

Query: 751 KRPAEQQGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSED 810
           +R   +   + E  K      + S     ++ D  K          +  +L     +   
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD---HYDIH 162

Query: 811 RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
             +G G FG V+R      G   A K +       +   R E++ +S       HP LV 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRHPTLVN 218

Query: 870 LYGWCLDGSEKILVYEYMEGGSL-EDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP 928
           L+    D +E +++YE+M GG L E +  +  +++    ++    V + L  +H      
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275

Query: 929 IVHRDVKASNVLL-DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
            VH D+K  N++   K    L + DFGL   +            GT  + APE       
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPV 333

Query: 981 GQTWQATTKGDVYSFGVLA 999
           G         D++S GVL+
Sbjct: 334 G------YYTDMWSVGVLS 346

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  119 bits (301), Expect = 1e-28
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 30/210 (14%)

Query: 804 TGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE--FRAEMEVLS 856
             +F+E+      +GKG F  V R V +  G+E A   +  + L          E  +  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 857 GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                  HPN+V L+    +     L+++ + GG L + I  R   +          +  
Sbjct: 66  LLK----HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 917 ALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHVSTTIAGTV 973
           A++  H      +VHR++K  N+LL  K   A V   DFGLA  V  G+       AGT 
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177

Query: 974 GYVAPE------YGQTWQATTKGDVYSFGV 997
           GY++PE      YG+        D+++ GV
Sbjct: 178 GYLSPEVLRKDPYGK------PVDLWACGV 201

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (295), Expect = 1e-28
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF---RAEMEVLSGNG 859
               FS+ R IG G FG VY    + +   VA+KK+   G +   ++     E+  L    
Sbjct: 53   EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL- 111

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI---DVAR 916
                HPN +   G  L      LV EY  G + + +   +  L     ++IA       +
Sbjct: 112  ---RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ---EVEIAAVTHGALQ 165

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
             L +LH      ++HRDVKA N+LL + G   + DFG     ++  +  + +  GT  ++
Sbjct: 166  GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAP-ANSFVGTPYWM 217

Query: 977  APE---YGQTWQATTKGDVYSFGVLAMELATG 1005
            APE        Q   K DV+S G+  +ELA  
Sbjct: 218  APEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (288), Expect = 3e-28
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 49/227 (21%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
              +G+  FG VY+G L           VA+K L+ +     R EFR E  + +       
Sbjct: 15   EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR--LQ-- 70

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL----------------EDIISDRTRLTWRRR 907
            HPN+V L G         +++ Y   G L                +D  + ++ L     
Sbjct: 71   HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130

Query: 908  LDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV 965
            + +   +A  + +L  HH     +VH+D+   NVL+  +    ++D GL R V A D   
Sbjct: 131  VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD--- 182

Query: 966  STTIAGTVGYV-----APE---YGQTWQATTKGDVYSFGVLAMELAT 1004
                      +     APE   YG+    +   D++S+GV+  E+ +
Sbjct: 183  -YYKLLGNSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLWEVFS 225

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (287), Expect = 3e-28
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGEREFRAEMEVLSGN 858
              F    ++GKG F  VYR   +  G EVA+K      + + G+   +  + E+++    
Sbjct: 11   EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQ- 67

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR-- 916
                 HP+++ LY +  D +   LV E    G +   + +R      +      + AR  
Sbjct: 68   ---LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKPFSE--NEARHF 117

Query: 917  ------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
                   +++LH      I+HRD+  SN+LL +     + DFGLA            T+ 
Sbjct: 118  MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLC 173

Query: 971  GTVGYVAPE------YGQTWQATTKGDVYSFGVLAMELATGR 1006
            GT  Y++PE      +G       + DV+S G +   L  GR
Sbjct: 174  GTPNYISPEIATRSAHG------LESDVWSLGCMFYTLLIGR 209

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  113 bits (286), Expect = 6e-28
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 811 RIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGERE-FRAEMEVLSGNGFGWP 863
             +G G F  V +      G+E A K     +L        RE    E+ +L        
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE----IR 66

Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
           HPN++TL+    + ++ +L+ E + GG L D ++++  LT          +   + +LH 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 924 ECYPPIVHRDVKASNVLL---DKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
           +    I H D+K  N++L   +     + + DFG+A  + AG+      I GT  +VAPE
Sbjct: 127 KR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPE 181

Query: 980 ------YGQTWQATTKGDVYSFGVLA 999
                  G       + D++S GV+ 
Sbjct: 182 IVNYEPLG------LEADMWSIGVIT 201

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (290), Expect = 7e-28
 Identities = 59/247 (23%), Positives = 87/247 (35%), Gaps = 46/247 (18%)

Query: 771 ASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDG 829
              SGG    L      +  +               +    +IGKG F  V R +    G
Sbjct: 3   PGISGGGGGILDMADDDVLFED-------------VYELCEVIGKGPFSVVRRCINRETG 49

Query: 830 REVAVK-----KLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY 884
           ++ AVK     K          + + E  +         HP++V L           +V+
Sbjct: 50  QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK----HPHIVELLETYSSDGMLYMVF 105

Query: 885 EYMEGGSLEDIISDRTRLTW----RRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVL 940
           E+M+G  L   I  R    +             +  AL + H      I+HRDVK   VL
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162

Query: 941 L-DKEGKALV--TDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQTWQATTKGD 991
           L  KE  A V    FG+A  +      V+    GT  ++APE      YG+        D
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKREPYGK------PVD 215

Query: 992 VYSFGVL 998
           V+  GV+
Sbjct: 216 VWGCGVI 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  114 bits (288), Expect = 1e-27
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 32/243 (13%)

Query: 765 KYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRG 824
            Y   ++S +  ++P  +  V    +D +      +      F  +  +G+G    VYR 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSD---FFEVESELGRGATSIVYRC 72

Query: 825 V-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV 883
                 +  A+K L++     ++  R E+ VL        HPN++ L       +E  LV
Sbjct: 73  KQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLR----LSHPNIIKLKEIFETPTEISLV 126

Query: 884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-D 942
            E + GG L D I ++   + R   D    +  A+ +LH      IVHRD+K  N+L   
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYAT 183

Query: 943 KEGKALV--TDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQTWQATTKGDVYS 994
               A +   DFGL+++V         T+ GT GY APE      YG       + D++S
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG------PEVDMWS 235

Query: 995 FGV 997
            G+
Sbjct: 236 VGI 238

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  114 bits (288), Expect = 1e-27
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 57/235 (24%)

Query: 811  RIIGKGGFGTVYRGVLPDGRE------VAVKKLQREGLEGER-EFRAEMEVLSGNGFGWP 863
            R IG+G FG V++   P          VAVK L+ E     + +F+ E  +++   F   
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE--FD-- 108

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSL------------------------EDIISDR 899
            +PN+V L G C  G    L++EYM  G L                               
Sbjct: 109  NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 900  TRLTWRRRLDIAIDVARALVFL--HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
              L+   +L IA  VA  + +L          VHRD+   N L+ +     + DFGL+R 
Sbjct: 169  PPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 958  VSAGDSHVSTTIAGTVGYV-----APE---YGQTWQATTKGDVYSFGVLAMELAT 1004
            + + D +     A     +      PE   Y +    TT+ DV+++GV+  E+ +
Sbjct: 224  IYSADYYK----ADGNDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEIFS 271

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  112 bits (283), Expect = 2e-27
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 29/206 (14%)

Query: 806 KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
            F   R +G G FG V+       G E  +K + ++  +   E   AE+EVL        
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD---- 78

Query: 864 HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALV 919
           HPN++ ++    D     +V E  EGG L + I         L+     ++   +  AL 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 920 FLHHECYPPIVHRDVKASNVLL-DKEGKAL--VTDFGLARVVSAGDSHVSTTIAGTVGYV 976
           + H +    +VH+D+K  N+L  D    +   + DFGLA +  + +   ST  AGT  Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYM 193

Query: 977 APE-----YGQTWQATTKGDVYSFGV 997
           APE              K D++S GV
Sbjct: 194 APEVFKRDVTF------KCDIWSAGV 213

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  113 bits (284), Expect = 2e-27
 Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL----EGEREFRAEMEV--LSG 857
            ++    ++GKGGFGTV+ G  L D  +VA+K + R  +             +EV  L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 858 NGFGWPHPNLVTLYGWCLDGSEKILVYEYME-GGSLEDIISDRTRLTWRRRLDIAIDVAR 916
            G G  HP ++ L  W       +LV E       L D I+++  L           V  
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150

Query: 917 ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
           A+   H      +VHRD+K  N+L+D       + DFG   ++   D   +    GT  Y
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF-DGTRVY 204

Query: 976 VAPEY--GQTWQATTKGDVYSFGVL 998
             PE+     + A     V+S G+L
Sbjct: 205 SPPEWISRHQYHA-LPATVWSLGIL 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (284), Expect = 3e-27
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 36/217 (16%)

Query: 804 TGKFSE----DRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGERE-FRAEM 852
                +       +G G F  V +      G + A K     + +       RE    E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 853 EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
            +L        HPN++TL+    + ++ IL+ E + GG L D ++++  LT     +   
Sbjct: 66  SILKE----IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121

Query: 913 DVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKAL-VTDFGLARVVSAGDSHVSTT 968
            +   + +LH      I H D+K  N++L   +     + + DFGLA  +  G+      
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176

Query: 969 IAGTVGYVAPE------YGQTWQATTKGDVYSFGVLA 999
           I GT  +VAPE       G       + D++S GV+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLG------LEADMWSIGVIT 207

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  116 bits (293), Expect = 3e-27
 Identities = 94/550 (17%), Positives = 161/550 (29%), Gaps = 99/550 (18%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLS---GLRSLEILDLSVN 159
            +   L LS+N+ S     D+S    L+ L LSHN +   L+       + LE LD+S N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTC--FDGCLNLRYLDLSSNNFRGNIWNG 217
           R+   IS         L   +LS N+    +  C  F     L +L LS+  FR      
Sbjct: 111 RLQ-NISCCPM---ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165

Query: 218 LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFG 277
           +A L    +  +                L  + +   E       E     N  VL+L  
Sbjct: 166 VAHLHLSCILLD----------------LVSYHIKGGET------ESLQIPNTTVLHLVF 203

Query: 278 NNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG 337
           +  S        S++ L  L L          + L+          +  N          
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV--------- 254

Query: 338 RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILA 397
               ++     S           +  L NI  L ++            + ++SL    + 
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYL-NIYNLTITERIDREEFTYSETALKSLMIEHVK 313

Query: 398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI 457
           +  F  S  A+Y     +    LS ++          + +S  +L    N  +  +    
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC 373

Query: 458 GNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIP 517
                L  L L  N L                                            
Sbjct: 374 STLKRLQTLILQRNGLK------------------------------------------- 390

Query: 518 ADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGE 577
            ++   + +   ++      +    L  +  +        S        L LS N L+G 
Sbjct: 391 -NFFKVALMTKNMSSLETLDVSLNSLN-SHAYDRTCAWAESIL-----VLNLSSNMLTGS 443

Query: 578 LSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCL 635
           +   +       ++ L  N+    +P     L  L  LN+  N     +P   F  +  L
Sbjct: 444 VFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499

Query: 636 QNLDLSYNNF 645
           Q + L  N +
Sbjct: 500 QYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  116 bits (291), Expect = 5e-27
 Identities = 80/408 (19%), Positives = 146/408 (35%), Gaps = 36/408 (8%)

Query: 94  DIFNN------FSALTQLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILSGDLNL 145
           D+ +N         +  L +LDLS N F   +P   +  +   L +L LS       L+L
Sbjct: 106 DVSHNRLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDL 163

Query: 146 SGLRSLEI----LDLSVNRIHGEISFSFPAICEK---LVVANLSLNNLTGRIDTCFDGCL 198
             +  L +    LDL    I G  + S          LV    SL ++   +     G L
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223

Query: 199 NLRYLDLSSNNFRGNIW-------NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
            L  + L+  N +  +              V     E      V    F     +E  ++
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283

Query: 252 SENEFIG-----DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLS 306
                       +F    +  ++L++ ++    F     A     + +    L  ++   
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343

Query: 307 VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL-KLP 365
           +      + S    L+ + N F   V +      +++ L L  N   +    + +   + 
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403

Query: 366 NISRLDLSHNNFT-GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
           ++  LD+S N+          +   S+  L L+ N   GS+       P ++ LDL  N 
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNR 461

Query: 425 LTGPIPPSIGNLTSLLWLMLANNSLSGEIP-GEIGNCTSLLWLNLSNN 471
           +   IP  + +L +L  L +A+N L   +P G     TSL ++ L +N
Sbjct: 462 IMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  106 bits (266), Expect = 7e-24
 Identities = 101/586 (17%), Positives = 171/586 (29%), Gaps = 130/586 (22%)

Query: 104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRI 161
             S +D S    +  +P DL      K L+LS N +S     ++S L  L +L LS NRI
Sbjct: 32  LESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88

Query: 162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQL 221
                 S                         F    +L YLD+S N           +L
Sbjct: 89  R-----SLDF--------------------HVFLFNQDLEYLDVSHN-----------RL 112

Query: 222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF--IGDFPGEVSNCRNLVVLNLFGNN 279
                        +S        SL   DLS N+F  +     E  N   L  L L    
Sbjct: 113 QN-----------ISCCPMA---SLRHLDLSFNDFDVLPV-CKEFGNLTKLTFLGLSAAK 157

Query: 280 FSGPIPAEIGSISGLEALFLG-KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR 338
           F   +     +   L  + L   +  +       L +    VL L  +       ++   
Sbjct: 158 FRQ-LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216

Query: 339 FTQVKILALHSNSYIDGMNSS------GILKLPNISRLDLSHNNFTGPLPVEISQ---MR 389
              +  L L +    D            + + P +  + L H   T    V++ Q    R
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276

Query: 390 SLKFLILAHNRFNGSIPAVYGN-----MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML 444
            +++L + +      I           + +L    +                  +   ML
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIA 504
           + +           + +S  +LN + N  + +   +        R      QRNG +   
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQG--CSTLKRLQTLILQRNGLKNF- 392

Query: 505 GSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQIT 564
                              + +   ++      +    L  +  +        S      
Sbjct: 393 ----------------FKVALMTKNMSSLETLDVSLNSLN-SHAYDRTCAWAESIL---- 431

Query: 565 GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP--LIVLNLTRNNFS 622
             L LS N L+                            S F  LP  + VL+L  N   
Sbjct: 432 -VLNLSSNMLT---------------------------GSVFRCLPPKVKVLDLHNNRIM 463

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
             IP +  +++ LQ L+++ N         F+ LT L  + +  NP
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  101 bits (254), Expect = 2e-22
 Identities = 61/379 (16%), Positives = 124/379 (32%), Gaps = 36/379 (9%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI----FGRFTQVKILALHSNSYIDGMN 357
           N  L+ +P+ L    + + L LS N+      ++        +++++L L  N  I  ++
Sbjct: 40  NRNLTHVPKDLP--PRTKALSLSQNSI----SELRMPDISFLSELRVLRLSHNR-IRSLD 92

Query: 358 SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP--AVYGNMPNL 415
               L   ++  LD+SHN     +      M SL+ L L+ N F+  +P    +GN+  L
Sbjct: 93  FHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKL 148

Query: 416 QTLDLSFNELT-GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGN-CTSLLWLNLSNNKL 473
             L LS  +     + P      S + L L +  + G     +    T++L L    N L
Sbjct: 149 TFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208

Query: 474 SGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRK 533
                   +               N +         ++    +             +T +
Sbjct: 209 FSVQVNMSVN------ALGHLQLSNIKLNDENCQRLMTFLSELTRGPT-----LLNVTLQ 257

Query: 534 SCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHL 593
              + W   +K                  I   L ++      E +     L++  + H+
Sbjct: 258 HIETTWKCSVK----LFQFFWPRPVEYLNIYN-LTITERIDREEFTYSETALKSLMIEHV 312

Query: 594 GFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS 652
               F     + +     + +  L+ ++          +      L+ + N F+      
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372

Query: 653 FNNLTELSKLNISYNPLVS 671
            + L  L  L +  N L +
Sbjct: 373 CSTLKRLQTLILQRNGLKN 391

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 98.0 bits (244), Expect = 4e-21
 Identities = 84/520 (16%), Positives = 146/520 (28%), Gaps = 118/520 (22%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV 239
           +LS N+++            LR L LS N           ++             +   V
Sbjct: 58  SLSQNSISELRMPDISFLSELRVLRLSHN-----------RIRS-----------LDFHV 95

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNF-SGPIPAEIGSISGLEALF 298
           F  N  LE  D+S N         +++   L  L+L  N+F   P+  E G+++ L  L 
Sbjct: 96  FLFNQDLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152

Query: 299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI-FGRFTQVKILALHSNSYIDGMN 357
           L    F  +    LL ++ L +  +  +     ++              LH         
Sbjct: 153 LSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH--------- 200

Query: 358 SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQT 417
               L     S    S         +   Q+ ++K       R    +  +    P L  
Sbjct: 201 ----LVFHPNS--LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG-PTLLN 253

Query: 418 LDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI 477
           + L   E T         L    W                     + +LN+ N  ++  I
Sbjct: 254 VTLQHIETTWK---CSVKLFQFFWP------------------RPVEYLNIYNLTITERI 292

Query: 478 PPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRS 537
             E  T    A  +                                  +Y++    + + 
Sbjct: 293 DREEFTYSETALKSLMIEHVK-----------------NQVFLFSKEALYSVFAEMNIKM 335

Query: 538 LWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQ 597
           L   +     I  VC P  +S T     +L  + N  +  +      L+    + L  N 
Sbjct: 336 LS--ISDTPFIHMVCPPSPSSFT-----FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388

Query: 598 FDGKLPSQFDQL----PLIVLNLTRNNF-SGEIPSEFGNIKCLQNLDLSYNNF-SGPF-- 649
                            L  L+++ N+  S          + +  L+LS N      F  
Sbjct: 389 LK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447

Query: 650 ------------------PASFNNLTELSKLNISYNPLVS 671
                             P    +L  L +LN++ N L S
Sbjct: 448 LPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKS 487

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 84.5 bits (209), Expect = 6e-17
 Identities = 51/256 (19%), Positives = 89/256 (34%), Gaps = 21/256 (8%)

Query: 87  TDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDL-----SSCRSLKYLNLSHNILSG 141
           T W  S  +F  F     + YL++   T +  I  +      ++ +SL   ++ + +   
Sbjct: 261 TTWKCSVKLFQFFW-PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 142 DLNL--SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLN 199
                 S    + I  LS++     I    P         N + N  T  +         
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 200 LRYLDLSSNNFR-----GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
           L+ L L  N  +       +   ++ L    VS N L+            S+ + +LS N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438

Query: 255 EFIGDFPGEVSNC--RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
                  G V  C    + VL+L  N     IP ++  +  L+ L +  N   SV     
Sbjct: 439 ML----TGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVF 493

Query: 313 LNLSKLEVLDLSSNNF 328
             L+ L+ + L  N +
Sbjct: 494 DRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 80.7 bits (199), Expect = 9e-16
 Identities = 53/334 (15%), Positives = 113/334 (33%), Gaps = 46/334 (13%)

Query: 61  NQSSSPCEWPGIICSPDKARVNGLNLTDWNISG--DIFNNFSALTQLSYLDLSR-NTFSG 117
             S    +    + +    +++ + L D N        +  +    L  + L    T   
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264

Query: 118 SIPDDLSS--CRSLKYLNLSHNILSG-------DLNLSGLRSLEILDLSVNRIHGEISFS 168
                      R ++YLN+ +  ++          + + L+SL I  +            
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324

Query: 169 FPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF---RGNIWNGLAQLVEFS 225
           +     ++ +  LS+++       C     +  +L+ + N F        + L +L    
Sbjct: 325 YSVF-AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 226 VSENVLSGV-VSSSVFKENCSLEIFDLSENEF-IGDFPGEVSNCRNLVVLNLFGNNFSGP 283
           +  N L      + + K   SLE  D+S N      +    +   +++VLNL  N  +G 
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           +   +     ++ L L  N  +  IP+ + +L  L+ L+++SN        +F R     
Sbjct: 444 VFRCLPP--KVKVLDLHNNR-IMSIPKDVTHLQALQELNVASNQLKSVPDGVFDR----- 495

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
                               L ++  + L  N +
Sbjct: 496 --------------------LTSLQYIWLHDNPW 509

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (287), Expect = 4e-27
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 41/229 (17%)

Query: 795 FTYSDILKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-- 847
            T  D         ++    + +G G  G V         ++VA++ + +          
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 848 ------FRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR 901
                    E+E+L        HP ++ +  +  D  +  +V E MEGG L D +    R
Sbjct: 181 ADPALNVETEIEILKKLN----HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR 235

Query: 902 LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL---VTDFGLARVV 958
           L           +  A+ +LH      I+HRD+K  NVLL  + +     +TDFG ++++
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292

Query: 959 SAGDSHVSTTIAGTVGYVAPE---------YGQTWQATTKGDVYSFGVL 998
             G++ +  T+ GT  Y+APE         Y +        D +S GV+
Sbjct: 293 --GETSLMRTLCGTPTYLAPEVLVSVGTAGYNR------AVDCWSLGVI 333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (282), Expect = 5e-27
 Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)

Query: 804 TGKFSE----DRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGERE-FRAEM 852
             K  +       +G G F  V +      G E A K     + +       RE    E+
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 853 EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
            +L        H N++TL+    + ++ +L+ E + GG L D ++ +  L+         
Sbjct: 67  SILRQ----VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122

Query: 913 DVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL---VTDFGLARVVSAGDSHVSTT 968
            +   + +LH +    I H D+K  N++L DK        + DFGLA  +  G       
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KN 177

Query: 969 IAGTVGYVAPE------YGQTWQATTKGDVYSFGVLA 999
           I GT  +VAPE       G       + D++S GV+ 
Sbjct: 178 IFGTPEFVAPEIVNYEPLG------LEADMWSIGVIT 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (281), Expect = 5e-27
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 25/203 (12%)

Query: 810 DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE--------FRAEMEVLSGNGF 860
            + +G G  G V         ++VA+K + +                   E+E+L     
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN- 73

Query: 861 GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
              HP ++ +  +  D  +  +V E MEGG L D +    RL           +  A+ +
Sbjct: 74  ---HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 921 LHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
           LH      I+HRD+K  NVLL   +++    +TDFG ++++  G++ +  T+ GT  Y+A
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLA 184

Query: 978 PE--YGQTWQATTKG-DVYSFGV 997
           PE           +  D +S GV
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGV 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (282), Expect = 9e-27
 Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 36/217 (16%)

Query: 804 TGKFSE----DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGER------EFRAEM 852
             K  +       +G G F  V +      G E A K +++      R      E   E+
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 853 EVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI 912
            +L        HPN++TL+    + ++ +L+ E + GG L D ++ +  L+         
Sbjct: 67  SILRQ----VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122

Query: 913 DVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKAL---VTDFGLARVVSAGDSHVSTT 968
            +   + +LH +    I H D+K  N++L DK        + DFGLA  +  G       
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KN 177

Query: 969 IAGTVGYVAPE------YGQTWQATTKGDVYSFGVLA 999
           I GT  +VAPE       G       + D++S GV+ 
Sbjct: 178 IFGTPEFVAPEIVNYEPLG------LEADMWSIGVIT 208

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (280), Expect = 9e-27
 Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 39/222 (17%)

Query: 800 ILKATGKFSE-----DRIIGKGGFGTVYRGV-LPDGREVAVK--KLQREGLEGEREFRAE 851
             ++   F+       + +G+G F  V + +    G+E A K  K +R G +   E   E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78

Query: 852 MEV---LSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSL-EDIISDRT-RLTWRR 906
           + V             P ++ L+    + SE IL+ EY  GG +    + +    ++   
Sbjct: 79  IAVLELAKS------CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132

Query: 907 RLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDS 963
            + +   +   + +LH      IVH D+K  N+LL        +   DFG++R +     
Sbjct: 133 VIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 964 HVSTTIAGTVGYVAPE------YGQTWQATTKGDVYSFGVLA 999
                I GT  Y+APE              T  D+++ G++A
Sbjct: 190 L--REIMGTPEYLAPEILNYDPIT------TATDMWNIGIIA 223

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  112 bits (281), Expect = 2e-26
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 46/225 (20%)

Query: 798 SDILKATGKFSED-----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAE 851
           S +        +D     +++G G  G V +        + A+K LQ       +  R E
Sbjct: 50  SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARR-E 104

Query: 852 MEVL---SGNGFGWPHPNLVTLYGWCLDGSEKI----LVYEYMEGGSLEDIISDR--TRL 902
           +E+    S        P++V +     +         +V E ++GG L   I DR     
Sbjct: 105 VELHWRASQ------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158

Query: 903 TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVS 959
           T R   +I   +  A+ +LH      I HRDVK  N+L   K   A++  TDFG A+  +
Sbjct: 159 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215

Query: 960 AGDSHVSTTIAGTVGYVAPE------YGQTWQATTKGDVYSFGVL 998
           + +S   TT   T  YVAPE      Y +        D++S GV+
Sbjct: 216 SHNSL--TTPCYTPYYVAPEVLGPEKYDK------SCDMWSLGVI 252

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  109 bits (273), Expect = 4e-26
 Identities = 68/303 (22%), Positives = 101/303 (33%), Gaps = 45/303 (14%)

Query: 170 PAICEKLVVANLSLNNLTGRIDTCFD--------GCLNLRYLDLSSNNFRGNIWNGLAQL 221
            A   +L     SL  L  R+DT  D          L+L+ L + +      I  G  ++
Sbjct: 32  GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV 91

Query: 222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS 281
           +  S                    L+   L   E  G  P  +       +  L   N S
Sbjct: 92  LGIS-------------------GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132

Query: 282 -GPIPAEIGSIS-----GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI 335
                A +  +      GL+ L + + + L+   E +     L  LDLS N   GE   I
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192

Query: 336 ----FGRFTQVKILALHSNSY--IDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQ-M 388
                 +F  +++LAL +       G+ S+       +  LDLSHN+             
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
             L  L L+       +P   G    L  LDLS+N L     PS   L  +  L L  N 
Sbjct: 253 SQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNP 307

Query: 449 LSG 451
              
Sbjct: 308 FLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  108 bits (272), Expect = 6e-26
 Identities = 54/249 (21%), Positives = 89/249 (35%), Gaps = 22/249 (8%)

Query: 245 SLEIFDLSENEFIGDFP-GEVSNCRNLVVLNLFGNNFSGPIPA---EIGSISGLEALFLG 300
           SLE      +         ++    +L  L +        I      +  ISGL+ L L 
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 301 KNNFLSVIPESLLNLS--KLEVLDLSSNNFGGEVQKIFGRF----TQVKILALHSNSYID 354
                   P  LL  +   L +L+L + ++      +          +K+L++       
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH-SL 162

Query: 355 GMNSSGILKLPNISRLDLSHNNFTGPLPVEIS----QMRSLKFLILAHNRFN---GSIPA 407
             +   +   P +S LDLS N   G   +  +    +  +L+ L L +       G   A
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222

Query: 408 VYGNMPNLQTLDLSFNELTG-PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWL 466
           +      LQ LDLS N L      PS    + L  L L+   L  ++P  +     L  L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVL 279

Query: 467 NLSNNKLSG 475
           +LS N+L  
Sbjct: 280 DLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  100 bits (251), Expect = 3e-23
 Identities = 49/265 (18%), Positives = 74/265 (27%), Gaps = 25/265 (9%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLS---SCRSLKYLNLSHNILS 140
           L   D       F +      L  L +        I            L+ L L +  ++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 141 GDLNLSGLR----SLEILDLSVNRIHGEISFS---FPAICEKLVVANLSLNNLTGRIDTC 193
           G      L      L IL+L         ++       +   L V +++  +        
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 194 FDGCLNLRYLDLSSNNFRGNIW-------NGLAQLVEFSVSENVLSGV--VSSSVFKENC 244
                 L  LDLS N   G               L   ++    +     V S++     
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 245 SLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN 303
            L+  DLS N                L  LNL        +P  +   + L  L L   N
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLS-YN 284

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNF 328
            L   P S   L ++  L L  N F
Sbjct: 285 RLDRNP-SPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.2 bits (247), Expect = 9e-23
 Identities = 51/304 (16%), Positives = 88/304 (28%), Gaps = 51/304 (16%)

Query: 145 LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFD-----GCLN 199
             G RSLE L   V+         F  I + L +  L++          F      G   
Sbjct: 39  YGGGRSLEYLLKRVD--TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96

Query: 200 LRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKE--------NCSLEIFDL 251
           L+ L L +    G     L +     ++   L  V  ++               L++  +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI----GSISGLEALFLGKNNFLS- 306
           ++   +     +V     L  L+L  N   G               L+ L L      + 
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 307 --VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL 364
             V         +L+ LDLS N+                              +      
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAA------------------------GAPSCDWP 252

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
             ++ L+LS       +P  +     L  L L++NR +   P+    +P +  L L  N 
Sbjct: 253 SQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLD-RNPSP-DELPQVGNLSLKGNP 307

Query: 425 LTGP 428
               
Sbjct: 308 FLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 38/185 (20%), Positives = 57/185 (30%), Gaps = 17/185 (9%)

Query: 61  NQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIP 120
              ++   W   +    K  +  L++   +              LS LDLS N   G   
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 121 DDLSSC----RSLKYLNLSHNILS-----GDLNLSGLRSLEILDLSVNRIHGEISFSFPA 171
              + C     +L+ L L +  +           +    L+ LDLS N +          
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 172 ICEKLVVANLSLNNLTGRIDTCFDGCL--NLRYLDLSSNNFRGN-IWNGLAQLVEFSVSE 228
              +L   NLS   L           L   L  LDLS N    N   + L Q+   S+  
Sbjct: 251 WPSQLNSLNLSFTGL-----KQVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKG 305

Query: 229 NVLSG 233
           N    
Sbjct: 306 NPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.3 bits (203), Expect = 6e-17
 Identities = 41/204 (20%), Positives = 69/204 (33%), Gaps = 32/204 (15%)

Query: 90  NISGDIFNNFSA------LTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           N+S    + + A         L  L +++        + +    +L  L+LS N   G+ 
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L               I       FP + + L + N  +   +G         + L+ L
Sbjct: 190 GL---------------ISALCPLKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGL 233

Query: 204 DLSSNNFRGNI----WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD 259
           DLS N+ R        +  +QL   ++S   L   V   +      L + DLS N  +  
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA---KLSVLDLSYNR-LDR 288

Query: 260 FPGEVSNCRNLVVLNLFGNNFSGP 283
            P        +  L+L GN F   
Sbjct: 289 NP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 48/286 (16%), Positives = 83/286 (29%), Gaps = 41/286 (14%)

Query: 408 VYGNMPNLQTLDLSFNELTGPIPPS-IGNLTSLLWLMLANNSLSGEIPG---EIGNCTSL 463
           +YG   +L+ L    +        + I    SL  L +    +   I      +   + L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 464 LWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPF 523
             L L N +++G  PP +                            L+++    A    +
Sbjct: 98  QELTLENLEVTGTAPPPL------------------LEATGPDLNILNLRNVSWATRDAW 139

Query: 524 SFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELS---- 579
                   +   + L    +               R F     L LS N   GE      
Sbjct: 140 LAELQQWLKPGLKVL---SIAQAHSLN--FSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 580 ---PDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKC 634
                   LQ  ++ + G     G   +       L  L+L+ N+      +        
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 635 LQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL 680
           L +L+LS+             L+    L++SYN L     PS  +L
Sbjct: 255 LNSLNLSFTGLKQVPKGLPAKLSV---LDLSYNRLDR--NPSPDEL 295

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 61/295 (20%), Positives = 92/295 (31%), Gaps = 39/295 (13%)

Query: 366 NISRLDLSHNNFTGPLP-VEISQMRSLKFLILAHNRFNGSIPA---VYGNMPNLQTLDLS 421
           ++  L    +         +I +  SLK L +   R    I         +  LQ L L 
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 422 FNELTGPIPPSIGNLT--SLLWLMLANNSLSGE--IPGEIGNC--TSLLWLNLSNNKLSG 475
             E+TG  PP +   T   L  L L N S +       E+       L  L+++      
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL- 162

Query: 476 NIPPEVMTIGRNARP-TFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKS 534
           N   E + +           N   GER +  +               P  F        +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISAL-------------CPLKF-------PT 202

Query: 535 CRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHL 593
            + L  R         VC    A+R  Q+   L LS N L               + ++L
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARV-QLQ-GLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260

Query: 594 GFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGP 648
            F     ++P       L VL+L+ N      PS    +  + NL L  N F   
Sbjct: 261 SFTGLK-QVPKGLPAK-LSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 20/136 (14%), Positives = 42/136 (30%), Gaps = 13/136 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHL--------GFNQFDGKLPSQFDQLPLIVLNLT 617
            L L   +++G   P + +     +  L          + +  +L   + +  L VL++ 
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQ-WLKPGLKVLSIA 157

Query: 618 RNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFP----ASFNNLTELSKLNISYNPLVSGT 673
           + +       +      L  LDLS N   G               L  L +    + + +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217

Query: 674 IPSTGQLATFEKTSYL 689
              +   A   +   L
Sbjct: 218 GVCSALAAARVQLQGL 233

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 7e-26
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 5/217 (2%)

Query: 268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN 327
            N   LNL  NN           +  LE L LG+N+   +   +   L+ L  L+L  N 
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

Query: 328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-S 386
                   F   ++++ L L +N  I+ + S    ++P++ RLDL        +      
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNP-IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 387 QMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN 446
            + +LK+L L        +P     +  L+ L++S N      P S   L+SL  L + N
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 447 NSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           + +S           SL+ LNL++N LS ++P ++ T
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (270), Expect = 1e-24
 Identities = 57/283 (20%), Positives = 95/283 (33%), Gaps = 40/283 (14%)

Query: 74  CSPDKARV--NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY 131
           CS   ++V      L++  +   I       +   YL+L  N       D       L+ 
Sbjct: 52  CSNQFSKVVCTRRGLSE--VPQGIP------SNTRYLNLMENNIQMIQADTFRHLHHLEV 103

Query: 132 LNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR 189
           L L  N +        +GL SL  L+L  N +   I         KL    L  N +   
Sbjct: 104 LQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESI 162

Query: 190 IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIF 249
               F+   +L  LDL              +L    +SE    G+ +         L+  
Sbjct: 163 PSYAFNRVPSLMRLDLGELK----------KLE--YISEGAFEGLFN---------LKYL 201

Query: 250 DLSENEF--IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV 307
           +L       + +     +    L  L + GN+F    P     +S L+ L++  +    +
Sbjct: 202 NLGMCNIKDMPNL----TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257

Query: 308 IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
              +   L+ L  L+L+ NN       +F     +  L LH N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (251), Expect = 2e-22
 Identities = 66/325 (20%), Positives = 109/325 (33%), Gaps = 84/325 (25%)

Query: 104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRI 161
           Q S +  +R   S  +P  + S  + +YLNL  N +          L  LE+L L  N I
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQL 221
             +I                            F+G  +L  L+L  N             
Sbjct: 112 R-QIE------------------------VGAFNGLASLNTLELFDNWLT---------- 136

Query: 222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNF 280
                       V+ S  F+    L    L  N  I   P    +   +L+ L+L     
Sbjct: 137 ------------VIPSGAFEYLSKLRELWLRNNP-IESIPSYAFNRVPSLMRLDLGELKK 183

Query: 281 SGPIPAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRF 339
              I       +  L+ L LG  N +  +P +L  L  LE L++S N+F       F   
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCN-IKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241

Query: 340 TQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHN 399
           + +K L + ++  +  +  +    L ++  L+L+HNN +                     
Sbjct: 242 SSLKKLWVMNSQ-VSLIERNAFDGLASLVELNLAHNNLS--------------------- 279

Query: 400 RFNGSIPA-VYGNMPNLQTLDLSFN 423
               S+P  ++  +  L  L L  N
Sbjct: 280 ----SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 12/134 (8%)

Query: 84  LNLTDWN----ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL 139
           L+L +      IS   F     L  L YL+L        +P+ L+    L+ L +S N  
Sbjct: 176 LDLGELKKLEYISEGAFEG---LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHF 230

Query: 140 SGDLN--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC 197
                    GL SL+ L +  +++      +F  +   LV  NL+ NNL+      F   
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL-ASLVELNLAHNNLSSLPHDLFTPL 289

Query: 198 LNLRYLDLSSNNFR 211
             L  L L  N + 
Sbjct: 290 RYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.4 bits (144), Expect = 4e-09
 Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 6/109 (5%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L+L  N L+  +       L     + L  N  +      F+++P L+ L+L       
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            I    F  +  L+ L+L   N       +   L  L +L +S N    
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFPE 232

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL L    +     P++  L     + +  N F    P  F  L  L  L +  +  S  
Sbjct: 200 YLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-L 256

Query: 625 IPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
           I    F  +  L  L+L++NN S      F  L  L +L++ +NP  
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 28/110 (25%), Positives = 47/110 (42%), Gaps = 8/110 (7%)

Query: 566 YLQLSG-NQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
            L L    +L   +S      L N   ++LG       +P+    L  L  L ++ N+F 
Sbjct: 175 RLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP 231

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            EI    F  +  L+ L +  +  S     +F+ L  L +LN+++N L S
Sbjct: 232 -EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 3/82 (3%)

Query: 592 HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPF 649
           +L  N         F  L  L VL L RN+   +I    F  +  L  L+L  N  +   
Sbjct: 81  NLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIP 139

Query: 650 PASFNNLTELSKLNISYNPLVS 671
             +F  L++L +L +  NP+ S
Sbjct: 140 SGAFEYLSKLRELWLRNNPIES 161

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 17/59 (28%), Positives = 24/59 (40%)

Query: 613 VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            LNL  NN        F ++  L+ L L  N+       +FN L  L+ L +  N L  
Sbjct: 79  YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV 137

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (273), Expect = 8e-26
 Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 47/219 (21%)

Query: 804 TGKFSED-----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVL-- 855
               ++D     +++G G  G V        G++ A+K L         + R E++    
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77

Query: 856 -SGNGFGWPHPNLVTLYGWCLDGSEKI----LVYEYMEGGSLEDIISDR--TRLTWRRRL 908
            SG       P++V +     +         ++ E MEGG L   I +R     T R   
Sbjct: 78  ASG------GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131

Query: 909 DIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVVSAGDSHV 965
           +I  D+  A+ FLH      I HRDVK  N+L   KE  A++  TDFG A+  +      
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---A 185

Query: 966 STTIAGTVGYVAPE------YGQTWQATTKGDVYSFGVL 998
             T   T  YVAPE      Y +        D++S GV+
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDK------SCDMWSLGVI 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (272), Expect = 1e-25
 Identities = 56/262 (21%), Positives = 89/262 (33%), Gaps = 64/262 (24%)

Query: 802  KATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEGEREFRAE 851
             +  +  +       IG+G +G V   +        A+K     K+++   +     + E
Sbjct: 19   GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 852  MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRL--- 908
            + ++        HPN+  LY    D     LV E   GG L D ++     +  +     
Sbjct: 79   VRLMKK----LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134

Query: 909  -------------------------------------DIAIDVARALVFLHHECYPPIVH 931
                                                 +I   +  AL +LH++    I H
Sbjct: 135  VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICH 191

Query: 932  RDVKASNVLLDKEGKALV--TDFGLARVVSA---GDSHVSTTIAGTVGYVAPE--YGQTW 984
            RD+K  N L        +   DFGL++       G+ +  TT AGT  +VAPE       
Sbjct: 192  RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251

Query: 985  QATTKGDVYSFGVLAMELATGR 1006
                K D +S GVL   L  G 
Sbjct: 252  SYGPKCDAWSAGVLLHLLLMGA 273

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (276), Expect = 1e-25
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 5/217 (2%)

Query: 268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN 327
            N  +LNL  N            +  LE L L +N+  ++   +   L+ L  L+L  N 
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-S 386
                   F   +++K L L +N  I+ + S    ++P++ RLDL        +      
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 387 QMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN 446
            + +L++L LA       IP +   +  L  LDLS N L+   P S   L  L  L +  
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 447 NSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           + +         N  SL+ +NL++N L+  +P ++ T
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (259), Expect = 2e-23
 Identities = 61/284 (21%), Positives = 102/284 (35%), Gaps = 42/284 (14%)

Query: 74  CSPDKARV--NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY 131
           CS   ++V     NL +  +   I  N         L+L  N       +     R L+ 
Sbjct: 41  CSNQFSKVICVRKNLRE--VPDGISTN------TRLLNLHENQIQIIKVNSFKHLRHLEI 92

Query: 132 LNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR 189
           L LS N +        +GL +L  L+L  NR+   I         KL    L  N +   
Sbjct: 93  LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-S 150

Query: 190 IDT-CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEI 248
           I +  F+   +LR LDL              +L    +SE    G+          +L  
Sbjct: 151 IPSYAFNRIPSLRRLDLGELK----------RLS--YISEGAFEGLS---------NLRY 189

Query: 249 FDLSENEF--IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLS 306
            +L+      I +     +    L  L+L GN+ S   P     +  L+ L++ ++    
Sbjct: 190 LNLAMCNLREIPNL----TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245

Query: 307 VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
           +   +  NL  L  ++L+ NN       +F     ++ + LH N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (258), Expect = 3e-23
 Identities = 64/280 (22%), Positives = 101/280 (36%), Gaps = 38/280 (13%)

Query: 104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRI 161
           Q S +   R      +PD +S+  + + LNL  N +      +   LR LEIL LS N I
Sbjct: 44  QFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGL 218
              I                            F+G  NL  L+L  N         +  L
Sbjct: 101 R-TIE------------------------IGAFNGLANLNTLELFDNRLTTIPNGAFVYL 135

Query: 219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFG 277
           ++L E  +  N +   + S  F    SL   DL E + +            NL  LNL  
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194

Query: 278 NNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG 337
            N    IP  +  +  L+ L L  N+  ++ P S   L  L+ L +  +      +  F 
Sbjct: 195 CNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252

Query: 338 RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
               +  + L  N+ +  +       L ++ R+ L HN +
Sbjct: 253 NLQSLVEINLAHNN-LTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 69.0 bits (169), Expect = 3e-12
 Identities = 38/134 (28%), Positives = 57/134 (42%), Gaps = 12/134 (8%)

Query: 84  LNLTDWN----ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL 139
           L+L +      IS   F     L+ L YL+L+       IP+ L+    L  L+LS N L
Sbjct: 165 LDLGELKRLSYISEGAFEG---LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHL 219

Query: 140 S--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC 197
           S     +  GL  L+ L +  ++I   I  +     + LV  NL+ NNLT      F   
Sbjct: 220 SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278

Query: 198 LNLRYLDLSSNNFR 211
            +L  + L  N + 
Sbjct: 279 HHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.8 bits (132), Expect = 9e-08
 Identities = 25/107 (23%), Positives = 44/107 (41%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL L+   L     P++  L     + L  N      P  F  L  L  L + ++     
Sbjct: 189 YLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-V 245

Query: 625 IPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
           I    F N++ L  ++L++NN +      F  L  L ++++ +NP  
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.7 bits (124), Expect = 9e-07
 Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 11/123 (8%)

Query: 556 LASRTFQITGYLQL----SGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP 610
           + S  F     L+        +LS  +S      L N   ++L       ++P+    L 
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLI 207

Query: 611 -LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
            L  L+L+ N+ S  I    F  +  LQ L +  +        +F+NL  L ++N+++N 
Sbjct: 208 KLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266

Query: 669 LVS 671
           L  
Sbjct: 267 LTL 269

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 26/111 (23%), Positives = 41/111 (36%), Gaps = 4/111 (3%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFS 622
           T  L L  NQ+          L++  ++ L  N         F+ L  L  L L  N  +
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNIS-YNPLVS 671
             IP+  F  +  L+ L L  N        +FN +  L +L++     L  
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY 175

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  106 bits (266), Expect = 2e-25
 Identities = 45/202 (22%), Positives = 78/202 (38%), Gaps = 7/202 (3%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           +P  I +    + +FL  N    V   S      L +L L SN         F     ++
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFN 402
            L L  N+ +  ++ +    L  +  L L        L   +   + +L++L L  N   
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ 142

Query: 403 GSIPA-VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT 461
            ++P   + ++ NL  L L  N ++     +   L SL  L+L  N ++   P    +  
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 462 SLLWLNLSNNKLSGNIPPEVMT 483
            L+ L L  N LS  +P E + 
Sbjct: 202 RLMTLYLFANNLS-ALPTEALA 222

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 50/228 (21%), Positives = 79/228 (34%), Gaps = 18/228 (7%)

Query: 244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKN 302
            + +   L  N            CRNL +L L  N  +  I A     ++ LE L L  N
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90

Query: 303 NFLSVIPESLL-NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
             L  +  +    L +L  L L           +F     ++ L L  N+ +  +     
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA-LQALPDDTF 149

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDL 420
             L N++ L L  N  +         + SL  L+L  NR    +    + ++  L TL L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYL 208

Query: 421 SFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCT-SLLWL 466
             N L+  +P      L +L +L L +N            C      L
Sbjct: 209 FANNLSA-LPTEALAPLRALQYLRLNDNPW---------VCDCRARPL 246

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 60/274 (21%), Positives = 89/274 (32%), Gaps = 48/274 (17%)

Query: 66  PCEWPGI-ICSPDKARV---NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPD 121
           PC  PG  +C  +           L    +   I            + L  N  S     
Sbjct: 1   PC--PGACVCYNEPKVTTSCPQQGLQA--VPVGIPAA------SQRIFLHGNRISHVPAA 50

Query: 122 DLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA 179
              +CR+L  L L  N+L+       +GL  LE LDLS N                    
Sbjct: 51  SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN-------------------- 90

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVS 236
                 L       F G   L  L L     +     ++ GLA L    + +N L   + 
Sbjct: 91  ----AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALP 145

Query: 237 SSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI-GSISGL 294
              F++  +L    L  N  I   P        +L  L L  N  +  +       +  L
Sbjct: 146 DDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRL 203

Query: 295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNF 328
             L+L  NN  ++  E+L  L  L+ L L+ N +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 39/183 (21%), Positives = 67/183 (36%), Gaps = 9/183 (4%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
              L  +P  +   +  + + L  N         F     + IL LHSN  +  ++++  
Sbjct: 20  QQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAF 76

Query: 362 LKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLD 419
             L  + +LDLS N     +       +  L  L L        +   ++  +  LQ L 
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135

Query: 420 LSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           L  N L   +P     +L +L  L L  N +S           SL  L L  N+++ ++ 
Sbjct: 136 LQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH 193

Query: 479 PEV 481
           P  
Sbjct: 194 PHA 196

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 47/214 (21%), Positives = 76/214 (35%), Gaps = 11/214 (5%)

Query: 169 FPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFS 225
            PA  +++    L  N ++      F  C NL  L L SN         + GLA L +  
Sbjct: 30  IPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86

Query: 226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPI 284
           +S+N     V  + F     L    L     + +    +      L  L L  N     +
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNALQA-L 144

Query: 285 PAEI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           P +    +  L  LFL  N   SV   +   L  L+ L L  N         F    ++ 
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
            L L +N+ +  + +  +  L  +  L L+ N +
Sbjct: 205 TLYLFANN-LSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 5/116 (4%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILD 155
           F  L  L YL L  N    ++PDD      +L +L L  N +S   +    GL SL+ L 
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           L  NR+      +F     +L+   L  NNL+            L+YL L+ N + 
Sbjct: 184 LHQNRVAHVHPHAF-RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 30/108 (27%), Positives = 41/108 (37%), Gaps = 5/108 (4%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
           YL L  N L   L  D    L N + + L  N+        F  L  L  L L +N  + 
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA- 190

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
            +    F ++  L  L L  NN S     +   L  L  L ++ NP V
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 26/110 (23%), Positives = 38/110 (34%), Gaps = 6/110 (5%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L L  N L+  +       L     + L  N     +    F  L  L  L+L R    
Sbjct: 60  ILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            E+    F  +  LQ L L  N        +F +L  L+ L +  N + S
Sbjct: 119 -ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 31/110 (28%), Positives = 41/110 (37%), Gaps = 7/110 (6%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L L    L  EL P +   L     ++L  N     LP   F  L  L  L L  N  S
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +P   F  +  L  L L  N  +   P +F +L  L  L +  N L +
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 27/110 (24%), Positives = 39/110 (35%), Gaps = 6/110 (5%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L LS N     + P     L     +HL       +L    F  L  L  L L  N   
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ 142

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +P + F ++  L +L L  N  S     +F  L  L +L +  N +  
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 18/79 (22%), Positives = 29/79 (36%), Gaps = 5/79 (6%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
              + L  N  S    + F   + L  L L  N  +    A+F  L  L +L++S N  +
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 671 SGTIPSTGQLATFEKTSYL 689
             ++       TF     L
Sbjct: 94  R-SVDPA----TFHGLGRL 107

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (277), Expect = 3e-25
 Identities = 59/343 (17%), Positives = 112/343 (32%), Gaps = 84/343 (24%)

Query: 148 LRSLEILDLSVNRIHGEISFSFPAIC------EKLVVANLSLNNLTGRIDTCFDGCLNLR 201
           L       LS N  +  IS ++          EK  +   + N     +  C        
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFS 62

Query: 202 YLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
            L L+  N               S+ +N+               + + ++++N  +   P
Sbjct: 63  ELQLNRLNLS-------------SLPDNLPP------------QITVLEITQNA-LISLP 96

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
              ++   L  L+   N  S  +P    S+  L+      NN L+++PE     + LE +
Sbjct: 97  ELPAS---LEYLDACDNRLST-LPELPASLKHLDVD----NNQLTMLPELP---ALLEYI 145

Query: 322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPL 381
           +  +N                ++  L                  ++  L + +N  T  L
Sbjct: 146 NADNN----------------QLTMLPE-------------LPTSLEVLSVRNNQLTF-L 175

Query: 382 PVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQT----LDLSFNELTGPIPPSIGNLT 437
           P       SL+ L ++ N    S+PAV     + +          N +T  IP +I +L 
Sbjct: 176 P---ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLD 230

Query: 438 SLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
               ++L +N LS  I   +   T+    +      S +   +
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (259), Expect = 6e-23
 Identities = 61/395 (15%), Positives = 106/395 (26%), Gaps = 112/395 (28%)

Query: 102 LTQLSYLDLSRNTFSG---SIPDDLSSC----RSLKYLNLSHNILSGDLNLSGLRSLEIL 154
           L   +   LS+N+F         D  S             + N     L    +     L
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64

Query: 155 DLSVNRIHGEISFSFPA-ICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN 213
            L+   +      S P  +  ++ V  ++ N L   +        +L YLD   N     
Sbjct: 65  QLNRLNLS-----SLPDNLPPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-- 113

Query: 214 IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVL 273
                                                          P   ++ ++   L
Sbjct: 114 ---------------------------------------------TLPELPASLKH---L 125

Query: 274 NLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQ 333
           ++  N  +  +P        LE +    NN L+++PE     + LEVL + +N       
Sbjct: 126 DVDNNQLTM-LPELPAL---LEYINAD-NNQLTMLPEL---PTSLEVLSVRNN------- 170

Query: 334 KIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK- 392
                    ++  L                  ++  LD+S N     LP    +    + 
Sbjct: 171 ---------QLTFLPE-------------LPESLEALDVSTNLLES-LPAVPVRNHHSEE 207

Query: 393 ---FLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSL 449
              F     NR    IP    ++    T+ L  N L+  I  S+   T+           
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

Query: 450 SGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI 484
           S     +  N       +        N   +V  I
Sbjct: 267 SMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQI 299

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.2 bits (187), Expect = 3e-14
 Identities = 59/376 (15%), Positives = 109/376 (28%), Gaps = 84/376 (22%)

Query: 83  GLNLTDWNISGDIFNNFSAL----TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNI 138
              +T   I+    N   +L      L YLD   N  S ++P+  +   SLK+L++ +N 
Sbjct: 79  PPQITVLEITQ---NALISLPELPASLEYLDACDNRLS-TLPELPA---SLKHLDVDNNQ 131

Query: 139 LSGDLNL-SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC 197
           L+    L      LE ++   N++        P +                         
Sbjct: 132 LT---MLPELPALLEYINADNNQLT-----MLPELPT----------------------- 160

Query: 198 LNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI 257
            +L  L + +N         L +L E                     SLE  D+S N  +
Sbjct: 161 -SLEVLSVRNNQL-----TFLPELPE---------------------SLEALDVSTN-LL 192

Query: 258 GDFPGEVSNCRNL----VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL 313
              P       +     +      N  +  IP  I S+     + L  +N LS      L
Sbjct: 193 ESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILE-DNPLSSRIRESL 250

Query: 314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
           +    +        +            +    A+   ++      S + ++ +    +  
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWFPENKQSDVSQIWHAFEHEEH 308

Query: 374 HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI 433
            N F+  L   +S   S +       +    + A    +     L      +      S 
Sbjct: 309 ANTFSAFL-DRLSDTVSARNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESC 363

Query: 434 GNLTSLLWLMLANNSL 449
            +  +L W  L    L
Sbjct: 364 EDRVALTWNNLRKTLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 27/145 (18%), Positives = 49/145 (33%), Gaps = 14/145 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
           Y+    NQL+  L      L+   ++ +  NQ    LP   + L    L+++ N     +
Sbjct: 144 YINADNNQLT-MLPELPTSLE---VLSVRNNQL-TFLPELPESL--EALDVSTNLLE-SL 195

Query: 626 PSEFGNIKCLQN----LDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLA 681
           P+        +          N  +   P +  +L     + +  NPL S    S  Q  
Sbjct: 196 PAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ- 253

Query: 682 TFEKTSYLGDPLLDLPDFIENGPHH 706
           T +   +       + D  +N  H 
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHR 278

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 19/106 (17%), Positives = 36/106 (33%), Gaps = 15/106 (14%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
            L+++ N L   L      L+    +    N+    LP     L    L++  N  +  +
Sbjct: 84  VLEITQNALI-SLPELPASLEY---LDACDNRLS-TLPELPASL--KHLDVDNNQLT-ML 135

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           P        L+ ++   N  +   P    +L     L++  N L  
Sbjct: 136 PELPAL---LEYINADNNQLTM-LPELPTSLEV---LSVRNNQLTF 174

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.9 bits (124), Expect = 1e-06
 Identities = 23/106 (21%), Positives = 36/106 (33%), Gaps = 11/106 (10%)

Query: 567 LQLSGNQLSGELS-PDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEI 625
             L G   +  +S      +  FS + L        LP       + VL +T+N     +
Sbjct: 39  QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQ-ITVLEITQNALI-SL 95

Query: 626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           P    +   L+ LD   N  S   P    +L     L++  N L  
Sbjct: 96  PELPAS---LEYLDACDNRLST-LPELPASLKH---LDVDNNQLTM 134

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  108 bits (271), Expect = 3e-25
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREFR---AEMEVLSGNGFGWPHPN 866
            R IGKG FG V      D +++ A+K + ++      E R    E++++ G      HP 
Sbjct: 21   RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG----LEHPF 76

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLT-WRRRLDIAIDVARALVFLHHE 924
            LV L+       E + +V + + GG L   +           +L I  ++  AL +L ++
Sbjct: 77   LVNLWY-SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQ 134

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                I+HRD+K  N+LLD+ G   +TDF +A ++        TT+AGT  Y+APE    +
Sbjct: 135  ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSR 189

Query: 983  TWQATTKG-DVYSFGVLAMELATGRR 1007
                 +   D +S GV A EL  GRR
Sbjct: 190  KGAGYSFAVDWWSLGVTAYELLRGRR 215

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  106 bits (266), Expect = 8e-25
 Identities = 60/352 (17%), Positives = 108/352 (30%), Gaps = 95/352 (26%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILDLSVN 159
             +  LDLS N  +     DL  C +L+ L L+ N ++  +     S L SLE LDLS N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLA 219
            +                    +L++        F    +L +L+L  N           
Sbjct: 111 YLS-------------------NLSSSW------FKPLSSLTFLNLLGNP---------- 135

Query: 220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGN 278
                         +  +S+F     L+I  +   +       +  +    L  L +  +
Sbjct: 136 -----------YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184

Query: 279 NFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR 338
           +                          S  P+SL ++  +  L L        ++     
Sbjct: 185 DLQ------------------------SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220

Query: 339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH 398
            + V+ L L     +D  + S   +L       L                 + + + +  
Sbjct: 221 TSSVECLELRDT-DLDTFHFS---ELSTGETNSLIK-------------KFTFRNVKITD 263

Query: 399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSL 449
                 +  +   +  L  L+ S N+L   +P  I   LTSL  + L  N  
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 51/262 (19%), Positives = 102/262 (38%), Gaps = 22/262 (8%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDL-SSCRSLKYLNLSHNILSGD 142
           L+L++  I+    ++      L  L L+ N  + +I +D  SS  SL++L+LS+N LS +
Sbjct: 57  LDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-N 114

Query: 143 LN---LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI-DTCFDGCL 198
           L+      L SL  L+L  N        S  +   KL +  +   +   +I    F G  
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174

Query: 199 NLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
            L  L++ +++ +         +  +    +       ++         S+E  +L + +
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233

Query: 256 FIGDFPGEVS--------NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV 307
                  E+S               + +   +    +   +  ISGL  L     N L  
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF-SRNQLKS 291

Query: 308 IPESLL-NLSKLEVLDLSSNNF 328
           +P+ +   L+ L+ + L +N +
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 58/322 (18%), Positives = 103/322 (31%), Gaps = 50/322 (15%)

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
           L          S  +    +P  +++  ++K L L++NR      +      NLQ L L+
Sbjct: 28  LSCDRNGICKGSSGSLNS-IPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84

Query: 422 FNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
            N +   I      +L SL  L L+ N LS          +SL +LNL  N     +   
Sbjct: 85  SNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGE- 141

Query: 481 VMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
                     +  ++    +    G+ +  +    I      F+     LT      L  
Sbjct: 142 ---------TSLFSHLTKLQILRVGNMDTFTK---IQRK--DFAG----LT--FLEELE- 180

Query: 541 RLLKG---TGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFN 596
             +         P  L  + + +     +L L   Q    L         +   + L   
Sbjct: 181 --IDASDLQSYEPKSLKSIQNVS-----HLILHMKQHI-LLLEIFVDVTSSVECLELRDT 232

Query: 597 QFDG----KLPS-QFDQLP----LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG 647
             D     +L + + + L        + +T  +   ++      I  L  L+ S N    
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

Query: 648 PFPASFNNLTELSKLNISYNPL 669
                F+ LT L K+ +  NP 
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 62/303 (20%), Positives = 111/303 (36%), Gaps = 33/303 (10%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
           +  L+ IP  L     ++ LDLS+N           R   ++ L L SN  I+ +     
Sbjct: 40  SGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSF 96

Query: 362 LKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIP--AVYGNMPNLQTL 418
             L ++  LDLS+N  +  L       + SL FL L  N +  ++   +++ ++  LQ L
Sbjct: 97  SSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154

Query: 419 DLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI 477
            +   +    I       LT L  L +  + L    P  + +  ++  L L   +    +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LL 213

Query: 478 PPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRS 537
               + +  +                     CL + R    D   FS + T  T    + 
Sbjct: 214 LEIFVDVTSSVE-------------------CLEL-RDTDLDTFHFSELSTGETNSLIKK 253

Query: 538 LWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFN 596
              R +K T      +  L ++   +   L+ S NQL   +   I  +L +   + L  N
Sbjct: 254 FTFRNVKITDESLFQVMKLLNQISGLL-ELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311

Query: 597 QFD 599
            +D
Sbjct: 312 PWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 22/153 (14%), Positives = 45/153 (29%), Gaps = 15/153 (9%)

Query: 566 YLQLSGNQLSGELSPDI--GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNF 621
           +L L GN     L        L    ++ +G      K+  + F  L  L  L +  ++ 
Sbjct: 128 FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV--------SG 672
                 +   +I+ + +L L             +  + +  L +    L         +G
Sbjct: 187 Q-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245

Query: 673 TIPSTGQLATFEKTSYLGDPLLDLPDFIENGPH 705
              S  +  TF       + L  +   +     
Sbjct: 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISG 278

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 12/116 (10%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            L++  + L     P     +QN S + L   Q    L    D    +  L L   +   
Sbjct: 178 ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236

Query: 624 ----EIPS----EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               E+ +            +N+ ++  +         N ++ L +L  S N L S
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 3/82 (3%)

Query: 592 HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPF 649
            L  N+      S   +   L  L LT N  +  I  + F ++  L++LDLSYN  S   
Sbjct: 58  DLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLS 116

Query: 650 PASFNNLTELSKLNISYNPLVS 671
            + F  L+ L+ LN+  NP  +
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKT 138

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (264), Expect = 8e-25
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNG 859
            ++    ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+    
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 860 FGWPHPNLVTLYGWCLDGSEKILVYEYMEG-GSLEDIISDRTRLTWRRRLDIAIDVARAL 918
                  ++ L  W       +L+ E  E    L D I++R  L           V  A+
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 919 VFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
              H+     ++HRD+K  N+L+D     L + DFG   ++   D+  +    GT  Y  
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDF-DGTRVYSP 216

Query: 978 PEY--GQTWQATTKGDVYSFGVL 998
           PE+     +       V+S G+L
Sbjct: 217 PEWIRYHRYHG-RSAAVWSLGIL 238

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  107 bits (269), Expect = 2e-24
 Identities = 67/430 (15%), Positives = 120/430 (27%), Gaps = 79/430 (18%)

Query: 103 TQLSYLDLSRNTFS-GSIPDDLSSCRSLKYLNLSHNILSGD------LNLSGLRSLEILD 155
             +  LD+     S     + L   +  + + L    L+          L    +L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 156 LSVNRIHGEISFSFPAICEKLVVAN-------LSLNNLTGR----IDTCFDGCLNLRYLD 204
           L  N +          + + L   +       L    LTG     + +       L+ L 
Sbjct: 63  LRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 205 LSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE- 263
           LS N         L + +                     C LE   L     +     E 
Sbjct: 120 LSDNLLGDAGLQLLCEGLL-----------------DPQCRLEKLQLEYCS-LSAASCEP 161

Query: 264 ----VSNCRNLVVLNLFGNNFSGPIPAEIGSI-----SGLEALFLGKNNF----LSVIPE 310
               +    +   L +  N+ +      +          LEAL L            +  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 311 SLLNLSKLEVLDLSSNNFGGE-VQKIFGRF----TQVKILALHSNSY-IDGMN--SSGIL 362
            + + + L  L L SN  G   + ++        ++++ L +        G       + 
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 363 KLPNISRLDLSHNNFTGPLPVEISQM-----RSLKFLILAHNRFNG----SIPAVYGNMP 413
              ++  L L+ N         + +        L+ L +    F         +V     
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 414 NLQTLDLSFNELTGPIPPSIG-----NLTSLLWLMLANNSLSGEIPGEIG----NCTSLL 464
            L  L +S N L       +        + L  L LA+  +S      +        SL 
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 465 WLNLSNNKLS 474
            L+LSNN L 
Sbjct: 402 ELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 95.4 bits (238), Expect = 1e-20
 Identities = 71/412 (17%), Positives = 137/412 (33%), Gaps = 73/412 (17%)

Query: 84  LNLTDWNIS----GDIFNNFSALTQLSYLDLSRNTFSGS----IPDDLSSC-RSLKYLNL 134
           + L D  ++     DI +       L+ L+L  N         +   L +    ++ L+L
Sbjct: 33  VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 92

Query: 135 SHNILSGD------LNLSGLRSLEILDLSVNRIHGEISFSFPAICE-------KLVVANL 181
            +  L+G         L  L +L+ L LS N +          +CE       +L    L
Sbjct: 93  QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA---GLQLLCEGLLDPQCRLEKLQL 149

Query: 182 SLNNLTGR----IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQ--------LVEFSVSEN 229
              +L+      + +      + + L +S+N+        L Q        L    +   
Sbjct: 150 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209

Query: 230 VLS--GVVS-SSVFKENCSLEIFDLSENEFIGDF------PGEVSNCRNLVVLNLFGNNF 280
            ++         +     SL    L  N+ +GD       PG +     L  L ++    
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNK-LGDVGMAELCPGLLHPSSRLRTLWIWECGI 268

Query: 281 SGPIPAEIGSI----SGLEALFLGKNNF----LSVIPESLLN-LSKLEVLDLSSNNFGGE 331
           +     ++  +      L+ L L  N        ++ E+LL    +LE L + S +F   
Sbjct: 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328

Query: 332 VQKIFG----RFTQVKILALHSNSYID-GMNS-SGILKLPN--ISRLDLSHNNFTGPLPV 383
               F     +   +  L + +N   D G+      L  P   +  L L+  + +     
Sbjct: 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 388

Query: 384 EISQM----RSLKFLILAHNRFNGS-----IPAVYGNMPNLQTLDLSFNELT 426
            ++       SL+ L L++N    +     + +V      L+ L L     +
Sbjct: 389 SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 79.2 bits (196), Expect = 2e-15
 Identities = 52/302 (17%), Positives = 91/302 (30%), Gaps = 54/302 (17%)

Query: 84  LNLTDWNIS----GDIFNNFSALTQLSYLDLSRNTFSGS----IPDDLSSCR-SLKYLNL 134
           L L   ++S      + +   A      L +S N  + +    +   L      L+ L L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 135 SHNILSGD------LNLSGLRSLEILDLSVNRIHGE----ISFSFPAICEKLVVANLSLN 184
               ++ D        ++   SL  L L  N++       +         +L    +   
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266

Query: 185 NLTGR----IDTCFDGCLNLRYLDLSSNNFRG----NIWNGLA----QLVEFSVSENVLS 232
            +T +    +        +L+ L L+ N         +   L     QL    V     +
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

Query: 233 --GVVS-SSVFKENCSLEIFDLSENEFIGDFPG--------EVSNCRNLVVLNLFGNNFS 281
                  SSV  +N  L    +S N  + D  G               L VL L   + S
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNR-LED-AGVRELCQGLGQPGS-VLRVLWLADCDVS 383

Query: 282 GPIPAEIGSI----SGLEALFLGKNNF----LSVIPESL-LNLSKLEVLDLSSNNFGGEV 332
               + + +       L  L L  N      +  + ES+      LE L L    +  E+
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 443

Query: 333 QK 334
           + 
Sbjct: 444 ED 445

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.6 bits (158), Expect = 8e-11
 Identities = 33/184 (17%), Positives = 59/184 (32%), Gaps = 23/184 (12%)

Query: 313 LNLSKLEVLDLSSNNFGGE-VQKIFGRFTQVKILALHSNS-YIDGMN--SSGILKLPNIS 368
           ++L  ++ LD+           ++     Q +++ L             SS +   P ++
Sbjct: 1   MSLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59

Query: 369 RLDLSHNNFTGPLPVEISQM-----RSLKFLILAHNRFN----GSIPAVYGNMPNLQTLD 419
            L+L  N         + Q        ++ L L +        G + +    +P LQ L 
Sbjct: 60  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 420 LSFNELTGPIPPSIG-----NLTSLLWLMLANNSLSGEIPGEIG----NCTSLLWLNLSN 470
           LS N L       +          L  L L   SLS      +            L +SN
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179

Query: 471 NKLS 474
           N ++
Sbjct: 180 NDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.3 bits (100), Expect = 8e-04
 Identities = 50/352 (14%), Positives = 93/352 (26%), Gaps = 78/352 (22%)

Query: 366 NISRLDLSHNNFTGP-LPVEISQMRSLKFLILAHNRFN----GSIPAVYGNMPNLQTLDL 420
           +I  LD+     +       +  ++  + + L            I +     P L  L+L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 421 SFNELTGPIPPSIGNL-----TSLLWLMLANNSLSGE----IPGEIGNCTSLLWLNLSNN 471
             NEL       +          +  L L N  L+G     +   +    +L  L+    
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH---- 119

Query: 472 KLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILT 531
            LS N       +G             G + +         +             Y  L+
Sbjct: 120 -LSDN------LLGDA-----------GLQLLCEGLLDPQCRLEK------LQLEYCSLS 155

Query: 532 RKSCRSLWDRL---------------LKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG 576
             SC  L   L               +   G+  +C  GL     Q+   L+L    ++ 
Sbjct: 156 AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC-QGLKDSPCQLE-ALKLESCGVTS 213

Query: 577 E----LSPDIGKLQNFSMVHLGFNQFDG---KLPSQFDQLP---LIVLNLTRNNFSGE-- 624
           +    L   +    +   + LG N+               P   L  L +     + +  
Sbjct: 214 DNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC 273

Query: 625 --IPSEFGNIKCLQNLDLSYNNFSGP-----FPASFNNLTELSKLNISYNPL 669
             +       + L+ L L+ N                   +L  L +     
Sbjct: 274 GDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (272), Expect = 2e-24
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS      
Sbjct: 191  FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TG 249

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              P +V +  +     +K+  + + M GG L   +S     +       A ++   L  +
Sbjct: 250  DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H+     +V+RD+K +N+LLD+ G   ++D GLA   S    H      GT GY+APE  
Sbjct: 309  HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 362

Query: 982  QTWQATTKG-DVYSFGVLAMELATGR 1006
            Q   A     D +S G +  +L  G 
Sbjct: 363  QKGVAYDSSADWFSLGCMLFKLLRGH 388

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (262), Expect = 2e-24
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG------EREFRAEMEVLSG 857
            G +   + IGKG F  V     +  GREVA+K + +  L         RE R  M++L+ 
Sbjct: 15   GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI-MKILN- 72

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                  HPN+V L+   ++  + + L+ EY  GG + D +    R+  +        +  
Sbjct: 73   ------HPNIVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            A+ + H +    IVHRD+KA N+LLD +    + DFG +   + G         G   Y 
Sbjct: 126  AVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYA 180

Query: 977  APE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            APE   G+ +    + DV+S GV+   L +G 
Sbjct: 181  APELFQGKKYDG-PEVDVWSLGVILYTLVSGS 211

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (259), Expect = 2e-24
 Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 55/226 (24%)

Query: 811 RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP------ 863
             IGKG +G V       D    A+K L ++ L  +  F                     
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 864 ----------------HPNLVTLYG-WCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWR 905
                           HPN+V L         + + +V+E +  G + ++ +    L+  
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLS-- 135

Query: 906 RRLDIAIDVAR--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
                  D AR         + +LH++    I+HRD+K SN+L+ ++G   + DFG++  
Sbjct: 136 ------EDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKG------DVYSFGV 997
               D+ +S T  GT  ++APE   +   T K       DV++ GV
Sbjct: 187 FKGSDALLSNT-VGTPAFMAPE---SLSETRKIFSGKALDVWAMGV 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (259), Expect = 4e-24
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 28/209 (13%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            +I+G+G F TV         RE A+K L++  +  E +      E +V+S       HP 
Sbjct: 36   KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD----HPF 91

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR--------AL 918
             V LY    D  +      Y + G L   I                   R        AL
Sbjct: 92   FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--------ETCTRFYTAEIVSAL 143

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST-TIAGTVGYVA 977
             +LH +    I+HRD+K  N+LL+++    +TDFG A+V+S         +  GT  YV+
Sbjct: 144  EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGR 1006
            PE      A    D+++ G +  +L  G 
Sbjct: 201  PELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  100 bits (251), Expect = 2e-23
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 42/221 (19%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEG--EREFRAEMEVLS 856
            G +     +G G FG V  G     G +VAVK     K++   + G  +RE +  +++  
Sbjct: 11   GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN-LKLFR 69

Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                   HP+++ LY   +       +V EY+ GG L D I    R+            A
Sbjct: 70   -------HPHIIKLYQ-VISTPTDFFMVMEYVSGGELFDYICKHGRVE--------EMEA 113

Query: 916  R--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            R        A+ + H      +VHRD+K  NVLLD    A + DFGL+ ++S G      
Sbjct: 114  RRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 168

Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            T  G+  Y APE   G+ +    + D++S GV+   L  G 
Sbjct: 169  TSCGSPNYAAPEVISGRLYAG-PEVDIWSCGVILYALLCGT 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 3e-23
 Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 44/226 (19%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG--------EREFRAEMEVL 855
            GK+    ++G+G +G V   +        AVK L+++ L          ++E +  +  L
Sbjct: 5    GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL-LRRL 63

Query: 856  SGNGFGWPHPNLVTLYG-WCLDGSEKI-LVYEYMEGGSLE--DIISDRTRLTWRRRLDIA 911
                    H N++ L      +  +K+ +V EY   G  E  D +         +R  + 
Sbjct: 64   R-------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-------EKRFPV- 108

Query: 912  IDVAR--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV-SAGD 962
               A          L +LH +    IVH+D+K  N+LL   G   ++  G+A  +     
Sbjct: 109  -CQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 963  SHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
                 T  G+  +  PE   G    +  K D++S GV    + TG 
Sbjct: 165  DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.2 bits (248), Expect = 5e-23
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 37/219 (16%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG-----EREFRAEMEVLSGN 858
              +   + +G+G +G V   V       VAVK +  +         ++E     ++L+  
Sbjct: 7    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLN-- 63

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR-- 916
                 H N+V  YG   +G+ + L  EY  GG L D I     +            A+  
Sbjct: 64   -----HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP--------EPDAQRF 110

Query: 917  ------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTI 969
                   +V+LH      I HRD+K  N+LLD+     ++DFGLA V    +   +   +
Sbjct: 111  FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 970  AGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
             GT+ YVAPE    + + A    DV+S G++   +  G 
Sbjct: 168  CGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAGE 205

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  100 bits (250), Expect = 7e-23
 Identities = 56/269 (20%), Positives = 92/269 (34%), Gaps = 72/269 (26%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVL-------- 855
             F   + +G+GGFG V+      D    A+K+++    E  RE    E++ L        
Sbjct: 7    DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 856  -----SGNGFGWPHPNLVTLYGWCLDG--------------------------------- 877
                 +                W  D                                  
Sbjct: 67   VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 878  ----SEKILVY---EYMEGGSLEDIISDRTRLTWRRR---LDIAIDVARALVFLHHECYP 927
                S K+ +Y   +     +L+D ++ R  L  R     L I I +A A+ FLH +   
Sbjct: 127  LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG-- 184

Query: 928  PIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS-----------TTIAGTVGYV 976
             ++HRD+K SN+    +    V DFGL   +   +   +           T   GT  Y+
Sbjct: 185  -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 977  APEYGQTWQATTKGDVYSFGVLAMELATG 1005
            +PE       + K D++S G++  EL   
Sbjct: 244  SPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 99.8 bits (249), Expect = 7e-23
 Identities = 45/352 (12%), Positives = 108/352 (30%), Gaps = 90/352 (25%)

Query: 123 LSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS 182
             +  +   +    + ++  +  + L  +  L      +                    +
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-------------------T 55

Query: 183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKE 242
           +  +            NL  L+L  N    ++                       +  K 
Sbjct: 56  IEGV--------QYLNNLIGLELKDNQIT-DL-----------------------APLKN 83

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
              +   +LS N  + +    ++  +++  L+L     +   P  +  +S L+ L+L  N
Sbjct: 84  LTKITELELSGNP-LKNVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLN 139

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
             ++ I   L  L+ L+ L + +      V  +                       + + 
Sbjct: 140 Q-ITNI-SPLAGLTNLQYLSIGNAQ----VSDL-----------------------TPLA 170

Query: 363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSF 422
            L  ++ L    N  +   P  ++ + +L  + L +N+ +  +  +  N  NL  + L+ 
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS-DVSPL-ANTSNLFIVTLTN 226

Query: 423 NELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
             +T        NL     +   + +     P  I +  +    NL+ N  S
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 43/245 (17%), Positives = 85/245 (34%), Gaps = 41/245 (16%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           +     N++  +    + L  ++ L       + +I   +    +L  L L  N ++   
Sbjct: 24  IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLA 79

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L  L  +  L+LS N +   +S               ++  L            +++ L
Sbjct: 80  PLKNLTKITELELSGNPLK-NVS---------------AIAGLQ-----------SIKTL 112

Query: 204 DLSSNNFRGNIW-NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           DL+S          GL+ L    +  N ++ +   S      +L+   +   + + D   
Sbjct: 113 DLTSTQITDVTPLAGLSNLQVLYLDLNQITNI---SPLAGLTNLQYLSIGNAQ-VSDLTP 168

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
            ++N   L  L    N  S  I   + S+  L  + L  N    V    L N S L ++ 
Sbjct: 169 -LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223

Query: 323 LSSNN 327
           L++  
Sbjct: 224 LTNQT 228

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 56/250 (22%), Positives = 98/250 (39%), Gaps = 16/250 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L L D  I+ D+      LT+++ L+LS N    ++   ++  +S+K L+L+   ++   
Sbjct: 68  LELKDNQIT-DL-APLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVT 123

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L+GL +L++L L +N+I      +       L   ++    ++  +         L  L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAG---LTNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178

Query: 204 DLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
               N     +    L  L+E  +  N +S V   S      +L I  L+    I + P 
Sbjct: 179 KADDNKISDISPLASLPNLIEVHLKNNQISDV---SPLANTSNLFIVTLTNQT-ITNQPV 234

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
             +N  NLVV N+       PI     S +G  A      N  S I       ++     
Sbjct: 235 FYNN--NLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292

Query: 323 LSSNNFGGEV 332
            ++  F G V
Sbjct: 293 NTTVPFSGTV 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 11/69 (15%), Positives = 29/69 (42%), Gaps = 5/69 (7%)

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            + N   +    + +T  +     +L  +  L      ++  I G +    +L+ L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 471 NKLSGNIPP 479
           N+++ ++ P
Sbjct: 73  NQIT-DLAP 80

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 25/107 (23%), Positives = 42/107 (39%), Gaps = 9/107 (8%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L+L  NQ++ +L+P +  L   + + L  N    K  S    L  +  L+LT    +  
Sbjct: 67  GLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD- 121

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +    +  LQ L L  N  +    +    LT L  L+I    +  
Sbjct: 122 -VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 12/132 (9%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           YL +   Q+S +L+P +  L   + +    N+    +      LP LI ++L  N  S  
Sbjct: 155 YLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV 210

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKL-NISYNPLVSGTIPSTGQLA-- 681
             S   N   L  + L+    +       NNL   + +   S  P+   TI   G  A  
Sbjct: 211 --SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASP 268

Query: 682 --TFEKTSYLGD 691
             T+  TS++ +
Sbjct: 269 NLTWNLTSFINN 280

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  103 bits (258), Expect = 7e-23
 Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 52/271 (19%)

Query: 757  QGYLLEGMKYRHDLASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSEDRIIGKG 816
            Q       +Y      +    S + +  ++   L++   T +        F + R++GKG
Sbjct: 143  QELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNT-------FRQYRVLGKG 195

Query: 817  GFGTVYRGVLPDGREV-AVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYG 872
            GFG V    +    ++ A KKL+++ +   +GE     E ++L           +V+L  
Sbjct: 196  GFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN----SRFVVSLA- 250

Query: 873  WCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR--------ALVFLHH 923
            +  +  + + LV   M GG L      +  +    +       A          L  LH 
Sbjct: 251  YAYETKDALCLVLTLMNGGDL------KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE---- 979
            E    IV+RD+K  N+LLD  G   ++D GLA  V  G +       GTVGY+APE    
Sbjct: 305  ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN 359

Query: 980  --YGQT--WQATTKGDVYSFGVLAMELATGR 1006
              Y  +  W        ++ G L  E+  G+
Sbjct: 360  ERYTFSPDW--------WALGCLLYEMIAGQ 382

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.8 bits (249), Expect = 8e-23
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG------------EREFRAE 851
            K+S    +G G FG V+  V     +EV VK +++E +                E    
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI- 82

Query: 852 MEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE-YMEGGSLEDIISDRTRLTWRRRLDI 910
           +  +        H N++ +     +     LV E +  G  L   I    RL       I
Sbjct: 83  LSRVE-------HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135

Query: 911 AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
              +  A+ +L  +    I+HRD+K  N+++ ++    + DFG A  +  G   +  T  
Sbjct: 136 FRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFC 190

Query: 971 GTVGYVAPE--YGQTWQATTKGDVYSFGVL 998
           GT+ Y APE   G  ++   + +++S GV 
Sbjct: 191 GTIEYCAPEVLMGNPYRG-PELEMWSLGVT 219

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 37/219 (16%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG-----EREFRAEMEVLSGN 858
              +   + +G+G +G V   V       VAVK +  +         ++E     ++L+  
Sbjct: 7    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLN-- 63

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR-- 916
                 H N+V  YG   +G+ + L  EY  GG L D I     +            A+  
Sbjct: 64   -----HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP--------EPDAQRF 110

Query: 917  ------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTI 969
                   +V+LH      I HRD+K  N+LLD+     ++DFGLA V    +   +   +
Sbjct: 111  FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 970  AGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
             GT+ YVAPE    + + A    DV+S G++   +  G 
Sbjct: 168  CGTLPYVAPELLKRREFHA-EPVDVWSCGIVLTAMLAGE 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.6 bits (246), Expect = 6e-22
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 50/225 (22%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
             ++  ++IG G FG V++  L +  EVA+KK+ ++     RE +  M ++        HP
Sbjct: 41   AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI-MRIVK-------HP 92

Query: 866  NLVTLYGWCLDGSEKI------LVYEYMEGGSLEDIISDRTRLTWRRRLDIAID------ 913
            N+V L  +     +K       LV EY+   ++        R   + +  + +       
Sbjct: 93   NVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRAS----RHYAKLKQTMPMLLIKLYM 147

Query: 914  --VARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIA 970
              + R+L ++H      I HRD+K  N+LLD     L + DFG A+++ AG+ +VS    
Sbjct: 148  YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---- 200

Query: 971  GTVGYV------APE--YGQTWQATTKGDVYSFG-VLAMELATGR 1006
                Y+      APE  +G T   TT  D++S G V+A EL  G+
Sbjct: 201  ----YICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMA-ELMQGQ 239

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 36/184 (19%), Positives = 72/184 (39%), Gaps = 15/184 (8%)

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI--FGRFTQVKILALHSNS 351
                LG++   S    +   ++ L  + L++ N    V  +        +K L +++  
Sbjct: 25  YLNGLLGQS---STANITEAQMNSLTYITLANIN----VTDLTGIEYAHNIKDLTINNIH 77

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
             +    + I  L N+ RL +   + T      +S + SL  L ++H+  + SI      
Sbjct: 78  ATN---YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           +P + ++DLS+N     I P +  L  L  L +  + +       I +   L  L   + 
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

Query: 472 KLSG 475
            + G
Sbjct: 192 TIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 25/184 (13%), Positives = 71/184 (38%), Gaps = 14/184 (7%)

Query: 271 VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG 330
            +  L G + +  I      ++ L  + L   N   +    +     ++ L +++ +   
Sbjct: 25  YLNGLLGQSSTANI--TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH--- 77

Query: 331 EVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
                      + ++ L +     +       +  L +++ LD+SH+     +  +I+ +
Sbjct: 78  -ATNYNPISGLSNLERLRIMGKD-VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
             +  + L++N     I  +   +P L++L++ F+ +       I +   L  L   + +
Sbjct: 136 PKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 449 LSGE 452
           + G+
Sbjct: 193 IGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 24/119 (20%), Positives = 53/119 (44%), Gaps = 4/119 (3%)

Query: 361 ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
             ++ +++ + L++ N T      I    ++K L + +       P     + NL+ L +
Sbjct: 40  EAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
              ++T    P++  LTSL  L +++++    I  +I     +  ++LS N    +I P
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 43/258 (16%), Positives = 80/258 (31%), Gaps = 81/258 (31%)

Query: 76  PDKARVNGLNLT-DWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL 134
           PD      LN     + + +I    + +  L+Y+ L+    +  +   +    ++K L +
Sbjct: 18  PDSTFKAYLNGLLGQSSTANI--TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTI 73

Query: 135 SHNILSGDLNLSGLRSLEILDLSVNRIHGE-ISFSFPAICEKLVVANLSLNNLTGRIDTC 193
           ++   +    +SGL +LE L +    +  + I                +L+ LT      
Sbjct: 74  NNIHATNYNPISGLSNLERLRIMGKDVTSDKIP---------------NLSGLT------ 112

Query: 194 FDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSE 253
                +L  LD+S +    +I   +  L                        +   DLS 
Sbjct: 113 -----SLTLLDISHSAHDDSILTKINTLP----------------------KVNSIDLSY 145

Query: 254 NEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL 313
           N  I D    +     L  LN+  +         +    G+E                  
Sbjct: 146 NGAITDIMP-LKTLPELKSLNIQFDG--------VHDYRGIE------------------ 178

Query: 314 NLSKLEVLDLSSNNFGGE 331
           +  KL  L   S   GG+
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 26/181 (14%), Positives = 64/181 (35%), Gaps = 30/181 (16%)

Query: 199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
           +L Y+ L++ N   ++  G+                          +++   ++      
Sbjct: 45  SLTYITLANINVT-DL-TGIEYAH----------------------NIKDLTINNIH-AT 79

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL 318
           ++   +S   NL  L + G + +      +  ++ L  L +  +     I   +  L K+
Sbjct: 80  NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138

Query: 319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT 378
             +DLS N    ++  +     ++K L +  +  +   +  GI   P +++L        
Sbjct: 139 NSIDLSYNGAITDIMPL-KTLPELKSLNIQFDG-VH--DYRGIEDFPKLNQLYAFSQTIG 194

Query: 379 G 379
           G
Sbjct: 195 G 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 21/117 (17%), Positives = 47/117 (40%), Gaps = 7/117 (5%)

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
                   L  ++      +  +QM SL ++ LA+      +  +     N++ L ++  
Sbjct: 22  FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTGI-EYAHNIKDLTINNI 76

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
             T   P  I  L++L  L +    ++ +    +   TSL  L++S++    +I  +
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 14/105 (13%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L++ G  ++ +  P++  L + +++ +  +  D  + ++ + LP +  ++L+ N    +
Sbjct: 92  RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           I      +  L++L++ ++           +  +L++L      +
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 17/107 (15%), Positives = 42/107 (39%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
           Y+ L+   ++ +L+  I    N   + +          +    L  L  L +   + + +
Sbjct: 48  YITLANINVT-DLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSD 103

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                  +  L  LD+S++          N L +++ +++SYN  ++
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 20/107 (18%), Positives = 40/107 (37%), Gaps = 4/107 (3%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L ++    +   +P I  L N   + +               L  L +L+++ +     
Sbjct: 70  DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           I ++   +  + ++DLSYN            L EL  LNI ++ +  
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHD 173

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 13/91 (14%), Positives = 32/91 (35%), Gaps = 4/91 (4%)

Query: 390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSL 449
           + K  +      + +       M +L  + L+   +T  +   I    ++  L + N   
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHA 78

Query: 450 SGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           +   P  I   ++L  L +    ++ +  P 
Sbjct: 79  TNYNP--ISGLSNLERLRIMGKDVTSDKIPN 107

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 10/70 (14%), Positives = 27/70 (38%), Gaps = 2/70 (2%)

Query: 611 LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
           +  L +   + +    +    +  L+ L +   + +     + + LT L+ L+IS++   
Sbjct: 68  IKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125

Query: 671 SGTIPSTGQL 680
              +     L
Sbjct: 126 DSILTKINTL 135

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  100 bits (251), Expect = 6e-22
 Identities = 43/301 (14%), Positives = 95/301 (31%), Gaps = 19/301 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
                  I   IF    A  +    +L + + + ++    +   S+  +  +++ +    
Sbjct: 4   TITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ 59

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            +  L ++  L L+ N++            + L    L  N +   + +       L+ L
Sbjct: 60  GIQYLPNVTKLFLNGNKL---TDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSL 114

Query: 204 DLSSNNFR--GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
            L  N       + + L QL    +  N ++ +   +V      L+   L +N+ I D  
Sbjct: 115 SLEHNGISDINGLVH-LPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQ-ISDIV 169

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
             ++    L  L L  N+ S      +  +  L+ L L     L+       NL     +
Sbjct: 170 P-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

Query: 322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPL 381
             +  +             +   +  H   + + ++      +         H   T PL
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286

Query: 382 P 382
            
Sbjct: 287 K 287

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  100 bits (249), Expect = 1e-21
 Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 36/266 (13%)

Query: 217 GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLF 276
             A+ ++ ++ +  ++  V+ +      S++    + ++ I    G +    N+  L L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQNELN---SIDQIIANNSD-IKSVQG-IQYLPNVTKLFLN 73

Query: 277 GNNFSGPIPAEIGSISG------LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG 330
           GN         +  I        L  LFL +N  +  +  SL +L KL+ L L  N    
Sbjct: 74  GNK--------LTDIKPLTNLKNLGWLFLDENK-IKDL-SSLKDLKKLKSLSLEHNG--- 120

Query: 331 EVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
            +  I       Q++ L L +N  I  +  + + +L  +  L L  N  +  +P  ++ +
Sbjct: 121 -ISDINGLVHLPQLESLYLGNNK-ITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGL 174

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
             L+ L L+ N  +  + A+   + NL  L+L   E          NL     +   + S
Sbjct: 175 TKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232

Query: 449 LSGEIPGEIGNCTSLLWLNLSNNKLS 474
           L    P  I +       N+  +   
Sbjct: 233 L--VTPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.0 bits (233), Expect = 8e-20
 Identities = 41/216 (18%), Positives = 81/216 (37%), Gaps = 21/216 (9%)

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
                 +  NL   + +  +      ++ ++ +    ++  SV  + +  L  +  L L+
Sbjct: 18  DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 73

Query: 325 SNNFGGEVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP 382
            N     +  I        +  L L  N  I  +  S +  L  +  L L HN  +    
Sbjct: 74  GNK----LTDIKPLTNLKNLGWLFLDENK-IKDL--SSLKDLKKLKSLSLEHNGISDING 126

Query: 383 VEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL 442
             +  +  L+ L L +N+    I  +   +  L TL L  N+++  I P +  LT L  L
Sbjct: 127 --LVHLPQLESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNL 180

Query: 443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
            L+ N +S ++   +    +L  L L + +      
Sbjct: 181 YLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPI 214

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 49/258 (18%), Positives = 85/258 (32%), Gaps = 12/258 (4%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L L +  I  D+ ++   L +L  L L  N  S  I + L     L+ L L +N ++   
Sbjct: 92  LFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDIT 147

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID-TCFDGCLNLRY 202
            LS L  L+ L L  N+I         A   KL    LS N+++   D     G  NL  
Sbjct: 148 VLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDV 201

Query: 203 LDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           L+L S        N  + LV  +  +N    +V+  +  ++   E  ++  +        
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH-LPEFTNE 260

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
                   V +      F G +   +  +  +     G      V   + +   K     
Sbjct: 261 VSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQ 320

Query: 323 LSSNNFGGEVQKIFGRFT 340
                     +     + 
Sbjct: 321 GYVFKGWYTEKNGGHEWN 338

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 23/126 (18%), Positives = 46/126 (36%), Gaps = 8/126 (6%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            L L  N+++ +++  + +L     + L  NQ    +      L  L  L L++N+ S +
Sbjct: 135 SLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-D 189

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKL-NISYNPLVSGTIPSTGQLATF 683
           +      +K L  L+L             +NL   + + N   + +    I   G     
Sbjct: 190 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248

Query: 684 EKTSYL 689
               +L
Sbjct: 249 NVKWHL 254

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.1 bits (245), Expect = 6e-22
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 47/231 (20%)

Query: 802  KATGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF 860
            K   +F  +R+ G+G FGTV  G     G  VA+KK+ ++     RE +  M+ L+    
Sbjct: 20   KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAV--- 75

Query: 861  GWPHPNLVTLYGWCLDGSEK-------ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
               HPN+V L  +     E+        +V EY+   +L        R  +RR++     
Sbjct: 76   -LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC----RNYYRRQVAPPPI 129

Query: 914  --------VARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSH 964
                    + R++  LH      + HRD+K  NVL+++    L + DFG A+ +S  + +
Sbjct: 130  LIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 965  VSTTIAGTVGYV------APE--YGQTWQATTKGDVYSFG-VLAMELATGR 1006
            V+        Y+      APE  +G     TT  D++S G + A E+  G 
Sbjct: 189  VA--------YICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFA-EMMLGE 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (250), Expect = 7e-22
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREV-AVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            F + R++G+GGFG V+   +    ++ A KKL ++ L   +G +    E ++L+      
Sbjct: 187  FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--- 243

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSL----EDIISDRTRLTWRRRLDIAIDVARA 917
                +V+L  +  +    + LV   M GG +     ++  D       R +     +   
Sbjct: 244  -SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L  LH      I++RD+K  NVLLD +G   ++D GLA  + AG +  +   AGT G++A
Sbjct: 302  LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMA 357

Query: 978  PE------YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            PE      Y  +  +        ++ GV   E+   R
Sbjct: 358  PELLLGEEYDFSVDY--------FALGVTLYEMIAAR 386

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 97.8 bits (244), Expect = 1e-21
 Identities = 57/212 (26%), Positives = 85/212 (40%), Gaps = 32/212 (15%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G FG V        R+V A+K L +  +    +   F  E ++++        P 
Sbjct: 75   KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----SPW 130

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR--------AL 918
            +V L+    D     +V EYM GG L         +      D+    AR        AL
Sbjct: 131  VVQLFYAFQDDRYLYMVMEYMPGGDL---------VNLMSNYDVPEKWARFYTAEVVLAL 181

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
              +H       +HRDVK  N+LLDK G   + DFG    ++        T  GT  Y++P
Sbjct: 182  DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

Query: 979  E----YGQTWQATTKGDVYSFGVLAMELATGR 1006
            E     G       + D +S GV   E+  G 
Sbjct: 239  EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 98.7 bits (246), Expect = 1e-21
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 42/221 (19%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEG--EREFRAEMEVLS 856
            G +     +G G FG V  G     G +VAVK     K++   + G   RE +  +++  
Sbjct: 16   GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN-LKLFR 74

Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                   HP+++ LY   +     I +V EY+ GG L D I    RL            +
Sbjct: 75   -------HPHIIKLYQ-VISTPSDIFMVMEYVSGGELFDYICKNGRLD--------EKES 118

Query: 916  R--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            R         + + H      +VHRD+K  NVLLD    A + DFGL+ ++S G      
Sbjct: 119  RRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 173

Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            T  G+  Y APE   G+ +    + D++S GV+   L  G 
Sbjct: 174  TSCGSPNYAAPEVISGRLYAG-PEVDIWSSGVILYALLCGT 213

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 35/215 (16%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G FG V    L +  +V A+K L +  +    E   FR E +VL           
Sbjct: 80   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD----SKW 135

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD--IAIDVAR-------- 916
            + TL+    D +   LV +Y  GG L         LT   + +  +  ++AR        
Sbjct: 136  ITTLHYAFQDDNNLYLVMDYYVGGDL---------LTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYV 976
            A+  +H       VHRD+K  N+L+D  G   + DFG    +    +  S+   GT  Y+
Sbjct: 187  AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 977  APEYGQTWQATTKG-----DVYSFGVLAMELATGR 1006
            +PE  Q  +          D +S GV   E+  G 
Sbjct: 244  SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.8 bits (239), Expect = 3e-21
 Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 47/264 (17%)

Query: 771  ASSSGGSSPWLSDTVKVIRLDKTAFTYSDILKATGKFSED-----RIIGKGGFGTVY--- 822
            +  + G+S    D  + +   K     +++     K   +     +++G G +G V+   
Sbjct: 15   SGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR 74

Query: 823  RGVLPDGREV-AVKKLQREGLEGEREF----RAEMEVLSGNGFGWPHPNLVTLYGWCLDG 877
            +    D  ++ A+K L++  +  + +     R E +VL         P LVTL+ +    
Sbjct: 75   KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI---RQSPFLVTLH-YAFQT 130

Query: 878  SEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR--------ALVFLHHECYPP 928
              K+ L+ +Y+ GG L       T L+ R R        +        AL  LH      
Sbjct: 131  ETKLHLILDYINGGEL------FTHLSQRERFTE--HEVQIYVGEIVLALEHLHKL---G 179

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------YGQ 982
            I++RD+K  N+LLD  G  ++TDFGL++   A ++  +    GT+ Y+AP+       G 
Sbjct: 180  IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239

Query: 983  TWQATTKGDVYSFGVLAMELATGR 1006
                    D +S GVL  EL TG 
Sbjct: 240  DKAV----DWWSLGVLMYELLTGA 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 5e-21
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK-----KLQREGLEG--EREFRAEMEVLS 856
            G +     +G+G FG V         ++VA+K      L++  +    ERE    +++L 
Sbjct: 9    GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY-LKLLR 67

Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                   HP+++ LY   +     I +V EY  GG L D I ++ R+T         D  
Sbjct: 68   -------HPHIIKLYD-VITTPTDIVMVIEYA-GGELFDYIVEKKRMT--------EDEG 110

Query: 916  R--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
            R        A+ + H      IVHRD+K  N+LLD      + DFGL+ +++ G  +   
Sbjct: 111  RRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLK 165

Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            T  G+  Y APE   G+ +    + DV+S G++   +  GR
Sbjct: 166  TSCGSPNYAAPEVINGKLYAG-PEVDVWSCGIVLYVMLVGR 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 51/226 (22%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
             +++ ++IG G FG VY+  L   G  VA+KK+ ++     RE +  M  L        H
Sbjct: 55   SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI-MRKLD-------H 106

Query: 865  PNLVTLYGWCLDGSEKI------LVYEYMEGGSLEDIISDRTRLTWRRRLDIAID----- 913
             N+V L  +     EK       LV +Y+   ++  +     R   R +  + +      
Sbjct: 107  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLY 161

Query: 914  ---VARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTI 969
               + R+L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS   
Sbjct: 162  MYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--- 215

Query: 970  AGTVGYV------APE--YGQTWQATTKGDVYSFG-VLAMELATGR 1006
                 Y+      APE  +G T   T+  DV+S G VLA EL  G+
Sbjct: 216  -----YICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLA-ELLLGQ 254

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 39/218 (17%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGERE---FRAEMEVLSGNGFGWPHPN 866
            ++IG+G F  V    +    +V A+K + +  +    E   FR E +VL           
Sbjct: 67   KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD----RRW 122

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAI--DVAR------- 916
            +  L+ +       + LV EY  GG L         LT   +    I  ++AR       
Sbjct: 123  ITQLH-FAFQDENYLYLVMEYYVGGDL---------LTLLSKFGERIPAEMARFYLAEIV 172

Query: 917  -ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             A+  +H       VHRD+K  N+LLD+ G   + DFG    + A  +  S    GT  Y
Sbjct: 173  MAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 976  VAPEYGQTWQATTKGDVY-------SFGVLAMELATGR 1006
            ++PE  Q          Y       + GV A E+  G+
Sbjct: 230  LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 45/287 (15%), Positives = 94/287 (32%), Gaps = 44/287 (15%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEI 153
            IF+   A  +    +L + + + ++    +   S+  +  +++ +     +  L ++  
Sbjct: 16  QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTK 72

Query: 154 LDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN 213
           L L+ N++         A  + L    L  N +   + +       L+ L L  N    +
Sbjct: 73  LFLNGNKL---TDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-D 126

Query: 214 IWN--GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV 271
           I     L QL    +  N ++ +   +V      L+   L +N+ I D    ++    L 
Sbjct: 127 INGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQ-ISDIVP-LAGLTKLQ 181

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
            L L  N+        I  +  L                    L  L+VL+L S     +
Sbjct: 182 NLYLSKNH--------ISDLRALA------------------GLKNLDVLELFSQECLNK 215

Query: 332 VQKIFGRFTQVKILALHSNSYI--DGMNSSGILKLPNISRLDLSHNN 376
                        +     S +  + ++  G  + PN+        N
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 262

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 50/263 (19%), Positives = 100/263 (38%), Gaps = 21/263 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
            NL   +++  +    + L  +  +  + +    S+   +    ++  L L+ N L+   
Sbjct: 29  DNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIK 84

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L+ L++L  L L  N++      S     +KL   +L  N ++  I+        L  L
Sbjct: 85  PLANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 139

Query: 204 DLSSNNFRGNIWN--GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
            L +N    +I     L +L   S+ +N +S +           L+   LS+N  I D  
Sbjct: 140 YLGNNKIT-DITVLSRLTKLDTLSLEDNQISDI---VPLAGLTKLQNLYLSKNH-ISDLR 194

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
             ++  +NL VL LF             ++     +     + ++  PE + +    E  
Sbjct: 195 A-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKP 251

Query: 322 DLSSNN--FGGEVQKIFGRFTQV 342
           ++  +   F  EV  IF +   +
Sbjct: 252 NVKWHLPEFTNEVSFIFYQPVTI 274

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 52/268 (19%), Positives = 100/268 (37%), Gaps = 36/268 (13%)

Query: 217 GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLF 276
             A+ ++ ++ +  ++  V+ +      S++    + ++ I    G +    N+  L L 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNELN---SIDQIIANNSD-IKSVQG-IQYLPNVTKLFLN 76

Query: 277 GNNFSGPIPAEIGSISG------LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGG 330
           GN         +  I        L  LFL +N    +   SL +L KL+ L L  N    
Sbjct: 77  GNK--------LTDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNG--- 123

Query: 331 EVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
            +  I       Q++ L L +N  I  +  + + +L  +  L L  N  +  +P  ++ +
Sbjct: 124 -ISDINGLVHLPQLESLYLGNN-KITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGL 177

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
             L+ L L+ N  +  + A+   + NL  L+L   E          NL     +   + S
Sbjct: 178 TKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 449 LSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           L    P  I +       N+  +     
Sbjct: 236 LVT--PEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 39/186 (20%), Positives = 82/186 (44%), Gaps = 15/186 (8%)

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYI 353
           L +  +     +  I  S    ++    +L   +    V         +  +  +++   
Sbjct: 3   LGSETITVPTPIKQI-FSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK 59

Query: 354 DGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMP 413
                 GI  LPN+++L L+ N  T   P  ++ +++L +L L  N+    + ++  ++ 
Sbjct: 60  S---VQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSSL-KDLK 112

Query: 414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
            L++L L  N ++  I   + +L  L  L L NN ++ +I   +   T L  L+L +N++
Sbjct: 113 KLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 168

Query: 474 SGNIPP 479
           S +I P
Sbjct: 169 S-DIVP 173

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 57/218 (26%), Positives = 81/218 (37%), Gaps = 44/218 (20%)

Query: 799 DILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFR--AEMEVL 855
            I+  + ++   + IG G FG             VAVK ++R     E   R       L
Sbjct: 14  PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL 73

Query: 856 SGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                   HPN+V      L  +   ++ EY  GG L + I +  R +         D A
Sbjct: 74  R-------HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS--------EDEA 118

Query: 916 R--------ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL--VTDFGLARVVSAGDSHV 965
           R         + + H      I HRD+K  N LLD        + DFG ++  S   S  
Sbjct: 119 RFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP 174

Query: 966 STTIAGTVGYVAPE------YGQTWQATTKGDVYSFGV 997
            +T+ GT  Y+APE      Y          DV+S GV
Sbjct: 175 KSTV-GTPAYIAPEVLLRQEY-----DGKIADVWSCGV 206

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 3e-20
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 27/206 (13%)

Query: 811  RIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            + +G G FG V        G   A+K L ++ +   ++      E  +L         P 
Sbjct: 47   KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN----FPF 102

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            LV L     D S   +V EY+ GG +   +    R +       A  +     +LH    
Sbjct: 103  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD- 161

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------Y 980
              +++RD+K  N+L+D++G   VTDFG A+ V       + T+ GT   +APE      Y
Sbjct: 162  --LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILSKGY 215

Query: 981  GQTWQATTKGDVYSFGVLAMELATGR 1006
             +        D ++ GVL  E+A G 
Sbjct: 216  NKAV------DWWALGVLIYEMAAGY 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 36/227 (15%), Positives = 82/227 (36%), Gaps = 20/227 (8%)

Query: 267 CRNLVVLNLFGNNFSGPIPAEIGSI-SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
           C       +   +        I S+    + L L + +  ++   +  NL  +  + +S 
Sbjct: 10  CHQEEDFRVTCKDIQ-----RIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 326 NNFGGEVQKI----FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG-P 380
           +     +Q++    F   ++V  + + +   +  ++   + +LP +  L + +      P
Sbjct: 65  DV---TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121

Query: 381 LPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPN-LQTLDLSFNELTGPIPPSIGNLTS 438
              ++        L +  N +  SIP   +  + N   TL L  N  T  +     N T 
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK 180

Query: 439 LLWLMLANNSLSGEIPGEI--GNCTSLLWLNLSNNKLSGNIPPEVMT 483
           L  + L  N     I  +   G  +    L++S   ++  +P + + 
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 31/235 (13%), Positives = 69/235 (29%), Gaps = 37/235 (15%)

Query: 100 SALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILD 155
           S       L L       +IP    S+  ++  + +S ++    L       L  +  ++
Sbjct: 28  SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---- 211
           +   R                     +L  +             L++L + +   +    
Sbjct: 87  IRNTR---------------------NLTYIDPDA---LKELPLLKFLGIFNTGLKMFPD 122

Query: 212 GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLSENEFIGDFPGEVSNCRNL 270
                         +++N     +  + F+  C+      L  N       G   N   L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG-FTSVQGYAFNGTKL 181

Query: 271 VVLNLFGNNFSGPIPAEI--GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
             + L  N +   I  +   G  SG   L + + +  ++  + L +L +L   + 
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 22/120 (18%), Positives = 43/120 (35%), Gaps = 11/120 (9%)

Query: 566 YLQLSGNQLSGELSPD--IGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP--LIVLNLTRNN 620
           +L +    L         +     F ++ +  N +   +P   F  L    + L L  N 
Sbjct: 109 FLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167

Query: 621 FSGEIPSEFGNIKCLQNLDLSYNNFSGPFPA-SFNNLTE-LSKLNISYNPLVSGTIPSTG 678
           F+  +     N   L  + L+ N +       +F  +    S L++S   + +  +PS G
Sbjct: 168 FT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA--LPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 5/101 (4%)

Query: 592 HLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNF-SGP 648
            L            F  LP +  + ++ +    ++ S  F N+  + ++++      +  
Sbjct: 37  KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96

Query: 649 FPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYL 689
            P +   L  L  L I    L     P   ++ + +    L
Sbjct: 97  DPDALKELPLLKFLGIFNTGLKM--FPDLTKVYSTDIFFIL 135

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.1 bits (227), Expect = 7e-20
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 34/212 (16%)

Query: 811  RIIGKGGFGTVY----RGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPH 864
            +++G+G FG V+           +  A+K L++  L        + E ++L        H
Sbjct: 30   KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN----H 85

Query: 865  PNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRR-RLDIAIDVARALVFLH 922
            P +V L+ +      K+ L+ +++ GG L   +S     T    +  +A ++A AL  LH
Sbjct: 86   PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH 143

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--- 979
                  I++RD+K  N+LLD+EG   +TDFGL++  S      + +  GTV Y+APE   
Sbjct: 144  SLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 980  ---YGQT--WQATTKGDVYSFGVLAMELATGR 1006
               + Q+  W        +SFGVL  E+ TG 
Sbjct: 200  RRGHTQSADW--------WSFGVLMFEMLTGT 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.9 bits (231), Expect = 7e-20
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            +++GKG FG V            A+K L++E +  + E      E  VL  +     HP 
Sbjct: 154  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR----HPF 209

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L  +     +++  V EY  GG L   +S     +  R      ++  AL +LH E 
Sbjct: 210  LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE      
Sbjct: 269  --NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG+   W        +  GV+  E+  GR
Sbjct: 326  YGRAVDW--------WGLGVVMYEMMCGR 346

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 45/308 (14%), Positives = 82/308 (26%), Gaps = 66/308 (21%)

Query: 74  CSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLN 133
           CS          +T+  I  D+  N         L               S    L+ + 
Sbjct: 9   CSNRVFLCQESKVTE--IPSDLPRN------AIELRFVLTKLRVIQKGAFSGFGDLEKIE 60

Query: 134 LSHNILSGDLN---LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI 190
           +S N +   +     S L  L  + +                           NNL    
Sbjct: 61  ISQNDVLEVIEADVFSNLPKLHEIRIEKA------------------------NNLLYIN 96

Query: 191 DTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFD 250
              F    NL+YL +S+   +                       +       +    + D
Sbjct: 97  PEAFQNLPNLQYLLISNTGIK----------------------HLPDVHKIHSLQKVLLD 134

Query: 251 LSENEFIGDFPGEVSN--CRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI 308
           + +N  I               V+L L  N     I     + + L+ L L  NN L  +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 309 PE-SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
           P       S   +LD+S                +++  + ++   +  +      KL  +
Sbjct: 194 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLE-----KLVAL 248

Query: 368 SRLDLSHN 375
               L++ 
Sbjct: 249 MEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 1e-17
 Identities = 38/232 (16%), Positives = 76/232 (32%), Gaps = 11/232 (4%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNN 303
           +         +      G  S   +L  + +  N+    I A++  ++  L  + + K N
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 304 FLSVIPESLL-NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
            L  I      NL  L+ L +S+               Q  +L +  N  I  +  +  +
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 363 KLPNISR-LDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
            L   S  L L+ N     +     +  +  +  +  +N        V+        LD+
Sbjct: 151 GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209

Query: 421 SFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           S   +   +P     NL  L      N     ++P  +    +L+  +L+  
Sbjct: 210 SRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 82.6 bits (204), Expect = 7e-17
 Identities = 36/203 (17%), Positives = 76/203 (37%), Gaps = 10/203 (4%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK-IFGRFTQV 342
           IP+++        L         +   +      LE +++S N+    ++  +F    ++
Sbjct: 24  IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 343 KILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN 402
             + +   + +  +N      LPN+  L +S+        V          L +  N   
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 403 GSIP--AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL-MLANNSLSGEIPGEI-G 458
            +I   +  G       L L+ N +   I  S  N T L  L +  NN+L  E+P ++  
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFH 199

Query: 459 NCTSLLWLNLSNNKLSGNIPPEV 481
             +  + L++S  ++  ++P   
Sbjct: 200 GASGPVILDISRTRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 82.2 bits (203), Expect = 9e-17
 Identities = 56/349 (16%), Positives = 95/349 (27%), Gaps = 113/349 (32%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEI 165
                +  +  IP DL   R+   L      L        SG   LE +++S N +   I
Sbjct: 14  FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 166 SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFS 225
                                       F     L  + +   N           L+   
Sbjct: 71  EAD------------------------VFSNLPKLHEIRIEKAN----------NLLY-- 94

Query: 226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPI 284
                    ++   F+   +L+   +S    I   P     +    V+L++  N     I
Sbjct: 95  ---------INPEAFQNLPNLQYLLISNTG-IKHLPDVHKIHSLQKVLLDIQDNINIHTI 144

Query: 285 PAEIGSISGL----EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
                S  GL      L+L KN  +  I  S  N ++L+ L+LS NN             
Sbjct: 145 ER--NSFVGLSFESVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNN------------- 188

Query: 341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR 400
              +  L ++                   LD+S                           
Sbjct: 189 --NLEELPNDV---------FHGASGPVILDISRTRIH---------------------- 215

Query: 401 FNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS 448
              S+P+    N+  L+       +      P++  L +L+   L   S
Sbjct: 216 ---SLPSYGLENLKKLRARSTYNLKKL----PTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 44/270 (16%), Positives = 83/270 (30%), Gaps = 58/270 (21%)

Query: 413 PNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSN 470
            N   L     +L   I          L  + ++ N +   I  ++  N   L  + +  
Sbjct: 30  RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 471 -NKLSGNIPPEVMTIGRNARPTFEANQR--------NGERTIAGSSECLSMKRWIPADYP 521
            N L   I PE           F+             G + +                 P
Sbjct: 89  ANNLL-YINPEA----------FQNLPNLQYLLISNTGIKHL-----------------P 120

Query: 522 PFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPD 581
               ++    +K    + D  +    I      GL+  +      L L+ N +  E+   
Sbjct: 121 DVHKIH--SLQKVLLDIQD-NINIHTIERNSFVGLSFESV----ILWLNKNGIQ-EIHNS 172

Query: 582 I-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQN 637
                Q   +     N  + +LP+  F      ++L+++R      +PS    N+K L+ 
Sbjct: 173 AFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 230

Query: 638 LDLSYNNFSGPFPASFNNLTELSKLNISYN 667
               YN    P   +   L  L + +++Y 
Sbjct: 231 RST-YNLKKLP---TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.5 bits (139), Expect = 8e-09
 Identities = 46/257 (17%), Positives = 81/257 (31%), Gaps = 33/257 (12%)

Query: 414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           + +      +++T  IP  +    + + L      L     G       L  + +S N +
Sbjct: 10  SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 474 SGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRK 533
              I  +V          F    +  E  I  ++  L +         P +F       +
Sbjct: 67  LEVIEADV----------FSNLPKLHEIRIEKANNLLYI--------NPEAF-------Q 101

Query: 534 SCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI--GKLQNFSMV 591
           +  +L   L+  TGI    LP +          L +  N     +  +   G      ++
Sbjct: 102 NLPNLQYLLISNTGI--KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159

Query: 592 HLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFP 650
            L  N       S F+   L  LNL+ NN   E+P++ F        LD+S         
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219

Query: 651 ASFNNLTELSKLNISYN 667
               NL +L   +    
Sbjct: 220 YGLENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 5/109 (4%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNN 620
              L+    +L   +         +   + +  N     + +  F  LP L  + + + N
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 621 FSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
               I  E F N+  LQ L +S             +  +   L+I  N 
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 7/111 (6%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP--LIVLNLTRNNF 621
           YL +S   +   L            ++ +  N     +    F  L    ++L L +N  
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             EI +  F   +  +      NN        F+  +    L+IS   + S
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 92.5 bits (229), Expect = 2e-19
 Identities = 71/400 (17%), Positives = 125/400 (31%), Gaps = 26/400 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY-LNLSHNILSGD 142
           L  TD  I+ +  N  S+    S L    +    S P        L   L L  N    D
Sbjct: 164 LAFTDSLITRNFSNY-SSWHYRSCLLPQLHPQPDSGPQGRLPENVLLKELELVQNAFFTD 222

Query: 143 LN-------LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFD 195
            N          L  L   +         +S     +           + +   +    +
Sbjct: 223 PNDQSAWFYHRWL--LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDE 280

Query: 196 GCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE 255
             L++ +      N   ++W     L   S+++ +            +   E   L +  
Sbjct: 281 APLSVEWRTPDGRNRPSHVWL--CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDR- 337

Query: 256 FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL 315
               +  + +    L    L     S  + +E+ S   L+ L       L  I   +  L
Sbjct: 338 -PECWCRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRAL 395

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
             L     +   F         R   +  L          +     ++  ++  L L+H 
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL----KMEYADVRVLHLAHK 451

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
           + T  +   + Q+  +  L L+HNR   ++P     +  L+ L  S N L   +   + N
Sbjct: 452 DLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VAN 506

Query: 436 LTSLLWLMLANNSLSG-EIPGEIGNCTSLLWLNLSNNKLS 474
           L  L  L+L NN L        + +C  L+ LNL  N L 
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 7/158 (4%)

Query: 30  DSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDW 89
           D L  ++E L    +       V+       +   S       +   + A V  L+L   
Sbjct: 396 DPLLYEKETLQYFSTLKA----VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLR 149
           +++  +  +   L  +++LDLS N    ++P  L++ R L+ L  S N L     ++ L 
Sbjct: 452 DLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLP 508

Query: 150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLT 187
            L+ L L  NR+    +      C +LV+ NL  N+L 
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 2e-13
 Identities = 55/377 (14%), Positives = 117/377 (31%), Gaps = 41/377 (10%)

Query: 51  PVNE--GHYMQW--NQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLS 106
           P ++    Y +W   ++        +  S ++A ++ +  +     G        +   +
Sbjct: 223 PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLS-VCFSRPLTVGSRMGTLLLMVDEA 281

Query: 107 YLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEIS 166
            L +   T  G           L   +L+  +      +    S    +  + +   E  
Sbjct: 282 PLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW 341

Query: 167 FSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSV 226
               A  E+L    LS+   T  + +  + C  L+ L+  +      I   +  L     
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 227 SENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA 286
            +  L    +     +       D   ++F+ +         ++ VL+L   + +  +  
Sbjct: 401 EKETLQYFSTLKAV-DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLC 457

Query: 287 EIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILA 346
            +  +  +  L L  +N L  +P +L  L  LEVL  S N                 +  
Sbjct: 458 HLEQLLLVTHLDLS-HNRLRALPPALAALRCLEVLQASDN----------------ALEN 500

Query: 347 LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG-PLPVEISQMRSLKFLILAHNRF---N 402
           +            G+  LP +  L L +N          +     L  L L  N      
Sbjct: 501 V-----------DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549

Query: 403 GSIPAVYGNMPNLQTLD 419
           G    +   +P++ ++ 
Sbjct: 550 GIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 48.6 bits (115), Expect = 1e-05
 Identities = 48/369 (13%), Positives = 92/369 (24%), Gaps = 73/369 (19%)

Query: 339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH 398
             +  +    S     G     +L + + + L +      G        +  L    L  
Sbjct: 252 REEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLND 311

Query: 399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
                +   ++    + +   L  +               L    L+    +  +  E+ 
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKST-VLQSELE 369

Query: 459 NCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPA 518
           +C  L  L   N      I   +  +                  +    E L        
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALD----------------PLLYEKETLQ------- 406

Query: 519 DYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGEL 578
                       T K+   +    L       +    +    +     L L+   L+  L
Sbjct: 407 ---------YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456

Query: 579 SPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNL 638
              + +L   + + L  N+                  L        +P     ++CL+ L
Sbjct: 457 -CHLEQLLLVTHLDLSHNR------------------LR------ALPPALAALRCLEVL 491

Query: 639 DLSYN---NFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYL---GDP 692
             S N   N  G       NL  L +L +  N L      +   L +  +   L   G+ 
Sbjct: 492 QASDNALENVDG-----VANLPRLQELLLCNNRL--QQSAAIQPLVSCPRLVLLNLQGNS 544

Query: 693 LLDLPDFIE 701
           L       E
Sbjct: 545 LCQEEGIQE 553

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.8 bits (230), Expect = 2e-19
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
             ++GKG FG V         E+ AVK L+++ +  + +      E  VL+        P 
Sbjct: 347  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA---LPGKPPF 403

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L+  C    +++  V EY+ GG L   I    R      +  A ++A  L FL  + 
Sbjct: 404  LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK- 461

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               I++RD+K  NV+LD EG   + DFG+ +  +  D   + T  GT  Y+APE      
Sbjct: 462  --GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQP 518

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG++  W        ++FGVL  E+  G+
Sbjct: 519  YGKSVDW--------WAFGVLLYEMLAGQ 539

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 25/207 (12%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            +++GKG FG V+        +  A+K L+++ +  + +      E  VLS     W HP 
Sbjct: 23   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---WEHPF 79

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  ++       E +  V EY+ GG L   I    +    R    A ++   L FLH + 
Sbjct: 80   LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK- 137

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               IV+RD+K  N+LLDK+G   + DFG+ +  +      + T  GT  Y+APE      
Sbjct: 138  --GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGR 1006
            Y  +       D +SFGVL  E+  G+
Sbjct: 195  YNHS------VDWWSFGVLLYEMLIGQ 215

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 20/208 (9%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           IP  +      + L L  N    +   S  +  +L+VLDLS           +   + + 
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 344 ILALHSN--SYIDGMNSSGIL-KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR 400
            L L  N    +    + G    L ++ +L     N        I  +++LK L +AHN 
Sbjct: 80  TLILTGNPIQSL----ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 401 FNGSIPA--VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSL----LWLMLANNSLSGEI 453
              S      + N+ NL+ LDLS N++   I  +    L  +    L L L+ N ++  I
Sbjct: 136 IQ-SFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 454 PGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
                    L  L L  N+L  ++P  +
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGI 219

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 48/210 (22%), Positives = 77/210 (36%), Gaps = 11/210 (5%)

Query: 269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL-NLSKLEVLDLSSNN 327
           +   L+L  N           S   L+ L L +   +  I +    +LS L  L L+ N 
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNP 87

Query: 328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG-PLPVEIS 386
                   F   + ++ L     + +  + +  I  L  +  L+++HN      LP   S
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 387 QMRSLKFLILAHNRFNGSIPA-VYGNMPNLQ----TLDLSFNELTGPIPPSIGNLTSLLW 441
            + +L+ L L+ N+   SI       +  +     +LDLS N +   I P       L  
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204

Query: 442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           L L  N L     G     TSL  + L  N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 57/272 (20%), Positives = 80/272 (29%), Gaps = 50/272 (18%)

Query: 66  PCEWPGIICSPDKARVN--GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDL 123
           PC     +            LN         I +N    T+   LDLS N          
Sbjct: 2   PC-----VEVVPNITYQCMELNFYK------IPDNLPFSTK--NLDLSFNPLRHLGSYSF 48

Query: 124 SSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            S   L+ L+LS   +    D     L  L  L L+ N I      S             
Sbjct: 49  FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-----SLAL---------- 93

Query: 182 SLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSS 238
                       F G  +L+ L     N           L  L E +V+ N++       
Sbjct: 94  ----------GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143

Query: 239 VFKENCSLEIFDLSENEF----IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGL 294
            F    +LE  DLS N+       D           + L+L  N  +  I         L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202

Query: 295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSN 326
           + L L  N   SV       L+ L+ + L +N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 8/111 (7%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L LS  ++   +       L + S + L  N     L    F  L  L  L     N +
Sbjct: 56  VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNF-SGPFPASFNNLTELSKLNISYNPLVS 671
             + +   G++K L+ L++++N   S   P  F+NLT L  L++S N + S
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 25/119 (21%), Positives = 39/119 (32%), Gaps = 9/119 (7%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNN 620
           T  L LS N L   L            ++ L   +    +    +  L  L  L LT N 
Sbjct: 30  TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 621 FSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTG 678
               +    F  +  LQ L     N +        +L  L +LN+++N + S       
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS--FKLPE 143

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 26/124 (20%), Positives = 43/124 (34%), Gaps = 14/124 (11%)

Query: 556 LASRTFQI---TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP 610
           L +           L ++ N +     P+    L N   + L  N+    +       L 
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLH 173

Query: 611 -----LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNI 664
                 + L+L+ N  +  I    F  I+ L+ L L  N         F+ LT L K+ +
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWL 231

Query: 665 SYNP 668
             NP
Sbjct: 232 HTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 6/77 (7%)

Query: 613 VLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSG 672
            L+L+ N         F +   LQ LDLS          ++ +L+ LS L ++ NP+ S 
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS- 90

Query: 673 TIPSTGQLATFEKTSYL 689
            +        F   S L
Sbjct: 91  -LALG----AFSGLSSL 102

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 6e-19
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 36/214 (16%)

Query: 811  RIIGKGGFGTVY---RGVLPDGREV-AVKKLQREGL---EGEREF-RAEMEVLSGNGFGW 862
            R++GKGG+G V+   +    +  ++ A+K L++  +     +    +AE  +L       
Sbjct: 23   RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--- 79

Query: 863  PHPNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRR-RLDIAIDVARALVF 920
             HP +V L  +      K+ L+ EY+ GG L   +              +A +++ AL  
Sbjct: 80   -HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGH 136

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE- 979
            LH +    I++RD+K  N++L+ +G   +TDFGL +  S  D  V+ T  GT+ Y+APE 
Sbjct: 137  LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEI 192

Query: 980  -----YGQT--WQATTKGDVYSFGVLAMELATGR 1006
                 + +   W        +S G L  ++ TG 
Sbjct: 193  LMRSGHNRAVDW--------WSLGALMYDMLTGA 218

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 89.0 bits (221), Expect = 9e-19
 Identities = 60/368 (16%), Positives = 102/368 (27%), Gaps = 93/368 (25%)

Query: 98  NFSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSHNILSGD---------LN 144
            FS    +    L  +  +     S+   L    S+K + LS N +  +          +
Sbjct: 3   RFS----IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58

Query: 145 LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA------NLSLNNLTGR----IDTCF 194
              L   E  D+   R+  EI  +   + + L+         LS N         +    
Sbjct: 59  KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118

Query: 195 DGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
                L +L L +N   G      A++         L  +  +   K    L       N
Sbjct: 119 SKHTPLEHLYLHNNGL-GPQ--AGAKIAR------ALQELAVNKKAKNAPPLRSIICGRN 169

Query: 255 EFIGDFPGE-----VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
             + +   +       + R L  + +  N         I        L            
Sbjct: 170 R-LENGSMKEWAKTFQSHRLLHTVKMVQNG--------IRPEGIEHLLL----------- 209

Query: 310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISR 369
           E L    +L+VLDL  N F                LA              +   PN+  
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLG---------SSALA------------IALKSWPNLRE 248

Query: 370 LDLSHNNFTGPLPVEISQM------RSLKFLILAHNRFNGS-----IPAVYGNMPNLQTL 418
           L L+    +      +           L+ L L +N             +   MP+L  L
Sbjct: 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308

Query: 419 DLSFNELT 426
           +L+ N  +
Sbjct: 309 ELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 74.4 bits (183), Expect = 5e-14
 Identities = 52/276 (18%), Positives = 88/276 (31%), Gaps = 59/276 (21%)

Query: 241 KENCSLEIFDLSENEFIGDFPGEV-----SNCRNLVVLNLFGNNFSGPIPAEIGSISGLE 295
            E+ S++   LS N  IG           ++ ++L +     + F+G +  EI     L 
Sbjct: 29  LEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEI--PEALR 84

Query: 296 ALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRF----TQVKILALHSNS 351
            L            ++LL   KL  + LS N FG   Q+    F    T ++ L LH+N 
Sbjct: 85  LLL-----------QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 133

Query: 352 ------------YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM----RSLKFLI 395
                         +   +      P +  +    N        E ++     R L  + 
Sbjct: 134 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193

Query: 396 LAHNRFN-----GSIPAVYGNMPNLQTLDLSFNELTGP----IPPSIGNLTSLLWLMLAN 446
           +  N          +         L+ LDL  N  T      +  ++ +  +L  L L +
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253

Query: 447 NSLSGEIPG--------EIGNCTSLLWLNLSNNKLS 474
             LS    G               L  L L  N++ 
Sbjct: 254 CLLSAR--GAAAVVDAFSKLENIGLQTLRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 37/224 (16%), Positives = 69/224 (30%), Gaps = 43/224 (19%)

Query: 294 LEALFLGKNNF----LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRF----TQVKIL 345
           +E   L  +         +   LL    ++ + LS N  G E  +           ++I 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 346 ALHSNSYIDGMN---------SSGILKLPNISRLDLSHNNFTG----PLPVEISQMRSLK 392
                      +            +LK P +  + LS N F      PL   +S+   L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 393 FLILAHNRF-------------NGSIPAVYGNMPNLQTLDLSFNELTGP----IPPSIGN 435
            L L +N                 ++     N P L+++    N L          +  +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 436 LTSLLWLMLANNSLSGE-----IPGEIGNCTSLLWLNLSNNKLS 474
              L  + +  N +  E     +   +  C  L  L+L +N  +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 27/187 (14%), Positives = 59/187 (31%), Gaps = 47/187 (25%)

Query: 99  FSALTQLSYLDLSRNTF-----SGSIPDDLSSCRSLKYLNLSHNILSGD------LNLSG 147
           F +   L  + + +N          + + L+ C+ LK L+L  N  +        + L  
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 148 LRSLEILDLSVNRIHGEISFSFPAICEKLVVA--------NLSLNNLTGR-----IDTCF 194
             +L  L L+   +         A+ +              L  N +             
Sbjct: 243 WPNLRELGLNDCLLSAR---GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 195 DGCLNLRYLDLSSNNFR--GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
           +   +L +L+L+ N F    ++ + + ++                  F      E+ +L 
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREV------------------FSTRGRGELDELD 341

Query: 253 ENEFIGD 259
           + E + D
Sbjct: 342 DMEELTD 348

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            +++GKG FG V            A+K L++E +  + E      E  VL        HP 
Sbjct: 11   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR----HPF 66

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L  +     +++  V EY  GG L   +S     T  R      ++  AL +LH   
Sbjct: 67   LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               +V+RD+K  N++LDK+G   +TDFGL +     D     T  GT  Y+APE      
Sbjct: 125  --DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG+   W        +  GV+  E+  GR
Sbjct: 182  YGRAVDW--------WGLGVVMYEMMCGR 202

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            R++GKG FG V    + +  ++ AVK L+++ +  + +      E  +LS       HP 
Sbjct: 29   RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA---RNHPF 85

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L+  C    +++  V E++ GG L   I    R    R    A ++  AL+FLH + 
Sbjct: 86   LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK- 143

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               I++RD+K  NVLLD EG   + DFG+ +     +   + T  GT  Y+APE      
Sbjct: 144  --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEML 200

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG    W        ++ GVL  E+  G 
Sbjct: 201  YGPAVDW--------WAMGVLLYEMLCGH 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.7 bits (218), Expect = 2e-18
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            ++IGKG FG V            AVK LQ++ +  ++E     +E  VL  N     HP 
Sbjct: 44   KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPF 100

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRR-RLDIAIDVARALVFLHHE 924
            LV L+ +    ++K+  V +Y+ GG L   +         R R   A ++A AL +LH  
Sbjct: 101  LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSL 158

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLA-RVVSAGDSHVSTTIAGTVGYVAPE---- 979
                IV+RD+K  N+LLD +G  ++TDFGL    +    +  ++T  GT  Y+APE    
Sbjct: 159  ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHK 213

Query: 980  --YGQT--WQATTKGDVYSFGVLAMELATGR 1006
              Y +T  W        +  G +  E+  G 
Sbjct: 214  QPYDRTVDW--------WCLGAVLYEMLYGL 236

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.4 bits (215), Expect = 2e-18
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 53/219 (24%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREF---RAEMEVLSGNGFGWP 863
            R +G G FG V+   L     +GR  A+K L++E +   ++      E  +LS       
Sbjct: 12   RTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT---- 64

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR------- 916
            HP ++ ++G   D  +  ++ +Y+EGG L       + L   +R      VA+       
Sbjct: 65   HPFIIRMWGTFQDAQQIFMIMDYIEGGEL------FSLLRKSQRFPN--PVAKFYAAEVC 116

Query: 917  -ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             AL +LH +    I++RD+K  N+LLDK G   +TDFG A+ V      V+ T+ GT  Y
Sbjct: 117  LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDY 169

Query: 976  VAPE------YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            +APE      Y ++  W        +SFG+L  E+  G 
Sbjct: 170  IAPEVVSTKPYNKSIDW--------WSFGILIYEMLAGY 200

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     + A+K +++E +  + +    + E  V         HP 
Sbjct: 15   RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 71

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            LV L+  C     ++  V EY+ GG L   +  + +L        + +++ AL +LH   
Sbjct: 72   LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER- 129

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               I++RD+K  NVLLD EG   +TD+G+ +         ++T  GT  Y+APE      
Sbjct: 130  --GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGED 186

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG +  W        ++ GVL  E+  GR
Sbjct: 187  YGFSVDW--------WALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.9 bits (216), Expect = 3e-18
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
             ++GKG FG V         E+ AVK L+++ +  + +      E  VL+        P 
Sbjct: 26   MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA---LPGKPPF 82

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            L  L+  C    +++  V EY+ GG L   I    R      +  A ++A  L FL  + 
Sbjct: 83   LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK- 140

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               I++RD+K  NV+LD EG   + DFG+ +  +  D   + T  GT  Y+APE      
Sbjct: 141  --GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEIIAYQP 197

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG++  W        ++FGVL  E+  G+
Sbjct: 198  YGKSVDW--------WAFGVLLYEMLAGQ 218

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 32/179 (17%)

Query: 798 SDILKATGKFSED-----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAE 851
           S +        +D     +++G G  G V +        + A+K LQ        + R E
Sbjct: 6   SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60

Query: 852 MEVL---SGNGFGWPHPNLVTLYGWCLDGSEKI----LVYEYMEGGSLEDIISDR--TRL 902
           +E+    S        P++V +     +         +V E ++GG L   I DR     
Sbjct: 61  VELHWRASQ------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 903 TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL-DKEGKALV--TDFGLARVV 958
           T R   +I   +  A+ +LH      I HRDVK  N+L   K   A++  TDFG A+  
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 86.6 bits (215), Expect = 5e-18
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 811  RIIGKGGFGTVYRGVLPDGREV-AVKKLQREGLEGEREF---RAEMEVLSGNGFGWPHPN 866
            R+IG+G +  V    L     + A++ +++E +  + +    + E  V         HP 
Sbjct: 58   RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPF 114

Query: 867  LVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            LV L+  C     ++  V EY+ GG L   +  + +L        + +++ AL +LH   
Sbjct: 115  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER- 172

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE------ 979
               I++RD+K  NVLLD EG   +TD+G+ +         ++T  GT  Y+APE      
Sbjct: 173  --GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 980  YGQT--WQATTKGDVYSFGVLAMELATGR 1006
            YG +  W        ++ GVL  E+  GR
Sbjct: 230  YGFSVDW--------WALGVLMFEMMAGR 250

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.9 bits (211), Expect = 7e-18
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 28/208 (13%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-----REFRAEMEVLSGNGFGWPHPN 866
            +G G + TVY+G+    G  VA+K+++ +  EG      RE     E+         H N
Sbjct: 13   LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL--------KHEN 64

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI------DVARALVF 920
            +V LY      ++  LV+E+M+   L+  +  RT     R L++ +       + + L F
Sbjct: 65   IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE- 979
             H      I+HRD+K  N+L++K G+  + DFGLAR       +  ++   T+ Y AP+ 
Sbjct: 124  CHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDV 179

Query: 980  -YGQTWQATTKGDVYSFGVLAMELATGR 1006
              G     +T  D++S G +  E+ TG+
Sbjct: 180  LMGSR-TYSTSIDIWSCGCILAEMITGK 206

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 9e-18
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-------REFRAEMEVLSG 857
            K+ +   IG+G +G V++      G+ VA+KK   E  +         RE R   ++   
Sbjct: 4    KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL--- 59

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
                  HPNLV L           LV+EY +   L ++   +  +       I     +A
Sbjct: 60   -----KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQA 114

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            + F H       +HRDVK  N+L+ K     + DFG AR+++    +    +A T  Y +
Sbjct: 115  VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170

Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            PE   G T Q     DV++ G +  EL +G 
Sbjct: 171  PELLVGDT-QYGPPVDVWAIGCVFAELLSGV 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLV 868
            R +G+G +  V+  + + +  +V VK L+     + +RE +  +E L G       PN++
Sbjct: 42   RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI-LENLRG------GPNII 94

Query: 869  TLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAI-----DVARALVFL 921
            TL     D   +   LV+E++     + +      LT     D  I     ++ +AL + 
Sbjct: 95   TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLT-----DYDIRFYMYEILKALDYC 146

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY 980
            H      I+HRDVK  NV++D E + L + D+GLA     G  +       +  +  PE 
Sbjct: 147  HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 201

Query: 981  GQTWQATTKG-DVYSFGVLAMELATGRRAL 1009
               +Q      D++S G +   +   +   
Sbjct: 202  LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.7 bits (210), Expect = 2e-17
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
            ++   + IG G  G V         R VA+KKL R        +R +R E+ ++      
Sbjct: 26   RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC--VN 82

Query: 862  WPHPNLVTLY-----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
              H N++ L         L+  + + +V E M+  +L  +I  +  L   R   +   + 
Sbjct: 83   --HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSYLLYQML 137

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              +  LH      I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y
Sbjct: 138  CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
             APE           D++S G +  E+  G 
Sbjct: 193  RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 60/213 (28%), Positives = 87/213 (40%), Gaps = 32/213 (15%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKL----QREGLEGE-----REFRAEMEVLSGNGFGW 862
            IG G +GTVY+      G  VA+K +       G  G      RE      + +      
Sbjct: 17   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF----- 71

Query: 863  PHPNLVTLY----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRL--DIAIDVA 915
             HPN+V L         D   K+ LV+E+++   L   +              D+     
Sbjct: 72   EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            R L FLH  C   IVHRD+K  N+L+   G   + DFGLAR+         T +  T+ Y
Sbjct: 131  RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTLWY 185

Query: 976  VAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
             APE     T+   T  D++S G +  E+   +
Sbjct: 186  RAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 18/215 (8%)

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL 321
            EVS   + + +N    N +  +P ++        L L +N   +    +L+  ++L  L
Sbjct: 4   CEVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 322 DLSSNNFGGEVQKIFGRFTQVKILALHSN--SYIDGMNSSGILKLPNISRLDLSHNNFTG 379
           +L          ++ G    +  L L  N    +          LP ++ LD+S N  T 
Sbjct: 61  NLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQSL----PLLGQTLPALTVLDVSFNRLTS 114

Query: 380 PLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GNL 436
            LP+     +  L+ L L  N    ++P  +    P L+ L L+ N LT  +P  +   L
Sbjct: 115 -LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGL 171

Query: 437 TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
            +L  L+L  NSL   IP        L +  L  N
Sbjct: 172 ENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 13/181 (7%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
              L+ +P  L       +L LS N            +T++  L L     +  +   G 
Sbjct: 19  KRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-LTKLQVDG- 74

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDL 420
             LP +  LDLSHN     LP+    + +L  L ++ NR   S+P      +  LQ L L
Sbjct: 75  -TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 421 SFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGNIP 478
             NEL   +PP +      L  L LANN+L+ E+P  +     +L  L L  N L   IP
Sbjct: 132 KGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 479 P 479
            
Sbjct: 189 K 189

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 10/169 (5%)

Query: 314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS 373
            ++    ++    N       +        IL L  N  +   + + ++    +++L+L 
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENL-LYTFSLATLMPYTRLTQLNLD 63

Query: 374 HNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI 433
               T  L V+   +  L  L L+HN+   S+P +   +P L  LD+SFN LT  +P   
Sbjct: 64  RAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGA 119

Query: 434 -GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
              L  L  L L  N L    PG +     L  L+L+NN L+  +P  +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGL 167

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 48/211 (22%), Positives = 70/211 (33%), Gaps = 45/211 (21%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
              I  LSEN         +     L  LNL     +  +  + G++  L  L L  N  
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQ- 88

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKI----FGRFTQVKILALHSN--SYIDGMNS 358
           L  +P     L  L VLD+S N        +         +++ L L  N    +     
Sbjct: 89  LQSLPLLGQTLPALTVLDVSFNRL----TSLPLGALRGLGELQELYLKGNELKTL----P 140

Query: 359 SGIL-KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQ 416
            G+L   P + +L L++NN T                          +PA +   + NL 
Sbjct: 141 PGLLTPTPKLEKLSLANNNLT-------------------------ELPAGLLNGLENLD 175

Query: 417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANN 447
           TL L  N L   IP        L +  L  N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 41/179 (22%), Positives = 63/179 (35%), Gaps = 7/179 (3%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIH 162
              + L LS N         L     L  LNL    L+       L  L  LDLS N++ 
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 163 GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLA 219
             +      +   L V ++S N LT        G   L+ L L  N  +     +     
Sbjct: 91  -SLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148

Query: 220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN 278
           +L + S++ N L+  + + +     +L+   L EN  +   P        L    L GN
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 6/110 (5%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           T  L LS N L    S          + ++L   +   KL      LP L  L+L+ N  
Sbjct: 33  TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQL 89

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
              +P     +  L  LD+S+N  +     +   L EL +L +  N L +
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 43/174 (24%), Positives = 62/174 (35%), Gaps = 8/174 (4%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSSS 238
           +LS N L             L  L+L         +   L  L    +S N L  +    
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL--PL 94

Query: 239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEAL 297
           + +   +L + D+S N       G +     L  L L GN     +P  +      LE L
Sbjct: 95  LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKL 153

Query: 298 FLGKNNFLSVIPESLL-NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
            L  NN L+ +P  LL  L  L+ L L  N+     +  FG    +    LH N
Sbjct: 154 SLANNN-LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS-HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 29/109 (26%), Positives = 40/109 (36%), Gaps = 6/109 (5%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSG 623
            L LS NQL   L      L   +++ + FN+    LP      L  L  L L  N    
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            +P         L+ L L+ NN +       N L  L  L +  N L +
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPHPN 866
            +G+G +G VY+     GR VA+K+++   L+ E E       R E+ +L        HPN
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIR-EISLLKE----LHHPN 80

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHEC 925
            +V+L           LV+E+ME   L+ ++ + +T L   +       + R +   H   
Sbjct: 81   IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
               I+HRD+K  N+L++ +G   + DFGLAR          T    T+ Y AP+   G  
Sbjct: 140  ---ILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 984  WQATTKGDVYSFGVLAMELATGR 1006
             + +T  D++S G +  E+ TG+
Sbjct: 196  -KYSTSVDIWSIGCIFAEMITGK 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPHP 865
            IG+G +GTV++         VA+K+++   L+ + E       R E+ +L        H 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALR-EICLLKE----LKHK 61

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHE 924
            N+V L+       +  LV+E+ +   L+         L           + + L F H  
Sbjct: 62   NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQ 982
                ++HRD+K  N+L+++ G+  + +FGLAR          +    T+ Y  P+  +G 
Sbjct: 121  N---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGA 176

Query: 983  TWQATTKGDVYSFGVLAMELATGRRAL 1009
                +T  D++S G +  ELA   R L
Sbjct: 177  K-LYSTSIDMWSAGCIFAELANAGRPL 202

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 806  KFSEDRIIGKGGFGTVYRG--VLPDGREVAVKKLQREGLEGERE------FRAEMEVLSG 857
            ++     IG+G +G V++   +   GR VA+K+++   ++   E       R E+ VL  
Sbjct: 12   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIR-EVAVLR- 66

Query: 858  NGFGWPHPNLVTLY----GWCLDGSEKI-LVYEYMEGGSLEDIISD--RTRLTWRRRLDI 910
            +   + HPN+V L+        D   K+ LV+E+++   L   +       +      D+
Sbjct: 67   HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125

Query: 911  AIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
               + R L FLH      +VHRD+K  N+L+   G+  + DFGLAR+         T++ 
Sbjct: 126  MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVV 180

Query: 971  GTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
             T+ Y APE     ++   T  D++S G +  E+   +
Sbjct: 181  VTLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-------REFRAEMEVLSG 857
            K+    ++G+G +G V +      GR VA+KK   E  + +       RE +   ++   
Sbjct: 26   KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQL--- 81

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
                  H NLV L   C       LV+E+++   L+D+      L ++        +   
Sbjct: 82   -----RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            + F H      I+HRD+K  N+L+ + G   + DFG AR ++A        +A T  Y A
Sbjct: 137  IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192

Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            PE   G   +     DV++ G L  E+  G 
Sbjct: 193  PELLVGDV-KYGKAVDVWAIGCLVTEMFMGE 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.1 bits (208), Expect = 6e-17
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 23/211 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
            ++   + IG G  G V         R VA+KKL R        +R +R E+ ++      
Sbjct: 63   RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC--VN 119

Query: 862  WPHPNLVTLY------GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
              H N+++L           +  +  LV E M+  +L  +I  +  L   R   +   + 
Sbjct: 120  --HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQML 174

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              +  LH      I+HRD+K SN+++  +    + DFGLAR  +AG S + T    T  Y
Sbjct: 175  CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGR 1006
             APE           D++S G +  E+   +
Sbjct: 230  RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.1 bits (201), Expect = 2e-16
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGE-----REFRAEMEVLSGNG 859
             + +   +G+G + TVY+G        VA+K+++ E  EG      RE     ++     
Sbjct: 3    TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL----- 57

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARAL 918
                H N+VTL+          LV+EY++   L+  + D    +           + R L
Sbjct: 58   ---KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAP 978
             + H +    ++HRD+K  N+L+++ G+  + DFGLAR  S         +  T+ Y  P
Sbjct: 114  AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169

Query: 979  E--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            +   G T   +T+ D++  G +  E+ATGR
Sbjct: 170  DILLGST-DYSTQIDMWGVGCIFYEMATGR 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 2e-16
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 53/218 (24%)

Query: 813  IGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWP--------- 863
            IG+G +G VY+     G   A+KK++   LE E E             G P         
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDE-------------GIPSTTIREISI 53

Query: 864  -----HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA--- 915
                 H N+V LY         +LV+E+++         D  +L       +    A   
Sbjct: 54   LKELKHSNIVKLYDVIHTKKRLVLVFEHLD--------QDLKKLLDVCEGGLESVTAKSF 105

Query: 916  -----RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA 970
                   + + H      ++HRD+K  N+L+++EG+  + DFGLAR         +  I 
Sbjct: 106  LLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162

Query: 971  GTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
             T+ Y AP+   G   + +T  D++S G +  E+  G 
Sbjct: 163  -TLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 30/220 (13%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE------------REFRAEME 853
             ++  R I  G +G V  GV  +G  VA+K++     +G             R  R E+ 
Sbjct: 23   PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIR 81

Query: 854  VLSGNGFGWPHPNLVTLYG----WCLDGSEKI-LVYEYMEGGSLEDII-SDRTRLTWRRR 907
            +L+     + HPN++ L      +      K+ LV E M    L  +I   R  ++ +  
Sbjct: 82   LLNH----FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHI 136

Query: 908  LDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVST 967
                  +   L  LH      +VHRD+   N+LL       + DF LAR  +A  +   T
Sbjct: 137  QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KT 191

Query: 968  TIAGTVGYVAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
                   Y APE    ++  TK  D++S G +  E+   +
Sbjct: 192  HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 71/252 (28%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K+S  + +G G FG V     +  G+  A+KK+ ++     RE    M+VL        H
Sbjct: 8    KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD-IMKVLD-------H 59

Query: 865  PNLVTLYGWCLDGSEKI--------------------------------------LVYEY 886
             N++ L  +     ++                                       ++ EY
Sbjct: 60   VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 887  MEGGSLEDIISDRTRLTWRRRLDIAID--------VARALVFLHHECYPPIVHRDVKASN 938
            +   +L  ++    +   R    I ++        + RA+ F+H      I HRD+K  N
Sbjct: 120  VPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQN 171

Query: 939  VLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSF 995
            +L++ +   L + DFG A+ +   +  V+  I  +  Y APE   G T + T   D++S 
Sbjct: 172  LLVNSKDNTLKLCDFGSAKKLIPSEPSVA-YIC-SRFYRAPELMLGAT-EYTPSIDLWSI 228

Query: 996  G-VLAMELATGR 1006
            G V   EL  G+
Sbjct: 229  GCVFG-ELILGK 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 41/232 (17%)

Query: 809  EDRIIGKGGFGTVYRGV---LPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWP 863
            E   +G+G +G VY+       D ++ A+K+++  G+     RE     E L        
Sbjct: 25   EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE-LK------- 76

Query: 864  HPNLVTLYGWCLDGSEKI--LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA------ 915
            HPN+++L    L  +++   L+++Y E   L  II    R +   +  + +         
Sbjct: 77   HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQLPRGMVKSLL 134

Query: 916  ----RALVFLHHECYPPIVHRDVKASNVLLDKEGKAL----VTDFGLARVVSAGD---SH 964
                  + +LH      ++HRD+K +N+L+  EG       + D G AR+ ++     + 
Sbjct: 135  YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 965  VSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            +   +  T  Y APE   G     T   D+++ G +  EL T        +E
Sbjct: 192  LDPVVV-TFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 20/183 (10%)

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG--RFTQVKILALHSNS 351
                LGK +   +   S   LS ++  +  ++N    +Q + G   FT +K L L  N 
Sbjct: 21  AVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSN----IQSLAGMQFFTNLKELHLSHNQ 74

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
             D    S +  L  +  L ++ N       +       L  L L +N       ++  +
Sbjct: 75  ISD---LSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELR-DTDSL-IH 126

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           + NL+ L +  N+L   I   +G L+ L  L L  N ++    G +     + W++L+  
Sbjct: 127 LKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQ 182

Query: 472 KLS 474
           K  
Sbjct: 183 KCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 48/253 (18%), Positives = 87/253 (34%), Gaps = 23/253 (9%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
            NL   +++ D+  +   L+ +   +   +    S+   +    +LK L+LSHN +S   
Sbjct: 24  QNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLS 79

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L  L  LE L ++ NR+   ++         L    L  N L    D+      NL  L
Sbjct: 80  PLKDLTKLEELSVNRNRLK-NLN---GIPSACLSRLFLDNNELR-DTDS-LIHLKNLEIL 133

Query: 204 DLSSNNFRGNIWN--GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP 261
            + +N  + +I     L++L    +  N ++             +   DL+  +   + P
Sbjct: 134 SIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNT---GGLTRLKKVNWIDLTGQK-CVNEP 188

Query: 262 GEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLG--KNNFLSVIPESLLNLSKLE 319
             V     L + N   +     I      IS   +   G           E     S+  
Sbjct: 189 --VKYQPELYITNTVKDPDGRWI--SPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYI 244

Query: 320 VLDLSSNNFGGEV 332
            +  +   F G V
Sbjct: 245 NVGETEAIFDGTV 257

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 42/252 (16%), Positives = 83/252 (32%), Gaps = 19/252 (7%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEI 153
            +F +   L      +L + + +  +         ++  N  ++ +     +    +L+ 
Sbjct: 11  QVFPD-PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQFFTNLKE 67

Query: 154 LDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG- 212
           L LS N+I      S      KL   +++ N L    +        L  L L +N  R  
Sbjct: 68  LHLSHNQIS---DLSPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRDT 121

Query: 213 NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVV 272
           +    L  L   S+  N L  +    +      LE+ DL  NE I +  G ++  + +  
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSI---VMLGFLSKLEVLDLHGNE-ITNTGG-LTRLKKVNW 176

Query: 273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN--FGG 330
           ++L G             +     +      ++S  P  + N        +      +  
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTD 234

Query: 331 EVQKIFGRFTQV 342
           EV   F  +  V
Sbjct: 235 EVSYKFSEYINV 246

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 36/233 (15%), Positives = 76/233 (32%), Gaps = 20/233 (8%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
           +    +L +   + D          +   N   +N        +   + L+ L L  N  
Sbjct: 20  NAVKQNLGKQS-VTDLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQ- 74

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG-RFTQVKILALHSNSYIDGMNSSGILK 363
           +S +   L +L+KLE L ++ N     ++ + G     +  L L +N   D      ++ 
Sbjct: 75  ISDL-SPLKDLTKLEELSVNRNR----LKNLNGIPSACLSRLFLDNNELRDT---DSLIH 126

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
           L N+  L + +N     +   +  +  L+ L L  N    +   +   +  +  +DL+  
Sbjct: 127 LKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NTGGL-TRLKKVNWIDLTGQ 182

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           +           L     +   +       P  I N  S +   +        
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 17/116 (14%), Positives = 42/116 (36%), Gaps = 30/116 (25%)

Query: 359 SGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL 418
                L N  + +L   +        ++ + S K                   +  +Q  
Sbjct: 13  FPDPGLANAVKQNLGKQS--------VTDLVSQK------------------ELSGVQNF 46

Query: 419 DLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           +   + +   +   +   T+L  L L++N +S ++   + + T L  L+++ N+L 
Sbjct: 47  NGDNSNIQS-LAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 66/397 (16%), Positives = 114/397 (28%), Gaps = 106/397 (26%)

Query: 123 LSSCRSLKYLNLSHNILSGDLNLSGL--------RSLEILDLSVNRIHGE----ISFSFP 170
            S    +  L+LS N L   ++   L         S+  L+LS N +  +    +     
Sbjct: 18  TSIPHGVTSLDLSLNNL-YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76

Query: 171 AICEKLVVANLSLNNLTGRIDTCF-----DGCLNLRYLDLSSNNFRGNIWNGLAQLVEFS 225
           AI   +   NLS N L+ +               +  LDL  N+F     +   Q     
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS-- 134

Query: 226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV------SNCRNLVVLNLFGNN 279
                              S+   +L  N+ +G    +       +   N+  LNL GNN
Sbjct: 135 ---------------NLPASITSLNLRGND-LGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 280 FSGPIPAEIGSISGLEAL--FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG 337
                   + S      L  FL                + +  LDLS+N  G +      
Sbjct: 179 --------LAS-KNCAELAKFLASIP------------ASVTSLDLSANLLGLKSYAELA 217

Query: 338 RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM----RSLKF 393
                      S                ++  L+L  N   GP    +  +    + L+ 
Sbjct: 218 Y-------IFSSIP-------------NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 394 LILAHNRFNG-------SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL-----TSLLW 441
           + L ++           ++ A + N+  +  +D +  E+       I NL          
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317

Query: 442 LMLANNSLS-----GEIPGEIGNCTSLLWLNLSNNKL 473
             L N  L           ++     L     +   L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 42/300 (14%), Positives = 84/300 (28%), Gaps = 81/300 (27%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIH 162
             ++ LDL  N FS     +    ++   L                 S+  L+L  N + 
Sbjct: 109 FTITVLDLGWNDFSSKSSSEF--KQAFSNLP---------------ASITSLNLRGNDLG 151

Query: 163 GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLV 222
            +   S   + + L     +                 +  L+L  NN         A+L 
Sbjct: 152 IK---SSDELIQILAAIPAN-----------------VNSLNLRGNNLAS---KNCAELA 188

Query: 223 EFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV------SNCRNLVVLNLF 276
           +       L+ +          S+   DLS N  +G            S   ++V LNL 
Sbjct: 189 K------FLASI--------PASVTSLDLSANL-LGLKSYAELAYIFSSIPNHVVSLNLC 233

Query: 277 GNNFSGPIPAEIGSI----SGLEALFLGKNNF-------LSVIPESLLNLSKLEVLDLSS 325
            N   GP    +  +      L+ ++L  +            +  +  N+ K+ ++D + 
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293

Query: 326 NNFGGEVQKIFGRFTQ-----VKILALHSNSYID----GMNSSGILKLPNISRLDLSHNN 376
                          +       + +L +   I       N   +     +     +   
Sbjct: 294 KEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 45/242 (18%), Positives = 73/242 (30%), Gaps = 54/242 (22%)

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSI-----SGLEALFLGKNNF----LSVIPESLL-N 314
           S    +  L+L  NN       E+        + + +L L  N+        + + L   
Sbjct: 19  SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78

Query: 315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPN--ISRLDL 372
            + +  L+LS N    +             L                L      I+ LDL
Sbjct: 79  PANVTSLNLSGNFLSYK---------SSDELV-------------KTLAAIPFTITVLDL 116

Query: 373 SHNNFTGPLPVEISQM-----RSLKFLILAHNRFNGS-----IPAVYGNMPNLQTLDLSF 422
             N+F+     E  Q       S+  L L  N          I  +     N+ +L+L  
Sbjct: 117 GWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG 176

Query: 423 NELTGPIPPSIGNL-----TSLLWLMLANNSLSGEIPGEIG-----NCTSLLWLNLSNNK 472
           N L       +         S+  L L+ N L  +   E+          ++ LNL  N 
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236

Query: 473 LS 474
           L 
Sbjct: 237 LH 238

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 39/196 (19%), Positives = 67/196 (34%), Gaps = 29/196 (14%)

Query: 308 IPESLLNLSKLEVLDLSSNNFGGEVQKIFGR-----FTQVKILALHSNS-YIDGMNS-SG 360
           + E       +  LDLS NN          +        V  L L  NS      +    
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 361 ILKLPN--ISRLDLSHNNFTGPLPVEISQM-----RSLKFLILAHNRFNGS-----IPAV 408
           IL      ++ L+LS N  +     E+ +       ++  L L  N F+         A 
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 409 YGNMPNLQTLDLSFNELTGPIPPSIGNL-----TSLLWLMLANNSLSGEIPGEIG----- 458
                ++ +L+L  N+L       +  +      ++  L L  N+L+ +   E+      
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193

Query: 459 NCTSLLWLNLSNNKLS 474
              S+  L+LS N L 
Sbjct: 194 IPASVTSLDLSANLLG 209

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 1e-15
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 35/211 (16%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEV-----LSGNGFGWP 863
            +G+G F TVY+       + VA+KK++       ++     A  E+     LS       
Sbjct: 18   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------- 70

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIA------IDVARA 917
            HPN++ L       S   LV+++ME   LE II D         L  +      +   + 
Sbjct: 71   HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-----SLVLTPSHIKAYMLMTLQG 124

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L +LH      I+HRD+K +N+LLD+ G   + DFGLA+   + +   +  +  T  Y A
Sbjct: 125  LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180

Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            PE  +G         D+++ G +  EL    
Sbjct: 181  PELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.4 bits (194), Expect = 2e-15
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE------FRAEMEVL-SG 857
            K+ +   IG+G FG V++      G++VA+KK+    +E E+E       R E+++L   
Sbjct: 18   KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALR-EIKILQLL 73

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKI--------LVYEYME---GGSLEDIISDRTRLTWRR 906
                  H N+V L   C   +           LV+++ E    G L ++     + T   
Sbjct: 74   K-----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSE 125

Query: 907  RLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
               +   +   L ++H      I+HRD+KA+NVL+ ++G   + DFGLAR  S   +   
Sbjct: 126  IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 967  ---TTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
               T    T+ Y  PE   G+        D++  G +  E+ T  
Sbjct: 183  NRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 28/208 (13%)

Query: 813  IGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE------FRAEMEVLSGNGFGWPHP 865
            +G+G +G VY+ +       VA+K+++   LE E E       R E+ +L        H 
Sbjct: 42   LGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIR-EVSLLKE----LQHR 93

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC 925
            N++ L           L++EY E   L+  +     ++ R        +   + F H   
Sbjct: 94   NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152

Query: 926  YPPIVHRDVKASNVLLDKEGKAL-----VTDFGLARVVSAGDSHVSTTIAGTVGYVAPE- 979
                +HRD+K  N+LL     +      + DFGLAR          T    T+ Y  PE 
Sbjct: 153  ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEI 208

Query: 980  -YGQTWQATTKGDVYSFGVLAMELATGR 1006
              G     +T  D++S   +  E+    
Sbjct: 209  LLGSR-HYSTSVDIWSIACIWAEMLMKT 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 4e-15
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
             +     +G G +G+V   +    G +VA+KKL R     +  +R +R E+ +L      
Sbjct: 25   TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKH---- 79

Query: 862  WPHPNLVTLY-----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
              H N++ L         L       LV  +M+   L+ I+    + +  +   +   + 
Sbjct: 80   MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQML 136

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + L ++H      +VHRD+K  N+ ++++ +  + DFGLAR   A      T    T  Y
Sbjct: 137  KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 189

Query: 976  VAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
             APE   +W    +  D++S G +  E+ TG+
Sbjct: 190  RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 1e-14
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGFGW 862
             F    ++G+G +G V      P G  VA+KK++   + L   R  R E+++L      +
Sbjct: 12   DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKH----F 66

Query: 863  PHPNLVTLY-----GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
             H N++T++         + +E  ++ E M+   L  +IS    L+            RA
Sbjct: 67   KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS-TQMLSDDHIQYFIYQTLRA 124

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV---G 974
            +  LH      ++HRD+K SN+L++      V DFGLAR++    +  S           
Sbjct: 125  VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 975  YV------APEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
            +V      APE   T    ++  DV+S G +  EL   R
Sbjct: 182  FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 17/225 (7%)

Query: 254 NEFIGDFPGEVSNCRN-LVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
           NE +    G V +C N    ++      +  IP+ I +    + L L  N   S+  ++ 
Sbjct: 1   NEALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIPA--DTKKLDLQSNKLSSLPSKAF 57

Query: 313 LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNS--SGIL-KLPNISR 369
             L+KL +L L+ N        IF     ++ L +  N     + +   G+  +L N++ 
Sbjct: 58  HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK----LQALPIGVFDQLVNLAE 113

Query: 370 LDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTG 427
           L L  N     LP  +   +  L +L L +N    S+P  V+  + +L+ L L  N+L  
Sbjct: 114 LRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR 171

Query: 428 PIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
            +P      LT L  L L NN L     G   +   L  L L  N
Sbjct: 172 -VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 8/169 (4%)

Query: 318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF 377
            + LDL SN       K F R T++++L L+ N  +  + +    +L N+  L ++ N  
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDNKL 97

Query: 378 TGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-G 434
              LP+ +  Q+ +L  L L  N+   S+P  V+ ++  L  L L +NEL   +P  +  
Sbjct: 98  QA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFD 154

Query: 435 NLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
            LTSL  L L NN L     G     T L  L L NN+L   +P     
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFD 202

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 51/219 (23%), Positives = 77/219 (35%), Gaps = 31/219 (14%)

Query: 74  CSPDKARVN--GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKY 131
           C+ +K  V+     LT   I  +I            LDL  N  S            L+ 
Sbjct: 14  CNNNKNSVDCSSKKLTA--IPSNIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRL 65

Query: 132 LNLSHNILSGDLNLS-----GLRSLEILDLSVNRIHGEISFSFPA-ICEKLV---VANLS 182
           L L+ N L     L       L++LE L ++ N++      + P  + ++LV      L 
Sbjct: 66  LYLNDNKLQ---TLPAGIFKELKNLETLWVTDNKLQ-----ALPIGVFDQLVNLAELRLD 117

Query: 183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVSSSV 239
            N L       FD    L YL L  N  +     +++ L  L E  +  N L   V    
Sbjct: 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGA 176

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN 278
           F +   L+   L  N+      G   +   L +L L  N
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 8/176 (4%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSVSENVLSGVVS 236
           +L  N L+      F     LR L L+ N  +     I+  L  L    V++N L   + 
Sbjct: 43  DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALP 101

Query: 237 SSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI-GSISGL 294
             VF +  +L    L  N+ +   P  V  +   L  L+L  N     +P  +   ++ L
Sbjct: 102 IGVFDQLVNLAELRLDRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSL 159

Query: 295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
           + L L  N    V   +   L++L+ L L +N      +  F    ++K+L L  N
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 60/260 (23%), Positives = 88/260 (33%), Gaps = 65/260 (25%)

Query: 414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           N  ++D S  +LT  IP +I   T  L L   +N LS          T L  L L++NKL
Sbjct: 17  NKNSVDCSSKKLTA-IPSNIPADTKKLDLQ--SNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 474 SGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRK 533
                                                     +PA       ++  L   
Sbjct: 74  QT----------------------------------------LPAG------IFKELKNL 87

Query: 534 SCRSLWDRLLKG--TGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-GKLQNFSM 590
               + D  L+    G+F      L +        L+L  NQL   L P +   L   + 
Sbjct: 88  ETLWVTDNKLQALPIGVFD----QLVNLA-----ELRLDRNQLK-SLPPRVFDSLTKLTY 137

Query: 591 VHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGP 648
           + LG+N+    LP   FD+L  L  L L  N         F  +  L+ L L  N     
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196

Query: 649 FPASFNNLTELSKLNISYNP 668
              +F++L +L  L +  NP
Sbjct: 197 PEGAFDSLEKLKMLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.7 bits (122), Expect = 9e-07
 Identities = 32/111 (28%), Positives = 48/111 (43%), Gaps = 5/111 (4%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNF 621
           T  L L  N+LS  L      +L    +++L  N+        F +L  L  L +T N  
Sbjct: 39  TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
              +P   F  +  L  L L  N      P  F++LT+L+ L++ YN L S
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 34/110 (30%), Positives = 47/110 (42%), Gaps = 7/110 (6%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L L+ N+L   L   I  +L+N   + +  N+    LP   FDQL  L  L L RN   
Sbjct: 65  LLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +P   F ++  L  L L YN         F+ LT L +L +  N L  
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 7/110 (6%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L ++ N+L   L   +  +L N + + L  NQ    LP + FD L  L  L+L  N   
Sbjct: 89  TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
             +P   F  +  L+ L L  N        +F+ LTEL  L +  N L  
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 38/225 (16%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ-REGLEGEREFRAEMEVLSGNGFGWP 863
            ++ + + +G GG G V+  V     + VA+KK+   +    +   R E++++        
Sbjct: 12   RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRR--LD-- 66

Query: 864  HPNLVTLY-------------GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLD 909
            H N+V ++                L     + +V EYME   L +++     L       
Sbjct: 67   HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG-PLLEEHARL 124

Query: 910  IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTT 968
                + R L ++H      ++HRD+K +N+ ++ E   L + DFGLAR++   D H S  
Sbjct: 125  FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHK 178

Query: 969  IAGTVGYV------APEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
               +   +      +P    +    TK  D+++ G +  E+ TG+
Sbjct: 179  GHLS-EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 76.1 bits (187), Expect = 3e-14
 Identities = 63/370 (17%), Positives = 122/370 (32%), Gaps = 47/370 (12%)

Query: 100 SALTQLSYLDLSRNTFSGSIPDDLS----SCRSLKYLNLSHNILS--GDLNL----SGLR 149
           +   ++  L +  ++FS      L        SL+ LN      +     +L       R
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220

Query: 150 SLEILDLS-VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN 208
           SL  + +     +     F   A  E+    +L+ +               L  L LS  
Sbjct: 221 SLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280

Query: 209 NFRG--NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD--FPGEV 264
                  ++   AQ+ +  +   +L      ++ ++  +LE+ +      IGD       
Sbjct: 281 GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN--VIGDRGLEVLA 338

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSIS--GLEALFLG--------------KNNFLSVI 308
             C+ L  L +        +  E G +S  GL AL  G               N  L  I
Sbjct: 339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI 398

Query: 309 PESLLNLSKLEVLDLSSNN------FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
              L NL    ++ L              V+ +     +++  A +      G+   G+ 
Sbjct: 399 GTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--GGLTDLGLS 456

Query: 363 KL----PNISRLDLSHNNFTGPLPVEISQ-MRSLKFLILAHNRF-NGSIPAVYGNMPNLQ 416
            +    PN+  + L +   +    +E S+   +L+ L +    F   +I A    +P+L+
Sbjct: 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516

Query: 417 TLDLSFNELT 426
            L +     +
Sbjct: 517 YLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 70.7 bits (173), Expect = 1e-12
 Identities = 47/376 (12%), Positives = 110/376 (29%), Gaps = 55/376 (14%)

Query: 112 RNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPA 171
              ++ +         +L+ L L     +   NL        +   V  I          
Sbjct: 58  ALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNN------- 110

Query: 172 ICEKLVVANLSLNNLT--GRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSEN 229
              +L   +     ++             +L  L L   +                 + +
Sbjct: 111 -LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCS---------------GFTTD 154

Query: 230 VLSGVVSSSVFKENC-SLEIFDLSENEFIGDFPGEVS----NCRNLVVLNLFGNNFSGPI 284
            L  +V+      +C  ++   + E+ F       +     +  +L VLN +   F+   
Sbjct: 155 GLLSIVT------HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS 208

Query: 285 PAEIGSI----SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
           P ++ +I      L ++ +G    L ++       + LE     S N    + + +    
Sbjct: 209 PKDLETIARNCRSLVSVKVGDFEILELV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267

Query: 341 QVKILALHSNSYIDGMNSSGILKL-PNISRLDLSHNNFTGPLPVE-ISQMRSLKFLILAH 398
             + L     SY+       +      I +LDL +           I +  +L+ L   +
Sbjct: 268 FPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327

Query: 399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
              +  +  +      L+ L +        +    G ++    + LA             
Sbjct: 328 VIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ------------ 375

Query: 459 NCTSLLWLNLSNNKLS 474
            C  L ++ +  + ++
Sbjct: 376 GCQELEYMAVYVSDIT 391

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 44/271 (16%), Positives = 77/271 (28%), Gaps = 50/271 (18%)

Query: 84  LNLTD-WNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD 142
           L+L      + D          L  L+         +      C+ LK L +        
Sbjct: 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQG 357

Query: 143 LNLS--------------GLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL-SLNNLT 187
           +                 G + LE + + V+ I  E   S     + L    L  L+   
Sbjct: 358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE 417

Query: 188 GRIDTCFD--------GCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV 239
              D   D        GC  LR                        +++  LS +   S 
Sbjct: 418 RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGG--------------LTDLGLSYIGQYSP 463

Query: 240 FKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGP-IPAEIGSISGLEAL 297
                ++    L       +   E    C NL  L + G  FS   I A +  +  L  L
Sbjct: 464 -----NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL 518

Query: 298 FLGKNNFLSVIPESLLNLS----KLEVLDLS 324
           ++      S+  + L+ ++     +E++   
Sbjct: 519 WVQGYR-ASMTGQDLMQMARPYWNIELIPSR 548

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 39/233 (16%), Positives = 72/233 (30%), Gaps = 24/233 (10%)

Query: 264 VSNCRNLVVLNLFGNNFSGPIPAEIGSIS----GLEALFLGKNNFLSVIPESLLNLS--- 316
           +       + NL   N+ G +   +  IS     L+++       + V    L  L+   
Sbjct: 80  LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHF---RRMIVSDLDLDRLAKAR 136

Query: 317 --KLEVLDLSS-NNFGGE-VQKIFGRFTQVKILALHSNSYID--GMNSSGILK-LPNISR 369
              LE L L   + F  + +  I     ++K L +  +S+ +  G     + +   ++  
Sbjct: 137 ADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEV 196

Query: 370 LDLSHNNFTG----PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNEL 425
           L+     F       L       RSL  + +        +   +    NL+         
Sbjct: 197 LNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE-ILELVGFFKAAANLEEFCGGSLNE 255

Query: 426 TGPIPPSIGNLTSLLWLMLANNSLSG--EIPGEIGNCTSLLWLNLSNNKLSGN 476
              +P    NL     L     S  G  E+P        +  L+L    L   
Sbjct: 256 DIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 3e-14
 Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 24/190 (12%)

Query: 898  DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV 957
             +  LT    +  +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR 
Sbjct: 186  YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242

Query: 958  VSAGDSHVSTTIAGT-VGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC 1015
            +     +V    A   + ++APE       T + DV+SFGVL  E+ + G     G    
Sbjct: 243  IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---- 298

Query: 1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGA-EEMSELLRIGVRCTAEAPNARPNVK 1074
             V+         + G  R   P         +    EM + +     C    P+ RP   
Sbjct: 299  -VKIDEEFCRRLKEG-TRMRAP---------DYTTPEMYQTML---DCWHGEPSQRPTFS 344

Query: 1075 EVLAMLIKIL 1084
            E++  L  +L
Sbjct: 345  ELVEHLGNLL 354

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 18/163 (11%)

Query: 810 DRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGER-EFRAEMEVLSGNGFGW 862
            + +G+G FG V              R VAVK L+      E     +E+++L   G   
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--- 83

Query: 863 PHPNLVTLYGWCLDGSEKILV-YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
            H N+V L G C      ++V  E+ + G+L   +         +R +      +   F 
Sbjct: 84  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFR 136

Query: 922 HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH 964
             + Y   +  D+K     +     +  + F   + +S  +  
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.8 bits (180), Expect = 5e-14
 Identities = 35/213 (16%), Positives = 60/213 (28%), Gaps = 49/213 (23%)

Query: 801 LKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL------------QREGLEGEREF 848
              T K      IG+G FG V++ +  D   VA+K +            Q+   E   E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 849 RA--EMEVLSGNGFGWPHPNLVTLYGWCL------------------------------D 876
               E+ +LSG          + L                                    
Sbjct: 75  IISKELSLLSGEVCNR-TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKA 936
             +  +V E+  GG   + +  +   +      I   +  +L            HRD+  
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHW 190

Query: 937 SNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI 969
            NVLL K     +      +  +     +  +I
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 39/122 (31%), Positives = 62/122 (50%), Gaps = 10/122 (8%)

Query: 365 PNISRLDLSHNNFTGPLPVEI--SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLS 421
              + LDLSHNN +  L  E   +++ +L  L+L+HN  N  I +  +  +PNL+ LDLS
Sbjct: 39  SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96

Query: 422 FNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEI-GNCTSLLWLNLSNNKLSGNIPP 479
            N L   +   +  +L +L  L+L NN +   +      +   L  L LS N++S   P 
Sbjct: 97  SNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153

Query: 480 EV 481
           E+
Sbjct: 154 EL 155

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 48/221 (21%), Positives = 70/221 (31%), Gaps = 61/221 (27%)

Query: 118 SIPDDLSSCRSLKYLNLSHN---ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICE 174
           ++P  L S      L+LSHN    L  +   + L +L  L LS N ++            
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN------------ 77

Query: 175 KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGV 234
                   +++        F    NLRYLDLSSN+                         
Sbjct: 78  -------FISSEA------FVPVPNLRYLDLSSNHLH----------------------T 102

Query: 235 VSSSVFKENCSLEIFDLSENEFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI----G 289
           +   +F +  +LE+  L  N  I         +   L  L L  N  S   P E+     
Sbjct: 103 LDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGN 160

Query: 290 SISGLEALFLGKNNFLSVIPESLLNLSKL--EVLDLSSNNF 328
            +  L  L L  N    +    L  L       L L +N  
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 43/213 (20%), Positives = 71/213 (33%), Gaps = 61/213 (28%)

Query: 268 RNLVVLNLFGNNFSGPIPAEI--GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
               +L+L  NN S  + AE     ++ L +L L  N+   +  E+ + +  L  LDLSS
Sbjct: 39  SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97

Query: 326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI 385
           N                 +  L    + D         L  +  L L +N+         
Sbjct: 98  N----------------HLHTLDEFLFSD---------LQALEVLLLYNNHIV------- 125

Query: 386 SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPP----SIGNLTSLL 440
                              +    + +M  LQ L LS N+++   P         L  L+
Sbjct: 126 ------------------VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLM 166

Query: 441 WLMLANNSLSGEIPGEIGNCTSL--LWLNLSNN 471
            L L++N L      ++    +     L L NN
Sbjct: 167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 48/212 (22%), Positives = 76/212 (35%), Gaps = 33/212 (15%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPE-SLLNLSKLEVLDLSSNNFGGEVQKI----FGR 338
           +P  + S      L L  NN   +  E +   L+ L  L LS N+    +  I    F  
Sbjct: 33  VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH----LNFISSEAFVP 86

Query: 339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILA 397
              ++ L L SN  +  ++      L  +  L L +N+    +       M  L+ L L+
Sbjct: 87  VPNLRYLDLSSNH-LHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLS 144

Query: 398 HNRFNGSIPA----VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL--LWLMLANNSLSG 451
            N+ +   P         +P L  LDLS N+L       +  L +     L L NN L  
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL-- 201

Query: 452 EIPGEIGNCT-SLLWL--NLSNNKLSGNIPPE 480
                   C   L  L  +    +LS  +  +
Sbjct: 202 -------ECDCKLYQLFSHWQYRQLSSVMDFQ 226

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 41/217 (18%), Positives = 72/217 (33%), Gaps = 62/217 (28%)

Query: 64  SSPCEWPGIICSPDKARVNGLNLTDW--NISGDI------FNN---------FSALTQLS 106
            + C     +C+ +    +   L +   ++           NN          + LT L 
Sbjct: 13  PANC-----LCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLH 67

Query: 107 YLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHG 163
            L LS N  +  I  +      +L+YL+LS N L    +   S L++LE+L L  N I  
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV- 125

Query: 164 EISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNN--------FRGNIW 215
                              ++         F+    L+ L LS N          +    
Sbjct: 126 ------------------VVDRNA------FEDMAQLQKLYLSQNQISRFPVELIKD--G 159

Query: 216 NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
           N L +L+   +S N L   +  +  ++  +     L 
Sbjct: 160 NKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 29/120 (24%), Positives = 45/120 (37%), Gaps = 8/120 (6%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDD-LSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILD 155
           F  +  L YLDLS N    ++ +   S  ++L+ L L +N +          +  L+ L 
Sbjct: 84  FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142

Query: 156 LSVNRIHG--EISFSFPAICEKLVVANLSLNNLTGRIDTCFDGC--LNLRYLDLSSNNFR 211
           LS N+I               KL++ +LS N L     T            L L +N   
Sbjct: 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 30/113 (26%), Positives = 52/113 (46%), Gaps = 8/113 (7%)

Query: 564 TGYLQLSGNQLSGELSPDI--GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRN 619
           T  L LS N LS  L  +    +L N   + L  N  +  + S+ F  +P L  L+L+ N
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 620 NFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +    +    F +++ L+ L L  N+       +F ++ +L KL +S N +  
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 36/139 (25%), Positives = 49/139 (35%), Gaps = 18/139 (12%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L LS N L+  +S +    + N   + L  N     L    F  L  L VL L  N+  
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125

Query: 623 GEIPSE-FGNIKCLQNLDLSYNNFS----GPFPASFNNLTELSKLNISYNPLVSGTIPST 677
             +    F ++  LQ L LS N  S           N L +L  L++S N L        
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLDLSSNKL------KK 177

Query: 678 GQLATFEKTSYLGDPLLDL 696
             L   +K        L L
Sbjct: 178 LPLTDLQKLPAWVKNGLYL 196

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 31/112 (27%), Positives = 41/112 (36%), Gaps = 10/112 (8%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
           YL LS N L   L   +   LQ   ++ L  N       + F+ +  L  L L++N  S 
Sbjct: 92  YLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS- 149

Query: 624 EIPSE----FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSK--LNISYNPL 669
             P E       +  L  LDLS N            L    K  L +  NPL
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 28/224 (12%)

Query: 764 MKYRHDLASSSGGSSPWLSDTVKVIRLDK--TAFTYSDILKATGKFSEDRIIGKGGFGTV 821
           M + H  +S     +  L        L+   T    +D      ++       +   G +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSG--RQWKLKSFQTRDNQGIL 58

Query: 822 YRGV---------LPDGREVAVK------KLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
           Y             P  ++ ++K      +L  E    +R  +          +  P   
Sbjct: 59  YEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118

Query: 867 LVTLYGWCLDGSE-KILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHH 923
           + T  G+ +   + + LV   + G SL+  +  S +  L+ R  L +A  +  AL FLH 
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177

Query: 924 ECYPPIVHRDVKASNVLLDKEGKALVT--DFGLARVVSAGDSHV 965
             Y   VH +V A N+ +D E ++ VT   +G A        HV
Sbjct: 178 NEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 8e-14
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 25/214 (11%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNG 859
               + + + +G G +G V   V    G +VA+KKL R     L  +R +R E+ +L    
Sbjct: 24   RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH-- 80

Query: 860  FGWPHPNLVTLY-----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
                H N++ L         LD      LV  +M    L  ++    +L   R   +   
Sbjct: 81   --MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-KLGEDRIQFLVYQ 136

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV 973
            + + L ++H      I+HRD+K  N+ ++++ +  + DFGLAR     DS ++  +  T 
Sbjct: 137  MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVV-TR 189

Query: 974  GYVAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
             Y APE    W   T+  D++S G +  E+ TG+
Sbjct: 190  WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 40/234 (17%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
             +    +IG+G +G VY        + VA+KK+ R   + ++ +R  R E+ +L  N   
Sbjct: 27   NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITIL--NRLK 83

Query: 862  WPHPNLVTLYGWCLDGSEKI-----LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                 ++ LY   +           +V E  +   L+ +      LT      I  ++  
Sbjct: 84   --SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL 140

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV--- 973
               F+H      I+HRD+K +N LL+++    V DFGLAR +++                
Sbjct: 141  GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 974  ------------GYV------APEYGQTWQATTKG-DVYSFGVLAMELATGRRA 1008
                         +V      APE     +  TK  D++S G +  EL    ++
Sbjct: 198  GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 40/195 (20%), Positives = 79/195 (40%), Gaps = 20/195 (10%)

Query: 806 KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQRE---GLEGEREFRAEMEVLSGNGFG 861
           ++    +IG G +G V       + R VA+KK+ R     ++ +R  R E+ +L  N   
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAIL--NRLN 110

Query: 862 WPHPNLVTLY----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
             H ++V +        ++  +++ +V E  +    + +      LT      +  ++  
Sbjct: 111 --HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV 167

Query: 917 ALVFLH-HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            + ++H       I+HRD+K +N L++++    V DFGLAR V   ++  S         
Sbjct: 168 GVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 976 VAPEYGQTWQATTKG 990
                        K 
Sbjct: 224 DMNLVTFPHTKNLKR 238

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 38/178 (21%), Positives = 63/178 (35%), Gaps = 21/178 (11%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG---EREFRAEMEVLSGNGF 860
            ++   + IG GGFG +Y         + A   ++ E  E      E +    V   +  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 861 G-WPHPNLVTLYG-----WC-----LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLD 909
             W     +   G               S + +V E + G  L+ I            L 
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQ 155

Query: 910 IAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT--DFGLARVVSAGDSHV 965
           + I +   L ++H   Y   VH D+KA+N+LL  +    V   D+GL+       +H 
Sbjct: 156 LGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 35/184 (19%), Positives = 61/184 (33%), Gaps = 30/184 (16%)

Query: 805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVK-------------KLQREG-----LEGER 846
             +     IG+GGFG +Y   +     V                 L  E           
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 847 EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTR-LT 903
           + +  +        G P        G      +    ++ +   G  L+ I     +  +
Sbjct: 95  QIQKWIRTRKLKYLGVPK---YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFS 150

Query: 904 WRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT--DFGLARVVSAG 961
            +  L +++ +   L ++H   Y   VH D+KASN+LL+ +    V   D+GLA      
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 962 DSHV 965
             H 
Sbjct: 208 GVHK 211

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
            ++     +G G +G+V        G  VAVKKL R     +  +R +R E+ +L      
Sbjct: 30   RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH---- 84

Query: 862  WPHPNLVTLY-----GWCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
              H N++ L         L+    + LV   M    L +I+  + +LT      +   + 
Sbjct: 85   MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-KLTDDHVQFLIYQIL 142

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
            R L ++H      I+HRD+K SN+ ++++ +  + DFGLAR      +   T    T  Y
Sbjct: 143  RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT----ADEMTGYVATRWY 195

Query: 976  VAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
             APE    W    +  D++S G +  EL TGR
Sbjct: 196  RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQ--REGLEGEREFRAEMEVLSGNGFGW 862
            +++    IG+G +G V       +   VA+KK+         +R  R E+++L      +
Sbjct: 28   RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR----F 82

Query: 863  PHPNLVTLYG----WCLDGSEKI-LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
             H N++ +        ++  + + +V + ME   L  ++  +  L+          + R 
Sbjct: 83   RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRG 140

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAGTVGY 975
            L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    T  Y
Sbjct: 141  LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 976  VAPEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
             APE     +  TK  D++S G +  E+ + R
Sbjct: 198  RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK----KLQREGLEGEREFRAEMEVLSGNG 859
            ++   R IG G FG +Y G  +  G EVA+K    K +   L  E +     +++ G G
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---YKMMQG-G 64

Query: 860 FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARAL 918
            G P      +     +G   ++V E + G SLED+ +  +R  + +  L +A  +   +
Sbjct: 65  VGIPT-----IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118

Query: 919 VFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLAR 956
            ++H + +   +HRDVK  N L+    K     + DFGLA+
Sbjct: 119 EYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 8e-13
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 36/228 (15%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQR---EGLEGEREFRAEMEVLSGNGFG 861
            K+   + +GKG +G V++ +    G  VAVKK+        + +R FR E+ +L      
Sbjct: 10   KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMIL--TELS 66

Query: 862  WPHPNLVTLYGWCL--DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
              H N+V L       +  +  LV++YME   L  +I     L    +  +   + + + 
Sbjct: 67   -GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIK 123

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTV------ 973
            +LH      ++HRD+K SN+LL+ E    V DFGL+R         +             
Sbjct: 124  YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 974  --------GYV------APEYGQTWQATTKG-DVYSFGVLAMELATGR 1006
                     YV      APE        TKG D++S G +  E+  G+
Sbjct: 181  DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 31/112 (27%), Positives = 46/112 (41%), Gaps = 4/112 (3%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLS 157
             +A+ +L  LD  ++   G I    +   +L++L+L +  L    NL  L  L+ L+LS
Sbjct: 22  TPAAVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELS 79

Query: 158 VNRIHGEISFSFPAICEKLVVANLSLNNLTGRID-TCFDGCLNLRYLDLSSN 208
            NRI G            L   NLS N L              L+ LDL + 
Sbjct: 80  ENRIFG-GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 8/137 (5%)

Query: 292 SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS 351
           SG   + + +   L +   +   + +L VLD   +N G +++ +   F  ++ L+L +  
Sbjct: 3   SGSSGMDMKRRIHLELRNRTPAAVREL-VLDNCKSNDG-KIEGLTAEFVNLEFLSLINVG 60

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY-- 409
            +  +  S + KLP + +L+LS N   G L +   ++ +L  L L+ N+    I  +   
Sbjct: 61  -LISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPL 116

Query: 410 GNMPNLQTLDLSFNELT 426
             +  L++LDL   E+T
Sbjct: 117 KKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.1 bits (133), Expect = 8e-09
 Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 9/89 (10%)

Query: 390 SLKFLILAHNRFN-GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL---TSLLWLMLA 445
           +++ L+L + + N G I  +     NL+ L L    L      S+ NL     L  L L+
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELS 79

Query: 446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
            N + G +        +L  LNLS NKL 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 7/120 (5%)

Query: 90  NISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSG-- 147
           +  G I    +    L +L L       S+  +L     LK L LS N + G L++    
Sbjct: 36  SNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEK 93

Query: 148 LRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID---TCFDGCLNLRYLD 204
           L +L  L+LS N++    +       E L   +L    +T   D   + F     L YLD
Sbjct: 94  LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 7/123 (5%)

Query: 331 EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE-ISQMR 389
            ++        V+ L L +    DG       +  N+  L L +        V  + ++ 
Sbjct: 15  HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLP 71

Query: 390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP--IPPSIGNLTSLLWLMLANN 447
            LK L L+ NR  G +  +   +PNL  L+LS N+L     + P +  L  L  L L N 
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130

Query: 448 SLS 450
            ++
Sbjct: 131 EVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 45/190 (23%), Positives = 64/190 (33%), Gaps = 52/190 (27%)

Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGL 218
            RIH E+    PA   +LV+ N   N+  G+I+      +NL +L L +        + L
Sbjct: 12  RRIHLELRNRTPAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLI--SVSNL 67

Query: 219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN 278
            +L                        L+  +LSEN   G          NL  LNL GN
Sbjct: 68  PKLP----------------------KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105

Query: 279 NFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN---NFGGEVQKI 335
                    +  IS LE L                 L  L+ LDL +    N     + +
Sbjct: 106 K--------LKDISTLEPLK---------------KLECLKSLDLFNCEVTNLNDYRESV 142

Query: 336 FGRFTQVKIL 345
           F    Q+  L
Sbjct: 143 FKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 40/152 (26%), Positives = 57/152 (37%), Gaps = 32/152 (21%)

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
           VL+   +N  G I         LE L L  N  L  +  +L  L KL+ L+LS N     
Sbjct: 30  VLDNCKSN-DGKIEGLTAEFVNLEFLSLI-NVGLISV-SNLPKLPKLKKLELSENR---- 82

Query: 332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE-ISQMRS 390
                                I G       KLPN++ L+LS N       +E + ++  
Sbjct: 83  ---------------------IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC 121

Query: 391 LKFLILAHN---RFNGSIPAVYGNMPNLQTLD 419
           LK L L +      N    +V+  +P L  LD
Sbjct: 122 LKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 70.7 bits (173), Expect = 1e-12
 Identities = 61/425 (14%), Positives = 126/425 (29%), Gaps = 50/425 (11%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDL----SSCRSLKYLNLSHNILS-GDLNL--SGLRS 150
                   +  +L  + + G +   +    SS   L+ + L   +++   L L     ++
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131

Query: 151 LEILDLS-VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCF----DGCLNLRYLDL 205
            ++L LS       +   +  A C  L   +L  +++            D   +L  L++
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191

Query: 206 SSNNFR------GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS------E 253
           S             +      L    ++  V    + +++ +    LE            
Sbjct: 192 SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKL-ATLLQRAPQLEELGTGGYTAEVR 250

Query: 254 NEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL 313
            +        +S C+ L  L+ F +     +PA     S L  L L      S     LL
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310

Query: 314 -NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI---------LK 363
               KL+ L +        ++ +      ++ L +  +       +  +         + 
Sbjct: 311 CQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG 370

Query: 364 LPNISRLDLSHNNFTG--------PLP----VEISQMRSLKFLILAHNRFNGSIPAVYGN 411
            P +  +       T           P      +  +       L     +    A+  +
Sbjct: 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH 430

Query: 412 MPNLQTLDLSFNELTGPIPPSIG-NLTSLLWLMLANNSLSGEIPGEIG-NCTSLLWLNLS 469
             +L+ L LS   LT  +   IG     +  L +A    S      +   C SL  L + 
Sbjct: 431 CKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489

Query: 470 NNKLS 474
           +    
Sbjct: 490 DCPFG 494

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 67.2 bits (164), Expect = 2e-11
 Identities = 67/437 (15%), Positives = 133/437 (30%), Gaps = 73/437 (16%)

Query: 84  LNLTDWNISGDIFNNFSA-LTQLSYLDLSRNTFSGSIPDD-----LSSCRSLKYLNLSHN 137
           + L    ++ D     +        L LS          D      ++CR+LK L+L  +
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE---GFSTDGLAAIAATCRNLKELDLRES 166

Query: 138 ILS--GDLNLS----GLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
            +       LS       SL  L++S   +  E+SFS             +L  L     
Sbjct: 167 DVDDVSGHWLSHFPDTYTSLVSLNIS--CLASEVSFS-------------ALERLV---- 207

Query: 192 TCFDGCLNLRYLDLS---SNNFRGNIWNGLAQLVEFSV---SENVLSGVVSSSVFKENCS 245
                C NL+ L L+          +     QL E      +  V   V S      +  
Sbjct: 208 ---TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264

Query: 246 LEIFDLSENEFIGD--FPGEVSNCRNLVVLNLFGNNFSGP-IPAEIGSISGLEALFLGKN 302
            E+  LS          P   S C  L  LNL         +   +     L+ L++   
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILAL--------HSNSYID 354
              + +         L  L +  +             T+  ++++            +  
Sbjct: 325 IEDAGLEVLASTCKDLRELRVFPSEPFVMEP--NVALTEQGLVSVSMGCPKLESVLYFCR 382

Query: 355 GMNSSGILKL----PNISRLDLSHNNFTGPLPVEISQM-----------RSLKFLILAHN 399
            M ++ ++ +    PN++R  L       P  + +  +           + L+ L L+  
Sbjct: 383 QMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL 442

Query: 400 RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIG-NLTSLLWLMLANNSLSGE-IPGEI 457
             +     +      ++ L ++F   +      +     SL  L + +     + +    
Sbjct: 443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANA 502

Query: 458 GNCTSLLWLNLSNNKLS 474
               ++  L +S+  +S
Sbjct: 503 SKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 61.8 bits (150), Expect = 8e-10
 Identities = 56/378 (14%), Positives = 110/378 (29%), Gaps = 77/378 (20%)

Query: 101 ALTQLSYLDLS-RNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN 159
            + +     +   N ++ S    +     ++ + L       D NL        +   + 
Sbjct: 39  EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE 98

Query: 160 RIHGEISFSFPAICEKLVVANLSLNNLTGR-IDTCFDGCLNLRYLDLSSNNFRGNIWNGL 218
            +         +    L    L    +T   ++       N + L LSS           
Sbjct: 99  AMS--------SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE--------- 141

Query: 219 AQLVEFSVSENVLSGVVSSSVFKENCS-LEIFDLSENEFIGDFPGEVS----NCRNLVVL 273
                   S + L+ + +       C  L+  DL E++        +S       +LV L
Sbjct: 142 ------GFSTDGLAAIAA------TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189

Query: 274 NLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQ 333
           N+  +  +  +     S S LE L              +     L+ L L+      ++ 
Sbjct: 190 NI--SCLASEV-----SFSALERL--------------VTRCPNLKSLKLNRAVPLEKLA 228

Query: 334 KIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKF 393
            +  R  Q++ L     +                        +    L V +S  + L+ 
Sbjct: 229 TLLQRAPQLEELGTGGYT-------------------AEVRPDVYSGLSVALSGCKELRC 269

Query: 394 LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP-IPPSIGNLTSLLWLMLANNSLSGE 452
           L    +     +PAVY     L TL+LS+  +    +   +     L  L + +      
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAG 329

Query: 453 IPGEIGNCTSLLWLNLSN 470
           +      C  L  L +  
Sbjct: 330 LEVLASTCKDLRELRVFP 347

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 57.6 bits (139), Expect = 2e-08
 Identities = 61/364 (16%), Positives = 116/364 (31%), Gaps = 38/364 (10%)

Query: 85  NLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSH-NILSGDL 143
                ++   +    S   +L  L    +     +P   S C  L  LNLS+  + S DL
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL 306

Query: 144 N--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS---------LNNLTGR-ID 191
              L     L+ L +  + I         + C+ L    +             LT + + 
Sbjct: 307 VKLLCQCPKLQRLWVL-DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365

Query: 192 TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
           +   GC  L  +              L  +     +       +      +  +LE  D+
Sbjct: 366 SVSMGCPKLESVLYFCRQMT---NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG-LEALFLGKNNFLSVIPE 310
                   F   V +C++L  L+L G   +  +   IG+ +  +E L +       +   
Sbjct: 423 G-------FGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474

Query: 311 SLL-NLSKLEVLDLSSNNFGGE-VQKIFGRFTQVKILALHSNSYIDGMNSSGILKL---- 364
            +L     L  L++    FG + +     +   ++ L + S S    ++      L    
Sbjct: 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS----VSFGACKLLGQKM 530

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
           P ++   +         P      R   +  +A  RF+  +P    NM    T+  S   
Sbjct: 531 PKLNVEVIDERGAPDSRPESCPVERVFIYRTVAGPRFD--MPGFVWNMDQDSTMRFSRQI 588

Query: 425 LTGP 428
           +T  
Sbjct: 589 ITTN 592

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 20/161 (12%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK--KLQREGLEGEREFRAEMEVLSGNGFG 861
             F   + IG G FG +  G  L     VA+K   ++    +   E+R   ++ SG+G  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGI- 67

Query: 862 WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVF 920
            P      +Y +   G    +V E + G SLED+     R  + +  L IAI +   + +
Sbjct: 68  -PQ-----VYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 921 LHHECYPPIVHRDVKASNVLLDKEG-----KALVTDFGLAR 956
           +H +     ++RDVK  N L+ + G        + DF LA+
Sbjct: 121 VHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 20/161 (12%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK--KLQREGLEGEREFRAEMEVLSGNGFG 861
             +   R IG+G FG ++ G  L + ++VA+K    + +  +   E+R    +    G  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI- 68

Query: 862 WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVF 920
            P+     +Y +  +G   +LV + + G SLED++    R  + +     A  +   +  
Sbjct: 69  -PN-----VYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 921 LHHECYPPIVHRDVKASNVLLDKEG-----KALVTDFGLAR 956
           +H +     V+RD+K  N L+ +          V DFG+ +
Sbjct: 122 IHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 30/182 (16%)

Query: 98  NFSALTQLSYLDLSRNTFSG--SIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILD 155
                T+   ++L          +   LS+ ++ K+L LS N +    +LSG+ +L IL 
Sbjct: 18  KSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILS 76

Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIW 215
           L  N I  +I  +  A+ + L    +S N +   +    +  +NLR L +S+N      W
Sbjct: 77  LGRNLIK-KIE-NLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITN--W 130

Query: 216 NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN--EFIGDFPGEVSNCRNLVVL 273
             + +L                        LE   L+ N            S  R  VV 
Sbjct: 131 GEIDKL-------------------AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171

Query: 274 NL 275
            L
Sbjct: 172 RL 173

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 34/152 (22%), Positives = 57/152 (37%), Gaps = 36/152 (23%)

Query: 132 LNLSHN-ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRI 190
           L+     I   D  LS L++ + L LS N I                     +++L    
Sbjct: 30  LHGMIPPIEKMDATLSTLKACKHLALSTNNIE-------------------KISSL---- 66

Query: 191 DTCFDGCLNLRYLDLSSNNFR--GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEI 248
                G  NLR L L  N  +   N+      L E  +S N ++ +   S  ++  +L +
Sbjct: 67  ----SGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL---SGIEKLVNLRV 119

Query: 249 FDLSENEFIGDFPG--EVSNCRNLVVLNLFGN 278
             +S N  I ++    +++    L  L L GN
Sbjct: 120 LYMSNN-KITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 29/154 (18%), Positives = 63/154 (40%), Gaps = 20/154 (12%)

Query: 287 EIGSISGLEALFL-GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI--FGRFTQVK 343
           +    +  E + L G    +  +  +L  L   + L LS+NN     +KI        ++
Sbjct: 18  KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----EKISSLSGMENLR 73

Query: 344 ILALHSN--SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE-ISQMRSLKFLILAHNR 400
           IL+L  N    I+ +++        +  L +S+N       +  I ++ +L+ L +++N+
Sbjct: 74  ILSLGRNLIKKIENLDA----VADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNK 126

Query: 401 FNGSIPAVY--GNMPNLQTLDLSFNELTGPIPPS 432
              +   +     +  L+ L L+ N L      +
Sbjct: 127 IT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 8/89 (8%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+L    I   I N  +    L  L +S N  + S+   +    +L+ L +S+N ++ + 
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NW 130

Query: 144 N----LSGLRSLEILDLSVNRIHGEISFS 168
                L+ L  LE L L+ N ++ +   +
Sbjct: 131 GEIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 3e-11
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 22/161 (13%)

Query: 805 GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK----KLQREGLEGEREFRAEMEVLSGNG 859
            KF   R IG G FG +Y G  +    EVA+K    K +   L  E +      +L G G
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI---YRILQG-G 62

Query: 860 FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARAL 918
            G P+     +  + ++G   +LV + + G SLED+ +  +R L+ +  L +A  +   +
Sbjct: 63  TGIPN-----VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116

Query: 919 VFLHHECYPPIVHRDVKASNVLLDKEGKA---LVTDFGLAR 956
            F+H + +   +HRD+K  N L+    +A    + DFGLA+
Sbjct: 117 EFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 33/136 (24%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 340 TQVKILALHSNSYIDGMNSSGIL-KLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILA 397
                L L++N     + ++GI  KLP + +++ S+N  T  +          +  ++L 
Sbjct: 32  QYTAELRLNNNE-FTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLT 89

Query: 398 HNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPG 455
            NR   ++   ++  + +L+TL L  N +T  +       L+S+  L L +N ++   PG
Sbjct: 90  SNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPG 147

Query: 456 EIGNCTSLLWLNLSNN 471
                 SL  LNL  N
Sbjct: 148 AFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 24/118 (20%), Positives = 51/118 (43%), Gaps = 6/118 (5%)

Query: 365 PNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSF 422
              + L L++N FT      I  ++  L+ +  ++N+    I    +     +  + L+ 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 423 NELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
           N L   +   +   L SL  LML +N ++          +S+  L+L +N+++  + P
Sbjct: 91  NRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 8/92 (8%)

Query: 394 LILAHNRFNGSIP--AVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLS 450
           L L +N F   +    ++  +P L+ ++ S N++T  I        + +  ++L +N L 
Sbjct: 37  LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE 94

Query: 451 GEIPGEI-GNCTSLLWLNLSNNKLSGNIPPEV 481
             +  ++     SL  L L +N+++  +  + 
Sbjct: 95  -NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 23/107 (21%), Positives = 44/107 (41%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            +  S N+++ ++           + + L  N+ +      F  L  L  L L  N  + 
Sbjct: 61  KINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT- 118

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            + ++ F  +  ++ L L  N  +   P +F+ L  LS LN+  NP 
Sbjct: 119 CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 6/112 (5%)

Query: 564 TGYLQLSGNQLSGELSPDIG--KLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNN 620
           T  L+L+ N+ +  L       KL     ++   N+        F+    +  + LT N 
Sbjct: 34  TAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92

Query: 621 FSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               +  + F  ++ L+ L L  N  +     SF  L+ +  L++  N + +
Sbjct: 93  LE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 15/120 (12%)

Query: 99  FSALTQLSYLDLSRNTFSGSIP----DDLSSCRSLKYLNLSHNIL----SGDLNLSGLRS 150
           F  L QL  ++ S N  +  I     +  S    +  + L+ N L           GL S
Sbjct: 53  FKKLPQLRKINFSNNKIT-DIEEGAFEGAS---GVNEILLTSNRLENVQHKM--FKGLES 106

Query: 151 LEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF 210
           L+ L L  NRI    + SF  +   + + +L  N +T      FD   +L  L+L +N F
Sbjct: 107 LKTLMLRSNRITCVGNDSFIGL-SSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 9/136 (6%)

Query: 199 NLRYLDLSSNNFR----GNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
               L L++N F       I+  L QL + + S N ++  +    F+    +    L+ N
Sbjct: 33  YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91

Query: 255 EFIGDFPGEV-SNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGKNNFLSVIPESL 312
             + +   ++     +L  L L  N  +  +  +    +S +  L L  N   +V P + 
Sbjct: 92  R-LENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149

Query: 313 LNLSKLEVLDLSSNNF 328
             L  L  L+L +N F
Sbjct: 150 DTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 34/169 (20%), Positives = 58/169 (34%), Gaps = 34/169 (20%)

Query: 118 SIPDDLSSCRSLKYLNLSHN---ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICE 174
            IP+ +        L L++N   +L        L  L  ++ S N+I             
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-----DIEE--- 74

Query: 175 KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN---NFRGNIWNGLAQLVEFSVSENVL 231
                              F+G   +  + L+SN   N +  ++ GL  L    +  N +
Sbjct: 75  -----------------GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117

Query: 232 SGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNF 280
           +  V +  F    S+ +  L +N+     PG      +L  LNL  N F
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 38/229 (16%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRA---EMEVLS-------GNG 859
            R +G G F TV+    + +   VA+K ++ +    +    A   E+++L           
Sbjct: 25   RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 860  FGWPHPNLVTLYGW----CLDGSEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAID 913
                  +++ L         +G   ++V+E + G +L  +I       +       I+  
Sbjct: 81   DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVT------DFGLARVVSAGDSHVST 967
            +   L ++H  C   I+H D+K  NVL++              D G A      D H + 
Sbjct: 140  LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTN 194

Query: 968  TIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            +I  T  Y +PE   G  W      D++S   L  EL TG    E  E 
Sbjct: 195  SIQ-TREYRSPEVLLGAPW--GCGADIWSTACLIFELITGDFLFEPDEG 240

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 54/347 (15%), Positives = 91/347 (26%), Gaps = 65/347 (18%)

Query: 100 SALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN 159
             L  L      +          L     L +L   +   +   +   L SL  L+L+  
Sbjct: 23  KNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGV 82

Query: 160 RIHGEISFSFPAICEKLVVA-------NLSLNNLTGRIDTCFDGCL-------NLRYLDL 205
           R+   +  +   +   L          NL+   L         G           R L L
Sbjct: 83  RM-TPVKCT--VVAAVLGSGRHALDEVNLASCQLDP------AGLRTLLPVFLRARKLGL 133

Query: 206 SSNNFRGN----IWNGL----AQLVEFSVSENVL--SGVVS-SSVFKENCSLEIFDLSEN 254
             N+        + + L     Q+    +S N L  +GV         N S+    L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 255 EFIGDFPGE-----VSNCRNLVVLNLFGNNFSGPIPAEIGSI----SGLEALFLGKNNF- 304
             +GD   E     +   R L  LN+  N         +         LE L L  N   
Sbjct: 194 G-LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

Query: 305 ------LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNS 358
                 L  +  +    +++ V              I             + +  D    
Sbjct: 253 SEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSE-------VQRNLNSWDRARV 305

Query: 359 SGILKLPNISRLDLSHNNFTGPLPVEISQM----RSLKFLILAHNRF 401
              L+L      DL  +      P   +Q+      ++ L+      
Sbjct: 306 QRHLEL---LLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 49/291 (16%), Positives = 85/291 (29%), Gaps = 66/291 (22%)

Query: 100 SALTQLSYLDLSRNTFSGSIPDD--------LSSCRSLKYLNLSHNILSGD----LNLSG 147
             L+ L  L+L+    +   P           S   +L  +NL+   L       L L  
Sbjct: 69  EVLSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPV 124

Query: 148 LRSLEILDLSVNRIHGEISFSFPAICEKLVVAN-------LSLNNLTGR----IDTCFDG 196
                 L L +N +  E   +   + + L+          LS N LT      +     G
Sbjct: 125 FLRARKLGLQLNSLGPE---ACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181

Query: 197 CLNLRYLDLSSNNFRGN----IWNGLAQ---LVEFSVSENVL--SGVVS-SSVFKENCSL 246
             ++ +L L            +   L +   L E +V+ N    +  ++ +   +E+ SL
Sbjct: 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241

Query: 247 EIFDLSENEF-------IGDFPGEVSNCRNLVVLNLFGNNFS---------------GPI 284
           E+  L  NE        + D  G       +VV    G   S                  
Sbjct: 242 ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWD 301

Query: 285 PAEIGSISGLEALFLGKNNF----LSVIPESLLNLSKLEVLDLSSNNFGGE 331
            A +     L    L  +           + L    ++  L     + G  
Sbjct: 302 RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSP 352

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 36/199 (18%), Positives = 59/199 (29%), Gaps = 38/199 (19%)

Query: 294 LEALFLGKNNF----LSVIPESLL-NLSKLEVLDLSSNNFGGE-VQKIFGRFTQVKILAL 347
           L  L L          +V+   L      L+ ++L+S       ++ +   F + + L L
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 348 HSNSYID-GMNS-SGILKLPNIS--RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG 403
             NS           +L         L LS+N  T      + +        LA N    
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEG-------LAGNT--- 183

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGP----IPPSIGNLTSLLWLMLANNSLSGE----IPG 455
                     ++  L L    L       +   +     L  L +A N         +  
Sbjct: 184 ----------SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233

Query: 456 EIGNCTSLLWLNLSNNKLS 474
                 SL  L+L  N+LS
Sbjct: 234 AAREHPSLELLHLYFNELS 252

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 3/112 (2%)

Query: 98  NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLS 157
            ++   +   LDL        I +  ++      ++ S N +        LR L+ L ++
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVN 72

Query: 158 VNRIHGEISFSFPAICEKLVVANLSLNNLTGRID-TCFDGCLNLRYLDLSSN 208
            NRI   I          L    L+ N+L    D        +L YL +  N
Sbjct: 73  NNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 20/119 (16%), Positives = 39/119 (32%), Gaps = 7/119 (5%)

Query: 310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISR 369
               N  +   LDL        ++ +     Q   +    N  I  +   G   L  +  
Sbjct: 13  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNE-IRKL--DGFPLLRRLKT 68

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVY--GNMPNLQTLDLSFNELT 426
           L +++N            +  L  LIL +N     +  +    ++ +L  L +  N +T
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 11/108 (10%)

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
           + L+          + +     + L L   +    I  +   +     +D S NE+    
Sbjct: 2   VKLTAELIE--QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55

Query: 430 PPSIGN---LTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
              +     L  L  L++ NN +     G       L  L L+NN L 
Sbjct: 56  --KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 26/157 (16%), Positives = 55/157 (35%), Gaps = 39/157 (24%)

Query: 320 VLDLSSNNFGGEVQKI--FGRFTQVKILALHSN--SYIDGMNSSGILKLPNISRLDLSHN 375
           ++ L++      +++   +    + + L L       I+ + ++    L     +D S N
Sbjct: 1   MVKLTAEL----IEQAAQYTNAVRDRELDLRGYKIPVIENLGAT----LDQFDAIDFSDN 52

Query: 376 NFTGPLPVE-ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIG 434
                  ++    +R LK L++ +NR       +   +P+L  L L+ N         + 
Sbjct: 53  EIR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LV 101

Query: 435 NLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
            L  L  L                +  SL +L +  N
Sbjct: 102 ELGDLDPL---------------ASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 4/88 (4%)

Query: 123 LSSCRSLKYLNLSHNILSGDLNL-SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
            ++    + L+L    +    NL + L   + +D S N I     F       +L    +
Sbjct: 15  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPL---LRRLKTLLV 71

Query: 182 SLNNLTGRIDTCFDGCLNLRYLDLSSNN 209
           + N +    +       +L  L L++N+
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNS 99

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 21/81 (25%), Positives = 35/81 (43%), Gaps = 5/81 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--G 141
           ++ +D  I     + F  L +L  L ++ N           +   L  L L++N L   G
Sbjct: 47  IDFSDNEIR--KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104

Query: 142 DL-NLSGLRSLEILDLSVNRI 161
           DL  L+ L+SL  L +  N +
Sbjct: 105 DLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 24/151 (15%), Positives = 43/151 (28%), Gaps = 30/151 (19%)

Query: 178 VANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR--GNIWNGLAQLVEFSVSENVLSGVV 235
           +  L+   +       +   +  R LDL         N+   L Q      S+N +  + 
Sbjct: 1   MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL- 57

Query: 236 SSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLE 295
               F     L+   ++ N       G      +L  L L  N+        +  +  L+
Sbjct: 58  --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLD 107

Query: 296 ALFLGKNNFLSVIPESLLNLSKLEVLDLSSN 326
            L                +L  L  L +  N
Sbjct: 108 PLA---------------SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 22/138 (15%), Positives = 41/138 (29%), Gaps = 20/138 (14%)

Query: 244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEA------L 297
                 DL   + I       +       ++   N        EI  + G         L
Sbjct: 19  VRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDN--------EIRKLDGFPLLRRLKTL 69

Query: 298 FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFG--GEVQKIFGRFTQVKILALHSNSYIDG 355
            +  N    +       L  L  L L++N+    G++  +      +  L +  N   + 
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS-LKSLTYLCILRNPVTNK 128

Query: 356 MN--SSGILKLPNISRLD 371
            +     I K+P +  LD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 4/112 (3%)

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFN 423
             I+ + L  N      P   S  + L+ + L++N+ +  +    +  + +L +L L  N
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 424 ELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           ++T  +P S+   L SL  L+L  N ++        +  +L  L+L +NKL 
Sbjct: 91  KITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 30/135 (22%), Positives = 59/135 (43%), Gaps = 7/135 (5%)

Query: 340 TQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAH 398
             +  + L  N+ I  +          + R+DLS+N  +  L  +    +RSL  L+L  
Sbjct: 32  ETITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYG 89

Query: 399 NRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPGE 456
           N+    +P  ++  + +LQ L L+ N++   +      +L +L  L L +N L     G 
Sbjct: 90  NKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147

Query: 457 IGNCTSLLWLNLSNN 471
                ++  ++L+ N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 21/154 (13%)

Query: 319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSN--SYIDGMNSSGIL-KLPNISRLDLSHN 375
             + L  N         F  + +++ + L +N  S +    +      L +++ L L  N
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL----APDAFQGLRSLNSLVLYGN 90

Query: 376 NFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI 433
             T  LP  +   + SL+ L+L  N+ N  +    + ++ NL  L L  N+L      + 
Sbjct: 91  KITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148

Query: 434 GNLTSLLWLMLANNSLSGEIPGEIGNCT-SLLWL 466
             L ++  + LA N            C   L WL
Sbjct: 149 SPLRAIQTMHLAQNPF---------ICDCHLKWL 173

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 7/116 (6%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDL-SSCRSLKYLNLSHNILSGDLN---LSGLRSLEIL 154
           FS   +L  +DLS N  S  +  D     RSL  L L  N ++ +L      GL SL++L
Sbjct: 52  FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLL 109

Query: 155 DLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF 210
            L+ N+I+     +F  +   L + +L  N L       F     ++ + L+ N F
Sbjct: 110 LLNANKINCLRVDAFQDL-HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 5/90 (5%)

Query: 394 LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGE 452
           + L  N      P  +     L+ +DLS N+++  + P     L SL  L+L  N ++ E
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 453 IPGEI-GNCTSLLWLNLSNNKLSGNIPPEV 481
           +P  +     SL  L L+ NK++  +  + 
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDA 123

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSG 623
            + LS NQ+S EL+PD    L++ + + L  N+      S F+ L  L +L L  N  + 
Sbjct: 60  RIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN- 117

Query: 624 EIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            +  + F ++  L  L L  N        +F+ L  +  ++++ NP 
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 7/112 (6%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNN 620
              ++L  N +   + P      +    + L  NQ   +L    F  L  L  L L  N 
Sbjct: 34  ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91

Query: 621 FSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
            + E+P   F  +  LQ L L+ N  +     +F +L  L+ L++  N L +
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT 142

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 49/179 (27%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLS-----GLRSLEILDLSVNRIH 162
           + L +NT     P   S  + L+ ++LS+N +S    L+     GLRSL  L L  N+I 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS---ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 163 GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG---NIWNGLA 219
                  P                     + F+G  +L+ L L++N       + +  L 
Sbjct: 94  -----ELPK--------------------SLFEGLFSLQLLLLNANKINCLRVDAFQDLH 128

Query: 220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN------------EFIGDFPGEVSN 266
            L   S+ +N L   ++   F    +++   L++N            +++   P E S 
Sbjct: 129 NLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADYLHTNPIETSG 186

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 29/172 (16%), Positives = 53/172 (30%), Gaps = 48/172 (27%)

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV 239
            L  N +       F     LR +DLS+N           Q+    ++ +   G+     
Sbjct: 38  RLEQNTIKVIPPGAFSPYKKLRRIDLSNN-----------QIS--ELAPDAFQGLR---- 80

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALF 298
                                        +L  L L+GN  +  +P  +   +  L+ L 
Sbjct: 81  -----------------------------SLNSLVLYGNKITE-LPKSLFEGLFSLQLLL 110

Query: 299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN 350
           L  N    +  ++  +L  L +L L  N      +  F     ++ + L  N
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 19/195 (9%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
            P +           L K +    + ++   L+ ++ +  ++++   +  +       V+
Sbjct: 13  FPDDA-FAET-IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVR 66

Query: 344 ILALHSNSYIDGMNSSGIL-KLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRF 401
            LAL  N     ++    L +L N++ L L+ N     LP  +  ++ +LK L+L  N+ 
Sbjct: 67  YLALGGNK----LHDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQL 121

Query: 402 NGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIP-GEIG 458
             S+P  V+  + NL  L+L+ N+L   +P  +   LT+L  L L+ N L   +P G   
Sbjct: 122 Q-SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178

Query: 459 NCTSLLWLNLSNNKL 473
             T L  L L  N+L
Sbjct: 179 KLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 10/148 (6%)

Query: 336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLI 395
                 +  +  +++      +  GI  LPN+  L L  N     +   + ++ +L +LI
Sbjct: 37  QNELNSIDQIIANNSDI---KSVQGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLI 91

Query: 396 LAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSIGN-LTSLLWLMLANNSLSGEI 453
           L  N+   S+P  V+  + NL+ L L  N+L   +P  + + LT+L +L LA+N L    
Sbjct: 92  LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLP 149

Query: 454 PGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            G     T+L  L+LS N+L  ++P  V
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQ-SLPEGV 176

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)

Query: 244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN 303
                 +L +            N  + ++ N   N+    +   I  +  +  L LG N 
Sbjct: 19  AETIKANLKKKSVTDAVTQNELNSIDQIIAN---NSDIKSVQG-IQYLPNVRYLALGGNK 74

Query: 304 FLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNS--SGI 361
            L  I  +L  L+ L  L L+ N        +F + T +K L L  N     + S   G+
Sbjct: 75  -LHDIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ----LQSLPDGV 128

Query: 362 L-KLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTL 418
             KL N++ L+L+HN     LP  +  ++ +L  L L++N+   S+P  V+  +  L+ L
Sbjct: 129 FDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186

Query: 419 DLSFNELTGPIPPSI-GNLTSLLWLMLANN 447
            L  N+L   +P  +   LTSL ++ L +N
Sbjct: 187 RLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 38/124 (30%), Positives = 55/124 (44%), Gaps = 13/124 (10%)

Query: 553 LPGLASRTFQITGYLQLSGNQLSGELSPDIG---KLQNFSMVHLGFNQFDGKLPSQ-FDQ 608
           + G+         YL L GN+L      DI    +L N + + L  NQ    LP+  FD+
Sbjct: 56  VQGIQYLP--NVRYLALGGNKLH-----DISALKELTNLTYLILTGNQL-QSLPNGVFDK 107

Query: 609 LP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYN 667
           L  L  L L  N         F  +  L  L+L++N         F+ LT L++L++SYN
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167

Query: 668 PLVS 671
            L S
Sbjct: 168 QLQS 171

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 5/107 (4%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGE 624
            +  + + +       I  L N   + LG N+    + +   +L  L  L LT N     
Sbjct: 45  QIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSL 100

Query: 625 IPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
               F  +  L+ L L  N         F+ LT L+ LN+++N L S
Sbjct: 101 PNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 41/115 (35%), Positives = 50/115 (43%), Gaps = 7/115 (6%)

Query: 564 TGYLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNN 620
             YL L+GNQL   L   +  KL N   + L  NQ    LP   FD+L  L  LNL  N 
Sbjct: 87  LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144

Query: 621 FSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIP 675
                   F  +  L  LDLSYN         F+ LT+L  L +  N L S  +P
Sbjct: 145 LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS--VP 197

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 7/109 (6%)

Query: 366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNE 424
           +++ L L  N FT  +P E+S  + L  + L++NR + ++    + NM  L TL LS+N 
Sbjct: 32  DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89

Query: 425 LTGPIPPSI-GNLTSLLWLMLANNSLSGEIP-GEIGNCTSLLWLNLSNN 471
           L   IPP     L SL  L L  N +S  +P G   + ++L  L +  N
Sbjct: 90  LRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 3/82 (3%)

Query: 394 LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGE 452
           L L  N+F   +P    N  +L  +DLS N ++  +      N+T LL L+L+ N L   
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCI 93

Query: 453 IPGEIGNCTSLLWLNLSNNKLS 474
            P       SL  L+L  N +S
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 25/79 (31%), Positives = 36/79 (45%), Gaps = 6/79 (7%)

Query: 404 SIPAVYGNMP-NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS 462
            +P     +P ++  L L  N+ T  +P  + N   L  + L+NN +S        N T 
Sbjct: 24  VLPK---GIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79

Query: 463 LLWLNLSNNKLSGNIPPEV 481
           LL L LS N+L   IPP  
Sbjct: 80  LLTLILSYNRLR-CIPPRT 97

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 6/109 (5%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNF 621
              L L GNQ +  +  ++   ++ +++ L  N+    L +Q F  +  L+ L L+ N  
Sbjct: 33  VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRL 90

Query: 622 SGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
              IP   F  +K L+ L L  N+ S     +FN+L+ LS L I  NPL
Sbjct: 91  R-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 27/117 (23%), Positives = 46/117 (39%), Gaps = 27/117 (23%)

Query: 95  IFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEIL 154
                S + +L  LD SR+   G +         L++L+  +  L+   NL  L  L+ L
Sbjct: 12  RNRTPSDVKEL-VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKL 69

Query: 155 DLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR 211
           +LS NR+                         +G ++   + C NL +L+LS N  +
Sbjct: 70  ELSDNRV-------------------------SGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 28/115 (24%), Positives = 56/115 (48%), Gaps = 5/115 (4%)

Query: 314 NLSKLEVLDLSSNNFG-GEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL 372
             S ++ L L ++    G+++ +   F +++ L+   N  +  +  + + KL  + +L+L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSI--ANLPKLNKLKKLEL 71

Query: 373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLSFNELT 426
           S N  +G L V   +  +L  L L+ N+    S       + NL++LDL   E+T
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.1 bits (133), Expect = 6e-09
 Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 9/89 (10%)

Query: 390 SLKFLILAHNRFN-GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL---TSLLWLMLA 445
            +K L+L ++R N G +  +      L+ L      LT     SI NL     L  L L+
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72

Query: 446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           +N +SG +      C +L  LNLS NK+ 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 26/119 (21%), Positives = 48/119 (40%), Gaps = 5/119 (4%)

Query: 331 EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE-ISQMR 389
            ++      + VK L L ++   +G       +   +  L   +   T    +  + ++ 
Sbjct: 8   HLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLN 64

Query: 390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP-IPPSIGNLTSLLWLMLANN 447
            LK L L+ NR +G +  +    PNL  L+LS N++        +  L +L  L L N 
Sbjct: 65  KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 24/79 (30%), Positives = 37/79 (46%), Gaps = 5/79 (6%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--G 141
           L+  +  ++  I  N   L +L  L+LS N  SG +      C +L +LNLS N +    
Sbjct: 47  LSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS 104

Query: 142 DL-NLSGLRSLEILDLSVN 159
            +  L  L +L+ LDL   
Sbjct: 105 TIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 37/168 (22%), Positives = 57/168 (33%), Gaps = 49/168 (29%)

Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGL 218
            RIH E+    P+  ++LV+ N   N   G+++   D    L +L   +         GL
Sbjct: 5   RRIHLELRNRTPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINV--------GL 54

Query: 219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN 278
             +                +   +   L+  +LS+N   G        C NL  LNL GN
Sbjct: 55  TSI----------------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98

Query: 279 NFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN 326
                    I  +S +E L                 L  L+ LDL + 
Sbjct: 99  K--------IKDLSTIEPLK---------------KLENLKSLDLFNC 123

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.9 bits (144), Expect = 5e-09
 Identities = 103/676 (15%), Positives = 215/676 (31%), Gaps = 189/676 (27%)

Query: 247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSI-------SGLEALF- 298
           +I  + E+ F+ +F     +C++  V ++  +  S     EI  I       SG   LF 
Sbjct: 20  DILSVFEDAFVDNF-----DCKD--VQDMPKSILSK---EEIDHIIMSKDAVSGTLRLFW 69

Query: 299 --LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM 356
             L K             + +  V ++   N+   +  I     Q  ++        D +
Sbjct: 70  TLLSKQE----------EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL 119

Query: 357 -NSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNL 415
            N + +    N+SRL          L   + ++R  K ++            + G +   
Sbjct: 120 YNDNQVFAKYNVSRLQPYLK-----LRQALLELRPAKNVL------------IDG-VL-- 159

Query: 416 QTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG 475
                      G      G  T +   +  +  +  ++  +I       WLNL N     
Sbjct: 160 -----------G-----SGK-TWVALDVCLSYKVQCKMDFKI------FWLNLKNCNSPE 196

Query: 476 NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC 535
            +   +  +     P + +   +            +  R +     P+     +L     
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS-KPYENCLLVL----- 250

Query: 536 RSLWD-RLLKGTGIFPV-C--LPGLASRTFQITGYL------QLSGNQLSGELSPDIGKL 585
            ++ + +       F + C  L  L +R  Q+T +L       +S +  S  L+PD    
Sbjct: 251 LNVQNAKAWNA---FNLSCKIL--LTTRFKQVTDFLSAATTTHISLDHHSMTLTPD---- 301

Query: 586 QNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNL----------TRNNFSGEIPSEFGNI-- 632
           +  S++    +     LP +     P   L++          T +N+      +   I  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPR-RLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 633 KCLQNLDLS-----YNNFSGPFPASFNNLTE--LSKL--NISYNPLVSGTIPSTGQLATF 683
             L  L+ +     ++  S  FP S  ++    LS +  ++  +      +    +L  +
Sbjct: 361 SSLNVLEPAEYRKMFDRLS-VFPPSA-HIPTILLSLIWFDVIKS--DVMVV--VNKLHKY 414

Query: 684 --------EKTSYLGDPLLDLPDFIENGPHHGHK-----YPNSNGRTGNNTKLTI----I 726
                   E T  +    L+L   +EN     H+     Y        ++          
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYF 473

Query: 727 LAFLALLMACLICGVLSIIIY-MLVKRPAEQQG-----YL----LEGMKYRHDLASSSGG 776
            + +                + +      E+       +L    LE  K RHD  + +  
Sbjct: 474 YSHIG---------------HHLKNIEHPERMTLFRMVFLDFRFLEQ-KIRHDSTAWNAS 517

Query: 777 SSPWLSDTVKVIRLDKTAFT-----YSDILKATGKF----SEDRIIGKGGFGTVYR-GVL 826
            S  + +T++ ++  K         Y  ++ A   F     E+ I  K  +  + R  ++
Sbjct: 518 GS--ILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK--YTDLLRIALM 573

Query: 827 PDGREV---AVKKLQR 839
            +   +   A K++QR
Sbjct: 574 AEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 8e-09
 Identities = 113/705 (16%), Positives = 193/705 (27%), Gaps = 247/705 (35%)

Query: 104 QLSYLDLSRNTFSGSIPDDLSSCRS--------LKYLNLSHNILSGDLNLSGLRSLEILD 155
           Q  Y D+    F  +  D+   C+         L    + H I+S D     LR    L 
Sbjct: 15  QYQYKDILS-VFEDAFVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72

Query: 156 LSVNRIHGEISFSFPAICEKLVVANLSLNN--LTGRIDT-CFDGCLNLR-YLDLSSNNFR 211
                +            +K V   L +N   L   I T      +  R Y++     + 
Sbjct: 73  SKQEEMV-----------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121

Query: 212 GN----------------IWNGLAQLVEFSVSENVL------SG--VVSSSVFKENCSLE 247
            N                +   L +L     ++NVL      SG   V+  V        
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLEL---RPAKNVLIDGVLGSGKTWVALDV-------- 170

Query: 248 IFDLSENEFIGDFPGEV-----SNCRN----LVVL-NLF---------GNNFSGPIPAEI 288
                  +       ++      NC +    L +L  L           ++ S  I   I
Sbjct: 171 ---CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 289 GSISG-LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQ--KIFGRFT-QVKI 344
            SI   L  L   K          LL      VL          VQ  K +  F    KI
Sbjct: 228 HSIQAELRRLLKSKPY-----ENCLL------VLL--------NVQNAKAWNAFNLSCKI 268

Query: 345 LALHSN-SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG 403
           L         D ++++    +     LD      T   P E         L         
Sbjct: 269 LLTTRFKQVTDFLSAATTTHIS----LDHHSMTLT---PDE-----VKSLL--------- 307

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSI--GN--LTSLLWLMLANNSLSGEIPGEIGN 459
                      L+ LD    +L    P  +   N    S++   + +           G 
Sbjct: 308 -----------LKYLDCRPQDL----PREVLTTNPRRLSIIAESIRD-----------GL 341

Query: 460 CTSLLWLNLSNNKLSGNI--------PPEVMTIGRNARPTFEANQRNGERTIAGSSECLS 511
            T   W +++ +KL+  I        P E        R  F+                LS
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEY-------RKMFDR---------------LS 379

Query: 512 MKR---WIPAD-------YPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTF 561
           +      IP             S V  ++ +    SL ++  K + I    +P +     
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS---IPSIYLELK 436

Query: 562 Q------------ITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL 609
                        +  Y  +     S +L P    L  +   H+G +  + + P +    
Sbjct: 437 VKLENEYALHRSIVDHY-NIPKTFDSDDLIPP--YLDQYFYSHIGHHLKNIEHPERMTLF 493

Query: 610 PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
            ++ L+     F             L+   + +++ +     S  N   L +L   Y P 
Sbjct: 494 RMVFLDF---RF-------------LEQ-KIRHDSTAWNASGSILNT--LQQLKF-YKPY 533

Query: 670 VSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYPNSN 714
           +    P   +L            +  + DF+     +      ++
Sbjct: 534 ICDNDPKYERL------------VNAILDFLPKIEENLICSKYTD 566

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 6e-08
 Identities = 81/558 (14%), Positives = 165/558 (29%), Gaps = 158/558 (28%)

Query: 1   MNMSDDEND-SWRFALFVFAVLVIATHVAGDSLETDREVLSN--LRSFLENNNPVNEGHY 57
           M+    E+   ++  L VF    +      D  +  + +LS   +   + + + V+    
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66

Query: 58  MQWNQSSSPCE---------------WPGIICSPDKARVNG--LNLTDWNISGD-IFNNF 99
           + W   S   E               +   + SP K       +    +    D ++N+ 
Sbjct: 67  LFWTLLSKQEEMVQKFVEEVLRINYKF---LMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 100 SALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNIL-SGD--LNLSGLRSLEILDL 156
               + +   +SR      +   L   R  K + +   +L SG   + L    S ++   
Sbjct: 124 QVFAKYN---VSRLQPYLKLRQALLELRPAKNVLI-DGVLGSGKTWVALDVCLSYKVQCK 179

Query: 157 SVNRIH----GEISFSFPAICEKLVVANLSLNNLTGRIDTCF----DGCLNLRY-LDLSS 207
              +I        +        + V+  L    L  +ID  +    D   N++  +    
Sbjct: 180 MDFKIFWLNLKNCN------SPETVLEML--QKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231

Query: 208 NNFRG---------------NIWNGLAQLVE-FSVS------------ENVLSGVVSSSV 239
              R                N+ N  A+    F++S             + LS   ++ +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQN--AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 240 --------FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFG----------NNFS 281
                      +    +     +    D P EV    N   L++            +N+ 
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRRLSIIAESIRDGLATWDNWK 348

Query: 282 GPIPAEIGSI--SGLEAL--FLGKNNF--LSVIPESLLNLSK--LEVL--DLSSNNFGGE 331
                ++ +I  S L  L     +  F  LSV P S  ++    L ++  D+  +    +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS-AHIPTILLSLIWFDVIKS----D 403

Query: 332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS---------HNNFTGPLP 382
           V  +        +  LH  S ++       + +P+I  L+L          H +      
Sbjct: 404 VMVV--------VNKLHKYSLVEKQPKESTISIPSIY-LELKVKLENEYALHRSI----- 449

Query: 383 VEISQMRSLK----------------FLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE-- 424
             +      K                +  + H+  N   P        +  LD  F E  
Sbjct: 450 --VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-FLDFRFLEQK 506

Query: 425 --LTGPIPPSIGNLTSLL 440
                    + G++ + L
Sbjct: 507 IRHDSTAWNASGSILNTL 524

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 6e-05
 Identities = 52/322 (16%), Positives = 92/322 (28%), Gaps = 93/322 (28%)

Query: 705 HHGHKYPNSNGRTGNNTKLTIILAFLALLMACLIC--------GVLS--IIIYMLVKRPA 754
           HH H      G      K  I+  F    +    C         +LS   I ++++ + A
Sbjct: 2   HHHHHMDFETGEHQYQYK-DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA 60

Query: 755 EQQGYLLEGM--KYRHDLASSSGGSS-----PWLSDTVKVIRLDKTAFT----------Y 797
                 L       + ++              +L   +K  +   +  T          Y
Sbjct: 61  VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 798 SD--------------ILKATGKFSEDR------IIGKGGFG-TVYRGVLPDGREVAVKK 836
           +D               LK      E R      I G  G G T           VA+  
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW----------VALDV 170

Query: 837 LQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI-----LVYEYMEGGS 891
                ++ + +F+          F W     + L   C      +     L+Y+     +
Sbjct: 171 CLSYKVQCKMDFKI---------F-W-----LNL-KNCNSPETVLEMLQKLLYQIDPNWT 214

Query: 892 LEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVL--LDKEGKA 947
                S   +L    R+       R L  L  + Y    +V  +V+ +      +   K 
Sbjct: 215 SRSDHSSNIKL----RIHSIQAELRRL--LKSKPYENCLLVLLNVQNAKAWNAFNLSCKI 268

Query: 948 LVT--DFGLARVVSAGD-SHVS 966
           L+T     +   +SA   +H+S
Sbjct: 269 LLTTRFKQVTDFLSAATTTHIS 290

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 9/157 (5%)

Query: 319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL-KLPNISRLDLSHNNF 377
           E LDL S          F   T++  L L  N       S+G+   L  +  L L++N  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL--QTLSAGVFDDLTELGTLGLANNQL 95

Query: 378 TGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-G 434
              LP+ +   +  L  L L  N+   S+P+ V+  +  L+ L L+ N+L   IP     
Sbjct: 96  AS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFD 152

Query: 435 NLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
            LT+L  L L+ N L     G       L  + L  N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 32/115 (27%), Positives = 50/115 (43%), Gaps = 5/115 (4%)

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTG 427
           +LDL               +  L +L L +N+   ++ A V+ ++  L TL L+ N+L  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 428 PIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            +P  +  +LT L  L L  N L     G     T L  L L+ N+L  +IP   
Sbjct: 98  -LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 11/158 (6%)

Query: 295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYID 354
           E L L      ++   +   L+KL  L+L  N        +F   T++  L L +N    
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ--- 94

Query: 355 GMNS--SGIL-KLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VY 409
            + S   G+   L  + +L L  N     LP  +  ++  LK L L  N+   SIPA  +
Sbjct: 95  -LASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151

Query: 410 GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN 447
             + NLQTL LS N+L      +   L  L  + L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 29/110 (26%), Positives = 43/110 (39%), Gaps = 3/110 (2%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPS-QFDQLP-LIVLNLTRNNF 621
           T  L L    L+         L   + ++L +NQ    L +  FD L  L  L L  N  
Sbjct: 37  TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQL 95

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +      F ++  L  L L  N         F+ LT+L +L ++ N L S
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 43/163 (26%), Positives = 63/163 (38%), Gaps = 9/163 (5%)

Query: 170 PAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIWNGLAQLVEFSV 226
           PA  EKL   +L    L    D  F G   L +L+L  N  +     +++ L +L    +
Sbjct: 34  PADTEKL---DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90

Query: 227 SENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA 286
           + N L+  +   VF     L+   L  N+      G       L  L L  N     IPA
Sbjct: 91  ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPA 148

Query: 287 EI-GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNF 328
                ++ L+ L L  N   SV   +   L KL+ + L  N F
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 5/79 (6%)

Query: 404 SIPAVYGNMP-NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS 462
           S+P+    +P + + LDL    L      +   LT L WL L  N L     G   + T 
Sbjct: 28  SVPS---GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84

Query: 463 LLWLNLSNNKLSGNIPPEV 481
           L  L L+NN+L+ ++P  V
Sbjct: 85  LGTLGLANNQLA-SLPLGV 102

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 39/159 (24%), Positives = 55/159 (34%), Gaps = 21/159 (13%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLS-----GLRSLEILDLSVNRIH 162
           LDL     +            L +LNL +N L     LS      L  L  L L+ N++ 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ---TLSAGVFDDLTELGTLGLANNQLA 96

Query: 163 GEISFSFPA-ICEKLV---VANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFR---GNIW 215
                S P  + + L       L  N L       FD    L+ L L++N  +      +
Sbjct: 97  -----SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151

Query: 216 NGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN 254
           + L  L   S+S N L   V    F     L+   L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 5/107 (4%)

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTG 427
            L L  N  T   P     + +LK L L  N+   ++P  V+ ++  L  LDL  N+LT 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 428 PIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
            +P ++   L  L  L +  N L+ E+P  I   T L  L L  N+L
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 40/134 (29%), Positives = 56/134 (41%), Gaps = 6/134 (4%)

Query: 340 TQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAH 398
           T  +IL LH N  I  +       L N+  L L  N     LPV +   +  L  L L  
Sbjct: 40  TNAQILYLHDNQ-ITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGT 97

Query: 399 NRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI 457
           N+    +P+ V+  + +L+ L +  N+LT  +P  I  LT L  L L  N L     G  
Sbjct: 98  NQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAF 155

Query: 458 GNCTSLLWLNLSNN 471
              +SL    L  N
Sbjct: 156 DRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 6/106 (5%)

Query: 566 YLQLSGNQLSGELSPDI-GKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFS 622
            L L  NQL   L   +   L   +++ LG NQ    LPS  FD+L  L  L +  N  +
Sbjct: 68  ELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT 125

Query: 623 GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNP 668
            E+P     +  L +L L  N        +F+ L+ L+   +  NP
Sbjct: 126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 4/110 (3%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNF 621
              L L  NQ++         L N   ++LG NQ    LP   FD L  L VL+L  N  
Sbjct: 42  AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           +    + F  +  L+ L +  N  +   P     LT L+ L +  N L S
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS 149

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)

Query: 394 LILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGE 452
           L L  N+     P V+ ++ NL+ L L  N+L   +P  +  +LT L  L L  N L+  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVL 103

Query: 453 IPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQ 496
                     L  L +  NKL+  +P  +  +        + NQ
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 54/264 (20%), Positives = 83/264 (31%), Gaps = 79/264 (29%)

Query: 811  RIIGKGGFGTVYRGVL----PDGREVAVKKLQREGLEGEREFRAEMEVLS------GNGF 860
             +I K G+G      L       + VA+K ++      E     E+ +L        N  
Sbjct: 40   HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDP 98

Query: 861  GWPHPNLVTLYGW-CLDGSEKI---LVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDV 914
                  +V L     + G       +V+E + G  L   I  S+   L       I   V
Sbjct: 99   NREM--VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 915  ARALVFLHHECYPPIVHRDVKASNVLL--------------------------------- 941
             + L +LH +C   I+H D+K  N+LL                                 
Sbjct: 156  LQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 942  ----------------DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE--YGQT 983
                             ++ K  + D G A        H +  I  T  Y + E   G  
Sbjct: 214  PATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDI-QTRQYRSLEVLIGSG 269

Query: 984  WQATTKGDVYSFGVLAMELATGRR 1007
            +   T  D++S   +A ELATG  
Sbjct: 270  Y--NTPADIWSTACMAFELATGDY 291

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 33/132 (25%), Positives = 58/132 (43%), Gaps = 18/132 (13%)

Query: 340 TQVKILALHSNSYIDGMNSSGIL-KLPNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILA 397
                L L+ N  +  ++S G+  +LP++ +L+L  N  TG +          ++ L L 
Sbjct: 29  LHTTELLLNDNE-LGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLG 86

Query: 398 HNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLSGEIPG 455
            N+    I   ++  +  L+TL+L  N+++  + P    +L SL  L LA+N        
Sbjct: 87  ENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF------ 138

Query: 456 EIGNCT-SLLWL 466
              NC   L W 
Sbjct: 139 ---NCNCHLAWF 147

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 8/90 (8%)

Query: 394 LILAHNRFNGSIPA--VYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLS 450
           L+L  N     I +  ++G +P+L  L+L  N+LTG I P+     + +  L L  N + 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91

Query: 451 GEIP-GEIGNCTSLLWLNLSNNKLSGNIPP 479
            EI          L  LNL +N++S  + P
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMP 119

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 8/111 (7%)

Query: 564 TGYLQLSGNQLSGELSPD--IGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRN 619
           T  L L+ N+L   +S D   G+L +   + L  NQ    +    F+    +  L L  N
Sbjct: 31  TTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGEN 88

Query: 620 NFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
               EI ++ F  +  L+ L+L  N  S   P SF +L  L+ LN++ NP 
Sbjct: 89  KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 33/107 (30%), Positives = 46/107 (42%), Gaps = 4/107 (3%)

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTG 427
            LDL  N+          ++ SL  L L  N+   S+P  V+  + +L  L+LS N+L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 428 PIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
            +P  +   LT L  L L  N L     G     T L  L L  N+L
Sbjct: 91  -LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 13/135 (9%)

Query: 319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNS--SGIL-KLPNISRLDLSHN 375
             LDL +N+       +F   T +  L L  N     + S  +G+  KL +++ L+LS N
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK----LQSLPNGVFNKLTSLTYLNLSTN 86

Query: 376 NFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPIPPSI 433
                LP  +  ++  LK L L  N+   S+P  V+  +  L+ L L  N+L   +P  +
Sbjct: 87  QLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGV 143

Query: 434 -GNLTSLLWLMLANN 447
              LTSL ++ L +N
Sbjct: 144 FDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 3/110 (2%)

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNF 621
           T YL L  N L    +    +L + + ++LG N+    LP+  F++L  L  LNL+ N  
Sbjct: 30  TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88

Query: 622 SGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
                  F  +  L+ L L+ N         F+ LT+L  L +  N L S
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 52.3 bits (126), Expect = 6e-07
 Identities = 47/199 (23%), Positives = 75/199 (37%), Gaps = 34/199 (17%)

Query: 789 RLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVA---VKKLQR-----E 840
           R D     +   +K   +   + +IGKG    + R    D   +    VKK  R     E
Sbjct: 320 RTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDE 379

Query: 841 GLEGEREFRAEMEVLS-GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR 899
            +   R    E   L+    FG P P +     + +D   K ++  Y+ G   +D+I D 
Sbjct: 380 NIRKSRT-AREARYLALVKDFGIPAPYI-----FDVDLDNKRIMMSYINGKLAKDVIEDN 433

Query: 900 TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
                   LDIA  +   +  LH      ++H D+  SN + D      + DFGL ++ +
Sbjct: 434 --------LDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFD--KDLYIIDFGLGKISN 480

Query: 960 -----AGDSHV-STTIAGT 972
                A D  V    +  T
Sbjct: 481 LDEDKAVDLIVFKKAVLST 499

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 7e-07
 Identities = 13/72 (18%), Positives = 23/72 (31%), Gaps = 3/72 (4%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPD-DLSSCRSLKYLNLSHNILS--GDLNLSGLRS 150
           D  ++      L+ L +        +   DL     L+ L +  + L             
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 151 LEILDLSVNRIH 162
           L  L+LS N + 
Sbjct: 82  LSRLNLSFNALE 93

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 2/71 (2%)

Query: 603 PSQFDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPASFNNLTELS 660
                    L  L +        +       +  L+NL +  +      P +F+    LS
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 661 KLNISYNPLVS 671
           +LN+S+N L S
Sbjct: 84  RLNLSFNALES 94

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 22/148 (14%), Positives = 36/148 (24%), Gaps = 49/148 (33%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
            +        L     L  L + +                  +  L              
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQ---------------HLQHLELRDLRG------- 54

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
             L  +  L +  +                    +A + F+          P L  L+LS
Sbjct: 55  --LGELRNLTIVKSGLR----------------FVAPDAFHF--------TPRLSRLNLS 88

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSL 449
           FN L   +        SL  L+L+ N L
Sbjct: 89  FNALES-LSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 5e-06
 Identities = 15/85 (17%), Positives = 24/85 (28%), Gaps = 2/85 (2%)

Query: 398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGE 456
                           NL  L +   +    +    +  L  L  L +  + L    P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 457 IGNCTSLLWLNLSNNKLSGNIPPEV 481
                 L  LNLS N L  ++  + 
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 4e-05
 Identities = 18/94 (19%), Positives = 31/94 (32%), Gaps = 2/94 (2%)

Query: 259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAE-IGSISGLEALFLGKNNFLSVIPESLLNLSK 317
           D    +    NL  L +        +    +  +  L  L + K+    V P++     +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS 351
           L  L+LS N       K     +  + L L  N 
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSL-QELVLSGNP 114

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 17/107 (15%), Positives = 26/107 (24%), Gaps = 28/107 (26%)

Query: 118 SIPDDLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILDLSVNRIHGEISFSFPAICE 174
                L    +L  L + +      L    L GL  L  L +  + +             
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69

Query: 175 KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQL 221
                   +          F     L  L+LS N      W  +  L
Sbjct: 70  -------FVAPDA------FHFTPRLSRLNLSFNALESLSWKTVQGL 103

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 7e-04
 Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 5/94 (5%)

Query: 580 PDIGKLQNFSMVHLGFNQFDGKLPSQ-FDQLP-LIVLNLTRNNFSGEIPSE-FGNIKCLQ 636
             +   +N + +++   Q    L  +    L  L  L + ++     +  + F     L 
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83

Query: 637 NLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV 670
            L+LS+N        +   L+ L +L +S NPL 
Sbjct: 84  RLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.4 bits (123), Expect = 9e-07
 Identities = 62/333 (18%), Positives = 106/333 (31%), Gaps = 78/333 (23%)

Query: 120 PDDLSSCRSLKYLNLSHNILSGDLNLSGLRS---LEILDLSVNRIHGEISFSFPAICEKL 176
           PD      S   +         D  L+   S   ++ +DLS + I         + C KL
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 177 VVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVS 236
              +L    L+  I        NL  L+LS  +                 SE  L  ++S
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---------------GFSEFALQTLLS 165

Query: 237 SSVFKENCS-LEIFDLSENEFIGDFPGEV---SNCRNLVVLNLFGNNFSGPIPAEIGSIS 292
                 +CS L+  +LS      +   +V        +  LNL G          +   S
Sbjct: 166 ------SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG------YRKNLQK-S 212

Query: 293 GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSY 352
            L  L              +     L  LDLS +               +K         
Sbjct: 213 DLSTL--------------VRRCPNLVHLDLSDS-------------VMLKNDCFQE--- 242

Query: 353 IDGMNSSGILKLPNISRLDLSH-NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
                     +L  +  L LS   +      +E+ ++ +LK L +     +G++  +   
Sbjct: 243 --------FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA 294

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNL-TSLLWLM 443
           +P+LQ   ++ +  T    P+IGN     +W +
Sbjct: 295 LPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 324

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 43/236 (18%), Positives = 74/236 (31%), Gaps = 16/236 (6%)

Query: 247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLS 306
           +  DL+      D  G + + + ++      +    P+                    +S
Sbjct: 50  QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108

Query: 307 VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL-- 364
            +   L   SKL+ L L        +     + + +  L L   S   G +   +  L  
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL---SGCSGFSEFALQTLLS 165

Query: 365 --PNISRLDLSH-NNFT--GPLPVEISQMRSLKFLILAHNRFN---GSIPAVYGNMPNLQ 416
               +  L+LS   +FT             ++  L L+  R N     +  +    PNL 
Sbjct: 166 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225

Query: 417 TLDLSF-NELTGPIPPSIGNLTSLLWLMLAN-NSLSGEIPGEIGNCTSLLWLNLSN 470
            LDLS    L          L  L  L L+    +  E   E+G   +L  L +  
Sbjct: 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 32/136 (23%), Positives = 51/136 (37%), Gaps = 14/136 (10%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTF--SGSIPDDLSSCRSLKYLNLSHNILSG 141
           L+L    +S  I N  +  + L  L+LS  +     ++   LSSC  L  LNLS      
Sbjct: 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182

Query: 142 DLNL-----SGLRSLEILDLSVNRIHGEIS-FSFPAI---CEKLVVANLS-LNNLTGRID 191
           + ++         ++  L+LS       +       +   C  LV  +LS    L     
Sbjct: 183 EKHVQVAVAHVSETITQLNLS--GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 240

Query: 192 TCFDGCLNLRYLDLSS 207
             F     L++L LS 
Sbjct: 241 QEFFQLNYLQHLSLSR 256

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 9e-07
 Identities = 28/187 (14%), Positives = 59/187 (31%), Gaps = 42/187 (22%)

Query: 282 GPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQ 341
             +   + ++  L  L +   N LS+          L+ L++ S                
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSI---GKKPRPNLKSLEIISGGLPDS---------- 208

Query: 342 VKILALHSNSYIDGMNSSGILKLPNISRLDLS--HNNFTGPLPVEI-------SQMRSLK 392
                         +       LPN+ +L L     ++     + +        +  +LK
Sbjct: 209 -------------VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 393 FLILAHNRFNGSIP---AVYGNMPNLQTLDLSFNELTG----PIPPSIGNLTSLLWLMLA 445
           +L +        +         +P L+T+D+S   LT      +   +  +  L ++ + 
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315

Query: 446 NNSLSGE 452
            N LS E
Sbjct: 316 YNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 4e-06
 Identities = 34/192 (17%), Positives = 66/192 (34%), Gaps = 31/192 (16%)

Query: 301 KNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSG 360
           +  F   I      +S +E +DLS          +      +  L +   + +    S G
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSP---------VLDAMPLLNNLKIKGTNNL----SIG 188

Query: 361 ILKLPNISRLDLSHNNFTGPLPVEI--SQMRSLKFLILAHNR----FNGSIPAVY----- 409
               PN+  L++        +  +I  S + +L+ L+L        F+G +         
Sbjct: 189 KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248

Query: 410 GNMPNLQTLDLSFNELTGPIPPSIGN---LTSLLWLMLANNSLSGE----IPGEIGNCTS 462
              PNL+ L +   E    +         L  L  + ++   L+ E    +   +     
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 463 LLWLNLSNNKLS 474
           L ++N+  N LS
Sbjct: 309 LKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 4e-05
 Identities = 23/164 (14%), Positives = 52/164 (31%), Gaps = 21/164 (12%)

Query: 85  NLTDWNISGDIFNNFSAL--TQLSYLDLSRNTFSGSIPDDL--SSCRSLKYLNLSHN--- 137
            L +  I G    +        L  L++       S+ +D+  S   +L+ L L      
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232

Query: 138 --------ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPA--ICEKLVVANLSLNNLT 187
                   +     +     +L+ L +        +   F    I  +L   ++S   LT
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292

Query: 188 GR----IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVS 227
                 +    D   +L+++++  N     +   L + +   + 
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 1e-04
 Identities = 28/238 (11%), Positives = 66/238 (27%), Gaps = 66/238 (27%)

Query: 105 LSYLDLSRNTFSGSIPDDLSSC-RSLKYLNLSHNILSGDLNLSGLRS--LEILDLSVNRI 161
              +D      S     DLS    ++  LN      + +L++       L+ L++    +
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205

Query: 162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLS--SNNFRGNIWNGLA 219
              +        E ++ ++L                 NL  L L     ++  +    + 
Sbjct: 206 PDSV-------VEDILGSDLP----------------NLEKLVLYVGVEDYGFD--GDMN 240

Query: 220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFP---GEVSNCRNLVVLNLF 276
                         + S   F    +L+   + + E          E      L  +++ 
Sbjct: 241 VF----------RPLFSKDRFP---NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 277 GNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK 334
               +           G   L            + +  +  L+ +++  N    E++K
Sbjct: 288 AGVLTD---------EGARLLL-----------DHVDKIKHLKFINMKYNYLSDEMKK 325

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 5e-04
 Identities = 21/160 (13%), Positives = 54/160 (33%), Gaps = 35/160 (21%)

Query: 243 NCSLEIFDLSENEFIGDFPGEV--SNCRNLVVLNLFG--NNFSGPIPAEI-------GSI 291
             +L+  ++           ++  S+  NL  L L+    ++       +          
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 292 SGLEALFLGKNNFLSVIPESLLN---LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALH 348
             L+ L +      +V+ E  L    L +LE +D+S+     E           ++L   
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE---------GARLLL-- 300

Query: 349 SNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM 388
                       + K+ ++  +++ +N  +  +  E+ + 
Sbjct: 301 ----------DHVDKIKHLKFINMKYNYLSDEMKKELQKS 330

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 52/222 (23%)

Query: 810  DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFR--AEMEV-----LSGNGFG 861
             ++IGKG FG V +       + VA+K      +  E+ F   A  E+     L      
Sbjct: 102  LKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 862  WPHPNLVTLYGW-------CLDGSEKILVYEYMEGGSLEDIISDR------TRLTWRRRL 908
                N++ +          C+        +E +   +L ++I           L  +   
Sbjct: 157  NTM-NVIHMLENFTFRNHICM-------TFELL-SMNLYELIKKNKFQGFSLPLVRK--- 204

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL--VTDFGLARVVSAGDSHVS 966
              A  + + L  LH      I+H D+K  N+LL ++G++   V DFG +         V 
Sbjct: 205  -FAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVY 257

Query: 967  TTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
            T I  +  Y APE   G  +      D++S G +  EL TG 
Sbjct: 258  TYIQ-SRFYRAPEVILGARY--GMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 48/227 (21%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVK------KLQREGLEGEREFRAEMEVLS 856
              ++  D +IGKG FG V +     +   VA+K          +          E+ +L 
Sbjct: 53   MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-------EVRLLE 105

Query: 857  GNGFGWPH--PNLVTLYGW-------CLDGSEKILVYEYMEGGSLEDIISDRTR----LT 903
                        +V L          CL       V+E +   +L D++ +       L 
Sbjct: 106  LMNKHDTEMKYYIVHLKRHFMFRNHLCL-------VFEML-SYNLYDLLRNTNFRGVSLN 157

Query: 904  WRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL--VTDFGLARVVSAG 961
              R+   A  +  AL+FL       I+H D+K  N+LL    ++   + DFG +  +   
Sbjct: 158  LTRK--FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--- 211

Query: 962  DSHVSTTIAGTVGYVAPE--YGQTWQATTKGDVYSFGVLAMELATGR 1006
               +   I  +  Y +PE   G  +      D++S G + +E+ TG 
Sbjct: 212  GQRIYQYIQ-SRFYRSPEVLLGMPY--DLAIDMWSLGCILVEMHTGE 255

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 30/105 (28%), Positives = 42/105 (40%), Gaps = 4/105 (3%)

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTG 427
           RL+L  N           ++  L  L L+ N+   S+P  V+  +  L  L L  N+L  
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQS 90

Query: 428 PIPPSI-GNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
            +P  +   LT L  L L  N L     G     TSL  + L  N
Sbjct: 91  -LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 24/83 (28%), Positives = 32/83 (38%), Gaps = 2/83 (2%)

Query: 392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSI-GNLTSLLWLMLANNSLS 450
             L L  N+       V+  +  L  L LS N++   +P  +   LT L  L L  N L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89

Query: 451 GEIPGEIGNCTSLLWLNLSNNKL 473
               G     T L  L L  N+L
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQL 112

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 24/188 (12%), Positives = 44/188 (23%), Gaps = 56/188 (29%)

Query: 819 GTVYRGVLPDGREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWPHPNLVTLYGWCLD 876
             V+R +   GR V   K    G   E   E    +  L+  G   P      +     +
Sbjct: 34  AAVFR-LSAQGRPVLFVKTDLSGALNELQDEAAR-LSWLATTGV--PCA---AVLDVVTE 86

Query: 877 GSEKILVYEYMEGGSLED------------------------------------------ 894
                L+   + G  L                                            
Sbjct: 87  AGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERART 146

Query: 895 ----IISDRTRLTWRRRLDIAIDVARALVFLHHECYPP-IVHRDVKASNVLLDKEGKALV 949
                + D+  L    +     ++   L     +     + H D    N++++    +  
Sbjct: 147 RMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGF 206

Query: 950 TDFGLARV 957
            D G   V
Sbjct: 207 IDCGRLGV 214

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 31/179 (17%), Positives = 58/179 (32%), Gaps = 52/179 (29%)

Query: 308 IPESLLNLSKLEVLDLSS-NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPN 366
           +     N   LE ++L++  N      K           AL +N+Y+             
Sbjct: 28  LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAE-------ALKTNTYV------------- 67

Query: 367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT 426
             +  +       P+   +++M       L  N               L++L++  N ++
Sbjct: 68  -KKFSIVGTRSNDPVAFALAEM-------LKVNN-------------TLKSLNVESNFIS 106

Query: 427 GPIPPSIGNL----TSLLWLMLANNS--LSGEIPGEIGNC----TSLLWLNLSNNKLSG 475
           G    ++       TSL+ L + N S  L   +  EI N     T+LL       +   
Sbjct: 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 12/111 (10%), Positives = 29/111 (26%), Gaps = 10/111 (9%)

Query: 813 IGKGGFG-TVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLY 871
             +G     VY+ ++ +   + +K           +   E +++       P P    + 
Sbjct: 21  DTEGMSPAKVYK-LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVP---KVL 76

Query: 872 GWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
            +        L+    +G               +    I    A  +   H
Sbjct: 77  HFERHDGWSNLLMSEADGVLC-----SEEYEDEQSPEKIIELYAECIRLFH 122

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1088
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.93
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.93
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.93
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.87
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.85
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.84
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.83
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.83
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.76
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.76
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.74
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.74
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.74
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.73
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.73
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.73
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.72
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.72
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.71
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.69
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.69
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.68
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.67
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.67
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.64
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.62
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.61
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.57
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.57
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.55
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.54
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.53
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.53
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.52
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.51
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.51
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.5
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.45
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.43
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.42
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.41
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.41
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.4
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.39
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.36
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.24
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.17
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.16
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.15
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.09
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.07
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.93
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.8
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.78
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.78
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.74
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.72
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.71
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.63
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.49
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.35
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.34
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.2
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.15
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.12
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.92
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.89
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.78
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.6
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.58
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.54
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.51
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.37
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.36
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.49
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.4
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.39
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.16
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.85
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.34
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.23
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.63
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.58
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.5e-80  Score=780.24  Aligned_cols=657  Identities=30%  Similarity=0.496  Sum_probs=471.9

Q ss_pred             cCCCchhhHHHHHHHHhhcccCCCCCcccccccCCCCCCcccCCceeCCCCceeEEecccccccccc---cc--------
Q 001384           28 AGDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGD---IF--------   96 (1088)
Q Consensus        28 ~~~~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~---~~--------   96 (1088)
                      ++.+.++|++||++||+.+.+    +. .++||+.++|||.|.||+|+  .+||++|+|+++++.|.   ++        
T Consensus         6 ~~~~~~~~~~all~~k~~~~~----~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~   78 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLPD----KN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG   78 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCSC----TT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred             cccCCHHHHHHHHHHHhhCCC----cc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence            444478899999999999963    23 79999988999999999998  68999999999999886   43        


Q ss_pred             ---------------ccccCCccCCeeeCCCCCCCCCcCc--cCCCCCCCcEEECccccccCccc---CCCCCCCceeec
Q 001384           97 ---------------NNFSALTQLSYLDLSRNTFSGSIPD--DLSSCRSLKYLNLSHNILSGDLN---LSGLRSLEILDL  156 (1088)
Q Consensus        97 ---------------~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~~---l~~l~~L~~L~L  156 (1088)
                                     +.++.+++|++|||++|.++|.+|.  .++++++|++|+|++|.+++..+   +.++++|++|||
T Consensus        79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  158 (768)
T 3rgz_A           79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL  158 (768)
T ss_dssp             CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred             ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence                           4678889999999999999998888  89999999999999998876443   256777777777


Q ss_pred             ccccccccccCch--h----------------------hhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc
Q 001384          157 SVNRIHGEISFSF--P----------------------AICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       157 s~N~l~~~~~~~~--~----------------------~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ++|++++..+..+  .                      ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++
T Consensus       159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~  237 (768)
T 3rgz_A          159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG  237 (768)
T ss_dssp             CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred             CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence            7777766554331  1                      2356677777777777777766 7778888888888888776


Q ss_pred             cc---cccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCC-CCCcEEEccCccccCCCcccc
Q 001384          213 NI---WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNC-RNLVVLNLFGNNFSGPIPAEI  288 (1088)
Q Consensus       213 ~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~  288 (1088)
                      .+   +..+++|++|++++|.+++.++..   .+++|++|+|++|++++.+|..+..+ ++|++|+|++|++++.+|..|
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~  314 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF  314 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence            44   345677778888888777665543   56778888888888877777777664 888888888888887788888


Q ss_pred             CCCCCCCEEeCCCCcCCccCccc-ccCCCCCcEEEcCCCcCCCchhHhhhccc-ccceeecCcCcccCCCCCccccC--C
Q 001384          289 GSISGLEALFLGKNNFLSVIPES-LLNLSKLEVLDLSSNNFGGEVQKIFGRFT-QVKILALHSNSYIDGMNSSGILK--L  364 (1088)
Q Consensus       289 ~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~~--l  364 (1088)
                      +.+++|++|+|++|++++.+|.. +.++++|++|+|++|.+++.+|..+..++ +|+.|++++|.+....... +..  +
T Consensus       315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~-~~~~~~  393 (768)
T 3rgz_A          315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN-LCQNPK  393 (768)
T ss_dssp             GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT-TTCSTT
T ss_pred             hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh-hhhccc
Confidence            88888888888888887667765 77888888888888888777777777776 7777777777654333222 222  5


Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      ++|++|++++|++++.+|..++++++|++|++++|++++.+|..++.+++|+.|++++|++++.+|..++.+++|++|+|
T Consensus       394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  473 (768)
T 3rgz_A          394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL  473 (768)
T ss_dssp             CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence            56666666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             cccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCccccc----CCccccccccc-cCCC
Q 001384          445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIA----GSSECLSMKRW-IPAD  519 (1088)
Q Consensus       445 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~----~~~~~~~~~~~-~~~~  519 (1088)
                      ++|+++|.+|..++++++|++|+|++|+++|.+|..+..+.++..+.+..|.+.+.....    ...+.+++... +...
T Consensus       474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~  553 (768)
T 3rgz_A          474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT  553 (768)
T ss_dssp             CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred             cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence            666666666666666666666666666666666666666666666666666554322100    00000000000 0000


Q ss_pred             CCCCcceeeehhccccchhhhhcccCCccc----cc-------------ccCC---CcccceeeeceEEccCCccccccC
Q 001384          520 YPPFSFVYTILTRKSCRSLWDRLLKGTGIF----PV-------------CLPG---LASRTFQITGYLQLSGNQLSGELS  579 (1088)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~-------------~l~~---~~~~~~~~l~~L~l~~N~l~g~~p  579 (1088)
                      .|...+        .+.......+.....+    ..             ...+   .....+.....++++.|.++|.+|
T Consensus       554 ip~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~  625 (768)
T 3rgz_A          554 IPAAMF--------KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS  625 (768)
T ss_dssp             CCGGGG--------TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred             CChHHh--------cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence            000000        0000000000000000    00             0000   000111222345677899999999


Q ss_pred             cccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccc
Q 001384          580 PDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTE  658 (1088)
Q Consensus       580 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~  658 (1088)
                      ..++.+++|+.|||++|+++|.+|..++.+ .|+.|+|++|+++|.||.+|+++++|+.|||++|+++|.+|..++++++
T Consensus       626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~  705 (768)
T 3rgz_A          626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM  705 (768)
T ss_dssp             CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCC
T ss_pred             hhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence            999999999999999999999999999999 6999999999999999999999999999999999999999999999999


Q ss_pred             cceeeccCCCCccccCCCCCcccccccCccCCCCCCCCCCccCCCCCCCCCCC
Q 001384          659 LSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGPHHGHKYP  711 (1088)
Q Consensus       659 L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~~P~~~~~~p~~~~~~~  711 (1088)
                      |+.|||++|++ +|.||+.+++.+|...+|.||+.+|  |.+    ...|...
T Consensus       706 L~~L~ls~N~l-~g~iP~~~~~~~~~~~~~~gN~~Lc--g~~----l~~C~~~  751 (768)
T 3rgz_A          706 LTEIDLSNNNL-SGPIPEMGQFETFPPAKFLNNPGLC--GYP----LPRCDPS  751 (768)
T ss_dssp             CSEEECCSSEE-EEECCSSSSGGGSCGGGGCSCTEEE--STT----SCCCCSC
T ss_pred             CCEEECcCCcc-cccCCCchhhccCCHHHhcCCchhc--CCC----CcCCCCC
Confidence            99999999999 8999999999999999999999999  543    3367543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.1e-64  Score=639.02  Aligned_cols=585  Identities=32%  Similarity=0.448  Sum_probs=470.9

Q ss_pred             ceeEEeccccccccccccc--cccCCccCCeeeCCCCCCCCCcCccC-CCCCCCcEEECcccccc---------------
Q 001384           79 ARVNGLNLTDWNISGDIFN--NFSALTQLSYLDLSRNTFSGSIPDDL-SSCRSLKYLNLSHNILS---------------  140 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~Ls~n~l~---------------  140 (1088)
                      .+.+.|+|++|.++|.++.  .++++++|++|||++|.+++.+|..+ .++++|++|+|++|.++               
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~  179 (768)
T 3rgz_A          100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE  179 (768)
T ss_dssp             TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred             CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence            4677899999999998888  89999999999999999888877665 56666666666666554               


Q ss_pred             ------------CcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCc
Q 001384          141 ------------GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN  208 (1088)
Q Consensus       141 ------------~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N  208 (1088)
                                  +..++..+++|++|+|++|++++.+|.  ...+++|++|+|++|++++.+|..+.++++|++|+|++|
T Consensus       180 L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n  257 (768)
T 3rgz_A          180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN  257 (768)
T ss_dssp             CCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSS
T ss_pred             CCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCC
Confidence                        333446778888888888888877776  456789999999999999999999999999999999999


Q ss_pred             cccccccc-cCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccc
Q 001384          209 NFRGNIWN-GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAE  287 (1088)
Q Consensus       209 ~l~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  287 (1088)
                      ++++.++. .+++|++|++++|.+++.++...+..+++|++|+|++|++++.+|..++++++|++|+|++|+++|.+|..
T Consensus       258 ~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~  337 (768)
T 3rgz_A          258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD  337 (768)
T ss_dssp             CCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH
T ss_pred             cccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH
Confidence            99875543 68899999999999999888887777799999999999999999999999999999999999999888876


Q ss_pred             -cCCCCCCCEEeCCCCcCCccCcccccCCC-CCcEEEcCCCcCCCchhHhhhc--ccccceeecCcCcccCCCCCccccC
Q 001384          288 -IGSISGLEALFLGKNNFLSVIPESLLNLS-KLEVLDLSSNNFGGEVQKIFGR--FTQVKILALHSNSYIDGMNSSGILK  363 (1088)
Q Consensus       288 -~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~n~~~~~~~~~~~~~  363 (1088)
                       ++.+++|++|+|++|.+++.+|..+.+++ +|++|+|++|.+++..+..+..  +++|+.|++++|.+.. ..+..+..
T Consensus       338 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~p~~l~~  416 (768)
T 3rgz_A          338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG-KIPPTLSN  416 (768)
T ss_dssp             HHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEE-ECCGGGGG
T ss_pred             HHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccc-ccCHHHhc
Confidence             89999999999999999989999998887 8999999999998888777766  7888999998887643 34566788


Q ss_pred             CCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEE
Q 001384          364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM  443 (1088)
Q Consensus       364 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  443 (1088)
                      +++|++|+|++|++++.+|..++.+++|+.|++++|++++.+|..++.+++|++|++++|++++.+|..++++++|++|+
T Consensus       417 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  496 (768)
T 3rgz_A          417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS  496 (768)
T ss_dssp             CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             CCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEE
Confidence            88899999999988888888888888899999999988888888888888899999999998888888888888899999


Q ss_pred             ccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCcccccccc--ccC----
Q 001384          444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKR--WIP----  517 (1088)
Q Consensus       444 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~--~~~----  517 (1088)
                      |++|+++|.+|..++++++|++|+|++|+++|.+|..+..+.++..+.+..|.+.+.....-.. ......  ...    
T Consensus       497 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~-~~~~~~~~~~~~~~~  575 (768)
T 3rgz_A          497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK-QSGKIAANFIAGKRY  575 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGT-TTTCBCCSTTCSCEE
T ss_pred             ccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhc-ccchhhhhccccccc
Confidence            9999988888888888888999999999998888888888888888888888776543321100 000000  000    


Q ss_pred             ----C----CCCCCc-ceeee--hhccccchhhhhc------ccCCcccccccCCCcccceeeeceEEccCCccccccCc
Q 001384          518 ----A----DYPPFS-FVYTI--LTRKSCRSLWDRL------LKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSP  580 (1088)
Q Consensus       518 ----~----~~~~~~-~~~~~--~~~~~~~~l~~~~------~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~  580 (1088)
                          .    ...... .....  ........+....      ..-.+..|..+     ..+..+++|+|++|+++|.+|.
T Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~-----~~l~~L~~LdLs~N~l~g~ip~  650 (768)
T 3rgz_A          576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF-----DNNGSMMFLDMSYNMLSGYIPK  650 (768)
T ss_dssp             EEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSC-----SSSBCCCEEECCSSCCBSCCCG
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccceecccCchhh-----hccccccEEECcCCcccccCCH
Confidence                0    000000 00000  0000000000000      00011122221     2345678999999999999999


Q ss_pred             ccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCccccccccc
Q 001384          581 DIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTEL  659 (1088)
Q Consensus       581 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  659 (1088)
                      .++++++|+.|+|++|+++|.+|+.++.+ .|++|+|++|+++|.||..++++++|+.|||++|+|+|.||.. +.+.++
T Consensus       651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~  729 (768)
T 3rgz_A          651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETF  729 (768)
T ss_dssp             GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGS
T ss_pred             HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccC
Confidence            99999999999999999999999999999 6999999999999999999999999999999999999999975 567777


Q ss_pred             ceeeccCCCCcccc
Q 001384          660 SKLNISYNPLVSGT  673 (1088)
Q Consensus       660 ~~l~l~~N~l~~g~  673 (1088)
                      ....+.+|+..||.
T Consensus       730 ~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          730 PPAKFLNNPGLCGY  743 (768)
T ss_dssp             CGGGGCSCTEEEST
T ss_pred             CHHHhcCCchhcCC
Confidence            78888899876875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9e-57  Score=553.81  Aligned_cols=518  Identities=21%  Similarity=0.308  Sum_probs=346.9

Q ss_pred             CchhhHHHHHHHHhhcccCCCC----CcccccccCCCCCCccc---CCceeCCCCceeEEeccccccccccccccccCCc
Q 001384           31 SLETDREVLSNLRSFLENNNPV----NEGHYMQWNQSSSPCEW---PGIICSPDKARVNGLNLTDWNISGDIFNNFSALT  103 (1088)
Q Consensus        31 ~~~~d~~~l~~~~~~~~~~~~~----~~~~~~sW~~~~~~C~W---~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~  103 (1088)
                      ....|++||.+++.++...+..    +....++|+.+++||.|   +||+|+.. +||++|+|++++++|.+|+++++|+
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence            3457999999999998653322    11235589999999999   99999865 8999999999999999999999999


Q ss_pred             cCCeeeCCCCCCC------C------CcCccCCCCCCCcEEECccccccCccc--CCC-CCCCceeecccccccccccCc
Q 001384          104 QLSYLDLSRNTFS------G------SIPDDLSSCRSLKYLNLSHNILSGDLN--LSG-LRSLEILDLSVNRIHGEISFS  168 (1088)
Q Consensus       104 ~L~~L~Ls~n~l~------~------~~p~~l~~l~~L~~L~Ls~n~l~~~~~--l~~-l~~L~~L~Ls~N~l~~~~~~~  168 (1088)
                      +|++|||++|.+.      |      .+|...  +.+|+ +++++|.+.+...  +.. +..+..+++....+....   
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~---  179 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS---  179 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCC---
T ss_pred             cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccccc---
Confidence            9999999999772      2      223222  33344 4555544443221  110 112222222222111000   


Q ss_pred             hhhhcccceEEec--cCccCCCCCCccccCCCCCcEEEccCcccccc-ccccCcccceecccCccccccccccccc--CC
Q 001384          169 FPAICEKLVVANL--SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN-IWNGLAQLVEFSVSENVLSGVVSSSVFK--EN  243 (1088)
Q Consensus       169 ~~~~~~~L~~L~L--~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~l  243 (1088)
                          ...++.+.+  ..|++++ +|..|+++++|++|+|++|++++. +....     +.-+.+...+.++ ..+.  .+
T Consensus       180 ----~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~-----~~~~~~~~~~~ip-~~l~~~~l  248 (636)
T 4eco_A          180 ----RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW-----ENENSEYAQQYKT-EDLKWDNL  248 (636)
T ss_dssp             ----CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC-----SCTTSHHHHHHTT-SCCCGGGC
T ss_pred             ----ccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccc-----cccccchhcccCc-hhhhhccc
Confidence                011122222  2578888 788899999999999999988873 11000     0000011111122 1223  55


Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCcc-ccC-CCccccCCC------CCCCEEeCCCCcCCccCcc--ccc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN-FSG-PIPAEIGSI------SGLEALFLGKNNFLSVIPE--SLL  313 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~l~  313 (1088)
                      ++|++|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..++.+      ++|++|+|++|+++ .+|.  .++
T Consensus       249 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~  327 (636)
T 4eco_A          249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQ  327 (636)
T ss_dssp             TTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHT
T ss_pred             CCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhc
Confidence            566666666666666666666666666666666666 665 566666554      66666666666666 4565  666


Q ss_pred             CCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcC-cc
Q 001384          314 NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS-LK  392 (1088)
Q Consensus       314 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~  392 (1088)
                      ++++|++|+|++|+++|.+| .|                         ..+++|++|+|++|+++ .+|..+..+++ |+
T Consensus       328 ~l~~L~~L~L~~N~l~g~ip-~~-------------------------~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~  380 (636)
T 4eco_A          328 KMKKLGMLECLYNQLEGKLP-AF-------------------------GSEIKLASLNLAYNQIT-EIPANFCGFTEQVE  380 (636)
T ss_dssp             TCTTCCEEECCSCCCEEECC-CC-------------------------EEEEEESEEECCSSEEE-ECCTTSEEECTTCC
T ss_pred             cCCCCCEEeCcCCcCccchh-hh-------------------------CCCCCCCEEECCCCccc-cccHhhhhhcccCc
Confidence            66666666666666665554 44                         44556677777777777 67777777777 77


Q ss_pred             eeeccccccCCcCCcccCCCC--CCcEEEccCCcCCCCCCcccc-------CCCCCcEEEccccccccCCCcc-ccCCCC
Q 001384          393 FLILAHNRFNGSIPAVYGNMP--NLQTLDLSFNELTGPIPPSIG-------NLTSLLWLMLANNSLSGEIPGE-IGNCTS  462 (1088)
Q Consensus       393 ~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~-l~~l~~  462 (1088)
                      +|++++|+++ .+|..+..++  +|++|++++|++++.+|..++       .+++|++|+|++|+++ .+|.. +..+++
T Consensus       381 ~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~  458 (636)
T 4eco_A          381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSP  458 (636)
T ss_dssp             EEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCC
T ss_pred             EEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCC
Confidence            7777777777 6777766654  777788888877777777777       6777888888888887 45544 445777


Q ss_pred             CCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhc
Q 001384          463 LLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRL  542 (1088)
Q Consensus       463 L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  542 (1088)
                      |++|+|++|+++ .+|..++....-                                              .        
T Consensus       459 L~~L~Ls~N~l~-~i~~~~~~~~~~----------------------------------------------~--------  483 (636)
T 4eco_A          459 LSSINLMGNMLT-EIPKNSLKDENE----------------------------------------------N--------  483 (636)
T ss_dssp             CSEEECCSSCCS-BCCSSSSEETTE----------------------------------------------E--------
T ss_pred             CCEEECCCCCCC-CcCHHHhccccc----------------------------------------------c--------
Confidence            888888888877 677654321000                                              0        


Q ss_pred             ccCCcccccccCCCcccceeeeceEEccCCccccccCcccc--cCCCccEEeccccccccCCCCcccCc-cceEEEc---
Q 001384          543 LKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIG--KLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNL---  616 (1088)
Q Consensus       543 ~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l---  616 (1088)
                                     ...+..+++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..++.+ .|+.|+|   
T Consensus       484 ---------------~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          484 ---------------FKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             ---------------CTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             ---------------ccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence                           001123456788888887 6777776  77888888888888886 77777776 5778877   


Q ss_pred             ---cCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          617 ---TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       617 ---~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                         ++|++.+.+|..|+++++|+.|+|++|+| +.+|..+.  ++|+.|++++|++.+
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence               67889999999999999999999999999 58999877  899999999999964

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-54  Score=543.09  Aligned_cols=562  Identities=22%  Similarity=0.204  Sum_probs=459.1

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeec
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDL  156 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~L  156 (1088)
                      .+++.|+|++++|++..+..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+++..  .+.++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            47899999999999988888999999999999999999999999999999999999999999755  4899999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccc-----cCcccceecccCccc
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN-----GLAQLVEFSVSENVL  231 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-----~l~~L~~L~L~~n~l  231 (1088)
                      ++|++++..+..+ ..+++|++|+|++|++++..+..+.++++|++|++++|++++..+.     .+++|++|++++|.+
T Consensus       105 ~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          105 MSNSIQKIKNNPF-VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CSSCCCCCCSCTT-TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCccCccChhHc-cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            9999987666555 4568999999999999999999999999999999999999875432     357899999999999


Q ss_pred             ccccccccccCCCccCEEEcCCCcccccCccccc---CCCCCcEEEccCccccCCCccccCCCCC--CCEEeCCCCcCCc
Q 001384          232 SGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVS---NCRNLVVLNLFGNNFSGPIPAEIGSISG--LEALFLGKNNFLS  306 (1088)
Q Consensus       232 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~  306 (1088)
                      ++. ++..|..+.+|+.|++++|.+.......+.   ..++|+.|++++|.+++..|..+..++.  |+.|+|++|++.+
T Consensus       184 ~~~-~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~  262 (680)
T 1ziw_A          184 KEF-SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV  262 (680)
T ss_dssp             CCB-CTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred             ccc-ChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence            864 456778888999999999887643322221   3578999999999999888888888754  9999999999999


Q ss_pred             cCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccC--------CCCCccccCCCCcCEEEccCCccC
Q 001384          307 VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYID--------GMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       307 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~--------~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      ..|..|+.+++|++|+|++|.+.+..+..|+.+++|+.|++++|....        .+....+..+++|++|++++|.++
T Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            888899999999999999999999999999999999999998765322        112236678899999999999999


Q ss_pred             CCCCccccCCcCcceeeccccccCCc-C-CcccCC--CCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCC
Q 001384          379 GPLPVEISQMRSLKFLILAHNRFNGS-I-PAVYGN--MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP  454 (1088)
Q Consensus       379 ~~~p~~l~~l~~L~~L~L~~N~l~~~-~-p~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  454 (1088)
                      +..|..|.++++|++|++++|.+... + +..|..  .++|+.|++++|++++..|..+..+++|++|+|++|++++.+|
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  422 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT  422 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred             CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence            88888899999999999999986532 2 222332  2589999999999998888899999999999999999987776


Q ss_pred             -ccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhcc
Q 001384          455 -GEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRK  533 (1088)
Q Consensus       455 -~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (1088)
                       ..+.++++|++|++++|++++..|..+..+.++..+.+..|...+.                                 
T Consensus       423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~---------------------------------  469 (680)
T 1ziw_A          423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV---------------------------------  469 (680)
T ss_dssp             SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT---------------------------------
T ss_pred             cccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc---------------------------------
Confidence             6788999999999999999877777777777777766666543211                                 


Q ss_pred             ccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCC--------Cc
Q 001384          534 SCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLP--------SQ  605 (1088)
Q Consensus       534 ~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--------~~  605 (1088)
                                   +..|..+     ..+..+++|+|++|++++..|..++.+++|+.|+|++|++++..+        ..
T Consensus       470 -------------~~~p~~~-----~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  531 (680)
T 1ziw_A          470 -------------DSSPSPF-----QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF  531 (680)
T ss_dssp             -------------TCSSCTT-----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCT
T ss_pred             -------------ccCCccc-----ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchh
Confidence                         0111111     122346789999999998777789999999999999999986422        23


Q ss_pred             ccCc-cceEEEccCCcccccCCc-cccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCC-C-ccc
Q 001384          606 FDQL-PLIVLNLTRNNFSGEIPS-EFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST-G-QLA  681 (1088)
Q Consensus       606 ~~~l-~l~~l~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~-~-~~~  681 (1088)
                      ++.+ .|++|+|++|+++ .+|. .|+++++|+.|||++|+|++..|..|.++++|+.|+|++|++ ++.+|.. + .+.
T Consensus       532 ~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~~~~  609 (680)
T 1ziw_A          532 LKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI-TSVEKKVFGPAFR  609 (680)
T ss_dssp             TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCC-CBCCHHHHHHHHT
T ss_pred             hcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcC-CccChhHhccccc
Confidence            5666 6899999999999 6664 689999999999999999966666678999999999999999 5554432 2 456


Q ss_pred             ccccCccCCCCCCC
Q 001384          682 TFEKTSYLGDPLLD  695 (1088)
Q Consensus       682 ~~~~~~~~~n~~~~  695 (1088)
                      ++....+.+||..|
T Consensus       610 ~L~~l~l~~N~~~c  623 (680)
T 1ziw_A          610 NLTELDMRFNPFDC  623 (680)
T ss_dssp             TCSEEECTTCCCCB
T ss_pred             ccCEEEccCCCccc
Confidence            66777788998887

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.2e-53  Score=520.67  Aligned_cols=482  Identities=22%  Similarity=0.245  Sum_probs=315.2

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCc--ccCCCCCCCceeecc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD--LNLSGLRSLEILDLS  157 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~--~~l~~l~~L~~L~Ls  157 (1088)
                      .++.|+|++|.|++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.  ..+.++++|++|+|+
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            577888888888887778888888888888888888877788888888888888888888764  357888888888888


Q ss_pred             cccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccc---cccCcccc--eecccCcccc
Q 001384          158 VNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI---WNGLAQLV--EFSVSENVLS  232 (1088)
Q Consensus       158 ~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~--~L~L~~n~l~  232 (1088)
                      +|++++..+..+ ..+++|++|+|++|++++.....+..+++|++|++++|++++..   +..+++|+  .|++++|.++
T Consensus       114 ~n~i~~l~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~  192 (606)
T 3t6q_A          114 QTGISSIDFIPL-HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA  192 (606)
T ss_dssp             TSCCSCGGGSCC-TTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred             ccCcccCCcchh-ccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence            888887655555 44578888888888888765445555888888888888887633   45667777  7788888887


Q ss_pred             cccccccccCCCccCEEEcCCCcccccCcccccCCC-------------------------------CCcEEEccCcccc
Q 001384          233 GVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCR-------------------------------NLVVLNLFGNNFS  281 (1088)
Q Consensus       233 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-------------------------------~L~~L~L~~N~l~  281 (1088)
                      +..+ ..|.. .+|+.|++++|..   ++..+..+.                               +|+.|++++|.++
T Consensus       193 ~~~~-~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~  267 (606)
T 3t6q_A          193 GIEP-GAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF  267 (606)
T ss_dssp             EECT-TTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred             ccCh-hHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC
Confidence            6543 33433 4788888877751   111111111                               4555555555555


Q ss_pred             CCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccc
Q 001384          282 GPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI  361 (1088)
Q Consensus       282 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~  361 (1088)
                      +..+..|+.+++|++|++++|+++ .+|..+.++++|++|++++|.+.+..+..++.+++|+.|++++|.+........+
T Consensus       268 ~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~  346 (606)
T 3t6q_A          268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL  346 (606)
T ss_dssp             SCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTT
T ss_pred             ccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhh
Confidence            554555555555555555555555 3455555555555555555555555555555555555555555444333333344


Q ss_pred             cCCCCcCEEEccCCccCCCC--CccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCcc-ccCCCC
Q 001384          362 LKLPNISRLDLSHNNFTGPL--PVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS-IGNLTS  438 (1088)
Q Consensus       362 ~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~  438 (1088)
                      ..+++|++|++++|.+++..  |..+..+++|++|++++|++++..|..+..+++|++|++++|++++..|.. +.++++
T Consensus       347 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  426 (606)
T 3t6q_A          347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL  426 (606)
T ss_dssp             TTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTT
T ss_pred             hccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCccc
Confidence            44444444444444444332  334444444444444444444444444444444444444444444333322 444444


Q ss_pred             CcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCC
Q 001384          439 LLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPA  518 (1088)
Q Consensus       439 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~  518 (1088)
                      |++|++++|.+++..|..++.+++|++|+                                                   
T Consensus       427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~---------------------------------------------------  455 (606)
T 3t6q_A          427 LKVLNLSHSLLDISSEQLFDGLPALQHLN---------------------------------------------------  455 (606)
T ss_dssp             CCEEECTTCCCBTTCTTTTTTCTTCCEEE---------------------------------------------------
T ss_pred             CCEEECCCCccCCcCHHHHhCCCCCCEEE---------------------------------------------------
Confidence            44444444444444444444444444444                                                   


Q ss_pred             CCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccc---cCcccccCCCccEEeccc
Q 001384          519 DYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGE---LSPDIGKLQNFSMVHLGF  595 (1088)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~---~p~~~~~l~~L~~L~l~~  595 (1088)
                                                                        +++|++++.   .+..++.+++|+.|++++
T Consensus       456 --------------------------------------------------L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~  485 (606)
T 3t6q_A          456 --------------------------------------------------LQGNHFPKGNIQKTNSLQTLGRLEILVLSF  485 (606)
T ss_dssp             --------------------------------------------------CTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred             --------------------------------------------------CCCCCCCccccccchhhccCCCccEEECCC
Confidence                                                              444444431   224567778888888888


Q ss_pred             cccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCc
Q 001384          596 NQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLV  670 (1088)
Q Consensus       596 N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  670 (1088)
                      |++++.+|..++.+ .|+.|+|++|++++..|..+.++++| .|+|++|++++.+|..+..+++|+.|++++|++.
T Consensus       486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            88888888888877 68888888888888889999999999 9999999999888888999999999999999994

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.6e-52  Score=521.56  Aligned_cols=539  Identities=21%  Similarity=0.206  Sum_probs=388.0

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeec
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDL  156 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~L  156 (1088)
                      .+++.|+|+++.+++..+..++++++|++|+|++|.+++..+..|+++++|++|+|++|.+++..  .+.++++|++|+|
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            46778999999999988888999999999999999999665567999999999999999998754  5889999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCCCCcccc--CCCCCcEEEccCcccccccc---ccCcccceecccCccc
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFD--GCLNLRYLDLSSNNFRGNIW---NGLAQLVEFSVSENVL  231 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~--~l~~L~~L~Ls~N~l~~~~~---~~l~~L~~L~L~~n~l  231 (1088)
                      ++|.+++..+..+ ..+++|++|++++|++++..+..+.  .+++|++|++++|++++..+   ..+.+|+.|+++++.+
T Consensus       129 s~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          129 SHNGLSSTKLGTQ-VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CSSCCSCCCCCSS-SCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCcccccCchhh-cccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence            9999988776665 3468899999999999988877654  56889999999998876443   4566677777777666


Q ss_pred             ccccccccc--cCCCccCEEEcCCCcccccCcccccCCCC--CcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCcc
Q 001384          232 SGVVSSSVF--KENCSLEIFDLSENEFIGDFPGEVSNCRN--LVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV  307 (1088)
Q Consensus       232 ~~~~~~~~~--~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  307 (1088)
                      .+.......  -..++|+.|++++|.+++..|..+.+++.  |++|+|++|++++..|..|+.+++|++|+|++|++.+.
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred             ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence            533221111  02356777777777777666666666644  77777777777766666677777777777777777776


Q ss_pred             CcccccCCCCCcEEEcCCCcCCCc-----hh----HhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          308 IPESLLNLSKLEVLDLSSNNFGGE-----VQ----KIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       308 ~p~~l~~l~~L~~L~L~~N~l~~~-----~~----~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      .|..+.++++|++|++++|...+.     +|    ..|+.+++|+.|++++|.+. ...+..|..+++|++|++++|.++
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~~~  366 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP-GIKSNMFTGLINLKYLSLSNSFTS  366 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC-CCCTTTTTTCTTCCEEECTTCBSC
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC-CCChhHhccccCCcEEECCCCchh
Confidence            666777777777777776654431     11    25666777777777777643 344555666777777777777643


Q ss_pred             CCC--CccccC--CcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC-ccccCCCCCcEEEccccccccCC
Q 001384          379 GPL--PVEISQ--MRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP-PSIGNLTSLLWLMLANNSLSGEI  453 (1088)
Q Consensus       379 ~~~--p~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~  453 (1088)
                      +..  +..+..  .++|+.|++++|++++..|..+..+++|+.|++++|++++.+| ..+.++++|++|++++|++++..
T Consensus       367 ~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  446 (680)
T 1ziw_A          367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT  446 (680)
T ss_dssp             CCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECC
T ss_pred             hhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeC
Confidence            221  112222  2467777777777776666677777777777777777765554 45666777777777777776666


Q ss_pred             CccccCCCCCCeEEccCCcCc--cCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehh
Q 001384          454 PGEIGNCTSLLWLNLSNNKLS--GNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILT  531 (1088)
Q Consensus       454 p~~l~~l~~L~~L~L~~N~l~--g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (1088)
                      +..+..+++|+.|++++|.++  +.+|..+..+.++..+.+..|...+..                              
T Consensus       447 ~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~------------------------------  496 (680)
T 1ziw_A          447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN------------------------------  496 (680)
T ss_dssp             TTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCC------------------------------
T ss_pred             hhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCC------------------------------
Confidence            666777777777777777765  456666666666666666555433210                              


Q ss_pred             ccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccC--------cccccCCCccEEeccccccccCCC
Q 001384          532 RKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELS--------PDIGKLQNFSMVHLGFNQFDGKLP  603 (1088)
Q Consensus       532 ~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p--------~~~~~l~~L~~L~l~~N~l~g~~p  603 (1088)
                                             ......+..+++|+|++|++++..+        ..++.+++|+.|+|++|+++...+
T Consensus       497 -----------------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~  553 (680)
T 1ziw_A          497 -----------------------DDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV  553 (680)
T ss_dssp             -----------------------TTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             -----------------------hhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCH
Confidence                                   0000112345789999999986422        237889999999999999994444


Q ss_pred             CcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccc-cccccceeeccCCCCccc
Q 001384          604 SQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN-NLTELSKLNISYNPLVSG  672 (1088)
Q Consensus       604 ~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~~g  672 (1088)
                      ..|+.+ .|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+. .+++|+.|++++|+|.+.
T Consensus       554 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             HHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            568887 799999999999966666789999999999999999987777787 799999999999999553

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=8.6e-53  Score=525.37  Aligned_cols=412  Identities=18%  Similarity=0.186  Sum_probs=241.8

Q ss_pred             CCCchhhHHHHHHHHhhcccCCCCCcccccccCCCC-----CC--ccc------------CCceeCCCCceeEEeccccc
Q 001384           29 GDSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSS-----SP--CEW------------PGIICSPDKARVNGLNLTDW   89 (1088)
Q Consensus        29 ~~~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~-----~~--C~W------------~gv~C~~~~~~v~~L~L~~~   89 (1088)
                      ++...+|++||++||+++.+.         +|+.+.     +|  |.|            +||+|+. .+||+.|+|+++
T Consensus       264 ~~~~~~d~~ALl~~k~~l~~~---------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~  333 (876)
T 4ecn_A          264 TAEYIKDYKALKAIWEALDGK---------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGF  333 (876)
T ss_dssp             CCHHHHHHHHHHHHHHHTTGG---------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTT
T ss_pred             cccchHHHHHHHHHHHHcCCC---------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccC
Confidence            334567999999999999531         687554     56  999            9999986 689999999999


Q ss_pred             cccccccccccCCccCCeeeC-CCCCCCCCcCccCCCC-CCCcE-----EEC----------cccccc------------
Q 001384           90 NISGDIFNNFSALTQLSYLDL-SRNTFSGSIPDDLSSC-RSLKY-----LNL----------SHNILS------------  140 (1088)
Q Consensus        90 ~l~~~~~~~l~~l~~L~~L~L-s~n~l~~~~p~~l~~l-~~L~~-----L~L----------s~n~l~------------  140 (1088)
                      +++|.+|+++++|++|++||| ++|.++|..|...... ..+..     +..          ....++            
T Consensus       334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~  413 (876)
T 4ecn_A          334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE  413 (876)
T ss_dssp             CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred             CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence            999999999999999999999 8998887754321111 00000     000          000000            


Q ss_pred             -CcccCCCCCCCceeeccc--ccccccccCchhhhcccceEEeccCccCCC-----------------CCCcccc--CCC
Q 001384          141 -GDLNLSGLRSLEILDLSV--NRIHGEISFSFPAICEKLVVANLSLNNLTG-----------------RIDTCFD--GCL  198 (1088)
Q Consensus       141 -~~~~l~~l~~L~~L~Ls~--N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~-----------------~~~~~l~--~l~  198 (1088)
                       ..........++.+.++.  |++++ +|..+. .+++|++|+|++|++++                 .+|..++  +++
T Consensus       414 ~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~  491 (876)
T 4ecn_A          414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK  491 (876)
T ss_dssp             SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred             ccccccccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCC
Confidence             000011222333333333  55555 554433 24566666666666665                 2555555  666


Q ss_pred             CCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCc-ccc-cCcccccCCC-------C
Q 001384          199 NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE-FIG-DFPGEVSNCR-------N  269 (1088)
Q Consensus       199 ~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~-l~~-~~p~~l~~l~-------~  269 (1088)
                      +|++|+|++|++.+.+|..                      |..+++|++|+|++|+ +++ .+|..+++++       +
T Consensus       492 ~L~~L~Ls~N~l~~~iP~~----------------------l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~  549 (876)
T 4ecn_A          492 DLTDVELYNCPNMTQLPDF----------------------LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK  549 (876)
T ss_dssp             TCCEEEEESCTTCCSCCGG----------------------GGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTT
T ss_pred             CCCEEECcCCCCCccChHH----------------------HhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCC
Confidence            6777777666665544322                      2222344444444443 333 3333332222       4


Q ss_pred             CcEEEccCccccCCCcc--ccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccc-cceee
Q 001384          270 LVVLNLFGNNFSGPIPA--EIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQ-VKILA  346 (1088)
Q Consensus       270 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~  346 (1088)
                      |++|+|++|+++ .+|.  .++.+++|+.|+|++|+++ .+| .|+++++|+.|+|++|+++ .+|..+..+++ |+.|+
T Consensus       550 L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~  625 (876)
T 4ecn_A          550 IQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG  625 (876)
T ss_dssp             CCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEE
T ss_pred             ccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEE
Confidence            444444444444 4444  4444444444444444444 333 4444444444444444444 33333444444 44444


Q ss_pred             cCcCcccCCCCCccccCC--CCcCEEEccCCccCCCCCcc---cc--CCcCcceeeccccccCCcCCccc-CCCCCCcEE
Q 001384          347 LHSNSYIDGMNSSGILKL--PNISRLDLSHNNFTGPLPVE---IS--QMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTL  418 (1088)
Q Consensus       347 L~~n~~~~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~---l~--~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L  418 (1088)
                      +++|.+. .+ +..+..+  ++|+.|+|++|++++.+|..   +.  .+++|+.|+|++|+++ .+|..+ ..+++|+.|
T Consensus       626 Ls~N~L~-~l-p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L  702 (876)
T 4ecn_A          626 FSHNKLK-YI-PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTI  702 (876)
T ss_dssp             CCSSCCC-SC-CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEE
T ss_pred             CcCCCCC-cC-chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEE
Confidence            4444433 11 2233333  34788888888887765532   22  3347888888888888 556554 477888888


Q ss_pred             EccCCcCCCCCCccccCC--------CCCcEEEccccccccCCCcccc--CCCCCCeEEccCCcCccCCCchhhcc
Q 001384          419 DLSFNELTGPIPPSIGNL--------TSLLWLMLANNSLSGEIPGEIG--NCTSLLWLNLSNNKLSGNIPPEVMTI  484 (1088)
Q Consensus       419 ~L~~N~l~~~~p~~~~~l--------~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~L~~N~l~g~ip~~~~~~  484 (1088)
                      +|++|+++ .+|..+...        ++|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+
T Consensus       703 ~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L  775 (876)
T 4ecn_A          703 ILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS  775 (876)
T ss_dssp             ECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred             ECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcC
Confidence            88888888 666655432        37888888888888 6787776  88888888888888875 66655433

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=523.92  Aligned_cols=511  Identities=23%  Similarity=0.234  Sum_probs=423.3

Q ss_pred             cccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCc-CccCCCCCCCcEEECccccccCc--c
Q 001384           67 CEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSI-PDDLSSCRSLKYLNLSHNILSGD--L  143 (1088)
Q Consensus        67 C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~--~  143 (1088)
                      |.|..|.+  ...+++.|+|++|.|++..+..|+++++|++|||++|.+.+.+ |.+|+++++|++|+|++|.+++.  .
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            56888887  3568899999999999998999999999999999999777777 78999999999999999999875  4


Q ss_pred             cCCCCCCCceeecccccccccccCc-hhhhcccceEEeccCccCCCCCC-ccccCCCCCcEEEccCcccccccccc---C
Q 001384          144 NLSGLRSLEILDLSVNRIHGEISFS-FPAICEKLVVANLSLNNLTGRID-TCFDGCLNLRYLDLSSNNFRGNIWNG---L  218 (1088)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~---l  218 (1088)
                      .+.++++|++|+|++|.+++.++.. +...+++|++|+|++|++++..+ ..|+++++|++|+|++|.+++..+..   +
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            6999999999999999999866543 44567999999999999998765 67999999999999999998755443   3


Q ss_pred             --cccceecccCcccccccccccccCCC------ccCEEEcCCCcccccCcccccCC---CCCcEEEccC---------c
Q 001384          219 --AQLVEFSVSENVLSGVVSSSVFKENC------SLEIFDLSENEFIGDFPGEVSNC---RNLVVLNLFG---------N  278 (1088)
Q Consensus       219 --~~L~~L~L~~n~l~~~~~~~~~~~l~------~L~~L~Ls~n~l~~~~p~~l~~l---~~L~~L~L~~---------N  278 (1088)
                        ++|+.|++++|.+++..+.. +..+.      +|+.|++++|++++..|..+...   ++++.|.++.         +
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVD-WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCC-CCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             cCCccceEECCCCccccccccc-hhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence              78999999999998765543 22222      59999999999988888776543   6788888873         3


Q ss_pred             cccCCCccccCCC--CCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCC
Q 001384          279 NFSGPIPAEIGSI--SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGM  356 (1088)
Q Consensus       279 ~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~  356 (1088)
                      .+.+..+..|..+  ++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..+..|..+++|+.|++++|.+ ...
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l-~~~  329 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL-GEL  329 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCC-SCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCC-Ccc
Confidence            3444444555554  6899999999999998899999999999999999999999999999999999999999985 455


Q ss_pred             CCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCC
Q 001384          357 NSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNL  436 (1088)
Q Consensus       357 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  436 (1088)
                      .+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++ ++.    +++|+.|++++|+++ .+|..   .
T Consensus       330 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~----~~~L~~L~l~~N~l~-~l~~~---~  400 (844)
T 3j0a_A          330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHF----IPSIPDIFLSGNKLV-TLPKI---N  400 (844)
T ss_dssp             CSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSS----CCSCSEEEEESCCCC-CCCCC---C
T ss_pred             CHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccC----CCCcchhccCCCCcc-ccccc---c
Confidence            66778889999999999999998777889999999999999999983 433    788999999999998 67654   4


Q ss_pred             CCCcEEEccccccccCC-CccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccc
Q 001384          437 TSLLWLMLANNSLSGEI-PGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRW  515 (1088)
Q Consensus       437 ~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~  515 (1088)
                      .+++.|++++|++++.. +..++++++|++|+|++|++++..+....                                 
T Consensus       401 ~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------------------------------  447 (844)
T 3j0a_A          401 LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP---------------------------------  447 (844)
T ss_dssp             TTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSS---------------------------------
T ss_pred             cccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccc---------------------------------
Confidence            67899999999998532 23466899999999999999853222110                                 


Q ss_pred             cCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccc-----cccCcccccCCCccE
Q 001384          516 IPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLS-----GELSPDIGKLQNFSM  590 (1088)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~-----g~~p~~~~~l~~L~~  590 (1088)
                                                                 .....+++|+|++|.++     +..|..+..+++|+.
T Consensus       448 -------------------------------------------~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~  484 (844)
T 3j0a_A          448 -------------------------------------------SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV  484 (844)
T ss_dssp             -------------------------------------------CSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEEC
T ss_pred             -------------------------------------------ccCCccccccCCCCccccccccccchhhhcCcccccE
Confidence                                                       00123467899999997     455677889999999


Q ss_pred             EeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCC
Q 001384          591 VHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL  669 (1088)
Q Consensus       591 L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  669 (1088)
                      |+|++|+|++.+|..++.+ .|+.|+|++|++++..|..+.  ++|+.|||++|+|+|.+|..+.   +|+.|++++|++
T Consensus       485 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~  559 (844)
T 3j0a_A          485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKF  559 (844)
T ss_dssp             CCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECC
T ss_pred             EECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCc
Confidence            9999999999999999888 799999999999976666666  8999999999999999998764   788999999999


Q ss_pred             cc
Q 001384          670 VS  671 (1088)
Q Consensus       670 ~~  671 (1088)
                      .|
T Consensus       560 ~C  561 (844)
T 3j0a_A          560 IC  561 (844)
T ss_dssp             CC
T ss_pred             cc
Confidence            55

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.4e-51  Score=507.82  Aligned_cols=520  Identities=19%  Similarity=0.198  Sum_probs=399.8

Q ss_pred             ccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeeccccccccc
Q 001384           87 TDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGE  164 (1088)
Q Consensus        87 ~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~  164 (1088)
                      ++.+++. +|..+.  ..+++|||++|.|++..|..|+++++|++|+|++|.+++..  .+.++++|++|+|++|++++.
T Consensus        20 ~~~~l~~-iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~   96 (606)
T 3t6q_A           20 ENLGLNE-IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM   96 (606)
T ss_dssp             TTSCCSS-CCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred             CCCCccc-CcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc
Confidence            3334442 344443  36899999999999888999999999999999999998753  589999999999999999987


Q ss_pred             ccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCcccccc---ccccCcccceecccCccccccccccccc
Q 001384          165 ISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN---IWNGLAQLVEFSVSENVLSGVVSSSVFK  241 (1088)
Q Consensus       165 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~~  241 (1088)
                      .|..+. .+++|++|+|++|++++..+..+.++++|++|++++|++++.   .+..+++|++|++++|.+++. .+..|.
T Consensus        97 ~~~~~~-~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~  174 (606)
T 3t6q_A           97 AETALS-GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL-SKEDMS  174 (606)
T ss_dssp             CTTTTS-SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEE-CHHHHH
T ss_pred             Chhhhc-ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccccc-Chhhhh
Confidence            776664 468999999999999998888899999999999999998762   223366777777777777643 344566


Q ss_pred             CCCccC--EEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCC-----ccCcccccC
Q 001384          242 ENCSLE--IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFL-----SVIPESLLN  314 (1088)
Q Consensus       242 ~l~~L~--~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~  314 (1088)
                      .+++|+  .|++++|.+++..|..+.. .+|++|++++|.   .++..+..+.++....+..+.+.     ...+..+..
T Consensus       175 ~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~  250 (606)
T 3t6q_A          175 SLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG  250 (606)
T ss_dssp             TTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGG
T ss_pred             hhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhch
Confidence            666666  6777777777666555443 567777777765   22333444444333222222111     112223333


Q ss_pred             CC--CCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcc
Q 001384          315 LS--KLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK  392 (1088)
Q Consensus       315 l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  392 (1088)
                      +.  +|+.|++++|.+++..+..|+.+++|+.|++++|.+.  ..+..+..+++|++|++++|.+++..|..+..+++|+
T Consensus       251 l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  328 (606)
T 3t6q_A          251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS--ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT  328 (606)
T ss_dssp             GGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS--CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred             hhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC--CCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence            32  6888888888888888888888888888888888754  2344567788888888888888877777888888888


Q ss_pred             eeeccccccCCcCCc-ccCCCCCCcEEEccCCcCCCCC--CccccCCCCCcEEEccccccccCCCccccCCCCCCeEEcc
Q 001384          393 FLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNELTGPI--PPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLS  469 (1088)
Q Consensus       393 ~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  469 (1088)
                      +|++++|.+.+.+|. .+..+++|++|++++|++++..  |..++++++|++|++++|++++..|..++++++|++|+++
T Consensus       329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  408 (606)
T 3t6q_A          329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA  408 (606)
T ss_dssp             EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred             EEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence            888888888766654 4788888888888888888654  6778888888888888888887778888888888888888


Q ss_pred             CCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCccc
Q 001384          470 NNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIF  549 (1088)
Q Consensus       470 ~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  549 (1088)
                      +|++++..|....                                                                   
T Consensus       409 ~n~l~~~~~~~~~-------------------------------------------------------------------  421 (606)
T 3t6q_A          409 FTRLKVKDAQSPF-------------------------------------------------------------------  421 (606)
T ss_dssp             TCCEECCTTCCTT-------------------------------------------------------------------
T ss_pred             CCcCCCcccchhh-------------------------------------------------------------------
Confidence            8888765543210                                                                   


Q ss_pred             ccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccC---CCCcccCc-cceEEEccCCcccccC
Q 001384          550 PVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK---LPSQFDQL-PLIVLNLTRNNFSGEI  625 (1088)
Q Consensus       550 ~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~---~p~~~~~l-~l~~l~l~~N~l~~~~  625 (1088)
                               ..+..+++|++++|++++..|..++.+++|++|++++|++++.   .+..++.+ .|++|+|++|++++..
T Consensus       422 ---------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  492 (606)
T 3t6q_A          422 ---------QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID  492 (606)
T ss_dssp             ---------TTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC
T ss_pred             ---------hCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC
Confidence                     0112356899999999999999999999999999999999873   33567777 6999999999999999


Q ss_pred             CccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCC-CcccccccCccCCCCCCC
Q 001384          626 PSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST-GQLATFEKTSYLGDPLLD  695 (1088)
Q Consensus       626 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~-~~~~~~~~~~~~~n~~~~  695 (1088)
                      |..|+++++|+.|+|++|++++.+|+.+.++++| .|++++|++ ++.+|.. +.+..+....+.+||..|
T Consensus       493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l-~~~~~~~~~~l~~L~~L~l~~N~~~c  561 (606)
T 3t6q_A          493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI-SIILPSLLPILSQQRTINLRQNPLDC  561 (606)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC-CCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred             hhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc-cccCHhhcccCCCCCEEeCCCCCccc
Confidence            9999999999999999999999999999999999 999999999 5666653 556677778889999887

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.7e-51  Score=507.09  Aligned_cols=502  Identities=21%  Similarity=0.223  Sum_probs=424.6

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCc--ccCCCCCCCceeec
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD--LNLSGLRSLEILDL  156 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~--~~l~~l~~L~~L~L  156 (1088)
                      .+++.|+|+++.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.  ..+.++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            4688999999999998888999999999999999999988888999999999999999999875  35889999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCC-CCCccccCCCCCcEEEccCccccccccccC---ccc----ceecccC
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNLRYLDLSSNNFRGNIWNGL---AQL----VEFSVSE  228 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l---~~L----~~L~L~~  228 (1088)
                      ++|++++..+..+ ..+.+|++|+|++|++++ .+|..|+++++|++|++++|++++..+..+   .+|    ..|++++
T Consensus       112 ~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          112 VETKLASLESFPI-GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             TTSCCCCSSSSCC-TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             cCCcccccccccc-CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            9999987766665 456899999999999987 568899999999999999999987554433   333    3789999


Q ss_pred             cccccccccccccCCCccCEEEcCCCccc-ccCcccccCCCCCcEEEccCccccC------CCccccCCCC--CCCEEeC
Q 001384          229 NVLSGVVSSSVFKENCSLEIFDLSENEFI-GDFPGEVSNCRNLVVLNLFGNNFSG------PIPAEIGSIS--GLEALFL  299 (1088)
Q Consensus       229 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~--~L~~L~L  299 (1088)
                      |.+++ ++...|... +|++|++++|.++ +.+|..+.++++|+.+++..+.+.+      ..+..+..+.  .++.+++
T Consensus       191 n~l~~-~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  268 (606)
T 3vq2_A          191 NPIDF-IQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL  268 (606)
T ss_dssp             CCCCE-ECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEE
T ss_pred             CCcce-eCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheec
Confidence            99885 455556555 8999999999886 5677888899999998887655442      1122222322  3566777


Q ss_pred             -CCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          300 -GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       300 -~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                       ..|.+.+.+|. +..+++|+.|++++|.+....  .+..+++|+.|++++|.+ ..++  .+ .+++|++|++++|+..
T Consensus       269 ~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l-~~lp--~~-~l~~L~~L~l~~n~~~  341 (606)
T 3vq2_A          269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL-KQFP--TL-DLPFLKSLTLTMNKGS  341 (606)
T ss_dssp             CCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC-SSCC--CC-CCSSCCEEEEESCSSC
T ss_pred             cccccccccccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccC-cccc--cC-CCCccceeeccCCcCc
Confidence             77888888877 899999999999999997654  788899999999999997 4444  34 8999999999999665


Q ss_pred             CCCCccccCCcCcceeeccccccCCc--CCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCC-c
Q 001384          379 GPLPVEISQMRSLKFLILAHNRFNGS--IPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP-G  455 (1088)
Q Consensus       379 ~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~  455 (1088)
                      +.+  .+..+++|++|++++|++++.  +|..+..+++|++|++++|+++ .+|..+.++++|++|++++|++++..| .
T Consensus       342 ~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  418 (606)
T 3vq2_A          342 ISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS  418 (606)
T ss_dssp             EEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTT
T ss_pred             cch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChh
Confidence            443  677899999999999999865  4888999999999999999999 477899999999999999999998777 6


Q ss_pred             cccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhcccc
Q 001384          456 EIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC  535 (1088)
Q Consensus       456 ~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (1088)
                      .+.++++|++|++++|++++.+|..+..+                                                   
T Consensus       419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---------------------------------------------------  447 (606)
T 3vq2_A          419 AFLSLEKLLYLDISYTNTKIDFDGIFLGL---------------------------------------------------  447 (606)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTC---------------------------------------------------
T ss_pred             hhhccccCCEEECcCCCCCccchhhhcCC---------------------------------------------------
Confidence            89999999999999999997776654322                                                   


Q ss_pred             chhhhhcccCCcccccccCCCcccceeeeceEEccCCcccc-ccCcccccCCCccEEeccccccccCCCCcccCc-cceE
Q 001384          536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG-ELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIV  613 (1088)
Q Consensus       536 ~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~  613 (1088)
                                                ..+++|++++|++++ .+|..++.+++|+.|+|++|++++.+|..++.+ .|+.
T Consensus       448 --------------------------~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  501 (606)
T 3vq2_A          448 --------------------------TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL  501 (606)
T ss_dssp             --------------------------TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             --------------------------CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence                                      124679999999998 489999999999999999999999999999988 7999


Q ss_pred             EEccCCcccccCCccccCCccCcEEEccccccCCcCCccccccc-ccceeeccCCCCcc
Q 001384          614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLT-ELSKLNISYNPLVS  671 (1088)
Q Consensus       614 l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~-~L~~l~l~~N~l~~  671 (1088)
                      |+|++|++++.+|..|+++++|+.|||++|+|+ .+|..+..++ +|+.|++++|++.+
T Consensus       502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c  559 (606)
T 3vq2_A          502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVAC  559 (606)
T ss_dssp             EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred             EECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCccc
Confidence            999999999999999999999999999999999 7898899997 59999999999954

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6e-50  Score=493.36  Aligned_cols=517  Identities=20%  Similarity=0.189  Sum_probs=426.1

Q ss_pred             eccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccccc
Q 001384           84 LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRI  161 (1088)
Q Consensus        84 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l  161 (1088)
                      ++.++++++. +|..+.  ++|++|+|++|.+++..+..|+++++|++|+|++|.+++..  .+.++++|++|+|++|++
T Consensus        16 ~~c~~~~l~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           16 YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             EECTTSCCSS-CCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             eEccCCCccc-CCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            4566666664 344443  78999999999999888889999999999999999999753  589999999999999999


Q ss_pred             cccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc-c---ccccCcccceecccCccccccccc
Q 001384          162 HGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG-N---IWNGLAQLVEFSVSENVLSGVVSS  237 (1088)
Q Consensus       162 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~---~~~~l~~L~~L~L~~n~l~~~~~~  237 (1088)
                      ++..|..+. .+++|++|+|++|++++..+..++++++|++|++++|++++ .   .+..+++|++|++++|.+++. +.
T Consensus        93 ~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~-~~  170 (606)
T 3vq2_A           93 QSFSPGSFS-GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI-TV  170 (606)
T ss_dssp             CCCCTTSST-TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE-CT
T ss_pred             cccChhhcC-CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec-Ch
Confidence            988787774 46899999999999999998899999999999999999975 3   355678899999999998864 34


Q ss_pred             ccccCCCcc----CEEEcCCCcccccCcccccCCCCCcEEEccCcccc-CCCccccCCCCCCCEEeCCCCcCCc------
Q 001384          238 SVFKENCSL----EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS-GPIPAEIGSISGLEALFLGKNNFLS------  306 (1088)
Q Consensus       238 ~~~~~l~~L----~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~------  306 (1088)
                      ..|..+++|    .+|++++|.+++..+..+... +|++|++++|.+. +..|..+.++++|+.+++..+.+..      
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~  249 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI  249 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence            445555544    489999999886666655554 8999999999886 4567788889999888876544332      


Q ss_pred             cCcccccCCC--CCcEEEc-CCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCc
Q 001384          307 VIPESLLNLS--KLEVLDL-SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV  383 (1088)
Q Consensus       307 ~~p~~l~~l~--~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  383 (1088)
                      ..+..+..+.  +++.+++ ..|.+.+.++. |..+++|+.|++++|.+.. ..  .+..+++|++|++++|.+ +.+| 
T Consensus       250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~--~l~~~~~L~~L~l~~n~l-~~lp-  323 (606)
T 3vq2_A          250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE--DVPKHFKWQSLSIIRCQL-KQFP-  323 (606)
T ss_dssp             CCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC--CCCTTCCCSEEEEESCCC-SSCC-
T ss_pred             cChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh--hccccccCCEEEcccccC-cccc-
Confidence            1122222222  4677777 77888888887 9999999999999998643 32  778889999999999999 5788 


Q ss_pred             cccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCC--CCccccCCCCCcEEEccccccccCCCccccCCC
Q 001384          384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP--IPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT  461 (1088)
Q Consensus       384 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  461 (1088)
                      .+ .+++|+.|++++|+..+.+  .++.+++|++|++++|++++.  +|..+..+++|++|++++|.++ .+|..+..++
T Consensus       324 ~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~  399 (606)
T 3vq2_A          324 TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE  399 (606)
T ss_dssp             CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCT
T ss_pred             cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCC
Confidence            55 8999999999999766444  577899999999999999865  4888999999999999999998 4778899999


Q ss_pred             CCCeEEccCCcCccCCCc-hhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhh
Q 001384          462 SLLWLNLSNNKLSGNIPP-EVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD  540 (1088)
Q Consensus       462 ~L~~L~L~~N~l~g~ip~-~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  540 (1088)
                      +|++|++++|++++..|. .+..                                                         
T Consensus       400 ~L~~L~l~~n~l~~~~~~~~~~~---------------------------------------------------------  422 (606)
T 3vq2_A          400 ELQHLDFQHSTLKRVTEFSAFLS---------------------------------------------------------  422 (606)
T ss_dssp             TCCEEECTTSEEESTTTTTTTTT---------------------------------------------------------
T ss_pred             CCCeeECCCCccCCccChhhhhc---------------------------------------------------------
Confidence            999999999999866552 2211                                                         


Q ss_pred             hcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEecccccccc-CCCCcccCc-cceEEEccC
Q 001384          541 RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG-KLPSQFDQL-PLIVLNLTR  618 (1088)
Q Consensus       541 ~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l-~l~~l~l~~  618 (1088)
                                          +..+++|++++|++++.+|..++.+++|+.|++++|++++ .+|..++.+ .|++|+|++
T Consensus       423 --------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~  482 (606)
T 3vq2_A          423 --------------------LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK  482 (606)
T ss_dssp             --------------------CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             --------------------cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence                                1235689999999999999999999999999999999998 489999988 799999999


Q ss_pred             CcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCC-Cccc-ccccCccCCCCCCC
Q 001384          619 NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST-GQLA-TFEKTSYLGDPLLD  695 (1088)
Q Consensus       619 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~-~~~~-~~~~~~~~~n~~~~  695 (1088)
                      |++++..|..|+++++|+.|+|++|++++.+|..++++++|+.|++++|+++  .+|.. ..+. ++....+.+||..|
T Consensus       483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~p~~~~~l~~~L~~l~l~~N~~~c  559 (606)
T 3vq2_A          483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE--TSKGILQHFPKSLAFFNLTNNSVAC  559 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC--CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred             CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc--ccCHhHhhhcccCcEEEccCCCccc
Confidence            9999999999999999999999999999988999999999999999999994  56654 3332 35666788999888

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.1e-51  Score=448.22  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=213.6

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++    ++|||||+++++|.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~----l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN----LQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHh----CCCCCCccEEEEEeeCC
Confidence            45778899999999999999864      467899999987665666789999999997    68999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC
Q 001384          879 EKILVYEYMEGGSLEDIISDR-------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG  945 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~  945 (1088)
                      ..++|||||++|+|.++++..             .+++|.+++.|+.|||.||+|||++   +||||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            999999999999999999764             3599999999999999999999999   999999999999999999


Q ss_pred             CEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          946 KALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      .+||+|||+|+.....+.. ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....  ....+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i  243 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI  243 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            9999999999876543332 2334578999999999999999999999999999999999 899998765421  11111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .                .+...+.+..++.++.+++.+||+.||++||+++||++.|+++.+
T Consensus       244 ~----------------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          244 T----------------QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             H----------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H----------------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1                111112233455678999999999999999999999999998754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=501.65  Aligned_cols=515  Identities=21%  Similarity=0.201  Sum_probs=318.8

Q ss_pred             eccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccC---cccCCCCCCCceeeccccc
Q 001384           84 LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG---DLNLSGLRSLEILDLSVNR  160 (1088)
Q Consensus        84 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~---~~~l~~l~~L~~L~Ls~N~  160 (1088)
                      .+.++++++.. |.   -.++|++|||++|.|++..|..|+++++|++|+|++|.+.+   ...+.++++|++|+|++|.
T Consensus         9 ~dcs~~~L~~v-P~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A            9 AFYRFCNLTQV-PQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             EEESCCCSSCC-CS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred             EEccCCCCCCC-CC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence            34566677764 33   45789999999999998889999999999999999996554   2358899999999999999


Q ss_pred             ccccccCchhhhcccceEEeccCccCCCCCCcc--ccCCCCCcEEEccCcccccc----ccccCcccceecccCcccccc
Q 001384          161 IHGEISFSFPAICEKLVVANLSLNNLTGRIDTC--FDGCLNLRYLDLSSNNFRGN----IWNGLAQLVEFSVSENVLSGV  234 (1088)
Q Consensus       161 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~--l~~l~~L~~L~Ls~N~l~~~----~~~~l~~L~~L~L~~n~l~~~  234 (1088)
                      +++..|..|. .+++|++|+|++|++++..+..  |.++++|++|+|++|.+++.    .+..+++|++|++++|.+++.
T Consensus        85 l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~  163 (844)
T 3j0a_A           85 IYFLHPDAFQ-GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV  163 (844)
T ss_dssp             CCEECTTSSC-SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred             CcccCHhHcc-CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence            8877676664 3577888888888888755543  77888888888888877652    233455555555555555443


Q ss_pred             cccccccCC--CccCEEEcCCCcccccCcccccCCCC------CcEEEccCccccCCCccccCCC---CCCCEEeCCCC-
Q 001384          235 VSSSVFKEN--CSLEIFDLSENEFIGDFPGEVSNCRN------LVVLNLFGNNFSGPIPAEIGSI---SGLEALFLGKN-  302 (1088)
Q Consensus       235 ~~~~~~~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N-  302 (1088)
                      .+ ..+..+  ++|+.|+|+.|.+.+..|..+..+++      |++|++++|.+++.++..+...   .+++.|.++.+ 
T Consensus       164 ~~-~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          164 CE-HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CS-GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             CH-HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            22 222222  45555555555555555444444433      5555555555554444444322   34444444421 


Q ss_pred             --------cCCccCcccccCC--CCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEc
Q 001384          303 --------NFLSVIPESLLNL--SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL  372 (1088)
Q Consensus       303 --------~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L  372 (1088)
                              ++....+..|..+  ++|+.|+|++|.+.+..+..|+.                         +++|+.|+|
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~-------------------------l~~L~~L~L  297 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET-------------------------LKDLKVLNL  297 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS-------------------------CCCCCEEEE
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc-------------------------CCCCCEEEC
Confidence                    2222222223322  34555555555554444444444                         455555555


Q ss_pred             cCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC
Q 001384          373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       373 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      ++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..+.++++|++|+|++|.+++ 
T Consensus       298 ~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-  376 (844)
T 3j0a_A          298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-  376 (844)
T ss_dssp             ESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-
T ss_pred             CCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-
Confidence            5555554444445555555555555555544444455555555555555555544444444455555555555555542 


Q ss_pred             CCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhc
Q 001384          453 IPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTR  532 (1088)
Q Consensus       453 ~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (1088)
                      ++.    +++|+.|++++|+++ .+|...   ..+..+.+..|...+..                    ...        
T Consensus       377 i~~----~~~L~~L~l~~N~l~-~l~~~~---~~l~~L~ls~N~l~~l~--------------------~~~--------  420 (844)
T 3j0a_A          377 IHF----IPSIPDIFLSGNKLV-TLPKIN---LTANLIHLSENRLENLD--------------------ILY--------  420 (844)
T ss_dssp             CSS----CCSCSEEEEESCCCC-CCCCCC---TTCCEEECCSCCCCSST--------------------THH--------
T ss_pred             ccC----CCCcchhccCCCCcc-cccccc---cccceeecccCccccCc--------------------hhh--------
Confidence            221    444555555555554 343321   11112222222211100                    000        


Q ss_pred             cccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCc-ccccCCCccEEeccccccc-----cCCCCcc
Q 001384          533 KSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSP-DIGKLQNFSMVHLGFNQFD-----GKLPSQF  606 (1088)
Q Consensus       533 ~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~-----g~~p~~~  606 (1088)
                                              ....+..+++|+|++|++++..+. .+..+++|+.|+|++|.++     +..|..|
T Consensus       421 ------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~  476 (844)
T 3j0a_A          421 ------------------------FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF  476 (844)
T ss_dssp             ------------------------HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCS
T ss_pred             ------------------------hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhh
Confidence                                    000122357899999999976554 4566899999999999997     4555677


Q ss_pred             cCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCccccccc
Q 001384          607 DQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEK  685 (1088)
Q Consensus       607 ~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~  685 (1088)
                      ..+ .|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|+|++|++ .|.+|..  +..+..
T Consensus       477 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l-~~~~~~~--~~~L~~  551 (844)
T 3j0a_A          477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQL-LAPNPDV--FVSLSV  551 (844)
T ss_dssp             SCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECC-CCCCSCC--CSSCCE
T ss_pred             cCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcC-CCCChhH--hCCcCE
Confidence            777 699999999999998899999999999999999999976666665  8999999999999 7787755  556777


Q ss_pred             CccCCCCCCC
Q 001384          686 TSYLGDPLLD  695 (1088)
Q Consensus       686 ~~~~~n~~~~  695 (1088)
                      ..+.+||..|
T Consensus       552 l~l~~Np~~C  561 (844)
T 3j0a_A          552 LDITHNKFIC  561 (844)
T ss_dssp             EEEEEECCCC
T ss_pred             EEecCCCccc
Confidence            7788998777

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=450.06  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=207.8

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      +|.+.+.||+|+||+||+|+++      +++.||||+++.......++|.+|++++++    ++|||||+++++|.+++.
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~----l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM----LQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECSSSS
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCE
Confidence            4667789999999999999864      478899999987766666789999999997    689999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          880 KILVYEYMEGGSLEDIISDR---------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      .|+|||||++|+|.++++..               .+++|.++++|+.|||.||+|||++   +||||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            99999999999999999753               3589999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHh
Q 001384          945 GKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRR 1022 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1088)
                      +.+||+|||+|+.....+.. ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....  ....
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~  272 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDC  272 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence            99999999999876543322 3345679999999999999999999999999999999999 899998764421  1111


Q ss_pred             hhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      +.                .+...+.+..++.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus       273 i~----------------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 IT----------------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HH----------------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HH----------------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11                1111122334456788999999999999999999999999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-49  Score=440.50  Aligned_cols=254  Identities=23%  Similarity=0.322  Sum_probs=211.3

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++++.+.||+|+||+||+|++.      +++.||||+++.... ...++|.+|+.++++    ++|||||+++|+|.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~----l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR----LQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHH----CCCTTBCCEEEEECSSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHh----CCCCCCCCcceEEEECC
Confidence            3566789999999999999863      467899999976532 345789999999997    68999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          879 EKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ..++|||||++|+|.++++..                ..++|.++.+|+.|||+||+|||++   +||||||||+|||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence            999999999999999999653                3489999999999999999999999   999999999999999


Q ss_pred             CCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHH
Q 001384          943 KEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWG 1020 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 1020 (1088)
                      +++.+||+|||+|+.....+. .......||++|||||++.+..|+.++|||||||++|||+| |+.||.+.....  ..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~  257 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VV  257 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence            999999999999987654332 23445689999999999999999999999999999999998 899998765421  11


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+.                .+...+.+..++..+.+++.+||+.||++||+|+||++.|+...
T Consensus       258 ~~i~----------------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          258 EMIR----------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHH----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHH----------------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            1221                11112223445677899999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=427.99  Aligned_cols=257  Identities=28%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|+++  ..||||+++....  ...+.|.+|++++++    ++|||||++++++.+ +..++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~----l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRK----TRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECS-SSCEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEC-CeEEE
Confidence            56788899999999999999975  3699999975432  234679999999997    689999999998865 56899


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||||++|+|.++++.. .++++.++..|+.|||.||+|||++   +||||||||+|||+++++.+||+|||+|+.....
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999999764 5799999999999999999999999   9999999999999999999999999999876533


Q ss_pred             C-CcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          962 D-SHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       962 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      . .......+||+.|||||++.   ...|+.++|||||||++|||+||+.||.+........ ..... ....+.     
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~-~~~~~-~~~~p~-----  258 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII-FMVGR-GYASPD-----  258 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-HHHHT-TCCCCC-----
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH-HHHhc-CCCCCC-----
Confidence            2 22345578999999999875   3468999999999999999999999998754321111 11110 000000     


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                            ....+..++..+.+++.+||+.||++|||++||++.|+.+.
T Consensus       259 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          259 ------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                  00112334567889999999999999999999999998764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-48  Score=434.06  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=210.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++++.    ++|||||++++++.+++..|+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~----l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHH----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCEEEEE
Confidence            46888999999999999999976 699999999987655566778999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||||+||+|.++++. .++++.+++.|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+.... 
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999999999976 5699999999999999999999999   99999999999999999999999999998875432 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......  ...+... . ..            
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~-~-~~------------  288 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDN-L-PP------------  288 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS-S-CC------------
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcC-C-CC------------
Confidence            234567899999999999999999999999999999999999999987644211  1111100 0 00            


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..........++.+|+.+||+.||++|||++|+++
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00112233457888999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-49  Score=440.78  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=202.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+....  ..+.+.+|++++++    ++|||||++++++.+++..|
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~----l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN----MKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHH----CCCCCCCcEEEEEEECCEEE
Confidence            58999999999999999999975 6999999999765432  34578999999997    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +|||||+||+|.++++..+  .+++.+++.|+.||+.||+|||++   +||||||||+|||+++++.+||+|||+|+.+.
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999997543  578999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.....  ....+.....           
T Consensus       177 ~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~-----------  242 (350)
T 4b9d_A          177 ST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVLKIISGSF-----------  242 (350)
T ss_dssp             HH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHTCC-----------
T ss_pred             CC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCC-----------
Confidence            21 122345689999999999999999999999999999999999999998765422  2222221110           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           .+.+.....++.+++.+||+.||++||+++|+++
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0112223457888999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.2e-49  Score=435.32  Aligned_cols=252  Identities=26%  Similarity=0.292  Sum_probs=206.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|++.++||+|+||+||+|+++ +|+.||||+++.....     .+|+.+++.    ++|||||++++++.+++..|+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~----l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG----LSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTT----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHh----CCCCCCCcEEEEEEECCEEEEE
Confidence            46788889999999999999976 6899999999765322     468888876    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+||+|.+++++.+++++.+++.|+.||+.||+|||++   +||||||||+|||++.+| ++||+|||+|+.+....
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999999988999999999999999999999999   999999999999999998 69999999999875432


Q ss_pred             Cc----ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          963 SH----VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       963 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ..    .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+........  .+...   ....     
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~---~~~~-----  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KIASE---PPPI-----  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--HHHHS---CCGG-----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--HHHcC---CCCc-----
Confidence            11    1234679999999999999999999999999999999999999998754311111  11100   0000     


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                            ...+...+..+.+++.+||+.||++|||+.|+++.+.+++
T Consensus       276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                  0112334567888999999999999999999999988764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.1e-49  Score=430.86  Aligned_cols=247  Identities=24%  Similarity=0.332  Sum_probs=210.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+.+|++++++    ++|||||++++++.+++..
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~----l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----LDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEEeCCEE
Confidence            46999999999999999999975 78999999997642   2334678999999987    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+|||||+||+|.+++++.+.+++.+++.|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+..
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999999999988999999999999999999999999   999999999999999999999999999998764


Q ss_pred             CC-CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+...  ....+.....           
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~-----------  251 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFAKIIKLEY-----------  251 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCC-----------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC-----------
Confidence            33 233456789999999999999999999999999999999999999998765422  1222221110           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                            ..+.....++.+++.+|++.||++||+++|+.
T Consensus       252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                  00112235678899999999999999999863

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-47  Score=466.66  Aligned_cols=489  Identities=20%  Similarity=0.216  Sum_probs=363.6

Q ss_pred             CcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--
Q 001384           66 PCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--  143 (1088)
Q Consensus        66 ~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--  143 (1088)
                      .|.|.|+ |+..          +++++. +|+.+.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++..  
T Consensus         3 ~C~~~~~-c~~~----------~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDGR----------SRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EECT----------TSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EECC----------CCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999999 8643          344443 444443  78999999999999888899999999999999999998754  


Q ss_pred             cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCC-CCccccCCCCCcEEEccCccccccccccCcccc
Q 001384          144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR-IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLV  222 (1088)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~  222 (1088)
                      .+.++++|++|+|++|++++..+..+ ..+++|++|+|++|++++. .|..+.++++|++|++++|++.+          
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~----------  137 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWF-GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS----------  137 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHH-TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC----------
T ss_pred             hccccccCCEEECCCCccCccCHHHh-ccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcccc----------
Confidence            48899999999999999886655444 3457788888888888763 45677778888888887776332          


Q ss_pred             eecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCcccc-CCCCCCCEEeCCC
Q 001384          223 EFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEI-GSISGLEALFLGK  301 (1088)
Q Consensus       223 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~  301 (1088)
                                 .++...|..+++|++|++++|++++..|..+.++++|++|++++|.+. .+|..+ ..+++|+.|++++
T Consensus       138 -----------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~  205 (549)
T 2z81_A          138 -----------EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRD  205 (549)
T ss_dssp             -----------EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEES
T ss_pred             -----------ccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccC
Confidence                       334445666778888888888888878888888888888888888876 444443 5678888888888


Q ss_pred             CcCCccC--c-ccccCCCCCcEEEcCCCcCCCchhHh----hhcccccceeecCcCcccCCC-----CCccccCCCCcCE
Q 001384          302 NNFLSVI--P-ESLLNLSKLEVLDLSSNNFGGEVQKI----FGRFTQVKILALHSNSYIDGM-----NSSGILKLPNISR  369 (1088)
Q Consensus       302 N~l~~~~--p-~~l~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~n~~~~~~-----~~~~~~~l~~L~~  369 (1088)
                      |++++..  | .....+++|+.|++++|.+++..+..    +..+++|+.+++++|.+....     ....+..+++|+.
T Consensus       206 n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~  285 (549)
T 2z81_A          206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET  285 (549)
T ss_dssp             CBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCE
T ss_pred             CccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccc
Confidence            8887642  2 22345678888888888887655443    355677888888877654321     1234456788888


Q ss_pred             EEccCCccCCC-----CCccccCCcCcceeeccccccCCcCCccc-CCCCCCcEEEccCCcCCCCCCc---cccCCCCCc
Q 001384          370 LDLSHNNFTGP-----LPVEISQMRSLKFLILAHNRFNGSIPAVY-GNMPNLQTLDLSFNELTGPIPP---SIGNLTSLL  440 (1088)
Q Consensus       370 L~Ls~N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~  440 (1088)
                      |++.++.+...     ++..+...++|+.|++++|+++ .+|..+ ..+++|++|++++|++++.+|.   .++.+++|+
T Consensus       286 L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~  364 (549)
T 2z81_A          286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQ  364 (549)
T ss_dssp             EEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCC
T ss_pred             ccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCc
Confidence            88888876531     2222344567888999999887 677666 4688899999999998876643   467888899


Q ss_pred             EEEccccccccCCC--ccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCC
Q 001384          441 WLMLANNSLSGEIP--GEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPA  518 (1088)
Q Consensus       441 ~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~  518 (1088)
                      +|+|++|++++..+  ..++.+++|++|++++|+++ .+|..+..+                                  
T Consensus       365 ~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~----------------------------------  409 (549)
T 2z81_A          365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP----------------------------------  409 (549)
T ss_dssp             EEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCC----------------------------------
T ss_pred             EEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccc----------------------------------
Confidence            99999998885322  45788889999999999888 566543211                                  


Q ss_pred             CCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEecccccc
Q 001384          519 DYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQF  598 (1088)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l  598 (1088)
                                                                 ..+++|++++|+++ .+|..+.  ++|+.|+|++|++
T Consensus       410 -------------------------------------------~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l  443 (549)
T 2z81_A          410 -------------------------------------------EKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL  443 (549)
T ss_dssp             -------------------------------------------TTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCC
T ss_pred             -------------------------------------------ccccEEECCCCCcc-cccchhc--CCceEEECCCCCh
Confidence                                                       12457888888887 4565543  5788999999999


Q ss_pred             ccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCC
Q 001384          599 DGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPST  677 (1088)
Q Consensus       599 ~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~  677 (1088)
                      ++.+    +.+ .|++|+|++|+++ .||. .+.+++|+.|||++|+|++.+|..++.+++|+.|++++|++ .+.+|..
T Consensus       444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~-~~~~~~~  516 (549)
T 2z81_A          444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW-DCSCPRI  516 (549)
T ss_dssp             SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB-CCCHHHH
T ss_pred             hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc-cCCCccH
Confidence            8643    234 6889999999998 7887 57899999999999999988888899999999999999999 5666643


Q ss_pred             Ccc
Q 001384          678 GQL  680 (1088)
Q Consensus       678 ~~~  680 (1088)
                      ..+
T Consensus       517 ~~l  519 (549)
T 2z81_A          517 DYL  519 (549)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            333

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.1e-48  Score=416.55  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=193.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+...   ...+.+.+|++++++    ++|||||++++++.+++..
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~----l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL----LRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHH----CCCCCCCeEEEEEEECCEE
Confidence            68999999999999999999975 699999999976532   234578999999997    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+ +|+|.+++.+++++++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999999 679999999999999999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .  ......+||+.|+|||++.+..| +.++||||+||++|||+||+.||.+....  +....+.....           
T Consensus       165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i~~~~~-----------  229 (275)
T 3hyh_A          165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNISNGVY-----------  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC-----------
T ss_pred             C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcCCC-----------
Confidence            2  23345789999999999988776 57999999999999999999999875432  22222221100           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+.....++.+++.+|++.||++|||++|+++
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  001122356788999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-47  Score=417.64  Aligned_cols=244  Identities=28%  Similarity=0.450  Sum_probs=198.8

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CCeE
Q 001384          808 SEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GSEK  880 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~~~  880 (1088)
                      ++.+.||+|+||+||+|+++ +++.||||++.....  ...+.+.+|++++++    ++|||||++++++.+    +...
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~----l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG----LQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEeeccCCCcEE
Confidence            56678999999999999976 688999999976532  234578999999997    689999999999865    3568


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcC-CCCEEEeeccccee
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDK-EGKALVTDFGLARV  957 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~  957 (1088)
                      |+|||||+||+|.+++++...+++..++.|+.||+.||+|||++   +  ||||||||+|||++. ++.+||+|||+|+.
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            99999999999999999988999999999999999999999998   6  999999999999984 79999999999975


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ..   .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..... ...........        +
T Consensus       182 ~~---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~--------~  248 (290)
T 3fpq_A          182 KR---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK--------P  248 (290)
T ss_dssp             CC---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC--------C
T ss_pred             CC---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCC--------C
Confidence            43   223456789999999998875 69999999999999999999999997654322 22222211000        0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...       +.....++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~-------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC-------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000       1112346788999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=435.15  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=210.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++++.    ++|||||++++++.+++..|+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~----l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD----YQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHH----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHh----CCCCCCCceEEEEEECCEEEEE
Confidence            56999999999999999999976 699999999987666666778999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||||+||+|.++++. .++++.+++.|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+.... 
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999999965 4699999999999999999999999   99999999999999999999999999998875432 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......  ...+..... ..            
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~~~-~~------------  366 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRDNLP-PR------------  366 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC-CC------------
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcCCC-CC------------
Confidence            234567899999999999999999999999999999999999999987654211  111110000 00            


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       .........++.+|+.+||+.||++||+++|+++
T Consensus       367 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          367 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0011223457888999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.7e-48  Score=435.13  Aligned_cols=264  Identities=26%  Similarity=0.387  Sum_probs=214.6

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEe
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLY  871 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~  871 (1088)
                      ++....++|++.+.||+|+||+||+|++..      ++.||||++...... ..+.+.+|++++.++.   +|||||+++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~---hhpnIV~l~  134 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---HHLNVVNLL  134 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC---CCCcEEEEE
Confidence            333445789999999999999999998642      367999999875433 3457899999998743   569999999


Q ss_pred             eEEecC-CeEEEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          872 GWCLDG-SEKILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       872 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      ++|.++ ...++|||||++|+|.++++..                ..+++.++..|+.|||+||+|||++   +||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence            998764 5789999999999999999753                2489999999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGG 1012 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 1012 (1088)
                      ||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332 3445689999999999999999999999999999999998 99999875


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .... .......                .+.....+..++.++.+++.+||+.||++|||++||++.|+++++
T Consensus       292 ~~~~-~~~~~i~----------------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          292 KIDE-EFCRRLK----------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCSH-HHHHHHH----------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHH-HHHHHHH----------------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            3211 1111111                111112233445678899999999999999999999999999875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=454.59  Aligned_cols=494  Identities=21%  Similarity=0.197  Sum_probs=335.3

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceEEe
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVAN  180 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~  180 (1088)
                      +++++|||++|.+++..+..|.++++|++|+|++|.+++..  .+.++++|++|+|++|++++..+..|. .+++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS-GLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEE
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhc-Ccccccccc
Confidence            57899999999999887889999999999999999988653  488889999999999888865555443 357777777


Q ss_pred             ccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccC
Q 001384          181 LSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF  260 (1088)
Q Consensus       181 L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  260 (1088)
                      +++|++++..+..++++++|++|++++|.+++                     .-.+..|..+++|++|++++|++++..
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~---------------------~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQS---------------------FKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCC---------------------CCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             ccccccccCCCccccccccccEEecCCCccce---------------------ecChhhhcccCCCCEEeCcCCccceec
Confidence            77777777766667777777777777776653                     111334566778888999988888877


Q ss_pred             cccccCCCCC----cEEEccCccccCCCccccCCCCCCCEEeCCCCcCC-ccCcccccCCCCCcEEEcCCCcC------C
Q 001384          261 PGEVSNCRNL----VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFL-SVIPESLLNLSKLEVLDLSSNNF------G  329 (1088)
Q Consensus       261 p~~l~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l------~  329 (1088)
                      |..++.+++|    +.|++++|.+++..|..+... +|+.|++++|... ..++..+..+++++.+.+..+.+      .
T Consensus       166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~  244 (570)
T 2z63_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE  244 (570)
T ss_dssp             GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred             HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhh
Confidence            8888888888    788898888887777666655 7888888877432 12344455555555444332211      1


Q ss_pred             CchhHhhhcccc--cceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCc
Q 001384          330 GEVQKIFGRFTQ--VKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA  407 (1088)
Q Consensus       330 ~~~~~~~~~l~~--L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  407 (1088)
                      ......|..+.+  ++.+++..+.......+..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|.
T Consensus       245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~  321 (570)
T 2z63_A          245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT  321 (570)
T ss_dssp             ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB
T ss_pred             hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc
Confidence            111222222222  2333344442223333444555566666666666665 455555555 6666666666665 4443


Q ss_pred             ccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCC--CccccCCCCCCeEEccCCcCccCCCchhhccC
Q 001384          408 VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEI--PGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIG  485 (1088)
Q Consensus       408 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~  485 (1088)
                        ..+++|+.|++++|.+.+.++.  ..+++|++|++++|++++..  |..+.++++|++|++++|++++ +|..+..+.
T Consensus       322 --~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~  396 (570)
T 2z63_A          322 --LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLE  396 (570)
T ss_dssp             --CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCT
T ss_pred             --ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccC
Confidence              3455666666666665544443  45566666666666665432  4555566666666666666553 333344444


Q ss_pred             CCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeec
Q 001384          486 RNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITG  565 (1088)
Q Consensus       486 ~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~  565 (1088)
                      ++..+.+..|...+...                                                    ......+..++
T Consensus       397 ~L~~L~l~~n~l~~~~~----------------------------------------------------~~~~~~l~~L~  424 (570)
T 2z63_A          397 QLEHLDFQHSNLKQMSE----------------------------------------------------FSVFLSLRNLI  424 (570)
T ss_dssp             TCCEEECTTSEEESCTT----------------------------------------------------SCTTTTCTTCC
T ss_pred             CCCEEEccCCccccccc----------------------------------------------------hhhhhcCCCCC
Confidence            44444444433221100                                                    00001123457


Q ss_pred             eEEccCCccccccCcccccCCCccEEeccccccc-cCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEcccc
Q 001384          566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD-GKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN  643 (1088)
Q Consensus       566 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  643 (1088)
                      +|++++|++++.+|..++.+++|+.|++++|+++ +.+|..++.+ .|++|+|++|++++..|..|+++++|+.|+|++|
T Consensus       425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            8999999999999999999999999999999997 6799999888 6999999999999888999999999999999999


Q ss_pred             ccCCcCCcccccccccceeeccCCCCccccCCCCCcc
Q 001384          644 NFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL  680 (1088)
Q Consensus       644 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~  680 (1088)
                      ++++.+|..+.++++|+.|++++|++ .+.+|....+
T Consensus       505 ~l~~~~~~~~~~l~~L~~L~l~~N~~-~~~~~~~~~~  540 (570)
T 2z63_A          505 QLKSVPDGIFDRLTSLQKIWLHTNPW-DCSCPRIDYL  540 (570)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCB-CCCTTTTHHH
T ss_pred             cCCCCCHHHhhcccCCcEEEecCCcc-cCCCcchHHH
Confidence            99988888899999999999999999 6777765433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-47  Score=421.00  Aligned_cols=242  Identities=26%  Similarity=0.324  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.+...  .....+.+|++++++    ++|||||++++++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE----VNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCC----CCCTTEECEEEEEEETT
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHH----CCCCCCCeEEEEEEECC
Confidence            46999999999999999999863    468899999976532  223467889888876    78999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..|+|||||+||+|.+++++.+.+++.+++.++.||+.||+|||++   +||||||||+|||+++++.+||+|||+|+..
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999999999988999999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+...  ....+.....          
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~----------  243 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTMILKAKL----------  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC----------
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHHHHcCCC----------
Confidence            4322 23445789999999999999999999999999999999999999998765422  2222221000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                             ..+...+.++.+++.+||+.||++||++
T Consensus       244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                   0112234568889999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-46  Score=417.50  Aligned_cols=264  Identities=28%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----eEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----EKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----~~~  881 (1088)
                      +|.+.+.||+|+||+||+|++ +|+.||||++...   ..+++..|.++....  .++|||||++++++.+++    ..|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~--~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTV--MLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTST--TCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHh--cCCCCCCCcEEEEEEecCCCceEEE
Confidence            467789999999999999998 5899999999754   234444555554332  278999999999998653    579


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-----YPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +|||||++|+|.++++.. +++|.++.+++.|++.||+|||+++     .++||||||||+|||++.++.+||+|||+|+
T Consensus        78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999999765 5899999999999999999999862     3589999999999999999999999999998


Q ss_pred             eecCCCCc---ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCcCCCCCch-------------
Q 001384          957 VVSAGDSH---VSTTIAGTVGYVAPEYGQTW------QATTKGDVYSFGVLAMELATGRRALEGGEE------------- 1014 (1088)
Q Consensus       957 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg~~p~~~~~~------------- 1014 (1088)
                      ........   ......||+.|||||++.+.      .++.++|||||||++|||+||+.||....+             
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            87654322   22346799999999988654      467899999999999999999887754321             


Q ss_pred             hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ...+..........    +-.++      ......+....+.+++.+||+.||++||||+||++.|+++.++
T Consensus       237 ~~~~~~~~~~~~~~----rp~~p------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          237 SVEEMRKVVCEQKL----RPNIP------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCC----CCCCC------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhcccC----CCCCC------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            01111111110000    00000      0011335667899999999999999999999999999998643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=448.81  Aligned_cols=484  Identities=22%  Similarity=0.231  Sum_probs=384.5

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeec
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDL  156 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~L  156 (1088)
                      .+++.|+|+++.+++..+.+|.++++|++|||++|++++..|..|+++++|++|+|++|.+++..  .+.++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            46889999999999988889999999999999999999888889999999999999999998753  6999999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCC-CCccccCCCCCcEEEccCcccccccc---ccCccc----ceecccC
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGR-IDTCFDGCLNLRYLDLSSNNFRGNIW---NGLAQL----VEFSVSE  228 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~---~~l~~L----~~L~L~~  228 (1088)
                      ++|++++..+..+ ..+++|++|+|++|++++. +|..|.++++|++|++++|++++..+   ..+.+|    +.|++++
T Consensus       108 ~~n~l~~l~~~~~-~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          108 VETNLASLENFPI-GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             TTSCCCCSTTCSC-TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             cccccccCCCccc-cccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            9999997665554 4578999999999999984 69999999999999999999987443   345566    6788888


Q ss_pred             cccccccccccccCCCccCEEEcCCCccc-ccCcccccCCCCCcEEEccCccccC------CCccccCCCC--CCCEEeC
Q 001384          229 NVLSGVVSSSVFKENCSLEIFDLSENEFI-GDFPGEVSNCRNLVVLNLFGNNFSG------PIPAEIGSIS--GLEALFL  299 (1088)
Q Consensus       229 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~--~L~~L~L  299 (1088)
                      |.+++.. +..|... +|+.|++++|... ..++..+..+++++.+.+..+.+..      .....+..+.  .++.+++
T Consensus       187 n~l~~~~-~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  264 (570)
T 2z63_A          187 NPMNFIQ-PGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  264 (570)
T ss_dssp             CCCCEEC-TTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred             CCceecC-HHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence            8888643 4555554 7888888887533 2345566677777766654433221      1112222222  2456666


Q ss_pred             CCC-cCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          300 GKN-NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       300 ~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      ++| .+.+.+|..+..+++|++|++++|.+++ +|..+..+ +|+.|++++|.+. .++.   ..+++|+.|++++|.+.
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~---~~l~~L~~L~l~~n~~~  338 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPT---LKLKSLKRLTFTSNKGG  338 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCB---CBCSSCCEEEEESCBSC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCc---ccccccCEEeCcCCccc
Confidence            666 6667777778888888888888888774 55556666 8888888887754 2222   36788888999988888


Q ss_pred             CCCCccccCCcCcceeeccccccCCcC--CcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCC-c
Q 001384          379 GPLPVEISQMRSLKFLILAHNRFNGSI--PAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP-G  455 (1088)
Q Consensus       379 ~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~  455 (1088)
                      +..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|++++ +|..+..+++|++|++++|++++..| .
T Consensus       339 ~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~  415 (570)
T 2z63_A          339 NAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS  415 (570)
T ss_dssp             CBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSC
T ss_pred             ccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCCEEEccCCccccccchh
Confidence            66554  67888999999999888543  6778888899999999998884 55558888899999999999887665 4


Q ss_pred             cccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhcccc
Q 001384          456 EIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC  535 (1088)
Q Consensus       456 ~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (1088)
                      .+.++++|++|++++|++++.+|..+..+                                                   
T Consensus       416 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---------------------------------------------------  444 (570)
T 2z63_A          416 VFLSLRNLIYLDISHTHTRVAFNGIFNGL---------------------------------------------------  444 (570)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTC---------------------------------------------------
T ss_pred             hhhcCCCCCEEeCcCCcccccchhhhhcC---------------------------------------------------
Confidence            68888999999999998886655443221                                                   


Q ss_pred             chhhhhcccCCcccccccCCCcccceeeeceEEccCCccc-cccCcccccCCCccEEeccccccccCCCCcccCc-cceE
Q 001384          536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLS-GELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIV  613 (1088)
Q Consensus       536 ~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~  613 (1088)
                                                ..+++|++++|+++ +.+|..++.+++|+.|++++|++++..|..++.+ .|++
T Consensus       445 --------------------------~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  498 (570)
T 2z63_A          445 --------------------------SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  498 (570)
T ss_dssp             --------------------------TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             --------------------------CcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence                                      13467999999998 6899999999999999999999999889999988 6999


Q ss_pred             EEccCCcccccCCccccCCccCcEEEccccccCCcCCc
Q 001384          614 LNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPA  651 (1088)
Q Consensus       614 l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~  651 (1088)
                      |+|++|++++..|..|.++++|+.|+|++|++++..|.
T Consensus       499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999999988888899999999999999999988775

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=4.1e-46  Score=458.84  Aligned_cols=446  Identities=17%  Similarity=0.245  Sum_probs=356.8

Q ss_pred             CCceeecccccccccccCchhhhcccceEEeccCccC------CC------CCCccccCCCCCcEEEccCcccccccccc
Q 001384          150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNL------TG------RIDTCFDGCLNLRYLDLSSNNFRGNIWNG  217 (1088)
Q Consensus       150 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l------~~------~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  217 (1088)
                      .++.|+|++|.++|.+|.++. .++.|++|+|++|.+      .+      .+|...  +.+|+ +++++|.+.+.++..
T Consensus        82 ~V~~L~L~~~~l~g~lp~~l~-~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           82 RVTGLSLEGFGASGRVPDAIG-QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CEEEEECTTSCCEEEECGGGG-GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CEEEEEecCcccCCcCChHHh-cCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            566777777777766665543 345666666666654      11      122211  33444 555555555544443


Q ss_pred             Ccc----cceecccCcccccccccccccCCCccCEEEcC--CCcccccCcccccCCCCCcEEEccCccccCC--------
Q 001384          218 LAQ----LVEFSVSENVLSGVVSSSVFKENCSLEIFDLS--ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGP--------  283 (1088)
Q Consensus       218 l~~----L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls--~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--------  283 (1088)
                      +..    +..+++....+..       .....++.+.+.  .|++++ +|..++++++|++|+|++|++++.        
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~  229 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN  229 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred             HHHHHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence            331    1222222111110       111123333333  688998 899999999999999999999985        


Q ss_pred             ---------CccccC--CCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCc-CCC-chhHhhhcc------cccce
Q 001384          284 ---------IPAEIG--SISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN-FGG-EVQKIFGRF------TQVKI  344 (1088)
Q Consensus       284 ---------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~  344 (1088)
                               +|..++  ++++|++|+|++|++.+.+|..++++++|++|+|++|+ +++ .+|..++.+      ++|+.
T Consensus       230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~  309 (636)
T 4eco_A          230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI  309 (636)
T ss_dssp             TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred             cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence                     999999  99999999999999999999999999999999999998 998 889888887      99999


Q ss_pred             eecCcCcccCCCCCc--cccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCC-CcEEEcc
Q 001384          345 LALHSNSYIDGMNSS--GILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPN-LQTLDLS  421 (1088)
Q Consensus       345 L~L~~n~~~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~  421 (1088)
                      |++++|.+. . .+.  .+.++++|++|+|++|+++|.+| .++.+++|++|++++|+++ .+|..++.+++ |++|+++
T Consensus       310 L~L~~n~l~-~-ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls  385 (636)
T 4eco_A          310 IYIGYNNLK-T-FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFA  385 (636)
T ss_dssp             EECCSSCCS-S-CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECC
T ss_pred             EECCCCcCC-c-cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEcc
Confidence            999999976 3 344  78899999999999999999999 9999999999999999999 89999999999 9999999


Q ss_pred             CCcCCCCCCccccCCC--CCcEEEccccccccCCCcccc-------CCCCCCeEEccCCcCccCCCchhhccCCCCCccc
Q 001384          422 FNELTGPIPPSIGNLT--SLLWLMLANNSLSGEIPGEIG-------NCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTF  492 (1088)
Q Consensus       422 ~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~l~-------~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~  492 (1088)
                      +|+++ .+|..++.++  +|++|++++|++++.+|..+.       .+++|++|+|++|+++ .+|..++..        
T Consensus       386 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~--------  455 (636)
T 4eco_A          386 HNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFST--------  455 (636)
T ss_dssp             SSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHT--------
T ss_pred             CCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHcc--------
Confidence            99999 8999888765  899999999999999999998       8889999999999999 677765320        


Q ss_pred             cccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCC
Q 001384          493 EANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGN  572 (1088)
Q Consensus       493 ~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N  572 (1088)
                                                                                          +..+++|+|++|
T Consensus       456 --------------------------------------------------------------------l~~L~~L~Ls~N  467 (636)
T 4eco_A          456 --------------------------------------------------------------------GSPLSSINLMGN  467 (636)
T ss_dssp             --------------------------------------------------------------------TCCCSEEECCSS
T ss_pred             --------------------------------------------------------------------CCCCCEEECCCC
Confidence                                                                                112467999999


Q ss_pred             ccccccCcccccC--------CCccEEeccccccccCCCCccc--Cc-cceEEEccCCcccccCCccccCCccCcEEEc-
Q 001384          573 QLSGELSPDIGKL--------QNFSMVHLGFNQFDGKLPSQFD--QL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDL-  640 (1088)
Q Consensus       573 ~l~g~~p~~~~~l--------~~L~~L~l~~N~l~g~~p~~~~--~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l-  640 (1088)
                      +++ .+|..+...        ++|+.|+|++|+++ .+|..+.  .+ .|+.|+|++|++++ +|..++++++|+.|+| 
T Consensus       468 ~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls  544 (636)
T 4eco_A          468 MLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR  544 (636)
T ss_dssp             CCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECC
T ss_pred             CCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECC
Confidence            999 777765443        29999999999999 7888886  66 79999999999997 9999999999999999 


Q ss_pred             -----cccccCCcCCcccccccccceeeccCCCCccccCCCCCcccccccCccCCCCCCC
Q 001384          641 -----SYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLD  695 (1088)
Q Consensus       641 -----~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~  695 (1088)
                           ++|++.+.+|..++++++|+.|+|++|++  +.||..- ..++....+.+|+..|
T Consensus       545 ~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l--~~ip~~~-~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI--RKVNEKI-TPNISVLDIKDNPNIS  601 (636)
T ss_dssp             SCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC--CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred             CCcccccCcccccChHHHhcCCCCCEEECCCCcC--CccCHhH-hCcCCEEECcCCCCcc
Confidence                 56889999999999999999999999999  6788752 2566777788998877

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.5e-46  Score=447.82  Aligned_cols=451  Identities=20%  Similarity=0.234  Sum_probs=337.0

Q ss_pred             EeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCc--ccCCCCCCCceeeccccc
Q 001384           83 GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD--LNLSGLRSLEILDLSVNR  160 (1088)
Q Consensus        83 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~--~~l~~l~~L~~L~Ls~N~  160 (1088)
                      .|++++++|+. +|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++.  ..+.++++|++|||++|+
T Consensus         4 ~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            57899999985 666665  8999999999999988888999999999999999999875  358999999999999999


Q ss_pred             ccccccCchhhhcccceEEeccCccCCC-CCCccccCCCCCcEEEccCccccccccccCcccceecccCccccccccccc
Q 001384          161 IHGEISFSFPAICEKLVVANLSLNNLTG-RIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV  239 (1088)
Q Consensus       161 l~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  239 (1088)
                      ++ .+|..   .+++|++|+|++|++++ .+|..|+++++|++|++++|++++..+..+++|                  
T Consensus        81 l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L------------------  138 (520)
T 2z7x_B           81 LV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL------------------  138 (520)
T ss_dssp             CC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTS------------------
T ss_pred             ee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccc------------------
Confidence            98 45544   56889999999999987 467889999999999999888875443333333                  


Q ss_pred             ccCCCccCEEEcCCCcc--cccCcccccCCC-CCcEEEccCccccCCCcc-ccCCCCCCCEEeCCCCc-------CCccC
Q 001384          240 FKENCSLEIFDLSENEF--IGDFPGEVSNCR-NLVVLNLFGNNFSGPIPA-EIGSISGLEALFLGKNN-------FLSVI  308 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l--~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~  308 (1088)
                           +|++|++++|.+  .+..|..+..+. +...+++++|++.+.++. .+..+++|+.|++++|.       +.+.+
T Consensus       139 -----~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  213 (520)
T 2z7x_B          139 -----NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL  213 (520)
T ss_dssp             -----CEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHH
T ss_pred             -----eeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecch
Confidence                 125566666665  555566655554 233456666666554443 44556666667666665       44544


Q ss_pred             cccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccc---
Q 001384          309 PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI---  385 (1088)
Q Consensus       309 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l---  385 (1088)
                      | .+..+++|+.|++++|.+++..+..+...                      ...++|++|++++|+++|.+|..+   
T Consensus       214 ~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~----------------------~~~~~L~~L~l~~n~l~~~~p~~~~~~  270 (520)
T 2z7x_B          214 A-KLQTNPKLSNLTLNNIETTWNSFIRILQL----------------------VWHTTVWYFSISNVKLQGQLDFRDFDY  270 (520)
T ss_dssp             H-GGGGCTTCCEEEEEEEEEEHHHHHHHHHH----------------------HHTSSCSEEEEEEEEEESCCCCCCCCC
T ss_pred             h-hhccccchhhccccccccCHHHHHHHHHH----------------------hhhCcccEEEeecccccCccccchhhc
Confidence            4 56667777777777776654433222100                      013478888888888888888877   


Q ss_pred             --cCCcCcceeeccccccCCcCC-cccCCC---CCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccC
Q 001384          386 --SQMRSLKFLILAHNRFNGSIP-AVYGNM---PNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGN  459 (1088)
Q Consensus       386 --~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  459 (1088)
                        +.+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|++.+ ++ ....+++|++|++++|++++.+|..+++
T Consensus       271 ~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  346 (520)
T 2z7x_B          271 SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVH-ML-CPSKISPFLHLDFSNNLLTDTVFENCGH  346 (520)
T ss_dssp             CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCC-CC-CCSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred             ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccc-cc-chhhCCcccEEEeECCccChhhhhhhcc
Confidence              7888888888888888  455 444444   568888888888764 22 1257788888888888888778888888


Q ss_pred             CCCCCeEEccCCcCcc--CCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccch
Q 001384          460 CTSLLWLNLSNNKLSG--NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRS  537 (1088)
Q Consensus       460 l~~L~~L~L~~N~l~g--~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (1088)
                      +++|++|+|++|++++  .+|..+..+                                                     
T Consensus       347 l~~L~~L~L~~N~l~~l~~~~~~~~~l-----------------------------------------------------  373 (520)
T 2z7x_B          347 LTELETLILQMNQLKELSKIAEMTTQM-----------------------------------------------------  373 (520)
T ss_dssp             CSSCCEEECCSSCCCBHHHHHHHHTTC-----------------------------------------------------
T ss_pred             CCCCCEEEccCCccCccccchHHHhhC-----------------------------------------------------
Confidence            8888888888888874  333322211                                                     


Q ss_pred             hhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcc-cccCCCccEEeccccccccCCCCcccCccceEEEc
Q 001384          538 LWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNL  616 (1088)
Q Consensus       538 l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l  616 (1088)
                                              ..+++|++++|++++.+|.. +..+++|+.|++++|++++.+|..+. -.|+.|+|
T Consensus       374 ------------------------~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~L  428 (520)
T 2z7x_B          374 ------------------------KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDL  428 (520)
T ss_dssp             ------------------------TTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEEC
T ss_pred             ------------------------CCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEEC
Confidence                                    12457888888888766664 77788999999999999888887765 46889999


Q ss_pred             cCCcccccCCccccCCccCcEEEccccccCCcCCcc-cccccccceeeccCCCCc
Q 001384          617 TRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS-FNNLTELSKLNISYNPLV  670 (1088)
Q Consensus       617 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~  670 (1088)
                      ++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|++.
T Consensus       429 s~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~  481 (520)
T 2z7x_B          429 HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  481 (520)
T ss_dssp             CSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCc
Confidence            999999 89999999999999999999999 57776 999999999999999994

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.9e-45  Score=459.31  Aligned_cols=457  Identities=18%  Similarity=0.255  Sum_probs=297.7

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEEC-ccccccCcccCCCCCC------Cc--eeecc----------cccccc
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL-SHNILSGDLNLSGLRS------LE--ILDLS----------VNRIHG  163 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L-s~n~l~~~~~l~~l~~------L~--~L~Ls----------~N~l~~  163 (1088)
                      .+++.|+|++|.++|.+|++|++|++|++|+| ++|.++|...+.....      ++  .+...          ...+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 9999987644432111      00  00000          001110


Q ss_pred             cccCchh----------hhcccceEEeccC--ccCCCCCCccccCCCCCcEEEccCcccccc-ccccCcccceecccCcc
Q 001384          164 EISFSFP----------AICEKLVVANLSL--NNLTGRIDTCFDGCLNLRYLDLSSNNFRGN-IWNGLAQLVEFSVSENV  230 (1088)
Q Consensus       164 ~~~~~~~----------~~~~~L~~L~L~~--n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~L~~L~L~~n~  230 (1088)
                      ..+..+.          .....++.+.+..  |++++ +|..|+++++|++|+|++|++++. ++...     +..+.|.
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~-----~~~s~n~  476 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW-----EDANSDY  476 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC-----SCTTSHH
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccc-----ccccccc
Confidence            0000000          0011233344443  78888 788899999999999999998872 22111     1112233


Q ss_pred             ccccccccc-ccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCcc-ccC-CCccccCCCC-------CCCEEeCC
Q 001384          231 LSGVVSSSV-FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN-FSG-PIPAEIGSIS-------GLEALFLG  300 (1088)
Q Consensus       231 l~~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~  300 (1088)
                      +++.+|... |..+++|++|+|++|++.+.+|..++++++|++|+|++|+ +++ .+|..++.++       +|+.|+|+
T Consensus       477 ~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls  556 (876)
T 4ecn_A          477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG  556 (876)
T ss_dssp             HHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECC
T ss_pred             ccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEee
Confidence            333333332 3345555555555555555555555555555555555554 444 4444333332       45555555


Q ss_pred             CCcCCccCcc--cccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          301 KNNFLSVIPE--SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       301 ~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      +|+++ .+|.  .++++++|+.|+|++|.++ .+|                          .+..+++|+.|+|++|+++
T Consensus       557 ~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp--------------------------~~~~L~~L~~L~Ls~N~l~  608 (876)
T 4ecn_A          557 YNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE--------------------------AFGTNVKLTDLKLDYNQIE  608 (876)
T ss_dssp             SSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC--------------------------CCCTTSEESEEECCSSCCS
T ss_pred             CCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch--------------------------hhcCCCcceEEECcCCccc
Confidence            55544 3444  4444555555555554444 222                          4566777888888888887


Q ss_pred             CCCCccccCCcC-cceeeccccccCCcCCcccCCCCC--CcEEEccCCcCCCCCCcc---cc--CCCCCcEEEccccccc
Q 001384          379 GPLPVEISQMRS-LKFLILAHNRFNGSIPAVYGNMPN--LQTLDLSFNELTGPIPPS---IG--NLTSLLWLMLANNSLS  450 (1088)
Q Consensus       379 ~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~---~~--~l~~L~~L~L~~N~l~  450 (1088)
                       .+|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+|++|+++|.+|..   ++  .+++|++|+|++|+++
T Consensus       609 -~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~  686 (876)
T 4ecn_A          609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ  686 (876)
T ss_dssp             -CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC
T ss_pred             -cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC
Confidence             77777888887 888888888888 77777776654  888888888887765532   22  3347888888888887


Q ss_pred             cCCCcccc-CCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeee
Q 001384          451 GEIPGEIG-NCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTI  529 (1088)
Q Consensus       451 ~~~p~~l~-~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  529 (1088)
                       .+|..+. .+++|+.|+|++|+++ .+|..++.....                                          
T Consensus       687 -~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~------------------------------------------  722 (876)
T 4ecn_A          687 -KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDG------------------------------------------  722 (876)
T ss_dssp             -SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTS------------------------------------------
T ss_pred             -ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccc------------------------------------------
Confidence             5666554 7788888888888887 777765321100                                          


Q ss_pred             hhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccc--cCCCccEEeccccccccCCCCccc
Q 001384          530 LTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIG--KLQNFSMVHLGFNQFDGKLPSQFD  607 (1088)
Q Consensus       530 ~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~  607 (1088)
                          .                       ...+..|++|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..++
T Consensus       723 ----~-----------------------l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~  773 (876)
T 4ecn_A          723 ----N-----------------------YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL  773 (876)
T ss_dssp             ----C-----------------------CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG
T ss_pred             ----c-----------------------ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhh
Confidence                0                       001123457888888888 6787776  78888888888888886 777777


Q ss_pred             Cc-cceEEEccC------CcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          608 QL-PLIVLNLTR------NNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       608 ~l-~l~~l~l~~------N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      .+ .|+.|+|++      |++.+.+|..|+++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++..
T Consensus       774 ~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS  841 (876)
T ss_dssp             GCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred             cCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence            77 588888865      889999999999999999999999999 68999876  699999999999843

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.4e-45  Score=446.73  Aligned_cols=475  Identities=20%  Similarity=0.193  Sum_probs=361.6

Q ss_pred             cccCCceeCCC--CceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCccc
Q 001384           67 CEWPGIICSPD--KARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN  144 (1088)
Q Consensus        67 C~W~gv~C~~~--~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~  144 (1088)
                      |++.+++.-+.  ..+++.|+|++++|++..+..|+++++|++|+|++|++++..|..|+.+++|++|+|++|.+++...
T Consensus        12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~   91 (549)
T 2z81_A           12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS   91 (549)
T ss_dssp             CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred             CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence            45666665443  2478999999999999888999999999999999999998888999999999999999999998653


Q ss_pred             --CCCCCCCceeecccccccccccCchhhhcccceEEeccCccC-CCCCCccccCCCCCcEEEccCccccccccc---cC
Q 001384          145 --LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNL-TGRIDTCFDGCLNLRYLDLSSNNFRGNIWN---GL  218 (1088)
Q Consensus       145 --l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~---~l  218 (1088)
                        ++++++|++|+|++|++++.........+++|++|++++|++ ....+..|.++++|++|++++|++++..+.   .+
T Consensus        92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l  171 (549)
T 2z81_A           92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI  171 (549)
T ss_dssp             HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred             HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence              899999999999999998743323345578999999999994 555557899999999999999999875443   45


Q ss_pred             cccceecccCcccccccccccccCCCccCEEEcCCCcccccC--c-ccccCCCCCcEEEccCccccCCCcc----ccCCC
Q 001384          219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF--P-GEVSNCRNLVVLNLFGNNFSGPIPA----EIGSI  291 (1088)
Q Consensus       219 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--p-~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l  291 (1088)
                      ++|++|++++|.+. .++...+..+++|++|++++|++++..  | .....+++|+.|++++|.+++..+.    .+..+
T Consensus       172 ~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~  250 (549)
T 2z81_A          172 RDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI  250 (549)
T ss_dssp             SEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGC
T ss_pred             ccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhh
Confidence            66677777777664 233344455667777777777766531  1 1223456677777777766654332    23455


Q ss_pred             CCCCEEeCCCCcCCccC------cccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCC
Q 001384          292 SGLEALFLGKNNFLSVI------PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP  365 (1088)
Q Consensus       292 ~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  365 (1088)
                      ++|+.|++++|.+.+..      ...+..+.+|+.|++.++.+.....  +..                  ....+...+
T Consensus       251 ~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~~~------------------l~~~~~~~~  310 (549)
T 2z81_A          251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--FYD------------------LSTVYSLLE  310 (549)
T ss_dssp             TTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--SCC------------------CCHHHHHST
T ss_pred             ccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--ccc------------------chhhhhhcc
Confidence            66666666666654421      1223445556666666555432110  000                  011122356


Q ss_pred             CcCEEEccCCccCCCCCccc-cCCcCcceeeccccccCCcCC---cccCCCCCCcEEEccCCcCCCCCC--ccccCCCCC
Q 001384          366 NISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIP---AVYGNMPNLQTLDLSFNELTGPIP--PSIGNLTSL  439 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L  439 (1088)
                      +|+.|++++|.++ .+|..+ ..+++|++|++++|++++.+|   ..++.+++|++|++++|++++..+  ..++.+++|
T Consensus       311 ~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L  389 (549)
T 2z81_A          311 KVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL  389 (549)
T ss_dssp             TCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTC
T ss_pred             cceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCC
Confidence            8999999999998 778776 579999999999999998764   347889999999999999985322  458899999


Q ss_pred             cEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCC
Q 001384          440 LWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPAD  519 (1088)
Q Consensus       440 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~  519 (1088)
                      ++|+|++|+++ .+|..++.+++|++|++++|+++ .+|..+                                      
T Consensus       390 ~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--------------------------------------  429 (549)
T 2z81_A          390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--------------------------------------  429 (549)
T ss_dssp             CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--------------------------------------
T ss_pred             CEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--------------------------------------
Confidence            99999999999 78999999999999999999987 344221                                      


Q ss_pred             CCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccc
Q 001384          520 YPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD  599 (1088)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  599 (1088)
                                                        |       ..+++|+|++|++++.+    +.+++|++|+|++|+++
T Consensus       430 ----------------------------------~-------~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~  464 (549)
T 2z81_A          430 ----------------------------------P-------QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK  464 (549)
T ss_dssp             ----------------------------------C-------TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS
T ss_pred             ----------------------------------c-------CCceEEECCCCChhhhc----ccCChhcEEECCCCccC
Confidence                                              0       12467999999999743    57899999999999999


Q ss_pred             cCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCC
Q 001384          600 GKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFP  650 (1088)
Q Consensus       600 g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  650 (1088)
                       .+|+. +.+ .|++|+|++|++++.+|..|+++++|+.|+|++|++++..|
T Consensus       465 -~ip~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          465 -TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             -SCCCG-GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             -cCCCc-ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence             78874 444 79999999999999888899999999999999999998766

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.7e-45  Score=403.50  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=188.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----  878 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...... ..+.+.+|++++++    ++|||||++++++.+.+    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~----l~HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK----LEHPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEEEC----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEEecCcccc
Confidence            35889999999999999999976 7899999999765332 34578899999987    68999999999987543    


Q ss_pred             --------eEEEEEEecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          879 --------EKILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       879 --------~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                              ..|+|||||++|+|.++++....   .++..++.|+.||+.||+|||++   +||||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence                    36899999999999999987654   45567889999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCc-----------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH
Q 001384          948 LVTDFGLARVVSAGDSH-----------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL 1016 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~ 1016 (1088)
                      ||+|||+|+.+......           .....+||+.|||||++.+..|+.++||||+||++|||++   ||.+..+..
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            99999999876543211           1234579999999999999999999999999999999996   776532211


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ... .....                ....+........+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~-~~~~~----------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTL-TDVRN----------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH-HHHHT----------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHhc----------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111 11110                0001112233445678999999999999999999986

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=435.08  Aligned_cols=437  Identities=21%  Similarity=0.184  Sum_probs=339.8

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccc
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV  158 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~  158 (1088)
                      .+++.|+|++|.|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.... .+++|++|+|++
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-~l~~L~~L~L~~   99 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH-PTVNLKHLDLSF   99 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC-CCCCCSEEECCS
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc-ccCCccEEeccC
Confidence            5788999999999998888999999999999999999988899999999999999999999965545 899999999999


Q ss_pred             cccccc-ccCchhhhcccceEEeccCccCCCCCCccccCCCCC--cEEEccCccc--cccccccCcccc----eecccCc
Q 001384          159 NRIHGE-ISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL--RYLDLSSNNF--RGNIWNGLAQLV----EFSVSEN  229 (1088)
Q Consensus       159 N~l~~~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~l~~L~----~L~L~~n  229 (1088)
                      |++++. +|..+ ..+++|++|+|++|++++   ..+..+++|  ++|++++|++  .+..+..+..++    .+++++|
T Consensus       100 N~l~~~~~p~~~-~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n  175 (520)
T 2z7x_B          100 NAFDALPICKEF-GNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN  175 (520)
T ss_dssp             SCCSSCCCCGGG-GGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSS
T ss_pred             Cccccccchhhh-ccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccC
Confidence            999974 55555 456899999999999987   357777888  9999999999  777777776654    6788899


Q ss_pred             ccccccccccccCCCccCEEEcCCCc-------ccccCcccccCCCCCcEEEccCccccCCCccccC---CCCCCCEEeC
Q 001384          230 VLSGVVSSSVFKENCSLEIFDLSENE-------FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIG---SISGLEALFL  299 (1088)
Q Consensus       230 ~l~~~~~~~~~~~l~~L~~L~Ls~n~-------l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L  299 (1088)
                      .+.+.++...+..+++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+++..+..+.   ..++|++|++
T Consensus       176 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l  254 (520)
T 2z7x_B          176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI  254 (520)
T ss_dssp             SCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred             cchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence            98888888888899999999999987       666666 788889999999999888754333221   2458889999


Q ss_pred             CCCcCCccCcccc-----cCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccC
Q 001384          300 GKNNFLSVIPESL-----LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSH  374 (1088)
Q Consensus       300 ~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~  374 (1088)
                      ++|++++.+|..+     .++++|+.+++++|.+ ..+...+..+                      ....+|+.|++++
T Consensus       255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~----------------------~~~~~L~~L~l~~  311 (520)
T 2z7x_B          255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEI----------------------FSNMNIKNFTVSG  311 (520)
T ss_dssp             EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHH----------------------HHTCCCSEEEEES
T ss_pred             ecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcc----------------------cccCceeEEEcCC
Confidence            9998888888888     7888888888888887 3332333322                      0113577777777


Q ss_pred             CccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCC--CCCccccCCCCCcEEEccccccccC
Q 001384          375 NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG--PIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       375 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      |.+.+. + .+..+++|++|++++|++++.+|..++.+++|++|++++|++++  .+|..++++++|++|+|++|++++.
T Consensus       312 n~l~~~-~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~  389 (520)
T 2z7x_B          312 TRMVHM-L-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD  389 (520)
T ss_dssp             SCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred             Cccccc-c-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence            777632 1 12577888888888888887788888888888888888888886  4567788888899999999988875


Q ss_pred             CCcc-ccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehh
Q 001384          453 IPGE-IGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILT  531 (1088)
Q Consensus       453 ~p~~-l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (1088)
                      +|.. +..+++|++|++++|++++.+|..+.                                                 
T Consensus       390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-------------------------------------------------  420 (520)
T 2z7x_B          390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-------------------------------------------------  420 (520)
T ss_dssp             GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-------------------------------------------------
T ss_pred             cccchhccCccCCEEECcCCCCCcchhhhhc-------------------------------------------------
Confidence            6654 78888899999999988765443210                                                 


Q ss_pred             ccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccc
Q 001384          532 RKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPL  611 (1088)
Q Consensus       532 ~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l  611 (1088)
                                                    ..+++|+|++|+++ .+|..+..+++|+.|+|++|+++            
T Consensus       421 ------------------------------~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~------------  457 (520)
T 2z7x_B          421 ------------------------------PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK------------  457 (520)
T ss_dssp             ------------------------------TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC------------
T ss_pred             ------------------------------ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC------------
Confidence                                          01235666666666 55655556666666666555555            


Q ss_pred             eEEEccCCcccccCCcc-ccCCccCcEEEccccccCCcCC
Q 001384          612 IVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFP  650 (1088)
Q Consensus       612 ~~l~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~g~~p  650 (1088)
                                  .+|.. |..+++|+.|+|++|++++..+
T Consensus       458 ------------~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          458 ------------SVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             ------------CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ------------ccCHHHhccCCcccEEECcCCCCcccCC
Confidence                        45554 7788899999999999987544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-43  Score=402.30  Aligned_cols=205  Identities=27%  Similarity=0.402  Sum_probs=174.8

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .+....++|++.+.||+|+||+||+|+++    +++.||||++.+.  ....++.+|++++..+.   +|||||++++++
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~---~h~nIv~l~~~~   89 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAG---GQDNVMGVKYCF   89 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTC---SBTTBCCCSEEE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhc---CCCCCceEEEEE
Confidence            33455688999999999999999999853    4678999998765  34467889999998642   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeecc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFG  953 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Dfg  953 (1088)
                      .++++.|+||||+++|+|.++++   ++++.+++.++.|++.||+|||++   +||||||||+|||++.+ +.+||+|||
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999999984   489999999999999999999999   99999999999999877 799999999


Q ss_pred             cceeecCCCC---------------------------cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhC
Q 001384          954 LARVVSAGDS---------------------------HVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATG 1005 (1088)
Q Consensus       954 ~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg 1005 (1088)
                      +|+.......                           ......+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9986543221                           112345799999999988764 589999999999999999999


Q ss_pred             CcCCCCCch
Q 001384         1006 RRALEGGEE 1014 (1088)
Q Consensus      1006 ~~p~~~~~~ 1014 (1088)
                      +.||....+
T Consensus       244 ~~Pf~~~~~  252 (361)
T 4f9c_A          244 RYPFYKASD  252 (361)
T ss_dssp             CSSSSCCSS
T ss_pred             CCCCCCCCC
Confidence            999976544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=405.82  Aligned_cols=267  Identities=22%  Similarity=0.276  Sum_probs=203.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----  876 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.+...  ...+.+.+|+++++.    ++|||||++++++..    
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~----l~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH----FKHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHH----CCCTTBCCEEEECCCSSCT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHh----cCCCCcceEeeeeeccccc
Confidence            357999999999999999999975 799999999976532  233568899999997    679999999998764    


Q ss_pred             --CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          877 --GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       877 --~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                        .+..|+|||||+ |+|.+++...+++++.+++.|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence              367899999996 68999999989999999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCC---CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCC
Q 001384          955 ARVVSAGD---SHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRH 1029 (1088)
Q Consensus       955 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 1029 (1088)
                      |+.+....   .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+.... .-..........
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98764322   2234567899999999987764 579999999999999999999999987654211 111111100000


Q ss_pred             CCCcc----ccchhhc--CCCccc-----cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRA----VIPVVLL--GSGLAE-----GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~----~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....    .......  ....+.     ......++.+|+.+||+.||++|||++|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000    0000000  000000     0112356788999999999999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.4e-43  Score=425.26  Aligned_cols=458  Identities=19%  Similarity=0.205  Sum_probs=326.8

Q ss_pred             EEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccc
Q 001384           82 NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVN  159 (1088)
Q Consensus        82 ~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N  159 (1088)
                      ..++++++++++ +|..+.  ++|++|+|++|.|++..|..|+++++|++|+|++|.+++..  .+.++++|++|||++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            568899999997 666554  89999999999999888889999999999999999999753  5899999999999999


Q ss_pred             cccccccCchhhhcccceEEeccCccCCCC-CCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccc
Q 001384          160 RIHGEISFSFPAICEKLVVANLSLNNLTGR-IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSS  238 (1088)
Q Consensus       160 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~  238 (1088)
                      +++ .+|..   .+++|++|+|++|++++. .|..|+++++|++|++++|++++..+..+++|                 
T Consensus       111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-----------------  169 (562)
T 3a79_B          111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-----------------  169 (562)
T ss_dssp             CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-----------------
T ss_pred             cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-----------------
Confidence            998 45544   568899999999998874 46788888888888888888765333333222                 


Q ss_pred             cccCCCccCEEEcCCCcc--cccCcccccCCC-CCcEEEccCccccCCCcc-ccCCCCCCCEEeCCCCcC-----CccCc
Q 001384          239 VFKENCSLEIFDLSENEF--IGDFPGEVSNCR-NLVVLNLFGNNFSGPIPA-EIGSISGLEALFLGKNNF-----LSVIP  309 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l--~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l-----~~~~p  309 (1088)
                            +|++|++++|.+  ++..|..+..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|..     .+ .+
T Consensus       170 ------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~  242 (562)
T 3a79_B          170 ------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FL  242 (562)
T ss_dssp             ------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HH
T ss_pred             ------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HH
Confidence                  235555555555  455555555443 111345556655544333 234455555555555531     11 12


Q ss_pred             ccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccc----
Q 001384          310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEI----  385 (1088)
Q Consensus       310 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l----  385 (1088)
                      ..+..+++|+.|+++++.+.+.....+.                      .....++|++|++++|.++|.+|..+    
T Consensus       243 ~~l~~l~~L~~L~L~~~~l~~~~~~~~~----------------------~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~  300 (562)
T 3a79_B          243 SELTRGPTLLNVTLQHIETTWKCSVKLF----------------------QFFWPRPVEYLNIYNLTITERIDREEFTYS  300 (562)
T ss_dssp             HHHHSCSSCEEEEEEEEEECHHHHHHHH----------------------HHHTTSSEEEEEEEEEEECSCCCCCCCCCC
T ss_pred             HHHhccCcceEEEecCCcCcHHHHHHHH----------------------HhhhcccccEEEEeccEeeccccchhhhcc
Confidence            2345555666666655555433211110                      00123478888888888888888877    


Q ss_pred             -cCCcCcceeeccccccCCcCC-cccCC---CCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCC
Q 001384          386 -SQMRSLKFLILAHNRFNGSIP-AVYGN---MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNC  460 (1088)
Q Consensus       386 -~~l~~L~~L~L~~N~l~~~~p-~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  460 (1088)
                       .+++.|+.++++.|.+  .+| ..+..   ..+|+.|++++|.+.. ++ ..+.+++|++|++++|++++.+|..++++
T Consensus       301 ~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~-~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  376 (562)
T 3a79_B          301 ETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIH-MV-CPPSPSSFTFLNFTQNVFTDSVFQGCSTL  376 (562)
T ss_dssp             SCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCC-CC-CCSSCCCCCEEECCSSCCCTTTTTTCCSC
T ss_pred             cccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccc-cc-CccCCCCceEEECCCCccccchhhhhccc
Confidence             6777777777777776  344 22222   2568888888888763 22 12677888888888888888788888888


Q ss_pred             CCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhh
Q 001384          461 TSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWD  540 (1088)
Q Consensus       461 ~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  540 (1088)
                      ++|++|+|++|++++ +|.....+.                                                       
T Consensus       377 ~~L~~L~L~~N~l~~-~~~~~~~~~-------------------------------------------------------  400 (562)
T 3a79_B          377 KRLQTLILQRNGLKN-FFKVALMTK-------------------------------------------------------  400 (562)
T ss_dssp             SSCCEEECCSSCCCB-TTHHHHTTT-------------------------------------------------------
T ss_pred             CCCCEEECCCCCcCC-cccchhhhc-------------------------------------------------------
Confidence            888888888888873 332100000                                                       


Q ss_pred             hcccCCcccccccCCCcccceeeeceEEccCCccccccCcc-cccCCCccEEeccccccccCCCCcccCccceEEEccCC
Q 001384          541 RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPD-IGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRN  619 (1088)
Q Consensus       541 ~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N  619 (1088)
                                         .+..+++|++++|++++.+|.. +..+++|+.|++++|++++.+|..+. -.|+.|+|++|
T Consensus       401 -------------------~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N  460 (562)
T 3a79_B          401 -------------------NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNN  460 (562)
T ss_dssp             -------------------TCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-TTCSEEECCSS
T ss_pred             -------------------CCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-CcCCEEECCCC
Confidence                               0122457888888888766654 77889999999999999888887765 46889999999


Q ss_pred             cccccCCccccCCccCcEEEccccccCCcCCcc-cccccccceeeccCCCCccccCC
Q 001384          620 NFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS-FNNLTELSKLNISYNPLVSGTIP  675 (1088)
Q Consensus       620 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~~g~ip  675 (1088)
                      +++ .+|..+.++++|+.|+|++|+|+ .+|.. +..+++|+.|++++|++ .+..|
T Consensus       461 ~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~-~c~c~  514 (562)
T 3a79_B          461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW-DCTCP  514 (562)
T ss_dssp             CCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCB-CCCHH
T ss_pred             cCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCc-CCCcc
Confidence            999 89998889999999999999999 67776 99999999999999999 44544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.2e-41  Score=421.76  Aligned_cols=544  Identities=21%  Similarity=0.178  Sum_probs=333.7

Q ss_pred             ccccccCCCCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEEC
Q 001384           55 GHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL  134 (1088)
Q Consensus        55 ~~~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  134 (1088)
                      ..+++|+.+. |..|....|......|   +=++.+++. +|+.+-  +++++|||++|+|++..|.+|.++++|++|+|
T Consensus        11 ~~~~~~~~~~-p~~~~~c~~~~~~~~~---~c~~~~l~~-vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~L   83 (635)
T 4g8a_A           11 DKLAAANSSI-PESWEPCVEVVPNITY---QCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL   83 (635)
T ss_dssp             ---------------CCSEEEETTTEE---ECTTSCCSS-CCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             chhhcccCCC-CCCCCCccccCCCCEE---ECCCCCcCc-cCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEEC
Confidence            3577777543 3335443333211111   222334443 444332  47889999999999777788999999999999


Q ss_pred             ccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc
Q 001384          135 SHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       135 s~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ++|+|++..  .|.++++|++|+|++|+|++..+..| ..+++|++|+|++|++++..+..|+++++|++|+|++|++++
T Consensus        84 s~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f-~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~  162 (635)
T 4g8a_A           84 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS  162 (635)
T ss_dssp             TTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGG-TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHh-cCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcccc
Confidence            999998754  58899999999999999986544444 556889999999999999888889999999999999998865


Q ss_pred             ----cccccCcccceecccCcccccccccccccCCC----ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccC-C
Q 001384          213 ----NIWNGLAQLVEFSVSENVLSGVVSSSVFKENC----SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSG-P  283 (1088)
Q Consensus       213 ----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~----~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~  283 (1088)
                          ..+..+++|++|++++|.+++..+ ..|..+.    .+..++++.|.+....+..+ ....++.+++.+|.... .
T Consensus       163 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~  240 (635)
T 4g8a_A          163 FKLPEYFSNLTNLEHLDLSSNKIQSIYC-TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNV  240 (635)
T ss_dssp             CCCCGGGGGCTTCCEEECCSSCCCEECG-GGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHH
T ss_pred             CCCchhhccchhhhhhcccCcccccccc-ccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccc
Confidence                334567888889999988886543 3343332    34578899999886555544 44567888888887653 2


Q ss_pred             CccccCCCCCCCEEeCCCCc------CCccCcccccCCCCCcEEEcCCCcCCCc---hhHhhhcccccceeecCcCcccC
Q 001384          284 IPAEIGSISGLEALFLGKNN------FLSVIPESLLNLSKLEVLDLSSNNFGGE---VQKIFGRFTQVKILALHSNSYID  354 (1088)
Q Consensus       284 ~p~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~n~~~~  354 (1088)
                      .+..+..+..++...+..+.      +....+..+..+..+..+++..+.....   ....+..+..++.+.+..+.+..
T Consensus       241 ~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~  320 (635)
T 4g8a_A          241 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER  320 (635)
T ss_dssp             HHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE
T ss_pred             cchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc
Confidence            34456677777766654332      2233344455555666666655443322   33456667778888877776433


Q ss_pred             CCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCC--CCCcc
Q 001384          355 GMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG--PIPPS  432 (1088)
Q Consensus       355 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~  432 (1088)
                      .   ..+....+|+.|++++|.+.+..+.   .++.|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..
T Consensus       321 ~---~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~  392 (635)
T 4g8a_A          321 V---KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQS  392 (635)
T ss_dssp             C---GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred             c---cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccc
Confidence            2   2344567788889988888754333   456788888888887632  234568888889998888753  45666


Q ss_pred             ccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchh-hccCCCCCccccccccCCcccccCCccccc
Q 001384          433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV-MTIGRNARPTFEANQRNGERTIAGSSECLS  511 (1088)
Q Consensus       433 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~  511 (1088)
                      +..+.+|++|++..|.+. .++..+..+++|+.+++++|+..+..+... ..+..+..+.+..|...+.           
T Consensus       393 ~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~-----------  460 (635)
T 4g8a_A          393 DFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA-----------  460 (635)
T ss_dssp             HHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEEC-----------
T ss_pred             hhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccc-----------
Confidence            777888888888888887 466678888888888888888875544322 1111111111111110000           


Q ss_pred             cccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccc-cccCcccccCCCccE
Q 001384          512 MKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLS-GELSPDIGKLQNFSM  590 (1088)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~-g~~p~~~~~l~~L~~  590 (1088)
                                                           .+     ........+++|+|++|++. +.+|..+..+++|++
T Consensus       461 -------------------------------------~~-----~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~  498 (635)
T 4g8a_A          461 -------------------------------------FN-----GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  498 (635)
T ss_dssp             -------------------------------------CT-----TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             -------------------------------------cc-----cccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence                                                 00     00001112344555555432 234455555555555


Q ss_pred             EeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccc-cccceeeccCCC
Q 001384          591 VHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNL-TELSKLNISYNP  668 (1088)
Q Consensus       591 L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~~L~~l~l~~N~  668 (1088)
                      |+|++|+|++.+|..|+.+ .|++|+|++|+|++..|..|.++++|+.|||++|+|++..|..+..+ ++|+.|+|++||
T Consensus       499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np  578 (635)
T 4g8a_A          499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND  578 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred             EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence            5555555555555555555 45555555555555445555555555555555555555555555554 355555555555


Q ss_pred             Cc
Q 001384          669 LV  670 (1088)
Q Consensus       669 l~  670 (1088)
                      |.
T Consensus       579 ~~  580 (635)
T 4g8a_A          579 FA  580 (635)
T ss_dssp             BC
T ss_pred             Cc
Confidence            53

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-43  Score=417.61  Aligned_cols=246  Identities=26%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHH---HHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAE---MEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.++||+|+||+||+|+.+ +|+.||||++.+...   .....+.+|   +.++..    ++|||||++++++.++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~----~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS----SCCTTBCCEEEEEECS
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh----CCCCCEeEEEEEEEEC
Confidence            46899999999999999999976 699999999976432   222334444   445543    6899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      +..|+|||||+||+|.+++++.+.+++..++.|+.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999999999989999999999999999999999999   999999999999999999999999999988


Q ss_pred             ecCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      +...   .....+||+.|||||++. +..|+.++||||+||++|||++|+.||.+... ...+..........       
T Consensus       342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~-------  411 (689)
T 3v5w_A          342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------  411 (689)
T ss_dssp             CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------
T ss_pred             cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------
Confidence            7532   234568999999999986 45799999999999999999999999976432 11122222221110       


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVL 1077 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil 1077 (1088)
                                ..+.....++.+++.+|++.||.+|++     ++||+
T Consensus       412 ----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          412 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             ----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence                      112223456888999999999999998     67765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.8e-42  Score=412.41  Aligned_cols=250  Identities=23%  Similarity=0.352  Sum_probs=210.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||+|++........+.+.+|+++|+.    ++|||||++++++.++...|+|
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~----l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHH----TCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHh----CCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999976 799999999987765666788999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CCEEEeecccceeecC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE--GKALVTDFGLARVVSA  960 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~--~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+||+|.+++.. ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999999964 45799999999999999999999999   99999999999999854  8999999999998754


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .  ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.....  ....+......      ++.  
T Consensus       310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~i~~~~~~------~~~--  377 (573)
T 3uto_A          310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKSCDWN------MDD--  377 (573)
T ss_dssp             T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHTTCCC------CCS--
T ss_pred             C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHhCCCC------CCc--
Confidence            3  23445689999999999999999999999999999999999999998765422  12222211110      000  


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ........++.+|+.+||+.||.+||+++|+++
T Consensus       378 -----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001122356788999999999999999999986

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2e-41  Score=412.58  Aligned_cols=368  Identities=23%  Similarity=0.183  Sum_probs=285.2

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccc
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV  158 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~  158 (1088)
                      .+++.|+|++|.|++..+.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|.++..... .+++|++|+|++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-~l~~L~~L~Ls~  130 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC-PMASLRHLDLSF  130 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC-CCTTCSEEECCS
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc-ccccCCEEECCC
Confidence            5788999999999998888999999999999999999988899999999999999999999965544 899999999999


Q ss_pred             ccccccc-cCchhhhcccceEEeccCccCCCCCCccccCCCCC--cEEEccCccc--cccccccCcccc----eecccCc
Q 001384          159 NRIHGEI-SFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL--RYLDLSSNNF--RGNIWNGLAQLV----EFSVSEN  229 (1088)
Q Consensus       159 N~l~~~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~l~~L~----~L~L~~n  229 (1088)
                      |++++.. |..+ ..+++|++|+|++|++++..   +..+++|  ++|++++|++  ++..+..+..+.    .+++++|
T Consensus       131 N~l~~l~~p~~~-~~l~~L~~L~L~~n~l~~~~---~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n  206 (562)
T 3a79_B          131 NDFDVLPVCKEF-GNLTKLTFLGLSAAKFRQLD---LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN  206 (562)
T ss_dssp             SCCSBCCCCGGG-GGCTTCCEEEEECSBCCTTT---TGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSS
T ss_pred             CCccccCchHhh-cccCcccEEecCCCccccCc---hhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCc
Confidence            9998743 4444 45689999999999999754   4455555  9999999999  776666665544    5678888


Q ss_pred             ccccccccccccCCCccCEEEcCCCc-----ccccCcccccCCCCCcEEEccCccccCCC----ccccCCCCCCCEEeCC
Q 001384          230 VLSGVVSSSVFKENCSLEIFDLSENE-----FIGDFPGEVSNCRNLVVLNLFGNNFSGPI----PAEIGSISGLEALFLG  300 (1088)
Q Consensus       230 ~l~~~~~~~~~~~l~~L~~L~Ls~n~-----l~~~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~  300 (1088)
                      .+.+.++...+..+++|+.|++++|+     +. ..+..+..+++|+.|+++++.+.+..    +..+ ..++|++|+++
T Consensus       207 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~-~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~  284 (562)
T 3a79_B          207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM-TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIY  284 (562)
T ss_dssp             SCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH-HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEE
T ss_pred             cchhhhhhhcccccceEEEecccccccccchHH-HHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEe
Confidence            88888888888888899999999885     22 22345777888888888888776432    2222 23478888888


Q ss_pred             CCcCCccCcccc-----cCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCC
Q 001384          301 KNNFLSVIPESL-----LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN  375 (1088)
Q Consensus       301 ~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N  375 (1088)
                      +|.+++.+|..+     .++++|+.++++.|.+ ..+...+..+                      ....+|+.|++++|
T Consensus       285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~----------------------~~~~~L~~L~l~~n  341 (562)
T 3a79_B          285 NLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSV----------------------FAEMNIKMLSISDT  341 (562)
T ss_dssp             EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHH----------------------HHTCCCSEEEEESS
T ss_pred             ccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhh----------------------hccCcceEEEccCC
Confidence            888887788777     6667777777777766 2222222211                      01246778888888


Q ss_pred             ccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCC--CCCccccCCCCCcEEEccccccccCC
Q 001384          376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG--PIPPSIGNLTSLLWLMLANNSLSGEI  453 (1088)
Q Consensus       376 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~  453 (1088)
                      .+....  ....+++|++|++++|++++.+|..++++++|++|++++|++++  .+|..++++++|++|+|++|++++.+
T Consensus       342 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  419 (562)
T 3a79_B          342 PFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA  419 (562)
T ss_dssp             CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCC
T ss_pred             Cccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCcc
Confidence            776321  12577888899999999888888888889999999999999885  23466888899999999999998756


Q ss_pred             Cc-cccCCCCCCeEEccCCcCccCCC
Q 001384          454 PG-EIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       454 p~-~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      |. .+..+++|++|++++|++++.+|
T Consensus       420 ~~~~~~~l~~L~~L~l~~n~l~~~~~  445 (562)
T 3a79_B          420 YDRTCAWAESILVLNLSSNMLTGSVF  445 (562)
T ss_dssp             SSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred             ChhhhcCcccCCEEECCCCCCCcchh
Confidence            65 47888999999999998875444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.9e-41  Score=396.22  Aligned_cols=320  Identities=20%  Similarity=0.193  Sum_probs=162.5

Q ss_pred             CCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceE
Q 001384          101 ALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVV  178 (1088)
Q Consensus       101 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~  178 (1088)
                      ..++|++|++++|.+ |.+|++++++++|++|+|++|.+++..  .++++++|+.+++..|..            .++++
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~~   75 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAHE   75 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCSE
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCCE
Confidence            346677777777777 577777777777777777777766432  466666666666655532            34566


Q ss_pred             EeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccc
Q 001384          179 ANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG  258 (1088)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~  258 (1088)
                      |++++|++++...    -.++|++|++++|++++ ++..+++|+.|++++|.+++...     ..++|++|++++|++++
T Consensus        76 L~l~~~~l~~lp~----~~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~-----~~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           76 LELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSD-----LPPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             EECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCS-----CCTTCCEEECCSSCCSS
T ss_pred             EEecCCccccCCC----CcCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccC-----CCCCCCEEECcCCCCCC
Confidence            6666666665332    12566777777776665 44445566666666666654211     11577888888887775


Q ss_pred             cCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhc
Q 001384          259 DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR  338 (1088)
Q Consensus       259 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  338 (1088)
                       +| .++++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .++++++|++|++++|++++.+. .   
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~---  213 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L---  213 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---
Confidence             66 57788888888888888774 55433   477888888887776 45 57777888888888887775321 1   


Q ss_pred             ccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEE
Q 001384          339 FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTL  418 (1088)
Q Consensus       339 l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  418 (1088)
                      .++|+.|++++|.+. .++  .+..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   +++|++|
T Consensus       214 ~~~L~~L~l~~n~l~-~lp--~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L  282 (454)
T 1jl5_A          214 PLSLESIVAGNNILE-ELP--ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL  282 (454)
T ss_dssp             CTTCCEEECCSSCCS-SCC--CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred             cCcccEEECcCCcCC-ccc--ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence            124444444444432 111  13444455555555555542 3321   2444555555555542 3332   2444555


Q ss_pred             EccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          419 DLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       419 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      ++++|++++ +|..   .++|++|++++|++++ ++..   .++|++|++++|+++
T Consensus       283 ~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~  330 (454)
T 1jl5_A          283 DVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLI  330 (454)
T ss_dssp             ECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCS
T ss_pred             ECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCccc
Confidence            555555443 1111   1344455555554442 2210   124455555555444

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.5e-41  Score=381.16  Aligned_cols=282  Identities=40%  Similarity=0.731  Sum_probs=234.2

Q ss_pred             CCccCHHHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEE
Q 001384          792 KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTL  870 (1088)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l  870 (1088)
                      ...+++.++....++|++.+.||+|+||.||+|+.++++.||||++...... ....+.+|++++..    ++||||+++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~   92 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM----AVHRNLLRL   92 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGT----CCCTTBCCC
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHh----ccCCCccce
Confidence            4568899999999999999999999999999999888999999999865322 23468899999986    679999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC
Q 001384          871 YGWCLDGSEKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK  946 (1088)
Q Consensus       871 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~  946 (1088)
                      ++++.++...++||||+++|+|.++++...    .+++..++.++.|++.||+|||+++.++|+||||||+||+++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            999999999999999999999999997654    3999999999999999999999987778999999999999999999


Q ss_pred             EEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC------chhHHHHH
Q 001384          947 ALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG------EECLVEWG 1020 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~------~~~~~~~~ 1020 (1088)
                      +||+|||+++..............||+.|+|||++.+..++.++||||+|+++|||++|+.||...      .....+|.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999999987655555555667999999999998888999999999999999999999999621      12344444


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      ....   .........+....   ..........+.+++.+|++.||.+||+++||++.|++.
T Consensus       253 ~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLL---KEKKLEALVDVDLQ---GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTT---SSCCSTTSSCTTCT---TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHh---hchhhhhhcChhhc---cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3332   11222222222222   223567788999999999999999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-41  Score=382.77  Aligned_cols=280  Identities=38%  Similarity=0.616  Sum_probs=229.6

Q ss_pred             ccCHHHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          794 AFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      .+++.++...+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+++++.    ++||||++++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~  103 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF----CRHPHLVSLIGF  103 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGS----CCCTTBCCEEEE
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHh----CCCCCEeeEEEE
Confidence            3445556667899999999999999999999988899999999987655566789999999986    679999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          874 CLDGSEKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      +.+++..++||||+++|+|.+++....    .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  180 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI  180 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEE
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999996543    589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeecCCC-CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch----hHHHHHHhhh
Q 001384          950 TDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE----CLVEWGRRVM 1024 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~----~~~~~~~~~~ 1024 (1088)
                      +|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+    ....|.....
T Consensus       181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            9999998754322 2223445689999999998888999999999999999999999999976532    2334433322


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ..   .......+...   ...........+.+++.+|++.||++||+++|+++.|+++++.
T Consensus       261 ~~---~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          261 NN---GQLEQIVDPNL---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TT---TCCCSSSSSSC---TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cc---ccHHHhcChhh---ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            11   11112222111   1123567788999999999999999999999999999998654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1e-40  Score=374.05  Aligned_cols=296  Identities=30%  Similarity=0.480  Sum_probs=204.6

Q ss_pred             CCchhhHHHHHHHHhhcccCCCCCcccccccCCCCCCcc--cCCceeCCCC--ceeEEeccccccccc--cccccccCCc
Q 001384           30 DSLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCE--WPGIICSPDK--ARVNGLNLTDWNISG--DIFNNFSALT  103 (1088)
Q Consensus        30 ~~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C~--W~gv~C~~~~--~~v~~L~L~~~~l~~--~~~~~l~~l~  103 (1088)
                      .|.++|++||++||+++.+    +. .+++|+.+++||.  |.||+|+...  ++|+.|+|++++++|  .+++.+++++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~----~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~   76 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGN----PT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP   76 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTC----CG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred             CCCHHHHHHHHHHHHhcCC----cc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCC
Confidence            3678899999999999953    22 6899998889999  9999998655  788888888888888  7777888888


Q ss_pred             cCCeeeCCC-CCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEecc
Q 001384          104 QLSYLDLSR-NTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLS  182 (1088)
Q Consensus       104 ~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~  182 (1088)
                      +|++|+|++ |.+++.+|..|+++++|++|+|++|.+++                                         
T Consensus        77 ~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-----------------------------------------  115 (313)
T 1ogq_A           77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG-----------------------------------------  115 (313)
T ss_dssp             TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE-----------------------------------------
T ss_pred             CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCC-----------------------------------------
Confidence            888888884 77777777766666666655555543331                                         


Q ss_pred             CccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcc
Q 001384          183 LNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG  262 (1088)
Q Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~  262 (1088)
                            .+|..|.++++|++|+|                                              ++|++++.+|.
T Consensus       116 ------~~p~~~~~l~~L~~L~L----------------------------------------------s~N~l~~~~p~  143 (313)
T 1ogq_A          116 ------AIPDFLSQIKTLVTLDF----------------------------------------------SYNALSGTLPP  143 (313)
T ss_dssp             ------ECCGGGGGCTTCCEEEC----------------------------------------------CSSEEESCCCG
T ss_pred             ------cCCHHHhCCCCCCEEeC----------------------------------------------CCCccCCcCCh
Confidence                  11222233333333333                                              33333334455


Q ss_pred             cccCCCCCcEEEccCccccCCCccccCCCC-CCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccc
Q 001384          263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSIS-GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQ  341 (1088)
Q Consensus       263 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  341 (1088)
                      .+.++++|++|+|++|++++.+|..++.++ +|+.|+|++|++++.+|..+..++                         
T Consensus       144 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-------------------------  198 (313)
T 1ogq_A          144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------------------  198 (313)
T ss_dssp             GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-------------------------
T ss_pred             HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-------------------------
Confidence            555556666666666666555555555544 455555555444444444443332                         


Q ss_pred             cceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEcc
Q 001384          342 VKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS  421 (1088)
Q Consensus       342 L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  421 (1088)
                                               |++|+|++|.+++..|..+..+++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus       199 -------------------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls  252 (313)
T 1ogq_A          199 -------------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR  252 (313)
T ss_dssp             -------------------------CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred             -------------------------ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence                                     55566666666666666777777777777777777755555 7778888888888


Q ss_pred             CCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCc-Ccc
Q 001384          422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK-LSG  475 (1088)
Q Consensus       422 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~g  475 (1088)
                      +|++++.+|.+++++++|++|+|++|+++|.+|.. +++++|+.|++++|+ +.|
T Consensus       253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             CCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence            88888888888888888888999988888888876 888888999999888 554

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.5e-39  Score=403.17  Aligned_cols=480  Identities=21%  Similarity=0.221  Sum_probs=328.8

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeec
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDL  156 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~L  156 (1088)
                      ..++.|+|++|.|++..+.+|+++++|++|||++|+|++..|.+|+++++|++|+|++|+|++..  .|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            36889999999999988889999999999999999999877889999999999999999999754  5899999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCC-CCccccCCCCCcEEEccCccccccccccCc---cc----ceecccC
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGR-IDTCFDGCLNLRYLDLSSNNFRGNIWNGLA---QL----VEFSVSE  228 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~---~L----~~L~L~~  228 (1088)
                      ++|++++..+..| ..+++|++|+|++|++++. .|..+..+++|++|+|++|++++..+..+.   ++    ..++++.
T Consensus       132 s~N~l~~l~~~~~-~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~  210 (635)
T 4g8a_A          132 VETNLASLENFPI-GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  210 (635)
T ss_dssp             TTSCCCCSTTCCC-TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             CCCcCCCCChhhh-hcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence            9999997665555 4568999999999999874 578899999999999999999875544433   22    3577888


Q ss_pred             cccccccccccccCCCccCEEEcCCCcccc-cCcccccCCCCCcEEEccCcccc------CCCc----------------
Q 001384          229 NVLSGVVSSSVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNLVVLNLFGNNFS------GPIP----------------  285 (1088)
Q Consensus       229 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~------~~~p----------------  285 (1088)
                      |.++.. +...+.. ..++.+++++|.... ..+..+..+..++...+..+...      ....                
T Consensus       211 n~l~~i-~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~  288 (635)
T 4g8a_A          211 NPMNFI-QPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  288 (635)
T ss_dssp             CCCCEE-CTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred             Cccccc-Ccccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence            888753 3344433 356778888775542 22344555555555554332211      1111                


Q ss_pred             -----------cccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccC
Q 001384          286 -----------AEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYID  354 (1088)
Q Consensus       286 -----------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~  354 (1088)
                                 ..+..+.+++.+.+.+|.+...  ..+....+|+.|++.+|.+.+..+.   .+..|+.+.+..|....
T Consensus       289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~  363 (635)
T 4g8a_A          289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGN  363 (635)
T ss_dssp             ECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCC
T ss_pred             hhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCC
Confidence                       2223334455555555544432  2233444555555555555444332   23444555555544322


Q ss_pred             CCCCccccCCCCcCEEEccCCccCC--CCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC-c
Q 001384          355 GMNSSGILKLPNISRLDLSHNNFTG--PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP-P  431 (1088)
Q Consensus       355 ~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~  431 (1088)
                      .   .....+++|+.|++++|.+..  ..+..+..+.+|+.|++..|.+. .++..+..+++|+.+++++|+.....+ .
T Consensus       364 ~---~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~  439 (635)
T 4g8a_A          364 A---FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS  439 (635)
T ss_dssp             B---CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSC
T ss_pred             C---cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccc
Confidence            1   122345556666666665532  23444445556666666666555 344445556666666666555443332 2


Q ss_pred             cccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC-CCchhhccCCCCCccccccccCCcccccCCcccc
Q 001384          432 SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN-IPPEVMTIGRNARPTFEANQRNGERTIAGSSECL  510 (1088)
Q Consensus       432 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~-ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~  510 (1088)
                      .+.++++++.++++.|.+.+..|..+..+++|++|+|++|++.+. +|..+.                            
T Consensus       440 ~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~----------------------------  491 (635)
T 4g8a_A          440 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT----------------------------  491 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT----------------------------
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhh----------------------------
Confidence            345556666666666666655555566666666666666654322 121111                            


Q ss_pred             ccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccE
Q 001384          511 SMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSM  590 (1088)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~  590 (1088)
                                                                       .+..+++|+|++|+|++..|..++++++|++
T Consensus       492 -------------------------------------------------~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~  522 (635)
T 4g8a_A          492 -------------------------------------------------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  522 (635)
T ss_dssp             -------------------------------------------------TCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             -------------------------------------------------hccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence                                                             1223578999999999999999999999999


Q ss_pred             EeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCC-ccCcEEEccccccCC
Q 001384          591 VHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNI-KCLQNLDLSYNNFSG  647 (1088)
Q Consensus       591 L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~g  647 (1088)
                      |+|++|+|++..|..|+.+ .|++|+|++|+|++..|..|.++ ++|+.|+|++|+++-
T Consensus       523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            9999999998888899988 69999999999999999999998 689999999999984

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.6e-40  Score=364.93  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=210.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|.+. +++.||||++........+.+.+|+.+++.    ++||||+++++++..++..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE----NKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhc----CCCCCCCeEeEEEEECCEEEE
Confidence            457999999999999999999964 789999999987655667788999999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|.++++.. .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999999765 589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      . ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.......+.........              
T Consensus       171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------  235 (297)
T 3fxz_A          171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE--------------  235 (297)
T ss_dssp             C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC--------------
T ss_pred             c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence            2 3345679999999999999999999999999999999999999998765422222111110000              


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ...+......+.+++.+|++.||++||+++|+++
T Consensus       236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0112233456888999999999999999999976

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.6e-40  Score=367.77  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=211.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++    ++||||+++++++.++...++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC----LEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHh----CCCcCcccEEEEEecCCeeEEE
Confidence            56888999999999999999976 689999999877655666789999999987    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++|+|.++++. ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999987 56799999999999999999999999   99999999999999999999999999998765332


Q ss_pred             Ccc-------------cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          963 SHV-------------STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       963 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      ...             .....||+.|+|||++.+..++.++||||||+++|||++|..||.........           
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-----------  231 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-----------  231 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----------
Confidence            211             11457999999999999999999999999999999999999998754221000           


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                        ............   .+...+..+.+++.+|++.||++||+++|+++.|+++.+
T Consensus       232 --~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          232 --FGLNVRGFLDRY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             --SSBCHHHHHHHT---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --Hhhhhhcccccc---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              000000000000   012233468889999999999999999999999998753

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3e-39  Score=380.51  Aligned_cols=323  Identities=22%  Similarity=0.199  Sum_probs=253.7

Q ss_pred             cccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhh
Q 001384           92 SGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPA  171 (1088)
Q Consensus        92 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  171 (1088)
                      .+..+..++++++|++|+|++|.|++. | .++.+++|++|+|++|.+++. +++.+++|++|+|++|++++. +   ..
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~~~~l~~L~~L~Ls~N~l~~~-~---~~  103 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-DLSQNTNLTYLACDSNKLTNL-D---VT  103 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSCC-C---CT
T ss_pred             CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-ccccCCCCCEEECcCCCCcee-e---cC
Confidence            333445677778888888888888754 5 677888888888888888775 477788888888888888764 2   23


Q ss_pred             hcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEc
Q 001384          172 ICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL  251 (1088)
Q Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  251 (1088)
                      .+++|++|++++|++++. +  ++.+++|++|++++|++++..+..+++|++|++++|...+.+   .+..+++|++|++
T Consensus       104 ~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~l  177 (457)
T 3bz5_A          104 PLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL---DVTPQTQLTTLDC  177 (457)
T ss_dssp             TCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCSCCCCC---CCTTCTTCCEEEC
T ss_pred             CCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCCccccc---ccccCCcCCEEEC
Confidence            457788888888888874 2  778888888888888887755667778888888888554444   4677889999999


Q ss_pred             CCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCc
Q 001384          252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE  331 (1088)
Q Consensus       252 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  331 (1088)
                      ++|++++ +|  +..+++|+.|++++|++++.   .++.+++|+.|++++|++++ +|  +..+++|++|++++|++++.
T Consensus       178 s~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~  248 (457)
T 3bz5_A          178 SFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL  248 (457)
T ss_dssp             CSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred             CCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence            9999886 45  78889999999999999864   48888999999999999988 55  88889999999999999886


Q ss_pred             hhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCC
Q 001384          332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN  411 (1088)
Q Consensus       332 ~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  411 (1088)
                      +   ++.+++|+.|+++.|               +|+.|++++|.+.+.+|  ++.+++|+.|++++|.+.+.+|.   .
T Consensus       249 ~---~~~l~~L~~L~l~~n---------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~  305 (457)
T 3bz5_A          249 D---VSTLSKLTTLHCIQT---------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---Q  305 (457)
T ss_dssp             C---CTTCTTCCEEECTTC---------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---T
T ss_pred             C---HHHCCCCCEEeccCC---------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---C
Confidence            5   456777888887665               46788899998887776  56788999999999988877774   3


Q ss_pred             CCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       412 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      .++|+.|++++|             ++|++|++++|++++ ++  ++++++|+.|++++|+++|
T Consensus       306 ~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          306 AAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             TCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB
T ss_pred             CCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC
Confidence            456666666555             689999999999997 43  8999999999999999985

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.7e-40  Score=369.87  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=207.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+++++.    ++||||+++++++..++..
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI----LNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEECCEE
Confidence            468999999999999999999974 799999999976532  234568899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++...+++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999976643


Q ss_pred             CCCcccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQAT-TKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .  .......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....  +..........           
T Consensus       167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~-----------  231 (328)
T 3fe3_A          167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGKY-----------  231 (328)
T ss_dssp             S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-----------
T ss_pred             C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC-----------
Confidence            3  234556799999999998887765 7999999999999999999999876432  22222211100           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+.....++.+++.+|++.||.+|||++|+++
T Consensus       232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  011123356788999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-40  Score=366.98  Aligned_cols=258  Identities=31%  Similarity=0.445  Sum_probs=204.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|++ +|+.||||++......  ..+.+.+|++++++    ++||||+++++++.+....+
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKR----LRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSTTCCE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEECCceE
Confidence            46789999999999999999987 5889999999765432  23578899999997    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          882 LVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +||||+++|+|.++++....   +++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999987653   99999999999999999999999   8  9999999999999999999999999997


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ..... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||...............  ..        
T Consensus       188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~--------  256 (309)
T 3p86_A          188 LKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK--CK--------  256 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS--CC--------
T ss_pred             ccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CC--------
Confidence            64322 22234567899999999999999999999999999999999999999876542221111111  00        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                             ....+.....++.+++.+|++.||++||+++|+++.|+++++.+
T Consensus       257 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          257 -------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                   00112233457889999999999999999999999999998753

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=4.9e-40  Score=386.92  Aligned_cols=343  Identities=21%  Similarity=0.237  Sum_probs=249.9

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccc
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV  158 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~  158 (1088)
                      .++..|+++++++ |.+|++++++++|++|++++|.++|.+|..++++.+|+.+++++|..         .+|++|++++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~---------~~l~~L~l~~   80 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD---------RQAHELELNN   80 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH---------HTCSEEECTT
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc---------cCCCEEEecC
Confidence            4677899999999 89999999999999999999999999999999999987777777643         4577788888


Q ss_pred             ccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccc
Q 001384          159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSS  238 (1088)
Q Consensus       159 N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~  238 (1088)
                      |.+++. |.    ..++|++|++++|++++ +|..   +++|++|++++|++++ ++...++|++|++++|.+++ ++  
T Consensus        81 ~~l~~l-p~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~~~L~~L~L~~n~l~~-lp--  147 (454)
T 1jl5_A           81 LGLSSL-PE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLPPLLEYLGVSNNQLEK-LP--  147 (454)
T ss_dssp             SCCSCC-CS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCCTTCCEEECCSSCCSS-CC--
T ss_pred             CccccC-CC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCCCCCCEEECcCCCCCC-Cc--
Confidence            877752 22    23578888888888887 4432   3678888888888775 22223688888888888886 44  


Q ss_pred             cccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCC
Q 001384          239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL  318 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  318 (1088)
                      .|..+++|++|++++|++++ +|..+   ++|++|++++|++++ +| .++.+++|+.|++++|++++ +|...   ++|
T Consensus       148 ~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L  217 (454)
T 1jl5_A          148 ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSL  217 (454)
T ss_dssp             CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTC
T ss_pred             ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Ccc
Confidence            48888999999999999885 56543   589999999999986 56 68999999999999999887 44433   589


Q ss_pred             cEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccc
Q 001384          319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH  398 (1088)
Q Consensus       319 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  398 (1088)
                      ++|++++|.++. +|. |+.+++|+.|++++|.+.. .+.    .+++|+.|++++|++++ +|..   +++|++|++++
T Consensus       218 ~~L~l~~n~l~~-lp~-~~~l~~L~~L~l~~N~l~~-l~~----~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~  286 (454)
T 1jl5_A          218 ESIVAGNNILEE-LPE-LQNLPFLTTIYADNNLLKT-LPD----LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSE  286 (454)
T ss_dssp             CEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSS-CCS----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred             cEEECcCCcCCc-ccc-cCCCCCCCEEECCCCcCCc-ccc----cccccCEEECCCCcccc-cCcc---cCcCCEEECcC
Confidence            999999999984 443 8899999999999998654 221    24789999999999995 6654   37899999999


Q ss_pred             cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       399 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      |++++ +|..   .++|+.|++++|++++ ++..   .++|++|++++|++++ +|..   +++|++|++++|+++ .+|
T Consensus       287 N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp  353 (454)
T 1jl5_A          287 NIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVP  353 (454)
T ss_dssp             SCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCC
T ss_pred             CccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-ccc
Confidence            99995 3432   2689999999999995 3321   2589999999999995 7765   588999999999887 344

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.5e-40  Score=377.02  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=211.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++..... ..+.+.+|+++++++.   +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---KHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC---CCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc---CCCCEeeEEEEE
Confidence            357889999999999999999852        3457999999865332 3357889999999732   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                      .+++..|+||||+++|+|.++++...                .+++.+++.++.||+.||+|||++   +|+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence            99999999999999999999997643                479999999999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999999876543322 2334567889999999998899999999999999999999 999998754321


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .  .....                .+.....+.....++.+++.+|++.||++||++.|+++.|++++.
T Consensus       314 ~--~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 L--FKLLK----------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             H--HHHHH----------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHHHh----------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1  11111                000111123344678899999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5e-40  Score=360.53  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=214.4

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.++++..||||++.... ...+++.+|++++.+    ++||||+++++++.++...++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMK----LSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHh----CCCCCEeeEEEEEccCCceEEE
Confidence            35788999999999999999999888899999998653 345678999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++++|.+++.... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999997754 599999999999999999999999   99999999999999999999999999998765544


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.........  ........             
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~~~~-------------  223 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--LKVSQGHR-------------  223 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHHTTCC-------------
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--HHHHcCCC-------------
Confidence            333344556778999999988889999999999999999999 99999875442211  11110000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                         ...+......+.+++.+|++.||++||+++|+++.|+++.+.
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               001112235688899999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-40  Score=362.48  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=213.2

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|++.+++.||+|++.... ...+++.+|++++++    ++||||+++++++.++...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMK----LSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHT----CCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHh----CCCCCEeeEEEEEecCCceEEEE
Confidence            4688899999999999999999888999999998653 345679999999997    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++++|.++++.. ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999999654 4689999999999999999999999   999999999999999999999999999986543322


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .......+|..|+|||.+.+..++.++||||+|+++|+|++ |+.||.......  .........               
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~---------------  224 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF---------------  224 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC---------------
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCc---------------
Confidence            23334556788999999988899999999999999999999 999998754421  111111000               


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       ....+......+.+++.+|++.||++||+++|+++.|+++.+.
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             0011122345688899999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9e-40  Score=363.40  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=210.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......   ..+.+.+|+.++.+    ++||||+++++++.+++.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ----LSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTT----CCBTTBCCEEEEEECSSE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhc----CCCCCCceEEEeeeeCCe
Confidence            468999999999999999999975 6899999998654322   23568899999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.++++...++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999999999888999999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...........||+.|+|||.+.+..++.++||||+|+++|||++|+.||.+........  .......    . .....
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~~----~-~~~~~  235 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--KHIQDSV----P-NVTTD  235 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--HHHSSCC----C-CHHHH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhhccC----C-Ccchh
Confidence            443333445679999999999999899999999999999999999999998765422211  1110000    0 00000


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHHhhCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~i~~~ 1086 (1088)
                             .....+..+.+++.+|++.||++|| +++++.+.|++++..
T Consensus       236 -------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          236 -------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             -------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             -------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                   0122346788899999999999999 999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=371.32  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=210.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .++|++.+.||+|+||.||+|++.    .+..||||++..... ...+.+.+|++++++    ++||||+++++++.++.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ----FDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECGGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEeCC
Confidence            357889999999999999999974    345699999986532 334678999999987    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.++++.. ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999754 5799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .......  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+......  .......        
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~--------  270 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--ISSVEEG--------  270 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHHTT--------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHcC--------
Confidence            6543222  1223456778999999988899999999999999999999 9999987544211  1111100        


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                              ...+.+...+..+.+++.+|++.||++||+++||++.|+++++..
T Consensus       271 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 --------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             --------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                    011112234467889999999999999999999999999987653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.7e-39  Score=381.55  Aligned_cols=362  Identities=22%  Similarity=0.217  Sum_probs=293.3

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCC-ccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEE
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPI-PAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD  322 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  322 (1088)
                      ++|++|+|++|++++..|..|.++++|++|+|++|.+.+.+ +..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            57888888888888888888888888999999888887555 55688888899999998888888888888888899999


Q ss_pred             cCCCcCCCchhHh--hhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCC--cCcceeeccc
Q 001384          323 LSSNNFGGEVQKI--FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM--RSLKFLILAH  398 (1088)
Q Consensus       323 L~~N~l~~~~~~~--~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~  398 (1088)
                      |++|.+++..+..  |+.+++|+.|++++|.+........+.++++|++|+|++|++++..|..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            9999888766554  88888888888888886554444447788889999999999988888888776  6888899999


Q ss_pred             cccCCcCCcc--------cCCCCCCcEEEccCCcCCCCCCccccCC---CCCcEEEccccccccCC----------Cccc
Q 001384          399 NRFNGSIPAV--------YGNMPNLQTLDLSFNELTGPIPPSIGNL---TSLLWLMLANNSLSGEI----------PGEI  457 (1088)
Q Consensus       399 N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~----------p~~l  457 (1088)
                      |.+.+..+..        +..+++|++|++++|++++.+|..+..+   ++|+.|++++|.+.+..          +..+
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~  269 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF  269 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence            9888654443        3356789999999999888777777654   78889999888665421          1222


Q ss_pred             cC--CCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhcccc
Q 001384          458 GN--CTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC  535 (1088)
Q Consensus       458 ~~--l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (1088)
                      ..  .++|++|++++|++++.+|..+..+                                                   
T Consensus       270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l---------------------------------------------------  298 (455)
T 3v47_A          270 KGLEASGVKTCDLSKSKIFALLKSVFSHF---------------------------------------------------  298 (455)
T ss_dssp             GGGTTSCCCEEECCSSCCCEECTTTTTTC---------------------------------------------------
T ss_pred             ccccccCceEEEecCccccccchhhcccC---------------------------------------------------
Confidence            22  3688999999999887666544222                                                   


Q ss_pred             chhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEE
Q 001384          536 RSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVL  614 (1088)
Q Consensus       536 ~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l  614 (1088)
                                                ..+++|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+ .|++|
T Consensus       299 --------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  352 (455)
T 3v47_A          299 --------------------------TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL  352 (455)
T ss_dssp             --------------------------TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEE
T ss_pred             --------------------------CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEE
Confidence                                      124679999999998889999999999999999999998888888888 79999


Q ss_pred             EccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCccccc
Q 001384          615 NLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATF  683 (1088)
Q Consensus       615 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~  683 (1088)
                      +|++|++++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|++++|++ .+.+|....+..+
T Consensus       353 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l-~~~~~~~~~l~~~  420 (455)
T 3v47_A          353 DLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW-DCSCPRIDYLSRW  420 (455)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB-CCCTTTTHHHHHH
T ss_pred             ECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc-ccCCCcchHHHHH
Confidence            9999999988899999999999999999999976666789999999999999999 7888876555443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.3e-39  Score=367.06  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=208.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++.+....      ..+.+.+|+.++..    ++||||+++++++.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ----VLHPNIITLHDVYEN   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTT----CCCTTBCCEEEEEEC
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHh----CCCcCCCcEEEEEEe
Confidence            467999999999999999999976 6899999999865432      24678999999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeec
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDF  952 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Df  952 (1088)
                      +...++||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++    .+||+||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999999999888899999999999999999999999   999999999999998877    7999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |+++......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....  +....+.....    
T Consensus       164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~~~----  235 (361)
T 2yab_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITAVSY----  235 (361)
T ss_dssp             SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCC----
T ss_pred             CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCC----
Confidence            9998765432  234567999999999999989999999999999999999999999875442  11122211100    


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ..+...       .......+.+++.+|++.||++||++.|+++
T Consensus       236 --~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 --DFDEEF-------FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --CCCHHH-------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CCCchh-------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              001000       1122356788999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-39  Score=364.39  Aligned_cols=247  Identities=27%  Similarity=0.304  Sum_probs=207.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++.+..   ......+.+|++++..    ++||||+++++++.+.+..
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----TRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----CCCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHh----CCCCcCcceEEEEEeCCEE
Confidence            46889999999999999999976 68999999997642   2334578899999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      . ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ....+.....            
T Consensus       158 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~------------  222 (337)
T 1o6l_A          158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELILMEEI------------  222 (337)
T ss_dssp             T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC------------
T ss_pred             C-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC------------
Confidence            2 223445689999999999999999999999999999999999999998754321  1112211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                           ..+.....++.+++.+|++.||++||     +++||++
T Consensus       223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 01122345788899999999999999     8888865

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=9.2e-39  Score=379.08  Aligned_cols=354  Identities=22%  Similarity=0.242  Sum_probs=262.6

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCc---ccCCCCCCCceeecccccccccccCchhhhcccceEE
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGD---LNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA  179 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~---~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L  179 (1088)
                      ++|++|||++|.|++..|..|+++++|++|+|++|.+.+.   ..+.++++|++|+|++|++++..|..+.. +++|++|
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L  108 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNG-LANLEVL  108 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTT-CTTCCEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccC-cccCCEE
Confidence            7899999999999988899999999999999999988753   34788888888888888887655554432 3556666


Q ss_pred             eccCccCCCCCCc--cccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCccc
Q 001384          180 NLSLNNLTGRIDT--CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI  257 (1088)
Q Consensus       180 ~L~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  257 (1088)
                      +|++|++++..+.  .|..+++|++|+|++|+++                     +..+...|..+++|++|++++|+++
T Consensus       109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~---------------------~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A          109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK---------------------KIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC---------------------SCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             eCCCCCCCccccCcccccCcccCCEEECCCCccC---------------------ccCcccccCCCCcccEEeCCCCccc
Confidence            6666655553332  2555555555555555554                     3334444666667777777777777


Q ss_pred             ccCcccccCC--CCCcEEEccCccccCCCccc--------cCCCCCCCEEeCCCCcCCccCcccccCC---CCCcEEEcC
Q 001384          258 GDFPGEVSNC--RNLVVLNLFGNNFSGPIPAE--------IGSISGLEALFLGKNNFLSVIPESLLNL---SKLEVLDLS  324 (1088)
Q Consensus       258 ~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~  324 (1088)
                      +..|..+..+  .+|+.|++++|.+.+..+..        +..+++|++|+|++|++++.+|..+...   ++|+.|+++
T Consensus       168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~  247 (455)
T 3v47_A          168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS  247 (455)
T ss_dssp             CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred             ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence            6666666655  56777777777776544333        2355677777777777777666665443   677777777


Q ss_pred             CCcCCCc----------hhHhhhc--ccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcc
Q 001384          325 SNNFGGE----------VQKIFGR--FTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK  392 (1088)
Q Consensus       325 ~N~l~~~----------~~~~~~~--l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  392 (1088)
                      +|.+.+.          .+..+..  .++|+.|++++|.+. ...+..+..+++|++|+|++|++++..|..|..+++|+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  326 (455)
T 3v47_A          248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL  326 (455)
T ss_dssp             TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             cccccccccchhhhccCcccccccccccCceEEEecCcccc-ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCC
Confidence            7654432          2222332  257888888887754 34456677888999999999999988888899999999


Q ss_pred             eeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCc
Q 001384          393 FLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK  472 (1088)
Q Consensus       393 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  472 (1088)
                      +|+|++|++++..|..++.+++|++|+|++|++++..|..++++++|++|+|++|++++..+..+..+++|++|+|++|+
T Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             EEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            99999999987778889999999999999999998888899999999999999999997666677899999999999999


Q ss_pred             CccCCCc
Q 001384          473 LSGNIPP  479 (1088)
Q Consensus       473 l~g~ip~  479 (1088)
                      +++.+|.
T Consensus       407 l~~~~~~  413 (455)
T 3v47_A          407 WDCSCPR  413 (455)
T ss_dssp             BCCCTTT
T ss_pred             cccCCCc
Confidence            9988873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-38  Score=354.54  Aligned_cols=280  Identities=34%  Similarity=0.558  Sum_probs=227.4

Q ss_pred             cCCccCHHHHHHHcCCCCcc------ceecccCceEEEEEEeCCCcEEEEEEccccC----ccchHHHHHHHHHHhCCCC
Q 001384          791 DKTAFTYSDILKATGKFSED------RIIGKGGFGTVYRGVLPDGREVAVKKLQREG----LEGEREFRAEMEVLSGNGF  860 (1088)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~  860 (1088)
                      +...|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++   
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~---   86 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK---   86 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH---
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh---
Confidence            34568999999999998877      8999999999999997 58899999987532    2234678899999987   


Q ss_pred             CCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001384          861 GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD---RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKAS  937 (1088)
Q Consensus       861 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~  937 (1088)
                       ++||||+++++++.+.+..++||||+++|+|.+++..   ..++++..++.++.|++.||+|||++   +|+||||||+
T Consensus        87 -l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~  162 (307)
T 2nru_A           87 -CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA  162 (307)
T ss_dssp             -CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             -cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence             6799999999999999999999999999999999974   34599999999999999999999999   9999999999


Q ss_pred             CEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--
Q 001384          938 NVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-- 1014 (1088)
Q Consensus       938 NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-- 1014 (1088)
                      ||+++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....  
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            999999999999999999876543222 2334578999999998875 589999999999999999999999987543  


Q ss_pred             hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....+......  .    ...++..+.......+......+.+++.+|++.||.+||+++||++.|+++..
T Consensus       242 ~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          242 LLLDIKEEIED--E----EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BTTHHHHHHHT--T----SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHhhh--h----hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            12222222210  0    11111222222233456778889999999999999999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.7e-39  Score=364.54  Aligned_cols=264  Identities=28%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----eE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----EK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----~~  880 (1088)
                      ++|++.+.||+|+||+||+|++. ++.||||++.... ........|+.++.+    ++||||+++++++....    ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPG----MKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTT----CCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhc----CCCCCchhhcceeccCCCCCceE
Confidence            57899999999999999999985 7899999997642 223345567777765    68999999999998744    46


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-------YPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                      ++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+|||
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            9999999999999999764 5999999999999999999999861       2389999999999999999999999999


Q ss_pred             cceeecCCCCc-ccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-------------
Q 001384          954 LARVVSAGDSH-VSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEE------------- 1014 (1088)
Q Consensus       954 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~------------- 1014 (1088)
                      +++........ ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..+             
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            99887643322 2334678999999998876     3556788999999999999999999976432             


Q ss_pred             -hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1015 -CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1015 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                       ...++.........    ....+.      .........++.+++.+||+.||++||+++||++.|+++.+
T Consensus       257 ~~~~~~~~~~~~~~~----~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          257 PSLEDMQEVVVHKKK----RPVLRD------YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CCHHHHHHHHTTSCC----CCCCCG------GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccC----CCCccc------cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             11111111110000    000000      00123456779999999999999999999999999998854

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.8e-40  Score=361.70  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||+||+|.+++++.||||++.... ...+++.+|++++.+    ++||||+++++++.++...++|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMN----LSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHT----CCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhc----CCCCCEeeEEEEEecCCCeEEE
Confidence            35788899999999999999999888899999998653 345678999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++|+|.+++.. ..++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999976 55799999999999999999999999   99999999999999999999999999998664332


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      ........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||........  .........             
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~~~~-------------  239 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQGLR-------------  239 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHTTCC-------------
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHHhcccC-------------
Confidence            222334456788999999988899999999999999999998 9999987654211  111110000             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                         ...+......+.+++.+|++.||++||+++|+++.|+++++
T Consensus       240 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence               00112223578889999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-38  Score=358.50  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=214.7

Q ss_pred             CCccCHHHHHHHcCC----------CCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC
Q 001384          792 KTAFTYSDILKATGK----------FSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF  860 (1088)
Q Consensus       792 ~~~~~~~~~~~~~~~----------~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~  860 (1088)
                      ...++++++..+++.          |+..+.||+|+||.||+|+++ +|+.||||++........+.+.+|+.++++   
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~---   98 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD---   98 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT---
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh---
Confidence            345778887777653          667789999999999999986 799999999987665666788999999986   


Q ss_pred             CCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001384          861 GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVL  940 (1088)
Q Consensus       861 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIl  940 (1088)
                       ++||||+++++++...+..++||||+++|+|.++++. .++++.+++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        99 -l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A           99 -YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             -CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             -CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence             6799999999999999999999999999999999865 4699999999999999999999999   9999999999999


Q ss_pred             EcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          941 LDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       941 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                      ++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.......  ..
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~  250 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AM  250 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH
T ss_pred             ECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence            9999999999999998765432 22345679999999999999899999999999999999999999998754421  11


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........ ..             ..........+.+++.+|++.||++||+++|+++
T Consensus       251 ~~~~~~~~-~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 KRLRDSPP-PK-------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHSSC-CC-------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCC-CC-------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110000 00             0011223356888999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-40  Score=366.91  Aligned_cols=272  Identities=25%  Similarity=0.362  Sum_probs=210.0

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      ++|++.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++.+    ++||||+++++++...  
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEECHHHH
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEecCCC
Confidence            5789999999999999999983     2688999999987655555788999999997    6799999999998653  


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++||||+++|+|.+++.... ++++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            56899999999999999997754 599999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC-CCc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG-PGR 1033 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 1033 (1088)
                      ........  ......++..|+|||.+.+..++.++||||+|+++|||++|..|+..........   ........ ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~  239 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM---IGNDKQGQMIVF  239 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH---HCTTCCTHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh---hcCccccchhHH
Confidence            76543221  2233457788999999988899999999999999999999999987542211111   10000000 000


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ............+.+...+.++.+++.+|++.||++||+++|+++.|+++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            01111111222223444557889999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.7e-39  Score=359.26  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~~  879 (1088)
                      .++|++.+.||+|+||+||+|++ +++.||||++...   ....+..|.+++....  ++||||+++++++..    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~--l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVM--LRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTC--CCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhh--ccCcCeeeEEEeeccccCCCce
Confidence            45799999999999999999998 6899999998754   3455666777666543  689999999998654    346


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH--------HECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                      .++||||+++|+|.++++. ..+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            8999999999999999965 46999999999999999999999        76   999999999999999999999999


Q ss_pred             cccceeecCCCCcc---cccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhC----------CcCCCCC
Q 001384          952 FGLARVVSAGDSHV---STTIAGTVGYVAPEYGQTW------QATTKGDVYSFGVLAMELATG----------RRALEGG 1012 (1088)
Q Consensus       952 fg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg----------~~p~~~~ 1012 (1088)
                      ||+++.........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99998765433222   2334799999999988776      455799999999999999999          8888654


Q ss_pred             ch---hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1013 EE---CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1013 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      ..   ..............    ....+.      ..........+.+++.+|++.||++||+++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~----~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQQ----RPNIPN------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSCC----CCCCCG------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcchhhhhHHHhccCC----CCCCCh------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22   11122111110000    000000      001345678899999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-39  Score=374.69  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.+.||+|+||.||+|+++    ++..||||+++.... ...+++.+|++++.+    ++||||+++++++.++..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ----FDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECSSSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEeeCCc
Confidence            47999999999999999999965    567899999986532 334578999999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++|+|.++++... .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999998754 699999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .......  .....++..|+|||++.+..++.++||||||+++|||++ |+.||........  .......         
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~i~~~---------  266 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKAVDEG---------  266 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHHHHTT---------
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC---------
Confidence            5432211  122345778999999998899999999999999999998 9999987544211  1111100         


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                             ...+.+...+..+.+++.+|++.||++||++.||++.|+++++.
T Consensus       267 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 -------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                   00011223446788999999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=367.99  Aligned_cols=249  Identities=27%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.+..   ....+.+..|.+++....   +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~---~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR---NHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc---CCCceeeEEEEEEeCCE
Confidence            468999999999999999999976 68999999998642   223356778888887632   79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||+++|+|.++++....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++...
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999999999888999999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      . ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ....+.....           
T Consensus       176 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~~~~-----------  241 (353)
T 3txo_A          176 C-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAILNDEV-----------  241 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC-----------
T ss_pred             c-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC-----------
Confidence            2 2223445689999999999998899999999999999999999999998765421  1222221000           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH------HHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV------KEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~ 1078 (1088)
                            ..+......+.+++.+|++.||++||++      +|+++
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  0111233567889999999999999998      66654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-39  Score=383.55  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=212.4

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++    ++||||+++++++. ....++|
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKT----LQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTT----CCCTTBCCEEEEEC-SSSCEEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhh----CCCCCEeeEEEEEe-CCccEEE
Confidence            45788899999999999999999888999999998653 456789999999987    67999999999986 5678999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.++++..  ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999999754  3689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........++..|+|||++....++.++||||||+++|||++ |+.||.+......  ......               
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~---------------  400 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALER---------------  400 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHHHH---------------
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc---------------
Confidence            2222233456789999999988899999999999999999999 9999987543211  111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       +...+.+..++.++.+++.+|++.||++||++++|++.|+++...
T Consensus       401 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          401 -GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence             001111233456788999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-39  Score=374.50  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=210.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|+++ +++.||||+++..... ....+.+|++++++    ++||||+++++++..++..+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ----YSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTT----CCCTTBCCEEEEECSSSSCE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHh----CCCCCEEEEEEEEecCCCcE
Confidence            356888999999999999999986 7899999999865322 23468889999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++|+|.++++... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999999997654 699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCccc-ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH-HHHHHhhhccCCCCCCccccc
Q 001384          961 GDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL-VEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       961 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ...... ....++..|+|||.+....++.++||||||+++|||++ |+.||.+..... .+.....              
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~--------------  331 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------------  331 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT--------------
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------
Confidence            221111 12345778999999988899999999999999999998 999998764421 1111110              


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                           ...+.+..++.++.+++.+||+.||++||++++|++.|+++.+
T Consensus       332 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          332 -----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                 0111122344678899999999999999999999999998853

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=358.59  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=207.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++......      ..+.+.+|++++..    ++||||+++++++.++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE----IQHPNVITLHEVYENK   86 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHH----CCCTTBCCEEEEEECS
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHh----CCCCCCCcEEEEEEeC
Confidence            46899999999999999999976 6899999999765322      35678999999997    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeecc
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDFG  953 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Dfg  953 (1088)
                      ...++||||+++|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999999998888899999999999999999999999   999999999999999887    89999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      +++......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..............+.      
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------  235 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE------  235 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC------
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC------
Confidence            998765332  233457999999999999889999999999999999999999999875442111111111000      


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .+...       .......+.+++.+|++.||++||++.|+++
T Consensus       236 --~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 --FEDEY-------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --CCHHH-------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --cCccc-------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00000       1122356788999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=358.17  Aligned_cols=250  Identities=22%  Similarity=0.266  Sum_probs=207.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|++++..    ++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNI----ARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHH----SCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHh----CCCCCCCeEeEEEecCCEEEE
Confidence            468999999999999999999976 6889999998754 2344568899999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--CCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK--EGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~--~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++|+|.+++.... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||+++...
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            999999999999997654 699999999999999999999999   9999999999999997  7899999999998875


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...  ......||+.|+|||++.+..++.++||||+|+++|+|++|..||.+.....  ...........      .+..
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~------~~~~  225 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMNAEYT------FDEE  225 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCCC------CCHH
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHHHcCCCC------CChh
Confidence            432  2345678999999999998889999999999999999999999998764421  11111110000      0000


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             .....+.++.+++.+|++.||++||++.|+++
T Consensus       226 -------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 -------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   01122457889999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-39  Score=367.47  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=212.3

Q ss_pred             HcCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ..++|++.+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|++++++    ++||||+++++++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE----FDNPNIVKLLGVCA  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEC
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHh----CCCCCEEEEEEEEc
Confidence            4578999999999999999999974      347899999986532 234678999999997    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR------------------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVH  931 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  931 (1088)
                      +++..++||||+++|+|.++++..                        ..+++.+++.++.||+.||+|||++   +|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            999999999999999999999763                        4689999999999999999999999   9999


Q ss_pred             cCCCCCCEEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCC
Q 001384          932 RDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRAL 1009 (1088)
Q Consensus       932 ~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~ 1009 (1088)
                      |||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999986543222 12334567889999999888899999999999999999999 99999


Q ss_pred             CCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1010 EGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                      .+......  ........                ....+...+.++.+++.+|++.||++||++.|+++.|+++.+.+
T Consensus       278 ~~~~~~~~--~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          278 YGMAHEEV--IYYVRDGN----------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTSCHHHH--HHHHHTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCChHHH--HHHHhCCC----------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            87544211  11111000                00112233457889999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.8e-39  Score=369.73  Aligned_cols=245  Identities=24%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.++||+|+||+||+|+++ +++.||+|++++.....   ...+..|..++.+.   .+||||+++++++.++...
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~---~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHH---TTCTTBCCEEEEEECSSEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhc---CCCCCcCeeEEEEEECCEE
Confidence            46899999999999999999976 57899999998653222   23577888888753   3799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++++...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999999999888999999999999999999999999   999999999999999999999999999986332


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh------HHH-HHHhhhccCCCCCCc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC------LVE-WGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~------~~~-~~~~~~~~~~~~~~~ 1033 (1088)
                      . .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......      ..+ ....+.         
T Consensus       206 ~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~---------  275 (396)
T 4dc2_A          206 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------  275 (396)
T ss_dssp             T-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH---------
T ss_pred             C-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh---------
Confidence            2 22345578999999999999999999999999999999999999999743210      011 111111         


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                              ......+.....++.+++.+|++.||++||++
T Consensus       276 --------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          276 --------EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --------HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --------ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                    01111122334578889999999999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-39  Score=356.58  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .++|++.+.||+|+||.||+|++..    +..||+|++..... ...+.+.+|+.++++    ++||||+++++++. ++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ----FDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEC-SS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCccceEEEEEc-cC
Confidence            3578999999999999999999743    45799999876432 234578899999987    67999999999984 56


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.++++... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            7889999999999999997654 699999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .............+++.|+|||.+....++.++||||+|+++|||++ |..||.+......  ......           
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~i~~-----------  232 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIEN-----------  232 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHT-----------
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHHHHc-----------
Confidence            65443333344567789999999988899999999999999999997 9999987543211  111110           


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                           +.....+...+..+.+++.+|++.||++||++.|+++.|+++++
T Consensus       233 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          233 -----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 00011122344678889999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-39  Score=361.37  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=204.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++.+..   ......+.+|+++++.    ++||||+++++++.++..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL----LRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTT----CCCTTBCCEEEEEECSSE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHh----CCCCCCCeEEEEEEeCCE
Confidence            468999999999999999999974 78999999987542   2234578899999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+ +|+|.+++....++++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999999 679999998888999999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ..  .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+....               .....+  
T Consensus       160 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------------~~~~~i--  220 (336)
T 3h4j_B          160 DG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---------------NLFKKV--  220 (336)
T ss_dssp             TS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST---------------TCBCCC--
T ss_pred             CC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH---------------HHHHHH--
Confidence            32  22345679999999999988776 78999999999999999999999764220               000000  


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .......+......+.+++.+|++.||.+|||++|+++
T Consensus       221 --~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          221 --NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              00011112233457888999999999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=356.20  Aligned_cols=244  Identities=28%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|++.+..   ....+.+.+|..+++.    ++||||+++++++.+....
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI----VTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----CCBTTBCCEEEEEECSSEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhh----CCCCCCceEeEEEEeCCEE
Confidence            46889999999999999999976 68999999997642   2334567889999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.++++....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                          ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +....+.....            
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~------------  220 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNAEL------------  220 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHCCC------------
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC------------
Confidence                233467999999999999999999999999999999999999999875432  11122221000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                           ..+.....++.+++.+|++.||++||     +++|+++
T Consensus       221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 00112335688899999999999999     8888873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=369.75  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=206.7

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++......  ..+.+.+|+++++.    ++||||+++++++.+++.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL----LKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHH----CCBTTBCCEEEEEECSSE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh----CCCcCCCeEEEEEEECCE
Confidence            4567999999999999999999975 7899999999765432  23568899999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCCEEEeecccce
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLAR  956 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~---~~~~~kl~Dfg~a~  956 (1088)
                      .|+||||+++|+|.+++.....+++.++..++.||+.||+|||++   +|+||||||+||+++   .++.+||+|||+++
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999999999988999999999999999999999999   999999999999998   46789999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+......  ............     
T Consensus       162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~~~~~~-----  233 (444)
T 3soa_A          162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQQIKAGAYDFP-----  233 (444)
T ss_dssp             CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHTCCCCC-----
T ss_pred             EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHhCCCCCC-----
Confidence            765332 223456799999999999998999999999999999999999999987654221  111110000000     


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .        +.......++.+++.+|++.||++||++.|+++
T Consensus       234 ~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 S--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0        001122356888999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-38  Score=362.82  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|++......  ..+.+.+|+++++.    ++||||+++++++.+++.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK----LQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEEeCCE
Confidence            3467999999999999999999976 6899999999765332  33568899999997    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---CEEEeecccce
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---KALVTDFGLAR  956 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~~kl~Dfg~a~  956 (1088)
                      .|+||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .+||+|||+++
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999999998888899999999999999999999999   999999999999998654   59999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.....  ....+........ .   
T Consensus       180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~~~~~~-~---  251 (362)
T 2bdw_A          180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAGAYDYP-S---  251 (362)
T ss_dssp             CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTCCCCC-T---
T ss_pred             EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCCCCCC-c---
Confidence            765322  2344679999999999999899999999999999999999999998764421  1111110000000 0   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               ........++.+++.+|++.||++||++.|+++
T Consensus       252 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          252 ---------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ---------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                     001123456888999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.2e-39  Score=360.85  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+++.    ++||||+++++++.+++..+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----LNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHH----CCCTTBCCEEEEEECSSEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHh----CCCCCCCeEEEEEecCCeEE
Confidence            368999999999999999999976 789999999875432 233568899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.++++....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CC-cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DS-HVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.........+..........          
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------  228 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----------  228 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS----------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC----------
Confidence            22 22345679999999999877665 7899999999999999999999987654323222222110000          


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .........+.+++.+|++.||++||+++|+++
T Consensus       229 ------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  001223356788999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-39  Score=353.43  Aligned_cols=255  Identities=29%  Similarity=0.435  Sum_probs=211.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++    ++||||+++++++.+++..++||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMK----LSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHT----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHh----CCCCCEeeEEEEEccCCCeEEEE
Confidence            4688899999999999999999888999999998763 345678999999997    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++++|.++++.. ..+++.+++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||.++.......
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999765 4689999999999999999999999   999999999999999999999999999986543222


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .......++..|+|||...+..++.++||||+|+++|+|++ |+.||.......  ..........              
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~--------------  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR--------------  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC--------------
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCc--------------
Confidence            22233456788999999988899999999999999999999 899998754321  1111110000              


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                        ...+......+.+++.+|++.||++||+++|+++.|+++.+
T Consensus       224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              00112234568889999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.8e-39  Score=363.08  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=196.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeCC-C---cEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLPD-G---REVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      ..++|++.+.||+|+||.||+|++.. +   ..||||++....  ....+.+.+|++++++    ++||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE----FDHPHVAKLVGVSLR   96 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTT----CCCTTBCCCCEEEEC
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHH----CCCCceehhhceeec
Confidence            35689999999999999999999763 3   279999998653  2334678999999987    679999999999987


Q ss_pred             CCeE------EEEEEecCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          877 GSEK------ILVYEYMEGGSLEDIISDRT------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       877 ~~~~------~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ....      ++||||+++|+|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence            7655      99999999999999996533      589999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHh
Q 001384          945 GKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRR 1022 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1088)
                      +.+||+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.+......  ...
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~  251 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNY  251 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHH
Confidence            99999999999876543322 2233456789999999998899999999999999999999 9999987544211  111


Q ss_pred             hhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                      ...                +.....+...+..+.+++.+|++.||++||++.|+++.|++++++.
T Consensus       252 ~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 LIG----------------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHT----------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             Hhc----------------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            110                0011112233467889999999999999999999999999998653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.1e-39  Score=383.17  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=214.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..+|++.+.||+|+||.||+|+++ ++..||||+++... ...+++.+|++++++    ++||||+++++++..+...++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKE----IKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHh----cCCCCEeeEEEEEecCCcEEE
Confidence            346888899999999999999987 48899999998653 345789999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.++++..  ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999764  4589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCccccch
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ..........++..|+|||++....++.++|||||||++|||++ |+.||.+.... ..+....                
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~----------------  434 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------------  434 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----------------
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------------
Confidence            33333334456789999999988899999999999999999999 99999875432 1111111                


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                         +.....+..++..+.+++.+||+.||++||+++||++.|++++..
T Consensus       435 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          435 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence               001111233456788999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-38  Score=375.91  Aligned_cols=251  Identities=32%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-eEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-EKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.++ ++.||||+++...  ..+.+.+|++++++    ++||||+++++++.... ..++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQ----LRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHT----CCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHh----ccCCCEEEEEEEEEcCCCceEE
Confidence            356888999999999999999985 7899999998753  45689999999997    67999999999987665 7899


Q ss_pred             EEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.++++....  +++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999987543  79999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+......  .....               
T Consensus       342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~---------------  400 (450)
T 1k9a_A          342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVE---------------  400 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHH---------------
T ss_pred             c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHH---------------
Confidence            1    122357889999999999999999999999999999998 9999986533111  11111               


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       .+.....+..++..+.+++.+||+.||++||++.++++.|+++..+
T Consensus       401 -~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          401 -KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence             1111122334456788999999999999999999999999998643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.8e-39  Score=363.02  Aligned_cols=249  Identities=28%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ..++|++.+.||+|+||.||+|+++ +|+.||||++++..   ......+..|.+++...   .+||||+++++++.+..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~---~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---WEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH---TTCTTBCCEEEEEECSS
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc---CCCCCCCcEEEEEEeCC
Confidence            4578999999999999999999976 68999999997642   22345677888888752   37999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..|+||||+++|+|.++++....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999999999888899999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      .... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+......  ...+.....          
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~~~~----------  235 (345)
T 1xjd_A          169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMDNP----------  235 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC----------
T ss_pred             ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHhCCC----------
Confidence            3222 234456899999999999998999999999999999999999999987654221  111110000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVK-EVL 1077 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1077 (1088)
                             ..+.....++.+++.+|++.||++||++. ||+
T Consensus       236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                   00112335688899999999999999997 554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-39  Score=359.78  Aligned_cols=258  Identities=27%  Similarity=0.405  Sum_probs=211.7

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++..... ...+.+.+|+++++.    ++||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ----VNHPHVIKLYGACSQ   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhh----CCCCceeeEEEEEec
Confidence            45789999999999999999986      2457899999986532 234678899999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTR------------------------LTWRRRLDIAIDVARALVFLHHECYPPIVHR  932 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~  932 (1088)
                      ++..++||||+++|+|.+++.....                        +++.+++.++.|++.||+|||++   +|+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999986543                        89999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCC
Q 001384          933 DVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALE 1010 (1088)
Q Consensus       933 DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~ 1010 (1088)
                      ||||+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876543322 2234457789999999988889999999999999999999 999998


Q ss_pred             CCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1011 GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      +.......  .......                ....+...+..+.+++.+|++.||++||+++|+++.|++++..
T Consensus       255 ~~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          255 GIPPERLF--NLLKTGH----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             TCCGGGHH--HHHHTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCHHHHH--HHhhcCC----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            75432111  1111000                0111223346788999999999999999999999999998653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-39  Score=370.57  Aligned_cols=267  Identities=25%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             CHHHHHHHcCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCcee
Q 001384          796 TYSDILKATGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       796 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      ...+.....++|++.+.||+|+||.||+|++      .+++.||||++...... ..+.+.+|++++.++.   +||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hpniv   89 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---HHLNVV   89 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc---CCccee
Confidence            3444445567899999999999999999983      24678999999865333 3357899999998742   799999


Q ss_pred             EEeeEEecCC-eEEEEEEecCCCCHHHHHhhcCC----------------------------------------------
Q 001384          869 TLYGWCLDGS-EKILVYEYMEGGSLEDIISDRTR----------------------------------------------  901 (1088)
Q Consensus       869 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------  901 (1088)
                      ++++++.+.+ ..++||||+++|+|.++++....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999988755 48999999999999999976543                                              


Q ss_pred             --------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          902 --------------------LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       902 --------------------l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                                          +++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                                89999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.............  ..           
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--~~-----------  313 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GT-----------  313 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH--TC-----------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc--CC-----------
Confidence            22 23345678899999999988899999999999999999998 99999875432211111111  00           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                          ....+.....++.+++.+|++.||++||+++|+++.|+++++
T Consensus       314 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          314 ----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                001112233568889999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-38  Score=362.02  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=207.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++..........+.+|++++..    ++||||+++++++.++...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ----LHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTT----CCSTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHh----CCCcCCCeEEEEEEeCCEEEE
Confidence            357999999999999999999976 688999999987655556678999999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--CCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK--EGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~--~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++|+|.+++.... .+++.+++.++.||+.||+|||++   +|+||||||+||+++.  ++.+||+|||+++...
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            999999999999997654 699999999999999999999999   9999999999999974  4789999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ............      +. 
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~~~~~~~------~~-  271 (387)
T 1kob_A          203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRCDWEF------DE-  271 (387)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHCCCCC------CS-
T ss_pred             CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCCC------Cc-
Confidence            432  2334578999999999999899999999999999999999999998765421  111111100000      00 


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ........++.+++.+|++.||++||+++|+++
T Consensus       272 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 ------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  001123457888999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=370.21  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=210.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++|++.+.||+|+||+||+|++.        .+..||||++...... ....+.+|++++.++.   +||||+++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG---KHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc---CCchhhhheeee
Confidence            457899999999999999999852        2357999999865332 2357889999998732   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                      ..++..++||||+++|+|.++++...                .+++.+++.++.|++.||+|||++   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            99999999999999999999997653                489999999999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987654332 22334567889999999999999999999999999999999 99999875432 


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                       +..........                ...+.....++.+++.+|++.||++||+++||++.|++++
T Consensus       301 -~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          301 -ELFKLLKEGHR----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             -HHHHHHHTTCC----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHcCCC----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             11111111000                0112223457889999999999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-38  Score=351.88  Aligned_cols=262  Identities=22%  Similarity=0.299  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+.++.+    ++||||+++++++..++.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR----LQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEETTE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhh----cCCCCeeEEEEEEeeCCe
Confidence            478999999999999999999976 68899999997653322   3678899999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.++++...++++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...........+++.|+|||.+.+..++.++||||||+++|||++|+.||.+.......  .... ..  .....     
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~--~~~~~-----  255 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG--AHIN-QA--IPRPS-----  255 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH--HHHH-SC--CCCGG-----
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH--HHhc-cC--CCCcc-----
Confidence            43333344567899999999999989999999999999999999999999876442111  1111 00  00000     


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHHhhCCCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKILPHCD 1088 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~i~~~~~ 1088 (1088)
                            ..+...+.++.+++.+|++.||++|| +++++++.|++++..++
T Consensus       256 ------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          256 ------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             ------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                  01122335688899999999999999 99999999999987653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.8e-39  Score=357.24  Aligned_cols=271  Identities=23%  Similarity=0.358  Sum_probs=209.5

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-  877 (1088)
                      .+|++.+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|++++..    ++||||+++++++... 
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN----LYHENIVKYKGICTEDG   96 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHT----CCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHh----CCCCCeeeeeeEEecCC
Confidence            3588899999999999999983     368899999998543 2334678999999997    6799999999999876 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 -SEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                       ...++||||+++|+|.++++. ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence             668999999999999999954 45799999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDS--HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ........  .......+|..|+|||.+.+..++.++||||+|+++|+|++|+.|+........   .............
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~  250 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL---KMIGPTHGQMTVT  250 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HHHCSCCGGGHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh---hccCCcccccCHH
Confidence            88754432  123345678889999999888999999999999999999999998754311111   1000000000000


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ........+.....+...+..+.+++.+|++.||.+||+++|+++.|+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            1111111111222233445678899999999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.4e-39  Score=378.27  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=206.6

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.++.+..||||+++... ...+.+.+|++++++    ++||||+++++++.+ ...++|
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK----LRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECS-SSCEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHh----CCCCCEeeEEEEEcC-CceEEE
Confidence            35688899999999999999999888889999998654 345689999999997    679999999999876 678999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.++++..  ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999753  4699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........++..|+|||.+....++.++||||||+++|||++ |+.||.+.....  .......               
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~---------------  396 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER---------------  396 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT---------------
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---------------
Confidence            3333334557789999999988899999999999999999999 999998754321  1111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       +...+.+..++..+.+++.+|++.||++||+++++++.|+++...
T Consensus       397 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence             011111233456788999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=363.17  Aligned_cols=248  Identities=26%  Similarity=0.348  Sum_probs=204.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||+|++.+..   ....+.+.+|++++..    ++||||+++++++.+....
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~----l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG----LEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEeCCEE
Confidence            46899999999999999999976 68899999997542   2234678899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.++++....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCcccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .  .......||+.|+|||++..   ..++.++||||+||++|||++|+.||..... ...+.........         
T Consensus       168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------  236 (384)
T 4fr4_A          168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV---------  236 (384)
T ss_dssp             T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------
T ss_pred             C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------
Confidence            2  23455689999999998863   4589999999999999999999999975433 1122212111000         


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-VKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 1078 (1088)
                              ...+......+.+++.+|++.||.+||+ ++++.+
T Consensus       237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    0112223467889999999999999998 666653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-38  Score=359.00  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=206.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++.+..   ....+.+.+|++++..    ++||||+++++++.+....
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA----VNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEEcCCEE
Confidence            46889999999999999999976 68999999997642   2334678889999986    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++.+..++++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +....+.....            
T Consensus       194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~------------  255 (350)
T 1rdq_E          194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVSGKV------------  255 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------------
T ss_pred             C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHHHHHcCCC------------
Confidence            2    23467999999999999989999999999999999999999999875442  12222211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                           ..+......+.+++.+|++.||++||+     ++||++
T Consensus       256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 011223456888999999999999998     787764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.3e-38  Score=359.92  Aligned_cols=248  Identities=27%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||+||+|+.+ +++.||||++.+..   ....+.+..|..++....   +||||+++++++.+.+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~---~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG---KPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT---CCTTBCCEEEEEECSSE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC---CCCEEeeEEEEEEcCCE
Confidence            467999999999999999999986 47899999998642   233456788999987632   79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||++||+|.++++..+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +....+.....           
T Consensus       173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~~~-----------  238 (353)
T 2i0e_A          173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEHNV-----------  238 (353)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-----------
T ss_pred             cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHHHhCCC-----------
Confidence            22 22344568999999999999999999999999999999999999999875442  22222221100           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVL 1077 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil 1077 (1088)
                            ..+.....++.+++.+|++.||++||+     ++||+
T Consensus       239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                  011223457888999999999999995     46665

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8e-39  Score=353.20  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=211.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|++++++    ++||||+++++++.+ +..++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~-~~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ----LQHQRLVRLYAVVTQ-EPIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHh----CCCcCcceEEEEEcC-CCcEEE
Confidence            35788999999999999999998888899999997653 345678999999997    679999999999864 568999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++++|.+++....  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999997643  699999999999999999999999   9999999999999999999999999999887544


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........++..|+|||.+.+..++.++||||+|+++|||++ |+.||.+.....  .........             
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~-------------  227 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY-------------  227 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC-------------
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhccc-------------
Confidence            3333344557789999999988889999999999999999999 999998754321  111111000             


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                         ....+...+..+.+++.+|++.||++||+++++++.|++++..
T Consensus       228 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence               0011222345788999999999999999999999999988643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-38  Score=372.02  Aligned_cols=261  Identities=22%  Similarity=0.264  Sum_probs=209.2

Q ss_pred             HHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          797 YSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      +.++....++|++.++||+|+||+||+|+++ +++.||+|++.+....   ....+.+|..++..    ++||||+++++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~----~~hp~Iv~l~~  141 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----GDSKWITTLHY  141 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHH----SCTTTBCCEEE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHh----CCCCCEEEEEE
Confidence            3444445678999999999999999999986 5789999999763211   22347889999886    67999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          873 WCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                      ++.+++..|+||||+++|+|.+++++ ...+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            99999999999999999999999987 56799999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      ||+++.............+||+.|+|||++.     ...++.++||||+||++|||++|+.||.+......  ...+...
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~  296 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKIMNH  296 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTH
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HHhhhhc
Confidence            9999877654444445578999999999876     56789999999999999999999999987644211  1111100


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~ 1078 (1088)
                      ....    ..+.        .......++.+++.+|+..+|++  ||+++|+++
T Consensus       297 ~~~~----~~p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 KERF----QFPT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHC----CCCS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cccc----cCCc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0000    0000        01112356788899999888888  999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-38  Score=346.07  Aligned_cols=252  Identities=28%  Similarity=0.472  Sum_probs=204.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccch-------HHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGE-------REFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++........       +.+.+|++++++    ++||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN----LNHPNIVKLYGLMH   93 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTT----CCCTTBCCEEEEET
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHh----CCCCCchhhheeec
Confidence            367999999999999999999975 789999999976433221       678899999987    67999999999987


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCC-----E
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDKEGK-----A  947 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~~~~-----~  947 (1088)
                      +..  ++||||+++|+|.+++... ..+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.     +
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence            655  6999999999999888654 4699999999999999999999999   8  999999999999988876     9


Q ss_pred             EEeecccceeecCCCCcccccccccccccCcccc--CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhc
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG--QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      ||+|||+++....    ......||+.|+|||.+  ....++.++||||+|+++|||++|+.||.........+......
T Consensus       169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            9999999975432    23446789999999988  45567899999999999999999999998765433332222221


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      .....               ..+...+.++.+++.+|++.||++||+++|+++.|+++
T Consensus       245 ~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 EGLRP---------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SCCCC---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cCCCC---------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11100               11223346788999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=362.97  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++....  ..+.+.+|++++.+    ++||||+++++++.++...+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLR----LSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHH----CCCTTBCCEEEEEECSSEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHh----CCCCCCcceeeeEecCCeEE
Confidence            4568999999999999999999986 57899999998652  34568889999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeecccceee
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDFGLARVV  958 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Dfg~a~~~  958 (1088)
                      +||||+++|+|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++..
T Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999999999888899999999999999999999999   9999999999999975   889999999999875


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.. ......     .... 
T Consensus       202 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-i~~~~~-----~~~~-  272 (349)
T 2w4o_A          202 EHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-ILNCEY-----YFIS-  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-HHTTCC-----CCCT-
T ss_pred             Ccc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-HHhCCC-----ccCC-
Confidence            432  2234467899999999999989999999999999999999999999765442222211 111000     0000 


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             +.......++.+++.+|++.||++||++.|+++
T Consensus       273 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 -------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   001223457888999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.5e-38  Score=348.36  Aligned_cols=265  Identities=22%  Similarity=0.263  Sum_probs=201.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|+++ +++.||||++......  ....+.+|++++++    ++||||+++++++.++...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----LKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTT----CCCTTBCCEEEEEEETTEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhc----CCCCCEeeEEeEEEeCCEEE
Confidence            57899999999999999999976 6899999999765332  23678899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDII-SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++ ++.+.+ .....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        78 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            99999987 555554 4467899999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH--hhhccCCCCCCc--cc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR--RVMGYGRHGPGR--AV 1035 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~--~~ 1035 (1088)
                      .. .......+|+.|+|||++.+.. ++.++||||+||++|||++|+.||............  ............  ..
T Consensus       154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          154 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             cc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence            22 2234457899999999887655 899999999999999999999986554332211111  111100000000  00


Q ss_pred             cchh-------hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVV-------LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+..       ..............++.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000       000000112234467788999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=370.45  Aligned_cols=257  Identities=28%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||+||+|++.      +++.||||++.... .....++.+|+.++.+    ++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK----FNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHh----CCCCCCCeEEEEEec
Confidence            357889999999999999999943      46789999997543 2334578899999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---C
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT-------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---K  946 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~  946 (1088)
                      +...++||||+++|+|.++++...       .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999997643       489999999999999999999999   999999999999999555   5


Q ss_pred             EEEeecccceeecCCC-CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhh
Q 001384          947 ALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      +||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||........  .....
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~i~  300 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEFVT  300 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHH
Confidence            9999999997653222 222334567899999999988899999999999999999998 9999987654221  11111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....                ...+...+..+.+++.+|++.||++||+++||++.|+.+..
T Consensus       301 ~~~~----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 SGGR----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TTCC----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC----------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            1000                01122334568899999999999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-38  Score=368.67  Aligned_cols=256  Identities=23%  Similarity=0.285  Sum_probs=206.5

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      +....++|++.+.||+|+||+||+|+++ +++.||+|++.+...   .....+.+|+.++..    ++||||+++++++.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~----l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----ANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHH----CCCTTBCCEEEEEE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHh----CCCCCCCeEEEEEE
Confidence            3344578999999999999999999976 588999999976321   223457889999986    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      ++...|+||||++||+|.++++.. .+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||++
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999999999764 689999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ----ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      +.............+||+.|+|||++....    ++.++||||+||++|||++|+.||.+....  +....+....... 
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~-  292 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNSL-  292 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHC-
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhccccc-
Confidence            887654433445678999999999887655    789999999999999999999999876442  1111111000000 


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNA--RPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~ 1078 (1088)
                         ..         +.......++.+++.+|++.+|.+  ||+++||++
T Consensus       293 ---~~---------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          293 ---TF---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ---CC---------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ---cC---------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence               00         001112356788899999999988  999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-38  Score=352.60  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=201.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|++.+|+.||+|++......  ....+.+|++++++    ++||||+++++++.++...+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE----LHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHH----CCCTTBCCEEEEECCSSCEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHH----cCCCCEeeeeeEEccCCEEE
Confidence            4689999999999999999999988999999999764322  23578899999997    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++ +|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999985 888887654 4599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccc-
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIP- 1037 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~- 1037 (1088)
                      .. .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..+ ......................+ 
T Consensus       172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            22 22334578999999998765 5789999999999999999999999987544 12111111111111000000000 


Q ss_pred             -hhh-------cCC-CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 -VVL-------LGS-GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 -~~~-------~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...       ... ..........++.+++.+|++.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             000       000 00001122357889999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.8e-39  Score=356.12  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=214.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|++.... ...+.+.+|++++++    ++||||+++++++.++...+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKE----IKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHh----CCCCCEeeEEEEEccCCCEE
Confidence            3467889999999999999999986 48899999997653 345678899999997    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          882 LVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      +||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999864  3599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCccccc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ...........+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..+......             
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-------------  229 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------  229 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------------
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-------------
Confidence            444444445567889999999988899999999999999999999 99999875432 111111110             


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                            ....+...+..+.+++.+|++.||.+||+++|+++.|++++.
T Consensus       230 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                  011122334678899999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-38  Score=347.08  Aligned_cols=253  Identities=32%  Similarity=0.527  Sum_probs=196.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc----chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE----GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|.+. ++.||||++......    ..+.+.+|+++++.    ++||||+++++++.+++..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM----LKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHH----CCCTTBCCEEEEECCC--C
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHh----cCCCCEeeEEEEEecCCce
Confidence            57889999999999999999985 889999999764322    23578899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--------CCCEEEeec
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK--------EGKALVTDF  952 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~--------~~~~kl~Df  952 (1088)
                      ++||||+++++|.++++. .++++.+++.++.|++.||+|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999999864 47999999999999999999999992222999999999999986        778999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |.++......   .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.......+........     
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  232 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-----  232 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC-----
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC-----
Confidence            9998654322   22456899999999998889999999999999999999999999876553332222211000     


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                                  ...+...+..+.+++.+|++.||++||+++|+++.|+++
T Consensus       233 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 ------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                        001222345788999999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-38  Score=352.27  Aligned_cols=261  Identities=20%  Similarity=0.290  Sum_probs=209.6

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++ .+++.||||++....  ....+.+|++++..+.   +|+|++++++++.++...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~---~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA---GCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT---TCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHh---cCCCCCeEEeecCCCceeEE
Confidence            46799999999999999999996 478999999987542  3345778888888743   79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-----EEEeecccce
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----ALVTDFGLAR  956 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-----~kl~Dfg~a~  956 (1088)
                      ||||+ +++|.++++... ++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+++
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999 899999998754 599999999999999999999999   9999999999999987776     9999999998


Q ss_pred             eecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCC
Q 001384          957 VVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRH 1029 (1088)
Q Consensus       957 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 1029 (1088)
                      ........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.... ..+...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            77543221      234567999999999999999999999999999999999999999875321 11111111000000


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..    .+ .       .....+..+.+++.+|++.||++||++++|++.|+++++
T Consensus       240 ~~----~~-~-------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          240 TP----LR-E-------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             SC----HH-H-------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cc----HH-H-------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00    00 0       011234678899999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-38  Score=359.58  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=200.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++.+.....   .+.+..|..++.+.   .+||||+++++++.++...
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~---~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHT---TTCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhc---CCCCccCeEEEEEEeCCEE
Confidence            46889999999999999999976 68899999998653322   34577889888763   2799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++.....+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++....
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-------hHHHHHHhhhccCCCCCCc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-------CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      . ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ........+..        
T Consensus       163 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--------  233 (345)
T 3a8x_A          163 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------  233 (345)
T ss_dssp             T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--------
T ss_pred             C-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--------
Confidence            2 2234456899999999999998999999999999999999999999975311       00011111110        


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                               .....+.....++.+++.+|++.||++||++
T Consensus       234 ---------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          234 ---------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                     0001122234578889999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.6e-38  Score=358.48  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=195.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.... ...+.+.+|+.+++.    ++||||+++++++.++...++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRS----LRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHh----CCCCCCCcEEEEEeeCCEEEE
Confidence            468999999999999999999986 78999999997653 334678899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC--EEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK--ALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~--~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.+++....++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++....
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999999998888899999999999999999999999   9999999999999987765  99999999975332


Q ss_pred             CCCcccccccccccccCccccCCCCCCcc-hhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCccccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTK-GDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      .  .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+...  ................+      
T Consensus       171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------  242 (361)
T 3uc3_A          171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP------  242 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC------
T ss_pred             c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC------
Confidence            2  22334579999999999888777665 8999999999999999999986533  12222222221111000      


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               ........+.+++.+|++.||++||++.|+++
T Consensus       243 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 ---------DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                     01112356788999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.6e-38  Score=359.30  Aligned_cols=272  Identities=25%  Similarity=0.333  Sum_probs=213.7

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe--cC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL--DG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~--~~  877 (1088)
                      ++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++    ++||||+++++++.  +.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA----LHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHh----cCCCceeEEEEEEecCCC
Confidence            5788999999999999999983     3688999999987765566779999999997    68999999999887  45


Q ss_pred             CeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++||||+++++|.++++. ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence            678999999999999999976 45699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........  ......+|..|+|||++.+..++.++||||+|+++|+|++|+.||..........   ............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~~~  252 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM---MGCERDVPALSR  252 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---CC----CCHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh---cccccccccHHH
Confidence            77543322  2234567888999999988889999999999999999999999997643211111   000000000011


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .......+.....+...+..+.+++.+|++.||++||+++|+++.|+++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            1111111222223344557789999999999999999999999999998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-38  Score=359.45  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=201.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||+||+|++. +++    +||+|++.... ....+.+.+|+.++++    ++||||+++++++.++.
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VDNPHVCRLLGICLTST   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHH----CCBTTBCCEEEEEESSS
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHh----CCCCCEeEEEEEEecCC
Confidence            56889999999999999999964 444    36888886543 2345689999999997    67999999999998765


Q ss_pred             eEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                       .++|+||+++|+|.+++.. ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence             7789999999999999977 45799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH-HHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV-EWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ....... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.+...... ......           
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-----------  235 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----------  235 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-----------
Confidence            6543322 2233456889999999999999999999999999999999 9999987544221 111111           


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                              .....+......+.+++.+|++.||++||+++|+++.|+++.+
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          236 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    0111122344578899999999999999999999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.1e-38  Score=358.26  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=203.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-----ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-----LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||+||+|+++ +++.||||++....     ....+.+.+|++++..    ++||||+++++++.+++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM----LKHPHIVELLETYSSDG   99 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHH----CCCTTBCCEEEEEEETT
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHh----CCCCCCCcEEEEEEeCC
Confidence            46999999999999999999975 68999999986432     1235678999999987    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC---EEEee
Q 001384          879 EKILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTD  951 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~---~kl~D  951 (1088)
                      ..|+||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999999887543    2489999999999999999999999   9999999999999987655   99999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..+.....   ...... . 
T Consensus       177 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---i~~~~~-~-  250 (351)
T 3c0i_A          177 FGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG---IIKGKY-K-  250 (351)
T ss_dssp             CTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH---HHHTCC-C-
T ss_pred             CcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH---HHcCCC-C-
Confidence            99998765432 22345679999999999998899999999999999999999999998754322111   110000 0 


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ..+..        ......++.+++.+|++.||++||++.|+++
T Consensus       251 ---~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ---MNPRQ--------WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---CCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCccc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00000        0122357888999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=354.17  Aligned_cols=270  Identities=27%  Similarity=0.376  Sum_probs=207.5

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      ...++|++.+.||+|+||.||+|+++ ++.||||++...   ....+..|.+++....  ++||||+++++++...    
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~--~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVL--MRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTT--CCCTTBCCEEEEEEESCGGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHh--hcCCCeeeEEEEEccCCCCC
Confidence            34568999999999999999999985 899999998654   3445566777766543  5899999999999887    


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-----YPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                      ...++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+++     .++|+||||||+||+++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            7889999999999999999765 6999999999999999999999862     238999999999999999999999999


Q ss_pred             ccceeecCCCCcc---cccccccccccCccccCCCCCCcc------hhHHHHHHHHHHHHhC----------CcCCCCCc
Q 001384          953 GLARVVSAGDSHV---STTIAGTVGYVAPEYGQTWQATTK------GDVYSFGVLAMELATG----------RRALEGGE 1013 (1088)
Q Consensus       953 g~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~elltg----------~~p~~~~~ 1013 (1088)
                      |+++.+.......   .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            9998765432221   234579999999999887766655      9999999999999999          66665432


Q ss_pred             h---hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCCC
Q 001384         1014 E---CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD 1088 (1088)
Q Consensus      1014 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 1088 (1088)
                      .   .......... ...   .....+.      ......+..++.+++.+|++.||++||+++||++.|+++.+..|
T Consensus       267 ~~~~~~~~~~~~~~-~~~---~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          267 PSDPSYEDMREIVC-IKK---LRPSFPN------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             CSSCCHHHHHHHHT-TSC---CCCCCCG------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCchhhhHHHHh-hhc---cCccccc------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            1   1111111111 000   0000000      00123677889999999999999999999999999999876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-38  Score=361.47  Aligned_cols=247  Identities=26%  Similarity=0.303  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.+ +++.||||++.+.....   ...+..|..++.+   .++||||+++++++.+.+..
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~---~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK---NVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBC---CCCCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHH---hCCCCCCCCEEEEEEeCCEE
Confidence            46899999999999999999976 58899999998754322   2345556555322   36899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++++...+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++....
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999976432


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      . .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  +....+.....            
T Consensus       192 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~~~------------  256 (373)
T 2r5t_A          192 H-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILNKPL------------  256 (373)
T ss_dssp             C-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHHHHSCC------------
T ss_pred             C-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHhccc------------
Confidence            2 22344568999999999999999999999999999999999999999875442  12222221100            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                           ..+......+.+++.+|++.||.+||++.+.+
T Consensus       257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                 00112235678899999999999999986433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-38  Score=359.03  Aligned_cols=260  Identities=20%  Similarity=0.280  Sum_probs=209.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ....+..|+++++++.   +||||+++++++..+...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~---~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLG---SGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHC---SCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhh---CCCCCCEEEEEEecCCccEE
Confidence            467999999999999999999964 78999999987653  2345788999998732   79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-----EEEeecccce
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----ALVTDFGLAR  956 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-----~kl~Dfg~a~  956 (1088)
                      ||||+ +++|.++++. ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999 8999999986 46799999999999999999999999   9999999999999998887     9999999998


Q ss_pred             eecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCC
Q 001384          957 VVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       957 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~ 1029 (1088)
                      .+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+... ...+...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76543321      12456799999999999999999999999999999999999999987532 121111111100000


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..     ....       ....+ ++.+++.+|++.||.+||++++|++.|+++.+
T Consensus       239 ~~-----~~~~-------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          239 TP-----IEVL-------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             SC-----HHHH-------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CC-----HHHH-------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            00     0000       01122 78899999999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=361.23  Aligned_cols=262  Identities=26%  Similarity=0.369  Sum_probs=209.3

Q ss_pred             HcCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ..++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.++.++.   .||||+++++++.
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv~~~~~~~  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG---SHENIVNLLGACT  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC---CCTTBCCEEEEEC
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc---CCCCeeeEEEEEe
Confidence            346799999999999999999996      245689999997643 233467899999998732   7999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT-----------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHR  932 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~  932 (1088)
                      .++..++||||+++|+|.+++....                       .+++.+++.++.|++.||+|||++   +|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            9999999999999999999997653                       279999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCC
Q 001384          933 DVKASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALE 1010 (1088)
Q Consensus       933 DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~ 1010 (1088)
                      ||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876543322 2334567889999999888899999999999999999998 999998


Q ss_pred             CCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1011 GGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                      +........ ..... ..               ....+...+.++.+++.+|++.||.+||++.|+++.|+.++..+
T Consensus       277 ~~~~~~~~~-~~~~~-~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          277 GIPVDANFY-KLIQN-GF---------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TCCCSHHHH-HHHHT-TC---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCCcHHHHH-HHHhc-CC---------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            754321111 11110 00               00112223467888999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.5e-38  Score=354.44  Aligned_cols=247  Identities=25%  Similarity=0.340  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEe----CCCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|++.+...    .....+.+|+++++.    ++||||+++++++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE----VKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHH----CCCTTBCCEEEEEEC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHh----CCCCCccceeEEEEc
Confidence            5789999999999999999997    4689999999986532    223457789999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++..|+||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999999999888899999999999999999999999   99999999999999999999999999997


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.....  ....+.....        
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~--------  238 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TIDKILKCKL--------  238 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHTCC--------
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhCCC--------
Confidence            643221 22344679999999999998899999999999999999999999998764421  1111211000        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                               ..+......+.+++.+|++.||++||     ++.|+++
T Consensus       239 ---------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 ---------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     01122345788899999999999999     6777764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-38  Score=352.17  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=204.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-C-------cEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD-G-------REVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      .++|++.+.||+|+||+||+|+++. +       +.||+|++........+.+.+|++++++    ++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK----LSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHT----SCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHh----CCCCCEeEEEEEEE
Confidence            3578899999999999999999653 3       4799999987666666789999999997    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC--------
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK--------  946 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~--------  946 (1088)
                      +++..++||||+++|+|.++++.... +++..++.++.|++.||+|||++   +|+||||||+||+++.++.        
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999999987654 99999999999999999999999   9999999999999998887        


Q ss_pred             EEEeecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhc
Q 001384          947 ALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      +||+|||.+.....     .....++..|+|||++.+ ..++.++||||+|+++|||++|+.|+............... 
T Consensus       160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-  233 (289)
T 4fvq_A          160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-  233 (289)
T ss_dssp             EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-
T ss_pred             eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-
Confidence            99999999865421     233467889999998877 77999999999999999999966555443321111111110 


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ...       .           +.....++.+++.+|++.||++||+++|+++.|++++..
T Consensus       234 ~~~-------~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          234 RHQ-------L-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             TCC-------C-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             cCC-------C-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            000       0           001123577899999999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-37  Score=346.00  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=200.6

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|++.+|+.||||++......  ....+.+|++++++    ++||||+++++++.+++..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----LKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGG----CCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHh----cCCCCEeeeeeEEccCCeEEE
Confidence            578999999999999999999988999999999765322  23678899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ +|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9999986 999998764 5799999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCCCccc--c-
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGPGRAV--I- 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~- 1036 (1088)
                      . .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ..................  . 
T Consensus       154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          154 V-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence            1 12234568999999998765 4689999999999999999999999987654211 111111100000000000  0 


Q ss_pred             --chhhcC----CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 --PVVLLG----SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 --~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        +.....    ...........++.+++.+|++.||++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000000    000001123457789999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=348.72  Aligned_cols=270  Identities=23%  Similarity=0.252  Sum_probs=211.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--eE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--EK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--~~  880 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++    ++||||+++++++....  ..
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK----LNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHH----CCCTTBCCEEEEEECTTTCCE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHh----cCCCCcceEEEEeecCCCceE
Confidence            57899999999999999999976 58999999998643 2334677899999997    67999999999988765  78


Q ss_pred             EEEEEecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCCEEEeecc
Q 001384          881 ILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----DKEGKALVTDFG  953 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----~~~~~~kl~Dfg  953 (1088)
                      ++||||+++|+|.++++....   +++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999999986543   99999999999999999999999   99999999999999    788889999999


Q ss_pred             cceeecCCCCcccccccccccccCccccC--------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhh
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQ--------TWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRV 1023 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~ 1023 (1088)
                      +++......  ......||..|+|||++.        +..++.++||||+||++|||++|+.||.....  ...+.....
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            998765432  233457899999999875        56889999999999999999999999975322  111222222


Q ss_pred             hccCCCCCCccc---------cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1024 MGYGRHGPGRAV---------IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1024 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ............         .... ..............+.+++.+|++.||++||+++|+++...+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCcc-CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111100000000         0000 00111234667788999999999999999999999999887654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.8e-37  Score=341.81  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++......  ..+.+.+|++++++    ++||||+++++++.++...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK----LQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHH----cCCCCcCeEEEEEEcCCEE
Confidence            578999999999999999999976 6899999999765322  23567889999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC---EEEeeccccee
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARV  957 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~---~kl~Dfg~a~~  957 (1088)
                      ++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||.+..
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999999999998888899999999999999999999999   9999999999999987665   99999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      .....  ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+..............+....       
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T 3kk8_A          158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------  228 (284)
T ss_dssp             CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------
T ss_pred             cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-------
Confidence            65322  234467899999999999989999999999999999999999999876542211111111000000       


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              +.......++.+++.+|++.||++||+++|+++
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 --------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    001122356888999999999999999999976

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-37  Score=342.91  Aligned_cols=255  Identities=24%  Similarity=0.312  Sum_probs=210.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.++ ++..||+|++........+.+.+|++++++    ++||||+++++++.++...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS----LDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHh----CCCCCEeeEEEEEecCCeEEE
Confidence            457999999999999999999976 577999999987656667789999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999999998888899999999999999999999999   99999999999999   788999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ...  ......+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||...............  .. .     .+..
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~-~-----~~~~  229 (277)
T 3f3z_A          161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TF-T-----FPEK  229 (277)
T ss_dssp             TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-C-----CCHH
T ss_pred             Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CC-C-----CCch
Confidence            432  2344578999999998876 4899999999999999999999999876542211111110  00 0     0000


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHHhh
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA--MLIKI 1083 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~i 1083 (1088)
                      .       .......+.+++.+|++.||++||++.|+++  .+++.
T Consensus       230 ~-------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          230 D-------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             H-------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             h-------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            0       0122457888999999999999999999985  44443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=365.20  Aligned_cols=260  Identities=24%  Similarity=0.291  Sum_probs=206.9

Q ss_pred             HHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          797 YSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      +.+.....++|++.+.||+|+||+||+|+.+ +|+.||||++.+...   .....+.+|..++..    ++||||+++++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~----~~hp~Iv~l~~  128 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN----GDRRWITQLHF  128 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHH----SCTTTBCCEEE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHh----cCCCCeeeEEE
Confidence            3444445678999999999999999999976 689999999976422   122357889998886    57999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          873 WCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                      ++.+++..|+||||+++|+|.+++++. ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|
T Consensus       129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999999875 4799999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-------TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      ||+++.............+||+.|+|||++.       ...++.++||||+||++|||++|+.||.+.....  ....+.
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~  283 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TYGKIV  283 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence            9999887654433344568999999999876       4578999999999999999999999998764421  111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCC---CCHHHHHH
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNAR---PNVKEVLA 1078 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~ 1078 (1088)
                      .......    .+.        .......++.+++.+|++ +|++|   |+++||++
T Consensus       284 ~~~~~~~----~p~--------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HYKEHLS----LPL--------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             THHHHCC----CC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hcccCcC----CCc--------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0000000    000        011233578889999999 99998   58888864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-38  Score=357.73  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=209.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++|++.+.||+|+||.||+|++.        +++.||||++...... ..+.+.+|+++++++.   +||||+++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---KHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh---cCCCEeeEEEEE
Confidence            467899999999999999999863        4678999999865322 3356889999998732   799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                      .+++..++||||+++|+|.+++....                .+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            99999999999999999999997654                389999999999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.+.....
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999999876543322 2233456789999999888889999999999999999999 999998754321


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                        ..........                ...+......+.+++.+|++.||.+||+++|+++.|++++.
T Consensus       268 --~~~~~~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 --LFKLLKEGHR----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHTCC----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHhcCCC----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              1111110000                01122334578889999999999999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-38  Score=354.86  Aligned_cols=258  Identities=26%  Similarity=0.442  Sum_probs=198.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++.......   ...+.+|++++.+    ++||||+++++++.....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----LNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCC----CCCTTBCCEEEEEEEEET
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHc----CCCCCcceEEEeeeccCC
Confidence            468999999999999999999974 78999999998653332   2467788887775    689999999999876543


Q ss_pred             ----EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          880 ----KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       880 ----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                          .|+||||+++|+|.++++...++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence                499999999999999999888899999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      +........  ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.+.......+.....  ..     
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~-----  236 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DP-----  236 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CC-----
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CC-----
Confidence            876543221  233457899999999999989999999999999999999999999876543322222111  00     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHH-HHHHHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE-VLAMLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-il~~L~~i 1083 (1088)
                       ..+..       .....+.++.+++.+|++.||++||++.+ +.+.+.++
T Consensus       237 -~~~~~-------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 -IPPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -CCHHH-------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -CCccc-------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence             00000       01123457889999999999999996555 45555554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.2e-38  Score=343.40  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--CeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--SEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--~~~  880 (1088)
                      ++|++.+.||+|+||.||+|+++ ++.||||++.....  ...+.+.+|++++++    ++||||+++++++.+.  ...
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRI----FSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCC----CSCTTEECEEEEECTTTSSSC
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHh----cCCCchhheEEEEccCCCCCe
Confidence            46889999999999999999985 88999999986532  234578899998886    6799999999999887  788


Q ss_pred             EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++|+|.++++...  .+++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.++++|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999999998765  489999999999999999999998   7  9999999999999999999999998875


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCc---chhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATT---KGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ...      .....+|+.|+|||.+.+..++.   ++||||+|+++|||++|+.||.+.............  ..     
T Consensus       162 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~-----  228 (271)
T 3kmu_A          162 SFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE--GL-----  228 (271)
T ss_dssp             TTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS--CC-----
T ss_pred             eec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc--CC-----
Confidence            432      22346789999999887655444   899999999999999999999876542221111111  00     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                ....+...+..+.+++.+|++.||++||+++|+++.|+++.+
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ----------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      001122234578899999999999999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-38  Score=356.39  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=212.0

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|++++.++.   +||||+++++++.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~i~~~~~~~~~   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG---NHMNIVNLLGACTI   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEEEEECS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc---cCCCeeeEEEEEec
Confidence            35789999999999999999985      2467899999986543 23467889999998732   79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                      ++..++||||+++|+|.+++....                  .+++.+++.++.|++.||+|||++   +|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            999999999999999999997654                  389999999999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL 1016 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 1016 (1088)
                      |+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.+.....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999876543322 2334567889999999888899999999999999999999 999998754321


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ..+........                 ...+...+..+.+++.+|++.||.+||+++|+++.|+++++.
T Consensus       256 ~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          256 KFYKMIKEGFR-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHHHHTCC-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCC-----------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11111111000                 001122346788899999999999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=356.99  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=197.8

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      .+.||+|+||.||+|++. +|+.||+|++........+.+.+|++++.+    ++||||+++++++.+.+..++||||++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ----LDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHh----CCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            568999999999999975 689999999987655566789999999987    679999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--cCCCCEEEeecccceeecCCCCcc
Q 001384          889 GGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL--DKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       889 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      +|+|.+++... ..+++.+++.++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||+++.+....  .
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~  244 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K  244 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence            99999988654 4699999999999999999999999   99999999999999  567889999999998775432  2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCc
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1088)
                      .....||+.|+|||++....++.++|||||||++|||++|+.||.+..+...  ...+........     +.       
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~~~-----~~-------  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWDLE-----DE-------  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCCSC-----SG-------
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCCCC-----hh-------
Confidence            3345699999999999988999999999999999999999999987654211  111111000000     00       


Q ss_pred             cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1046 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       .......++.+++.+|++.||.+||+++|+++
T Consensus       311 -~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 -EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             01123457888999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-38  Score=367.65  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++.....   .....+.+|+++++.    ++||||+++++++.....
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~----l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL----FRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCE
Confidence            367999999999999999999976 799999999976422   234578899999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++|+|.+++...+++++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ...  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+....  .....+.....          
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~----------  233 (476)
T 2y94_A          168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDGIF----------  233 (476)
T ss_dssp             TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTTCC----------
T ss_pred             ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCCc----------
Confidence            432  2345679999999999887765 78999999999999999999999875431  11122211000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ..+.....++.+++.+|++.||++||+++|+++
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                   001122356888999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-38  Score=364.56  Aligned_cols=264  Identities=18%  Similarity=0.254  Sum_probs=201.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCC------CcEEEEEEccccCccch-----------HHHHHHHHHHhCCCCCCCCCc
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGE-----------REFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      .++|++.+.||+|+||.||+|.++.      ++.||||++........           ..+..|+..+.    .++|||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~----~l~h~~  109 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTR----KLKYLG  109 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHT----TCSCCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHh----hccCCC
Confidence            4689999999999999999999764      47899999876531110           11222333333    367999


Q ss_pred             eeEEeeEEecC----CeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001384          867 LVTLYGWCLDG----SEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL  941 (1088)
Q Consensus       867 iv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll  941 (1088)
                      |+++++++...    ...++||||+ +++|.++++.. ..+++.+++.++.||+.||+|||++   +|+||||||+||++
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99999998764    4589999999 99999999876 5799999999999999999999999   99999999999999


Q ss_pred             c--CCCCEEEeecccceeecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCc
Q 001384          942 D--KEGKALVTDFGLARVVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013 (1088)
Q Consensus       942 ~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~ 1013 (1088)
                      +  .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  8899999999999876533211      1133559999999999999999999999999999999999999998532


Q ss_pred             h--hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1014 E--CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1014 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .  ....+......    .......+....      ....+.++.+++.+|++.||++||++++|++.|+++++
T Consensus       266 ~~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          266 KDPKYVRDSKIRYR----ENIASLMDKCFP------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TCHHHHHHHHHHHH----HCHHHHHHHHSC------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHhh----hhHHHHHHHhcc------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            2  22222111110    000111111110      01224578889999999999999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-38  Score=348.78  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .++|++.+.||+|+||.||+|++..    +..||||++.... ....+.+.+|+++++.    ++||||+++++++.+ +
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN----LDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHH----HCCTTBCCEEEEECS-S
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHh----CCCCCcceEEEEEcC-C
Confidence            3578899999999999999998542    3469999998653 2345678899999987    679999999999865 4


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++++|.++++.. ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            568999999999999999765 4599999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchh-HHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEEC-LVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .........           
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-----------  231 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-----------  231 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-----------
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-----------
Confidence            65443333344567889999999988899999999999999999998 99999765432 111111110           


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                              ....+...+..+.+++.+|++.||++||++.|+++.|+++..
T Consensus       232 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          232 --------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                    001122234568889999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-37  Score=348.34  Aligned_cols=273  Identities=23%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|.++ +|+.||||++..... .....+.+|++++++    ++||||+++++++.+++..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE----LKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTT----CCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHh----cCCCCcceEEEEEEECCeEE
Confidence            467999999999999999999976 689999999976532 234678899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          882 LVYEYMEGGSLEDIISDR------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      +||||++ |+|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            9999998 5999998653      3589999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 1033 (1088)
                      +...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..... .................
T Consensus       156 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          156 RAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             EETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred             eecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence            8764322 22334578999999998865 468999999999999999999999998765421 11111111100000000


Q ss_pred             cc--cc---hhhcCCC---------ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHHhhCC
Q 001384         1034 AV--IP---VVLLGSG---------LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA--MLIKILP 1085 (1088)
Q Consensus      1034 ~~--~~---~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~i~~ 1085 (1088)
                      ..  .+   .......         .........++.+++.+|++.||++||+++|+++  .+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence            00  00   0000000         0001123357889999999999999999999975  3444433

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-38  Score=357.91  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcE----EEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGRE----VAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|++.... ......+.+|+.++..    ++||||+++++++. +.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS----LDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHT----CCCTTBCCEEEEEC-BS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhc----CCCCCcCeEEEEEc-CC
Confidence            57889999999999999999965 4443    7888775442 2233467788988886    67999999999986 45


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            688999999999999999764 5799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhH-HHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECL-VEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ....... ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||.+..... ........   .      
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~------  235 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---R------  235 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---B------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---C------
Confidence            6543322 2344567889999999998899999999999999999999 999998754321 11111110   0      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                                ...+.....++.+++.+|++.||.+||+++|+++.|+++.+
T Consensus       236 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 ----------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      00111223357789999999999999999999999999865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-37  Score=349.61  Aligned_cols=251  Identities=21%  Similarity=0.283  Sum_probs=208.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......      ..+.+.+|++++..    +.||||+++++++.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ----VLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHH----CCCTTBCCEEEEEEC
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHh----CCCCCcceEEEEEec
Confidence            356899999999999999999976 6899999999765322      35678999999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeec
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDF  952 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Df  952 (1088)
                      +...++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999999999888899999999999999999999999   999999999999999888    7999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |+++......  ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.....  ..........    
T Consensus       164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~----  235 (321)
T 2a2a_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANITSVSY----  235 (321)
T ss_dssp             TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHTTCC----
T ss_pred             ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhccc----
Confidence            9998765432  2344568999999999998899999999999999999999999998754321  1111111000    


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ..+...       .......+.+++.+|++.||++||+++|+++
T Consensus       236 --~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 --DFDEEF-------FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --CCCHHH-------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --ccChhh-------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              001000       1122356888999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-38  Score=355.42  Aligned_cols=257  Identities=24%  Similarity=0.406  Sum_probs=203.0

Q ss_pred             CCCCccceecccCceEEEEEEeCC-----CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-----GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+.||+|+||.||+|.++.     +..||||++..... .....+.+|++++..    ++||||+++++++.+.+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ----FSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEECSSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEecCC
Confidence            567788999999999999998642     23599999986532 234568899999987    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999999764 5799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          958 VSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       958 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........  .......        
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~~~~--------  266 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAINDG--------  266 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTT--------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHCC--------
Confidence            6543221  1223346788999999988899999999999999999999 9999976543211  1111100        


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                              ...+.+...+..+.+++.+|++.||++||+++|+++.|+++++.
T Consensus       267 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          267 --------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             --------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                    00111223345788999999999999999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-37  Score=344.13  Aligned_cols=246  Identities=27%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|++++++    ++||||+++++++.+...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHc----CCCCCCcchhheEecCCE
Confidence            357899999999999999999976 57799999986542   1234678899999986    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++|+|.+++....++++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999999999888899999999999999999999999   99999999999999999999999999886543


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ..   ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........  .........           
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~-----------  224 (279)
T 3fdn_A          161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISRVEF-----------  224 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCC-----------
T ss_pred             cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHhCCC-----------
Confidence            21   23345789999999999998999999999999999999999999987543211  111110000           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+......+.+++.+|++.||++||+++|+++
T Consensus       225 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  011223356788999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=349.14  Aligned_cols=252  Identities=26%  Similarity=0.453  Sum_probs=198.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||+||+|++. ++.||||++...  ...+.+.+|++++++    ++||||+++++++.+  ..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSR----VNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHH----CCCTTBCCEEEBCTT--TTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhc----CCCCCcCeEEEEEcC--CcEEEE
Confidence            46888999999999999999985 788999999754  345678999999987    679999999998874  478999


Q ss_pred             EecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-EEEeecccceeecC
Q 001384          885 EYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-ALVTDFGLARVVSA  960 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-~kl~Dfg~a~~~~~  960 (1088)
                      ||+++|+|.++++...   .+++.+++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999999998765   3789999999999999999999932228999999999999998887 79999999976532


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....||+.|+|||++.+..++.++||||||+++|||++|+.||..................             
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------  221 (307)
T 2eva_A          159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-------------  221 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-------------
T ss_pred             c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-------------
Confidence            1    22346899999999999989999999999999999999999999864332221111111000             


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                         ........+..+.+++.+|++.||++||+++|+++.|+++.+
T Consensus       222 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          222 ---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               001112234568889999999999999999999999998864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=344.44  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------------------------chHHHHHHHHHHh
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------------------------GEREFRAEMEVLS  856 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  856 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999975 6889999999764321                          1245889999999


Q ss_pred             CCCCCCCCCceeEEeeEEec--CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          857 GNGFGWPHPNLVTLYGWCLD--GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       857 ~~~~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      +    ++||||+++++++.+  ....++||||+++++|.+++. ..++++.+++.++.|++.||+|||++   +|+||||
T Consensus        92 ~----l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 K----LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             T----CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             h----CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            7    679999999999986  568899999999999988654 45699999999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCcCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEG 1011 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~ 1011 (1088)
                      ||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||+|+++|||++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999987654322 234467999999999987655   47889999999999999999999987


Q ss_pred             CchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1012 GEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....  .+............               .......++.+++.+|++.||++||+++|+++
T Consensus       243 ~~~~--~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIM--CLHSKIKSQALEFP---------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHH--HHHHHHHHCCCCCC---------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHH--HHHHHHhcccCCCC---------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            5432  12121111000000               01122356888999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.5e-38  Score=354.28  Aligned_cols=248  Identities=22%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS---  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~---  878 (1088)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++..... ...+.+.+|++++++    ++||||+++++++.+..   
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK----LEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTS----CCCTTBCCEEEEEEECCSCH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHh----CCCCCEeeEEEEEEEeccch
Confidence            357899999999999999999986 799999999975432 344678999999997    67999999999986543   


Q ss_pred             ------------------------------------------------------eEEEEEEecCCCCHHHHHhhcCC---
Q 001384          879 ------------------------------------------------------EKILVYEYMEGGSLEDIISDRTR---  901 (1088)
Q Consensus       879 ------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~---  901 (1088)
                                                                            ..++||||+++|+|.++++....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  37999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC-----------ccccccc
Q 001384          902 LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-----------HVSTTIA  970 (1088)
Q Consensus       902 l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~  970 (1088)
                      .++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......           .......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            56677899999999999999999   999999999999999999999999999988754321           1223457


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHH
Q 001384          971 GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAE 1050 (1088)
Q Consensus       971 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1088)
                      ||+.|+|||++.+..++.++||||+|+++|||++|..|+....    ........                .........
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~~~~~~----------------~~~~~~~~~  297 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RIITDVRN----------------LKFPLLFTQ  297 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHHHHHHT----------------TCCCHHHHH
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHHHHhhc----------------cCCCccccc
Confidence            9999999999999899999999999999999999877753211    11111110                001111234


Q ss_pred             HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1051 EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1051 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....+.+++.+|++.||++||+++|+++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            4467789999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=381.26  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=211.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      .++|++.+.||+|+||.||+|.++.+..||||+++... ...+++.+|++++++    ++||||+++++++.+ ...++|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK----LRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECS-SSCEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHh----CCCCCEeeEEEEEee-ccceEe
Confidence            45688899999999999999999888889999998654 345689999999997    679999999999876 678999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.++++..  ..+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999753  4699999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .........++..|+|||.+....++.++|||||||++|||++ |+.||.+.....  .......               
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~---------------  479 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER---------------  479 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHT---------------
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---------------
Confidence            2122233456789999999888899999999999999999999 999998754321  1111110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       +.....+..+...+.+++.+||+.||++||++++|++.|++++..
T Consensus       480 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          480 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence             001111233446788999999999999999999999999998764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.3e-37  Score=362.15  Aligned_cols=369  Identities=17%  Similarity=0.154  Sum_probs=241.0

Q ss_pred             CCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCC
Q 001384          112 RNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID  191 (1088)
Q Consensus       112 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~  191 (1088)
                      ...+.+..+..++++++|++|+|++|.+++...+..+++|++|+|++|++++. +   ...+++|++|+|++|++++. +
T Consensus        27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~-~  101 (457)
T 3bz5_A           27 AFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNL-D  101 (457)
T ss_dssp             HTTCCTTSEEEHHHHTTCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCC-C
T ss_pred             hcCcCcccccChhHcCCCCEEEccCCCcccChhhcccCCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCcee-e
Confidence            34455566667889999999999999999877788999999999999999874 3   23457788888888888875 2


Q ss_pred             ccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCc
Q 001384          192 TCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV  271 (1088)
Q Consensus       192 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~  271 (1088)
                        ++++++|++|++++|++++..+..+++|+                         +|++++|++++. +  ++++++|+
T Consensus       102 --~~~l~~L~~L~L~~N~l~~l~~~~l~~L~-------------------------~L~l~~N~l~~l-~--l~~l~~L~  151 (457)
T 3bz5_A          102 --VTPLTKLTYLNCDTNKLTKLDVSQNPLLT-------------------------YLNCARNTLTEI-D--VSHNTQLT  151 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSCCCCTTCTTCC-------------------------EEECTTSCCSCC-C--CTTCTTCC
T ss_pred             --cCCCCcCCEEECCCCcCCeecCCCCCcCC-------------------------EEECCCCcccee-c--cccCCcCC
Confidence              77788888888888877653334444444                         455554444432 1  44445555


Q ss_pred             EEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCc
Q 001384          272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS  351 (1088)
Q Consensus       272 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~  351 (1088)
                      +|++++|+..+.+  .++.+++|+.|++++|++++. |  +..+++|+.|++++|++++.   .++.+++|+.|++++|+
T Consensus       152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~  223 (457)
T 3bz5_A          152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK  223 (457)
T ss_dssp             EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSC
T ss_pred             EEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCc
Confidence            5555555333233  244455555555555555442 2  44455555555555555543   14445555555555555


Q ss_pred             ccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCc
Q 001384          352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP  431 (1088)
Q Consensus       352 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  431 (1088)
                      +.. ++   +..+++|+.|++++|++++..   ++.+++|+.|++++|              +|+.|++++|++.|.+| 
T Consensus       224 l~~-ip---~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~-  281 (457)
T 3bz5_A          224 LTE-ID---VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ-  281 (457)
T ss_dssp             CSC-CC---CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE-
T ss_pred             ccc-cC---ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc-
Confidence            433 11   456788888888888888643   456778888887775              35567888888877776 


Q ss_pred             cccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccc
Q 001384          432 SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLS  511 (1088)
Q Consensus       432 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~  511 (1088)
                       ++++++|+.|++++|.+.|.+|.   ..++|+.|++++|+                                       
T Consensus       282 -~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~~---------------------------------------  318 (457)
T 3bz5_A          282 -AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQNP---------------------------------------  318 (457)
T ss_dssp             -CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTCT---------------------------------------
T ss_pred             -ccccccCCEEECCCCcccceecc---CCCcceEechhhcc---------------------------------------
Confidence             46677888888888877776664   33455555555441                                       


Q ss_pred             cccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEE
Q 001384          512 MKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMV  591 (1088)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L  591 (1088)
                                                                         .+++|++++|+|+| +|  ++++++|+.|
T Consensus       319 ---------------------------------------------------~L~~L~L~~N~l~~-l~--l~~l~~L~~L  344 (457)
T 3bz5_A          319 ---------------------------------------------------KLVYLYLNNTELTE-LD--VSHNTKLKSL  344 (457)
T ss_dssp             ---------------------------------------------------TCCEEECTTCCCSC-CC--CTTCTTCSEE
T ss_pred             ---------------------------------------------------cCCEEECCCCcccc-cc--cccCCcCcEE
Confidence                                                               12467888888887 43  7888888888


Q ss_pred             eccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccc
Q 001384          592 HLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFN  654 (1088)
Q Consensus       592 ~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  654 (1088)
                      ++++|+|+| +|      .|..|++++|+++|.     +++..|+.++|++|+++|.||..+.
T Consensus       345 ~l~~N~l~~-l~------~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          345 SCVNAHIQD-FS------SVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             ECCSSCCCB-CT------TGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             ECCCCCCCC-cc------ccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence            888888885 32      244556777777765     3556677777777777777776543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-37  Score=354.16  Aligned_cols=257  Identities=24%  Similarity=0.251  Sum_probs=202.2

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-----ccchHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-----LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      +....++|++.+.||+|+||.||+|++. +++.||+|++....     ....+.+.+|++++++    ++||||++++++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~   96 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK----LHHPNIARLYEV   96 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHH----CCCTTBCCEEEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHh----CCCCCcceeehh
Confidence            3456678999999999999999999975 68899999987542     2334678999999997    679999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHHHhh----------------------------------------cCCCCHHHHHHHHHH
Q 001384          874 CLDGSEKILVYEYMEGGSLEDIISD----------------------------------------RTRLTWRRRLDIAID  913 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~q  913 (1088)
                      +.+++..++||||+++|+|.+++..                                        ...+++..++.++.|
T Consensus        97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence            9999999999999999999999852                                        112467888999999


Q ss_pred             HHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC--CEEEeecccceeecCCCC---cccccccccccccCccccCC--CCC
Q 001384          914 VARALVFLHHECYPPIVHRDVKASNVLLDKEG--KALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAPEYGQT--WQA  986 (1088)
Q Consensus       914 i~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~  986 (1088)
                      ++.||+|||++   +|+||||||+||+++.++  .+||+|||+++.+.....   .......||+.|+|||++.+  ..+
T Consensus       177 i~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999999   999999999999998776  899999999987643222   12345679999999998764  688


Q ss_pred             CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccC
Q 001384          987 TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEA 1066 (1088)
Q Consensus       987 ~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 1066 (1088)
                      +.++||||||+++|||++|+.||.+........  ..........             .+........+.+++.+|++.|
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS--QVLNKKLCFE-------------NPNYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCCCCTT-------------SGGGGGSCHHHHHHHHHHSCSC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH--HHHhcccccC-------------CcccccCCHHHHHHHHHHcCCC
Confidence            999999999999999999999998765422211  1110000000             0011123457888999999999


Q ss_pred             CCCCCCHHHHHH
Q 001384         1067 PNARPNVKEVLA 1078 (1088)
Q Consensus      1067 P~~RPs~~eil~ 1078 (1088)
                      |.+||++.|+++
T Consensus       319 p~~Rps~~~~l~  330 (345)
T 3hko_A          319 VDERFDAMRALQ  330 (345)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCCCHHHHhc
Confidence            999999999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.9e-36  Score=359.60  Aligned_cols=348  Identities=24%  Similarity=0.333  Sum_probs=246.0

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN  159 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N  159 (1088)
                      +++.|++.+++++..  +.+..+++|++|+|++|.+++..|  +..+++|++|+|++|.+++...+.++++|++|+|++|
T Consensus        47 ~l~~L~l~~~~i~~l--~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n  122 (466)
T 1o6v_A           47 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN  122 (466)
T ss_dssp             TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             cccEEecCCCCCccC--cchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChhhcCCCCCCEEECCCC
Confidence            455666666666542  236666777777777777664433  6667777777777776666555666666666666666


Q ss_pred             cccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCccccccccccc
Q 001384          160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV  239 (1088)
Q Consensus       160 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  239 (1088)
                      ++++..+   ...+++|++|++++|++++..  .+..+++|++|+++ |                     .+.+.   ..
T Consensus       123 ~l~~~~~---~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~---------------------~~~~~---~~  172 (466)
T 1o6v_A          123 QITDIDP---LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-N---------------------QVTDL---KP  172 (466)
T ss_dssp             CCCCCGG---GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-E---------------------SCCCC---GG
T ss_pred             CCCCChH---HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-C---------------------cccCc---hh
Confidence            6664432   233455555555555555432  25555555555553 2                     22221   12


Q ss_pred             ccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCc
Q 001384          240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE  319 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  319 (1088)
                      +..+++|++|++++|.+++.  ..+..+++|++|++++|.+.+..|  ++.+++|+.|++++|.+.+.  ..+..+++|+
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~  246 (466)
T 1o6v_A          173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLT  246 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCC
Confidence            56667777777777776643  246777778888888877775544  66677788888887777663  4577777888


Q ss_pred             EEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecccc
Q 001384          320 VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHN  399 (1088)
Q Consensus       320 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  399 (1088)
                      +|++++|.+++..+  +..+++|+.|++++|.+....   .+..+++|+.|+|++|++++..|  +..+++|+.|++++|
T Consensus       247 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~---~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n  319 (466)
T 1o6v_A          247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS---PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN  319 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSS
T ss_pred             EEECCCCccccchh--hhcCCCCCEEECCCCccCccc---cccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCC
Confidence            88888888777665  777778888888877754422   26678899999999999986544  788999999999999


Q ss_pred             ccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCc
Q 001384          400 RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP  479 (1088)
Q Consensus       400 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~  479 (1088)
                      ++++..|  +..+++|+.|++++|++++.  +.+.++++|++|++++|++++..|  +..+++|+.|++++|++++ +|.
T Consensus       320 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~  392 (466)
T 1o6v_A          320 NISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APV  392 (466)
T ss_dssp             CCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCB
T ss_pred             cCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cch
Confidence            9997665  77899999999999999964  578899999999999999998776  8999999999999999995 555


Q ss_pred             hh
Q 001384          480 EV  481 (1088)
Q Consensus       480 ~~  481 (1088)
                      .+
T Consensus       393 ~~  394 (466)
T 1o6v_A          393 NY  394 (466)
T ss_dssp             CC
T ss_pred             hh
Confidence            43

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.9e-38  Score=347.46  Aligned_cols=255  Identities=27%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             CCCCccc-eecccCceEEEEEEeC---CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDR-IIGKGGFGTVYRGVLP---DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ++|++.+ .||+|+||.||+|.+.   .++.||||++......  ..+.+.+|+++++.    ++||||+++++++ ..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT----CCCTTBCCEEEEE-ESS
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHh----CCCCCEEEEEEEE-CCC
Confidence            4677777 9999999999999642   4688999999865322  24678999999997    6799999999998 567


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..++||||+++++|.++++....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            7899999999999999999888899999999999999999999999   9999999999999999999999999999877


Q ss_pred             cCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .......  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+......  ........        
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~--------  237 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEKGE--------  237 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTC--------
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCC--------
Confidence            5433322  223346788999999988889999999999999999999 9999987654221  11111000        


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                              ....+...+..+.+++.+|++.||++||++.|+++.|++++.
T Consensus       238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                    011122334678899999999999999999999999998863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-38  Score=356.01  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=211.8

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ...++|++.+.||+|+||.||+|++.      +++.||||++..... .....+.+|+++++.    ++||||+++++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE----FNCHHVVRLLGVV   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGG----CCCTTBCCEEEEE
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHh----cCCCCEeeeEEEE
Confidence            44578999999999999999999864      367899999986533 234568899999987    6799999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDR----------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      .++...++||||+++|+|.++++..          ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence            9999999999999999999999753          3569999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHh
Q 001384          945 GKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRR 1022 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1088)
                      +.+||+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.+....  +....
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~  252 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF  252 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHH
Confidence            99999999999865432221 2233457889999999988899999999999999999999 89999875432  11111


Q ss_pred             hhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1023 VMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .....                ....+...+..+.+++.+|++.||++||++.|+++.|+++++.
T Consensus       253 ~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          253 VMEGG----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHcCC----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            11000                0011223345788899999999999999999999999998653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.2e-37  Score=344.98  Aligned_cols=258  Identities=25%  Similarity=0.415  Sum_probs=199.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ......+.+|++++++    ++||||+++++++.+++.
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ----LNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEEETTE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEcCCc
Confidence            357999999999999999999974 78999999997532   2234578899999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          880 KILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                      .++||||+++|+|.+++..    ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            9999999999999999864    45689999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+...................     
T Consensus       184 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  257 (310)
T 2wqm_A          184 RFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-----  257 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----
T ss_pred             eeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----
Confidence            8654322 1223456899999999999889999999999999999999999999865433333333322111100     


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                         .       .......++.+++.+|++.||++||+++||++.|+++.
T Consensus       258 ---~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          258 ---L-------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ---C-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C-------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               0       01123357888999999999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-38  Score=356.76  Aligned_cols=256  Identities=23%  Similarity=0.269  Sum_probs=200.1

Q ss_pred             cCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSED-RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++. +.||+|+||.||+|++. +++.||||++..........+.+|++++.+.   .+||||+++++++.+++..+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~---~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC---QGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHT---CCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHh---cCCCCeeeEEEEEeeCCEEE
Confidence            3568874 78999999999999965 7899999999876555667889999998763   37999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC---EEEeecccceee
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTDFGLARVV  958 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~---~kl~Dfg~a~~~  958 (1088)
                      +||||+++|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++...
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999999999888899999999999999999999999   9999999999999998776   999999998765


Q ss_pred             cCCCC------cccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH----------
Q 001384          959 SAGDS------HVSTTIAGTVGYVAPEYGQT-----WQATTKGDVYSFGVLAMELATGRRALEGGEECLV---------- 1017 (1088)
Q Consensus       959 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~---------- 1017 (1088)
                      .....      .......||+.|+|||++..     ..++.++||||+||++|||++|+.||.+......          
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211      11223468999999998764     4688999999999999999999999986532110          


Q ss_pred             ---HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1018 ---EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1018 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ...........      ..+..       ........+.+++.+|++.||++||+++|+++
T Consensus       245 ~~~~~~~~i~~~~~------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------EFPDK-------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCC------CCCHH-------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCc------ccCch-------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               01111110000      00000       00112457889999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-37  Score=355.32  Aligned_cols=214  Identities=26%  Similarity=0.310  Sum_probs=183.5

Q ss_pred             CCccCHHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCceeE
Q 001384          792 KTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVT  869 (1088)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~niv~  869 (1088)
                      ...+++.+.....++|++.+.||+|+||+||+|++. +++.||||++... ......+..|++++..+.. .+.||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            345566666667789999999999999999999975 6889999999753 2334567778888876431 235999999


Q ss_pred             EeeEEecCCeEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC----
Q 001384          870 LYGWCLDGSEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK----  943 (1088)
Q Consensus       870 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~----  943 (1088)
                      +++++...+..++||||+ +++|.+++....  .+++.+++.++.||+.||+|||++   +|+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999998754  599999999999999999999999   9999999999999975    


Q ss_pred             ---------------------CCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHH
Q 001384          944 ---------------------EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMEL 1002 (1088)
Q Consensus       944 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el 1002 (1088)
                                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||+||++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999864422    2345789999999999999999999999999999999


Q ss_pred             HhCCcCCCCCch
Q 001384         1003 ATGRRALEGGEE 1014 (1088)
Q Consensus      1003 ltg~~p~~~~~~ 1014 (1088)
                      ++|+.||.....
T Consensus       253 l~g~~pf~~~~~  264 (360)
T 3llt_A          253 YTGSLLFRTHEH  264 (360)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HHCCCCCCCCcH
Confidence            999999987644

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.3e-38  Score=369.78  Aligned_cols=247  Identities=26%  Similarity=0.296  Sum_probs=196.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.+|+++++.    ++||||+++++++.+.+..
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN----SRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCC----CSCTTSCCEEEEEEETTEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHh----CCCCeEeeEEEEEeeCCEE
Confidence            57999999999999999999975 68999999997642   1223456678777765    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++|+|.+++.....+++..++.++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++...
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999999999988899999999999999999999998 7   99999999999999999999999999997533


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+......  ...+.....           
T Consensus       301 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~~~~-----------  366 (446)
T 4ejn_A          301 KD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELILMEEI-----------  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC-----------
T ss_pred             CC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHHhCCC-----------
Confidence            22 2233456899999999999999999999999999999999999999987644211  111110000           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                            ..+.....++.+++.+|++.||.+||     +++|+++
T Consensus       367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  00112335688899999999999999     9999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.5e-38  Score=352.02  Aligned_cols=246  Identities=23%  Similarity=0.306  Sum_probs=181.2

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      .+.||+|+||+||+|+++ +++.||||++.+.   ....+.+|+.++..+.   .||||+++++++.++...|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~---~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCE---GHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhc---CCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            478999999999999976 6899999999754   4467788999988742   49999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---CEEEeecccceeecCCCCcc
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---KALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      +|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++...... ..
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~  165 (325)
T 3kn6_A           90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP  165 (325)
T ss_dssp             SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence            999999999988999999999999999999999999   999999999999998766   89999999998764332 23


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-----hHHHHHHhhhccCCCCCCccccchhh
Q 001384          966 STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-----CLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       966 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....     ...+..........     . .+   
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-----~-~~---  236 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-----S-FE---  236 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-----C-CC---
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-----C-CC---
Confidence            3445789999999999999999999999999999999999999986432     11122222210000     0 00   


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .........++.+++.+|++.||++||+++|+++
T Consensus       237 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          237 ----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ----SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ----cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                0001123467889999999999999999998863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-37  Score=359.46  Aligned_cols=268  Identities=23%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             cCCCCccceeccc--CceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          804 TGKFSEDRIIGKG--GFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .++|++.+.||+|  +||.||+|+++ +++.||||++......  ..+.+.+|+++++.    ++||||+++++++.+++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL----FNHPNIVPYRATFIADN   99 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETT
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHh----CCCCCCCcEeEEEEECC
Confidence            3579999999999  99999999986 6899999999865322  23567889999997    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          879 EKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ..++||||+++|+|.+++...  ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999999999999775  6799999999999999999999999   99999999999999999999999999987


Q ss_pred             eecCCCC------cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          957 VVSAGDS------HVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       957 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      .......      .......||..|+|||++.+  ..++.++||||+||++|||++|+.||.+.................
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            5432211      11223478899999998877  679999999999999999999999998754311111000000000


Q ss_pred             CC-----CCccc----------------------cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HG-----PGRAV----------------------IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~-----~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..     .....                      .+..........+......+.+++.+||+.||++||+++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00     00000                      0000000000112233457889999999999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=353.37  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|.+.+++.||||++......  ..+.+.+|++++..+.  -+||||+++++++.++...+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHT--TTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhh--hcCCceEEEeeeEeeCCEEE
Confidence            4579999999999999999999988999999999765332  2357889999998743  12399999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +|||+ .+|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++.....
T Consensus        86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99995 5779999999988999999999999999999999999   999999999999996 688999999999876543


Q ss_pred             CCc-ccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          962 DSH-VSTTIAGTVGYVAPEYGQT-----------WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       962 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      ... ......||+.|+|||++.+           ..++.++||||+||++|||++|+.||................ .. 
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~-  238 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-NH-  238 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-TS-
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC-Cc-
Confidence            222 2345679999999998754           678999999999999999999999998754433222222110 00 


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                         ...           .+.....++.+++.+|++.||.+||++.|+++.
T Consensus       239 ---~~~-----------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          239 ---EIE-----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---CCC-----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---ccC-----------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               000           011122467889999999999999999999753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=352.83  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=201.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcE----EEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGRE----VAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.++++    ++||||+++++++..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTT----CCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHh----CCCCCeeEEEEEEecC
Confidence            367999999999999999999965 4543    5777775432 3455788999999987    6799999999999876


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      . .++|+||+.+|+|.+++... ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            5 78899999999999999764 5699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ........ ......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||.+........  ....         
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--~~~~---------  234 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS--ILEK---------  234 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH--HHHT---------
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHc---------
Confidence            76543222 2233456789999999998899999999999999999999 999998764422111  1110         


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                             +.....+.....++.+++.+|++.||.+||++.|+++.|+++.+.
T Consensus       235 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          235 -------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                   001111223345788899999999999999999999999998653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-37  Score=350.05  Aligned_cols=266  Identities=26%  Similarity=0.355  Sum_probs=211.6

Q ss_pred             HHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          801 LKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       801 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      ....++|++.+.||+|+||.||+|++ +++.||||++...   ....+..|.+++....  ++||||+++++++....  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~--l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVM--LRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSC--CCCTTBCCEEEEEECCCSS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhh--cCCCcEEEEEeeecccCCc
Confidence            34557899999999999999999998 4899999999754   3456778888887643  68999999999998876  


Q ss_pred             --eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          879 --EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH--------HECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       879 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                        ..++||||+++|+|.+++++. ++++.+++.++.|++.||+|||        +.   +|+||||||+||+++.++.+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence              789999999999999999764 6899999999999999999999        66   999999999999999999999


Q ss_pred             EeecccceeecCCCCc---ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhC----------CcCC
Q 001384          949 VTDFGLARVVSAGDSH---VSTTIAGTVGYVAPEYGQTW------QATTKGDVYSFGVLAMELATG----------RRAL 1009 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg----------~~p~ 1009 (1088)
                      |+|||+++........   ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            9999999877644322   22445789999999988765      234789999999999999999          7788


Q ss_pred             CCCch---hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1010 EGGEE---CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1010 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .....   ....+.........    ....+..      .........+.+++.+|++.||++||++.||++.|+++.++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQKL----RPNIPNR------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC----CCCCCGG------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcCcccHHHHHHHHHHHHh----CCCCccc------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            65422   22233222221100    0001100      01235677899999999999999999999999999998654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-38  Score=354.27  Aligned_cols=263  Identities=27%  Similarity=0.441  Sum_probs=199.9

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      ++....++|.+.+.||+|+||.||+|.+.    .++.||||++......  ..+.+.+|+.++++    ++||||+++++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~  103 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD----FSHPNVIRLLG  103 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHT----CCCTTBCCCCE
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhc----CCCCCeeeeeE
Confidence            33344578999999999999999999864    3458999999765322  23568899999997    67999999999


Q ss_pred             EEecCC-----eEEEEEEecCCCCHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001384          873 WCLDGS-----EKILVYEYMEGGSLEDIIS------DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL  941 (1088)
Q Consensus       873 ~~~~~~-----~~~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll  941 (1088)
                      ++.+..     ..++||||+++|+|.+++.      ....+++.+++.++.|++.||+|||++   +|+||||||+||++
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli  180 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCML  180 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEE
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEE
Confidence            998755     3499999999999999984      334699999999999999999999999   99999999999999


Q ss_pred             cCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHH
Q 001384          942 DKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEW 1019 (1088)
Q Consensus       942 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~ 1019 (1088)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........  
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--  258 (313)
T 3brb_A          181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--  258 (313)
T ss_dssp             CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred             cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--
Confidence            99999999999999876543322 2234467889999999999899999999999999999999 8889976543211  


Q ss_pred             HHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ......                +.....+...+..+.+++.+|++.||++||++.|+++.|+++++.
T Consensus       259 ~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          259 YDYLLH----------------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHHHHT----------------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHc----------------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111110                001111223346788999999999999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.3e-37  Score=342.01  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=195.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|++.  ..||||++......  ..+.+.+|++++++    ++||||+++++++ .....+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK----TRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEE-CSSSCE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHh----CCCCcEEEEEeec-cCCccE
Confidence            468999999999999999999974  35999999765322  33578899999987    6799999999965 456689


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++++|.+++.. ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999999964 45699999999999999999999999   999999999999999999999999999976543


Q ss_pred             CC-CcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          961 GD-SHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       961 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .. ........||+.|+|||.+.   ...++.++||||+|+++|+|++|+.||........ ...............   
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~---  248 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLS---  248 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTT---
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchh---
Confidence            22 22234457899999999876   66788999999999999999999999987543211 111111000000000   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                               ......+.++.+++.+|++.||++||+++|+++.|+++.+
T Consensus       249 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 ---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                     0112334678899999999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=354.66  Aligned_cols=243  Identities=24%  Similarity=0.296  Sum_probs=203.9

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCceeEEeeE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNLVTLYGW  873 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~  873 (1088)
                      ..++|++.+.||+|+||.||+|++. +++.||||++......        ....+.+|++++++    ++||||++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~Iv~~~~~   97 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR----VEHANIIKVLDI   97 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTT----CCCTTBCCEEEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHh----CCCCCEeeEEEE
Confidence            3467999999999999999999965 6889999999865321        22356789999987    679999999999


Q ss_pred             EecCCeEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          874 CLDGSEKILVYEYMEGG-SLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       874 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                      +.+.+..++||||+.+| +|.+++.....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A           98 FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999999777 9999999988999999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      |+++......  ......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||....+.        .  ..   
T Consensus       175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~--~~---  239 (335)
T 3dls_A          175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------V--EA---  239 (335)
T ss_dssp             TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------T--TT---
T ss_pred             ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------H--hh---
Confidence            9998765432  2344678999999999887776 88999999999999999999999763220        0  00   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 1079 (1088)
                       .  .         ..+.....++.+++.+|++.||++||+++|+++.
T Consensus       240 -~--~---------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 -A--I---------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -C--C---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -c--c---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0  0         0011123568889999999999999999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.4e-38  Score=372.74  Aligned_cols=248  Identities=28%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.++||+|+||.||+|+.+ +|+.||||++.+..   ......+.+|++++..    ++||||+++++++.+.+..
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~----l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK----VNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHH----cCCCCEeeEEEEEeeCCEE
Confidence            46888999999999999999976 78999999997642   2334568899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 ILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      |+||||++||+|.+++.....  +++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+++..
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999999977543  99999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCcccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...  ...+..........        
T Consensus       337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--------  406 (576)
T 2acx_A          337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--------  406 (576)
T ss_dssp             CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--------
T ss_pred             ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--------
Confidence            5332  23345799999999999998999999999999999999999999987532  11122222211110        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                               ..+.....++.+++.+|++.||++||     +++||++
T Consensus       407 ---------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 ---------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                     01122345788899999999999999     6788864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-37  Score=345.21  Aligned_cols=255  Identities=24%  Similarity=0.325  Sum_probs=207.1

Q ss_pred             CCCCccc-eecccCceEEEEEEeC---CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDR-IIGKGGFGTVYRGVLP---DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|.+.+ .||+|+||.||+|.+.   +++.||||++..... ...+.+.+|++++..    ++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----LDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHh----CCCCCEeEEEEEe-cCCC
Confidence            4566665 9999999999999854   577899999987532 334678899999997    6799999999999 4566


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999999654 4699999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .......  .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.......  ........         
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~---------  229 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG---------  229 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTT---------
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcC---------
Confidence            5433222  223456889999999988889999999999999999998 999998754321  11111100         


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                             .....+...+.++.+++.+|++.||++||++.|+++.|++++.
T Consensus       230 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          230 -------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                   0011122344678899999999999999999999999998853

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=357.78  Aligned_cols=264  Identities=19%  Similarity=0.260  Sum_probs=200.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCcc-----------chHHHHHHHHHHhCCCCCCCCCcee
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGLE-----------GEREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      .++|++.+.||+|+||.||+|++.    ++..||||+.......           ....+.+|+..+..    +.||||+
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~----l~h~ni~  111 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ----LDYLGIP  111 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHT----CSCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcc----ccccCcc
Confidence            367999999999999999999975    5678999998765321           11335566777775    6899999


Q ss_pred             EEeeEEec----CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          869 TLYGWCLD----GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       869 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++++++..    ....++||||+ +++|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            99999987    77899999999 899999998887899999999999999999999999   99999999999999988


Q ss_pred             C--CEEEeecccceeecCCCC------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--
Q 001384          945 G--KALVTDFGLARVVSAGDS------HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-- 1014 (1088)
Q Consensus       945 ~--~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-- 1014 (1088)
                      +  .+||+|||+++.+.....      .......||..|+|||++.+..++.++|||||||++|||++|+.||.+...  
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999987643221      112445789999999999998999999999999999999999999965322  


Q ss_pred             hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ...........        ...+.......  .....+.++.+++.+|++.||++||++++|++.|+++..
T Consensus       268 ~~~~~~~~~~~--------~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAVQTAKTNLL--------DELPQSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHH--------HTTTHHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHHHhhc--------ccccHHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11111111110        00000000000  001234578899999999999999999999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-37  Score=342.27  Aligned_cols=269  Identities=26%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      ..++|++.+.||+|+||+||+|++. +++.||||++.....     .....+.+|+++++.+. .+.||||+++++++..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE-AFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHH-HHCCTTBCCEEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHh-hcCCCCeEEeeeeeec
Confidence            4678999999999999999999974 789999999975321     12345667777766532 2359999999999987


Q ss_pred             CC-----eEEEEEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          877 GS-----EKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       877 ~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      ..     ..++||||++ |+|.+++.....  +++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            55     5799999997 599999987654  99999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCC
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGR 1028 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~ 1028 (1088)
                      +|||+++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..+.. ............
T Consensus       162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999765432  22345678999999999988899999999999999999999999998765421 111111111111


Q ss_pred             CC--CCccccchhhcCCCcc-----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HG--PGRAVIPVVLLGSGLA-----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~--~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..  ......+.........     ........+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00  0000000000000000     01123457889999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=346.33  Aligned_cols=266  Identities=23%  Similarity=0.269  Sum_probs=200.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|++. +|+.||||++......  ..+.+.+|++++.+    ++||||+++++++.+++..+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ----LKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHh----CCCCCccchhheeecCCeEE
Confidence            67999999999999999999986 5899999998765332  23567889999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|.++++....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.....
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHH-HHHhhhcc-----------CC
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVE-WGRRVMGY-----------GR 1028 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~-----------~~ 1028 (1088)
                      .. ......+|..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+....... ........           ..
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            22 2334578999999998765 67899999999999999999999999876542111 11111000           00


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........+.................+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000000000000001123456889999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-37  Score=339.48  Aligned_cols=248  Identities=27%  Similarity=0.361  Sum_probs=197.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++    ++||||+++++++.+....++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS----LDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHh----CCCchHHhHHHheecCCeEEE
Confidence            46899999999999999999975 68899999997653 2345788999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccc
Q 001384          883 VYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLA  955 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a  955 (1088)
                      ||||+++|+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999998854    35799999999999999999999999   99999999999999   45688999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      +.....  .......||+.|+|||++.. .++.++||||+|+++|||++|+.||.+.............   ....... 
T Consensus       175 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~-  247 (285)
T 3is5_A          175 ELFKSD--EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK---EPNYAVE-  247 (285)
T ss_dssp             CC------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---CCCCCC--
T ss_pred             eecCCc--ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC---Ccccccc-
Confidence            865432  22344578999999998764 7899999999999999999999999876542222111111   0000000 


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                  ......++.+++.+|++.||++||+++|+++
T Consensus       248 ------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 ------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        0012356778999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.8e-37  Score=343.45  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++..........+.+|++++..    ++||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKK----IKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHH----CCCTTBCCEEEEEECSSEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHh----CCCCCeeehhhhcccCCEEEE
Confidence            357899999999999999999976 789999999987654455678899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ||||+++++|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||.++...
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999999998888899999999999999999999999   99999999999999   788999999999987543


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .   .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........  ..........      .+  
T Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~------~~--  227 (304)
T 2jam_A          161 N---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FEKIKEGYYE------FE--  227 (304)
T ss_dssp             C---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHCCCC------CC--
T ss_pred             C---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHcCCCC------CC--
Confidence            2   123345689999999999999999999999999999999999999987544211  1111100000      00  


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           .......+..+.+++.+|++.||++||+++|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 -----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0001223457888999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-37  Score=350.83  Aligned_cols=268  Identities=25%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             CCccceecccCceEEEEEEeC-----CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CC
Q 001384          807 FSEDRIIGKGGFGTVYRGVLP-----DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GS  878 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~  878 (1088)
                      |++.+.||+|+||+||+|.++     +++.||||++..... ...+.+.+|++++++    ++||||+++++++.+  ..
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT----LYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTTT
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHh----CCCcchhhEEEEEecCCCc
Confidence            488999999999999998642     578999999987532 234578999999997    679999999999987  46


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          879 EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..++||||+++|+|.+++.... +++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             eEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            7899999999999999997654 89999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          959 SAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       959 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ......  ......+|..|+|||++.+..++.++||||+|+++|+|++|+.||.........+.....   .........
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  261 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLT  261 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC---HHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc---cchhHHHHH
Confidence            543322  233456788899999998888999999999999999999999999764321111100000   000000000


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .....+.....+...+.++.+++.+|++.||++||+++|+++.|+++.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            0111111122233445688999999999999999999999999998854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-38  Score=344.80  Aligned_cols=250  Identities=31%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC-CeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG-SEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~-~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|.++ |+.||||++...  ...+.+.+|++++++    ++||||+++++++.+. +..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQ----LRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTT----CCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHh----CCCCCEeeEEEEEEcCCCceEE
Confidence            357899999999999999999984 889999999865  345678999999987    6799999999987654 47899


Q ss_pred             EEEecCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.+++.....  +++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999976543  89999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .    .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.......  .......              
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~--------------  229 (278)
T 1byg_A          170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEK--------------  229 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTT--------------
T ss_pred             c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhc--------------
Confidence            2    223357889999999988899999999999999999998 999998653311  1111110              


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                        +.....+...+..+.+++.+|++.||++||++.|+++.|+++..
T Consensus       230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          230 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence              00011122334678889999999999999999999999999854

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.7e-38  Score=353.35  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcE--EEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGRE--VAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. ++..  ||+|++.... ....+.+.+|++++.++.   +||||+++++++.+.+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---HHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC---CCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc---CCCchhhhceeeeeCCce
Confidence            56899999999999999999975 5654  4999887532 223456889999998732   799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          881 ILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++||||+++|+|.+++....                .+++.+++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997654                699999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhh
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      +.+||+|||+++....  ........++..|+|||++.+..++.++||||+|+++|||++ |+.||.+.....  .....
T Consensus       179 ~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~  254 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL  254 (327)
T ss_dssp             GCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG
T ss_pred             CeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHh
Confidence            9999999999874321  112233456889999999988889999999999999999998 999998764321  11111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....                ....+......+.+++.+|++.||++||+++|+++.|+++++
T Consensus       255 ~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          255 PQGY----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             GGTC----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCC----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1000                001122234578899999999999999999999999998864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-37  Score=359.22  Aligned_cols=248  Identities=25%  Similarity=0.290  Sum_probs=190.6

Q ss_pred             CCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CC
Q 001384          805 GKFSED-RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GS  878 (1088)
Q Consensus       805 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~  878 (1088)
                      ++|.+. ++||+|+||+||+|+++ +++.||||++...     ..+.+|++++.+.   .+||||+++++++..    ..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~---~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA---SQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHH---TTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHh---cCCCCcceEeEEEeecccCCc
Confidence            456665 68999999999999976 6899999998643     4567777776442   479999999998875    56


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeecc
Q 001384          879 EKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDFG  953 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Dfg  953 (1088)
                      ..|+||||+++|+|.+++....  .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            7899999999999999998754  599999999999999999999999   9999999999999997   7899999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH--HHHHhhhccCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV--EWGRRVMGYGRHGP 1031 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 1031 (1088)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......  ........... . 
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~-  285 (400)
T 1nxk_A          210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E-  285 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-C-
T ss_pred             cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-c-
Confidence            99875432  223456789999999999999999999999999999999999999976532100  00011100000 0 


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .+       .........++.+++.+||+.||++||++.|+++
T Consensus       286 ----~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          286 ----FP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             ----CC-------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                00       0001223457888999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.6e-38  Score=354.25  Aligned_cols=251  Identities=26%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.+....    ..+|++++.+.   .+||||+++++++.++...|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~---~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRY---GQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHH---TTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHh---cCCCCcCeEEEEEEcCCEEEE
Confidence            457999999999999999999976 6889999999765332    34566666653   279999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC----CCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE----GKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~----~~~kl~Dfg~a~~~  958 (1088)
                      ||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||++..+    +.+||+|||+++..
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999999888899999999999999999999999   99999999999998543    35999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccc
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+....+.......      +
T Consensus       171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------~  243 (342)
T 2qr7_A          171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL------S  243 (342)
T ss_dssp             BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC------C
T ss_pred             cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc------C
Confidence            54322 23456789999999998887899999999999999999999999986432 2222222222111000      0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .   .........+.+++.+|++.||++||++.|+++
T Consensus       244 ----~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 ----G---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----S---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----c---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0   001223456888999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-38  Score=359.40  Aligned_cols=251  Identities=27%  Similarity=0.371  Sum_probs=203.4

Q ss_pred             CCCCccceecccCceEEEEEEe----CCCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      ++|++.+.||+|+||.||+|+.    .+++.||||+++....    ...+.+.+|++++..+.   +||||+++++++..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---QSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH---TCTTBCCEEEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc---CCCceeEEEEEEee
Confidence            5799999999999999999997    3689999999975421    22345667888887632   69999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +...++||||+++|+|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999999999888899999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCC
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .+............||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....  .............     
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  282 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----  282 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-----
Confidence            765433334445679999999998875  4578999999999999999999999975432  2222222222100     


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                                  ...+......+.+++.+|++.||++||     +++|+++
T Consensus       283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence                        011223345678899999999999999     8999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-38  Score=358.32  Aligned_cols=255  Identities=31%  Similarity=0.464  Sum_probs=194.3

Q ss_pred             CCCccceecccCceEEEEEEeC--CC--cEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-CCe
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP--DG--REVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-GSE  879 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-~~~  879 (1088)
                      .|++.+.||+|+||+||+|++.  ++  ..||||.+..... ...+++.+|+.++++    ++||||+++++++.. ++.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTT----CCCTTBCCCCEEECCCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHh----CCCCCcceEEEEEEcCCCC
Confidence            4667789999999999999864  22  4689999876432 334678899998886    679999999998754 567


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++|+|.++++... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence            899999999999999997654 589999999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCc---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCch-hHHHHHHhhhccCCCCCCc
Q 001384          959 SAGDSH---VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEE-CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       959 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ......   ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..... ........           
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-----------  311 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----------  311 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-----------
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-----------
Confidence            433211   1233457789999999988899999999999999999999 6667765433 11111111           


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                              +.....+...+..+.+++.+||+.||++||+++|+++.|++++..
T Consensus       312 --------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          312 --------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    011111223446788999999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.5e-38  Score=352.63  Aligned_cols=267  Identities=25%  Similarity=0.356  Sum_probs=213.3

Q ss_pred             CHHHHHHHcCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCcee
Q 001384          796 TYSDILKATGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       796 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      .........++|++.+.||+|+||.||+|++      .+++.||||++...... ..+.+.+|++++.++.   +||||+
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~iv   94 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG---HHLNVV   94 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBC
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc---cCCCee
Confidence            3344444567899999999999999999984      24688999999865332 3357889999998742   699999


Q ss_pred             EEeeEEecCC-eEEEEEEecCCCCHHHHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001384          869 TLYGWCLDGS-EKILVYEYMEGGSLEDIISDRTR----------------LTWRRRLDIAIDVARALVFLHHECYPPIVH  931 (1088)
Q Consensus       869 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  931 (1088)
                      ++++++...+ ..++||||+++|+|.+++.....                +++.+++.++.|++.||+|||++   +|+|
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999987754 58999999999999999987553                89999999999999999999999   9999


Q ss_pred             cCCCCCCEEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCC
Q 001384          932 RDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRAL 1009 (1088)
Q Consensus       932 ~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~ 1009 (1088)
                      |||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654322 22334567889999999988899999999999999999998 99999


Q ss_pred             CCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1010 EGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .+............. ...                ...+.....++.+++.+|++.||.+||++.|+++.|+++++
T Consensus       252 ~~~~~~~~~~~~~~~-~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          252 PGVKIDEEFCRRLKE-GTR----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             TTCCCSHHHHHHHHH-TCC----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHHhcc-Ccc----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            765432111111111 000                00112233568889999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6e-37  Score=338.93  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||+|++......      ..+.+.+|++++++    ++||||+++++++.+.
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE----IRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH----CCCTTBCCEEEEEECS
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHh----CCCCCeeehhheecCC
Confidence            46889999999999999999986 6899999998764322      35678999999987    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeecc
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDFG  953 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Dfg  953 (1088)
                      ...++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999999998888899999999999999999999999   999999999999999877    89999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .+.......  ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.+......  .........     
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~-----  228 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTNISAVNY-----  228 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTTCC-----
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHHhHhccc-----
Confidence            998764322  22345689999999999988999999999999999999999999987644211  111110000     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA--MLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~i 1083 (1088)
                       ..+...       .......+.+++.+|++.||++||++.|+++  .++++
T Consensus       229 -~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          229 -DFDEEY-------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             -CCCHHH-------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             -CCcchh-------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence             000000       1122356888999999999999999999987  44443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.8e-38  Score=354.86  Aligned_cols=266  Identities=27%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----CCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----GSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----~~~  879 (1088)
                      ++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.++....  .++||||+++++++..     ...
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~--~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVP--LMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTST--TCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHH--hccCcchhhheecccccccCCCce
Confidence            5789999999999999999987 5899999999754   334555565555432  2689999999985542     336


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC------YPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                      .++||||+++|+|.++++... .++..++.++.|++.||+|||+.+      .++|+||||||+||+++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            789999999999999997654 599999999999999999999873      2389999999999999999999999999


Q ss_pred             cceeecCCCC-------cccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh----
Q 001384          954 LARVVSAGDS-------HVSTTIAGTVGYVAPEYGQT-------WQATTKGDVYSFGVLAMELATGRRALEGGEEC---- 1015 (1088)
Q Consensus       954 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~---- 1015 (1088)
                      +++.+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.||......    
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987653221       11234579999999998876       45678899999999999999998887543210    


Q ss_pred             ------------HHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1016 ------------LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1016 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                                  ..++..... .   ......++     ...........++.+++.+||+.||++||+++|+++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVS-R---EKQRPKFP-----EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHT-T---SCCCCCCC-----TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhc-c---cccCCCCC-----cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence                        000000000 0   00000011     11112344667899999999999999999999999999998


Q ss_pred             CCC
Q 001384         1084 LPH 1086 (1088)
Q Consensus      1084 ~~~ 1086 (1088)
                      +..
T Consensus       317 l~~  319 (336)
T 3g2f_A          317 MMI  319 (336)
T ss_dssp             HHC
T ss_pred             HHH
Confidence            754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=360.96  Aligned_cols=273  Identities=22%  Similarity=0.247  Sum_probs=212.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--e
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--E  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--~  879 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++    ++||||+++++++.+..  .
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK----LNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHH----CCCTTBCCEEEEEECTTTCC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHh----cCCCCCCeEEEeeccCCCCe
Confidence            357899999999999999999986 589999999986432 334677899999997    67999999999998755  7


Q ss_pred             EEEEEEecCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCCEEEeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTR---LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----DKEGKALVTDF  952 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----~~~~~~kl~Df  952 (1088)
                      .++||||+++|+|.++++....   +++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            7999999999999999976543   99999999999999999999999   99999999999999    77788999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCC--------CCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHh
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQT--------WQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRR 1022 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~ 1022 (1088)
                      |+++......  ......||..|+|||++..        ..++.++|||||||++|||++|+.||.....  ...+....
T Consensus       161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~  238 (396)
T 4eut_A          161 GAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK  238 (396)
T ss_dssp             GGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred             CCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence            9998765322  2334578999999998754        5678899999999999999999999974321  11122222


Q ss_pred             hhccCCCCCCccc---------cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1023 VMGYGRHGPGRAV---------IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1023 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .............         .... ..............+.+++.+|++.||++||+++|+++.++++++.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCcc-CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            2111100000000         0000 0011122466778899999999999999999999999999998753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5e-37  Score=354.83  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .+|++.+.||+|+||+||+|.+.+++.||||++.....  ...+.+.+|++++.++.  -.||||+++++++..++..|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHT--TTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcc--cCCCeEEEEEEEEecCCEEEE
Confidence            35899999999999999999988899999999976532  23367889999998743  237999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||| +.+++|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++ ++.+||+|||+++.+....
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999 56789999999888999999999999999999999999   999999999999995 6899999999998765432


Q ss_pred             Cc-ccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC
Q 001384          963 SH-VSTTIAGTVGYVAPEYGQT-----------WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       963 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1088)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||........... .........
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-~~~~~~~~~  287 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEI  287 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH-HHHCTTSCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH-HHhCccccC
Confidence            22 2345679999999998754           4689999999999999999999999986543222221 111100000


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .    .           +.....++.+++.+|++.||++||++.|+++
T Consensus       288 ~----~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          288 E----F-----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             C----C-----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----C-----------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            0    0           1111346788999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.7e-37  Score=347.93  Aligned_cols=262  Identities=22%  Similarity=0.302  Sum_probs=208.1

Q ss_pred             ccCHHHHHHHcCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeE
Q 001384          794 AFTYSDILKATGKFSED-RIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVT  869 (1088)
Q Consensus       794 ~~~~~~~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~  869 (1088)
                      ...+.......++|.+. +.||+|+||.||+|++. +++.||||++....  ......+.+|+.++....   +||||++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~~iv~   93 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK---SCPRVIN   93 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT---TCTTBCC
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc---CCCCEEE
Confidence            34444555667788887 89999999999999976 68999999997643  233567889999998743   6899999


Q ss_pred             EeeEEecCCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---C
Q 001384          870 LYGWCLDGSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---E  944 (1088)
Q Consensus       870 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~  944 (1088)
                      +++++.+....++||||+++|+|.+++...  ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.   +
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence            999999999999999999999999998653  5799999999999999999999999   9999999999999997   7


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      +.+||+|||+++......  ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+.............
T Consensus       171 ~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  248 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV  248 (327)
T ss_dssp             CCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             CcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence            899999999998764322  233457899999999999999999999999999999999999999876542221111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....   .            ..........+.+++.+|++.||++||+++|+++
T Consensus       249 ~~~~---~------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 NVDY---S------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CCCC---C------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccc---C------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0000   0            0011223456888999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.3e-37  Score=338.73  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.+++.    ++||||+++++++.+++..+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----LNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHT----CCCTTBCCEEEEEEETTEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHh----cCCCCceeeeeEEEcCCEEE
Confidence            357899999999999999999976 68999999997543 2334678899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999999998888899999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CC-cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DS-HVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. .......|+..|+|||.+.+..+ +.++||||+|+++|||++|+.||.........+.........       ..  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~--  229 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------LN--  229 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-------ST--
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-------cC--
Confidence            21 22344678999999999887665 789999999999999999999998765432222222110000       00  


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ........+.+++.+|++.||++||+++|+++
T Consensus       230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                   01123356788999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=349.58  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe----cCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL----DGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~----~~~  878 (1088)
                      .++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.    ++||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL----FNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHT----CCCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhh----cCCCCeeeEEEEEEeccCCCc
Confidence            35789999999999999999997 4789999999976655556788999999987    67999999999987    345


Q ss_pred             eEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          879 EKILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      ..++||||+++|+|.+++..    ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            78999999999999999875    45799999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCc--------ccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh
Q 001384          955 ARVVSAGDSH--------VSTTIAGTVGYVAPEYGQTWQ---ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       955 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      +.........        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||..............
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            8765321111        012345799999999887543   68999999999999999999999964211000001111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      .. .               ...+........+.+++.+|++.||.+||+++|+++.|+++...
T Consensus       261 ~~-~---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          261 QN-Q---------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HC-C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hc-c---------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            10 0               00011122345788999999999999999999999999998654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.6e-37  Score=339.99  Aligned_cols=245  Identities=25%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|+++++.    ++||||+++++++.+.+..
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH----LRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhc----CCCCCEeeEEEEEEcCCEE
Confidence            46889999999999999999976 57889999997542   2234678899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+++|+|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999999999888899999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .   ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.......  ..........            
T Consensus       167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~------------  229 (284)
T 2vgo_A          167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--THRRIVNVDL------------  229 (284)
T ss_dssp             S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTTCC------------
T ss_pred             c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HHHHHhcccc------------
Confidence            2   2334578999999999999899999999999999999999999998754321  1112211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ..+......+.+++.+|++.||.+||+++|+++
T Consensus       230 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 -----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 011223356788999999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.2e-37  Score=362.91  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=196.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++.+..  ....+.+.+|+.+++.    ++||||+++++++...   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC----VNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCCST
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHh----CCCCCCCcEEEEEccCCcc
Confidence            478999999999999999999975 68999999997642  2334578899999987    6799999999999654   


Q ss_pred             ---CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          878 ---SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       878 ---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                         ...|+||||+++ ++.+.+..  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence               457999999976 57777654  489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC-----
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH----- 1029 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 1029 (1088)
                      ++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ...+.......+..     
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred             eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence            9876432  234456899999999999999999999999999999999999999987643 11221111100000     


Q ss_pred             ---------------CCCc----cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 ---------------GPGR----AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ---------------~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                     ....    ...+................++.+++.+|++.||++|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                           0000    000000000111111223567899999999999999999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-37  Score=345.67  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=202.1

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe-cCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL-DGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~-~~~  878 (1088)
                      .+|++.+.||+|+||+||+|++.+    +..||+|++..... ...+.+.+|++++++    ++||||+++++++. .++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHT----CCCTTBCCCCEEECCSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHh----CCCCCEeeeeeEEEcCCC
Confidence            468888999999999999999642    23589999876432 234678899999997    67999999999864 456


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.++++.. ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            789999999999999999763 4589999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCC---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          958 VSAGDS---HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ......   .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||.........  .....        
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~--~~~~~--------  247 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYLLQ--------  247 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH--HHHHT--------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH--HHHhc--------
Confidence            643321   12234567789999999988899999999999999999999 55555544321111  11110        


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                              +.....+...+..+.+++.+|++.||++||+++|+++.|+++++.
T Consensus       248 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          248 --------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    001111222345788999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-37  Score=341.72  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.....   ...+.+.+|+.+++.    ++||||+++++++.+++.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS----LAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHh----CCCCCEeeeeeeeccCCE
Confidence            357889999999999999999986 578999999876532   234568889999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........ + ........           
T Consensus       167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-~~~~~~~~-----------  232 (294)
T 2rku_A          167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-Y-LRIKKNEY-----------  232 (294)
T ss_dssp             STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H-HHHHTTCC-----------
T ss_pred             cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHhhccC-----------
Confidence            322 223445789999999999988899999999999999999999999987543211 1 11110000           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+......+.+++.+|++.||++||+++|+++
T Consensus       233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                  001122356788999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=340.11  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=183.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|++++.+    ++||||+++++++.+.+..
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ----LKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----BCCTTBCCEEEEEECSSEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHh----CCCCCeEeEEEEEccCCeE
Confidence            56899999999999999999974 789999999975421   223678899999986    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++++|.+++... .++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999999875 5699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......  ......            .  
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~------------~--  226 (278)
T 3cok_A          164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNKVV------------L--  226 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CC------------S--
T ss_pred             CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HHHHHh------------h--
Confidence            3221 2234568999999999998899999999999999999999999998643210  000000            0  


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .....+.....++.+++.+|++.||++||+++|+++
T Consensus       227 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 ---ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               000012223457888999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-38  Score=352.83  Aligned_cols=271  Identities=25%  Similarity=0.359  Sum_probs=210.7

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL-----PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-  878 (1088)
                      ++|++.+.||+|+||.||+|+.     .+++.||||++........+.+.+|++++++    ++||||+++++++...+ 
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS----LQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHT----CCCTTBCCEEEEECC---
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHh----CCCCCeeeEEEEEEecCC
Confidence            5688999999999999999983     3688999999987655556789999999997    67999999999987654 


Q ss_pred             -eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          879 -EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ..++||||+++++|.++++.. ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence             689999999999999999875 4699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC-Cc
Q 001384          957 VVSAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP-GR 1033 (1088)
Q Consensus       957 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 1033 (1088)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||++|..||........   ........... ..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVF  270 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHHCTTCCTHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---HhhccccchhhhHH
Confidence            775433211  2234567789999998888899999999999999999999999875321111   11100000000 00


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ........+...+.+...+.++.+++.+|++.||++||++.|+++.|+++.+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0000111111122233445678899999999999999999999999998854

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-37  Score=343.99  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=199.6

Q ss_pred             HHcCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeE-EeeEEecCCe
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT-LYGWCLDGSE  879 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~-l~~~~~~~~~  879 (1088)
                      ...++|++.+.||+|+||.||+|++ .+++.||||++....  ....+..|++++..    +.|++++. +..++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~----l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKM----MQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHH----HTTSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHH----hcCCCCCCeeeeecCCCCc
Confidence            3457899999999999999999997 478999999876542  22357778888876    44665554 4445577788


Q ss_pred             EEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccc
Q 001384          880 KILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLA  955 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a  955 (1088)
                      .++||||+ +++|.+++.. ..++++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            89999999 8899999975 45799999999999999999999999   99999999999999   78999999999999


Q ss_pred             eeecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-----hHHHHHHhhh
Q 001384          956 RVVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-----CLVEWGRRVM 1024 (1088)
Q Consensus       956 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-----~~~~~~~~~~ 1024 (1088)
                      +........      ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+...     ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            887543321      22356789999999999999999999999999999999999999986432     1111111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .                ..........+.++.+++.+|++.||++||+++++++.|+++++
T Consensus       236 ~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          236 S----------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             H----------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             c----------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            0                00000001124578899999999999999999999999998864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=377.34  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             CCCccc-eecccCceEEEEEEeC---CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          806 KFSEDR-IIGKGGFGTVYRGVLP---DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       806 ~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++.+.+ .||+|+||.||+|.++   ++..||||+++.... ...+++.+|++++++    ++|||||++++++.. +..
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~----l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----LDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTT----CCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHh----CCCCCEeeEEEEecc-CCe
Confidence            344444 7999999999999864   456799999987532 345789999999987    679999999999976 568


Q ss_pred             EEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999999999999754 4599999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          960 AGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       960 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ......  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+......  ...+.            
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~i~------------  553 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIE------------  553 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--HHHHH------------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHHH------------
Confidence            332222  223345689999999988899999999999999999998 9999987644211  11111            


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                          .+.....+..++.++.+++.+||+.||++||++++|++.|+.++
T Consensus       554 ----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          554 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                01111123344568889999999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=345.95  Aligned_cols=244  Identities=28%  Similarity=0.339  Sum_probs=193.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.++||+|+||+||+|++. +++.||||++......  .......|+..+.+.   .+||||+++++++.+++..+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~---~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV---GQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH---CCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh---cCCCcEEEEEEEEEeCCEEE
Confidence            57999999999999999999986 7899999998764322  223445555555442   37999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+ +++|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999 66999888764 4699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .  .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+...    |.....     .    ..+...
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~-----~----~~~~~~  273 (311)
T 3p1a_A          210 A--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQ-----G----YLPPEF  273 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTT-----T----CCCHHH
T ss_pred             C--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhc-----c----CCCccc
Confidence            2  22344568999999998876 799999999999999999999887765321    111110     0    001111


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             +.....++.+++.+|++.||++||+++|+++
T Consensus       274 -------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 -------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   1123467889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-36  Score=363.51  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.+..  ......+.+|+.+++.    ++||||+++++++.+....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL----LDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHh----CCCCCCCeEEEEEEeCCEE
Confidence            346999999999999999999976 68899999997653  2335678999999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CCEEEeeccccee
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE---GKALVTDFGLARV  957 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~---~~~kl~Dfg~a~~  957 (1088)
                      ++||||+++|+|.+++....++++.+++.++.||+.||+|||++   +|+||||||+||+++..   +.+||+|||+++.
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999998888899999999999999999999999   99999999999999764   4599999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      +....  ......||+.|+|||++.. .++.++||||+||++|+|++|+.||.+......  ............     .
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~-----~  258 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LRKVEKGKYTFD-----S  258 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTCCCCC-----S
T ss_pred             CCCCc--cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCCCCCC-----c
Confidence            75432  2345679999999998864 799999999999999999999999987654221  111111000000     0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              +........+.+++.+|++.||.+|||+.|+++
T Consensus       259 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 --------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                    001122356888999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-37  Score=343.37  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=204.7

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....    ..+.+|++++++    ++||||+++++++..     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAK----LDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHH----CCCTTBCCEEEEEEEEEEC-
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHh----CCCCCEEEEeeeEeccccCc
Confidence            3457999999999999999999986 78999999997652    356788999887    679999999998864     


Q ss_pred             -----------CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC
Q 001384          877 -----------GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK  943 (1088)
Q Consensus       877 -----------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~  943 (1088)
                                 ....++||||+++|+|.++++..  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                       44579999999999999999754  5799999999999999999999999   9999999999999999


Q ss_pred             CCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh
Q 001384          944 EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       944 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 1023 (1088)
                      ++.+||+|||.+.......  ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.....    +....
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----~~~~~  231 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----FFTDL  231 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----HHHHH
T ss_pred             CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----HHHHh
Confidence            9999999999998765432  23345689999999999988999999999999999999999998753211    11111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ..    ..    .           +......+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus       232 ~~----~~----~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          232 RD----GI----I-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HT----TC----C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             hc----cc----c-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            10    00    0           011224577899999999999999999999999988754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.1e-37  Score=348.03  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|+.+++.    ++||||+++++++.+.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS----LAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEecCCe
Confidence            457899999999999999999976 578999999876532   234578889999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... .......|+..|+|||++.+..++.++||||||+++|||++|+.||........ + ........           
T Consensus       193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~-----------  258 (335)
T 2owb_A          193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-Y-LRIKKNEY-----------  258 (335)
T ss_dssp             STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H-HHHHHTCC-----------
T ss_pred             cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-H-HHHhcCCC-----------
Confidence            322 223446789999999999888899999999999999999999999987543211 1 11110000           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+......+.+++.+|++.||++||+++|+++
T Consensus       259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  001122346788999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-37  Score=378.41  Aligned_cols=248  Identities=28%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             ceecccCceEEEEEEeC---CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP---DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +.||+|+||+||+|.+.   .++.||||+++....  ...+++.+|++++.+    ++|||||++++++.. +..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHH----CCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEec-CCEEEEEE
Confidence            47999999999999653   467899999986532  235789999999997    679999999999865 55889999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCc-
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH-  964 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  964 (1088)
                      |+++|+|.++++....+++.+++.|+.||+.||+|||++   +||||||||+||+++.++.+||+|||+++.+...... 
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999999999888899999999999999999999999   9999999999999999999999999999876543321 


Q ss_pred             -ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          965 -VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       965 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                       ......+|..|+|||++....++.++|||||||++|||++ |+.||.+......  ......                +
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~i~~----------------~  588 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK----------------G  588 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT----------------T
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc----------------C
Confidence             2233456789999999998899999999999999999998 9999987654221  111110                0


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .....+..++.++.+++.+||+.||++||++++|++.|++++
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            011112334567889999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-37  Score=343.91  Aligned_cols=255  Identities=30%  Similarity=0.404  Sum_probs=203.1

Q ss_pred             CCCccceecccCceEEEEEEeCC----CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .|+..+.||+|+||+||+|++.+    +..||+|++..... ...+.+.+|++++++    ++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG----LNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHT----CCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHh----CCCCCeeeEEEEEecCCCC
Confidence            45567899999999999998532    23799999976433 234678899999997    6799999999999876655


Q ss_pred             -EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          881 -ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       881 -~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                       ++||||+.+|+|.+++.. ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence             999999999999999976 45689999999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCC---CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCC-ch-hHHHHHHhhhccCCCCCCc
Q 001384          959 SAGD---SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGG-EE-CLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       959 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~-~~-~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ....   ........++..|+|||...+..++.++||||+|+++|+|++|+.|+... .. ..........         
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------  245 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------  245 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---------
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---------
Confidence            4322   11223456788999999999999999999999999999999966665443 22 1111111110         


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                                ....+......+.+++.+|++.||.+||+++|+++.|++++++
T Consensus       246 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          246 ----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                      0111222345788999999999999999999999999998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-36  Score=335.82  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=197.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.    ++||||+++++++.+.+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL----FRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhc----CCCCCEeEEEEEEecCCe
Confidence            367999999999999999999986 78999999997542   2234578899999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .++||||+++++|.+++....++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999999998888899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ...  ......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.......  ..........          
T Consensus       163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~----------  228 (276)
T 2h6d_A          163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGGVF----------  228 (276)
T ss_dssp             C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC----------
T ss_pred             CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhcCcc----------
Confidence            322  2234568999999999887665 689999999999999999999998654321  1111110000          


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ..+......+.+++.+|++.||++||+++|+++
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                   001122356888999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.6e-37  Score=342.20  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=203.4

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeE-EeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-PDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT-LYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~-l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||.||+|++ .+++.||||++....  ...++.+|++++..    +.|++++. +..+...+...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~----l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKM----MQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHH----HTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHH----hhcCCCCCccccccCCCCceE
Confidence            46899999999999999999997 478999999987653  23467889998887    45666554 444556778889


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeeccccee
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARV  957 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a~~  957 (1088)
                      +||||+ +++|.++++. ..++++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||.++.
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999999 8899999974 45799999999999999999999999   99999999999999   4889999999999987


Q ss_pred             ecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-----hHHHHHHhhhcc
Q 001384          958 VSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-----CLVEWGRRVMGY 1026 (1088)
Q Consensus       958 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-----~~~~~~~~~~~~ 1026 (1088)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+...     ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            7644321      12456799999999999999999999999999999999999999986422     111111111100


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .         ...       .....+.++.+++.+|++.||++||+++||++.|++++.
T Consensus       238 ~---------~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          238 P---------IEV-------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             C---------HHH-------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             c---------hHH-------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            0         000       011234578899999999999999999999999998864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-36  Score=348.91  Aligned_cols=259  Identities=26%  Similarity=0.356  Sum_probs=208.2

Q ss_pred             HHHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCce
Q 001384          797 YSDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNL  867 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~ni  867 (1088)
                      +.......++|++.+.||+|+||.||+|+++ +|+.||||++......        ..+.+.+|+.++.++.   .||||
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~i  162 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA---GHPHI  162 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT---TCTTB
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc---CCCCE
Confidence            3444556678999999999999999999986 7999999998754311        1345778999888632   69999


Q ss_pred             eEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          868 VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       868 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      +++++++......++||||+++++|.+++.....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus       163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             CCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999999999888899999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH
Q 001384          948 LVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ------TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 1021 (1088)
                      ||+|||++..+....  ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........  ..
T Consensus       240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~  315 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--LR  315 (365)
T ss_dssp             EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH
T ss_pred             EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--HH
Confidence            999999998765432  234567999999999875      33688999999999999999999999987543211  11


Q ss_pred             hhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....... .    ...+.        .......+.+++.+|++.||++||+++|+++
T Consensus       316 ~i~~~~~-~----~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIMEGQY-Q----FSSPE--------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHTCC-C----CCHHH--------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCCC-C----CCCcc--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1110000 0    00000        0112356888999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5e-37  Score=347.18  Aligned_cols=266  Identities=23%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc--hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++.......  .+.+.+|++++++    ++||||+++++++.++...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE----LQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGG----CCCTTBCCEEEEEEETTEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHH----cCCCCcceEEEEEecCCEE
Confidence            467999999999999999999965 78999999997653222  3467789999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-----CCCCEEEeecccc
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-----KEGKALVTDFGLA  955 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-----~~~~~kl~Dfg~a  955 (1088)
                      ++||||+++ +|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++     .++.+||+|||++
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999999985 9999999988899999999999999999999999   999999999999994     4556999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH-HhhhccCCCCCCc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG-RRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 1033 (1088)
                      +...... .......+|..|+|||++.+. .++.++||||+||++|||++|+.||.+......... .............
T Consensus       185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            8764322 223345679999999988764 589999999999999999999999987654221111 1111111100000


Q ss_pred             --cccch------hhcCCCcc--ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 --AVIPV------VLLGSGLA--EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 --~~~~~------~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ...+.      ........  .......++.+++.+|++.||++||+++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence              00000      00000000  01113357889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.2e-37  Score=351.87  Aligned_cols=252  Identities=14%  Similarity=0.130  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCceEEEEEE------eCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGV------LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      .++|++.+.||+|+||+||+|+      ..+++.||||++...   ...++..|++++..+. ...|+||+++++++..+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~-~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLK-PSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSC-GGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhh-hhhhhhhhhhheeeecC
Confidence            4679999999999999999994      346889999999765   3456777777777643 24599999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---------
Q 001384          878 SEKILVYEYMEGGSLEDIISD-----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---------  943 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---------  943 (1088)
                      +..++||||+++|+|.++++.     ...+++.+++.|+.||+.||+|||++   +||||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974     45699999999999999999999999   9999999999999998         


Q ss_pred             --CCCEEEeecccceeecCC-CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH
Q 001384          944 --EGKALVTDFGLARVVSAG-DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020 (1088)
Q Consensus       944 --~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 1020 (1088)
                        ++.+||+|||+|+.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......     
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence              899999999999875422 223345567999999999999989999999999999999999999999653220     


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCC-CCHHHHHHHHHhhCC
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNAR-PNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~i~~ 1085 (1088)
                                  ...........      .....+.+++..|++.+|.+| |+++++.+.|++++.
T Consensus       292 ------------~~~~~~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          292 ------------ECKPEGLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             ------------EEEECSCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ------------ceeechhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                        00000000000      123456678889999999999 578888888888754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.4e-37  Score=376.38  Aligned_cols=248  Identities=27%  Similarity=0.338  Sum_probs=207.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.++||+|+||+||+|+++ +++.||||++++..   ....+.+..|..++....   +||+|+++++++.+.+.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~---~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG---KPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT---CCTTBCCEEEECBCSSE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc---CCCeEEEEEEEEEeCCE
Confidence            467999999999999999999976 68899999997642   223456788888887643   79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||+++|+|.++++..+++++.+++.|+.||+.||+|||++   +||||||||+|||++.++++||+|||+++...
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999999999888999999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      .. ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....  +....+.....           
T Consensus       494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~-----------  559 (674)
T 3pfq_A          494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEHNV-----------  559 (674)
T ss_dssp             CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHSSCC-----------
T ss_pred             cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHHHHhCCC-----------
Confidence            22 22345678999999999999999999999999999999999999999876442  22222221110           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH-----HHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV-----KEVL 1077 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil 1077 (1088)
                            ..+.....++.+++.+|++.||++||++     +||+
T Consensus       560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence                  0122234578889999999999999997     6654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3e-37  Score=353.90  Aligned_cols=265  Identities=23%  Similarity=0.343  Sum_probs=205.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++..    ++||||+++++++.+++..++
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE----CNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGG----CCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHH----CCCCCEEEEeEEEEECCEEEE
Confidence            57899999999999999999976 68999999998653 2234578899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|.++++....+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||++.....  
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  184 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  184 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence            9999999999999998888999999999999999999999842  899999999999999999999999999875532  


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC-------------
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH------------- 1029 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------- 1029 (1088)
                       .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....................             
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence             122345789999999999999999999999999999999999999987654322221110000000             


Q ss_pred             -----------CCCccccchhhcCCCccc-cHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 -----------GPGRAVIPVVLLGSGLAE-GAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 -----------~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 ....+..+.......... ......++.+++.+|++.||++||+++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                       000000011111111111 1123457889999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=354.72  Aligned_cols=258  Identities=16%  Similarity=0.216  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCceEEEEEEeCC---------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeE-----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD---------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT-----  869 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~-----  869 (1088)
                      .++|++.+.||+|+||.||+|++..         ++.||||++...     +.+.+|++++.+    ++||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~----l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQR----AAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHH----HCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHH----hcccchhhhhhhh
Confidence            3679999999999999999999763         789999998754     357788888886    56988887     


Q ss_pred             ----------EeeEEec-CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001384          870 ----------LYGWCLD-GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKA  936 (1088)
Q Consensus       870 ----------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp  936 (1088)
                                +++++.. +...++||||+ +++|.+++...  ..+++.+++.++.|++.||+|||++   +|+||||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp  187 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA  187 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence                      6677765 67889999999 99999999876  6799999999999999999999999   999999999


Q ss_pred             CCEEEcCCC--CEEEeecccceeecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcC
Q 001384          937 SNVLLDKEG--KALVTDFGLARVVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008 (1088)
Q Consensus       937 ~NIll~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 1008 (1088)
                      +||+++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  9999999999876532211      12345789999999999998999999999999999999999999


Q ss_pred             CCCCch---hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1009 LEGGEE---CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1009 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      |.....   .............     ....+...      .....+.++.+++.+|++.||++||+++|+++.|+++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKP-----GPFVGPCG------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSC-----CCEECTTS------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCCh-----hhhhhhcc------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            986532   1212211111000     00000000      001123678889999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-36  Score=362.70  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=204.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++.+..  ......+.+|++++++    ++||||+++++++.+....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK----LDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHh----CCCCCcCeEEEEEEcCCEE
Confidence            457999999999999999999976 78999999986532  2345678999999997    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCCEEEeeccccee
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARV  957 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~---~~~~~kl~Dfg~a~~  957 (1088)
                      ++||||+++|+|.+++....++++.+++.++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999999998888999999999999999999999999   999999999999995   456799999999986


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      +...  .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..............+..  .      
T Consensus       174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~------  242 (486)
T 3mwu_A          174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--D------  242 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--C------
T ss_pred             CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--C------
Confidence            6432  22344579999999999876 69999999999999999999999998765422211111110000  0      


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             .+.......++.+++.+|++.||.+||++.|+++
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   0111223457889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-37  Score=366.49  Aligned_cols=244  Identities=26%  Similarity=0.345  Sum_probs=202.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.++||+|+||.||+|+++ +|+.||+|++.+...   .....+..|++++.+    ++||||+++++++.+....
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~----l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK----VHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH----CCCTTBCCEEEEEECSSEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHh----cCCCCEeeEEEEEeeCCEE
Confidence            56888899999999999999986 689999999976432   234578889999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceee
Confidence            9999999999999999764    3699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCCcc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      ....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..+  ...+....+.....      
T Consensus       338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------  410 (543)
T 3c4z_A          338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------  410 (543)
T ss_dssp             ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC------
T ss_pred             eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc------
Confidence            7654322 23445899999999999999999999999999999999999999987532  12222222221100      


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                                 ..+......+.+++.+|++.||++||++
T Consensus       411 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 -----------TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -----------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                       1122234578889999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-37  Score=349.03  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-C-----cEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD-G-----REVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|.+.. +     +.||+|++..... ...+.+.+|++++..+.   +||||+++++++.+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG---QHENIVNLLGACTH  121 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEEEEECS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc---CCCCeeeEEEEEec
Confidence            4789999999999999999999642 2     4799999986532 23457889999998732   79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc
Q 001384          877 GSEKILVYEYMEGGSLEDIISDR--------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD  942 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~  942 (1088)
                      ++..++||||+++|+|.+++...              ..+++.+++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            99999999999999999999753              3579999999999999999999999   999999999999999


Q ss_pred             CCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHH
Q 001384          943 KEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWG 1020 (1088)
Q Consensus       943 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 1020 (1088)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.......+.
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            9999999999999876443322 2334567889999999888899999999999999999998 9999986543211111


Q ss_pred             HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .......                 ...+...+..+.+++.+|++.||.+||++.|+++.|+++.
T Consensus       279 ~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          279 LVKDGYQ-----------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCC-----------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1111000                 0011222457888999999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.6e-37  Score=347.54  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=196.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||++....... ...+.+|+++++.    ++||||+++++++.++...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----LKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSC----CCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHh----cCCCCCCeeeeEEeeCCEEEE
Confidence            57899999999999999999976 78999999997543221 1234578999986    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++ +|.+++.... .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999975 9999887654 599999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCCCccccchh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      . .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+... .........................
T Consensus       154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          154 T-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             c-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            2 22334568999999998765 5789999999999999999999999987654 2222222222111111111100000


Q ss_pred             ----------hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 ----------LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                ..............++.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                      000000011123456789999999999999999999976

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-36  Score=335.20  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=199.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----C
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----G  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~  877 (1088)
                      ..|++.+.||+|+||.||+|.+. ++..||+|++.....  ...+.+.+|+.++++    ++||||+++++++..    .
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG----LQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEEESSSC
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHh----CCCCCeeeeeeeeccccCCC
Confidence            34778889999999999999975 678999999876532  234568899999987    679999999998875    4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEc-CCCCEEEeeccc
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLD-KEGKALVTDFGL  954 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~-~~~~~kl~Dfg~  954 (1088)
                      ...++||||+++|+|.++++....+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            56899999999999999999888899999999999999999999998   7  99999999999998 789999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcc
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1088)
                      +.....   .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.........+ ........    ..
T Consensus       179 ~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~----~~  249 (290)
T 1t4h_A          179 ATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRVTSGVK----PA  249 (290)
T ss_dssp             GGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHHTTTCC----CG
T ss_pred             cccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-HHHhccCC----cc
Confidence            975432   22344578999999998875 69999999999999999999999998754422222 22210000    00


Q ss_pred             ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .           .+.....++.+++.+|++.||++||+++|+++
T Consensus       250 ~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 S-----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G-----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0           01112246889999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.1e-37  Score=364.23  Aligned_cols=250  Identities=28%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++....   ......+.+|++++++    ++||||+++++++.+...
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ----LDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHh----CCCCCCCcEEEEEEeCCE
Confidence            357999999999999999999976 78999999987543   2345678999999987    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccce
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLAR  956 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a~  956 (1088)
                      .++||||+.+|+|.+++....++++.+++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999999999888999999999999999999999999   99999999999999   567899999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .+....  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.......  ..+........     
T Consensus       178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~-----  247 (484)
T 3nyv_A          178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL--KKVEKGKYTFE-----  247 (484)
T ss_dssp             HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCCCC-----
T ss_pred             Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHcCCCCCC-----
Confidence            765332  2344579999999998876 7999999999999999999999999876542211  11110000000     


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              .+........+.+++.+|++.||++||++.|+++
T Consensus       248 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 --------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                    0111223457888999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-37  Score=339.78  Aligned_cols=244  Identities=23%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..++|++.+.||+|+||+||+|++. +++.||||++....  .....++.+|+..+...   .+||||+++++++.+++.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l---~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL---GQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHS---CSCTTBCCEEEEEEETTE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHh---CCCCCeeeeeeeeecCCe
Confidence            3467999999999999999999986 78999999998643  23345678888888763   279999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-----------
Q 001384          880 KILVYEYMEGGSLEDIISDR----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-----------  944 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-----------  944 (1088)
                      .++||||+++|+|.++++..    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.+           
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999999999764    5689999999999999999999999   99999999999999844           


Q ss_pred             --------CCEEEeecccceeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh
Q 001384          945 --------GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC 1015 (1088)
Q Consensus       945 --------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~ 1015 (1088)
                              ..+||+|||.+.......     ...||..|+|||.+.+. .++.++||||+|+++|+|++|..++..... 
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred             cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence                    479999999998764322     23589999999988765 667899999999999999999987755322 


Q ss_pred             HHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         +.....  ...               ...+......+.+++.+|++.||++||++.|+++
T Consensus       237 ---~~~~~~--~~~---------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ---WHEIRQ--GRL---------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---HHHHHT--TCC---------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHc--CCC---------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence               111110  000               0011123357888999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-37  Score=356.86  Aligned_cols=205  Identities=27%  Similarity=0.395  Sum_probs=164.6

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++....  ......+.+|+.++..+.   .||||+++++++..++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS---GHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc---CCCCCCeeeeEEecCC
Confidence            34578999999999999999999975 68999999986542  223456778999988732   4999999999997544


Q ss_pred             --eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          879 --EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       879 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                        ..|+||||++ |+|.++++. ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence              7899999997 599999976 4689999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCC--------------------CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          957 VVSAGD--------------------SHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       957 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      .+....                    ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            764311                    112334679999999998775 6799999999999999999999999987644

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.8e-35  Score=351.20  Aligned_cols=326  Identities=25%  Similarity=0.307  Sum_probs=239.6

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccc
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV  158 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~  158 (1088)
                      .+++.|+|+++.+++..+  ++.+++|++|+|++|.+++..|  ++.+++|++|+|++|.+++...+.++++|++|+|++
T Consensus        68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~  143 (466)
T 1o6v_A           68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS  143 (466)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEE
T ss_pred             cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChHHcCCCCCCEEECCC
Confidence            467889999999998654  9999999999999999997655  999999999999999999888899999999999999


Q ss_pred             ccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccc
Q 001384          159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSS  238 (1088)
Q Consensus       159 N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~  238 (1088)
                      |++++...   ...+++|++|+++ |.+.+..+  +.++++|++|++++|++++..                        
T Consensus       144 n~l~~~~~---~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~------------------------  193 (466)
T 1o6v_A          144 NTISDISA---LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDIS------------------------  193 (466)
T ss_dssp             EEECCCGG---GTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCCG------------------------
T ss_pred             CccCCChh---hccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCCh------------------------
Confidence            99986432   3557899999996 66666544  899999999999999887521                        


Q ss_pred             cccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCC
Q 001384          239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL  318 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  318 (1088)
                      .+..+++|++|++++|.+++..|  ++.+++|++|++++|++++.  +.+..+++|+.|++++|.+.+..|  +..+++|
T Consensus       194 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L  267 (466)
T 1o6v_A          194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKL  267 (466)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred             hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCC
Confidence            13334455555555555554333  44455555555555555532  245555555555555555555432  5555556


Q ss_pred             cEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccc
Q 001384          319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH  398 (1088)
Q Consensus       319 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  398 (1088)
                      ++|++++|.+++..+  +..+++|+.|++++|.+....   .+..+++|+.|+|++|++++..|  +..+++|+.|++++
T Consensus       268 ~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~---~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~  340 (466)
T 1o6v_A          268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDIS---PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN  340 (466)
T ss_dssp             SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG---GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred             CEEECCCCccCcccc--ccCCCccCeEEcCCCcccCch---hhcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence            666666665555444  555556666666655543321   25577889999999999987655  77889999999999


Q ss_pred             cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCcc
Q 001384          399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE  456 (1088)
Q Consensus       399 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  456 (1088)
                      |++++.  ..+..+++|+.|++++|++++..|  +..+++|++|++++|.+++ +|..
T Consensus       341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             SCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             CccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence            999854  468889999999999999997666  8889999999999999985 4443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-36  Score=362.09  Aligned_cols=251  Identities=25%  Similarity=0.327  Sum_probs=203.6

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-------------cchHHHHHHHHHHhCCCCCCCCCcee
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-------------EGEREFRAEMEVLSGNGFGWPHPNLV  868 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~~~~~l~h~niv  868 (1088)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++.....             ...+.+.+|++++++    ++||||+
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv  109 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS----LDHPNII  109 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT----CCCTTBC
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh----CCCCCCC
Confidence            4578999999999999999999976 578999999976432             224678899999997    6799999


Q ss_pred             EEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---
Q 001384          869 TLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---  945 (1088)
Q Consensus       869 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---  945 (1088)
                      ++++++.++...++||||+++|+|.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999999999998888899999999999999999999999   999999999999999776   


Q ss_pred             CEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhc
Q 001384          946 KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       946 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      .+||+|||+++.+...  .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.....  ....+..
T Consensus       187 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~  261 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVEK  261 (504)
T ss_dssp             SEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             cEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc
Confidence            6999999999876543  23345679999999998875 68999999999999999999999998765421  1111110


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....      .+..       .......++.+++.+|++.||.+||+++|+++
T Consensus       262 ~~~~------~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          262 GKYY------FDFN-------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CCCC------CCHH-------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC------CCcc-------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000      0000       00122357889999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.2e-37  Score=357.09  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=193.8

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      ...++|.+.+.||+|+||+||+|.++ +++.||||++......        ....+.+|++++++    ++||||+++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~l~~  207 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK----LNHPCIIKIKN  207 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHH----CCCTTBCCCCE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHh----CCCCCEeeEEE
Confidence            34678999999999999999999976 6899999998754211        11247889999997    67999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC---CEEE
Q 001384          873 WCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG---KALV  949 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~---~~kl  949 (1088)
                      ++.. ...++||||+++|+|.+++....++++.+++.++.|++.||+|||++   +|+||||||+||+++.++   .+||
T Consensus       208 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          208 FFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             EEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             EEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            9754 55799999999999999998888899999999999999999999999   999999999999997554   5999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhh
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVM 1024 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~ 1024 (1088)
                      +|||+++....  ........||+.|+|||++.   ...++.++||||+||++|+|++|+.||......  ........ 
T Consensus       284 ~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~-  360 (419)
T 3i6u_A          284 TDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-  360 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT-
T ss_pred             eecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC-
Confidence            99999987643  22334567999999999875   367889999999999999999999999764321  11111100 


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .    ....+..        .......+.+++.+|++.||++||+++|+++
T Consensus       361 ---~----~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          361 ---K----YNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ---C----CCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---C----CCCCchh--------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence               0    0000000        1123457889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-37  Score=357.97  Aligned_cols=242  Identities=14%  Similarity=0.134  Sum_probs=190.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEe-------e
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLY-------G  872 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~-------~  872 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|++++..+. .++|||||+++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGST-TCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcc-ccCCHHHHHHHhhhhhhhh
Confidence            457888999999999999999974 68999999997532   234467889997666543 46899999998       6


Q ss_pred             EEecCC-----------------eEEEEEEecCCCCHHHHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCCCC
Q 001384          873 WCLDGS-----------------EKILVYEYMEGGSLEDIISDRTRLTW-------RRRLDIAIDVARALVFLHHECYPP  928 (1088)
Q Consensus       873 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qi~~~L~yLH~~~~~~  928 (1088)
                      ++.+++                 ..|+||||+ +|+|.++++....+++       ..++.|+.||+.||+|||++   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            655543                 278999999 5799999987554554       88889999999999999999   9


Q ss_pred             eEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCC-----------CCCcchhHHHHHH
Q 001384          929 IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-----------QATTKGDVYSFGV  997 (1088)
Q Consensus       929 ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~  997 (1088)
                      |+||||||+||+++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999986321    2344567 999999998877           8999999999999


Q ss_pred             HHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHH
Q 001384          998 LAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus       998 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 1077 (1088)
                      ++|||++|+.||.+....                  .........     ....+.++.+++.+||+.||++||++.|++
T Consensus       302 il~elltg~~Pf~~~~~~------------------~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          302 VIYWIWCADLPITKDAAL------------------GGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHSSCCC------------------------CCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHCCCCCcccccc------------------cchhhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999999999999764320                  000000000     012235688899999999999999999998


Q ss_pred             H
Q 001384         1078 A 1078 (1088)
Q Consensus      1078 ~ 1078 (1088)
                      +
T Consensus       359 ~  359 (377)
T 3byv_A          359 E  359 (377)
T ss_dssp             T
T ss_pred             h
Confidence            5

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-37  Score=347.89  Aligned_cols=257  Identities=28%  Similarity=0.385  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||.||+|++      .+++.||||++.... .....++.+|+.++++    ++||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK----FNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhh----CCCCCCCeEEEEEcC
Confidence            35799999999999999999984      246789999997543 2334578899999987    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCC
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRT-------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGK  946 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~  946 (1088)
                      ....++||||+++|+|.+++....       .+++.+++.++.|++.||+|||++   +|+||||||+||+++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence            999999999999999999998653       489999999999999999999999   9999999999999994   446


Q ss_pred             EEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhh
Q 001384          947 ALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......  +......
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~  259 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVT  259 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHh
Confidence            99999999976543222 12234567889999999888899999999999999999998 99999875432  1111111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....                ...+...+..+.+++.+|++.||.+||++.|+++.++.+..
T Consensus       260 ~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          260 SGGR----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TTCC----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1000                00112234578889999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-37  Score=341.76  Aligned_cols=252  Identities=26%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~  878 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....  ...+.+.+|++++++    ++||||+++++++.+  ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE----LKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEEGGGT
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHh----cCCCCCCeEEEEEecCCCc
Confidence            357899999999999999999976 689999999976532  234578899999987    679999999998753  57


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCEEEcCCCCEEE
Q 001384          879 EKILVYEYMEGGSLEDIISDRT----RLTWRRRLDIAIDVARALVFLHHECYPP-----IVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~-----ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      ..++||||+++++|.+++....    .+++.+++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEE
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            8899999999999999997532    499999999999999999999999   7     999999999999999999999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      +|||.++...... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........  ......... 
T Consensus       158 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i~~~~~-  233 (279)
T 2w5a_A          158 GDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIREGKF-  233 (279)
T ss_dssp             CCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTCC-
T ss_pred             ecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HHHHhhccc-
Confidence            9999997654322 122345689999999999888999999999999999999999999987644211  111110000 


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHH
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLI 1081 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1081 (1088)
                                     ...+.....++.+++.+|++.||++||+++|+++.+.
T Consensus       234 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ---------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ---------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                           0011223457888999999999999999999987643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=338.17  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+|++++..    ++||||+++++++..+...+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQ----CDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHT----CCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHh----CCCCCCccEEEEEEeCCEEE
Confidence            4568999999999999999999976 5899999999765  234678899999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++++|.+++. ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+.....
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999999997 456799999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .. .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.........+.....  ..  . .       
T Consensus       178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--~-~-------  244 (314)
T 3com_A          178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PP--P-T-------  244 (314)
T ss_dssp             TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC--C-C-------
T ss_pred             hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CC--c-c-------
Confidence            22 2233457899999999999889999999999999999999999999876542222211111  00  0 0       


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ...+......+.+++.+|++.||.+||++.|+++
T Consensus       245 ----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                0012223457889999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-36  Score=339.42  Aligned_cols=248  Identities=29%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .+.|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++..    ++||||+++++++.++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ----CDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHh----CCCCCEeEEEEEEecCCeEE
Confidence            356889999999999999999975 689999999976532 334678999999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|.++++. .++++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......
T Consensus        97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999999999965 5699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1088)
                      . .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...............  ..             
T Consensus       173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------------  236 (303)
T 3a7i_A          173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP-------------  236 (303)
T ss_dssp             B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC-------------
T ss_pred             c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC-------------
Confidence            2 2234467899999999999889999999999999999999999999875442221111100  00             


Q ss_pred             CCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1042 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         ...+......+.+++.+|++.||++||++.|+++
T Consensus       237 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          237 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0001122356888999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-36  Score=358.17  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=155.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----  876 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||++....  ....+.+.+|+++++.    ++||||+++++++..    
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR----LNHDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHH----CCCTTBCCEEEECCCSCTT
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHh----CCCCCCCceEEEEecCCcc
Confidence            468999999999999999999976 68999999997642  2234678899999997    679999999999854    


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          877 -GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                       ....|+||||++ |+|.++++....+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+||+|||++
T Consensus       128 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence             357899999985 69999999888899999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC--------------------------cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHh
Q 001384          956 RVVSAGDS--------------------------HVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELAT 1004 (1088)
Q Consensus       956 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ellt 1004 (1088)
                      +.......                          ......+||+.|+|||++ ....++.++||||+||++|||++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            87643211                          122345789999999975 56679999999999999999999

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.6e-36  Score=334.50  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=205.5

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---------cchHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---------EGEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++.....         ...+.+.+|++++.++.   .||||+++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---~h~~i~~~~~   91 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS---GHPNIIQLKD   91 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT---TCTTBCCEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc---CCCCEeeeee
Confidence            3468999999999999999999986 689999999975431         12346778999988632   5999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          873 WCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                      ++..+...++||||+++++|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999999999888899999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhcc
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQ------TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1088)
                      |.+.......  ......+++.|+|||++.      ...++.++||||+|+++|+|++|+.||........  .......
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~  244 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMIMSG  244 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HHHHhcC
Confidence            9998765332  234456899999999864      45788999999999999999999999987544221  1111110


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....             .+.....+..+.+++.+|++.||++||+++|+++
T Consensus       245 ~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQFG-------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCCC-------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccC-------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00000             0011233467889999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-37  Score=347.79  Aligned_cols=263  Identities=23%  Similarity=0.322  Sum_probs=200.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||.||+|++. +|+.||||++......  ..+.+.+|++++++    ++||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ----LRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhh----CCCCCEeeEEEEeecCCEEE
Confidence            57999999999999999999976 5899999998765332  23457789999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++++|.++......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.....
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999999999988888899999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh-hhcc-------------
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR-VMGY------------- 1026 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-~~~~------------- 1026 (1088)
                      . .......+|..|+|||++.+. .++.++||||+|+++|+|++|+.||.+..+........ ....             
T Consensus       178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            2 223345689999999988765 78999999999999999999999998765421111100 0000             


Q ss_pred             -CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 -GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...........   ..............+.+++.+|++.||++||+++|+++
T Consensus       257 ~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKE---REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSS---CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccc---cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00000000000   00000001123467889999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-36  Score=344.74  Aligned_cols=266  Identities=23%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......  ....+.+|+++++.    ++||||+++++++..     
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL----LKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHH----CCCTTBCCEEEEEEEC----
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHh----ccCCCcccHhheeecccccc
Confidence            57999999999999999999975 7899999999765322  34577899999987    679999999999887     


Q ss_pred             ---CCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          877 ---GSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       877 ---~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                         .+..++||||+++ +|.+.+... .++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence               3468999999986 777776553 5799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCC---cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccC
Q 001384          953 GLARVVSAGDS---HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYG 1027 (1088)
Q Consensus       953 g~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~ 1027 (1088)
                      |+++.+.....   .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ..........
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99987653221   22344578999999998765 5689999999999999999999999987654211 1111111000


Q ss_pred             CCCCCccc-----cchhh-cCCCccccHH------HHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1028 RHGPGRAV-----IPVVL-LGSGLAEGAE------EMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1028 ~~~~~~~~-----~~~~~-~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ........     ..... ..........      ....+.+++.+|++.||++||+++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000     00000 0000000011      1245789999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-37  Score=346.98  Aligned_cols=244  Identities=27%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|+..+.||+|+||+||+|++. +++.||||++......   ..+.+.+|++++++    ++||||+++++++.++...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK----LRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHh----CCCCCEeeEEEEEEECCeE
Confidence            45888999999999999999964 7899999999754322   23568899999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          881 ILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      ++||||++ |+|.+++.. ..++++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99999997 588888754 56799999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .     .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.........+  ....... ..     
T Consensus       206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~-~~-----  272 (348)
T 1u5q_A          206 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNES-PA-----  272 (348)
T ss_dssp             S-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCC-CC-----
T ss_pred             C-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhcCC-CC-----
Confidence            2     23457899999999873   5678999999999999999999999998764422111  1110000 00     


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               .........+.+++.+|++.||++||+++++++
T Consensus       273 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          273 ---------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                     001122356788999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-36  Score=357.35  Aligned_cols=261  Identities=20%  Similarity=0.311  Sum_probs=207.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ...++..|++++..+.   +|+++..+..++.+....++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~---~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQ---GGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTT---TSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhc---CCCCCCeEEEEEeeCCEEEE
Confidence            468999999999999999999974 68999999887553  2335778888888743   45777777778888899999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---cCCCCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL---DKEGKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll---~~~~~~kl~Dfg~a~~~  958 (1088)
                      ||||+ +++|.++++. ...+++.+++.|+.||+.||+|||++   +||||||||+||||   +.++.+||+|||+++.+
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99999 8899999975 45799999999999999999999999   99999999999999   68899999999999887


Q ss_pred             cCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-hHHHHHHhhhccCCCCC
Q 001384          959 SAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-CLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       959 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~ 1031 (1088)
                      ......      ......||..|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---  233 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---  233 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH---
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc---
Confidence            643322      12356799999999999999999999999999999999999999987533 11111111110000   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                       ....+..        ....+.++.+++.+|++.||++||++++|++.|++++.
T Consensus       234 -~~~~~~l--------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          234 -ATSIEAL--------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             -HSCHHHH--------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -cccHHHH--------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence             0000000        01223578899999999999999999999999998853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-36  Score=343.41  Aligned_cols=268  Identities=26%  Similarity=0.304  Sum_probs=198.1

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-----hHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-----EREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ...++|++.+.||+|+||.||+|++. +|+.||||++.......     .+.+.+|+++++.    ++||||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE----LSHPNIIGLLDAFG   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH----CCCTTBCCEEEEEC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhh----CCCCCCCeEEEEEe
Confidence            34578999999999999999999976 68999999997543221     2467889999987    67999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      +....++||||+++ +|.+++.... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999986 8999887654 689999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCC--CC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGR--HG 1030 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~--~~ 1030 (1088)
                      ++.+.... .......+|+.|+|||++.+ ..++.++||||+||++|||++|..||.+...... ...........  ..
T Consensus       159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            98764322 22344578999999998865 4589999999999999999999999987654211 11111110000  00


Q ss_pred             CCccccchhh-cCCCcccc-----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVL-LGSGLAEG-----AEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ......+... .......+     .....++.+++.+|++.||++||+++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000000000 00000001     223467889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=347.35  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=187.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe--------
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL--------  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~--------  875 (1088)
                      .+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.++.++.   .||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS---GHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT---TSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc---cCCChhhcccccccccccccc
Confidence            47899999999999999999975 78999999997765555677889999988732   5999999999984        


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEcCCCCEEEe
Q 001384          876 DGSEKILVYEYMEGGSLEDIISD---RTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLDKEGKALVT  950 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~~~~~~kl~  950 (1088)
                      .....++||||++ |+|.+++..   ..++++.+++.++.|++.||+|||++   +  |+||||||+||+++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            3445799999996 699998865   45699999999999999999999998   7  9999999999999999999999


Q ss_pred             ecccceeecCCCCcc-----------cccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH
Q 001384          951 DFGLARVVSAGDSHV-----------STTIAGTVGYVAPEYG---QTWQATTKGDVYSFGVLAMELATGRRALEGGEECL 1016 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~ 1016 (1088)
                      |||+++.........           .....+|+.|+|||++   .+..++.++||||||+++|||++|+.||...... 
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence            999998765432211           1134689999999987   5667899999999999999999999999764321 


Q ss_pred             HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1017 VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                       ........          .+         ........+.+++.+|++.||++||+++|+++.|+++..
T Consensus       260 -~~~~~~~~----------~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 -RIVNGKYS----------IP---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -------CC----------CC---------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhhcCccc----------CC---------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             11000000          00         011112347788999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=334.06  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=198.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|....+||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.    ++||||+++++++.+.+..++|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH----LKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHT----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHh----CCCCCEeeEeeEEEeCCcEEEE
Confidence            34556679999999999999975 688999999987655556788999999987    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-CCCEEEeecccceeec
Q 001384          884 YEYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-EGKALVTDFGLARVVS  959 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-~~~~kl~Dfg~a~~~~  959 (1088)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||.+....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999997652   467899999999999999999999   9999999999999987 8999999999998764


Q ss_pred             CCCCcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHH-HHHhhhccCCCCCCcccc
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELATGRRALEGGEECLVE-WGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ... .......|+..|+|||++...  .++.++||||||+++|+|++|+.||......... +.....  ..        
T Consensus       175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~--------  243 (295)
T 2clq_A          175 GIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KV--------  243 (295)
T ss_dssp             C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CC--------
T ss_pred             CCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cc--------
Confidence            322 123345789999999987654  3889999999999999999999999754332211 111111  00        


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ....+.....++.+++.+|++.||++||+++|+++
T Consensus       244 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 -------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00112223457888999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.8e-37  Score=348.03  Aligned_cols=263  Identities=19%  Similarity=0.249  Sum_probs=205.4

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccch-----------------HHHHHHHHHHhCCCCCCCCCc
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGE-----------------REFRAEMEVLSGNGFGWPHPN  866 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~~~~~l~h~n  866 (1088)
                      .++|++.+.||+|+||.||+|++ +++.||||++........                 +.+.+|++++.+    ++|||
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~  104 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD----IKNEY  104 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT----CCCTT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh----CCCCC
Confidence            46899999999999999999999 899999999975422211                 789999999987    67999


Q ss_pred             eeEEeeEEecCCeEEEEEEecCCCCHHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCC
Q 001384          867 LVTLYGWCLDGSEKILVYEYMEGGSLEDI------ISD--RTRLTWRRRLDIAIDVARALVFLHH-ECYPPIVHRDVKAS  937 (1088)
Q Consensus       867 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~DLkp~  937 (1088)
                      |+++++++.+.+..++||||+++|+|.++      +..  ...+++..++.++.|++.||+|||+ .   +|+||||||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~  181 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS  181 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence            99999999999999999999999999998      665  5679999999999999999999999 8   9999999999


Q ss_pred             CEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCC-CCCc-chhHHHHHHHHHHHHhCCcCCCCCchh
Q 001384          938 NVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATT-KGDVYSFGVLAMELATGRRALEGGEEC 1015 (1088)
Q Consensus       938 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~elltg~~p~~~~~~~ 1015 (1088)
                      ||+++.++.+||+|||.+......   ......++..|+|||.+.+. .++. ++||||+|+++|||++|+.||......
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            999999999999999999876432   33456789999999998876 6666 999999999999999999999876442


Q ss_pred             HHHHHHhhhccCCCCCC--ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1016 LVEWGRRVMGYGRHGPG--RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ... .............  ......................+.+++.+|++.||.+||+++|+++
T Consensus       259 ~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VEL-FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHH-HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111 1111111100000  0000000000000001233467889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-36  Score=339.25  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++..    ++||||+++++++..++..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT----CDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHH----CCCTTBCCEEEEEECC-CEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhc----CCCCCEeeeeeeeeeCCeEEE
Confidence            467999999999999999999986 589999999987655666789999999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          883 VYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      ||||+++++|.+++.. ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999875 45699999999999999999999999   9999999999999999999999999987543211


Q ss_pred             CCcccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYG-----QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                       ........|+..|+|||++     ....++.++||||+|+++|+|++|+.||..........  .......  . .   
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~--~-~---  241 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKSDP--P-T---  241 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCC--C-C---
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhccCC--c-c---
Confidence             1112335689999999987     46788999999999999999999999998765422111  1110000  0 0   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              ...+......+.+++.+|++.||++||+++|+++
T Consensus       242 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 --------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    0012233457889999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.9e-36  Score=344.77  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=194.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|+.+++.    ++||||+++++++....  
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC----VNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSCCST
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHh----cCCCCccceEEeecccccc
Confidence            468999999999999999999975 688999999976422  233568899999987    67999999999997654  


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          879 ----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       879 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                          ..++||||+++ +|.+++.  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence                78999999975 8888886  3589999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC----
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG---- 1030 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 1030 (1088)
                      ++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+...........    
T Consensus       174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            9865422  223446789999999999988999999999999999999999999987643 222222111000000    


Q ss_pred             --------------------CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 --------------------PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                          ......+................++.+++.+|++.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                000000111111111112234678899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.5e-36  Score=353.00  Aligned_cols=198  Identities=26%  Similarity=0.360  Sum_probs=168.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      .++|++.+.||+|+||.||+|+++ +++.||||++....  ....+.+.+|+++++.    ++||||+++++++...   
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR----LKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHH----CCCTTBCCEEEECCCSCTT
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHH----cCCCCcceEEEEEecCCCC
Confidence            468999999999999999999976 68899999997642  2234678899999997    6799999999998766   


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 --SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                        ...|+||||++ |+|.++++....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence              57899999996 59999999888899999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecCCCC---------------------cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCcCC
Q 001384          956 RVVSAGDS---------------------HVSTTIAGTVGYVAPEYG-QTWQATTKGDVYSFGVLAMELATGRRAL 1009 (1088)
Q Consensus       956 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~ 1009 (1088)
                      +.......                     .......||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            87653321                     123556889999999975 6667999999999999999999854444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-36  Score=337.45  Aligned_cols=257  Identities=27%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCc--EEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--DGR--EVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||.||+|++.  +++  .||||++....   ....+.+.+|++++.+    ++||||+++++++.++
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS----LDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSS
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHh----CCCCCcccEEEEEccC
Confidence            57899999999999999999853  333  68999987643   2334678899999987    6799999999999876


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      . .++||||+++|+|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            5 88999999999999999764 5699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ........  ......+|..|+|||.+.+..++.++||||+|+++|+|++ |+.||.+.....  ..........     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-----  242 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGE-----  242 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTSCC-----
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHHccCC-----
Confidence            77543322  1234467788999999988889999999999999999999 999998764421  1112211000     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                                ....+...+.++.+++.+|++.||++||++.++++.|+++...
T Consensus       243 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          243 ----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ----------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                      0011223346788999999999999999999999999998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-36  Score=343.17  Aligned_cols=249  Identities=25%  Similarity=0.351  Sum_probs=197.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--------cchHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....        .....+.+|++++++    ++||||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~   84 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK----LNHPCIIKIKNFF   84 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHH----CCCTTBCCEEEEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHh----CCCCCCceEeeEE
Confidence            457999999999999999999976 688999999875421        122357889999987    6799999999998


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC---EEEee
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALVTD  951 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~---~kl~D  951 (1088)
                      ..+. .++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            7655 899999999999999998888899999999999999999999999   9999999999999987665   99999


Q ss_pred             cccceeecCCCCcccccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhcc
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYG---QTWQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGY 1026 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~ 1026 (1088)
                      ||+++.....  .......||+.|+|||++   ....++.++||||+|+++|+|++|+.||......  ........   
T Consensus       161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---  235 (322)
T 2ycf_A          161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---  235 (322)
T ss_dssp             CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT---
T ss_pred             Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC---
Confidence            9999876432  223345789999999985   3567899999999999999999999999764321  11111110   


Q ss_pred             CCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       .    ....+..        .......+.+++.+|++.||++||+++|+++
T Consensus       236 -~----~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 -K----YNFIPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -C----CCCCHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -c----cccCchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             0    0000000        1123457889999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.4e-36  Score=333.19  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=186.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHH-HHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEME-VLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++...... ...+...|.. .++.    ++||||+++++++.+++..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~----~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT----VDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSSE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHh----CCCCeEEEEeeeeeccCCE
Confidence            357899999999999999999975 7899999999765322 2223333333 3443    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ++||||+++ +|.++++.    ...+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            999999975 88877653    467999999999999999999999963  89999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYG----QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .....  .......||+.|+|||++    ....++.++||||+|+++|+|++|+.||.....................  
T Consensus       159 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  234 (290)
T 3fme_A          159 YLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--  234 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--
T ss_pred             ccccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--
Confidence            76432  223334689999999985    5668899999999999999999999999865443333332222110000  


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                    .......++.+++.+|++.||++||+++|+++
T Consensus       235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                          01123356888999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-36  Score=340.16  Aligned_cols=257  Identities=20%  Similarity=0.261  Sum_probs=199.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||++...   ..+.+.+|++++.++.   .||||+++++++.+  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~---~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLR---GGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHT---TSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcC---CCCCEEEeeeeeccCCCCceE
Confidence            57999999999999999999964 7899999999754   4567889999998732   49999999999987  66789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++++|.++++.   +++.+++.++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||+++....
T Consensus       110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999999854   89999999999999999999999   999999999999999777 899999999987654


Q ss_pred             CCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh------------hccC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV------------MGYG 1027 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~------------~~~~ 1027 (1088)
                      ..  ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..............            ....
T Consensus       184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            32  2344578999999998776 6789999999999999999999999965433211111100            0000


Q ss_pred             CCC----------CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1028 RHG----------PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1028 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...          ............   ........++.+++.+|++.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccc---cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000          000000000000   011223567889999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=332.05  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC----ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe--
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG----LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL--  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~--  875 (1088)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....    ......+.+|+++++.    ++||||+++++++.  
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR----LRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTT----CCCTTBCCEEEEEECC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHh----cCCCCeeEEEEEEEcC
Confidence            3578999999999999999999975 68899999997642    2335678999999987    67999999999984  


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          876 DGSEKILVYEYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                      +....++||||++++ |.+++..  ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence            456789999999876 8777765  34699999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCC-CcccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC
Q 001384          954 LARVVSAGD-SHVSTTIAGTVGYVAPEYGQTWQ--ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG 1030 (1088)
Q Consensus       954 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1088)
                      .+....... ........|+..|+|||+..+..  ++.++||||+|+++|||++|+.||.+....  +..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~--  230 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKGSY--  230 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCC--
T ss_pred             cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcCCC--
Confidence            998765322 22234557899999999887643  478999999999999999999999875431  11111110000  


Q ss_pred             CCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                     ..+......+.+++.+|++.||++||+++|+++
T Consensus       231 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 ---------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ---------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                           001123356788999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-36  Score=345.30  Aligned_cols=258  Identities=23%  Similarity=0.297  Sum_probs=194.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||||++.....  ...+.+.+|+++++.    ++||||+++++++....  
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----MRHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH----CCBTTBCCCSEEECSCSST
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh----CCCcCCCCceeeEecCCcc
Confidence            468999999999999999999975 689999999965422  224568899999997    67999999999998653  


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          879 ----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       879 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                          ..|+||||+ +++|.++++. .++++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence                469999999 7799999976 5699999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCCCCC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 1032 (1088)
                      ++.....    .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+..... ........  .  ...
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~--g--~~~  246 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT--G--TPP  246 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH--C--CCC
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--C--CCC
Confidence            9875422    334578999999998766 689999999999999999999999998764311 11000000  0  000


Q ss_pred             ccccc---------------hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIP---------------VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+...               .................+.+++.+|++.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00000               00000000011223457888999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-36  Score=372.77  Aligned_cols=257  Identities=26%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ..++|++.+.||+|+||.||+|++..    +..||||++..... ...+.+.+|+.++++    ++||||+++++++. +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ----FDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEC-S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEe-c
Confidence            35678999999999999999999742    45799999876432 233678899999987    67999999999985 4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +..++||||+++|+|.++++... .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            56899999999999999998654 689999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ..............+|+.|+|||++.+..++.++||||||+++|||++ |..||.+......  .......         
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~~~i~~~---------  608 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENG---------  608 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHHT---------
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC---------
Confidence            765443333344567789999999988899999999999999999997 9999987644211  1111100         


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                             ...+.+...+..+.+++.+|++.||++||++.|+++.|+++++
T Consensus       609 -------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          609 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                   0011122334678899999999999999999999999998863

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=353.81  Aligned_cols=343  Identities=19%  Similarity=0.195  Sum_probs=263.1

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      +.++.++++++ .+|..+.  +++++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45666666665 5565543  57788888888887766777788888888888888887777777888888888888888


Q ss_pred             cCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCC
Q 001384          327 NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP  406 (1088)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  406 (1088)
                      .+++.++..                         |.++++|++|+|++|++++..|..|..+++|+.|++++|.+++..|
T Consensus        91 ~l~~~~~~~-------------------------~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  145 (477)
T 2id5_A           91 RLKLIPLGV-------------------------FTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH  145 (477)
T ss_dssp             CCCSCCTTS-------------------------STTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT
T ss_pred             cCCccCccc-------------------------ccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh
Confidence            776554433                         3456677778888888877777788888888888888888887778


Q ss_pred             cccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCC
Q 001384          407 AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGR  486 (1088)
Q Consensus       407 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~  486 (1088)
                      ..|.++++|++|+|++|++++..+..+.++++|+.|+|++|.+++..+..+.++++|+.|++++|++.+.+|......  
T Consensus       146 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~--  223 (477)
T 2id5_A          146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG--  223 (477)
T ss_dssp             TSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTT--
T ss_pred             hhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccC--
Confidence            888888888888888888886555668888888888888888887777788888888888888888776666543210  


Q ss_pred             CCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeece
Q 001384          487 NARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGY  566 (1088)
Q Consensus       487 ~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~  566 (1088)
                                                                                                 ..+++
T Consensus       224 ---------------------------------------------------------------------------~~L~~  228 (477)
T 2id5_A          224 ---------------------------------------------------------------------------LNLTS  228 (477)
T ss_dssp             ---------------------------------------------------------------------------CCCSE
T ss_pred             ---------------------------------------------------------------------------ccccE
Confidence                                                                                       02457


Q ss_pred             EEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEcccccc
Q 001384          567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNF  645 (1088)
Q Consensus       567 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  645 (1088)
                      |+|++|++++..+..++.+++|+.|+|++|++++..+..+..+ .|+.|+|++|++++..|..|.++++|+.|+|++|+|
T Consensus       229 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  308 (477)
T 2id5_A          229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL  308 (477)
T ss_dssp             EEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCC
T ss_pred             EECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcC
Confidence            8888888885444678889999999999999998888888877 699999999999988899999999999999999999


Q ss_pred             CCcCCcccccccccceeeccCCCCccccCCCCCcccccccCccCCCCCCC
Q 001384          646 SGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLD  695 (1088)
Q Consensus       646 ~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~  695 (1088)
                      ++..|..|..+++|+.|+|++|+|.+. .+....+.......+.++...|
T Consensus       309 ~~~~~~~~~~l~~L~~L~l~~N~l~c~-c~~~~~~~~~~~~~~~~~~~~C  357 (477)
T 2id5_A          309 TTLEESVFHSVGNLETLILDSNPLACD-CRLLWVFRRRWRLNFNRQQPTC  357 (477)
T ss_dssp             SCCCGGGBSCGGGCCEEECCSSCEECS-GGGHHHHTTTTSSCCTTCCCBE
T ss_pred             ceeCHhHcCCCcccCEEEccCCCccCc-cchHhHHhhhhccccCccCcee
Confidence            976667789999999999999999542 2211111222234456666665

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-36  Score=350.24  Aligned_cols=254  Identities=11%  Similarity=0.009  Sum_probs=181.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEe-------eE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLY-------GW  873 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~-------~~  873 (1088)
                      .+|++.+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|++++..+. . +||||++++       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL-G-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHH-C-----------CBCCCCEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhc-c-cChhhhhhceeEEeeehh
Confidence            35888999999999999999976 789999999987543   22346777865554433 2 699988755       34


Q ss_pred             EecC-----------------CeEEEEEEecCCCCHHHHHhhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 001384          874 CLDG-----------------SEKILVYEYMEGGSLEDIISDR-TRLTWRRR------LDIAIDVARALVFLHHECYPPI  929 (1088)
Q Consensus       874 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~i  929 (1088)
                      +..+                 ...|+||||++ |+|.++++.. ..+.+..+      ..++.||+.||+|||++   +|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i  215 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL  215 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence            4332                 34799999998 7999999864 34555666      68889999999999999   99


Q ss_pred             EecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCc
Q 001384          930 VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRR 1007 (1088)
Q Consensus       930 vH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~ 1007 (1088)
                      +||||||+||+++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++||||+||++|||++|+.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999986532    1223456799999999887  789999999999999999999999


Q ss_pred             CCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1008 ALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1008 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ||.+........      +....    ...........+.....+..+.+++.+|++.||++||++.|+++
T Consensus       292 Pf~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS------WKRPS----LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC------CCBCC----TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccc------hhhhh----hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            998753311000      00000    00000000001111233567888999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-36  Score=337.70  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=185.9

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+++.+|++++.+    ++||||+++++++...+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ----CHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCC----CCCTTBCCEEEEEESSSCE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhh----cCCCCEeeEEEEEeecCCc
Confidence            3578999999999999999999975 689999999875432 234567788888775    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeec
Q 001384          881 ILVYEYMEGGSLEDIISD--------RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDF  952 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Df  952 (1088)
                      ++||||+++++|.+++..        ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            999999999999999864        44699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceeecCCCC----cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccC
Q 001384          953 GLARVVSAGDS----HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG 1027 (1088)
Q Consensus       953 g~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1088)
                      |.+........    .......||+.|+|||++.. ..++.++||||+|+++|||++|+.||............ .. ..
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~  243 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-LQ-ND  243 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HT-SS
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-hc-cC
Confidence            99876543221    11234578999999998765 56899999999999999999999999876442221111 11 00


Q ss_pred             CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .........+..       .......++.+++.+|++.||.+||++.|+++
T Consensus       244 ~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKE-------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----C-------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccch-------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000000000       01122356888999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=341.46  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=198.8

Q ss_pred             HHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-
Q 001384          799 DILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-  876 (1088)
Q Consensus       799 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-  876 (1088)
                      ++....++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.++.++.   +||||+++++++.. 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~---~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS---HHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHC---CSTTBCCEEEEEEEC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhcc---CCCCeeeeeeEEeec
Confidence            33445788999999999999999999975 78999999987543 34567889999988632   79999999999986 


Q ss_pred             -----CCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          877 -----GSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       877 -----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                           ....++||||+++|+|.+++...  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence                 46789999999999999999764  4699999999999999999999999   9999999999999999999999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM 1024 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1088)
                      +|||++....... .......|+..|+|||++.     ...++.++||||||+++|+|++|+.||.+.......+.....
T Consensus       171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            9999998654321 1233457899999999876     567899999999999999999999999876542222211111


Q ss_pred             ccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1025 GYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ..    ...           ........+.+++.+|++.||.+||+++|+++
T Consensus       250 --~~----~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 --PA----PRL-----------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             --CC----CCC-----------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --cc----ccC-----------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              00    000           01122357888999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-36  Score=346.85  Aligned_cols=262  Identities=22%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      ...++|++.+.||+|+||+||+|++. +|+.||||++......    ..+|+++++.    ++||||+++++++...   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~----l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKV----LDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTT----CCCTTBCCEEEEEEEC---
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHH----cCCCCccchhheeeecCcc
Confidence            45678999999999999999999974 7899999998765322    2468899886    6899999999998543   


Q ss_pred             -----------------------------------CeEEEEEEecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHH
Q 001384          878 -----------------------------------SEKILVYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVARAL  918 (1088)
Q Consensus       878 -----------------------------------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L  918 (1088)
                                                         ...++||||+++ +|.+.+.    ....+++..++.++.|++.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                               347899999985 8777664    356799999999999999999


Q ss_pred             HHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeecccceeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHH
Q 001384          919 VFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFG  996 (1088)
Q Consensus       919 ~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG  996 (1088)
                      +|||++   +|+||||||+||+++ .++.+||+|||+++......  ......+|..|+|||.+.+. .++.++||||+|
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            999999   999999999999998 68899999999998765432  23445789999999987664 589999999999


Q ss_pred             HHHHHHHhCCcCCCCCchh--HHHHHHhhhccCC--------CCCCccccchhhcC-CCccccHHHHHHHHHHHhhhccc
Q 001384          997 VLAMELATGRRALEGGEEC--LVEWGRRVMGYGR--------HGPGRAVIPVVLLG-SGLAEGAEEMSELLRIGVRCTAE 1065 (1088)
Q Consensus       997 ~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~ 1065 (1088)
                      |++|||++|+.||.+....  ....... .....        ........+..... .....+...+.++.+++.+|++.
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            9999999999999876441  1111110 00000        00000000000000 00001222345688999999999


Q ss_pred             CCCCCCCHHHHHH
Q 001384         1066 APNARPNVKEVLA 1078 (1088)
Q Consensus      1066 dP~~RPs~~eil~ 1078 (1088)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.6e-36  Score=345.33  Aligned_cols=274  Identities=22%  Similarity=0.269  Sum_probs=199.4

Q ss_pred             cCHHHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccc-----------hHHHHHHHHHHhCCCCCCC
Q 001384          795 FTYSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEG-----------EREFRAEMEVLSGNGFGWP  863 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~~~~~l~  863 (1088)
                      ....++....++|++.+.||+|+||.||+|.+.+|+.||||++.......           .+.+.+|++++.+    ++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~----l~   87 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH----FH   87 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH----CC
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh----CC
Confidence            34567778899999999999999999999998889999999997543221           2678999999997    67


Q ss_pred             CCceeEEeeEEec-----CCeEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001384          864 HPNLVTLYGWCLD-----GSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKAS  937 (1088)
Q Consensus       864 h~niv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~  937 (1088)
                      ||||+++++++..     ....++||||++ |+|.+++... ..+++.+++.++.|++.||+|||++   +|+||||||+
T Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999999999853     346899999998 5888887654 3699999999999999999999999   9999999999


Q ss_pred             CEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH
Q 001384          938 NVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL 1016 (1088)
Q Consensus       938 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~ 1016 (1088)
                      ||+++.++.+||+|||+++.....  .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.....
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             HEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999999754322  22344578999999998766 679999999999999999999999998764311


Q ss_pred             H-HHHHhhhccCCCC--------CCccccchhhcC----CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1017 V-EWGRRVMGYGRHG--------PGRAVIPVVLLG----SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1017 ~-~~~~~~~~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      . .............        ............    ............+.+++.+|++.||++||++.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1 1100000000000        000000000000    000001122456889999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.6e-36  Score=349.82  Aligned_cols=202  Identities=24%  Similarity=0.288  Sum_probs=173.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCC--CCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNG--FGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~--~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++... .....++.+|++++..+.  ....|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999976 5889999999764 223356677777766532  124789999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC--EEEeecccce
Q 001384          881 ILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK--ALVTDFGLAR  956 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~--~kl~Dfg~a~  956 (1088)
                      ++||||++ ++|.+++....  .+++..++.++.||+.||+|||++   +||||||||+||+++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999997654  499999999999999999999999   9999999999999999987  9999999997


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      ....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+
T Consensus       251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            6432    22345789999999999998999999999999999999999999987654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-35  Score=328.22  Aligned_cols=256  Identities=26%  Similarity=0.330  Sum_probs=207.2

Q ss_pred             HcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ..++|++.+.||+|+||.||+|++. +++.||||++....  ......+.+|++++++    ++||||+++++++.+...
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK----LDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHh----ccCCCccEEEEEEeCCCe
Confidence            3468999999999999999999986 68999999987543  2345678899999997    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC---CCEEEeecccce
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE---GKALVTDFGLAR  956 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~---~~~kl~Dfg~a~  956 (1088)
                      .++||||+++++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++.+   +.+||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999999998888899999999999999999999999   99999999999999754   479999999997


Q ss_pred             eecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      ......  ......+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||.+.....  .............     
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~-----  242 (287)
T 2wei_A          173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVETGKYAFD-----  242 (287)
T ss_dssp             TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCCCC-----
T ss_pred             eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCCCCC-----
Confidence            654322  2233468899999998876 58999999999999999999999998765421  1111111000000     


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH--HHHhh
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA--MLIKI 1083 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~i 1083 (1088)
                              .+.......++.+++.+|++.||++||+++|+++  .+++.
T Consensus       243 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          243 --------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             --------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             --------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                    0001123457888999999999999999999987  45544

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.3e-36  Score=338.26  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=200.9

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ...++|++.+.||+|+||.||+|+++.  .||+|++.....  ...+.+.+|+.++++    ++||||+++++++.++..
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQ----TRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTT----CCCTTBCCCCEEEECSSC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhc----CCCCCEeEEEEEEecCCc
Confidence            345789999999999999999999853  599999975432  223457788888876    679999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++||||+++++|.+++.... .+++.+++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++..
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            999999999999999998755 699999999999999999999999   999999999999998 789999999998765


Q ss_pred             cCCC----CcccccccccccccCccccCC---------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhc
Q 001384          959 SAGD----SHVSTTIAGTVGYVAPEYGQT---------WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       959 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      ....    ........|++.|+|||++..         ..++.++||||||+++|||++|+.||.........+..... 
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-  258 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-  258 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-
Confidence            3211    112234568999999998764         45789999999999999999999999876543322221111 


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       .. ..    ..          ....+.++.+++.+|++.||++||+++|+++.|+++.+.
T Consensus       259 -~~-~~----~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          259 -MK-PN----LS----------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -CC-CC----CC----------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -CC-CC----CC----------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             00 00    00          001224578899999999999999999999999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.2e-36  Score=342.24  Aligned_cols=266  Identities=22%  Similarity=0.288  Sum_probs=200.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++.+    ++||||+++++++...    
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR----FRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHH----CCCTTBCCCCEEECCSSTTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHh----cCCCCCccceeEEecCCccc
Confidence            468999999999999999999976 6889999999754322 33678899999987    6799999999998754    


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||+++ +|.++++.. .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          102 MKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence             468999999975 999999764 599999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc--ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCC
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 1032 (1088)
                      ........  ......||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.... .................
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            76533221  124457999999999754 456899999999999999999999999876431 11111111100000000


Q ss_pred             cccc--------chhhcCCCc---cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVI--------PVVLLGSGL---AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~--------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....        .........   ........++.+++.+|++.||++||+++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000        000000000   001122356889999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1e-35  Score=344.65  Aligned_cols=260  Identities=25%  Similarity=0.310  Sum_probs=192.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-----  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-----  878 (1088)
                      ..+|++.+.||+|+||+||+|++..+..||+|++......    ..+|+++++.    ++||||+++++++....     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~----l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRI----VKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHT----CCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHh----CCCCCcceEEEEEEecCCCCCc
Confidence            3468999999999999999999987777999988754322    2368888886    67999999999986543     


Q ss_pred             -eEEEEEEecCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeec
Q 001384          879 -EKILVYEYMEGGSLEDII----SDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDF  952 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Df  952 (1088)
                       ..++||||++++ +.+.+    .....+++..++.++.|++.||+|||++   +|+||||||+||+++ .++.+||+||
T Consensus       111 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          111 VFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence             378999999874 44333    2356799999999999999999999999   999999999999999 7999999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGRH 1029 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~ 1029 (1088)
                      |+++......  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....  ......... ....
T Consensus       187 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~~  263 (394)
T 4e7w_A          187 GSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSR  263 (394)
T ss_dssp             TTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCH
T ss_pred             CCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCH
Confidence            9998765432  2334578999999998765 46899999999999999999999999876431  111111100 0000


Q ss_pred             --------CCCccccchhhcCC-CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 --------GPGRAVIPVVLLGS-GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 --------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              .......+...... ..........++.+++.+|++.||++||++.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                    00000000000000 00001123457889999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-35  Score=339.38  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=182.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+++++.    ++||||+++++++...   
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH----MKHENVIGLLDVFTPARSL  103 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCSSG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEecCCcc
Confidence            478999999999999999999965 68999999997642  2234578899999987    6799999999998754   


Q ss_pred             ---CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          878 ---SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       878 ---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                         ...++||||+ +++|.++++. .++++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence               5679999999 6799999876 5699999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 1032 (1088)
                      ++....    ......||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ...........    +.
T Consensus       179 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~----p~  250 (367)
T 2fst_X          179 ARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT----PG  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS----CC
T ss_pred             cccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC----CC
Confidence            986542    1334678999999998776 68999999999999999999999999876541 11111111100    00


Q ss_pred             ccccchh-----------hcC-CCcc---ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVV-----------LLG-SGLA---EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~-----------~~~-~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+.....           +.. ....   ........+.+++.+|++.||++||+++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            0000000           000 0000   00112356889999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-35  Score=333.87  Aligned_cols=269  Identities=24%  Similarity=0.308  Sum_probs=201.0

Q ss_pred             HcCCCCccceecccCceEEEEEEeC--CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEe---
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP--DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL---  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~---  875 (1088)
                      ..++|++.+.||+|+||.||+|++.  +|+.||||++......  ....+.+|+.+++.+. .+.||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE-TFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHH-HTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhh-ccCCCCeEeeeeeeeecc
Confidence            4578999999999999999999973  6789999998754321  2234566776665421 147999999999987   


Q ss_pred             --cCCeEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEee
Q 001384          876 --DGSEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTD  951 (1088)
Q Consensus       876 --~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~D  951 (1088)
                        .....++||||++ |+|.+++....  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence              5567899999998 59999997654  499999999999999999999999   999999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCC--
Q 001384          952 FGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGR-- 1028 (1088)
Q Consensus       952 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~-- 1028 (1088)
                      ||.++.....  .......+|..|+|||++.+..++.++||||+|+++|+|++|+.||.+..... ............  
T Consensus       164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999765422  22344678999999999998899999999999999999999999998765421 111111110000  


Q ss_pred             CCCCc-----cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGR-----AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .....     .....................+.+++.+|++.||++||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000     000000000000011223467888999999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-35  Score=330.80  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=197.4

Q ss_pred             HcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..++|++.+.||+|+||.||+|.+.+++.||||++......  ....+.+|++++.++.  -.||||+++++++.++...
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHG--GGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhcc--ccCCceEEEEEEeecCCEE
Confidence            34679999999999999999999988999999999754322  3457889999988743  1369999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||| +.+++|.+++.....+++.+++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++....
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999 55789999999888999999999999999999999999   999999999999996 58999999999987653


Q ss_pred             CCCc-ccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          961 GDSH-VSTTIAGTVGYVAPEYGQT-----------WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       961 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      .... ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||............... ...
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~  257 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNH  257 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTS
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh-ccc
Confidence            3221 2234578999999998765           47889999999999999999999999875443222222111 000


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ...           .+.....++.+++.+|++.||++||+++|+++
T Consensus       258 ----~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          258 ----EIE-----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----CCC-----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----ccC-----------CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                000           01112356888999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.6e-35  Score=332.74  Aligned_cols=266  Identities=22%  Similarity=0.284  Sum_probs=202.6

Q ss_pred             cCCCCccceecccCceEEEEEEe-C-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVL-P-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|.+ + +++.||||++... ....+.+.+|++++..+..  ...|++++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999997 3 6889999999754 2334567788887765321  1345569999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--------------
Q 001384          880 KILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK--------------  943 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~--------------  943 (1088)
                      .++||||+ +++|.+++....  ++++.+++.++.|++.||+|||++   +|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999998765  689999999999999999999999   9999999999999987              


Q ss_pred             -----CCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-
Q 001384          944 -----EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV- 1017 (1088)
Q Consensus       944 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~- 1017 (1088)
                           ++.+||+|||.++.....    .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ 
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 678999999999864322    2345789999999999998999999999999999999999999987644211 


Q ss_pred             HHHHhhhc-cCC-----------------CCCCcccc----chhh--cCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1018 EWGRRVMG-YGR-----------------HGPGRAVI----PVVL--LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1018 ~~~~~~~~-~~~-----------------~~~~~~~~----~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      ........ ...                 .+......    ....  .............++.+++.+|++.||++||++
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            11111110 000                 00000000    0000  000011234556789999999999999999999


Q ss_pred             HHHHH
Q 001384         1074 KEVLA 1078 (1088)
Q Consensus      1074 ~eil~ 1078 (1088)
                      +|+++
T Consensus       324 ~ell~  328 (339)
T 1z57_A          324 REALK  328 (339)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=336.95  Aligned_cols=248  Identities=27%  Similarity=0.399  Sum_probs=193.2

Q ss_pred             HHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEee
Q 001384          800 ILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYG  872 (1088)
Q Consensus       800 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~  872 (1088)
                      .....++|++.+.||+|+||.||+|++. +++.||||++......      ....+..|++++.++....+||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999975 6889999999765322      12234567777776432347999999999


Q ss_pred             EEecCCeEEEEEEe-cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEe
Q 001384          873 WCLDGSEKILVYEY-MEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVT  950 (1088)
Q Consensus       873 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~  950 (1088)
                      ++...+..++|||| +.+++|.+++.....+++.+++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence            99999999999999 78999999999888899999999999999999999999   999999999999999 88999999


Q ss_pred             ecccceeecCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC
Q 001384          951 DFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029 (1088)
Q Consensus       951 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1088)
                      |||+++.....   ......|+..|+|||++.+..+ +.++||||+|+++|||++|+.||....+    ......     
T Consensus       183 dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~-----  250 (312)
T 2iwi_A          183 DFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----ILEAEL-----  250 (312)
T ss_dssp             CCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHTCC-----
T ss_pred             EcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----Hhhhcc-----
Confidence            99999876532   2334568999999998776555 4589999999999999999999976321    111000     


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                      ..+.....++.+++.+|++.||++||+++|+++
T Consensus       251 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          251 ----------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            001123356788999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-35  Score=340.76  Aligned_cols=270  Identities=23%  Similarity=0.253  Sum_probs=188.1

Q ss_pred             HHHHHHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          798 SDILKATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       798 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .......++|++.+.||+|+||.||+|+++ +|+.||||++..... ......+|++.+..    ++||||+++++++..
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~----l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAV----LHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHH----HCCTTBCCEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHh----cCCCCcccHHHhhhc
Confidence            344566789999999999999999999975 689999999866532 23345566766665    579999999999875


Q ss_pred             CCe-------EEEEEEecCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCEEEcC
Q 001384          877 GSE-------KILVYEYMEGGSLEDII----SDRTRLTWRRRLDIAIDVARALVFLH--HECYPPIVHRDVKASNVLLDK  943 (1088)
Q Consensus       877 ~~~-------~~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~ivH~DLkp~NIll~~  943 (1088)
                      ...       .++||||+++ +|.+.+    .....+++..++.++.|++.|++|||  +.   +|+||||||+||+++.
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence            333       7899999987 555443    35567899999999999999999999  77   9999999999999996


Q ss_pred             -CCCEEEeecccceeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHH
Q 001384          944 -EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEW 1019 (1088)
Q Consensus       944 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~ 1019 (1088)
                       ++.+||+|||+++......  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....  ....
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence             8999999999998765332  23345689999999987654 5899999999999999999999999876542  1111


Q ss_pred             HHhhhcc--------CCCCCCccccch---hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1020 GRRVMGY--------GRHGPGRAVIPV---VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1020 ~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+.....        ............   ...............++.+++.+|++.||.+||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111000        000000000000   0000000011224567899999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=344.04  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=182.7

Q ss_pred             CCCc-cceecccCceEEEEEEeC---CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCe
Q 001384          806 KFSE-DRIIGKGGFGTVYRGVLP---DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSE  879 (1088)
Q Consensus       806 ~~~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~  879 (1088)
                      .|++ .++||+|+||+||+|+++   +++.||||++....  ....+.+|++++++    ++||||+++++++..  +..
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~----l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRE----LKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHH----CCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHh----cCCCCeeeEeeEEecCCCCe
Confidence            3655 458999999999999965   57899999997653  34578899999997    679999999999954  678


Q ss_pred             EEEEEEecCCCCHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----cCCCC
Q 001384          880 KILVYEYMEGGSLEDIISDR---------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----DKEGK  946 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----~~~~~  946 (1088)
                      .++||||+++ +|.+++...         ..+++..++.++.||+.||+|||++   +|+||||||+||++    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            9999999975 888887532         2499999999999999999999999   99999999999999    67899


Q ss_pred             EEEeecccceeecCCCC--cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--------
Q 001384          947 ALVTDFGLARVVSAGDS--HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEEC-------- 1015 (1088)
Q Consensus       947 ~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------- 1015 (1088)
                      +||+|||+++.+.....  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+.        
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            99999999987653221  22345678999999998876 45899999999999999999999999765331        


Q ss_pred             --HHHHHHhhhccCCCCCCccccc-------------hhhcCCCc-----cccHHHHHHHHHHHhhhcccCCCCCCCHHH
Q 001384         1016 --LVEWGRRVMGYGRHGPGRAVIP-------------VVLLGSGL-----AEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075 (1088)
Q Consensus      1016 --~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1075 (1088)
                        ........+.............             ........     .........+.+|+.+||+.||.+|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence              1111111111111111000000             00000000     000001346788999999999999999999


Q ss_pred             HHH
Q 001384         1076 VLA 1078 (1088)
Q Consensus      1076 il~ 1078 (1088)
                      +++
T Consensus       331 ~L~  333 (405)
T 3rgf_A          331 AMQ  333 (405)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-35  Score=329.50  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=191.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec------
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD------  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~------  876 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|++++++    ++||||+++++++.+      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~----l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLAS----LNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEECCCCCC
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHh----cCchHHHHHHHHHHhhcchhh
Confidence            457899999999999999999975 7899999999653 2334678899999987    679999999998865      


Q ss_pred             -------CCeEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEE
Q 001384          877 -------GSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKAL  948 (1088)
Q Consensus       877 -------~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~k  948 (1088)
                             ....++||||+++|+|.++++... .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                   356799999999999999998544 588999999999999999999999   999999999999999999999


Q ss_pred             EeecccceeecCCC-------------CcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          949 VTDFGLARVVSAGD-------------SHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       949 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      |+|||.++......             ........|+..|+|||++.+. .++.++||||+|+++|||++   ||....+
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999997654221             1122345689999999988754 78999999999999999998   5543222


Q ss_pred             hHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ..+..........      ..+.       ..+...+..+.+++.+|++.||.+||+++|+++
T Consensus       234 -~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -RVNILKKLRSVSI------EFPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHHHHHHHHSTTC------CCCT-------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHHHHHhcccccc------ccCc-------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             1122222211000      0010       112233456788999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-35  Score=344.67  Aligned_cols=267  Identities=23%  Similarity=0.246  Sum_probs=200.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC----CCCCCceeEEeeEEe---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF----GWPHPNLVTLYGWCL---  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~----~l~h~niv~l~~~~~---  875 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.+..    ...|+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999965 6889999999754 2334567889888876421    113889999999987   


Q ss_pred             -cCCeEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-------
Q 001384          876 -DGSEKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-------  945 (1088)
Q Consensus       876 -~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-------  945 (1088)
                       .....++||||+ ++++.+++...  ..+++.+++.++.||+.||+|||+++  +|+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence             556889999999 55776666543  46999999999999999999999964  899999999999999775       


Q ss_pred             ------------------------------------------CEEEeecccceeecCCCCcccccccccccccCccccCC
Q 001384          946 ------------------------------------------KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT  983 (1088)
Q Consensus       946 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  983 (1088)
                                                                .+||+|||.++.....    .....||..|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      8999999999876432    234578999999999998


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCcCCCCCchh----HHHHHHhh---hc----------------cCCCCCCccccch--
Q 001384          984 WQATTKGDVYSFGVLAMELATGRRALEGGEEC----LVEWGRRV---MG----------------YGRHGPGRAVIPV-- 1038 (1088)
Q Consensus       984 ~~~~~~~DvwslG~~l~elltg~~p~~~~~~~----~~~~~~~~---~~----------------~~~~~~~~~~~~~-- 1038 (1088)
                      ..++.++|||||||++|||++|+.||......    ........   ..                +............  
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            89999999999999999999999999764320    00100000   00                0000000000000  


Q ss_pred             ----hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 ----VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .........+......+.+++.+||+.||++||+++|+++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                0000011234667788999999999999999999999985

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.7e-35  Score=337.71  Aligned_cols=350  Identities=20%  Similarity=0.165  Sum_probs=222.2

Q ss_pred             cccccCCCCCCcc-cCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEEC
Q 001384           56 HYMQWNQSSSPCE-WPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL  134 (1088)
Q Consensus        56 ~~~sW~~~~~~C~-W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  134 (1088)
                      .+++|....+||. |.+..|.....++     ............-..++++++|++++|.++...+..+..+++|++|+|
T Consensus         2 ~~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L   76 (390)
T 3o6n_A            2 NVKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL   76 (390)
T ss_dssp             -----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred             CcCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence            3678998888885 5555553222222     111111111122235688999999999998444445788999999999


Q ss_pred             ccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc
Q 001384          135 SHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       135 s~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ++|.+++..  .+.++++|++|+|++|++++..+..+ ..+++|++|+|++|+++...+..|.+++              
T Consensus        77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~l~~~~~~~l~--------------  141 (390)
T 3o6n_A           77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF-QNVPLLTVLVLERNDLSSLPRGIFHNTP--------------  141 (390)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCT--------------
T ss_pred             CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh-cCCCCCCEEECCCCccCcCCHHHhcCCC--------------
Confidence            999887643  57777777777777777764433332 2224444444444444443333344444              


Q ss_pred             cccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCC
Q 001384          213 NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSIS  292 (1088)
Q Consensus       213 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  292 (1088)
                                                      +|++|++++|++++..|..+.++++|++|++++|++++.   .+..++
T Consensus       142 --------------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~  186 (390)
T 3o6n_A          142 --------------------------------KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP  186 (390)
T ss_dssp             --------------------------------TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCT
T ss_pred             --------------------------------CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cccccc
Confidence                                            444444444444444444444555555555555554432   133444


Q ss_pred             CCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEc
Q 001384          293 GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL  372 (1088)
Q Consensus       293 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L  372 (1088)
                      +|+.|++++|.+.+.     ...++|++|++++|.+......   ..++|+.|++++|.+.+.   ..+..+++|++|+|
T Consensus       187 ~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~L  255 (390)
T 3o6n_A          187 SLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT---AWLLNYPGLVEVDL  255 (390)
T ss_dssp             TCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC---GGGGGCTTCSEEEC
T ss_pred             ccceeeccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc---HHHcCCCCccEEEC
Confidence            555555555544331     2223455555555555443221   124555555555554331   35667889999999


Q ss_pred             cCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC
Q 001384          373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       373 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      ++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..++.+++|++|+|++|+++. 
T Consensus       256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-  332 (390)
T 3o6n_A          256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-  332 (390)
T ss_dssp             CSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-
T ss_pred             CCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-
Confidence            999999888999999999999999999999 57777889999999999999999 688889999999999999999984 


Q ss_pred             CCccccCCCCCCeEEccCCcCccC
Q 001384          453 IPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       453 ~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      +|  +..+++|+.|++++|++++.
T Consensus       333 ~~--~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          333 LK--LSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             CC--CCTTCCCSEEECCSSCEEHH
T ss_pred             eC--chhhccCCEEEcCCCCccch
Confidence            44  78899999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-35  Score=345.47  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=192.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC------
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG------  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~------  877 (1088)
                      .+|++.+.||+|+||+||+|++. +|+.||||++.....    ...+|+++++.    ++||||+++++++...      
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~----l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRK----LDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHT----CCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHH----cCCCCccceeeEEeccCCCCcc
Confidence            35888999999999999999986 689999999875422    23468899986    6799999999988542      


Q ss_pred             CeEEEEEEecCCCCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeec
Q 001384          878 SEKILVYEYMEGGSLEDIIS----DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDF  952 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Df  952 (1088)
                      ...++||||+++ ++.+.+.    ....+++..++.++.||++||+|||++   +|+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            236789999986 7766654    346799999999999999999999999   99999999999999965 56899999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchh--HHHHHHhhhccCC-
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEEC--LVEWGRRVMGYGR- 1028 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~- 1028 (1088)
                      |+++......  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....  ..+...... ... 
T Consensus       202 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg-~p~~  278 (420)
T 1j1b_A          202 GSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG-TPTR  278 (420)
T ss_dssp             TTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-SCCH
T ss_pred             hhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCH
Confidence            9998765332  23346789999999987654 7999999999999999999999999876431  112111100 000 


Q ss_pred             ------CCCCcc-ccchhhcCCCc--cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 ------HGPGRA-VIPVVLLGSGL--AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ------~~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .....+ .++. ......  ........++.+++.+|++.||.+||++.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQ-IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCC-CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCc-cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                  000000 0000 000000  001123467889999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-35  Score=336.12  Aligned_cols=249  Identities=25%  Similarity=0.314  Sum_probs=171.3

Q ss_pred             cCCCCccc-eecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----C
Q 001384          804 TGKFSEDR-IIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----G  877 (1088)
Q Consensus       804 ~~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~  877 (1088)
                      .++|++.+ +||+|+||+||+|+++ +++.||||++...     ....+|+....+   .+.||||+++++++..    +
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~---~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ---ASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHH---HTTSTTBCCEEEEEEEEETTE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHH---hcCCCChHHHHHHHhhccCCC
Confidence            45788854 6999999999999986 6899999998654     122223332221   1479999999999876    4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeec
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDF  952 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Df  952 (1088)
                      ...++||||+++|+|.+++....  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+||
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence            55899999999999999998754  699999999999999999999999   9999999999999986   455999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH-HHhhhccCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW-GRRVMGYGRHGP 1031 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 1031 (1088)
                      |+++.....   ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||.......... .........   
T Consensus       176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  249 (336)
T 3fhr_A          176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---  249 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---
Confidence            999865422   2334568999999999988899999999999999999999999997653311100 000000000   


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                               .............++.+++.+|++.||++||+++|+++
T Consensus       250 ---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 ---------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     00000111233467889999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=335.01  Aligned_cols=266  Identities=20%  Similarity=0.236  Sum_probs=194.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe-------
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL-------  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~-------  875 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++    ++||||+++++++.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~----l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR----LDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHT----CCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHh----cCCCCeeEEEEeccccccccc
Confidence            468999999999999999999986 589999999987655556788999999997    67999999999874       


Q ss_pred             -------cCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCE
Q 001384          876 -------DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKA  947 (1088)
Q Consensus       876 -------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~  947 (1088)
                             +....++||||++ |+|.++++. .++++..++.++.|++.||+|||++   +|+||||||+||+++ +++.+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence                   3467899999998 599999965 5689999999999999999999999   999999999999997 56799


Q ss_pred             EEeecccceeecCCCC--cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhh
Q 001384          948 LVTDFGLARVVSAGDS--HVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRV 1023 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~ 1023 (1088)
                      ||+|||.++.......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.+...... ......
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987643211  12234567899999997654 6889999999999999999999999987654211 110000


Q ss_pred             hccCCCC-------CCccccchhhcCCCc---cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1024 MGYGRHG-------PGRAVIPVVLLGSGL---AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1024 ~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......       ...............   ........++.+++.+|++.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000       000000000000000   001123467889999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-36  Score=337.57  Aligned_cols=244  Identities=25%  Similarity=0.400  Sum_probs=200.5

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ...++|++.+.||+|+||.||+|++. +++.||||++......      ....+..|+.++.++.  ..||||+++++++
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~~~i~~~~~~~  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS--SGFSGVIRLLDWF  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC--SSSCSBCCEEEEE
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc--cCCCCceEEEEEE
Confidence            34578999999999999999999965 6899999999765322      1234667888887643  2479999999999


Q ss_pred             ecCCeEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc-CCCCEEEeec
Q 001384          875 LDGSEKILVYEYMEG-GSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD-KEGKALVTDF  952 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~-~~~~~kl~Df  952 (1088)
                      ..++..++||||+.+ ++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999999986 89999999888899999999999999999999999   999999999999999 7899999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1088)
                      |+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....    ......      .
T Consensus       195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~------~  261 (320)
T 3a99_A          195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIRGQV------F  261 (320)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHCCC------C
T ss_pred             ccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----hhcccc------c
Confidence            999876532   2334568999999998776655 6889999999999999999999976321    111000      0


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          .           +.....++.+++.+|++.||++||+++|+++
T Consensus       262 ----~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          262 ----F-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----C-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----c-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0           1112356888999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.3e-35  Score=335.11  Aligned_cols=266  Identities=23%  Similarity=0.271  Sum_probs=199.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG----  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~----  877 (1088)
                      .++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+++++.    ++||||+++++++..+    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH----FKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHH----CCCTTBCCEEEECCCSCSTT
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHh----CcCCCcCCeeeeecccccCc
Confidence            468999999999999999999976 689999999975432 234567899999987    6799999999987754    


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 -SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                       ...++||||++ |+|.+++.. ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence             67899999997 599999876 4699999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCc---------ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhc
Q 001384          957 VVSAGDSH---------VSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMG 1025 (1088)
Q Consensus       957 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~ 1025 (1088)
                      ........         ......||+.|+|||++. +..++.++||||+||++|+|++|+.||.+..... .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            76532211         122357899999999764 4688999999999999999999999998765311 111111111


Q ss_pred             cCCCCCCccccc-h----hhc---C----CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAVIP-V----VLL---G----SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~~~-~----~~~---~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ............ .    ...   .    ...........++.+++.+|++.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            100000000000 0    000   0    000001223467889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.7e-35  Score=344.21  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=188.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      +.|...++||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.+.   .+||||+++++++.++...++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l---~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTES---DDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHH---TTSTTBCCEEEEEECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhc---cCCCCcCeEEEEEecCCeEEEEE
Confidence            345556889999999998777668999999998754   235678899988752   37999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-------------
Q 001384          885 EYMEGGSLEDIISDRTRL-------TWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-------------  944 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l-------~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-------------  944 (1088)
                      ||++ |+|.++++.....       ++..++.++.||+.||+|||++   +|+||||||+||+++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9996 5999999875432       2334578999999999999999   99999999999999754             


Q ss_pred             CCEEEeecccceeecCCCCc---ccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCcCCCCCc
Q 001384          945 GKALVTDFGLARVVSAGDSH---VSTTIAGTVGYVAPEYGQT-------WQATTKGDVYSFGVLAMELAT-GRRALEGGE 1013 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~p~~~~~ 1013 (1088)
                      +.+||+|||+++........   ......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            48999999999887543322   1234579999999998765       678999999999999999999 999997653


Q ss_pred             hhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...............    .          ..........++.+++.+|++.||.+||++.||++
T Consensus       245 ~~~~~i~~~~~~~~~----~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRESNIIRGIFSLDE----M----------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THHHHHHHTCCCCCC----C----------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhHHHHhcCCCCccc----c----------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            322222211110000    0          01113456678999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-35  Score=335.75  Aligned_cols=206  Identities=23%  Similarity=0.285  Sum_probs=170.9

Q ss_pred             HHcCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCC--CCCCCCceeEEeeEEecCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNG--FGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~--~~l~h~niv~l~~~~~~~~  878 (1088)
                      ...++|++.+.||+|+||+||+|++. +++.||||++.... ....++..|++++..+.  ....|++++++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999976 68899999997542 22345667777765432  0122346999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCCEEEeeccc
Q 001384          879 EKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGL  954 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~--~~~~~kl~Dfg~  954 (1088)
                      ..++||||+++ +|.+++...  ..+++..++.++.|++.||+|||++ ..+||||||||+||+++  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            99999999965 999999765  4599999999999999999999952 12899999999999995  478899999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 1014 (1088)
                      ++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus       208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9876432    2345789999999999998999999999999999999999999987654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.5e-35  Score=332.04  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=177.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||.||+|.++ +|+.||||++..... ....++..|+..+.+   .++||||+++++++.+++..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~---~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR---SSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHS---SCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHH---cCCCCcEeeeeeEEEeCCceEE
Confidence            67889999999999999999985 689999999976532 223455666664333   2689999999999999999999


Q ss_pred             EEEecCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          883 VYEYMEGGSLEDIISD-----RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ||||+++ +|.+++..     ...+++..++.++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            9999986 88888763     567999999999999999999999963  899999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYG----QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .....  ......||..|+|||++    .+..++.++||||||+++|+|++|+.||.......... ....   . .   
T Consensus       176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~---~-~---  245 (327)
T 3aln_A          176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVV---K-G---  245 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCC---C-S---
T ss_pred             ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-HHHh---c-C---
Confidence            64322  22334689999999988    46678999999999999999999999998643211110 0000   0 0   


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        .......   .........+.+++.+|++.||++||++.|+++
T Consensus       246 --~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 --DPPQLSN---SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --CCCCCCC---CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCCCC---cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              0000000   001123457889999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.3e-35  Score=334.14  Aligned_cols=257  Identities=22%  Similarity=0.292  Sum_probs=195.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++......  ..+.+.+|+.+++.    ++||||+++++++......
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH----MQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCSSS
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHh----cCCCCchhhhhheeccCCc
Confidence            468999999999999999999976 6899999999864322  24578899999987    6799999999999877654


Q ss_pred             ------EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          881 ------ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       881 ------~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                            ++||||++ ++|.+++..  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          117 RNFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             TTCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             ccceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence                  99999997 589888743  489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCCCCC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 1032 (1088)
                      ++....    ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..... ...........    .
T Consensus       191 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~  262 (371)
T 4exu_A          191 ARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP----G  262 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC----C
T ss_pred             cccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC----c
Confidence            986532    2334578999999998776 789999999999999999999999998764311 11111111000    0


Q ss_pred             ccccch-----------hhcCCC----ccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPV-----------VLLGSG----LAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~-----------~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+....           ......    ..........+.+++.+|++.||++||+++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000           000000    0001123467889999999999999999999975

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-34  Score=353.28  Aligned_cols=350  Identities=20%  Similarity=0.191  Sum_probs=229.8

Q ss_pred             cccccccCCCCCCcc----cCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCC
Q 001384           54 EGHYMQWNQSSSPCE----WPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSL  129 (1088)
Q Consensus        54 ~~~~~sW~~~~~~C~----W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L  129 (1088)
                      +..+++|..+.+||.    |.++.|+.   ++   +-.......  ...--.+++++.|++++|.++...+..++.+++|
T Consensus         6 ~~~l~~~~~~~~C~~~~~~~~c~~~~~---~i---~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L   77 (597)
T 3oja_B            6 RYNVKPRQPEYKCIDSNLQYDCVFYDV---HI---DMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV   77 (597)
T ss_dssp             -----CCCSEECCCCC--CCSEEECSC---EE---CSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred             cccccCCCCCCcCcccCcCceeEecCc---ee---ccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence            346789998888885    66665542   21   111111111  1112246788999999999986555567889999


Q ss_pred             cEEECccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccC
Q 001384          130 KYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSS  207 (1088)
Q Consensus       130 ~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~  207 (1088)
                      ++|+|++|.+++..  .+.++++|++|+|++|.+++..+..| ..+++|++|+|++|++++.++..|.+++         
T Consensus        78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~l~~~~~~~l~---------  147 (597)
T 3oja_B           78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF-QNVPLLTVLVLERNDLSSLPRGIFHNTP---------  147 (597)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCT---------
T ss_pred             cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH-cCCCCCCEEEeeCCCCCCCCHHHhccCC---------
Confidence            99999999888644  57777777777777777765433322 2234444444444444444444444444         


Q ss_pred             ccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccc
Q 001384          208 NNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAE  287 (1088)
Q Consensus       208 N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  287 (1088)
                                                           +|++|+|++|.+++..|..|.++++|++|+|++|.+++.   .
T Consensus       148 -------------------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~  187 (597)
T 3oja_B          148 -------------------------------------KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---D  187 (597)
T ss_dssp             -------------------------------------TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---C
T ss_pred             -------------------------------------CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---C
Confidence                                                 444444444444444444455555555555555555432   1


Q ss_pred             cCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCc
Q 001384          288 IGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI  367 (1088)
Q Consensus       288 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L  367 (1088)
                      ++.+++|+.|++++|.+.+     +...++|+.|++++|.+....+..   .++|+.|++++|.+.+   ...+..+++|
T Consensus       188 ~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~---~~~l~~l~~L  256 (597)
T 3oja_B          188 LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD---TAWLLNYPGL  256 (597)
T ss_dssp             GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC---CGGGGGCTTC
T ss_pred             hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC---ChhhccCCCC
Confidence            3334455555555554443     122334555555555554433222   1345555555555433   2456678999


Q ss_pred             CEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcccc
Q 001384          368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN  447 (1088)
Q Consensus       368 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  447 (1088)
                      +.|+|++|.+++..|..|+.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..++.+++|++|+|++|
T Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N  334 (597)
T 3oja_B          257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN  334 (597)
T ss_dssp             SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred             CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCC
Confidence            99999999999999999999999999999999999 47888888999999999999999 68999999999999999999


Q ss_pred             ccccCCCccccCCCCCCeEEccCCcCccCC
Q 001384          448 SLSGEIPGEIGNCTSLLWLNLSNNKLSGNI  477 (1088)
Q Consensus       448 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i  477 (1088)
                      .+++ +|  +..+++|+.|+|++|++++..
T Consensus       335 ~l~~-~~--~~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          335 SIVT-LK--LSTHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             CCCC-CC--CCTTCCCSEEECCSSCEEHHH
T ss_pred             CCCC-cC--hhhcCCCCEEEeeCCCCCChh
Confidence            9985 44  778899999999999998753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=324.59  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=179.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-hHHHHHH-HHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-EREFRAE-MEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E-~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||.||+|+++ +|+.||||++....... ..+...| ..++..    ++||||+++++++.+++..+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~----~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS----HDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHT----TTCTTBCCEEEEEECSSEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHh----cCCCceeeEEEEEecCCcEE
Confidence            56888999999999999999986 68999999997653322 2233333 344553    58999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+ ++.+..+... ...+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||++.....
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999999 5566666544 467999999999999999999999832  899999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQ-----TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ..  ......+++.|+|||++.     ...++.++||||||+++|||++|+.||.........+..........      
T Consensus       178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  249 (318)
T 2dyl_A          178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC------
T ss_pred             Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC------
Confidence            22  233456899999999874     56789999999999999999999999987543322222222110000      


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .+         .......++.+++.+|++.||.+||+++|+++
T Consensus       250 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LP---------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC---------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00         01122356888999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.6e-35  Score=336.34  Aligned_cols=267  Identities=19%  Similarity=0.215  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC-------CCCCCceeEEeeEEe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-------GWPHPNLVTLYGWCL  875 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-------~l~h~niv~l~~~~~  875 (1088)
                      .++|++.+.||+|+||+||+|++. +++.||||++... ......+.+|++++.++..       .+.||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357999999999999999999974 7899999999754 2334567788888775321       012899999999988


Q ss_pred             cCC----eEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc------C
Q 001384          876 DGS----EKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD------K  943 (1088)
Q Consensus       876 ~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~------~  943 (1088)
                      ...    ..++||||+ +++|.+++...  ..+++..++.++.||+.||+|||+++  +|+||||||+||+++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            654    789999999 88999999763  45999999999999999999999963  899999999999995      3


Q ss_pred             CCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh--------
Q 001384          944 EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-------- 1015 (1088)
Q Consensus       944 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------- 1015 (1088)
                      .+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....        
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            447999999999876432    23357899999999999989999999999999999999999999864310        


Q ss_pred             HHHHHHhhhcc---------------CCCCCCccc------cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHH
Q 001384         1016 LVEWGRRVMGY---------------GRHGPGRAV------IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVK 1074 (1088)
Q Consensus      1016 ~~~~~~~~~~~---------------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1074 (1088)
                      ...........               .........      ............+.....++.+++.+|++.||++||+++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            11111000000               000000000      000000111123466778999999999999999999999


Q ss_pred             HHHH
Q 001384         1075 EVLA 1078 (1088)
Q Consensus      1075 eil~ 1078 (1088)
                      |+++
T Consensus       330 ell~  333 (373)
T 1q8y_A          330 GLVN  333 (373)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9986

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-34  Score=340.76  Aligned_cols=321  Identities=23%  Similarity=0.242  Sum_probs=218.3

Q ss_pred             CeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc--cCCCCCCCceeecccccccccccCchhhhcccceEEeccC
Q 001384          106 SYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL--NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSL  183 (1088)
Q Consensus       106 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~  183 (1088)
                      +.++.++++++ .+|..+.  ++|++|+|++|.+++..  .+.++++|++|+|++|.+++..|..|. .+++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN-NLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhh-CCccCCEEECCC
Confidence            46888888888 6777653  57888888888887643  477777777777777777654444332 224444444444


Q ss_pred             ccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCccc
Q 001384          184 NNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE  263 (1088)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~  263 (1088)
                      |++++..+..|.++++|+                                              +|+|++|++++..|..
T Consensus        90 n~l~~~~~~~~~~l~~L~----------------------------------------------~L~Ls~n~i~~~~~~~  123 (477)
T 2id5_A           90 NRLKLIPLGVFTGLSNLT----------------------------------------------KLDISENKIVILLDYM  123 (477)
T ss_dssp             SCCCSCCTTSSTTCTTCC----------------------------------------------EEECTTSCCCEECTTT
T ss_pred             CcCCccCcccccCCCCCC----------------------------------------------EEECCCCccccCChhH
Confidence            444444444444444444                                              4444444444444444


Q ss_pred             ccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccc
Q 001384          264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK  343 (1088)
Q Consensus       264 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  343 (1088)
                      |.++++|++|+|++|.+.+..+..|..+++|+.|+|++|++++..+..+.++++|+.|+|++|.+.+..+..|..+++|+
T Consensus       124 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~  203 (477)
T 2id5_A          124 FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK  203 (477)
T ss_dssp             TTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred             ccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence            55555555555555555544444455555555555555555544444455555555555555555555444555555555


Q ss_pred             eeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCC
Q 001384          344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN  423 (1088)
Q Consensus       344 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  423 (1088)
                      .|++++|..........+ ...+|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|
T Consensus       204 ~L~l~~~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  282 (477)
T 2id5_A          204 VLEISHWPYLDTMTPNCL-YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG  282 (477)
T ss_dssp             EEEEECCTTCCEECTTTT-TTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSS
T ss_pred             eeeCCCCccccccCcccc-cCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCC
Confidence            555555544443333332 3348999999999999655567899999999999999999888888999999999999999


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCC
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI  477 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i  477 (1088)
                      ++++..|..+.++++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus       283 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          283 QLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             CCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred             ccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence            999988999999999999999999999766777899999999999999998653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-34  Score=328.31  Aligned_cols=266  Identities=22%  Similarity=0.251  Sum_probs=198.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CC-cEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DG-REVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||+||+|.+. ++ +.||||++... ......+..|+++++.+..  ...|.+++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999975 34 68999999754 2334567788888776320  1233449999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----------------
Q 001384          880 KILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLL----------------  941 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll----------------  941 (1088)
                      .++||||+ ++++.+++....  ++++.+++.++.||+.||+|||++   +|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567777776543  699999999999999999999999   99999999999999                


Q ss_pred             ---cCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HH
Q 001384          942 ---DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LV 1017 (1088)
Q Consensus       942 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~ 1017 (1088)
                         +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence               67889999999999864322    23457899999999999889999999999999999999999999876442 11


Q ss_pred             HHHHhhhc-cCC-----CCCC------ccccch----------hh--cCCCccccHHHHHHHHHHHhhhcccCCCCCCCH
Q 001384         1018 EWGRRVMG-YGR-----HGPG------RAVIPV----------VL--LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073 (1088)
Q Consensus      1018 ~~~~~~~~-~~~-----~~~~------~~~~~~----------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1073 (1088)
                      ........ ...     ....      ....+.          ..  .............++.+++.+|++.||++||++
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            11111110 000     0000      000000          00  000001123445688999999999999999999


Q ss_pred             HHHHH
Q 001384         1074 KEVLA 1078 (1088)
Q Consensus      1074 ~eil~ 1078 (1088)
                      +|+++
T Consensus       329 ~e~l~  333 (355)
T 2eu9_A          329 AEALL  333 (355)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.8e-35  Score=351.39  Aligned_cols=271  Identities=26%  Similarity=0.367  Sum_probs=205.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++.+    ++||||+++++++..     
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~----L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK----LNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHH----CCBTTBCCEEECCTTTCCCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHh----CCCCCCCceeeeeccccccc
Confidence            368999999999999999999975 68999999987642 2334578899999997    679999999998765     


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC---EEE
Q 001384          877 -GSEKILVYEYMEGGSLEDIISDRT---RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK---ALV  949 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~---~kl  949 (1088)
                       ++..++||||+++|+|.+++....   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence             677899999999999999998754   589999999999999999999999   9999999999999997765   999


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccC--
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG-- 1027 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-- 1027 (1088)
                      +|||.+.......  ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+... ...|........  
T Consensus       166 ~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          166 IDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKSNE  242 (676)
T ss_dssp             CSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC-----
T ss_pred             ccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhcccch
Confidence            9999998765332  23456789999999999999999999999999999999999999976432 222322111000  


Q ss_pred             -----CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHH-----HHHHHHhhCC
Q 001384         1028 -----RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE-----VLAMLIKILP 1085 (1088)
Q Consensus      1028 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----il~~L~~i~~ 1085 (1088)
                           ........... ...............+.+++.+|++.||++||+++|     +.+.++++++
T Consensus       243 ~~~~~~~l~g~~~~~~-~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSS-VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             -CCSCCCCSSSCCCCS-SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhcccccccc-ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                 00000000000 001111123446678999999999999999999988     5666666653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.8e-35  Score=332.37  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=195.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe-
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE-  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~-  879 (1088)
                      .++|.+.+.||+|+||.||+|+++ +|+.||||++......  ..+.+.+|+.+++.    ++||||+++++++..... 
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~----l~h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH----MQHENVIGLLDVFTPASSL   98 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCSSG
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHh----cCCCCcccHhheEeccccc
Confidence            367899999999999999999975 6899999999764322  23568899999987    679999999999987654 


Q ss_pred             -----EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          880 -----KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       880 -----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                           .++||||++ ++|.+++..  ++++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence                 499999997 588887753  489999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCC---
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRH--- 1029 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~--- 1029 (1088)
                      ++.....    .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..... .............   
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9765321    234578999999998776 688999999999999999999999998764311 1111110000000   


Q ss_pred             CCC-cc-------ccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 GPG-RA-------VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 ~~~-~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ... ..       ..+................++.+++.+|++.||++||+++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000 00       00000000000112234567889999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=336.98  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=187.3

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      .+|+..++||+|+||+||.....+++.||||++......   .+.+|+++++...   +|||||++++++.+....|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~---~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESD---EHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSC---CCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhcc---CCCCcCeEEEEEecCCEEEEEE
Confidence            358888999999999976555567999999999765332   3467888888632   7999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-----CCCEEEeecccceee
Q 001384          885 EYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-----EGKALVTDFGLARVV  958 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-----~~~~kl~Dfg~a~~~  958 (1088)
                      ||++ |+|.+++.... ...+.+++.++.||+.||+|||++   +|+||||||+||+++.     ...+||+|||+++..
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9996 59999997654 456667789999999999999999   9999999999999953     336889999999876


Q ss_pred             cCCCC--cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          959 SAGDS--HVSTTIAGTVGYVAPEYGQ---TWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       959 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .....  .......||+.|+|||++.   ...++.++||||+||++|||++ |..||...............      . 
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~------~-  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC------S-  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC------C-
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC------C-
Confidence            53321  2234467999999999887   4577889999999999999999 99999654332211111000      0 


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..         ...........+.+++.+|++.||.+||+++||++
T Consensus       247 ~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LD---------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CT---------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc---------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00         00012234456788999999999999999999983

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1e-33  Score=328.28  Aligned_cols=316  Identities=19%  Similarity=0.182  Sum_probs=177.0

Q ss_pred             cccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccC
Q 001384          235 VSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN  314 (1088)
Q Consensus       235 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  314 (1088)
                      ++...|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.++...+..|.+
T Consensus        60 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~  139 (390)
T 3o6n_A           60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN  139 (390)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcC
Confidence            34455566667777777777776666667777777777777777777666666777777777777777776544444567


Q ss_pred             CCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCccee
Q 001384          315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFL  394 (1088)
Q Consensus       315 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  394 (1088)
                      +++|++|+|++|.+++..+..|+.+++|+.|++++|.+...    .+..+++|+.|++++|.+++     +...++|+.|
T Consensus       140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L  210 (390)
T 3o6n_A          140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYNLLST-----LAIPIAVEEL  210 (390)
T ss_dssp             CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC----CGGGCTTCSEEECCSSCCSE-----EECCSSCSEE
T ss_pred             CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc----ccccccccceeecccccccc-----cCCCCcceEE
Confidence            77777777777777666555555444444444444443221    12334444455555444432     1222344444


Q ss_pred             eccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          395 ILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       395 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      ++++|+++. +|..  ..++|+.|++++|++++.  +.++++++|++|+|++|.+++..|..+.++++|++|+|++|+++
T Consensus       211 ~l~~n~l~~-~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  285 (390)
T 3o6n_A          211 DASHNSINV-VRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV  285 (390)
T ss_dssp             ECCSSCCCE-EECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC
T ss_pred             ECCCCeeee-cccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc
Confidence            444444442 2221  123444444444444421  23444444444444444444433444444444444444444433


Q ss_pred             cCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccC
Q 001384          475 GNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLP  554 (1088)
Q Consensus       475 g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  554 (1088)
                                                                                                      
T Consensus       286 --------------------------------------------------------------------------------  285 (390)
T 3o6n_A          286 --------------------------------------------------------------------------------  285 (390)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             CCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCcc
Q 001384          555 GLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKC  634 (1088)
Q Consensus       555 ~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~  634 (1088)
                                           + +|..++.+++|++|+|++|+                       ++ .+|..++.+++
T Consensus       286 ---------------------~-~~~~~~~l~~L~~L~L~~n~-----------------------l~-~~~~~~~~l~~  319 (390)
T 3o6n_A          286 ---------------------A-LNLYGQPIPTLKVLDLSHNH-----------------------LL-HVERNQPQFDR  319 (390)
T ss_dssp             ---------------------E-EECSSSCCTTCCEEECCSSC-----------------------CC-CCGGGHHHHTT
T ss_pred             ---------------------c-cCcccCCCCCCCEEECCCCc-----------------------ce-ecCccccccCc
Confidence                                 1 22223334444444444444                       44 56777778888


Q ss_pred             CcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCcccccccCccCCCCCCC
Q 001384          635 LQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLD  695 (1088)
Q Consensus       635 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~  695 (1088)
                      |+.|+|++|+|+ .+|  +..+++|+.|++++|++.+...  ...+..+....+.+++..|
T Consensus       320 L~~L~L~~N~i~-~~~--~~~~~~L~~L~l~~N~~~~~~~--~~~~~~~~~~~~~~~~~~c  375 (390)
T 3o6n_A          320 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSL--RALFRNVARPAVDDADQHC  375 (390)
T ss_dssp             CSEEECCSSCCC-CCC--CCTTCCCSEEECCSSCEEHHHH--HHHTTTCCTTTBCCCCSCC
T ss_pred             CCEEECCCCccc-eeC--chhhccCCEEEcCCCCccchhH--HHHHHHHHhhcccccCcee
Confidence            888888888887 444  6778888999999998854322  1234455556667777666

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-33  Score=344.95  Aligned_cols=316  Identities=19%  Similarity=0.186  Sum_probs=183.9

Q ss_pred             cccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccC
Q 001384          235 VSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN  314 (1088)
Q Consensus       235 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  314 (1088)
                      ++...|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..+..|++
T Consensus        66 lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~  145 (597)
T 3oja_B           66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN  145 (597)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhcc
Confidence            44455666667777777777777666667777777777777777777666666677777777777777777655555677


Q ss_pred             CCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCccee
Q 001384          315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFL  394 (1088)
Q Consensus       315 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  394 (1088)
                      +++|++|+|++|.+++.++..|+.+++|+.|+++                         +|.+++.   .++.+++|+.|
T Consensus       146 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~-------------------------~N~l~~~---~~~~l~~L~~L  197 (597)
T 3oja_B          146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS-------------------------SNRLTHV---DLSLIPSLFHA  197 (597)
T ss_dssp             CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECT-------------------------TSCCSBC---CGGGCTTCSEE
T ss_pred             CCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECc-------------------------CCCCCCc---Chhhhhhhhhh
Confidence            7777777777777776666555554444444444                         4444432   13334444555


Q ss_pred             eccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          395 ILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       395 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      ++++|.+++     +...++|+.|++++|.++. +|..+  .++|+.|+|++|.+++  +..++.+++|+.|+|++|.++
T Consensus       198 ~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~  267 (597)
T 3oja_B          198 NVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE  267 (597)
T ss_dssp             ECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred             hcccCcccc-----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence            555554442     1123345555555555542 22222  1355555555555553  244555555555555555554


Q ss_pred             cCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccC
Q 001384          475 GNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLP  554 (1088)
Q Consensus       475 g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  554 (1088)
                      +.+|..                                                                          
T Consensus       268 ~~~~~~--------------------------------------------------------------------------  273 (597)
T 3oja_B          268 KIMYHP--------------------------------------------------------------------------  273 (597)
T ss_dssp             EEESGG--------------------------------------------------------------------------
T ss_pred             CCCHHH--------------------------------------------------------------------------
Confidence            332222                                                                          


Q ss_pred             CCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCc
Q 001384          555 GLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIK  633 (1088)
Q Consensus       555 ~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~  633 (1088)
                                                 ++.+++|+.|+|++|++++ +|..++.+ .|+.|+|++|+++ .+|..++.++
T Consensus       274 ---------------------------~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~  324 (597)
T 3oja_B          274 ---------------------------FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD  324 (597)
T ss_dssp             ---------------------------GTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHT
T ss_pred             ---------------------------hcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCC
Confidence                                       1122222233333333322 12222222 2444444445454 6777888888


Q ss_pred             cCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCcccccccCccCCCCCCCC
Q 001384          634 CLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDL  696 (1088)
Q Consensus       634 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~~~~~~~~~~~n~~~~~  696 (1088)
                      +|+.|+|++|+|++ +|  +..+++|+.|++++|+|.+...  ...+..+....+.+++..|.
T Consensus       325 ~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~~~~~~~--~~~~~~~~~~~~~~~~~~C~  382 (597)
T 3oja_B          325 RLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSL--RALFRNVARPAVDDADQHCK  382 (597)
T ss_dssp             TCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHH--HHHTTTCCTTTBCCCCCCCC
T ss_pred             CCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCCCCChhH--HHHHHHHhhhccccccccCC
Confidence            99999999999984 44  6778899999999999954332  23456667777888888884

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.4e-34  Score=314.25  Aligned_cols=231  Identities=14%  Similarity=0.136  Sum_probs=184.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      .++|++.+.||+|+||.||+|++. +++.||||++.......   .+.+.+|+..+.+    +.||||+++++++.+++.
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~----l~hp~iv~~~~~~~~~~~  105 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR----IDKPGVARVLDVVHTRAG  105 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEEETTE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhc----CCCCCcceeeEEEEECCc
Confidence            367999999999999999999986 58999999998754332   2678899999886    689999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||++|++|.++++..  ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+||+++|      
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            99999999999999999653  46668899999999999999999   99999999999999999999998543      


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhH-HHHHHhhhccCCCCCCccccch
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECL-VEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                                     |++       .++.++|||||||++|||++|+.||.+..... ....      ..... ......
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~-~~~~~~  225 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------ERDTA-GQPIEP  225 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------CBCTT-SCBCCH
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------HHHhc-cCCCCh
Confidence                           333       37889999999999999999999998753210 0000      00000 000000


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .      ......+.++.+++.+|++.||++| ++.|+++.|+++..
T Consensus       226 ~------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          226 A------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             H------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             h------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0      0112234678899999999999999 99999999998754

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.1e-33  Score=317.00  Aligned_cols=252  Identities=28%  Similarity=0.514  Sum_probs=226.5

Q ss_pred             CCcCEEEccCCccCC--CCCccccCCcCcceeeccc-cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcE
Q 001384          365 PNISRLDLSHNNFTG--PLPVEISQMRSLKFLILAH-NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW  441 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  441 (1088)
                      .+++.|+|++|.+++  .+|..+.++++|++|++++ |.+.+.+|..|+++++|++|+|++|++++.+|..++++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            478899999999998  8899999999999999995 9999899999999999999999999999889999999999999


Q ss_pred             EEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCC
Q 001384          442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYP  521 (1088)
Q Consensus       442 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (1088)
                      |+|++|++++.+|..++++++|++|+|++|+++|.+|..+..+.                                    
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~------------------------------------  173 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS------------------------------------  173 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC------------------------------------
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh------------------------------------
Confidence            99999999999999999999999999999999988887764331                                    


Q ss_pred             CCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccC
Q 001384          522 PFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK  601 (1088)
Q Consensus       522 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  601 (1088)
                                                              ..+++|++++|+++|.+|..++.++ |+.|++++|++++.
T Consensus       174 ----------------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~  212 (313)
T 1ogq_A          174 ----------------------------------------KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD  212 (313)
T ss_dssp             ----------------------------------------TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEEC
T ss_pred             ----------------------------------------hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCc
Confidence                                                    0235789999999999999999987 99999999999999


Q ss_pred             CCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCcc
Q 001384          602 LPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL  680 (1088)
Q Consensus       602 ~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~  680 (1088)
                      +|..++.+ .|+.|+|++|++++.+|. +..+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|++ +|.+|..+++
T Consensus       213 ~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~~ip~~~~l  290 (313)
T 1ogq_A          213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL-CGEIPQGGNL  290 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE-EEECCCSTTG
T ss_pred             CCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcc-cccCCCCccc
Confidence            99988888 699999999999977766 88899999999999999999999999999999999999999 7899998889


Q ss_pred             cccccCccCCCCCCC
Q 001384          681 ATFEKTSYLGDPLLD  695 (1088)
Q Consensus       681 ~~~~~~~~~~n~~~~  695 (1088)
                      .++....+.+|+.+|
T Consensus       291 ~~L~~l~l~~N~~lc  305 (313)
T 1ogq_A          291 QRFDVSAYANNKCLC  305 (313)
T ss_dssp             GGSCGGGTCSSSEEE
T ss_pred             cccChHHhcCCCCcc
Confidence            999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-33  Score=311.77  Aligned_cols=229  Identities=23%  Similarity=0.280  Sum_probs=178.0

Q ss_pred             CCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CC
Q 001384          805 GKFSED-RIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GS  878 (1088)
Q Consensus       805 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~  878 (1088)
                      ++|.+. +.||+|+||.||+|.+. +++.||+|++...     ..+.+|++++.+.   .+||||+++++++..    +.
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~---~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA---SQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHH---TTSTTBCCEEEEEEEEETTEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHh---ccCCCchhHHhhhhhhcCCCc
Confidence            457776 78999999999999975 6899999998643     4567788777442   479999999999876    67


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeecc
Q 001384          879 EKILVYEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDFG  953 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Dfg  953 (1088)
                      ..++||||+++|+|.+++....  .+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            7899999999999999998754  699999999999999999999999   9999999999999998   7899999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ++....                       +..++.++||||+||++|||++|+.||.........  .         ...
T Consensus       166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~---------~~~  211 (299)
T 3m2w_A          166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P---------GMK  211 (299)
T ss_dssp             TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------C---------CSC
T ss_pred             cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--H---------HHH
Confidence            987543                       135678999999999999999999999764321100  0         000


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....................++.+++.+|++.||++||+++|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000000000001223467889999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-33  Score=349.38  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=193.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC--CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe-
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP--DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE-  879 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~-  879 (1088)
                      .++|++.+.||+|+||+||+|++.  +++.||||++..... .....+.+|++++.+    ++||||+++++++...+. 
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~----l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE----VVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGG----CCCTTBCCEEEEEEEECTT
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHh----cCCCCcCeEeeeEeecCCC
Confidence            478999999999999999999975  589999999875432 334568899999986    679999999999987655 


Q ss_pred             ----EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          880 ----KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       880 ----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                          .|+||||+++++|.+++..  ++++.+++.++.||+.||+|||++   +||||||||+||+++.+ .+||+|||++
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence                6999999999999998765  699999999999999999999999   99999999999999885 8999999999


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      +.....     ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...             ....  . 
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~-------------~~~~--~-  286 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV-------------DGLP--E-  286 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC-------------SSCC--T-
T ss_pred             hhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc-------------cccc--c-
Confidence            876432     345789999999988764 48999999999999999999988875210             0000  0 


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~i~ 1084 (1088)
                               ..........+.+++.+|++.||++|| +++++.+.+.+++
T Consensus       287 ---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 ---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                     001122346788999999999999999 5666777776653

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.1e-32  Score=309.60  Aligned_cols=318  Identities=21%  Similarity=0.284  Sum_probs=242.0

Q ss_pred             CCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCC
Q 001384          110 LSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR  189 (1088)
Q Consensus       110 Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~  189 (1088)
                      +....+++.  ..+..+++|++|++++|.+.....+..+++|++|++++|++++..+   ...+++|++|++++|++++.
T Consensus        29 ~~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~~  103 (347)
T 4fmz_A           29 LQKASVTDV--VTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITDI  103 (347)
T ss_dssp             HTCSCTTSE--ECHHHHTTCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCC
T ss_pred             ccccccCCc--ccchhcccccEEEEeCCccccchhhhhcCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccCc
Confidence            344444433  2356789999999999999887778889999999999998886544   34567788888888877764


Q ss_pred             CCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCC
Q 001384          190 IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRN  269 (1088)
Q Consensus       190 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~  269 (1088)
                        ..+.++++|++|++++|++++.                      +  .+..+++|++|++++|.....++ .+..+++
T Consensus       104 --~~~~~l~~L~~L~l~~n~i~~~----------------------~--~~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~  156 (347)
T 4fmz_A          104 --SALQNLTNLRELYLNEDNISDI----------------------S--PLANLTKMYSLNLGANHNLSDLS-PLSNMTG  156 (347)
T ss_dssp             --GGGTTCTTCSEEECTTSCCCCC----------------------G--GGTTCTTCCEEECTTCTTCCCCG-GGTTCTT
T ss_pred             --hHHcCCCcCCEEECcCCcccCc----------------------h--hhccCCceeEEECCCCCCccccc-chhhCCC
Confidence              3477777788887777776531                      1  15566677888888776554444 3777888


Q ss_pred             CcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCc
Q 001384          270 LVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHS  349 (1088)
Q Consensus       270 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  349 (1088)
                      |++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++
T Consensus       157 L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~  230 (347)
T 4fmz_A          157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN  230 (347)
T ss_dssp             CCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             CcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC
Confidence            8888888888774433  7778888888888888776433  7777888888888888877655  77778888888888


Q ss_pred             CcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCC
Q 001384          350 NSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI  429 (1088)
Q Consensus       350 n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  429 (1088)
                      |.+.....   +..+++|++|++++|.+++.  ..+..+++|++|++++|++++ + ..+..+++|+.|++++|++++..
T Consensus       231 n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~  303 (347)
T 4fmz_A          231 NKITDLSP---LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNED  303 (347)
T ss_dssp             SCCCCCGG---GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGG
T ss_pred             CccCCCcc---hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcC
Confidence            77544222   67888999999999999853  468888999999999999985 4 45788999999999999999888


Q ss_pred             CccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          430 PPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       430 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      |..++++++|++|++++|++++..|  +..+++|++|++++|+++
T Consensus       304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            8889999999999999999986555  888999999999999885

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=9.5e-32  Score=306.56  Aligned_cols=308  Identities=21%  Similarity=0.287  Sum_probs=238.1

Q ss_pred             cccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccce
Q 001384           98 NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLV  177 (1088)
Q Consensus        98 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~  177 (1088)
                      .+..+++|++|++++|.++. +| .+..+++|++|+|++|.+++...+.++++|++|+|++|.+++. + . ...+++|+
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i~~~-~-~-~~~l~~L~  113 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDI-S-A-LQNLTNLR  113 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-G-G-GTTCTTCS
T ss_pred             cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchhhhcCCcCCEEEccCCcccCc-h-H-HcCCCcCC
Confidence            45688999999999999984 45 4899999999999999999877799999999999999999864 2 2 45678999


Q ss_pred             EEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCccc
Q 001384          178 VANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI  257 (1088)
Q Consensus       178 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  257 (1088)
                      +|++++|++++..+  +..+++|++|++++|.....+                       ..+..+++|++|++++|.+.
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-----------------------~~~~~l~~L~~L~l~~~~~~  168 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-----------------------SPLSNMTGLNYLTVTESKVK  168 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-----------------------GGGTTCTTCCEEECCSSCCC
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCcccc-----------------------cchhhCCCCcEEEecCCCcC
Confidence            99999999998765  899999999999999643211                       11445556666666666665


Q ss_pred             ccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhh
Q 001384          258 GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG  337 (1088)
Q Consensus       258 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  337 (1088)
                      +..+  +..+++|++|++++|.+.+. +. +..+++|+.|++++|.+.+..+  +..+++|++|++++|.+++..+  +.
T Consensus       169 ~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~  240 (347)
T 4fmz_A          169 DVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LA  240 (347)
T ss_dssp             CCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred             Cchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hh
Confidence            4333  66667777777777776643 22 6666777777777776665433  6666777777777777766554  66


Q ss_pred             cccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcE
Q 001384          338 RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQT  417 (1088)
Q Consensus       338 ~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  417 (1088)
                      .+++|+.|++++|.+...   ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|..++.+++|++
T Consensus       241 ~l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  315 (347)
T 4fmz_A          241 NLSQLTWLEIGTNQISDI---NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT  315 (347)
T ss_dssp             TCTTCCEEECCSSCCCCC---GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred             cCCCCCEEECCCCccCCC---hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence            677777777777765432   4567889999999999999864  46888999999999999999888899999999999


Q ss_pred             EEccCCcCCCCCCccccCCCCCcEEEccccccc
Q 001384          418 LDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS  450 (1088)
Q Consensus       418 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  450 (1088)
                      |++++|++++..|  +..+++|++|++++|.|+
T Consensus       316 L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEccCCccccccC--hhhhhccceeehhhhccc
Confidence            9999999996555  889999999999999886

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=5.1e-33  Score=323.84  Aligned_cols=237  Identities=15%  Similarity=0.137  Sum_probs=176.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCC-Cc-------------
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPH-PN-------------  866 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h-~n-------------  866 (1088)
                      .+|...++||+|+||+||+|++. +|+.||||++......   ..+.+.+|+.++..+    .| +|             
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l----~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL----RGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS----TTCCSHHHHHHHTCBCCC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh----ccCCCHHHHHHhcccccc
Confidence            34777899999999999999965 7999999998843222   246788999988864    34 21             


Q ss_pred             --------eeEEeeEEec-----CCeEEEEEEecCCCCHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 001384          867 --------LVTLYGWCLD-----GSEKILVYEYMEGGSLEDIISD-------RTRLTWRRRLDIAIDVARALVFLHHECY  926 (1088)
Q Consensus       867 --------iv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~  926 (1088)
                              ...+..++..     ....+++|+++ +++|.++++.       ...+++..++.++.|++.||+|||++  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  230 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--  230 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence                    1111111111     22456777776 5699998842       23478889999999999999999999  


Q ss_pred             CCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCcccc----------CCCCCCcchhHHHHH
Q 001384          927 PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG----------QTWQATTKGDVYSFG  996 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG  996 (1088)
                       +||||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++||||||
T Consensus       231 -~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          231 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             -TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             -CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence             9999999999999999999999999998865322    344567 999999988          666789999999999


Q ss_pred             HHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHH
Q 001384          997 VLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEV 1076 (1088)
Q Consensus       997 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 1076 (1088)
                      |++|||++|+.||.......                  ..........     ..+..+.+++.+|++.||++||++.|+
T Consensus       305 vil~elltg~~Pf~~~~~~~------------------~~~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALG------------------GSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGS------------------CSGGGGSSCC-----CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHCCCCCCCcchhh------------------hHHHHHhhcc-----cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999999998653210                  0111111110     123568889999999999999997776


Q ss_pred             H
Q 001384         1077 L 1077 (1088)
Q Consensus      1077 l 1077 (1088)
                      +
T Consensus       362 l  362 (413)
T 3dzo_A          362 M  362 (413)
T ss_dssp             T
T ss_pred             H
Confidence            4

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=4.5e-33  Score=315.85  Aligned_cols=245  Identities=16%  Similarity=0.120  Sum_probs=183.1

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--------cchHHHHHHHHHHhCCCC-----CCCCCceeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--------EGEREFRAEMEVLSGNGF-----GWPHPNLVTLY  871 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~-----~l~h~niv~l~  871 (1088)
                      ++|++.+.||+|+||+||+|++ +|+.||||++.....        ...+.+.+|+++++.+..     .-.||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            5688999999999999999998 689999999986532        122677888888765320     01366666666


Q ss_pred             eEE-----------------ec-------------CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 001384          872 GWC-----------------LD-------------GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL  921 (1088)
Q Consensus       872 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yL  921 (1088)
                      +++                 .+             +...|+||||+++|++.+.+.+ ..+++.+++.++.||+.||+||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            653                 32             6789999999999977766644 5689999999999999999999


Q ss_pred             H-hcCCCCeEecCCCCCCEEEcCCC--------------------CEEEeecccceeecCCCCcccccccccccccCccc
Q 001384          922 H-HECYPPIVHRDVKASNVLLDKEG--------------------KALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEY  980 (1088)
Q Consensus       922 H-~~~~~~ivH~DLkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~  980 (1088)
                      | ++   +|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|+|||+
T Consensus       178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~  248 (336)
T 2vuw_A          178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred             HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence            9 88   999999999999999887                    8999999999876532      3479999999999


Q ss_pred             cCCCCCCcchhHHHHHHH-HHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHH
Q 001384          981 GQTWQATTKGDVYSFGVL-AMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIG 1059 (1088)
Q Consensus       981 ~~~~~~~~~~DvwslG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1059 (1088)
                      +.+.. +.++||||++++ .+++++|..||.... .............. .. .        ............++.+++
T Consensus       249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~-~--------~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMT-FK-T--------KCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHTCC-CS-S--------CCCSHHHHHHHHHHHHHH
T ss_pred             hcCCC-ccceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhhhc-cC-c--------ccchhhhhhcCHHHHHHH
Confidence            98766 899999998776 788999999985310 00000111110000 00 0        001112345678899999


Q ss_pred             hhhcccCCCCCCCHHHHH
Q 001384         1060 VRCTAEAPNARPNVKEVL 1077 (1088)
Q Consensus      1060 ~~cl~~dP~~RPs~~eil 1077 (1088)
                      .+|++.|     |++|++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999976     898887

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=7.3e-32  Score=303.85  Aligned_cols=276  Identities=17%  Similarity=0.219  Sum_probs=190.4

Q ss_pred             CCchhhHHHHHHHHhhcccCCCCCccccccc----CCCCCCcccCCceeCC--------CCceeEEeccccccccccccc
Q 001384           30 DSLETDREVLSNLRSFLENNNPVNEGHYMQW----NQSSSPCEWPGIICSP--------DKARVNGLNLTDWNISGDIFN   97 (1088)
Q Consensus        30 ~~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW----~~~~~~C~W~gv~C~~--------~~~~v~~L~L~~~~l~~~~~~   97 (1088)
                      ....+|++||++||+.+...   +.+.+.+|    +...++|.|.|++|+.        ...+|+.|+|++++++ .+|+
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~---~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~   98 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNAD---RNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD   98 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHC---CTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred             ccCchHHHHHHHHHHhccCC---chhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence            34578999999999998542   34578899    5567899999999952        3468999999999998 6788


Q ss_pred             cccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc-cCCCCCCCceeecccccccccccCchhhhcccc
Q 001384           98 NFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL-NLSGLRSLEILDLSVNRIHGEISFSFPAICEKL  176 (1088)
Q Consensus        98 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L  176 (1088)
                      .++.+++|++|+|++|.++ .+|..++.+++|++|+|++|.++... .+.++++|++|+|++|.+.+.+|..+...    
T Consensus        99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~----  173 (328)
T 4fcg_A           99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLAST----  173 (328)
T ss_dssp             CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE----
T ss_pred             hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhc----
Confidence            8999999999999999999 89999999999999999999998543 58889999999999988888777665321    


Q ss_pred             eEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcc
Q 001384          177 VVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEF  256 (1088)
Q Consensus       177 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  256 (1088)
                                  ..+..|.++++|++|+|++|+++ .++.                      .+..+++|++|+|++|++
T Consensus       174 ------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~----------------------~l~~l~~L~~L~L~~N~l  218 (328)
T 4fcg_A          174 ------------DASGEHQGLVNLQSLRLEWTGIR-SLPA----------------------SIANLQNLKSLKIRNSPL  218 (328)
T ss_dssp             ------------C-CCCEEESTTCCEEEEEEECCC-CCCG----------------------GGGGCTTCCEEEEESSCC
T ss_pred             ------------cchhhhccCCCCCEEECcCCCcC-cchH----------------------hhcCCCCCCEEEccCCCC
Confidence                        11223445666666666666554 2211                      133344555555555555


Q ss_pred             cccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhh
Q 001384          257 IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIF  336 (1088)
Q Consensus       257 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  336 (1088)
                      ++ +|..+..+++|++|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..+
T Consensus       219 ~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l  297 (328)
T 4fcg_A          219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI  297 (328)
T ss_dssp             CC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred             Cc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence            52 34445555566666666655555555555566666666666655555556556666666666666666666666666


Q ss_pred             hcccccceeecCcC
Q 001384          337 GRFTQVKILALHSN  350 (1088)
Q Consensus       337 ~~l~~L~~L~L~~n  350 (1088)
                      +.+++|+.+++..+
T Consensus       298 ~~L~~L~~l~l~~~  311 (328)
T 4fcg_A          298 AQLPANCIILVPPH  311 (328)
T ss_dssp             GGSCTTCEEECCGG
T ss_pred             hhccCceEEeCCHH
Confidence            66666666655544

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=2.2e-30  Score=293.08  Aligned_cols=294  Identities=20%  Similarity=0.249  Sum_probs=195.0

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      ++++.++++++.++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            35677777777766 5555553  56777777777777666667777777777777777777776777777777777777


Q ss_pred             CCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccC-
Q 001384          324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN-  402 (1088)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-  402 (1088)
                      ++|+++..++..                            .++|++|++++|++++..+..+..+++|+.|++++|.++ 
T Consensus       110 ~~n~l~~l~~~~----------------------------~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~  161 (332)
T 2ft3_A          110 SKNHLVEIPPNL----------------------------PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN  161 (332)
T ss_dssp             CSSCCCSCCSSC----------------------------CTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG
T ss_pred             CCCcCCccCccc----------------------------cccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc
Confidence            777766332211                            156778888888887665666788888888888888885 


Q ss_pred             -CcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchh
Q 001384          403 -GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV  481 (1088)
Q Consensus       403 -~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~  481 (1088)
                       +..|..+..+ +|+.|++++|++++ +|..+.  ++|++|++++|++++..|..+.++++|++|+|++|++++..|..+
T Consensus       162 ~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  237 (332)
T 2ft3_A          162 SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL  237 (332)
T ss_dssp             GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred             CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence             3567777777 88888888888884 666554  678888888888887667778888888888888888875333322


Q ss_pred             hccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccce
Q 001384          482 MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTF  561 (1088)
Q Consensus       482 ~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  561 (1088)
                      ..+                                                                             
T Consensus       238 ~~l-----------------------------------------------------------------------------  240 (332)
T 2ft3_A          238 SFL-----------------------------------------------------------------------------  240 (332)
T ss_dssp             GGC-----------------------------------------------------------------------------
T ss_pred             hCC-----------------------------------------------------------------------------
Confidence            111                                                                             


Q ss_pred             eeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcEEEcc
Q 001384          562 QITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLS  641 (1088)
Q Consensus       562 ~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~  641 (1088)
                      ..+++|+|++|+++ .+|..++.+++|+.|++++|++++..+..|....               +  -....+|+.|+|+
T Consensus       241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~---------------~--~~~~~~l~~L~l~  302 (332)
T 2ft3_A          241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG---------------F--GVKRAYYNGISLF  302 (332)
T ss_dssp             TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS---------------C--CSSSCCBSEEECC
T ss_pred             CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccc---------------c--ccccccccceEee
Confidence            12346777777777 6777777777788888888877755555443321               0  0012345555555


Q ss_pred             ccccC--CcCCcccccccccceeeccCC
Q 001384          642 YNNFS--GPFPASFNNLTELSKLNISYN  667 (1088)
Q Consensus       642 ~N~l~--g~~p~~~~~l~~L~~l~l~~N  667 (1088)
                      +|.+.  +..|..|..+++|+.+++++|
T Consensus       303 ~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          303 NNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             SSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             cCcccccccCcccccccchhhhhhcccc
Confidence            55554  344555555666666666555

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=6.1e-30  Score=289.29  Aligned_cols=198  Identities=21%  Similarity=0.297  Sum_probs=120.9

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      ++++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+|
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            35666666666655 3444443  45666666666666555555666666666666666666655666666666666666


Q ss_pred             CCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCC
Q 001384          324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG  403 (1088)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  403 (1088)
                      ++|+++..+...                            .++|++|++++|.+++..+..+.++++|+.|++++|+++.
T Consensus       108 s~n~l~~l~~~~----------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A          108 SKNQLKELPEKM----------------------------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             CSSCCSBCCSSC----------------------------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             CCCcCCccChhh----------------------------cccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence            666655321110                            1456666666666665555556666666666666666642


Q ss_pred             --cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          404 --SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       404 --~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                        ..+..+..+++|++|++++|+++ .+|..+.  ++|++|++++|++++..|..+..+++|++|+|++|++++
T Consensus       160 ~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  230 (330)
T 1xku_A          160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  230 (330)
T ss_dssp             GGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             cCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence              45556666666666666666666 3555443  566677777777666556666666677777777666664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=7.2e-34  Score=337.62  Aligned_cols=379  Identities=18%  Similarity=0.114  Sum_probs=213.1

Q ss_pred             CCCceeecccccccccccCchhhhcccceEEeccCccCCC----CCCccccCCCCCcEEEccCccccccccccCccccee
Q 001384          149 RSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG----RIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEF  224 (1088)
Q Consensus       149 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L  224 (1088)
                      ++|++|||++|++++.....+...+++|++|+|++|++++    .++..+..+++|++|+|++|++++..+..       
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~-------   75 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC-------   75 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH-------
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHH-------
Confidence            4677888888887765555545556677777777777764    23455666677777777777665422211       


Q ss_pred             cccCcccccccccccccCCC----ccCEEEcCCCcccc----cCcccccCCCCCcEEEccCccccCCCccccC-----CC
Q 001384          225 SVSENVLSGVVSSSVFKENC----SLEIFDLSENEFIG----DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIG-----SI  291 (1088)
Q Consensus       225 ~L~~n~l~~~~~~~~~~~l~----~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l  291 (1088)
                                    .+..+.    +|++|+|++|+++.    .+|..+..+++|++|+|++|.+++..+..+.     ..
T Consensus        76 --------------l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           76 --------------VLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             --------------HHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             --------------HHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence                          111122    56777777776663    4566677777777777777776643333222     24


Q ss_pred             CCCCEEeCCCCcCCcc----CcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCc
Q 001384          292 SGLEALFLGKNNFLSV----IPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI  367 (1088)
Q Consensus       292 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L  367 (1088)
                      ++|++|+|++|++++.    ++..+..+++|++|+|++|.+.+..+..+...                    .....++|
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~--------------------l~~~~~~L  201 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQG--------------------LKDSPCQL  201 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHH--------------------HHHSCCCC
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHH--------------------HhcCCCCc
Confidence            4566666666666553    24444555666666666666554433332210                    00023456


Q ss_pred             CEEEccCCccCCC----CCccccCCcCcceeeccccccCCcC-----CcccCCCCCCcEEEccCCcCCCC----CCcccc
Q 001384          368 SRLDLSHNNFTGP----LPVEISQMRSLKFLILAHNRFNGSI-----PAVYGNMPNLQTLDLSFNELTGP----IPPSIG  434 (1088)
Q Consensus       368 ~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~  434 (1088)
                      ++|+|++|.+++.    ++..+..+++|++|++++|++++..     +..+..+++|++|++++|++++.    ++..+.
T Consensus       202 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  281 (461)
T 1z7x_W          202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR  281 (461)
T ss_dssp             CEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             eEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHh
Confidence            6666666666542    3444455555555555555554321     12222344555555555555432    333344


Q ss_pred             CCCCCcEEEccccccccCCCccccC-----CCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccc
Q 001384          435 NLTSLLWLMLANNSLSGEIPGEIGN-----CTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSEC  509 (1088)
Q Consensus       435 ~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~  509 (1088)
                      ++++|++|+|++|.+++..+..+..     .++|++                                            
T Consensus       282 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~--------------------------------------------  317 (461)
T 1z7x_W          282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLES--------------------------------------------  317 (461)
T ss_dssp             HCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCE--------------------------------------------
T ss_pred             hCCCcceEECCCCCCchHHHHHHHHHhccCCcccee--------------------------------------------
Confidence            4444444444444444322222221     134444                                            


Q ss_pred             cccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccc----cCcccccC
Q 001384          510 LSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGE----LSPDIGKL  585 (1088)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~----~p~~~~~l  585 (1088)
                                                                               |++++|++++.    +|..+..+
T Consensus       318 ---------------------------------------------------------L~L~~n~l~~~~~~~l~~~l~~~  340 (461)
T 1z7x_W          318 ---------------------------------------------------------LWVKSCSFTAACCSHFSSVLAQN  340 (461)
T ss_dssp             ---------------------------------------------------------EECTTSCCBGGGHHHHHHHHHHC
T ss_pred             ---------------------------------------------------------eEcCCCCCchHHHHHHHHHHhhC
Confidence                                                                     44555554433    45556667


Q ss_pred             CCccEEeccccccccCCCCcccC------ccceEEEccCCcccc----cCCccccCCccCcEEEccccccCCcCCcccc-
Q 001384          586 QNFSMVHLGFNQFDGKLPSQFDQ------LPLIVLNLTRNNFSG----EIPSEFGNIKCLQNLDLSYNNFSGPFPASFN-  654 (1088)
Q Consensus       586 ~~L~~L~l~~N~l~g~~p~~~~~------l~l~~l~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-  654 (1088)
                      ++|+.|+|++|++++..+..+..      -.|+.|+|++|++++    .+|..+..+++|+.|||++|++++.--..+. 
T Consensus       341 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~  420 (461)
T 1z7x_W          341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE  420 (461)
T ss_dssp             SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred             CCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHH
Confidence            77788888888777554443332      267888888888886    7888888889999999999988754111111 


Q ss_pred             ----cccccceeeccCCCC
Q 001384          655 ----NLTELSKLNISYNPL  669 (1088)
Q Consensus       655 ----~l~~L~~l~l~~N~l  669 (1088)
                          ...+|+.|++.++.+
T Consensus       421 ~l~~~~~~L~~L~~~~~~~  439 (461)
T 1z7x_W          421 SVRQPGCLLEQLVLYDIYW  439 (461)
T ss_dssp             HHTSTTCCCCEEECTTCCC
T ss_pred             HhccCCcchhheeeccccc
Confidence                123566666666665

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=8.9e-30  Score=288.12  Aligned_cols=287  Identities=22%  Similarity=0.289  Sum_probs=217.9

Q ss_pred             CCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeec
Q 001384          268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILAL  347 (1088)
Q Consensus       268 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  347 (1088)
                      .+|+.+++++|.++ .+|..+.  ++|+.|+|++|.+.+..|..|.++++|++|+|++|.+++..+..|+          
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------   99 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFS----------   99 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGST----------
T ss_pred             ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhh----------
Confidence            36899999999988 6777664  6899999999999888888899999999999999988876665544          


Q ss_pred             CcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCC-
Q 001384          348 HSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELT-  426 (1088)
Q Consensus       348 ~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-  426 (1088)
                                     ++++|++|+|++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|+++ 
T Consensus       100 ---------------~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~  161 (332)
T 2ft3_A          100 ---------------PLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN  161 (332)
T ss_dssp             ---------------TCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG
T ss_pred             ---------------CcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc
Confidence                           5677888888888888 6676665  79999999999999777778999999999999999996 


Q ss_pred             -CCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccC
Q 001384          427 -GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAG  505 (1088)
Q Consensus       427 -~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~  505 (1088)
                       +..|..+..+ +|++|++++|+++ .+|..+.  ++|++|++++|++++..|.                          
T Consensus       162 ~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~--------------------------  211 (332)
T 2ft3_A          162 SGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELE--------------------------  211 (332)
T ss_dssp             GGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTT--------------------------
T ss_pred             CCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHH--------------------------
Confidence             3678888888 9999999999999 4777664  7889999988888743222                          


Q ss_pred             CccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccC
Q 001384          506 SSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKL  585 (1088)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l  585 (1088)
                                                                                                 .+..+
T Consensus       212 ---------------------------------------------------------------------------~l~~l  216 (332)
T 2ft3_A          212 ---------------------------------------------------------------------------DLLRY  216 (332)
T ss_dssp             ---------------------------------------------------------------------------SSTTC
T ss_pred             ---------------------------------------------------------------------------HhcCC
Confidence                                                                                       23334


Q ss_pred             CCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccc------cc
Q 001384          586 QNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNL------TE  658 (1088)
Q Consensus       586 ~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l------~~  658 (1088)
                      ++|+.|+|++|++++..|..++.+ .|+.|+|++|+++ .+|..++.+++|+.|+|++|+|++..+..|..+      .+
T Consensus       217 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~  295 (332)
T 2ft3_A          217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY  295 (332)
T ss_dssp             TTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCC
T ss_pred             CCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccccc
Confidence            455555555555555445455554 4666666666666 788889999999999999999997666666653      67


Q ss_pred             cceeeccCCCCccccCCCC--CcccccccCccCCC
Q 001384          659 LSKLNISYNPLVSGTIPST--GQLATFEKTSYLGD  691 (1088)
Q Consensus       659 L~~l~l~~N~l~~g~ip~~--~~~~~~~~~~~~~n  691 (1088)
                      |+.|++++|++....++..  ..+..+....+.+|
T Consensus       296 l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             BSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             ccceEeecCcccccccCcccccccchhhhhhcccc
Confidence            9999999999965566543  23333444334443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=4e-34  Score=339.78  Aligned_cols=376  Identities=19%  Similarity=0.135  Sum_probs=208.5

Q ss_pred             eeEEecccccccccccccc-ccCCccCCeeeCCCCCCCC----CcCccCCCCCCCcEEECccccccCcccCCCCCCCcee
Q 001384           80 RVNGLNLTDWNISGDIFNN-FSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEIL  154 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L  154 (1088)
                      +++.|+|++++++...... +..+++|++|+|++|.+++    .++..+..+++|++|+|++|.+               
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l---------------   68 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL---------------   68 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC---------------
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcC---------------
Confidence            3445555555544432222 4445555555555555543    2334444445555555555544               


Q ss_pred             ecccccccccccCchhhhcc----cceEEeccCccCCC----CCCccccCCCCCcEEEccCccccccccc--------cC
Q 001384          155 DLSVNRIHGEISFSFPAICE----KLVVANLSLNNLTG----RIDTCFDGCLNLRYLDLSSNNFRGNIWN--------GL  218 (1088)
Q Consensus       155 ~Ls~N~l~~~~~~~~~~~~~----~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~--------~l  218 (1088)
                             ++..+..+...+.    +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+.        ..
T Consensus        69 -------~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           69 -------GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             -------HHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             -------ChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence                   4333333333333    35555555555542    3345556666666666666666542221        12


Q ss_pred             cccceecccCcccccccc---cccccCCCccCEEEcCCCcccccCccccc-----CCCCCcEEEccCccccCC----Ccc
Q 001384          219 AQLVEFSVSENVLSGVVS---SSVFKENCSLEIFDLSENEFIGDFPGEVS-----NCRNLVVLNLFGNNFSGP----IPA  286 (1088)
Q Consensus       219 ~~L~~L~L~~n~l~~~~~---~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~----~p~  286 (1088)
                      ++|++|++++|.+++...   ...+..+++|++|++++|.+++..+..+.     ..++|++|+|++|.+++.    ++.
T Consensus       142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  221 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  221 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence            345666666665554321   22344456666666666666543333332     245666666666666643    355


Q ss_pred             ccCCCCCCCEEeCCCCcCCccC-----cccccCCCCCcEEEcCCCcCCCc----hhHhhhcccccceeecCcCcccCCCC
Q 001384          287 EIGSISGLEALFLGKNNFLSVI-----PESLLNLSKLEVLDLSSNNFGGE----VQKIFGRFTQVKILALHSNSYIDGMN  357 (1088)
Q Consensus       287 ~~~~l~~L~~L~L~~N~l~~~~-----p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~~~~~~~  357 (1088)
                      .+..+++|++|+|++|.+....     +..+..+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+.+.. 
T Consensus       222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~-  300 (461)
T 1z7x_W          222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG-  300 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH-
T ss_pred             HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH-
Confidence            5556666666666666655432     12223456666777776666654    3445555666666666666532210 


Q ss_pred             Cccc-----cCCCCcCEEEccCCccCCC----CCccccCCcCcceeeccccccCCcCCcccCC-----CCCCcEEEccCC
Q 001384          358 SSGI-----LKLPNISRLDLSHNNFTGP----LPVEISQMRSLKFLILAHNRFNGSIPAVYGN-----MPNLQTLDLSFN  423 (1088)
Q Consensus       358 ~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N  423 (1088)
                      ...+     ...++|++|+|++|.+++.    ++..+..+++|++|++++|++++..+..+..     .++|++|++++|
T Consensus       301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n  380 (461)
T 1z7x_W          301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC  380 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence            1111     1235788888888887754    4555666788888888888877554443332     567888888888


Q ss_pred             cCCC----CCCccccCCCCCcEEEccccccccCCCcccc-----CCCCCCeEEccCCcCccCCC
Q 001384          424 ELTG----PIPPSIGNLTSLLWLMLANNSLSGEIPGEIG-----NCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       424 ~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      ++++    .+|..+..+++|++|+|++|++++.-...+.     ...+|+.|++.++.+....+
T Consensus       381 ~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~  444 (461)
T 1z7x_W          381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME  444 (461)
T ss_dssp             CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred             CCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHH
Confidence            8875    6777777788888888888888753111111     23457777777776664333

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=2.7e-29  Score=283.92  Aligned_cols=289  Identities=20%  Similarity=0.258  Sum_probs=192.6

Q ss_pred             CCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeec
Q 001384          268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILAL  347 (1088)
Q Consensus       268 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  347 (1088)
                      .+|+.++++++.++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|.+++..|..|           
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----------   96 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-----------   96 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-----------
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh-----------
Confidence            36788888888887 5665543  577888888888877766677777788888888777776555443           


Q ss_pred             CcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCC
Q 001384          348 HSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG  427 (1088)
Q Consensus       348 ~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  427 (1088)
                                    ..+++|++|+|++|+++ .+|..+.  ++|++|++++|++++..+..+.++++|++|++++|+++.
T Consensus        97 --------------~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A           97 --------------APLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             --------------TTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             --------------cCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc
Confidence                          34566777777777776 4555544  678888888888876666677778888888888887753


Q ss_pred             --CCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccC
Q 001384          428 --PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAG  505 (1088)
Q Consensus       428 --~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~  505 (1088)
                        ..+..+.++++|++|++++|+++ .+|..+.  ++|++|++++|++++..|..+..+                     
T Consensus       160 ~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l---------------------  215 (330)
T 1xku_A          160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGL---------------------  215 (330)
T ss_dssp             GGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTC---------------------
T ss_pred             cCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCC---------------------
Confidence              56667777777777777777777 4665553  677777777777775444333211                     


Q ss_pred             CccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccC
Q 001384          506 SSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKL  585 (1088)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l  585 (1088)
                                                                              ..+++|+|++|++++..|..++.+
T Consensus       216 --------------------------------------------------------~~L~~L~Ls~n~l~~~~~~~~~~l  239 (330)
T 1xku_A          216 --------------------------------------------------------NNLAKLGLSFNSISAVDNGSLANT  239 (330)
T ss_dssp             --------------------------------------------------------TTCCEEECCSSCCCEECTTTGGGS
T ss_pred             --------------------------------------------------------CCCCEEECCCCcCceeChhhccCC
Confidence                                                                    123457777777776666667777


Q ss_pred             CCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCC------ccCcEEEccccccCC--cCCcccccc
Q 001384          586 QNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNI------KCLQNLDLSYNNFSG--PFPASFNNL  656 (1088)
Q Consensus       586 ~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l------~~L~~L~l~~N~l~g--~~p~~~~~l  656 (1088)
                      ++|+.|+|++|+++ .+|..+..+ .|++|+|++|++++.-+..|+..      ..|+.|+|++|.+..  ..|..|..+
T Consensus       240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~  318 (330)
T 1xku_A          240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  318 (330)
T ss_dssp             TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence            77777777777777 666666655 46677777777775444455432      556677777776642  345566666


Q ss_pred             cccceeeccCCC
Q 001384          657 TELSKLNISYNP  668 (1088)
Q Consensus       657 ~~L~~l~l~~N~  668 (1088)
                      .+++.++|++|+
T Consensus       319 ~~l~~l~L~~N~  330 (330)
T 1xku_A          319 YVRAAVQLGNYK  330 (330)
T ss_dssp             CCGGGEEC----
T ss_pred             cceeEEEecccC
Confidence            777777776663

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=5.5e-32  Score=332.13  Aligned_cols=409  Identities=14%  Similarity=0.092  Sum_probs=235.6

Q ss_pred             chhhHHHHHHHHhhcccCCCCCcccccccCCCCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCC
Q 001384           32 LETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLS  111 (1088)
Q Consensus        32 ~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls  111 (1088)
                      .++|  .|..+.+++.+     ...+.++  +.-|++|.++.+..  .+.  +.+.+ .....++..+..+++|++|+|+
T Consensus        16 LPde--il~~I~~~L~~-----~~d~~~~--s~vck~W~~~~~~~--~~~--l~~~~-~~~~~~~~~~~~~~~L~~L~L~   81 (592)
T 3ogk_B           16 TVDD--VIEQVMTYITD-----PKDRDSA--SLVCRRWFKIDSET--REH--VTMAL-CYTATPDRLSRRFPNLRSLKLK   81 (592)
T ss_dssp             CGGG--THHHHHTTCCC-----HHHHHHH--TTSCHHHHHHHHHH--CCE--EEESC-GGGSCHHHHHHHCTTCSEEEEE
T ss_pred             CCHH--HHHHHHHhcCC-----HHHHHHH--HHHhHHHHHhhhcc--ccE--EEEee-ccccChHHHHHhCCCCeEEEec
Confidence            4555  56677777731     1112233  23466899996532  122  22222 1223334456678889999998


Q ss_pred             CCCC---CCCcCccCC------------CCCCCcEEECccccccCcc--cCCC-CC-CCceeeccccc-ccccccCchhh
Q 001384          112 RNTF---SGSIPDDLS------------SCRSLKYLNLSHNILSGDL--NLSG-LR-SLEILDLSVNR-IHGEISFSFPA  171 (1088)
Q Consensus       112 ~n~l---~~~~p~~l~------------~l~~L~~L~Ls~n~l~~~~--~l~~-l~-~L~~L~Ls~N~-l~~~~~~~~~~  171 (1088)
                      ++..   .+.+|..++            .+++|++|+|++|.+++..  .+.. ++ +|++|+|++|. ++......+..
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~  161 (592)
T 3ogk_B           82 GKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVT  161 (592)
T ss_dssp             CSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHH
T ss_pred             CCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHh
Confidence            7532   134444433            5666666666666655321  2222 22 36666666654 22111112222


Q ss_pred             hcccceEEeccCccCCCC----CCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccC
Q 001384          172 ICEKLVVANLSLNNLTGR----IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLE  247 (1088)
Q Consensus       172 ~~~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~  247 (1088)
                      .+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++..                  .......+..+++|+
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~------------------~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS------------------PKDLETIARNCRSLV  223 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCC------------------HHHHHHHHHHCTTCC
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccC------------------HHHHHHHHhhCCCCc
Confidence            345555555555555443    2223334455555555555443100                  001122344556777


Q ss_pred             EEEcCCCcccccCcccccCCCCCcEEEccCcccc---CCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS---GPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       248 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      .|+|++|.+.+ +|..+.++++|++|+++++...   +..+..+..+++|+.|+++++. ...+|..+..+++|++|+|+
T Consensus       224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls  301 (592)
T 3ogk_B          224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLL  301 (592)
T ss_dssp             EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEET
T ss_pred             EEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecC
Confidence            77777777664 5666777777777777653322   2344556667777777777653 34456667777778888888


Q ss_pred             CCcCCCchh-HhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEcc-----------CCccCCCC-CccccCCcCc
Q 001384          325 SNNFGGEVQ-KIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLS-----------HNNFTGPL-PVEISQMRSL  391 (1088)
Q Consensus       325 ~N~l~~~~~-~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls-----------~N~l~~~~-p~~l~~l~~L  391 (1088)
                      +|.+++... ..+..+++|+.|+++ +.+.+......+..+++|++|+|+           .|.+++.. +.....+++|
T Consensus       302 ~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L  380 (592)
T 3ogk_B          302 YALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQEL  380 (592)
T ss_dssp             TCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTC
T ss_pred             CCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccC
Confidence            777665443 446777778877777 333222222233456778888888           35555322 2223457888


Q ss_pred             ceeeccccccCCcCCcccCC-CCCCcEEEcc----CCcCCCC-----CCccccCCCCCcEEEcccc--ccccCCCccccC
Q 001384          392 KFLILAHNRFNGSIPAVYGN-MPNLQTLDLS----FNELTGP-----IPPSIGNLTSLLWLMLANN--SLSGEIPGEIGN  459 (1088)
Q Consensus       392 ~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~l~~  459 (1088)
                      ++|+++.|++++..+..++. +++|+.|+++    .|++++.     ++..+.++++|++|+|++|  .+++..+..++.
T Consensus       381 ~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~  460 (592)
T 3ogk_B          381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ  460 (592)
T ss_dssp             SEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHH
T ss_pred             eEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHH
Confidence            88888888888766666655 7888888885    6677753     3334666888888888743  366655555543


Q ss_pred             -CCCCCeEEccCCcCcc
Q 001384          460 -CTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       460 -l~~L~~L~L~~N~l~g  475 (1088)
                       +++|++|+|++|++++
T Consensus       461 ~~~~L~~L~L~~n~l~~  477 (592)
T 3ogk_B          461 YSPNVRWMLLGYVGESD  477 (592)
T ss_dssp             SCTTCCEEEECSCCSSH
T ss_pred             hCccceEeeccCCCCCH
Confidence             7888888888888764

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.4e-28  Score=295.71  Aligned_cols=299  Identities=23%  Similarity=0.244  Sum_probs=179.7

Q ss_pred             ccccccCCCCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEEC
Q 001384           55 GHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNL  134 (1088)
Q Consensus        55 ~~~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  134 (1088)
                      ..+++|..+.+||.|.|..|.-...                  ......++++|++++|.++ .+|..+.  ++|++|+|
T Consensus        10 ~~w~~W~~~~~~~~~~~r~~~~~~~------------------~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L   68 (622)
T 3g06_A           10 AVWSAWRRAAPAEESRGRAAVVQKM------------------RACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVI   68 (622)
T ss_dssp             CHHHHHHHTCCGGGHHHHHHHHHHH------------------HHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEE
T ss_pred             HHHHHHHhcCCcchhccccccCccc------------------ccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEe
Confidence            4577898888999998764421000                  0011123556666666666 5555544  56666666


Q ss_pred             ccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccc
Q 001384          135 SHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI  214 (1088)
Q Consensus       135 s~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  214 (1088)
                      ++|.|+....  .+++|++|+|++|+|++ +|.                            .+++|++|+|++|++++ +
T Consensus        69 ~~N~l~~lp~--~l~~L~~L~Ls~N~l~~-lp~----------------------------~l~~L~~L~Ls~N~l~~-l  116 (622)
T 3g06_A           69 PDNNLTSLPA--LPPELRTLEVSGNQLTS-LPV----------------------------LPPGLLELSIFSNPLTH-L  116 (622)
T ss_dssp             CSCCCSCCCC--CCTTCCEEEECSCCCSC-CCC----------------------------CCTTCCEEEECSCCCCC-C
T ss_pred             cCCCCCCCCC--cCCCCCEEEcCCCcCCc-CCC----------------------------CCCCCCEEECcCCcCCC-C
Confidence            6666554332  34455555555555442 111                            23344444444443331 0


Q ss_pred             cccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCC
Q 001384          215 WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGL  294 (1088)
Q Consensus       215 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  294 (1088)
                      +.                         .+++|+.|++++|++++ +|..   +++|++|+|++|++++ +|.   .+.+|
T Consensus       117 ~~-------------------------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L  163 (622)
T 3g06_A          117 PA-------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSEL  163 (622)
T ss_dssp             CC-------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTC
T ss_pred             CC-------------------------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCC
Confidence            00                         11234444444444432 3322   2556666666666653 332   23456


Q ss_pred             CEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccC
Q 001384          295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSH  374 (1088)
Q Consensus       295 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~  374 (1088)
                      +.|++++|.+++ +|   ..+++|+.|+|++|.+++.+.                             .+++|+.|++++
T Consensus       164 ~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~-----------------------------~~~~L~~L~L~~  210 (622)
T 3g06_A          164 CKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT-----------------------------LPSELYKLWAYN  210 (622)
T ss_dssp             CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC-----------------------------CCTTCCEEECCS
T ss_pred             CEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC-----------------------------ccchhhEEECcC
Confidence            666666666655 33   334666777777776654211                             124677777777


Q ss_pred             CccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCC
Q 001384          375 NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP  454 (1088)
Q Consensus       375 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  454 (1088)
                      |.++ .+|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|
T Consensus       211 N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp  277 (622)
T 3g06_A          211 NRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLP  277 (622)
T ss_dssp             SCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCC
T ss_pred             Cccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCC
Confidence            7777 45532   3678888888888884 66   45678889999999988 5776   5678999999999998 788


Q ss_pred             ccccCCCCCCeEEccCCcCccCCCchhhccC
Q 001384          455 GEIGNCTSLLWLNLSNNKLSGNIPPEVMTIG  485 (1088)
Q Consensus       455 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~  485 (1088)
                      ..+.++++|+.|+|++|+++|.+|..+..+.
T Consensus       278 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          278 ESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             GGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             HHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            8899999999999999999988887776543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.9e-28  Score=271.36  Aligned_cols=224  Identities=20%  Similarity=0.259  Sum_probs=202.5

Q ss_pred             CCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEE
Q 001384          364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM  443 (1088)
Q Consensus       364 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  443 (1088)
                      .++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            467899999999998 78888999999999999999999 88999999999999999999999 7899999999999999


Q ss_pred             ccccccccCCCccccC---------CCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCcccccccc
Q 001384          444 LANNSLSGEIPGEIGN---------CTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKR  514 (1088)
Q Consensus       444 L~~N~l~~~~p~~l~~---------l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~  514 (1088)
                      |++|++.+.+|..++.         +++|++|+|++|+++ .+|..+..+.                             
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~-----------------------------  206 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ-----------------------------  206 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCT-----------------------------
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCC-----------------------------
Confidence            9999988899988765         999999999999998 7887654332                             


Q ss_pred             ccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEecc
Q 001384          515 WIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLG  594 (1088)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  594 (1088)
                                                                      .+++|+|++|++++ +|..++.+++|+.|+|+
T Consensus       207 ------------------------------------------------~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls  237 (328)
T 4fcg_A          207 ------------------------------------------------NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR  237 (328)
T ss_dssp             ------------------------------------------------TCCEEEEESSCCCC-CCGGGGGCTTCCEEECT
T ss_pred             ------------------------------------------------CCCEEEccCCCCCc-CchhhccCCCCCEEECc
Confidence                                                            24578999999995 77789999999999999


Q ss_pred             ccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCC
Q 001384          595 FNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL  669 (1088)
Q Consensus       595 ~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  669 (1088)
                      +|++.+.+|..++.+ .|+.|+|++|++.+.+|..++++++|+.|+|++|++.|.+|+.++++++|+.+++..|.+
T Consensus       238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            999999999999988 799999999999999999999999999999999999999999999999999999997766

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=277.91  Aligned_cols=280  Identities=20%  Similarity=0.256  Sum_probs=156.1

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      ...++++|+++ .+|..+.  ++|++|++++|++++..+..+..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  110 (353)
T 2z80_A           34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN  110 (353)
T ss_dssp             SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence            34555555555 3444433  35566666666655444445555555555555555555555555555555555555555


Q ss_pred             cCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCc--cccCCcCcceeecccc-ccCC
Q 001384          327 NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV--EISQMRSLKFLILAHN-RFNG  403 (1088)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N-~l~~  403 (1088)
                      ++++..+..|+                         ++++|++|+|++|++++ +|.  .+..+++|++|++++| .+++
T Consensus       111 ~l~~~~~~~~~-------------------------~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~  164 (353)
T 2z80_A          111 YLSNLSSSWFK-------------------------PLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTK  164 (353)
T ss_dssp             CCSSCCHHHHT-------------------------TCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCE
T ss_pred             cCCcCCHhHhC-------------------------CCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccc
Confidence            55544333332                         34455555555555553 332  4555556666666655 3443


Q ss_pred             cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCcc-ccCCCCCCeEEccCCcCccCCCchhh
Q 001384          404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE-IGNCTSLLWLNLSNNKLSGNIPPEVM  482 (1088)
Q Consensus       404 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~g~ip~~~~  482 (1088)
                      ..|..++++++|++|++++|++++..|..++++++|++|++++|+++ .+|.. +..+++|++|++++|++++..+..+.
T Consensus       165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  243 (353)
T 2z80_A          165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS  243 (353)
T ss_dssp             ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred             cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccc
Confidence            44455555555555555555555555555555555555555555554 23322 23355555555555555421111000


Q ss_pred             ccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCccccee
Q 001384          483 TIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQ  562 (1088)
Q Consensus       483 ~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  562 (1088)
                                                                                                      
T Consensus       244 --------------------------------------------------------------------------------  243 (353)
T 2z80_A          244 --------------------------------------------------------------------------------  243 (353)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             eeceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcEEEccc
Q 001384          563 ITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSY  642 (1088)
Q Consensus       563 ~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~  642 (1088)
                                        .......++.++|++|.++                  +|.+. .+|+.++++++|+.|||++
T Consensus       244 ------------------~~~~~~~l~~l~L~~~~l~------------------~~~l~-~l~~~l~~l~~L~~L~Ls~  286 (353)
T 2z80_A          244 ------------------TGETNSLIKKFTFRNVKIT------------------DESLF-QVMKLLNQISGLLELEFSR  286 (353)
T ss_dssp             ---------------------CCCCCCEEEEESCBCC------------------HHHHH-HHHHHHHTCTTCCEEECCS
T ss_pred             ------------------cccccchhhcccccccccc------------------Ccchh-hhHHHHhcccCCCEEECCC
Confidence                              0011223444444444433                  23333 6788899999999999999


Q ss_pred             cccCCcCCcc-cccccccceeeccCCCCccccCC
Q 001384          643 NNFSGPFPAS-FNNLTELSKLNISYNPLVSGTIP  675 (1088)
Q Consensus       643 N~l~g~~p~~-~~~l~~L~~l~l~~N~l~~g~ip  675 (1088)
                      |+|+ .+|.. |+++++|+.|++++|++ .+..|
T Consensus       287 N~l~-~i~~~~~~~l~~L~~L~L~~N~~-~~~~~  318 (353)
T 2z80_A          287 NQLK-SVPDGIFDRLTSLQKIWLHTNPW-DCSCP  318 (353)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCB-CCCHH
T ss_pred             CCCC-ccCHHHHhcCCCCCEEEeeCCCc-cCcCC
Confidence            9998 67766 58899999999999999 55555

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=5.2e-30  Score=314.59  Aligned_cols=335  Identities=18%  Similarity=0.150  Sum_probs=237.3

Q ss_pred             CcCccCCCCCCCcEEECccccccC---cc--cC------------CCCCCCceeecccccccccccCchhhhccc-ceEE
Q 001384          118 SIPDDLSSCRSLKYLNLSHNILSG---DL--NL------------SGLRSLEILDLSVNRIHGEISFSFPAICEK-LVVA  179 (1088)
Q Consensus       118 ~~p~~l~~l~~L~~L~Ls~n~l~~---~~--~l------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~-L~~L  179 (1088)
                      .++..+..+++|++|+|+++....   ..  .+            ..+++|++|+|++|.+++..+..+...+++ |++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            445566788999999998864311   00  11            156777777777777776655555554444 7777


Q ss_pred             eccCcc-CCC-CCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCccc
Q 001384          180 NLSLNN-LTG-RIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI  257 (1088)
Q Consensus       180 ~L~~n~-l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  257 (1088)
                      +|++|. ++. ..+....++++|++|+|++|.+++.....                  ....+..+++|++|+|++|.++
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~------------------l~~~~~~~~~L~~L~L~~n~~~  205 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW------------------LHELAQHNTSLEVLNFYMTEFA  205 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH------------------HHHHHHHCCCCCEEECTTCCCS
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH------------------HHHHHhcCCCccEEEeeccCCC
Confidence            776665 211 11122235666666666666654321110                  1123445678999999999887


Q ss_pred             ----ccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCC---ccCcccccCCCCCcEEEcCCCcCCC
Q 001384          258 ----GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFL---SVIPESLLNLSKLEVLDLSSNNFGG  330 (1088)
Q Consensus       258 ----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~L~~N~l~~  330 (1088)
                          +.++..+.++++|++|+|++|.+.+ ++..+..+++|++|+++.+...   ...+..+..+++|+.|+++++. .+
T Consensus       206 ~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~  283 (592)
T 3ogk_B          206 KISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PN  283 (592)
T ss_dssp             SCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TT
T ss_pred             ccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hh
Confidence                3556667789999999999999985 7788999999999999864332   3345678889999999999864 45


Q ss_pred             chhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecc-----------cc
Q 001384          331 EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILA-----------HN  399 (1088)
Q Consensus       331 ~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-----------~N  399 (1088)
                      .++..+..+++|+.|++++|.+........+..+++|+.|+++++-..+.++..+..+++|++|+++           .|
T Consensus       284 ~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~  363 (592)
T 3ogk_B          284 EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG  363 (592)
T ss_dssp             TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTC
T ss_pred             HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccC
Confidence            6778889999999999999984333333445789999999999443333444445678999999999           36


Q ss_pred             ccCCc-CCcccCCCCCCcEEEccCCcCCCCCCccccC-CCCCcEEEcc----ccccccC-----CCccccCCCCCCeEEc
Q 001384          400 RFNGS-IPAVYGNMPNLQTLDLSFNELTGPIPPSIGN-LTSLLWLMLA----NNSLSGE-----IPGEIGNCTSLLWLNL  468 (1088)
Q Consensus       400 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~l~~l~~L~~L~L  468 (1088)
                      .+++. ++.....+++|++|+++.|++++..+..++. +++|++|+++    .|.+++.     ++..+.++++|++|+|
T Consensus       364 ~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L  443 (592)
T 3ogk_B          364 LVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAF  443 (592)
T ss_dssp             CCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEE
T ss_pred             ccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEE
Confidence            77643 3333456899999999999999877777776 8999999996    7788863     4444778999999999


Q ss_pred             cCCc
Q 001384          469 SNNK  472 (1088)
Q Consensus       469 ~~N~  472 (1088)
                      +++.
T Consensus       444 ~~~~  447 (592)
T 3ogk_B          444 YLRQ  447 (592)
T ss_dssp             ECCG
T ss_pred             ecCC
Confidence            8543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=5e-28  Score=276.26  Aligned_cols=227  Identities=19%  Similarity=0.178  Sum_probs=179.0

Q ss_pred             cccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEe
Q 001384          219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALF  298 (1088)
Q Consensus       219 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  298 (1088)
                      +.....+++++.++.. |...+   ++|++|++++|++++..+..+.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus        31 ~~~~~c~~~~~~l~~i-P~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           31 DRNGICKGSSGSLNSI-PSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             CTTSEEECCSTTCSSC-CTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCeEeeCCCCCcccc-ccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            3344577888888853 44333   4899999999999987777999999999999999999988888999999999999


Q ss_pred             CCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCC-cc
Q 001384          299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN-NF  377 (1088)
Q Consensus       299 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N-~l  377 (1088)
                      |++|++++..+..+.++++|++|+|++|++++..+                        ...+..+++|++|++++| .+
T Consensus       107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~------------------------~~~~~~l~~L~~L~l~~n~~~  162 (353)
T 2z80_A          107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE------------------------TSLFSHLTKLQILRVGNMDTF  162 (353)
T ss_dssp             CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCS------------------------SCSCTTCTTCCEEEEEESSSC
T ss_pred             CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCc------------------------hhhhccCCCCcEEECCCCccc
Confidence            99999998766679999999999999999885433                        023446677888888887 46


Q ss_pred             CCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCcc-ccCCCCCcEEEccccccccCCCcc
Q 001384          378 TGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS-IGNLTSLLWLMLANNSLSGEIPGE  456 (1088)
Q Consensus       378 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~  456 (1088)
                      ++..|..+..+++|++|++++|++++..|..++.+++|++|++++|+++ .+|.. +..+++|++|++++|++++..+..
T Consensus       163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  241 (353)
T 2z80_A          163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSE  241 (353)
T ss_dssp             CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred             cccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccc
Confidence            6555678888899999999999998888888999999999999999987 45554 445889999999999998755544


Q ss_pred             cc---CCCCCCeEEccCCcCc
Q 001384          457 IG---NCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       457 l~---~l~~L~~L~L~~N~l~  474 (1088)
                      +.   ..+.++.++|++|.++
T Consensus       242 l~~~~~~~~l~~l~L~~~~l~  262 (353)
T 2z80_A          242 LSTGETNSLIKKFTFRNVKIT  262 (353)
T ss_dssp             -----CCCCCCEEEEESCBCC
T ss_pred             cccccccchhhcccccccccc
Confidence            33   2445555665555544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=5.7e-27  Score=275.88  Aligned_cols=231  Identities=21%  Similarity=0.228  Sum_probs=210.1

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++...+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            47888999999988888888999999999999999998777788999999999999999998877778899999999999


Q ss_pred             CCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCC
Q 001384          324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG  403 (1088)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  403 (1088)
                      ++|.++...+..|..+++|+.|++++|..+.......|.++++|++|+|++|+++ .+| .+..+++|+.|+|++|++++
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~  221 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA  221 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCE
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCc
Confidence            9999998888889999999999999987777777888899999999999999999 566 58899999999999999998


Q ss_pred             cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       404 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      ..|..|.++++|+.|+|++|++++..|..+.++++|++|+|++|++++..+..+..+++|+.|+|++|++...
T Consensus       222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred             cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence            8899999999999999999999988889999999999999999999977777889999999999999999853

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=5.8e-27  Score=276.80  Aligned_cols=231  Identities=21%  Similarity=0.200  Sum_probs=210.6

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      +++++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            47888999999998888889999999999999999999888888999999999999999998877778889999999999


Q ss_pred             CCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCC
Q 001384          324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG  403 (1088)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  403 (1088)
                      ++|+++...+..|..+++|+.|++++|..+..+....|.++++|++|+|++|++++ +| .+..+++|+.|+|++|++++
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~  232 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPE  232 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSE
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcc
Confidence            99999988888899999999999999877777778888999999999999999995 45 58899999999999999998


Q ss_pred             cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       404 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      ..|..|.++++|+.|+|++|++++..|..+.++++|++|+|++|++++..+..+..+++|+.|+|++|++.+.
T Consensus       233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD  305 (452)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred             cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence            8899999999999999999999988899999999999999999999977777889999999999999999854

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=9.3e-28  Score=268.27  Aligned_cols=248  Identities=23%  Similarity=0.262  Sum_probs=152.6

Q ss_pred             EEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCccc
Q 001384          178 VANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFI  257 (1088)
Q Consensus       178 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  257 (1088)
                      .+++++++++..+...   .++|++|+|++|+++                      .++...|..+++|++|+|++|+++
T Consensus        11 ~l~c~~~~l~~ip~~~---~~~l~~L~L~~n~l~----------------------~i~~~~~~~l~~L~~L~L~~n~l~   65 (306)
T 2z66_A           11 EIRCNSKGLTSVPTGI---PSSATRLELESNKLQ----------------------SLPHGVFDKLTQLTKLSLSSNGLS   65 (306)
T ss_dssp             EEECCSSCCSSCCSCC---CTTCCEEECCSSCCC----------------------CCCTTTTTTCTTCSEEECCSSCCC
T ss_pred             EEEcCCCCcccCCCCC---CCCCCEEECCCCccC----------------------ccCHhHhhccccCCEEECCCCccC
Confidence            4555566655443321   135555555555544                      233445556666666677666665


Q ss_pred             c--cCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCc-ccccCCCCCcEEEcCCCcCCCchhH
Q 001384          258 G--DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP-ESLLNLSKLEVLDLSSNNFGGEVQK  334 (1088)
Q Consensus       258 ~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~  334 (1088)
                      .  ..|..+..+++|++|+|++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+.
T Consensus        66 ~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  144 (306)
T 2z66_A           66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG  144 (306)
T ss_dssp             EEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT
T ss_pred             cccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh
Confidence            2  23455556677777777777766 455566667777777777776665543 4566666777777777766655444


Q ss_pred             hhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCC-CCCccccCCcCcceeeccccccCCcCCcccCCCC
Q 001384          335 IFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG-PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMP  413 (1088)
Q Consensus       335 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  413 (1088)
                      .|+                         .+++|++|+|++|.+++ .+|..+..+++|++|++++|++++..|..+..++
T Consensus       145 ~~~-------------------------~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  199 (306)
T 2z66_A          145 IFN-------------------------GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS  199 (306)
T ss_dssp             TTT-------------------------TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hcc-------------------------cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC
Confidence            443                         45556666666666654 3556666666666666666666655566666666


Q ss_pred             CCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCC-CCCeEEccCCcCccC
Q 001384          414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT-SLLWLNLSNNKLSGN  476 (1088)
Q Consensus       414 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~g~  476 (1088)
                      +|++|+|++|++++..+..+..+++|++|+|++|++++..|..+..++ +|++|+|++|++++.
T Consensus       200 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             TCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             CCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            666666666666655555566666666677776666666666666663 667777777766654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=1.5e-27  Score=266.69  Aligned_cols=228  Identities=22%  Similarity=0.221  Sum_probs=124.9

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCcc--CcccccCCCCCcEEEcC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV--IPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~L~  324 (1088)
                      +.++.+++.++ .+|..+.  ++|++|+|++|+++...+..|..+++|++|+|++|.++..  .|..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            34555555554 3444332  4566666666666533333355666666666666665532  24455555666666666


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCC-
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG-  403 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-  403 (1088)
                      +|.+.+. +..+..+++|+.|++++|.+........+..+++|++|++++|.+++..|..+..+++|++|++++|.+++ 
T Consensus        87 ~n~i~~l-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEEEE-EEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccccC-hhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            6655532 22233344444444443333222222334455666666666666665555566666666666666666654 


Q ss_pred             cCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       404 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      .+|..+..+++|++|++++|++++..|..+.++++|++|+|++|++++..+..+..+++|++|+|++|++++..|
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  240 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK  240 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence            355666666666666666666665555566666666666666666665444455666666666666666654444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=1.6e-26  Score=255.38  Aligned_cols=200  Identities=22%  Similarity=0.235  Sum_probs=111.0

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      +.++.+++.++ .+|..+  .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            56777777766 445443  357777777777777665566777777777777777777766777777777777777777


Q ss_pred             c-CCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcC
Q 001384          327 N-FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSI  405 (1088)
Q Consensus       327 ~-l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  405 (1088)
                      . +....+..|..++                         +|++|+|++|.+++..|..+.++++|++|++++|++++..
T Consensus        91 ~~l~~~~~~~~~~l~-------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (285)
T 1ozn_A           91 AQLRSVDPATFHGLG-------------------------RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP  145 (285)
T ss_dssp             TTCCCCCTTTTTTCT-------------------------TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccccCHHHhcCCc-------------------------CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence            5 5555455444444                         4444444444444444444444444444444444444333


Q ss_pred             CcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          406 PAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       406 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      +..++.+++|++|+|++|++++..+..+.++++|++|+|++|++++..|..++++++|+.|++++|+++
T Consensus       146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  214 (285)
T 1ozn_A          146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence            333444444444444444444333333444444444444444444444444444444444444444444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=8.6e-26  Score=273.32  Aligned_cols=268  Identities=24%  Similarity=0.286  Sum_probs=173.7

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +++.|++++|.++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|++++ +|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence            5788888888887 6676665  78888888888887 4554   46778888888888765 444   56777788888


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|.+++.+.                             .+++|+.|++++|++++ +|..   +++|++|+|++|+++ .
T Consensus       110 ~N~l~~l~~-----------------------------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-~  155 (622)
T 3g06_A          110 SNPLTHLPA-----------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-S  155 (622)
T ss_dssp             SCCCCCCCC-----------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-C
T ss_pred             CCcCCCCCC-----------------------------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC-C
Confidence            777764322                             23566777777777763 4543   367777777777777 3


Q ss_pred             CCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhcc
Q 001384          405 IPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI  484 (1088)
Q Consensus       405 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~  484 (1088)
                      +|.   .+++|+.|++++|+++ .+|   ..+++|+.|+|++|++++ +|..   +++|+.|++++|.++ .+|..+   
T Consensus       156 l~~---~~~~L~~L~L~~N~l~-~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~~---  220 (622)
T 3g06_A          156 LPA---LPSELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---  220 (622)
T ss_dssp             CCC---CCTTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCCC---
T ss_pred             cCC---ccCCCCEEECCCCCCC-CCc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCCC---
Confidence            443   2456777777777777 355   345677777777777773 5543   366777777777776 333210   


Q ss_pred             CCCCCccccccccCCcccccCCccccccccccCCCCCCCcceeeehhccccchhhhhcccCCcccccccCCCcccceeee
Q 001384          485 GRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQIT  564 (1088)
Q Consensus       485 ~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l  564 (1088)
                                                                                                   ..+
T Consensus       221 -----------------------------------------------------------------------------~~L  223 (622)
T 3g06_A          221 -----------------------------------------------------------------------------SGL  223 (622)
T ss_dssp             -----------------------------------------------------------------------------TTC
T ss_pred             -----------------------------------------------------------------------------CCC
Confidence                                                                                         013


Q ss_pred             ceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcEEEccccc
Q 001384          565 GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN  644 (1088)
Q Consensus       565 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  644 (1088)
                      ++|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|..  .-.|+.|+|++|+|+ .+|..|+++++|+.|+|++|+
T Consensus       224 ~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~~--~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~  295 (622)
T 3g06_A          224 KELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  295 (622)
T ss_dssp             CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred             CEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCcc--cccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence            456677777764 55   34466677777777776 45541  124566666666666 666666666666667777666


Q ss_pred             cCCcCCccccccc
Q 001384          645 FSGPFPASFNNLT  657 (1088)
Q Consensus       645 l~g~~p~~~~~l~  657 (1088)
                      ++|.+|..+..++
T Consensus       296 l~~~~~~~l~~L~  308 (622)
T 3g06_A          296 LSERTLQALREIT  308 (622)
T ss_dssp             CCHHHHHHHHHHH
T ss_pred             CCCcCHHHHHhcc
Confidence            6666666555544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=7.1e-28  Score=269.73  Aligned_cols=253  Identities=22%  Similarity=0.242  Sum_probs=189.8

Q ss_pred             ccccCCCCCcEEEccCccccccccccC-cccceecccCccccccccccccc-------CCCccCEEEcCCCcccccCccc
Q 001384          192 TCFDGCLNLRYLDLSSNNFRGNIWNGL-AQLVEFSVSENVLSGVVSSSVFK-------ENCSLEIFDLSENEFIGDFPGE  263 (1088)
Q Consensus       192 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~-------~l~~L~~L~Ls~n~l~~~~p~~  263 (1088)
                      +.++..++|++|++++|.+  .+|..+ ..|+.|++++|.++....+..+.       .+++|++|+|++|++++.+|..
T Consensus        37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEEEECTTHHHHCCTT--CCCHHHHHHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EEEccCCCceeEeeccccc--ccHHHHHHHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            3456777888888988888  455433 23788888888875432222222       5677888888888887777776


Q ss_pred             c--cCCCCCcEEEccCccccCCCccccCCC-----CCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchh--H
Q 001384          264 V--SNCRNLVVLNLFGNNFSGPIPAEIGSI-----SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQ--K  334 (1088)
Q Consensus       264 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~--~  334 (1088)
                      +  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++.+..|..|+++++|++|+|++|++.+..+  .
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            5  7778888888888888765 6666665     778888888888777777777777888888888887765422  1


Q ss_pred             hhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCC--CCC-ccccCCcCcceeeccccccCCcCC-cccC
Q 001384          335 IFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG--PLP-VEISQMRSLKFLILAHNRFNGSIP-AVYG  410 (1088)
Q Consensus       335 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p-~~l~~l~~L~~L~L~~N~l~~~~p-~~~~  410 (1088)
                      .+                       .+..+++|++|+|++|++++  .++ ..+..+++|++|+|++|++++..| ..+.
T Consensus       194 ~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  250 (312)
T 1wwl_A          194 AL-----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD  250 (312)
T ss_dssp             HS-----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred             HH-----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence            11                       12467788888999998883  122 334577899999999999997765 5567


Q ss_pred             CCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       411 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      .+++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus       251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            7899999999999999 7888877  8999999999999964 66 8999999999999999985

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=1.4e-27  Score=267.23  Aligned_cols=262  Identities=20%  Similarity=0.157  Sum_probs=171.6

Q ss_pred             ccccCCCCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCC-CCCcCccCC-------CCCC
Q 001384           57 YMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF-SGSIPDDLS-------SCRS  128 (1088)
Q Consensus        57 ~~sW~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~  128 (1088)
                      ..+|.....|+.|..+.......+++.|+++++.+  .+|..+...  |++|+|++|.+ .+.+|..+.       ++++
T Consensus        21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~   96 (312)
T 1wwl_A           21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG   96 (312)
T ss_dssp             SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred             ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence            44687667777777665443345778888999998  667666554  89999999999 456777665       7899


Q ss_pred             CcEEECccccccCcc--cC--CCCCCCceeecccccccccccCchhhh----cccceEEeccCccCCCCCCccccCCCCC
Q 001384          129 LKYLNLSHNILSGDL--NL--SGLRSLEILDLSVNRIHGEISFSFPAI----CEKLVVANLSLNNLTGRIDTCFDGCLNL  200 (1088)
Q Consensus       129 L~~L~Ls~n~l~~~~--~l--~~l~~L~~L~Ls~N~l~~~~~~~~~~~----~~~L~~L~L~~n~l~~~~~~~l~~l~~L  200 (1088)
                      |++|+|++|.+++..  .+  ..+++|++|+|++|++++. |..+...    +++|++|+|++|++++..+..|+++++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            999999999998643  33  7899999999999999987 6555544    2789999999999999998999999999


Q ss_pred             cEEEccCccccccc-------cccCcccceecccCccccc--ccccccccCCCccCEEEcCCCcccccCcccccCCCCCc
Q 001384          201 RYLDLSSNNFRGNI-------WNGLAQLVEFSVSENVLSG--VVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLV  271 (1088)
Q Consensus       201 ~~L~Ls~N~l~~~~-------~~~l~~L~~L~L~~n~l~~--~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~  271 (1088)
                      ++|+|++|++.+.+       +..+++|++|++++|.+++  .++...+.                        ++++|+
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~------------------------~l~~L~  231 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA------------------------ARVQLQ  231 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHH------------------------TTCCCS
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHh------------------------cCCCCC
Confidence            99999999876531       1334444444444444442  12223333                        445555


Q ss_pred             EEEccCccccCCCc-cccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcC
Q 001384          272 VLNLFGNNFSGPIP-AEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN  350 (1088)
Q Consensus       272 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  350 (1088)
                      +|+|++|++++.+| ..+..+++|++|+|++|+++ .+|..+.  ++|++|+|++|++++. |. +..+++|+.|++++|
T Consensus       232 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N  306 (312)
T 1wwl_A          232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGN  306 (312)
T ss_dssp             EEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTC
T ss_pred             EEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCC
Confidence            55555555554432 23334455555555555554 3344443  4555555555555544 22 455555555555555


Q ss_pred             cc
Q 001384          351 SY  352 (1088)
Q Consensus       351 ~~  352 (1088)
                      .+
T Consensus       307 ~l  308 (312)
T 1wwl_A          307 PF  308 (312)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=8.3e-28  Score=269.80  Aligned_cols=268  Identities=18%  Similarity=0.137  Sum_probs=170.6

Q ss_pred             CceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcc
Q 001384          151 LEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENV  230 (1088)
Q Consensus       151 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~  230 (1088)
                      ++.++++.+.+... +..+...+++|++|+|++|++++..|..|..+++|++|+|++|++++.                 
T Consensus        12 l~i~~ls~~~l~~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------   73 (317)
T 3o53_A           12 YKIEKVTDSSLKQA-LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-----------------   73 (317)
T ss_dssp             EEEESCCTTTHHHH-HHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEE-----------------
T ss_pred             eeEeeccccchhhh-HHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcc-----------------
Confidence            44556666666422 223334455677777777777776666677777777777776666431                 


Q ss_pred             cccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcc
Q 001384          231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPE  310 (1088)
Q Consensus       231 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  310 (1088)
                          .   .|..+++|++|+|++|++++..     ..++|++|++++|++++..+.   .+++|++|++++|++++..+.
T Consensus        74 ----~---~~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~  138 (317)
T 3o53_A           74 ----L---DLESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDL  138 (317)
T ss_dssp             ----E---EETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGB
T ss_pred             ----h---hhhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccch
Confidence                1   1555667777777777766322     236777777777777644332   245677777777777666666


Q ss_pred             cccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcC
Q 001384          311 SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRS  390 (1088)
Q Consensus       311 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  390 (1088)
                      .+..+++|++|+|++|.+++..+..+.                        ..+++|++|+|++|.+++. | ....+++
T Consensus       139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------------------~~l~~L~~L~L~~N~l~~~-~-~~~~l~~  192 (317)
T 3o53_A          139 DEGCRSRVQYLDLKLNEIDTVNFAELA------------------------ASSDTLEHLNLQYNFIYDV-K-GQVVFAK  192 (317)
T ss_dssp             CTGGGSSEEEEECTTSCCCEEEGGGGG------------------------GGTTTCCEEECTTSCCCEE-E-CCCCCTT
T ss_pred             hhhccCCCCEEECCCCCCCcccHHHHh------------------------hccCcCCEEECCCCcCccc-c-ccccccc
Confidence            666667777777777766655444332                        2345666666666666633 2 2234677


Q ss_pred             cceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccc-cCCCccccCCCCCCeEEcc
Q 001384          391 LKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS-GEIPGEIGNCTSLLWLNLS  469 (1088)
Q Consensus       391 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~  469 (1088)
                      |++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|.++ +.+|..++.+++|+.|+++
T Consensus       193 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          193 LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             CCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             CCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            777777777777 34445777777777777777777 46777777777777777777777 5667777777777777777


Q ss_pred             -CCcCccCCCc
Q 001384          470 -NNKLSGNIPP  479 (1088)
Q Consensus       470 -~N~l~g~ip~  479 (1088)
                       .+.++|..|.
T Consensus       271 ~~~~l~~~~~~  281 (317)
T 3o53_A          271 TVKKLTGQNEE  281 (317)
T ss_dssp             HHHHHHSSSSC
T ss_pred             CchhccCCchh
Confidence             4445554443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.1e-27  Score=288.36  Aligned_cols=187  Identities=18%  Similarity=0.122  Sum_probs=134.0

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEccccCc----------cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          812 IIGKGGFGTVYRGVLP-DGREVAVKKLQREGL----------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       812 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ..+.|++|.+..++.. .|+.+|||++.+...          ...+++.+|+++|+++.   .|+||++++++++++...
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~---~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP---AGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC---TTCCCCCEEEEEECSSEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC---CCCCeeEEEEEEEECCEE
Confidence            3567777777766532 588999999976421          12356899999999854   799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||||++|++|.+++.+.+++++.   +|+.||+.||+|+|++   |||||||||+|||++++|.+||+|||+|+....
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999999998888765   4889999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCC
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~ 1009 (1088)
                      .. ......+||+.|+|||++.+ .+..++|+||+|++.+++.++..++
T Consensus       392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            32 23445689999999999876 5678899999999988776655443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.93  E-value=3.8e-26  Score=252.32  Aligned_cols=218  Identities=21%  Similarity=0.232  Sum_probs=144.9

Q ss_pred             cccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCcc-ccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCC
Q 001384          239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN-FSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK  317 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  317 (1088)
                      .|..+++|++|+|++|.+++..|..+.++++|++|+|++|. +.+..|..+..+++|++|+|++|.+++..|..+.++++
T Consensus        51 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  130 (285)
T 1ozn_A           51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA  130 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT
T ss_pred             HcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC
Confidence            34445555555555555555555555555555555555554 54444555555555555555555555555555555555


Q ss_pred             CcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecc
Q 001384          318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILA  397 (1088)
Q Consensus       318 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  397 (1088)
                      |++|+|++|.+++..+                         ..+..+++|++|+|++|++++..+..+..+++|+.|+++
T Consensus       131 L~~L~l~~n~l~~~~~-------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  185 (285)
T 1ozn_A          131 LQYLYLQDNALQALPD-------------------------DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (285)
T ss_dssp             CCEEECCSSCCCCCCT-------------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcccccCH-------------------------hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence            5555555555554333                         344567778888888888886555568888888888888


Q ss_pred             ccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCC
Q 001384          398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNI  477 (1088)
Q Consensus       398 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i  477 (1088)
                      +|++++..|..+..+++|+.|++++|++++..+..+..+++|++|+|++|.+....+.. .-...++.+..+.|.+.+..
T Consensus       186 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~  264 (285)
T 1ozn_A          186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSL  264 (285)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEE
T ss_pred             CCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCC
Confidence            88888777888888888888888888888655566888888888888888887543321 12234556667788888888


Q ss_pred             Cchhh
Q 001384          478 PPEVM  482 (1088)
Q Consensus       478 p~~~~  482 (1088)
                      |..+.
T Consensus       265 p~~l~  269 (285)
T 1ozn_A          265 PQRLA  269 (285)
T ss_dssp             SGGGT
T ss_pred             chHhC
Confidence            87654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.93  E-value=1.2e-26  Score=260.25  Aligned_cols=259  Identities=22%  Similarity=0.223  Sum_probs=212.1

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN  159 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N  159 (1088)
                      +....+++++++...+...+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..++..+++|++|+|++|
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNN   90 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEEETTCTTCCEEECCSS
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchhhhhcCCCCEEECcCC
Confidence            44556777777776666667778899999999999998888899999999999999999998777999999999999999


Q ss_pred             cccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCcccccc---ccccCcccceecccCcccccccc
Q 001384          160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN---IWNGLAQLVEFSVSENVLSGVVS  236 (1088)
Q Consensus       160 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~~~~l~~L~~L~L~~n~l~~~~~  236 (1088)
                      ++++..+      .++|++|++++|++++..+..   +++|++|++++|++++.   .+..+++|++|++++|.+++..+
T Consensus        91 ~l~~l~~------~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (317)
T 3o53_A           91 YVQELLV------GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (317)
T ss_dssp             EEEEEEE------CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred             ccccccC------CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence            9986442      278999999999999877654   57799999999998864   34567888899999998887766


Q ss_pred             cccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCC
Q 001384          237 SSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLS  316 (1088)
Q Consensus       237 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  316 (1088)
                      ...+..+++|++|+|++|++++. | ....+++|++|+|++|++++ +|..+..+++|+.|+|++|++++ +|..+..++
T Consensus       162 ~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~  237 (317)
T 3o53_A          162 AELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ  237 (317)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred             HHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCC
Confidence            66666788899999999988755 3 23358889999999999984 55568888999999999998885 577788888


Q ss_pred             CCcEEEcCCCcCC-CchhHhhhcccccceeecCcCc
Q 001384          317 KLEVLDLSSNNFG-GEVQKIFGRFTQVKILALHSNS  351 (1088)
Q Consensus       317 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~  351 (1088)
                      +|+.|+|++|.+. +.++..+..+++|+.+++..+.
T Consensus       238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~  273 (317)
T 3o53_A          238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK  273 (317)
T ss_dssp             TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred             CCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence            9999999999988 7777888877777777776554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.93  E-value=2.8e-25  Score=262.34  Aligned_cols=247  Identities=21%  Similarity=0.215  Sum_probs=176.4

Q ss_pred             CceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcc
Q 001384          151 LEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENV  230 (1088)
Q Consensus       151 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~  230 (1088)
                      ...++.+++.++ .+|..++   +++++|+|++|++++..+..|.++++|++|+|++|++++                  
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------  113 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ------------------  113 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE------------------
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC------------------
Confidence            456777777766 3444433   456777777777777666667777777777666666542                  


Q ss_pred             cccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCc-CCccCc
Q 001384          231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN-FLSVIP  309 (1088)
Q Consensus       231 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p  309 (1088)
                          ++...|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+ +....+
T Consensus       114 ----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~  189 (452)
T 3zyi_A          114 ----IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE  189 (452)
T ss_dssp             ----ECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred             ----cChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence                223345555566666666666665555556666666666666666664444456666666666666633 333333


Q ss_pred             ccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCc
Q 001384          310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMR  389 (1088)
Q Consensus       310 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  389 (1088)
                      ..|.++++|++|+|++|++++.                           ..+..+++|++|+|++|++++..|..|.+++
T Consensus       190 ~~~~~l~~L~~L~L~~n~l~~~---------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  242 (452)
T 3zyi_A          190 GAFEGLFNLKYLNLGMCNIKDM---------------------------PNLTPLVGLEELEMSGNHFPEIRPGSFHGLS  242 (452)
T ss_dssp             TTTTTCTTCCEEECTTSCCSSC---------------------------CCCTTCTTCCEEECTTSCCSEECGGGGTTCT
T ss_pred             hhccCCCCCCEEECCCCccccc---------------------------ccccccccccEEECcCCcCcccCcccccCcc
Confidence            3455666666666666655432                           1255788999999999999988899999999


Q ss_pred             CcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccc
Q 001384          390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS  450 (1088)
Q Consensus       390 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  450 (1088)
                      +|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|++|+|++|.+.
T Consensus       243 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            9999999999999888999999999999999999999777777899999999999999887

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.93  E-value=3.4e-25  Score=260.74  Aligned_cols=247  Identities=20%  Similarity=0.210  Sum_probs=170.5

Q ss_pred             CceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcc
Q 001384          151 LEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENV  230 (1088)
Q Consensus       151 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~  230 (1088)
                      ...++.+++.++ .+|..++   ++++.|+|++|++++..+..|.++++|++|+|++|++++                  
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------  102 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT------------------  102 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE------------------
T ss_pred             CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc------------------
Confidence            456666666665 3444333   456666666666666666666666666666666665542                  


Q ss_pred             cccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCc-CCccCc
Q 001384          231 LSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN-FLSVIP  309 (1088)
Q Consensus       231 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p  309 (1088)
                          ++...|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+ +....+
T Consensus       103 ----i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~  178 (440)
T 3zyj_A          103 ----IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE  178 (440)
T ss_dssp             ----ECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred             ----cChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence                223345555566666666666655444555666666666666666654444455556666666665533 222233


Q ss_pred             ccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCc
Q 001384          310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMR  389 (1088)
Q Consensus       310 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  389 (1088)
                      ..|.++++|++|+|++|.++..                           ..+..+++|++|+|++|++++..|..|.+++
T Consensus       179 ~~~~~l~~L~~L~L~~n~l~~~---------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  231 (440)
T 3zyj_A          179 GAFEGLSNLRYLNLAMCNLREI---------------------------PNLTPLIKLDELDLSGNHLSAIRPGSFQGLM  231 (440)
T ss_dssp             TTTTTCSSCCEEECTTSCCSSC---------------------------CCCTTCSSCCEEECTTSCCCEECTTTTTTCT
T ss_pred             chhhcccccCeecCCCCcCccc---------------------------cccCCCcccCEEECCCCccCccChhhhccCc
Confidence            3455555566666655555422                           1255788999999999999988899999999


Q ss_pred             CcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccc
Q 001384          390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS  450 (1088)
Q Consensus       390 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  450 (1088)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus       232 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             cCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            9999999999999888999999999999999999999777777899999999999999987

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=1.6e-26  Score=274.44  Aligned_cols=83  Identities=20%  Similarity=0.135  Sum_probs=52.5

Q ss_pred             cCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCcccc-CCCCCCeEE
Q 001384          389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG-NCTSLLWLN  467 (1088)
Q Consensus       389 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~  467 (1088)
                      ++|+.|++++|.+++..+.   .+++|+.|+|++|++++..|..++++++|++|+|++|.+++.+|..+. .+++|++|+
T Consensus        99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~  175 (487)
T 3oja_A           99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (487)
T ss_dssp             TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence            4555555555555533332   245666677777776666666666677777777777777766666664 567777777


Q ss_pred             ccCCcCc
Q 001384          468 LSNNKLS  474 (1088)
Q Consensus       468 L~~N~l~  474 (1088)
                      |++|.++
T Consensus       176 Ls~N~l~  182 (487)
T 3oja_A          176 LQYNFIY  182 (487)
T ss_dssp             CTTSCCC
T ss_pred             cCCCccc
Confidence            7777766

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=6.1e-28  Score=296.31  Aligned_cols=355  Identities=16%  Similarity=0.167  Sum_probs=179.4

Q ss_pred             CCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCC---CcCcc------------CCCCCCC
Q 001384           65 SPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSG---SIPDD------------LSSCRSL  129 (1088)
Q Consensus        65 ~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~---~~p~~------------l~~l~~L  129 (1088)
                      -|++|.++..    .....+++.+.... .....+.++++|++|+|+++....   ..|..            ...+++|
T Consensus        33 vck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           33 VCKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             SCHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            3667998822    22234445433211 112345678889999998875321   12211            2356777


Q ss_pred             cEEECccccccCcc--cCC-CCCCCceeecccc-cccccccCchhhhcccceEEeccCccCCCCCCcccc----CCCCCc
Q 001384          130 KYLNLSHNILSGDL--NLS-GLRSLEILDLSVN-RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFD----GCLNLR  201 (1088)
Q Consensus       130 ~~L~Ls~n~l~~~~--~l~-~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~----~l~~L~  201 (1088)
                      ++|+|++|.+++..  .+. .+++|++|+|++| .+++.....+...+++|++|+|++|.+++..+..+.    .+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            77777777766432  232 4677777777776 454433334444556666666666666654433332    445666


Q ss_pred             EEEccCcc--ccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCc-
Q 001384          202 YLDLSSNN--FRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN-  278 (1088)
Q Consensus       202 ~L~Ls~N~--l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N-  278 (1088)
                      +|++++|.  ++...                     .......+++|++|+|++|...+.+|..+.++++|++|+++.+ 
T Consensus       188 ~L~l~~~~~~~~~~~---------------------l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~  246 (594)
T 2p1m_B          188 SLNISCLASEVSFSA---------------------LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYT  246 (594)
T ss_dssp             EEECTTCCSCCCHHH---------------------HHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCC
T ss_pred             EEEecccCCcCCHHH---------------------HHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEccccccc
Confidence            66666554  22111                     1111223456666666666222235566666667777764433 


Q ss_pred             ------cccCCCccccCCCCCCCEE-eCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchh-HhhhcccccceeecCcC
Q 001384          279 ------NFSGPIPAEIGSISGLEAL-FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQ-KIFGRFTQVKILALHSN  350 (1088)
Q Consensus       279 ------~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n  350 (1088)
                            .+.+ ++..+.++++|+.| .+.+.. ...++..+..+++|++|+|++|.+++... ..+..++          
T Consensus       247 ~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~----------  314 (594)
T 2p1m_B          247 AEVRPDVYSG-LSVALSGCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP----------  314 (594)
T ss_dssp             CCCCHHHHHH-HHHHHHTCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCT----------
T ss_pred             CccchhhHHH-HHHHHhcCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCC----------
Confidence                  3332 33455666666666 333222 12234444455666777776666553322 2233344          


Q ss_pred             cccCCCCCccccCCCCcCEEEccCCccCCC-CCccccCCcCcceeec---------cccccCCcCCcccC-CCCCCcEEE
Q 001384          351 SYIDGMNSSGILKLPNISRLDLSHNNFTGP-LPVEISQMRSLKFLIL---------AHNRFNGSIPAVYG-NMPNLQTLD  419 (1088)
Q Consensus       351 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~  419 (1088)
                                     +|+.|++++| +++. ++.....+++|+.|++         +.+.+++.....+. .+++|+.|+
T Consensus       315 ---------------~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~  378 (594)
T 2p1m_B          315 ---------------KLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVL  378 (594)
T ss_dssp             ---------------TCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEE
T ss_pred             ---------------CcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHH
Confidence                           4444444444 2211 1111123444555544         22333322222222 356666666


Q ss_pred             ccCCcCCCCCCcccc-CCCCCcEEEcc--c----cccccC-----CCccccCCCCCCeEEccCCcCc
Q 001384          420 LSFNELTGPIPPSIG-NLTSLLWLMLA--N----NSLSGE-----IPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       420 L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~-----~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      ++.|++++..+..+. .+++|++|+|+  +    |.+++.     ++..+..+++|+.|+|++ .++
T Consensus       379 ~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~  444 (594)
T 2p1m_B          379 YFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT  444 (594)
T ss_dssp             EEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred             HhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence            666666654444443 36666777666  3    444421     122255667777777765 444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=2.2e-28  Score=300.26  Aligned_cols=352  Identities=19%  Similarity=0.204  Sum_probs=186.4

Q ss_pred             cCCccCCeeeCCCCCCCCCcCccCC-CCCCCcEEECccc-cccC--ccc-CCCCCCCceeecccccccccccCch---hh
Q 001384          100 SALTQLSYLDLSRNTFSGSIPDDLS-SCRSLKYLNLSHN-ILSG--DLN-LSGLRSLEILDLSVNRIHGEISFSF---PA  171 (1088)
Q Consensus       100 ~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n-~l~~--~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~---~~  171 (1088)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++| .+++  ... +.++++|++|+|++|.+++..+..+   ..
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~  181 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD  181 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence            4678999999999999987777775 6999999999999 5554  223 3479999999999999987665444   33


Q ss_pred             hcccceEEeccCcc--CCCC-CCccccCCCCCcEEEccCc-cccc--cccccCcccceecccCcccccccccccccCCCc
Q 001384          172 ICEKLVVANLSLNN--LTGR-IDTCFDGCLNLRYLDLSSN-NFRG--NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCS  245 (1088)
Q Consensus       172 ~~~~L~~L~L~~n~--l~~~-~~~~l~~l~~L~~L~Ls~N-~l~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~  245 (1088)
                      .+++|++|++++|.  ++.. +...+..+++|++|++++| .+++  .....+++|++|.++.+..              
T Consensus       182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~--------------  247 (594)
T 2p1m_B          182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA--------------  247 (594)
T ss_dssp             TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCC--------------
T ss_pred             cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccC--------------
Confidence            56799999999997  3211 1222355799999999988 3333  1223345555555332210              


Q ss_pred             cCEEEcCCCcccccCcccccCCCCCcEE-EccCccccCCCccccCCCCCCCEEeCCCCcCCccC-cccccCCCCCcEEEc
Q 001384          246 LEIFDLSENEFIGDFPGEVSNCRNLVVL-NLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI-PESLLNLSKLEVLDL  323 (1088)
Q Consensus       246 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L  323 (1088)
                          +++.|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+|++|.++... +..+.++++|++|++
T Consensus       248 ----~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l  321 (594)
T 2p1m_B          248 ----EVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV  321 (594)
T ss_dssp             ----CCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEE
T ss_pred             ----ccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeC
Confidence                011222222 23345555555555 3332222 133333344556666666666544322 122345566666666


Q ss_pred             CCCcCCCc-hhHhhhcccccceeecCcC--------cccCCCCCccc-cCCCCcCEEEccCCccCCCCCcccc-CCcCcc
Q 001384          324 SSNNFGGE-VQKIFGRFTQVKILALHSN--------SYIDGMNSSGI-LKLPNISRLDLSHNNFTGPLPVEIS-QMRSLK  392 (1088)
Q Consensus       324 ~~N~l~~~-~~~~~~~l~~L~~L~L~~n--------~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~  392 (1088)
                      ++| +... .+.....+++|+.|++..+        ..+.......+ ..+++|++|+++.|.+++..+..+. .+++|+
T Consensus       322 ~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~  400 (594)
T 2p1m_B          322 LDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMT  400 (594)
T ss_dssp             EGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCC
T ss_pred             cCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcc
Confidence            655 3221 2222233555555555221        11110000111 1245555555555555543333333 345555


Q ss_pred             eeecc--c----cccCCc-----CCcccCCCCCCcEEEccCCcCCCCCCccccC-CCCCcEEEccccccccCCCccc-cC
Q 001384          393 FLILA--H----NRFNGS-----IPAVYGNMPNLQTLDLSFNELTGPIPPSIGN-LTSLLWLMLANNSLSGEIPGEI-GN  459 (1088)
Q Consensus       393 ~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~l-~~  459 (1088)
                      .|+++  +    |.+++.     ++..+..+++|+.|+|++ .+++..+..++. +++|++|+|++|.+++..+..+ ..
T Consensus       401 ~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~  479 (594)
T 2p1m_B          401 RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG  479 (594)
T ss_dssp             EEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH
T ss_pred             eeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc
Confidence            55555  2    333311     111133445555555544 444333333333 4555555555555544333333 34


Q ss_pred             CCCCCeEEccCCcC
Q 001384          460 CTSLLWLNLSNNKL  473 (1088)
Q Consensus       460 l~~L~~L~L~~N~l  473 (1088)
                      +++|++|+|++|++
T Consensus       480 ~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          480 CDSLRKLEIRDCPF  493 (594)
T ss_dssp             CTTCCEEEEESCSC
T ss_pred             CCCcCEEECcCCCC
Confidence            55555555555554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.92  E-value=6.5e-25  Score=260.66  Aligned_cols=248  Identities=23%  Similarity=0.230  Sum_probs=182.7

Q ss_pred             ccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccccccccccc
Q 001384           87 TDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEIS  166 (1088)
Q Consensus        87 ~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~  166 (1088)
                      ...++...+.......++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..++.++++|++|+|++|.|++..+
T Consensus        18 ~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~   97 (487)
T 3oja_A           18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLV   97 (487)
T ss_dssp             CTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEECTTCTTCCEEECCSSEEEEEEE
T ss_pred             chhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcccccCCCCCEEEecCCcCCCCCC
Confidence            33344333333444556899999999999988888999999999999999999887778999999999999999886443


Q ss_pred             CchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccc---cccCcccceecccCcccccccccccccCC
Q 001384          167 FSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNI---WNGLAQLVEFSVSENVLSGVVSSSVFKEN  243 (1088)
Q Consensus       167 ~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~~n~l~~~~~~~~~~~l  243 (1088)
                      .      ++|++|+|++|++++..+..   +++|++|+|++|++++..   +..+++|+.|+|++|.+++..+...+..+
T Consensus        98 ~------~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l  168 (487)
T 3oja_A           98 G------PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS  168 (487)
T ss_dssp             C------TTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGT
T ss_pred             C------CCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhC
Confidence            2      67888888888888877653   567888888888887643   34567777777777777776655555567


Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      ++|++|+|++|.+++. | .+..+++|++|+|++|.+++ +|+.+..+++|+.|+|++|.+++ +|..+..+++|+.|++
T Consensus       169 ~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l  244 (487)
T 3oja_A          169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDL  244 (487)
T ss_dssp             TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEEC
T ss_pred             CcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEc
Confidence            7888888888887755 2 23357788888888888875 44457777888888888888776 5667777788888888


Q ss_pred             CCCcCC-CchhHhhhcccccceeec
Q 001384          324 SSNNFG-GEVQKIFGRFTQVKILAL  347 (1088)
Q Consensus       324 ~~N~l~-~~~~~~~~~l~~L~~L~L  347 (1088)
                      ++|.+. +.+|..+..++.|+.+++
T Consensus       245 ~~N~l~c~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          245 RGNGFHCGTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             TTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred             CCCCCcCcchHHHHHhCCCCcEEec
Confidence            888777 555666665555544443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=8.9e-24  Score=231.16  Aligned_cols=217  Identities=24%  Similarity=0.313  Sum_probs=146.5

Q ss_pred             CCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc
Q 001384           64 SSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL  143 (1088)
Q Consensus        64 ~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  143 (1088)
                      .++|.|.|+.|+- ...++.+++++++++. +|..+.  ++|++|+|++|++++..+..|+.+++|++|+|++|.++...
T Consensus         2 ~~~C~~~~~~C~c-~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSC-NNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEE-ETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEe-CCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            4799999999863 2345567888888885 454443  67888888888888776678888888888888888777543


Q ss_pred             c--CCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCccc
Q 001384          144 N--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQL  221 (1088)
Q Consensus       144 ~--l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L  221 (1088)
                      .  +.++++|++|+|++|+++                         +..+..|.++++|++|+|++|++++         
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~---------  123 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQ-------------------------ALPIGVFDQLVNLAELRLDRNQLKS---------  123 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCC-------------------------CCCTTTTTTCSSCCEEECCSSCCCC---------
T ss_pred             hhhhcCCCCCCEEECCCCcCC-------------------------cCCHhHcccccCCCEEECCCCccCe---------
Confidence            2  455666666666666554                         3334445556666666666665542         


Q ss_pred             ceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCC
Q 001384          222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK  301 (1088)
Q Consensus       222 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  301 (1088)
                                   ++...|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus       124 -------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (270)
T 2o6q_A          124 -------------LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN  190 (270)
T ss_dssp             -------------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             -------------eCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCC
Confidence                         2233344555666666666666655555567777777777777777765555677777777777777


Q ss_pred             CcCCccCcccccCCCCCcEEEcCCCcCCCc
Q 001384          302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGE  331 (1088)
Q Consensus       302 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  331 (1088)
                      |++++..+..+..+++|+.|+|++|.+...
T Consensus       191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          191 NQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             CcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            777766666677777777777777776543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=5.2e-24  Score=234.00  Aligned_cols=208  Identities=22%  Similarity=0.209  Sum_probs=140.3

Q ss_pred             CCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecC
Q 001384          269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALH  348 (1088)
Q Consensus       269 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  348 (1088)
                      +|++|++++|++++..+..|..+++|++|+|++|++.+..+..|.++++|++|+|++|.+++..+..|..+++|+.|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444444444443333344444444444444444444444444444444444444444444444444444444444444


Q ss_pred             cCcccCCCCCccccCCCCcCEEEccCCccCCC-CCccccCCcCcceeeccccccCCcCCcccCCCCCCc----EEEccCC
Q 001384          349 SNSYIDGMNSSGILKLPNISRLDLSHNNFTGP-LPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ----TLDLSFN  423 (1088)
Q Consensus       349 ~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N  423 (1088)
                      +|.+. ......+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+..+..+++|+    .|++++|
T Consensus       109 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            44432 22233466788899999999999863 688999999999999999999977777777777776    8999999


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      ++++ +|.......+|++|+|++|++++..+..+.++++|++|+|++|++++..|
T Consensus       188 ~l~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          188 PMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCCE-ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             cccc-cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            9995 44444455689999999999997666668999999999999999998765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=3.4e-24  Score=234.73  Aligned_cols=228  Identities=21%  Similarity=0.282  Sum_probs=173.5

Q ss_pred             cccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEe
Q 001384          219 AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALF  298 (1088)
Q Consensus       219 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  298 (1088)
                      .++..+++.++.+.+...   ...+++|+.|++++|.++. + ..+..+++|++|++++|.+++.  +.+..+++|++|+
T Consensus        19 ~~l~~l~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           19 AETIKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHTCSCTTSEEC---HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHhcCcccccccc---cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            344455555555544322   3345677888888887763 2 3477788888888888888752  4677888888888


Q ss_pred             CCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          299 LGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       299 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      |++|.+++..+..+.++++|++|+|++|++++.++..|                         ..+++|++|+|++|+++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~n~l~  146 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF-------------------------DKLTNLTYLNLAHNQLQ  146 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHh-------------------------ccCCCCCEEECCCCccC
Confidence            88888887777777788888888888888776555443                         45677888888888888


Q ss_pred             CCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCcccc
Q 001384          379 GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG  458 (1088)
Q Consensus       379 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~  458 (1088)
                      +..+..+..+++|+.|++++|++++..+..++.+++|++|++++|++++..|..++.+++|++|+|++|.+.+.      
T Consensus       147 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------  220 (272)
T 3rfs_A          147 SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------  220 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC------
T ss_pred             ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc------
Confidence            77677778888999999999999877777788899999999999999987777788899999999999988754      


Q ss_pred             CCCCCCeEEccCCcCccCCCchhhccC
Q 001384          459 NCTSLLWLNLSNNKLSGNIPPEVMTIG  485 (1088)
Q Consensus       459 ~l~~L~~L~L~~N~l~g~ip~~~~~~~  485 (1088)
                       +++|++|+++.|.++|.+|..++.+.
T Consensus       221 -~~~l~~l~~~~n~~~g~ip~~~~~~~  246 (272)
T 3rfs_A          221 -CPGIRYLSEWINKHSGVVRNSAGSVA  246 (272)
T ss_dssp             -TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred             -CcHHHHHHHHHHhCCCcccCcccccC
Confidence             55788899999999999998876553

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.90  E-value=9.3e-23  Score=223.05  Aligned_cols=206  Identities=22%  Similarity=0.285  Sum_probs=168.2

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +.+.+++++++++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|.++...+..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4677888888877 4665554  578888888888886666678888888888888888877666667778888888888


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|.+++.++..                         +..+++|++|+|++|++++..|..|..+++|++|+|++|++++.
T Consensus        94 ~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  148 (270)
T 2o6q_A           94 DNKLQALPIGV-------------------------FDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL  148 (270)
T ss_dssp             SSCCCCCCTTT-------------------------TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCcCCcCCHhH-------------------------cccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence            88877654443                         34567888888888889877777889999999999999999976


Q ss_pred             CCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          405 IPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       405 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      .+..|..+++|++|+|++|++++..+..+.++++|++|+|++|++++..+..+..+++|+.|+|++|++.+.-+
T Consensus       149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            66678999999999999999997666678999999999999999997666678999999999999999986543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=1.1e-23  Score=230.69  Aligned_cols=228  Identities=21%  Similarity=0.248  Sum_probs=184.7

Q ss_pred             cceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCC
Q 001384          175 KLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN  254 (1088)
Q Consensus       175 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n  254 (1088)
                      ++..+++..+.+.....  +..+++|+.|++++|.++.                     .   ..+..+++|++|+|++|
T Consensus        20 ~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~---------------------~---~~l~~l~~L~~L~l~~n   73 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---------------------V---QGIQYLPNVRYLALGGN   73 (272)
T ss_dssp             HHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC---------------------C---TTGGGCTTCCEEECTTS
T ss_pred             HHHHHHhcCcccccccc--cccccceeeeeeCCCCccc---------------------c---cccccCCCCcEEECCCC
Confidence            44455566666555432  4556667777776666542                     1   23556778999999999


Q ss_pred             cccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhH
Q 001384          255 EFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK  334 (1088)
Q Consensus       255 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  334 (1088)
                      .+++ + ..+.++++|++|+|++|.+++..+..++.+++|++|+|++|++++..+..+..+++|++|+|++|.+++.++.
T Consensus        74 ~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  151 (272)
T 3rfs_A           74 KLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG  151 (272)
T ss_dssp             CCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHH
Confidence            9875 3 4788999999999999999987777789999999999999999988888899999999999999999876654


Q ss_pred             hhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCC
Q 001384          335 IFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPN  414 (1088)
Q Consensus       335 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  414 (1088)
                      .|                         ..+++|+.|++++|++++..+..+..+++|++|++++|++++..|..+..+++
T Consensus       152 ~~-------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  206 (272)
T 3rfs_A          152 VF-------------------------DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS  206 (272)
T ss_dssp             TT-------------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             Hh-------------------------ccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcC
Confidence            44                         35678888888899998777777889999999999999999888888899999


Q ss_pred             CcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCC
Q 001384          415 LQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS  462 (1088)
Q Consensus       415 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  462 (1088)
                      |+.|++++|.+.+.       +++|+.|++..|+++|.+|..++.++.
T Consensus       207 L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          207 LQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             CCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             CCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            99999999998854       457899999999999999999887765

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.89  E-value=4.5e-23  Score=226.50  Aligned_cols=207  Identities=23%  Similarity=0.172  Sum_probs=157.6

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            56777777777766666667777777777777777775555567777777777777777777666677777777777777


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcc----eeeccccc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK----FLILAHNR  400 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~L~~N~  400 (1088)
                      +|.+.+..+..++.+++|+.|++++|.+.....+..+..+++|++|+|++|++++..+..+..+++|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            77777666666777777777777777654433456777889999999999999977777888777777    89999999


Q ss_pred             cCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC
Q 001384          401 FNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       401 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      +++..+..+ ...+|+.|++++|++++..+..+.++++|++|+|++|.+++.
T Consensus       189 l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          189 MNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             CCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             ccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence            996555544 455899999999999966566678999999999999999854

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=2.3e-24  Score=257.86  Aligned_cols=185  Identities=21%  Similarity=0.288  Sum_probs=145.5

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEccccCcc--------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          808 SEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ...+.||+|+||+||+|.. .++.+|+|+.......        ..+.+.+|++++++    ++||||+++..++...+.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~----l~h~nIv~~~~~~~~~~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLAL----VKDFGIPAPYIFDVDLDN  413 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHH----GGGGTCCCCCEEEEETTT
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHh----cCCCCcCceEEEEEeCCc
Confidence            3357899999999999955 5788999986543221        12457899999997    679999966666667777


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeec
Q 001384          880 KILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS  959 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~  959 (1088)
                      .|+||||+++++|.++++.        +..++.|++.||+|||++   +|+||||||+||+++.  .+||+|||+++...
T Consensus       414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            8999999999999999976        568999999999999999   9999999999999998  99999999999875


Q ss_pred             CCCCcc------cccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCcCCC
Q 001384          960 AGDSHV------STTIAGTVGYVAPEYGQT--WQATTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       960 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      ......      .....||+.|+|||++..  ..|+...|+|+..+-..+-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            432211      235689999999999876  567888999999998888888777663

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=1.9e-22  Score=222.49  Aligned_cols=206  Identities=23%  Similarity=0.217  Sum_probs=164.5

Q ss_pred             cccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCC
Q 001384          239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL  318 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  318 (1088)
                      .+..+++++.+++++|+++ .+|..+.  ++++.|+|++|++++..+..|..+++|+.|+|++|.+++..+  ...+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence            3556677788888887776 4555543  577778888887776666777777777777777777776432  2667777


Q ss_pred             cEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccc
Q 001384          319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH  398 (1088)
Q Consensus       319 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  398 (1088)
                      ++|+|++|+++..                          +..+..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus        80 ~~L~Ls~N~l~~l--------------------------~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~  133 (290)
T 1p9a_G           80 GTLDLSHNQLQSL--------------------------PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG  133 (290)
T ss_dssp             CEEECCSSCCSSC--------------------------CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred             CEEECCCCcCCcC--------------------------chhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence            7777777776532                          22345678899999999999977778899999999999999


Q ss_pred             cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       399 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      |++++..+..|..+++|+.|+|++|+|++..+..+.++++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.
T Consensus       134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            9999777778899999999999999999655556788999999999999999 7899999999999999999999753

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=1.5e-22  Score=223.39  Aligned_cols=202  Identities=23%  Similarity=0.230  Sum_probs=133.6

Q ss_pred             cCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcE
Q 001384          362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW  441 (1088)
Q Consensus       362 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  441 (1088)
                      .++++++.+++++|.++ .+|..+.  ++++.|+|++|++++..|..|..+++|++|+|++|++++ ++.. +.+++|++
T Consensus         7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~   81 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGT   81 (290)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCE
T ss_pred             cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCE
Confidence            45566666666666666 4554443  456666666666665555666666666666666666663 3322 55566666


Q ss_pred             EEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCC
Q 001384          442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYP  521 (1088)
Q Consensus       442 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (1088)
                      |+|++|+++ .+|..+..+++|++|+|++|+++                                               
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~-----------------------------------------------  113 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-----------------------------------------------  113 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC-----------------------------------------------
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCc-----------------------------------------------
Confidence            666666665 45555556666666666666555                                               


Q ss_pred             CCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccC
Q 001384          522 PFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK  601 (1088)
Q Consensus       522 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  601 (1088)
                                                                            +..|..++.+++|+.|+|++|++++.
T Consensus       114 ------------------------------------------------------~l~~~~~~~l~~L~~L~L~~N~l~~~  139 (290)
T 1p9a_G          114 ------------------------------------------------------SLPLGALRGLGELQELYLKGNELKTL  139 (290)
T ss_dssp             ------------------------------------------------------CCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred             ------------------------------------------------------ccCHHHHcCCCCCCEEECCCCCCCcc
Confidence                                                                  33334455566677777777777755


Q ss_pred             CCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          602 LPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       602 ~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      .|..|..+ .|+.|+|++|++++..+..|.++++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|+|.+
T Consensus       140 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            55556655 5777777777777444455788899999999999998 788888888899999999999854

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=4.7e-23  Score=230.32  Aligned_cols=229  Identities=20%  Similarity=0.190  Sum_probs=165.3

Q ss_pred             ccceecccCcccccccccc--cccCCCccCEEEcCCCcccccCcccc--cCCCCCcEEEccCccccCCCc----cccCCC
Q 001384          220 QLVEFSVSENVLSGVVSSS--VFKENCSLEIFDLSENEFIGDFPGEV--SNCRNLVVLNLFGNNFSGPIP----AEIGSI  291 (1088)
Q Consensus       220 ~L~~L~L~~n~l~~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l  291 (1088)
                      .++.+.+.++.++......  .+..+++|++|+|++|.+++..|..+  .++++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            3455666666554321111  11223457778888777777777776  777777888888777776444    344567


Q ss_pred             CCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEE
Q 001384          292 SGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD  371 (1088)
Q Consensus       292 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  371 (1088)
                      ++|++|+|++|++.+..|..+..+++|++|+|++|++.+...-.                     ....+..+++|++|+
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------~~~~~~~l~~L~~L~  203 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLM---------------------AALCPHKFPAIQNLA  203 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHH---------------------TTSCTTSSCCCCSCB
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhh---------------------HHHhhhcCCCCCEEE
Confidence            77777777777777777777777777777777777765431100                     011234677888899


Q ss_pred             ccCCccCCCCCc----cccCCcCcceeeccccccCCcCCcccCCC---CCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          372 LSHNNFTGPLPV----EISQMRSLKFLILAHNRFNGSIPAVYGNM---PNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       372 Ls~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      |++|+++ .+|.    .+..+++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|
T Consensus       204 Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L  279 (310)
T 4glp_A          204 LRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL  279 (310)
T ss_dssp             CCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred             CCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence            9999887 3444    25678999999999999998778777776   69999999999999 7888775  79999999


Q ss_pred             cccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       445 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ++|++++ +|. +..+++|+.|+|++|+++.
T Consensus       280 s~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          280 SSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             CCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence            9999995 454 6888999999999999973

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=6e-24  Score=243.08  Aligned_cols=224  Identities=18%  Similarity=0.143  Sum_probs=102.4

Q ss_pred             EcCCCcccccCcccccCCCCCcEEEccCccccCCCc----cccCCCC-CCCEEeCCCCcCCccCcccccCC-----CCCc
Q 001384          250 DLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIP----AEIGSIS-GLEALFLGKNNFLSVIPESLLNL-----SKLE  319 (1088)
Q Consensus       250 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l-----~~L~  319 (1088)
                      +++.|++++.+|..+...++|++|+|++|.+++..+    ..+..++ +|++|+|++|.+++..+..+..+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            444444444444444444445555555555543333    3444444 45555555555544444444432     4555


Q ss_pred             EEEcCCCcCCCchhHhhhcc-----cccceeecCcCcccCCCCCc----cccC-CCCcCEEEccCCccCCCCCcc----c
Q 001384          320 VLDLSSNNFGGEVQKIFGRF-----TQVKILALHSNSYIDGMNSS----GILK-LPNISRLDLSHNNFTGPLPVE----I  385 (1088)
Q Consensus       320 ~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~~~~~~~~~----~~~~-l~~L~~L~Ls~N~l~~~~p~~----l  385 (1088)
                      +|+|++|.+++..+..+...     ++|+.|++++|.+... ...    .+.. .++|++|+|++|.+++..+..    +
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~-~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK-SSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGS-CHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcH-HHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            55555555544444333221     2333333333332111 110    1112 135566666666655432222    2


Q ss_pred             cCCc-CcceeeccccccCCcCCccc----CCC-CCCcEEEccCCcCCCC----CCccccC-CCCCcEEEccccccccCCC
Q 001384          386 SQMR-SLKFLILAHNRFNGSIPAVY----GNM-PNLQTLDLSFNELTGP----IPPSIGN-LTSLLWLMLANNSLSGEIP  454 (1088)
Q Consensus       386 ~~l~-~L~~L~L~~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p  454 (1088)
                      ..++ +|++|+|++|++++..+..+    ..+ ++|++|+|++|++++.    ++..+.. .++|++|+|++|.+++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            3333 56666666666654444322    223 3566666666665532    3333333 2356666666666654322


Q ss_pred             ----ccccCCCCCCeEEccCCcCc
Q 001384          455 ----GEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       455 ----~~l~~l~~L~~L~L~~N~l~  474 (1088)
                          ..+..+++|++|+|++|++.
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l~  266 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIVK  266 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred             HHHHHHHhcCCCccEEEeccCCcc
Confidence                22345556666666666554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=6.9e-24  Score=242.63  Aligned_cols=265  Identities=21%  Similarity=0.238  Sum_probs=169.8

Q ss_pred             EeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCC-ccCEEEcCCCccc
Q 001384          179 ANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENC-SLEIFDLSENEFI  257 (1088)
Q Consensus       179 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~  257 (1088)
                      +.|++|++++.+|..+...++|++|+|++|++++..+..+                  ...|..++ +|++|+|++|+++
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l------------------~~~l~~~~~~L~~L~Ls~N~l~   64 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVEL------------------IQAFANTPASVTSLNLSGNSLG   64 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHH------------------HHHHHTCCTTCCEEECCSSCGG
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHH------------------HHHHHhCCCceeEEECcCCCCC
Confidence            4566666666666666666667777777777664322100                  02334444 5666666666666


Q ss_pred             ccCcccccCC-----CCCcEEEccCccccCCCccccC----CC-CCCCEEeCCCCcCCccCccccc----C-CCCCcEEE
Q 001384          258 GDFPGEVSNC-----RNLVVLNLFGNNFSGPIPAEIG----SI-SGLEALFLGKNNFLSVIPESLL----N-LSKLEVLD  322 (1088)
Q Consensus       258 ~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~  322 (1088)
                      +..+..+..+     ++|++|+|++|++++..+..+.    .+ ++|++|+|++|.+++..+..+.    . .++|++|+
T Consensus        65 ~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~  144 (362)
T 3goz_A           65 FKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLN  144 (362)
T ss_dssp             GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEE
T ss_pred             HHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEE
Confidence            6555555553     6777777777777655555333    33 6777777777777665554433    2 25777777


Q ss_pred             cCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCC-CcCEEEccCCccCCCCCccccC----C-cCcceeec
Q 001384          323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP-NISRLDLSHNNFTGPLPVEISQ----M-RSLKFLIL  396 (1088)
Q Consensus       323 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~----l-~~L~~L~L  396 (1088)
                      |++|.+++.....+..                     .+..++ +|++|+|++|++++..+..+..    . ++|+.|+|
T Consensus       145 Ls~N~l~~~~~~~l~~---------------------~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L  203 (362)
T 3goz_A          145 LRGNDLGIKSSDELIQ---------------------ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL  203 (362)
T ss_dssp             CTTSCGGGSCHHHHHH---------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEEC
T ss_pred             ccCCcCCHHHHHHHHH---------------------HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEEC
Confidence            7777776544433321                     112333 7778888888887666554443    3 58888888


Q ss_pred             cccccCCc----CCcccCC-CCCCcEEEccCCcCCCCCC----ccccCCCCCcEEEcccccccc-------CCCccccCC
Q 001384          397 AHNRFNGS----IPAVYGN-MPNLQTLDLSFNELTGPIP----PSIGNLTSLLWLMLANNSLSG-------EIPGEIGNC  460 (1088)
Q Consensus       397 ~~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~-------~~p~~l~~l  460 (1088)
                      ++|++++.    ++..+.. .++|++|+|++|++++..+    ..+..+++|++|+|++|.+.+       .++..+.++
T Consensus       204 s~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l  283 (362)
T 3goz_A          204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI  283 (362)
T ss_dssp             TTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTC
T ss_pred             CCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccC
Confidence            88888752    4555555 3588888888888886443    334667889999999998543       234467888


Q ss_pred             CCCCeEEccCCcCccCCCchhh
Q 001384          461 TSLLWLNLSNNKLSGNIPPEVM  482 (1088)
Q Consensus       461 ~~L~~L~L~~N~l~g~ip~~~~  482 (1088)
                      ++|++||+++|++.+..|..+.
T Consensus       284 ~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          284 QKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             CEEEEECTTSCBCCGGGCHHHH
T ss_pred             CceEEEecCCCcCCCcchHHHH
Confidence            9999999999999876665543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.87  E-value=7.5e-24  Score=244.79  Aligned_cols=239  Identities=20%  Similarity=0.227  Sum_probs=174.3

Q ss_pred             ccCCCccCEEEcCCCcccccC----cccccCCCCCcEEEccCc---cccCCCcccc-------CCCCCCCEEeCCCCcCC
Q 001384          240 FKENCSLEIFDLSENEFIGDF----PGEVSNCRNLVVLNLFGN---NFSGPIPAEI-------GSISGLEALFLGKNNFL  305 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~N~l~  305 (1088)
                      +..+++|++|+|++|++++..    +..+..+++|++|+|++|   ++.+.+|..+       ..+++|++|+|++|.+.
T Consensus        28 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  107 (386)
T 2ca6_A           28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  107 (386)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             HhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCC
Confidence            344556777777777766543    334566777777777774   3444455444       56777777777777777


Q ss_pred             c----cCcccccCCCCCcEEEcCCCcCCCchhHhhhc----c---------cccceeecCcCcccCCCCC---ccccCCC
Q 001384          306 S----VIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR----F---------TQVKILALHSNSYIDGMNS---SGILKLP  365 (1088)
Q Consensus       306 ~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~n~~~~~~~~---~~~~~l~  365 (1088)
                      .    .+|..+.++++|++|+|++|.+++..+..+..    +         ++|+.|++++|.+.....+   ..+..++
T Consensus       108 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~  187 (386)
T 2ca6_A          108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR  187 (386)
T ss_dssp             TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCC
Confidence            6    35666777777777777777776554444333    3         7777777777775433222   3455778


Q ss_pred             CcCEEEccCCccCC-----CCCccccCCcCcceeeccccccC----CcCCcccCCCCCCcEEEccCCcCCCC----CCcc
Q 001384          366 NISRLDLSHNNFTG-----PLPVEISQMRSLKFLILAHNRFN----GSIPAVYGNMPNLQTLDLSFNELTGP----IPPS  432 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~  432 (1088)
                      +|++|+|++|+++.     ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+|++|++++.    +|..
T Consensus       188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~  267 (386)
T 2ca6_A          188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA  267 (386)
T ss_dssp             TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred             CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHH
Confidence            89999999998872     34447888899999999999995    57888888999999999999999865    5666


Q ss_pred             c--cCCCCCcEEEcccccccc----CCCccc-cCCCCCCeEEccCCcCccCCC
Q 001384          433 I--GNLTSLLWLMLANNSLSG----EIPGEI-GNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       433 ~--~~l~~L~~L~L~~N~l~~----~~p~~l-~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      +  +.+++|++|+|++|.+++    .+|..+ .++++|++|+|++|++++..|
T Consensus       268 l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            6  448999999999999997    488877 678999999999999997664

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.87  E-value=1.6e-22  Score=225.91  Aligned_cols=226  Identities=17%  Similarity=0.172  Sum_probs=180.4

Q ss_pred             CCcEEEccCcccccccc------ccCcccceecccCcccccccccccc-cCCCccCEEEcCCCcccccCc----ccccCC
Q 001384          199 NLRYLDLSSNNFRGNIW------NGLAQLVEFSVSENVLSGVVSSSVF-KENCSLEIFDLSENEFIGDFP----GEVSNC  267 (1088)
Q Consensus       199 ~L~~L~Ls~N~l~~~~~------~~l~~L~~L~L~~n~l~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~p----~~l~~l  267 (1088)
                      .++.|.+.++.++....      ..+++|++|++++|.+++..+...+ ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            46778888777765221      2346799999999999988777666 889999999999999997665    455689


Q ss_pred             CCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCcc--C--cccccCCCCCcEEEcCCCcCCCchhHhhhcccccc
Q 001384          268 RNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSV--I--PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK  343 (1088)
Q Consensus       268 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  343 (1088)
                      ++|++|+|++|++.+..+..++.+++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++........      
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~------  218 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAA------  218 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHH------
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHH------
Confidence            9999999999999988889999999999999999998753  2  23347889999999999999754332110      


Q ss_pred             eeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCC---cCcceeeccccccCCcCCcccCCCCCCcEEEc
Q 001384          344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM---RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL  420 (1088)
Q Consensus       344 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  420 (1088)
                                      .+..+++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|
T Consensus       219 ----------------l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L  279 (310)
T 4glp_A          219 ----------------LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL  279 (310)
T ss_dssp             ----------------HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred             ----------------HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence                            01245678888888888887778777776   68999999999999 7787764  78999999


Q ss_pred             cCCcCCCCCCccccCCCCCcEEEcccccccc
Q 001384          421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSG  451 (1088)
Q Consensus       421 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  451 (1088)
                      ++|+|++ +|. +..+++|++|+|++|+++.
T Consensus       280 s~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          280 SSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             CCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence            9999995 444 6788999999999999874

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=4.3e-23  Score=233.73  Aligned_cols=233  Identities=16%  Similarity=0.165  Sum_probs=133.7

Q ss_pred             cCEEEcCCCcccccCcccccCCCCCcEEEccCccccCC-CccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGP-IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       246 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      ++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..|..++.+++|++|+|+
T Consensus        72 l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~  150 (336)
T 2ast_B           72 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  150 (336)
T ss_dssp             CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence            33344444443333222 22344444444444444432 33444444444444444444444444444444444444444


Q ss_pred             CC-cCCCc-hhHhhhcccccceeecCcC-cccCCCCCccccCCC-CcCEEEccCC--ccC-CCCCccccCCcCcceeecc
Q 001384          325 SN-NFGGE-VQKIFGRFTQVKILALHSN-SYIDGMNSSGILKLP-NISRLDLSHN--NFT-GPLPVEISQMRSLKFLILA  397 (1088)
Q Consensus       325 ~N-~l~~~-~~~~~~~l~~L~~L~L~~n-~~~~~~~~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~l~~l~~L~~L~L~  397 (1088)
                      +| .+++. .+..+..+++|+.|++++| .+.+...+..+..++ +|++|+|++|  .++ +.+|..+..+++|+.|+++
T Consensus       151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~  230 (336)
T 2ast_B          151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  230 (336)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCC
Confidence            44 34332 3334444444444444444 322111122344566 7777778777  444 3566677788889999999


Q ss_pred             ccc-cCCcCCcccCCCCCCcEEEccCCc-CCCCCCccccCCCCCcEEEccccccccCCCccccCC-CCCCeEEccCCcCc
Q 001384          398 HNR-FNGSIPAVYGNMPNLQTLDLSFNE-LTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNC-TSLLWLNLSNNKLS  474 (1088)
Q Consensus       398 ~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~  474 (1088)
                      +|. +++..+..+..+++|++|++++|. +.......++++++|++|++++| ++.   ..+..+ .+|..|++++|+++
T Consensus       231 ~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~  306 (336)
T 2ast_B          231 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFT  306 (336)
T ss_dssp             TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSC
T ss_pred             CCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCc
Confidence            888 776777788888999999999885 32222225778899999999988 432   234444 34777788999999


Q ss_pred             cCCCchhhc
Q 001384          475 GNIPPEVMT  483 (1088)
Q Consensus       475 g~ip~~~~~  483 (1088)
                      +..|..++.
T Consensus       307 ~~~~~~~~~  315 (336)
T 2ast_B          307 TIARPTIGN  315 (336)
T ss_dssp             CTTCSSCSS
T ss_pred             cccCCcccc
Confidence            888877654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.86  E-value=5.2e-23  Score=233.09  Aligned_cols=255  Identities=23%  Similarity=0.272  Sum_probs=200.2

Q ss_pred             CCcEEEccCccccccccccC--cccceecccCcccccccccccccCCCccCEEEcCCCccccc-CcccccCCCCCcEEEc
Q 001384          199 NLRYLDLSSNNFRGNIWNGL--AQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD-FPGEVSNCRNLVVLNL  275 (1088)
Q Consensus       199 ~L~~L~Ls~N~l~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~L  275 (1088)
                      .++.+++++|.+.+..+..+  ++++.|++++|.+++..+.  +..+++|++|+|++|.+++. +|..+..+++|++|+|
T Consensus        48 ~~~~l~l~~~~~~~~~~~~~~~~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L  125 (336)
T 2ast_B           48 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL  125 (336)
T ss_dssp             TSSEEECTTCBCCHHHHHHHHHTTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred             hheeeccccccCCHHHHHhhhhccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence            47889999998887666666  8889999999998876554  44678999999999988765 7888888999999999


Q ss_pred             cCccccCCCccccCCCCCCCEEeCCCC-cCCcc-CcccccCCCCCcEEEcCCC-cCCCc-hhHhhhccc-ccceeecCcC
Q 001384          276 FGNNFSGPIPAEIGSISGLEALFLGKN-NFLSV-IPESLLNLSKLEVLDLSSN-NFGGE-VQKIFGRFT-QVKILALHSN  350 (1088)
Q Consensus       276 ~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~n  350 (1088)
                      ++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|+.|++++|
T Consensus       126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            999988888888888999999999998 67653 6677888899999999999 88865 577788888 9999999988


Q ss_pred             c--ccCCCCCccccCCCCcCEEEccCCc-cCCCCCccccCCcCcceeeccccc-cCCcCCcccCCCCCCcEEEccCCcCC
Q 001384          351 S--YIDGMNSSGILKLPNISRLDLSHNN-FTGPLPVEISQMRSLKFLILAHNR-FNGSIPAVYGNMPNLQTLDLSFNELT  426 (1088)
Q Consensus       351 ~--~~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~  426 (1088)
                      .  +.+...+..+..+++|++|+|++|. +++..+..+..+++|++|++++|. ++......++++++|+.|++++| ++
T Consensus       206 ~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~  284 (336)
T 2ast_B          206 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP  284 (336)
T ss_dssp             GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC
T ss_pred             cccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC
Confidence            4  3323334455678899999999998 777778888889999999999985 33222235778899999999988 44


Q ss_pred             CCCCccccCC-CCCcEEEccccccccCCCccccC
Q 001384          427 GPIPPSIGNL-TSLLWLMLANNSLSGEIPGEIGN  459 (1088)
Q Consensus       427 ~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~  459 (1088)
                      .   ..+..+ .+|..|++++|++++..|..+++
T Consensus       285 ~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          285 D---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             T---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             H---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            2   233444 34777778999999888887765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.86  E-value=1.7e-23  Score=241.77  Aligned_cols=206  Identities=23%  Similarity=0.302  Sum_probs=139.5

Q ss_pred             cCCCCCcEEEccCccccC----CCccccCCCCCCCEEeCCCCcCCccCcccc----cCC---------CCCcEEEcCCCc
Q 001384          265 SNCRNLVVLNLFGNNFSG----PIPAEIGSISGLEALFLGKNNFLSVIPESL----LNL---------SKLEVLDLSSNN  327 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----~~l---------~~L~~L~L~~N~  327 (1088)
                      ..+++|++|+|++|.+++    .+|..+..+++|++|+|++|.++...+..+    ..+         ++|++|+|++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            455666666666666654    245555556666666666666543322222    222         566666666666


Q ss_pred             CC-Cchh---HhhhcccccceeecCcCcccCC----CCCccccCCCCcCEEEccCCccC----CCCCccccCCcCcceee
Q 001384          328 FG-GEVQ---KIFGRFTQVKILALHSNSYIDG----MNSSGILKLPNISRLDLSHNNFT----GPLPVEISQMRSLKFLI  395 (1088)
Q Consensus       328 l~-~~~~---~~~~~l~~L~~L~L~~n~~~~~----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~L~  395 (1088)
                      ++ +..+   ..+..+++|+.|++++|.+...    ..+..+..+++|+.|+|++|.++    +.+|..+..+++|++|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            65 2333   3455666666666666654321    11225667889999999999996    57788899999999999


Q ss_pred             ccccccCCc----CCccc--CCCCCCcEEEccCCcCCC----CCCccc-cCCCCCcEEEccccccccCCC--ccc-cCCC
Q 001384          396 LAHNRFNGS----IPAVY--GNMPNLQTLDLSFNELTG----PIPPSI-GNLTSLLWLMLANNSLSGEIP--GEI-GNCT  461 (1088)
Q Consensus       396 L~~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~p--~~l-~~l~  461 (1088)
                      |++|++++.    +|..+  +.+++|++|+|++|++++    .+|..+ .++++|++|+|++|.+++..|  ..+ ..++
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~  330 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFS  330 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHH
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhh
Confidence            999999865    56766  458999999999999997    488888 668999999999999997664  222 2244


Q ss_pred             CCCeEEccC
Q 001384          462 SLLWLNLSN  470 (1088)
Q Consensus       462 ~L~~L~L~~  470 (1088)
                      +++.+++..
T Consensus       331 ~~~~~~l~~  339 (386)
T 2ca6_A          331 TRGRGELDE  339 (386)
T ss_dssp             HHTCCEECC
T ss_pred             hcCcchhhh
Confidence            555555544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=7e-21  Score=205.66  Aligned_cols=178  Identities=21%  Similarity=0.285  Sum_probs=109.2

Q ss_pred             cEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcC
Q 001384          271 VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN  350 (1088)
Q Consensus       271 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  350 (1088)
                      ++++++++.++ .+|..+.  ++|+.|+|++|.+.+..+..|.++++|++|+|++|.+++..+..|              
T Consensus        17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--------------   79 (251)
T 3m19_A           17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF--------------   79 (251)
T ss_dssp             TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT--------------
T ss_pred             eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh--------------
Confidence            34444444444 3333332  344555555555554444445555555555555555544333322              


Q ss_pred             cccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC
Q 001384          351 SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP  430 (1088)
Q Consensus       351 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  430 (1088)
                                 ..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+
T Consensus        80 -----------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A           80 -----------DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             -----------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             -----------ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence                       234455555555555555555556666777777777777775555566777777888888887775555


Q ss_pred             ccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          431 PSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       431 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      ..++++++|++|+|++|++++..|..+..+++|++|+|++|++++.
T Consensus       149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            5677778888888888888766666777888888888888888754

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.85  E-value=3.9e-21  Score=214.22  Aligned_cols=213  Identities=21%  Similarity=0.341  Sum_probs=154.6

Q ss_pred             eecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCC
Q 001384          223 EFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN  302 (1088)
Q Consensus       223 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  302 (1088)
                      .+.+..+.+++.+.   +..+++|++|++++|.++. +| .+..+++|++|+|++|++++. +. +..+++|++|+|++|
T Consensus        23 ~~~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n   95 (308)
T 1h6u_A           23 KIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGN   95 (308)
T ss_dssp             HHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSC
T ss_pred             HHHhCCCCcCceec---HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCC
Confidence            33444444444332   2334577777888777763 44 577778888888888888744 33 777888888888888


Q ss_pred             cCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCC
Q 001384          303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP  382 (1088)
Q Consensus       303 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  382 (1088)
                      .+.+.  ..+..+++|++|+|++|++++..+                           +..+++|++|++++|.+++..+
T Consensus        96 ~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~---------------------------l~~l~~L~~L~l~~n~l~~~~~  146 (308)
T 1h6u_A           96 PLKNV--SAIAGLQSIKTLDLTSTQITDVTP---------------------------LAGLSNLQVLYLDLNQITNISP  146 (308)
T ss_dssp             CCSCC--GGGTTCTTCCEEECTTSCCCCCGG---------------------------GTTCTTCCEEECCSSCCCCCGG
T ss_pred             cCCCc--hhhcCCCCCCEEECCCCCCCCchh---------------------------hcCCCCCCEEECCCCccCcCcc
Confidence            77763  357777788888888887765321                           3456778888888888875433


Q ss_pred             ccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCC
Q 001384          383 VEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS  462 (1088)
Q Consensus       383 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  462 (1088)
                        +..+++|+.|++++|++++ ++. +..+++|+.|++++|++++ ++. +..+++|++|+|++|++++..  .+..+++
T Consensus       147 --l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~  218 (308)
T 1h6u_A          147 --LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVS--PLANTSN  218 (308)
T ss_dssp             --GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCG--GGTTCTT
T ss_pred             --ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCccCccc--cccCCCC
Confidence              7888889999999998884 444 8888999999999999985 443 788899999999999998544  3888999


Q ss_pred             CCeEEccCCcCccCCCch
Q 001384          463 LLWLNLSNNKLSGNIPPE  480 (1088)
Q Consensus       463 L~~L~L~~N~l~g~ip~~  480 (1088)
                      |++|+|++|+++ ..|..
T Consensus       219 L~~L~l~~N~i~-~~~~~  235 (308)
T 1h6u_A          219 LFIVTLTNQTIT-NQPVF  235 (308)
T ss_dssp             CCEEEEEEEEEE-CCCEE
T ss_pred             CCEEEccCCeee-cCCee
Confidence            999999999997 34543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=1.5e-21  Score=233.25  Aligned_cols=189  Identities=24%  Similarity=0.332  Sum_probs=157.0

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcc
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA  445 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  445 (1088)
                      +|+.|+|++|.+++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +++  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999986 777663  78999999999999 677   457899999999999996 777 665  89999999


Q ss_pred             ccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCCCcc
Q 001384          446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSF  525 (1088)
Q Consensus       446 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (1088)
                      +|+|++ +|.   .+++|++|+|++|+|++ +|..   +                                         
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~---l-----------------------------------------  159 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPEL---P-----------------------------------------  159 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCC---C-----------------------------------------
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCCc---C-----------------------------------------
Confidence            999996 776   68999999999999984 5541   0                                         


Q ss_pred             eeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCCCCc
Q 001384          526 VYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQ  605 (1088)
Q Consensus       526 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  605 (1088)
                                                          ..+++|+|++|+|++ +|. ++  ++|+.|+|++|+|+ .+|. 
T Consensus       160 ------------------------------------~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-  197 (571)
T 3cvr_A          160 ------------------------------------TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-  197 (571)
T ss_dssp             ------------------------------------TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-
T ss_pred             ------------------------------------CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-
Confidence                                                124578999999996 777 66  89999999999999 7777 


Q ss_pred             ccCccc-------eEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccc
Q 001384          606 FDQLPL-------IVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTE  658 (1088)
Q Consensus       606 ~~~l~l-------~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~  658 (1088)
                      +.. .|       +.|+|++|+|+ .||..++.+++|+.|+|++|+|++.+|..+..++.
T Consensus       198 ~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          198 VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            655 66       89999999999 79999988999999999999999999988888765

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.85  E-value=1.8e-20  Score=202.46  Aligned_cols=180  Identities=21%  Similarity=0.254  Sum_probs=150.1

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +.++++++++.++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            5678888888887 6666665  689999999999998888889999999999999999999888889999999999999


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|++++.++..|+                         .+++|++|+|++|++++..+..+..+++|++|+|++|++++.
T Consensus        92 ~n~l~~~~~~~~~-------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  146 (251)
T 3m19_A           92 NNQLASLPLGVFD-------------------------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI  146 (251)
T ss_dssp             TSCCCCCCTTTTT-------------------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCcccccChhHhc-------------------------ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence            9999876655443                         566778888888888866666678888888889988888866


Q ss_pred             CCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC
Q 001384          405 IPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       405 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      .+..|+.+++|++|+|++|++++..+..+..+++|++|+|++|.+++.
T Consensus       147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            666788888999999999999876666788888999999999988864

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.85  E-value=3.9e-21  Score=206.06  Aligned_cols=197  Identities=16%  Similarity=0.188  Sum_probs=113.1

Q ss_pred             CCcEEEccCccccCCCccccCCCCCCCEEeCCCCc-CCccCcccccCCCCCcEEEcCC-CcCCCchhHhhhcccccceee
Q 001384          269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN-FLSVIPESLLNLSKLEVLDLSS-NNFGGEVQKIFGRFTQVKILA  346 (1088)
Q Consensus       269 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  346 (1088)
                      +|++|++++|++++..+..|..+++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|+.|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            44444444444443333344444444444444443 4443333444444444444444 444444434444444444444


Q ss_pred             cCcCcccCCCCCccccCCCCcC---EEEccCC-ccCCCCCccccCCcCcc-eeeccccccCCcCCcccCCCCCCcEEEcc
Q 001384          347 LHSNSYIDGMNSSGILKLPNIS---RLDLSHN-NFTGPLPVEISQMRSLK-FLILAHNRFNGSIPAVYGNMPNLQTLDLS  421 (1088)
Q Consensus       347 L~~n~~~~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  421 (1088)
                      +++|.+.. ++ . +..+++|+   +|++++| .+++..+..|..+++|+ .|++++|+++ .+|......++|+.|+++
T Consensus       112 l~~n~l~~-lp-~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~  187 (239)
T 2xwt_C          112 IFNTGLKM-FP-D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN  187 (239)
T ss_dssp             EEEECCCS-CC-C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred             CCCCCCcc-cc-c-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence            43333222 11 1 34455555   7888888 77765556677788888 8888888887 555443334778888888


Q ss_pred             CCc-CCCCCCccccCC-CCCcEEEccccccccCCCccccCCCCCCeEEccCCc
Q 001384          422 FNE-LTGPIPPSIGNL-TSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK  472 (1088)
Q Consensus       422 ~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  472 (1088)
                      +|+ +++..+..+.++ ++|++|++++|+++ .+|..  .+++|+.|+++++.
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC-
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCcc
Confidence            884 775555667777 88888888888887 45544  56778888877653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=5.2e-21  Score=228.55  Aligned_cols=211  Identities=23%  Similarity=0.320  Sum_probs=140.9

Q ss_pred             cccccCCCCCCc-----ccCCc-eeCCCCceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCC
Q 001384           56 HYMQWNQSSSPC-----EWPGI-ICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSL  129 (1088)
Q Consensus        56 ~~~sW~~~~~~C-----~W~gv-~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L  129 (1088)
                      .+.+|..+.++|     .|.|+ .|..  .+++.|+|++++|++ +|..+  +++|++|+|++|+|+ .+|   ..+++|
T Consensus        32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L  102 (571)
T 3cvr_A           32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASL  102 (571)
T ss_dssp             HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred             HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCC
Confidence            456787777888     79999 7863  366777777777776 55544  266777777777777 555   345666


Q ss_pred             cEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCcc
Q 001384          130 KYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNN  209 (1088)
Q Consensus       130 ~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~  209 (1088)
                      ++|+|++|.|++...+.+  +                         |++|+|++|+|++. |.   .+++|++|+|++|+
T Consensus       103 ~~L~Ls~N~l~~ip~l~~--~-------------------------L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~  151 (571)
T 3cvr_A          103 EYLDACDNRLSTLPELPA--S-------------------------LKHLDVDNNQLTML-PE---LPALLEYINADNNQ  151 (571)
T ss_dssp             CEEECCSSCCSCCCCCCT--T-------------------------CCEEECCSSCCSCC-CC---CCTTCCEEECCSSC
T ss_pred             CEEEccCCCCCCcchhhc--C-------------------------CCEEECCCCcCCCC-CC---cCccccEEeCCCCc
Confidence            666666666554322222  4                         44445555555542 22   45666666666666


Q ss_pred             ccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccC
Q 001384          210 FRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIG  289 (1088)
Q Consensus       210 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  289 (1088)
                      +++ ++.                         .+++|++|+|++|++++ +|. +.  ++|++|+|++|+|+ .+|. +.
T Consensus       152 l~~-lp~-------------------------~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~  199 (571)
T 3cvr_A          152 LTM-LPE-------------------------LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VP  199 (571)
T ss_dssp             CSC-CCC-------------------------CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC
T ss_pred             cCc-CCC-------------------------cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HH
Confidence            653 111                         23466667777776665 555 54  77888888888887 5666 54


Q ss_pred             CCCCC-------CEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccc
Q 001384          290 SISGL-------EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQ  341 (1088)
Q Consensus       290 ~l~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  341 (1088)
                      .  +|       +.|+|++|+|+. +|..+.++++|+.|+|++|.+++.+|..+..++.
T Consensus       200 ~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          200 V--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             ----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             H--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            4  66       999999999886 7888888999999999999999999988876543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.84  E-value=5.9e-21  Score=204.70  Aligned_cols=197  Identities=19%  Similarity=0.213  Sum_probs=138.4

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCcc-ccCCCccccCCCCCCCEEeCCC-CcCCccCcccccCCCCCcEEE
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN-FSGPIPAEIGSISGLEALFLGK-NNFLSVIPESLLNLSKLEVLD  322 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~  322 (1088)
                      +|++|++++|++++..+..|.++++|++|++++|+ +++..+..|..+++|++|+|++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            56666666666665555566666666666666665 6544444566666666666666 666665556666666666666


Q ss_pred             cCCCcCCCchhHhhhcccccc---eeecCcCcccCCCCCccccCCCCcC-EEEccCCccCCCCCccccCCcCcceeeccc
Q 001384          323 LSSNNFGGEVQKIFGRFTQVK---ILALHSNSYIDGMNSSGILKLPNIS-RLDLSHNNFTGPLPVEISQMRSLKFLILAH  398 (1088)
Q Consensus       323 L~~N~l~~~~~~~~~~l~~L~---~L~L~~n~~~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  398 (1088)
                      +++|.+++.+ . |+.+++|+   .|++++|..+.......|..+++|+ .|++++|+++ .+|......++|+.|++++
T Consensus       112 l~~n~l~~lp-~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKMFP-D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCSCC-C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred             CCCCCCcccc-c-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence            6666666533 2 56666665   6666666334445555667788888 9999999988 5565544448999999999


Q ss_pred             cc-cCCcCCcccCCC-CCCcEEEccCCcCCCCCCccccCCCCCcEEEcccc
Q 001384          399 NR-FNGSIPAVYGNM-PNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN  447 (1088)
Q Consensus       399 N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  447 (1088)
                      |+ +++..+..|..+ ++|+.|++++|+++ .+|..  .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence            95 986667788899 99999999999999 56654  6789999999876

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=2e-21  Score=212.95  Aligned_cols=153  Identities=16%  Similarity=0.117  Sum_probs=120.2

Q ss_pred             HHHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc------------------cchHHHHHHHHHHhCC
Q 001384          797 YSDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL------------------EGEREFRAEMEVLSGN  858 (1088)
Q Consensus       797 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~~  858 (1088)
                      ...+......|++.+.||+|+||.||+|.+.+|+.||||+++....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444555677888899999999999999997799999999974321                  1235688999999974


Q ss_pred             CCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 001384          859 GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASN  938 (1088)
Q Consensus       859 ~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~N  938 (1088)
                          +  | +++.+++.. +..++||||++||+|.+ +..      .+...++.|++.||+|||+.   +|+||||||+|
T Consensus       162 ----~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 ----Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             ----T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             ----c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence                3  3 455554433 55699999999999988 422      33457999999999999999   99999999999


Q ss_pred             EEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccC
Q 001384          939 VLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ  982 (1088)
Q Consensus       939 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  982 (1088)
                      |+++ ++.+||+|||+|+..              ..+.|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~--------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV--------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET--------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC--------------CCCCHHHHHH
Confidence            9999 999999999999743              3467788653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.83  E-value=4.5e-20  Score=205.56  Aligned_cols=178  Identities=21%  Similarity=0.323  Sum_probs=140.6

Q ss_pred             cccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCC
Q 001384          239 VFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKL  318 (1088)
Q Consensus       239 ~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  318 (1088)
                      .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  +.+..+++|++|+|++|++++. + .+..+++|
T Consensus        58 ~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L  131 (308)
T 1h6u_A           58 GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNL  131 (308)
T ss_dssp             TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTC
T ss_pred             hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCC
Confidence            35667889999999999885444  89999999999999999853  3689999999999999999874 3 38999999


Q ss_pred             cEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccc
Q 001384          319 EVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAH  398 (1088)
Q Consensus       319 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  398 (1088)
                      ++|+|++|.+++..+  ++                         .+++|++|+|++|++++. +. +..+++|+.|++++
T Consensus       132 ~~L~l~~n~l~~~~~--l~-------------------------~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~  182 (308)
T 1h6u_A          132 QVLYLDLNQITNISP--LA-------------------------GLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADD  182 (308)
T ss_dssp             CEEECCSSCCCCCGG--GG-------------------------GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCS
T ss_pred             CEEECCCCccCcCcc--cc-------------------------CCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCC
Confidence            999999999986543  33                         456777777888877753 33 77888888888888


Q ss_pred             cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCcc
Q 001384          399 NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE  456 (1088)
Q Consensus       399 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  456 (1088)
                      |++++. +. +..+++|++|++++|++++ ++ .+..+++|++|+|++|.+++ .|..
T Consensus       183 n~l~~~-~~-l~~l~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~l~~N~i~~-~~~~  235 (308)
T 1h6u_A          183 NKISDI-SP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTNQTITN-QPVF  235 (308)
T ss_dssp             SCCCCC-GG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEEEEEEC-CCEE
T ss_pred             CccCcC-hh-hcCCCCCCEEEccCCccCc-cc-cccCCCCCCEEEccCCeeec-CCee
Confidence            888843 33 7788888888888888885 44 37888888888888888874 4443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.83  E-value=2.5e-20  Score=211.85  Aligned_cols=225  Identities=18%  Similarity=0.152  Sum_probs=167.3

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCcc-ccCCCCCCCE-EeCCCCcCCccCcccccCCCCCcEE
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPA-EIGSISGLEA-LFLGKNNFLSVIPESLLNLSKLEVL  321 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~L~~N~l~~~~p~~l~~l~~L~~L  321 (1088)
                      +++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|.++++|.+ +.++.|+++...|..|..+++|++|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            4677778888877765556778888888888888887655553 5677777665 5566678877777788888888888


Q ss_pred             EcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCC-CcCEEEccCCccCCCCCccccCCcCcceeeccc-c
Q 001384          322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLP-NISRLDLSHNNFTGPLPVEISQMRSLKFLILAH-N  399 (1088)
Q Consensus       322 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N  399 (1088)
                      ++++|++....+..+....++..|++.++..+..+....|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n  188 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN  188 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence            88888888777777777777777777666555555666666554 6889999999999 5666666678899999975 6


Q ss_pred             ccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcC
Q 001384          400 RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL  473 (1088)
Q Consensus       400 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  473 (1088)
                      .++...++.|..+++|++|||++|+|+ .+|..  .+.+|+.|.+.++.--..+| .+.++++|+.++++++.-
T Consensus       189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~  258 (350)
T 4ay9_X          189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH  258 (350)
T ss_dssp             TCCCCCTTTTTTEECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred             cccCCCHHHhccCcccchhhcCCCCcC-ccChh--hhccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence            777444457899999999999999999 56653  35667777665554334777 488999999999986653

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.82  E-value=3.2e-20  Score=210.97  Aligned_cols=241  Identities=20%  Similarity=0.201  Sum_probs=159.1

Q ss_pred             ceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCccc
Q 001384          152 EILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVL  231 (1088)
Q Consensus       152 ~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l  231 (1088)
                      +.++.++++++ .+|..++   .++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+                   
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-------------------   68 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-------------------   68 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-------------------
T ss_pred             CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-------------------
Confidence            34566666666 4454442   467777777777777777778888888888888777643                   


Q ss_pred             ccccccccccCCCccCE-EEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCC-CcCCccCc
Q 001384          232 SGVVSSSVFKENCSLEI-FDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK-NNFLSVIP  309 (1088)
Q Consensus       232 ~~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p  309 (1088)
                        .++...|.+++++++ +.++.|+++...|..|.++++|++|++++|++++..+..+....++..|++.+ |++....+
T Consensus        69 --~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~  146 (350)
T 4ay9_X           69 --VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER  146 (350)
T ss_dssp             --EECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT
T ss_pred             --ccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc
Confidence              345566777777664 56667888877788888899999999999988866666666777788888855 56666555


Q ss_pred             ccccCCC-CCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccC-CccCCCCCccccC
Q 001384          310 ESLLNLS-KLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSH-NNFTGPLPVEISQ  387 (1088)
Q Consensus       310 ~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~  387 (1088)
                      ..|..+. .++.|+|++|+|+...+..|.                          ..+|++|++++ |.++...+..|..
T Consensus       147 ~~f~~~~~~l~~L~L~~N~i~~i~~~~f~--------------------------~~~L~~l~l~~~n~l~~i~~~~f~~  200 (350)
T 4ay9_X          147 NSFVGLSFESVILWLNKNGIQEIHNSAFN--------------------------GTQLDELNLSDNNNLEELPNDVFHG  200 (350)
T ss_dssp             TSSTTSBSSCEEEECCSSCCCEECTTSST--------------------------TEEEEEEECTTCTTCCCCCTTTTTT
T ss_pred             cchhhcchhhhhhccccccccCCChhhcc--------------------------ccchhHHhhccCCcccCCCHHHhcc
Confidence            6666664 588888888888765554442                          23456666653 4444332345667


Q ss_pred             CcCcceeeccccccCCcCCcccCCCCCCcEEEccCCc-CCCCCCccccCCCCCcEEEccccc
Q 001384          388 MRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE-LTGPIPPSIGNLTSLLWLMLANNS  448 (1088)
Q Consensus       388 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~  448 (1088)
                      +++|+.|+|++|+|+ .+|..  .+.+|+.|.+.++. ++ .+| .+.++++|+.+++.++.
T Consensus       201 l~~L~~LdLs~N~l~-~lp~~--~~~~L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          201 ASGPVILDISRTRIH-SLPSY--GLENLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             EECCSEEECTTSCCC-CCCSS--SCTTCCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             CcccchhhcCCCCcC-ccChh--hhccchHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence            777777777777777 44432  23444455444433 33 566 36677777777776654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=8e-20  Score=191.30  Aligned_cols=181  Identities=20%  Similarity=0.243  Sum_probs=98.4

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      +.++.+++.++ .+|..+  .++|++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            34555555554 334333  246666666666666544445566666666666666666554445555666666666666


Q ss_pred             cCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCC
Q 001384          327 NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP  406 (1088)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  406 (1088)
                      ++++.++..|                         ..+++|++|+|++|++++..+..+..+++|++|++++|++++..+
T Consensus        87 ~l~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A           87 QLQSLPNGVF-------------------------DKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             CCCCCCTTTT-------------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             cCCccCHhHh-------------------------cCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence            5554333222                         234455555555555554444445555556666666655554444


Q ss_pred             cccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCC
Q 001384          407 AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTS  462 (1088)
Q Consensus       407 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  462 (1088)
                      ..+..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..+++++.
T Consensus       142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            445555556666666555542       2334555555555555555555554443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.81  E-value=1.7e-19  Score=188.75  Aligned_cols=181  Identities=22%  Similarity=0.280  Sum_probs=149.1

Q ss_pred             cEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcC
Q 001384          271 VVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN  350 (1088)
Q Consensus       271 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  350 (1088)
                      +.++.+++.++ .+|..+  .++|++|+|++|++++..+..+..+++|++|+|++|++++..+..               
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------   71 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV---------------   71 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT---------------
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh---------------
Confidence            56777888777 455444  357888888888888766667778888888888888877554433               


Q ss_pred             cccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC
Q 001384          351 SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP  430 (1088)
Q Consensus       351 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  430 (1088)
                                +..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+
T Consensus        72 ----------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A           72 ----------FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             ----------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             ----------cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence                      4467889999999999997767778999999999999999997777778999999999999999997666


Q ss_pred             ccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCC
Q 001384          431 PSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGR  486 (1088)
Q Consensus       431 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~  486 (1088)
                      ..+..+++|++|+|++|.+.+       .+++|++|+++.|+++|.+|+.++.+..
T Consensus       142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            678999999999999998874       4568999999999999999998876543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.76  E-value=1.5e-18  Score=209.83  Aligned_cols=171  Identities=23%  Similarity=0.335  Sum_probs=95.3

Q ss_pred             CCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEE
Q 001384          242 ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL  321 (1088)
Q Consensus       242 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  321 (1088)
                      .+.+|+.|++++|.+.. +| .+..+++|+.|+|++|++++..+  +..+++|+.|+|++|.+.+.  ..+..+++|+.|
T Consensus        41 ~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L  114 (605)
T 1m9s_A           41 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSL  114 (605)
T ss_dssp             HHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEE
T ss_pred             cCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEE
Confidence            34456666666666553 23 35666666666666666664433  66666666666666666552  256666666777


Q ss_pred             EcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecccccc
Q 001384          322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRF  401 (1088)
Q Consensus       322 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l  401 (1088)
                      +|++|.+++.  ..+..+++|+.|+|++|.+...   ..+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|+|
T Consensus       115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l---~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC---GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EecCCCCCCC--ccccCCCccCEEECCCCccCCc---hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            7766666643  2244444444444444433221   234455556666666666654433  55556666666666666


Q ss_pred             CCcCCcccCCCCCCcEEEccCCcCCC
Q 001384          402 NGSIPAVYGNMPNLQTLDLSFNELTG  427 (1088)
Q Consensus       402 ~~~~p~~~~~l~~L~~L~L~~N~l~~  427 (1088)
                      ++ +| .+..+++|+.|+|++|++++
T Consensus       188 ~~-l~-~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          188 SD-LR-ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CB-CG-GGTTCTTCSEEECCSEEEEC
T ss_pred             CC-Ch-HHccCCCCCEEEccCCcCcC
Confidence            53 22 35556666666666666553

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.7e-19  Score=223.91  Aligned_cols=82  Identities=16%  Similarity=0.239  Sum_probs=22.9

Q ss_pred             cccCCCccEEeccccccccCCCCcccCcc--ceEEEccCCcccccCCccccCCccCcEEEcccc--------ccCCcCCc
Q 001384          582 IGKLQNFSMVHLGFNQFDGKLPSQFDQLP--LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN--------NFSGPFPA  651 (1088)
Q Consensus       582 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N--------~l~g~~p~  651 (1088)
                      |+++++|+.|+|++|.|+|.+|..++.+.  ...++|++|.++|.+|.++      +.|++++|        .|.+.++.
T Consensus       312 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l~~n~~~~~~~~~l~~~~~~  385 (727)
T 4b8c_D          312 FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEINTDGEPQREYDSLQQSTEH  385 (727)
T ss_dssp             TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------------
T ss_pred             hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------ceeEeecccccccccCCccccccc
Confidence            34444444444444444444444443331  2234555555555555432      33344444        44445555


Q ss_pred             ccccccccceeeccCCCC
Q 001384          652 SFNNLTELSKLNISYNPL  669 (1088)
Q Consensus       652 ~~~~l~~L~~l~l~~N~l  669 (1088)
                      .+.++.++....+++|-+
T Consensus       386 ~~~~l~~~~~~~ls~Nil  403 (727)
T 4b8c_D          386 LATDLAKRTFTVLSYNTL  403 (727)
T ss_dssp             ----------------CC
T ss_pred             hhhcccccceeeeecccc
Confidence            666777777788888877

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.76  E-value=3.2e-18  Score=188.86  Aligned_cols=189  Identities=24%  Similarity=0.355  Sum_probs=99.5

Q ss_pred             ccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeC
Q 001384          220 QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL  299 (1088)
Q Consensus       220 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  299 (1088)
                      ++..+.+..+.+++...   +..+++|+.|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|+.|+|
T Consensus        25 ~~~~~~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC---HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHhcCCCcccccc---hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            34444555555544322   22344556666666655432 2 25555556666666655553322  555555555555


Q ss_pred             CCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCC
Q 001384          300 GKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG  379 (1088)
Q Consensus       300 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  379 (1088)
                      ++|.+++.  ..+..+++|++|+|++|++++.                           ..+..+++|+.|++++|++++
T Consensus        98 ~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~---------------------------~~l~~l~~L~~L~l~~n~l~~  148 (291)
T 1h6t_A           98 DENKVKDL--SSLKDLKKLKSLSLEHNGISDI---------------------------NGLVHLPQLESLYLGNNKITD  148 (291)
T ss_dssp             CSSCCCCG--GGGTTCTTCCEEECTTSCCCCC---------------------------GGGGGCTTCCEEECCSSCCCC
T ss_pred             CCCcCCCC--hhhccCCCCCEEECCCCcCCCC---------------------------hhhcCCCCCCEEEccCCcCCc
Confidence            55555442  2255555555555555555432                           122344556666666666654


Q ss_pred             CCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccc
Q 001384          380 PLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS  450 (1088)
Q Consensus       380 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  450 (1088)
                      .  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++ +| .+..+++|+.|++++|+++
T Consensus       149 ~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          149 I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             c--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence            3  355556666666666666654333  5566666666666666653 33 2555666666666666655

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.76  E-value=1.2e-18  Score=210.74  Aligned_cols=192  Identities=21%  Similarity=0.255  Sum_probs=116.7

Q ss_pred             eEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccccc
Q 001384           81 VNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNR  160 (1088)
Q Consensus        81 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~  160 (1088)
                      +..++|..+.+.+.++  +..|++|+.|+|++|.++. +| .++.+++|++|+|++|.+++...+..+++|++|+|++|.
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~   98 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENK   98 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChhhccCCCCCEEECcCCC
Confidence            3444555555554432  4566666667777666653 33 466666666666666666655555555666666655555


Q ss_pred             ccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccc
Q 001384          161 IHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVF  240 (1088)
Q Consensus       161 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  240 (1088)
                      |+                         +.  ..+..+++|++|+|++|++++.                        ..+
T Consensus        99 l~-------------------------~l--~~l~~l~~L~~L~Ls~N~l~~l------------------------~~l  127 (605)
T 1m9s_A           99 IK-------------------------DL--SSLKDLKKLKSLSLEHNGISDI------------------------NGL  127 (605)
T ss_dssp             CC-------------------------CC--TTSTTCTTCCEEECTTSCCCCC------------------------GGG
T ss_pred             CC-------------------------CC--hhhccCCCCCEEEecCCCCCCC------------------------ccc
Confidence            54                         21  1356666777777776665530                        123


Q ss_pred             cCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcE
Q 001384          241 KENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV  320 (1088)
Q Consensus       241 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  320 (1088)
                      ..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|++.+.  ..+..+++|+.
T Consensus       128 ~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~  201 (605)
T 1m9s_A          128 VHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDV  201 (605)
T ss_dssp             GGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSE
T ss_pred             cCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCE
Confidence            4455666666666666643  456677777777777777775544  66777777777777777663  34667777777


Q ss_pred             EEcCCCcCCCchh
Q 001384          321 LDLSSNNFGGEVQ  333 (1088)
Q Consensus       321 L~L~~N~l~~~~~  333 (1088)
                      |+|++|.+.+.+.
T Consensus       202 L~L~~N~l~~~p~  214 (605)
T 1m9s_A          202 LELFSQECLNKPI  214 (605)
T ss_dssp             EECCSEEEECCCC
T ss_pred             EEccCCcCcCCcc
Confidence            7777777665433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.75  E-value=2.3e-18  Score=189.98  Aligned_cols=191  Identities=20%  Similarity=0.282  Sum_probs=159.0

Q ss_pred             CCCCcEEEccCcccccc-ccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEc
Q 001384          197 CLNLRYLDLSSNNFRGN-IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNL  275 (1088)
Q Consensus       197 l~~L~~L~Ls~N~l~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  275 (1088)
                      +.++..+.+..+.+++. ....+++|+.|++++|.+++.   ..+..+++|++|+|++|++++..+  +.++++|++|++
T Consensus        23 l~~~~~~~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~---~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV---QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCCCC---TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHHHhcCCCcccccchhhcCcccEEEccCCCcccC---hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            44455666777777663 245789999999999999865   247889999999999999986544  999999999999


Q ss_pred             cCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCC
Q 001384          276 FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDG  355 (1088)
Q Consensus       276 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~  355 (1088)
                      ++|++++ ++ .+..+++|++|+|++|++++.  ..+..+++|++|++++|++++.  ..                    
T Consensus        98 ~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~--------------------  151 (291)
T 1h6t_A           98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV--------------------  151 (291)
T ss_dssp             CSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG--------------------
T ss_pred             CCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh--------------------
Confidence            9999985 33 499999999999999999885  5788999999999999999864  22                    


Q ss_pred             CCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCC
Q 001384          356 MNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG  427 (1088)
Q Consensus       356 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  427 (1088)
                           +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++ +|. +..+++|+.|++++|+++.
T Consensus       152 -----l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          152 -----LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             -----GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEEC
T ss_pred             -----hccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccC
Confidence                 3456788889999999986544  8889999999999999984 554 8899999999999999984

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=3.7e-19  Score=220.76  Aligned_cols=209  Identities=22%  Similarity=0.231  Sum_probs=101.7

Q ss_pred             CchhhHHHHHHHHhhcccCCCCCcccccccCC-CCCCcccCCceeCCCCceeEEeccccccccccccccccCCccCCeee
Q 001384           31 SLETDREVLSNLRSFLENNNPVNEGHYMQWNQ-SSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLD  109 (1088)
Q Consensus        31 ~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~-~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~  109 (1088)
                      ....++++|.++........   +..-..|.. .+.++.|.+++++.  .+++.|+|.++++... +     ...|+.++
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~-----~~~l~~l~  197 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSK---TAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-N-----QALLQHKK  197 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHH---TTC------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhccccc---CcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-h-----hhHhhcCc
Confidence            34678899999988764321   223345643 34567899888863  5677777766665542 1     12233444


Q ss_pred             CCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCC
Q 001384          110 LSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR  189 (1088)
Q Consensus       110 Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~  189 (1088)
                      |+.|.|++                                    ++++.|.+                         . .
T Consensus       198 Ls~~~i~~------------------------------------~~~~~n~~-------------------------~-~  215 (727)
T 4b8c_D          198 LSQYSIDE------------------------------------DDDIENRM-------------------------V-M  215 (727)
T ss_dssp             --------------------------------------------------------------------------------
T ss_pred             cCcccccC------------------------------------ccccccce-------------------------e-c
Confidence            44444431                                    11222222                         1 3


Q ss_pred             CCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCC
Q 001384          190 IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRN  269 (1088)
Q Consensus       190 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~  269 (1088)
                      .+..+..+++|+.|+|++|++. .                     ++...| .+++|++|+|++|.++ .+|..|.++++
T Consensus       216 ~~~~~~~l~~L~~L~Ls~n~l~-~---------------------l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~  271 (727)
T 4b8c_D          216 PKDSKYDDQLWHALDLSNLQIF-N---------------------ISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSN  271 (727)
T ss_dssp             ------CCCCCCEEECTTSCCS-C---------------------CCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTT
T ss_pred             ChhhhccCCCCcEEECCCCCCC-C---------------------CChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCC
Confidence            3444556666666666666654 1                     111122 3456777777777777 77888888888


Q ss_pred             CcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhc
Q 001384          270 LVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGR  338 (1088)
Q Consensus       270 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  338 (1088)
                      |++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|++.+|..+..
T Consensus       272 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  338 (727)
T 4b8c_D          272 LRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE  338 (727)
T ss_dssp             CCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred             CCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence            888999888888 77888888888999999888886 46778888888999999999888888887754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.74  E-value=6.5e-18  Score=178.11  Aligned_cols=157  Identities=24%  Similarity=0.269  Sum_probs=134.5

Q ss_pred             CEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccC
Q 001384          295 EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSH  374 (1088)
Q Consensus       295 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~  374 (1088)
                      +.+++++|.++. +|..+.  ..+++|+|++|++++..+                        ...|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~------------------------~~~~~~l~~L~~L~L~~   66 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEA------------------------TGIFKKLPQLRKINFSN   66 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECC------------------------CCCGGGCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCc------------------------hhhhccCCCCCEEECCC
Confidence            578888888876 566554  356788888888876533                        22345678899999999


Q ss_pred             CccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCC
Q 001384          375 NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIP  454 (1088)
Q Consensus       375 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  454 (1088)
                      |++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..+.++++|++|+|++|++++..|
T Consensus        67 N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  146 (220)
T 2v70_A           67 NKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP  146 (220)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred             CcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence            99997777789999999999999999998888889999999999999999998889999999999999999999998889


Q ss_pred             ccccCCCCCCeEEccCCcCccCCC
Q 001384          455 GEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       455 ~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      ..|..+++|+.|+|++|++++..+
T Consensus       147 ~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          147 GAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTTTTCTTCCEEECCSCCEECSGG
T ss_pred             HHhcCCCCCCEEEecCcCCcCCCc
Confidence            999999999999999999997655

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.74  E-value=4.5e-18  Score=194.04  Aligned_cols=175  Identities=26%  Similarity=0.303  Sum_probs=110.0

Q ss_pred             EEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCccccc-CCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcC
Q 001384          272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL-NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSN  350 (1088)
Q Consensus       272 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  350 (1088)
                      .+++++|+++ .+|..+.  ..++.|+|++|++++..+..+. ++++|++|+|++|+|++..+..|              
T Consensus        22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~--------------   84 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF--------------   84 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT--------------
T ss_pred             EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc--------------
Confidence            4444444444 3333332  2345555555555554444454 55555666666555554433332              


Q ss_pred             cccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC
Q 001384          351 SYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP  430 (1088)
Q Consensus       351 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  430 (1088)
                                 ..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++ +|
T Consensus        85 -----------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~  152 (361)
T 2xot_A           85 -----------VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FP  152 (361)
T ss_dssp             -----------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CC
T ss_pred             -----------cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eC
Confidence                       234455556666666654445566677777777777777776667777888888888888888884 55


Q ss_pred             ccc----cCCCCCcEEEccccccccCCCccccCCCC--CCeEEccCCcCcc
Q 001384          431 PSI----GNLTSLLWLMLANNSLSGEIPGEIGNCTS--LLWLNLSNNKLSG  475 (1088)
Q Consensus       431 ~~~----~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~N~l~g  475 (1088)
                      ..+    ..+++|++|+|++|+|++..+..+..++.  |+.|+|++|++.+
T Consensus       153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            443    56888888888888888554566777776  4889999999985

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.74  E-value=1.5e-17  Score=175.38  Aligned_cols=113  Identities=23%  Similarity=0.291  Sum_probs=84.2

Q ss_pred             CCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEE
Q 001384          363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL  442 (1088)
Q Consensus       363 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  442 (1088)
                      .+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..+.++++|++|
T Consensus        54 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  133 (220)
T 2v9t_B           54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL  133 (220)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence            44555566666666665556667777777777777777775555556778888888888888887777778888888888


Q ss_pred             EccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       443 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      +|++|++++..+..+..+++|++|+|++|++.+
T Consensus       134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            888888886666678888888888888888875

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.73  E-value=4.4e-20  Score=221.92  Aligned_cols=217  Identities=16%  Similarity=0.138  Sum_probs=140.0

Q ss_pred             CCCCCCcEEECccccccCcc-cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcE
Q 001384          124 SSCRSLKYLNLSHNILSGDL-NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRY  202 (1088)
Q Consensus       124 ~~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  202 (1088)
                      ..+++|+.|+|++|.++... .+++|++|++|++++|......+.            .+..+++.+.+|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~------------ll~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIIL------------LMRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHH------------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHH------------HHHhcccccCCHHHHHHHHhccc
Confidence            45666666666666665432 366666677777655542111110            01122345566777778888888


Q ss_pred             EE-ccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCcccc
Q 001384          203 LD-LSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFS  281 (1088)
Q Consensus       203 L~-Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  281 (1088)
                      |+ ++.|.+        ..|+.+.+++|.++....       ..|+.|+|++|++++ +|. ++++++|+.|+|++|+|+
T Consensus       414 L~~l~~n~~--------~~L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~  476 (567)
T 1dce_A          414 VDPMRAAYL--------DDLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR  476 (567)
T ss_dssp             HCGGGHHHH--------HHHHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC
T ss_pred             Ccchhhccc--------chhhhhhhhcccccccCc-------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc
Confidence            87 666654        245556666666654322       147777777777774 555 777777777777777777


Q ss_pred             CCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCch-hHhhhcccccceeecCcCcccCCCCC--
Q 001384          282 GPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEV-QKIFGRFTQVKILALHSNSYIDGMNS--  358 (1088)
Q Consensus       282 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~~~~~~~~--  358 (1088)
                       .+|..|+.+++|+.|+|++|++++ +| .++++++|++|+|++|+|++.. |..|+.+++|+.|++++|.+......  
T Consensus       477 -~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  553 (567)
T 1dce_A          477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE  553 (567)
T ss_dssp             -CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred             -ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence             667777777777777777777776 45 6777777777777777777776 77777777777777777776543321  


Q ss_pred             ccccCCCCcCEEEc
Q 001384          359 SGILKLPNISRLDL  372 (1088)
Q Consensus       359 ~~~~~l~~L~~L~L  372 (1088)
                      ..+..+++|+.|++
T Consensus       554 ~l~~~lp~L~~L~l  567 (567)
T 1dce_A          554 RLAEMLPSVSSILT  567 (567)
T ss_dssp             HHHHHCTTCSEEEC
T ss_pred             HHHHHCcccCccCC
Confidence            12334788888864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.73  E-value=2.4e-17  Score=173.78  Aligned_cols=134  Identities=22%  Similarity=0.249  Sum_probs=81.1

Q ss_pred             CCEEeCCCCcCCccCc-ccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEc
Q 001384          294 LEALFLGKNNFLSVIP-ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL  372 (1088)
Q Consensus       294 L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L  372 (1088)
                      ++.|+|++|++++..| ..|..+++|++|+|++|+|++..+..|                         .++++|++|+|
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~-------------------------~~l~~L~~L~L   88 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF-------------------------EGASGVNEILL   88 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTT-------------------------TTCTTCCEEEC
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHh-------------------------CCCCCCCEEEC
Confidence            3455555555544432 234555555555555555554433322                         23445555555


Q ss_pred             cCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccC
Q 001384          373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGE  452 (1088)
Q Consensus       373 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  452 (1088)
                      ++|++++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+++|++|+|++|.+.+.
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            66666555555566666677777777777666666677777777777777777766666777777777777777777653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.73  E-value=3.7e-17  Score=173.54  Aligned_cols=115  Identities=26%  Similarity=0.278  Sum_probs=86.3

Q ss_pred             CCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEE
Q 001384          363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL  442 (1088)
Q Consensus       363 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  442 (1088)
                      .+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|
T Consensus        62 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L  140 (229)
T 3e6j_A           62 SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL  140 (229)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred             CccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence            3445555555555555444455667777777777777777666666778888888888888888 788888888888888


Q ss_pred             EccccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       443 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      +|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus       141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            888888886556678888899999999998886544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.72  E-value=3.2e-17  Score=172.72  Aligned_cols=86  Identities=23%  Similarity=0.245  Sum_probs=47.2

Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      ++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|++|+|
T Consensus        80 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  159 (220)
T 2v9t_B           80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL  159 (220)
T ss_dssp             SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEe
Confidence            34444444444444333333455555555555555555555555666666666666666666544445566666666666


Q ss_pred             cccccc
Q 001384          445 ANNSLS  450 (1088)
Q Consensus       445 ~~N~l~  450 (1088)
                      ++|.+.
T Consensus       160 ~~N~~~  165 (220)
T 2v9t_B          160 AQNPFI  165 (220)
T ss_dssp             CSSCEE
T ss_pred             CCCCcC
Confidence            666665

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.72  E-value=1.2e-17  Score=190.61  Aligned_cols=178  Identities=25%  Similarity=0.284  Sum_probs=138.1

Q ss_pred             cCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccC-CCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIG-SISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       246 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      -+.+++++++++ .+|..+.  +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            357888888877 4666554  4588999999999877777777 89999999999999998888889999999999999


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCc
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGS  404 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  404 (1088)
                      +|+|++..+..|.                         .+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.
T Consensus        97 ~N~l~~~~~~~~~-------------------------~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l  151 (361)
T 2xot_A           97 SNHLHTLDEFLFS-------------------------DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRF  151 (361)
T ss_dssp             SSCCCEECTTTTT-------------------------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSC
T ss_pred             CCcCCcCCHHHhC-------------------------CCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCee
Confidence            9998866555443                         556777777777777766677888888888888888888853


Q ss_pred             CCccc---CCCCCCcEEEccCCcCCCCCCccccCCCC--CcEEEcccccccc
Q 001384          405 IPAVY---GNMPNLQTLDLSFNELTGPIPPSIGNLTS--LLWLMLANNSLSG  451 (1088)
Q Consensus       405 ~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~  451 (1088)
                      .+..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|.+..
T Consensus       152 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             CHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            33444   56888999999999998544466777776  4889999998873

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.71  E-value=7e-17  Score=171.39  Aligned_cols=87  Identities=24%  Similarity=0.302  Sum_probs=48.0

Q ss_pred             CCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEE
Q 001384          364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM  443 (1088)
Q Consensus       364 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  443 (1088)
                      +++|+.|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|++|+
T Consensus        87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  165 (229)
T 3e6j_A           87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAY  165 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEE
Confidence            344444444444444433444455555555555555555 4555555566666666666666644444455666666666


Q ss_pred             cccccccc
Q 001384          444 LANNSLSG  451 (1088)
Q Consensus       444 L~~N~l~~  451 (1088)
                      |++|.+.+
T Consensus       166 l~~N~~~c  173 (229)
T 3e6j_A          166 LFGNPWDC  173 (229)
T ss_dssp             CTTSCBCT
T ss_pred             eeCCCccC
Confidence            66666654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=1.2e-17  Score=180.60  Aligned_cols=137  Identities=21%  Similarity=0.206  Sum_probs=105.1

Q ss_pred             CCCccceecccCceEEEEEEe-CCCcE--EEEEEccccCcc------------------------chHHHHHHHHHHhCC
Q 001384          806 KFSEDRIIGKGGFGTVYRGVL-PDGRE--VAVKKLQREGLE------------------------GEREFRAEMEVLSGN  858 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~~  858 (1088)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|++.+.+ 
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-  126 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER-  126 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH-
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH-
Confidence            367789999999999999998 67888  999987543211                        01257788888876 


Q ss_pred             CCCCCCCce--eEEeeEEecCCeEEEEEEecCC-C----CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 001384          859 GFGWPHPNL--VTLYGWCLDGSEKILVYEYMEG-G----SLEDIISDRTRLTWRRRLDIAIDVARALVFLH-HECYPPIV  930 (1088)
Q Consensus       859 ~~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iv  930 (1088)
                         +.|+++  ..++++    ...++||||+.+ |    +|.++...   .++.++..++.|++.||+||| +.   +|+
T Consensus       127 ---l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---giv  193 (258)
T 1zth_A          127 ---AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELV  193 (258)
T ss_dssp             ---HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred             ---HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence               345432  333332    356899999942 4    77776543   245677899999999999999 87   999


Q ss_pred             ecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          931 HRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       931 H~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ||||||+|||++.  .++|+|||+|...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999988  9999999999765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.69  E-value=3.8e-17  Score=169.20  Aligned_cols=154  Identities=20%  Similarity=0.285  Sum_probs=124.9

Q ss_pred             CCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcC
Q 001384          289 GSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNIS  368 (1088)
Q Consensus       289 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~  368 (1088)
                      +.+++|+.|++++|.+.. +| .+..+++|++|++++|.++..                           ..+..+++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~---------------------------~~l~~l~~L~   91 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNY---------------------------NPISGLSNLE   91 (197)
T ss_dssp             HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCC---------------------------GGGTTCTTCC
T ss_pred             hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcc---------------------------hhhhcCCCCC
Confidence            556677777777777764 34 577777777777777755422                           2355788999


Q ss_pred             EEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCc-CCCCCCccccCCCCCcEEEcccc
Q 001384          369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE-LTGPIPPSIGNLTSLLWLMLANN  447 (1088)
Q Consensus       369 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N  447 (1088)
                      +|++++|++++..|..++.+++|++|++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|++|++++|
T Consensus        92 ~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A           92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFD  169 (197)
T ss_dssp             EEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTB
T ss_pred             EEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCC
Confidence            99999999998788899999999999999999998888999999999999999998 66 566 6899999999999999


Q ss_pred             ccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          448 SLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       448 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ++++ ++ .+..+++|++|++++|++.+
T Consensus       170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            9985 55 78999999999999999864

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.69  E-value=6.1e-19  Score=212.00  Aligned_cols=190  Identities=25%  Similarity=0.319  Sum_probs=130.5

Q ss_pred             cCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCc-------------CCccCcccccCCCCCcEEE-cCCCcCCC
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN-------------FLSVIPESLLNLSKLEVLD-LSSNNFGG  330 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~  330 (1088)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+.+|..++++++|+.|+ ++.|.+  
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence            34455555555555555 455555555555555554443             2333444444444444444 333322  


Q ss_pred             chhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccC
Q 001384          331 EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYG  410 (1088)
Q Consensus       331 ~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  410 (1088)
                               ..|+.+.+..|.+..      + ....|+.|+|++|.+++ +|. ++.+++|+.|+|++|+|+ .+|..++
T Consensus       423 ---------~~L~~l~l~~n~i~~------l-~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~  483 (567)
T 1dce_A          423 ---------DDLRSKFLLENSVLK------M-EYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA  483 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHH------H-HHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred             ---------chhhhhhhhcccccc------c-CccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence                     112222222332211      0 01258899999999985 676 899999999999999999 8898999


Q ss_pred             CCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCC-CccccCCCCCCeEEccCCcCccCCC
Q 001384          411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEI-PGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       411 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      .+++|+.|+|++|+|++ +| .++++++|++|+|++|+|++.. |..++.+++|+.|+|++|++++..|
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            99999999999999995 77 8899999999999999999766 8999999999999999999986544

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.68  E-value=2.1e-17  Score=179.25  Aligned_cols=80  Identities=25%  Similarity=0.385  Sum_probs=38.7

Q ss_pred             cCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEc
Q 001384          389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNL  468 (1088)
Q Consensus       389 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  468 (1088)
                      ++|+.|++++|++++ ++ .+..+++|+.|++++|++++ +| .++.+++|++|+|++|++++.  ..+..+++|+.|++
T Consensus       106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l  179 (263)
T 1xeu_A          106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL  179 (263)
T ss_dssp             SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred             CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence            444444444444442 22 24445555555555555543 22 344555555555555555532  34455555555555


Q ss_pred             cCCcCc
Q 001384          469 SNNKLS  474 (1088)
Q Consensus       469 ~~N~l~  474 (1088)
                      ++|+++
T Consensus       180 ~~N~~~  185 (263)
T 1xeu_A          180 TGQKCV  185 (263)
T ss_dssp             EEEEEE
T ss_pred             CCCccc
Confidence            555554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.67  E-value=1.5e-16  Score=164.76  Aligned_cols=152  Identities=19%  Similarity=0.230  Sum_probs=103.4

Q ss_pred             CCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEE
Q 001384          242 ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL  321 (1088)
Q Consensus       242 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  321 (1088)
                      .+++|++|++++|+++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|.+++..|..++.+++|++|
T Consensus        42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            3457788888888877 555 5778888888888888665  23477888888888888888887777888888888888


Q ss_pred             EcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCc-cCCCCCccccCCcCcceeeccccc
Q 001384          322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNN-FTGPLPVEISQMRSLKFLILAHNR  400 (1088)
Q Consensus       322 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~  400 (1088)
                      +|++|.+++..+..++.++                         +|++|+|++|. ++ .+| .+..+++|+.|++++|+
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~-------------------------~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLP-------------------------KVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCS-------------------------SCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred             EecCCccCcHhHHHHhhCC-------------------------CCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence            8888888877676666444                         44555555554 33 333 45556666666666666


Q ss_pred             cCCcCCcccCCCCCCcEEEccCCcCC
Q 001384          401 FNGSIPAVYGNMPNLQTLDLSFNELT  426 (1088)
Q Consensus       401 l~~~~p~~~~~l~~L~~L~L~~N~l~  426 (1088)
                      +++ ++ .+..+++|+.|++++|++.
T Consensus       171 i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             CcC-hH-HhccCCCCCEEEeeCcccC
Confidence            653 33 4556666666666666654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.67  E-value=5.9e-17  Score=175.77  Aligned_cols=170  Identities=19%  Similarity=0.259  Sum_probs=117.4

Q ss_pred             CcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEE
Q 001384          218 LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEAL  297 (1088)
Q Consensus       218 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  297 (1088)
                      +.++..+++++|.+++..   .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+  +..+++|+.|
T Consensus        18 l~~l~~l~l~~~~i~~~~---~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV---SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE---CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHhcCCCccccc---chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            344555555555555433   3555667778888888776 344 57777888888888888875433  7778888888


Q ss_pred             eCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCcc
Q 001384          298 FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF  377 (1088)
Q Consensus       298 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l  377 (1088)
                      +|++|++++. |. +.. ++|++|+|++|++++..                           .+..+++|+.|+|++|++
T Consensus        91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~~---------------------------~l~~l~~L~~L~Ls~N~i  140 (263)
T 1xeu_A           91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDTD---------------------------SLIHLKNLEILSIRNNKL  140 (263)
T ss_dssp             ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBSG---------------------------GGTTCTTCCEEECTTSCC
T ss_pred             ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCCh---------------------------hhcCcccccEEECCCCcC
Confidence            8888877763 33 222 77888888887776531                           234566777777777877


Q ss_pred             CCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCC
Q 001384          378 TGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP  428 (1088)
Q Consensus       378 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  428 (1088)
                      ++. | .+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.
T Consensus       141 ~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          141 KSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            753 3 577788888888888888754  5677888888888888888753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.64  E-value=1.6e-16  Score=178.92  Aligned_cols=260  Identities=17%  Similarity=0.175  Sum_probs=161.9

Q ss_pred             CCCCcEEEccCcccc--ccccccCcccceecccCcccccccccccccC--------CCccCEEEcCCCcccccCcccccC
Q 001384          197 CLNLRYLDLSSNNFR--GNIWNGLAQLVEFSVSENVLSGVVSSSVFKE--------NCSLEIFDLSENEFIGDFPGEVSN  266 (1088)
Q Consensus       197 l~~L~~L~Ls~N~l~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~--------l~~L~~L~Ls~n~l~~~~p~~l~~  266 (1088)
                      +++|++|||++|++.  ......++.+..+.+..|    .++...|.+        +++|+.|+|.+ +++..-+.+|.+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~----~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~  122 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMAN----FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG  122 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTT----EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred             hccCeEEecCcceeEEecCcccccccccccccccc----ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence            555666666666655  111112222233333333    244556666        77777777777 666666667777


Q ss_pred             CCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCc----CCccCcccccCCCCCc-EEEcCCCcCCCchhH-hhh---
Q 001384          267 CRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNN----FLSVIPESLLNLSKLE-VLDLSSNNFGGEVQK-IFG---  337 (1088)
Q Consensus       267 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~----l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~-~~~---  337 (1088)
                      +++|+.|++++|.+..+.+.+|..+.++..+.+..+.    ........|.++.+|+ .+.+....   .++. .+.   
T Consensus       123 ~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~  199 (329)
T 3sb4_A          123 CDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGL  199 (329)
T ss_dssp             CTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTC
T ss_pred             CcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhccc
Confidence            7777777777777765666667666666666655421    1222334455566666 45554321   2222 221   


Q ss_pred             cccccceeecCcCcccCCCCCccc-cCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCc
Q 001384          338 RFTQVKILALHSNSYIDGMNSSGI-LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ  416 (1088)
Q Consensus       338 ~l~~L~~L~L~~n~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  416 (1088)
                      ...++..+.+.++-.  ......+ ..+++|+.|+|++|+++...+..|.++++|+.|+|.+| ++...+.+|.++++|+
T Consensus       200 ~~~~~~~l~~~~~l~--~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          200 QPRDINFLTIEGKLD--NADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             CGGGCSEEEEEECCC--HHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             CccccceEEEeeeec--HHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence            234444444443310  0001111 12678888999988888666667888888999999887 7756677888888898


Q ss_pred             -EEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEc
Q 001384          417 -TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNL  468 (1088)
Q Consensus       417 -~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  468 (1088)
                       .+++.+ .++..-+..|.++++|+.|++++|+++...+..|.++++|+.++.
T Consensus       277 ~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          277 GTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence             888888 676455677888889999998888888655668888888888764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.62  E-value=1.2e-15  Score=157.10  Aligned_cols=114  Identities=25%  Similarity=0.269  Sum_probs=104.9

Q ss_pred             CcCEEEccCCccCCCCCc-cccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          366 NISRLDLSHNNFTGPLPV-EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      +|++|+|++|++++..+. .+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+.++++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            789999999999865554 4899999999999999999888999999999999999999999888888999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEEccCCcCccCCCc
Q 001384          445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP  479 (1088)
Q Consensus       445 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~  479 (1088)
                      ++|++++..|..+..+++|++|+|++|++++..+-
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            99999998899999999999999999999987653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.61  E-value=7.5e-16  Score=173.29  Aligned_cols=283  Identities=14%  Similarity=0.139  Sum_probs=172.2

Q ss_pred             CCCCcEEECccccccC-cccCCC-CCCCceeeccccccc--ccccCchhhhcccceEEeccCccCCCCCCccccCCCCCc
Q 001384          126 CRSLKYLNLSHNILSG-DLNLSG-LRSLEILDLSVNRIH--GEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLR  201 (1088)
Q Consensus       126 l~~L~~L~Ls~n~l~~-~~~l~~-l~~L~~L~Ls~N~l~--~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~  201 (1088)
                      +.+|+.|.++++--.. ...+.. +++|++|||++|++.  ......+.                            .++
T Consensus        24 ~~~l~~L~l~g~i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~----------------------------~~~   75 (329)
T 3sb4_A           24 ANSITHLTLTGKLNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP----------------------------NGK   75 (329)
T ss_dssp             HHHCSEEEEEEEECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG----------------------------GGC
T ss_pred             hCceeEEEEeccccHHHHHHHHHhhccCeEEecCcceeEEecCcccccc----------------------------ccc
Confidence            6678888888752111 112333 677888888888876  22211111                            123


Q ss_pred             EEEccCcccccccccc--------CcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEE
Q 001384          202 YLDLSSNNFRGNIWNG--------LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVL  273 (1088)
Q Consensus       202 ~L~Ls~N~l~~~~~~~--------l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L  273 (1088)
                      .+.+..|.+....+.+        +++|++|++.+ .++ .+...+|.++++|+.|++++|.+....+.+|.++.++..+
T Consensus        76 ~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l  153 (329)
T 3sb4_A           76 FYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFI  153 (329)
T ss_dssp             CEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEE
T ss_pred             cccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEe
Confidence            3333333443333444        44555555544 333 4667788888888888888888877777888888877777


Q ss_pred             EccCccc----cCCCccccCCCCCCC-EEeCCCCcCCccCcccc----cCCCCCcEEEcCCCcCCCchhHhhhcccccce
Q 001384          274 NLFGNNF----SGPIPAEIGSISGLE-ALFLGKNNFLSVIPESL----LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKI  344 (1088)
Q Consensus       274 ~L~~N~l----~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  344 (1088)
                      .+..+..    .......|.++..|+ .+.+....   .++..+    ....+++.+.+.++-...........+++|+.
T Consensus       154 ~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~  230 (329)
T 3sb4_A          154 PLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVS  230 (329)
T ss_dssp             CTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCE
T ss_pred             cCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeE
Confidence            7766332    223334555666666 45554322   122211    12345566666554222222222233666777


Q ss_pred             eecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcc-eeeccccccCCcCCcccCCCCCCcEEEccCC
Q 001384          345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK-FLILAHNRFNGSIPAVYGNMPNLQTLDLSFN  423 (1088)
Q Consensus       345 L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  423 (1088)
                      +++.+|. +..+....|.++++|+.|+|++| ++...+..|.++++|+ .|++.+ .++...+.+|.++++|+.|++++|
T Consensus       231 l~L~~n~-i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n  307 (329)
T 3sb4_A          231 LDISKTN-ATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD  307 (329)
T ss_dssp             EECTTBC-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred             EECCCCC-cceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence            7777665 44555666777778888888777 6655566778888888 888877 666556678888888888888888


Q ss_pred             cCCCCCCccccCCCCCcEEEc
Q 001384          424 ELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      +++..-+..|.++++|+.++.
T Consensus       308 ~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          308 KITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCCEECTTTTCTTCCCCEEEC
T ss_pred             ccCccchhhhcCCcchhhhcc
Confidence            888555557788888887763

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.59  E-value=1.7e-15  Score=155.89  Aligned_cols=64  Identities=22%  Similarity=0.316  Sum_probs=34.1

Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCC
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP  428 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  428 (1088)
                      ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|++|+|++|++++.
T Consensus        78 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           78 SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             TTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            3344444444444444444455555555555555555555555555566666666666665543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=3.1e-16  Score=175.38  Aligned_cols=141  Identities=13%  Similarity=0.179  Sum_probs=99.9

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCcc--------------chHHH--------HHHHHHHhCCC
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE--------------GEREF--------RAEMEVLSGNG  859 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~E~~~l~~~~  859 (1088)
                      ....-|++.+.||+|+||.||+|.+.+|+.||||+++.....              ....+        ..|...+.+  
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r--  169 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA--  169 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH--
Confidence            333449999999999999999999999999999987532110              01111        234444433  


Q ss_pred             CCCCCCce--eEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001384          860 FGWPHPNL--VTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKAS  937 (1088)
Q Consensus       860 ~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~  937 (1088)
                        +.+..+  ...+++    ...++||||++|++|.++..      ......++.|++.+|.|||+.   |||||||||.
T Consensus       170 --L~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~  234 (397)
T 4gyi_A          170 --LYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEF  234 (397)
T ss_dssp             --HHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             --HHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence              112221  122221    12379999999988865432      234567899999999999998   9999999999


Q ss_pred             CEEEcCCCC----------EEEeecccceeec
Q 001384          938 NVLLDKEGK----------ALVTDFGLARVVS  959 (1088)
Q Consensus       938 NIll~~~~~----------~kl~Dfg~a~~~~  959 (1088)
                      |||+++++.          +.|+||+-+....
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            999998773          8999999887644

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.57  E-value=5.5e-15  Score=148.60  Aligned_cols=90  Identities=26%  Similarity=0.296  Sum_probs=41.0

Q ss_pred             cccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC--ccccCCCCCcEEEccccccccCCC---cccc
Q 001384          384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP--PSIGNLTSLLWLMLANNSLSGEIP---GEIG  458 (1088)
Q Consensus       384 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p---~~l~  458 (1088)
                      .+..+++|++|++++|++++.+|..+..+++|++|++++|++++ +|  ..++.+++|++|++++|.+++..+   ..+.
T Consensus        66 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~  144 (168)
T 2ell_A           66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFK  144 (168)
T ss_dssp             SCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHT
T ss_pred             hhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHH
Confidence            33344444444444444443344444444444444444444442 22  344445555555555555543222   2445


Q ss_pred             CCCCCCeEEccCCcCc
Q 001384          459 NCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       459 ~l~~L~~L~L~~N~l~  474 (1088)
                      .+++|++|++++|.+.
T Consensus       145 ~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          145 LLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             TCSSCCEETTEETTSC
T ss_pred             hCccCcEecCCCCChh
Confidence            5555555555555544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.57  E-value=7.6e-15  Score=147.55  Aligned_cols=84  Identities=20%  Similarity=0.254  Sum_probs=43.0

Q ss_pred             CccCEEEcCCCccc-ccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEE
Q 001384          244 CSLEIFDLSENEFI-GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD  322 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  322 (1088)
                      ++|++|++++|+++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45556666665555 45555555555555555555555533  4444455555555555554444444444444444444


Q ss_pred             cCCCcCC
Q 001384          323 LSSNNFG  329 (1088)
Q Consensus       323 L~~N~l~  329 (1088)
                      |++|.++
T Consensus       102 Ls~N~l~  108 (168)
T 2ell_A          102 LSGNKLK  108 (168)
T ss_dssp             CBSSSCC
T ss_pred             ccCCccC
Confidence            4444443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.55  E-value=1.7e-14  Score=148.28  Aligned_cols=111  Identities=31%  Similarity=0.412  Sum_probs=102.2

Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      ++|++|+|++|+++ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            47899999999998 78899999999999999999999888889999999999999999999877888999999999999


Q ss_pred             cccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       445 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      ++|+|++..+..|..+++|+.|+|++|++.+.
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            99999965566799999999999999999854

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.54  E-value=2.3e-14  Score=145.39  Aligned_cols=114  Identities=25%  Similarity=0.253  Sum_probs=102.0

Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEc
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLML  444 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  444 (1088)
                      ++|+.|++++|++++..+..+..+++|++|++++|++++..+..++.+++|++|++++|++++..+..+.++++|++|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            57899999999999777777899999999999999999777777899999999999999999776677899999999999


Q ss_pred             cccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       445 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      ++|++++..+..+..+++|++|+|++|++++..|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            9999996555567899999999999999997665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.53  E-value=1.9e-13  Score=157.03  Aligned_cols=229  Identities=11%  Similarity=0.136  Sum_probs=143.3

Q ss_pred             cccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccC
Q 001384          235 VSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN  314 (1088)
Q Consensus       235 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  314 (1088)
                      +....|.+ ++|+.+++.. .++..-+.+|.++++|+.++|.+|+++......|. ..+|+.+.|.. .+..+-..+|.+
T Consensus       149 I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~  224 (401)
T 4fdw_A          149 IGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLK  224 (401)
T ss_dssp             ECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECTTTTTT
T ss_pred             ECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCC-chheehhhHhhC
Confidence            34445555 3566777664 45555566677777777777777777633333343 56777777763 355555666777


Q ss_pred             CCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccC-----CCCCccccCCc
Q 001384          315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT-----GPLPVEISQMR  389 (1088)
Q Consensus       315 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~  389 (1088)
                      +++|+.+++..| ++......|.. .+|+.+.+..+  +..+....|.++++|+.+++.+|.+.     ...+..|.+++
T Consensus       225 ~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~~--i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~  300 (401)
T 4fdw_A          225 TSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPNG--VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCP  300 (401)
T ss_dssp             CTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEETT--CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCT
T ss_pred             CCCCCEEecCCC-ccCcccccccc-CCccEEEeCCC--ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCc
Confidence            777777777654 55555566665 56666666332  34445566667777777777766654     23445667777


Q ss_pred             CcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCC-CCCeEEc
Q 001384          390 SLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT-SLLWLNL  468 (1088)
Q Consensus       390 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L  468 (1088)
                      +|+.++|. +.++..-..+|.++++|+.++|..| ++..-+..|.++ +|+.+++.+|.+....+..|..++ +++.|++
T Consensus       301 ~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~v  377 (401)
T 4fdw_A          301 KLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRV  377 (401)
T ss_dssp             TCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEE
T ss_pred             cCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEe
Confidence            77777777 3466455567777777777777544 553445567777 777777777777654455566663 5667766


Q ss_pred             cCCcCc
Q 001384          469 SNNKLS  474 (1088)
Q Consensus       469 ~~N~l~  474 (1088)
                      ..|.+.
T Consensus       378 p~~~~~  383 (401)
T 4fdw_A          378 PAESVE  383 (401)
T ss_dssp             CGGGHH
T ss_pred             CHHHHH
Confidence            665543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.53  E-value=3.9e-14  Score=145.63  Aligned_cols=105  Identities=29%  Similarity=0.435  Sum_probs=70.3

Q ss_pred             eEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccc
Q 001384          566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN  644 (1088)
Q Consensus       566 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  644 (1088)
                      +|+|++|+++ .+|..+..+++|+.|+|++|++++..|..|..+ .|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus        35 ~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             EEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            3444444444 344455555555566666666655555555555 46666666666665666678888888888888888


Q ss_pred             cCCcCCcccccccccceeeccCCCCcc
Q 001384          645 FSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       645 l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      |++..+..|..+++|+.|+|++|+|.+
T Consensus       114 l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          114 ISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCeeChhhhhcCccccEEEeCCCCeec
Confidence            886555568888888888888888843

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.52  E-value=2e-14  Score=141.31  Aligned_cols=85  Identities=18%  Similarity=0.207  Sum_probs=50.8

Q ss_pred             CccCEEEcCCCccc-ccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEE
Q 001384          244 CSLEIFDLSENEFI-GDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD  322 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  322 (1088)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666665 55666666666666666666666643  4555556666666666665555555555555555555


Q ss_pred             cCCCcCCC
Q 001384          323 LSSNNFGG  330 (1088)
Q Consensus       323 L~~N~l~~  330 (1088)
                      +++|.+++
T Consensus        95 ls~N~i~~  102 (149)
T 2je0_A           95 LSGNKIKD  102 (149)
T ss_dssp             CTTSCCCS
T ss_pred             CCCCcCCC
Confidence            55555554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.51  E-value=1.2e-14  Score=142.95  Aligned_cols=105  Identities=22%  Similarity=0.248  Sum_probs=53.5

Q ss_pred             CCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCC-CCccccCCCCCcE
Q 001384          363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP-IPPSIGNLTSLLW  441 (1088)
Q Consensus       363 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~  441 (1088)
                      .+++|++|++++|.+++.  ..+..+++|++|++++|++++.+|..++.+++|++|++++|++++. .|..++.+++|++
T Consensus        40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~  117 (149)
T 2je0_A           40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS  117 (149)
T ss_dssp             TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred             hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence            344555555555555533  4445555555555555555544555444555555555555555531 2244555555555


Q ss_pred             EEccccccccCCC---ccccCCCCCCeEEcc
Q 001384          442 LMLANNSLSGEIP---GEIGNCTSLLWLNLS  469 (1088)
Q Consensus       442 L~L~~N~l~~~~p---~~l~~l~~L~~L~L~  469 (1088)
                      |++++|.+++..+   ..++.+++|++|+++
T Consensus       118 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A          118 LDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             EeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            5555555553333   245555555555554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.51  E-value=3.9e-13  Score=154.39  Aligned_cols=224  Identities=13%  Similarity=0.124  Sum_probs=129.2

Q ss_pred             ceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCc
Q 001384          176 LVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENE  255 (1088)
Q Consensus       176 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  255 (1088)
                      |+.+.+.. +++.+.+.+|.+|++|+.++|++|+++                      .++...|. .++|+.+.|..+ 
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~----------------------~I~~~aF~-~~~L~~l~lp~~-  213 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT----------------------KLPASTFV-YAGIEEVLLPVT-  213 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS----------------------EECTTTTT-TCCCSEEECCTT-
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce----------------------EechhhEe-ecccCEEEeCCc-
Confidence            44444442 444444455555555555555555443                      23344444 356666666533 


Q ss_pred             ccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHh
Q 001384          256 FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI  335 (1088)
Q Consensus       256 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  335 (1088)
                      ++..-..+|.++++|+.+++..| ++.+...+|.+ .+|+.+.| .+.++.....+|.++++|+.+++.+|.+....   
T Consensus       214 l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~---  287 (401)
T 4fdw_A          214 LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP---  287 (401)
T ss_dssp             CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT---
T ss_pred             hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc---
Confidence            44455556666666666666653 33333444444 56666666 34445544556666666666666665543100   


Q ss_pred             hhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCC
Q 001384          336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNL  415 (1088)
Q Consensus       336 ~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  415 (1088)
                                       ...+....|.++++|+.++|. +.++......|.++++|+.++|..| ++..-+.+|.++ +|
T Consensus       288 -----------------~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L  347 (401)
T 4fdw_A          288 -----------------EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GI  347 (401)
T ss_dssp             -----------------TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CC
T ss_pred             -----------------ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CC
Confidence                             112334455666777777776 3455455566777778888888554 554556677777 88


Q ss_pred             cEEEccCCcCCCCCCccccCC-CCCcEEEccccccc
Q 001384          416 QTLDLSFNELTGPIPPSIGNL-TSLLWLMLANNSLS  450 (1088)
Q Consensus       416 ~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~  450 (1088)
                      +.+++++|.+....+..+.++ .+++.|++..+.+.
T Consensus       348 ~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          348 KEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            888888887775555566666 36778888777654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.50  E-value=1.2e-13  Score=139.91  Aligned_cols=87  Identities=23%  Similarity=0.307  Sum_probs=43.3

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcc
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA  445 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  445 (1088)
                      +|++|+|++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|+
T Consensus        53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  132 (177)
T 2o6r_A           53 QLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLH  132 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEec
Confidence            33444444444443333334445555555555555554444445555555555555555553333334555566666666


Q ss_pred             ccccccC
Q 001384          446 NNSLSGE  452 (1088)
Q Consensus       446 ~N~l~~~  452 (1088)
                      +|.+.+.
T Consensus       133 ~N~~~~~  139 (177)
T 2o6r_A          133 TNPWDCS  139 (177)
T ss_dssp             SSCBCCC
T ss_pred             CCCeecc
Confidence            6655543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.45  E-value=1.4e-15  Score=157.39  Aligned_cols=84  Identities=23%  Similarity=0.264  Sum_probs=39.6

Q ss_pred             CcCcceeeccccccCCcCCc------ccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCC
Q 001384          388 MRSLKFLILAHNRFNGSIPA------VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT  461 (1088)
Q Consensus       388 l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  461 (1088)
                      ...++.++++.|.++|.+|.      .+..+++|++|++++|++++ +| .+.++++|++|++++|+++ .+|..+..++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~   93 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD   93 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence            34455555555555544443      44444445555555554442 33 4444444444444444444 3444444444


Q ss_pred             CCCeEEccCCcCc
Q 001384          462 SLLWLNLSNNKLS  474 (1088)
Q Consensus       462 ~L~~L~L~~N~l~  474 (1088)
                      +|++|+|++|+++
T Consensus        94 ~L~~L~L~~N~l~  106 (198)
T 1ds9_A           94 TLEELWISYNQIA  106 (198)
T ss_dssp             HCSEEEEEEEECC
T ss_pred             cCCEEECcCCcCC
Confidence            4444444444443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.43  E-value=3.9e-12  Score=146.70  Aligned_cols=333  Identities=14%  Similarity=0.163  Sum_probs=182.0

Q ss_pred             ccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECcccccc--CcccCCCCCCCceeecccccccccccCc
Q 001384           91 ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFS  168 (1088)
Q Consensus        91 l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  168 (1088)
                      ++..-..+|.++++|+.+.|.. .++.....+|.+|.+|+.++|..+ ++  +...+.++++|+.+.+..+ +......+
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            4444456788999999999974 477555678999999999999765 43  4556888888888877654 33233333


Q ss_pred             hhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCE
Q 001384          169 FPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEI  248 (1088)
Q Consensus       169 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~  248 (1088)
                      |. .+..+....  .+.+......+|.++++|+.+.+..+..                       .+....|.++.+|+.
T Consensus       136 F~-~~~~~~~~~--~~~~~~i~~~aF~~c~~L~~i~l~~~~~-----------------------~I~~~~F~~c~~L~~  189 (394)
T 4fs7_A          136 FK-GCDFKEITI--PEGVTVIGDEAFATCESLEYVSLPDSME-----------------------TLHNGLFSGCGKLKS  189 (394)
T ss_dssp             TT-TCCCSEEEC--CTTCCEECTTTTTTCTTCCEEECCTTCC-----------------------EECTTTTTTCTTCCB
T ss_pred             ee-ccccccccc--CccccccchhhhcccCCCcEEecCCccc-----------------------eeccccccCCCCceE
Confidence            32 222222221  2233334455677777777777654421                       133444555555555


Q ss_pred             EEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcC
Q 001384          249 FDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNF  328 (1088)
Q Consensus       249 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  328 (1088)
                      +++..+ ++..-..+|.++..|+.+.+..+...  +........+|+.+.+..+ ++......+..+.+|+.+.+..+..
T Consensus       190 i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~  265 (394)
T 4fs7_A          190 IKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL  265 (394)
T ss_dssp             CCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC
T ss_pred             EEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc
Confidence            555544 33334445555666665555544322  2223333455666655432 2333334555566666666655432


Q ss_pred             CCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcc
Q 001384          329 GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAV  408 (1088)
Q Consensus       329 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  408 (1088)
                       ......|.....++.+....+.    .....|..+.+|+.+.+..+ ++......|.++++|+.++|.++ ++..-..+
T Consensus       266 -~i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          266 -RIGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             -EECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             -eeeccccccccccceeccCcee----eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence             2334445555555554444332    12234445566666666544 33333445666666666666533 44344556


Q ss_pred             cCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeE
Q 001384          409 YGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWL  466 (1088)
Q Consensus       409 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  466 (1088)
                      |.++++|+.+++..| ++..-...|.++++|+.+++..+ ++ .+...|.++++|+.+
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            666666777666655 44333445666666766666544 22 234456666666543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=5.3e-13  Score=134.06  Aligned_cols=110  Identities=27%  Similarity=0.316  Sum_probs=97.7

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcc
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA  445 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  445 (1088)
                      ..+.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+.++++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            3578999999999 5787664  799999999999998889999999999999999999997666678999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEEccCCcCccCCC
Q 001384          446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP  478 (1088)
Q Consensus       446 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip  478 (1088)
                      +|+|++..+..|.++++|++|+|++|++++..+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            999997666679999999999999999996543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.42  E-value=1.4e-13  Score=139.42  Aligned_cols=105  Identities=23%  Similarity=0.305  Sum_probs=82.3

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCc--cccCCCCCcEEE
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPP--SIGNLTSLLWLM  443 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~  443 (1088)
                      +|++|+|++|.+++.  ..+..+++|++|++++|++++..|..++.+++|++|++++|+++ .+|.  .++.+++|++|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            677777777777643  56777888888888888888544455578888888888888886 5666  788888899999


Q ss_pred             ccccccccCCCcc----ccCCCCCCeEEccCCcCc
Q 001384          444 LANNSLSGEIPGE----IGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       444 L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~  474 (1088)
                      +++|.++ .+|..    ++.+++|++||+++|...
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            9999887 56664    888999999999998876

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.41  E-value=3e-13  Score=136.89  Aligned_cols=131  Identities=20%  Similarity=0.297  Sum_probs=61.3

Q ss_pred             cCCCCCcEEEccCccccCCCccccCCCC-CCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccc
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIGSIS-GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK  343 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  343 (1088)
                      .++++|++|++++|+++. +|. +..+. +|+.|+|++|.+++.  ..+..+++|++|+|++|.+++.++..|+.     
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----   86 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQA-----   86 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHH-----
T ss_pred             CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhc-----
Confidence            344455555555555542 222 22222 555555555555543  34555555555555555555443333332     


Q ss_pred             eeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCc--cccCCcCcceeeccccccCCcCCcc----cCCCCCCcE
Q 001384          344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV--EISQMRSLKFLILAHNRFNGSIPAV----YGNMPNLQT  417 (1088)
Q Consensus       344 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~  417 (1088)
                                          +++|++|+|++|+++ .+|.  .+..+++|+.|++++|.++ .+|..    ++.+++|+.
T Consensus        87 --------------------l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~  144 (176)
T 1a9n_A           87 --------------------LPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV  144 (176)
T ss_dssp             --------------------CTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred             --------------------CCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence                                233444444444443 2333  4444455555555555554 33332    445555555


Q ss_pred             EEccCCcCC
Q 001384          418 LDLSFNELT  426 (1088)
Q Consensus       418 L~L~~N~l~  426 (1088)
                      ||+++|.+.
T Consensus       145 Ld~~~n~~~  153 (176)
T 1a9n_A          145 LDFQKVKLK  153 (176)
T ss_dssp             ETTEECCHH
T ss_pred             eCCCcCCHH
Confidence            555555443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.41  E-value=2.1e-15  Score=156.20  Aligned_cols=152  Identities=22%  Similarity=0.226  Sum_probs=98.3

Q ss_pred             CCCCCCEEeCCCCcCCccCcc------cccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccC
Q 001384          290 SISGLEALFLGKNNFLSVIPE------SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILK  363 (1088)
Q Consensus       290 ~l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~  363 (1088)
                      ....++.++++.+.+.+.+|.      .+..+++|++|+|++|.+++. |                          .+..
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~--------------------------~~~~   68 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-S--------------------------SLSG   68 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-C--------------------------CHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-c--------------------------cccc
Confidence            344555555555555555443      455555555555555554431 1                          3345


Q ss_pred             CCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC--ccccCCCCCcE
Q 001384          364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP--PSIGNLTSLLW  441 (1088)
Q Consensus       364 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~  441 (1088)
                      +++|++|++++|.++ .+|..+..+++|++|++++|++++ +| .+..+++|++|++++|++++ +|  ..+..+++|++
T Consensus        69 l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~  144 (198)
T 1ds9_A           69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLED  144 (198)
T ss_dssp             HTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSE
T ss_pred             CCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCE
Confidence            566777777777777 566666667778888888887774 44 46677778888888887773 33  36777778888


Q ss_pred             EEccccccccCCCcc----------ccCCCCCCeEEccCCcCc
Q 001384          442 LMLANNSLSGEIPGE----------IGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       442 L~L~~N~l~~~~p~~----------l~~l~~L~~L~L~~N~l~  474 (1088)
                      |++++|.+++.+|..          +..+++|++||  +|+++
T Consensus       145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            888888877665543          67777888776  66665

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.40  E-value=9.7e-13  Score=132.63  Aligned_cols=112  Identities=26%  Similarity=0.292  Sum_probs=97.2

Q ss_pred             cCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccc
Q 001384          367 ISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN  446 (1088)
Q Consensus       367 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  446 (1088)
                      -+.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..+..+.++++|++|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            368999999997 7887775  8999999999999988899999999999999999999965555678999999999999


Q ss_pred             cccccCCCccccCCCCCCeEEccCCcCccCCCchhh
Q 001384          447 NSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVM  482 (1088)
Q Consensus       447 N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~  482 (1088)
                      |+|++..+..|..+++|++|+|++|++.+ .|..+.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~~  125 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDIM  125 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGGH
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccc-ccccHH
Confidence            99996555569999999999999999984 454443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.39  E-value=8.9e-13  Score=132.44  Aligned_cols=103  Identities=25%  Similarity=0.322  Sum_probs=93.3

Q ss_pred             ceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEcccc
Q 001384          565 GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN  643 (1088)
Q Consensus       565 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  643 (1088)
                      +.+++++|+++ .+|..+.  .+|+.|+|++|+|++..|..|+.+ .|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            46999999999 5888774  889999999999998889999988 7999999999999766677899999999999999


Q ss_pred             ccCCcCCcccccccccceeeccCCCCc
Q 001384          644 NFSGPFPASFNNLTELSKLNISYNPLV  670 (1088)
Q Consensus       644 ~l~g~~p~~~~~l~~L~~l~l~~N~l~  670 (1088)
                      +|++..|..|..+++|+.|+|++|++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            999766677999999999999999994

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.36  E-value=1.5e-12  Score=131.23  Aligned_cols=103  Identities=23%  Similarity=0.320  Sum_probs=92.0

Q ss_pred             ceEEccCCccccccCcccccCCCccEEeccccccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEcccc
Q 001384          565 GYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN  643 (1088)
Q Consensus       565 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  643 (1088)
                      ..+++++|+++ .+|..+.  .+|+.|+|++|+|++.+|..|+.+ .|+.|+|++|+|++..|..|+++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            46899999997 7888776  899999999999998889999988 7999999999999655566899999999999999


Q ss_pred             ccCCcCCcccccccccceeeccCCCCc
Q 001384          644 NFSGPFPASFNNLTELSKLNISYNPLV  670 (1088)
Q Consensus       644 ~l~g~~p~~~~~l~~L~~l~l~~N~l~  670 (1088)
                      +|++..|..|..+++|+.|+|++|+|.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            999655566999999999999999994

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.33  E-value=2.8e-11  Score=139.50  Aligned_cols=316  Identities=16%  Similarity=0.147  Sum_probs=211.5

Q ss_pred             CCCCcCccCCCCCCCcEEECcccccc--CcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCc
Q 001384          115 FSGSIPDDLSSCRSLKYLNLSHNILS--GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDT  192 (1088)
Q Consensus       115 l~~~~p~~l~~l~~L~~L~Ls~n~l~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~  192 (1088)
                      ++.....+|.+|.+|+.+.|..+ ++  +..+|.+|++|+.++|..+ ++. ++......|.+|+.+.+.. .+......
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~-I~~~aF~~c~~L~~i~~p~-~l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKM-IGRCTFSGCYALKSILLPL-MLKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCCCCCCT-TCCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceE-ccchhhcccccchhhcccC-ceeeecce
Confidence            44344567888888888888754 44  3446777888888877654 332 2222222333444333321 12223333


Q ss_pred             cccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcE
Q 001384          193 CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVV  272 (1088)
Q Consensus       193 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~  272 (1088)
                      +|.++..++.                     .......   .+....|.++.+|+.+.+.++. ...-...|.++++|+.
T Consensus       135 aF~~~~~~~~---------------------~~~~~~~---~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~  189 (394)
T 4fs7_A          135 AFKGCDFKEI---------------------TIPEGVT---VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKS  189 (394)
T ss_dssp             TTTTCCCSEE---------------------ECCTTCC---EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCB
T ss_pred             eeeccccccc---------------------ccCcccc---ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceE
Confidence            3333322211                     1111111   2445678889999999998664 4456678889999999


Q ss_pred             EEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcc
Q 001384          273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSY  352 (1088)
Q Consensus       273 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~  352 (1088)
                      +++..| ++.+....|.++..|+.+.+..+...  +.......++|+.+.+..+ ++......|.....++.+.+..+. 
T Consensus       190 i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~-  264 (394)
T 4fs7_A          190 IKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK-  264 (394)
T ss_dssp             CCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT-
T ss_pred             EEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc-
Confidence            999876 55455677888999999988766432  3344556678999988654 455566778888899998887663 


Q ss_pred             cCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCcc
Q 001384          353 IDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS  432 (1088)
Q Consensus       353 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  432 (1088)
                       ..+....|.....++.+....+.+.   ...+..+.+|+.+.+.++ ++..-..+|.++++|+.+++.++ ++..-...
T Consensus       265 -~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          265 -LRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             -CEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             -ceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence             3455667778888888888776654   246778889999998765 65455678889999999999754 66344567


Q ss_pred             ccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       433 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      |.++++|+.+++..| ++..-...|.+|++|+.+++..+
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            889999999999877 66445678999999999988644

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.24  E-value=4.3e-13  Score=152.47  Aligned_cols=75  Identities=16%  Similarity=0.240  Sum_probs=42.0

Q ss_pred             ccCCCCCcEEEccCccccCC----CccccCCCCCCCEEeCCCCcCCcc----CcccccCCCCCcEEEcCCCcCCCchhHh
Q 001384          264 VSNCRNLVVLNLFGNNFSGP----IPAEIGSISGLEALFLGKNNFLSV----IPESLLNLSKLEVLDLSSNNFGGEVQKI  335 (1088)
Q Consensus       264 l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~  335 (1088)
                      +..+++|++|+|++|.|++.    ++..+...++|++|+|++|.++..    ++..+...++|++|+|++|.|+......
T Consensus       179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~  258 (372)
T 3un9_A          179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV  258 (372)
T ss_dssp             HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHH
T ss_pred             HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHH
Confidence            34455555555555555432    233444555666666666666532    3344445667777777777777665555


Q ss_pred             hhc
Q 001384          336 FGR  338 (1088)
Q Consensus       336 ~~~  338 (1088)
                      +..
T Consensus       259 L~~  261 (372)
T 3un9_A          259 LRD  261 (372)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.17  E-value=3.8e-11  Score=135.90  Aligned_cols=103  Identities=20%  Similarity=0.243  Sum_probs=92.2

Q ss_pred             eEEccCC-ccccccCcccccCCCccEEeccc-cccccCCCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccc
Q 001384          566 YLQLSGN-QLSGELSPDIGKLQNFSMVHLGF-NQFDGKLPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSY  642 (1088)
Q Consensus       566 ~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~  642 (1088)
                      .++++++ +|+ .+|. ++.+.+|+.|+|++ |+|++..|..|+.+ .|+.|+|++|+|++..|..|++|++|+.|||++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4788998 899 5888 99999999999996 99998888899988 799999999999999999999999999999999


Q ss_pred             cccCCcCCcccccccccceeeccCCCCcc
Q 001384          643 NNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       643 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      |+|++..|..+..++ |+.|+|++|+|.+
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            999965555566665 9999999999964

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=8.5e-11  Score=127.30  Aligned_cols=147  Identities=12%  Similarity=0.018  Sum_probs=113.9

Q ss_pred             HHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          802 KATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       802 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ...+.|++...++.|+.+.||++... ++.+++|+...........+.+|++++..+.   .+..+.++++++...+..|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~---~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLE---GKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHT---TTSCCCCEEEEEEETTEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHh---cCCCCCeEEEEEecCCceE
Confidence            34467888888999999999999864 6889999987532223346888888888754   2566778888888888999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC------------------------------------  925 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------  925 (1088)
                      +||||++|.+|.+.+.     +..+...++.+++++++.||+..                                    
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999987631     22334578899999999999810                                    


Q ss_pred             --------------------CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          926 --------------------YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       926 --------------------~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                                          .+.++|+|++|.||+++.+..+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                03589999999999998765567999997754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.16  E-value=9.4e-13  Score=149.68  Aligned_cols=159  Identities=18%  Similarity=0.169  Sum_probs=94.1

Q ss_pred             CCCCCEEeCCCCcCCccCcccccC-----CCCCcEEEcCCCcCCCchhHhhh-cccccceeecCcCcccCCCCCccccCC
Q 001384          291 ISGLEALFLGKNNFLSVIPESLLN-----LSKLEVLDLSSNNFGGEVQKIFG-RFTQVKILALHSNSYIDGMNSSGILKL  364 (1088)
Q Consensus       291 l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~n~~~~~~~~~~~~~l  364 (1088)
                      ++.|+.|+|++|.++......+..     .++|++|+|++|.++......+. .+++                       
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~-----------------------  127 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR-----------------------  127 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHT-----------------------
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHh-----------------------
Confidence            467889999999887654443332     26899999999988765444332 3344                       


Q ss_pred             CCcCEEEccCCccCCCCCccc-----cCCcCcceeeccccccCC----cCCcccCCCCCCcEEEccCCcCCCC----CCc
Q 001384          365 PNISRLDLSHNNFTGPLPVEI-----SQMRSLKFLILAHNRFNG----SIPAVYGNMPNLQTLDLSFNELTGP----IPP  431 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~  431 (1088)
                        |+.|+|++|.+++.....+     ...++|+.|+|++|.|+.    .++..+..+++|++|+|++|+|++.    ++.
T Consensus       128 --L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~  205 (372)
T 3un9_A          128 --ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA  205 (372)
T ss_dssp             --EEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred             --ccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence              5555555555543222222     123556666666666643    1333345566666777777666531    244


Q ss_pred             cccCCCCCcEEEccccccccC----CCccccCCCCCCeEEccCCcCc
Q 001384          432 SIGNLTSLLWLMLANNSLSGE----IPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       432 ~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      .+...++|++|+|++|.|++.    ++..+..+++|++|+|++|+++
T Consensus       206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            455556677777777776642    3334445567777777777765

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.15  E-value=6.4e-11  Score=134.04  Aligned_cols=106  Identities=19%  Similarity=0.128  Sum_probs=93.4

Q ss_pred             CEEEccCC-ccCCCCCccccCCcCcceeeccc-cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcc
Q 001384          368 SRLDLSHN-NFTGPLPVEISQMRSLKFLILAH-NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLA  445 (1088)
Q Consensus       368 ~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  445 (1088)
                      ..++++++ +++ .+|. +..+++|+.|+|++ |+|++..|..|+.+++|+.|+|++|+|++..|..|++|++|++|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35788888 898 5888 99999999999996 99997777899999999999999999999888899999999999999


Q ss_pred             ccccccCCCccccCCCCCCeEEccCCcCccC
Q 001384          446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN  476 (1088)
Q Consensus       446 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~  476 (1088)
                      +|+|++..|..+..++ |+.|+|.+|+|...
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            9999965555566565 99999999999853

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.09  E-value=3.3e-09  Score=122.06  Aligned_cols=328  Identities=13%  Similarity=0.169  Sum_probs=153.5

Q ss_pred             cccccCCc-cCCeeeCCCCCCCCCcCccCCCCCCCcEEECcccc---cc--CcccCCCCCCCceeecccccccccccCch
Q 001384           96 FNNFSALT-QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNI---LS--GDLNLSGLRSLEILDLSVNRIHGEISFSF  169 (1088)
Q Consensus        96 ~~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~---l~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~  169 (1088)
                      ..+|.+.. .|+.+.+-.+ ++.....+|.+|.+|+.+.++.|.   ++  +..+|.++.+|+.+.+..+ ++ .+....
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~a  132 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEA  132 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhh
Confidence            34566663 4777777643 664556677788888888777664   33  2345667777776665543 22 122222


Q ss_pred             hhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEE
Q 001384          170 PAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIF  249 (1088)
Q Consensus       170 ~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L  249 (1088)
                      ...|.+|+.+.+.. .+......+|.++.+|+.+.+..+                      ++ .+....|.. ++|+.+
T Consensus       133 F~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~----------------------~~-~I~~~aF~~-~~l~~i  187 (394)
T 4gt6_A          133 FHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS----------------------VT-AIEERAFTG-TALTQI  187 (394)
T ss_dssp             TTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT----------------------CC-EECTTTTTT-CCCSEE
T ss_pred             hhhhcccccccccc-eeeeecccceecccccccccccce----------------------ee-Eeccccccc-cceeEE
Confidence            22334444444432 223333334444444444443322                      11 233444443 456666


Q ss_pred             EcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCC-CCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcC
Q 001384          250 DLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGS-ISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNF  328 (1088)
Q Consensus       250 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  328 (1088)
                      .+..+- +..-..+|.++.+|+......+... .+...+.. ......-.           ..+.....+..+.+.. .+
T Consensus       188 ~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip~-~v  253 (394)
T 4gt6_A          188 HIPAKV-TRIGTNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIPN-GV  253 (394)
T ss_dssp             EECTTC-CEECTTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECCT-TE
T ss_pred             EECCcc-cccccchhhhccccceecccccccc-cccceeecccccccccc-----------cccccccccceEEcCC-cc
Confidence            665442 2244455666666666665554433 11111100 00000000           0011111222222221 12


Q ss_pred             CCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcc
Q 001384          329 GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAV  408 (1088)
Q Consensus       329 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  408 (1088)
                      +......|.....|+.+.+..+.  ..+....|.++++|+.+.+. +.++......|.++.+|+.++|..+ ++..-..+
T Consensus       254 ~~i~~~aF~~c~~L~~i~lp~~~--~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  329 (394)
T 4gt6_A          254 ARIETHAFDSCAYLASVKMPDSV--VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDA  329 (394)
T ss_dssp             EEECTTTTTTCSSCCEEECCTTC--CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred             eEcccceeeecccccEEeccccc--ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhH
Confidence            22223334444444444443221  12233445556666666664 3344333455666677777777644 44344566


Q ss_pred             cCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcC
Q 001384          409 YGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL  473 (1088)
Q Consensus       409 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  473 (1088)
                      |.++.+|+.+.+..+ ++..-...|.++++|+.+++.+|....   ..+..+.+|+.+.+..|.+
T Consensus       330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            777777777777544 542334456777777777777765431   3456667777776665544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.07  E-value=4.7e-09  Score=120.75  Aligned_cols=319  Identities=11%  Similarity=0.153  Sum_probs=168.8

Q ss_pred             eEEeccccccccccccccccCCccCCeeeCCCCC---CCCCcCccCCCCCCCcEEECcccccc-CcccCCCCCCCceeec
Q 001384           81 VNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNT---FSGSIPDDLSSCRSLKYLNLSHNILS-GDLNLSGLRSLEILDL  156 (1088)
Q Consensus        81 v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~---l~~~~p~~l~~l~~L~~L~Ls~n~l~-~~~~l~~l~~L~~L~L  156 (1088)
                      ++++.+.+ +++..-..+|.++++|+.+.+..|.   ++.....+|..+.+|+.+.+..+--. +...+.++.+|+.+.+
T Consensus        66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~~~~I~~~aF~~c~~L~~i~l  144 (394)
T 4gt6_A           66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDSVTEIDSEAFHHCEELDTVTI  144 (394)
T ss_dssp             CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTTCSEECTTTTTTCTTCCEEEC
T ss_pred             CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCccceehhhhhhhhcccccccc
Confidence            33444443 3444445678999999999998764   66455678999999999988765322 4557899999999999


Q ss_pred             ccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCcc--ccccccccCcccceecccCcccccc
Q 001384          157 SVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNN--FRGNIWNGLAQLVEFSVSENVLSGV  234 (1088)
Q Consensus       157 s~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~--l~~~~~~~l~~L~~L~L~~n~l~~~  234 (1088)
                      ..+- + .+.......|..|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-  +....+.....++......+.... 
T Consensus       145 p~~~-~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~~~~~~-  219 (394)
T 4gt6_A          145 PEGV-T-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTRIGTNAFSECFALSTITSDSESYPA-  219 (394)
T ss_dssp             CTTC-C-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCEECTTTTTTCTTCCEEEECCSSSCB-
T ss_pred             ccee-e-eecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccccccchhhhccccceeccccccccc-
Confidence            7643 3 344445566789999998754 66666777765 579999887653  222344444444444333322211 


Q ss_pred             cccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccC
Q 001384          235 VSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLN  314 (1088)
Q Consensus       235 ~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  314 (1088)
                      +....+.........           ...+.....+..+.+.. .+......+|.++..|+.+.+..+. .......|.+
T Consensus       220 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~  286 (394)
T 4gt6_A          220 IDNVLYEKSANGDYA-----------LIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMN  286 (394)
T ss_dssp             SSSCEEEECTTSCEE-----------EEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTC-CEECTTTTTT
T ss_pred             ccceeeccccccccc-----------ccccccccccceEEcCC-cceEcccceeeecccccEEeccccc-ceecCccccc
Confidence            011111100000000           00011112222222221 1221223344444555555554322 2223344445


Q ss_pred             CCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCccee
Q 001384          315 LSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFL  394 (1088)
Q Consensus       315 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  394 (1088)
                      +++|+.+.+. +.++......|.++.+|+.+.+..+  +..+....|.++.+|+.+.|..+ ++..-...|.++++|+.+
T Consensus       287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~--v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i  362 (394)
T 4gt6_A          287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG--ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNI  362 (394)
T ss_dssp             CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT--CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred             ccccccccCC-CcccccCceeecCCCCcCEEEeCCc--ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence            5555555553 3344444445555555555555433  33344555666777777777544 543445667777777777


Q ss_pred             eccccccCCcCCcccCCCCCCcEEEccCCcC
Q 001384          395 ILAHNRFNGSIPAVYGNMPNLQTLDLSFNEL  425 (1088)
Q Consensus       395 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  425 (1088)
                      ++.++...   -..+....+|+.+.+..|.+
T Consensus       363 ~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          363 EYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             EESSCHHH---HHTCBCCCCC----------
T ss_pred             EECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            77776543   13455666777777766554

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.93  E-value=9.9e-10  Score=118.66  Aligned_cols=138  Identities=17%  Similarity=0.069  Sum_probs=98.5

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCC-ceeEEeeEEecCCeEEEEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP-NLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~-niv~l~~~~~~~~~~~lv~  884 (1088)
                      .|.+..+.+.|..+.||++...+|+.+++|+....   ....+..|+++++.+.   .+. .+.+++++...++..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~---~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLA---TTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHH---TTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHH---hCCCCCCeEEEeccCCCCCEEEE
Confidence            34443333466679999998777888999997654   2235677777776543   221 2556888888777889999


Q ss_pred             EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001384          885 EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC---------------------------------------  925 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------  925 (1088)
                      ||++|.++.  ...   .+   ...++.++++.++.||+..                                       
T Consensus        95 e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998884  211   12   2367788888888888752                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          926 ----------------YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       926 ----------------~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                                      .+.++|+|++|.||+++.++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            01299999999999998776667999998754

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.80  E-value=1.2e-09  Score=123.06  Aligned_cols=181  Identities=17%  Similarity=0.225  Sum_probs=104.7

Q ss_pred             ccCCCCCcEEEccCcccc---------CCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhH
Q 001384          264 VSNCRNLVVLNLFGNNFS---------GPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQK  334 (1088)
Q Consensus       264 l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  334 (1088)
                      +..+++|+.|.+.++...         +.+...+..+++|+.|.|++|.-.. ++. +. +++|+.|+|..|.+......
T Consensus       135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~  211 (362)
T 2ra8_A          135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVE  211 (362)
T ss_dssp             HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHH
T ss_pred             hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHH
Confidence            345566777766554321         1233445566778888887663112 222 32 67888888888877655444


Q ss_pred             hhh--cccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCC-----CCccc--cCCcCcceeeccccccCCcC
Q 001384          335 IFG--RFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGP-----LPVEI--SQMRSLKFLILAHNRFNGSI  405 (1088)
Q Consensus       335 ~~~--~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~l--~~l~~L~~L~L~~N~l~~~~  405 (1088)
                      .+.  .+++|+.|+|+.+.                       |...+.     +...+  ..+++|+.|+|++|.+++..
T Consensus       212 ~l~~~~lp~L~~L~L~~~~-----------------------~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~  268 (362)
T 2ra8_A          212 DILGSDLPNLEKLVLYVGV-----------------------EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV  268 (362)
T ss_dssp             HHHHSBCTTCCEEEEECBC-----------------------GGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHH
T ss_pred             HHHHccCCCCcEEEEeccc-----------------------cccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHH
Confidence            443  44555555443210                       111100     00111  23567777777777766433


Q ss_pred             Cccc---CCCCCCcEEEccCCcCCCC----CCccccCCCCCcEEEccccccccCCCccccC-CCCCCeEEccCCc
Q 001384          406 PAVY---GNMPNLQTLDLSFNELTGP----IPPSIGNLTSLLWLMLANNSLSGEIPGEIGN-CTSLLWLNLSNNK  472 (1088)
Q Consensus       406 p~~~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~L~~N~  472 (1088)
                      +..+   ..+++|++|+|+.|.+.+.    ++..+..+++|+.|+|++|.++...-..|.. +  ...+++++|+
T Consensus       269 ~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          269 VEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            2222   2467888999988888763    4445566788999999999887544333333 2  4668888887

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.78  E-value=1e-08  Score=116.43  Aligned_cols=144  Identities=18%  Similarity=0.294  Sum_probs=105.8

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEcc--ccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---CeEEE
Q 001384          809 EDRIIGKGGFGTVYRGVLPDGREVAVKKLQ--REG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---SEKIL  882 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---~~~~l  882 (1088)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|+++++.+..  .+..+.++++++.+.   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~--~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAG--TDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTT--SSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhc--CCCCCCcEEEECCCCCccCCeEE
Confidence            3567899999999999875 4678888876  332 1223467788888876542  245577888887766   45899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-------------------------------------  925 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------  925 (1088)
                      ||||++|..+.+.  ....++..++..++.++++.|+.||+..                                     
T Consensus       119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999999877542  1224678888999999999999999831                                     


Q ss_pred             ------------------CCCeEecCCCCCCEEEcCCCC--EEEeeccccee
Q 001384          926 ------------------YPPIVHRDVKASNVLLDKEGK--ALVTDFGLARV  957 (1088)
Q Consensus       926 ------------------~~~ivH~DLkp~NIll~~~~~--~kl~Dfg~a~~  957 (1088)
                                        .+.++|||+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              147999999999999997764  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.78  E-value=3.4e-09  Score=117.29  Aligned_cols=188  Identities=20%  Similarity=0.229  Sum_probs=122.6

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEecCC---eEEEEE
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLDGS---EKILVY  884 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~~~---~~~lv~  884 (1088)
                      .+.++.|....||++.    +.+++|+....  .....+.+|.++++.+..  .+..|   +++.+.....   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP---~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIP---EVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCC---CEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCC---ceEeecCCCCCCCcceEEE
Confidence            3568999999999864    56889986543  334578889888865421  12233   3444333332   347899


Q ss_pred             EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001384          885 EYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC---------------------------------------  925 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------  925 (1088)
                      |+++|.++.+...  ..++..++..++.++++.++.||+..                                       
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999988865432  24678888899999999999999610                                       


Q ss_pred             ----------------CCCeEecCCCCCCEEEcC--CCCEEEeecccceeecCCCCccccc--------------ccccc
Q 001384          926 ----------------YPPIVHRDVKASNVLLDK--EGKALVTDFGLARVVSAGDSHVSTT--------------IAGTV  973 (1088)
Q Consensus       926 ----------------~~~ivH~DLkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~--------------~~gt~  973 (1088)
                                      .+.++|+|++|.||+++.  ...+.++||+.+..-.+.. .....              +...+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHc
Confidence                            135899999999999998  4567899999987643210 00000              00000


Q ss_pred             cccC-ccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCC
Q 001384          974 GYVA-PEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011 (1088)
Q Consensus       974 ~y~a-PE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~ 1011 (1088)
                      +... |+...  ....-.+.|+++.++|.+.+|+.+|..
T Consensus       253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            1111 22111  112236899999999999999988753

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.74  E-value=4e-09  Score=118.63  Aligned_cols=140  Identities=16%  Similarity=0.266  Sum_probs=95.1

Q ss_pred             hhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCcccc--CCcCcceeeccc--cccCCc---
Q 001384          332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEIS--QMRSLKFLILAH--NRFNGS---  404 (1088)
Q Consensus       332 ~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~--~l~~L~~L~L~~--N~l~~~---  404 (1088)
                      +...+..+++|+.|.+++|.... ..  .+ .+++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.   
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~-l~--~~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLS-IG--KK-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCB-CC--SC-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCce-ec--cc-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            34555566666666666552111 11  12 378999999999887644333444  689999999863  222211   


Q ss_pred             --CCccc--CCCCCCcEEEccCCcCCCCCCcccc---CCCCCcEEEccccccccC----CCccccCCCCCCeEEccCCcC
Q 001384          405 --IPAVY--GNMPNLQTLDLSFNELTGPIPPSIG---NLTSLLWLMLANNSLSGE----IPGEIGNCTSLLWLNLSNNKL  473 (1088)
Q Consensus       405 --~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l  473 (1088)
                        +...+  ..+++|++|+|++|.+.+..+..+.   .+++|++|+|+.|.+++.    ++..+.++++|+.|+|++|.+
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence              11223  3579999999999998754433332   578999999999999863    455556789999999999988


Q ss_pred             cc
Q 001384          474 SG  475 (1088)
Q Consensus       474 ~g  475 (1088)
                      +.
T Consensus       320 ~d  321 (362)
T 2ra8_A          320 SD  321 (362)
T ss_dssp             CH
T ss_pred             CH
Confidence            74

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.72  E-value=5.9e-07  Score=102.60  Aligned_cols=100  Identities=11%  Similarity=0.082  Sum_probs=56.6

Q ss_pred             ccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCC
Q 001384          359 SGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTS  438 (1088)
Q Consensus       359 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  438 (1088)
                      ..|..+.+|+.+.+..+ ++......|.++++|+.+.+.++.++..-..+|.++.+|+.+.|..+ ++..-...|.++++
T Consensus       257 ~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~  334 (379)
T 4h09_A          257 FLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKA  334 (379)
T ss_dssp             TTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             cccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCC
Confidence            33444555555555433 33233345666667777777666666444566777777777777644 44233345667777


Q ss_pred             CcEEEccccccccCCCccccCCC
Q 001384          439 LLWLMLANNSLSGEIPGEIGNCT  461 (1088)
Q Consensus       439 L~~L~L~~N~l~~~~p~~l~~l~  461 (1088)
                      |+.+.+..+ ++..-...|.+++
T Consensus       335 L~~i~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          335 LSTISYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             CCCCCCCTT-CCEECTTTTTTSS
T ss_pred             CCEEEECCc-cCEEchhHhhCCC
Confidence            777777544 4423344555553

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.71  E-value=8.4e-07  Score=101.31  Aligned_cols=111  Identities=13%  Similarity=0.122  Sum_probs=79.9

Q ss_pred             CccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCC
Q 001384          358 SSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLT  437 (1088)
Q Consensus       358 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  437 (1088)
                      ...+.....|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++..-...|.+++
T Consensus       233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~  310 (379)
T 4h09_A          233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV  310 (379)
T ss_dssp             TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred             cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC
Confidence            344556667777777665 44344566778888888888654 5535556788889999999988888744456788889


Q ss_pred             CCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          438 SLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       438 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      +|+.+.|..+ ++..-...|.+|++|+.+.+..+
T Consensus       311 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          311 KLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             TCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            9999999765 65344567888999998877544

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.63  E-value=2.7e-09  Score=113.70  Aligned_cols=158  Identities=18%  Similarity=0.134  Sum_probs=85.8

Q ss_pred             CCcccCCceeCCCCceeEEecccc---cccccccc-ccccCCccCCeeeCCCCCCCCCcC-ccCCCCCCCcE--EECccc
Q 001384           65 SPCEWPGIICSPDKARVNGLNLTD---WNISGDIF-NNFSALTQLSYLDLSRNTFSGSIP-DDLSSCRSLKY--LNLSHN  137 (1088)
Q Consensus        65 ~~C~W~gv~C~~~~~~v~~L~L~~---~~l~~~~~-~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~--L~Ls~n  137 (1088)
                      ..|.|.|+.|+.+..+|+.+...+   ..+.+.+. ..+..++.  .|..++|.-++.++ +.+...+.|+.  ++++.|
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N  153 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN  153 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence            358899999998777776554433   23334432 22233322  23333333333222 12444444544  555666


Q ss_pred             cccC---cc--cCCCCCCCceeecccccccccccC-chhhhcccceEEeccCccCCCCC-CccccCCCCCcEEEccCccc
Q 001384          138 ILSG---DL--NLSGLRSLEILDLSVNRIHGEISF-SFPAICEKLVVANLSLNNLTGRI-DTCFDGCLNLRYLDLSSNNF  210 (1088)
Q Consensus       138 ~l~~---~~--~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l  210 (1088)
                      ....   ..  ...++++|+.|+|++|+|++..+. .+...+++|+.|+|++|+|++.. ...+..+ +|++|+|++|.+
T Consensus       154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl  232 (267)
T 3rw6_A          154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSL  232 (267)
T ss_dssp             SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcC
Confidence            4321   11  123566777777777777663321 23345567777777777777651 1223333 788888888887


Q ss_pred             cccc----------cccCcccceec
Q 001384          211 RGNI----------WNGLAQLVEFS  225 (1088)
Q Consensus       211 ~~~~----------~~~l~~L~~L~  225 (1088)
                      .+.+          ...+++|+.|+
T Consensus       233 ~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          233 CDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             ccccCcchhHHHHHHHHCcccCeEC
Confidence            7532          34567776654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.49  E-value=8.8e-09  Score=104.56  Aligned_cols=118  Identities=12%  Similarity=0.086  Sum_probs=75.7

Q ss_pred             cccccccCCccCCeeeCCCC-CCCCC----cCccCCCCCCCcEEECccccccCcc------cCCCCCCCceeeccccccc
Q 001384           94 DIFNNFSALTQLSYLDLSRN-TFSGS----IPDDLSSCRSLKYLNLSHNILSGDL------NLSGLRSLEILDLSVNRIH  162 (1088)
Q Consensus        94 ~~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~------~l~~l~~L~~L~Ls~N~l~  162 (1088)
                      .+...+...+.|++|+|++| .|+..    +...+...++|++|+|++|.|++..      .+...++|++|+|++|.|+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34556677788888888888 88642    4455667788888888888887422      2445677888888888887


Q ss_pred             ccccCchhhhc---ccceEEec--cCccCCCC----CCccccCCCCCcEEEccCcccc
Q 001384          163 GEISFSFPAIC---EKLVVANL--SLNNLTGR----IDTCFDGCLNLRYLDLSSNNFR  211 (1088)
Q Consensus       163 ~~~~~~~~~~~---~~L~~L~L--~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~  211 (1088)
                      +.....+...+   .+|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            66544444332   35666666  55666533    2233444566666666666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.34  E-value=8.8e-08  Score=97.14  Aligned_cols=52  Identities=12%  Similarity=0.127  Sum_probs=33.7

Q ss_pred             cCccCCCCCCCcEEECccc-cccCcc------cCCCCCCCceeecccccccccccCchh
Q 001384          119 IPDDLSSCRSLKYLNLSHN-ILSGDL------NLSGLRSLEILDLSVNRIHGEISFSFP  170 (1088)
Q Consensus       119 ~p~~l~~l~~L~~L~Ls~n-~l~~~~------~l~~l~~L~~L~Ls~N~l~~~~~~~~~  170 (1088)
                      +...+...++|++|+|++| .++...      .+...++|++|+|++|.|++.....+.
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~   86 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA   86 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHH
Confidence            3445667788888888888 776421      355667777777777777655444443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.26  E-value=1.2e-07  Score=101.00  Aligned_cols=80  Identities=28%  Similarity=0.309  Sum_probs=52.6

Q ss_pred             cCCCCCcEEEccCccccC--CCccccCCCCCCCEEeCCCCcCCccCcccccCCC--CCcEEEcCCCcCCCchh-------
Q 001384          265 SNCRNLVVLNLFGNNFSG--PIPAEIGSISGLEALFLGKNNFLSVIPESLLNLS--KLEVLDLSSNNFGGEVQ-------  333 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~~-------  333 (1088)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|.+.  ..+..++  +|++|+|++|.+.+..|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            456777777777777776  3445566777788888888877764  3344444  78888888888876433       


Q ss_pred             Hhhhcccccceee
Q 001384          334 KIFGRFTQVKILA  346 (1088)
Q Consensus       334 ~~~~~l~~L~~L~  346 (1088)
                      ..+..+++|+.|+
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            3455555555554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.15  E-value=1.1e-05  Score=87.10  Aligned_cols=137  Identities=19%  Similarity=0.133  Sum_probs=98.0

Q ss_pred             ceecccCce-EEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecC
Q 001384          811 RIIGKGGFG-TVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYME  888 (1088)
Q Consensus       811 ~~LG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~  888 (1088)
                      +.+..|..| .||+.... ++..+++|+-...   ....+..|.+.++.+...+.   +.++++++.+++..++|||+++
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vP---VP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMP---LPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSC---CCCEEEEEEETTEEEEEEECCC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCC---cCeEEEEEEECCeEEEEEEeeC
Confidence            345556555 69998865 4677899986543   34567888888876553333   5567777888889999999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-------------------------------------------  925 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------------  925 (1088)
                      |.++.+.....    ..+...++.+++..++.||+..                                           
T Consensus       104 G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          104 GKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             SEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             CccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            98888765432    2233456677777777777520                                           


Q ss_pred             ------------CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          926 ------------YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       926 ------------~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                                  .+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        02389999999999999877677999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.12  E-value=1.1e-05  Score=88.86  Aligned_cols=139  Identities=16%  Similarity=0.116  Sum_probs=94.6

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEe-cCCeEEEEEEecC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL-DGSEKILVYEYME  888 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  888 (1088)
                      .+.++.|....||+.    |+.+++|+....  .....+..|.+++..+..... -.+.+.+.+.. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~-v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVK-VNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCS-SBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCC-CCCCCeEeecccCCCceEEEEeccC
Confidence            356888888999998    567889985432  334578899998887542111 12445555553 4556789999999


Q ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 001384          889 GGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-------------------------------------------  925 (1088)
Q Consensus       889 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------------  925 (1088)
                      |.++.+..-  ..++..+...++.++++.|+.||+..                                           
T Consensus        97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            988876321  22455566666666666666666531                                           


Q ss_pred             --------------CCCeEecCCCCCCEEEcC---CCCE-EEeeccccee
Q 001384          926 --------------YPPIVHRDVKASNVLLDK---EGKA-LVTDFGLARV  957 (1088)
Q Consensus       926 --------------~~~ivH~DLkp~NIll~~---~~~~-kl~Dfg~a~~  957 (1088)
                                    .+.++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          125699999999999987   4565 7999998865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.89  E-value=9.1e-06  Score=91.79  Aligned_cols=82  Identities=10%  Similarity=0.010  Sum_probs=51.2

Q ss_pred             cee-cccCceEEEEEEeC-------CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC--
Q 001384          811 RII-GKGGFGTVYRGVLP-------DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG--  877 (1088)
Q Consensus       811 ~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~--  877 (1088)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|++++..+... ..-.+.++++++.+.  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~-~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGEL-TDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHH-CCSCCCCEEEEECSSTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhc-CCCCCCcEEEEccCCCc
Confidence            567 88889999998764       26788999876532   11123456676666653210 012345566666554  


Q ss_pred             -CeEEEEEEecCCCCHH
Q 001384          878 -SEKILVYEYMEGGSLE  893 (1088)
Q Consensus       878 -~~~~lv~e~~~~gsL~  893 (1088)
                       +..++||||++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999986653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.78  E-value=6.9e-06  Score=80.93  Aligned_cols=89  Identities=13%  Similarity=0.119  Sum_probs=48.3

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhh---hcccceEE
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPA---ICEKLVVA  179 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~---~~~~L~~L  179 (1088)
                      ..|++|||+++.|+...-..+.++++|++|+|++|.                     .|++..-..+..   .+++|++|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~---------------------~ItD~gL~~L~~~~~~~~~L~~L  119 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH---------------------YIEDGCLERLSQLENLQKSMLEM  119 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT---------------------TCCHHHHHHHHTCHHHHHHCCEE
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC---------------------ccCHHHHHHHHhcccccCCCCEE
Confidence            356666666666665444455566666666666653                     133322222222   12345555


Q ss_pred             eccCc-cCCCCCCccccCCCCCcEEEccCcc-ccc
Q 001384          180 NLSLN-NLTGRIDTCFDGCLNLRYLDLSSNN-FRG  212 (1088)
Q Consensus       180 ~L~~n-~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~  212 (1088)
                      +|++| +|+...-..+..+++|++|+|+++. +++
T Consensus       120 ~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~~Itd  154 (176)
T 3e4g_A          120 EIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVKE  154 (176)
T ss_dssp             EEESCTTCCHHHHHHGGGCTTCCEEEEESCTTCCC
T ss_pred             EcCCCCcCCHHHHHHHhcCCCCCEEECCCCCCCCc
Confidence            55554 2444433456677888888888874 554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.60  E-value=0.00013  Score=83.42  Aligned_cols=77  Identities=18%  Similarity=0.138  Sum_probs=47.4

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEccccCc-------cchHHHHHHHHHHhCCCCCCCCCc-eeEEeeEEecCCeE
Q 001384          810 DRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-------EGEREFRAEMEVLSGNGFGWPHPN-LVTLYGWCLDGSEK  880 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~~~~~l~h~n-iv~l~~~~~~~~~~  880 (1088)
                      .+.+|.|..+.||++... +++.++||.......       .....+..|.+++..+..  ..+. +.+++.+  +....
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~--~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGE--HVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHT--TCGGGSCCEEEE--ETTTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhh--hCCCCcCeEEEE--cCCcc
Confidence            467999999999999864 468899998653211       122345677777765321  1133 3345544  34456


Q ss_pred             EEEEEecCCC
Q 001384          881 ILVYEYMEGG  890 (1088)
Q Consensus       881 ~lv~e~~~~g  890 (1088)
                      ++||||+++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.58  E-value=5.3e-06  Score=83.36  Aligned_cols=116  Identities=14%  Similarity=0.127  Sum_probs=76.1

Q ss_pred             ccccccCCccCCeeeCCCC-CCCC----CcCccCCCCCCCcEEECccccccCcc------cCCCCCCCceeecccccccc
Q 001384           95 IFNNFSALTQLSYLDLSRN-TFSG----SIPDDLSSCRSLKYLNLSHNILSGDL------NLSGLRSLEILDLSVNRIHG  163 (1088)
Q Consensus        95 ~~~~l~~l~~L~~L~Ls~n-~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~------~l~~l~~L~~L~Ls~N~l~~  163 (1088)
                      +...+.+-+.|++|+|++| +|..    .+.+.+..-+.|+.|+|++|.|.+..      .+..-+.|++|+|++|.|++
T Consensus        33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            3444556688888999885 7754    24556677788888888888887432      24456788888888888887


Q ss_pred             cccCchhhhc---ccceEEeccCc---cCCC----CCCccccCCCCCcEEEccCccc
Q 001384          164 EISFSFPAIC---EKLVVANLSLN---NLTG----RIDTCFDGCLNLRYLDLSSNNF  210 (1088)
Q Consensus       164 ~~~~~~~~~~---~~L~~L~L~~n---~l~~----~~~~~l~~l~~L~~L~Ls~N~l  210 (1088)
                      .....+...+   ..|++|+|++|   .+..    .+...+...+.|+.|+++.|.+
T Consensus       113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            7666665543   34777777654   2232    1334455566677777766654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.57  E-value=3.4e-05  Score=76.01  Aligned_cols=34  Identities=9%  Similarity=0.015  Sum_probs=14.7

Q ss_pred             CCcEEEccCccccCCCccccCCCCCCCEEeCCCC
Q 001384          269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN  302 (1088)
Q Consensus       269 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  302 (1088)
                      +|++||++++.++...-..+..+++|++|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            3444444444444333333344444444444444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.00049  Score=74.85  Aligned_cols=78  Identities=28%  Similarity=0.366  Sum_probs=55.6

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC--CCCCCceeEEeeEEecCCeEEEEE
Q 001384          807 FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF--GWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       807 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~--~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ....+.+|.|..+.||+.+..+|+.|+||+...........+..|.+.|+.+..  ....|.   ++++.    ..++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~---v~~~~----~~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQ---VAGWD----DRTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCC---EEEEE----TTEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcce---EEecc----CceEEE
Confidence            444577999999999999999999999999776544445567888887775432  233343   34432    247899


Q ss_pred             EecCCCC
Q 001384          885 EYMEGGS  891 (1088)
Q Consensus       885 e~~~~gs  891 (1088)
                      ||++++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.54  E-value=0.00014  Score=84.04  Aligned_cols=77  Identities=13%  Similarity=0.127  Sum_probs=47.4

Q ss_pred             CCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccc-cccccccCccccCCC---CCCcchhHHHHHHHHHHH
Q 001384          927 PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI-AGTVGYVAPEYGQTW---QATTKGDVYSFGVLAMEL 1002 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el 1002 (1088)
                      +.++|||+++.||+++.++ ++++||+.+..-.+.- ...... .-...|.+|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998776 9999999887532110 000000 012346666654321   112335556778888877


Q ss_pred             HhC
Q 001384         1003 ATG 1005 (1088)
Q Consensus      1003 ltg 1005 (1088)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.51  E-value=0.00061  Score=76.09  Aligned_cols=142  Identities=20%  Similarity=0.284  Sum_probs=79.8

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCceeEEe-e--EEecCCeEEEEEEe
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVTLY-G--WCLDGSEKILVYEY  886 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~niv~l~-~--~~~~~~~~~lv~e~  886 (1088)
                      +.|+.|..+.||++...+| .+++|+....    ..++..|.+++..+.. .+..|.++... +  +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987654 5899988753    1233333333332110 13445555421 1  12345678899999


Q ss_pred             cCCCCHH--------------HHHhhc-C----C---------CCHHHH-------------------------------
Q 001384          887 MEGGSLE--------------DIISDR-T----R---------LTWRRR-------------------------------  907 (1088)
Q Consensus       887 ~~~gsL~--------------~~l~~~-~----~---------l~~~~~-------------------------------  907 (1088)
                      ++|.++.              ..+|.. .    +         -.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986531              111210 0    0         122211                               


Q ss_pred             HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          908 LDIAIDVARALVFLHH----------ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       908 ~~i~~qi~~~L~yLH~----------~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..+..++..++++|+.          ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1112234456667763          0124899999999999998888999999997753

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.37  E-value=4.9e-05  Score=76.35  Aligned_cols=70  Identities=17%  Similarity=0.176  Sum_probs=44.8

Q ss_pred             cCCCCCCCcEEECccc-cccCcc------cCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccc
Q 001384          122 DLSSCRSLKYLNLSHN-ILSGDL------NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCF  194 (1088)
Q Consensus       122 ~l~~l~~L~~L~Ls~n-~l~~~~------~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  194 (1088)
                      .+..-+.|++|+|++| .|....      .+..-+.|++|+|++|+|++.....+...                     +
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~a---------------------L   94 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIEL---------------------I   94 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHH---------------------H
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHH---------------------H
Confidence            3455677888888875 776421      35566778888888888876666555543                     3


Q ss_pred             cCCCCCcEEEccCccccc
Q 001384          195 DGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       195 ~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ...+.|++|+|++|.|++
T Consensus        95 ~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           95 ETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             HHCSSCCEEECCSSBCCH
T ss_pred             hcCCccCeEecCCCcCCH
Confidence            344556666666666654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.36  E-value=0.00046  Score=75.51  Aligned_cols=138  Identities=17%  Similarity=0.180  Sum_probs=88.5

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          810 DRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      .+.|+.|....+|+... +++.+++|+....   ....+..|.+.++.+... ....+.+++++....+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~-~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKT-NSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHT-TSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhh-CCCCcceEEEEeecCCceEEEEEeccC
Confidence            46789999999999987 4678889987643   345678887777654311 124566777777777889999999998


Q ss_pred             CCHH--------H---HHhhcC---C-------------------CCHHHHH---HHH----------------HHHHHH
Q 001384          890 GSLE--------D---IISDRT---R-------------------LTWRRRL---DIA----------------IDVARA  917 (1088)
Q Consensus       890 gsL~--------~---~l~~~~---~-------------------l~~~~~~---~i~----------------~qi~~~  917 (1088)
                      ..+.        +   .+|...   .                   -+|.+..   ++.                .+++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7541        1   223211   0                   1343321   111                111111


Q ss_pred             -HHHHHh-cCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          918 -LVFLHH-ECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       918 -L~yLH~-~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                       ...|.. ...+.+||+|+.+.||+++.++ +.|+|++
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223321 1235899999999999999887 8899974

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.95  E-value=0.00098  Score=62.51  Aligned_cols=57  Identities=21%  Similarity=0.356  Sum_probs=41.6

Q ss_pred             EEEccCCccc-ccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          613 VLNLTRNNFS-GEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       613 ~l~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      .++.++++|+ ..+|..+.  .+|+.|||++|+|+...+..|..+++|+.|+|++|+|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            4556666664 35665433  468899999999985555667889999999999999954

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.77  E-value=0.0065  Score=67.35  Aligned_cols=32  Identities=38%  Similarity=0.405  Sum_probs=27.8

Q ss_pred             CCeEecCCCCCCEEEcCC----CCEEEeecccceee
Q 001384          927 PPIVHRDVKASNVLLDKE----GKALVTDFGLARVV  958 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~----~~~kl~Dfg~a~~~  958 (1088)
                      +.++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    67999999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.74  E-value=0.011  Score=65.08  Aligned_cols=161  Identities=12%  Similarity=0.158  Sum_probs=87.2

Q ss_pred             ccCHHHHHHHcCCCCcc-----ceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCce
Q 001384          794 AFTYSDILKATGKFSED-----RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNL  867 (1088)
Q Consensus       794 ~~~~~~~~~~~~~~~~~-----~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~ni  867 (1088)
                      .++.+++...-.+|.+.     +.|+.|....||+....+| .+++|+.....  ....+..|.+++..+.. .+..|.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34555666555666552     3466788899999987655 68899887531  12234445554433211 1334544


Q ss_pred             eEEe-e--EEecCCeEEEEEEecCCCCHH-----H---------HHhhc----C-C----C---CHHHHHH---------
Q 001384          868 VTLY-G--WCLDGSEKILVYEYMEGGSLE-----D---------IISDR----T-R----L---TWRRRLD---------  909 (1088)
Q Consensus       868 v~l~-~--~~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~----~-~----l---~~~~~~~---------  909 (1088)
                      +... |  +....+..+++|+|++|..+.     .         .+|..    . +    .   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            4321 1  112245678999999886431     0         11211    0 0    0   1222100         


Q ss_pred             ---HHHHHHHHHHHHHhcC----CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          910 ---IAIDVARALVFLHHEC----YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       910 ---i~~qi~~~L~yLH~~~----~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                         +...+...++++++..    ..+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               0112445556665321    23799999999999998776568999997754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.68  E-value=0.0051  Score=68.01  Aligned_cols=143  Identities=15%  Similarity=0.105  Sum_probs=78.7

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCceeEEee--EEecCCeEEEEEEec
Q 001384          811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVTLYG--WCLDGSEKILVYEYM  887 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~niv~l~~--~~~~~~~~~lv~e~~  887 (1088)
                      ..++ |....||++...+|+.+++|+..... .....+..|..++..+.. .+.-|.++..-+  +...++..++||||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889999887778789999986431 133455666665544321 122333322201  112245668899999


Q ss_pred             CCCCHH-----H------H---Hhh----c-----CCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 001384          888 EGGSLE-----D------I---ISD----R-----TRLTWRRR----LDI---------------AIDVARALVFLHHE-  924 (1088)
Q Consensus       888 ~~gsL~-----~------~---l~~----~-----~~l~~~~~----~~i---------------~~qi~~~L~yLH~~-  924 (1088)
                      +|.++.     .      .   +|.    .     ...++...    ..+               ...+...++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875421     1      1   111    0     01222111    011               11111223333221 


Q ss_pred             ---CCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          925 ---CYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       925 ---~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                         ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               123689999999999998 4 899999988754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.49  E-value=0.021  Score=62.21  Aligned_cols=30  Identities=20%  Similarity=0.305  Sum_probs=25.8

Q ss_pred             CeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          928 PIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       928 ~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++|+|+.+.||+ ..++.+.++||..+..-
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            5899999999999 56778999999988653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.40  E-value=0.016  Score=58.22  Aligned_cols=101  Identities=17%  Similarity=0.140  Sum_probs=67.0

Q ss_pred             CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccc
Q 001384          891 SLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTI  969 (1088)
Q Consensus       891 sL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  969 (1088)
                      +|.++++.. .+++++++|.++.|.+.+|.-.-.+.  .-..+=+.|..|++..+|.|.+.+ ..+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            799999764 57999999999999999987763211  111233457899999999998764 1110             


Q ss_pred             cccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcC
Q 001384          970 AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRA 1008 (1088)
Q Consensus       970 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 1008 (1088)
                      .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            1223567888764 3667889999999999998854433

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.39  E-value=0.0048  Score=69.28  Aligned_cols=139  Identities=17%  Similarity=0.198  Sum_probs=80.3

Q ss_pred             ceecccCceEEEEEEeC--------CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.+..|-...+|++...        +++.+++|+.... ........+|.++++.+.   .+.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~---~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILA---ERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHH---HTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHH---hcCCCCeEEEEcCC----cc
Confidence            56777888899999864        2478999987432 223445667877775433   12222455665543    28


Q ss_pred             EEEecCCCCHH--------------HH---HhhcC-----CCC--HHHHHHHHHHHHH-------------------HHH
Q 001384          883 VYEYMEGGSLE--------------DI---ISDRT-----RLT--WRRRLDIAIDVAR-------------------ALV  919 (1088)
Q Consensus       883 v~e~~~~gsL~--------------~~---l~~~~-----~l~--~~~~~~i~~qi~~-------------------~L~  919 (1088)
                      ||||++|.++.              +.   +|...     ...  +.++.++..++..                   .++
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            99999876542              11   12211     122  4555555544422                   233


Q ss_pred             HHHh----c-CCCCeEecCCCCCCEEEcCC----CCEEEeeccccee
Q 001384          920 FLHH----E-CYPPIVHRDVKASNVLLDKE----GKALVTDFGLARV  957 (1088)
Q Consensus       920 yLH~----~-~~~~ivH~DLkp~NIll~~~----~~~kl~Dfg~a~~  957 (1088)
                      +|.+    . ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3322    1 12368999999999999876    7899999998864

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.35  E-value=0.0053  Score=57.45  Aligned_cols=58  Identities=22%  Similarity=0.259  Sum_probs=43.7

Q ss_pred             cEEEccCCcCC-CCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          416 QTLDLSFNELT-GPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       416 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ..++.+++.|+ ..+|..+.  .+|++|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence            36778888876 34665443  468888999999885555667888999999999999864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.25  E-value=0.025  Score=62.73  Aligned_cols=32  Identities=25%  Similarity=0.413  Sum_probs=28.3

Q ss_pred             CCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          927 PPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      ..++|+|+.+.||+++.++.+.++||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998889999999887653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.16  E-value=0.0082  Score=68.98  Aligned_cols=72  Identities=18%  Similarity=0.128  Sum_probs=45.3

Q ss_pred             ceecccCceEEEEEEeCC--------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.|+.|....||++...+        ++.+++|+....  .....+..|..++..+.   .+.-..++++.+.+    .+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~---~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLS---ERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHH---HTTSSSCEEEEETT----EE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHH---hCCCCCcEEEEeCC----CE
Confidence            568888889999998653        578999988542  11134556777666432   12222455665432    38


Q ss_pred             EEEecCCCC
Q 001384          883 VYEYMEGGS  891 (1088)
Q Consensus       883 v~e~~~~gs  891 (1088)
                      |+||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.85  E-value=0.026  Score=65.15  Aligned_cols=74  Identities=12%  Similarity=0.038  Sum_probs=43.3

Q ss_pred             ceecccCceEEEEEEeCC-CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCC
Q 001384          811 RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEG  889 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  889 (1088)
                      +.|+.|-...+|++...+ ++.+++|+..... ....+...|..++..+.   .+.-..++++++.  +  .+||||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~---~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILY---NKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHT---TSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHH---hcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            568888889999999764 4788899875432 11111245666665533   1222346666653  2  359999987


Q ss_pred             CCH
Q 001384          890 GSL  892 (1088)
Q Consensus       890 gsL  892 (1088)
                      .++
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.34  E-value=0.019  Score=64.65  Aligned_cols=30  Identities=17%  Similarity=0.306  Sum_probs=25.0

Q ss_pred             CCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          927 PPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       927 ~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++|+|+.+.||+++.++ +.++||+.+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            3689999999999997654 89999998764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.23  E-value=0.15  Score=57.89  Aligned_cols=29  Identities=17%  Similarity=0.445  Sum_probs=26.4

Q ss_pred             CeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          928 PIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       928 ~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            6899999999999 8888999999998865

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.63  E-value=0.55  Score=47.23  Aligned_cols=124  Identities=10%  Similarity=0.139  Sum_probs=85.8

Q ss_pred             HHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001384          850 AEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPI  929 (1088)
Q Consensus       850 ~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i  929 (1088)
                      .|+..+..     .||++++. .+-.+++.+.+.++.-+  ...+|-. -...+..++++++.+|+....+++..     
T Consensus        35 ~el~LL~~-----~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~r-----  100 (215)
T 4ann_A           35 HLMYLLEQ-----HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRTR-----  100 (215)
T ss_dssp             GGGGGGGS-----CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGSS-----
T ss_pred             HHHHHHhc-----cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcCc-----
Confidence            45666653     79999866 45566666655555543  2222211 23478999999999999999877766     


Q ss_pred             EecCCCCCCEEEcCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCC
Q 001384          930 VHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRAL 1009 (1088)
Q Consensus       930 vH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~ 1009 (1088)
                      +|--+.|+|++++.++.+++.-.|+...+                  +|.     ..+...=.-.+=+++..+++++..|
T Consensus       101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          101 YTFVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             eEEEEecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            89999999999999999999877653222                  221     2233333445678888899998888


Q ss_pred             C
Q 001384         1010 E 1010 (1088)
Q Consensus      1010 ~ 1010 (1088)
                      +
T Consensus       158 e  158 (215)
T 4ann_A          158 D  158 (215)
T ss_dssp             H
T ss_pred             H
Confidence            5

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.58  E-value=2.8  Score=42.26  Aligned_cols=115  Identities=12%  Similarity=0.132  Sum_probs=80.2

Q ss_pred             CCCceeEEeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCCEEE
Q 001384          863 PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV-FLHHECYPPIVHRDVKASNVLL  941 (1088)
Q Consensus       863 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~~ivH~DLkp~NIll  941 (1088)
                      .||++  -...-.+++.+.+.++.-+++.=..-+   ..++..++++++.+|+.... +++..     +|--+.|+|+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEE
Confidence            68888  444456777777777766443222333   34789999999999998888 77766     888999999999


Q ss_pred             cCCCCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCC
Q 001384          942 DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALE 1010 (1088)
Q Consensus       942 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~ 1010 (1088)
                      |.++.+++.-.|+-..                  ++|.     ..+...=.-.+=+++..++.++..|+
T Consensus       118 ~~~~~p~i~hRGi~~~------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          118 NRALEPFFLHVGVKES------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CTTCCEEESCCEETTT------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eCCCcEEEEEcCCccc------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999987775432                  2222     22222233456678888888887775

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=86.04  E-value=1.8  Score=48.74  Aligned_cols=30  Identities=27%  Similarity=0.507  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCEEE------cCCCCEEEeeccccee
Q 001384          928 PIVHRDVKASNVLL------DKEGKALVTDFGLARV  957 (1088)
Q Consensus       928 ~ivH~DLkp~NIll------~~~~~~kl~Dfg~a~~  957 (1088)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999998865

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1088
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-46
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-44
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-31
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-30
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-14
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-11
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-11
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-11
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-09
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	8e-07
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	9e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	7e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 2e-66
 Identities = 68/285 (23%), Positives = 127/285 (44%), Gaps = 26/285 (9%)

Query: 805  GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            G+ +  + IG G FGTVY+G       V +  +     +  + F+ E+ VL        H
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK----TRH 63

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHH 923
             N++   G+     +  +V ++ EG SL   +    T+    + +DIA   A+ + +LH 
Sbjct: 64   VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPEYGQ 982
                 I+HRD+K++N+ L ++    + DFGLA V S    SH    ++G++ ++APE  +
Sbjct: 123  ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 983  TWQA---TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
                   + + DVY+FG++  EL TG+           +    ++G G   P  + +   
Sbjct: 180  MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLSKVR-- 235

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                     +     + R+   C  +  + RP   ++LA +  + 
Sbjct: 236  ---------SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-62
 Identities = 73/277 (26%), Positives = 111/277 (40%), Gaps = 28/277 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
                   +G G FG V+ G      +VAVK L ++G      F AE  ++        H 
Sbjct: 14   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ----LQHQ 68

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLHH 923
             LV LY          ++ EYME GSL D +      +LT  + LD+A  +A  + F+  
Sbjct: 69   RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                  +HRD++A+N+L+       + DFGLAR++   +          + + APE    
Sbjct: 128  RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               T K DV+SFG+L  E+ T  R    G                      VI  +  G 
Sbjct: 185  GTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----------------TNPEVIQNLERGY 227

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +        EL ++   C  E P  RP    + ++L
Sbjct: 228  RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 2e-62
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 26/279 (9%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
             +  + IG G FG V+ G   +  +VA+K + REG   E +F  E EV+        HP 
Sbjct: 7    LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMK----LSHPK 61

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRL-TWRRRLDIAIDVARALVFLHHEC 925
            LV LYG CL+ +   LV+E+ME G L D +  +  L      L + +DV   +    +  
Sbjct: 62   LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLE 118

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
               ++HRD+ A N L+ +     V+DFG+ R V       ST     V + +PE     +
Sbjct: 119  EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 986  ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045
             ++K DV+SFGVL  E+ +  +                           V+  +  G  L
Sbjct: 179  YSSKSDVWSFGVLMWEVFSEGKIPYENR-----------------SNSEVVEDISTGFRL 221

Query: 1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             +     + + +I   C  E P  RP    +L  L +I 
Sbjct: 222  YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 3e-62
 Identities = 71/300 (23%), Positives = 128/300 (42%), Gaps = 36/300 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
             F +   +G G  G V++    P G  +A K +  E     R     E++VL        
Sbjct: 7    DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
             P +V  YG      E  +  E+M+GGSL+ ++    R+  +    ++I V + L +L  
Sbjct: 63   SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
            +    I+HRDVK SN+L++  G+  + DFG++  +      ++ +  GT  Y++PE  Q 
Sbjct: 123  KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGG--EECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
               + + D++S G+  +E+A GR  +     +E  + +G +V G     P R   P   L
Sbjct: 178  THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 1042 GSGLAEGAEEMS-----------------------ELLRIGVRCTAEAPNARPNVKEVLA 1078
             S   +    M+                       E      +C  + P  R ++K+++ 
Sbjct: 238  SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-60
 Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 26/278 (9%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPN 866
             +  + +G G FG V  G      +VA+K + +EG   E EF  E +V+        H  
Sbjct: 6    LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMN----LSHEK 60

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHEC 925
            LV LYG C       ++ EYM  G L + + +   R   ++ L++  DV  A+ +L    
Sbjct: 61   LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-- 118

Query: 926  YPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQ 985
                +HRD+ A N L++ +G   V+DFGL+R V   +   S      V +  PE     +
Sbjct: 119  -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 986  ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGL 1045
             ++K D+++FGVL  E+ +  +                               +  G  L
Sbjct: 178  FSSKSDIWAFGVLMWEIYSLGKMPYERF-----------------TNSETAEHIAQGLRL 220

Query: 1046 AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                    ++  I   C  E  + RP  K +L+ ++ +
Sbjct: 221  YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 2e-60
 Identities = 71/311 (22%), Positives = 134/311 (43%), Gaps = 43/311 (13%)

Query: 795  FTYSDILKATGKFSE---------DRIIGKGGFGTVYRGVLP----DGREVAVKKLQREG 841
            FT+ D  +A  +F++         +++IG G FG V  G L         VA+K L+   
Sbjct: 7    FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 842  LEGE-REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT 900
             E + R+F +E  ++      + HPN++ L G     +  +++ E+ME GSL+  +    
Sbjct: 67   TEKQRRDFLSEASIMGQ----FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122

Query: 901  -RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
             + T  + + +   +A  + +L        VHRD+ A N+L++      V+DFGL+R + 
Sbjct: 123  GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 960  AGDSHVSTT----IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC 1015
               S  + T        + + APE  Q  + T+  DV+S+G++  E+ +           
Sbjct: 180  DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-- 237

Query: 1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKE 1075
                             + VI  +     L    +  S L ++ + C  +  N RP   +
Sbjct: 238  ---------------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 1076 VLAMLIKILPH 1086
            ++  L K++ +
Sbjct: 283  IVNTLDKMIRN 293

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 9e-60
 Identities = 74/277 (26%), Positives = 113/277 (40%), Gaps = 28/277 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
                +  +G+G FG V+ G       VA+K L + G      F  E +V+        H 
Sbjct: 18   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKK----LRHE 72

Query: 866  NLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLHH 923
             LV LY    +     +V EYM  GSL D +   T   L   + +D+A  +A  + ++  
Sbjct: 73   KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                  VHRD++A+N+L+ +     V DFGLAR++   +          + + APE    
Sbjct: 132  MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
             + T K DV+SFG+L  EL T  R    G                    R V+  V  G 
Sbjct: 189  GRFTIKSDVWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQVERGY 231

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
             +    E    L  +  +C  + P  RP  + + A L
Sbjct: 232  RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-58
 Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 28/295 (9%)

Query: 811  RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTL 870
              IGKG FG V+RG    G EVAVK         ER +  E E+         H N++  
Sbjct: 9    ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVML--RHENILGF 62

Query: 871  YGWCLDGSEKI----LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
                   +       LV +Y E GSL D + +R  +T    + +A+  A  L  LH E  
Sbjct: 63   IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 927  -----PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS---TTIAGTVGYVAP 978
                 P I HRD+K+ N+L+ K G   + D GLA    +    +        GT  Y+AP
Sbjct: 122  GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 979  EY------GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            E        + +++  + D+Y+ G++  E+A         E+  + +   V         
Sbjct: 182  EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 1033 RAVIPVVLLGSGLAEG---AEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
            R V+    L   +       E +  + +I   C      AR     +   L ++ 
Sbjct: 242  RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 2e-58
 Identities = 80/284 (28%), Positives = 120/284 (42%), Gaps = 34/284 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +    + IGKG FG V  G    G +VAVK ++ +     + F AE  V++       H 
Sbjct: 8    ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQ----LRHS 60

Query: 866  NLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTR--LTWRRRLDIAIDVARALVFLH 922
            NLV L G  ++    + +V EYM  GSL D +  R R  L     L  ++DV  A+ +L 
Sbjct: 61   NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                   VHRD+ A NVL+ ++  A V+DFGL +  S        T    V + APE  +
Sbjct: 121  G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALR 173

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
              + +TK DV+SFG+L  E+ +  R                       P + V+P V  G
Sbjct: 174  EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----------------PLKDVVPRVEKG 216

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086
              +         +  +   C       RP+  ++   L  I  H
Sbjct: 217  YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-58
 Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 34/282 (12%)

Query: 805  GKFSE-DRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL--EGEREFRAEMEVLSGNGF 860
            G+F + D  IG+G F TVY+G+  +   EVA  +LQ   L     + F+ E E+L G   
Sbjct: 8    GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG--- 64

Query: 861  GWPHPNLVTLYGWCLDGSEK----ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
               HPN+V  Y       +     +LV E M  G+L+  +     +  +        + +
Sbjct: 65   -LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
             L FLH    PPI+HRD+K  N+ +    G   + D GLA +     +  +  + GT  +
Sbjct: 124  GLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEF 179

Query: 976  VAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035
            +APE  +  +     DVY+FG+  +E+AT        +     + R   G       +  
Sbjct: 180  MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238

Query: 1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            IP             E+ E++     C  +  + R ++K++L
Sbjct: 239  IP-------------EVKEIIE---GCIRQNKDERYSIKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-57
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 32/279 (11%)

Query: 809  EDRIIGKGGFGTVYRGVLPD---GREVAVKKLQREGLEGE--REFRAEMEVLSGNGFGWP 863
            ED+ +G G FGTV +G        + VAVK L+ E  +     E  AE  V+        
Sbjct: 11   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LD 66

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
            +P +V + G C +    +LV E  E G L   +     +  +  +++   V+  + +L  
Sbjct: 67   NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT--IAGTVGYVAPEYG 981
                  VHRD+ A NVLL  +  A ++DFGL++ + A +++          V + APE  
Sbjct: 126  SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
              ++ ++K DV+SFGVL  E  +  +    G                   G  V  ++  
Sbjct: 183  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----------------KGSEVTAMLEK 225

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G  +   A    E+  +   C       RP    V   L
Sbjct: 226  GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (502), Expect = 2e-57
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 28/282 (9%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
              +    +G G +G VY GV       VAVK L+ + +E E EF  E  V+        H
Sbjct: 18   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE----IKH 72

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDII--SDRTRLTWRRRLDIAIDVARALVFLH 922
            PNLV L G C       ++ E+M  G+L D +   +R  ++    L +A  ++ A+ +L 
Sbjct: 73   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                   +HRD+ A N L+ +     V DFGL+R+++             + + APE   
Sbjct: 133  K---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
              + + K DV++FGVL  E+AT   +   G +                    V  ++   
Sbjct: 190  YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKD 232

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
              +        ++  +   C    P+ RP+  E+      + 
Sbjct: 233  YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 6e-57
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 34/283 (12%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGW 862
             +     IG G +G   +     DG+ +  K+L    +    ++   +E+ +L       
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE----L 60

Query: 863  PHPNLVTLYGWCLDGSEKIL--VYEYMEGGSLEDIISDRTR----LTWRRRLDIAIDVAR 916
             HPN+V  Y   +D +   L  V EY EGG L  +I+  T+    L     L +   +  
Sbjct: 61   KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 917  ALVFLH--HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVG 974
            AL   H   +    ++HRD+K +NV LD +    + DFGLAR+++  D+  +    GT  
Sbjct: 121  ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 179

Query: 975  YVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRA 1034
            Y++PE         K D++S G L  EL           +      + + G  R G  R 
Sbjct: 180  YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGKFRR 233

Query: 1035 VIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
            +             ++E++E++    R        RP+V+E+L
Sbjct: 234  IPYRY---------SDELNEIIT---RMLNLKDYHRPSVEEIL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 7e-57
 Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 33/291 (11%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDG-----REVAVKKLQREGLEGER-EFRAEMEVLSGNGF 860
             +  ++IG G FG VY+G+L          VA+K L+    E +R +F  E  ++     
Sbjct: 9    VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS- 67

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALV 919
               H N++ L G        +++ EYME G+L+  + ++    +  + + +   +A  + 
Sbjct: 68   ---HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM- 123

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIA--GTVGYVA 977
               +      VHRD+ A N+L++      V+DFGL+RV+        TT      + + A
Sbjct: 124  --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 978  PEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037
            PE     + T+  DV+SFG++  E+ T                              V+ 
Sbjct: 182  PEAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------PYWELSNHEVMK 224

Query: 1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD 1088
             +  G  L    +  S + ++ ++C  +    RP   +++++L K++   D
Sbjct: 225  AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 1e-56
 Identities = 66/281 (23%), Positives = 104/281 (37%), Gaps = 36/281 (12%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE---REFRAEMEVLSGNG 859
               FS+ R IG G FG VY    + +   VA+KK+   G +     ++   E+  L    
Sbjct: 14   EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-- 71

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALV 919
                HPN +   G  L      LV EY  G + + +   +  L       +     + L 
Sbjct: 72   --LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +LH      ++HRDVKA N+LL + G   + DFG A ++       + +  GT  ++APE
Sbjct: 130  YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPE 181

Query: 980  YGQTW---QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036
                    Q   K DV+S G+  +ELA  +  L       +     +             
Sbjct: 182  VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPALQSGHW 239

Query: 1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                         E     +     C  + P  RP  + +L
Sbjct: 240  S------------EYFRNFVD---SCLQKIPQDRPTSEVLL 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (498), Expect = 1e-56
 Identities = 72/311 (23%), Positives = 121/311 (38%), Gaps = 56/311 (18%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLEGER-EFRAEMEVLSGN 858
                 R IG+G FG V++   P          VAVK L+ E     + +F+ E  +++  
Sbjct: 14   NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE- 72

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTR----------------- 901
               + +PN+V L G C  G    L++EYM  G L + +   +                  
Sbjct: 73   ---FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 902  -------LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL 954
                   L+   +L IA  VA  + +L        VHRD+   N L+ +     + DFGL
Sbjct: 130  SSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 955  ARVVSAGD-SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
            +R + + D        A  + ++ PE     + TT+ DV+++GV+  E+ +       G 
Sbjct: 187  SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 1014 ECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNV 1073
                                 VI  V  G+ LA       EL  +   C ++ P  RP+ 
Sbjct: 247  -----------------AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 289

Query: 1074 KEVLAMLIKIL 1084
              +  +L ++ 
Sbjct: 290  CSIHRILQRMC 300

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-56
 Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 32/279 (11%)

Query: 809  EDRIIGKGGFGTVYRGVL---PDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWPH 864
             D  +G G FG+V +GV        +VA+K L++   + + E    E +++        +
Sbjct: 13   ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----LDN 68

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLED-IISDRTRLTWRRRLDIAIDVARALVFLHH 923
            P +V L G C      +LV E   GG L   ++  R  +      ++   V+  + +L  
Sbjct: 69   PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPEYG 981
                  VHRD+ A NVLL     A ++DFGL++ + A DS+    +     + + APE  
Sbjct: 128  ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
               + +++ DV+S+GV   E  +  +                        G  V+  +  
Sbjct: 185  NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----------------KGPEVMAFIEQ 227

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            G  +    E   EL  +   C       RP+   V   +
Sbjct: 228  GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-56
 Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 31/279 (11%)

Query: 807  FSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQRE-GLEGEREFRAEMEVLSGNGF 860
            F ED    + +G+G +G V   V       VAVK +  +  ++     + E+ +      
Sbjct: 3    FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN- 61

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVF 920
               H N+V  YG   +G+ + L  EY  GG L D I     +           +   +V+
Sbjct: 62   ---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 921  LHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD-SHVSTTIAGTVGYVAPE 979
            LH      I HRD+K  N+LLD+     ++DFGLA V    +   +   + GT+ YVAPE
Sbjct: 119  LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 980  YGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038
              +  +      DV+S G++   +  G    +   +   E+           P + +   
Sbjct: 176  LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS- 234

Query: 1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                            LL    +   E P+AR  + ++ 
Sbjct: 235  ------------APLALLH---KILVENPSARITIPDIK 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-56
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 34/285 (11%)

Query: 810  DRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGWPH 864
            + +IG+G FG VY G L D        AVK L R    GE  +F  E  ++      + H
Sbjct: 32   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSH 87

Query: 865  PNLVTLYGWCLDGSEKI-LVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLH 922
            PN+++L G CL       +V  YM+ G L + I + T   T +  +   + VA+ +    
Sbjct: 88   PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIAGTVGYVAPE 979
                   VHRD+ A N +LD++    V DFGLAR +   +    H  T     V ++A E
Sbjct: 145  FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
              QT + TTK DV+SFGVL  EL T             +    ++   R           
Sbjct: 205  SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRR----------- 252

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                 L +       L  + ++C       RP+  E+++ +  I 
Sbjct: 253  -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-55
 Identities = 75/276 (27%), Positives = 117/276 (42%), Gaps = 33/276 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFG 861
             F   R +GKG FG VY          +A+K L +  LE    E + R E+E+ S     
Sbjct: 7    DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH---- 62

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              HPN++ LYG+  D +   L+ EY   G++   +   ++   +R      ++A AL + 
Sbjct: 63   LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H +    ++HRD+K  N+LL   G+  + DFG +       S   TT+ GT+ Y+ PE  
Sbjct: 123  HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMI 176

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
            +      K D++S GVL  E   G+   E               Y R        P  + 
Sbjct: 177  EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFPDFV- 227

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                    E   +L+    R     P+ RP ++EVL
Sbjct: 228  -------TEGARDLIS---RLLKHNPSQRPMLREVL 253

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-55
 Identities = 73/305 (23%), Positives = 118/305 (38%), Gaps = 48/305 (15%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGERE-FRAEMEVLSGN 858
            + S  + +G G FG V                VAVK L+      ERE   +E++VLS  
Sbjct: 24   RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII------------------SDRT 900
            G    H N+V L G C  G   +++ EY   G L + +                   D  
Sbjct: 84   G---NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 901  RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
             L     L  +  VA+ + FL  +     +HRD+ A N+LL       + DFGLAR +  
Sbjct: 141  ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 961  GDSHVSTT-IAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
              ++V        V ++APE       T + DV+S+G+   EL +   +   G     ++
Sbjct: 198  DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
             + +         R + P               +E+  I   C    P  RP  K+++ +
Sbjct: 258  YKMI-----KEGFRMLSP-----------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 1080 LIKIL 1084
            + K +
Sbjct: 302  IEKQI 306

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 8e-55
 Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 53/306 (17%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPD------GREVAVKKLQREGLEGERE-FRAEMEVLSGN 858
                 +++G G FG V               +VAVK L+ +    ERE   +E+++++  
Sbjct: 38   NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR------------------- 899
            G    H N+V L G C       L++EY   G L + +  +                   
Sbjct: 98   G---SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 900  ----TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA 955
                  LT+   L  A  VA+ + FL        VHRD+ A NVL+       + DFGLA
Sbjct: 155  EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 956  RVVSAGDSHVS-TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            R + +  ++V        V ++APE       T K DV+S+G+L  E+ +       G  
Sbjct: 212  RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 1015 CLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVK 1074
                + + +         +   P            EE+  +++    C A     RP+  
Sbjct: 272  VDANFYKLI-----QNGFKMDQPFYA--------TEEIYIIMQ---SCWAFDSRKRPSFP 315

Query: 1075 EVLAML 1080
             + + L
Sbjct: 316  NLTSFL 321

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 5e-54
 Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGW 862
              K++    IG+G  GTVY  + +  G+EVA++++  +    +     E+ V+  N    
Sbjct: 19   KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--- 75

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             +PN+V      L G E  +V EY+ GGSL D++   T +   +   +  +  +AL FLH
Sbjct: 76   -NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLH 133

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  ++HRD+K+ N+LL  +G   +TDFG    ++   S   +T+ GT  ++APE   
Sbjct: 134  SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVT 189

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
                  K D++S G++A+E+  G           +     +     +G      P  L  
Sbjct: 190  RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIA---TNGTPELQNPEKL-- 242

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                  +    + L    RC       R + KE+L
Sbjct: 243  ------SAIFRDFLN---RCLDMDVEKRGSAKELL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 8e-54
 Identities = 57/275 (20%), Positives = 110/275 (40%), Gaps = 31/275 (11%)

Query: 811  RIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
              +G G FG VY+    +     A K +  +  E   ++  E+++L+       HPN+V 
Sbjct: 18   GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD----HPNIVK 73

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDRTR-LTWRRRLDIAIDVARALVFLHHECYPP 928
            L       +   ++ E+  GG+++ ++ +  R LT  +   +      AL +LH      
Sbjct: 74   LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---K 130

Query: 929  IVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-- 986
            I+HRD+KA N+L   +G   + DFG++   +        +  GT  ++APE      +  
Sbjct: 131  IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKD 189

Query: 987  ---TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
                 K DV+S G+  +E+A             +    ++    +  P     P      
Sbjct: 190  RPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIA---KSEPPTLAQPSRW--- 241

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                 +    + L+   +C  +  +AR    ++L 
Sbjct: 242  -----SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-53
 Identities = 69/292 (23%), Positives = 131/292 (44%), Gaps = 32/292 (10%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGRE----VAVKKLQREG-LEGEREFRAEME 853
            ILK T +F + +++G G FGTVY+G+ +P+G +    VA+K+L+     +  +E   E  
Sbjct: 5    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 854  VLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
            V++       +P++  L G CL  + +++      G  L+ +   +  +  +  L+  + 
Sbjct: 64   VMAS----VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTT-IAGT 972
            +A+ + +L       +VHRD+ A NVL+       +TDFGLA+++ A +           
Sbjct: 120  IAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032
            + ++A E       T + DV+S+GV   EL T       G                  P 
Sbjct: 177  IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----------------PA 219

Query: 1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
              +  ++  G  L +      ++  I V+C     ++RP  +E++    K+ 
Sbjct: 220  SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-53
 Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 45/298 (15%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPDG---REVAVKKLQREGL-EGEREFRAEMEVLSGNGFGW 862
                 +IG+G FG V +  +       + A+K+++     +  R+F  E+EVL   G   
Sbjct: 12   IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--- 68

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SDRTRLTWRR 906
             HPN++ L G C       L  EY   G+L D +                S  + L+ ++
Sbjct: 69   HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 907  RLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS 966
             L  A DVAR    + +      +HRD+ A N+L+ +   A + DFGL+R          
Sbjct: 129  LLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183

Query: 967  TTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGY 1026
            T     V ++A E       TT  DV+S+GVL  E+ +       G  C   + +   GY
Sbjct: 184  TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 1027 GRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                P                  +E+ +L+R   +C  E P  RP+  ++L  L ++L
Sbjct: 244  RLEKPLNC--------------DDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 284

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 8e-53
 Identities = 68/285 (23%), Positives = 109/285 (38%), Gaps = 31/285 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLEGERE-FRAEMEVLSGNGF 860
            +    R IG+G FG V++G+          VA+K  +    +  RE F  E   +     
Sbjct: 8    RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ--- 64

Query: 861  GWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALV 919
             + HP++V L G   +     ++ E    G L   +  R   L     +  A  ++ AL 
Sbjct: 65   -FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 920  FLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
            +L        VHRD+ A NVL+       + DFGL+R +     + ++     + ++APE
Sbjct: 123  YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
                 + T+  DV+ FGV   E+         G +     GR   G     P        
Sbjct: 180  SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC----- 234

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                        +  L+    +C A  P+ RP   E+ A L  IL
Sbjct: 235  ---------PPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTIL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-52
 Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 32/286 (11%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE---REFRAEMEVLSGNGFG 861
             F   +I+G+G F TV     L   RE A+K L++  +  E        E +V+S     
Sbjct: 9    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              HP  V LY    D  +      Y + G L   I                ++  AL +L
Sbjct: 67   --HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEY 980
            H      I+HRD+K  N+LL+++    +TDFG A+V+S       + +  GT  YV+PE 
Sbjct: 125  HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040
                 A    D+++ G +  +L  G      G E L+        + +        P   
Sbjct: 182  LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--------FQKIIKLEYDFPEKF 233

Query: 1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086
                      +  +L+    +        R   +E+      +  H
Sbjct: 234  --------FPKARDLVE---KLLVLDATKRLGCEEMEGYG-PLKAH 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-51
 Identities = 69/283 (24%), Positives = 104/283 (36%), Gaps = 34/283 (12%)

Query: 811  RIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWP 863
              +G G FG V RG           VAVK L+ + L   E   +F  E+  +        
Sbjct: 14   EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS----LD 69

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDI-ISDRTRLTWRRRLDIAIDVARALVFLH 922
            H NL+ LYG  L    K+ V E    GSL D     +           A+ VA  + +L 
Sbjct: 70   HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSH--VSTTIAGTVGYVAPEY 980
             +     +HRD+ A N+LL       + DFGL R +   D H  +         + APE 
Sbjct: 129  SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 981  GQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040
             +T   +   D + FGV   E+ T  +    G     +   ++   G   P     P   
Sbjct: 186  LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPRPEDCP--- 241

Query: 1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083
                         ++  + V+C A  P  RP    +   L++ 
Sbjct: 242  ------------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  182 bits (462), Expect = 3e-51
 Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 28/277 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
             +     +G G FG V+R      G   A K +       +   R E++ +S       H
Sbjct: 27   HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRH 82

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHH 923
            P LV L+    D +E +++YE+M GG L + ++D   +++    ++    V + L  +H 
Sbjct: 83   PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 924  ECYPPIVHRDVKASNVLL--DKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
                  VH D+K  N++    +  +  + DFGL   +    S   TT  GT  + APE  
Sbjct: 143  NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
            +        D++S GVL+  L +G     G  +         +   +             
Sbjct: 198  EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMDDSAFSG 251

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
             S      E+  + +R   +     PN R  + + L 
Sbjct: 252  IS------EDGKDFIR---KLLLADPNTRMTIHQALE 279

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-50
 Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 42/297 (14%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLEGER-EFRAEMEVLSGN 858
            K +  R +G+G FG VY GV            VA+K +       ER EF  E  V+   
Sbjct: 21   KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 859  GFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------SDRTRLTWRRRL 908
                   ++V L G    G   +++ E M  G L+  +                +  + +
Sbjct: 81   N----CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 909  DIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVST 967
             +A ++A  + +L+       VHRD+ A N ++ ++    + DFG+ R +   D      
Sbjct: 137  QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 968  TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYG 1027
                 V +++PE  +    TT  DV+SFGV+  E+AT       G               
Sbjct: 194  KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------------- 239

Query: 1028 RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
                   V+  V+ G  L +       L  +   C    P  RP+  E+++ + + +
Sbjct: 240  ---SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-50
 Identities = 70/305 (22%), Positives = 124/305 (40%), Gaps = 49/305 (16%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLP--------DGREVAVKKLQREGLEGE-REFRAEMEVLS 856
            +    + +G+G FG V                 +VAVK L+ +  E +  +  +EME++ 
Sbjct: 14   RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 857  GNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDII----------------SDRT 900
              G    H N++ L G C       ++ EY   G+L + +                +   
Sbjct: 74   MIG---KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 901  RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
            +L+ +  +  A  VAR    + +      +HRD+ A NVL+ ++    + DFGLAR +  
Sbjct: 131  QLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 961  GDSHVST-TIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW 1019
             D +  T      V ++APE       T + DV+SFGVL  E+ T   +   G       
Sbjct: 188  IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------ 241

Query: 1020 GRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
                       P   +  ++  G  + + +   +EL  +   C    P+ RP  K+++  
Sbjct: 242  -----------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 1080 LIKIL 1084
            L +I+
Sbjct: 291  LDRIV 295

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 1e-49
 Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 23/275 (8%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSGNGFGWP 863
             +    ++G G F  V         + VA+K + ++ LEG+      E+ VL        
Sbjct: 10   IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK---- 65

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
            HPN+V L      G    L+ + + GG L D I ++   T R    +   V  A+ +LH 
Sbjct: 66   HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                    +        LD++ K +++DFGL+++       V +T  GT GYVAPE    
Sbjct: 126  LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVLAQ 183

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043
               +   D +S GV+A  L  G        +  +        Y    P    I       
Sbjct: 184  KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS------ 237

Query: 1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                  +   + +R       + P  R   ++ L 
Sbjct: 238  ------DSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (450), Expect = 2e-49
 Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 28/272 (10%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
              +G G FG V+R V    GR    K +       +   + E+ +++       HP L+ 
Sbjct: 35   EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----HPKLIN 90

Query: 870  LYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPP 928
            L+    D  E +L+ E++ GG L D I+    +++    ++        L  +H      
Sbjct: 91   LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---S 147

Query: 929  IVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
            IVH D+K  N++ +  K     + DFGLA  ++  +    TT   T  + APE       
Sbjct: 148  IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPV 205

Query: 987  TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLA 1046
                D+++ GVL   L +G     G ++       +   +       + +          
Sbjct: 206  GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--------- 256

Query: 1047 EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                E  + ++       + P  R  V + L 
Sbjct: 257  ---PEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  174 bits (442), Expect = 2e-49
 Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 39/289 (13%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---------EGEREFRAEMEVL 855
             +    I+G+G    V R +  P  +E AVK +   G          E       E+++L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 856  SGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                    HPN++ L       +   LV++ M+ G L D ++++  L+ +    I   + 
Sbjct: 64   RKVS---GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 120

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGY 975
              +  LH      IVHRD+K  N+LLD +    +TDFG +  +  G+      + GT  Y
Sbjct: 121  EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSY 175

Query: 976  VAPEYGQTWQA------TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029
            +APE  +            + D++S GV+   L  G       ++  +   R +M     
Sbjct: 176  LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIM----S 229

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            G  +   P         + ++ + +L+    R     P  R   +E LA
Sbjct: 230  GNYQFGSPE------WDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  173 bits (438), Expect = 7e-49
 Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 33/292 (11%)

Query: 804  TGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE---REFRAEMEVLSGNG 859
            + ++    I+G GG   V+    L   R+VAVK L+ +          FR E +  +   
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 860  FGWPHPNLVTLYGWCLD----GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVA 915
                HP +V +Y         G    +V EY++G +L DI+     +T +R +++  D  
Sbjct: 66   ----HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 916  RALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV--STTIAGTV 973
            +AL   +      I+HRDVK +N+++       V DFG+AR ++   + V  +  + GT 
Sbjct: 122  QAL---NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 974  GYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033
             Y++PE  +      + DVYS G +  E+ TG     G     V    + +      P  
Sbjct: 179  QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSA 236

Query: 1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKIL 1084
                +          + ++  ++    +  A+ P  R     E+ A L+++ 
Sbjct: 237  RHEGL----------SADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH 275

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 6e-48
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 47/304 (15%)

Query: 806  KFSEDRIIGKGGFGTVYRGV------LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGN 858
            +    + +G+G FG V              R VAVK L+      E R   +E+++L   
Sbjct: 14   RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 859  GFGWPHPNLVTLYGWCL-DGSEKILVYEYMEGGSLEDIISD----------------RTR 901
            G    H N+V L G C   G   +++ E+ + G+L   +                  +  
Sbjct: 74   G---HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 902  LTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG 961
            LT    +  +  VA+ + FL        +HRD+ A N+LL ++    + DFGLAR +   
Sbjct: 131  LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 962  DSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG 1020
              +V        + ++APE       T + DV+SFGVL  E+ +   +   G +   E+ 
Sbjct: 188  PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 1021 RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAML 1080
            RR+    R        P                E+ +  + C    P+ RP   E++  L
Sbjct: 248  RRLKEGTRMRAPDYTTP----------------EMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 1081 IKIL 1084
              +L
Sbjct: 292  GNLL 295

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-47
 Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 30/275 (10%)

Query: 807  FSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFGW 862
            F   +++GKG FG V+        +  A+K L+++ +  + +      E  VLS     W
Sbjct: 4    FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA---W 60

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             HP L  ++           V EY+ GG L   I    +    R    A ++   L FLH
Sbjct: 61   EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
             +    IV+RD+K  N+LLDK+G   + DFG+ +    GD+    T  GT  Y+APE   
Sbjct: 121  SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILL 176

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042
              +     D +SFGVL  E+  G+    G +E  +        +          P  L  
Sbjct: 177  GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--------FHSIRMDNPFYPRWL-- 226

Query: 1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                   +E  +LL    +     P  R  V+  +
Sbjct: 227  ------EKEAKDLLV---KLFVREPEKRLGVRGDI 252

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  169 bits (428), Expect = 2e-46
 Identities = 72/281 (25%), Positives = 109/281 (38%), Gaps = 28/281 (9%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGW 862
            FS  RIIG+GGFG VY     D G+  A+K L ++ +   +GE     E  +LS    G 
Sbjct: 6    FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG- 64

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
              P +V +        +   + + M GG L   +S     +       A ++   L  +H
Sbjct: 65   DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
            +     +V+RD+K +N+LLD+ G   ++D GLA   S    H S    GT GY+APE  Q
Sbjct: 125  NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 178

Query: 983  TWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
               A  +  D +S G +  +L  G       +        R+          +  P    
Sbjct: 179  KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP---- 234

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082
                     E+  LL           N R       A  +K
Sbjct: 235  ---------ELRSLLE---GLLQRDVNRRLGCLGRGAQEVK 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 9e-46
 Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 29/277 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPH 864
            K+     +G+G FG V+R V     +    K ++ +G + +   + E+ +L+       H
Sbjct: 6    KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR----H 60

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHH 923
             N++ L+       E ++++E++ G  + + I+     L  R  +     V  AL FLH 
Sbjct: 61   RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 924  ECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
                 I H D++  N++    +     + +FG AR +  GD+     +     Y APE  
Sbjct: 121  ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVH 175

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLL 1041
            Q    +T  D++S G L   L +G        E   +    +M    +         +  
Sbjct: 176  QHDVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENIMN-AEYTFDEEAFKEI-- 230

Query: 1042 GSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
                   + E  + +    R   +   +R    E L 
Sbjct: 231  -------SIEAMDFVD---RLLVKERKSRMTASEALQ 257

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-45
 Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 39/282 (13%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREF----RAEMEVLSGNG 859
             ++    ++G GGFG+VY G+ + D   VA+K ++++ +    E     R  MEV+    
Sbjct: 4    SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 860  FGWPHPNLVTLYGWCLDGSEKILVYEYMEGGS-LEDIISDRTRLTWRRRLDIAIDVARAL 918
                   ++ L  W       +L+ E  E    L D I++R  L           V  A 
Sbjct: 64   VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA- 122

Query: 919  VFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
              + H     ++HRD+K  N+L+D   G+  + DFG   ++      V T   GT  Y  
Sbjct: 123  --VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSP 177

Query: 978  PEYGQTWQATTKG-DVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036
            PE+ +  +   +   V+S G+L  ++  G    E  EE +               G+   
Sbjct: 178  PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQVFF 223

Query: 1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
               +        + E   L+R    C A  P+ RP  +E+  
Sbjct: 224  RQRV--------SSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 61/289 (21%), Positives = 106/289 (36%), Gaps = 27/289 (9%)

Query: 806  KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKL--QREGLEGEREFRAEMEVLSGNGFGWP 863
            K+     IG+G +G VY+     G   A+KK+  ++E          E+ +L        
Sbjct: 3    KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----LK 58

Query: 864  HPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHH 923
            H N+V LY         +LV+E+++    + +      L         + +   + + H 
Sbjct: 59   HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 924  ECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQT 983
                 ++HRD+K  N+L+++EG+  + DFGLAR         +  I             +
Sbjct: 119  ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 984  WQATTKGDVYSFGVLAMELATGRRALEG--------------GEECLVEWGRRVMGYGRH 1029
             + +T  D++S G +  E+  G     G              G      W   V    ++
Sbjct: 176  KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW-PNVTELPKY 234

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
             P   V   +   S L    E   +LL    +     PN R   K+ L 
Sbjct: 235  DPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (410), Expect = 1e-44
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPN 866
            R +G G FG V+      +GR  A+K L++E +   +       E  +LS       HP 
Sbjct: 10   RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT----HPF 65

Query: 867  LVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECY 926
            ++ ++G   D  +  ++ +Y+EGG L  ++    R         A +V      L +   
Sbjct: 66   IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---ALEYLHS 122

Query: 927  PPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
              I++RD+K  N+LLDK G   +TDFG A+ V      V+ T+ GT  Y+APE   T   
Sbjct: 123  KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 987  TTKGDVYSFGVLAMELATGRRALEG 1011
                D +SFG+L  E+  G      
Sbjct: 179  NKSIDWWSFGILIYEMLAGYTPFYD 203

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 1e-44
 Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 31/295 (10%)

Query: 801  LKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNG 859
            L+   ++   R IG G FG +Y G  +  G EVA+K    +      +   E ++     
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60

Query: 860  FGWPHPNLVTLYGWCL-DGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARAL 918
                    +    WC  +G   ++V E +     +       + + +  L +A  +   +
Sbjct: 61   ----GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 919  VFLHHECYPPIVHRDVKASNVL---LDKEGKALVTDFGLARVVSAGDSHV------STTI 969
             ++H +     +HRDVK  N L     K     + DFGLA+      +H       +  +
Sbjct: 117  EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 970  AGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH 1029
             GT  Y +       + + + D+ S G + M    G           ++   +   Y R 
Sbjct: 174  TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAATKRQKYERI 228

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
               +   P+ +L  G      E +  L     C +   + +P+   +  +   + 
Sbjct: 229  SEKKMSTPIEVLCKGY---PSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLF 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (402), Expect = 7e-44
 Identities = 52/293 (17%), Positives = 111/293 (37%), Gaps = 33/293 (11%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-REFRAEMEVLSGNGFGW 862
              +   R IG+G FG ++ G  L + ++VA+K   R     + R+     ++L+G     
Sbjct: 5    VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG----- 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
                +  +Y +  +G   +LV + +     + +     + + +     A  +   +  +H
Sbjct: 60   -CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 923  HECYPPIVHRDVKASNVLLDK-----EGKALVTDFGLARVVSAGDSHV------STTIAG 971
             +    +V+RD+K  N L+ +          V DFG+ +      +           ++G
Sbjct: 119  EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 972  TVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGP 1031
            T  Y++       + + + D+ + G + M    G    +G +    +       Y R G 
Sbjct: 176  TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIGE 230

Query: 1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084
             +   P+  L +G  E      E  +        A +A P+   +  +  K+L
Sbjct: 231  KKQSTPLRELCAGFPE------EFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-43
 Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 34/278 (12%)

Query: 810  DRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLV 868
             +++G G  G V +        + A+K L ++  +  RE                 P++V
Sbjct: 17   SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRASQ-------CPHIV 68

Query: 869  TLYGWCLDGSEK----ILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLH 922
             +     +        ++V E ++GG L   I DR     T R   +I   +  A+ +LH
Sbjct: 69   RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 923  HECYPPIVHRDVKASNVLLDK---EGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPE 979
                  I HRDVK  N+L           +TDFG A+  ++ +S   TT   T  YVAPE
Sbjct: 129  SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPE 183

Query: 980  YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039
                 +     D++S GV+   L  G           +     +    R G      P  
Sbjct: 184  VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFPNPE- 240

Query: 1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVL 1077
                  +E +EE+  L+R         P  R  + E +
Sbjct: 241  -----WSEVSEEVKMLIR---NLLKTEPTQRMTITEFM 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 9e-43
 Identities = 58/297 (19%), Positives = 110/297 (37%), Gaps = 38/297 (12%)

Query: 793  TAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGER----- 846
            T F   ++      +     +G G F  V +      G + A K +++   +  R     
Sbjct: 1    TVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57

Query: 847  -EFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWR 905
             +   E+ +L        HPN++TL+    + ++ IL+ E + GG L D ++++  LT  
Sbjct: 58   EDIEREVSILKEIQ----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE 113

Query: 906  RRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDFGLARVVSAG 961
               +    +      +++     I H D+K  N++L        +  + DFGLA  +  G
Sbjct: 114  EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170

Query: 962  DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR 1021
            +      I GT  +VAPE         + D++S GV+   L +G     G  +       
Sbjct: 171  NEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228

Query: 1022 RVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
              + Y       +                   + +R   R   + P  R  +++ L 
Sbjct: 229  SAVNYEFEDEYFSNTS------------ALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 34/300 (11%)

Query: 802  KATGKFSEDRIIGKGGFGTVYRG--VLPDGREVAVKKLQREGLEGEREFRAEMEV-LSGN 858
            +A  ++     IG+G +G V++   +   GR VA+K+++ +  E         EV +  +
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 859  GFGWPHPNLVTLYGWCLDGSEK-----ILVYEYMEGGSLEDI-ISDRTRLTWRRRLDIAI 912
               + HPN+V L+  C            LV+E+++      +       +      D+  
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGT 972
             + R L FLH      +VHRD+K  N+L+   G+  + DFGLAR+ S   +   T++  T
Sbjct: 124  QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 973  VGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG--------------GEECLVE 1018
            + Y APE        T  D++S G +  E+   +    G              G     +
Sbjct: 179  LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 1019 WGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078
            W R V    +    ++  P+    + + E  +   +LL    +C    P  R +    L+
Sbjct: 239  WPRDVALPRQAFHSKSAQPIEKFVTDIDELGK---DLLL---KCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 34/290 (11%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG-----EREFRAEMEVLSGNGFGWPH 864
              +G+G F TVY+       + VA+KK++            R    E+++L        H
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE----LSH 59

Query: 865  PNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHE 924
            PN++ L       S   LV+++ME      I  +   LT        +   + L +LH  
Sbjct: 60   PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 925  CYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTW 984
                I+HRD+K +N+LLD+ G   + DFGLA+   +  +   T    T  Y APE     
Sbjct: 120  W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGA 175

Query: 985  QA-TTKGDVYSFGVLAMELATGRRALEG--------------GEECLVEWGRRVMGYGRH 1029
            +      D+++ G +  EL      L G              G     +W          
Sbjct: 176  RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM 1079
                   P + L    +   +++ +L++         P AR    + L M
Sbjct: 236  TFKS--FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-41
 Identities = 61/306 (19%), Positives = 113/306 (36%), Gaps = 41/306 (13%)

Query: 800  ILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE-FRAEMEVLSG 857
            +     +++    IG+G +G V       +   VA+KK+     +   +    E+++L  
Sbjct: 3    VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 858  NGFGWPHPNLVTLYGWCLDGS----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
                + H N++ +       +    + + +  ++ G  L  ++  +  L+          
Sbjct: 63   ----FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQ 117

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVS--TTIAG 971
            + R L ++H      ++HRD+K SN+LL+      + DFGLARV      H    T    
Sbjct: 118  ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 972  TVGYVAPEY-GQTWQATTKGDVYSFGVLAMELATGRRALEG------------------G 1012
            T  Y APE    +   T   D++S G +  E+ + R    G                   
Sbjct: 175  TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN 1072
            E+       +   Y    P +  +P   L       A    +LL    +     P+ R  
Sbjct: 235  EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL---DLLD---KMLTFNPHKRIE 288

Query: 1073 VKEVLA 1078
            V++ LA
Sbjct: 289  VEQALA 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 4e-41
 Identities = 64/303 (21%), Positives = 106/303 (34%), Gaps = 32/303 (10%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGW 862
             F +   IG+G +G VY+      G  VA+KK++ +            E+ +L       
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--- 59

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDI-ISDRTRLTWRRRLDIAIDVARALVFL 921
             HPN+V L       ++  LV+E++     + +  S  T +           + + L F 
Sbjct: 60   -HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      ++HRD+K  N+L++ EG   + DFGLAR         +  +            
Sbjct: 119  HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV-------------EWGRRVMGYGR 1028
                 +T  D++S G +  E+ T R    G  E                     V     
Sbjct: 176  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAM-----LIKI 1083
            + P             +    E+   LL    +     PN R + K  LA      + K 
Sbjct: 236  YKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALAHPFFQDVTKP 292

Query: 1084 LPH 1086
            +PH
Sbjct: 293  VPH 295

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-40
 Identities = 68/294 (23%), Positives = 109/294 (37%), Gaps = 35/294 (11%)

Query: 807  FSEDRIIGKGGFGTVYRGVLPD-GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHP 865
            +++ ++IG G FG VY+  L D G  VA+KK+ ++    +R    E++++        H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLD----HC 73

Query: 866  NLVTLYGWCLDGSEK------ILVYEYMEGGSLEDI---ISDRTRLTWRRRLDIAIDVAR 916
            N+V L  +     EK       LV +Y+              +  L           + R
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 917  ALVFLHHECYPPIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGY 975
            +L ++H      I HRD+K  N+LLD +   L + DFG A+ +  G+ +VS     +  Y
Sbjct: 134  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 188

Query: 976  VAP-EYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE---------CLVEWGRRVMG 1025
             AP         T+  DV+S G +  EL  G+    G             L    R  + 
Sbjct: 189  RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMS-ELLRIGVRCTAEAPNARPNVKEVLA 1078
                       P +               E + +  R     P AR    E  A
Sbjct: 249  EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-39
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 12/210 (5%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFG 861
             F   +++GKG FG V        GR  A+K L++E +  + E      E  VL      
Sbjct: 6    DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN---- 61

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
              HP L  L            V EY  GG L   +S     T  R      ++  AL   
Sbjct: 62   TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--- 118

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
             +     +V+RD+K  N++LDK+G   +TDFGL +   +  +    T  GT  Y+APE  
Sbjct: 119  EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +        D +  GV+  E+  GR     
Sbjct: 178  EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-39
 Identities = 54/287 (18%), Positives = 99/287 (34%), Gaps = 21/287 (7%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGW 862
            K+ +   IG+G +GTV++         VA+K+++ +            E+ +L       
Sbjct: 3    KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----L 58

Query: 863  PHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLH 922
             H N+V L+       +  LV+E+ +    +   S    L           + + L    
Sbjct: 59   KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL---G 115

Query: 923  HECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQ 982
                  ++HRD+K  N+L+++ G+  + +FGLAR         S  +             
Sbjct: 116  FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 983  TWQATTKGDVYSFGVLAMELATGRRALEGGE----------ECLVEWGRRVMGYGRHGPG 1032
                +T  D++S G +  ELA   R L  G             L              P 
Sbjct: 176  AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 1033 RAVIPVVLLGSGLAEGAEEMSELLRIGV-RCTAEAPNARPNVKEVLA 1078
                P+    + L     +++   R  +       P  R + +E L 
Sbjct: 236  YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-38
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 22/225 (9%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEG--EREFRAEMEVLSGNGFG 861
             K+ +   IG+G FG V++      G++VA+KK+  E  +         E+++L      
Sbjct: 10   SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL---- 65

Query: 862  WPHPNLVTLYGWCLDGSEKI--------LVYEYMEGGSLEDIISDRTRLTWRRRLDIAID 913
              H N+V L   C   +           LV+++ E      + +   + T      +   
Sbjct: 66   LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 914  VARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS---HVSTTIA 970
            +   L   ++     I+HRD+KA+NVL+ ++G   + DFGLAR  S   +   +  T   
Sbjct: 126  LLNGL---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 971  GTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEE 1014
             T+ Y  PE     +      D++  G +  E+ T    ++G  E
Sbjct: 183  VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (364), Expect = 3e-38
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 15/213 (7%)

Query: 806  KFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGERE---FRAEMEVLSGNGFG 861
            +F   + +G G FG V        G   A+K L ++ +   ++      E  +L      
Sbjct: 42   QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-- 99

Query: 862  WPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFL 921
               P LV L     D S   +V EY+ GG +   +    R +       A  +     +L
Sbjct: 100  --FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 922  HHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYG 981
            H      +++RD+K  N+L+D++G   VTDFG A+         + T+ GT   +APE  
Sbjct: 158  HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEII 210

Query: 982  QTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
             +       D ++ GVL  E+A G       + 
Sbjct: 211  LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 16/219 (7%)

Query: 806  KFSEDRIIGKGGFGTVYRGVL----PDGREVAVKKLQREGL----EGEREFRAEMEVLSG 857
             F   +++G G +G V+          G+  A+K L++  +    +     R E +VL  
Sbjct: 25   NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 858  NGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARA 917
                   P LVTL+      ++  L+ +Y+ GG L   +S R R T         ++  A
Sbjct: 85   IR---QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141

Query: 918  LVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHVSTTIAGTVGYVA 977
            L    H     I++RD+K  N+LLD  G  ++TDFGL++   A ++  +    GT+ Y+A
Sbjct: 142  L---EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 978  PE--YGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE 1014
            P+   G         D +S GVL  EL TG        E
Sbjct: 199  PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 811  RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVT 869
            R +G+G +  V+  + + +  +V VK L+      +++ + E+++L         PN++T
Sbjct: 41   RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENL---RGGPNIIT 94

Query: 870  LYGWCLDGSEK--ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYP 927
            L     D   +   LV+E++     + +      LT         ++ +AL + H     
Sbjct: 95   LADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG-- 149

Query: 928  PIVHRDVKASNVLLDKEGKAL-VTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA 986
             I+HRDVK  NV++D E + L + D+GLA     G  +       +  +  PE    +Q 
Sbjct: 150  -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQM 206

Query: 987  -TTKGDVYSFGVLAMELATGRRALEGGEE 1014
                 D++S G +   +   +     G +
Sbjct: 207  YDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-36
 Identities = 59/315 (18%), Positives = 110/315 (34%), Gaps = 43/315 (13%)

Query: 792  KTAFTYSDILKATGKFSED----RIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EG 844
            ++ F   ++ K   +        + +G G +G V   V    G +VA+KKL R       
Sbjct: 1    RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 845  EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS------EKILVYEYMEGGSLEDIISD 898
             +    E+ +L        H N++ L              +  LV  +M  G+    +  
Sbjct: 61   AKRAYRELRLLKHMR----HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK 114

Query: 899  RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
              +L   R   +   + + L ++H        HRD+K  N+ ++++ +  + DFGLAR  
Sbjct: 115  HEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LV 1017
               DS ++  +               + T   D++S G +  E+ TG+   +G +    +
Sbjct: 172  ---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228

Query: 1018 EWGRRVMG--------------YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCT 1063
            +   +V G                 +  G   +      S L   +     LL    +  
Sbjct: 229  KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KML 285

Query: 1064 AEAPNARPNVKEVLA 1078
                  R    E LA
Sbjct: 286  VLDAEQRVTAGEALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 6e-35
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 27/233 (11%)

Query: 788  IRLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL--EG 844
            + +  + FT   +LK   ++   + IG G  G V         R VA+KKL R       
Sbjct: 6    VEVGDSTFT---VLK---RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 59

Query: 845  EREFRAEMEVLSGNGFGWPHPNLVTLYGWCL------DGSEKILVYEYMEGGSLEDIISD 898
             +    E+ ++        H N+++L           +  +  LV E M+    + I   
Sbjct: 60   AKRAYRELVLMKC----VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 112

Query: 899  RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV 958
            +  L   R   +   +   +  LH       +HRD+K SN+++  +    + DFGLAR  
Sbjct: 113  QMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-- 167

Query: 959  SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEG 1011
            +AG S + T    T  Y APE           D++S G +  E+   +    G
Sbjct: 168  TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-31
 Identities = 60/313 (19%), Positives = 109/313 (34%), Gaps = 43/313 (13%)

Query: 789  RLDKTAFTYSDILKATGKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGLEGE-- 845
             L+KT +   +      ++     +G G +G+V        G  VAVKKL R        
Sbjct: 8    ELNKTIWEVPE------RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 846  REFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-----EKILVYEYMEGGSLEDIISDRT 900
            +    E+ +L        H N++ L               + +  ++ G  L +I+  + 
Sbjct: 62   KRTYRELRLLKH----MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ- 116

Query: 901  RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA 960
            +LT      +   + R L ++H        HRD+K SN+ ++++ +  + DFGLAR    
Sbjct: 117  KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-- 171

Query: 961  GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC----- 1015
             D  ++  +A                    D++S G +  EL TGR    G +       
Sbjct: 172  -DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 1016 ----LVEWGRRVMGYGRHGPGRAVI------PVVLLGSGLAEGAEEMSELLRIGVRCTAE 1065
                +   G  ++        R  I      P +   +          +LL    +    
Sbjct: 231  ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVL 287

Query: 1066 APNARPNVKEVLA 1078
              + R    + LA
Sbjct: 288  DSDKRITAAQALA 300

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  120 bits (302), Expect = 6e-30
 Identities = 77/388 (19%), Positives = 148/388 (38%), Gaps = 31/388 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
             L   N++  +  + + L Q++ L   R     SI D +    +L  +N S+N L+   
Sbjct: 27  TVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDIT 82

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYL 203
            L  L  L  + ++ N+I      +       L + N  + ++    +      L L   
Sbjct: 83  PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 142

Query: 204 DLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE 263
            +S  +    + +         V++      +++    +  S ++               
Sbjct: 143 TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS----------DISV 192

Query: 264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL 323
           ++   NL  L    N  S   P  I  ++ L+ L L  N        +L +L+ L  LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 324 SSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPV 383
           ++N             T++  L L         N S +  L  ++ L+L+ N        
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKL---GANQISNISPLAGLTALTNLELNENQL--EDIS 301

Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
            IS +++L +L L  N  +   P    ++  LQ L  + N+++     S+ NLT++ WL 
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 444 LANNSLSGEIPGEIGNCTSLLWLNLSNN 471
             +N +S   P  + N T +  L L++ 
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.6 bits (239), Expect = 9e-22
 Identities = 68/366 (18%), Positives = 127/366 (34%), Gaps = 49/366 (13%)

Query: 146 SGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDL 205
           + L       L    +   +S +       L    L + ++ G      +   NL  ++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 206 SSNNFRGNI-WNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV 264
           S+N          L +LV+  ++ N ++ +   +       L +F+    +         
Sbjct: 74  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPE------------SL 312
            N   L    +   +    + +      G +   L     L+ +               L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 313 LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDL 372
             L+ LE L  ++N             T +  L+L+ N   D      +  L N++ LDL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD---IGTLASLTNLTDLDL 248

Query: 373 SHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP--------------------AVYGNM 412
           ++N  +   P  +S +  L  L L  N+ +   P                    +   N+
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306

Query: 413 PNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK 472
            NL  L L FN ++   P  + +LT L  L  ANN +S      + N T++ WL+  +N+
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362

Query: 473 LSGNIP 478
           +S   P
Sbjct: 363 ISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.3 bits (220), Expect = 2e-19
 Identities = 71/452 (15%), Positives = 135/452 (29%), Gaps = 89/452 (19%)

Query: 217 GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLF 276
            LA+ ++  + +  ++  VS +       +          I    G V    NL  +N  
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLD---QVTTLQADRLG-IKSIDG-VEYLNNLTQINFS 74

Query: 277 GNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIF 336
            N  +   P             L     L  I  +   ++ +  L   +N  G  +    
Sbjct: 75  NNQLTDITP-------------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121

Query: 337 GRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLIL 396
                      + N      N+  I  +  +S L        G    ++  + +L  L  
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNT--ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 397 AHNRFNGSIPAVY-GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPG 455
                N          + NL++L  + N+++   P  I   T+L  L L  N L     G
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235

Query: 456 EIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRW 515
            + + T+L  L+L+NN++S   P   +T                          L +   
Sbjct: 236 TLASLTNLTDLDLANNQISNLAPLSGLT----------------------KLTELKLGAN 273

Query: 516 IPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLS 575
             ++  P + +  +   +   +  + +   + +  +              YL L  N +S
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLT-------------YLTLYFNNIS 320

Query: 576 GELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCL 635
                 +  L                         L  L    N  S    S   N+  +
Sbjct: 321 D--ISPVSSLTK-----------------------LQRLFFANNKVSD--VSSLANLTNI 353

Query: 636 QNLDLSYNNFSGPFPASFNNLTELSKLNISYN 667
             L   +N  S   P    NLT +++L ++  
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.1 bits (204), Expect = 2e-17
 Identities = 65/361 (18%), Positives = 112/361 (31%), Gaps = 62/361 (17%)

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
           L    +  L   N T  +    + +  +  L         SI  V   + NL  ++ S N
Sbjct: 21  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV-EYLNNLTQINFSNN 76

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
           +LT   P  + NLT L+ +++ NN ++   P       + L L  +       +      
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 484 IGRNAR-------------PTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
                               + +      + T       L+    +       S +  + 
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 531 TRKSCRSLWDRLLKGTGIFPVC----LPGLASRTFQITG-----------YLQLSGNQLS 575
              +  SL     + + I P+     L  L+    Q+              L L+ NQ+S
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS 254

Query: 576 GELSPDIGKLQNFSMVHLGFNQFDGKLP---------------------SQFDQLPLIVL 614
                 +  L   + + LG NQ     P                        +   L  L
Sbjct: 255 N--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYL 312

Query: 615 NLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTI 674
            L  NN S   P    ++  LQ L  + N  S    +S  NLT ++ L+  +N + S   
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQI-SDLT 367

Query: 675 P 675
           P
Sbjct: 368 P 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.6 bits (200), Expect = 8e-17
 Identities = 51/231 (22%), Positives = 75/231 (32%), Gaps = 21/231 (9%)

Query: 49  NNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYL 108
           N    E   +  N+ S       +           L  T+  IS          T L  L
Sbjct: 173 NLTTLERLDISSNKVSDISVLAKLTNLES------LIATNNQISDITPLGIL--TNLDEL 224

Query: 109 DLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFS 168
            L+ N         L+S  +L  L+L++N +S    LSGL  L  L L  N+I      +
Sbjct: 225 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLA 282

Query: 169 FPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIW-NGLAQLVEFSVS 227
                      NL LN       +      NL YL L  NN       + L +L     +
Sbjct: 283 GLTALT-----NLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFA 337

Query: 228 ENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGN 278
            N +S V S        ++       N+     P  ++N   +  L L   
Sbjct: 338 NNKVSDVSS---LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.5 bits (153), Expect = 5e-11
 Identities = 41/265 (15%), Positives = 85/265 (32%), Gaps = 15/265 (5%)

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            +       L    +T  +  +  +L  +  L      +   I G +    +L  +N SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 471 NKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
           N+L+   P + +T   +                  +   L++      D  P   +  + 
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 531 TRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQL------SGELSPDIGK 584
             +   +    +   +G+  +      ++   +     L+  +              + K
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 585 LQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN 644
           L N   +    NQ     P       L  L+L  N           ++  L +LDL+ N 
Sbjct: 196 LTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252

Query: 645 FSGPFPASFNNLTELSKLNISYNPL 669
            S   P   + LT+L++L +  N +
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQI 275

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 1e-25
 Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 16/223 (7%)

Query: 805  GKFSEDRIIGKGGFGTVYRGV-LPDGREVAVKKLQREGL---EGEREFRAEMEVLSGNG- 859
             ++   R +G G F TV+    + +   VA+K ++ + +     E E +    V   +  
Sbjct: 13   ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72

Query: 860  --FGWPHPNLVTLYG----WCLDGSEKILVYEYMEGGSLEDIISDRTRL-TWRRRLDIAI 912
                    +++ L         +G   ++V+E +    L  I     R         I+ 
Sbjct: 73   KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 913  DVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVSAGDSHVS-TTIA 970
             +   L ++H  C   I+H D+K  NVL++       +    +A + +A       T   
Sbjct: 133  QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 971  GTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGE 1013
             T  Y +PE           D++S   L  EL TG    E  E
Sbjct: 191  QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.4 bits (239), Expect = 3e-23
 Identities = 26/163 (15%), Positives = 50/163 (30%), Gaps = 29/163 (17%)

Query: 811 RIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE----------GEREFRAEMEVLSGNGF 860
           +++G+G    V+        E  VK  +               G+  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS----A 61

Query: 861 GWPHPNLVTLYG----WCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVAR 916
                 L  L G             ++ E ++         +  R+      ++   +  
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILE 114

Query: 917 ALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVS 959
            +   +H     IVH D+   NVL+ +EG  ++ DF  +  V 
Sbjct: 115 EVAKFYHRG---IVHGDLSQYNVLVSEEGIWII-DFPQSVEVG 153

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 96.6 bits (239), Expect = 2e-22
 Identities = 57/279 (20%), Positives = 97/279 (34%), Gaps = 17/279 (6%)

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSL 463
            +P      P+   LDL  N++T        NL +L  L+L NN +S   PG       L
Sbjct: 24  KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 464 LWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPF 523
             L LS N+L   +P ++    +  R       +  +    G ++ + ++       P  
Sbjct: 82  ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG---TNPLK 137

Query: 524 SFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIG 583
           S        +  + L    +  T I  +      S T      L L GN+++   +  + 
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT-----ELHLDGNKITKVDAASLK 192

Query: 584 KLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYN 643
            L N + + L FN             P +      NN   ++P    + K +Q + L  N
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252

Query: 644 NFSGPFPASFN------NLTELSKLNISYNPLVSGTIPS 676
           N S      F            S +++  NP+    I  
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.1 bits (222), Expect = 4e-20
 Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 12/233 (5%)

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
            C L +   S+       P ++    +  +L+L  N  +     +  ++  L  L L  N
Sbjct: 9   QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65

Query: 303 NFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGIL 362
               + P +   L KLE L LS N      +K+     +++       + I  +  S   
Sbjct: 66  KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR----VHENEITKVRKSVFN 121

Query: 363 KLPNISRLDLSH--NNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
            L  +  ++L       +G        M+ L ++ +A      +IP   G  P+L  L L
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHL 178

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
             N++T     S+  L +L  L L+ NS+S    G + N   L  L+L+NNKL
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.4 bits (215), Expect = 4e-19
 Identities = 57/325 (17%), Positives = 107/325 (32%), Gaps = 38/325 (11%)

Query: 74  CSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLN 133
           C     + + L L    +  D+  +       + LDL  N  +     D  + ++L  L 
Sbjct: 10  CHLRVVQCSDLGLEK--VPKDLPPD------TALLDLQNNKITEIKDGDFKNLKNLHTLI 61

Query: 134 LSHNILSGDLN--LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRID 191
           L +N +S       + L  LE L LS N++  E+    P   ++L V    +  +   + 
Sbjct: 62  LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVF 120

Query: 192 TCFDGC--LNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIF 249
              +    + L    L S+      + G+ +L    +++  ++  +   +     SL   
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP---SLTEL 176

Query: 250 DLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
            L  N+        +    NL  L L  N+ S      + +   L       NN L  +P
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLVKVP 235

Query: 310 ESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISR 369
             L +   ++V+ L +NN        F                          K  + S 
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDF-------------------CPPGYNTKKASYSG 276

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFL 394
           + L  N       ++ S  R +   
Sbjct: 277 VSLFSNPVQY-WEIQPSTFRCVYVR 300

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.5 bits (192), Expect = 3e-16
 Identities = 54/308 (17%), Positives = 94/308 (30%), Gaps = 41/308 (13%)

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
           P+ + LDL +N  T     +   +++L  LIL +N+ +   P  +  +  L+ L LS N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 425 LTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI 484
           L          L  L         +   +   +     ++ L  +  K SG        +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSSGIENGAFQGM 149

Query: 485 GRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLK 544
            + +                           IP   PP           S   L     K
Sbjct: 150 KKLSYIRIADTNIT----------------TIPQGLPP-----------SLTELHLDGNK 182

Query: 545 GTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPS 604
            T +    L GL          L LS N +S   +  +    +   +HL  N+       
Sbjct: 183 ITKVDAASLKGL-----NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG 237

Query: 605 QFDQLPLIVLNLTRNNFSG------EIPSEFGNIKCLQNLDLSYN--NFSGPFPASFNNL 656
             D   + V+ L  NN S         P           + L  N   +    P++F  +
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

Query: 657 TELSKLNI 664
              + + +
Sbjct: 298 YVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 1e-15
 Identities = 52/272 (19%), Positives = 91/272 (33%), Gaps = 34/272 (12%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+L +  I+     +F  L  L  L L  N  S   P   +    L+ L LS N L  +L
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 94

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAI-CEKLVVANLSLNNLTGRIDTCFDGCLNLRY 202
                ++L+ L +  N I       F  +    +V    +    +G  +  F G   L Y
Sbjct: 95  PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154

Query: 203 LDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSE--------- 253
           + ++  N           L E  +  N ++ V ++S  K   +L    LS          
Sbjct: 155 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS-LKGLNNLAKLGLSFNSISAVDNG 213

Query: 254 --------------NEFIGDFPGEVSNCRNLVVLNLFGNNFSG------PIPAEIGSISG 293
                         N  +   PG +++ + + V+ L  NN S         P      + 
Sbjct: 214 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 273

Query: 294 LEALFLGKN--NFLSVIPESLLNLSKLEVLDL 323
              + L  N   +  + P +   +     + L
Sbjct: 274 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.0 bits (123), Expect = 2e-07
 Identities = 44/249 (17%), Positives = 77/249 (30%), Gaps = 33/249 (13%)

Query: 39  LSNLRSFLENNNPVNE--------GHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWN 90
           L  L     + N + E           ++ +++        +    ++  V  L      
Sbjct: 78  LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 91  ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN--LSGL 148
            SG     F  + +LSY+ ++    + +IP  L    SL  L+L  N ++      L GL
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194

Query: 149 RSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN 208
            +L  L LS N I         A    L   +L+ N L        D    ++ + L +N
Sbjct: 195 NNLAKLGLSFNSISAVD-NGSLANTPHLRELHLNNNKLVKVPGGLAD-HKYIQVVYLHNN 252

Query: 209 NFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSEN--EFIGDFPGEVSN 266
           N               ++  N            +  S     L  N  ++    P     
Sbjct: 253 NIS-------------AIGSNDFCP---PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296

Query: 267 CRNLVVLNL 275
                 + L
Sbjct: 297 VYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 2e-05
 Identities = 22/133 (16%), Positives = 34/133 (25%), Gaps = 1/133 (0%)

Query: 586 QNFSMVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNN 644
            + +++ L  N+        F  L  L  L L  N  S   P  F  +  L+ L LS N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 645 FSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIENGP 704
                      L EL         +         Q+   E  +             +   
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 705 HHGHKYPNSNGRT 717
              +        T
Sbjct: 151 KLSYIRIADTNIT 163

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.6 bits (104), Expect = 4e-05
 Identities = 44/271 (16%), Positives = 83/271 (30%), Gaps = 39/271 (14%)

Query: 446 NNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAG 505
           +  L  ++P ++        L+L NNK++  I        +N                  
Sbjct: 19  DLGLE-KVPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKN------------------ 56

Query: 506 SSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITG 565
               L +     +   P +F            L    L         L  L  +  +   
Sbjct: 57  -LHTLILINNKISKISPGAF-------APLVKLERLYLSKN-----QLKELPEKMPKTLQ 103

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGF--NQFDGKLPSQFDQLPLIVLNLTRNNFSG 623
            L++  N+++         L    +V LG    +  G     F  +  +      +    
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163

Query: 624 EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQLATF 683
            IP   G    L  L L  N  +    AS   L  L+KL +S+N + +    S       
Sbjct: 164 TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221

Query: 684 EKTSYLGDPLLDLPDFIENGPHHGHKYPNSN 714
            +     + L+ +P  + +  +    Y ++N
Sbjct: 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.4 bits (233), Expect = 2e-21
 Identities = 72/306 (23%), Positives = 125/306 (40%), Gaps = 17/306 (5%)

Query: 33  ETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCE--WPGIICSPDK--ARVNGLNLTD 88
             D++ L  ++  L N   ++      W  ++  C   W G++C  D    RVN L+L+ 
Sbjct: 5   PQDKQALLQIKKDLGNPTTLS-----SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 89  WNISGD--IFNNFSALTQLSYLDLSRNT-FSGSIPDDLSSCRSLKYLNLSHNILSGDLN- 144
            N+     I ++ + L  L++L +       G IP  ++    L YL ++H  +SG +  
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 145 -LSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRY- 202
            LS +++L  LD S N + G +  S  +    LV      N ++G I   +     L   
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISS-LPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 203 LDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPG 262
           + +S N   G I    A L    V  +       +SV   +             +    G
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
           +V   +NL  L+L  N   G +P  +  +  L +L +  NN    IP+   NL + +V  
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297

Query: 323 LSSNNF 328
            ++N  
Sbjct: 298 YANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 87.9 bits (216), Expect = 2e-19
 Identities = 60/266 (22%), Positives = 93/266 (34%), Gaps = 9/266 (3%)

Query: 410 GNMPNLQTLDLSFNELTG--PIPPSIGNLTSLLWLMLANN-SLSGEIPGEIGNCTSLLWL 466
                +  LDLS   L    PIP S+ NL  L +L +    +L G IP  I   T L +L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 467 NLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFV 526
            +++  +SG IP  +  I       F  N  +G          +S    +       + +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL-----PPSISSLPNLVGITFDGNRI 161

Query: 527 YTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQ 586
              +                    +      +       ++ LS N L G+ S   G  +
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 587 NFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFS 646
           N   +HL  N     L        L  L+L  N   G +P     +K L +L++S+NN  
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 647 GPFPASFNNLTELSKLNISYNPLVSG 672
           G  P    NL        + N  + G
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.3 bits (199), Expect = 4e-17
 Identities = 56/283 (19%), Positives = 88/283 (31%), Gaps = 13/283 (4%)

Query: 206 SSNNFRGNIWNG--------LAQLVEFSVSENVLSGVVS-SSVFKENCSLEIFDLSENE- 255
            + +     W G          ++    +S   L       S       L    +     
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 256 FIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNL 315
            +G  P  ++    L  L +   N SG IP  +  I  L  L    N     +P S+ +L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 316 SKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN 375
             L  +    N   G +   +G F+++      S + + G        L         + 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208

Query: 376 NFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGN 435
                  +  S        I              G   NL  LDL  N + G +P  +  
Sbjct: 209 LEGDASVLFGSDKN--TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 436 LTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           L  L  L ++ N+L GEIP + GN         +NNK     P
Sbjct: 267 LKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.6 bits (192), Expect = 3e-16
 Identities = 53/294 (18%), Positives = 100/294 (34%), Gaps = 35/294 (11%)

Query: 363 KLPNISRLDLSHNNFTG--PLPVEISQMRSLKFLILAHN-RFNGSIPAVYGNMPNLQTLD 419
           +   ++ LDLS  N     P+P  ++ +  L FL +       G IP     +  L  L 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 420 LSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
           ++   ++G IP  +  + +L+ L  + N+LSG +P  I +  +L+ +    N++SG IP 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 480 EVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLW 539
              +  +       +  R   +         +      A       +          S  
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKI------PPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 540 DRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD 599
           +          +          +    L L  N++ G L   + +L+    +++ FN   
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL- 280

Query: 600 GKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNF--SGPFPA 651
                                  GEIP + GN++       + N      P PA
Sbjct: 281 ----------------------CGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (186), Expect = 1e-15
 Identities = 48/258 (18%), Positives = 74/258 (28%), Gaps = 36/258 (13%)

Query: 103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL------------------- 143
                + L  N  S        +CR+L  L L  N+L+                      
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 144 --------NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFD 195
                      GL  L  L L       E+          L    L  N L    D  F 
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLD-RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 196 GCLNLRYLDLSSNNFRGNIWN---GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
              NL +L L  N           GL  L    + +N ++ V   + F++   L    L 
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA-FRDLGRLMTLYLF 209

Query: 253 ENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESL 312
            N         ++  R L  L L  N +     A     + L+      +     +P+ L
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268

Query: 313 LNLSKLEVLDLSSNNFGG 330
                  +  L++N+  G
Sbjct: 269 AGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (174), Expect = 5e-14
 Identities = 51/291 (17%), Positives = 91/291 (31%), Gaps = 37/291 (12%)

Query: 118 SIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEK 175
           ++P  + +  + + + L  N +S     +    R+L IL L  N +    + +F  +   
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 176 LVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNF---RGNIWNGLAQLVEFSVSENVLS 232
             +       L       F G   L  L L           ++ GLA L    + +N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 233 GVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSIS 292
            +   + F++  +L    L  N              +L  L L  N  +   P     + 
Sbjct: 143 ALPDDT-FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 293 GLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSY 352
            L  L+L  NN  ++  E+L  L  L+ L L+ N +                        
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC---------------------- 239

Query: 353 IDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG 403
               +         + +   S +     LP    ++       LA N   G
Sbjct: 240 ----DCRARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (174), Expect = 5e-14
 Identities = 40/219 (18%), Positives = 71/219 (32%), Gaps = 26/219 (11%)

Query: 284 IPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVK 343
           +P  I +    + +FL  N    V   S      L +L L SN         F     ++
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 344 ILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG 403
            L L  N+ +  ++ +    L  +  L L         P     + +L++L L  N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 404 SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI------ 457
                + ++ NL  L L  N ++     +   L SL  L+L  N ++   P         
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 458 ------------------GNCTSLLWLNLSNNKLSGNIP 478
                                 +L +L L++N    +  
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.2 bits (170), Expect = 1e-13
 Identities = 49/276 (17%), Positives = 82/276 (29%), Gaps = 13/276 (4%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
              L  +P  +      + + L  N         F     + IL LHSN       ++  
Sbjct: 20  QQGLQAVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
                       +       P     +  L  L L         P ++  +  LQ L L 
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            N L      +  +L +L  L L  N +S           SL  L L  N+++   P   
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 482 MTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDR 541
             +GR       AN  +   T A +       +++  +  P+           CR+    
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLR--ALQYLRLNDNPWVC--------DCRARPLW 247

Query: 542 L-LKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSG 576
             L+        +P    +        +L+ N L G
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (141), Expect = 6e-10
 Identities = 43/232 (18%), Positives = 73/232 (31%), Gaps = 9/232 (3%)

Query: 31  SLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWN 90
           +L       + L                     ++              R++ L+L    
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 91  ISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLN--LSGL 148
           +       F  L  L YL L  N       D      +L +L L  N +S        GL
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 149 RSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN 208
            SL+ L L  NR+      +F  +    +   L  NNL+            L+YL L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

Query: 209 NFRGN--IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG 258
            +  +       A L +F  S + +   +   +       ++  L+ N+  G
Sbjct: 236 PWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL----AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.1 bits (136), Expect = 3e-09
 Identities = 50/287 (17%), Positives = 80/287 (27%), Gaps = 39/287 (13%)

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
               R+ L  N  +          R+L  L L  N       A +  +  L+ LDLS N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 425 LTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMT 483
               + P +   L  L  L L    L    PG      +L +L L +N L          
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 484 IGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLL 543
           +G         N+ +                      P  +F       +   SL   LL
Sbjct: 152 LGNLTHLFLHGNRISS--------------------VPERAF-------RGLHSLDRLLL 184

Query: 544 ---KGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
              +   + P     L            L  N LS   +  +  L+    + L  N +  
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTL-----YLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239

Query: 601 KLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSG 647
              ++     L     + +     +P             L+ N+  G
Sbjct: 240 DCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (133), Expect = 8e-09
 Identities = 42/276 (15%), Positives = 73/276 (26%), Gaps = 35/276 (12%)

Query: 417 TLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGN 476
           T       L   +P  I   +  ++L    N +S         C +L  L L +N L+  
Sbjct: 15  TTSCPQQGLQA-VPVGIPAASQRIFL--HGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 477 IPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCR 536
                  +    +     N +        +   L     +  D      +      +   
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPG-LFRGLA 129

Query: 537 SLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFN 596
           +L    L+   +    LP    R      +L L GN++S         L +   + L  N
Sbjct: 130 ALQYLYLQDNALQ--ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187

Query: 597 QFDGKLPSQFDQLP-------------------------LIVLNLTRNNFSGEIPSEFGN 631
           +     P  F  L                          L  L L  N +  +  +    
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PL 246

Query: 632 IKCLQNLDLSYNNFSGPFPASFNN--LTELSKLNIS 665
              LQ    S +      P       L  L+  ++ 
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.1 bits (175), Expect = 2e-14
 Identities = 47/211 (22%), Positives = 77/211 (36%), Gaps = 8/211 (3%)

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
           EVS   + + +N    N +  +P ++        L L +N   +    +L+  ++L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLP 382
           L          K+    T   +  L  +             LP ++ LD+S N  T    
Sbjct: 62  LDRAEL----TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 383 VEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL 442
             +  +  L+ L L  N      P +    P L+ L L+ N LT      +  L +L  L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           +L  NSL   IP        L +  L  N  
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (138), Expect = 2e-09
 Identities = 36/237 (15%), Positives = 60/237 (25%), Gaps = 37/237 (15%)

Query: 410 GNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLS 469
             + +   ++     LT  +PP +   T++L L  + N L       +   T L  LNL 
Sbjct: 7   SKVASHLEVNCDKRNLTA-LPPDLPKDTTILHL--SENLLYTFSLATLMPYTRLTQLNLD 63

Query: 470 NNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTI 529
             +L+       +                           L               +   
Sbjct: 64  RAELTKLQVDGTLP-------------------------VLGTLDLSHNQLQSLPLLGQT 98

Query: 530 LTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFS 589
           L   +   +    L    +  +               L L GN+L       +       
Sbjct: 99  LPALTVLDVSFNRLTSLPLGALR-------GLGELQELYLKGNELKTLPPGLLTPTPKLE 151

Query: 590 MVHLGFNQFDGKLPSQFDQLP-LIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNF 645
            + L  N          + L  L  L L  N+    IP  F     L    L  N +
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 37/200 (18%), Positives = 61/200 (30%), Gaps = 11/200 (5%)

Query: 82  NGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG 141
           +  NLT   +  D+  +       + L LS N         L     L  LNL    L+ 
Sbjct: 18  DKRNLTA--LPPDLPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69

Query: 142 DLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL-SLNNLTGRIDTCFDGCLNL 200
                 L  L  LDLS N++              ++  +   L +L             L
Sbjct: 70  LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
                        +     +L + S++ N L+  + + +     +L+   L EN      
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TI 187

Query: 261 PGEVSNCRNLVVLNLFGNNF 280
           P        L    L GN +
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 29/216 (13%), Positives = 56/216 (25%), Gaps = 12/216 (5%)

Query: 384 EISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM 443
           E+S++ S   +         ++P       +   L LS N L      ++   T L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTI 503
           L           ++     +L     ++    ++P    T+          N+       
Sbjct: 62  LDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 504 AGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQI 563
           A        + ++  +         +        L       T +    L GL +     
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD--- 175

Query: 564 TGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFD 599
              L L  N L   +              L  N + 
Sbjct: 176 --TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 28/239 (11%), Positives = 55/239 (23%), Gaps = 37/239 (15%)

Query: 432 SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPT 491
            +  + S L +     +L+  +P ++        L+LS N L        +         
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYT-FSLATLMPYTRLTQL 60

Query: 492 FEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGIFPV 551
                   +  + G+   L               +   L   +   +    L    +  +
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 552 CLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPL 611
                                                  ++L  N+     P      P 
Sbjct: 121 RGL-------------------------------GELQELYLKGNELKTLPPGLLTPTPK 149

Query: 612 IVLNLT-RNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPL 669
           +       NN +         ++ L  L L  N+     P  F     L    +  NP 
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 4e-05
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 3/94 (3%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
             +    +      PG++    K      +L + N++       + L  L  L L  N+ 
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKL--SLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLR 149
             +IP        L +  L  N    +  +   R
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFR 217

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 27/178 (15%), Positives = 43/178 (24%), Gaps = 21/178 (11%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN--------------------FSGPI 284
              I  LSEN         +     L  LNL                             
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQS 91

Query: 285 PAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKI 344
              +G       +     N L+ +P   L             N    +       T    
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE 151

Query: 345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN 402
               +N+ +  + +  +  L N+  L L  N+    +P        L F  L  N + 
Sbjct: 152 KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 0.001
 Identities = 30/162 (18%), Positives = 39/162 (24%), Gaps = 46/162 (28%)

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR------------------------ 400
            + + L LS N         +     L  L L                            
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 401 ---------------------FNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSL 439
                                           +  LQ L L  NEL    P  +     L
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150

Query: 440 LWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
             L LANN+L+    G +    +L  L L  N L   IP   
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 48/276 (17%), Positives = 85/276 (30%), Gaps = 18/276 (6%)

Query: 203 LDLSSNNFRGNIWNGLA--QLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD- 259
           LDL+  N   ++   L    ++ F    + +   ++         ++  DLS +      
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVST 62

Query: 260 FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP--------ES 311
             G +S C  L  L+L G   S PI   +   S L  L L   +  S             
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
           L  L+     D +  +    V  +    TQ+ +     N     +++        +    
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 372 LSHNNFTGPLPVEISQMRSLKFLILAH-NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP 430
                       E  Q+  L+ L L+             G +P L+TL +      G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 431 PSIGNLTSLLWLMLANNSLSGEIPGEIGNC-TSLLW 465
                L     L +  +  +      IGN     +W
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGNKKNQEIW 275

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.9 bits (159), Expect = 4e-12
 Identities = 35/272 (12%), Positives = 81/272 (29%), Gaps = 12/272 (4%)

Query: 369 RLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG- 427
            LDL+  N    +   +   + +       +  +  +   + +   +Q +DLS + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 61

Query: 428 PIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRN 487
            +   +   + L  L L    LS  I   +   ++L+ LNLS          + +    +
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 488 ARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTG 547
                       + T       ++             +   +        +         
Sbjct: 122 RLDELN-LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 548 IFPVCLPGLASRTFQITG-----YLQLSG-NQLSGELSPDIGKLQNFSMVHLGFNQFDGK 601
                +        +        +L LS    +  E   ++G++     + +     DG 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 602 LPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIK 633
           L    + LP + +N   ++F+       GN K
Sbjct: 241 LQLLKEALPHLQINC--SHFTTIARPTIGNKK 270

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 41/276 (14%), Positives = 88/276 (31%), Gaps = 12/276 (4%)

Query: 416 QTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG 475
           QTLDL+   L   +   + +   ++      + +   +  E  +   +  ++LSN+ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 476 NIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSC 535
           +    +++     +       R  +  +   ++  ++ R   +    FS         SC
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 536 RSLWDR-LLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLG 594
             L +  L          +    +   +    L LSG + + + S     ++    +   
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 595 -----FNQFDGKLPSQFDQLPLIVLNLTR-NNFSGEIPSEFGNIKCLQNLDLSYNNFSGP 648
                    +      F    L  L+L+R  +   E   E G I  L+ L +      G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 649 FPASFNNLTELSKLNISYNPLVSGTIPSTGQLATFE 684
                  L     L I+ +   +   P+ G     E
Sbjct: 241 LQLLKEALP---HLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 3e-07
 Identities = 32/265 (12%), Positives = 79/265 (29%), Gaps = 20/265 (7%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+LT  N+  D+     +   +      R+     + +  S  R +++++LS++++    
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 144 ---NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
               LS    L+ L L   R+   I  +       + +     +  +           + 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS- 121

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
               L   N           +       +     ++ S +++N                 
Sbjct: 122 ---RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLS-VIPESLLNLSKLE 319
             ++S+                    E   ++ L+ L L +   +       L  +  L+
Sbjct: 179 HLDLSDS----------VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228

Query: 320 VLDLSSNNFGGEVQKIFGRFTQVKI 344
            L +      G +Q +      ++I
Sbjct: 229 TLQVFGIVPDGTLQLLKEALPHLQI 253

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.7 bits (151), Expect = 2e-11
 Identities = 34/231 (14%), Positives = 70/231 (30%), Gaps = 16/231 (6%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEI 153
            IF +  AL     +   ++  + ++    +    +  L+     ++    +  L +L  
Sbjct: 11  VIFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQYLNNLIG 67

Query: 154 LDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN 213
           L+L  N+I         A  + L        +     +      L        ++    +
Sbjct: 68  LELKDNQIT------DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121

Query: 214 IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVL 273
           +           +  ++      S +        +  LS           ++N   L  L
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTN---LQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 274 NLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
               N  S   P  + S+  L  + L  N    V P  L N S L ++ L+
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.0 bits (149), Expect = 4e-11
 Identities = 34/218 (15%), Positives = 80/218 (36%), Gaps = 21/218 (9%)

Query: 266 NCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
              N + +    +N +  +      + G+  L        ++  E +  L+ L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 326 NNF------GGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTG 379
           N            +      +   +  + + + +  + +  +          L+  +   
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 380 PLPVEISQMRSLKFLILAHNRFNGSIPAVY-------GNMPNLQTLDLSFNELTGPIPPS 432
            L ++++Q+ ++  L    N    SI            N+  L TL    N+++   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
           + +L +L+ + L NN +S   P  + N ++L  + L+N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.0 bits (123), Expect = 9e-08
 Identities = 32/230 (13%), Positives = 75/230 (32%), Gaps = 20/230 (8%)

Query: 217 GLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLF 276
            LA  ++ +  ++ ++  V+ +       +          +    G V    NL+ L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLD---GITTLSAFGTG-VTTIEG-VQYLNNLIGLELK 71

Query: 277 GNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIF 336
            N  +   P     +  L  +   + +   +   S +   +       ++    +V  + 
Sbjct: 72  DNQITDLAP-----LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 337 GRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLIL 396
           G      +    +        +         +   LS  N        ++ +  L  L  
Sbjct: 127 GLSNLQVLYLDLNQITNISPLA------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 397 AHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLAN 446
             N+ +   P    ++PNL  + L  N+++   P  + N ++L  + L N
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 2/102 (1%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
             +   Q            SP     N   L+  N         + L++L+ L    N  
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLS 157
           S   P  L+S  +L  ++L +N +S    L+   +L I+ L+
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 33/255 (12%), Positives = 70/255 (27%), Gaps = 46/255 (18%)

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            + N   +    + +T  +  +  +L  +  L      ++  I G +    +L+ L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 471 NKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
           N+++   P + +T                            ++          +      
Sbjct: 73  NQITDLAPLKNLTK------------------------ITELELSGNPLKNVSAIAGLQS 108

Query: 531 TRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSM 590
            +    +               L  L     QIT    L+G      LS    ++ + + 
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168

Query: 591 VHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFP 650
           +                   L  L    N  S   P    ++  L  + L  N  S   P
Sbjct: 169 LANLSK--------------LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

Query: 651 ASFNNLTELSKLNIS 665
               N + L  + ++
Sbjct: 213 --LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 5/84 (5%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNN---FSALTQLSYLDLSR 112
             +    +           S      N   LT      +  ++    ++L  L  + L  
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN 204

Query: 113 NTFSGSIPDDLSSCRSLKYLNLSH 136
           N  S   P  L++  +L  + L++
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTN 226

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 59.3 bits (143), Expect = 3e-11
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)

Query: 370 LDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPI 429
           L L+H + T      + Q+  +  L L+HNR     PA+   +  L+ L    ++     
Sbjct: 3   LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQ--ASDNALEN 57

Query: 430 PPSIGNLTSLLWLMLANNSL-SGEIPGEIGNCTSLLWLNLSNNKLSG 475
              + NL  L  L+L NN L        + +C  L+ LNL  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 84  LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL 143
           L+L   +++  +  +   L  +++LDLS N      P  L++ R L+ L  S N L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 144 NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG 188
            ++ L  L+ L L  NR+    +      C +LV+ NL  N+L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 3e-07
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 5/118 (4%)

Query: 178 VANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSS 237
           V +L+  +LT  +    +  L + +LDLS N  R      LA L    V +   + + + 
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENV 58

Query: 238 SVFKENCSLEIFDLSENEFIG-DFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGL 294
                   L+   L  N          + +C  LV+LNL GN+           ++ +
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 22/104 (21%), Positives = 32/104 (30%), Gaps = 21/104 (20%)

Query: 130 KYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEIS--------------------FSF 169
           + L+L+H  L+   +L  L  +  LDLS NR+                            
Sbjct: 1   RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 170 PAICEKLVVANLSLNNLTGRID-TCFDGCLNLRYLDLSSNNFRG 212
            A   +L    L  N L           C  L  L+L  N+   
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 3/83 (3%)

Query: 566 YLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNF-SGE 624
           +L LS N+L     P +  L+   ++    +     +    +   L  L L  N      
Sbjct: 24  HLDLSHNRLRAL-PPALAALRCLEVLQ-ASDNALENVDGVANLPRLQELLLCNNRLQQSA 81

Query: 625 IPSEFGNIKCLQNLDLSYNNFSG 647
                 +   L  L+L  N+   
Sbjct: 82  AIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 23/89 (25%), Positives = 36/89 (40%), Gaps = 5/89 (5%)

Query: 392 KFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG 451
           + L LAH     ++      +  +  LDLS N L    PP++  L  L  L    +  + 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNAL 55

Query: 452 EIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           E    + N   L  L L NN+L  +   +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQ 84

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 24/120 (20%), Positives = 46/120 (38%), Gaps = 6/120 (5%)

Query: 272 VLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGE 331
           VL+L   + +  +   +  +  +  L L  +N L  +P +L  L  LEVL  S N    E
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLS-HNRLRALPPALAALRCLEVLQASDNAL--E 56

Query: 332 VQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSL 391
                    +++ L L +N          ++  P +  L+L  N+          ++  +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (144), Expect = 6e-10
 Identities = 45/447 (10%), Positives = 94/447 (21%), Gaps = 29/447 (6%)

Query: 243 NCSLEIFDLSENEFIGD--FPGEVSNCRNLVVLNLFGNNFSG----PIPAEIGSISGLEA 296
           +  ++  D+   E + D  +   +   +   V+ L     +      I + +     L  
Sbjct: 1   SLDIQSLDIQCEE-LSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 297 LFLGKNNFLSVIPESLL-----NLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS 351
           L L  N    V    +L        K++ L L +    G    +     +     L +  
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT----LPTLQ 115

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
            +   ++        +    L                 S        +            
Sbjct: 116 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 175

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           + N    +     L   +  S   L +L          S       G   S   L     
Sbjct: 176 VSNNDINEAGVRVLCQGLKDSPCQLEALKLES--CGVTSDNCRDLCGIVASKASLRELAL 233

Query: 472 KLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILT 531
             +      +  +           +         +++       +         +     
Sbjct: 234 GSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 293

Query: 532 RKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMV 591
                                                   + L+        ++ N  + 
Sbjct: 294 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 353

Query: 592 HLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGE----IPSEFGNIKCLQNLDLSYNNFSG 647
             G  +    L      L   VL L   + S      + +       L+ LDLS N    
Sbjct: 354 DAGVRELCQGLGQPGSVL--RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411

Query: 648 PFPASF-----NNLTELSKLNISYNPL 669
                           L +L +     
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYW 438

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 6e-08
 Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 406 PAVYGNMPNLQTLDLSFNELTG----PIPPSIGNLTSLLWLMLANNSLSGEIPGEIG--- 458
             +      L+ L L+  +++      +  ++    SL  L L+NN L      ++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 459 --NCTSLLWLNLSNNKLSGNIPPEVMTIGRN 487
                 L  L L +   S  +   +  + ++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 23/131 (17%), Positives = 40/131 (30%), Gaps = 11/131 (8%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
                   S             + +++   L D  +           + L  L L+    
Sbjct: 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381

Query: 116 SG----SIPDDLSSCRSLKYLNLSHNILSGD---LNLSGLRS----LEILDLSVNRIHGE 164
           S     S+   L +  SL+ L+LS+N L        +  +R     LE L L       E
Sbjct: 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441

Query: 165 ISFSFPAICEK 175
           +     A+ + 
Sbjct: 442 MEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 5e-07
 Identities = 13/89 (14%), Positives = 28/89 (31%), Gaps = 10/89 (11%)

Query: 105 LSYLDLSRNTFSGS-IPDDLSSCRSLKYLNLSHNILSGD------LNLSGLRSLEILDLS 157
           +  LD+     S +   + L   +  + + L    L+          L    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 158 VNRIHGEISFSFPAICEKLVVANLSLNNL 186
            N +          + + L   +  +  L
Sbjct: 64  SNELGDV---GVHCVLQGLQTPSCKIQKL 89

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 21/96 (21%), Positives = 30/96 (31%), Gaps = 15/96 (15%)

Query: 388 MRSLKFLILAHNRFNG----SIPAVYGNMPNLQTLDLSFNELTGPIPPSIG-----NLTS 438
              L+ L LA    +     S+ A      +L+ LDLS N L       +          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 439 LLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS 474
           L  L+L +   S E+         L  L      L 
Sbjct: 428 LEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 5e-06
 Identities = 15/86 (17%), Positives = 25/86 (29%), Gaps = 12/86 (13%)

Query: 84  LNLTDWNISGDIFNN-FSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSHNI 138
           L++    +S   +      L Q   + L     +      I   L    +L  LNL  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 139 LS-------GDLNLSGLRSLEILDLS 157
           L             +    ++ L L 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 13/100 (13%), Positives = 26/100 (26%), Gaps = 23/100 (23%)

Query: 240 FKENCSLEIFDLSENEF----IGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLE 295
            +    L +  L++ +            +    +L  L+L  N             +G+ 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD---------AGIL 415

Query: 296 ALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI 335
            L                    LE L L    +  E++  
Sbjct: 416 QLVESVRQ----------PGCLLEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 14/99 (14%), Positives = 28/99 (28%), Gaps = 11/99 (11%)

Query: 128 SLKYLNLSHNILSGD---LNLSGLRSLEILDLSVNRIHGEISFSFPAI---CEKLVVANL 181
            ++ L++    LS       L  L+  +++ L    +         +       L   NL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 182 SLNNLTGR-----IDTCFDGCLNLRYLDLSSNNFRGNIW 215
             N L        +         ++ L L +    G   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 13/81 (16%), Positives = 27/81 (33%), Gaps = 9/81 (11%)

Query: 365 PNISRLDLSHNNFTG----PLPVEISQMRSLKFLILAHNRFNGSIP-----AVYGNMPNL 415
             +  L L+  + +      L   +    SL+ L L++N    +       +V      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 416 QTLDLSFNELTGPIPPSIGNL 436
           + L L     +  +   +  L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 13/76 (17%), Positives = 24/76 (31%), Gaps = 4/76 (5%)

Query: 150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGR----IDTCFDGCLNLRYLDL 205
            ++ LD+    +          + ++  V  L    LT      I +       L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 206 SSNNFRGNIWNGLAQL 221
            SN       + + Q 
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 5/77 (6%)

Query: 609 LPLIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSG----PFPASFNNLTELSKLN 663
           L +  L++     S    +E    ++  Q + L     +        ++      L++LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 664 ISYNPLVSGTIPSTGQL 680
           +  N L    +    Q 
Sbjct: 62  LRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 17/112 (15%), Positives = 31/112 (27%), Gaps = 24/112 (21%)

Query: 285 PAEIGSISGLEALFLGKNNF----LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFT 340
                  S L  L+L   +      S +  +LL    L  LDLS+N  G           
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-- 419

Query: 341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLK 392
                ++                   + +L L    ++  +   +  +   K
Sbjct: 420 -----SVRQPGC-------------LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 17/104 (16%), Positives = 30/104 (28%), Gaps = 23/104 (22%)

Query: 193 CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLS 252
                  LR L L+  +   +  + LA                  +    N SL   DLS
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLA------------------ATLLANHSLRELDLS 405

Query: 253 ENEFIGDFPGEVS-----NCRNLVVLNLFGNNFSGPIPAEIGSI 291
            N        ++          L  L L+   +S  +   + ++
Sbjct: 406 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 9e-04
 Identities = 18/109 (16%), Positives = 34/109 (31%), Gaps = 25/109 (22%)

Query: 173 CEKLVVANLSLNNLTGR----IDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSE 228
              L V  L+  +++      +        +LR LDLS+N         L + V      
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR----- 422

Query: 229 NVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVS----NCRNLVVL 273
                       +  C LE   L +  +  +    +     +  +L V+
Sbjct: 423 ------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 58.4 bits (139), Expect = 2e-09
 Identities = 45/340 (13%), Positives = 82/340 (24%), Gaps = 30/340 (8%)

Query: 389 RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP----IPPSIGNLTSLLWLML 444
           +SLK   +       S+ AV     +++ + LS N +       +  +I +   L     
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 445 ANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIA 504
           ++                LL   L   KL      +         P  +   ++      
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 505 GSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLKGTGI----------FPVCLP 554
                    +           +      K+   L   +     +                
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 555 GLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFD--QLPLI 612
            L +      G        L  E      +L+   +    F        +        L 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 613 VLNLTRNNFSGEIPSEFGNI------KCLQNLDLSYNNFSGP-----FPASFNNLTELSK 661
            L L     S    +   +         LQ L L YN                 + +L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 662 LNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIE 701
           L ++ N   S       ++     T   G+ L +L D  E
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVFSTRGRGE-LDELDDMEE 344

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 53.7 bits (127), Expect = 6e-08
 Identities = 40/345 (11%), Positives = 87/345 (25%), Gaps = 35/345 (10%)

Query: 105 LSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL------NLSGLRSLEILDLSV 158
           L    ++      S+   L    S+K + LS N +  +       N++  + LEI + S 
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNG- 217
                 +    P     L+ A L    L     +        +   +   +    + +  
Sbjct: 69  IFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 218 --LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNL 275
                L   + ++   +    +   K   +  +  +       +        +      L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 276 FGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI 335
                          I  L    L     L V+               SS          
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD----LQDNTFTHLGSSALAIALKSWP 243

Query: 336 FGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLI 395
             R   +    L +      +++   L+   +  L L +N         +          
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT-------- 295

Query: 396 LAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLL 440
                       +   MP+L  L+L+ N  +      +  +  + 
Sbjct: 296 -----------VIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 50.6 bits (119), Expect = 6e-07
 Identities = 49/368 (13%), Positives = 95/368 (25%), Gaps = 59/368 (16%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGI 361
                 +   LL    ++ + LS N  G E  +                          I
Sbjct: 17  TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLS---------------------ENI 55

Query: 362 LKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLS 421
               ++   + S + FTG +  EI +                 +       P L T+ LS
Sbjct: 56  ASKKDLEIAEFS-DIFTGRVKDEIPEALR-------------LLLQALLKCPKLHTVRLS 101

Query: 422 FNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEV 481
            N         + +  S    +      +  +  + G   +     L+ NK + N PP  
Sbjct: 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 161

Query: 482 MTIGRNARPTFEANQRNGERTIAGSSECL-SMKRWIPADYPPFSFVYTILTRKSCRSLWD 540
             I    R    + +   +   +        M +           +   L       + D
Sbjct: 162 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 221

Query: 541 RLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDG 600
                          +A +++     L L+   LS   +  +    +             
Sbjct: 222 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK------------ 269

Query: 601 KLPSQFDQLPLIVLNLTRNNFSGEIPSE-----FGNIKCLQNLDLSYNNFSGPFPASFNN 655
                 + + L  L L  N    +            +  L  L+L+ N FS       + 
Sbjct: 270 -----LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDE 323

Query: 656 LTELSKLN 663
           + E+    
Sbjct: 324 IREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 9e-06
 Identities = 44/351 (12%), Positives = 91/351 (25%), Gaps = 53/351 (15%)

Query: 83  GLNLTDWNISG--DIFNNFSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSH 136
            L L          +F        +  + LS NT        + ++++S + L+    S 
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 137 N---------------ILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANL 181
                           +L   L    L ++ + D +      E    F +    L    L
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 182 SLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG----NIWNGLAQLVEFSVSENVLSGVVSS 237
             N L  +        L    ++  + N              +                 
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 238 SVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEAL 297
              K   +    +  E+  +             +  N F +  S  +   + S   L  L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 298 FLGKNNFLSVIPESL------LNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNS 351
            L      +    ++      L    L+ L L  N    +  +                 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK-------------- 294

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN 402
                 +    K+P++  L+L+ N F+      + ++R + F        +
Sbjct: 295 ------TVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV-FSTRGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.7 bits (101), Expect = 8e-05
 Identities = 19/127 (14%), Positives = 34/127 (26%), Gaps = 10/127 (7%)

Query: 45  FLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQ 104
            L+  +  +       + + +                  L+        D F+       
Sbjct: 216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE-NIG 274

Query: 105 LSYLDLSRNTFSGSIPDDLSS-----CRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN 159
           L  L L  N         L +        L +L L+ N  S +         EI ++   
Sbjct: 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE----DDVVDEIREVFST 330

Query: 160 RIHGEIS 166
           R  GE+ 
Sbjct: 331 RGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 34/383 (8%), Positives = 82/383 (21%), Gaps = 59/383 (15%)

Query: 245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNF 304
           SL++  ++  +        +    ++  + L GN                          
Sbjct: 9   SLKLDAITTED-EKSVFAVLLEDDSVKEIVLSGNTIG--------------------TEA 47

Query: 305 LSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKL 364
              + E++ +   LE+ + S                            +       +  L
Sbjct: 48  ARWLSENIASKKDLEIAEFSDI----------------------FTGRVKDEIPEALRLL 85

Query: 365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNE 424
                     +             +      L+ +     +      +       ++   
Sbjct: 86  LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 145

Query: 425 LTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTI 484
               +     N   L  ++   N L      E           L   K+  N        
Sbjct: 146 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR-LLHTVKMVQNGIRPEGIE 204

Query: 485 GRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSLWDRLLK 544
                      +         +   L       A     +     L      +      +
Sbjct: 205 HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA------R 258

Query: 545 GTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDI-----GKLQNFSMVHLGFNQFD 599
           G          L +   Q    L+L  N++  +    +      K+ +   + L  N+F 
Sbjct: 259 GAAAVVDAFSKLENIGLQ---TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF- 314

Query: 600 GKLPSQFDQLPLIVLNLTRNNFS 622
            +     D++  +     R    
Sbjct: 315 SEEDDVVDEIREVFSTRGRGELD 337

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 7e-09
 Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 9/88 (10%)

Query: 398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEI 457
            N  +  I ++    P+L+ L++S N+L   +P     L     L+ + N L+ E+P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLA-EVPELP 323

Query: 458 GNCTSLLWLNLSNNKLSGNIPPEVMTIG 485
            N   L  L++  N L    P    ++ 
Sbjct: 324 QN---LKQLHVEYNPLRE-FPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 1e-08
 Identities = 39/306 (12%), Positives = 80/306 (26%), Gaps = 16/306 (5%)

Query: 364 LPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
            P++  L  S N+ T  LP     ++SL          +   P +     +   L+    
Sbjct: 57  PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE 115

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNS------LSGEIPGEIGNCTSLLWLNLSNNKLSGNI 477
                    I    + L  +                  E+    +L +L       +   
Sbjct: 116 LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175

Query: 478 PPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRS 537
               + +   +                                 P               
Sbjct: 176 KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNY 235

Query: 538 LWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQ 597
           L D       +  + +                  N  S E+        +   +++  N+
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295

Query: 598 FDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLT 657
              +LP+   +  L  L  + N+ + E+P    N   L+ L + YN     FP    ++ 
Sbjct: 296 LI-ELPALPPR--LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVE 347

Query: 658 ELSKLN 663
           +L ++N
Sbjct: 348 DL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.4 bits (129), Expect = 3e-08
 Identities = 51/344 (14%), Positives = 86/344 (25%), Gaps = 44/344 (12%)

Query: 366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNEL 425
               L+L++   +                         S+P      P+L++L  S N L
Sbjct: 39  QAHELELNNLGLS-------------------------SLPE---LPPHLESLVASCNSL 70

Query: 426 TGPIPPSIGNLT-------SLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIP 478
           T  +P    +L        +L  L      L                 N S  K+     
Sbjct: 71  T-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDN 129

Query: 479 PEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRKSCRSL 538
             +  +             N +       + L     I AD      +  +         
Sbjct: 130 NSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189

Query: 539 WDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQF 598
            + +L+                                 L+     L +   +       
Sbjct: 190 GNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFL 249

Query: 599 DGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTE 658
           D           L       N  S EI S       L+ L++S N      PA    L  
Sbjct: 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE- 307

Query: 659 LSKLNISYNPLVSGTIPSTGQLATFEKTSYLGDPLLDLPDFIEN 702
             +L  S+N L    +P        ++     +PL + PD  E+
Sbjct: 308 --RLIASFNHL--AEVPEL--PQNLKQLHVEYNPLREFPDIPES 345

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.0 bits (102), Expect = 6e-05
 Identities = 18/80 (22%), Positives = 26/80 (32%), Gaps = 8/80 (10%)

Query: 249 FDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI 308
                N    +         +L  LN+  N     +PA       LE L     N L+ +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIAS-FNHLAEV 319

Query: 309 PESLLNLSKLEVLDLSSNNF 328
           PE   N   L+ L +  N  
Sbjct: 320 PELPQN---LKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 2e-04
 Identities = 28/146 (19%), Positives = 46/146 (31%), Gaps = 8/146 (5%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
           + +       P     +    +                   N FS L++L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEK 175
           S  I        SL+ LN+S+N L  +L  +    LE L  S N +        P + + 
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELP-ALPPRLERLIASFNHLA-----EVPELPQN 325

Query: 176 LVVANLSLNNLTGRIDTCFDGCLNLR 201
           L   ++  N L        +   +LR
Sbjct: 326 LKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 3e-04
 Identities = 58/338 (17%), Positives = 107/338 (31%), Gaps = 32/338 (9%)

Query: 85  NLTDWNISGDIFNNFSAL----TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILS 140
              +  ++       S+L      L  L  S N+ +  +P+   S   LK L + +N L 
Sbjct: 39  QAHELELNN---LGLSSLPELPPHLESLVASCNSLT-ELPELPQS---LKSLLVDNNNLK 91

Query: 141 GDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL 200
              +L  L  LE L +S N++         +  + + V N SL  L     +        
Sbjct: 92  ALSDLPPL--LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 201 RYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDF 260
             L+             +            L   + S V   N   E+ +L    F+   
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL--- 206

Query: 261 PGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEV 320
                   N ++  L     S        +             FL V       LS+L  
Sbjct: 207 --TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264

Query: 321 LDLSSNNFGGEVQKIFGRFTQVKILALHSN--SYIDGMNSSGILKLPNISRLDLSHNNFT 378
                N    E++ +      ++ L + +N    +  +        P + RL  S N+  
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL-------PPRLERLIASFNHLA 317

Query: 379 GPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ 416
             +P      ++LK L + +N      P +  ++ +L+
Sbjct: 318 E-VP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 9/81 (11%)

Query: 240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFL 299
                SLE  ++S N+ + + P        L  L    N+ +  +P    +   L+ L +
Sbjct: 280 CDLPPSLEELNVSNNK-LIELPALPPR---LERLIASFNHLAE-VPELPQN---LKQLHV 331

Query: 300 GKNNFLSVIPESLLNLSKLEV 320
              N L   P+   ++  L +
Sbjct: 332 E-YNPLREFPDIPESVEDLRM 351

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 8e-08
 Identities = 33/233 (14%), Positives = 75/233 (32%), Gaps = 38/233 (16%)

Query: 93  GDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLE 152
             IF++  A  +    +L + + + ++    +   S+  +  +++ +     +  L ++ 
Sbjct: 15  KQIFSD-DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVT 71

Query: 153 ILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG 212
            L L+ N++      +       L +          ++          +   LS  +   
Sbjct: 72  KLFLNGNKLTDIKPLANLKNLGWLFLDE-------NKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 213 NIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVV 272
           +  NGL  L +        + +   +V      L+   L +N+     P  ++    L  
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182

Query: 273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS 325
           L L  N+ S                             +L  L  L+VL+L S
Sbjct: 183 LYLSKNHISD--------------------------LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.4 bits (119), Expect = 2e-07
 Identities = 25/196 (12%), Positives = 62/196 (31%), Gaps = 21/196 (10%)

Query: 265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS 324
                 +  NL   + +  +      ++ ++ +    ++  SV    +  L  +  L L+
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 325 SNNFGGEVQ--------------KIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRL 370
            N                           + +K L    +  ++    S I  L ++ +L
Sbjct: 77  GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136

Query: 371 DLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP 430
           +  +        + +    +    +   +     I  +   +  LQ L LS N ++    
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-AGLTKLQNLYLSKNHISD--L 193

Query: 431 PSIGNLTSLLWLMLAN 446
            ++  L +L  L L +
Sbjct: 194 RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 2e-06
 Identities = 26/196 (13%), Positives = 59/196 (30%), Gaps = 16/196 (8%)

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
                   +L    +T  +  +   L S+  ++  N+ +       I    ++  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 471 NKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
           NKL+   P   +             +           + LS++    +D      +  + 
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 531 TRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITG---------YLQLSGNQLSGELSPD 581
           +     +    +   + +  +    L                   L LS N +S      
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195

Query: 582 IGKLQNFSMVHLGFNQ 597
           +  L+N  ++ L F+Q
Sbjct: 196 LAGLKNLDVLEL-FSQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 4e-05
 Identities = 33/203 (16%), Positives = 68/203 (33%), Gaps = 22/203 (10%)

Query: 283 PIPAEIGSISGLEAL------FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIF 336
            +P  I  I   +A        L K +    + ++   L+ ++ +  ++++      +  
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGI 64

Query: 337 GRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLIL 396
                V  L L+ N          +  +  ++ L      F     V+          + 
Sbjct: 65  QYLPNVTKLFLNGNK---------LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK 115

Query: 397 AHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGE 456
           + +  +  I  + G +   Q   L            +  LT L  L L +N +S  +P  
Sbjct: 116 SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-- 173

Query: 457 IGNCTSLLWLNLSNNKLSGNIPP 479
           +   T L  L LS N +S ++  
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRA 195

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 3e-04
 Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 4/128 (3%)

Query: 34  TDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISG 93
           TD + L+NL++        N+   +   +     +   +  +        ++L       
Sbjct: 81  TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSI----PDDLSSCRSLKYLNLSHNILSGDLNLSGLR 149
              N  + +T LS L                  L+    L+ L LS N +S    L+GL+
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLK 200

Query: 150 SLEILDLS 157
           +L++L+L 
Sbjct: 201 NLDVLELF 208

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.8 bits (122), Expect = 1e-07
 Identities = 35/264 (13%), Positives = 72/264 (27%), Gaps = 33/264 (12%)

Query: 414 NLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           + +      +++T  IP  +    + + L      L     G       L  + +S N +
Sbjct: 9   SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 474 SGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTRK 533
              I  +V +              N       + + L   +++         +  +    
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 534 SCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHL 593
           S + +   +     I  +                              +G      ++ L
Sbjct: 126 SLQKVLLDIQDNINIHTIERN-------------------------SFVGLSFESVILWL 160

Query: 594 GFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSE-FGNIKCLQNLDLSYNNFSGPFPAS 652
             N         F+   L  LNL+ NN   E+P++ F        LD+S           
Sbjct: 161 NKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220

Query: 653 FNNLTELSKLNISYNPLVSGTIPS 676
             NL +L   +          +P+
Sbjct: 221 LENLKKLRARSTYNL----KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (121), Expect = 2e-07
 Identities = 29/240 (12%), Positives = 63/240 (26%), Gaps = 9/240 (3%)

Query: 243 NCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN 302
           +CS  +F   E++ + + P ++   RN + L                    LE + + +N
Sbjct: 7   HCSNRVFLCQESK-VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63

Query: 303 NFLSVIPESLLNLSKLEVLDLS---SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSS 359
           + L VI   + +             +N      +          +L  ++          
Sbjct: 64  DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 123

Query: 360 GILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLD 419
                  +  +  + N  T      +        L L  N         +      +   
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183

Query: 420 LSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
              N L           +  + L ++   +       + N   L   +  N K    +P 
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 13/97 (13%), Positives = 27/97 (27%), Gaps = 8/97 (8%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
             +    + +  +                   + N+     + F   +    LD+SR   
Sbjct: 154 ESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLE 152
                  L + + L+  +          NL  L +LE
Sbjct: 214 HSLPSYGLENLKKLRARSTY--------NLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 3e-05
 Identities = 39/226 (17%), Positives = 68/226 (30%), Gaps = 10/226 (4%)

Query: 108 LDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLSVNRIHGEI 165
                +  +  IP DL   R+   L      L        SG   LE +++S N +   I
Sbjct: 13  FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 166 SFSFPAICEKLVVANLSL-NNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEF 224
                +   KL    +   NNL       F    NL+YL +S+   +          ++ 
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 225 SVSENVLSGVVSSSVFKENCSLEIF----DLSENEFIGDFPGEVSNCRNLVVLNLFGNNF 280
            + +   +  + +        L        L++N          +  +   +     NN 
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189

Query: 281 SGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSN 326
                      SG   L + +    S+    L NL KL      + 
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 23/247 (9%), Positives = 49/247 (19%), Gaps = 37/247 (14%)

Query: 413 PNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK 472
            N   L     +L      +      L  + ++ N +   I  ++ +    L        
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 473 LSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTILTR 532
            +                    +    +            K  +              + 
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 533 KSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVH 592
                    L               + T      L                   N ++  
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS-----------------DNNNLEE 191

Query: 593 LGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPAS 652
           L  + F G           ++L+++R            N+K L+                
Sbjct: 192 LPNDVFHG-ASG------PVILDISRTRIHSLPSYGLENLKKLRARST------------ 232

Query: 653 FNNLTEL 659
             NL +L
Sbjct: 233 -YNLKKL 238

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 11/104 (10%), Positives = 19/104 (18%), Gaps = 2/104 (1%)

Query: 56  HYMQWNQSSSPCEWPGIICSPDKARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTF 115
             +    + +                  L L    I       F+            N  
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189

Query: 116 SGSIPDDLSSCRSLKYLNLSHNILSG--DLNLSGLRSLEILDLS 157
                D          L++S   +       L  L+ L      
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 27/240 (11%), Positives = 63/240 (26%), Gaps = 9/240 (3%)

Query: 120 PDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA 179
              +  C S +      + ++ ++     R+   L   + ++      +F      L   
Sbjct: 2   HHRICHC-SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSG-FGDLEKI 58

Query: 180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSG------ 233
            +S N++   I+      L   +             N  A     ++   ++S       
Sbjct: 59  EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118

Query: 234 VVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISG 293
                +      L     + N    +    V      V+L L  N               
Sbjct: 119 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQL 178

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYI 353
            E      NN   +  +     S   +LD+S                +++  + ++   +
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 4e-07
 Identities = 30/144 (20%), Positives = 53/144 (36%), Gaps = 9/144 (6%)

Query: 341 QVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNR 400
             + L L        + +  I  + N        ++    L +    +  L  L L++NR
Sbjct: 23  SQQALDLKGLRSDPDLVAQNIDVVLNRR------SSMAATLRIIEENIPELLSLNLSNNR 76

Query: 401 FNG--SIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIG 458
                 + ++    PNL+ L+LS NEL             L  L L  NSLS     +  
Sbjct: 77  LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136

Query: 459 NCTSLLWLNLSNNKLSGN-IPPEV 481
             +++        +L G+ +PP +
Sbjct: 137 YISAIRERFPKLLRLDGHELPPPI 160

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 4e-06
 Identities = 25/115 (21%), Positives = 38/115 (33%), Gaps = 6/115 (5%)

Query: 104 QLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSG-DLNLSGLRSLEILDLSVNRIH 162
               LDL           DL +      LN   ++ +   +    +  L  L+LS NR++
Sbjct: 23  SQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLY 78

Query: 163 GEISFSF-PAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN 216
                S        L + NLS N L    +      L L  L L  N+      +
Sbjct: 79  RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 30/182 (16%), Positives = 60/182 (32%), Gaps = 26/182 (14%)

Query: 250 DLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
           +L   + +      +S   +     L           ++ + +    L    ++  + + 
Sbjct: 3   ELKPEQ-VEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58

Query: 310 ESLLNLSKLEVLDLSSNNFGG--EVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNI 367
               N+ +L  L+LS+N      ++  I  +   +KIL L  N  +        +K   +
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGN-ELKSERELDKIKGLKL 117

Query: 368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTG 427
             L L  N+ +     +                 +  I A+    P L  LD   +EL  
Sbjct: 118 EELWLDGNSLSDTFRDQ-----------------STYISAIRERFPKLLRLD--GHELPP 158

Query: 428 PI 429
           PI
Sbjct: 159 PI 160

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 6e-04
 Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 8/119 (6%)

Query: 556 LASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLP-LIVL 614
           ++ R       L L G +      PD+       +++   +     L    + +P L+ L
Sbjct: 16  MSKRYDGSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL 70

Query: 615 NLTRNNFSG--EIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS 671
           NL+ N      ++ S       L+ L+LS N              +L +L +  N L  
Sbjct: 71  NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 20/136 (14%), Positives = 40/136 (29%), Gaps = 25/136 (18%)

Query: 361 ILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDL 420
           + K  + S+  L           ++        L    +    ++  +  N+P L +L+L
Sbjct: 16  MSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNL 72

Query: 421 SFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE 480
           S N L                           +   +    +L  LNLS N+L      +
Sbjct: 73  SNNRLYRLDD----------------------MSSIVQKAPNLKILNLSGNELKSERELD 110

Query: 481 VMTIGRNARPTFEANQ 496
            +   +      + N 
Sbjct: 111 KIKGLKLEELWLDGNS 126

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 8e-07
 Identities = 27/207 (13%), Positives = 64/207 (30%), Gaps = 26/207 (12%)

Query: 250 DLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIP 309
           D   N+   D     +     +   L   N +  +      +  +  L   +    S+  
Sbjct: 5   DTPINQIFTD-----TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI-- 55

Query: 310 ESLLNLSKLEVLDLSSNNFGGEVQ--------------KIFGRFTQVKILALHSNSYIDG 355
           + +  L+ L  ++ S+N                           T +  L   +   +  
Sbjct: 56  DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 115

Query: 356 MNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNL 415
              + I  L N++ L+    +      +      +    +   +     +  +  N+  L
Sbjct: 116 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL-ANLTTL 174

Query: 416 QTLDLSFNELTGPIPPSIGNLTSLLWL 442
           + LD+S N+++      +  LT+L  L
Sbjct: 175 ERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.0 bits (110), Expect = 3e-06
 Identities = 29/204 (14%), Positives = 63/204 (30%), Gaps = 14/204 (6%)

Query: 94  DIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEI 153
            IF + +AL +     L +   + ++    +    +  L      +     +  L +L  
Sbjct: 10  QIFTD-TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQ 66

Query: 154 LDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGN 213
           ++ S N++                   L  NN    I    +          ++     +
Sbjct: 67  INFSNNQLTDITPLKNLTKLVD----ILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122

Query: 214 IWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVL 273
               L  L    +S N +S + + S       L        +        ++N   L  L
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK-----PLANLTTLERL 177

Query: 274 NLFGNNFSGPIPAEIGSISGLEAL 297
           ++  N  S    + +  ++ LE+L
Sbjct: 178 DISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 31/184 (16%), Positives = 60/184 (32%), Gaps = 19/184 (10%)

Query: 294 LEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKI--FGRFTQVKILALHSNS 351
                LGK N    + ++  +L ++  L          ++ I        +  +   +N 
Sbjct: 20  KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG----IKSIDGVEYLNNLTQINFSNNQ 73

Query: 352 YIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGN 411
             D      + KL +              +              L       +      N
Sbjct: 74  LTDITPLKNLTKLVD-------ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126

Query: 412 MPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN 471
           + NL  L+LS N ++     S         L  ++N ++   P  + N T+L  L++S+N
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQ--QLNFSSNQVTDLKP--LANLTTLERLDISSN 182

Query: 472 KLSG 475
           K+S 
Sbjct: 183 KVSD 186

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 28/188 (14%), Positives = 56/188 (29%), Gaps = 19/188 (10%)

Query: 411 NMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN 470
            +       L    +T  +  +  +L  +  L      +   I G +    +L  +N SN
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 471 NKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPPFSFVYTIL 530
           N+L+   P + +T   +                  +   L++      D  P   +  + 
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 531 TRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITG-----------YLQLSGNQLSGELS 579
             +   +               L  L   + Q+T             L +S N++S    
Sbjct: 132 RLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI-- 187

Query: 580 PDIGKLQN 587
             + KL N
Sbjct: 188 SVLAKLTN 195

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 8e-06
 Identities = 21/118 (17%), Positives = 36/118 (30%), Gaps = 2/118 (1%)

Query: 99  FSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV 158
           ++   +   LDL        I +  ++      ++ S N +        LR L+ L ++ 
Sbjct: 14  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 72

Query: 159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWN 216
           NRI              L    L+ N+L    D      L          N   N  +
Sbjct: 73  NRICRIGEGLDQ-ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (102), Expect = 2e-05
 Identities = 19/84 (22%), Positives = 29/84 (34%), Gaps = 3/84 (3%)

Query: 391 LKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLS 450
            + L L   +    I  +   +     +D S NE+          L  L  L++ NN + 
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRIC 76

Query: 451 GEIPGEIGNCTSLLWLNLSNNKLS 474
               G       L  L L+NN L 
Sbjct: 77  RIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 19/136 (13%), Positives = 36/136 (26%), Gaps = 8/136 (5%)

Query: 311 SLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRL 370
              N  +   LDL        ++ +     Q   +    N         G   L  +  L
Sbjct: 13  QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKTL 68

Query: 371 DLSHNNFTGPLPVEISQMRSLKFLILAHNRFNG-SIPAVYGNMPNLQTLDLS---FNELT 426
            +++N            +  L  LIL +N            ++ +L  L +         
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 427 GPIPPSIGNLTSLLWL 442
                 I  +  +  L
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 6/43 (13%), Positives = 12/43 (27%), Gaps = 1/43 (2%)

Query: 431 PSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
               N      L L    +   I            ++ S+N++
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 21/135 (15%), Positives = 50/135 (37%), Gaps = 6/135 (4%)

Query: 263 EVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLD 322
           + +N      L+L G      I     ++   +A+    N    +       L +L+ L 
Sbjct: 13  QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 69

Query: 323 LSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT---G 379
           +++N      + +      +  L L +NS ++  +   +  L +++ L +  N  T    
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 380 PLPVEISQMRSLKFL 394
                I ++  ++ L
Sbjct: 130 YRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 18/125 (14%), Positives = 35/125 (28%), Gaps = 9/125 (7%)

Query: 302 NNFLSVIPESLLNLSKLEVLDLSSNNF-----GGEVQKIFGRFTQVKILALHSNSYIDGM 356
              + VI      L + + +D S N          ++++         +          +
Sbjct: 27  GYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQAL 86

Query: 357 NSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ 416
                L L N S ++L   +    L      +  L  L             V   +P ++
Sbjct: 87  PDLTELILTNNSLVELGDLDPLASLK----SLTYLCILRNPVTNKKHYRLYVIYKVPQVR 142

Query: 417 TLDLS 421
            LD  
Sbjct: 143 VLDFQ 147

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.6 bits (106), Expect = 9e-06
 Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 1/116 (0%)

Query: 365 PNISRLDLSHNNFTGPLPVEI-SQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN 423
            + + L L+ N         +  ++  L  L L  N+  G  P  +    ++Q L L  N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP 479
           ++          L  L  L L +N +S  +PG   +  SL  LNL++N  + N   
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 6e-04
 Identities = 37/187 (19%), Positives = 67/187 (35%), Gaps = 6/187 (3%)

Query: 193 CFDGCL-NLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDL 251
           C   C      +D +    +    +      E  +++N L  + S  +F     L   +L
Sbjct: 2   CPAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLEL 61

Query: 252 SENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPES 311
             N+  G  P       ++  L L  N            +  L+ L L  N    V+P S
Sbjct: 62  KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121

Query: 312 LLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD 371
             +L+ L  L+L+SN F      +      ++  +L+  +   G  S     + ++   D
Sbjct: 122 FEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSK----VRDVQIKD 176

Query: 372 LSHNNFT 378
           L H+ F 
Sbjct: 177 LPHSEFK 183

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (97), Expect = 7e-05
 Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 3/109 (2%)

Query: 366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA-VYGNMPNLQTLDLSFNE 424
             S L  + +         +    +L  L + + +    +       +  L+ L +  + 
Sbjct: 9   GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 425 LTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKL 473
           L    P +      L  L L+ N+L   +  +     SL  L LS N L
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (95), Expect = 1e-04
 Identities = 20/152 (13%), Positives = 41/152 (26%), Gaps = 5/152 (3%)

Query: 267 CRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLL-NLSKLEVLDLSS 325
                 L    +         +     L  L++     L  +    L  L +L  L +  
Sbjct: 7   PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVE- 384
           +         F    ++  L L  N+      S   ++  ++  L LS N       +  
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE--SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123

Query: 385 ISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQ 416
           + +        +   +          +MPN  
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1088
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.91
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.91
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.7
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.66
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.66
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.43
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.42
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.4
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.21
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.15
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.14
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.12
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.23
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.02
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.68
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.58
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.44
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.19
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.03
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.72
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.5

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=421.00  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||+||+|++++++.||||++... ...++++.+|++++++    ++|||||+++|++.+++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~----l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMK----LSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHh----cCCCCcccccceeccCCceEEEE
Confidence            468889999999999999999988899999999865 3456789999999997    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++|+|.+++... ..+++..++.++.|||.||+|||++   +|+||||||+||++++++.+||+|||+++.......
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999998654 5689999999999999999999999   999999999999999999999999999987765444


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      .......||..|+|||++.+..|+.++|||||||++|||+|++.|+...... .+........                .
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~----------------~  219 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG----------------F  219 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHT----------------C
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhc----------------C
Confidence            4444567899999999999999999999999999999999965554433221 1111111100                0


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ....+..++.++.+++.+||+.||++||+++||++.|+++.+
T Consensus       220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            111122334578899999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-48  Score=425.87  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=216.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+++.+|++++++    ++|||||++++++.+++..++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKE----IKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHh----CCCCCEecCCccEeeCCeeEE
Confidence            356888899999999999999976 58899999997653 345679999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          883 VYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+++|+|.+++...  ..+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999999754  4689999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      ..........|++.|+|||++.+..|+.++|||||||++|||++|+.||....+....+ .....               
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-~~i~~---------------  231 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEK---------------  231 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHT---------------
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-HHHhc---------------
Confidence            44444455678999999999999999999999999999999999877765543321111 11110               


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                       +.....+...+.++.+++.+||+.||++|||++||++.|+.+.+..
T Consensus       232 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         232 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             -CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence             0011112334467889999999999999999999999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=414.65  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=210.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++++.    ++|||||++++++.+++..|+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE----NKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHh----CCCCCEeeEeEEEEECCEEEEE
Confidence            57999999999999999999975 699999999987655666789999999997    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          884 YEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      |||+++|+|.+++.+. .+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+.... 
T Consensus        96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            9999999999988664 699999999999999999999999   99999999999999999999999999999875433 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcCC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGS 1043 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1088)
                      .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.......+.........               
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---------------  235 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------------  235 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------------
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence            23455679999999999999999999999999999999999999998765422222111110000               


Q ss_pred             CccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1044 GLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1044 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ...+.....++.+++.+||+.||++|||++|+++
T Consensus       236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0112233467888999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=414.73  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=206.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++    ++|||||++++++.+++..|+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~----l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM----LNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHT----CCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHh----CCCCCEeeEeeeeccCceeEE
Confidence            57999999999999999999976 689999999976532 234568999999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+++|+|.++++....+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999999998888999999999999999999999999   99999999999999999999999999999875433


Q ss_pred             C-cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          963 S-HVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       963 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      . ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+....+..........           
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-----------  226 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-----------  226 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-----------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence            2 23455789999999999887775 5789999999999999999999987654333222222100000           


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ........++.+++.+|++.||++|||++|+++
T Consensus       227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 001122356778999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=411.12  Aligned_cols=245  Identities=28%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.+..   ....+.+.+|++++++    ++|||||++++++.+++..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH----LRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHT----CCCTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHh----cCCCCCCeEEEEEEECCEE
Confidence            35889999999999999999986 68999999987532   2345678899999997    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.+++....++++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999999999888999999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .   ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.....  ....+.....            
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~------------  221 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVEF------------  221 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTTCC------------
T ss_pred             C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC------------
Confidence            2   2345679999999999999999999999999999999999999998754321  1122211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ..+...+.++.+++.+|++.||++|||++|+++
T Consensus       222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                 011223457888999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.4e-48  Score=423.26  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=201.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CC---cEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DG---REVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|++.++||+|+||+||+|+++ ++   ..||||++...... ..++|.+|++++++    ++|||||++++++.+++.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ----FDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEECSSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh----CCCCCCccEEEEEeeCCE
Confidence            45677889999999999999975 33   25899998765333 34579999999987    689999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .++|||||++|+|.+++... +.+++.++..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999999988764 4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcc----cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          959 SAGDSHV----STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       959 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      .......    .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.....  ....+..        
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i~~--------  248 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAIEQ--------  248 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT--------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHHHc--------
Confidence            5432211    123457899999999999999999999999999999998 899998764421  1111110        


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHC 1087 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 1087 (1088)
                              +...+.+...+.++.+++.+||+.||++||+++||++.|++++++.
T Consensus       249 --------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         249 --------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                    1111123344567889999999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=408.80  Aligned_cols=253  Identities=27%  Similarity=0.439  Sum_probs=215.5

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||+||+|++++++.||||++++.. ..++++.+|++++++    ++||||++++|++.+++..++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~----l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMN----LSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHT----CCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHh----cCCCceeeEEEEEeeCCceEEEE
Confidence            5789999999999999999999888899999998753 345789999999997    67999999999999999999999


Q ss_pred             EecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCC
Q 001384          885 EYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDS  963 (1088)
Q Consensus       885 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  963 (1088)
                      ||+++|+|.+++.. ...+++..+++++.|+++||+|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            99999999998755 45699999999999999999999999   999999999999999999999999999987765554


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          964 HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      .......+|..|+|||++.+..++.++|||||||++|||+| |+.||.+.......  ..+..                +
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~--~~i~~----------------~  217 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--EHIAQ----------------G  217 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH--HHHHT----------------T
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH--HHHHh----------------C
Confidence            44455678999999999999999999999999999999998 89999876542222  22211                0


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                      .....+...+.++.+++.+||+.||++|||++||++.|.+|
T Consensus       218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            11111233346788999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=416.55  Aligned_cols=255  Identities=27%  Similarity=0.411  Sum_probs=210.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||+||+|++++++.||||++.... ...+.+.+|++++++    ++|||||++++++.+ +..++||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~----l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ----LQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHh----CCCCCEeEEEeeecc-CCeEEEE
Confidence            5688899999999999999999888999999997653 445689999999997    679999999998765 5678999


Q ss_pred             EecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++|+|.+++....  ++++.++++|+.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999999876543  599999999999999999999999   99999999999999999999999999999876554


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ........||+.|+|||++.+..++.++|||||||++|||+||+.|+........ .......                +
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~----------------~  226 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLER----------------G  226 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT----------------T
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh----------------c
Confidence            4445566789999999999988999999999999999999997666554332111 1111110                1


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .....+...+.++.+++.+||+.||++|||++||++.|++++.
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            1111123344678899999999999999999999999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-47  Score=410.86  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=204.4

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEccccC--ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREG--LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|+++  ..||||+++...  ....+.+.+|++++++    ++|||||++++++.+ ...+
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK----TRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTT----CCCTTBCCEEEEECS-SSCE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHh----CCCCCEeeeeEEEec-cEEE
Confidence            467999999999999999999874  369999997543  2334678999999987    689999999998754 5689


Q ss_pred             EEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++|+|.++++.. .++++.++..|+.||++||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            999999999999999754 5699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC-CcccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          961 GD-SHVSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       961 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .. ........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+.............  ....+..   
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~--~~~~p~~---  231 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR--GYLSPDL---  231 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH--TSCCCCG---
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc--CCCCCcc---
Confidence            32 223445689999999998754   35899999999999999999999999876442211111111  0000000   


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                              ...+..++.++.+++.+||+.||++|||++||++.|+.+.++
T Consensus       232 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 --------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             --------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                    011223446788999999999999999999999999988543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=409.94  Aligned_cols=251  Identities=26%  Similarity=0.360  Sum_probs=193.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSE  879 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~  879 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......  ..+.+.+|++++++    ++|||||++++++.+  +..
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE----LKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTS----CCCTTBCCEEEEEEC----C
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHH----CCCCCEeeEEEEEEeCCCCE
Confidence            46999999999999999999975 6899999999765432  23568899999986    689999999999865  456


Q ss_pred             EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          880 KILVYEYMEGGSLEDIISD----RTRLTWRRRLDIAIDVARALVFLHHEC--YPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                      .|+||||+++|+|.+++.+    ...+++.+++.++.|++.||+|||+++  ..+||||||||+|||++.++.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            8999999999999999864    456999999999999999999999972  1149999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      +|+.+.... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.....  ....+.....     
T Consensus       160 ~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i~~~~~-----  231 (269)
T d2java1         160 LARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREGKF-----  231 (269)
T ss_dssp             HHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHTCC-----
T ss_pred             ceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHHHcCCC-----
Confidence            998765322 23345789999999999999999999999999999999999999998754422  1111110000     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                 ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       232 -----------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -----------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                       0112223457888999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=410.16  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=207.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      +.|++.+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++    ++|||||++++++.+++..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~----l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS----CDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHH----CCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHh----CCCCCCCeEEEEEeeCCeEEEE
Confidence            46889999999999999999976 689999999987655666788999999997    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++|+|.+++.+ ...+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..... 
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-  163 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  163 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence            999999999999765 45699999999999999999999999   9999999999999999999999999999865422 


Q ss_pred             CcccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          963 SHVSTTIAGTVGYVAPEYG-----QTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ........||+.|+|||++     ....|+.++||||+||++|||+||+.||.+......-  ........         
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~i~~~~~---------  232 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LKIAKSEP---------  232 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHHSCC---------
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHcCCC---------
Confidence            1123456799999999987     3557899999999999999999999999876442211  11110000         


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           .....+...+.++.+++.+||+.||++|||++|+++
T Consensus       233 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 -----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001112334467889999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=418.93  Aligned_cols=266  Identities=23%  Similarity=0.353  Sum_probs=207.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|+++... .....++.+|+.++++    ++|||||++++++.+++..|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~----l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE----CNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGG----CCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCEEE
Confidence            467999999999999999999975 68999999997653 2334678999999987    67999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +||||+++|+|.+++++.+++++..++.++.|++.||+|||+++  +|+||||||+|||+++++.+||+|||+|+.+.. 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            99999999999999998889999999999999999999999742  899999999999999999999999999987642 


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCC--C--------
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHG--P-------- 1031 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~-------- 1031 (1088)
                        ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+......+............  .        
T Consensus       158 --~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         158 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             --HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             --CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence              2234568999999999999999999999999999999999999999876442221111100000000  0        


Q ss_pred             --------------CccccchhhcCCCcccc-HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1032 --------------GRAVIPVVLLGSGLAEG-AEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1032 --------------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                                    ..+.............+ .....++.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                          00000000000000000 112356888999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=409.21  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=206.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+.+|++++++    ++|||||++++++.+++..
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~l~~~~~~~~~~   83 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR----LDHPFFVKLYFTFQDDEKL   83 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH----CCSTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHH----cCCCCeeEEEEEEEECCEE
Confidence            46999999999999999999975 68999999997542   2334678999999987    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.++++..+.+++.+++.++.|++.||+|||++   +||||||||+||++++++.+||+|||+|+.+..
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999999989999999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          961 GDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       961 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+......  ...+.....           
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~~~~~-----------  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQKIIKLEY-----------  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHTTCC-----------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--HHHHHcCCC-----------
Confidence            332 233456799999999999999999999999999999999999999987654221  122221100           


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            ..+.....++.+++.+||+.||++|||++|+++
T Consensus       228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                  011223356788999999999999999998743

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=408.98  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=204.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCC-----cEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDG-----REVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      +.|+..++||+|+||+||+|.++..     ..||||++...... ...++.+|++++++    ++|||||+++|++.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~----l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ----FSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHh----cCCCCEeeeeEEEecCC
Confidence            4577889999999999999997532     36999999765333 33578899999997    67999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+.+|++.+++... ..+++.++++++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999987654 5799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+......           
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~-----------  227 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAIN-----------  227 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHH-----------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHh-----------
Confidence            6543222  233456899999999999999999999999999999999977766543221 11111111           


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCCCC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPHCD 1088 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 1088 (1088)
                           .+...+.+...+.++.+++.+||+.||++||+++||++.|+++++.+|
T Consensus       228 -----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         228 -----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             -----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -----ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence                 011112233345678899999999999999999999999999876654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=406.90  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=207.4

Q ss_pred             CCCCccce-ecccCceEEEEEEeC---CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCe
Q 001384          805 GKFSEDRI-IGKGGFGTVYRGVLP---DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSE  879 (1088)
Q Consensus       805 ~~~~~~~~-LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~  879 (1088)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++..... ..+++.+|++++++    ++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~----l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ----LDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHh----CCCCCEeeEeeeecc-Ce
Confidence            34566664 999999999999864   3557999999765333 34679999999997    679999999999875 45


Q ss_pred             EEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceee
Q 001384          880 KILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVV  958 (1088)
Q Consensus       880 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~  958 (1088)
                      .|+||||+++|+|.+++.. +..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.+
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            7899999999999999865 45799999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          959 SAGDSHV--STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       959 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.....  ....+.           
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~-----------  226 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE-----------  226 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH-----------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH-----------
Confidence            6543322  234568999999999998899999999999999999998 899998754321  111111           


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                           .+...+.+...+.++.+++.+||+.||++||++.+|++.|+.+.
T Consensus       227 -----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         227 -----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 11111223344567889999999999999999999999998764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=398.34  Aligned_cols=244  Identities=29%  Similarity=0.440  Sum_probs=198.2

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CCeE
Q 001384          808 SEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GSEK  880 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~~~  880 (1088)
                      +..+.||+|+||+||+|+++ +++.||+|++.....  ...+.+.+|++++++    ++|||||++++++.+    +...
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG----LQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEEESSSCEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHh----CCCCCeeeEEEEEeeccccCCEE
Confidence            56678999999999999976 688999999876532  233578899999987    689999999999865    3567


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEc-CCCCEEEeeccccee
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPP--IVHRDVKASNVLLD-KEGKALVTDFGLARV  957 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~DLkp~NIll~-~~~~~kl~Dfg~a~~  957 (1088)
                      |+||||+++|+|.+++++...+++.+++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+|+.
T Consensus        88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            99999999999999999988999999999999999999999998   6  99999999999997 578999999999976


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIP 1037 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1088)
                      ...   .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+...... ....+.....        +
T Consensus       165 ~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~~~~--------~  231 (270)
T d1t4ha_         165 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVK--------P  231 (270)
T ss_dssp             CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCC--------C
T ss_pred             ccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHcCCC--------C
Confidence            432   23345689999999999876 699999999999999999999999976543222 2222221000        0


Q ss_pred             hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..       .+.....++.+++.+||+.||++|||++|+++
T Consensus       232 ~~-------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 AS-------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GG-------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc-------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            00       01112346788999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=404.54  Aligned_cols=248  Identities=28%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             ceecccCceEEEEEEeC---CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEE
Q 001384          811 RIIGKGGFGTVYRGVLP---DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYE  885 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e  885 (1088)
                      +.||+|+||+||+|.++   .++.||||+++....  ...+++.+|++++++    ++|||||++++++.+ +..++|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ----LDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHT----CCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHh----CCCCCCceEEEEecc-CCEEEEEE
Confidence            57999999999999864   346899999976432  234679999999997    689999999999865 45789999


Q ss_pred             ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCCCcc
Q 001384          886 YMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGDSHV  965 (1088)
Q Consensus       886 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  965 (1088)
                      |+++|+|.++++...++++.+++.++.||+.||+|||++   +||||||||+||+++.++.+|++|||+++.+.......
T Consensus        88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999999999988999999999999999999999999   99999999999999999999999999998875443322


Q ss_pred             --cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          966 --STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       966 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                        .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+......  ...+..                +
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~~i~~----------------~  226 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK----------------G  226 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT----------------T
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HHHHHc----------------C
Confidence              234578999999999998899999999999999999998 8999987654211  111110                1


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ...+.+...+.++.+++.+||+.||++||+++||++.|+...
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            111223334567889999999999999999999999888753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-45  Score=407.82  Aligned_cols=251  Identities=26%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.+.... ....+.+|+++++.    ++|||||++++++.+++..|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~----l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK----IKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHT----CCCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCEEE
Confidence            457999999999999999999976 6899999999765433 34567899999987    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCCEEEeecccceee
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVV  958 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~---~~~~~kl~Dfg~a~~~  958 (1088)
                      +||||++||+|.+++...+++++.+++.++.||+.||+|||++   +||||||||+||+++   +++.+||+|||+|+..
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999999999988999999999999999999999999   999999999999995   5789999999999876


Q ss_pred             cCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          959 SAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                      ....  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+......  ...+......      .+ 
T Consensus       161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~~~~~~------~~-  229 (307)
T d1a06a_         161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FEQILKAEYE------FD-  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHTTCCC------CC-
T ss_pred             cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHhccCCC------CC-
Confidence            4322  23456799999999999999999999999999999999999999987644221  1122110000      00 


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                            .+.....+.++.+++.+|++.||++|||++|+++
T Consensus       230 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 ------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  0011223457888999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=405.84  Aligned_cols=256  Identities=28%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVY  884 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~  884 (1088)
                      ++|++.+.||+|+||+||+|++++++.||||++.... ...+.+.+|+.++++    ++|||||++++++.+ +..++||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~----l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKK----LRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHH----CCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHh----cccCCEeEEEEEEec-CCeEEEE
Confidence            4689999999999999999999888899999997653 345789999999997    689999999999865 5678999


Q ss_pred             EecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          885 EYMEGGSLEDIISD--RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       885 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||+++|+|.+++..  ...++|.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999998864  34699999999999999999999999   99999999999999999999999999998775444


Q ss_pred             CcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhhcC
Q 001384          963 SHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLG 1042 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1088)
                      ........||+.|+|||++....++.++|||||||++|||++|+.|+...... .+....+..                +
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~----------------~  230 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVER----------------G  230 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHT----------------T
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHh----------------c
Confidence            44444567899999999999999999999999999999999977776544321 111111110                0


Q ss_pred             CCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1043 SGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1043 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                      ...+.+...+.++.+++.+||+.||++||++++|+++|++.+.+
T Consensus       231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            01111233446788999999999999999999999999987754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-45  Score=410.34  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=209.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++    ++|||||++++++.+++..|+|
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV----LRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHH----TCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCEEEEE
Confidence            47999999999999999999975 789999999987765666788999999987    6799999999999999999999


Q ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC--CCCEEEeecccceeecC
Q 001384          884 YEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK--EGKALVTDFGLARVVSA  960 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~--~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+||+|.+++.+ .+++++.+++.|+.||+.||+|||++   +||||||||+|||++.  ++.+||+|||+|+....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999999854 55799999999999999999999999   9999999999999964  67899999999988753


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....  +....+........     .   
T Consensus       179 ~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~-----~---  246 (350)
T d1koaa2         179 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWNMD-----D---  246 (350)
T ss_dssp             T--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCSC-----C---
T ss_pred             c--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCCC-----c---
Confidence            3  2344568999999999999999999999999999999999999999876442  11222211111000     0   


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ........++.+++.+||+.||++|||++|+++
T Consensus       247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001223357888999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.1e-45  Score=408.85  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=209.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv  883 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++..........+.+|++++++    ++|||||++++++.+++..|+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~----l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ----LHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTT----CCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHh----CCCCCCCcEEEEEEECCEEEEE
Confidence            46999999999999999999975 799999999987655556778899999987    6899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc--CCCCEEEeecccceeecC
Q 001384          884 YEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD--KEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~--~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ||||+||+|.+++.... ++++.+++.|+.||+.||+|||++   +||||||||+|||++  .++.+||+|||+|+.+..
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999999999876554 699999999999999999999999   999999999999998  678999999999998764


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .  .......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+..............+..        +.  
T Consensus       182 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~--  249 (352)
T d1koba_         182 D--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF--------DE--  249 (352)
T ss_dssp             T--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC--------CS--
T ss_pred             C--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------Cc--
Confidence            3  23445678999999999999999999999999999999999999998765422211111110000        00  


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                           ........++.+++.+||+.||.+|||++|+++
T Consensus       250 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         250 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001223456788999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-45  Score=399.93  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=208.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc------cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL------EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.+...      ...+.+.+|++++++    ++|||||++++++.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~   84 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE----IQHPNVITLHEVYEN   84 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHH----CCCTTBCCEEEEEEC
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHh----CCCCCCCcEEEEEEE
Confidence            357999999999999999999975 789999999875432      234679999999997    679999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC----CEEEeec
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG----KALVTDF  952 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~----~~kl~Df  952 (1088)
                      ++..|+|||||++|+|.++++....+++.+++.++.|++.||+|||++   +||||||||+||+++.++    .+|++||
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999999999888999999999999999999999999   999999999999998776    5999999


Q ss_pred             ccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCC
Q 001384          953 GLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       953 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      |+|+......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+......  ...+.....  . 
T Consensus       162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i~~~~~--~-  234 (293)
T d1jksa_         162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVSAVNY--E-  234 (293)
T ss_dssp             TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHTTCC--C-
T ss_pred             hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHHHHhcCC--C-
Confidence            9998875432  33456789999999999999999999999999999999999999987654221  111111000  0 


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                         .+..       .+...+..+.+++.+||+.||++|||++|+++
T Consensus       235 ---~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 ---FEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---CCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000       01123456888999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-45  Score=403.27  Aligned_cols=244  Identities=27%  Similarity=0.365  Sum_probs=202.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccc---hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG---EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      .|+..+.||+|+||+||+|++. +|+.||||++.......   .+.+.+|++++++    ++|||||++++++.+++..|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~----l~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK----LRHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTT----CCCTTBCCEEEEEEETTEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHH----CCCCCEeeEEEEEEECCEEE
Confidence            4888999999999999999975 68899999997654332   2468899999987    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +|||||++|+|..++....++++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.... 
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999999988888888899999999999999999999999   999999999999999999999999999986532 


Q ss_pred             CCcccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccch
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQT---WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPV 1038 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1088)
                          .....||+.|+|||++.+   ..|+.++||||+||++|||++|+.||.+...... ...... .....        
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~-~~~~~--------  233 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ-NESPA--------  233 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH-SCCCC--------
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHh-CCCCC--------
Confidence                234579999999998753   4689999999999999999999999987544221 111111 00000        


Q ss_pred             hhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1039 VLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1039 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                             ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       234 -------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                   001123357888999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=409.67  Aligned_cols=255  Identities=26%  Similarity=0.363  Sum_probs=206.1

Q ss_pred             CCCCccceecccCceEEEEEEeCC-C-----cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD-G-----REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||+||+|++.. +     ..||||++.... ......+.+|+.++.++   .+|||||++++++.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l---~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL---GSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH---CCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHh---cCCCcEeEEEEEEeeC
Confidence            578899999999999999999642 2     369999987543 33446788999999863   2799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT-----------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDV  934 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DL  934 (1088)
                      +..++||||+++|+|.++++...                       .+++.+++.|+.||+.||+|||++   +||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            99999999999999999997542                       489999999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCC
Q 001384          935 KASNVLLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGG 1012 (1088)
Q Consensus       935 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 1012 (1088)
                      ||+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876544332 2345678999999999999999999999999999999998 89999875


Q ss_pred             chhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHh
Q 001384         1013 EECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIK 1082 (1088)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1082 (1088)
                      .....-+ .....                +...+.+...+.++.+++.+||+.||++|||++||++.|..
T Consensus       271 ~~~~~~~-~~~~~----------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 PVDANFY-KLIQN----------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSHHHH-HHHHT----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHH-HHHhc----------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            4321111 11110                00111223344678899999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=402.86  Aligned_cols=247  Identities=27%  Similarity=0.305  Sum_probs=208.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++.+..   ....+.+.+|+.++++    ++||||+++++++.+++..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~----l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----TRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----CCCTTBCCEEEEEECSSEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHh----CCCCCEEEEEeeecccccc
Confidence            46899999999999999999975 79999999997642   2334678899999997    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++   +||||||||+|||++++|.+||+|||+|+....
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      . .......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+....  .........            
T Consensus       158 ~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~i~~~~~------------  222 (337)
T d1o6la_         158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELILMEEI------------  222 (337)
T ss_dssp             T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC------------
T ss_pred             C-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HHHHhcCCC------------
Confidence            2 2234557899999999999999999999999999999999999999988654221  122211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                           ..+.....++.++|.+||++||.+||+     ++|+++
T Consensus       223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 011223356788999999999999995     777765

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-45  Score=405.26  Aligned_cols=258  Identities=28%  Similarity=0.399  Sum_probs=211.1

Q ss_pred             HcCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          803 ATGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       803 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ..++|++.+.||+|+||+||+|+++      +++.||||++...... ..+++.+|++++++    ++||||+++++++.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~----l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE----FDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEC
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHh----cCCCCcccceeeec
Confidence            4568999999999999999999863      3578999999765433 34579999999997    68999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT------------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVH  931 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  931 (1088)
                      +....++||||+++|+|.++++...                        .+++.+++.|+.|++.||+|||++   +|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            9999999999999999999996532                        389999999999999999999999   9999


Q ss_pred             cCCCCCCEEEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-cCC
Q 001384          932 RDVKASNVLLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR-RAL 1009 (1088)
Q Consensus       932 ~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~ 1009 (1088)
                      |||||+||+++.++.+||+|||+|+....... .......+++.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986644322 2334567889999999999999999999999999999999996 567


Q ss_pred             CCCchhHHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1010 EGGEECLVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .+..+...  ......                +...+.+...+.++.+++.+||+.||++||||.||+++|++|.+
T Consensus       244 ~~~~~~e~--~~~v~~----------------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         244 YGMAHEEV--IYYVRD----------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTSCHHHH--HHHHHT----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCHHHH--HHHHHc----------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            66544221  111211                01111123344578899999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=397.84  Aligned_cols=256  Identities=26%  Similarity=0.366  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLPD----GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .++|++.+.||+|+||+||+|++..    +..||||+++..... ..+.+.+|++++++    ++|||||++++++. ++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ----FDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEC-SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEe-cC
Confidence            3578999999999999999998642    356899998754333 34578999999997    67999999999986 46


Q ss_pred             eEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++   +||||||||+||++++++.+||+|||+|+.
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence            78999999999999998765 44699999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCcccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVI 1036 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1088)
                      .............||+.|+|||++.+..++.++|||||||++|||+| |..||.+.......  ..+.            
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~--~~i~------------  223 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIE------------  223 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHH------------
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH--HHHH------------
Confidence            76544445556678999999999999999999999999999999998 88898876442211  1111            


Q ss_pred             chhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1037 PVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1037 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                          .+...+.+...+..+.+++.+||+.||++|||++||++.|+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         224 ----NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                111111233345678899999999999999999999999998864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=392.66  Aligned_cols=248  Identities=31%  Similarity=0.401  Sum_probs=197.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-CCeEEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-GSEKILV  883 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-~~~~~lv  883 (1088)
                      ++|++.+.||+|+||.||+|+++ |+.||||+++++  ...+.+.+|++++++    ++||||++++|++.+ .+..++|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~----l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQ----LRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTT----CCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHh----CCCCCEeeEEEEEEecCCcEEEE
Confidence            35778899999999999999985 789999999765  345679999999987    689999999999865 4568999


Q ss_pred             EEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          884 YEYMEGGSLEDIISDRT--RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      |||+++|+|.+++....  .+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999996543  589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                          .....+|..|+|||++.+..++.++||||||+++|||+| |+.||......  +....+.                
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~----------------  214 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVE----------------  214 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHT----------------
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----------------
Confidence                233467889999999988899999999999999999998 67777765332  1111111                


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      .+...+.+...+.++.+++.+||+.||++|||++|++++|+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            01111223334467889999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.3e-44  Score=390.99  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC-
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS-  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~-  878 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++.....   ....+.+|+++++.    ++|||||++++++...+ 
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~----~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA----LNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHT----CCCTTBCCEEEEEEEECS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHh----cCCCCCCcccceeeeccC
Confidence            467999999999999999999975 7899999999865433   23468899999987    68999999999987643 


Q ss_pred             ---eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          879 ---EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       879 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                         ..|+||||++||+|.+++...+++++.+++.++.||+.||+|||++   +||||||||+||+++.++..+++|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence               3789999999999999999988999999999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCC--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          956 RVVSAGDS--HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       956 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ........  .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.......+.....  ..  .  
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~--~~--~--  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DP--I--  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CC--C--
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc--CC--C--
Confidence            76543322  2344568999999999999999999999999999999999999999876543222211111  00  0  


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCC-CHHHHHHHHHhhC
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARP-NVKEVLAMLIKIL 1084 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~i~ 1084 (1088)
                        .+..       .....+.++.+++.+|+++||++|| +++|+.+.|.++.
T Consensus       233 --~~~~-------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 --PPSA-------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --CGGG-------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --CCch-------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              0000       0112335788899999999999999 8999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-44  Score=396.02  Aligned_cols=244  Identities=27%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+.+|+.+++.    ++|||||++++++.+++..
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~----l~HpnIv~~~~~~~~~~~~   79 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI----VTHPFIIRMWGTFQDAQQI   79 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHS----CCBTTBCCEEEEEECSSEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHh----ccCcChhheeeeEeeCCee
Confidence            35899999999999999999975 68999999997542   2334678899999997    6799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||++||+|.+++.....+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+......  ...+.....            
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~~~~------------  218 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILNAEL------------  218 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHCCC------------
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HHHHHcCCC------------
Confidence            2    3346899999999999999999999999999999999999999987654221  122211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                           ..+.....++.+++.+|++.||.+||     +++|+++
T Consensus       219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                 01122335678899999999999996     8998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9e-44  Score=386.07  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=206.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc---------chHHHHHHHHHHhCCCCCCCCCceeEEeeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE---------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWC  874 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~  874 (1088)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+....         ..+.+.+|+.+++++.   .||||+++++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hpnIv~~~~~~   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS---GHPNIIQLKDTY   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT---TCTTBCCEEEEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc---CCCCeEEEEeec
Confidence            68999999999999999999975 7899999999764321         1235788999998732   499999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          875 LDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       875 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                      .+++..|+||||+++|+|.++++.++++++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          80 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999999999988999999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCC
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQ------TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGR 1028 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1088)
                      ++......  ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.+..+...........+..
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            99875432  334567999999999764      3357889999999999999999999999875533222111110000


Q ss_pred             CCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              +       .+.....+.++.+++.+|+++||++||+++||++
T Consensus       235 --------~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         235 --------G-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --------C-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --------C-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                    0       0012233467889999999999999999999865

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-43  Score=398.45  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=200.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc---cchHHHHHH---HHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL---EGEREFRAE---MEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.++||+|+||+||+|+++ +|+.||||++.+...   .....+.+|   +++++.    ++|||||++++++.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~----~~hpnIv~l~~~~~~~   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMSYAFHTP   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS----SCCTTBCCEEEEEECS
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc----CCCCcEEEEEEEEEEC
Confidence            57999999999999999999976 689999999865322   122334444   555554    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      +..|+||||++||+|.+++.+...+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999999999988999999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      +...   ......||+.|+|||++. +..|+.++||||+||++|||+||+.||.+.... .....+......        
T Consensus       157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~--------  225 (364)
T d1omwa3         157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------  225 (364)
T ss_dssp             CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC--------
T ss_pred             cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--------
Confidence            6533   234567999999999886 457899999999999999999999999875432 212212111000        


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                               ...+.....++.++|.+||+.||++||+     ++|+++
T Consensus       226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                     0111223456888999999999999999     677764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-43  Score=397.60  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=207.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+.+|+++++.    ++|||||++++++.+....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA----VNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHH----cCCCcEeeccccccccccc
Confidence            36999999999999999999975 79999999987542   2334578899999986    6899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      ++||||+.+|+|.+++.+.+.+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999999999888999999999999999999999999   999999999999999999999999999988753


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .    .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  .....+.....            
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~~~------------  255 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVSGKV------------  255 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------------
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHHHhcCCC------------
Confidence            2    33467999999999999999999999999999999999999999876442  22222211000            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARP-----NVKEVLA 1078 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 1078 (1088)
                           ..+.....++.+++.+||+.||.+|+     +++|+++
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 01122345788899999999999994     8999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=393.14  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=207.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++.... ..+..+.+|+++++.    ++|||||++++++.+++..|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~----l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNI----ARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHH----SCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHh----CCCCCCCeEEEEEEECCEEEE
Confidence            468999999999999999999976 68899999998763 334568899999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC--CCEEEeecccceeec
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE--GKALVTDFGLARVVS  959 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~--~~~kl~Dfg~a~~~~  959 (1088)
                      |||||+||+|.++++..+ ++++.+++.|+.||+.||+|||++   +|+||||||+|||++.+  ..+||+|||+++...
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999999999999998765 799999999999999999999999   99999999999999854  589999999998765


Q ss_pred             CCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          960 AGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ..  .......+|+.|+|||...+..|+.++||||+||++|+|++|+.||.+......  ...+.....      ..+..
T Consensus       156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~~i~~~~~------~~~~~  225 (321)
T d1tkia_         156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMNAEY------TFDEE  225 (321)
T ss_dssp             TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCC------CCCHH
T ss_pred             cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCCC------CCChh
Confidence            32  234456789999999999999999999999999999999999999987654221  122221000      00000


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .       ......++.+++.+|++.||++|||++|+++
T Consensus       226 ~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 A-------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             H-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0       0112356788999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-44  Score=397.20  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=202.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR----EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS  878 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~  878 (1088)
                      .+|++.++||+|+||+||+|++. +|+    +||||++.... ....+++.+|++++++    ++|||||++++++.++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS----VDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHH----CCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHh----CCCCCEeeEEEEEecC-
Confidence            46899999999999999999975 444    58999887542 3445789999999997    6799999999999875 


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 EKILVYEYMEGGSLEDIISDR-TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ..+++|||+.+|+|.+++... ..+++..+++++.|||.||+|||++   +||||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            467888999999999887654 5799999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCCcc-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCccc
Q 001384          958 VSAGDSHV-STTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGRAV 1035 (1088)
Q Consensus       958 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1088)
                      ........ .....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+......  .....           
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~~~i~-----------  227 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILE-----------  227 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--HHHHH-----------
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--HHHHH-----------
Confidence            65443332 334568999999999999999999999999999999998 7888876543211  11111           


Q ss_pred             cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1036 IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                           .+...+.+..++.++.+++.+||+.||++|||++||++.|+++.
T Consensus       228 -----~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         228 -----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -----HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                 11112223344567889999999999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=396.04  Aligned_cols=247  Identities=28%  Similarity=0.400  Sum_probs=204.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccC---ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREG---LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..   ....+.+..|..++.+   .++|||||++++++.+++..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~---~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL---AWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHH---HTTCTTBCCEEEEEECSSEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHH---hCCCCcEEEEEEEEccCCce
Confidence            57999999999999999999976 68999999997542   1233456667666543   25899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          881 ILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      |+||||+++|+|.++++...++++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999999999989999999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchhh
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVVL 1040 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1088)
                      .. .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+........  .+.. ..            
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~--~i~~-~~------------  219 (320)
T d1xjda_         156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRM-DN------------  219 (320)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH-CC------------
T ss_pred             cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH--HHHc-CC------------
Confidence            32 23445689999999999999999999999999999999999999998765422211  1110 00            


Q ss_pred             cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 001384         1041 LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVK-EVL 1077 (1088)
Q Consensus      1041 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 1077 (1088)
                          ...+...+.++.+++.+|++.||++||++. |++
T Consensus       220 ----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 ----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                001122345688999999999999999985 664

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=396.06  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=199.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++..... ..+.+..|...+.+.   .+|+||+.+++++.+
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~---~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI---GHHLNVVNLLGACTK   88 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHH---CCCTTBCCEEEEECS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhh---cCCCeEEEeeeeecc
Confidence            367999999999999999999853      2468999999765332 345677787777663   379999999998876


Q ss_pred             C-CeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          877 G-SEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       877 ~-~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      + ...++|||||++|+|.++++...                .+++.+++.++.||+.||+|||++   +||||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence            4 56899999999999999997532                489999999999999999999999   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-cCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR-RALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~ 1017 (1088)
                      |+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||.+..... 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999999999876543332 344567999999999999999999999999999999999975 5676543211 


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ........                +.....+...+.++.+++.+||+.||++|||++||++.|+++++
T Consensus       245 ~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 EFCRRLKE----------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHHH----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhc----------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111110                00111122334578899999999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=395.02  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=204.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc--EEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGR--EVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEK  880 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~  880 (1088)
                      ++|++.+.||+|+||+||+|+++ +|.  .||||++.... ....+.+.+|+++++++.   +|||||++++++.+++..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~---~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG---HHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC---CCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc---CCCCEeeEEEEEecCCee
Confidence            46888899999999999999976 444  47888876442 223457899999999732   699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC
Q 001384          881 ILVYEYMEGGSLEDIISDR----------------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE  944 (1088)
Q Consensus       881 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~  944 (1088)
                      ++||||+++|+|.++++..                ..+++.++++++.|||.||.|+|++   +|+||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            9999999999999999754                4699999999999999999999999   99999999999999999


Q ss_pred             CCEEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCc-CCCCCchhHHHHHHhh
Q 001384          945 GKALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRR-ALEGGEECLVEWGRRV 1023 (1088)
Q Consensus       945 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~-p~~~~~~~~~~~~~~~ 1023 (1088)
                      +.+||+|||+++.....  .......||..|+|||.+....++.++|||||||++|||++|.. ||.+.....  ....+
T Consensus       164 ~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~~i  239 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL  239 (309)
T ss_dssp             GCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHG
T ss_pred             CceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence            99999999999765322  22234568999999999999999999999999999999999765 566543311  11111


Q ss_pred             hccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1024 MGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..                +.....+...+.++.+++.+||+.||++||+|+||++.|+++++
T Consensus       240 ~~----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         240 PQ----------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             GG----------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh----------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11                11111223344678899999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-44  Score=385.90  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=196.3

Q ss_pred             CCCCccceecccCceEEEEEEeC--CC--cEEEEEEccccCc---cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP--DG--REVAVKKLQREGL---EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||+||+|++.  ++  ..||||++.+...   ...++|.+|++++++    ++|||||++++++.+ 
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~----l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS----LDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHH----CCCTTBCCEEEEECS-
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHh----CCCCCEEEEEEEEee-
Confidence            46888999999999999999853  22  3789999876432   234578999999997    689999999999976 


Q ss_pred             CeEEEEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          878 SEKILVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ...++||||+++|++.+++.. ...+++..++.++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            467899999999999988765 45699999999999999999999999   99999999999999999999999999999


Q ss_pred             eecCCCCc--ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          957 VVSAGDSH--VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       957 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      ........  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.......  ..+.....     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~--~~i~~~~~-----  232 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--HKIDKEGE-----  232 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTSCC-----
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH--HHHHhCCC-----
Confidence            87543322  2334567889999999999999999999999999999998 89999876543221  12211110     


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhh
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKI 1083 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i 1083 (1088)
                                ..+.+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus       233 ----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 ----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      0111223345788999999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-44  Score=392.91  Aligned_cols=257  Identities=28%  Similarity=0.395  Sum_probs=205.2

Q ss_pred             CCCCccceecccCceEEEEEEeCC--------CcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEe
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPD--------GREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCL  875 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~  875 (1088)
                      ++|++.+.||+|+||.||+|+...        +..||||+++..... ...++.+|...+.+.   .+|||||++++++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~---~~HpnIv~~~~~~~   89 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI---GKHKNIINLLGACT   89 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHH---CCCTTBCCEEEEEC
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHh---cCCCeEEecccccc
Confidence            578899999999999999998532        247999999876433 336788888888763   27999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          876 DGSEKILVYEYMEGGSLEDIISDRT----------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       876 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      +++..++||||+++|+|.+++....                .+++.++++++.||+.||+|||+.   +||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            9999999999999999999997543                489999999999999999999999   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCcCCCCCchhHH
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELAT-GRRALEGGEECLV 1017 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 1017 (1088)
                      |++.++.+||+|||+++........ ......+|+.|+|||.+.+..|+.++|||||||++|||++ |+.||.+......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            9999999999999999877543322 2345678999999999999999999999999999999998 6888876544221


Q ss_pred             HHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1018 EWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      .  ..+.. .               .....+...+.++.+++.+||+.||++|||++||++.|++++.
T Consensus       247 ~--~~i~~-~---------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 F--KLLKE-G---------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H--HHHHT-T---------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHHHc-C---------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1  11110 0               0111122334578899999999999999999999999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=393.42  Aligned_cols=249  Identities=25%  Similarity=0.294  Sum_probs=198.1

Q ss_pred             CCCCccc-eecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec----CC
Q 001384          805 GKFSEDR-IIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD----GS  878 (1088)
Q Consensus       805 ~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~----~~  878 (1088)
                      ++|++.+ +||+|+||+||+|++. +++.||||++++.     ..+.+|++++.+.   .+|||||++++++.+    +.
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~---~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA---SQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHH---TTSTTBCCEEEEEEEEETTEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHh---cCCCCCCeEEEEEeecccCCC
Confidence            5788764 6999999999999975 7899999998643     4567888876542   479999999999875    46


Q ss_pred             eEEEEEEecCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC---CCCEEEeecc
Q 001384          879 EKILVYEYMEGGSLEDIISDR--TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK---EGKALVTDFG  953 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~---~~~~kl~Dfg  953 (1088)
                      ..|+|||||+||+|.+++++.  .++++.+++.|+.||+.||+|||++   +|+||||||+||+++.   ++.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            789999999999999999764  3699999999999999999999999   9999999999999985   5679999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCCC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 1032 (1088)
                      +|+......  ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+...... .......     ...
T Consensus       160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i-----~~~  232 (335)
T d2ozaa1         160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-----RMG  232 (335)
T ss_dssp             TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-----CSC
T ss_pred             eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-----hcC
Confidence            998765433  23456799999999999999999999999999999999999999976533111 1000000     000


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ....+       .+.......++.+++.+|++.||++||++.|+++
T Consensus       233 ~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 QYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSSCC-------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00000       0112234567899999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-43  Score=387.92  Aligned_cols=253  Identities=31%  Similarity=0.462  Sum_probs=203.5

Q ss_pred             cceecccCceEEEEEEeCCC----cEEEEEEccccC-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-CCeEEEE
Q 001384          810 DRIIGKGGFGTVYRGVLPDG----REVAVKKLQREG-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-GSEKILV  883 (1088)
Q Consensus       810 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-~~~~~lv  883 (1088)
                      .++||+|+||+||+|++.++    ..||||++.+.. ....+++.+|++++++    ++||||++++|++.. +...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~----l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD----FSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHT----CCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh----CCCCCEeEEeEEEEecCCceEEE
Confidence            47899999999999997532    358999997543 2334679999999997    679999999999875 5688999


Q ss_pred             EEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          884 YEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       884 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      |||+++|+|.++++... ..++.++++++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999999999987544 578899999999999999999999   99999999999999999999999999998765433


Q ss_pred             Cc---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCccccchh
Q 001384          963 SH---VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGRAVIPVV 1039 (1088)
Q Consensus       963 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1088)
                      ..   ......||..|+|||.+.+..++.++||||||+++|||+||+.||..... ..++.....               
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~---------------  248 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLL---------------  248 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH---------------
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHH---------------
Confidence            22   22345789999999999999999999999999999999999888875432 111222221               


Q ss_pred             hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1040 LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1040 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                       .+.....+...+..+.+++.+||+.||++||++.||++.|+++++.
T Consensus       249 -~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         249 -QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             1111122233446788999999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=382.72  Aligned_cols=263  Identities=29%  Similarity=0.382  Sum_probs=200.0

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC----eEE
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS----EKI  881 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~----~~~  881 (1088)
                      +|.+.+.||+|+||.||+|++ +|+.||||++...   ..+++..|.+++....  ++|||||++++++.+++    ..+
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~--~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVM--LRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTT--CCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhh--CCCCcCcceEEEEEeCCCcceEEE
Confidence            466778999999999999997 5899999999754   3345555666554322  68999999999998653    679


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC-----YPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      +||||+++|+|.+++++. +++|.++++++.|+|.||+|+|+..     .++||||||||+||||+.++.+||+|||+++
T Consensus        78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999999875 5899999999999999999999731     2499999999999999999999999999999


Q ss_pred             eecCCCCc---ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCcCCCCCchh------------
Q 001384          957 VVSAGDSH---VSTTIAGTVGYVAPEYGQTW------QATTKGDVYSFGVLAMELATGRRALEGGEEC------------ 1015 (1088)
Q Consensus       957 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg~~p~~~~~~~------------ 1015 (1088)
                      ........   ......||+.|+|||++...      .++.++|||||||++|||+||..||......            
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            87654322   23456799999999987654      3577899999999999999999887543210            


Q ss_pred             HHHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1016 LVEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                      ..+...........   +..++      ...........+.+++.+||+.||++|||+.||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~---~p~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         237 SVEEMRKVVCEQKL---RPNIP------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCC---CCCCC------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccc---CCCCC------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            00111111100000   00000      01113345677999999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=390.60  Aligned_cols=256  Identities=26%  Similarity=0.379  Sum_probs=209.6

Q ss_pred             CCCCccceecccCceEEEEEEe------CCCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVL------PDGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.++||+|+||.||+|++      .+++.||||+++..... ....+.+|+.+++++.   +|||||++++++.++
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~---~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG---NHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC---CCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc---CCCCEEEEEEEEeeC
Confidence            5788899999999999999985      24578999999865433 3457889999998742   699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001384          878 SEKILVYEYMEGGSLEDIISDRT------------------RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNV  939 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NI  939 (1088)
                      ...++||||+++|+|.++++...                  .+++.++..++.||+.||+|||++   ++|||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            99999999999999999997543                  489999999999999999999999   999999999999


Q ss_pred             EEcCCCCEEEeecccceeecCCCC-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CcCCCCCchhH-
Q 001384          940 LLDKEGKALVTDFGLARVVSAGDS-HVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATG-RRALEGGEECL- 1016 (1088)
Q Consensus       940 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~- 1016 (1088)
                      +++.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||....... 
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987654433 334457889999999999999999999999999999999995 54554433211 


Q ss_pred             -HHHHHhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1017 -VEWGRRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1017 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                       ........                   ....+...+.++.+++.+||+.||++||++++|+++|++++.
T Consensus       257 ~~~~i~~~~-------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 FYKMIKEGF-------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHHHHTC-------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCC-------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence             11111111                   111122344678899999999999999999999999998764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-43  Score=387.94  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=210.6

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEccccCcc-chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP------DGREVAVKKLQREGLE-GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      ++|++.+.||+|+||+||+|.++      +++.||||+++..... ....+.+|++++++    ++|||||++++++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~----l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE----FNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGG----CCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHH----cCCCCEeeeeeEEecC
Confidence            57888999999999999999863      3578999999865333 33468899999997    6799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCE
Q 001384          878 SEKILVYEYMEGGSLEDIISDR----------TRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKA  947 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~  947 (1088)
                      ...++||||+++|+|.+++...          ..+++..+.+++.|+|+||+|||++   +|+||||||+|||+++++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence            9999999999999999998643          2478999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceeecCCCCc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-cCCCCCchhHHHHHHhhhc
Q 001384          948 LVTDFGLARVVSAGDSH-VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGR-RALEGGEECLVEWGRRVMG 1025 (1088)
Q Consensus       948 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~ 1025 (1088)
                      ||+|||+|+........ ......+|+.|+|||.+.+..++.++||||||+++|||+||+ .||.+...  .++...+..
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~~~~i~~  250 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVME  250 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHHHHT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh
Confidence            99999999876543322 234457899999999999999999999999999999999985 66665433  222222221


Q ss_pred             cCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCCC
Q 001384         1026 YGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILPH 1086 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 1086 (1088)
                                      +...+.+...+..+.+++.+||+.||++|||+++|++.|++.++.
T Consensus       251 ----------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         251 ----------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             ----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                            111112233446789999999999999999999999999988753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=384.13  Aligned_cols=262  Identities=24%  Similarity=0.246  Sum_probs=198.4

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEccccCccc-----hHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          809 EDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEG-----EREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       809 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ..++||+|+||+||+|+++ +|+.||||++.......     .+.+.+|++++++    ++|||||++++++.+++..|+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~----l~hpnIv~~~~~~~~~~~~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE----LSHPNIIGLLDAFGHKSNISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHH----CCCTTBCCEEEEECCTTCCEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHh----CCCCCEeEEEeeeccCCceee
Confidence            3578999999999999976 68999999997543221     2468899999997    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      ||||+.++++..+......+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            999999988888887778899999999999999999999999   99999999999999999999999999998764332


Q ss_pred             CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhhccCCCCC---Cccccc
Q 001384          963 SHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVMGYGRHGP---GRAVIP 1037 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~ 1037 (1088)
                       .......||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+..+... .-............   ......
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence             22344679999999998754 4689999999999999999999999987654211 11111110000000   000000


Q ss_pred             hhhcCCCcccc-----HHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1038 VVLLGSGLAEG-----AEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1038 ~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..........+     .....++.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000001     122357889999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=382.41  Aligned_cols=242  Identities=26%  Similarity=0.415  Sum_probs=199.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc------chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE------GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+....      ...++.+|+.+++++.  ..|||||++++++.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--~~h~nIv~~~~~~~~   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS--SGFSGVIRLLDWFER   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC--SSSCSBCCEEEEEEC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhc--cCCCCccEEEEEEee
Confidence            468999999999999999999975 7899999999754321      1234668888887643  359999999999999


Q ss_pred             CCeEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCC-CCEEEeeccc
Q 001384          877 GSEKILVYEYMEG-GSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKE-GKALVTDFGL  954 (1088)
Q Consensus       877 ~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~-~~~kl~Dfg~  954 (1088)
                      ++..++||||+.+ +++.+++.....+++.+++.++.||+.||+|||++   +|+||||||+||+++.+ +.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            9999999999976 68899998888999999999999999999999999   99999999999999854 7999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCCCCCc
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQA-TTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRHGPGR 1033 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1088)
                      |+....   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..+ .   .+...         
T Consensus       158 a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-i---~~~~~---------  221 (273)
T d1xwsa_         158 GALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-I---IRGQV---------  221 (273)
T ss_dssp             CEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-H---HHCCC---------
T ss_pred             ceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-H---hhccc---------
Confidence            987543   23345689999999998876655 5778999999999999999999976321 0   00000         


Q ss_pred             cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       ..           +...+.++.+++.+|++.||++|||++|+++
T Consensus       222 -~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 -FF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -CC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CC-----------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             00           1112356888999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-42  Score=376.96  Aligned_cols=266  Identities=23%  Similarity=0.255  Sum_probs=203.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      ++|++.+.||+|+||+||+|++++|+.||||++.....  ...+.+.+|+.++++    ++|||||++++++.+++..++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~----l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----LKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGG----CCCTTBCCEEEEEECSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHh----CCCCcEEeeeeecccCCceeE
Confidence            58999999999999999999999999999999976532  234688999999987    679999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCCC
Q 001384          883 VYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAGD  962 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~~  962 (1088)
                      +|||+.++.+..+.+....+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+|++|||.+.......
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            999999888888888788899999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHH-HhhhccCCCCCCccc-----
Q 001384          963 SHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWG-RRVMGYGRHGPGRAV----- 1035 (1088)
Q Consensus       963 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~----- 1035 (1088)
                       .......+++.|+|||.+.. ..++.++||||+||++|||++|+.||.+..+...... ...............     
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence             22344568999999998754 5679999999999999999999999987654221111 111100000000000     


Q ss_pred             ----cchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1036 ----IPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1036 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                          ...................+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000000111223457889999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-42  Score=376.29  Aligned_cols=266  Identities=24%  Similarity=0.278  Sum_probs=199.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|++++++    ++|||||++++++.+++..|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~----l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE----LNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTT----CCCTTBCCEEEEEEETTEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHh----CCCCcEEEecccccccccee
Confidence            57999999999999999999975 789999999976532  234678999999987    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISD-RTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+.++.+...... ...+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||.|+....
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence            99999976444433333 45699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHh-hhccCCCCCCccc--c
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTWQ-ATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRR-VMGYGRHGPGRAV--I 1036 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~ 1036 (1088)
                      .. .......||+.|+|||...... ++.++||||+||++|+|++|+.||.+......-+... .............  .
T Consensus       155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            32 2344567999999999766554 5889999999999999999999998765422211111 1100010000000  0


Q ss_pred             chhhc---CCCcc----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 PVVLL---GSGLA----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~~~~~---~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      +....   .....    .......++.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000   00000    01122357888999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=375.16  Aligned_cols=269  Identities=24%  Similarity=0.297  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-C-CcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-D-GREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD---  876 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~---  876 (1088)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++.....  ....+.+|+++++.+. ..+||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~-~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE-TFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHH-HTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHh-hcCCCCcceeeeeeccccc
Confidence            468999999999999999999974 4 567999998754222  2234566777665422 2479999999999853   


Q ss_pred             --CCeEEEEEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          877 --GSEKILVYEYMEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       877 --~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                        ....+++|||++++.+..... ....+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence              346799999999877765543 345699999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH-HHhhhccCC--CC
Q 001384          954 LARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW-GRRVMGYGR--HG 1030 (1088)
Q Consensus       954 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~--~~ 1030 (1088)
                      .++....  ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..+..... .........  ..
T Consensus       162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            9876532  233456789999999999999999999999999999999999999998765421111 111110000  00


Q ss_pred             CCccccchhh-----cCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1031 PGRAVIPVVL-----LGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1031 ~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..........     ..............+.+|+.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000000     00000011223456788999999999999999999976

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-40  Score=371.15  Aligned_cols=298  Identities=31%  Similarity=0.498  Sum_probs=216.4

Q ss_pred             CchhhHHHHHHHHhhcccCCCCCcccccccCCCCCCcc--cCCceeCCCC--ceeEEecccccccccc--ccccccCCcc
Q 001384           31 SLETDREVLSNLRSFLENNNPVNEGHYMQWNQSSSPCE--WPGIICSPDK--ARVNGLNLTDWNISGD--IFNNFSALTQ  104 (1088)
Q Consensus        31 ~~~~d~~~l~~~~~~~~~~~~~~~~~~~sW~~~~~~C~--W~gv~C~~~~--~~v~~L~L~~~~l~~~--~~~~l~~l~~  104 (1088)
                      |.++|++||++||+++.+.     ..++||+.++|||.  |+||+|+...  +||++|+|++++++|.  +|+++++|++
T Consensus         3 c~~~e~~aLl~~k~~~~~~-----~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~   77 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNP-----TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY   77 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCC-----GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred             CCHHHHHHHHHHHHHCCCC-----CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence            6789999999999999741     37999999999995  9999998754  4899999999999884  6788888888


Q ss_pred             CCeeeCCC-CCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccC
Q 001384          105 LSYLDLSR-NTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSL  183 (1088)
Q Consensus       105 L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~  183 (1088)
                      |++|||++ |+++|.+|..|+++++|++|+|++|++.+.                                         
T Consensus        78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~-----------------------------------------  116 (313)
T d1ogqa_          78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA-----------------------------------------  116 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE-----------------------------------------
T ss_pred             ccccccccccccccccccccccccccchhhhcccccccc-----------------------------------------
Confidence            88888886 788888888777777777777666654421                                         


Q ss_pred             ccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCccc
Q 001384          184 NNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGE  263 (1088)
Q Consensus       184 n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~  263 (1088)
                            .+..+..+.                                              +|++++++.|.+.+.+|..
T Consensus       117 ------~~~~~~~~~----------------------------------------------~L~~l~l~~N~~~~~~p~~  144 (313)
T d1ogqa_         117 ------IPDFLSQIK----------------------------------------------TLVTLDFSYNALSGTLPPS  144 (313)
T ss_dssp             ------CCGGGGGCT----------------------------------------------TCCEEECCSSEEESCCCGG
T ss_pred             ------ccccccchh----------------------------------------------hhcccccccccccccCchh
Confidence                  111122222                                              3333333344444455666


Q ss_pred             ccCCCCCcEEEccCccccCCCccccCCCCCC-CEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhccccc
Q 001384          264 VSNCRNLVVLNLFGNNFSGPIPAEIGSISGL-EALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQV  342 (1088)
Q Consensus       264 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  342 (1088)
                      +.++++|+++++++|.+.+.+|..+..+..+ +.+++++|++++..|..+.++                           
T Consensus       145 l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l---------------------------  197 (313)
T d1ogqa_         145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL---------------------------  197 (313)
T ss_dssp             GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC---------------------------
T ss_pred             hccCcccceeecccccccccccccccccccccccccccccccccccccccccc---------------------------
Confidence            6666666666666666666666555555443 444555554444444333322                           


Q ss_pred             ceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccC
Q 001384          343 KILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSF  422 (1088)
Q Consensus       343 ~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  422 (1088)
                                             .+..+++++|.+.+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++
T Consensus       198 -----------------------~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~  253 (313)
T d1ogqa_         198 -----------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN  253 (313)
T ss_dssp             -----------------------CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCS
T ss_pred             -----------------------ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccCcc
Confidence                                   23356677777777788888888888888888888886554 578888999999999


Q ss_pred             CcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCc-CccC-CC
Q 001384          423 NELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNK-LSGN-IP  478 (1088)
Q Consensus       423 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~g~-ip  478 (1088)
                      |+++|.+|++++++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ ++|. +|
T Consensus       254 N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp  310 (313)
T d1ogqa_         254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             SCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred             CeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence            999999999999999999999999999988884 6888999999999997 5553 44

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-40  Score=366.35  Aligned_cols=267  Identities=22%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.....  ...+++.+|++++++    ++|||++++++++..     
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~----l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL----LKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHH----CCCTTBCCEEEEEEC-----
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHH----hcCCCccceEeeeecccccc
Confidence            68999999999999999999975 799999999865432  334678899999997    689999999998865     


Q ss_pred             ---CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecc
Q 001384          877 ---GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFG  953 (1088)
Q Consensus       877 ---~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg  953 (1088)
                         +...++||||++++.+..+......+++.+++.++.|++.||.|||++   +||||||||+||+++.++.+|++|||
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence               346799999999877777777777899999999999999999999999   99999999999999999999999999


Q ss_pred             cceeecCCCCc---ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH-HHHHhhh-ccC
Q 001384          954 LARVVSAGDSH---VSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLV-EWGRRVM-GYG 1027 (1088)
Q Consensus       954 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~~~~~~-~~~ 1027 (1088)
                      +++.+......   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..+... .-..... ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876543221   2234579999999998765 4789999999999999999999999987654211 1111111 111


Q ss_pred             CCC--CC--ccccchhhcCCCccccH-------HHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1028 RHG--PG--RAVIPVVLLGSGLAEGA-------EEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1028 ~~~--~~--~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ...  ..  .................       .....+.+|+.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000  00  00000000000000111       11235678999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-40  Score=366.08  Aligned_cols=260  Identities=20%  Similarity=0.287  Sum_probs=199.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ...++..|+++++.+.   +|++|+.+.+++.+.+..++
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~---~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQ---GGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHST---TSTTCCCEEEEEEETTEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHcc---CCCcccEEEEEEecCCEEEE
Confidence            357999999999999999999975 68999999987653  2345788999988743   34556667777788889999


Q ss_pred             EEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEc---CCCCEEEeecccceee
Q 001384          883 VYEYMEGGSLEDIIS-DRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLD---KEGKALVTDFGLARVV  958 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~---~~~~~kl~Dfg~a~~~  958 (1088)
                      ||||+++ ++.+.+. ....+++..+..++.|++.||+|||++   +||||||||+||+++   .+..+|++|||+|+.+
T Consensus        81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999954 6666554 456799999999999999999999999   999999999999986   3557999999999987


Q ss_pred             cCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHH-HHhhhccCCCCC
Q 001384          959 SAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEW-GRRVMGYGRHGP 1031 (1088)
Q Consensus       959 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 1031 (1088)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.........+ .....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-------  229 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------  229 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-------
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-------
Confidence            643321      2345679999999999999999999999999999999999999998654311111 11100       


Q ss_pred             CccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhC
Q 001384         1032 GRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKIL 1084 (1088)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~ 1084 (1088)
                           ...............+.++.+++.+|++.+|++||+++++.+.|+++.
T Consensus       230 -----~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         230 -----EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             -----HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             -----cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                 000000000001123467889999999999999999999999888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-40  Score=360.82  Aligned_cols=266  Identities=22%  Similarity=0.240  Sum_probs=206.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|++. +++.||||+++....  ....++.+|+.+++.    ++||||+++++++.+....+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~----l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE----LKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTT----CCCTTBCCEEEEEECSSEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHh----cCcCCEEeecccccccccee
Confidence            57999999999999999999975 789999999975432  234678999999986    68999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccceeecCC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARVVSAG  961 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~~~~~  961 (1088)
                      +|+|++.++++..+++..+.+++.+++.++.|++.||+|||++   +||||||||+|||++.++.+|++|||.++.....
T Consensus        78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999999999999998888999999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH--hhhccCCCCC--Ccccc
Q 001384          962 DSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR--RVMGYGRHGP--GRAVI 1036 (1088)
Q Consensus       962 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~ 1036 (1088)
                      .. ......++..|+|||.+... .++.++||||+||++|||++|+.||............  ..........  .....
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            22 23344577889999987655 4699999999999999999999998665442222211  1110000000  00000


Q ss_pred             c-------hhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1037 P-------VVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1037 ~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .       .................+.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0       00000111112233456788999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.3e-40  Score=362.45  Aligned_cols=261  Identities=20%  Similarity=0.290  Sum_probs=206.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+++|++.+..+.   +|+|++.+++++.++...++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~---~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA---GCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT---TCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhc---CCCCCCEEEEEeecCCccEE
Confidence            468999999999999999999976 68999999986542  2234667777777643   56999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcC-----CCCEEEeecccce
Q 001384          883 VYEYMEGGSLEDIISDRT-RLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDK-----EGKALVTDFGLAR  956 (1088)
Q Consensus       883 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~-----~~~~kl~Dfg~a~  956 (1088)
                      ||||+ +++|.++++... .+++.++..++.|++.||+|||++   +|+||||||+||+++.     ++.+||+|||+|+
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99999 679999987654 699999999999999999999999   9999999999999974     5789999999999


Q ss_pred             eecCCCCc------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchh-HHHHHHhhhccCCC
Q 001384          957 VVSAGDSH------VSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEEC-LVEWGRRVMGYGRH 1029 (1088)
Q Consensus       957 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 1029 (1088)
                      .+......      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.... ..+...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            87543221      233467999999999999999999999999999999999999999865331 11111111100000


Q ss_pred             CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHHHHHhhCC
Q 001384         1030 GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLAMLIKILP 1085 (1088)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 1085 (1088)
                      ..     ...+       ....+.++.+++..|++.+|++||+++.+.+.|+++++
T Consensus       235 ~~-----~~~l-------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         235 TP-----LREL-------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             SC-----HHHH-------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CC-----hHHh-------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            00     0000       11223568888999999999999999999999988764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=371.28  Aligned_cols=251  Identities=27%  Similarity=0.366  Sum_probs=204.2

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEccccCc----cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP----DGREVAVKKLQREGL----EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~  876 (1088)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++.+...    ...+.+.+|+++++++.   +||||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~---h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---QSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH---TCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc---CCCeEEEeeeeecc
Confidence            45999999999999999999852    478999999875432    23356788999998732   44899999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccce
Q 001384          877 GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLAR  956 (1088)
Q Consensus       877 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~  956 (1088)
                      ....++||||+.+|+|.++++....+++..++.++.|++.|++|+|++   +||||||||+||+++.++.+||+|||+++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999999999998999999999999999999999999   99999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCcCCCCCch--hHHHHHHhhhccCCCCCC
Q 001384          957 VVSAGDSHVSTTIAGTVGYVAPEYGQTW--QATTKGDVYSFGVLAMELATGRRALEGGEE--CLVEWGRRVMGYGRHGPG 1032 (1088)
Q Consensus       957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 1032 (1088)
                      .+............|++.|+|||.+...  .++.++||||+||++|||++|+.||.+...  ............      
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------  251 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  251 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC------
Confidence            8765444445567899999999987643  578899999999999999999999987543  111111111100      


Q ss_pred             ccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 001384         1033 RAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPN-----VKEVLA 1078 (1088)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 1078 (1088)
                                 ....+.....++.+++.+|+++||++||+     ++|+++
T Consensus       252 -----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                       01112334567888999999999999994     788875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-39  Score=364.78  Aligned_cols=267  Identities=21%  Similarity=0.249  Sum_probs=197.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc-cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL-EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS---  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~---  878 (1088)
                      +++|++.+.||+|+||+||+|++. +|+.||||++.+... ...+.+.+|++++++    ++||||+++++++..+.   
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~----l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR----FRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHH----CCCTTBCCCCEEECCSSTTT
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHH----cCCCCCCcEEEEEeeccccc
Confidence            468999999999999999999964 799999999976432 234578899999997    68999999999987653   


Q ss_pred             -eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          879 -EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       879 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                       ..+++++|+.+|+|.++++.. ++++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence             234555667799999999764 699999999999999999999999   999999999999999999999999999987


Q ss_pred             ecCCCC--cccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhh-ccCCCCCCc
Q 001384          958 VSAGDS--HVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVM-GYGRHGPGR 1033 (1088)
Q Consensus       958 ~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 1033 (1088)
                      ......  .......||+.|+|||++. ...++.++||||+||++|||++|+.||.+.......+..... .........
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            654322  2234567999999999874 456789999999999999999999999876542222211111 000000000


Q ss_pred             c-----ccchhh-cCCCcc-----ccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1034 A-----VIPVVL-LGSGLA-----EGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1034 ~-----~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .     ...... ......     .......++.+++.+|++.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     000000 000000     00112246889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=367.33  Aligned_cols=256  Identities=24%  Similarity=0.270  Sum_probs=191.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC------C
Q 001384          806 KFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG------S  878 (1088)
Q Consensus       806 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~------~  878 (1088)
                      +|+..++||+|+||+||+|++. +|+.||||++.+....    ..+|++++++    ++||||+++++++...      .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~----l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRK----LDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHH----CCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHh----cCCCCCCcEEEEEEecCccCCce
Confidence            4777899999999999999986 6899999999765322    2468899987    6799999999998643      3


Q ss_pred             eEEEEEEecCCCCHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeeccc
Q 001384          879 EKILVYEYMEGGSLEDI---ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGL  954 (1088)
Q Consensus       879 ~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~  954 (1088)
                      +.++||||++++.+..+   ......+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            57899999987543333   23455799999999999999999999998   999999999999999775 899999999


Q ss_pred             ceeecCCCCcccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHH--HHH-----------
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQ-TWQATTKGDVYSFGVLAMELATGRRALEGGEECLV--EWG----------- 1020 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--~~~----------- 1020 (1088)
                      ++......  ......||..|+|||.+. ...++.++||||+||++|||++|+.||........  ...           
T Consensus       170 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         170 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            98775433  234467999999999765 45789999999999999999999999987644211  110           


Q ss_pred             -HhhhccCCCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1021 -RRVMGYGRHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1021 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                       .....+.. .............   ........++.+|+.+|++.||++|||++|+++
T Consensus       248 ~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNYTE-FKFPQIKAHPWTK---VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC---C-CCCCCCCCCCGGG---TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhh-ccccccccCchhh---hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000000 0000000000000   011223456888999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-39  Score=362.33  Aligned_cols=262  Identities=22%  Similarity=0.258  Sum_probs=193.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCC--
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGS--  878 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~--  878 (1088)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++++....  ..+.+.+|+++++.    ++|||||++++++...+  
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~----l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----MRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHH----CCBTTBCCCSEEECSCSST
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHh----cCCCCeeEEEEEeccCccc
Confidence            468999999999999999999975 6999999999864322  23568899999987    67999999999998654  


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeeccc
Q 001384          879 ----EKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGL  954 (1088)
Q Consensus       879 ----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~  954 (1088)
                          +.|+||||+ +++|.++.+. .++++..++.++.||+.||+|||++   +||||||||+|||++.++.+|++|||.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence                569999999 5578887754 5699999999999999999999999   999999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhhhccCCC----
Q 001384          955 ARVVSAGDSHVSTTIAGTVGYVAPEYGQT-WQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRVMGYGRH---- 1029 (1088)
Q Consensus       955 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1029 (1088)
                      |+.....    .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+.....+..........    
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            9876432    344678999999998765 4678999999999999999999999987654221111100000000    


Q ss_pred             --CCCc------cccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1030 --GPGR------AVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1030 --~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                        ....      .....................+.+|+.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0000      000000000000011122346788999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-39  Score=361.70  Aligned_cols=260  Identities=19%  Similarity=0.236  Sum_probs=197.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEec--CCeEE
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD--GSEKI  881 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~--~~~~~  881 (1088)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++..   ..+++.+|++++..+.   .||||+++++++..  ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~---~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLR---GGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHT---TSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhcc---CCCCCcEEEEEEEecCCCcee
Confidence            47999999999999999999975 7899999998754   3567889999998732   59999999999874  45689


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCC-CEEEeecccceeecC
Q 001384          882 LVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEG-KALVTDFGLARVVSA  960 (1088)
Q Consensus       882 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~-~~kl~Dfg~a~~~~~  960 (1088)
                      +||||+++++|.++.   ..+++.+++.++.||+.||+|||++   +||||||||+|||++.++ .+|++|||+|+....
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999999997764   4699999999999999999999999   999999999999998765 589999999987654


Q ss_pred             CCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHHhh------------h--c
Q 001384          961 GDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGRRV------------M--G 1025 (1088)
Q Consensus       961 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~------------~--~ 1025 (1088)
                      ..  ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+....+....            .  .
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            32  23456789999999986654 579999999999999999999999987654322211100            0  0


Q ss_pred             cCCCCCCccccchh-----hcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1026 YGRHGPGRAVIPVV-----LLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1026 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      ..............     ..............++.+|+.+|++.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000000000     000000011223456889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-39  Score=362.21  Aligned_cols=262  Identities=22%  Similarity=0.240  Sum_probs=192.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCcc--chHHHHHHHHHHhCCCCCCCCCceeEEeeEEec-----
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLE--GEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLD-----  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~-----  876 (1088)
                      ++|++.++||+|+||+||+|+++ +|+.||||++.+....  ....+.+|+.++++    ++|||||++++++..     
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~----l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC----VNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCCSTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHh----cCCCCeeEEEEEEecccccc
Confidence            67999999999999999999976 6999999999765332  23468899999987    679999999999864     


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          877 -GSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       877 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                       ..+.|+||||+.++ +.+.+.  ..+++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|||++
T Consensus        93 ~~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          93 EFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             TCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             cCceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence             36889999999765 444443  4589999999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH-h------------
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR-R------------ 1022 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~------------ 1022 (1088)
                      +.....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+........ .            
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            765432  2344567899999999999999999999999999999999999999876432111000 0            


Q ss_pred             --------hhccC--CCCCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1023 --------VMGYG--RHGPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1023 --------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                              .....  .........+................++.+|+.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    00000  000000111111112222223445678899999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-38  Score=354.68  Aligned_cols=263  Identities=23%  Similarity=0.294  Sum_probs=194.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCc--cchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC---
Q 001384          804 TGKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGL--EGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG---  877 (1088)
Q Consensus       804 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~---  877 (1088)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+...  ...+.+.+|++++++    ++|||+|++++++...   
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~----l~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH----MKHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHH----CCCTTBCCCSEEECSCSST
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHh----cCCCCeeeEEEEEeecccc
Confidence            568999999999999999999975 799999999986532  233568899999997    6799999999998643   


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEEeecccc
Q 001384          878 --SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALVTDFGLA  955 (1088)
Q Consensus       878 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a  955 (1088)
                        ...+++|+|+.+|+|.++++. .++++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+|++|||.+
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence              344667788889999999965 4699999999999999999999999   9999999999999999999999999998


Q ss_pred             eeecCCCCcccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCcCCCCCchhHHHHHH-hhhccCC-----
Q 001384          956 RVVSAGDSHVSTTIAGTVGYVAPEYGQTW-QATTKGDVYSFGVLAMELATGRRALEGGEECLVEWGR-RVMGYGR----- 1028 (1088)
Q Consensus       956 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~----- 1028 (1088)
                      ....    .......|+..|+|||...+. .++.++||||+||++|+|++|+.||.+.+........ .......     
T Consensus       169 ~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         169 RHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             -CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            7643    233456789999999975554 5689999999999999999999999876542221111 1100000     


Q ss_pred             CCCCccc---cchhhcCCCc---cccHHHHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 001384         1029 HGPGRAV---IPVVLLGSGL---AEGAEEMSELLRIGVRCTAEAPNARPNVKEVLA 1078 (1088)
Q Consensus      1029 ~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 1078 (1088)
                      .......   ..........   ........++.+|+.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000000   0000000000   000112356788999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.3e-34  Score=323.64  Aligned_cols=267  Identities=18%  Similarity=0.157  Sum_probs=189.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEccccCccchHHHHHHHHHHhCCCC-------CCCCCceeEEeeEEec
Q 001384          805 GKFSEDRIIGKGGFGTVYRGVLP-DGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-------GWPHPNLVTLYGWCLD  876 (1088)
Q Consensus       805 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-------~l~h~niv~l~~~~~~  876 (1088)
                      ++|++.+.||+|+||+||+|++. +|+.||||++++... ..+.+.+|+++++.+..       .+.|+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999975 799999999986532 23466778777765320       1247899999998764


Q ss_pred             --CCeEEEEEEecCCCCHHH-H--HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCC-----
Q 001384          877 --GSEKILVYEYMEGGSLED-I--ISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGK-----  946 (1088)
Q Consensus       877 --~~~~~lv~e~~~~gsL~~-~--l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~-----  946 (1088)
                        ....+++|+++..+.... .  ......+++..++.++.||+.|++|||+..  +|+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence              356667777766554332 2  233457899999999999999999999832  9999999999999987654     


Q ss_pred             -EEEeecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCcCCCCCch-----hHHHHH
Q 001384          947 -ALVTDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVLAMELATGRRALEGGEE-----CLVEWG 1020 (1088)
Q Consensus       947 -~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~-----~~~~~~ 1020 (1088)
                       ++++|||.+.....    ......||+.|+|||++....++.++||||+||++++|++|+.||.....     ......
T Consensus       170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             99999999986542    23446799999999999999999999999999999999999999975422     000110


Q ss_pred             HhhhccCC-----------------------C-CCCccccchhhcCCCccccHHHHHHHHHHHhhhcccCCCCCCCHHHH
Q 001384         1021 RRVMGYGR-----------------------H-GPGRAVIPVVLLGSGLAEGAEEMSELLRIGVRCTAEAPNARPNVKEV 1076 (1088)
Q Consensus      1021 ~~~~~~~~-----------------------~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 1076 (1088)
                      ........                       . ........................++.+|+.+|++.||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            00000000                       0 00000000000001112245667889999999999999999999999


Q ss_pred             HH
Q 001384         1077 LA 1078 (1088)
Q Consensus      1077 l~ 1078 (1088)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             hc
Confidence            86

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=3.7e-32  Score=302.29  Aligned_cols=252  Identities=28%  Similarity=0.498  Sum_probs=227.5

Q ss_pred             CCcCEEEccCCccCC--CCCccccCCcCcceeeccc-cccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcE
Q 001384          365 PNISRLDLSHNNFTG--PLPVEISQMRSLKFLILAH-NRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLW  441 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  441 (1088)
                      .+++.|+|++|.++|  .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..|..+..+.+|++
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            368899999999988  4789999999999999987 8999999999999999999999999999988888999999999


Q ss_pred             EEccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCC
Q 001384          442 LMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYP  521 (1088)
Q Consensus       442 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~  521 (1088)
                      +++++|++.+.+|..+++++.|+++++++|.++|.+|+.+..+..+                                  
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l----------------------------------  175 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL----------------------------------  175 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT----------------------------------
T ss_pred             cccccccccccCchhhccCcccceeecccccccccccccccccccc----------------------------------
Confidence            9999999999999999999999999999999999999876543221                                  


Q ss_pred             CCcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccC
Q 001384          522 PFSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGK  601 (1088)
Q Consensus       522 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  601 (1088)
                                                                +.++++++|+++|..|..++++..+ .+++++|.+.|.
T Consensus       176 ------------------------------------------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~  212 (313)
T d1ogqa_         176 ------------------------------------------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD  212 (313)
T ss_dssp             ------------------------------------------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEEC
T ss_pred             ------------------------------------------ccccccccccccccccccccccccc-cccccccccccc
Confidence                                                      2368889999999999999888655 699999999999


Q ss_pred             CCCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCccccCCCCCcc
Q 001384          602 LPSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVSGTIPSTGQL  680 (1088)
Q Consensus       602 ~p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~g~ip~~~~~  680 (1088)
                      +|..++.+ .++.+++++|++++.+| .++.+++|+.|||++|+|+|.+|+.|+++++|+.|+|++|++ +|.||+.+++
T Consensus       213 ~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l-~g~iP~~~~L  290 (313)
T d1ogqa_         213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL-CGEIPQGGNL  290 (313)
T ss_dssp             CGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE-EEECCCSTTG
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcc-cccCCCcccC
Confidence            99998887 68899999999997665 689999999999999999999999999999999999999999 7999998899


Q ss_pred             cccccCccCCCCCCC
Q 001384          681 ATFEKTSYLGDPLLD  695 (1088)
Q Consensus       681 ~~~~~~~~~~n~~~~  695 (1088)
                      .+++...+.||+.+|
T Consensus       291 ~~L~~l~l~~N~~l~  305 (313)
T d1ogqa_         291 QRFDVSAYANNKCLC  305 (313)
T ss_dssp             GGSCGGGTCSSSEEE
T ss_pred             CCCCHHHhCCCcccc
Confidence            999999999999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.9e-27  Score=272.21  Aligned_cols=339  Identities=23%  Similarity=0.293  Sum_probs=208.5

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN  159 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N  159 (1088)
                      .++.|++++++|+..  +.+..+++|++|||++|+|++..  .++++++|++|+|++|.+++..+++++++|+.|++++|
T Consensus        45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~l~~l~~L~~L~~~~~  120 (384)
T d2omza2          45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN  120 (384)
T ss_dssp             TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccccccccccccccccccc
Confidence            456666666666542  34566666666666666666432  26666666666666666666556666666666666666


Q ss_pred             cccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCccccccccccc
Q 001384          160 RIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSV  239 (1088)
Q Consensus       160 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  239 (1088)
                      .+++..+...   ...+..+....|.+.......................                           ...
T Consensus       121 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~  170 (384)
T d2omza2         121 QITDIDPLKN---LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD---------------------------LKP  170 (384)
T ss_dssp             CCCCCGGGTT---CTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC---------------------------CGG
T ss_pred             cccccccccc---cccccccccccccccccccccccccccccccccccch---------------------------hhh
Confidence            6654333211   1233334444444433322222111111111111111                           111


Q ss_pred             ccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCc
Q 001384          240 FKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLE  319 (1088)
Q Consensus       240 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  319 (1088)
                      +.............|..  ..+..+..+++++.+++++|.+++..|  +...++|+.|++++|.++..  ..+..+++|+
T Consensus       171 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~  244 (384)
T d2omza2         171 LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLT  244 (384)
T ss_dssp             GTTCTTCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             hcccccccccccccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccc
Confidence            22223333344444432  223445556666666666666664433  34456666666666666542  3456666666


Q ss_pred             EEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecccc
Q 001384          320 VLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHN  399 (1088)
Q Consensus       320 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N  399 (1088)
                      .|++++|.+++..+  ++.+++|+.|+++.|.+..   ...+..++.++.++++.|.+++.  ..+..+++++.|++++|
T Consensus       245 ~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~---~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n  317 (384)
T d2omza2         245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISN---ISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFN  317 (384)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC---CGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSS
T ss_pred             hhccccCccCCCCc--ccccccCCEeeccCcccCC---CCccccccccccccccccccccc--cccchhcccCeEECCCC
Confidence            66666666665543  5566666666666665432   12355778889999999998852  45788899999999999


Q ss_pred             ccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCC
Q 001384          400 RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNN  471 (1088)
Q Consensus       400 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  471 (1088)
                      ++++. + .+..+++|++|++++|+|++ ++ .++++++|++|++++|++++..|  +.++++|+.|+|++|
T Consensus       318 ~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         318 NISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            99854 3 37889999999999999984 54 68899999999999999996544  889999999999988

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=3.5e-27  Score=269.91  Aligned_cols=318  Identities=24%  Similarity=0.299  Sum_probs=208.4

Q ss_pred             ceeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccc
Q 001384           79 ARVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSV  158 (1088)
Q Consensus        79 ~~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~  158 (1088)
                      ...+.|+|++|.|++..  .++++++|++|+|++|.+++..  .++.+++|+.|++++|.+++.........+..+....
T Consensus        66 ~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (384)
T d2omza2          66 NNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS  141 (384)
T ss_dssp             TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEE
T ss_pred             CCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            36788999999999853  4999999999999999998653  3899999999999999999887777888899999999


Q ss_pred             ccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccc-cccccCcccceecccCccccccccc
Q 001384          159 NRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRG-NIWNGLAQLVEFSVSENVLSGVVSS  237 (1088)
Q Consensus       159 N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~L~~L~L~~n~l~~~~~~  237 (1088)
                      |.+........... ..........     .....+.............|.... .....+++++.+.+++|.+++    
T Consensus       142 ~~l~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~----  211 (384)
T d2omza2         142 NTISDISALSGLTS-LQQLSFGNQV-----TDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISD----  211 (384)
T ss_dssp             EEECCCGGGTTCTT-CSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC----
T ss_pred             cccccccccccccc-cccccccccc-----chhhhhccccccccccccccccccccccccccccceeeccCCccCC----
Confidence            88865443322111 1222222211     122234455556666666665432 223344444444444444443    


Q ss_pred             ccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCC
Q 001384          238 SVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSK  317 (1088)
Q Consensus       238 ~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  317 (1088)
                                           ..|  +..+++|++|++++|++++ + +.+..+++|+.|++++|.+++..  .+..+++
T Consensus       212 ---------------------~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~  264 (384)
T d2omza2         212 ---------------------ITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTK  264 (384)
T ss_dssp             ---------------------CGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred             ---------------------CCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--ccccccc
Confidence                                 322  2334445555555555542 1 23444555555555555554432  2444555


Q ss_pred             CcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecc
Q 001384          318 LEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILA  397 (1088)
Q Consensus       318 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  397 (1088)
                      |++|++++|++++..+  +..++.++.+.+..|.+..   ...+..+++++.|++++|++++..  .+..+++|++|+++
T Consensus       265 L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~---~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~  337 (384)
T d2omza2         265 LTELKLGANQISNISP--LAGLTALTNLELNENQLED---ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFA  337 (384)
T ss_dssp             CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC---CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECC
T ss_pred             CCEeeccCcccCCCCc--ccccccccccccccccccc---ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECC
Confidence            5555555555544332  4445555555555554322   223556788999999999999643  38889999999999


Q ss_pred             ccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccc
Q 001384          398 HNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNS  448 (1088)
Q Consensus       398 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  448 (1088)
                      +|+++ .++ .++++++|++|++++|++++..|  +.++++|++|+|++|.
T Consensus       338 ~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         338 NNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             SSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            99998 455 58899999999999999996443  8899999999999984

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.91  E-value=1.8e-23  Score=230.67  Aligned_cols=228  Identities=26%  Similarity=0.387  Sum_probs=194.6

Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      +++++|+|++|+++...+..|.++++|++|++++|.+....|..|..+++|++|++++|+++. +|..+  ...++.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~  107 (305)
T d1xkua_          31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRV  107 (305)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEEC
T ss_pred             CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhc
Confidence            478899999999886666788999999999999999997778889999999999999999876 44443  357889999


Q ss_pred             CCCcCCCchhHhhhcccccceeecCcCcccC-CCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccC
Q 001384          324 SSNNFGGEVQKIFGRFTQVKILALHSNSYID-GMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN  402 (1088)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  402 (1088)
                      ++|.+.+..+..+.....+..+....|.... ......+..+++|+.+++++|.++ .+|..+  +++|+.|++++|.++
T Consensus       108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~  184 (305)
T d1xkua_         108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT  184 (305)
T ss_dssp             CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC
T ss_pred             cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC
Confidence            9999998888888888888888888775432 334456778899999999999998 566554  578999999999999


Q ss_pred             CcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCc
Q 001384          403 GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPP  479 (1088)
Q Consensus       403 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~  479 (1088)
                      +..+..+.+++.++.|++++|++++..+.++.++++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+ .|+.
T Consensus       185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~  259 (305)
T d1xkua_         185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS  259 (305)
T ss_dssp             EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCT
T ss_pred             CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccCh
Confidence            889999999999999999999999888888999999999999999998 78989999999999999999998 5554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.91  E-value=2.1e-23  Score=230.06  Aligned_cols=197  Identities=21%  Similarity=0.282  Sum_probs=156.1

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      .++.+|-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            5677888888877 6676664  689999999999985555678899999999999999998888889999999999999


Q ss_pred             CCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccC--
Q 001384          325 SNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFN--  402 (1088)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--  402 (1088)
                      +|+++..+..                            ..+.++.|++++|.+.+..+..+.....+..++...|...  
T Consensus        88 ~n~l~~l~~~----------------------------~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~  139 (305)
T d1xkua_          88 KNQLKELPEK----------------------------MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS  139 (305)
T ss_dssp             SSCCSBCCSS----------------------------CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred             CCccCcCccc----------------------------hhhhhhhhhccccchhhhhhhhhhcccccccccccccccccc
Confidence            9988754322                            1246778888888888655556667777888888877543  


Q ss_pred             CcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          403 GSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       403 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ...+..+..+++|+.+++++|+++ .+|..+  +++|++|++++|.+++..+..+.+++.+++|++++|.+++
T Consensus       140 ~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~  209 (305)
T d1xkua_         140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  209 (305)
T ss_dssp             GBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             CCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence            244567788889999999999988 566654  5789999999999998888889999999999999888873

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=6.2e-24  Score=231.67  Aligned_cols=223  Identities=20%  Similarity=0.234  Sum_probs=131.0

Q ss_pred             EEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC-CC
Q 001384          248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS-SN  326 (1088)
Q Consensus       248 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~-~N  326 (1088)
                      .++.++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|++....+..+..++.++.+... .|
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            4566666666 5565543  456777777777775555567777777777777777777666666666777776554 44


Q ss_pred             cCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCC
Q 001384          327 NFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIP  406 (1088)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  406 (1088)
                      .++...+..|+++++|+.|++++|.+ .......+...++|+.+++++|.+++..+..|..+++|+.|++++|++++..+
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~-~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCC-CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccccchhhcccccCCEEecCCccc-ccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            55555555666666666655555553 22333344445555555555555554444455555555555555555554445


Q ss_pred             cccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          407 AVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       407 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      ..|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..|..|+++++|++|+|++|++.
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            55555555555555555555555555555555555555555555544455555555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.2e-23  Score=229.35  Aligned_cols=200  Identities=21%  Similarity=0.244  Sum_probs=111.6

Q ss_pred             EEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcc
Q 001384          273 LNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSY  352 (1088)
Q Consensus       273 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~  352 (1088)
                      ++.++++++ .+|..+.  +++++|+|++|+|++..+.+|.++++|++|++++|++....+..+..++.++.+....+..
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~   92 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ   92 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            344555555 4444332  3455566666655555445555555566666666655555555555555555555554444


Q ss_pred             cCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCcc
Q 001384          353 IDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPS  432 (1088)
Q Consensus       353 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  432 (1088)
                      +....+..+.++++|++|++++|.+.+..+..+...++|+.+++++|++++..+..|..+++|+.|++++|++++..+..
T Consensus        93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~  172 (284)
T d1ozna_          93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA  172 (284)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence            44555555555555666666665555444445555555556666666655444455555555666666666555444555


Q ss_pred             ccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          433 IGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       433 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      +.++++|+++++++|++++..|..|.++++|++|++++|++++
T Consensus       173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~  215 (284)
T d1ozna_         173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA  215 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             hccccccchhhhhhccccccChhHhhhhhhccccccccccccc
Confidence            5555566666666666555555555555566666666666553

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=7.3e-22  Score=212.62  Aligned_cols=202  Identities=23%  Similarity=0.219  Sum_probs=166.1

Q ss_pred             CCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEE
Q 001384          242 ENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVL  321 (1088)
Q Consensus       242 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  321 (1088)
                      ....+.++|.++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. | .++.+++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence            3445666788888877 4676554  5788888888888866566788888888888888888753 3 45678888888


Q ss_pred             EcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeecccccc
Q 001384          322 DLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRF  401 (1088)
Q Consensus       322 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l  401 (1088)
                      +|++|++++..                          ..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.+
T Consensus        83 ~Ls~N~l~~~~--------------------------~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l  136 (266)
T d1p9ag_          83 DLSHNQLQSLP--------------------------LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL  136 (266)
T ss_dssp             ECCSSCCSSCC--------------------------CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred             ccccccccccc--------------------------cccccccccccccccccccceeecccccccccccccccccccc
Confidence            88888876432                          2344677888999999998877788888899999999999999


Q ss_pred             CCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCcc
Q 001384          402 NGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       402 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ++..+..+..+++|+.|++++|+|++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+
T Consensus       137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            9777788888999999999999999877788999999999999999999 899999999999999999999975

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=5.4e-22  Score=213.67  Aligned_cols=201  Identities=23%  Similarity=0.256  Sum_probs=144.4

Q ss_pred             CCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEE
Q 001384          363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL  442 (1088)
Q Consensus       363 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  442 (1088)
                      +...+.+.+.++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence            3455666788888887 5676654  46788888888887555567778888888888888887 444 34677788888


Q ss_pred             EccccccccCCCccccCCCCCCeEEccCCcCccCCCchhhccCCCCCccccccccCCcccccCCccccccccccCCCCCC
Q 001384          443 MLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPEVMTIGRNARPTFEANQRNGERTIAGSSECLSMKRWIPADYPP  522 (1088)
Q Consensus       443 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (1088)
                      +|++|+++ .+|..+.++++|++|++++|.+.+ ++                                            
T Consensus        83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~-~~--------------------------------------------  116 (266)
T d1p9ag_          83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LP--------------------------------------------  116 (266)
T ss_dssp             ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCC-CC--------------------------------------------
T ss_pred             cccccccc-ccccccccccccccccccccccce-ee--------------------------------------------
Confidence            88888877 456677777778888777777652 22                                            


Q ss_pred             CcceeeehhccccchhhhhcccCCcccccccCCCcccceeeeceEEccCCccccccCcccccCCCccEEeccccccccCC
Q 001384          523 FSFVYTILTRKSCRSLWDRLLKGTGIFPVCLPGLASRTFQITGYLQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKL  602 (1088)
Q Consensus       523 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~l~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  602 (1088)
                                                                              +..+..+.+++.|++++|.+++..
T Consensus       117 --------------------------------------------------------~~~~~~l~~l~~L~l~~n~l~~l~  140 (266)
T d1p9ag_         117 --------------------------------------------------------LGALRGLGELQELYLKGNELKTLP  140 (266)
T ss_dssp             --------------------------------------------------------SSTTTTCTTCCEEECTTSCCCCCC
T ss_pred             --------------------------------------------------------ccccccccccccccccccccceec
Confidence                                                                    222333445566666666666444


Q ss_pred             CCcccCc-cceEEEccCCcccccCCccccCCccCcEEEccccccCCcCCcccccccccceeeccCCCCcc
Q 001384          603 PSQFDQL-PLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFSGPFPASFNNLTELSKLNISYNPLVS  671 (1088)
Q Consensus       603 p~~~~~l-~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  671 (1088)
                      |..+..+ .++.+++++|++++..|..|+.+++|+.|||++|+|+ .+|+.+..+++|+.|+|++|||.+
T Consensus       141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            4555544 4667777777777666677888899999999999998 789888899999999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=2e-21  Score=197.66  Aligned_cols=168  Identities=19%  Similarity=0.187  Sum_probs=118.7

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEccccCcc------------------chHHHHHHHHHHhCCCCCCCCCceeE
Q 001384          808 SEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLE------------------GEREFRAEMEVLSGNGFGWPHPNLVT  869 (1088)
Q Consensus       808 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~~~~~l~h~niv~  869 (1088)
                      .+.+.||+|+||+||+|++.+|++||||+++.....                  .......|...+.+    +.|++++.
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----l~~~~v~~   78 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK----LQGLAVPK   78 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH----TTTSSSCC
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH----ccCCCcce
Confidence            457899999999999999989999999987532110                  01234457777775    57889888


Q ss_pred             EeeEEecCCeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEcCCCCEEE
Q 001384          870 LYGWCLDGSEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHECYPPIVHRDVKASNVLLDKEGKALV  949 (1088)
Q Consensus       870 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~DLkp~NIll~~~~~~kl  949 (1088)
                      .+++..    .+++|||++++.+.       .++...+..++.|++.+++|||++   +|+||||||+|||++++ .+++
T Consensus        79 ~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          79 VYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             EEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            876532    37999999885443       356666788999999999999999   99999999999999865 4899


Q ss_pred             eecccceeecCCCCcccccccccccccCccccCCCCCCcchhHHHHHHH
Q 001384          950 TDFGLARVVSAGDSHVSTTIAGTVGYVAPEYGQTWQATTKGDVYSFGVL  998 (1088)
Q Consensus       950 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~  998 (1088)
                      +|||.|+..........  ....... -.|.+ .+.|+.++|+||+.--
T Consensus       144 iDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence            99999987543221100  0000000 00111 2467889999997543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=1.1e-18  Score=195.66  Aligned_cols=302  Identities=23%  Similarity=0.239  Sum_probs=148.5

Q ss_pred             CCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCc
Q 001384          105 LSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLN  184 (1088)
Q Consensus       105 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n  184 (1088)
                      +++|||++|.++ .+|+.   .++|++|+|++|+|+....  ...+|+.|++++|+++.. +    ...+.|++|++++|
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~--~~~~L~~L~l~~n~l~~l-~----~lp~~L~~L~L~~n  108 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPE--LPQSLKSLLVDNNNLKAL-S----DLPPLLEYLGVSNN  108 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCC--CCTTCCEEECCSSCCSCC-C----SCCTTCCEEECCSS
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccccc--chhhhhhhhhhhcccchh-h----hhcccccccccccc
Confidence            445555555554 34432   2345555555555543221  123455555555554421 1    11234666666666


Q ss_pred             cCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccc
Q 001384          185 NLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEV  264 (1088)
Q Consensus       185 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l  264 (1088)
                      .++... . ++.+++|++|++++|.+... +.....+..+.+.++....   ...+..++.++.+++++|.+.. .+.. 
T Consensus       109 ~l~~lp-~-~~~l~~L~~L~l~~~~~~~~-~~~~~~l~~l~~~~~~~~~---~~~l~~l~~l~~L~l~~n~~~~-~~~~-  180 (353)
T d1jl5a_         109 QLEKLP-E-LQNSSFLKIIDVDNNSLKKL-PDLPPSLEFIAAGNNQLEE---LPELQNLPFLTAIYADNNSLKK-LPDL-  180 (353)
T ss_dssp             CCSSCC-C-CTTCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSCCSS---CCCCTTCTTCCEEECCSSCCSS-CCCC-
T ss_pred             cccccc-c-hhhhccceeecccccccccc-ccccccccchhhccccccc---cccccccccceecccccccccc-cccc-
Confidence            666543 2 46778888888887776532 2223334444443333221   1223344455555555554432 1111 


Q ss_pred             cCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccce
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKI  344 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  344 (1088)
                        ....+.+...++.+. .++ .+..++.|+.+++++|.... +|.   ...++..+.+.+|.+....            
T Consensus       181 --~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~------------  240 (353)
T d1jl5a_         181 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP------------  240 (353)
T ss_dssp             --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC------------
T ss_pred             --ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---ccccccccccccccccccc------------
Confidence              122233444433333 222 23444455555555444332 121   1223444444444433211            


Q ss_pred             eecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCC-cCcceeeccccccCCcCCcccCCCCCCcEEEccCC
Q 001384          345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQM-RSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFN  423 (1088)
Q Consensus       345 L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  423 (1088)
                                       ...+.+...++..+.+.+ +    ..+ ......++..|.+. .++   ..+++|++|+|++|
T Consensus       241 -----------------~~~~~l~~~~~~~~~~~~-l----~~l~~~~~~~~~~~~~~~-~~~---~~~~~L~~L~Ls~N  294 (353)
T d1jl5a_         241 -----------------ELPQSLTFLDVSENIFSG-L----SELPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNN  294 (353)
T ss_dssp             -----------------CCCTTCCEEECCSSCCSE-E----SCCCTTCCEEECCSSCCS-EEC---CCCTTCCEEECCSS
T ss_pred             -----------------cccccccccccccccccc-c----ccccchhcccccccCccc-ccc---ccCCCCCEEECCCC
Confidence                             123345556665555442 1    111 23345555666555 222   33567788888888


Q ss_pred             cCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeEEccCCcCccCCCch
Q 001384          424 ELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSNNKLSGNIPPE  480 (1088)
Q Consensus       424 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~  480 (1088)
                      +|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|++|+|++|+++ .+|+.
T Consensus       295 ~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~  342 (353)
T d1jl5a_         295 KLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI  342 (353)
T ss_dssp             CCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred             ccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence            877 56654   457777888888887 56653   456778888888877 66653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=3.1e-18  Score=192.03  Aligned_cols=74  Identities=24%  Similarity=0.359  Sum_probs=44.7

Q ss_pred             EEccCCccccccCcccccCCCccEEeccccccccCCCCcccCccceEEEccCCcccccCCccccCCccCcEEEccccccC
Q 001384          567 LQLSGNQLSGELSPDIGKLQNFSMVHLGFNQFDGKLPSQFDQLPLIVLNLTRNNFSGEIPSEFGNIKCLQNLDLSYNNFS  646 (1088)
Q Consensus       567 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~l~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  646 (1088)
                      .++..|.+.+ ++   ..+++|++|+|++|+|+ .+|+.+.  .|+.|+|++|+|+ .+|+.   +++|+.|+|++|+|+
T Consensus       269 ~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~-~lp~~~~--~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         269 LNASSNEIRS-LC---DLPPSLEELNVSNNKLI-ELPALPP--RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             EECCSSCCSE-EC---CCCTTCCEEECCSSCCS-CCCCCCT--TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             cccccCcccc-cc---ccCCCCCEEECCCCccC-ccccccC--CCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence            4455555553 22   23466777777777777 5665443  3556677777766 56643   345667777777776


Q ss_pred             CcCCcc
Q 001384          647 GPFPAS  652 (1088)
Q Consensus       647 g~~p~~  652 (1088)
                       .+|+.
T Consensus       338 -~lp~~  342 (353)
T d1jl5a_         338 -EFPDI  342 (353)
T ss_dssp             -SCCCC
T ss_pred             -CCCcc
Confidence             56653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=2.7e-21  Score=225.80  Aligned_cols=381  Identities=19%  Similarity=0.135  Sum_probs=202.6

Q ss_pred             eeEEeccccccccccc-cccccCCccCCeeeCCCCCCCC----CcCccCCCCCCCcEEECccccccCcc------cCC-C
Q 001384           80 RVNGLNLTDWNISGDI-FNNFSALTQLSYLDLSRNTFSG----SIPDDLSSCRSLKYLNLSHNILSGDL------NLS-G  147 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~-~~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~------~l~-~  147 (1088)
                      +++.||+++++|++.. ..-+..+++++.|+|++|.|+.    .++..+..+++|++|+|++|.|+...      .+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            4555666666665532 2234445555666666665552    23334455556666666666554211      111 1


Q ss_pred             CCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccC--------c
Q 001384          148 LRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGL--------A  219 (1088)
Q Consensus       148 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l--------~  219 (1088)
                      ..+|++|+|++|++++.....+                     +.++..+++|++|++++|.+++..+..+        .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l---------------------~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~  141 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVL---------------------SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  141 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHH---------------------HHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCCCEEECCCCCccccccccc---------------------cchhhccccccccccccccchhhhhhhhhhccccccc
Confidence            2345555555555544332222                     2334555566666666665543211111        1


Q ss_pred             ccceecccCcccccc---cccccccCCCccCEEEcCCCccccc----Ccccc-cCCCCCcEEEccCccccCC----Cccc
Q 001384          220 QLVEFSVSENVLSGV---VSSSVFKENCSLEIFDLSENEFIGD----FPGEV-SNCRNLVVLNLFGNNFSGP----IPAE  287 (1088)
Q Consensus       220 ~L~~L~L~~n~l~~~---~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l-~~l~~L~~L~L~~N~l~~~----~p~~  287 (1088)
                      ...........+...   .....+.....++.++++++.+...    ....+ ........+++..+.+...    ....
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~  221 (460)
T d1z7xw1         142 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI  221 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred             ccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccc
Confidence            111111111111100   0011223344566666666654311    00111 1223445566666655421    1122


Q ss_pred             cCCCCCCCEEeCCCCcCCc-----cCcccccCCCCCcEEEcCCCcCCCchh----HhhhcccccceeecCcCcccCCCCC
Q 001384          288 IGSISGLEALFLGKNNFLS-----VIPESLLNLSKLEVLDLSSNNFGGEVQ----KIFGRFTQVKILALHSNSYIDGMNS  358 (1088)
Q Consensus       288 ~~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~n~~~~~~~~  358 (1088)
                      +.....++.+++++|.+..     ..+.......+|+.|++++|.+.....    ..+...+.++.++++.|.+.+....
T Consensus       222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~  301 (460)
T d1z7xw1         222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  301 (460)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3445666777777665432     122333445567777777776654432    2344566667777766654221100


Q ss_pred             ---c-cccCCCCcCEEEccCCccCCCCCccc----cCCcCcceeeccccccCCc----CCcccC-CCCCCcEEEccCCcC
Q 001384          359 ---S-GILKLPNISRLDLSHNNFTGPLPVEI----SQMRSLKFLILAHNRFNGS----IPAVYG-NMPNLQTLDLSFNEL  425 (1088)
Q Consensus       359 ---~-~~~~l~~L~~L~Ls~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l  425 (1088)
                         . .......|+.+++++|.++......+    ...++|++|+|++|++++.    +++.+. ..+.|++|+|++|+|
T Consensus       302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i  381 (460)
T d1z7xw1         302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  381 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence               0 11234578999999998875433333    3456899999999998742    344443 467799999999999


Q ss_pred             CCC----CCccccCCCCCcEEEccccccccCCCccc----c-CCCCCCeEEccCCcCccCCCchh
Q 001384          426 TGP----IPPSIGNLTSLLWLMLANNSLSGEIPGEI----G-NCTSLLWLNLSNNKLSGNIPPEV  481 (1088)
Q Consensus       426 ~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l----~-~l~~L~~L~L~~N~l~g~ip~~~  481 (1088)
                      ++.    +++.+..+++|++|+|++|+|+......|    . +.+.|+.|++.+|.+....+..+
T Consensus       382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l  446 (460)
T d1z7xw1         382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  446 (460)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence            742    45556677999999999999985433333    2 34579999999999875444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=4.1e-18  Score=178.30  Aligned_cols=205  Identities=20%  Similarity=0.330  Sum_probs=142.5

Q ss_pred             ceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCC
Q 001384          222 VEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGK  301 (1088)
Q Consensus       222 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  301 (1088)
                      ..++++.+.+++.+.   +..+.+|+.|++.+|+++. ++ .+.++++|++|++++|++++..|  +..+++|+.+++++
T Consensus        22 ~~~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            334444455544332   2334567777777777763 33 46777777777777777775432  67777777777777


Q ss_pred             CcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCC
Q 001384          302 NNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPL  381 (1088)
Q Consensus       302 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  381 (1088)
                      |.++..  ..+..+++|+.+++++|...+..                           .+...+.+..++++++.+... 
T Consensus        95 n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~---------------------------~~~~~~~~~~l~~~~~~~~~~-  144 (227)
T d1h6ua2          95 NPLKNV--SAIAGLQSIKTLDLTSTQITDVT---------------------------PLAGLSNLQVLYLDLNQITNI-  144 (227)
T ss_dssp             CCCSCC--GGGTTCTTCCEEECTTSCCCCCG---------------------------GGTTCTTCCEEECCSSCCCCC-
T ss_pred             cccccc--ccccccccccccccccccccccc---------------------------hhccccchhhhhchhhhhchh-
Confidence            776643  34667777777777777665432                           223456777888888887643 


Q ss_pred             CccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCC
Q 001384          382 PVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCT  461 (1088)
Q Consensus       382 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  461 (1088)
                       ..+..+++|+.|++++|.+++. + .++++++|++|+|++|++++ +| .++++++|++|+|++|++++ +| .+.+++
T Consensus       145 -~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~  217 (227)
T d1h6ua2         145 -SPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTS  217 (227)
T ss_dssp             -GGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCT
T ss_pred             -hhhccccccccccccccccccc-h-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCC
Confidence             3466778889999999888743 2 37888999999999999884 44 37888999999999999984 54 388899


Q ss_pred             CCCeEEccC
Q 001384          462 SLLWLNLSN  470 (1088)
Q Consensus       462 ~L~~L~L~~  470 (1088)
                      +|++|++++
T Consensus       218 ~L~~L~lsn  226 (227)
T d1h6ua2         218 NLFIVTLTN  226 (227)
T ss_dssp             TCCEEEEEE
T ss_pred             CCCEEEeeC
Confidence            999999863

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=3.1e-20  Score=216.68  Aligned_cols=116  Identities=17%  Similarity=0.206  Sum_probs=68.1

Q ss_pred             CCceeecccccccccccCchhhhcccceEEeccCccCCC----CCCccccCCCCCcEEEccCccccccccccCcccceec
Q 001384          150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTG----RIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFS  225 (1088)
Q Consensus       150 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~  225 (1088)
                      +|+.||+++|++++..-..+...+++++.|+|++|+++.    .+..++..+++|++|||++|++++.....+.+     
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~-----   77 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ-----   77 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH-----
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH-----
Confidence            355566666666554434444445566666666665552    23344667788888888888776432221110     


Q ss_pred             ccCcccccccccccccCCCccCEEEcCCCccccc----CcccccCCCCCcEEEccCccccC
Q 001384          226 VSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD----FPGEVSNCRNLVVLNLFGNNFSG  282 (1088)
Q Consensus       226 L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~  282 (1088)
                                  ......++|++|+|++|++++.    ++..+..+++|++|+|++|.++.
T Consensus        78 ------------~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          78 ------------GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             ------------TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             ------------HHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence                        0111224677777777777642    45566777888888888887763

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=9.2e-18  Score=175.55  Aligned_cols=79  Identities=18%  Similarity=0.202  Sum_probs=58.7

Q ss_pred             eeEEeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccc
Q 001384           80 RVNGLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVN  159 (1088)
Q Consensus        80 ~v~~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N  159 (1088)
                      .++.+++..+++++.+  .++.+.+|++|++++|+|+. + +.+..+++|++|+|++|.+++..++..+++|++|++++|
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n   95 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGN   95 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSC
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccccccccccccccccccc
Confidence            3445666666666653  45677888888888888874 4 357888888888888888887777788888888888777


Q ss_pred             ccc
Q 001384          160 RIH  162 (1088)
Q Consensus       160 ~l~  162 (1088)
                      .++
T Consensus        96 ~~~   98 (227)
T d1h6ua2          96 PLK   98 (227)
T ss_dssp             CCS
T ss_pred             ccc
Confidence            765

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=2.5e-17  Score=174.11  Aligned_cols=200  Identities=17%  Similarity=0.123  Sum_probs=106.2

Q ss_pred             CCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccC-cccccCCCCCcEEEcCC-CcCCCchhHhhhcccccceee
Q 001384          269 NLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVI-PESLLNLSKLEVLDLSS-NNFGGEVQKIFGRFTQVKILA  346 (1088)
Q Consensus       269 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  346 (1088)
                      ++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|..++++++|.+.. |.+....+..|..+++|+.++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            4444455444444322233444444555555444444322 22344444444444432 344444444444444444444


Q ss_pred             cCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCc-CcceeeccccccCCcCCcccCCCCCCcEE-EccCCc
Q 001384          347 LHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMR-SLKFLILAHNRFNGSIPAVYGNMPNLQTL-DLSFNE  424 (1088)
Q Consensus       347 L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~L~~N~  424 (1088)
                      +++|.+........+..+..+..+..+++.+....+..+..++ .++.|++++|+++ .++....+.++++.+ ++++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccc
Confidence            4444433222223333455566666666666644445555543 6777888888887 444444444554444 466777


Q ss_pred             CCCCCCc-cccCCCCCcEEEccccccccCCCccccCCCCCCeEEccC
Q 001384          425 LTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWLNLSN  470 (1088)
Q Consensus       425 l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  470 (1088)
                      ++ .+|. .+.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus       189 l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         189 LE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            77 4444 467788888888888888743344566666666665543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=4.2e-17  Score=172.41  Aligned_cols=199  Identities=15%  Similarity=0.076  Sum_probs=123.2

Q ss_pred             ccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcc---cCCCCCCCceeecccccccccccCchhhhcccceEE
Q 001384          103 TQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDL---NLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVA  179 (1088)
Q Consensus       103 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~---~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L  179 (1088)
                      +++++|||++|.|+...+..|.++++|++|+|++|.+....   .+.+++.+++|++..                     
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~---------------------   87 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK---------------------   87 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC---------------------
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc---------------------
Confidence            46788888888887544456788888888888888765422   345556666655543                     


Q ss_pred             eccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCccccc
Q 001384          180 NLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGD  259 (1088)
Q Consensus       180 ~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  259 (1088)
                         .|++....+..|.++++|++|++++|++....                     ....+..+..+..+..+++.+...
T Consensus        88 ---~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~---------------------~~~~~~~l~~l~~~~~~n~~l~~i  143 (242)
T d1xwdc1          88 ---ANNLLYINPEAFQNLPNLQYLLISNTGIKHLP---------------------DVHKIHSLQKVLLDIQDNINIHTI  143 (242)
T ss_dssp             ---CTTCCEECTTSEECCTTCCEEEEESCCCCSCC---------------------CCTTTCBSSCEEEEEESCTTCCEE
T ss_pred             ---cccccccccccccccccccccccchhhhcccc---------------------cccccccccccccccccccccccc
Confidence               23444455566777778888888777765311                     111122333455555555555554


Q ss_pred             CcccccCCC-CCcEEEccCccccCCCccccCCCCCCCEE-eCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhh
Q 001384          260 FPGEVSNCR-NLVVLNLFGNNFSGPIPAEIGSISGLEAL-FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFG  337 (1088)
Q Consensus       260 ~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  337 (1088)
                      .+..+..++ .++.|++++|+++. ++.......+++.+ ++++|+++...+..|.++++|++|+|++|+|+..++..|.
T Consensus       144 ~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         144 ERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             CTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             cccccccccccceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence            455555553 67777777777773 44444444554444 4566677665555677788888888888888766666666


Q ss_pred             cccccceeec
Q 001384          338 RFTQVKILAL  347 (1088)
Q Consensus       338 ~l~~L~~L~L  347 (1088)
                      ++++|+.+++
T Consensus       223 ~l~~L~~l~~  232 (242)
T d1xwdc1         223 NLKKLRARST  232 (242)
T ss_dssp             TCCEEESSSE
T ss_pred             CCcccccCcC
Confidence            6665555544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=1e-16  Score=165.03  Aligned_cols=78  Identities=24%  Similarity=0.339  Sum_probs=34.9

Q ss_pred             ccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          245 SLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       245 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      +|++|++++|.+++. + .+..+++|++|+|++|++++. + .++.+++|+.|++++|++++. | .+.++++|+.|+++
T Consensus        47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECT
T ss_pred             CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccccc-c-cccccccccccccc
Confidence            455555555554422 1 244455555555555555432 1 234444444444444444432 1 24444444444444


Q ss_pred             CCcC
Q 001384          325 SNNF  328 (1088)
Q Consensus       325 ~N~l  328 (1088)
                      +|.+
T Consensus       121 ~~~~  124 (210)
T d1h6ta2         121 HNGI  124 (210)
T ss_dssp             TSCC
T ss_pred             cccc
Confidence            4433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=8e-17  Score=165.82  Aligned_cols=180  Identities=21%  Similarity=0.259  Sum_probs=97.1

Q ss_pred             eccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccc
Q 001384           84 LNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHG  163 (1088)
Q Consensus        84 L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~  163 (1088)
                      .++....+++.++.  ..+..|++|++++|.+++. + .+..+++|++|+|++|+|++..+++++++|++|++++|++++
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~  104 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD  104 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCccccccCccccccccccccccc
Confidence            34444444444332  3455666666666666632 2 356666666666666666655555556666666666665542


Q ss_pred             cccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCC
Q 001384          164 EISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKEN  243 (1088)
Q Consensus       164 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l  243 (1088)
                                               . + .+.++++|+.|++++|.+..                        ...+..+
T Consensus       105 -------------------------l-~-~l~~l~~L~~L~l~~~~~~~------------------------~~~l~~l  133 (210)
T d1h6ta2         105 -------------------------L-S-SLKDLKKLKSLSLEHNGISD------------------------INGLVHL  133 (210)
T ss_dssp             -------------------------G-G-GGTTCTTCCEEECTTSCCCC------------------------CGGGGGC
T ss_pred             -------------------------c-c-cccccccccccccccccccc------------------------ccccccc
Confidence                                     1 1 24555666666666655431                        0112333


Q ss_pred             CccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEc
Q 001384          244 CSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDL  323 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  323 (1088)
                      ++++.+++++|.+++  +..+..+++|+++++++|++++. + .++++++|++|+|++|+++. +| .+.++++|++|+|
T Consensus       134 ~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L  207 (210)
T d1h6ta2         134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL  207 (210)
T ss_dssp             TTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEE
T ss_pred             ccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEc
Confidence            445555555555442  22344556666666666666532 2 25566666666666666654 23 4666666666665


Q ss_pred             C
Q 001384          324 S  324 (1088)
Q Consensus       324 ~  324 (1088)
                      +
T Consensus       208 s  208 (210)
T d1h6ta2         208 F  208 (210)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=3.5e-16  Score=159.51  Aligned_cols=178  Identities=22%  Similarity=0.313  Sum_probs=112.5

Q ss_pred             EEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCc
Q 001384          248 IFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNN  327 (1088)
Q Consensus       248 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  327 (1088)
                      .+.++.+.+++.++  ...++++++|++++|.++. + +.+..+++|++|++++|++++..|  ++++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34556666554332  2345677777777777763 2 235666777777777777665422  6666677777777666


Q ss_pred             CCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCc
Q 001384          328 FGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPA  407 (1088)
Q Consensus       328 l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  407 (1088)
                      +....                           .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++. .++ 
T Consensus        96 ~~~~~---------------------------~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-  144 (199)
T d2omxa2          96 IADIT---------------------------PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-  144 (199)
T ss_dssp             CCCCG---------------------------GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-
T ss_pred             ccccc---------------------------ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-
Confidence            55322                           234556667777777766532  24666777777777777776 333 


Q ss_pred             ccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEccccccccCCCccccCCCCCCeE
Q 001384          408 VYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSGEIPGEIGNCTSLLWL  466 (1088)
Q Consensus       408 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  466 (1088)
                      .+..+++|+.|++++|++++ ++ .++++++|++|++++|++++ +| .++.+++|++|
T Consensus       145 ~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         145 ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            46677777777777777774 33 36777777777777777763 44 46677777765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.66  E-value=5.7e-17  Score=164.44  Aligned_cols=154  Identities=18%  Similarity=0.183  Sum_probs=89.7

Q ss_pred             CCCEEeCCCCcCCccC-cccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEE
Q 001384          293 GLEALFLGKNNFLSVI-PESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLD  371 (1088)
Q Consensus       293 ~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  371 (1088)
                      ++++|+|++|+|++.+ +..|.++++|++|+|++|.+...++..|                         ..+++|++|+
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~-------------------------~~~~~L~~L~   84 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF-------------------------EGASHIQELQ   84 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT-------------------------TTCTTCCEEE
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc-------------------------ccccccceee
Confidence            4444444444444322 3334455555555555555544433332                         2344555555


Q ss_pred             ccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcccccccc
Q 001384          372 LSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANNSLSG  451 (1088)
Q Consensus       372 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  451 (1088)
                      |++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+... +....-...++.+.+..|.++.
T Consensus        85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c  163 (192)
T d1w8aa_          85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARC  163 (192)
T ss_dssp             CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBB
T ss_pred             eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEe
Confidence            556666555555666777777777777777766666777777777777777777642 2211112335566677777776


Q ss_pred             CCCccccCCCCCCeEEccCCcCcc
Q 001384          452 EIPGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       452 ~~p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      ..|..   +..++.++|+.|.|+.
T Consensus       164 ~~p~~---l~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         164 GAPSK---VRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             CSSTT---TTTSBGGGSCTTTCCC
T ss_pred             CCChh---hcCCEeeecCHhhCcC
Confidence            66654   4556677888888874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.66  E-value=5.1e-16  Score=158.25  Aligned_cols=183  Identities=23%  Similarity=0.355  Sum_probs=145.6

Q ss_pred             CcccceecccCcccccccccccccCCCccCEEEcCCCcccccCcccccCCCCCcEEEccCccccCCCccccCCCCCCCEE
Q 001384          218 LAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEAL  297 (1088)
Q Consensus       218 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  297 (1088)
                      +.+...+.++.+.+++.+...   .+.++++|++++|.++. + +.+..+++|++|++++|++++..|  ++++++|++|
T Consensus        17 l~~~i~~~l~~~~~~~~~~~~---~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEECHH---HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHhCCCCCCCccCHH---HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            445556678888888765443   45689999999999884 3 357889999999999999996433  8999999999


Q ss_pred             eCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCcc
Q 001384          298 FLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNF  377 (1088)
Q Consensus       298 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l  377 (1088)
                      ++++|.+... + .+.++++|+.|++++|.+....                           .+..+++|+.|++++|++
T Consensus        90 ~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~~---------------------------~~~~l~~L~~L~l~~n~l  140 (199)
T d2omxa2          90 LMNNNQIADI-T-PLANLTNLTGLTLFNNQITDID---------------------------PLKNLTNLNRLELSSNTI  140 (199)
T ss_dssp             ECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCCG---------------------------GGTTCTTCSEEECCSSCC
T ss_pred             cccccccccc-c-cccccccccccccccccccccc---------------------------ccchhhhhHHhhhhhhhh
Confidence            9999998764 3 5889999999999999886532                           133567888888888888


Q ss_pred             CCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEE
Q 001384          378 TGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWL  442 (1088)
Q Consensus       378 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  442 (1088)
                      .. ++ .+..+++|+.|++++|++++ ++ .++++++|++|++++|++++ ++ .++++++|++|
T Consensus       141 ~~-~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         141 SD-IS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CC-CG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cc-cc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            73 33 57888899999999999984 43 37889999999999999984 54 57888888876

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.64  E-value=2.9e-16  Score=159.12  Aligned_cols=172  Identities=20%  Similarity=0.246  Sum_probs=83.3

Q ss_pred             CEEEcCCCcccccCcccccCCCCCcEEEccCccccCCC-ccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCC
Q 001384          247 EIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNNFSGPI-PAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSS  325 (1088)
Q Consensus       247 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  325 (1088)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++.+ +..|..+++|+.|+|++|++....+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            44555555555 4454442  45666666666665422 34455566666666666666666666666666666666666


Q ss_pred             CcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcC
Q 001384          326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSI  405 (1088)
Q Consensus       326 N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  405 (1088)
                      |+|+...+..|.++++|+.|+|++|.+ ..+.+..|..+++|++|+|++|.+....+.. .-...++.+.+..|.++...
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l-~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCC-CEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred             ccccccCHHHHhCCCcccccccCCccc-cccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence            666555444444333333333333331 1222233334455555555555554322111 11123444445555554444


Q ss_pred             CcccCCCCCCcEEEccCCcCC
Q 001384          406 PAVYGNMPNLQTLDLSFNELT  426 (1088)
Q Consensus       406 p~~~~~l~~L~~L~L~~N~l~  426 (1088)
                      |..   +..++.++|+.|.+.
T Consensus       166 p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         166 PSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             STT---TTTSBGGGSCTTTCC
T ss_pred             Chh---hcCCEeeecCHhhCc
Confidence            432   233444455555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=5.4e-16  Score=167.54  Aligned_cols=211  Identities=22%  Similarity=0.247  Sum_probs=114.4

Q ss_pred             CccCEEEcCCCccccc-CcccccCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCC-cCCcc-CcccccCCCCCcE
Q 001384          244 CSLEIFDLSENEFIGD-FPGEVSNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKN-NFLSV-IPESLLNLSKLEV  320 (1088)
Q Consensus       244 ~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~  320 (1088)
                      .+|++|||++|.++.. ++..+.++++|++|+|++|.+++..+..++.+++|++|+|+++ .++.. +...+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            3566666666665532 3344556666666666666666555556666666666666664 33321 1112234566666


Q ss_pred             EEcCCC-cCCCch-hHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCC--ccCCC-CCccccCCcCcceee
Q 001384          321 LDLSSN-NFGGEV-QKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHN--NFTGP-LPVEISQMRSLKFLI  395 (1088)
Q Consensus       321 L~L~~N-~l~~~~-~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N--~l~~~-~p~~l~~l~~L~~L~  395 (1088)
                      |++++| .++... ...+..                        ..++|+.|+++++  .+++. +...+.++++|++|+
T Consensus       126 L~ls~c~~~~~~~~~~~~~~------------------------~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~  181 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAH------------------------VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD  181 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHH------------------------SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred             cccccccccccccchhhhcc------------------------cccccchhhhcccccccccccccccccccccccccc
Confidence            666664 233211 112221                        1245666666543  23221 112234566777777


Q ss_pred             cccc-ccCCcCCcccCCCCCCcEEEccCC-cCCCCCCccccCCCCCcEEEccccccc-cCCCccccCCCCCCeEEccCCc
Q 001384          396 LAHN-RFNGSIPAVYGNMPNLQTLDLSFN-ELTGPIPPSIGNLTSLLWLMLANNSLS-GEIPGEIGNCTSLLWLNLSNNK  472 (1088)
Q Consensus       396 L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~  472 (1088)
                      +++| .+++..+..+.++++|++|+|++| .+++.....++++++|++|+++++ ++ +.++.....+++|   .+..++
T Consensus       182 L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~  257 (284)
T d2astb2         182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSH  257 (284)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCC
T ss_pred             cccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCcc
Confidence            7765 466556666777777777777774 566555556677777777777776 32 1222222334443   456677


Q ss_pred             CccCCCchhh
Q 001384          473 LSGNIPPEVM  482 (1088)
Q Consensus       473 l~g~ip~~~~  482 (1088)
                      +++..++.++
T Consensus       258 ls~~~~~~~~  267 (284)
T d2astb2         258 FTTIARPTIG  267 (284)
T ss_dssp             SCCTTCSSCS
T ss_pred             CCCCCCCccC
Confidence            7755555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1.5e-15  Score=163.86  Aligned_cols=177  Identities=21%  Similarity=0.199  Sum_probs=90.7

Q ss_pred             CCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCCcEEEccCc-ccccc----ccccCccccee
Q 001384          150 SLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNLRYLDLSSN-NFRGN----IWNGLAQLVEF  224 (1088)
Q Consensus       150 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~----~~~~l~~L~~L  224 (1088)
                      +|++|||++|.+++.....+...|++|++|+|++|++++..+..++.+++|++|+++++ .+++.    +...+++|++|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence            44444444444443333333344444555555555544444445556666666666663 45432    12344555555


Q ss_pred             cccCc-cccccccc-ccccCCCccCEEEcCCCc--ccc-cCcccccCCCCCcEEEccCc-cccCCCccccCCCCCCCEEe
Q 001384          225 SVSEN-VLSGVVSS-SVFKENCSLEIFDLSENE--FIG-DFPGEVSNCRNLVVLNLFGN-NFSGPIPAEIGSISGLEALF  298 (1088)
Q Consensus       225 ~L~~n-~l~~~~~~-~~~~~l~~L~~L~Ls~n~--l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~  298 (1088)
                      +++++ .+++.... ......++|+.|+++++.  ++. .+...+.++++|++|++++| .+++.....+..+++|++|+
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~  206 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  206 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence            55553 23222111 112223466667666542  222 12223345667777777664 35555556666666777777


Q ss_pred             CCCC-cCCccCcccccCCCCCcEEEcCCC
Q 001384          299 LGKN-NFLSVIPESLLNLSKLEVLDLSSN  326 (1088)
Q Consensus       299 L~~N-~l~~~~p~~l~~l~~L~~L~L~~N  326 (1088)
                      |++| .++......++++++|+.|+++++
T Consensus       207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         207 LSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            7664 455544455666667777777666

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=4.4e-15  Score=165.53  Aligned_cols=243  Identities=19%  Similarity=0.186  Sum_probs=136.1

Q ss_pred             cccCCCCCcEEEccCccccccccccCcccceecccCcccccccccccccCCCccCEEEcCCCcccc----------cCcc
Q 001384          193 CFDGCLNLRYLDLSSNNFRGNIWNGLAQLVEFSVSENVLSGVVSSSVFKENCSLEIFDLSENEFIG----------DFPG  262 (1088)
Q Consensus       193 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~----------~~p~  262 (1088)
                      .+....+|+.|+|++|.+....+..+.                  ..+...++|+.|+++++....          .+..
T Consensus        26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~------------------~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~   87 (344)
T d2ca6a1          26 VLLEDDSVKEIVLSGNTIGTEAARWLS------------------ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ   87 (344)
T ss_dssp             HHHHCSCCCEEECTTSEECHHHHHHHH------------------HTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHH
T ss_pred             HHhhCCCCCEEECcCCcCCHHHHHHHH------------------HHHHhCCCCCEEECCCCcccccccccchHHHHHHH
Confidence            355566677777777766543222111                  122333455555555443221          1123


Q ss_pred             cccCCCCCcEEEccCccccCC----CccccCCCCCCCEEeCCCCcCCccCcc-------------cccCCCCCcEEEcCC
Q 001384          263 EVSNCRNLVVLNLFGNNFSGP----IPAEIGSISGLEALFLGKNNFLSVIPE-------------SLLNLSKLEVLDLSS  325 (1088)
Q Consensus       263 ~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------~l~~l~~L~~L~L~~  325 (1088)
                      .+..+++|++|+|++|.+...    +...+...++|++|++++|.+......             .....+.|+.|++++
T Consensus        88 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~  167 (344)
T d2ca6a1          88 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR  167 (344)
T ss_dssp             HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred             HHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccc
Confidence            344556666666666666543    222333455666666666654321000             112345666777777


Q ss_pred             CcCCCchhHhhhcccccceeecCcCcccCCCCCccccCCCCcCEEEccCCccCCC-----CCccccCCcCcceeeccccc
Q 001384          326 NNFGGEVQKIFGRFTQVKILALHSNSYIDGMNSSGILKLPNISRLDLSHNNFTGP-----LPVEISQMRSLKFLILAHNR  400 (1088)
Q Consensus       326 N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~L~~N~  400 (1088)
                      |.++......+.                     ..+...+.|+.|+|++|.++..     +...+...++|+.|+|++|.
T Consensus       168 n~i~~~~~~~l~---------------------~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~  226 (344)
T d2ca6a1         168 NRLENGSMKEWA---------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT  226 (344)
T ss_dssp             SCCTGGGHHHHH---------------------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred             cccccccccccc---------------------chhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccc
Confidence            666543332221                     1122345667777777766531     22335566778888888887


Q ss_pred             cCCc----CCcccCCCCCCcEEEccCCcCCCCCCc----cccC--CCCCcEEEccccccccC----CCccc-cCCCCCCe
Q 001384          401 FNGS----IPAVYGNMPNLQTLDLSFNELTGPIPP----SIGN--LTSLLWLMLANNSLSGE----IPGEI-GNCTSLLW  465 (1088)
Q Consensus       401 l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~--l~~L~~L~L~~N~l~~~----~p~~l-~~l~~L~~  465 (1088)
                      ++..    +...+..+++|++|+|++|.|++.-..    .+..  .+.|++|++++|+++..    +...+ .++++|+.
T Consensus       227 i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~  306 (344)
T d2ca6a1         227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF  306 (344)
T ss_dssp             CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred             ccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCE
Confidence            7532    344566778888888888888753222    2222  35789999999988743    23334 25788999


Q ss_pred             EEccCCcCc
Q 001384          466 LNLSNNKLS  474 (1088)
Q Consensus       466 L~L~~N~l~  474 (1088)
                      |+|++|++.
T Consensus       307 L~l~~N~~~  315 (344)
T d2ca6a1         307 LELNGNRFS  315 (344)
T ss_dssp             EECTTSBSC
T ss_pred             EECCCCcCC
Confidence            999999986

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.43  E-value=1.5e-14  Score=161.01  Aligned_cols=186  Identities=17%  Similarity=0.104  Sum_probs=102.2

Q ss_pred             cccccCCccCCeeeCCCCCCCCC----cCccCCCCCCCcEEECccccccCcc------------cCCCCCCCceeecccc
Q 001384           96 FNNFSALTQLSYLDLSRNTFSGS----IPDDLSSCRSLKYLNLSHNILSGDL------------NLSGLRSLEILDLSVN  159 (1088)
Q Consensus        96 ~~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~------------~l~~l~~L~~L~Ls~N  159 (1088)
                      ...+...+.|+.|+|++|.|+..    +...+...++|+.|+++++......            .+..+++|++|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34566778888888888887642    3445677788888888876543211            2456778888888888


Q ss_pred             cccccccCchhh---hcccceEEeccCccCCCCCCcc-------------ccCCCCCcEEEccCcccccccc-------c
Q 001384          160 RIHGEISFSFPA---ICEKLVVANLSLNNLTGRIDTC-------------FDGCLNLRYLDLSSNNFRGNIW-------N  216 (1088)
Q Consensus       160 ~l~~~~~~~~~~---~~~~L~~L~L~~n~l~~~~~~~-------------l~~l~~L~~L~Ls~N~l~~~~~-------~  216 (1088)
                      .++......+..   .+++|++|++++|+++......             ....+.|+.|++++|+++....       .
T Consensus       104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~  183 (344)
T d2ca6a1         104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  183 (344)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence            877654443332   2456777777777664211111             1234567777777776654221       2


Q ss_pred             cCcccceecccCcccccc----cccccccCCCccCEEEcCCCccccc----CcccccCCCCCcEEEccCcccc
Q 001384          217 GLAQLVEFSVSENVLSGV----VSSSVFKENCSLEIFDLSENEFIGD----FPGEVSNCRNLVVLNLFGNNFS  281 (1088)
Q Consensus       217 ~l~~L~~L~L~~n~l~~~----~~~~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~  281 (1088)
                      ....|++|++++|.++..    .....+...++|+.|+|++|.++..    +...+..+++|++|+|++|.|+
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence            234455555555544421    1112233444455555555544321    2233444455555555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.43  E-value=1.9e-13  Score=126.52  Aligned_cols=103  Identities=31%  Similarity=0.455  Sum_probs=88.6

Q ss_pred             CEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEEcccc
Q 001384          368 SRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLMLANN  447 (1088)
Q Consensus       368 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  447 (1088)
                      +.|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..++.+++|++|++++|+|+ .+| .++++++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            47899999998 555 4889999999999999998 67888999999999999999999 455 5899999999999999


Q ss_pred             ccccCC-CccccCCCCCCeEEccCCcCcc
Q 001384          448 SLSGEI-PGEIGNCTSLLWLNLSNNKLSG  475 (1088)
Q Consensus       448 ~l~~~~-p~~l~~l~~L~~L~L~~N~l~g  475 (1088)
                      +++... +..++.+++|++|++++|++++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            998432 2568899999999999999973

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.2e-13  Score=134.73  Aligned_cols=111  Identities=17%  Similarity=0.183  Sum_probs=50.4

Q ss_pred             cCCCCCcEEEccCccccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcCCCcCCCchhHhhhcccccce
Q 001384          265 SNCRNLVVLNLFGNNFSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLSSNNFGGEVQKIFGRFTQVKI  344 (1088)
Q Consensus       265 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  344 (1088)
                      .++.+|++|+|++|+|+ .++..+..+++|+.|+|++|.++..  +.+..+++|++|++++|+++...+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            34445555555555555 3344344455555555555555443  23455555555555555555444443433333333


Q ss_pred             eecCcCcccCCCCCccccCCCCcCEEEccCCccC
Q 001384          345 LALHSNSYIDGMNSSGILKLPNISRLDLSHNNFT  378 (1088)
Q Consensus       345 L~L~~n~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  378 (1088)
                      |++++|.+.+......+..+++|++|++++|.++
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ceeccccccccccccccccccccchhhcCCCccc
Confidence            3333332211111122334455555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=3.1e-13  Score=131.74  Aligned_cols=114  Identities=20%  Similarity=0.161  Sum_probs=95.9

Q ss_pred             ccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccc
Q 001384           97 NNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKL  176 (1088)
Q Consensus        97 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L  176 (1088)
                      +.+.+...+++|||++|+|+ .++..+..+++|++|+|++|.|+....+..+++|++|+|++|+++. ++..+...+++|
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l~~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L   89 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDL   89 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEECCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTC
T ss_pred             HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCccCCcccCcchhhhhcccccccC-CCcccccccccc
Confidence            44677889999999999998 5677778899999999999999987789999999999999999985 444555667899


Q ss_pred             eEEeccCccCCCCCC-ccccCCCCCcEEEccCccccc
Q 001384          177 VVANLSLNNLTGRID-TCFDGCLNLRYLDLSSNNFRG  212 (1088)
Q Consensus       177 ~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~  212 (1088)
                      ++|+|++|+++.... ..+..+++|++|++++|.++.
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCcccc
Confidence            999999999987643 567888999999999988763

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.37  E-value=7.5e-13  Score=122.49  Aligned_cols=101  Identities=29%  Similarity=0.361  Sum_probs=71.9

Q ss_pred             EeccccccccccccccccCCccCCeeeCCCCCCCCCcCccCCCCCCCcEEECccccccCcccCCCCCCCceeeccccccc
Q 001384           83 GLNLTDWNISGDIFNNFSALTQLSYLDLSRNTFSGSIPDDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIH  162 (1088)
Q Consensus        83 ~L~L~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~  162 (1088)
                      .|+|++|+|+..  +.+..+++|++|||++|.|+ .+|..++.+++|++|++++|.|++...+..+++|++|++++|+|+
T Consensus         2 ~L~Ls~n~l~~l--~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3           2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             EEECTTSCCSSC--CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCCC
T ss_pred             EEEcCCCCCCCC--cccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccCccccccccCeEECCCCccC
Confidence            378888888743  35888888888888888887 677788888888888888888888777888888888888888877


Q ss_pred             ccccCchhhhcccceEEeccCccC
Q 001384          163 GEISFSFPAICEKLVVANLSLNNL  186 (1088)
Q Consensus       163 ~~~~~~~~~~~~~L~~L~L~~n~l  186 (1088)
                      +.........+++|++|++++|++
T Consensus        79 ~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          79 QSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             CCCCchhhcCCCCCCEEECCCCcC
Confidence            433222222233444444444443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.21  E-value=2.4e-13  Score=137.41  Aligned_cols=87  Identities=30%  Similarity=0.366  Sum_probs=48.6

Q ss_pred             ccCCCCCCCcEEECccccccCcccCCCCCCCceeecccccccccccCchhhhcccceEEeccCccCCCCCCccccCCCCC
Q 001384          121 DDLSSCRSLKYLNLSHNILSGDLNLSGLRSLEILDLSVNRIHGEISFSFPAICEKLVVANLSLNNLTGRIDTCFDGCLNL  200 (1088)
Q Consensus       121 ~~l~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L  200 (1088)
                      ..++.+++|++|+|++|.|+....+.++++|++|+|++|.|+.. + .+...+++|++|++++|+++..  ..+..+++|
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~~i-~-~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKI-E-NLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEECSC-S-SHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             hHHhcccccceeECcccCCCCcccccCCccccChhhcccccccc-c-cccccccccccccccccccccc--ccccccccc
Confidence            34445555555555555555444455555555556655655422 2 2223334566666666666653  235667777


Q ss_pred             cEEEccCcccc
Q 001384          201 RYLDLSSNNFR  211 (1088)
Q Consensus       201 ~~L~Ls~N~l~  211 (1088)
                      ++|++++|+++
T Consensus       118 ~~L~L~~N~i~  128 (198)
T d1m9la_         118 RVLYMSNNKIT  128 (198)
T ss_dssp             SEEEESEEECC
T ss_pred             cccccccchhc
Confidence            77777777765

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.15  E-value=6.9e-13  Score=133.96  Aligned_cols=85  Identities=24%  Similarity=0.252  Sum_probs=43.3

Q ss_pred             CCCCcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCCCC--ccccCCCCCc
Q 001384          363 KLPNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGPIP--PSIGNLTSLL  440 (1088)
Q Consensus       363 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~  440 (1088)
                      .+++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. ++ .+..+++|+.|++++|+++. ++  ..+..+++|+
T Consensus        68 ~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~  143 (198)
T d1m9la_          68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLE  143 (198)
T ss_dssp             HHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCS
T ss_pred             CCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhcc-ccccccccCCCccc
Confidence            4445555555555555 344333444455555555555552 22 24455555555555555552 22  2345555555


Q ss_pred             EEEcccccccc
Q 001384          441 WLMLANNSLSG  451 (1088)
Q Consensus       441 ~L~L~~N~l~~  451 (1088)
                      +|+|++|.+..
T Consensus       144 ~L~L~~N~l~~  154 (198)
T d1m9la_         144 DLLLAGNPLYN  154 (198)
T ss_dssp             EEEECSSHHHH
T ss_pred             eeecCCCcccc
Confidence            55555555543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=6.8e-11  Score=113.94  Aligned_cols=108  Identities=19%  Similarity=0.094  Sum_probs=93.0

Q ss_pred             CCcCEEEccCCccCCCCCccccCCcCcceeecccc-ccCCcCCcccCCCCCCcEEEccCCcCCCCCCccccCCCCCcEEE
Q 001384          365 PNISRLDLSHNNFTGPLPVEISQMRSLKFLILAHN-RFNGSIPAVYGNMPNLQTLDLSFNELTGPIPPSIGNLTSLLWLM  443 (1088)
Q Consensus       365 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  443 (1088)
                      ...+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34567889999888 67888999999999999866 58866667899999999999999999977788899999999999


Q ss_pred             ccccccccCCCccccCCCCCCeEEccCCcCc
Q 001384          444 LANNSLSGEIPGEIGNCTSLLWLNLSNNKLS  474 (1088)
Q Consensus       444 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  474 (1088)
                      |++|+|+ .+|.......+|+.|+|++|++.
T Consensus        87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCc-ccChhhhccccccccccCCCccc
Confidence            9999999 66666555568999999999996

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.12  E-value=4e-11  Score=115.63  Aligned_cols=91  Identities=16%  Similarity=0.152  Sum_probs=62.1

Q ss_pred             cCEEEcCCCcccccCcccccCCCCCcEEEccCcc-ccCCCccccCCCCCCCEEeCCCCcCCccCcccccCCCCCcEEEcC
Q 001384          246 LEIFDLSENEFIGDFPGEVSNCRNLVVLNLFGNN-FSGPIPAEIGSISGLEALFLGKNNFLSVIPESLLNLSKLEVLDLS  324 (1088)
Q Consensus       246 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  324 (1088)
                      .+.++.++++++ ..|..+..+++|++|++++|+ |+...+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            345666666665 456667777777777776553 665555667777777777777777777767777777777777777


Q ss_pred             CCcCCCchhHhhh
Q 001384          325 SNNFGGEVQKIFG  337 (1088)
Q Consensus       325 ~N~l~~~~~~~~~  337 (1088)
                      +|+|+...+..|.
T Consensus        89 ~N~l~~l~~~~~~  101 (156)
T d2ifga3          89 FNALESLSWKTVQ  101 (156)
T ss_dssp             SSCCSCCCSTTTC
T ss_pred             CCCCcccChhhhc
Confidence            7777755555443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=9.9e-07  Score=92.40  Aligned_cols=151  Identities=13%  Similarity=0.054  Sum_probs=102.4

Q ss_pred             HHHHHHcCCCCccceecccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecC
Q 001384          798 SDILKATGKFSEDRIIGKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDG  877 (1088)
Q Consensus       798 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~  877 (1088)
                      .++.+.-+.|+..+..+-++.+.||+... +++.+++|+...........+.+|...+..+...+.   +.+++++..++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vp---vP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLP---VPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSC---CCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCC---CCcEEEEEecC
Confidence            45566667887776655555678999875 466778888876544444456777777664432233   34566777778


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 001384          878 SEKILVYEYMEGGSLEDIISDRTRLTWRRRLDIAIDVARALVFLHHEC--------------------------------  925 (1088)
Q Consensus       878 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------  925 (1088)
                      +..++||++++|.++.+....     ......++.++++.++.||+..                                
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             CceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            889999999999888665422     1123335566666666666420                                


Q ss_pred             ------------------------CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          926 ------------------------YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       926 ------------------------~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                                              .+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    12379999999999998776667999998754

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=3.3e-08  Score=95.37  Aligned_cols=82  Identities=29%  Similarity=0.267  Sum_probs=42.2

Q ss_pred             ccCCcCcceeeccccccCCc--CCcccCCCCCCcEEEccCCcCCCCCCc-cccCCCCCcEEEccccccccCCCcc-----
Q 001384          385 ISQMRSLKFLILAHNRFNGS--IPAVYGNMPNLQTLDLSFNELTGPIPP-SIGNLTSLLWLMLANNSLSGEIPGE-----  456 (1088)
Q Consensus       385 l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~-----  456 (1088)
                      ...+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++. +++ ...+..+|+.|++++|.++......     
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~  139 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS  139 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence            34455666666666666532  12334455666666666666662 332 2223345666666666665433221     


Q ss_pred             --ccCCCCCCeEE
Q 001384          457 --IGNCTSLLWLN  467 (1088)
Q Consensus       457 --l~~l~~L~~L~  467 (1088)
                        +..+++|+.||
T Consensus       140 ~i~~~~P~L~~LD  152 (162)
T d1koha1         140 AIRERFPKLLRLD  152 (162)
T ss_dssp             HHHTTSTTCCEET
T ss_pred             HHHHHCCCCCEEC
Confidence              34566666553

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.02  E-value=1.5e-07  Score=90.67  Aligned_cols=108  Identities=21%  Similarity=0.152  Sum_probs=76.5

Q ss_pred             CcCEEEccCCccCCCCCccccCCcCcceeeccccccCCcCCcccCCCCCCcEEEccCCcCCCC--CCccccCCCCCcEEE
Q 001384          366 NISRLDLSHNNFTGPLPVEISQMRSLKFLILAHNRFNGSIPAVYGNMPNLQTLDLSFNELTGP--IPPSIGNLTSLLWLM  443 (1088)
Q Consensus       366 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~  443 (1088)
                      ..+.|+++++...    ..+..+..+..++..++... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            3455666655432    23444555566666666555 5555566789999999999999953  234567899999999


Q ss_pred             ccccccccCCCc-cccCCCCCCeEEccCCcCccCCCc
Q 001384          444 LANNSLSGEIPG-EIGNCTSLLWLNLSNNKLSGNIPP  479 (1088)
Q Consensus       444 L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~g~ip~  479 (1088)
                      |++|+++. ++. ......+|+.|++++|++++....
T Consensus        98 Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1          98 LSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             CTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             cccCcccc-chhhhhhhccccceeecCCCCcCcCccc
Confidence            99999994 443 344456799999999999865543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.68  E-value=7.9e-06  Score=78.61  Aligned_cols=17  Identities=18%  Similarity=0.282  Sum_probs=7.8

Q ss_pred             CCCCCceeecccccccc
Q 001384          147 GLRSLEILDLSVNRIHG  163 (1088)
Q Consensus       147 ~l~~L~~L~Ls~N~l~~  163 (1088)
                      ..++|++|+|++|.+++
T Consensus        42 ~n~~L~~L~Ls~n~l~~   58 (167)
T d1pgva_          42 NSKHIEKFSLANTAISD   58 (167)
T ss_dssp             TCSCCCEEECTTSCCBH
T ss_pred             hCCccceeeccccccch
Confidence            33444444444444443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.58  E-value=0.00014  Score=74.91  Aligned_cols=133  Identities=18%  Similarity=0.090  Sum_probs=81.4

Q ss_pred             eecccCc-eEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEEEEEecCCC
Q 001384          812 IIGKGGF-GTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKILVYEYMEGG  890 (1088)
Q Consensus       812 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  890 (1088)
                      .+..|.. +.||+....++..+++|.......   ..+..|.+.++.+..  ..--+.+++++..+++..++||||++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~--~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLAT--TGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHT--TTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHh--cCCCCCceeeecccccceEEEEEeeecc
Confidence            3445543 689999988888899998765432   234555555543221  1223556777778888889999999886


Q ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 001384          891 SLEDIISDRTRLTWRRRLDIAIDVARALVFLH------------------------------------------------  922 (1088)
Q Consensus       891 sL~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH------------------------------------------------  922 (1088)
                      ++.+..     ...   ...+.++++.++-||                                                
T Consensus        92 ~~~~~~-----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          92 DLLSSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             ETTTSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cccccc-----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            542200     000   011122222222222                                                


Q ss_pred             ---hcC----CCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          923 ---HEC----YPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       923 ---~~~----~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                         ...    .+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               221    12489999999999999876678999997754

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.44  E-value=5.5e-05  Score=72.46  Aligned_cols=90  Identities=11%  Similarity=0.111  Sum_probs=55.5

Q ss_pred             CCCccCEEEcCCC-cccc----cCcccccCCCCCcEEEccCccccCC----CccccCCCCCCCEEeCCCCcCCcc----C
Q 001384          242 ENCSLEIFDLSEN-EFIG----DFPGEVSNCRNLVVLNLFGNNFSGP----IPAEIGSISGLEALFLGKNNFLSV----I  308 (1088)
Q Consensus       242 ~l~~L~~L~Ls~n-~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~  308 (1088)
                      +.++|++|+|+++ .+..    .+-..+...+.|++|+|++|.+...    +...+...+.|++|+|++|.++..    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            3456777777653 3432    2334456667777888877777632    223344556777778877777643    3


Q ss_pred             cccccCCCCCcEEEcCCCcCCCc
Q 001384          309 PESLLNLSKLEVLDLSSNNFGGE  331 (1088)
Q Consensus       309 p~~l~~l~~L~~L~L~~N~l~~~  331 (1088)
                      ...+...++|++|+|++|.+...
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHHhCCcCCEEECCCCcCCCc
Confidence            34566667788888887765543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.19  E-value=0.00035  Score=76.77  Aligned_cols=78  Identities=17%  Similarity=0.101  Sum_probs=46.3

Q ss_pred             ceecccCceEEEEEEeCC-CcEEEEEEcccc------C-ccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD-GREVAVKKLQRE------G-LEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.||.|....||++...+ ++.++||.....      . .....+...|.+.+..... .-...+.+++.+  ++...++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~-~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGE-HVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHT-TCGGGSCCEEEE--ETTTTEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhh-hCCCCcceEEEE--cCCCCEE
Confidence            568999999999999764 678999965421      0 1112234557766654321 111234555554  4455678


Q ss_pred             EEEecCCCC
Q 001384          883 VYEYMEGGS  891 (1088)
Q Consensus       883 v~e~~~~gs  891 (1088)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.03  E-value=6.1e-05  Score=72.11  Aligned_cols=16  Identities=6%  Similarity=0.009  Sum_probs=7.1

Q ss_pred             CCCCCceeeccccccc
Q 001384          147 GLRSLEILDLSVNRIH  162 (1088)
Q Consensus       147 ~l~~L~~L~Ls~N~l~  162 (1088)
                      ..++|++|+|++|.++
T Consensus        44 ~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCCSCCEEECTTSCCC
T ss_pred             cCCccCeeeccCCccc
Confidence            3444444444444443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.03  E-value=2.1e-05  Score=75.50  Aligned_cols=114  Identities=12%  Similarity=0.096  Sum_probs=69.3

Q ss_pred             ccccCCccCCeeeCCC-CCCCCC----cCccCCCCCCCcEEECccccccCcc------cCCCCCCCceeecccccccccc
Q 001384           97 NNFSALTQLSYLDLSR-NTFSGS----IPDDLSSCRSLKYLNLSHNILSGDL------NLSGLRSLEILDLSVNRIHGEI  165 (1088)
Q Consensus        97 ~~l~~l~~L~~L~Ls~-n~l~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~------~l~~l~~L~~L~Ls~N~l~~~~  165 (1088)
                      ....+.+.|++|+|++ +.++..    +-.++...++|++|+|++|.++...      .+...+.++.|++++|.+++..
T Consensus        11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g   90 (166)
T d1io0a_          11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG   90 (166)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence            3344567888888886 456532    3345567788888888888876422      2455678888888888877655


Q ss_pred             cCchhhhc---ccceEEec--cCccCCC----CCCccccCCCCCcEEEccCccc
Q 001384          166 SFSFPAIC---EKLVVANL--SLNNLTG----RIDTCFDGCLNLRYLDLSSNNF  210 (1088)
Q Consensus       166 ~~~~~~~~---~~L~~L~L--~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~l  210 (1088)
                      ...+...+   ++|+.++|  ++|.+..    .+...+...++|+.|+++.+..
T Consensus        91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            54444332   34554333  3455543    2333455667777777766543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.72  E-value=0.0018  Score=68.92  Aligned_cols=138  Identities=15%  Similarity=0.098  Sum_probs=77.2

Q ss_pred             CceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHHHHhCCCC-CCCCCceeEEe--eEEecCCeEEEEEEecCCCCH-
Q 001384          817 GFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEMEVLSGNGF-GWPHPNLVTLY--GWCLDGSEKILVYEYMEGGSL-  892 (1088)
Q Consensus       817 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-~l~h~niv~l~--~~~~~~~~~~lv~e~~~~gsL-  892 (1088)
                      ..-.||++...+|+.|++|+.+.. ....+++..|.+.+..+.. .+..+..+..-  ..+..+...+.++++++|..+ 
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            346899999999999999998654 2345566777665543221 12222222221  122345677889999976432 


Q ss_pred             ----HHH---------Hhh----c-----CC-------------------CCHHHHHHHHHHHHHHHHHHHhc----CCC
Q 001384          893 ----EDI---------ISD----R-----TR-------------------LTWRRRLDIAIDVARALVFLHHE----CYP  927 (1088)
Q Consensus       893 ----~~~---------l~~----~-----~~-------------------l~~~~~~~i~~qi~~~L~yLH~~----~~~  927 (1088)
                          ..+         ++.    .     ..                   ++......+...+...++.+...    ...
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                110         111    0     01                   11111122222333333343332    224


Q ss_pred             CeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          928 PIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       928 ~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ++||+|+.+.|||++. + ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            7899999999999974 3 46899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.91  E-value=0.027  Score=59.03  Aligned_cols=158  Identities=10%  Similarity=0.038  Sum_probs=82.2

Q ss_pred             cCHHHHHHHcCCCCcccee-----cccCceEEEEEEeCCCcEEEEEEccccCccchHHHHHHHH---HHhCCCCCCCCCc
Q 001384          795 FTYSDILKATGKFSEDRII-----GKGGFGTVYRGVLPDGREVAVKKLQREGLEGEREFRAEME---VLSGNGFGWPHPN  866 (1088)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~L-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~---~l~~~~~~l~h~n  866 (1088)
                      .+.+|+...-.+|.+.+..     ..|---+.|+....+|+ +++|++......  .++..|++   .+....  +..|.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g--~pvp~   77 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKG--LSCPL   77 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTT--CCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhcc--ccccc
Confidence            4567787788888876544     35666788999986654 899988653222  22333333   333322  33343


Q ss_pred             eeEEee---EEecCCeEEEEEEecCCCCHH--------------HHHhhc----C-----C------------------C
Q 001384          867 LVTLYG---WCLDGSEKILVYEYMEGGSLE--------------DIISDR----T-----R------------------L  902 (1088)
Q Consensus       867 iv~l~~---~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~----~-----~------------------l  902 (1088)
                      .+...+   +.........++.+..+....              ..++..    .     .                  .
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            332211   112234556677776654221              011100    0     0                  0


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEEcCCCCEEEeeccccee
Q 001384          903 TWRRRLDIAIDVARALVFLHHE-CYPPIVHRDVKASNVLLDKEGKALVTDFGLARV  957 (1088)
Q Consensus       903 ~~~~~~~i~~qi~~~L~yLH~~-~~~~ivH~DLkp~NIll~~~~~~kl~Dfg~a~~  957 (1088)
                      ........+......+...+.. ...++||+|+.+.||+++.+...-|+||+.+..
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111112222222323322221 124899999999999999887778999998754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.50  E-value=0.015  Score=63.46  Aligned_cols=73  Identities=19%  Similarity=0.144  Sum_probs=46.2

Q ss_pred             ceecccCceEEEEEEeCC--------CcEEEEEEccccCccchHHHHHHHHHHhCCCCCCCCCceeEEeeEEecCCeEEE
Q 001384          811 RIIGKGGFGTVYRGVLPD--------GREVAVKKLQREGLEGEREFRAEMEVLSGNGFGWPHPNLVTLYGWCLDGSEKIL  882 (1088)
Q Consensus       811 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~~l~h~niv~l~~~~~~~~~~~l  882 (1088)
                      +.|+.|-.-.+|++...+        .+.|++++....  ....+..+|..+++.+.   .+.-..++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls---~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLS---ERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHH---HTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHH---hCCCCCeEEEEcCC----ce
Confidence            568888889999998643        345777766532  23344566777766533   23333467776643    67


Q ss_pred             EEEecCCCCH
Q 001384          883 VYEYMEGGSL  892 (1088)
Q Consensus       883 v~e~~~~gsL  892 (1088)
                      |+||++|.++
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987543